<rdf:RDF xmlns:admin="http://webns.net/mvcb/" xmlns="http://purl.org/rss/1.0/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:prism="http://purl.org/rss/1.0/modules/prism/" xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:syn="http://purl.org/rss/1.0/modules/syndication/">
<channel rdf:about="https://biorxiv.org">
<admin:errorReportsTo rdf:resource="mailto:biorxiv@cshlpress.edu"/>
<title>bioRxiv Channel: Albert Einstein College of Medicine</title>
<link>https://biorxiv.org</link>
<description>
This feed contains articles for bioRxiv Channel "Albert Einstein College of Medicine"
</description>

<items>
<rdf:Seq>
</rdf:Seq>
</items>
<prism:eIssn/>
<prism:publicationName>bioRxiv</prism:publicationName>
<prism:issn/>

<image rdf:resource=""/>
</channel>
<image rdf:about="">
<title>bioRxiv</title>
<url/>
<link>https://biorxiv.org</link>
</image>
<item rdf:about="https://biorxiv.org/content/10.1101/004853v1?rss=1">
<title>
<![CDATA[
MOSAIC EPIGENETIC DYSREGULATION OF ECTODERMAL CELLS IN AUTISM SPECTRUM DISORDER 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/004853v1?rss=1</link>
<description><![CDATA[
DNA mutational events are increasingly being identified in autism spectrum disorder (ASD), but the potential additional role of dysregulation of the epigenome in the pathogenesis of the condition remains unclear. The epigenome is of interest as a possible mediator of environmental effects during development, encoding a cellular memory reflected by altered function of progeny cells. Advanced maternal age (AMA) is associated with an increased risk of having a child with ASD for reasons that are not understood. To explore whether AMA involves covert aneuploidy or epigenetic dysregulation leading to ASD in the offspring, we tested an homogeneous ectodermal cell type from 47 individuals with ASD compared with 48 typically developing (TD) controls born to mothers of [&ge;]35 years, using a quantitative genome-wide DNA methylation assay. We show that DNA methylation patterns are dysregulated in ectodermal cells in these individuals, having accounted for confounding effects due to subject age, sex and ancestral haplotype. We did not find mosaic aneuploidy or copy number variability to occur at differentially-methylated regions in these subjects. Of note, the loci with distinctive DNA methylation were found at genes expressed in the brain and encoding protein products significantly enriched for interactions with those produced by known ASD-causing genes, representing a perturbation by epigenomic dysregulation of the same networks compromised by DNA mutational mechanisms. The results indicate the presence of a mosaic subpopulation of epigenetically-dysregulated, ectodermally-derived cells in subjects with ASD. The epigenetic dysregulation observed in these ASD subjects born to older mothers may be associated with aging parental gametes, environmental influences during embryogenesis or could be the consequence of mutations of the chromatin regulatory genes increasingly implicated in ASD. The results indicate that epigenetic dysregulatory mechanisms may complement and interact with DNA mutations in the pathogenesis of the disorder.nnAUTHOR SUMMARYOlder mothers have a higher than expected risk of having a child with an autism spectrum disorder (ASD). The reason for this increased risk is unknown. The eggs of older mothers are more prone to abnormalities of chromosome numbers, suggesting this as one possible mechanism of the increased ASD risk. Age is also associated with a loss of control of epigenetic regulatory patterns that govern gene expression, indicating a second potential mechanism. To test both possibilities, we sampled cells from the same developmental origin as the brain, and performed genome-wide tests looking for unusual chromosome numbers and DNA methylation patterns. The studies were performed on individuals with ASD and typically developing controls, all born to mothers at least 35 years of age at the time of birth. We found the cells from individuals with ASD to have changes in DNA methylation at a number of loci, especially near genes encoding proteins known to interact with those already implicated in ASD. We conclude that epigenetic dysregulation occurring in gametes or early embryonic life may be one of the contributors to the development of ASD.
]]></description>
<dc:creator>Esther R. Berko</dc:creator>
<dc:creator>Masako Suzuki</dc:creator>
<dc:creator>Faygel Beren</dc:creator>
<dc:creator>Christophe Lemetre</dc:creator>
<dc:creator>Christine M. Alaimo</dc:creator>
<dc:creator>R. Brent Calder</dc:creator>
<dc:creator>Karen Ballaban-Gil</dc:creator>
<dc:creator>Batya Gounder</dc:creator>
<dc:creator>Kaylee Kampf</dc:creator>
<dc:creator>Jill Kirschen</dc:creator>
<dc:creator>Shahina B. Maqbool</dc:creator>
<dc:creator>Zeineen Momin</dc:creator>
<dc:creator>David M. Reynolds</dc:creator>
<dc:creator>Natalie Russo</dc:creator>
<dc:creator>Lisa Shulman</dc:creator>
<dc:creator>Edyta Stasiek</dc:creator>
<dc:creator>Jessica Tozour</dc:creator>
<dc:creator>Maria Valicenti-McDermott</dc:creator>
<dc:creator>Shenglong Wang</dc:creator>
<dc:creator>Brett S. Abrahams</dc:creator>
<dc:creator>Joseph Hargitai</dc:creator>
<dc:creator>Dov Inbar</dc:creator>
<dc:creator>Zhengdong Zhang</dc:creator>
<dc:creator>Joseph D. Buxbaum</dc:creator>
<dc:creator>Sophie Molholm</dc:creator>
<dc:creator>John J. Foxe</dc:creator>
<dc:creator>Robert W. Marion</dc:creator>
<dc:creator>Adam Auton</dc:creator>
<dc:creator>John Greally</dc:creator>
<dc:creator></dc:creator>
<dc:date>2014-05-06</dc:date>
<dc:identifier>doi:10.1101/004853</dc:identifier>
<dc:title><![CDATA[MOSAIC EPIGENETIC DYSREGULATION OF ECTODERMAL CELLS IN AUTISM SPECTRUM DISORDER]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2014-05-06</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/007591v1?rss=1">
<title>
<![CDATA[
The meta-epigenomic structure of purified human stem cell populations is defined at cis-regulatory sequences 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/007591v1?rss=1</link>
<description><![CDATA[
The mechanism and significance of epigenetic variability in the same cell type between healthy individuals are not clear. Here, we purify human CD34+ hematopoietic stem and progenitor cells (HSPCs) from different individuals and find that there is increased variability of DNA methylation at loci with properties of promoters and enhancers. The variability is especially enriched at candidate enhancers near genes transitioning between silent and expressed states, and encoding proteins with leukocyte differentiation properties. Our findings of increased variability at loci with intermediate DNA methylation values, at candidate "poised" enhancers, and at genes involved in HSPC lineage commitment suggest that CD34+ cell subtype heterogeneity between individuals is a major mechanism for the variability observed. Epigenomic studies performed on cell populations, even when purified, are testing collections of epigenomes, or meta-epigenomes. Our findings show that meta-epigenomic approaches to data analysis can provide insights into cell subpopulation structure.
]]></description>
<dc:creator>N. Ari Wijetunga</dc:creator>
<dc:creator>Fabien Delahaye</dc:creator>
<dc:creator>Yong Mei Zhao</dc:creator>
<dc:creator>Aaron Golden</dc:creator>
<dc:creator>Jessica C Mar</dc:creator>
<dc:creator>Francine H. Einstein</dc:creator>
<dc:creator>John M. Greally</dc:creator>
<dc:creator></dc:creator>
<dc:date>2014-08-01</dc:date>
<dc:identifier>doi:10.1101/007591</dc:identifier>
<dc:title><![CDATA[The meta-epigenomic structure of purified human stem cell populations is defined at cis-regulatory sequences]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2014-08-01</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/008482v1?rss=1">
<title>
<![CDATA[
Sexual dimorphism in epigenomic responses of stem cells to extreme fetal growth 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/008482v1?rss=1</link>
<description><![CDATA[
Extreme fetal growth is associated with increased susceptibility to a range of adult diseases through an unknown mechanism of cellular memory. We tested whether heritable epigenetic processes in long-lived CD34+ hematopoietic stem/progenitor cells (HSPCs) showed evidence for re-programming associated with the extremes of fetal growth. Here we show that both fetal growth restriction and over-growth are associated with global shifts towards DNA hypermethylation, targeting cis-regulatory elements in proximity to genes involved in glucose homeostasis and stem cell function. A sexually dimorphic response was found, intrauterine growth restriction (IUGR) associated with substantially greater epigenetic dysregulation in males but large for gestational age (LGA) growth affecting females predominantly. The findings are consistent with extreme fetal growth interacting with variable fetal susceptibility to influence cellular aging and metabolic characteristics through epigenetic mechanisms, potentially generating biomarkers that could identify infants at higher risk for chronic disease later in life.
]]></description>
<dc:creator>Fabien Delahaye</dc:creator>
<dc:creator>Neil Ari Wijetunga</dc:creator>
<dc:creator>Hye J Heo</dc:creator>
<dc:creator>Jessica N Tozour</dc:creator>
<dc:creator>Yong Mei Zhao</dc:creator>
<dc:creator>John M Greally</dc:creator>
<dc:creator>Francine H Einstein</dc:creator>
<dc:creator></dc:creator>
<dc:date>2014-08-27</dc:date>
<dc:identifier>doi:10.1101/008482</dc:identifier>
<dc:title><![CDATA[Sexual dimorphism in epigenomic responses of stem cells to extreme fetal growth]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2014-08-27</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/020545v1?rss=1">
<title>
<![CDATA[
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/020545v1?rss=1</link>
<description><![CDATA[
BackgroundRNA:DNA hybrids represent a non-canonical nucleic acid structure that has been associated with a range of human diseases and potential transcriptional regulatory functions. Mapping of RNA:DNA hybrids in human cells reveals them to have a number of characteristics that give insights into their functions.nnResultsWe find RNA:DNA hybrids to occupy millions of base pairs in the human genome. A directional sequencing approach shows the RNA component of the RNA:DNA hybrid to be purine-rich, indicating a thermodynamic contribution to their in vivo stability. The RNA:DNA hybrids are enriched at loci with decreased DNA methylation and increased DNase hypersensitivity, and within larger domains with characteristics of heterochromatin formation, indicating potential transcriptional regulatory properties. Mass spectrometry studies of chromatin at RNA:DNA hybrids shows the presence of the ILF2 and ILF3 transcription factors, supporting a model of certain transcription factors binding preferentially to the RNA:DNA conformation.nnConclusionsOverall, there is little to indicate a dependence for RNA:DNA hybrids forming co-transcriptionally, with results from the ribosomal DNA repeat unit instead supporting the intriguing model of RNA generating these structures in trans. The results of the study indicate heterogeneous functions of these genomic elements and new insights into their formation and stability in vivo.
]]></description>
<dc:creator>Julie Nadel</dc:creator>
<dc:creator>Rodoniki Athanasiadou</dc:creator>
<dc:creator>Christophe Lemetre</dc:creator>
<dc:creator>Neil Ari Wijetunga</dc:creator>
<dc:creator>Pilib Ó Broin</dc:creator>
<dc:creator>Hanae Sato</dc:creator>
<dc:creator>Zhengdong Zhang</dc:creator>
<dc:creator>Jeffrey Jeddeloh</dc:creator>
<dc:creator>Cristina Montagna</dc:creator>
<dc:creator>Aaron Golden</dc:creator>
<dc:creator>Cathal Seoighe</dc:creator>
<dc:creator>John M. Greally</dc:creator>
<dc:creator></dc:creator>
<dc:date>2015-06-07</dc:date>
<dc:identifier>doi:10.1101/020545</dc:identifier>
<dc:title><![CDATA[RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2015-06-07</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/025809v1?rss=1">
<title>
<![CDATA[
The genetics of Bene Israel from India reveals both substantial Jewish and Indian ancestry 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/025809v1?rss=1</link>
<description><![CDATA[
The Bene Israel Jewish community from West India is a unique population whose history before the 18th century remains largely unknown. Bene Israel members consider themselves as descendants of Jews, yet the identity of Jewish ancestors and their arrival time to India are unknown, with speculations on arrival time varying between the 8th century BCE and the 6th century CE. Here, we characterize the genetic history of Bene Israel by collecting and genotyping 18 Bene Israel individuals. Combining with 486 individuals from 41 other Jewish, Indian and Pakistani populations, and additional individuals from worldwide populations, we conducted comprehensive genome-wide analyses based on FST, principal component analysis, ADMIXTURE, identity-by-descent sharing, admixture linkage disequilibrium decay, haplotype sharing and allele sharing autocorrelation decay, as well as contrasted patterns between the X chromosome and the autosomes. The genetics of Bene Israel individuals resemble local Indian populations, while at the same time constituting a clearly separated and unique population in India. They are unique among Indian and Pakistani populations we analyzed in sharing considerable genetic ancestry with other Jewish populations. Putting together the results from all analyses point to Bene Israel being an admixed population with both Jewish and Indian ancestry, with the genetic contribution of each of these ancestral populations being substantial. The admixture took place in the last millennium, about 19-33 generations ago. It involved Middle-Eastern Jews and was sex-biased, with more male Jewish and local female contribution. It was followed by a population bottleneck and high endogamy, which can lead to increased prevalence of recessive diseases in this population. This study provides an example of how genetic analysis advances our knowledge of human history in cases where other disciplines lack the relevant data to do so.
]]></description>
<dc:creator>Yedael Y. Waldman</dc:creator>
<dc:creator>Arjun Biddanda</dc:creator>
<dc:creator>Natalie R. Davidson</dc:creator>
<dc:creator>Paul Billing-Ross</dc:creator>
<dc:creator>Maya Dubrovsky</dc:creator>
<dc:creator>Christopher L. Campbell</dc:creator>
<dc:creator>Carole Oddoux</dc:creator>
<dc:creator>Eitan Friedman</dc:creator>
<dc:creator>Gil Atzmon</dc:creator>
<dc:creator>Eran Halperin</dc:creator>
<dc:creator>Harry Ostrer</dc:creator>
<dc:creator>Alon Keinan</dc:creator>
<dc:creator></dc:creator>
<dc:date>2015-08-31</dc:date>
<dc:identifier>doi:10.1101/025809</dc:identifier>
<dc:title><![CDATA[The genetics of Bene Israel from India reveals both substantial Jewish and Indian ancestry]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2015-08-31</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/031070v1?rss=1">
<title>
<![CDATA[
Agent based models to investigate cooperation between cancer cells 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/031070v1?rss=1</link>
<description><![CDATA[
We present a type of agent-based model that uses off-lattice spheres to represent individual cells in a solid tumor. The model calculates chemical gradients and determines the dynamics of the tumor as emergent properties of the interactions between the cells. As an example, we present an investigation of cooperation among cancer cells where cooperators secrete a growth factor that is costly to synthesize. Simulations reveal that cooperation is favored when cancer cells from the same lineage stay in close proximity. The result supports the hypothesis that kin selection, a theory that explains the evolution of cooperation in animals, also applies to cancers.
]]></description>
<dc:creator>Joao Xavier</dc:creator>
<dc:creator>William Chang</dc:creator>
<dc:creator></dc:creator>
<dc:date>2015-11-09</dc:date>
<dc:identifier>doi:10.1101/031070</dc:identifier>
<dc:title><![CDATA[Agent based models to investigate cooperation between cancer cells]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2015-11-09</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/040162v1?rss=1">
<title>
<![CDATA[
Single-chromosome aneuploidy commonly functions as a tumor suppressor 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/040162v1?rss=1</link>
<description><![CDATA[
Whole-chromosome aneuploidy is a hallmark of human malignancies. The prevalence of chromosome segregation errors in cancer - first noted more than 100 years ago - has led to the widespread belief that aneuploidy plays a crucial role in tumor development. Here, we set out to test this hypothesis. We transduced congenic euploid and trisomic fibroblasts with 14 different oncogenes or oncogene combinations, thereby creating genetically-matched cancer cell lines that differ only in karyotype. Surprisingly, nearly all aneuploid cell lines divided slowly in vitro, formed few colonies in soft agar, and grew poorly as xenografts, relative to matched euploid lines. Similar results were obtained when comparing a near-diploid human colorectal cancer cell line with derivatives of that line that harbored extra chromosomes. Only a few aneuploid lines grew at close to wild-type levels, and no aneuploid line exhibited greater tumorigenic capabilities than its euploid counterpart. These results demonstrate that rather than promoting tumorigenesis, aneuploidy, particularly single chromosome gains, can very often function as a tumor suppressor. Moreover, our results suggest one potential way that cancers can overcome the tumor suppressive effects of aneuploidy: rapidly-growing aneuploid cell lines that had evolved in vitro or in vivo demonstrated recurrent karyotype changes that were absent from their euploid counterparts. Thus, the genome-destabilizing effects of single-chromosome aneuploidy may facilitate the development of balanced, high-complexity karyotypes that are frequently found in advanced malignancies.
]]></description>
<dc:creator>Jason Meyer Sheltzer</dc:creator>
<dc:creator>Julie H. Ko</dc:creator>
<dc:creator>Nicole C. Habibe Burgos</dc:creator>
<dc:creator>Erica S. Chung</dc:creator>
<dc:creator>Colleen M. Meehl</dc:creator>
<dc:creator>Verena Passerini</dc:creator>
<dc:creator>Zuzana Storchova</dc:creator>
<dc:creator>Angelika Amon</dc:creator>
<dc:creator></dc:creator>
<dc:date>2016-02-19</dc:date>
<dc:identifier>doi:10.1101/040162</dc:identifier>
<dc:title><![CDATA[Single-chromosome aneuploidy commonly functions as a tumor suppressor]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2016-02-19</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/040337v1?rss=1">
<title>
<![CDATA[
C. elegans paraoxonase-like proteins control the functional expression of DEG/ENaC mechanosensory proteins 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/040337v1?rss=1</link>
<description><![CDATA[
Caenorhabditis elegans senses gentle touch via a mechanotransduction channel formed from the DEG/ENaC proteins MEC-4 and MEC-10. An additional protein, the paraoxonase-like protein MEC-6, is essential for transduction, and previous work suggested that MEC-6 was part of the transduction complex. We found that MEC-6 and a similar protein, POML-1, reside primarily in the endoplasmic reticulum and do not colocalize with MEC-4 on the plasma membrane in vivo. As with MEC-6, POML-1 is needed for touch sensitivity, for the neurodegeneration caused by the mec-4(d) mutation, and for the expression and distribution of MEC-4 in vivo. Both proteins are likely needed for the proper folding or assembly of MEC-4 channels in vivo as measured by FRET. MEC-6 detectably increases the rate of MEC-4 accumulation on the Xenopus oocyte plasma membrane. These results suggest that MEC-6 and POML-1 interact with MEC-4 to facilitate expression and localization of MEC-4 on the cell surface. Thus, MEC-6 and POML-1 act more like chaperones for MEC-4 than channel components.
]]></description>
<dc:creator>Yushu Chen</dc:creator>
<dc:creator>Shashank Bharill</dc:creator>
<dc:creator>Zeynep Altun</dc:creator>
<dc:creator>Robert O'Hagan</dc:creator>
<dc:creator>Brian Coblitz</dc:creator>
<dc:creator>Ehud I. Isacoff</dc:creator>
<dc:creator>Martin Chalfie</dc:creator>
<dc:creator></dc:creator>
<dc:date>2016-02-19</dc:date>
<dc:identifier>doi:10.1101/040337</dc:identifier>
<dc:title><![CDATA[C. elegans paraoxonase-like proteins control the functional expression of DEG/ENaC mechanosensory proteins]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2016-02-19</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/059436v1?rss=1">
<title>
<![CDATA[
A direct multi-generational estimate of the human mutation rate from autozygous segments seen in thousands of parentally related individuals 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/059436v1?rss=1</link>
<description><![CDATA[
Heterozygous mutations within homozygous sequences descended from a recent common ancestor offer a way to ascertain de novo mutations (DNMs) across multiple generations. Using exome sequences from 3,222 British-Pakistani individuals with high parental relatedness, we estimate a mutation rate of 1. 45 {+/-} 0.05 x 10-8 per base pair per generation in autosomal coding sequence, with a corresponding noncrossover gene conversion rate of 8.75 {+/-} 0.05 x 10-6 per base pair per generation. This is at the lower end of exome mutation rates previously estimated in parent-offspring trios, suggesting that post-zygotic mutations contribute little to the human germline mutation rate. We found frequent recurrence of mutations at polymorphic CpG sites, and an increase in C to T mutations in a 5 CCG 3 [-&gt;] 5 CTG 3 context in the Pakistani population compared to Europeans, suggesting that mutational processes have evolved rapidly between human populations.
]]></description>
<dc:creator>Vagheesh M Narasimhan</dc:creator>
<dc:creator>Raheleh Rahbari</dc:creator>
<dc:creator>Aylwyn Scally</dc:creator>
<dc:creator>Arthur Wuster</dc:creator>
<dc:creator>Dan Mason</dc:creator>
<dc:creator>Yali Xue</dc:creator>
<dc:creator>John Wright</dc:creator>
<dc:creator>Richard C Trembath</dc:creator>
<dc:creator>Eamonn R Maher</dc:creator>
<dc:creator>David A van Heel</dc:creator>
<dc:creator>Adam Auton</dc:creator>
<dc:creator>Matthew E Hurles</dc:creator>
<dc:creator>Chris Tyler-Smith</dc:creator>
<dc:creator>Richard Durbin</dc:creator>
<dc:creator></dc:creator>
<dc:date>2016-06-17</dc:date>
<dc:identifier>doi:10.1101/059436</dc:identifier>
<dc:title><![CDATA[A direct multi-generational estimate of the human mutation rate from autozygous segments seen in thousands of parentally related individuals]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2016-06-17</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/066043v1?rss=1">
<title>
<![CDATA[
False Negatives Are a Significant Feature of Next Generation Sequencing Callsets 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/066043v1?rss=1</link>
<description><![CDATA[
Short-read, next-generation sequencing (NGS) is now broadly used to identify rare or de novo mutations in population samples and disease cohorts. However, NGS data is known to be error-prone and post-processing pipelines have primarily focused on the removal of spurious mutations or "false positives" in downstream genome datasets. Less attention has been paid to characterizing the fraction of missing mutations or "false negatives" (FN). We design a phylogeny-aware tool to determine false negatives [PhyloFaN] and describe how read coverage and reference bias affect the FN rate. Using thousand-fold coverage NGS data from both Illumina HiSeq and Complete Genomics platforms derived from the 1000 Genomes Project, we first characterize the false negative rate in human mtDNA genomes. The false negative rate for the publically available callsets is 17-20%, even for extremely high coverage haploid data. We demonstrate that high FN rates are not limited to mtDNA by comparing autosomal data from 28 publically available full genomes to intergenic Sanger sequenced regions for each individual. We examine both low-coverage Illumina and high-coverage Complete Genomics genomes. We show that the FN rate varies between [~]6%-18% and that false-positive rates are considerably lower (<3%). The FN rate is strongly dependent on calling pipeline parameters, as well as read coverage. Our results demonstrate that missing mutations are a significant feature of genomic datasets and imply additional fine-tuning of bioinformatics pipelines is needed. We provide a tool which can be used to quantify the FN rate for haploid genomic experiments, without additional generation of validation data.nnData depositionData and software are freely available on the Henn Lab website: https://ecoevo.stonybrook.edu/hennlab/data-software/nnSoftwareGITHUB via https://ecoevo.stonybrook.edu/hennlab/data-software/
]]></description>
<dc:creator>Dean Bobo</dc:creator>
<dc:creator>Mikhail Lipatov</dc:creator>
<dc:creator>Juan L. Rodriguez-Flores</dc:creator>
<dc:creator>Adam Auton</dc:creator>
<dc:creator>Brenna M Henn</dc:creator>
<dc:creator></dc:creator>
<dc:date>2016-07-26</dc:date>
<dc:identifier>doi:10.1101/066043</dc:identifier>
<dc:title><![CDATA[False Negatives Are a Significant Feature of Next Generation Sequencing Callsets]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2016-07-26</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/068403v1?rss=1">
<title>
<![CDATA[
The hidden treasure in your data: Phasing with unexpected weak anomalous scatterers from routine datasets 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/068403v1?rss=1</link>
<description><![CDATA[
Single wavelength anomalous dispersion (SAD) utilizing anomalous signal from native sulfurs, or other atoms with Z[&le;]20, generally requires highly redundant data collected with relatively long wavelength X-rays. Here we present experiences with two proteins, where anomalous signal from serendipitously acquired surface bound calcium atoms with data redundancy as low as 10 was utilized to drive de novo structure determination. In both the cases, the calcium atoms were acquired from the crystallization solution, and data collection strategy was not optimized for exploiting the anomalous signal from these scatterers. The X-ray data were collected at 0.98[A] in one case and at 1.74[A] in the other (wavelength optimized for sulfur but anomalous signal from Ca was exploited for structure solution). Similarly, using a test case, we show that the data collected at ~1.0[A] wavelength, where the f" value for sulfur is 0.28e, is sufficient for structure determination using intrinsic sulfur atoms from a strongly diffracting crystal. Interestingly, it was also observed that SHELXD was capable of generating a substructure solution from high-exposure data with a completeness of 70% for low-resolution reflections extending to 3.5[A], with relatively low redundancy (i.e., 6.0 fold). Considering the fact that many crystallization conditions contain anomalous scatterers such as Cl, Ca, Mn etc., it appears that the data from well diffracting crystals should be processed, with anomalous pairs kept separate, so as to detect any fortuitous signal that might be present, which could prove useful in either solving the structure de novo or in accurately assigning surface bound atoms.
]]></description>
<dc:creator>Raghurama P Hegde</dc:creator>
<dc:creator>Steven C Almo</dc:creator>
<dc:creator>Udupi A Ramagopal</dc:creator>
<dc:creator></dc:creator>
<dc:date>2016-08-08</dc:date>
<dc:identifier>doi:10.1101/068403</dc:identifier>
<dc:title><![CDATA[The hidden treasure in your data: Phasing with unexpected weak anomalous scatterers from routine datasets]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2016-08-08</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/069179v1?rss=1">
<title>
<![CDATA[
iELVis: An open source MATLAB toolbox for localizing and visualizing human intracranial electrode data 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/069179v1?rss=1</link>
<description><![CDATA[
BackgroundIntracranial electrical recordings (iEEG) and brain stimulation (iEBS) are invaluable human neuroscience methodologies. However, the value of such data is often unrealized as many laboratories lack tools for localizing electrodes relative to anatomy. To remedy this, we have developed a MATLAB toolbox for intracranial electrode localization and visualization, iELVis.nnNew MethodiELVis uses existing tools (BioImage Suite, FSL, and FreeSurfer) for preimplant magnetic resonance imaging (MRI) segmentation, neuroimaging coregistration, and manual identification of electrodes in postimplant neuroimaging.nnSubsequently, iELVis implements methods for correcting electrode locations for postimplant brain shift with millimeter-scale accuracy and provides interactive visualization on 3D surfaces or in 2D slices with optional functional neuroimaging overlays. iELVis also localizes electrodes relative to FreeSurfer-based atlases and can combine data across subjects via the FreeSurfer average brain.nnResultsIt takes 30-60 minutes of user time and 12-24 hours of computer time to localize and visualize electrodes from one brain. We demonstrate iELViss functionality by showing that three methods for mapping primary hand somatosensory cortex (iEEG, iEBS, and functional MRI) provide highly concordant results.nnComparison with Existing MethodsiELVis is the first public software for electrode localization that corrects for brain shift, maps electrodes to an average brain, and supports neuroimaging overlays. Moreover, its interactive visualizations are powerful and its tutorial material is extensive.nnConclusionsiELVis promises to speed the progress and enhance the robustness of intracranial electrode research. The software and extensive tutorial materials are freely available as part of the EpiSurg software project: https://github.com/episurg/episurg
]]></description>
<dc:creator>David M. Groppe</dc:creator>
<dc:creator>Stephan Bickel</dc:creator>
<dc:creator>Andrew R. Dykstra</dc:creator>
<dc:creator>Xiuyuan Wang</dc:creator>
<dc:creator>Pierre Mégevand</dc:creator>
<dc:creator>Manuel R. Mercier</dc:creator>
<dc:creator>Fred A. Lado</dc:creator>
<dc:creator>Ashesh D. Mehta</dc:creator>
<dc:creator>Christopher J. Honey</dc:creator>
<dc:creator></dc:creator>
<dc:date>2016-08-11</dc:date>
<dc:identifier>doi:10.1101/069179</dc:identifier>
<dc:title><![CDATA[iELVis: An open source MATLAB toolbox for localizing and visualizing human intracranial electrode data]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2016-08-11</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/077180v1?rss=1">
<title>
<![CDATA[
Insights into the genetic epidemiology of Crohn’s and rare diseases in the Ashkenazi Jewish population 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/077180v1?rss=1</link>
<description><![CDATA[
As part of a broader collaborative network of exome sequencing studies, we developed a jointly called data set of 5,685 Ashkenazi Jewish exomes. We make publicly available a resource of site and allele frequencies, which should serve as a reference for medical genetics in the Ashkenazim. We estimate that 30% of protein-coding alleles present in the Ashkenazi Jewish population at frequencies greater than 0.2% are significantly more frequent (mean 7.6-fold) than their maximum frequency observed in other reference populations. Arising via a well-described founder effect, this catalog of enriched alleles can contribute to differences in genetic risk and overall prevalence of diseases between populations. As validation we document 151 AJ enriched protein-altering alleles that overlap with "pathogenic" ClinVar alleles, including those that account for 10-100 fold differences in prevalence between AJ and non-AJ populations of some rare diseases including Gaucher disease (GBA, p.Asn409Ser, 8-fold enrichment); Canavan disease (ASPA, p.Glu285Ala, 12-fold enrichment); and Tay-Sachs disease (HEXA, c.1421+1G>C, 27-fold enrichment; p.Tyr427IlefsTer5, 12-fold enrichment). We next sought to use this catalog, of well-established relevance to Mendelian disease, to explore Crohns disease, a common disease with an estimated two to four-fold excess prevalence in AJ. We specifically evaluate whether strong acting rare alleles, enriched by the same founder-effect, contribute excess genetic risk to Crohns disease in AJ, and find that ten rare genetic risk factors in NOD2 and LRRK2 are strongly enriched in AJ, including several novel contributing alleles, show evidence of association to CD. Independently, we find that genomewide common variant risk defined by GWAS shows a strong difference between AJ and non-AJ European control population samples (0.97 s.d. higher, p<10-16). Taken together, the results suggest coordinated selection in AJ population for higher CD risk alleles in general. The results and approach illustrate the value of exome sequencing data in case-control studies along with reference data sets like ExAC to pinpoint genetic variation that contributes to variable disease predisposition across populations.
]]></description>
<dc:creator>Manuel Antonio Rivas</dc:creator>
<dc:creator>Jukka Koskela</dc:creator>
<dc:creator>Hailiang Huang</dc:creator>
<dc:creator>Christine Stevens</dc:creator>
<dc:creator>Brandon E Avila</dc:creator>
<dc:creator>Talin Haritunians</dc:creator>
<dc:creator>Benjamin Neale</dc:creator>
<dc:creator>Mitja Kurki</dc:creator>
<dc:creator>Andrea Ganna</dc:creator>
<dc:creator>Daniel Graham</dc:creator>
<dc:creator>Benjamin Glaser</dc:creator>
<dc:creator>Inga Peter</dc:creator>
<dc:creator>Gil Atzmon</dc:creator>
<dc:creator>Nir Barzilai</dc:creator>
<dc:creator>Adam Levine</dc:creator>
<dc:creator>Elena Schiff</dc:creator>
<dc:creator>Nikolas Pontikos</dc:creator>
<dc:creator>Ben Weisburd</dc:creator>
<dc:creator>Konrad J Karczewski</dc:creator>
<dc:creator>Eric Minikel</dc:creator>
<dc:creator>Britt-Sabina Petersen</dc:creator>
<dc:creator>Laurent Beaugerie</dc:creator>
<dc:creator>Philippe Seksik</dc:creator>
<dc:creator>Jacques Cosnes</dc:creator>
<dc:creator>Stefan Schreiber</dc:creator>
<dc:creator>Bernd Bokemeyer</dc:creator>
<dc:creator>Johannes Bethge</dc:creator>
<dc:creator>NIDDK IBD Genetics consortium</dc:creator>
<dc:creator>T2D-GENES consortium</dc:creator>
<dc:creator>Graham Heap</dc:creator>
<dc:creator>Tariq Ahmad</dc:creator>
<dc:creator>Vincent Plagnol</dc:creator>
<dc:creator>Anthony W Segal</dc:creator>
<dc:creator>Stephan Targan</dc:creator>
<dc:creator>Dan Turner</dc:creator>
<dc:creator>Paivi Saavalainen</dc:creator>
<dc:creator>Martti Farkkila</dc:creator>
<dc:creator>Kimmo Kontula</dc:creator>
<dc:creator>Matt</dc:creator>
<dc:date>2016-09-25</dc:date>
<dc:identifier>doi:10.1101/077180</dc:identifier>
<dc:title><![CDATA[Insights into the genetic epidemiology of Crohn’s and rare diseases in the Ashkenazi Jewish population]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2016-09-25</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/083014v1?rss=1">
<title>
<![CDATA[
p53 dynamically directs TFIID assembly on target gene promoters 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/083014v1?rss=1</link>
<description><![CDATA[
The p53 tumor suppressor protein is a central regulator that turns on vast gene networks to maintain cellular integrity upon various stimuli. p53 activates transcription initiation in part by aiding recruitment of TFIID to the promoter. However, the precise means by which p53 dynamically interacts with TFIID to facilitate assembly on target gene promoters remains elusive. To address this key question, we have undertaken an integrated approach involving single molecule fluorescence microscopy, single particle cryo-electron microscopy, and biochemistry. Our real-time single molecule imaging demonstrates that TFIID alone binds poorly to native p53 target promoters. p53 unlocks TFIIDs ability to bind DNA by increasing TFIID contacts with both the core promoter and a region surrounding p53s response element (RE). Analysis of single molecule dissociation kinetics reveals that TFIID interacts with promoters via transient and prolonged DNA binding modes that are each regulated by p53. Importantly, our structural work reveals that TFIIDs conversion from a canonical form to a rearranged DNA-binding conformation is enhanced in the presence of DNA and p53. Notably, TFIIDs interaction with DNA induces p53 to rapidly dissociate, effectively liberating the RE on the promoter. Collectively, these findings indicate that p53 dynamically escorts and loads the basal transcription machinery onto its target promoters.
]]></description>
<dc:creator>Coleman, R. A.</dc:creator>
<dc:creator>Qiao, Z.</dc:creator>
<dc:creator>Singh, S. K.</dc:creator>
<dc:creator>Peng, C. S.</dc:creator>
<dc:creator>Cianfrocco, M.</dc:creator>
<dc:creator>Zhang, Z.</dc:creator>
<dc:creator>Song, L.</dc:creator>
<dc:creator>Piasecka, A.</dc:creator>
<dc:creator>Aldeborgh, H.</dc:creator>
<dc:creator>Basishvili, G.</dc:creator>
<dc:creator>Rice, W.</dc:creator>
<dc:creator>Liu, W.-L.</dc:creator>
<dc:date>2016-10-24</dc:date>
<dc:identifier>doi:10.1101/083014</dc:identifier>
<dc:title><![CDATA[p53 dynamically directs TFIID assembly on target gene promoters]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2016-10-24</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/110544v1?rss=1">
<title>
<![CDATA[
mTORC1 in AGRP neurons integrates exteroceptive and interoceptive food-related cues in the modulation of adaptive energy expenditure in mice 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/110544v1?rss=1</link>
<description><![CDATA[
Energy dissipation through interscapular brown adipose tissue (iBAT) thermogenesis is an important contributor to adaptive energy expenditure. However, it remains unresolved how acute and chronic changes in energy availability are detected by the brain to adjust iBAT activity and maintain energy homeostasis. Here we provide evidence that AGRP inhibitory tone to iBAT represents an energy-sparing circuit that integrates environmental food cues and internal signals of energy availability. We establish a role for the nutrient-sensing mTORC1 signaling pathway within AGRP neurons in the detection of environmental food cues and internal signals of energy availability, and in the bi-directional control of iBAT thermogenesis during nutrient deficiency and excess. Collectively, our findings provide insights into how mTORC1 signaling within AGRP neurons surveys energy availability to engage iBAT thermogenesis, and identify AGRP neurons as a neuronal substrate for the coordination of energy intake and adaptive expenditure under varying physiological and environmental contexts.
]]></description>
<dc:creator>Blouet, C.</dc:creator>
<dc:creator>Burke, L.</dc:creator>
<dc:creator>Darwish, T.</dc:creator>
<dc:creator>Cavanaugh, A.</dc:creator>
<dc:creator>Virtue, S.</dc:creator>
<dc:creator>Roth, E.</dc:creator>
<dc:creator>Moro, J.</dc:creator>
<dc:creator>Liu, S.-M.</dc:creator>
<dc:creator>Xia, J.</dc:creator>
<dc:creator>Dalley, J.</dc:creator>
<dc:creator>Burling, K.</dc:creator>
<dc:creator>Chua, S.</dc:creator>
<dc:creator>Vidal-Puig, T.</dc:creator>
<dc:creator>Schwartz, G.</dc:creator>
<dc:date>2017-02-22</dc:date>
<dc:identifier>doi:10.1101/110544</dc:identifier>
<dc:title><![CDATA[mTORC1 in AGRP neurons integrates exteroceptive and interoceptive food-related cues in the modulation of adaptive energy expenditure in mice]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2017-02-22</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/111682v1?rss=1">
<title>
<![CDATA[
Identifying a TFIID interactome via integrated biochemical and high-throughput proteomic studies 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/111682v1?rss=1</link>
<description><![CDATA[
The core promoter recognition TFIID complex acts as a central regulator for eukaryotic gene expression. To direct transcription initiation, TFIID binds the core promoter DNA and aids recruitment of the transcription machinery (e.g., RNA polymerase II) to the transcription start site. Many transcription factors target TFIID to control vital cellular processes. Current studies on finding TFIID interactors have predominantly focused on transcription factors. Yet, a comprehensive interactome of mammalian TFIID has not been established. Therefore, this study sought to reveal potential TFIID-nucleated networks by identifying likely co-regulatory factors that bind TFIID. By using intact native human TFIID complexes, we have exploited three independent approaches including a high-throughput Next Generation DNA sequencing coupled with proteomic analysis. Among these methods, we found some overlapping and new candidates in which we further assessed three putative interactors (i.e., Sox2, H2A and EMSY) by co-immunoprecipitation assays. Notably, in addition to known TFIID interactors, we identified a number of novel factors that participate either in co-regulatory pathways or non-transcription related functions of TFIID. Overal, these results indicate that, in addition to transcription initiation, mammalian TFIID may be involved in broader regulatory pathways than previous studies suggested.
]]></description>
<dc:creator>Liu, W.-L.</dc:creator>
<dc:creator>Song, L.</dc:creator>
<dc:creator>Dailey, G.</dc:creator>
<dc:creator>Piasecka, A.</dc:creator>
<dc:creator>Coleman, R. A.</dc:creator>
<dc:date>2017-08-10</dc:date>
<dc:identifier>doi:10.1101/111682</dc:identifier>
<dc:title><![CDATA[Identifying a TFIID interactome via integrated biochemical and high-throughput proteomic studies]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2017-08-10</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/119180v1?rss=1">
<title>
<![CDATA[
Emergence of an adaptive command for orienting behavior in premotor brainstem neurons of barn owls 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/119180v1?rss=1</link>
<description><![CDATA[
The midbrain map of auditory space commands sound-orienting responses in barn owls. Owls precisely localize sounds in frontal space but underestimate the direction of peripheral sound sources. This bias for central locations was proposed to be adaptive to the decreased reliability in the periphery of sensory cues used for sound localization by the owl. Understanding the neural pathway supporting this biased behavior provides a means to address how adaptive motor commands are implemented by neurons. Here we find that the sensory input for sound direction is weighted by its reliability in premotor neurons of the owls midbrain tegmentum such that the mean population firing rate approximates the head-orienting behavior. We provide evidence that this coding may emerge through convergence of upstream projections from the midbrain map of auditory space. We further show that manipulating the sensory input yields changes predicted by the convergent network in both premotor neural responses and behavior. This work demonstrates how a topographic sensory representation can be linearly read out to adjust behavioral responses by the reliability of the sensory input.nnSignificance statementThis research shows how statistics of the sensory input can be integrated into a behavioral command by readout of a sensory representation. The firing rate of midbrain premotor neurons receiving sensory information from a topographic representation of auditory space is weighted by the reliability of sensory cues. We show that these premotor responses are consistent with a weighted convergence from the topographic sensory representation. This convergence was also tested behaviorally, where manipulation of stimulus properties led to bidirectional changes in sound localization errors. Thus a topographic representation of auditory space is translated into a premotor command for sound localization that is modulated by sensory reliability.
]]></description>
<dc:creator>Cazettes, F.</dc:creator>
<dc:creator>Fischer, B. J.</dc:creator>
<dc:creator>Beckert, M. V.</dc:creator>
<dc:creator>Pena, J. L.</dc:creator>
<dc:date>2017-03-22</dc:date>
<dc:identifier>doi:10.1101/119180</dc:identifier>
<dc:title><![CDATA[Emergence of an adaptive command for orienting behavior in premotor brainstem neurons of barn owls]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2017-03-22</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/122465v1?rss=1">
<title>
<![CDATA[
The Toxoplasma centrocone houses cell cycle regulatory factors 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/122465v1?rss=1</link>
<description><![CDATA[
Our knowledge of cell cycle regulatory mechanisms in apicomplexan parasites is very limited. In this study, we describe a novel Toxoplasma gondii factor, essential for chromosome replication 1 (ECR1), that has a vital role in chromosome replication and the regulation of cytoplasmic and nuclear mitotic structures. ECR1 was discovered by complementation of a temperature sensitive (ts) mutant that suffers lethal, uncontrolled chromosome replication at 40{degrees}C similar to a ts-mutant carrying a defect in topoisomerase. ECR1 is a 52kDa protein containing divergent RING and TRAF-Sina like zinc-binding domains that is dynamically expressed in the tachyzoite cell cycle. ECR1 first appears in the centrocone compartment of the nuclear envelope in early S phase and then in the nucleus in late S phase where it reaches maximum expression. Following nuclear division, but before daughters resolve from the mother, ECR1 is down regulated and is absent in new daughter parasites. The proteomics of ECR1 identified interactions with the ubiquitin-mediated protein degradation machinery and the minichromosome maintenance complex and the loss of ECR1 led to increased stability of a key member of this complex, MCM2. ECR1 also forms a stable complex with the CDK-related kinase, TgCrk5, which shares a similar cell cycle expression and localization during tachyzoite replication. Altogether, the results of this study suggest ECR1 may be a unique E3 ligase that regulates DNA licensing and other mitotic processes. Importantly, the localization of ECR1/TgCrk5 in the centrocone indicates this Apicomplexa-specific spindle compartment houses important regulatory factors that control the parasite cell cycle.nnIMPORTANCEParasites of the apicomplexan family are important causes of human disease including malaria, toxoplasmosis, and cryptosporidiosis. Parasite growth is the underlying cause of pathogenesis, yet despite this importance the molecular basis for parasite replication is poorly understood. Filling this knowledge gap cannot be accomplished by mining recent whole genome sequencing because apicomplexan cell cycles differ substantially and lack many of the key regulatory factors of well-studied yeast and mammalian cell division models. We have utilized forward genetics to discover essential factors that regulate cell division in these parasites using the Toxoplasma gondii model. An example of this approach is described here with the discovery of a putative E3 ligase/protein kinase mechanism involved in regulating chromosome replication and mitotic processes of asexual stage parasites.
]]></description>
<dc:creator>Naumov, A.</dc:creator>
<dc:creator>Kratzer, S.</dc:creator>
<dc:creator>Ting, L.-M.</dc:creator>
<dc:creator>Kim, K.</dc:creator>
<dc:creator>Suvorova, E. S.</dc:creator>
<dc:creator>White, M. W.</dc:creator>
<dc:date>2017-03-30</dc:date>
<dc:identifier>doi:10.1101/122465</dc:identifier>
<dc:title><![CDATA[The Toxoplasma centrocone houses cell cycle regulatory factors]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2017-03-30</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/131326v1?rss=1">
<title>
<![CDATA[
Distinct effects of tubulin isotype mutations on neurite growth in Caenorhabditis elegans 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/131326v1?rss=1</link>
<description><![CDATA[
Tubulins, the building block of microtubules (MTs), play a critical role in both supporting and regulating neurite growth. Eukaryotic genomes contain multiple tubulin isotypes, and their missense mutations cause a range of neurodevelopmental defects. Using the C. elegans touch receptor neurons, we analyzed the effects of 67 tubulin missense mutations on neurite growth. Three types of mutations emerged: 1) loss-of-function mutations, which cause mild defects in neurite growth; 2) antimorphic mutations, which map to the GTP binding site and intradimer and interdimer interfaces, significantly reduce MT stability, and cause severe neurite growth defects; and 3) neomorphic mutations, which map to the exterior surface, increase MT stability, and cause ectopic neurite growth. Structure-function analysis reveals a causal relationship between tubulin structure and MT stability. This stability affects neuronal morphogenesis. As part of this analysis, we engineered several disease-associated human tubulin mutations into C. elegans genes and examined their impact on neuronal development at the cellular level. We also discovered an -tubulin (TBA-7) that appears to destabilize MTs. Loss of TBA-7 led to the formation of hyperstable MTs and the generation of ectopic neurites; the lack of potential sites for polyamination and polyglutamination on TBA-7 may be responsible for this destabilization.nnTable of Content (TOC) Highlight SummaryDifferent tubulin isotypes perform different functions in the regulation of MT structure and neurite growth, and missense mutations of tubulin genes have three types of distinct effects on MT stability and neurite growth. One -tubulin isotype appears to induce relative instability due to the lack of potential post-translational modification sites.
]]></description>
<dc:creator>Zheng, C.</dc:creator>
<dc:creator>Diaz-Cuadros, M.</dc:creator>
<dc:creator>Jao, S. L.</dc:creator>
<dc:creator>Nguyen, K.</dc:creator>
<dc:creator>Hall, D. H.</dc:creator>
<dc:creator>Chalfie, M.</dc:creator>
<dc:date>2017-04-26</dc:date>
<dc:identifier>doi:10.1101/131326</dc:identifier>
<dc:title><![CDATA[Distinct effects of tubulin isotype mutations on neurite growth in Caenorhabditis elegans]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2017-04-26</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/132076v1?rss=1">
<title>
<![CDATA[
Intragenomic Redistribution Of Host Transcription Factor Binding With Toxoplasma gondii Infection 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/132076v1?rss=1</link>
<description><![CDATA[
The intracellular pathogen Toxoplasma gondii modifies a number of host cell processes. The mechanisms by which T. gondii alters host gene expression are incompletely understood. This study focuses on how the regulators of gene expression in human host cells respond to T. gondii 24 hours following infection to cause specific patterns of transcriptional dysregulation. The most striking finding was the altered landscape of transposase-accessible chromatin by infection. We found both gains and losses of loci of open chromatin enriched in proximity to transcriptionally altered genes. Both DNA sequence motif analysis at the loci changing chromatin accessibility and network analysis of the genes with transcription and regulatory changes implicate a central role for the AP-1 transcription factor. We validated the redistribution of AP-1 in the host genome using chromatin immunoprecipitation studies of the c-Fos component of AP-1. As infection with T. gondii is associated with the cell failing to progress through the cell cycle, all of the changes observed occur in the absence of cell division and within 24 hours, an insight into the dynamism of these transcriptional regulatory events. We conclude that T. gondii infection influences transcriptional regulation through transcription factor re-targeting to modify the cis-regulatory landscape of the host nucleus.nnAUTHOR SUMMARYThe complex interactions between the intracellular pathogen Toxoplasma gondii and the host cell manifest as expression changes of host genes. T. gondiis secreted effectors have been extensively studied and include factors that influence the properties of transcription factors, resulting in post-translational modifications and changes in intracellular localization. To gain insights into how T. gondii exerts specific influences on host transcriptional regulation, we used genome-wide approaches to study gene expression, cytosine modifications, and chromatin structure of the host cell 24 hours after infection. The greatest insights were gained from the mapping of loci of transposase-accessible chromatin, revealing a consistently altered pattern of a subset of loci becoming inaccessible, with the simultaneous acquisition of a new set of infection-associated loci of open chromatin. The sequences at these loci were enriched for certain transcription factor binding motifs, in particular that of AP-1, the transcription factor formed by c-Jun and c-Fos heterodimers. Network analysis revealed a central role for c-Jun and c-Fos in the infection-associated perturbations, prompting a chromatin immunoprecipitation approach that confirmed the redistribution of c-Fos in infected cells. We conclude that a T. gondii infection leads to an intragenomic redistribution of host transcription factor binding, with resulting effects on host gene expression.
]]></description>
<dc:creator>Ulahannan, N.</dc:creator>
<dc:creator>Suzuki, M.</dc:creator>
<dc:creator>Simoes-Pires, C. A.</dc:creator>
<dc:creator>Wicik, Z.</dc:creator>
<dc:creator>Wijetunga, N. A.</dc:creator>
<dc:creator>Croken, M. M.</dc:creator>
<dc:creator>Bhattacharyya, S.</dc:creator>
<dc:creator>Johnston, A. D.</dc:creator>
<dc:creator>Kong, Y.</dc:creator>
<dc:creator>Maqbool, S. B.</dc:creator>
<dc:creator>Verma, A.</dc:creator>
<dc:creator>Greally, J. M.</dc:creator>
<dc:date>2017-04-28</dc:date>
<dc:identifier>doi:10.1101/132076</dc:identifier>
<dc:title><![CDATA[Intragenomic Redistribution Of Host Transcription Factor Binding With Toxoplasma gondii Infection]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2017-04-28</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/132852v1?rss=1">
<title>
<![CDATA[
Polymorphisms in the vitamin D receptor gene are associated with reduced rate of sputum culture conversion in multidrug-resistant tuberculosis patients in South Africa 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/132852v1?rss=1</link>
<description><![CDATA[
BackgroundVitamin D modulates the inflammatory and immune response to tuberculosis (TB) and also mediates the induction of the antimicrobial peptide cathelicidin. Deficiency of 25-hydroxyvitamin D and single nucleotide polymorphisms (SNPs) in the vitamin D receptor (VDR) gene may increase the risk of TB disease and decrease culture conversion rates in drug susceptible TB. Whether these VDR SNPs are found in African populations or impact multidrug-resistant (MDR) TB treatment has not been established. We aimed to determine if SNPs in the VDR gene were associated with sputum culture conversion among a cohort of MDR TB patients in South Africa.nnMethodsWe conducted a prospective cohort study of adult MDR TB patients receiving second-line TB treatment in KwaZulu-Natal province. Subjects had monthly sputum cultures performed. In a subset of participants, whole blood samples were obtained for genomic analyses. Genomic DNA was extracted and genotyped with Affymetrix Axiom Pan-African Array. Cox proportional models were used to determine the association between VDR SNPs and rate of culture conversion.nnResultsGenomic analyses were performed on 91 MDR TB subjects enrolled in the sub-study; 60% were female and median age was 35 years (interquartile range [IQR] 29-42). Smoking was reported by 21% of subjects and most subjects had HIV (80%), were smear negative (57%), and had cavitary disease (55%). Overall, 87 (96%) subjects initially converted cultures to negative, with median time to culture conversion of 57 days (IQR 17-114). Of 121 VDR SNPs examined, 10 were significantly associated (p<0.01) with rate of sputum conversion in multivariable analyses. Each additional risk allele on SNP rs74085240 delayed culture conversion significantly (adjusted hazard ratio 0.30, 95% confidence interval 0.14-0.67).nnConclusionsPolymorphisms in the VDR gene were associated with rate of sputum culture conversion in MDR TB patients in this high HIV prevalence setting in South Africa.nnAuthor contributionsMJM, YVS, JCMB, SS, and NRG conceived and designed the study and drafted the initial manuscript. MJM, YVS, YN, and QH performed the data analyses. All authors contributed to interpretation of the data, revised the manuscript, and approved the final version.nnThe findings and conclusions in this article are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention (CDC). The use of trade names and commercial sources is for identification only and does not imply endorsement by the CDC.
]]></description>
<dc:creator>Magee, M. J.</dc:creator>
<dc:creator>Sun, Y. V.</dc:creator>
<dc:creator>Brust, J. C.</dc:creator>
<dc:creator>Shah, N. S.</dc:creator>
<dc:creator>Ning, Y.</dc:creator>
<dc:creator>Allana, S.</dc:creator>
<dc:creator>Campbell, A.</dc:creator>
<dc:creator>Hui, Q.</dc:creator>
<dc:creator>Mlisana, K.</dc:creator>
<dc:creator>Moodley, P.</dc:creator>
<dc:creator>Gandhi, N. R.</dc:creator>
<dc:date>2017-05-03</dc:date>
<dc:identifier>doi:10.1101/132852</dc:identifier>
<dc:title><![CDATA[Polymorphisms in the vitamin D receptor gene are associated with reduced rate of sputum culture conversion in multidrug-resistant tuberculosis patients in South Africa]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2017-05-03</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/132886v1?rss=1">
<title>
<![CDATA[
Spatial distribution of extensively drug-resistant tuberculosis (XDR-TB) patients in KwaZulu-Natal, South Africa 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/132886v1?rss=1</link>
<description><![CDATA[
BackgroundKwaZulu-Natal province, South Africa, has among the highest burden of XDR-TB worldwide with the majority of cases occurring due to transmission. Poor access to health facilities can be a barrier to timely diagnosis and treatment of TB, which can contribute to ongoing transmission. We sought to determine the geographic distribution of XDR-TB patients and proximity to health facilities in KwaZulu-Natal.nnMethodsWe recruited adults and children with XDR-TB diagnosed in KwaZulu-Natal. We calculated distance and time from participants home to the closest hospital or clinic, as well as to the actual facility that diagnosed XDR-TB, using tools within ArcGIS Network analyst. Speed of travel was assigned to road classes based on Department of Transport regulations. Results were compared to guidelines for the provision of social facilities in South Africa: 5km to a clinic and 30km to a hospital.nnResultsDuring 2011-2014, 1027 new XDR-TB cases were diagnosed throughout all 11 districts of KwaZulu-Natal, of whom 404 (39%) were enrolled and had geospatial data collected. Participants would have had to travel a mean distance of 2.9 km (CI 95%: 1.8-4.1) to the nearest clinic and 17.6 km (CI 95%: 11.4-23.8) to the nearest hospital. Actual distances that participants travelled to the health facility that diagnosed XDR-TB ranged from <10 km (n=143, 36%) to >50 km (n=109, 27%). The majority (77%) of participants travelled farther than the recommended distance to a clinic (5 km) and 39% travelled farther than the recommended distance to a hospital (30 km). Nearly half (46%) of participants were diagnosed at a health facility in eThekwini district, of whom, 36% resided outside the Durban metropolitan area.nnConclusionsXDR-TB cases are widely distributed throughout KwaZulu-Natal province with a denser focus in eThekwini district. Patients travelled long distances to the health facility where they were diagnosed with XDR-TB, suggesting a potential role for migration or transportation in the XDR-TB epidemic.
]]></description>
<dc:creator>Kapwata, T.</dc:creator>
<dc:creator>Morris, N.</dc:creator>
<dc:creator>Gandhi, N.</dc:creator>
<dc:creator>Campbell, A.</dc:creator>
<dc:creator>Mthiyane, T.</dc:creator>
<dc:creator>Mpangase, P.</dc:creator>
<dc:creator>Nelson, K.</dc:creator>
<dc:creator>Allana, S.</dc:creator>
<dc:creator>Brust, J.</dc:creator>
<dc:creator>Moodley, P.</dc:creator>
<dc:creator>Mlisana, K.</dc:creator>
<dc:creator>Shah, S.</dc:creator>
<dc:date>2017-05-03</dc:date>
<dc:identifier>doi:10.1101/132886</dc:identifier>
<dc:title><![CDATA[Spatial distribution of extensively drug-resistant tuberculosis (XDR-TB) patients in KwaZulu-Natal, South Africa]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2017-05-03</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/137836v1?rss=1">
<title>
<![CDATA[
Intercellular mRNA Trafficking Via Membrane Nanotubes In Mammalian Cells 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/137836v1?rss=1</link>
<description><![CDATA[
RNAs have been shown to undergo transfer between mammalian cells, though the mechanism behind this phenomenon and its overall importance to cell physiology is not well understood. Numerous publications have suggested that RNAs (microRNAs and incomplete mRNAs) undergo transfer via extracellular vesicles (e.g. exosomes). However, in contrast to a diffusion-based transfer mechanism, we find that full-length mRNAs undergo direct cell-cell transfer via cytoplasmic extensions, called membrane nanotubes (mNTs), which connect donor and acceptor cells. By employing a simple co-culture experimental model and using single-molecule imaging, we provide quantitative data showing that mRNAs are transferred between cells in contact. Examples of mRNAs that undergo transfer include those encoding GFP, mouse {beta}-actin, and human Cyclin D1, BRCA1, MT2A, and HER2. We show that intercellular mRNA transfer occurs in all co-culture models tested (e.g. between primary cells, immortalized cells, and in co-cultures of immortalized human and murine cells). Rapid mRNA transfer is dependent upon actin, but independent of de novo protein synthesis, and is modulated by stress conditions and gene expression levels. Hence, this work supports the hypothesis that full-length mRNAs undergo transfer between cells through a refined structural connection. Importantly, unlike the transfer of miRNA or RNA fragments, this process of communication transfers genetic information that could potentially alter the acceptor cell proteome. This phenomenon may prove important for the proper development and functioning of tissues, as well as host-parasite or symbiotic interactions.nnSignificanceMessenger RNA (mRNA) molecules convey genetic information within cells, beginning from genes in the nucleus to ribosomes in the cell body, where they are translated into proteins. Here, we show a novel mode of transferring genetic information from one cell to another. Contrary to previous publications suggesting that mRNAs transfer via extracellular vesicles, we provide visual and quantitative data showing that mRNAs transfer via membrane nanotubes and direct cell-to-cell contact. We predict that this process has a major role in regulating local cellular environments with respect to tissue development and maintenance, cellular responses to stress, interactions with parasites, tissue transplants, and the tumor microenvironment.nnAuthor contributionsG.H., A.R. and R.H.S. conceived the research and designed the experiments; C.M.E. performed and analyzed the experiments with WM983b+/-GFP, including transwell and exosomes; M.C.D. and E.E. performed and analyzed the WM983b/NIH393 co-culture experiments; G.H. performed and analyzed all other experiments; and G.H., J.E.G, A.R. and R.H.S. wrote the paper.
]]></description>
<dc:creator>Haimovich, G.</dc:creator>
<dc:creator>Ecker, C. M.</dc:creator>
<dc:creator>Dunagin, M. C.</dc:creator>
<dc:creator>Eggan, E.</dc:creator>
<dc:creator>Raj, A.</dc:creator>
<dc:creator>Gerst, J. E.</dc:creator>
<dc:creator>Singer, R. H.</dc:creator>
<dc:date>2017-05-14</dc:date>
<dc:identifier>doi:10.1101/137836</dc:identifier>
<dc:title><![CDATA[Intercellular mRNA Trafficking Via Membrane Nanotubes In Mammalian Cells]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2017-05-14</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/142299v1?rss=1">
<title>
<![CDATA[
Mosaic Chromosomal Aneuploidy Detection By Sequencing (MAD-seq) 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/142299v1?rss=1</link>
<description><![CDATA[
Current approaches to detect and characterize mosaic chromosomal aneuploidy are limited by sensitivity, efficiency, cost or the need to culture cells. We describe a combination of a new sequencing-based assay and a novel analytical approach that allows low levels of mosaicism for chromosomal aneuploidy to be detected, assigned to a meiotic or mitotic origin, and quantified as a proportion of the cells in the sample. We show results from a multi-ethnic assay design that is suitable for populations of diverse racial and ethnic origins, and how the MADSEQ analytical approach applied to exome sequencing data reveals unrecognized aneuploidy in 1000 Genomes samples and cell lines from public repositories. We have made the assay design and analytical software open for unrestricted use, with the goal that it can be applied in clinical samples to allow new insights into the unrecognized prevalence of mosaic chromosomal aneuploidy and its phenotypic associations.
]]></description>
<dc:creator>Kong, Y.</dc:creator>
<dc:creator>Berko, E. R.</dc:creator>
<dc:creator>Marcketta, A.</dc:creator>
<dc:creator>Maqbool, S. B.</dc:creator>
<dc:creator>Simoes-Pires, C. A.</dc:creator>
<dc:creator>Kronn, D. F.</dc:creator>
<dc:creator>Ye, K. Q.</dc:creator>
<dc:creator>Suzuki, M.</dc:creator>
<dc:creator>Auton, A.</dc:creator>
<dc:creator>Greally, J. M.</dc:creator>
<dc:date>2017-05-25</dc:date>
<dc:identifier>doi:10.1101/142299</dc:identifier>
<dc:title><![CDATA[Mosaic Chromosomal Aneuploidy Detection By Sequencing (MAD-seq)]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2017-05-25</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/142968v1?rss=1">
<title>
<![CDATA[
Enriched expression of genes associated with autism spectrum disorders in human inhibitory neurons 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/142968v1?rss=1</link>
<description><![CDATA[
Autism spectrum disorder (ASD) is highly heritable but genetically heterogeneous. The affected neural circuits and cell types remain unclear and may vary at different developmental stages. By analyzing multiple sets of human single cell transcriptome profiles, we found that ASD candidates showed enriched gene expression in neurons, especially in inhibitory neurons. ASD candidates were also more likely to be the hubs of the co-expressed module that is highly expressed in inhibitory neurons, a feature not detected for excitatory neurons. In addition, we found that upregulated genes in multiple ASD cortex samples were also enriched with genes highly expressed in inhibitory neurons, suggesting a potential increase of inhibitory neurons and an imbalance in the ratio between excitatory and inhibitory neurons. Furthermore, the downstream targets of several ASD candidates, such as CHD8, EHMT1 and SATB2, also displayed enriched expression in inhibitory neurons. Taken together, our analysis of single cell transcriptomic data suggest that inhibitory neurons may be the major neuron subtype affected by the disruption of ASD gene networks, providing single cell functional evidence to support the excitatory/inhibitory (E/I) imbalance hypothesis.
]]></description>
<dc:creator>Wang, P.</dc:creator>
<dc:creator>Zhao, D.</dc:creator>
<dc:creator>Lachman, H.</dc:creator>
<dc:creator>Zheng, D.</dc:creator>
<dc:date>2017-05-27</dc:date>
<dc:identifier>doi:10.1101/142968</dc:identifier>
<dc:title><![CDATA[Enriched expression of genes associated with autism spectrum disorders in human inhibitory neurons]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2017-05-27</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/148080v1?rss=1">
<title>
<![CDATA[
Multiple conserved cell adhesion protein interactions mediate neural wiring of a sensory circuit in C. elegans 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/148080v1?rss=1</link>
<description><![CDATA[
Nervous system function relies on precise synaptic connections. A number of widely-conserved cell adhesion proteins are implicated in cell recognition between synaptic partners, but how these proteins act as a group to specify a complex neural network is poorly understood. Taking advantage of known connectivity in C. elegans, we identified and studied cell adhesion genes expressed in three interacting neurons in the mating circuits of the adult male. Two interacting pairs of cell surface proteins independently promote fasciculation between sensory neuron HOA and its postsynaptic target interneuron AVG: BAM-2/neurexin-related in HOA binds to CASY-1/calsyntenin in AVG; SAX-7/L1CAM in sensory neuron PHC binds to RIG-6/contactin in AVG. A third, basal pathway results in considerable HOA-AVG fasciculation and synapse formation in the absence of the other two. The features of this multiplexed mechanism help to explain how complex connectivity is encoded and robustly established during nervous system development.
]]></description>
<dc:creator>Kim, B.</dc:creator>
<dc:creator>Emmons, S.</dc:creator>
<dc:date>2017-06-09</dc:date>
<dc:identifier>doi:10.1101/148080</dc:identifier>
<dc:title><![CDATA[Multiple conserved cell adhesion protein interactions mediate neural wiring of a sensory circuit in C. elegans]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2017-06-09</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/157198v1?rss=1">
<title>
<![CDATA[
A Genome-wide Association and Admixture Mapping Study of Bronchodilator Drug Response in African Americans with Asthma 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/157198v1?rss=1</link>
<description><![CDATA[
BackgroundShort-acting B2-adrenergic receptor agonists (SABAs) are the most commonly prescribed asthma medications worldwide. Response to SABAs is measured as bronchodilator drug response (BDR), which varies among racial/ethnic groups in the U.S 1, 2. However, the genetic variation that contributes to BDR is largely undefined in African Americans with asthma3nnObjectiveTo identify genetic variants that may contribute to differences in BDR in African Americans with asthma.nnMethodsWe performed a genome-wide association study of BDR in 949 African American children with asthma, genotyped with the Axiom World Array 4 (Affymetrix, Santa Clara, CA) followed by imputation using 1000 Genomes phase 3 genotypes. We used linear regression models adjusting for age, sex, body mass index and genetic ancestry to test for an association between BDR and genotype at single nucleotide polymorphisms (SNPs). To increase power and distinguish between shared vs. population-specific associations with BDR in children with asthma, we performed a meta-analysis across 949 African Americans and 1,830 Latinos (Total=2,779). Lastly, we performed genome-wide admixture mapping to identify regions whereby local African or European ancestry is associated with BDR in African Americans. Two additional populations of 416 Latinos and 1,325 African Americans were used to replicate significant associations.nnResultsWe identified a population-specific association with an intergenic SNP on chromosome 9q21 that was significantly associated with BDR (rs73650726, p=7.69 x 10-9). A trans-ethnic meta-analysis across African Americans and Latinos identified three additional SNPs within the intron of PRKG1 that were significantly associated with BDR (rs7903366, rs7070958, and rs7081864, p[&le;]5 x 10-8).nnConclusionsOur findings indicate that both population specific and shared genetic variation contributes to differences in BDR in minority children with asthma, and that the genetic underpinnings of BDR may differ between racial/ethnic groups.nnKey messagesO_LIA GWAS for BDR in African American children with asthma identified an intergenic population specific variant at 9q21 to be associated with increased bronchodilator drug response (BDR).nC_LIO_LIA meta-analysis of GWAS across African Americans and Latinos identified shared genetic variants at 10q21 in the intron of PRKG1 to be associated with differences in BDR.nC_LIO_LIFurther genetic studies need to be performed in diverse populations to identify the full set of genetic variants that contribute to BDR.nC_LI
]]></description>
<dc:creator>Spear, M. L.</dc:creator>
<dc:creator>Hu, D.</dc:creator>
<dc:creator>Pino-Yanes, M.</dc:creator>
<dc:creator>Huntsman, S.</dc:creator>
<dc:creator>Eng, C.</dc:creator>
<dc:creator>Levin, A. M.</dc:creator>
<dc:creator>White, M. J.</dc:creator>
<dc:creator>McGarry, M. E.</dc:creator>
<dc:creator>Thakur, N.</dc:creator>
<dc:creator>Galanter, J. M.</dc:creator>
<dc:creator>Mak, A. C. Y.</dc:creator>
<dc:creator>Oh, S. S.</dc:creator>
<dc:creator>Davis, A.</dc:creator>
<dc:creator>Kumar, R.</dc:creator>
<dc:creator>Farber, H. J.</dc:creator>
<dc:creator>Meade, K.</dc:creator>
<dc:creator>Avila, P. C.</dc:creator>
<dc:creator>Serebrisky, D.</dc:creator>
<dc:creator>Lenoir, M. A.</dc:creator>
<dc:creator>Brigino-Buenaventura, E. A.</dc:creator>
<dc:creator>Rodriquez Cintron, W.</dc:creator>
<dc:creator>Thyne, S. M.</dc:creator>
<dc:creator>Rodriguez-Santana, J. R.</dc:creator>
<dc:creator>Ford, J. G.</dc:creator>
<dc:creator>Chapela, R.</dc:creator>
<dc:creator>Moreno Estrada, A.</dc:creator>
<dc:creator>Sandoval, K.</dc:creator>
<dc:creator>Seibold, M. A.</dc:creator>
<dc:creator>Williams, L. K.</dc:creator>
<dc:creator>Winkler, C. A.</dc:creator>
<dc:creator>Torgerson, D. G.</dc:creator>
<dc:creator>Hernandez, R. D.</dc:creator>
<dc:creator>Burchard, E. G.</dc:creator>
<dc:date>2017-06-28</dc:date>
<dc:identifier>doi:10.1101/157198</dc:identifier>
<dc:title><![CDATA[A Genome-wide Association and Admixture Mapping Study of Bronchodilator Drug Response in African Americans with Asthma]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2017-06-28</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/157529v1?rss=1">
<title>
<![CDATA[
Differential activation of Fyn kinase distinguishes saturated and unsaturated fats in mouse macrophages 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/157529v1?rss=1</link>
<description><![CDATA[
Diet-induced obesity is associated with increased adipose tissue activated macrophage numbers. Yet, how macrophages integrate fatty acid (FA) signals remains unclear. We previously demonstrated that Fyn deficiency (FynKO) protects against high fat diet-induced adipose tissue macrophage accumulation. Herein, we show that inflammatory markers and reactive oxygen species are not induced in FynKO bone marrow-derived macrophages exposed to the saturated FA palmitate, suggesting that Fyn regulates macrophage function in response to FA signals. Saturated palmitate activates Fyn and re-localizes Fyn into the nucleus of RAW264.7, J774 and wild-type bone marrow-derived macrophages. Similarly, Fyn activity is increased in cells of AT stromal vascular fraction of high fat-fed control mice, with Fyn protein being located in the nucleus of these cells. We demonstrate that Fyn modulates palmitate-dependent oxidative stress in macrophages. Moreover, Fyn catalytic activity is necessary for its nuclear re-localization and downstream effects, as Fyn pharmacological inhibition abolishes palmitate-induced Fyn nuclear redistribution and palmitate-dependent increase of oxidative stress markers. Importantly, mono-or polyunsaturated FAs do not activate Fyn, and fail to re-localize Fyn to the nucleus. Together these data demonstrate that macrophages integrate nutritional FA signals via a differential activation of Fyn that distinguishes, at least partly, the effects of saturated versus unsaturated fats.
]]></description>
<dc:creator>Tarabra, E.</dc:creator>
<dc:creator>Lee, T.-W. A.</dc:creator>
<dc:creator>Zammit, V. A.</dc:creator>
<dc:creator>Vatish, M.</dc:creator>
<dc:creator>Yamada, E.</dc:creator>
<dc:creator>Pessin, J. E.</dc:creator>
<dc:creator>Bastie, C. C.</dc:creator>
<dc:date>2017-06-29</dc:date>
<dc:identifier>doi:10.1101/157529</dc:identifier>
<dc:title><![CDATA[Differential activation of Fyn kinase distinguishes saturated and unsaturated fats in mouse macrophages]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2017-06-29</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/167924v1?rss=1">
<title>
<![CDATA[
High-depth whole genome sequencing of a large population-specific reference panel: Enhancing sensitivity, accuracy, and imputation 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/167924v1?rss=1</link>
<description><![CDATA[
BackgroundWhile increasingly large reference panels for genome-wide imputation have been recently made available, the degree to which imputation accuracy can be enhanced by population-specific reference panels remains an open question. In the present study, we sequenced at full-depth ([&ge;]30x) a moderately large (n=738) cohort of samples drawn from the Ashkenazi Jewish population across two platforms (Illumina X Ten and Complete Genomics, Inc.). We developed and refined a series of quality control steps to optimize sensitivity, specificity, and comprehensiveness of variant calls in the reference panel, and then tested the accuracy of imputation against target cohorts drawn from the same population.nnResultsFor samples sequenced on the Illumina X Ten platform, quality thresholds were identified that permitted highly accurate calling of single nucleotide variants across 94% of the genome. The Complete Genomics, Inc. platform was more conservative (fewer variants called) compared to the Illumina platform, but also demonstrated relatively greater numbers of false positives that needed to be filtered. Quality control procedures also permitted detection of novel genome reads that are not mapped to current reference or alternate assemblies. After stringent quality control, the population-specific reference panel produced more accurate and comprehensive imputation results relative to publicly available, large cosmopolitan reference panels. The population-specific reference panel also permitted enhanced filtering of clinically irrelevant variants from personal genomes.nnConclusionsOur primary results demonstrate enhanced accuracy of a population-specific imputation panel relative to cosmopolitan panels, especially in the range of infrequent (<5% non-reference allele frequency) and rare (<1% non-reference allele frequency) variants that may be most critical to further progress in mapping of complex phenotypes.
]]></description>
<dc:creator>Lencz, T.</dc:creator>
<dc:creator>Yu, J.</dc:creator>
<dc:creator>Palmer, C.</dc:creator>
<dc:creator>Carmi, S.</dc:creator>
<dc:creator>Ben-Avraham, D.</dc:creator>
<dc:creator>Barzilai, N.</dc:creator>
<dc:creator>Bressman, S.</dc:creator>
<dc:creator>Darvasi, A.</dc:creator>
<dc:creator>Cho, J.</dc:creator>
<dc:creator>Clark, L.</dc:creator>
<dc:creator>Gumus, Z.</dc:creator>
<dc:creator>Joseph, V.</dc:creator>
<dc:creator>Klein, R.</dc:creator>
<dc:creator>Lipkin, S.</dc:creator>
<dc:creator>Offit, K.</dc:creator>
<dc:creator>Ostrer, H.</dc:creator>
<dc:creator>Ozelius, L.</dc:creator>
<dc:creator>Peter, I.</dc:creator>
<dc:creator>Atzmon, G.</dc:creator>
<dc:creator>Pe'er, I.</dc:creator>
<dc:date>2017-07-24</dc:date>
<dc:identifier>doi:10.1101/167924</dc:identifier>
<dc:title><![CDATA[High-depth whole genome sequencing of a large population-specific reference panel: Enhancing sensitivity, accuracy, and imputation]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2017-07-24</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/189084v1?rss=1">
<title>
<![CDATA[
On information metrics for spatial coding 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/189084v1?rss=1</link>
<description><![CDATA[
The hippocampal formation is involved in navigation, and its neuronal activity exhibits a variety of spatial correlates (e.g., place cells, grid cells). The quantification of the information encoded by spikes has been standard procedure to identify which cells have spatial correlates. For place cells, most of the established metrics derive from Shannons mutual information (Shannon, 1948), and convey information rate in bits/sec or bits/spike (Skaggs et al., 1993; Skaggs et al., 1996). Despite their widespread use, the performance of these metrics in relation to the original mutual information metric has never been investigated. In this work, using simulated and real data, we find that the current information metrics correlate less with the accuracy of spatial decoding than the original mutual information metric. We also find that the top informative cells may differ among metrics, and show a surrogate-based normalization that yields comparable spatial information estimates. Since different information metrics may identify different neuronal populations, we discuss current and alternative definitions of spatially informative cells, which affect the metric choice.
]]></description>
<dc:creator>Souza, B.</dc:creator>
<dc:creator>Pavao, R.</dc:creator>
<dc:creator>Belchior, H.</dc:creator>
<dc:creator>Tort, A.</dc:creator>
<dc:date>2017-09-15</dc:date>
<dc:identifier>doi:10.1101/189084</dc:identifier>
<dc:title><![CDATA[On information metrics for spatial coding]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2017-09-15</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/189225v1?rss=1">
<title>
<![CDATA[
Sociodemographic patterning in the oral microbiome of a diverse sample of New Yorkers 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/189225v1?rss=1</link>
<description><![CDATA[
11.1 PurposeVariations in the oral microbiome are potentially implicated in social inequalities in oral disease, cancers, and metabolic disease. We describe sociodemographic variation of oral microbiomes in a diverse sample.nn1.2 MethodsWe performed 16S rRNA sequencing on mouthwash specimens in a subsample (n=282) of the 2013-14 population-based New York City Health and Nutrition Examination Study (NYC-HANES). We examined differential abundance of 216 operational taxonomic units (OTUs), and alpha and beta diversity by age, sex, income, education, nativity, and race/ethnicity. For comparison, we also examined differential abundance by diet, smoking status, and oral health behaviors.nn1.3 Results69 OTUs were differentially abundant by any sociodemographic variable (false discovery rate < 0.01), including 27 by race/ethnicity, 21 by family income, 19 by education, three by sex. We also found 49 differentially abundant by smoking status, 23 by diet, 12 by oral health behaviors. Genera differing for multiple sociodemographic characteristics included Lactobacillus, Prevotella, Porphyromonas, Fusobacterium.nn1.4 ConclusionsWe identified oral microbiome variation consistent with health inequalities, with more taxa differing by race/ethnicity than diet, and more by SES variables than oral health behaviors. Investigation is warranted into possible mediating effects of the oral microbiome in social disparities in oral, metabolic and cancers.nnHighlightsO_LIMost microbiome studies to date have had minimal sociodemographic variability, limiting what is known about associations of social factors and the microbiome.nC_LIO_LIWe examined the oral microbiome in a population-based sample of New Yorkers with wide sociodemographic variation.nC_LIO_LINumerous taxa were differentially abundant by race/ethnicity, income, education, marital status, and nativity.nC_LIO_LIFrequently differentially abundant taxa include Porphyromonas, Fusobacterium, Streptococcus, and Prevotella, which are associated with oral and systemic disease.nC_LIO_LIMediation of health disparities by microbial factors may represent an important intervention site to reduce health disparities, and should be explored in prospective studies.nC_LI
]]></description>
<dc:creator>Renson, A.</dc:creator>
<dc:creator>Jones, H. E.</dc:creator>
<dc:creator>Beghini, F.</dc:creator>
<dc:creator>Segata, N.</dc:creator>
<dc:creator>Zolnik, C.</dc:creator>
<dc:creator>Usyk, M.</dc:creator>
<dc:creator>Thorpe, L.</dc:creator>
<dc:creator>Burk, R.</dc:creator>
<dc:creator>Waldron, L. D.</dc:creator>
<dc:creator>Dowd, J. B.</dc:creator>
<dc:date>2017-09-18</dc:date>
<dc:identifier>doi:10.1101/189225</dc:identifier>
<dc:title><![CDATA[Sociodemographic patterning in the oral microbiome of a diverse sample of New Yorkers]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2017-09-18</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/191049v1?rss=1">
<title>
<![CDATA[
C. elegans DBL-1/BMP Regulates Lipid Accumulation via Interaction with Insulin Signaling 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/191049v1?rss=1</link>
<description><![CDATA[
Metabolic homeostasis is coordinately controlled by diverse inputs, which must be understood to combat metabolic disorders. Here we introduce DBL-1, the C. elegans BMP2/4 homolog, as a significant regulator of lipid homeostasis. We used neutral lipid staining and a lipid droplet marker to demonstrate that both increases and decreases in DBL-1/BMP signaling result in reduced lipid stores and lipid droplet count. We find that lipid droplet size, however, correlates positively with the level of DBL 1/BMP signaling. Regulation of lipid accumulation in the intestine occurs through non-cell-autonomous signaling, since expression of SMA-3, a Smad signal transducer, in the epidermis (hypodermis) is sufficient to rescue the loss of lipid accumulation. Finally, genetic evidence indicates that DBL-1/BMP functions upstream of Insulin/IGF-1 Signaling (IIS) in lipid metabolism. We conclude that BMP signaling regulates lipid metabolism in C. elegans through inter-organ signaling to IIS, shedding light on a less well-studied regulatory mechanism for metabolic homeostasis.
]]></description>
<dc:creator>Clark, J.</dc:creator>
<dc:creator>Meade, M.</dc:creator>
<dc:creator>Ranepura, G.</dc:creator>
<dc:creator>Hall, D. H.</dc:creator>
<dc:creator>Savage-Dunn, C.</dc:creator>
<dc:date>2017-09-19</dc:date>
<dc:identifier>doi:10.1101/191049</dc:identifier>
<dc:title><![CDATA[C. elegans DBL-1/BMP Regulates Lipid Accumulation via Interaction with Insulin Signaling]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2017-09-19</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/193193v1?rss=1">
<title>
<![CDATA[
WHOLE GENOME BISULPHITE SEQUENCING USING THE ILLUMINA HISEQ X SYSTEM 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/193193v1?rss=1</link>
<description><![CDATA[
The Illumina HiSeq X platform has helped to reduce the cost of whole genome sequencing substantially, but its application for bisulphite sequencing is not straightforward. We describe the optimization of a library preparation and sequencing approach that maximizes the yield and quality of sequencing, and the elimination of a previously unrecognized artefact affecting several percent of bisulphite sequencing reads.
]]></description>
<dc:creator>Suzuki, M.</dc:creator>
<dc:creator>Liao, W.</dc:creator>
<dc:creator>Wos, F.</dc:creator>
<dc:creator>Johnston, A. D.</dc:creator>
<dc:creator>DeGrazia, J.</dc:creator>
<dc:creator>Ishii, J.</dc:creator>
<dc:creator>Bloom, T.</dc:creator>
<dc:creator>Zody, M. C.</dc:creator>
<dc:creator>Germer, S.</dc:creator>
<dc:creator>Greally, J. M.</dc:creator>
<dc:date>2017-09-24</dc:date>
<dc:identifier>doi:10.1101/193193</dc:identifier>
<dc:title><![CDATA[WHOLE GENOME BISULPHITE SEQUENCING USING THE ILLUMINA HISEQ X SYSTEM]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2017-09-24</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/193201v1?rss=1">
<title>
<![CDATA[
Electrophysiological correlates of semantic dissimilarity reflect the comprehension of natural, narrative speech. 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/193201v1?rss=1</link>
<description><![CDATA[
Understanding natural speech requires that the human brain convert complex spectrotemporal patterns of acoustic input into meaning in a rapid manner that is reasonably tightly time-locked to the incoming speech signal. However, neural evidence for such a time-locked process has been lacking. Here, we sought such evidence by using a computational model to quantify the meaning carried by each word based on how semantically dissimilar it was to its preceding context and then regressing this quantity against electroencephalographic (EEG) data recorded from subjects as they listened to narrative speech. This produced a prominent negativity at a time-lag of 200- 600 ms on centro-parietal EEG electrodes. Subsequent EEG experiments involving time-reversed speech, cocktail party attention and audiovisual speech-in-noise demonstrated that this response was exquisitely sensitive to whether or not subjects were understanding the speech they heard. These findings demonstrate that, when successfully comprehending natural speech, the human brain encodes meaning as a function of the amount of new information carried by each word in a relatively time-locked fashion.
]]></description>
<dc:creator>Broderick, M. P.</dc:creator>
<dc:creator>Anderson, A. J.</dc:creator>
<dc:creator>Di Liberto, G. M.</dc:creator>
<dc:creator>Crosse, M. J.</dc:creator>
<dc:creator>Lalor, E. C.</dc:creator>
<dc:date>2017-09-24</dc:date>
<dc:identifier>doi:10.1101/193201</dc:identifier>
<dc:title><![CDATA[Electrophysiological correlates of semantic dissimilarity reflect the comprehension of natural, narrative speech.]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2017-09-24</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/196048v1?rss=1">
<title>
<![CDATA[
Multiethnic Meta-analysis Identifies New Loci for Pulmonary Function 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/196048v1?rss=1</link>
<description><![CDATA[
Nearly 100 loci have been identified for pulmonary function, almost exclusively in studies of European ancestry populations. We extend previous research by meta-analyzing genome-wide association studies of 1000 Genomes imputed variants in relation to pulmonary function in a multiethnic population of 90,715 individuals of European (N=60,552), African (N=8,429), Asian (N=9,959), and Hispanic/Latino (N=11,775) ethnicities. We identified over 50 novel loci at genome-wide significance in ancestry-specific and/or multiethnic meta-analyses. Recent fine mapping methods incorporating functional annotation, gene expression, and/or differences in linkage disequilibrium between ethnicities identified potential causal variants and genes at known and newly identified loci. Sixteen of the novel genes encode proteins with predicted or established drug targets, including KCNK2 and CDK12.
]]></description>
<dc:creator>Wyss, A. B.</dc:creator>
<dc:creator>Sofer, T.</dc:creator>
<dc:creator>Lee, M. K.</dc:creator>
<dc:creator>Terzikhan, N.</dc:creator>
<dc:creator>Nguyen, J. N.</dc:creator>
<dc:creator>Lahousse, L.</dc:creator>
<dc:creator>Latourelle, J. C.</dc:creator>
<dc:creator>Smith, A. V.</dc:creator>
<dc:creator>Bartz, T. M.</dc:creator>
<dc:creator>Feitosa, M. F.</dc:creator>
<dc:creator>Gao, W.</dc:creator>
<dc:creator>Ahluwalia, T. S.</dc:creator>
<dc:creator>Tang, W.</dc:creator>
<dc:creator>Oldmeadow, C.</dc:creator>
<dc:creator>Duan, Q.</dc:creator>
<dc:creator>de Jong, K.</dc:creator>
<dc:creator>Wojczynski, M. K.</dc:creator>
<dc:creator>Wang, X.-Q.</dc:creator>
<dc:creator>Noordam, R.</dc:creator>
<dc:creator>Hartwig, F. P.</dc:creator>
<dc:creator>Jackson, V. E.</dc:creator>
<dc:creator>Wang, T.</dc:creator>
<dc:creator>Obeidat, M.</dc:creator>
<dc:creator>Hobbs, B. D.</dc:creator>
<dc:creator>Huan, T.</dc:creator>
<dc:creator>Kichaev, G.</dc:creator>
<dc:creator>Jin, J.</dc:creator>
<dc:creator>Graff, M.</dc:creator>
<dc:creator>Harris, T. B.</dc:creator>
<dc:creator>Kalhan, R.</dc:creator>
<dc:creator>Heckbert, S. R.</dc:creator>
<dc:creator>Paternoster, L.</dc:creator>
<dc:creator>Burkart, K. M.</dc:creator>
<dc:creator>Liu, Y.</dc:creator>
<dc:creator>Holliday, E. G.</dc:creator>
<dc:creator>Wilson, J. G.</dc:creator>
<dc:creator>Vonk, J. M.</dc:creator>
<dc:creator>Sanders, J.</dc:creator>
<dc:creator>Barr, R. G.</dc:creator>
<dc:creator>de Mutsert, R.</dc:creator>
<dc:creator>Baptista Menezes, A. M.</dc:creator>
<dc:creator>Adams, H. H. H.</dc:creator>
<dc:creator>van den Be</dc:creator>
<dc:date>2017-10-05</dc:date>
<dc:identifier>doi:10.1101/196048</dc:identifier>
<dc:title><![CDATA[Multiethnic Meta-analysis Identifies New Loci for Pulmonary Function]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2017-10-05</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/198580v1?rss=1">
<title>
<![CDATA[
ECM cross-linking regulates invadopodia dynamics 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/198580v1?rss=1</link>
<description><![CDATA[
InvadopodiInvadopodia are membrane protrusions dynamically assembled by invasive cancer cells in contact with extracellular matrix (ECM). Invadopodia are enriched for the structural proteins actin and cortactin, as well as metalloproteases such as MT1-MMP, whose function is to degrade the surrounding ECM. During metastasis, invadopodia are necessary for cancer cell intravasation and extravasation. While signaling pathways involved in the assembly and function of invadopodia are well studied, few studies address invadopodia dynamics and how the cell-ECM interactions contribute to cell invasion. Using iterative analysis based on time-lapse microscopy and mathematical modeling of invasive cancer cells, we found that cells oscillate between invadopodia presence and cell stasis, termed Invadopodia state and invadopodia absence during cell translocation, termed Migration state. Our data suggests that {beta}1-integrin-ECM binding and ECM cross-linking control the duration of each of the two states. By changing the concentration of cross-linkers in 2D and 3D cultures, we generate ECM where 0-0.92 of total lysine residues are cross-linked. Using ECM with a range of cross-linking degrees we demonstrate that the dynamics of invadopodia-related functions have a biphasic relationship to ECM cross-linking. At intermediate levels of ECM cross-linking (0.39), cells exhibit rapid invadopodia protrusion-retraction cycles and rapid calcium spikes, which lead to more frequent MT1-MMP delivery, causing maximal invadopodia-mediated ECM degradation. In contrast, both extremely high or low levels of cross-linking lead to slower invadopodia-related dynamics and lower ECM degradation. Additionally, {beta}1-integrin inhibition modifies dynamics of invadopodia-related functions, as well as the length of time cells spend in either of the states. Collectively, these data suggest that {beta}1-integrin-ECM binding non-linearly translates small physical differences in extracellular environment to differences in the dynamics of cancer cell behaviors. Understanding conditions under which invadopodia can be reduced by subtle environment-targeting treatments may lead to combination therapies for preventing metastatic spread.
]]></description>
<dc:creator>Esmaeili Pourfarhangi, K.</dc:creator>
<dc:creator>Bergman, A.</dc:creator>
<dc:creator>Gligorijevic, B.</dc:creator>
<dc:date>2017-10-04</dc:date>
<dc:identifier>doi:10.1101/198580</dc:identifier>
<dc:title><![CDATA[ECM cross-linking regulates invadopodia dynamics]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2017-10-04</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2019.12.17.876854v1?rss=1">
<title>
<![CDATA[
Molecular structures and mechanisms of DNA break processing in mouse meiosis 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2019.12.17.876854v1?rss=1</link>
<description><![CDATA[
Exonucleolytic resection, critical to repair double-strand breaks (DSBs) by recombination, is not well understood, particularly in mammalian meiosis. Here, we define structures of resected DSBs in mouse spermatocytes genome-wide at nucleotide resolution. Resection tracts averaged 1100 nucleotides, but with substantial fine-scale heterogeneity at individual hotspots. Surprisingly, EXO1 is not the major 5'[-&gt;]3' exonuclease, but the DSB-responsive kinase ATM proved a key regulator of both initiation and extension of resection. In wild type, apparent intermolecular recombination intermediates clustered near to but offset from DSB positions, consistent with joint molecules with incompletely invaded 3' ends. Finally, we provide evidence for PRDM9-dependent chromatin remodeling leading to increased accessibility at recombination sites. Our findings give insight into the mechanisms of DSB processing and repair in meiotic chromatin.
]]></description>
<dc:creator>Yamada, S.</dc:creator>
<dc:creator>Hinch, A. G.</dc:creator>
<dc:creator>Kamido, H.</dc:creator>
<dc:creator>Zhang, Y.</dc:creator>
<dc:creator>Edelmann, W.</dc:creator>
<dc:creator>Keeney, S.</dc:creator>
<dc:date>2019-12-17</dc:date>
<dc:identifier>doi:10.1101/2019.12.17.876854</dc:identifier>
<dc:title><![CDATA[Molecular structures and mechanisms of DNA break processing in mouse meiosis]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-12-17</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2019.12.19.868844v1?rss=1">
<title>
<![CDATA[
Implications of TP53 Allelic State for Genome Stability, Clinical Presentation and Outcomes in Myelodysplastic Syndromes 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2019.12.19.868844v1?rss=1</link>
<description><![CDATA[
TP53 mutations are associated with poor clinical outcomes and treatment resistance in myelodysplastic syndromes. However, the biological and clinical relevance of the underlying mono- or bi-allelic state of the mutations is unclear. We analyzed 3,324 MDS patients for TP53 mutations and allelic imbalances of the TP53 locus and found that 1 in 3 TP53-mutated patients had mono-allelic targeting of the gene whereas 2 in 3 had multiple hits consistent with bi-allelic targeting. The established associations for TP53 with complex karyotype, high-risk presentation, poor survival and rapid leukemic transformation were specific to patients with multi-hit state only. TP53 multi-hit state predicted risk of death and leukemic transformation independently of the Revised International Prognostic Scoring System, while mono-allelic patients did not differ from TP53 wild-type patients. The separation by allelic state was retained in therapy-related MDS. Findings were validated in a cohort of 1,120 patients. Ascertainment of TP53 allelic state is critical for diagnosis, risk estimation and prognostication precision in MDS, and future correlative studies of treatment response should consider TP53 allelic state.
]]></description>
<dc:creator>Bernard, E.</dc:creator>
<dc:creator>Nannya, Y.</dc:creator>
<dc:creator>Hasserjian, R. P.</dc:creator>
<dc:creator>Devlin, S. M.</dc:creator>
<dc:creator>Tuechler, H.</dc:creator>
<dc:creator>Medina-Martinez, J. S.</dc:creator>
<dc:creator>Yoshizato, T.</dc:creator>
<dc:creator>Shiozawa, Y.</dc:creator>
<dc:creator>Saiki, R.</dc:creator>
<dc:creator>Malcovati, L.</dc:creator>
<dc:creator>Levine, M. F.</dc:creator>
<dc:creator>Arango, J. E.</dc:creator>
<dc:creator>Zhou, Y.</dc:creator>
<dc:creator>Sole, F.</dc:creator>
<dc:creator>Cargo, C. A.</dc:creator>
<dc:creator>Haase, D.</dc:creator>
<dc:creator>Creignou, M.</dc:creator>
<dc:creator>Germing, U.</dc:creator>
<dc:creator>Zhang, Y.</dc:creator>
<dc:creator>Gundem, G.</dc:creator>
<dc:creator>Sarian, A.</dc:creator>
<dc:creator>van de Loosdrecht, A. A.</dc:creator>
<dc:creator>Jadersten, M.</dc:creator>
<dc:creator>Tobiasson, M.</dc:creator>
<dc:creator>Kosmider, O.</dc:creator>
<dc:creator>Follo, M. Y.</dc:creator>
<dc:creator>Thol, F.</dc:creator>
<dc:creator>Pinheiro, R. F.</dc:creator>
<dc:creator>Santini, V.</dc:creator>
<dc:creator>Kotsianidis, I.</dc:creator>
<dc:creator>Boultwood, J.</dc:creator>
<dc:creator>Santos, F. P. S.</dc:creator>
<dc:creator>Schanz, J.</dc:creator>
<dc:creator>Kasahara, S.</dc:creator>
<dc:creator>Ishikawa, T.</dc:creator>
<dc:creator>Tsurumi, H.</dc:creator>
<dc:creator>Takaori-Kondo, A.</dc:creator>
<dc:creator>Kiguchi, T.</dc:creator>
<dc:creator>Polprasert, C.</dc:creator>
<dc:creator>Bennett, J. M.</dc:creator>
<dc:creator>Klimek, V. M.</dc:creator>
<dc:creator>Savon</dc:creator>
<dc:date>2019-12-19</dc:date>
<dc:identifier>doi:10.1101/2019.12.19.868844</dc:identifier>
<dc:title><![CDATA[Implications of TP53 Allelic State for Genome Stability, Clinical Presentation and Outcomes in Myelodysplastic Syndromes]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-12-19</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2019.12.22.886382v1?rss=1">
<title>
<![CDATA[
Alteration of the premature tRNA landscape by gammaherpesvirus infection 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2019.12.22.886382v1?rss=1</link>
<description><![CDATA[
Transfer RNAs (tRNAs) are transcribed by RNA polymerase III (RNAPIII) and play a central role in decoding our genome, yet their expression and non-canonical function remain understudied. Many DNA tumor viruses enhance the activity of RNAPIII, yet whether infection alters tRNA expression is largely unknown. Here, we present the first genome-wide analysis of how viral infection alters the tRNAome. Using a tRNA-specific sequencing method (DM-tRNA-seq), we find that the murine gammaherpesvirus MHV68 induces global changes in pre-tRNA expression with 14% of tRNA genes upregulated more than 3-fold, indicating that differential tRNA gene induction is a characteristic of DNA virus infection. Elevated pre-tRNA expression corresponds to increased RNAPIII occupancy for the subset of tRNA genes tested; additionally, post-transcriptional mechanisms contribute to the accumulation of pre-tRNA species. We find increased abundance of tRNA fragments derived from pre-tRNAs upregulated by viral infection, suggesting that non-canonical tRNA cleavage is also affected. Further, pre-tRNA accumulation, but not RNAPIII recruitment, requires gammaherpesvirus-induced degradation of host mRNAs by the virally encoded mRNA endonuclease muSOX. We hypothesize that depletion of pre-tRNA maturation or turnover machinery contributes to robust accumulation of full-length pre-tRNAs in infected cells. Collectively, these findings reveal pervasive changes to tRNA expression during DNA virus infection and highlight the potential of using viruses to explore tRNA biology.

SignificanceViral infection can dramatically change the gene expression landscape of the host cell, yet little is known regarding changes in non-coding gene transcription by RNA polymerase III (RNAPIII). Among these are transfer RNAs (tRNAs), which are fundamental in protein translation, yet whose gene regulatory features remain largely undefined in mammalian cells. Here, we perform the first genome-wide analysis of tRNA expression changes during viral infection. We show that premature tRNAs accumulate during infection with the model gammaherpesvirus MHV68 as a consequence of increased transcription, but that transcripts do not undergo canonical maturation into mature tRNAs. These findings underscore how tRNA expression is a highly-regulated process and that cells have strategies to balance tRNA pools during conditions of elevated RNAPIII activity.
]]></description>
<dc:creator>Glaunsinger, B.</dc:creator>
<dc:creator>Tucker, J. M.</dc:creator>
<dc:creator>Schaller, A. M.</dc:creator>
<dc:creator>Willis, I. M.</dc:creator>
<dc:date>2019-12-23</dc:date>
<dc:identifier>doi:10.1101/2019.12.22.886382</dc:identifier>
<dc:title><![CDATA[Alteration of the premature tRNA landscape by gammaherpesvirus infection]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-12-23</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2019.12.23.885186v1?rss=1">
<title>
<![CDATA[
Microglial homeostasis requires balanced CSF-1/CSF-2 receptor signaling 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2019.12.23.885186v1?rss=1</link>
<description><![CDATA[
CSF-1R haploinsufficiency causes adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP). Previous studies in the Csf1r+/- mouse model of ALSP hypothesized a central role of elevated cerebral Csf2 expression. Here we show that monoallelic deletion of Csf2 rescues most behavioral deficits and histopathological changes in Csf1r+/- mice by preventing microgliosis and eliminating most microglial transcriptomic alterations, including those indicative of oxidative stress and demyelination. We also show elevation of Csf2 transcripts and of several CSF-2 downstream targets in the brains of ALSP patients, demonstrating that the mechanisms identified in the mouse model are functional in man. Our data provide new insights into the mechanisms underlying ALSP. Since both increased CSF2 levels and decreased microglial Csf1r expression have also been reported in Alzheimers disease and multiple sclerosis, we suggest that the unbalanced CSF-1R/CSF-2 signaling we describe in the present study may contribute to the pathogenesis of other neurodegenerative conditions.

HighlightsO_LIALSP is a CSF1R-deficiency dementia associated with increased CSF2 expression
C_LIO_LIIn Csf1r+/- ALSP mice CSF-2 promotes microgliosis by direct signaling in microglia
C_LIO_LITargeting Csf2 improves cognition, myelination and normalizes microglial function
C_LIO_LICSF-2 is a therapeutic target in ALSP
C_LI
]]></description>
<dc:creator>Chitu, V.</dc:creator>
<dc:creator>Biundo, F.</dc:creator>
<dc:creator>Shlager, G. G. L.</dc:creator>
<dc:creator>Park, E. S.</dc:creator>
<dc:creator>Wang, P.</dc:creator>
<dc:creator>Gulinello, M. E.</dc:creator>
<dc:creator>Gokhan, S.</dc:creator>
<dc:creator>Ketchum, H. C.</dc:creator>
<dc:creator>Saha, K.</dc:creator>
<dc:creator>DeTure, M. A.</dc:creator>
<dc:creator>Dickson, D. W.</dc:creator>
<dc:creator>Wszolek, Z. K.</dc:creator>
<dc:creator>Zheng, D.</dc:creator>
<dc:creator>Croxford, A. L.</dc:creator>
<dc:creator>Becher, B.</dc:creator>
<dc:creator>Sun, D.</dc:creator>
<dc:creator>Mehler, M. F.</dc:creator>
<dc:creator>Stanley, E. R.</dc:creator>
<dc:date>2019-12-23</dc:date>
<dc:identifier>doi:10.1101/2019.12.23.885186</dc:identifier>
<dc:title><![CDATA[Microglial homeostasis requires balanced CSF-1/CSF-2 receptor signaling]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-12-23</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2019.12.23.887224v1?rss=1">
<title>
<![CDATA[
A cellular stress response induced by the CRISPR/dCas9 activation system is not heritable through cell divisions 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2019.12.23.887224v1?rss=1</link>
<description><![CDATA[
The CRISPR/Cas9 system can be modified to perform  epigenetic editing by utilizing the catalytically-inactive (dead) Cas9 (dCas9) to recruit regulatory proteins to specific genomic locations. In prior studies, epigenetic editing with multimers of the transactivator VP16 and guide RNAs (gRNAs) was found to cause adverse cellular responses. These side effects may confound studies inducing new cellular properties, especially if the cellular responses are maintained through cell divisions - an epigenetic regulatory property. Here we show how distinct components of this CRISPR/dCas9 activation system, particularly untargeted gRNAs, upregulate genes associated with transcriptional stress, defense response, and regulation of cell death. Our results highlight a previously undetected acute stress response to CRISPR/dCas9 components in human cells, which is transient and not maintained through cell divisions.
]]></description>
<dc:creator>Johnston, A. D.</dc:creator>
<dc:creator>Abdulrazak, A.</dc:creator>
<dc:creator>Sato, H.</dc:creator>
<dc:creator>Maqbool, S.</dc:creator>
<dc:creator>Suzuki, M.</dc:creator>
<dc:creator>Greally, J. M.</dc:creator>
<dc:creator>Simoes-Pires, C. A.</dc:creator>
<dc:date>2019-12-23</dc:date>
<dc:identifier>doi:10.1101/2019.12.23.887224</dc:identifier>
<dc:title><![CDATA[A cellular stress response induced by the CRISPR/dCas9 activation system is not heritable through cell divisions]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-12-23</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2019.12.23.887687v1?rss=1">
<title>
<![CDATA[
Zebrafish dazl regulates cystogenesis upstream of the meiotic transition and germline stem cell specification and independent of meiotic checkpoints. 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2019.12.23.887687v1?rss=1</link>
<description><![CDATA[
Fertility and gamete reserves are maintained by asymmetric divisions of the germline stem cells to produce new stem cells or daughters that differentiate as gametes. Before entering meiosis, differentiating germ cells (GCs) of sexual animals typically undergo cystogenesis. This evolutionary conserved process involves synchronous and incomplete mitotic divisions of a germ cell daughter (cystoblast) to generate sister cells connected by stable intercellular bridges that facilitate exchange of materials to support a large synchronous population of gamete progenitors. Here we investigate cystogenesis in zebrafish and identified Deleted in azoospermia (Dazl), a conserved vertebrate RNA binding protein as a regulator of this process. Analysis of dazl mutants revealed an essential role for Dazl in regulating incomplete cytokinesis and germline cyst formation before the meiotic transition. Accordingly, dazl mutant GCs form defective ring canals, and ultimately remain as individual cells that fail to differentiate as meiocytes. In addition to promoting cystoblast divisions and meiotic entry, dazl function is required upstream of germline stem cell establishment and fertility.

Summary StatementWe show that zebrafish dazl is required for incomplete cytokinesis to generate germline cysts during cystogenesis, acts upstream of germline stem cell establishment, and is required for meiosis, and fertility.
]]></description>
<dc:creator>Bertho, S.</dc:creator>
<dc:creator>Clapp, M.</dc:creator>
<dc:creator>Banisch, T. U.</dc:creator>
<dc:creator>Bandemer, J.</dc:creator>
<dc:creator>Raz, E.</dc:creator>
<dc:creator>Marlow, F.</dc:creator>
<dc:date>2019-12-27</dc:date>
<dc:identifier>doi:10.1101/2019.12.23.887687</dc:identifier>
<dc:title><![CDATA[Zebrafish dazl regulates cystogenesis upstream of the meiotic transition and germline stem cell specification and independent of meiotic checkpoints.]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-12-27</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.01.06.895789v1?rss=1">
<title>
<![CDATA[
The conserved herpesviral kinase ORF36 activates B2 retrotransposons during murine gammaherpesvirus infection 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.01.06.895789v1?rss=1</link>
<description><![CDATA[
Short interspersed nuclear elements (SINEs) are RNA polymerase III (RNAPIII) transcribed, retrotransposable noncoding RNA (ncRNA) elements ubiquitously spread throughout mammalian genomes. While normally silenced in healthy somatic tissue, SINEs can be induced during infection with DNA viruses, including the model murine gammaherpesvirus MHV68. Here, we explored the mechanisms underlying MHV68 activation of SINE ncRNAs. We demonstrate that lytic MHV68 infection of B cells, macrophages and fibroblasts leads to robust activation of the B2 family of SINEs in a cell autonomous manner. B2 ncRNA induction requires neither host innate immune signaling factors nor involvement of the RNAPIII master regulator Maf1. However, we identify MHV68 ORF36, the conserved herpesviral kinase, as playing a key role in B2 induction during lytic infection. SINE activation is linked to ORF36 kinase activity and can also be induced by HDAC1/2 inhibition, which is one of the known ORF36 functions. Collectively, our data suggest that ORF36-mediated changes in chromatin modification contribute to B2 activation during MHV68 infection, and that this activity is conserved in other herpesviral protein kinase homologs.

AUTHOR SUMMARYViral infection dramatically changes the levels of many types of RNA in a cell. In particular, certain oncogenic viruses activate expression of repetitive genes called retrotransposons, which are normally silenced due to their ability to copy and spread throughout the genome. Here, we established that infection with the gammaherpesvirus MHV68 leads to a dramatic induction of a class of noncoding retrotransposons called B2 SINEs in multiple cell types. We then explored how MHV68 activates B2 SINEs, revealing a role for the conserved herpesviral protein kinase ORF36. Both ORF36 kinase-dependent and kinase-independent functions contribute to B2 induction, perhaps through ORF36 targeting of proteins involved in controlling the accessibility of chromatin surrounding SINE loci. Understanding features underlying induction of these elements following MHV68 infection should provide insight into core elements of SINE regulation, as well as dis-regulation of SINE elements associated with disease.
]]></description>
<dc:creator>Schaller, A.</dc:creator>
<dc:creator>Tucker, J.</dc:creator>
<dc:creator>Willis, I. M.</dc:creator>
<dc:creator>Glaunsinger, B. A.</dc:creator>
<dc:date>2020-01-06</dc:date>
<dc:identifier>doi:10.1101/2020.01.06.895789</dc:identifier>
<dc:title><![CDATA[The conserved herpesviral kinase ORF36 activates B2 retrotransposons during murine gammaherpesvirus infection]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-01-06</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.01.07.897546v1?rss=1">
<title>
<![CDATA[
Human papillomavirus 16 positive cervical cancer in Guatemala: The D2 and D3 sublineages differ in integration rate and age of diagnosis 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.01.07.897546v1?rss=1</link>
<description><![CDATA[
Human papillomavirus (HPV) 16 displays substantial sequence variation; four HPV16 lineages (A, B, C, D) have been described, as well as multiple sub-lineages. To identify molecular events associated with HPV16 carcinogenesis we evaluated viral variation, the integration of HPV16, and somatic mutation in 96 cervical cancer samples from Guatemala. A total of 64% (60/94) of the samples had integrated HPV16 sequences, and integration was associated with an earlier age of diagnosis (P=0.0007) and pre-menopausal disease. HPV16 integration sites were broadly distributed in the genome but in one tumor, HPV16 integrated into the promoter of the interferon regulatory factor 4 (IRF4) gene, which plays an important role in the regulation of the interferon response to viral infection. The HPV16 D2 and D3 sub-lineages were found in 23% and 30% of the tumors, respectively and were significantly associated with adenocarcinoma. D2-positive tumors had a higher rate of integration (P=0.011), earlier age of diagnosis (P=0.012), and a lower rate of somatic mutation (P=0.03). Whereas D3-positive tumors are less likely to integrate, have later age-of-diagnosis, and a higher rate of somatic mutation. In conclusion, Guatemalan cervical tumors have a high frequency of the very high-risk HPV16 D2 and D3 sub-lineages and cervical cancer patients with these variants of HPV16 differ in histology, age of- diagnosis, integration, and somatic mutation frequency. In summary, related lineages of HPV16 have different features of oncogenicity.
]]></description>
<dc:creator>Lou, H.</dc:creator>
<dc:creator>Boland, J. F.</dc:creator>
<dc:creator>Torres-Gonzalez, E.</dc:creator>
<dc:creator>Albanez, A.</dc:creator>
<dc:creator>Zhou, W.</dc:creator>
<dc:creator>Steinberg, M.</dc:creator>
<dc:creator>Diaw, L.</dc:creator>
<dc:creator>Mitchell, J.</dc:creator>
<dc:creator>Roberson, D.</dc:creator>
<dc:creator>Cullen, M.</dc:creator>
<dc:creator>Garland, L.</dc:creator>
<dc:creator>Bass, S.</dc:creator>
<dc:creator>Burk, R.</dc:creator>
<dc:creator>Yeager, M.</dc:creator>
<dc:creator>Wentzensen, N.</dc:creator>
<dc:creator>Schiffman, M.</dc:creator>
<dc:creator>Alvirez, E.</dc:creator>
<dc:creator>Gharzouzi, E.</dc:creator>
<dc:creator>Mirabello, L.</dc:creator>
<dc:creator>Dean, M.</dc:creator>
<dc:date>2020-01-08</dc:date>
<dc:identifier>doi:10.1101/2020.01.07.897546</dc:identifier>
<dc:title><![CDATA[Human papillomavirus 16 positive cervical cancer in Guatemala: The D2 and D3 sublineages differ in integration rate and age of diagnosis]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-01-08</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.01.08.899773v1?rss=1">
<title>
<![CDATA[
In vitro characterization of protein effector export in the bradyzoite stage of Toxoplasma gondii 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.01.08.899773v1?rss=1</link>
<description><![CDATA[
The ubiquitous parasite Toxoplasma gondii exhibits an impressive ability to maintain a chronic infection of its host for prolonged periods. Despite this, little is known regarding if and how T. gondii bradyzoites, a quasi-dormant life-stage residing within intracellular cysts, manipulate the host cell so as to maintain a persistent infection. A previous proteomic study of the cyst wall, an amorphous layer of proteins that forms underneath the cyst membrane, identified MYR1 as a putative cyst wall protein in vitro. As MYR1 is known to be involved in the translocation of parasite derived effector proteins into the host cell, we sought to determine whether parasites transitioning toward the bradyzoite life stage retain the capacity to translocate proteins via this pathway. By epitope tagging the endogenous loci of four known effectors that translocate from the parasitophorous vacuole into the host cell nucleus, we show by immunofluorescence that most effectors accumulate in the host nucleus at early but not late timepoints post-infection during the tachyzoite to bradyzoite transition and when parasites farther along the bradyzoite differentiation continuum invade a new host cell. We demonstrate that the suppression of interferon-gamma (IFN-{gamma}) signaling, previously shown to be mediated by the effector TgIST, also occurs in the context of prolonged infection with bradyzoites, and that TgIST export is a process that occurs beyond the early stages of host cell infection. These findings have important implications as to how this highly successful parasite maintains a persistent infection of its host.

IMPORTANCEToxoplasma bradyzoites persist within tissue cysts and are refractory to current treatments, serving as a reservoir for acute complications in settings of compromised immunity. Much remains to be understood regarding how this life-stage successfully establishes and maintains a persistent infection. In this study, we investigated whether the export of parasite effector proteins into the host cell occurs during the development of in vitro tissue cysts. We quantified the presence of four previously described effectors in host cell nuclei at different timepoints post-bradyzoite differentiation and found that they accumulate largely during the early stages of infection. Despite a decline in nuclear accumulation, we found that one of these effectors still mediates its function after prolonged infection with bradyzoites and provide evidence that this effector is exported beyond early infection stages. These findings suggest that effector export from within developing tissue cysts provides one potential mechanism by which this parasite achieves chronic infection.
]]></description>
<dc:creator>Mayoral, J. A.</dc:creator>
<dc:creator>Shamamian, P.</dc:creator>
<dc:creator>Weiss, L. M.</dc:creator>
<dc:date>2020-01-09</dc:date>
<dc:identifier>doi:10.1101/2020.01.08.899773</dc:identifier>
<dc:title><![CDATA[In vitro characterization of protein effector export in the bradyzoite stage of Toxoplasma gondii]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-01-09</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.01.09.900464v1?rss=1">
<title>
<![CDATA[
CB1 receptor-mediated inhibitory LTD triggers presynaptic remodeling via protein synthesis and ubiquitination 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.01.09.900464v1?rss=1</link>
<description><![CDATA[
Long-lasting forms of postsynaptic plasticity commonly involve protein synthesis-dependent structural changes of dendritic spines. However, the relationship between protein synthesis and presynaptic structural plasticity remains unclear. Here, we investigated structural changes in cannabinoid-receptor 1 (CB1)-mediated long-term depression of inhibitory transmission (iLTD), a form of presynaptic plasticity that requires protein synthesis and involves a long-lasting reduction in GABA release. We found that CB1-iLTD in acute rat hippocampal slices was associated with protein synthesis-dependent presynaptic structural changes. Using proteomics, we determined that CB1 activation in hippocampal neurons resulted in increased ribosomal proteins and initiation factors, but decreased levels of proteins involved in regulation of the actin cytoskeleton, such as Arp2/3, and presynaptic release. Moreover, while CB1-iLTD increased ubiquitin/proteasome activity, ubiquitination but not proteasomal degradation was critical for structural and functional presynaptic CB1-iLTD. Thus, CB1-iLTD relies on both protein synthesis and ubiquitination to elicit structural changes that underlie long-term reduction of GABA release.
]]></description>
<dc:creator>Monday, H. R.</dc:creator>
<dc:creator>Bourdenx, M.</dc:creator>
<dc:creator>Jordan, B. A.</dc:creator>
<dc:creator>Castillo, P. E.</dc:creator>
<dc:date>2020-01-09</dc:date>
<dc:identifier>doi:10.1101/2020.01.09.900464</dc:identifier>
<dc:title><![CDATA[CB1 receptor-mediated inhibitory LTD triggers presynaptic remodeling via protein synthesis and ubiquitination]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-01-09</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.01.09.900563v1?rss=1">
<title>
<![CDATA[
The neural computations for stimulus presence and modal identity diverge along a shared circuit 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.01.09.900563v1?rss=1</link>
<description><![CDATA[
The brain is comprised of neural circuits that are able to flexibly represent the complexity of the external world. In accomplishing this feat, one of the first attributes the brain must code for is whether a stimulus is present and subsequently what sensory information that stimulus contains. One of the core characteristics of that information is which sensory modality(ies) are being represented. How information regarding both the presence and modal identity of a given stimulus is represented and transformed within the brain remains poorly understood. In this study, we investigated how the brain represents the presence and modal identity of a given stimulus while tactile, audio, and audio-tactile stimuli were passively presented to non-human primates. We recorded spiking activity from primary somatosensory (S1) and ventral pre-motor (PMv) cortices, two areas known to be instrumental in transforming sensory information into motor commands for action. Using multivariate analyses to decode stimulus presence and identity, we found that information regarding stimulus presence and modal identity were found in both S1 and PMv and extended beyond the duration of significant evoked spiking activity, and that this information followed different time-courses in these two areas. Further, we combined time-generalization decoding with cross-area decoding to demonstrate that while signaling the presence of a stimulus involves a feedforward-feedback coupling between S1-PMv, the processing of modal identity is largely restricted to S1. Together, these results highlight the differing spatiotemporal dynamics of information flow regarding stimulus presence and modal identity in two nodes of an important cortical sensorimotor circuit.

Significance StatementIt is unclear how the structure and function of the brain support differing sensory functions, such as detecting the presence of a stimulus in the environment vs. identifying it. Here, we used multivariate decoding methods on monkey neuronal data to track how information regarding stimulus presence and modal identity flow within a sensorimotor circuit. Results demonstrate that while neural patterns in both primary somatosensory (S1) and ventral pre-motor (PMv) cortices can be used to detect and discriminate between stimuli, they follow different time-courses. Importantly, findings suggest that while information regarding the presence of a stimulus flows reciprocally between S1 and PMv, information regarding stimulus identity is largely contained in S1.
]]></description>
<dc:creator>Tovar, D. A.</dc:creator>
<dc:creator>Noel, J.-P.</dc:creator>
<dc:creator>Ishizawa, Y.</dc:creator>
<dc:creator>Patel, S. R.</dc:creator>
<dc:creator>Eskandar, E.</dc:creator>
<dc:creator>Wallace, M. T.</dc:creator>
<dc:date>2020-01-09</dc:date>
<dc:identifier>doi:10.1101/2020.01.09.900563</dc:identifier>
<dc:title><![CDATA[The neural computations for stimulus presence and modal identity diverge along a shared circuit]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-01-09</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.01.13.904581v1?rss=1">
<title>
<![CDATA[
A binary arginine methylation switch on histone H3 Arginine 2 regulates its interaction with WDR5 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.01.13.904581v1?rss=1</link>
<description><![CDATA[
Histone H3 arginine 2 (H3R2) is post-translationally modified in three different states by "writers" of the protein arginine methyltransferase (PRMT) family. H3R2 methylarginine isoforms include PRMT5-catalyzed mono- and symmetric di-methylation (me1, me2s), and PRMT6-catalyzed me1 and asymmetric dimethylation (me2a). WD-40 repeat-containing protein 5 (WDR5) is an epigenetic "reader" protein that interacts with H3R2 and is a subunit of numerous chromatin-modifying complexes, such as the Mixed Lineage Leukemia (MLL) H3 lysine 4 methyltransferase complex. Previous studies suggested that MLL recruitment to chromatin was specified by the high-affinity interaction between WDR5 and H3R2me2s. However, our prior biological data prompted the hypothesis that WDR5 may also interact with H3R2me1 to recruit MLL activity. Here, using highly accurate quantitative binding analysis combined with high-resolution crystal structures of WDR5 in complex with unmodified (me0) and me1/me2s L-Arginine amino acids and in complex with H3R2me1 peptide, we provide a rigorous biochemical study of this important biological interaction. Despite modest structural differences at the binding interface, our study supports an interaction model regulated by a binary arginine methylation switch: H3R2me2a prevents interaction with WDR5, whereas H3R2me0/me1/me2s are equally permissive.
]]></description>
<dc:creator>Lorton, B. M.</dc:creator>
<dc:creator>Harijan, R. K.</dc:creator>
<dc:creator>Burgos, E. S.</dc:creator>
<dc:creator>Bonnano, J. B.</dc:creator>
<dc:creator>Almo, S. C.</dc:creator>
<dc:creator>Shechter, D.</dc:creator>
<dc:date>2020-01-14</dc:date>
<dc:identifier>doi:10.1101/2020.01.13.904581</dc:identifier>
<dc:title><![CDATA[A binary arginine methylation switch on histone H3 Arginine 2 regulates its interaction with WDR5]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-01-14</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.01.18.911362v1?rss=1">
<title>
<![CDATA[
AAV Ablates Neurogenesis in the Adult Murine Hippocampus 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.01.18.911362v1?rss=1</link>
<description><![CDATA[
Recombinant adeno-associated virus (rAAV) has been widely used as a viral vector across mammalian biology and has been shown to be safe and effective in human gene therapy. We demonstrate that neural progenitor cells (NPCs) and immature dentate granule cells (DGCs) within the adult murine hippocampus are particularly sensitive to rAAV-induced cell death. Cell loss is dose dependent and nearly complete at experimentally relevant viral titers. rAAV-induced cell death is rapid and persistent, with loss of BrdU-labeled cells within 18 hours post-injection and no evidence of recovery of adult neurogenesis at 3 months post-injection. The remaining mature DGCs appear hyperactive 4 weeks post-injection based on immediate early gene expression, consistent with previous studies investigating the effects of attenuating adult neurogenesis. In vitro application of AAV or electroporation of AAV2 inverted terminal repeats (ITRs) is sufficient to induce cell death. Efficient transduction of the dentate gyrus (DG)--without ablating adult neurogenesis--can be achieved by injection of rAAV2-retro serotyped virus into CA3. rAAV2-retro results in efficient retrograde labeling of mature DGCs and permits in vivo 2-photon calcium imaging of dentate activity while leaving adult neurogenesis intact. These findings expand on recent reports implicating rAAV-linked toxicity in stem cells and other cell types and suggest that future work using rAAV as an experimental tool in the DG and as a gene therapy for diseases of the central nervous system (CNS) should be carefully evaluated.
]]></description>
<dc:creator>Johnston, S. T.</dc:creator>
<dc:creator>Parylak, S. L.</dc:creator>
<dc:creator>Kim, S.</dc:creator>
<dc:creator>Mac, N.</dc:creator>
<dc:creator>Lim, C.</dc:creator>
<dc:creator>Gallina, I.</dc:creator>
<dc:creator>Bloyd, C.</dc:creator>
<dc:creator>Newberry, A.</dc:creator>
<dc:creator>Saavedra, C.</dc:creator>
<dc:creator>Novák, O.</dc:creator>
<dc:creator>Goncalves, J. T.</dc:creator>
<dc:creator>Gage, F. H.</dc:creator>
<dc:creator>Shtrahman, M.</dc:creator>
<dc:date>2020-01-19</dc:date>
<dc:identifier>doi:10.1101/2020.01.18.911362</dc:identifier>
<dc:title><![CDATA[AAV Ablates Neurogenesis in the Adult Murine Hippocampus]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-01-19</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.01.24.917260v1?rss=1">
<title>
<![CDATA[
Transcriptional analysis supports the expression of human snRNA variants and reveals U2 snRNA homeostasis by an abundant U2 variant 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.01.24.917260v1?rss=1</link>
<description><![CDATA[
Although expansion of snRNA genes in the human genome and sequence variation in expressed transcripts were both identified long ago, no study has comprehensively analyzed which genes are transcriptionally active. Here, we use comprehensive bioinformatic analysis to differentiate between similar or identical genomic loci to determine that 49 snRNA genes are actively transcribed. This greatly expands on previous observation of sequence variation within snRNA transcripts. Further analysis of U2 snRNA variants reveals sequence variation maintains conserved secondary structures, yet sensitizes these U2 snRNAs to modulation of assembly factors. Homeostasis of total U2 snRNA level is maintained by altering the ratio of canonical and an abundant U2 snRNA variant. Both canonical and variant snRNA promoters respond to MYC and appear differentially sensitive to increased MYC levels. Thus, we identify transcribed snRNA variants and the sequence variation within, and propose mechanisms of transcriptional and post-transcriptional regulation of snRNA levels and pre-mRNA splicing.

HIGHLIGHTSO_LIChIP-seq of active promoters identifies uncharacterized snRNA genes
C_LIO_LITranscribed repetitive snRNA genes are distinguished from falsely-mapped snRNA loci
C_LIO_LIU2 snRNA variants are sensitive to modulations in snRNP assembly
C_LIO_LIWidely expressed U2 snRNA variants provide homeostasis for total U2 snRNP levels
C_LI
]]></description>
<dc:creator>Kosmyna, B.</dc:creator>
<dc:creator>Gupta, V.</dc:creator>
<dc:creator>Query, C. C.</dc:creator>
<dc:date>2020-01-25</dc:date>
<dc:identifier>doi:10.1101/2020.01.24.917260</dc:identifier>
<dc:title><![CDATA[Transcriptional analysis supports the expression of human snRNA variants and reveals U2 snRNA homeostasis by an abundant U2 variant]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-01-25</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.01.24.918813v1?rss=1">
<title>
<![CDATA[
Flexible contextual modulation of naturalistic texture perception in peripheral vision 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.01.24.918813v1?rss=1</link>
<description><![CDATA[
Peripheral vision comprises most of our visual field, and is essential in guiding visual behavior. Its characteristic capabilities and limitations, which distinguish it from foveal vision, have been explained by the most influential theory of peripheral vision as the product of representing the visual input using summary-statistics. Despite its success, this account may provide a limited understanding of peripheral vision, because it neglects processes of perceptual grouping and segmentation. To test this hypothesis, we studied how contextual modulation, namely the modulation of the perception of a stimulus by its surrounds, interacts with segmentation in human peripheral vision. We used naturalistic textures, which are directly related to summary-statistics representations. We show that segmentation cues affect contextual modulation, and that this is not captured by our implementation of the summary-statistics model. We then characterize the effects of different texture statistics on contextual modulation, providing guidance for extending the model, as well as for probing neural mechanisms of peripheral vision.
]]></description>
<dc:creator>Herrera, D.</dc:creator>
<dc:creator>Coen-Cagli, R.</dc:creator>
<dc:creator>Gomez-Sena, L.</dc:creator>
<dc:date>2020-01-25</dc:date>
<dc:identifier>doi:10.1101/2020.01.24.918813</dc:identifier>
<dc:title><![CDATA[Flexible contextual modulation of naturalistic texture perception in peripheral vision]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-01-25</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.02.04.934455v1?rss=1">
<title>
<![CDATA[
Joint Inference of Clonal Structure using Single-cell DNA-Seq and RNA-Seq data 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.02.04.934455v1?rss=1</link>
<description><![CDATA[
Latest advancements in high-throughput single-cell genome (scDNA) and transcriptome (scRNA) sequencing technologies enabled cell-resolved investigation of tissue clones. However, it remains challenging to cluster and couple single cells for heterogeneous scRNA and scDNA data generated from the same specimen. In this study, we present a computational framework called CC-NMF, which employs a novel Coupled-Clone Non-negative Matrix Factorization technique to jointly infer clonal structure for matched scDNA and scRNA data. CCNMF couples multi-omics single cells by linking copy number and gene expression profiles through their general concordance. We validated CC-NMF using both simulated benchmarks and real-world applications, demon-strating its robustness and accuracy. We analyzed scRNA and scDNA data from an ovarian cancer cell lines mixture, a gastric cancer cell line, as well as a primary gastric cancer, successfully resolving underlying clonal structures and identifying high correlations of coexisting clones between genome and transcriptome. Overall, CCNMF is a coherent computational framework that simultaneously resolves genomic and transcriptomic clonal architecture, facilitating understanding of how cellular gene expression changes along with clonal genome alternations.
]]></description>
<dc:creator>Bai, X.</dc:creator>
<dc:creator>Wan, L.</dc:creator>
<dc:creator>Xia, C.</dc:creator>
<dc:date>2020-02-05</dc:date>
<dc:identifier>doi:10.1101/2020.02.04.934455</dc:identifier>
<dc:title><![CDATA[Joint Inference of Clonal Structure using Single-cell DNA-Seq and RNA-Seq data]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-02-05</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.02.13.944967v1?rss=1">
<title>
<![CDATA[
F-box protein MEC-15 promotes microtubule stability and neurite growth by antagonizing the HSP90 chaperone network in Caenorhabditis elegans 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.02.13.944967v1?rss=1</link>
<description><![CDATA[
Molecular chaperones often work collaboratively with the ubiquitination-proteasome system (UPS) to facilitate the degradation of misfolded proteins, which typically safeguards cellular differentiation and protects cells from stress. In this study, however, we report that the Hsp70/Hsp90 chaperone machinery and an F-box protein, MEC-15, have opposing effects on neuronal differentiation and that the chaperones negatively regulate neuronal morphogenesis and functions. Using the touch receptor neurons (TRNs) of Caenorhabditis elegans, we find that mec-15(-) mutants display defects in microtubule formation, neurite growth, synaptic development, and neuronal functions, and these defects can be rescued by the loss of Hsp70/Hsp90 chaperones and cochaperones. MEC-15 likely functions in a SCF complex to degrade DLK-1, which is an Hsp90 client protein stabilized by the chaperones. The abundance of DLK-1, and likely other Hsp90 substrates, is fine-tuned by the antagonism between MEC-15 and chaperones; this antagonism regulates TRN development as well as synaptic functions of GABAergic motor neurons. Therefore, a balance between UPS and chaperones tightly controls neuronal differentiation.

Summary statementMolecular chaperones are known to protect cells from stress. However, in this study the authors showed that the Hsp90 chaperone negatively regulates neuronal differentiation when the ubiquitination-proteasome system is compromised.
]]></description>
<dc:creator>Zheng, C.</dc:creator>
<dc:creator>Atlas, E.</dc:creator>
<dc:creator>Lee, H. M. T.</dc:creator>
<dc:creator>Jao, S. L. J.</dc:creator>
<dc:creator>Nguyen, K. C. Q.</dc:creator>
<dc:creator>Hall, D. H.</dc:creator>
<dc:creator>Chalfie, M.</dc:creator>
<dc:date>2020-02-13</dc:date>
<dc:identifier>doi:10.1101/2020.02.13.944967</dc:identifier>
<dc:title><![CDATA[F-box protein MEC-15 promotes microtubule stability and neurite growth by antagonizing the HSP90 chaperone network in Caenorhabditis elegans]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-02-13</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.02.19.956656v1?rss=1">
<title>
<![CDATA[
C. elegans nuclear RNAi factor SET-32 deposits the transgenerational heritable histone modification, H3K23me3 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.02.19.956656v1?rss=1</link>
<description><![CDATA[
Nuclear RNAi provides a highly tractable system to study RNA-mediated chromatin changes and epigenetic inheritance. Recent studies have indicated that the regulation and function of nuclear RNAi-mediated heterochromatin are highly complex. Our knowledge of histone modifications and the corresponding histone modifying enzymes involved in the system remains limited. In this study, we show that the heterochromatin mark, H3K23me3, is induced by nuclear RNAi at both exogenous and endogenous targets in C. elegans. In addition, dsRNA-induced H3K23me3 can be inherited for four generations. We demonstrate that the histone methyltransferase SET-32, methylates H3K23 in vitro. Both set-32 and the germline nuclear RNAi Argonaute, hrde-1, are required for nuclear RNAi-induced H3K23me3 in vivo. Our data poise H3K23me3 as an additional chromatin modification in the nuclear RNAi pathway and provides the field with a new target for uncovering the role of heterochromatin in transgenerational epigenetic silencing.
]]></description>
<dc:creator>Schwartz-Orbach, L.</dc:creator>
<dc:creator>Zhang, C.</dc:creator>
<dc:creator>Sidoli, S.</dc:creator>
<dc:creator>Amin, R.</dc:creator>
<dc:creator>Kaur, D.</dc:creator>
<dc:creator>Zhebrun, A.</dc:creator>
<dc:creator>Ni, J.</dc:creator>
<dc:creator>Gu, S. G.</dc:creator>
<dc:date>2020-02-20</dc:date>
<dc:identifier>doi:10.1101/2020.02.19.956656</dc:identifier>
<dc:title><![CDATA[C. elegans nuclear RNAi factor SET-32 deposits the transgenerational heritable histone modification, H3K23me3]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-02-20</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.02.20.958272v1?rss=1">
<title>
<![CDATA[
A Multiscale and Comparative Model for Receptor Binding of 2019 Novel Coronavirus and the Implication of its Life Cycle in Host Cells 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.02.20.958272v1?rss=1</link>
<description><![CDATA[
The respiratory syndrome caused by a new type of coronavirus has been emerging from China and caused more than one million death globally since December 2019. This new virus, called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) uses the same receptor called Angiotensin-converting enzyme 2 (ACE2) to attack humans as the coronavirus that caused the severe acute respiratory syndrome (SARS) seventeen years ago. Both viruses recognize ACE2 through the spike proteins (S-protein) on their surfaces. It was found that the S-protein from the SARS coronavirus (SARS-CoV) bind stronger to ACE2 than SARS-CoV-2. However, function of a bio-system is often under kinetic, rather than thermodynamic, control. To address this issue, we constructed a structural model for complex formed between ACE2 and the S-protein from SARS-CoV-2, so that the rate of their association can be estimated and compared with the binding of S-protein from SARS-CoV by a multiscale simulation method. Our simulation results suggest that the association of new virus to the receptor is slower than SARS, which is consistent with the experimental data obtained very recently. We further integrated this difference of association rate between virus and receptor into a mathematical model which describes the life cycle of virus in host cells and its interplay with the innate immune system. Interestingly, we found that the slower association between virus and receptor can result in longer incubation period, while still maintaining a relatively higher level of viral concentration in human body. Our computational study therefore provides, from the molecular level, one possible explanation that this new pandemic by far spread much faster than SARS.
]]></description>
<dc:creator>Su, Z.</dc:creator>
<dc:creator>Wu, Y.</dc:creator>
<dc:date>2020-02-21</dc:date>
<dc:identifier>doi:10.1101/2020.02.20.958272</dc:identifier>
<dc:title><![CDATA[A Multiscale and Comparative Model for Receptor Binding of 2019 Novel Coronavirus and the Implication of its Life Cycle in Host Cells]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-02-21</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.02.25.965772v1?rss=1">
<title>
<![CDATA[
A virion-based assay for glycoprotein thermostability reveals key determinants of filovirus entry and its inhibition 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.02.25.965772v1?rss=1</link>
<description><![CDATA[
Ebola virus (EBOV) entry into cells is mediated by its spike glycoprotein (GP). Following attachment and internalization, virions traffic to late endosomes where GP is cleaved by host cysteine proteases. Cleaved GP then binds its cellular receptor, Niemann-Pick C1. In response to an unknown cellular trigger, GP undergoes conformational rearrangements that drive fusion of viral and endosomal membranes . The temperature-dependent stability (thermostability) of the pre-fusion conformers of  Class I viral fusion glycoproteins, including those of filovirus GPs, has provided insights into their propensity to undergo fusion-related rearrangements. However, previously described assays have relied on soluble glycoprotein ectodomains. Here, we developed a simple ELISA-based assay that uses the temperature-dependent loss of conformational epitopes to measure thermostability of GP embedded in viral membranes. The base and glycan cap subdomains of all filovirus GPs tested suffered a concerted loss of pre-fusion conformation at elevated temperatures, but did so at different temperature ranges, indicating virus-specific differences in thermostability. Despite these differences, all of these GPs displayed reduced thermostability upon cleavage to GPCL. Surprisingly, acid pH enhanced, rather than decreased, GP thermostability, suggesting it could enhance viral survival in hostile endo/lysosomal compartments. Finally, we confirmed and extended previous findings that some small-molecule inhibitors of filovirus entry destabilize EBOV GP and uncovered evidence that the most potent inhibitors act through multiple mechanisms. We establish the epitope-loss ELISA as a useful tool for studies of filovirus entry, engineering of GP variants with enhanced stability for use in vaccine development, and discovery of new stability-modulating antivirals.

ImportanceThough a vaccine for Ebola virus has been approved by the FDA within the past year, no FDA-approved therapeutics are available to treat infections by Ebola virus or other filoviruses. The development of such countermeasures is challenged by our limited understanding of the mechanism by which Ebola virus enters cells, especially at the final step of membrane fusion. The sole surface-exposed viral protein, GP, mediates key steps in virus entry, including membrane fusion, and undergoes major structural rearrangements during this process. The stability of GP at elevated temperatures (thermostability) can provide insights into its capacity to undergo these structural rearrangements. Here, we describe a new assay that uses GP-specific antibodies to measure GP thermostability under a variety of conditions relevant to viral entry. We show that proteolytic cleavage and acid pH have significant effects on GP thermostability that shed light on their respective roles in viral entry. We also show that the assay can be used to study how small-molecule entry inhibitors affect GP stability. This work provides a simple and readily accessible assay to engineer forms of GP with enhanced stability that could be useful as part of an antiviral vaccine and to discover and improve drugs that act by modulating the stability of GP.
]]></description>
<dc:creator>Bortz, R. H.</dc:creator>
<dc:creator>Wong, A. C.</dc:creator>
<dc:creator>Grodus, M. G.</dc:creator>
<dc:creator>Recht, H.</dc:creator>
<dc:creator>Pulanco, M. C.</dc:creator>
<dc:creator>Lasso, G.</dc:creator>
<dc:creator>Anthony, S. J.</dc:creator>
<dc:creator>Mittler, E.</dc:creator>
<dc:creator>Jangra, R. K.</dc:creator>
<dc:creator>Chandran, K.</dc:creator>
<dc:date>2020-02-26</dc:date>
<dc:identifier>doi:10.1101/2020.02.25.965772</dc:identifier>
<dc:title><![CDATA[A virion-based assay for glycoprotein thermostability reveals key determinants of filovirus entry and its inhibition]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-02-26</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.03.02.973412v1?rss=1">
<title>
<![CDATA[
A lipid metabolic map of the pathogenic fungus Histoplasma capsulatum 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.03.02.973412v1?rss=1</link>
<description><![CDATA[
Lipids play a fundamental role in fungal cell biology, being essential cell membrane components and major targets of antifungal drugs. A deeper knowledge of lipid metabolism is key for developing new drugs and a better understanding of fungal pathogenesis. Here we built a comprehensive map of the Histoplasma capsulatum lipid metabolic pathway by incorporating proteomic and lipidomic analyses. We performed genetic complementation and overexpression of H. capsulatum genes in Saccharomyces cerevisiae to validate reactions identified in the map and to determine enzymes responsible for catalyzing orphan reactions. The map led to the identification of both the fatty acid desaturation and the sphingolipid biosynthesis pathways as targets for drug development. We found that the sphingolipid biosynthesis inhibitor myriocin, the fatty acid desaturase inhibitor thiocarlide and the fatty acid analog 10-thiastearic acid inhibit H. capsulatum growth in nanomolar to low micromolar concentrations. These compounds also reduced the intracellular infection in an alveolar macrophage cell line. Overall, this lipid metabolic map revealed pathways that can be targeted for drug development.
]]></description>
<dc:creator>Zamith-Miranda, D.</dc:creator>
<dc:creator>Heyman, H. M.</dc:creator>
<dc:creator>Burnet, M. C.</dc:creator>
<dc:creator>Couvillion, S. P.</dc:creator>
<dc:creator>Zheng, X.</dc:creator>
<dc:creator>Munoz, N.</dc:creator>
<dc:creator>Kyle, J. E.</dc:creator>
<dc:creator>Zink, E. M.</dc:creator>
<dc:creator>Weitz, K. K.</dc:creator>
<dc:creator>Bloodsworth, K. J.</dc:creator>
<dc:creator>Clair, G. C.</dc:creator>
<dc:creator>Zucker, J. D.</dc:creator>
<dc:creator>Teuton, J. R.</dc:creator>
<dc:creator>Payne, S. H.</dc:creator>
<dc:creator>Kim, Y.-M.</dc:creator>
<dc:creator>Reyes Gil, M.</dc:creator>
<dc:creator>Baker, E. S.</dc:creator>
<dc:creator>Bredeweg, E. L.</dc:creator>
<dc:creator>Nosanchuk, J. D.</dc:creator>
<dc:creator>Nakayasu, E. S.</dc:creator>
<dc:date>2020-03-03</dc:date>
<dc:identifier>doi:10.1101/2020.03.02.973412</dc:identifier>
<dc:title><![CDATA[A lipid metabolic map of the pathogenic fungus Histoplasma capsulatum]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-03-03</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.03.15.992685v1?rss=1">
<title>
<![CDATA[
Structure of a Single Chain H2A/H2B Dimer 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.03.15.992685v1?rss=1</link>
<description><![CDATA[
Chromatin is the complex assembly of nucleic acids and proteins that makes up the physiological form of the eukaryotic genome. The nucleosome is the fundamental repeating unit of chromatin, composed of ~147bp of DNA wrapped around a histone octamer formed by two copies of each core histone: H2A, H2B, H3 and H4. Prior to nucleosome assembly, and during histone eviction, histones are typically assembled into soluble H2A/H2B dimers and H3/H4 dimers and tetramers. A multitude of factors interact with soluble histone dimers and tetramers, including chaperones, importins, histone modifying enzymes, and chromatin remodeling enzymes. It is still unclear how many of these proteins recognize soluble histones; therefore, there is a need for new structural tools to study non-nucleosomal histones. Here we created a single-chain, tailless Xenopus H2A/H2B dimer by directly fusing the C-terminus of H2B to the N-terminus of H2A. We show that this construct (termed scH2BH2A) is readily expressed in bacteria and can be purified under non-denaturing conditions. A 1.31[A] crystal structure of scH2BH2A shows that it adopts a conformation nearly identical to nucleosomal H2A/H2B. This new tool will facilitate future structural studies of a multitude of H2A/H2B-interacting proteins.
]]></description>
<dc:creator>Warren, C.</dc:creator>
<dc:creator>Bonanno, J. B.</dc:creator>
<dc:creator>Almo, S. C.</dc:creator>
<dc:creator>Shechter, D.</dc:creator>
<dc:date>2020-03-15</dc:date>
<dc:identifier>doi:10.1101/2020.03.15.992685</dc:identifier>
<dc:title><![CDATA[Structure of a Single Chain H2A/H2B Dimer]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-03-15</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.03.19.999508v1?rss=1">
<title>
<![CDATA[
Fidgetin-like 2 is a novel negative regulator of axonal growth and can be targeted to promote functional nerve regeneration after injury. 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.03.19.999508v1?rss=1</link>
<description><![CDATA[
The microtubule (MT) cytoskeleton plays a critical role in axon growth and guidance. Here, we identify the MT severing enzyme fidgetin-like 2 (FL2) as a negative regulator of axonal regeneration and a potential therapeutic target for promoting neural regeneration after injury. Genetic knockout of FL2 in cultured adult dorsal root ganglion (DRG) neurons resulted in longer axons and attenuated growth cone retraction in response to inhibitory molecules. Given the axonal growth-promoting effects of FL2 depletion in vitro, we tested whether the enzyme could be targeted to promote regeneration in a rodent model of peripheral nerve injury. In the model used in our experiments, the cavernous nerves (CN) are either crushed or transected, mimicking nerve injury caused by radical prostatectomy (RP). As with patients, CN injury results in erectile dysfunction, for which there are presently poor treatment options. At the time of injury, FL2-siRNA or control-siRNA was applied to the site using nanoparticles or chondroitin sulfate microgels as delivery agents. Treatment significantly enhanced functional nerve recovery, as determined by cavernosometry (measurements of corporal blood pressure in response to electrostimulation of the nerve). Remarkably, following complete bilateral nerve transection, visible and functional nerve regeneration was observed in 7 out of 8 animals treated with FL2-siRNA. In contrast, no control-siRNA treated animals showed regeneration. These observations suggest a novel therapeutic approach to treat peripheral nerve injury, particularly injuries resulting from surgical procedures such as RP, where treatments depleting FL2 could be applied locally at the time of injury.
]]></description>
<dc:creator>Baker, L. A.</dc:creator>
<dc:creator>Tar, M.</dc:creator>
<dc:creator>Villegas, G.</dc:creator>
<dc:creator>Charafeddine, R.</dc:creator>
<dc:creator>Kramer, A.</dc:creator>
<dc:creator>Vafaeva, O.</dc:creator>
<dc:creator>Nacharaju, P.</dc:creator>
<dc:creator>Friedman, J.</dc:creator>
<dc:creator>Davies, K.</dc:creator>
<dc:creator>Sharp, D.</dc:creator>
<dc:date>2020-03-20</dc:date>
<dc:identifier>doi:10.1101/2020.03.19.999508</dc:identifier>
<dc:title><![CDATA[Fidgetin-like 2 is a novel negative regulator of axonal growth and can be targeted to promote functional nerve regeneration after injury.]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-03-20</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.03.20.001032v1?rss=1">
<title>
<![CDATA[
Neural Correlates of Positive and Negative Valence System Dysfunction in Adolescents Revealed by Data-Driven Parcellation and Resting-State Network Modeling 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.03.20.001032v1?rss=1</link>
<description><![CDATA[
ObjectiveAdolescence is a period of rapid brain development when symptoms of mood, anxiety, and other disorders often first emerge, suggesting disruptions in maturing reward circuitry may play a role in mental illness onset. Here, we characterized associations between resting-state network properties and psychiatric symptomatology in medication-free adolescents with a wide range of symptom severity.

MethodsAdolescents (age 12-20) with mood and/or anxiety symptoms (n=68) and healthy controls (n=19) completed diagnostic interviews, depression/anhedonia/anxiety questionnaires, and 3T resting-state fMRI (10min/2.3mm/TR=1s). Data were preprocessed (HCP Pipelines), aligned (MSMAll), and parcellated into 750 nodes encompassing the entire cortex/subcortex (Cole-Anticevic Brain-wide Network Partition). Weighted graph theoretical metrics (Strength Centrality=CStr; Eigenvector Centrality=CEig; Local Efficiency=ELoc) were estimated within Whole Brain and task-derived Reward Anticipation/Attainment/Prediction Error networks. Associations with clinical status and symptoms were assessed non-parametrically (two-tailed pFWE<0.05).

ResultsRelative to controls, clinical adolescents had increased ventral striatum CEig within the Reward Attainment network. Across subjects, depression correlated with subgenual cingulate CStr and ELoc, anhedonia correlated with ventromedial prefrontal CStr and lateral amygdala ELoc, and anxiety negatively correlated with parietal operculum CEig and medial amygdala ELoc within the Whole Brain network.

ConclusionsUsing a data-driven analysis approach, high-quality parcellation, and clinically diverse adolescent cohort, we found that symptoms within positive and negative valence system constructs differentially associated with resting-state network abnormalities: depression and anhedonia, as well as clinical status, involved greater influence and communication efficiency in prefrontal and limbic reward areas, whereas anxiety was linked to reduced influence/efficiency in amygdala and cortical regions involved in stimulus monitoring.
]]></description>
<dc:creator>Gabbay, V.</dc:creator>
<dc:creator>Liu, Q.</dc:creator>
<dc:creator>DeWitt, S. J.</dc:creator>
<dc:creator>Mehra, L. M.</dc:creator>
<dc:creator>Alonso, C. M.</dc:creator>
<dc:creator>Ely, B. A.</dc:creator>
<dc:date>2020-03-23</dc:date>
<dc:identifier>doi:10.1101/2020.03.20.001032</dc:identifier>
<dc:title><![CDATA[Neural Correlates of Positive and Negative Valence System Dysfunction in Adolescents Revealed by Data-Driven Parcellation and Resting-State Network Modeling]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-03-23</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.03.21.001602v1?rss=1">
<title>
<![CDATA[
A role for KIF9 in male fertility 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.03.21.001602v1?rss=1</link>
<description><![CDATA[
A mouse was generated containing a floxed exon 3 of the gene for the kinesin family member KIF9. By in situ hybridization, expression of KIF9 mRNA was highest in the testis and was also strong in epithelia containing multi-ciliated cells such as the ependyma, bronchioles and oviduct. Deletion of the exon led to loss of KIF9 expression at the mRNA and protein level with no effect on viability. However, homozygous KIF9 knockout males were sterile. Although KIF9 knockout sperm were motile, they were unable to fertilize oocytes in an in vitro fertilization assay. Closer examination of sperm motility indicated a subtle difference in waveform. Our results suggest that KIF9 plays a role male fertility, possibly through regulation of flagellar waveforms in ciliated cells.
]]></description>
<dc:creator>Chen, K.</dc:creator>
<dc:creator>Cho, S. Y.</dc:creator>
<dc:creator>Zhang, Y.</dc:creator>
<dc:creator>Beck, A.</dc:creator>
<dc:creator>Segall, J. E.</dc:creator>
<dc:date>2020-03-23</dc:date>
<dc:identifier>doi:10.1101/2020.03.21.001602</dc:identifier>
<dc:title><![CDATA[A role for KIF9 in male fertility]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-03-23</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.03.26.009522v1?rss=1">
<title>
<![CDATA[
Loss of dmrt1 restores female fates in the absence of cyp19a1a but not rbpms2 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.03.26.009522v1?rss=1</link>
<description><![CDATA[
Sex determination and differentiation is a complex process regulated by multiple factors, including factors from the germline or surrounding somatic tissue. In zebrafish, sex-determination begins with establishment of a bipotential gonad that undergoes sex-specific differentiation and maintenance to form the functional adult gonad. However, the relationships among these factors are not fully understood. Here we identify potential Rbpms2 targets and apply genetic epistasis experiments to decipher the genetic hierarchy of regulators of sex-specific differentiation. We provide evidence that the critical female factor, rbpms2 is epistatic to the male factor dmrt1 in terms of adult sex. Moreover, Rbpms2s role in promoting female fates extends beyond repression of Dmrt1, as Rbpms2 is essential for female differentiation even in the absence of Dmrt1. In contrast, female fates can be restored in mutants lacking cyp19a1a in the absence of dmrt1. Taken together this work indicates that Cyp19a1a-mediated suppression of Dmrt1 is key to establish a bipotential gonad and initiate female fate acquisition, possibly by promoting rbpms2. Then, after female fate specification, Cyp19a1a regulates subsequent oocyte maturation and sustains female fates independent of Dmrt1 repression.

Author SummaryWe show that cyp19a1a-mediated suppression of dmrt1 establishes a bipotential gonad and female fate acquisition, possibly through rbpms2 which is required for female fates, even in the absence of Dmrt1.
]]></description>
<dc:creator>Romano, S.</dc:creator>
<dc:creator>Kaufman, O. H.</dc:creator>
<dc:creator>Marlow, F.</dc:creator>
<dc:date>2020-03-26</dc:date>
<dc:identifier>doi:10.1101/2020.03.26.009522</dc:identifier>
<dc:title><![CDATA[Loss of dmrt1 restores female fates in the absence of cyp19a1a but not rbpms2]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-03-26</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.03.31.018747v1?rss=1">
<title>
<![CDATA[
Nuclear Import of the HIV-1 Core Precedes Reverse Transcription and Uncoating 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.03.31.018747v1?rss=1</link>
<description><![CDATA[
HIV-1 particles contain a core formed by ~1500 capsid protein monomers housing viral RNA. HIV-1 core uncoating---disassembly---is required for infection. HIV-1 reverse transcription (RT) occurs before or during uncoating, but the cellular compartment where RT and uncoating occurs is unknown. Using imaging and biochemical assays to track HIV-1 capsids in nuclei during infection, we demonstrated that higher-order capsid complexes or complete cores containing viral genome are imported into nuclear compartments. Additionally, inhibition of RT that stabilizes the core during infection does not prevent capsid nuclear import; thus, RT may occur in nuclear compartments. We separated infected cells into cytosolic and nuclear fractions to measure RT during infection. Most observable RT intermediates were enriched in nuclear fractions, suggesting that most HIV-1 RT occurs in the nuclear compartment alongside uncoating. Thus, nuclear import precedes RT and uncoating, fundamentally changing our understanding of HIV-1 infection.
]]></description>
<dc:creator>Selyutina, A.</dc:creator>
<dc:creator>Persaud, M.</dc:creator>
<dc:creator>Lee, K.</dc:creator>
<dc:creator>KewalRamani, V.</dc:creator>
<dc:creator>Diaz-Griffero, F.</dc:creator>
<dc:date>2020-04-01</dc:date>
<dc:identifier>doi:10.1101/2020.03.31.018747</dc:identifier>
<dc:title><![CDATA[Nuclear Import of the HIV-1 Core Precedes Reverse Transcription and Uncoating]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-04-01</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.04.03.024042v1?rss=1">
<title>
<![CDATA[
Common Fronto-temporal Effective Connectivity in Humans and Monkeys 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.04.03.024042v1?rss=1</link>
<description><![CDATA[
Cognitive pathways supporting human language and declarative memory are thought to have uniquely evolutionarily differentiated in our species. However, cross-species comparisons are missing on site-specific effective connectivity between regions important for cognition. We harnessed a new approach using functional imaging to visualize the impact of direct electrical brain stimulation in human neurosurgery patients. Applying the same approach with macaque monkeys, we found remarkably comparable patterns of effective connectivity between auditory cortex and ventro-lateral prefrontal cortex (vlPFC) and parahippocampal cortex in both species. Moreover, in humans electrical tractography revealed rapid evoked potentials in vlPFC from stimulating auditory cortex and speech sounds drove vlPFC, consistent with prior evidence in monkeys of direct projections from auditory cortex to vocalization responsive regions in vlPFC. The results identify a common effective connectivity signature that from auditory cortex is equally direct to vlPFC and indirect to the hippocampus (via parahippocampal cortex) in human and nonhuman primates.

HighlightsO_LIPrivileged human auditory to inferior frontal connectivity, linked to monkeys
C_LIO_LICommon auditory to parahippocampal effective connectivity in both species
C_LIO_LIGreater lateralization in human effective connectivity, more symmetrical in monkeys
C_LIO_LIHuman fronto-temporal network function rooted in evolutionarily conserved signature
C_LI

eTOC short summaryFunctional connectivity between regions crucial for language and declarative memory is thought to have substantially differentiated in humans. Using a new technique to similarly visualize directional effective connectivity in humans and monkeys, we found remarkably comparable connectivity patterns in both species between fronto-temporal regions crucial for cognition.
]]></description>
<dc:creator>Rocchi, F.</dc:creator>
<dc:creator>Oya, H.</dc:creator>
<dc:creator>Balezeau, F.</dc:creator>
<dc:creator>Billig, A. J.</dc:creator>
<dc:creator>Kocsis, Z.</dc:creator>
<dc:creator>Jenison, R.</dc:creator>
<dc:creator>Nourski, K. V.</dc:creator>
<dc:creator>Kovach, C. K.</dc:creator>
<dc:creator>Steinschneider, M.</dc:creator>
<dc:creator>Kikuchi, Y.</dc:creator>
<dc:creator>Rhone, A. E.</dc:creator>
<dc:creator>Dlouhy, B. J.</dc:creator>
<dc:creator>Kawasaki, H.</dc:creator>
<dc:creator>Adolphs, R.</dc:creator>
<dc:creator>Greenlee, J. D. W.</dc:creator>
<dc:creator>Griffiths, T. D.</dc:creator>
<dc:creator>Howard, M. A.</dc:creator>
<dc:creator>Petkov, C. I.</dc:creator>
<dc:date>2020-04-05</dc:date>
<dc:identifier>doi:10.1101/2020.04.03.024042</dc:identifier>
<dc:title><![CDATA[Common Fronto-temporal Effective Connectivity in Humans and Monkeys]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-04-05</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.04.06.027540v1?rss=1">
<title>
<![CDATA[
The dynamic Nexus: Gap junctions control protein localization and mobility in distinct and surprising ways 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.04.06.027540v1?rss=1</link>
<description><![CDATA[
Gap junction (GJ) channels permit molecules, such as ions, metabolites and second messengers, to transfer between cells. Their function is critical for numerous cellular interactions. GJ channels are composed of Connexin (Cx) hexamers paired across extracellular space and typically form large rafts of clustered channels, called plaques, at cell appositions. Cxs together with molecules that interact with GJ channels make up a supramolecular structure known as the GJ Nexus. While the stability of connexin localization in GJ plaques has been studied, mobility of other Nexus components has yet to be addressed. Colocalization analysis of several nexus components and other membrane proteins reveal that certain molecules are excluded from the GJ plaque (Aquaporin 4, EAAT2b), while others are quite penetrant (lipophilic molecules, Cx30, ZO-1, Occludin). Fluorescence recovery after photobleaching (FRAP) of tagged Nexus-associated proteins showed that mobility in plaque domains is affected by mobility of the Cx proteins. These novel findings indicate that the GJ Nexus is a dynamic membrane organelle, with cytoplasmic and membrane-embedded proteins binding and diffusing according to distinct parameters.

Summary StatementGap junctions are clustered membrane channels in plasma membrane of astrocytes and other cells. We report new information on how gap junctions control location and mobility of other astrocyte proteins.
]]></description>
<dc:creator>McCutcheon, S.</dc:creator>
<dc:creator>Stout, R. F.</dc:creator>
<dc:creator>Spray, D. C.</dc:creator>
<dc:date>2020-04-07</dc:date>
<dc:identifier>doi:10.1101/2020.04.06.027540</dc:identifier>
<dc:title><![CDATA[The dynamic Nexus: Gap junctions control protein localization and mobility in distinct and surprising ways]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-04-07</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.04.14.041335v1?rss=1">
<title>
<![CDATA[
Spatio-temporal mapping of mechanical force generated by macrophages during FcγR-dependent phagocytosis reveals adaptation to target stiffness 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.04.14.041335v1?rss=1</link>
<description><![CDATA[
Macrophage phagocytosis is a strikingly flexible process central to pathogen clearance and is an attractive target for the development of anti-cancer immunotherapies. To harness the adaptability of phagocytosis, we must understand how macrophages can successfully deform their plasma membrane. While the signaling pathways and the molecular motors responsible for this deformation have been studied for many years, we only have limited insight into the mechanics that drive the formation of the phagocytic cup. Using Traction Force Microscopy (TFM), we have been able to characterize the spatio-temporal dynamics of mechanical forces generated in the course of Fc{gamma}R-dependent frustrated phagocytosis and we determined whether this was affected by the stiffness of the potential phagocytic targets. We observed that frustrated phagocytosis is an atypical form of spreading where the cell deformation rate is unaffected by the substrate stiffness. Interestingly, the cell initially extends without forces being recorded then switches to a mode of pseudopod extension involving spatially organized force transmission. Importantly we demonstrate that macrophages adapt to the substrate stiffness primarily through a modulation of the magnitude of mechanical stress exerted, and not through modification of the mechanical stress kinetics or distribution. Altogether, we suggest that macrophage phagocytosis exhibits a clear resilience to variations of the phagocytic target stiffness and this is favored by an adaptation of their mechanical response.
]]></description>
<dc:creator>Rougerie, P.</dc:creator>
<dc:creator>Cox, D.</dc:creator>
<dc:date>2020-04-15</dc:date>
<dc:identifier>doi:10.1101/2020.04.14.041335</dc:identifier>
<dc:title><![CDATA[Spatio-temporal mapping of mechanical force generated by macrophages during FcγR-dependent phagocytosis reveals adaptation to target stiffness]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-04-15</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.04.14.041483v1?rss=1">
<title>
<![CDATA[
A multi-layered and dynamic apical extracellular matrix shapes the vulva lumen in Caenorhabditis elegans 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.04.14.041483v1?rss=1</link>
<description><![CDATA[
Biological tubes must develop and maintain their proper diameter in order to transport materials efficiently. These tubes are molded and protected in part by apical extracellular matrices (aECMs) that line their lumens. Despite their importance, aECMs are difficult to image in vivo and therefore poorly understood. The C. elegans vulva has been a paradigm for understanding many aspects of organogenesis. Here we describe the vulva luminal matrix, which contains chondroitin proteoglycans, Zona Pellucida (ZP) domain proteins, and other glycoproteins and lipid transporters related to those in mammals. Confocal and transmission electron microscopy revealed, with unprecedented detail, a complex and dynamic aECM. Different matrix factors assemble on the apical surfaces of each vulva cell type, with clear distinctions seen between Ras-dependent (1{degrees}) and Notch-dependent (2{degrees}) cell types. Genetic perturbations suggest that chondroitin and other aECM factors together generate a structured scaffold that both expands and constricts lumen shape.
]]></description>
<dc:creator>Cohen, J. D.</dc:creator>
<dc:creator>Sparacio, A. P.</dc:creator>
<dc:creator>Belfi, A. C.</dc:creator>
<dc:creator>Forman-Rubinsky, R.</dc:creator>
<dc:creator>Hall, D. H.</dc:creator>
<dc:creator>Maul-Newby, H.</dc:creator>
<dc:creator>Frand, A. R.</dc:creator>
<dc:creator>Sundaram, M. V.</dc:creator>
<dc:date>2020-04-15</dc:date>
<dc:identifier>doi:10.1101/2020.04.14.041483</dc:identifier>
<dc:title><![CDATA[A multi-layered and dynamic apical extracellular matrix shapes the vulva lumen in Caenorhabditis elegans]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-04-15</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.04.18.048124v1?rss=1">
<title>
<![CDATA[
Neurophysiological indices of audiovisual speech integration are enhanced at the phonetic level for speech in noise 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.04.18.048124v1?rss=1</link>
<description><![CDATA[
Seeing a speakers face benefits speech comprehension, especially in challenging listening conditions. This perceptual benefit is thought to stem from the neural integration of visual and auditory speech at multiple stages of processing, whereby movement of a speakers face provides temporal cues to auditory cortex, and articulatory information from the speakers mouth can aid recognizing specific linguistic units (e.g., phonemes, syllables). However it remains unclear how the integration of these cues varies as a function of listening conditions. Here we sought to provide insight on these questions by examining EEG responses to natural audiovisual, audio, and visual speech in quiet and in noise. Specifically, we represented our speech stimuli in terms of their spectrograms and their phonetic features, and then quantified the strength of the encoding of those features in the EEG using canonical correlation analysis. The encoding of both spectrotemporal and phonetic features was shown to be more robust in audiovisual speech responses then what would have been expected from the summation of the audio and visual speech responses, consistent with the literature on multisensory integration. Furthermore, the strength of this multisensory enhancement was more pronounced at the level of phonetic processing for speech in noise relative to speech in quiet, indicating that listeners rely more on articulatory details from visual speech in challenging listening conditions. These findings support the notion that the integration of audio and visual speech is a flexible, multistage process that adapts to optimize comprehension based on the current listening conditions.

Significance StatementDuring conversation, visual cues impact our perception of speech. Integration of auditory and visual speech is thought to occur at multiple stages of speech processing and vary flexibly depending on the listening conditions. Here we examine audiovisual integration at two stages of speech processing using the speech spectrogram and a phonetic representation, and test how audiovisual integration adapts to degraded listening conditions. We find significant integration at both of these stages regardless of listening conditions, and when the speech is noisy, we find enhanced integration at the phonetic stage of processing. These findings provide support for the multistage integration framework and demonstrate its flexibility in terms of a greater reliance on visual articulatory information in challenging listening conditions.
]]></description>
<dc:creator>O'Sullivan, A. E.</dc:creator>
<dc:creator>Crosse, M. J.</dc:creator>
<dc:creator>Di Liberto, G. M.</dc:creator>
<dc:creator>de Cheveigne, A.</dc:creator>
<dc:creator>Lalor, E. C.</dc:creator>
<dc:date>2020-04-20</dc:date>
<dc:identifier>doi:10.1101/2020.04.18.048124</dc:identifier>
<dc:title><![CDATA[Neurophysiological indices of audiovisual speech integration are enhanced at the phonetic level for speech in noise]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-04-20</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.04.20.050062v1?rss=1">
<title>
<![CDATA[
One-shot analysis of translated mammalian lncRNAs with AHARIBO 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.04.20.050062v1?rss=1</link>
<description><![CDATA[
A vast portion of the mammalian genome is transcribed as long non-coding RNAs (lncRNAs) acting in the cytoplasm with largely unknown functions. Surprisingly, lncRNAs have been shown to interact with ribosomes, encode uncharacterized proteins, or act as ribosome sponges. These functions still remain mostly undetected and understudied owing to the lack of efficient tools for genome-wide simultaneous identification of ribosome-associated lncRNAs and peptide-producing lncRNAs.

Here we present AHARIBO, a method for the detection of lncRNAs either untranslated, but associated with ribosomes, or encoding small peptides. Using AHARIBO in mouse embryonic stem cells during neuronal differentiation, we isolated ribosome-protected RNA fragments, translated RNAs and corresponding de novo synthesized polypeptides. Besides identifying mRNAs under active translation and associated ribosomes, we found and distinguished lncRNAs acting as ribosome sponges or encoding micropeptides, laying the ground for a better functional understanding of hundreds lncRNAs.
]]></description>
<dc:creator>Minati, L.</dc:creator>
<dc:creator>Firrito, C.</dc:creator>
<dc:creator>Del Piano, A.</dc:creator>
<dc:creator>Peretti, A.</dc:creator>
<dc:creator>Sidoli, S.</dc:creator>
<dc:creator>Peroni, D.</dc:creator>
<dc:creator>Belli, R.</dc:creator>
<dc:creator>Gandolfi, F.</dc:creator>
<dc:creator>Romanel, A.</dc:creator>
<dc:creator>Bernabo, P.</dc:creator>
<dc:creator>Zasso, J.</dc:creator>
<dc:creator>Quattrone, A.</dc:creator>
<dc:creator>Guella, G.</dc:creator>
<dc:creator>Lauria, F.</dc:creator>
<dc:creator>Viero, G.</dc:creator>
<dc:creator>Clamer, M.</dc:creator>
<dc:date>2020-04-20</dc:date>
<dc:identifier>doi:10.1101/2020.04.20.050062</dc:identifier>
<dc:title><![CDATA[One-shot analysis of translated mammalian lncRNAs with AHARIBO]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-04-20</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.04.29.068932v1?rss=1">
<title>
<![CDATA[
Atypical response inhibition and error processing in 22q11.2 Deletion Syndrome and Schizophrenia: Towards neuromarkers of disease progression and risk 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.04.29.068932v1?rss=1</link>
<description><![CDATA[
22q11.2 deletion syndrome (also known as DiGeorge syndrome or velo-cardio-facial syndrome) is characterized by increased vulnerability to neuropsychiatric symptoms, with approximately 30% of individuals with the deletion going on to develop schizophrenia. Clinically, deficits in executive function have been noted in this population, but the underlying neural processes are not well understood. Using a Go/No-Go response inhibition task in conjunction with high-density electrophysiological recordings (EEG), we sought to investigate the behavioral and neural dynamics of inhibition of a prepotent response (a critical component of executive function) in individuals with 22q11.2DS with and without psychotic symptoms, when compared to individuals with idiopathic schizophrenia and age-matched neurotypical controls. Twenty-eight participants diagnosed with 22q11.2DS (14-35 years old; 14 with at least one psychotic symptom), 15 individuals diagnosed with schizophrenia (18-63 years old) and two neurotypical control groups (one age-matched to the 22q11.2DS sample, the other age-matched to the schizophrenia sample) participated in this study. Analyses focused on the N2 and P3 no-go responses and error-related negativity (Ne) and positivity (Pe). Atypical inhibitory processing was shown behaviorally and by significantly reduced P3, Ne, and Pe responses in 22q11.2DS and schizophrenia. Interestingly, whereas P3 was only reduced in the presence of psychotic symptoms, Ne and Pe were equally reduced in schizophrenia and 22q11.2DS, regardless of the presence of symptoms. We argue that while P3 may be a marker of disease severity, Ne and Pe might be candidate markers of risk.
]]></description>
<dc:creator>Francisco, A. A.</dc:creator>
<dc:creator>Horsthuis, D. J.</dc:creator>
<dc:creator>Popiel, M.</dc:creator>
<dc:creator>Foxe, J. J.</dc:creator>
<dc:creator>Molholm, S.</dc:creator>
<dc:date>2020-05-01</dc:date>
<dc:identifier>doi:10.1101/2020.04.29.068932</dc:identifier>
<dc:title><![CDATA[Atypical response inhibition and error processing in 22q11.2 Deletion Syndrome and Schizophrenia: Towards neuromarkers of disease progression and risk]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-05-01</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.05.02.074096v1?rss=1">
<title>
<![CDATA[
Multiethnic catalog of structural variants and their translational impact for disease phenotypes across 19,652 genomes 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.05.02.074096v1?rss=1</link>
<description><![CDATA[
Genome sequencing at population scale provides unprecedented access to the genetic foundations of human phenotypic diversity, but genotype-phenotype association analyses limited to small variants have failed to comprehensively characterize the genetic architecture of human health and disease because they ignore structural variants (SVs) known to contribute to phenotypic variation and pathogenic conditions1-3. Here we demonstrate the significance of SVs when assessing genotype-phenotype associations and the importance of ethnic diversity in study design by analyzing SVs across 19,652 individuals and the translational impact on 4,156 aptamerbased proteomic measurements across 4,021 multi-ethnic samples. The majority of 304,533 SVs detected are rare, although we identified 2,336 protein-coding genes impacted by common SVs.

We identified 64 significant SV-protein associations that comprise 36 cis- and 28 trans-acting relationships, and 21 distinct SV regions overlapped with genome-wide association study loci. These findings represent a more comprehensive mapping of regulatory and translational endophenotypes underlying health and disease.
]]></description>
<dc:creator>Sedlazeck, F. J.</dc:creator>
<dc:creator>Yu, B.</dc:creator>
<dc:creator>Mansfield, A. J.</dc:creator>
<dc:creator>Chen, H.</dc:creator>
<dc:creator>Krasheninina, O.</dc:creator>
<dc:creator>Tin, A.</dc:creator>
<dc:creator>Qi, Q.</dc:creator>
<dc:creator>Zarate, S.</dc:creator>
<dc:creator>Traynelis, J.</dc:creator>
<dc:creator>Menon, V.</dc:creator>
<dc:creator>BCM HGSC Sequencing Lab,</dc:creator>
<dc:creator>Hu, J.</dc:creator>
<dc:creator>doddapaneni, h. v.</dc:creator>
<dc:creator>Metcalf, G.</dc:creator>
<dc:creator>Coresh, J.</dc:creator>
<dc:creator>Kaplan, R.</dc:creator>
<dc:creator>muzny, d. m.</dc:creator>
<dc:creator>Jun, G.</dc:creator>
<dc:creator>Gibbs, R. A.</dc:creator>
<dc:creator>Salerno, W.</dc:creator>
<dc:creator>Boerwinkle, E.</dc:creator>
<dc:date>2020-05-03</dc:date>
<dc:identifier>doi:10.1101/2020.05.02.074096</dc:identifier>
<dc:title><![CDATA[Multiethnic catalog of structural variants and their translational impact for disease phenotypes across 19,652 genomes]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-05-03</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.05.05.080085v1?rss=1">
<title>
<![CDATA[
Direct intracellular visualization of Ebola virus-receptor interaction by in situ proximity ligation 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.05.05.080085v1?rss=1</link>
<description><![CDATA[
Ebola virus (EBOV) entry into host cells comprises stepwise and extensive interactions of the sole viral surface glycoprotein GP with multiple host factors. During the intricate process, following virus uptake and trafficking to late endosomal/lysosomal compartments, GP is proteolytically processed to GPCL by the endosomal proteases cathepsin B and L unmasking GPs receptor-binding site. Engagement of GPCL with the universal filoviral intracellular receptor Niemann-Pick C1 (NPC1) eventually culminates in fusion between viral and cellular membranes, cytoplasmic escape of the viral nucleocapsid and subsequent infection. Mechanistic delineation of the indispensable GPCL:NPC1 binding step has been severely hampered by the unavailability of a robust cell-based assay assessing interaction of GPCL with full-length endosomal NPC1.

Here, we describe a novel in situ assay to monitor GPCL:NPC1 engagement in intact, infected cells. Visualization of the subcellular localization of binding complexes is based on the principle of DNA-assisted, antibody-mediated proximity ligation. Virus-receptor binding monitored by proximity ligation was contingent on GPs proteolytic cleavage, and was sensitive to perturbations in the GPCL:NPC1 interface. Our assay also specifically decoupled detection of virus-receptor binding from steps post-receptor binding, such as membrane fusion and infection. Testing of multiple FDA-approved small molecule inhibitors revealed that drug treatments inhibited virus entry and GPCL:NPC1 recognition by distinctive mechanisms. Together, here we present a newly established proximity ligation assay, which will allow us to dissect cellular and viral requirements for filovirus-receptor binding, and to delineate the mechanisms of action of inhibitors on filovirus entry in a cell-based system.

IMPORTANCEEbola virus causes episodic but increasingly frequent outbreaks of severe disease in Middle Africa, as shown by a currently ongoing outbreak in the Democratic Republic of Congo. Despite considerable effort, FDA-approved anti-filoviral therapeutics or targeted interventions are not available yet. Virus host-cell invasion represents an attractive target for antivirals; however our understanding of the inhibitory mechanisms of novel therapeutics is often hampered by fragmented knowledge of the filovirus-host molecular interactions required for viral infection. To help close this critical knowledge gap, here, we report an in situ assay to monitor binding of the EBOV glycoprotein to its receptor NPC1 in intact, infected cells. We demonstrate that our in situ assay based on proximity ligation represents a powerful tool to delineate receptor-viral glycoprotein interactions. Similar assays can be utilized to examine receptor interactions of diverse viral surface proteins whose studies have been hampered until now by the lack of robust in situ assays.
]]></description>
<dc:creator>Mittler, E.</dc:creator>
<dc:creator>Alkutkar, T. P.</dc:creator>
<dc:creator>Jangra, R. K.</dc:creator>
<dc:creator>Chandran, K.</dc:creator>
<dc:date>2020-05-06</dc:date>
<dc:identifier>doi:10.1101/2020.05.05.080085</dc:identifier>
<dc:title><![CDATA[Direct intracellular visualization of Ebola virus-receptor interaction by in situ proximity ligation]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-05-06</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.05.07.083154v1?rss=1">
<title>
<![CDATA[
Oscillatory entrainment mechanisms and anticipatory predictive processes in Autism Spectrum Disorder (ASD) 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.05.07.083154v1?rss=1</link>
<description><![CDATA[
Anticipating near-future events is fundamental to adaptive behavior, whereby neural processing of predictable stimuli is significantly facilitated relative to non-predictable inputs. Neural oscillations appear to be a key anticipatory mechanism by which processing of upcoming stimuli is modified, and they often entrain to rhythmic environmental sequences. Clinical and anecdotal observations have led to the hypothesis that people with Autism Spectrum Disorder (ASD) may have deficits in generating predictions in daily life, and as such, a candidate neural mechanism may be failure to adequately entrain neural activity to repetitive environmental patterns. Here, we tested this hypothesis by interrogating rhythmic entrainment both behaviorally and electrophysiologically. We recorded high-density electroencephalography in children with ASD (n=31) and Typically Developing (TD) age- and IQ-matched controls (n=20), while they reacted to an auditory target as quickly as possible. This auditory event was either preceded by predictive rhythmic visual cues, or not. Results showed that while both groups presented highly comparable evoked responses to the visual stimuli, children with ASD showed reduced neural entrainment to the rhythmic visual cues, and altered anticipation of the occurrence of these stimuli. Further, in both groups, neuro-oscillatory phase coherence correlated with behavior. These results describe neural processes that may underlie impaired event anticipation in children with ASD, and support the notion that their perception of events is driven more by instantaneous sensory inputs and less by their temporal predictability.
]]></description>
<dc:creator>Beker, S.</dc:creator>
<dc:creator>Foxe, J. J.</dc:creator>
<dc:creator>Molholm, S.</dc:creator>
<dc:date>2020-05-08</dc:date>
<dc:identifier>doi:10.1101/2020.05.07.083154</dc:identifier>
<dc:title><![CDATA[Oscillatory entrainment mechanisms and anticipatory predictive processes in Autism Spectrum Disorder (ASD)]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-05-08</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.05.13.093872v1?rss=1">
<title>
<![CDATA[
The Effect of a Ketogenic Diet and Synergy with Rapamycin in a Mouse Model of Breast Cancer. 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.05.13.093872v1?rss=1</link>
<description><![CDATA[
BackgroundThe effects of diet in cancer, in general, and breast cancer in particular, are not well understood. Insulin inhibition in ketogenic, high fat diets, modulate downstream signaling molecules and are postulated to have therapeutic benefits. Obesity and diabetes have been associated with higher incidence of breast cancer. Addition of anti-cancer drugs together with diet is also not well studied.

MethodsTwo diets, one ketogenic, the other standard mouse chow, were tested in a spontaneous breast cancer model in mice. The diets were implemented either with or without added rapamycin, an mTOR inhibitor and potential anti-cancer drug.

ResultsBlood glucose and insulin concentrations in mice ingesting the ketogenic diet (KD) were significantly lower, whereas beta hydroxybutyrate (BHB) levels were significantly higher, respectively, than in mice on the standard diet (SD). Growth of primary breast tumors and lung metastases were inhibited, and lifespans were longer in the KD mice compared to mice on the SD (p<0.005). Rapamycin improved survival in both mouse diet groups, but when combined with the KD was more effective than when combined with the SD.

ConclusionsThe study provides proof of principle that a ketogenic diet a) results in serum insulin reduction and ketosis in a spontaneous breast cancer mouse model; b) can serve as a therapeutic anti-cancer agent; and c) can enhance the effects of rapamycin, an anti-cancer drug, permitting dose reduction for comparable effect. Further, the ketogenic diet in this model produces superior cancer control than standard mouse chow whether with or without added rapamycin.
]]></description>
<dc:creator>Zou, Y.</dc:creator>
<dc:creator>Feinman, R. D.</dc:creator>
<dc:creator>Fineberg, S.</dc:creator>
<dc:creator>Pearlman, A.</dc:creator>
<dc:creator>Fine, E. J.</dc:creator>
<dc:date>2020-05-13</dc:date>
<dc:identifier>doi:10.1101/2020.05.13.093872</dc:identifier>
<dc:title><![CDATA[The Effect of a Ketogenic Diet and Synergy with Rapamycin in a Mouse Model of Breast Cancer.]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-05-13</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.05.15.096511v1?rss=1">
<title>
<![CDATA[
Broad sarbecovirus neutralizing antibodies define a key site of vulnerability on the SARS-CoV-2 spike protein 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.05.15.096511v1?rss=1</link>
<description><![CDATA[
Broadly protective vaccines against known and pre-emergent coronaviruses are urgently needed. Critical to their development is a deeper understanding of cross-neutralizing antibody responses induced by natural human coronavirus (HCoV) infections. Here, we mined the memory B cell repertoire of a convalescent SARS donor and identified 200 SARS-CoV-2 binding antibodies that target multiple conserved sites on the spike (S) protein. A large proportion of the antibodies display high levels of somatic hypermutation and cross-react with circulating HCoVs, suggesting recall of pre-existing memory B cells (MBCs) elicited by prior HCoV infections. Several antibodies potently cross-neutralize SARS-CoV, SARS-CoV-2, and the bat SARS-like virus WIV1 by blocking receptor attachment and inducing S1 shedding. These antibodies represent promising candidates for therapeutic intervention and reveal a new target for the rational design of pan-sarbecovirus vaccines.
]]></description>
<dc:creator>Walker, L. M.</dc:creator>
<dc:creator>Wec, A. Z.</dc:creator>
<dc:creator>Wrap, D.</dc:creator>
<dc:creator>Herbert, A. S.</dc:creator>
<dc:creator>Maurer, D. P.</dc:creator>
<dc:creator>Haslwanter, D.</dc:creator>
<dc:creator>Sakharkar, M.</dc:creator>
<dc:creator>Jangra, R. K.</dc:creator>
<dc:creator>Dieterle, M. E.</dc:creator>
<dc:creator>Lilov, A.</dc:creator>
<dc:creator>Huang, D.</dc:creator>
<dc:creator>Tse, L. V.</dc:creator>
<dc:creator>Johnson, N. V.</dc:creator>
<dc:creator>Hsieh, C.-L.</dc:creator>
<dc:creator>Wang, N.</dc:creator>
<dc:creator>Nett, J. H.</dc:creator>
<dc:creator>Champney, E.</dc:creator>
<dc:creator>Burnina, I.</dc:creator>
<dc:creator>Brown, M.</dc:creator>
<dc:creator>Lin, S.</dc:creator>
<dc:creator>Sinclair, M.</dc:creator>
<dc:creator>Johnson, C.</dc:creator>
<dc:creator>Pudi, S.</dc:creator>
<dc:creator>Bortz, R.</dc:creator>
<dc:creator>Wirchnianski, A. S.</dc:creator>
<dc:creator>Laudermilch, E.</dc:creator>
<dc:creator>Florez, C.</dc:creator>
<dc:creator>Fels, J. M.</dc:creator>
<dc:creator>O'Brien, C. M.</dc:creator>
<dc:creator>Graham, B. S.</dc:creator>
<dc:creator>Nemazee, D.</dc:creator>
<dc:creator>Burton, D. R.</dc:creator>
<dc:creator>Baric, R. S.</dc:creator>
<dc:creator>Voss, J. E.</dc:creator>
<dc:creator>Chandran, K.</dc:creator>
<dc:creator>Dye, J. M.</dc:creator>
<dc:creator>McLellan, J. S.</dc:creator>
<dc:date>2020-05-15</dc:date>
<dc:identifier>doi:10.1101/2020.05.15.096511</dc:identifier>
<dc:title><![CDATA[Broad sarbecovirus neutralizing antibodies define a key site of vulnerability on the SARS-CoV-2 spike protein]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-05-15</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.05.20.105247v1?rss=1">
<title>
<![CDATA[
A replication-competent vesicular stomatitis virus for studies of SARS-CoV-2 spike-mediated cell entry and its inhibition 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.05.20.105247v1?rss=1</link>
<description><![CDATA[
There is an urgent need for vaccines and therapeutics to prevent and treat COVID-19. Rapid SARS-CoV-2 countermeasure development is contingent on the availability of robust, scalable, and readily deployable surrogate viral assays to screen antiviral humoral responses, and define correlates of immune protection, and to down-select candidate antivirals. Here, we describe a highly infectious recombinant vesicular stomatitis virus bearing the SARS-CoV-2 spike glycoprotein S as its sole entry glycoprotein that closely resembles the authentic agent in its entry-related properties. We show that the neutralizing activities of a large panel of COVID-19 convalescent sera can be assessed in high-throughput fluorescent reporter assay with rVSV-SARS-CoV-2 S and that neutralization of the rVSV and authentic SARS-CoV-2 by spike-specific antibodies in these antisera is highly correlated. Our findings underscore the utility of rVSV-SARS-CoV-2 S for the development of spike-specific vaccines and therapeutics and for mechanistic studies of viral entry and its inhibition.
]]></description>
<dc:creator>Dieterle, M. E.</dc:creator>
<dc:creator>Haslwanter, D.</dc:creator>
<dc:creator>Bortz, R. H.</dc:creator>
<dc:creator>Wirchnianski, A. S.</dc:creator>
<dc:creator>Lasso, G.</dc:creator>
<dc:creator>Vergnolle, O.</dc:creator>
<dc:creator>Abbasi, S. A.</dc:creator>
<dc:creator>Fels, J. M.</dc:creator>
<dc:creator>Laudermilch, E.</dc:creator>
<dc:creator>Florez, C.</dc:creator>
<dc:creator>Mengotto, A.</dc:creator>
<dc:creator>Kimmel, D.</dc:creator>
<dc:creator>Malonis, R. J.</dc:creator>
<dc:creator>Georgiev, G.</dc:creator>
<dc:creator>Quiroz, J.</dc:creator>
<dc:creator>Barnhill, J.</dc:creator>
<dc:creator>Pirofski, L.-A.</dc:creator>
<dc:creator>Daily, J. P.</dc:creator>
<dc:creator>Dye, J. M.</dc:creator>
<dc:creator>Lai, J. R.</dc:creator>
<dc:creator>Herbert, A. S.</dc:creator>
<dc:creator>Chandran, K.</dc:creator>
<dc:creator>Jangra, R. K.</dc:creator>
<dc:date>2020-05-20</dc:date>
<dc:identifier>doi:10.1101/2020.05.20.105247</dc:identifier>
<dc:title><![CDATA[A replication-competent vesicular stomatitis virus for studies of SARS-CoV-2 spike-mediated cell entry and its inhibition]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-05-20</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.05.22.110015v1?rss=1">
<title>
<![CDATA[
Cadherin clusters stabilized by a combination of specific and nonspecific Cis-Interactions 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.05.22.110015v1?rss=1</link>
<description><![CDATA[
We demonstrate a combined experimental and computational approach for the quantitative characterization of lateral interactions between membrane-associated proteins. In particular, weak, lateral (cis) interactions between E-cadherin extracellular domains tethered to supported lipid bilayers, were studied using a combination of dynamic single-molecule Forster Resonance Energy Transfer (FRET) and kinetic Monte Carlo (kMC) simulations. Cadherins are intercellular adhesion proteins that assemble into clusters at cell-cell contacts through cis- and trans- (adhesive) interactions. A detailed and quantitative understanding of cis-clustering has been hindered by a lack of experimental approaches capable of detecting and quantifying lateral interactions between proteins on membranes. Here single-molecule intermolecular FRET measurements of wild-type E-cadherin and cis-interaction mutants combined with simulations demonstrate that both nonspecific and specific cis-interactions contribute to lateral clustering on lipid bilayers. Moreover, the intermolecular binding and dissociation rate constants are quantitatively and independently determined, demonstrating an approach that is generalizable for other interacting proteins.
]]></description>
<dc:creator>Thompson, C. J.</dc:creator>
<dc:creator>Su, Z.</dc:creator>
<dc:creator>Vu, V. H.</dc:creator>
<dc:creator>Wu, Y.</dc:creator>
<dc:creator>Leckband, D. E.</dc:creator>
<dc:creator>Schwartz, D. K.</dc:creator>
<dc:date>2020-05-23</dc:date>
<dc:identifier>doi:10.1101/2020.05.22.110015</dc:identifier>
<dc:title><![CDATA[Cadherin clusters stabilized by a combination of specific and nonspecific Cis-Interactions]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-05-23</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.05.24.112870v1?rss=1">
<title>
<![CDATA[
Beyond the connectome: A map of a brain architecture derived from whole-brain volumetric reconstructions 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.05.24.112870v1?rss=1</link>
<description><![CDATA[
Animal nervous system organization is crucial for all body functions and its disruption can manifest in severe cognitive and behavioral impairment. This organization relies on features across scales, from nano-level localization of synapses, through multiplicities of neuronal morphologies and their contribution to circuit organization, to the high level stereotyped connections between different regions of the brain. The sheer complexity of this organ means that to date, we have yet to reconstruct and model the structure of a complete nervous system that is integrated across all these scales. Here, we present a complete structure-function model of the nematode C. elegans main neuropil, the nerve ring, which we derive by integrating the volumetric reconstruction from two animals with corresponding synaptic and gap junctional connectomes. Whereas previously the nerve ring was considered a densely packed tract of axons, we uncover internal organization into 5 functional bundles and show how they spatially constrain and support the synaptic connectome. We find that the C. elegans connectome is not invariant, but that a precisely wired core circuit is embedded in a background of variable connectivity, and propose a corresponding reference connectome for the core circuit. Using this reference, we show that the architecture of the C. elegans brain can be viewed as a modular Residual Network that supports sensory computation and integration, sensory-motor convergence, and brain-wide coordination. These findings point to scalable and robust features of brain organization that are likely universal across phyla.
]]></description>
<dc:creator>Brittin, C. A.</dc:creator>
<dc:creator>Cook, S. J.</dc:creator>
<dc:creator>Hall, D. H.</dc:creator>
<dc:creator>Emmons, S. W.</dc:creator>
<dc:creator>Cohen, N.</dc:creator>
<dc:date>2020-05-27</dc:date>
<dc:identifier>doi:10.1101/2020.05.24.112870</dc:identifier>
<dc:title><![CDATA[Beyond the connectome: A map of a brain architecture derived from whole-brain volumetric reconstructions]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-05-27</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.05.26.115006v1?rss=1">
<title>
<![CDATA[
HIV Diversity Considerations in the Application of the Intact Proviral DNA Assay (IPDA) 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.05.26.115006v1?rss=1</link>
<description><![CDATA[
Opening Paragraph (serves as abstract for submission) and BodyThe Intact Proviral DNA Assay (IPDA) was developed to address the critical need for a precise and scalable method for intact HIV reservoir quantification1. This duplexed droplet digital PCR (ddPCR) assay simultaneously targets the HIV Packaging Signal ({Psi}) and the Rev Responsive Element (RRE) within Envelope (env) to distinguish genomically intact proviruses against a large background of defective ones2. The IPDA requires less time, resources, and biological material than the gold standard for replication-competent HIV reservoir measurement, the Quantitative Viral Outgrowth Assay (QVOA)3, and is being adopted in research and clinical studies4-7. In our cohort of HIV-1 subtype B-infected individuals from North America however, the IPDA yielded a 28% failure rate due to HIV polymorphism. We further demonstrate that within-host HIV diversity can lead the IPDA to underestimate intact HIV reservoir size, which could negatively impact clinical trial results interpretation. While the IPDA represents an important methodological advance, HIV diversity should be addressed before its widespread adoption.
]]></description>
<dc:creator>Kinloch, N. N.</dc:creator>
<dc:creator>Ren, Y.</dc:creator>
<dc:creator>Conce Alberto, W. D.</dc:creator>
<dc:creator>Dong, W.</dc:creator>
<dc:creator>Khadka, P.</dc:creator>
<dc:creator>Huang, S. H.</dc:creator>
<dc:creator>Mota, T. M.</dc:creator>
<dc:creator>Wilson, A.</dc:creator>
<dc:creator>Shahid, A.</dc:creator>
<dc:creator>Kirkby, D.</dc:creator>
<dc:creator>Harris, M.</dc:creator>
<dc:creator>Kovacs, C.</dc:creator>
<dc:creator>Benko, E.</dc:creator>
<dc:creator>Ostrowski, M. A.</dc:creator>
<dc:creator>Del Rio Estrada, P. M.</dc:creator>
<dc:creator>Wimpelberg, A.</dc:creator>
<dc:creator>Cannon, C.</dc:creator>
<dc:creator>Hardy, W. D.</dc:creator>
<dc:creator>MacLaren, L.</dc:creator>
<dc:creator>Goldstein, H.</dc:creator>
<dc:creator>Brumme, C. J.</dc:creator>
<dc:creator>Lee, G. Q.</dc:creator>
<dc:creator>Lynch, R. M.</dc:creator>
<dc:creator>Brumme, Z. L.</dc:creator>
<dc:creator>Jones, R. B.</dc:creator>
<dc:date>2020-05-29</dc:date>
<dc:identifier>doi:10.1101/2020.05.26.115006</dc:identifier>
<dc:title><![CDATA[HIV Diversity Considerations in the Application of the Intact Proviral DNA Assay (IPDA)]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-05-29</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.06.01.128371v1?rss=1">
<title>
<![CDATA[
Structural basis of mechano-chemical coupling by the mitotic kinesin KIF14 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.06.01.128371v1?rss=1</link>
<description><![CDATA[
KIF14 is a mitotic kinesin protein important for cytokinesis. Its overexpression is associated with a variety of cancers and mutations in KIF14 result in cerebral and renal development defects. Like other kinesins, KIF14 contains a highly conserved catalytic motor domain where the energy from ATP hydrolysis is converted to directed movement along microtubules. Although much is known regarding the molecular mechanism of kinesin motility, there is a lack of structural information of kinesin-microtubule interactions at sufficient resolution to unambiguously assess how conformational changes related to ATP hydrolysis, microtubule binding and translocation are coupled. Here we determined the near-atomic resolution cryo-electron microscopy structures of five different KIF14 constructs bound to microtubules in the presence of different nucleotide analogues mimicking distinct steps of the ATPase cycle. Eighteen independent structures together with supporting functional assays provide a comprehensive view of the kinesin conformational changes occurring with microtubule and nucleotide binding. Our data shows that: 1) microtubule binding induces opening of the KIF14 nucleotide binding pocket; 2) AMP-PNP and ADP-AlFx induce closure of the nucleotide binding pocket in microtubule bound KIF14 and this conformational change is allosterically controlled by the neck-linker domain; 3) the neck-linker domain when undocked prevents the nucleotide-binding-pocket to fully close and dampens ATP hydrolysis; 4) fifteen neck-linker residues are required to assume the docked conformation; 5) the nucleotide analogue ADP-AlFx adopts a distinct configuration in an open nucleotide-binding-pocket; 6) the neck-linker position controls the hydrolysis step rather than nucleotide binding in the KIF14 ATPase cycle; 7) the two motor domains of a KIF14 dimer adopt distinct conformations when simultaneously bound to the microtubule. These observations provide the structural basis for a coordinated chemo-mechanical kinesin plus end translocation model.
]]></description>
<dc:creator>Benoit, M. P. M. H.</dc:creator>
<dc:creator>Asenjo, A. B.</dc:creator>
<dc:creator>Paydar, M.</dc:creator>
<dc:creator>Dhakal, S.</dc:creator>
<dc:creator>Kwok, B. H.</dc:creator>
<dc:creator>Sosa, H.</dc:creator>
<dc:date>2020-06-02</dc:date>
<dc:identifier>doi:10.1101/2020.06.01.128371</dc:identifier>
<dc:title><![CDATA[Structural basis of mechano-chemical coupling by the mitotic kinesin KIF14]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-06-02</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.06.02.129809v1?rss=1">
<title>
<![CDATA[
Nicotinamide combined with gemcitabine is an immunomodulatory therapy that restrains pancreatic cancer in mice 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.06.02.129809v1?rss=1</link>
<description><![CDATA[
Treatments for pancreatic ductal adenocarcinoma (PDAC) are poorly effective, at least partly due to the tumors immune-suppressive stromal compartment. New evidence of positive effects on immune responses in the tumor microenvironment, compelled us to test the combination of gemcitabine (GEM), a standard chemotherapeutic for pancreatic cancer, with nicotinamide (NAM), the amide form of niacin (vitamin B3), in various mouse tumor models of pancreatic cancer, i.e. peritoneal or orthotopic of Panc-02 (KrasG12D) and orthotopic KPC (KrasG12D, p53R172H, Pdx1-Cre) grafts. A significant reduction in tumor weight and number of metastases was found, as well as a significant improved survival of the NAM+GEM group compared to all control groups. Immunohistochemistry and flow cytometry of pancreatic tumors showed a significant decrease in tumor-associated macrophages (TAM) and myeloid-derived suppressor cells (MDSC), an increase in the number of CD4 and CD8 T cells and the production of granzyme B in the NAM+GEM group. Moreover, T cell responses to tumor-associated antigen survivin were observed in spleens of the mice that received NAM+GEM but not in those that received single agents or saline. In addition, remodeling of the tumor stroma was observed with decreased collagen I and expression of hyaluronic acid binding protein, reorganization of the immune cells into lymph node like structures, and CD31 positive vessels. Expression profiling for a panel of immuno-oncology genes revealed significant changes in genes involved in migration and activation of T cells, attraction of dendritic cells, and epitope spreading. This study highlights the potential of NAM+GEM as immunotherapy for advanced pancreatic cancer.
]]></description>
<dc:creator>Selvanesan, B. C.</dc:creator>
<dc:creator>Meena, K.</dc:creator>
<dc:creator>Beck, A.</dc:creator>
<dc:creator>Meheus, L.</dc:creator>
<dc:creator>Lara, O.</dc:creator>
<dc:creator>Rooman, I.</dc:creator>
<dc:creator>Gravekamp, C.</dc:creator>
<dc:date>2020-06-03</dc:date>
<dc:identifier>doi:10.1101/2020.06.02.129809</dc:identifier>
<dc:title><![CDATA[Nicotinamide combined with gemcitabine is an immunomodulatory therapy that restrains pancreatic cancer in mice]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-06-03</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.06.02.130674v1?rss=1">
<title>
<![CDATA[
Health benefits attributed to 17α-estradiol, a lifespan-extending compound, are mediated through estrogen receptor α 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.06.02.130674v1?rss=1</link>
<description><![CDATA[
Metabolic dysfunction underlies several chronic diseases, many of which are exacerbated by obesity. Dietary interventions can reverse metabolic declines and slow aging, although compliance issues remain paramount. 17-estradiol treatment improves metabolic parameters and slows aging in male mice. The mechanisms by which 17-estradiol elicits these benefits remain unresolved. Herein, we show that 17-estradiol elicits similar genomic binding and transcriptional activation through estrogen receptor  (ER) to that of 17{beta}-estradiol. In addition, we show that the ablation of ER completely attenuates the beneficial metabolic effects of 17-E2 in male mice. Our findings suggest that 17-E2 acts primarily through the liver and hypothalamus to improve metabolic parameters in male mice. Lastly, we also determined that 17-E2 improves metabolic parameters in male rats, thereby proving that the beneficial effects of 17-E2 are not limited to mice. Collectively, these studies suggest ER may be a drug target for mitigating chronic diseases in male mammals.
]]></description>
<dc:creator>Mann, S.</dc:creator>
<dc:creator>Hadad, N.</dc:creator>
<dc:creator>Nelson, M.</dc:creator>
<dc:creator>Rothman, A.</dc:creator>
<dc:creator>Sathiaseelan, R.</dc:creator>
<dc:creator>Ali-Mondal, S.</dc:creator>
<dc:creator>Agbaga, M.-P.</dc:creator>
<dc:creator>Unnikrishnan, A.</dc:creator>
<dc:creator>Malayannan, S.</dc:creator>
<dc:creator>Hawse, J.</dc:creator>
<dc:creator>Huffmam, D.</dc:creator>
<dc:creator>Freeman, W. M.</dc:creator>
<dc:creator>Stout, M. B.</dc:creator>
<dc:date>2020-06-03</dc:date>
<dc:identifier>doi:10.1101/2020.06.02.130674</dc:identifier>
<dc:title><![CDATA[Health benefits attributed to 17α-estradiol, a lifespan-extending compound, are mediated through estrogen receptor α]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-06-03</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.06.04.133439v1?rss=1">
<title>
<![CDATA[
SUMOylation of SAMHD1 at Lysine 595 is required for HIV-1 restriction in non-cycling cells 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.06.04.133439v1?rss=1</link>
<description><![CDATA[
SAMHD1 is a cellular triphosphohydrolase (dNTPase) proposed to inhibit HIV-1 reverse transcription in non-cycling immune cells by limiting the supply of the dNTP substrates. Yet, phosphorylation of T592 downregulates SAMHD1 antiviral activity, but not its dNTPase function, implying that additional mechanisms contribute to viral restriction. Here, we show that SAMHD1 is SUMOylated on residue K595, a modification that relies on the presence of a proximal SUMO-interacting motif (SIM). Loss of K595 SUMOylation suppresses the restriction activity of SAMHD1, even in the context of the constitutively active phospho-ablative T592A mutant but has no impact on dNTP depletion. Conversely, the artificial fusion of SUMO to a non-SUMOylatable inactive SAMHD1 variant restores its antiviral function. These observations clearly establish that the absence of T592 phosphorylation cannot fully account for the restriction activity of SAMHD1. We find that concomitant SUMOylation of K595 is required to stimulate a dNTPase-independent antiviral activity.
]]></description>
<dc:creator>Martinat, C.</dc:creator>
<dc:creator>Cormier, A.</dc:creator>
<dc:creator>Tobaly-Tapiero, J.</dc:creator>
<dc:creator>Palmic, N.</dc:creator>
<dc:creator>Casartelli, N.</dc:creator>
<dc:creator>Coggins, S. A.</dc:creator>
<dc:creator>Buchrieser, J.</dc:creator>
<dc:creator>Persaud, M.</dc:creator>
<dc:creator>Diaz-Griffero, F.</dc:creator>
<dc:creator>Espert, L.</dc:creator>
<dc:creator>Bossis, G.</dc:creator>
<dc:creator>Lesage, P.</dc:creator>
<dc:creator>Schwartz, O.</dc:creator>
<dc:creator>Kim, B.</dc:creator>
<dc:creator>Margottin, F.</dc:creator>
<dc:creator>Saib, A.</dc:creator>
<dc:creator>Zamborlini, A.</dc:creator>
<dc:date>2020-06-05</dc:date>
<dc:identifier>doi:10.1101/2020.06.04.133439</dc:identifier>
<dc:title><![CDATA[SUMOylation of SAMHD1 at Lysine 595 is required for HIV-1 restriction in non-cycling cells]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-06-05</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.06.06.137273v1?rss=1">
<title>
<![CDATA[
Adipose tissue-derived neurotrophic factor 3 regulates sympathetic innervation and thermogenesis in adipose tissue 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.06.06.137273v1?rss=1</link>
<description><![CDATA[
Activation of brown fat thermogenesis increases energy expenditure and alleviates obesity. Sympathetic nervous system (SNS) is important in brown/beige adipocyte thermogenesis. Here we discover a novel fat-derived “adipokine” neurotrophic factor neurotrophin 3 (NTF3) and its receptor Tropomyosin receptor kinase C (TRKC) as key regulators of SNS growth and innervation in adipose tissue. NTF3 is highly expressed in brown/beige adipocytes, and potently stimulates sympathetic neuron neurite growth. NTF3/TRKC regulates a plethora of pathways in neuronal axonal growth and elongation. Adipose tissue sympathetic innervation is significantly increased in mice with adipocyte-specific NTF3 overexpression, but profoundly reduced in mice with TRKC haploinsufficiency (TRKC+/-). Increasing NTF3 via pharmacological or genetic approach promotes beige adipocyte development, enhances cold-induced thermogenesis and protects against diet-induced obesity (DIO); whereas TRKC+/- mice or SNS TRKC deficient mice are cold intolerant and prone to DIO. Thus, NTF3 is an important fat-derived neurotrophic factor regulating SNS innervation, energy metabolism and obesity.Competing Interest StatementThe authors have declared no competing interest.View Full Text
]]></description>
<dc:creator>Cui, X.</dc:creator>
<dc:creator>Jing, J.</dc:creator>
<dc:creator>Wu, R.</dc:creator>
<dc:creator>Cao, Q.</dc:creator>
<dc:creator>Li, F.</dc:creator>
<dc:creator>Li, K.</dc:creator>
<dc:creator>Wang, S.</dc:creator>
<dc:creator>Yu, L.</dc:creator>
<dc:creator>Schwartz, G. J.</dc:creator>
<dc:creator>Shi, H.</dc:creator>
<dc:creator>Shi, H.</dc:creator>
<dc:creator>Xue, B.</dc:creator>
<dc:date>2020-06-07</dc:date>
<dc:identifier>doi:10.1101/2020.06.06.137273</dc:identifier>
<dc:title><![CDATA[Adipose tissue-derived neurotrophic factor 3 regulates sympathetic innervation and thermogenesis in adipose tissue]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-06-07</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.06.14.150607v1?rss=1">
<title>
<![CDATA[
Characterization of the SARS-CoV-2 S Protein: Biophysical, Biochemical, Structural, and Antigenic Analysis 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.06.14.150607v1?rss=1</link>
<description><![CDATA[
Coronavirus disease 2019 (COVID-19) is a global health crisis caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and there is a critical need to produce large quantities of high-quality SARS-CoV-2 Spike (S) protein for use in both clinical and basic science settings. To address this need, we have evaluated the expression and purification of two previously reported S protein constructs in Expi293F and ExpiCHO-S cells, two different cell lines selected for increased expression of secreted glycoproteins. We show that ExpiCHO-S cells produce enhanced yields of both SARS-CoV-2 S proteins. Biochemical, biophysical, and structural (cryo-EM) characterization of the SARS-CoV-2 S proteins produced in both cell lines demonstrate that the reported purification strategy yields high quality S protein (non-aggregated, uniform material with appropriate biochemical and biophysical properties). Importantly, we show that multiple preparations of these two recombinant S proteins from either cell line exhibit identical behavior in two different serology assays. We also evaluate the specificity of S protein-mediated host cell binding by examining interactions with proposed binding partners in the human secretome. In addition, the antigenicity of these proteins is demonstrated by standard ELISAs, and in a flexible protein microarray format. Collectively, we establish an array of metrics for ensuring the production of high-quality S protein to support clinical, biological, biochemical, structural and mechanistic studies to combat the global pandemic caused by SARS-CoV-2.
]]></description>
<dc:creator>Herrera, N. G.</dc:creator>
<dc:creator>Morano, N. C.</dc:creator>
<dc:creator>Celikgil, A.</dc:creator>
<dc:creator>Georgiev, G. I.</dc:creator>
<dc:creator>Malonis, R. J.</dc:creator>
<dc:creator>Lee, J. H.</dc:creator>
<dc:creator>Tong, K.</dc:creator>
<dc:creator>Vergnolle, O.</dc:creator>
<dc:creator>Massimi, A. B.</dc:creator>
<dc:creator>Yen, L. Y.</dc:creator>
<dc:creator>Noble, A. J.</dc:creator>
<dc:creator>Kopylov, M.</dc:creator>
<dc:creator>Bonanno, J. B.</dc:creator>
<dc:creator>Garrett-Thompson, S. C.</dc:creator>
<dc:creator>Hayes, D. B.</dc:creator>
<dc:creator>Brenowitz, M.</dc:creator>
<dc:creator>Garforth, S. J.</dc:creator>
<dc:creator>Eng, E. T.</dc:creator>
<dc:creator>Lai, J. R.</dc:creator>
<dc:creator>Almo, S. C.</dc:creator>
<dc:date>2020-06-15</dc:date>
<dc:identifier>doi:10.1101/2020.06.14.150607</dc:identifier>
<dc:title><![CDATA[Characterization of the SARS-CoV-2 S Protein: Biophysical, Biochemical, Structural, and Antigenic Analysis]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-06-15</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.06.15.152397v1?rss=1">
<title>
<![CDATA[
Resident macrophages establish and control lipid stores via PDGFcc production 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.06.15.152397v1?rss=1</link>
<description><![CDATA[
Macrophages control inflammation in obese animals, and may also directly or indirectly regulate energy storage. In a genetic screen we identify a PDGF-family growth factor, Pvf3, produced by macrophages and required for lipid storage in Drosophila larvaes fat body cells. We next demonstrate using genetic and pharmacological approaches that Pvf3 ortholog PDGFcc, produced by Ccr2-independent embryo-derived tissue macrophages, is also required for storage in mammalian white adipose tissue. PDGFcc production by resident macrophages is regulated by diet, acts on white adipocytes in a paracrine manner, and controls adipocyte hypertrophy in high-fat diet fed and genetically hyperphagic mice. Upon PDGFcc blockade, excess lipids are redirected at the organismal level toward thermogenesis and hepatic storage in adults. This process is altogether independent from inflammation and insulin resistance promoted by Ccr2-dependent monocytes/macrophages. Our data identify a conserved macrophagedependent mechanism that controls energy storage, conducive to the design of pharmacological interventions.
]]></description>
<dc:creator>Cox, N.</dc:creator>
<dc:creator>Crozet, L.</dc:creator>
<dc:creator>Holtman, I. R.</dc:creator>
<dc:creator>Loyher, P.-L.</dc:creator>
<dc:creator>Lazarov, T.</dc:creator>
<dc:creator>Mass, E.</dc:creator>
<dc:creator>Stanley, R.</dc:creator>
<dc:creator>Glass, C. K.</dc:creator>
<dc:creator>Geissmann, F.</dc:creator>
<dc:date>2020-06-15</dc:date>
<dc:identifier>doi:10.1101/2020.06.15.152397</dc:identifier>
<dc:title><![CDATA[Resident macrophages establish and control lipid stores via PDGFcc production]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-06-15</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.06.17.142182v1?rss=1">
<title>
<![CDATA[
Neuronal variability reflects probabilistic inference tuned to natural image statistics 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.06.17.142182v1?rss=1</link>
<description><![CDATA[
Neuronal activity in sensory cortex fluctuates over time and across repetitions of the same input. This variability is often considered detrimental to neural coding. The theory of neural sampling proposes instead that variability encodes the uncertainty of perceptual inferences. In primary visual cortex (V1), modulation of variability by sensory and non-sensory factors supports this view. However, it is unknown whether V1 variability reflects the statistical structure of visual inputs, as would be required for inferences correctly tuned to the statistics of the natural environment. Here we combine analysis of image statistics and recordings in macaque V1 to show that probabilistic inference tuned to natural image statistics explains the widely observed dependence between spike-count variance and mean, and the modulation of V1 activity and variability by spatial context in images. Our results show that the properties of a basic aspect of cortical responses -- their variability -- can be explained by a probabilistic representation tuned to naturalistic inputs.
]]></description>
<dc:creator>Festa, D.</dc:creator>
<dc:creator>Aschner, A.</dc:creator>
<dc:creator>Davila, A.</dc:creator>
<dc:creator>Kohn, A.</dc:creator>
<dc:creator>Coen-Cagli, R.</dc:creator>
<dc:date>2020-06-19</dc:date>
<dc:identifier>doi:10.1101/2020.06.17.142182</dc:identifier>
<dc:title><![CDATA[Neuronal variability reflects probabilistic inference tuned to natural image statistics]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-06-19</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.06.18.159533v1?rss=1">
<title>
<![CDATA[
A Novel Therapeutic Approach to Corneal Alkaline Burn Model by Targeting Fidgetin-like 2, a Microtubule Regulator 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.06.18.159533v1?rss=1</link>
<description><![CDATA[
Purpose To determine the efficacy of nanoparticle-encapsulated FL2 siRNA (FL2-NPsi), a novel therapeutic agent targeting the Fidgetin-like 2 (FL2) gene, for the treatment of corneal alkaline chemical injury.Methods Eighty 12-week-old, male Sprague-Dawley rats were divided evenly into 8 treatment groups: prednisolone, empty nanoparticles, control-NPsi (1 μM, 10 μM, 20 μM) and FL2-NPsi (1 μM, 10 μM, 20 μM). An alkaline burn was induced onto the cornea of each rat, which was then treated for 14 days according to group assignment. Clinical (N=10 per group), histopathologic (N=6 per group), and immunohistochemical (N=4 per group) analyses were conducted to assess for wound healing. FL2-NPsi-mediated knockdown of FL2 was confirmed by in vitro qPCR. Toxicity assays were performed to assess for apoptosis (TUNEL assay, N=3 per group) and nerve damage (whole mount immunochemical staining, N=2 per group). Statistical analyses were performed using student’s t-test and ANOVA.Results Compared to controls, FL2-NPsi-treated groups demonstrated enhanced corneal wound healing, with the 10 and 20 μM FL2-NPsi-treated groups demonstrating maximum rates of corneal re-epithelialization (p=0.0003 at Day 4 and p&lt;0.0001 at Day 8) as assessed by ImageJ software, enhanced corneal transparency, and improved stromal organization on histology. Immunohistochemical analysis of vascular endothelial cells, macrophages, and neutrophils did not show significant differences between treatment groups. FL2-NPsi was not found to be toxic to nerves or induce apoptosis (p=0.917).Conclusion Dose-response studies found both 10 and 20 μM FL2-NPsi to be efficacious in this rat model. FL2-NPsi may offer a novel treatment for corneal alkaline chemical injuries.Competing Interest StatementDr. Wang, Dr. Kramer, Dr. Baker, and Dr. Dey are employees of MicroCures, Inc. Dr. Sharp is co-founder and Chief Scientific Officer for MicroCures, Inc and is the inventor of U.S. Patent #20130022667 entitled "Fidgetin-like 2 as a target to enhance wound healing,” which has been licensed by MicroCures. Dr. Chuck is a scientific advisor for MicroCures, Inc. Dr. Friedman holds stock in MicroCures. No other author has a conflict of interest.View Full Text
]]></description>
<dc:creator>Wang, J.</dc:creator>
<dc:creator>Dey, A.</dc:creator>
<dc:creator>Kramer, A.</dc:creator>
<dc:creator>Miao, Y.</dc:creator>
<dc:creator>Liu, J.</dc:creator>
<dc:creator>Baker, L.</dc:creator>
<dc:creator>Friedman, J.</dc:creator>
<dc:creator>Nacharaju, P.</dc:creator>
<dc:creator>Chuck, R. S.</dc:creator>
<dc:creator>Zhang, C.</dc:creator>
<dc:creator>Sharp, D.</dc:creator>
<dc:date>2020-06-19</dc:date>
<dc:identifier>doi:10.1101/2020.06.18.159533</dc:identifier>
<dc:title><![CDATA[A Novel Therapeutic Approach to Corneal Alkaline Burn Model by Targeting Fidgetin-like 2, a Microtubule Regulator]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-06-19</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.06.19.161240v1?rss=1">
<title>
<![CDATA[
A forward genetic screen identifies Dolk as a regulator of startle magnitude through the potassium channel subunit Kv1.1 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.06.19.161240v1?rss=1</link>
<description><![CDATA[
The acoustic startle response is an evolutionary conserved avoidance behavior. Disruptions in startle behavior, in particular startle magnitude, are a hallmark of several human neurological disorders. While the neural circuitry underlying startle behavior has been studied extensively, the repertoire of genes and genetic pathways that regulate this locomotor behavior has not been explored using an unbiased genetic approach. To identify such genes, we took advantage of the stereotypic startle behavior in zebrafish larvae and performed a forward genetic screen coupled with whole genome analysis. This identified mutants in eight genes critical for startle behavior, including two genes encoding proteins associated with human neurological disorders, Dolichol kinase (Dolk), a broadly expressed regulator of the glycoprotein biosynthesis pathway, and the potassium Shaker-like channel subunit Kv1.1. We demonstrate that Kv1.1 acts independently of supraspinal inputs to regulate locomotion, suggesting its site of action is within spinal circuitry. Moreover, we show that Kv1.1 protein is mis-localized in dolk mutants, suggesting they act in a common genetic pathway to regulate movement magnitude. Combined, our results identify a diverse set of eight genes all associated with human disorders that regulate zebrafish startle behavior and reveal a previously unappreciated role for Dolk and Kv1.1 in regulating movement magnitude via a common genetic pathway.

Author summaryUnderlying all animal behaviors are neural circuits, which are controlled by numerous molecular pathways that direct neuron development and activity. To identify and study these molecular pathways that control behavior, we use a simple vertebrate behavior, the acoustic startle response, in the larval zebrafish. In response to an intense noise, larval zebrafish will quickly turn and swim away to escape. From a genetic screen, we have identified a number of mutants that behave in abnormal ways in response to an acoustic stimulus. We cloned these mutants and identified eight genes that regulate startle behavior. All eight genes are associated with human disorders, and here we focus on two genes, dolk and kcna1a, encoding Dolk, a key regulator of protein glycosylation, and the potassium channel Kv1.1, respectively. We demonstrate that loss of dolk or kcna1a causes larval zebrafish to perform exaggerated swim movements and that Dolk is required for Kv1.1 protein localization to axons of neurons throughout the nervous system, providing strong evidence that dolk and kcna1a act in a common molecular pathway. Combined, our studies provide new insights into the genetic regulation of startle behavior.
]]></description>
<dc:creator>Meserve, J. H.</dc:creator>
<dc:creator>Nelson, J. C.</dc:creator>
<dc:creator>Marsden, K. C.</dc:creator>
<dc:creator>Hsu, J.</dc:creator>
<dc:creator>Echeverry, F. A.</dc:creator>
<dc:creator>Jain, R. A.</dc:creator>
<dc:creator>Wolman, M. A.</dc:creator>
<dc:creator>Pereda, A. E.</dc:creator>
<dc:creator>Granato, M.</dc:creator>
<dc:date>2020-06-19</dc:date>
<dc:identifier>doi:10.1101/2020.06.19.161240</dc:identifier>
<dc:title><![CDATA[A forward genetic screen identifies Dolk as a regulator of startle magnitude through the potassium channel subunit Kv1.1]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-06-19</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.06.22.164566v1?rss=1">
<title>
<![CDATA[
Blockade of LAG-3 in PD-L1-deficient mice enhances clearance of blood stage malaria independent of humoral responses 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.06.22.164566v1?rss=1</link>
<description><![CDATA[
T cells expressing high levels of inhibitory receptors such as PD-1 and LAG-3 are a hallmark of chronic infections and cancer. Checkpoint blockade therapies targeting these receptors have been largely validated as promising strategies to restore exhausted T cell functions and clearance of chronic infections and tumors. The inability to develop long-term natural immunity in malaria-infected patients has been proposed to be at least partially accounted for by sustained expression of high levels of inhibitory receptors on T and B lymphocytes. While blockade or lack of PD-1/PD-L1 and/or LAG-3 was reported to promote better clearance of Plasmodium parasites in mice, how exactly these pathways contributes to protection is not known. Herein, using a mouse model of non-lethal P. yoelii (Py) infection, we reveal that the kinetics of blood parasitemia is indistinguishable between PD-1-/-, PD-L1-/- and WT mice. Yet, monoclonal antibody (mAb) blockade of LAG-3 in PD-L1-/- mice promoted accelerated control of blood parasite growth and clearance. We also report that i) the majority of LAG-3+ cells are T cells, ii) selective depletion of CD8+ T cells did not prevent anti-LAG-3-mediated protection, and iii) production of effector cytokines by CD4+ T cells is increased in anti-LAG-3-treated versus control mice. In addition, parasite-specific Ab serum titers and their ability to transfer protection from both groups of mice was comparable and depletion of CD4+ T cells prevented protection. Thus, taken together, these results are consistent with a model in which disruption of PD-L1 and LAG-3 on parasite-specific CD4+ T cells unleashes their ability to effectively clear blood parasites, independently from humoral responses.

Author SummaryMalaria, caused by Plasmodium parasites, is a global burden for which an efficacious vaccine is urgently needed. The development of long-term immunity against malaria is unclear, but we know that both T and B (that produce antibodies, Ab) lymphocytes, that are subsets of white blood cells, are required. Studies in mouse models of malaria have suggested that sets of inhibitory receptors, namely LAG-3 and PD-1, expressed on cytotoxic and helper T lymphocytes hamper the development of effective immunity against malaria. Therapeutic blockade of these receptors was reported to enhance blood parasite clearance through the development of more protective parasite-specific helper T lymphocytes and Abs. Herein, we reveal that, while mice genetically deficient for the PD-1 pathway fail to clear blood parasites better than WT counterparts, anti-LAG-3 treatment does. Importantly, we found comparable parasite-specific Ab responses between all mouse groups, and Ab transfers conferred similar protection to newly infected mice. We also show that LAG-3 is mostly expressed on T lymphocytes, and that cytotoxic T lymphocytes are not involved in anti-LAG-3 accelerated clearance of parasites. Our results suggest that LAG-3 blockade acts on helper T lymphocytes to unleash their effector responses and enhance the control of blood-stage malaria, independently from parasite-specific Abs.
]]></description>
<dc:creator>Furtado, R.</dc:creator>
<dc:creator>Chorro, L.</dc:creator>
<dc:creator>Zimmerman, N.</dc:creator>
<dc:creator>Guillen, E.</dc:creator>
<dc:creator>Spaulding, E.</dc:creator>
<dc:creator>Chin, S. S.</dc:creator>
<dc:creator>Daily, J.</dc:creator>
<dc:creator>Lauvau, G.</dc:creator>
<dc:date>2020-06-22</dc:date>
<dc:identifier>doi:10.1101/2020.06.22.164566</dc:identifier>
<dc:title><![CDATA[Blockade of LAG-3 in PD-L1-deficient mice enhances clearance of blood stage malaria independent of humoral responses]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-06-22</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.06.23.166959v1?rss=1">
<title>
<![CDATA[
Deconstructing glucose-mediated catabolite repression of the lac operon of Escherichia coli: II. Positive feedback exists and drives the repression 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.06.23.166959v1?rss=1</link>
<description><![CDATA[
The expression of the lac operon of E. coli is subject to positive feedback during growth in the presence of gratuitous inducers, but its existence in the presence of lactose remains controversial. The key question in this debate is: Do the lactose enzymes, Lac permease and β-galactosidase, promote accumulation of allolactose? If so, positive feedback exists since allolactose does stimulate synthesis of the lactose enzymes. Here, we addressed the above question by developing methods for determining the intracellular allolactose concentration as well as the kinetics of enzyme induction and dilution. We show that during lac induction in the presence of lactose, the intracellular allolactose concentration increases with the lactose enzyme level, which implies that lactose enzymes promote allolactose accumulation, and positive feedback exists. We also show that during lac repression in the presence of lactose + glucose, the intracellular allolactose concentration decreases with the lactose enzyme levels, which suggests that under these conditions, the positive feedback loop turns in the reverse direction. The induction and dilution rates derived from the transient data show that the positive feedback loop is reversed due to a radical shift of the steady state induction level. This is formally identical to the mechanism driving catabolite repression in the presence of TMG + glucose.Competing Interest StatementThe authors have declared no competing interest.View Full Text
]]></description>
<dc:creator>Aggarwal, R. K.</dc:creator>
<dc:creator>Narang, A.</dc:creator>
<dc:date>2020-06-24</dc:date>
<dc:identifier>doi:10.1101/2020.06.23.166959</dc:identifier>
<dc:title><![CDATA[Deconstructing glucose-mediated catabolite repression of the lac operon of Escherichia coli: II. Positive feedback exists and drives the repression]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-06-24</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.06.23.167601v1?rss=1">
<title>
<![CDATA[
Transcriptomic and proteomic regulation through abundant, dynamic, and independent arginine methylation by Type I and Type II PRMTs 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.06.23.167601v1?rss=1</link>
<description><![CDATA[
Arginine methylation is essential for both cellular viability and development and is also dysregulated in cancer. PRMTs catalyze the post translational monomethylation (Rme1/MMA, catalyzed by Type I-III), asymmetric (Rme2a/ADMA, Type I enzymes)-, or symmetric (Rme2s/SDMA, Type II enzymes) dimethylation of arginine. Despite many studies, a thorough integration of PRMT enzyme substrate determination and proteomic and transcriptomic consequences of inhibiting Type I and II PRMTs is lacking. To characterize cellular substrates for Type I (Rme2a) and Type II (Rme2s) PRMTs, human A549 lung adenocarcinoma cells were treated with either Type I (MS023) or Type II (GSK591) inhibitors. Using total proteome hydrolysis, we developed a new mass spectrometry approach to analyze total arginine and lysine content. We showed that Rme1 was a minor population ([~]0.1% of total arginine), Rme2a was highly abundant ([~]1.1%), and Rme2s was intermediate ([~]0.4%). While Rme2s was mostly eliminated by GSK591 treatment, total Rme1 and Rme2a were more resistant to perturbation. To quantitatively characterize substrate preferences of the major enzymes PRMT1, PRMT4(CARM1), and PRMT5, we used oriented peptide array libraries (OPAL) in methyltransferase assays. We demonstrated that while PRMT5 tolerates aspartic acid residues in the substrate, PRMT1 does not. Importantly, PRMT4 methylated previously uncharacterized hydrophobic motifs. To integrate our studies, we performed PTMScan on PRMT-inhibited A549 cells and enriched for methylated arginine containing tryptic peptides. For detection of highly charged peptides, a method to analyze the samples using electron transfer dissociation was developed. Proteomic analysis revealed distinct methylated species enriched in nuclear function, RNA-binding, intrinsically disordered domains, and liquid-liquid phase separation. Parallel studies with proteomics and RNA-Seq revealed distinct, but ontologically overlapping, consequences to PRMT inhibition. Overall, we demonstrate a wider PRMT substrate diversity and methylarginine functional consequence than previously shown.
]]></description>
<dc:creator>Lehman, S. M.</dc:creator>
<dc:creator>Chen, H.</dc:creator>
<dc:creator>Burgos, E. S.</dc:creator>
<dc:creator>Maron, M.</dc:creator>
<dc:creator>Gayatri, S.</dc:creator>
<dc:creator>Nieves, E.</dc:creator>
<dc:creator>Bai, D. L.</dc:creator>
<dc:creator>Sidoli, S.</dc:creator>
<dc:creator>Gupta, V.</dc:creator>
<dc:creator>Marunde, M. R.</dc:creator>
<dc:creator>Bone, J. R.</dc:creator>
<dc:creator>Sun, Z.-W.</dc:creator>
<dc:creator>Bedford, M. T.</dc:creator>
<dc:creator>Shabanowitz, J.</dc:creator>
<dc:creator>Hunt, D. F.</dc:creator>
<dc:creator>Shechter, D.</dc:creator>
<dc:date>2020-06-24</dc:date>
<dc:identifier>doi:10.1101/2020.06.23.167601</dc:identifier>
<dc:title><![CDATA[Transcriptomic and proteomic regulation through abundant, dynamic, and independent arginine methylation by Type I and Type II PRMTs]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-06-24</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.06.25.171322v1?rss=1">
<title>
<![CDATA[
The genome of North American beaver provides insights into the mechanisms of its longevity and cancer resistance 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.06.25.171322v1?rss=1</link>
<description><![CDATA[
The North American beaver (Castor canadensis) is an exceptionally long-lived and cancer-resistant rodent species, and thus an excellent model organism for comparative genomic studies of longevity. Here, we utilize a significantly improved beaver genome assembly to assess evolutionary changes in gene coding sequences, copy number, and expression. We found that the beaver Aldh1a1, a stem cell marker gene encoding an enzyme required for detoxification of ethanol and aldehydes, is expanded (~10 copies vs. two in mouse and one in human). We also show that the beaver cells are more resistant to ethanol, and beaver liver extracts show higher ability to metabolize aldehydes than the mouse samples. Furthermore, Hpgd, a tumor suppressor gene, is uniquely duplicated in the beaver among rodents. Our evolutionary analysis identified beaver genes under positive selection which are associated with tumor suppression and longevity. Genes involved in lipid metabolism show positive selection signals, changes in copy number and altered gene expression in beavers. Several genes involved in DNA repair showed a higher expression in beavers which is consistent with the trend observed in other long-lived mammals. In summary, we identified several genes that likely contribute to beaver longevity and cancer resistance, including increased ability to detoxify aldehydes, enhanced tumor suppression and DNA repair, and altered lipid metabolism.
]]></description>
<dc:creator>Zhang, Q.</dc:creator>
<dc:creator>Tombline, G.</dc:creator>
<dc:creator>Ablaeva, J.</dc:creator>
<dc:creator>Zhang, L.</dc:creator>
<dc:creator>Zhou, X.</dc:creator>
<dc:creator>Smith, Z.</dc:creator>
<dc:creator>Xiaoli, A. M.</dc:creator>
<dc:creator>Wang, Z.</dc:creator>
<dc:creator>Lin, J.-R.</dc:creator>
<dc:creator>Jabalameli, M. R.</dc:creator>
<dc:creator>Mitra, J.</dc:creator>
<dc:creator>Nguyen, N.</dc:creator>
<dc:creator>Vijg, J.</dc:creator>
<dc:creator>Seluanov, A.</dc:creator>
<dc:creator>Gladyshev, V. N.</dc:creator>
<dc:creator>Gorbunova, V.</dc:creator>
<dc:creator>Zhang, Z. D.</dc:creator>
<dc:date>2020-06-27</dc:date>
<dc:identifier>doi:10.1101/2020.06.25.171322</dc:identifier>
<dc:title><![CDATA[The genome of North American beaver provides insights into the mechanisms of its longevity and cancer resistance]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-06-27</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.06.26.173724v1?rss=1">
<title>
<![CDATA[
Genetics of human gut microbiome composition 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.06.26.173724v1?rss=1</link>
<description><![CDATA[
To study the effect of host genetics on gut microbiome composition, the MiBioGen consortium curated and analyzed genome-wide genotypes and 16S fecal microbiome data from 18,340 individuals (24 cohorts). Microbial composition showed high variability across cohorts: only 9 out of 410 genera were detected in more than 95% samples. A genome-wide association study (GWAS) of host genetic variation in relation to microbial taxa identified 31 loci affecting microbiome at a genome-wide significant (P<5x10-8) threshold. One locus, the lactase (LCT) gene locus, reached study-wide significance (GWAS signal P=1.28x10-20), and it showed an age-dependent association with Bifidobacterium abundance. Other associations were suggestive (1.95x10-10<P<5x10-8) but enriched for taxa showing high heritability and for genes expressed in the intestine and brain. A phenome-wide association study and Mendelian randomization identified enrichment of microbiome trait loci in the metabolic, nutrition and environment domains and suggested the microbiome has causal effects in ulcerative colitis and rheumatoid arthritis.
]]></description>
<dc:creator>Kurilshikov, A.</dc:creator>
<dc:creator>Medina-Gomez, C.</dc:creator>
<dc:creator>Bacigalupe, R.</dc:creator>
<dc:creator>Radjabzadeh, D.</dc:creator>
<dc:creator>Wang, J.</dc:creator>
<dc:creator>Demirkan, A.</dc:creator>
<dc:creator>Le Roy, C. I.</dc:creator>
<dc:creator>Raygoza Garay, J. A.</dc:creator>
<dc:creator>Finnicum, C.</dc:creator>
<dc:creator>Liu, X.</dc:creator>
<dc:creator>Zhernakova, D.</dc:creator>
<dc:creator>Bonder, M. J.</dc:creator>
<dc:creator>Hansen, T. H.</dc:creator>
<dc:creator>Frost, F.</dc:creator>
<dc:creator>Ruhlemann, M. C.</dc:creator>
<dc:creator>Turpin, W.</dc:creator>
<dc:creator>Moon, J.-Y.</dc:creator>
<dc:creator>Kim, H.-N.</dc:creator>
<dc:creator>Lull, K.</dc:creator>
<dc:creator>Barkan, E.</dc:creator>
<dc:creator>Shah, S. A.</dc:creator>
<dc:creator>Fornage, M.</dc:creator>
<dc:creator>Szopinska-Tokov, J.</dc:creator>
<dc:creator>Wallen, Z.</dc:creator>
<dc:creator>Borisevich, D.</dc:creator>
<dc:creator>Agreus, L.</dc:creator>
<dc:creator>Andreasson, A.</dc:creator>
<dc:creator>Bang, C.</dc:creator>
<dc:creator>Bedrani, L.</dc:creator>
<dc:creator>Bell, J. T.</dc:creator>
<dc:creator>Bisgaard, H.</dc:creator>
<dc:creator>Boehnke, M.</dc:creator>
<dc:creator>Boomsma, D. I.</dc:creator>
<dc:creator>Burk, R. D.</dc:creator>
<dc:creator>Claringbould, A.</dc:creator>
<dc:creator>Croitoru, K.</dc:creator>
<dc:creator>Davies, G.</dc:creator>
<dc:creator>Van Duijn, C.</dc:creator>
<dc:creator>Duijts, L.</dc:creator>
<dc:creator>Falony, G.</dc:creator>
<dc:creator>Fu, J.</dc:creator>
<dc:creator>van der Graaf, A.</dc:creator>
<dc:creator>Hansen, T</dc:creator>
<dc:date>2020-06-28</dc:date>
<dc:identifier>doi:10.1101/2020.06.26.173724</dc:identifier>
<dc:title><![CDATA[Genetics of human gut microbiome composition]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-06-28</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.06.30.180125v1?rss=1">
<title>
<![CDATA[
Functional characterization of Polr3a hypomyelinating leukodystrophy mutations in the S. cerevisiae homolog, RPC160. 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.06.30.180125v1?rss=1</link>
<description><![CDATA[
Mutations in RNA polymerase III (Pol III) cause hypomeylinating leukodystrophy (HLD) and neurodegeneration in humans. POLR3A and POLR3B, the two largest Pol III subunits, together form the catalytic center and carry the majority of disease alleles. Disease-causing mutations include invariant and highly conserved residues that are predicted to negatively affect Pol III activity and decrease transcriptional output. A subset of HLD missense mutations in POLR3A cluster in the pore region that provides nucleotide access to the Pol III active site. These mutations were engineered at the corresponding positions in the Saccharomyces cerevisiae homolog, Rpc160, to evaluate their functional deficits. None of the mutations caused a growth or transcription phenotype in yeast. Each mutation was combined with a frequently occurring pore mutation, POLR3A G672E, which was also wild-type for growth and transcription. The double mutants showed a spectrum of phenotypes from wild-type to lethal, with only the least fit combinations showing an effect on Pol III transcription. In one slow-growing temperature-sensitive mutant the steady-state level of tRNAs was unaffected, however global tRNA synthesis was compromised, as was the synthesis of RPR1 and SNR52 RNAs. Affinity-purified mutant Pol III was broadly defective in both factor-independent and factor-dependent transcription in vitro across genes that represent the yeast Pol III transcriptome. Thus, the robustness of yeast to Pol III leukodystrophy mutations in RPC160 can be overcome by a combinatorial strategy.Competing Interest StatementThe authors have declared no competing interest.View Full Text
]]></description>
<dc:creator>Moir, R. D.</dc:creator>
<dc:creator>Lavados, C.</dc:creator>
<dc:creator>Lee, J.</dc:creator>
<dc:creator>Willis, I. M.</dc:creator>
<dc:date>2020-07-02</dc:date>
<dc:identifier>doi:10.1101/2020.06.30.180125</dc:identifier>
<dc:title><![CDATA[Functional characterization of Polr3a hypomyelinating leukodystrophy mutations in the S. cerevisiae homolog, RPC160.]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-07-02</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.07.04.188094v1?rss=1">
<title>
<![CDATA[
Cell Type-Specific Chromatin Accessibility Analysis in the Mouse and Human Brain 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.07.04.188094v1?rss=1</link>
<description><![CDATA[
The Assay for Transposase Accessible Chromatin by sequencing (ATAC-seq) is becoming increasingly popular in the neuroscience field where chromatin regulation is thought to be involved in neurodevelopment, activity-dependent gene regulation, hormonal and environmental responses, and the pathophysiology of neuropsychiatric disorders. The advantages of using this assay include a small amount of material needed, relatively simple and fast protocol, and the ability to capture a range of gene regulatory elements with a single assay. However, with increasing interest in chromatin research, it is an imperative to have feasible, reliable assays that are compatible with a range of neuroscience study designs in both animals and humans. Here we tested three different protocols for neuronal chromatin accessibility analysis, including a varying brain tissue freezing method followed by fluorescent-activated nuclei sorting (FANS) and the ATAC-seq analysis. Our study shows that the cryopreservation method impacts the number of open chromatin regions that can be identified from frozen brain tissue using the cell-type specific ATAC-seq assay. However, we show that all three protocols generate consistent and robust data and enable the identification of functional regulatory elements, promoters and enhancers, in neuronal cells. Our study also implies that the broad biological interpretation of chromatin accessibility data is not significantly affected by the freezing condition. In comparison to the mouse brain analysis, we reveal the additional challenges of doing chromatin analysis on post mortem human brain tissue. However, we also show that these studies are revealing important cell type-specific information about gene regulation in the human brain. Overall, the ATAC-seq coupled with FANS is a powerful method to capture cell-type specific chromatin accessibility information in the mouse and human brain. Our study provides alternative brain preservation methods that generate high quality ATAC-seq data while fitting in different study designs, and further encourages the use of this method to uncover the role of epigenetic (dys)regulation in healthy and malfunctioning brain.
]]></description>
<dc:creator>Rocks, D.</dc:creator>
<dc:creator>Jaric, I.</dc:creator>
<dc:creator>Tesfa, L.</dc:creator>
<dc:creator>Greally, J. M.</dc:creator>
<dc:creator>Suzuki, M.</dc:creator>
<dc:creator>Kundakovic, M.</dc:creator>
<dc:date>2020-07-04</dc:date>
<dc:identifier>doi:10.1101/2020.07.04.188094</dc:identifier>
<dc:title><![CDATA[Cell Type-Specific Chromatin Accessibility Analysis in the Mouse and Human Brain]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-07-04</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.07.05.188433v1?rss=1">
<title>
<![CDATA[
Functional succinate dehydrogenase deficiency is a pathognomonic adverse feature of clear cell renal cancer 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.07.05.188433v1?rss=1</link>
<description><![CDATA[
BackgroundReduced succinate dehydrogenase (SDH) activity resulting in adverse succinate accumulation was previously thought to be relevant only in 0.05-0.5% of kidney cancers associated with germline SDH mutations (categorized  SDH-deficient Renal Cell Carcinoma in the 2016 WHO classification)

ResultsWe show that under-expression of SDH subunits resulting in accumulation of oncogenic succinate is a common feature in clear cell renal cell carcinoma (ccRCC) tumors during pathogenesis and progression, with a marked adverse impact on survival in a large cohort (n=516) of ccRCC patients. From a mechanistic standpoint, we show that von Hippel-Lindau (VHL) loss induced hypoxia-inducible factor (HIF) dependent upregulation of mir-210 in ccRCC causes direct inhibition of the SDHD transcript. We demonstrate that reduced expression of SDH subunits is associated with genome-wide increase in methylation and enhancement of epithelial mesenchymal transition (EMT) in ccRCC tumors, consistent with succinate-induced inhibition of TET activity and increase in invasiveness/ migratory ability of ccRCC cells. TET-2 inhibition-induced global regulatory DNA hypermethylation drives SDH loss-induced enrichment of EMT. SDH subunits under-expression had a striking association with CDHI (E-cadherin) loss in ccRCC tumors, in keeping with succinate-induced CDH1 hypermethylation and under-expression in ccRCC cells. Next, in conformity with recombinant TET-2 fluorescence quenching dynamics with succinate and ascorbic acid (AA, a TET enzyme co-factor), AA treatment led to reversal of succinate-induced inhibition of TET activity, CDH1 hypermethylation and under-expression, as well as enhanced invasiveness in ccRCC cells. Furthermore, using immunohistochemical analysis and artificial intelligence quantitation, we report that ccRCC is characterized by a marked loss of ascorbic acid transporter SLC23A1 [median percent positive cells in ccRCC primary tumors (n=104) and normal kidney cortex (n=7) was 0.7 and 32.4 respectively; p=0.0012]. Lower SLC23A1 was associated with worse survival in ccRCC (TCGA). Lastly, intravenous AA significantly prolonged survival in a metastatic ccRCC xenograft model with increased succinate and reduced SLC23A1 expression.

ConclusionsTaken together, these findings strongly indicate that functional SDH deficiency is a pathognomonic adverse feature of ccRCC (which accounts for [~]80% of all kidney cancers), and that the WHO category  SDH-deficient RCC should be re-named  SDH germline mutation-associated RCC. Furthermore, oncogenic accumulation of succinate can be abrogated by TET modulation with AA.

STATEMENT OF SIGNIFICANCEIn this study, we show that under-expression of succinate dehydrogenase (SDH) subunits resulting in the accumulation of oncogenic succinate is a common, adverse, epigenetic modulating feature occurring in a vast majority of clear cell renal cell carcinoma (ccRCC), during pathogenesis and progression. Functional SDH deficiency is therefore a pathognomonic feature of ccRCC (which accounts for [~]80% of all kidney cancers), and not just limited to the 0.05-0.5% of kidney cancer patients with germline SDH mutations. Based on the findings reported, we propose that the  SDH-deficient RCC category in the 2016 WHO classification of kidney tumors be renamed  SDH germline mutation-associated RCC. Furthermore, we demonstrate that oncogenic accumulation of succinate in ccRCC can be countered by TET modulation with ascorbic acid, and that ccRCC is characterized by a marked loss of ascorbic acid transporter SLC23A1.



O_FIG O_LINKSMALLFIG WIDTH=172 HEIGHT=200 SRC="FIGDIR/small/188433v2_ufig1.gif" ALT="Figure 1">
View larger version (28K):
org.highwire.dtl.DTLVardef@728d5eorg.highwire.dtl.DTLVardef@9f2e24org.highwire.dtl.DTLVardef@8e7011org.highwire.dtl.DTLVardef@15f8d33_HPS_FORMAT_FIGEXP  M_FIG Graphical abstract depicting the consequential adverse downregulation of Succinate Dehydrogenase in ccRCC and its central role in oxidative phosphorylation

C_FIG
]]></description>
<dc:creator>Aggarwal, R. K.</dc:creator>
<dc:creator>Zou, Y.</dc:creator>
<dc:creator>Luchtel, R. A.</dc:creator>
<dc:creator>Pradhan, K.</dc:creator>
<dc:creator>Ashai, N.</dc:creator>
<dc:creator>Ramachandra, N.</dc:creator>
<dc:creator>Albanese, J.</dc:creator>
<dc:creator>Yang, J.-i.</dc:creator>
<dc:creator>Wang, X.</dc:creator>
<dc:creator>Aluri, S.</dc:creator>
<dc:creator>Gordon, S.</dc:creator>
<dc:creator>Machha, V.</dc:creator>
<dc:creator>Tischer, A.</dc:creator>
<dc:creator>Aboumohamed, A.</dc:creator>
<dc:creator>Gartrell, B. A.</dc:creator>
<dc:creator>Hafizi, S.</dc:creator>
<dc:creator>Pullman, J.</dc:creator>
<dc:creator>Shenoy, N.</dc:creator>
<dc:date>2020-07-06</dc:date>
<dc:identifier>doi:10.1101/2020.07.05.188433</dc:identifier>
<dc:title><![CDATA[Functional succinate dehydrogenase deficiency is a pathognomonic adverse feature of clear cell renal cancer]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-07-06</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.07.06.189308v1?rss=1">
<title>
<![CDATA[
Toxoplasma gondii PPM3C, a secreted protein phosphatase, affects parasitophorous vacuole effector export 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.07.06.189308v1?rss=1</link>
<description><![CDATA[
ABSTRACTToxoplasma gondii is a highly successful parasite that infects a significant portion of the human population. As an intracellular parasite, T. gondii thrives within many different cell types due to its residence in the parasitophorous vacuole, a specialized and heavily modified compartment in which parasites divide. Within this vacuole, numerous secreted proteins facilitate functions that optimize intracellular survival. We characterized one such protein, TgPPM3C, which is predicted to contain a domain belonging to the PP2C class of serine/threonine phosphatases and is secreted by both tachyzoites and differentiating bradyzoites into the vacuolar lumen. Genetic deletion of TgPPM3C established that parasites lacking this predicted phosphatase exhibit a minor growth defect in vitro, are avirulent during acute infection in mice, and form fewer cysts in mouse brain during chronic infection. A label-free phosphoproteomic approach was utilized to identify putative TgPPM3C substrates and demonstrated several secreted proteins with altered phosphorylation status in the absence of TgPPM3C. Altered phosphorylation status was seen in MYR1, a protein essential to the process of protein effector export from the parasitophorous vacuole into the host cell, and in GRA16 and GRA28, two exported effector proteins. Defects were seen in the export of GRA16 and GRA28, but not the effector TgIST, in the TgPPM3C knockout strain. Parasites lacking TgPPM3C also exhibited defects in host c-Myc induction, a process influenced by effector export. Phosphomimetic mutations of GRA16 serine residues recapitulated export defects, implicating de-phosphorylation as an important process in facilitating the export of GRA16. These findings provide an example of the emerging critical role that phosphatases play in regulating the complex environment of the T. gondii parasitophorous vacuole.View Full Text
]]></description>
<dc:creator>Mayoral, J.</dc:creator>
<dc:creator>Tomita, T.</dc:creator>
<dc:creator>Tu, V.</dc:creator>
<dc:creator>Aguilan, J. T.</dc:creator>
<dc:creator>Sidoli, S.</dc:creator>
<dc:creator>Weiss, L. M.</dc:creator>
<dc:date>2020-07-06</dc:date>
<dc:identifier>doi:10.1101/2020.07.06.189308</dc:identifier>
<dc:title><![CDATA[Toxoplasma gondii PPM3C, a secreted protein phosphatase, affects parasitophorous vacuole effector export]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-07-06</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.07.07.190546v1?rss=1">
<title>
<![CDATA[
The evolutionary history of ACE2 usage within the coronavirus subgenus Sarbecovirus 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.07.07.190546v1?rss=1</link>
<description><![CDATA[
SARS-CoV-1 and SARS-CoV-2 are not phylogenetically closely related; however, both use the ACE2 receptor in humans for cell entry. This is not a universal sarbecovirus trait; for example, many known sarbecoviruses related to SARS-CoV-1 have two deletions in the receptor binding domain of the spike protein that render them incapable of using human ACE2. Here, we report three sequences of a novel sarbecovirus from Rwanda and Uganda which are phylogenetically intermediate to SARS-CoV-1 and SARS-CoV-2 and demonstrate via in vitro studies that they are also unable to utilize human ACE2. Furthermore, we show that the observed pattern of ACE2 usage among sarbecoviruses is best explained by recombination not of SARS-CoV-2, but of SARS-CoV-1 and its relatives. We show that the lineage that includes SARS-CoV-2 is most likely the ancestral ACE2-using lineage, and that recombination with at least one virus from this group conferred ACE2 usage to the lineage including SARS-CoV-1 at some time in the past. We argue that alternative scenarios such as convergent evolution are much less parsimonious; we show that biogeography and patterns of host tropism support the plausibility of a recombination scenario; and we propose a competitive release hypothesis to explain how this recombination event could have occurred and why it is evolutionarily advantageous. The findings provide important insights into the natural history of ACE2 usage for both SARS-CoV-1 and SARS-CoV-2, and a greater understanding of the evolutionary mechanisms that shape zoonotic potential of coronaviruses. This study also underscores the need for increased surveillance for sarbecoviruses in southwestern China, where most ACE2-using viruses have been found to date, as well as other regions such as Africa, where these viruses have only recently been discovered.
]]></description>
<dc:creator>Wells, H. L.</dc:creator>
<dc:creator>Letko, M. C.</dc:creator>
<dc:creator>Lasso, G.</dc:creator>
<dc:creator>Ssebide, B.</dc:creator>
<dc:creator>Nziza, J.</dc:creator>
<dc:creator>Byarugaba, D. K.</dc:creator>
<dc:creator>Navarrete-Macias, I.</dc:creator>
<dc:creator>Liang, E.</dc:creator>
<dc:creator>Cranfield, M.</dc:creator>
<dc:creator>Han, B. A.</dc:creator>
<dc:creator>Tingley, M. W.</dc:creator>
<dc:creator>Diuk-Wasser, M.</dc:creator>
<dc:creator>Goldstein, T.</dc:creator>
<dc:creator>Kreuder Johnson, C.</dc:creator>
<dc:creator>Mazet, J.</dc:creator>
<dc:creator>Chandran, K.</dc:creator>
<dc:creator>Munster, V.</dc:creator>
<dc:creator>Gilardi, K.</dc:creator>
<dc:creator>Anthony, S. J.</dc:creator>
<dc:date>2020-07-07</dc:date>
<dc:identifier>doi:10.1101/2020.07.07.190546</dc:identifier>
<dc:title><![CDATA[The evolutionary history of ACE2 usage within the coronavirus subgenus Sarbecovirus]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-07-07</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.07.10.196295v1?rss=1">
<title>
<![CDATA[
Metabolic features of mouse and human retinas: rods vs. cones, macula vs. periphery, retina vs. RPE 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.07.10.196295v1?rss=1</link>
<description><![CDATA[
Photoreceptors, especially cones, which are enriched in the human macula, have high energy demands, making them vulnerable to metabolic stress. Metabolic dysfunction of photoreceptors and their supporting retinal pigment epithelium (RPE) is an important underlying cause of degenerative retinal diseases. However, how cones and the macula support their exorbitant metabolic demand and communicate with RPE is unclear. By profiling metabolite uptake and release and analyzing metabolic genes, we have found cone-rich retinas and human macula share specific metabolic features with upregulated pathways in pyruvate metabolism, mitochondrial TCA cycle and lipid synthesis. Human neural retina and RPE have distinct but complementary metabolic features. Retinal metabolism centers on NADH production and neurotransmitter biosynthesis. The retina needs aspartate to sustain its aerobic glycolysis and mitochondrial metabolism. RPE metabolism is directed toward NADPH production and biosynthesis of acetyl-rich metabolites, serine and others. RPE consumes multiple nutrients, including proline, to produce metabolites for the retina.
]]></description>
<dc:creator>Bo Li</dc:creator>
<dc:creator>Ting Zhang</dc:creator>
<dc:creator>Wei Liu</dc:creator>
<dc:creator>Yekai Wang</dc:creator>
<dc:creator>Rong Xu</dc:creator>
<dc:creator>Shaoxue Zeng</dc:creator>
<dc:creator>Rui Zhang</dc:creator>
<dc:creator>Mark C Gillies</dc:creator>
<dc:creator>Ling Zhu</dc:creator>
<dc:creator>Jianhai Du</dc:creator>
<dc:date>2020-07-10</dc:date>
<dc:identifier>doi:10.1101/2020.07.10.196295</dc:identifier>
<dc:title><![CDATA[Metabolic features of mouse and human retinas: rods vs. cones, macula vs. periphery, retina vs. RPE]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-07-10</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.07.13.201863v1?rss=1">
<title>
<![CDATA[
A glycoprotein mutation that emerged during the 2013-2016 Ebola virus epidemic alters proteolysis and accelerates membrane fusion 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.07.13.201863v1?rss=1</link>
<description><![CDATA[
Genomic surveillance of viral isolates during the 2013-2016 Ebola virus epidemic in Western Africa--the largest and most devastating filovirus outbreak on record--revealed several novel mutations. The responsible strain, named Makona, carries an A to V substitution at position 82 in the glycoprotein (GP), which is associated with enhanced infectivity in vitro. Here, we investigated the mechanistic basis for this enhancement, as well as the interplay between A82V and a T to I substitution at residue 544 of GP, which also modulates infectivity in cell culture. We found that both 82V and 544I destabilize GP with the residue at 544 impacting overall stability, while 82V specifically destabilizes proteolytically cleaved GP. Both residues also promote faster kinetics of lipid mixing of the viral and host membranes in live cells, individually and in tandem, which correlates with faster times to fusion following co-localization with the viral receptor Niemann-Pick C1 (NPC1). Further, GPs bearing 82V are more sensitive to proteolysis by cathepsin L (CatL), a key host factor for viral entry. Intriguingly, CatL processed 82V variant GPs to a novel product of [~]12K size, which we hypothesize corresponds to a form of GP more fully primed for fusion than previously detected. We thus propose a model in which 82V promotes more efficient GP processing by CatL, leading to faster viral fusion kinetics and higher infectivity.

ImportanceThe 2013-2016 outbreak of Ebola virus disease in West Africa demonstrated the potential for previously localized outbreaks to turn into regional, or even global, health emergencies. With over 28,000 cases and 11,000 confirmed deaths, this outbreak was over 50 times as large as any previously recorded. This outbreak also afforded the largest ever collection of Ebola virus genomic sequence data, allowing new insights into viral transmission and evolution. Viral mutants arising during the outbreak have attracted attention for their potentially altered patterns of infectivity in cell culture, with potential, if unclear, implications for increased viral spread and/or virulence. Here, we report on the properties of one such mutation in the viral glycoprotein, A82V, and its interplay with a previously described polymorphism at position 544. We show that mutations at both residues promote infection and fusion activation in cells, but that A82V additionally leads to increased infectivity under cathepsin-limited conditions, and the generation of a novel glycoprotein cleavage product.
]]></description>
<dc:creator>Fels, J. M.</dc:creator>
<dc:creator>Bortz, R. H.</dc:creator>
<dc:creator>Alkutkar, T. P.</dc:creator>
<dc:creator>Mittler, E.</dc:creator>
<dc:creator>Jangra, R. K.</dc:creator>
<dc:creator>Spence, J. S.</dc:creator>
<dc:creator>Chandran, K.</dc:creator>
<dc:date>2020-07-15</dc:date>
<dc:identifier>doi:10.1101/2020.07.13.201863</dc:identifier>
<dc:title><![CDATA[A glycoprotein mutation that emerged during the 2013-2016 Ebola virus epidemic alters proteolysis and accelerates membrane fusion]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-07-15</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.07.19.188789v1?rss=1">
<title>
<![CDATA[
Exome-wide association studies in general and long-lived populations identify genetic variants related to human age 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.07.19.188789v1?rss=1</link>
<description><![CDATA[
Aging is characterized by degeneration in cellular and organismal functions leading to increased disease susceptibility and death. Although our understanding of aging biology in model systems has increased dramatically, large-scale sequencing studies to understand human aging are now just beginning. We applied exome sequencing and association analyses (ExWAS) to identify age-related variants on 58,470 participants of the DiscovEHR cohort. Linear Mixed Model regression analyses of age at last encounter revealed variants in genes known to be linked with clonal hematopoiesis of indeterminate potential, which are associated with myelodysplastic syndromes, as top signals in our analysis, suggestive of age-related somatic mutation accumulation in hematopoietic cells despite patients lacking clinical diagnoses. In addition to APOE, we identified rare DISP2 rs183775254 (p = 7.40x10-10) and ZYG11A rs74227999 (p = 2.50x10-08) variants that were negatively associated with age in either both sexes combined and females, respectively, which were replicated with directional consistency in two independent cohorts. Epigenetic mapping showed these variants are located within cell-type-specific enhancers, suggestive of important transcriptional regulatory functions. To discover variants associated with extreme age, we performed exome-sequencing on persons of Ashkenazi Jewish descent ascertained for extensive lifespans. Case-Control analyses in 525 Ashkenazi Jews cases (Males [&ge;] 92 years, Females [&ge;] 95years) were compared to 482 controls. Our results showed variants in APOE (rs429358, rs6857), and TMTC2 (rs7976168) passed Bonferroni-adjusted p-value, as well as several nominally-associated population-specific variants. Collectively, our Age-ExWAS, the largest performed to date, confirmed and identified previously unreported candidate variants associated with human age.
]]></description>
<dc:creator>Sin-Chan, P.</dc:creator>
<dc:creator>Gosalia, N.</dc:creator>
<dc:creator>Gao, C.</dc:creator>
<dc:creator>Van Hout, C. V.</dc:creator>
<dc:creator>Ye, B.</dc:creator>
<dc:creator>Marcketta, A.</dc:creator>
<dc:creator>Li, A. H.</dc:creator>
<dc:creator>O'Dushlaine, C.</dc:creator>
<dc:creator>Li, D.</dc:creator>
<dc:creator>Overton, J. D.</dc:creator>
<dc:creator>Reid, J. D.</dc:creator>
<dc:creator>Baras, A.</dc:creator>
<dc:creator>Genetics Center, R.</dc:creator>
<dc:creator>Carey, D. J.</dc:creator>
<dc:creator>Ledbetter, D. H.</dc:creator>
<dc:creator>Rader, D.</dc:creator>
<dc:creator>Ritchie, M. D.</dc:creator>
<dc:creator>Damrauer, S. M.</dc:creator>
<dc:creator>Milman, S.</dc:creator>
<dc:creator>Barzilai, N.</dc:creator>
<dc:creator>Glass, D. J.</dc:creator>
<dc:creator>Economides, A. N.</dc:creator>
<dc:creator>Shuldiner, A. R.</dc:creator>
<dc:date>2020-07-19</dc:date>
<dc:identifier>doi:10.1101/2020.07.19.188789</dc:identifier>
<dc:title><![CDATA[Exome-wide association studies in general and long-lived populations identify genetic variants related to human age]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-07-19</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.07.20.208835v1?rss=1">
<title>
<![CDATA[
HIV coinfection is associated with low fitness rpoB variants in rifampicin-resistant Mycobacterium tuberculosis 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.07.20.208835v1?rss=1</link>
<description><![CDATA[
We analysed 312 drug-resistant genomes of Mycobacterium tuberculosis (Mtb) collected from HIV coinfected and HIV negative TB patients from nine countries with a high tuberculosis burden. We found that rifampicin-resistant Mtb strains isolated from HIV coinfected patients carried disproportionally more resistance-conferring mutations in rpoB that are associated with a low fitness in the absence of the drug, suggesting these low fitness rpoB variants can thrive in the context of reduced host immunity.
]]></description>
<dc:creator>Loiseau, C.</dc:creator>
<dc:creator>Brites, D.</dc:creator>
<dc:creator>Reinhard, M.</dc:creator>
<dc:creator>Zuercher, K.</dc:creator>
<dc:creator>Borrell, S.</dc:creator>
<dc:creator>Ballif, M.</dc:creator>
<dc:creator>Fenner, L.</dc:creator>
<dc:creator>Cox, H.</dc:creator>
<dc:creator>Rutaihwa, L. K.</dc:creator>
<dc:creator>Wilkinson, R. J.</dc:creator>
<dc:creator>Yotebieng, M.</dc:creator>
<dc:creator>Carter, E. J.</dc:creator>
<dc:creator>Abimiku, A.</dc:creator>
<dc:creator>Marcy, O.</dc:creator>
<dc:creator>Gotuzzo, E.</dc:creator>
<dc:creator>Avihingsanon, A.</dc:creator>
<dc:creator>Zetola, N.</dc:creator>
<dc:creator>Doulla, B.</dc:creator>
<dc:creator>Boettger, E. C.</dc:creator>
<dc:creator>Egger, M.</dc:creator>
<dc:creator>Gagneux, S.</dc:creator>
<dc:date>2020-07-22</dc:date>
<dc:identifier>doi:10.1101/2020.07.20.208835</dc:identifier>
<dc:title><![CDATA[HIV coinfection is associated with low fitness rpoB variants in rifampicin-resistant Mycobacterium tuberculosis]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-07-22</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.07.20.212746v1?rss=1">
<title>
<![CDATA[
Multiple Capsid Protein Binding Sites Mediate Selective Packaging of the Alphavirus Genomic RNA 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.07.20.212746v1?rss=1</link>
<description><![CDATA[
The alphavirus capsid protein (Cp) selectively packages genomic RNA (gRNA) into the viral nucleocapsid to produce infectious virus. Using photoactivatable ribonucleoside crosslinking and an innovative biotinylated Cp retrieval method, we comprehensively defined binding sites for Semliki Forest virus (SFV) Cp on the gRNA. While data in infected cells demonstrated Cp binding to the proposed genome packaging signal (PS), mutagenesis experiments showed that PS was not required for production of infectious SFV or Chikungunya virus. Instead, we identified multiple novel Cp binding sites that were enriched on gRNA-specific regions and promoted infectious SFV production and gRNA packaging. Comparisons of binding sites in cytoplasmic vs. viral nucleocapsids demonstrated that budding caused discrete changes in Cp-gRNA interactions. Notably, Cps top binding site was maintained throughout virus assembly, and specifically bound and assembled with Cp into core-like particles in vitro. Together our data suggest a new model for selective alphavirus genome recognition and assembly.
]]></description>
<dc:creator>Brown, R. S.</dc:creator>
<dc:creator>Anastasakis, D. G.</dc:creator>
<dc:creator>Hafner, M.</dc:creator>
<dc:creator>Kielian, M.</dc:creator>
<dc:date>2020-07-20</dc:date>
<dc:identifier>doi:10.1101/2020.07.20.212746</dc:identifier>
<dc:title><![CDATA[Multiple Capsid Protein Binding Sites Mediate Selective Packaging of the Alphavirus Genomic RNA]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-07-20</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.07.30.229468v1?rss=1">
<title>
<![CDATA[
Quantitative sub-cellular acyl-CoA analysis reveals distinct nuclear regulation 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.07.30.229468v1?rss=1</link>
<description><![CDATA[
Quantitative sub-cellular metabolomic measurements can yield crucial insights into the roles of metabolites in cellular processes, but are subject to multiple confounding factors. We developed Stable Isotope Labeling of Essential nutrients in cell Culture - Sub-cellular Fractionation (SILEC-SF), which uses isotope labeled internal standard controls that are present throughout fractionation and processing to quantify acyl-Coenzyme A thioesters in sub-cellular compartments by liquid chromatography-mass spectrometry. We tested SILEC-SF in a range of sample types and examined the compartmentalized responses to oxygen tension, cellular differentiation, and nutrient availability. Application of SILEC-SF to the challenging analysis of the nuclear compartment revealed a nuclear acyl-CoA profile distinct from that of the cytosol, with notable nuclear enrichment of propionyl-CoA. Using isotope tracing we identified the branched chain amino acid (BCAA) isoleucine as a major metabolic source of nuclear propionyl-CoA and histone propionylation, thus revealing a new mechanism of crosstalk between metabolism and the epigenome.
]]></description>
<dc:creator>Trefely, S.</dc:creator>
<dc:creator>Huber, K.</dc:creator>
<dc:creator>Liu, J.</dc:creator>
<dc:creator>Singh, J.</dc:creator>
<dc:creator>Doan, M.</dc:creator>
<dc:creator>Lovell, C. D.</dc:creator>
<dc:creator>Noji, M.</dc:creator>
<dc:creator>von Krusenstiern, E.</dc:creator>
<dc:creator>Jiang, H.</dc:creator>
<dc:creator>Bostwick, A.</dc:creator>
<dc:creator>Izzo, L.</dc:creator>
<dc:creator>Zhao, S.</dc:creator>
<dc:creator>Bedi, K. C.</dc:creator>
<dc:creator>Rame, J. E.</dc:creator>
<dc:creator>Bogner-Strauss, J. G.</dc:creator>
<dc:creator>Mesaros, C.</dc:creator>
<dc:creator>Wellen, K. E.</dc:creator>
<dc:creator>Snyder, N. W.</dc:creator>
<dc:date>2020-07-30</dc:date>
<dc:identifier>doi:10.1101/2020.07.30.229468</dc:identifier>
<dc:title><![CDATA[Quantitative sub-cellular acyl-CoA analysis reveals distinct nuclear regulation]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-07-30</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.08.01.230433v1?rss=1">
<title>
<![CDATA[
Hematopoietic stem cells fail to regenerate following inflammatory challenge. 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.08.01.230433v1?rss=1</link>
<description><![CDATA[
Hematopoietic stem cells (HSCs) are canonically defined by their capacity to maintain the HSC pool via self-renewal divisions. However, accumulating evidence suggests that HSC function is instead preserved by sustaining long-term quiescence. Here, we study the kinetics of HSC recovery in mice, following an inflammatory challenge that induces HSCs to exit dormancy. Repeated inflammatory challenge resulted in a progressive depletion of functional HSCs, with no sign of later recovery. Underlying this observation, label retention experiments demonstrated that self-renewal divisions were absent or extremely rare during challenge, as well as during any subsequent recovery period. While depletion of functional HSCs held no immediate consequences, young mice exposed to inflammatory challenge developed blood and bone marrow hypocellularity in old age, similar to elderly humans. The progressive, irreversible attrition of HSC function demonstrates that discreet instances of inflammatory stress can have an irreversible and therefore cumulative impact on HSC function, even when separated by several months. These findings have important implications for our understanding of the role of inflammation as a mediator of dysfunctional tissue maintenance and regeneration during ageing.
]]></description>
<dc:creator>Bogeska, R.</dc:creator>
<dc:creator>Kaschutnig, P.</dc:creator>
<dc:creator>Fawaz, M.</dc:creator>
<dc:creator>Mikecin, A.-M.</dc:creator>
<dc:creator>Buechler-Schaeff, M.</dc:creator>
<dc:creator>Paffenholz, S.</dc:creator>
<dc:creator>Asada, N.</dc:creator>
<dc:creator>Frauhammer, F.</dc:creator>
<dc:creator>Buettner, F.</dc:creator>
<dc:creator>Ball, M.</dc:creator>
<dc:creator>Knoch, J.</dc:creator>
<dc:creator>Staeble, S.</dc:creator>
<dc:creator>Walter, D.</dc:creator>
<dc:creator>Petri, A.</dc:creator>
<dc:creator>Carreno-Gonzalez, M. J.</dc:creator>
<dc:creator>Wagner, V.</dc:creator>
<dc:creator>Brors, B.</dc:creator>
<dc:creator>Haas, S.</dc:creator>
<dc:creator>Lipka, D. B.</dc:creator>
<dc:creator>Essers, M. A. G.</dc:creator>
<dc:creator>Holland-Letz, T.</dc:creator>
<dc:creator>Mallm, J.-P.</dc:creator>
<dc:creator>Rippe, K.</dc:creator>
<dc:creator>Frenette, P. S.</dc:creator>
<dc:creator>Rieger, M. A.</dc:creator>
<dc:creator>Milsom, M. D.</dc:creator>
<dc:date>2020-08-03</dc:date>
<dc:identifier>doi:10.1101/2020.08.01.230433</dc:identifier>
<dc:title><![CDATA[Hematopoietic stem cells fail to regenerate following inflammatory challenge.]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-08-03</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.08.04.235549v1?rss=1">
<title>
<![CDATA[
Hypertonic saline solution inhibits SARS-CoV-2 in vitro assay 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.08.04.235549v1?rss=1</link>
<description><![CDATA[
We are facing an unprecedented global health crisis caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). At this date more than 680 thousand people have died due to coronavirus disease 2019 (COVID-19). Unfortunately, until now no effective treatment to combat the virus and vaccine are available. We performed experiments to test if hypertonic saline solution is able to inhibit virus replication in vitro. Our data shows that 260 mM NaCl (1.5%) inhibits 100% SARS-CoV-2 replication in Vero cells. Furthermore, our results suggest that the virus replication inhibition is due to an intracellular mechanism and not due to the dissociation between spike SARS-CoV-2 protein and its human receptor angiotensin-converting enzyme 2 interaction. NaCl depolarizes the plasma membrane supposedly associated with the inhibition of the SARS-CoV-2 life cycle. This observation could lead to simple, safe and low cost interventions at various stages of COVID-19 treatment, improving the prognosis of infected patients, thereby mitigating the social and economic costs of the pandemic.
]]></description>
<dc:creator>Machado, R. R. G.</dc:creator>
<dc:creator>Glaser, T.</dc:creator>
<dc:creator>Araujo, D. B.</dc:creator>
<dc:creator>Petiz, L. L.</dc:creator>
<dc:creator>Oliveira, D. B. L.</dc:creator>
<dc:creator>Durigon, G. S.</dc:creator>
<dc:creator>Leal, A. L.</dc:creator>
<dc:creator>Pinho, J. R. R.</dc:creator>
<dc:creator>Ferreira, L. C. S.</dc:creator>
<dc:creator>Ulrich, H.</dc:creator>
<dc:creator>Durigon, E. L. R.</dc:creator>
<dc:creator>Guzzo, C. R.</dc:creator>
<dc:date>2020-08-04</dc:date>
<dc:identifier>doi:10.1101/2020.08.04.235549</dc:identifier>
<dc:title><![CDATA[Hypertonic saline solution inhibits SARS-CoV-2 in vitro assay]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-08-04</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.08.05.237768v1?rss=1">
<title>
<![CDATA[
Orphan CpG islands boost the regulatory activity of poisedenhancers and dictate the responsiveness of their target genes 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.08.05.237768v1?rss=1</link>
<description><![CDATA[
ARTICLECpG islands (CGIs) represent a distinctive and widespread genetic feature of vertebrate genomes, being associated with [~]70% of all annotated gene promoters1. CGIs have been proposed to control transcription initiation by conferring nearby promoters with unique chromatin properties2-4. In addition, there are thousands of distal or orphan CGIs (oCGIs) whose functional relevance and mechanism of action are barely known5-7. Here we show that oCGIs are an essential component of poised enhancers (PEs)8, 9 that boost their long-range regulatory activity and dictate the responsiveness of their target genes. Using a CRISPR/Cas9 knock-in strategy in mESC, we introduced PEs with or without oCGIs within topological associating domains (TADs) harbouring genes with different types of promoters. By evaluating the chromatin, topological and regulatory properties of the engineered PEs, we uncover that, rather than increasing their local activation, oCGIs boost the physical and functional communication between PEs and distally located developmental genes. Furthermore, we demonstrate that developmental genes with CpG rich promoters are particularly responsive to PEs and that such responsiveness depends on the presence of oCGIs. Therefore, our work unveils a novel role for CGIs as genetic determinants of the compatibility between genes and enhancers, thus providing major insights into how developmental gene expression programs are deployed under both physiological and pathological conditions10-12.
]]></description>
<dc:creator>Pachano, T.</dc:creator>
<dc:creator>Sanchez-Gaya, V.</dc:creator>
<dc:creator>Mariner-Fauli, M.</dc:creator>
<dc:creator>Ealo, T.</dc:creator>
<dc:creator>Asenjo, H. G.</dc:creator>
<dc:creator>Respuela, P.</dc:creator>
<dc:creator>Cruz-Molina, S.</dc:creator>
<dc:creator>van IJcken, W.</dc:creator>
<dc:creator>Landeira, D.</dc:creator>
<dc:creator>Rada-Iglesias, A.</dc:creator>
<dc:date>2020-08-05</dc:date>
<dc:identifier>doi:10.1101/2020.08.05.237768</dc:identifier>
<dc:title><![CDATA[Orphan CpG islands boost the regulatory activity of poisedenhancers and dictate the responsiveness of their target genes]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-08-05</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.08.06.240325v1?rss=1">
<title>
<![CDATA[
Signatures and mechanisms of efficacious therapeutic ribonucleotides against SARS-CoV-2 revealed by analysis of its replicase using magnetic tweezers 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.08.06.240325v1?rss=1</link>
<description><![CDATA[
The nucleotide analog Remdesivir (RDV) is the only FDA-approved antiviral therapy to treat infection by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The physical basis for efficient utilization of RDV by SARS-CoV-2 polymerase is unknown. Here, we characterize the impact of RDV and other nucleotide analogs on RNA synthesis by the polymerase using a high-throughput, single-molecule, magnetic-tweezers platform. The location of the modification in the ribose or in the base dictates the catalytic pathway(s) used for its incorporation. We reveal that RDV incorporation does not terminate viral RNA synthesis, but leads the polymerase into deep backtrack, which may appear as termination in traditional ensemble assays. SARS-CoV-2 is able to evade the endogenously synthesized product of the viperin antiviral protein, ddhCTP, though the polymerase incorporates this nucleotide analog well. This experimental paradigm is essential to the discovery and development of therapeutics targeting viral polymerases.

TeaserWe revise Remdesivirs mechanism of action and reveal SARS-CoV-2 ability to evade interferon-induced antiviral ddhCTP
]]></description>
<dc:creator>Seifert, M.</dc:creator>
<dc:creator>Bera, S. C.</dc:creator>
<dc:creator>van Nies, P.</dc:creator>
<dc:creator>Kirchdoerfer, R. N.</dc:creator>
<dc:creator>Shannon, A.</dc:creator>
<dc:creator>Le, T.-T.-N.</dc:creator>
<dc:creator>Grove, T. L.</dc:creator>
<dc:creator>Papini, F. S.</dc:creator>
<dc:creator>Arnold, J. J.</dc:creator>
<dc:creator>Almo, S. C.</dc:creator>
<dc:creator>Canard, B.</dc:creator>
<dc:creator>Depken, M.</dc:creator>
<dc:creator>Cameron, C. E.</dc:creator>
<dc:creator>Dulin, D.</dc:creator>
<dc:date>2020-08-06</dc:date>
<dc:identifier>doi:10.1101/2020.08.06.240325</dc:identifier>
<dc:title><![CDATA[Signatures and mechanisms of efficacious therapeutic ribonucleotides against SARS-CoV-2 revealed by analysis of its replicase using magnetic tweezers]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-08-06</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.08.12.248294v1?rss=1">
<title>
<![CDATA[
The Posterior Insular Cortex is Necessary for the Consolidation of Tone Fear 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.08.12.248294v1?rss=1</link>
<description><![CDATA[
The insular cortex (IC) is notably implicated in emotional and cognitive processing; however, little is known regarding to what extent its two main subregions play functionally distinct roles on memory consolidation of conditioned fear tasks. Here we verified the effects of temporary functional inactivation of the anterior (aIC) and posterior IC (pIC) on contextual and tone fear memory. Rats received post-training bilateral infusions of the GABAA receptor agonist muscimol into either the aIC or pIC and were tested 48 and 72 hours after the conditioning session to assess contextual (CFC) and tone (TFC) fear conditioning, respectively. Inactivation of the aIC during memory consolidation did not affect fear memory for CFC or TFC. On the other hand, post-training inactivation of the pIC impaired TFC but not CFC. Our findings indicate that the pIC is a necessary part of the neural circuitry related to the consolidation of cued-fear memories.

HighlightsO_LIWe studied the role of the anterior (aIC) and posterior (pIC) insula in fear memory
C_LIO_LIPost-training inactivation of aIC and pIC did not impact contextual fear conditioning
C_LIO_LIThe pIC but not aIC is necessary for the consolidation of tone fear conditioning
C_LI
]]></description>
<dc:creator>de Paiva, J. P. Q.</dc:creator>
<dc:creator>Bueno, A. P. A.</dc:creator>
<dc:creator>dos Santos Corrêa, M.</dc:creator>
<dc:creator>Oliveira, M. G.</dc:creator>
<dc:creator>Ferreira, T. L.</dc:creator>
<dc:creator>Fornari, R. V.</dc:creator>
<dc:date>2020-08-12</dc:date>
<dc:identifier>doi:10.1101/2020.08.12.248294</dc:identifier>
<dc:title><![CDATA[The Posterior Insular Cortex is Necessary for the Consolidation of Tone Fear]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-08-12</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.08.28.271536v1?rss=1">
<title>
<![CDATA[
miRNA-mediated loss of m6A increases nascent translation in glioblastoma 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.08.28.271536v1?rss=1</link>
<description><![CDATA[
Within the glioblastoma cellular niche, glioma stem cells (GSCs) can give rise to differentiated glioma cells (DGCs) and, when necessary, DGCs can reciprocally give rise to GSCs to maintain the cellular equilibrium necessary for optimal tumor growth. Here, using ribosome profiling, transcriptome and m6A RNA sequencing, we show that GSCs from patients with different subtypes of glioblastoma share a set of transcripts, which exhibit a pattern of m6A loss and increased protein translation during differentiation. The target sequences of a group of miRNAs overlap the canonical RRACH m6A motifs of these transcripts, many of which confer a survival advantage in glioblastoma. Ectopic expression of the RRACH-binding miR-145 induces loss of m6A, formation of FTO/AGO1/ILF3/miR-145 complexes on a clinically relevant tumor suppressor gene (CLIP3) and significant increase in its nascent translation. Inhibition of miR-145 maintains RRACH m6A levels of CLIP3 and inhibits its nascent translation. This study highlights a critical role of miRNAs in assembling complexes for m6A demethylation and induction of protein translation during GSC state transition.

Author SummaryCellular plasticity and epigenetic adaptation of human glioblastoma stem cells to the tumor microenvironment is a hallmark of this devastating disease. With our present work, we discover the relationship between miRNAs and the RNA methylation machinery in human glioblastoma and show how miRNA-induced loss of m6A results in increase in protein translation of clinically important transcripts during glioblastoma stem cell differentiation. Leveraging the dynamic functions of these miRNAs can be important in the design of optimal therapeutics targeted at cancer cell plasticity.
]]></description>
<dc:creator>Zepecki, J. P.</dc:creator>
<dc:creator>Karambizi, D.</dc:creator>
<dc:creator>Fajardo, J. E.</dc:creator>
<dc:creator>Snyder, K. M.</dc:creator>
<dc:creator>Guetta-Terrier, C.</dc:creator>
<dc:creator>Tang, O. Y.</dc:creator>
<dc:creator>Chen, J.-S.</dc:creator>
<dc:creator>Sarkar, A.</dc:creator>
<dc:creator>Fiser, A.</dc:creator>
<dc:creator>Toms, S. A.</dc:creator>
<dc:creator>Tapinos, N.</dc:creator>
<dc:date>2020-08-29</dc:date>
<dc:identifier>doi:10.1101/2020.08.28.271536</dc:identifier>
<dc:title><![CDATA[miRNA-mediated loss of m6A increases nascent translation in glioblastoma]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-08-29</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.08.30.274316v1?rss=1">
<title>
<![CDATA[
Confinement Discerns Swarmers from Planktonic Bacteria 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.08.30.274316v1?rss=1</link>
<description><![CDATA[
Powered by flagella, many bacterial species exhibit collective motion on a solid surface commonly known as swarming. As a natural example of active matter, swarming is also an essential biological phenotype associated with virulence, chemotaxis, and host pathogenesis. Physical changes like cell elongation and hyper flagellation have been shown to accompany the swarming phenotype. However, less noticeable, are the contrasts of collective motion between the swarming cells and the planktonic cells of comparable cell density. Here, we show that confining bacterial movement in designed dimensions allows distinguishing bacterial swarming from collective swimming. We found that on a soft agar plate, a novel bacterial strain Enterobacter sp. SM3 exhibited different motion patterns in swarming and planktonic states when confined to circular microwells of a specific range of sizes. When the confinement diameter was between 40 m and 90 m, swarming SM3 formed a single swirl motion pattern in the microwells whereas planktonic SM3 showed multiple swirls. Similar differential behavior is observed across a range of randomly selected gram-negative bacteria. We hypothesize that the "rafting behavior" of the swarming bacteria upon dilution might account for the motion pattern difference. We verified our conjectures via numerical simulations where swarming cells are modeled with lower repulsion and more substantial alignment force. The novel technical approach enabled us to observe swarming on a non-agar tissue surface for the first time. Our work provides the basis for characterizing bacterial swarming under more sophisticated environments, such as polymicrobial swarmer detection, and in vivo swarming exploration.
]]></description>
<dc:creator>Chen, W.</dc:creator>
<dc:creator>Mani, N.</dc:creator>
<dc:creator>Karani, H.</dc:creator>
<dc:creator>Li, H.</dc:creator>
<dc:creator>Mani, S.</dc:creator>
<dc:creator>Tang, J. X.</dc:creator>
<dc:date>2020-08-30</dc:date>
<dc:identifier>doi:10.1101/2020.08.30.274316</dc:identifier>
<dc:title><![CDATA[Confinement Discerns Swarmers from Planktonic Bacteria]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-08-30</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.08.31.276006v1?rss=1">
<title>
<![CDATA[
A genetic screen identifies processes that couple oocyte maturation to proteostasis in the immortal C. elegans germ lineage 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.08.31.276006v1?rss=1</link>
<description><![CDATA[
Somatic cells age and die, but the germ-cell lineage is immortal. In C. elegans, germline immortality involves proteostasis renewal at the beginning of each new generation, when oocyte-maturation signals from sperm trigger the clearance of carbonylated proteins and protein aggregates. Here, we explore the cell biology of this proteostasis renewal in the context of a whole-genome RNAi screen. Oocyte maturation signals are known to trigger protein-aggregate removal via lysosome acidification. Our findings suggest that lysosomes are acidified as a consequence of changes in ER activity that permit assembly of the lysosomal V-ATPase, which in turn allows lysosomes to clear the aggregates via microautophagy. We define two functions for mitochondria, both of which appear to be independent of ATP generation. Many genes from the screen also regulate lysosome acidification and age-dependent protein aggregation in the soma, suggesting a fundamental mechanistic link between proteostasis renewal in the germline and somatic longevity.
]]></description>
<dc:creator>Samaddar, M.</dc:creator>
<dc:creator>Goudeau, J.</dc:creator>
<dc:creator>Sanchez, M.</dc:creator>
<dc:creator>Hall, D. H.</dc:creator>
<dc:creator>Bohnert, K. A.</dc:creator>
<dc:creator>Ingaramo, M.</dc:creator>
<dc:creator>Kenyon, C.</dc:creator>
<dc:date>2020-08-31</dc:date>
<dc:identifier>doi:10.1101/2020.08.31.276006</dc:identifier>
<dc:title><![CDATA[A genetic screen identifies processes that couple oocyte maturation to proteostasis in the immortal C. elegans germ lineage]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-08-31</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.09.03.281576v1?rss=1">
<title>
<![CDATA[
Pathogenic Mutations in the Kinesin-3 Motor KIF1A Diminish Force Generation and Movement Through Allosteric Mechanisms 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.09.03.281576v1?rss=1</link>
<description><![CDATA[
The kinesin-3 motor KIF1A functions in neurons where its fast and superprocessive motility is thought to be critical for long-distance transport. However, little is known about the force-generating properties of kinesin-3 motors. Using optical tweezers, we demonstrate that KIF1A and its C. elegans homolog UNC-104 undergo force-dependent detachments at ~3 pN and then rapidly reattach to the microtubule to resume motion, resulting in a sawtooth pattern of clustered force generation events that is unique among the kinesin superfamily. Whereas UNC-104 motors stall before detaching, KIF1A motors do not. To examine the mechanism of KIF1A force generation, we introduced mutations linked to human neurodevelopmental disorders, V8M and Y89D, based on their location in structural elements required for force generation in kinesin-1. Molecular dynamics simulations predict that the V8M and Y89D mutations impair docking of the N-terminal ({beta}9) or C-terminal ({beta}10) portions of the neck linker, respectively, to the KIF1A motor domain. Indeed, both mutations dramatically impair force generation of KIF1A but not the motors ability to rapidly reattach to the microtubule track. Homodimeric and heterodimeric mutant motors also display decreased velocities, run lengths, and landing rates and homodimeric Y89D motors exhibit a higher frequency of non-productive, diffusive events along the microtubule. In cells, cargo transport by the mutant motors is delayed. Our work demonstrates the importance of the neck linker in the force generation of kinesin-3 motors and advances our understanding of how mutations in the kinesin motor domain can manifest in disease.
]]></description>
<dc:creator>Budaitis, B. G.</dc:creator>
<dc:creator>Jariwala, S.</dc:creator>
<dc:creator>Rao, L.</dc:creator>
<dc:creator>Sept, D.</dc:creator>
<dc:creator>Verhey, K.</dc:creator>
<dc:creator>Gennerich, A.</dc:creator>
<dc:date>2020-09-03</dc:date>
<dc:identifier>doi:10.1101/2020.09.03.281576</dc:identifier>
<dc:title><![CDATA[Pathogenic Mutations in the Kinesin-3 Motor KIF1A Diminish Force Generation and Movement Through Allosteric Mechanisms]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-09-03</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.09.04.282657v1?rss=1">
<title>
<![CDATA[
The kinesin-8 member Kif19 alters microtubule dynamics, suppresses cell adhesion, and promotes cancer cell invasion 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.09.04.282657v1?rss=1</link>
<description><![CDATA[
Metastasis is one of the deadliest aspects of cancer. Initial Metastatic spread is dependent on the detachment and dissemination of cells from a parent tumor, and invasion into the surrounding tissue. In this study, we characterize the kinesin-8 member Kif19 as a promoter of cancer cell invasion that suppresses cell-cell adherens junctions and cell-matrix focal adhesions. Initial analysis of publicly available cancer patient data sets demonstrated that Kif19 expression correlates with worse overall survival probability in several cancers and that Kif19 expression is increased in metastases of colorectal and breast carcinoma compared to the primary tumor. Depletion of Kif19 from two human cancer cell lines (DMS53 and MDA-MB-231) did not alter viability, but decreased the cells ability to invade a Matrigel matrix by half and impaired the invasion of spheroids into a primary cell monolayer. Ectopically expressed Kif19 localized to, and partially depolymerized, microtubules in the cell periphery. However, Kif19 depletion increased microtubule dynamicity and sensitivity to pharmacological depolymerization without altering total microtubule polymer levels. These data indicate that Kif19 can both depolymerize and stabilize microtubules. Given this activity, we then studied Kif19s effect on focal adhesions and adherens junctions, which are both regulated by microtubule dynamics. Kif19 knockdown increased the proportion of cell surface area covered by Vinculin focal adhesions. Further, Kif19 depletion increased whole cell E-cadherin expression and the accumulation of E-cadherin at cell-cell adherens junctions. Conversely, ectopic overexpression of full-length Kif19 led to proportionally smaller focal adhesions and impaired E-cadherin accumulation at cell-cell junctions. Our current hypothesis is that aberrant Kif19 expression in cancer alters focal adhesion dynamics and suppresses E-cadherin expression, which enhance cell invasiveness. Further, we propose that these changes in cell adhesion are due to modification of peripheral microtubule dynamics by Kif19, potentially through disruption of local rho GTPase activity.
]]></description>
<dc:creator>Eisenberg, S.</dc:creator>
<dc:creator>Dey, A.</dc:creator>
<dc:creator>Brinbaum, R.</dc:creator>
<dc:creator>Sharp, D.</dc:creator>
<dc:date>2020-09-04</dc:date>
<dc:identifier>doi:10.1101/2020.09.04.282657</dc:identifier>
<dc:title><![CDATA[The kinesin-8 member Kif19 alters microtubule dynamics, suppresses cell adhesion, and promotes cancer cell invasion]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-09-04</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.09.10.292086v1?rss=1">
<title>
<![CDATA[
Combined protein and transcript single cell RNA sequencing reveals cardiovascular disease and HIV signatures 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.09.10.292086v1?rss=1</link>
<description><![CDATA[
Cryopreserved peripheral blood mononuclear cells (PBMCs) are frequently collected and provide disease- and treatment-relevant data in clinical studies. Here, we developed combined protein (40 antibodies) and transcript single cell (sc)RNA sequencing in PBMCs. Among 31 participants in the WIHS Study, we sequenced 41,611 cells. Using Boolean gating followed by Seurat UMAPs and Louvain clustering, we identified 58 subsets among CD4 T, CD8 T, B, NK cells and monocytes. This resolution was superior to flow cytometry, mass cytometry or scRNA-sequencing without antibodies. Since the transcriptome was not needed for cell identification, combined protein and transcript scRNA-Seq allowed for the assessment of disease-related changes in transcriptomes and cell type proportion. As a proof-of-concept, we showed such differences between healthy and matched individuals living with HIV with and without cardiovascular disease. In conclusion, combined protein and transcript scRNA sequencing is a suitable and powerful method for clinical investigations using PBMCs.
]]></description>
<dc:creator>Vallejo, J.</dc:creator>
<dc:creator>Saigusa, R.</dc:creator>
<dc:creator>Gulati, R.</dc:creator>
<dc:creator>Ghosheh, Y.</dc:creator>
<dc:creator>Durant, C. P.</dc:creator>
<dc:creator>Roy, P.</dc:creator>
<dc:creator>Ehinger, E.</dc:creator>
<dc:creator>Pattarabanjird, T.</dc:creator>
<dc:creator>Padgett, L. E.</dc:creator>
<dc:creator>Olingy, C. E.</dc:creator>
<dc:creator>Hanna, D. B.</dc:creator>
<dc:creator>Landay, A. L.</dc:creator>
<dc:creator>Tracy, R. P.</dc:creator>
<dc:creator>Lazar, J. M.</dc:creator>
<dc:creator>Mack, W. J.</dc:creator>
<dc:creator>Weber, K. M.</dc:creator>
<dc:creator>Adimora, A. A.</dc:creator>
<dc:creator>Hodis, H. N.</dc:creator>
<dc:creator>Tien, P. C.</dc:creator>
<dc:creator>Ofotokun, I.</dc:creator>
<dc:creator>Heath, S. L.</dc:creator>
<dc:creator>Dinh, H. Q.</dc:creator>
<dc:creator>Shemesh, A.</dc:creator>
<dc:creator>McNamara, C. A.</dc:creator>
<dc:creator>Lanier, L. L.</dc:creator>
<dc:creator>Hedrick, C. C.</dc:creator>
<dc:creator>Kaplan, R. C.</dc:creator>
<dc:creator>Ley, K.</dc:creator>
<dc:date>2020-09-12</dc:date>
<dc:identifier>doi:10.1101/2020.09.10.292086</dc:identifier>
<dc:title><![CDATA[Combined protein and transcript single cell RNA sequencing reveals cardiovascular disease and HIV signatures]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-09-12</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.09.17.302596v1?rss=1">
<title>
<![CDATA[
YY1 cistrome analysis uncovers an essential requirement of the YY1:BRD4-PFKP regulatory axis for promoting tumorigenesis of castration-resistant prostate cancer 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.09.17.302596v1?rss=1</link>
<description><![CDATA[
Castration-resistant prostate cancer (CRPC) is a terminal disease, demanding a better understanding of its pathogenesis. Targeted therapy needs to be developed for CRPC due to its heterogeneity and resistance to current treatments. Here, through cistrome study of YY1, a transcription factor significantly overexpressed during prostate cancer progression, we identify a YY1-PFKP axis to be essential for CRPC tumorigenesis. Depletion of YY1 in independent CRPC models dramatically reduced tumor cell growth in vitro and delayed oncogenic progression in vivo. Importantly, YY1 functions as a master regulator of prostate tumor metabolism including the Warburg effect and mitochondria respiration. Loss-of-function and rescue studies further reveals a mechanistic underpinning in which YY1 directly binds and trans-activates PFKP, a gene encoding the rate-limiting enzyme for glycolysis, significantly contributing to the YY1-enforced oncogenic phenotypes such as enhanced tumor cell glycolysis and malignant growth. Additionally, a vast majority of gene-regulatory element in advanced prostate cancer cells are bound by YY1, lending a support for its role as a master regulator of prostate cancer progression. YY1 interactome studies point to bromodomain-containing coactivators in prostate cancer, which act as functional partners of YY1 to potentiate YY1-related target gene activation. Altogether, this study unveils an unexplored YY1:BRD4-PFKP oncogenic axis operating in advanced prostate cancer with implications for therapy.
]]></description>
<dc:creator>Cai, L.</dc:creator>
<dc:creator>Xu, C.</dc:creator>
<dc:creator>Tsai, Y.-H.</dc:creator>
<dc:creator>Galbo, P.</dc:creator>
<dc:creator>Gong, W.</dc:creator>
<dc:creator>Storey, A.</dc:creator>
<dc:creator>Xu, Y.</dc:creator>
<dc:creator>Byrum, S.</dc:creator>
<dc:creator>Whang, Y.</dc:creator>
<dc:creator>Parker, J.</dc:creator>
<dc:creator>Mackintosh, S.</dc:creator>
<dc:creator>Edmondson, R.</dc:creator>
<dc:creator>Tackett, A.</dc:creator>
<dc:creator>Huang, J.</dc:creator>
<dc:creator>Zheng, D.</dc:creator>
<dc:creator>Earp, S.</dc:creator>
<dc:creator>Wang, G. G.</dc:creator>
<dc:date>2020-09-19</dc:date>
<dc:identifier>doi:10.1101/2020.09.17.302596</dc:identifier>
<dc:title><![CDATA[YY1 cistrome analysis uncovers an essential requirement of the YY1:BRD4-PFKP regulatory axis for promoting tumorigenesis of castration-resistant prostate cancer]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-09-19</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.09.18.303388v1?rss=1">
<title>
<![CDATA[
Live imaging of breast tumors shows macrophage-dependent induction and TMEM-mediated enrichment of cancer stem cells during metastatic dissemination 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.09.18.303388v1?rss=1</link>
<description><![CDATA[
Cancer stem cells (CSCs) play an important role during metastasis, but the dynamic behavior and induction mechanisms of CSCs are not well understood. We employed high-resolution intravital microscopy using a CSC biosensor to directly observe CSCs in live mice with mammary tumors. CSCs display the slow-migratory, invadopod-rich phenotype that is the hallmark of disseminating tumor cells. CSCs are enriched near macrophages, particularly near macrophage-containing intravasation sites called Tumor Microenvironment of Metastasis (TMEM) doorways. A dramatic enrichment of CSCs occurs on association with TMEM doorways, contributing to the finding that CSCs represent [~]>60% of circulating tumor cells. Mechanistically, stemness is induced in non-stem cancer cells upon their direct contact with macrophages via Notch signaling. In breast cancers from patients, the density of TMEM doorways correlates strongly with the proportion of cancer cells expressing stem cell markers, indicating that in human breast cancer TMEM doorways are not only cancer cell intravasation portals but also CSC programming sites.

One Sentence SummaryIntravital imaging reveals macrophage-mediated induction of cancer stem cells in vivo and their dramatic enrichment on dissemination through TMEM doorways.
]]></description>
<dc:creator>Sharma, V. P.</dc:creator>
<dc:creator>Tang, B.</dc:creator>
<dc:creator>Wang, Y.</dc:creator>
<dc:creator>Karagiannis, G. S.</dc:creator>
<dc:creator>Xue, E. A.</dc:creator>
<dc:creator>Entenberg, D.</dc:creator>
<dc:creator>Borriello, L.</dc:creator>
<dc:creator>Coste, A.</dc:creator>
<dc:creator>Duran, C. L.</dc:creator>
<dc:creator>Eddy, R. J.</dc:creator>
<dc:creator>Kim, G.</dc:creator>
<dc:creator>Ye, X.</dc:creator>
<dc:creator>Jones, J. G.</dc:creator>
<dc:creator>Grunblatt, E.</dc:creator>
<dc:creator>Agi, N.</dc:creator>
<dc:creator>Roy, S.</dc:creator>
<dc:creator>Bandyopadhyaya, G.</dc:creator>
<dc:creator>Adler, E.</dc:creator>
<dc:creator>Surve, C. R.</dc:creator>
<dc:creator>Esposito, D.</dc:creator>
<dc:creator>Goswami, S.</dc:creator>
<dc:creator>Guo, W.</dc:creator>
<dc:creator>Condeelis, J. S.</dc:creator>
<dc:creator>Wakefield, L. M.</dc:creator>
<dc:creator>Oktay, M. H.</dc:creator>
<dc:date>2020-09-20</dc:date>
<dc:identifier>doi:10.1101/2020.09.18.303388</dc:identifier>
<dc:title><![CDATA[Live imaging of breast tumors shows macrophage-dependent induction and TMEM-mediated enrichment of cancer stem cells during metastatic dissemination]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-09-20</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.09.20.305243v1?rss=1">
<title>
<![CDATA[
The regulatory function of the AAA4 ATPase domain of cytoplasmic dynein 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.09.20.305243v1?rss=1</link>
<description><![CDATA[
Cytoplasmic dynein is the primary motor for microtubule minus-end-directed transport and is indispensable to eukaryotic cells. Although each motor domain of dynein contains three active AAA+ ATPases (AAA1, 3, and 4), only the functions of AAA1 and 3 are known. Here, we use single-molecule fluorescence and optical tweezers studies to elucidate the role of AAA4 in dyneins mechanochemical cycle. We demonstrate that AAA4 controls the priming stroke of the motion-generating linker, which connects the dimerizing tail of the motor to the AAA+ ring. Before ATP binds to AAA4, dynein remains incapable of generating motion. However, when AAA4 is bound to ATP, the gating of AAA1 by AAA3 prevails and dynein motion can occur. Thus, AAA1, 3, and 4 work together to regulate dynein function. Our work elucidates an essential role for AAA4 in dyneins stepping cycle and underscores the complexity and crosstalk among the motors multiple AAA+ domains.
]]></description>
<dc:creator>Gennerich, A.</dc:creator>
<dc:creator>Liu, X.</dc:creator>
<dc:creator>Rao, L.</dc:creator>
<dc:date>2020-09-20</dc:date>
<dc:identifier>doi:10.1101/2020.09.20.305243</dc:identifier>
<dc:title><![CDATA[The regulatory function of the AAA4 ATPase domain of cytoplasmic dynein]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-09-20</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.09.22.304451v1?rss=1">
<title>
<![CDATA[
Degenerating Drosophila Larval Epidermal Cells Drive Thorax Closure 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.09.22.304451v1?rss=1</link>
<description><![CDATA[
Adult thorax formation in Drosophila begins during pre-pupal development by fusion of its two contralateral progenitor halves, the heminotal epithelia (HE). HEs migrate and replace an underlying cell layer of thoracic larval epidermal cells (LECs) during a morphogenetic process called thorax closure. The LEC layer has so far been proposed to be a passive substrate over which HEs migrate before their zipping. By contrast, here we show that the pull forces generated within the LEC layer drive HE migration. During thorax closure, the LECs display actomyosin-mediated contraction, via enrichment of non-muscle myosin-II and actin, besides squamous-to-pseudostratified columnar epithelial transition and tissue shrinkage. This shrinkage of the LEC layer is further accompanied by cell extrusion and death, that prevent overcrowding of LECs, thereby promoting further shrinkage. The pull forces thus generated by the shrinking LEC layer are then relayed to the HEs by their mutual adhesions via {beta}PS1 (Mys) and PS3 (Scb) integrins. Suppression of cell death in the LEC layer by a gain of p35 leads to cell overcrowding, which impedes HE migration and zipping. Further, knockdown of sqh, the light chain of non-muscle myosin II, in LECs or integrins (mys or scb) in either the LEC layer or in the HEs, or both abrogate thorax closure. Mathematical modeling also reveals the biophysical underpinnings of the forces that drive this tissue closure process wherein a degenerating LEC layer mediates its succession by the future adult primodia. These essential principles of thorax closure appear ancient in origin and recur in multiple morphogenetic contexts and tissue repair.
]]></description>
<dc:creator>Athilingam, T.</dc:creator>
<dc:creator>Parihar, S. S.</dc:creator>
<dc:creator>Bhattacharya, R.</dc:creator>
<dc:creator>Rizvi, M. S.</dc:creator>
<dc:creator>Kumar, A.</dc:creator>
<dc:creator>Sinha, P.</dc:creator>
<dc:date>2020-09-22</dc:date>
<dc:identifier>doi:10.1101/2020.09.22.304451</dc:identifier>
<dc:title><![CDATA[Degenerating Drosophila Larval Epidermal Cells Drive Thorax Closure]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-09-22</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.09.22.308320v1?rss=1">
<title>
<![CDATA[
A Highly Conserved 310-Helix Within the Kinesin Motor Domain is Critical for Kinesin Function and Human Health. 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.09.22.308320v1?rss=1</link>
<description><![CDATA[
KIF1A, a kinesin-3 family member, plays critical roles as a long-distance cargo-transporter within neurons. Over 100 known KIF1A mutations in humans result in KIF1A Associated Neurological Disease (KAND), developmental and degenerative neurological conditions for which there is no cure. A de novo missense mutation, P305L, was recently identified in several children diagnosed with KAND, but the underlying molecular basis for the disease phenotype is unknown. Interestingly, this residue is highly conserved in kinesin-family proteins, and together with adjacent conserved residues also implicated in KAND, forms an unusual 310-helical element immediately C-terminal to loop-12 (L12, also known as the K-loop in KIF1A) in the conserved kinesin motor core. In KIF1A, the disordered K-loop contains a highly charged insertion of lysines that is thought to endow the motor with a high microtubule-association rate. Here, we characterize the molecular defects of the P305L mutation in KIF1A using genetic, biochemical, and single-molecule approaches. We find the mutation negatively impacts the velocity, run-length, and force generation of the motor. However, a much more dramatic effect is observed on the microtubule-association rate of the motor, revealing that the presence of an intact K-loop is not sufficient for its function. We hypothesize that an elusive K-loop conformation, mediated by formation of a highly conserved adjacent 310-helix that is modulated via P305, is critically important for the kinesin-microtubule interaction. Importantly, we find that the function of this proline is conserved in the canonical kinesin, KIF5, revealing a fundamental principle of the kinesin motor mechanism.
]]></description>
<dc:creator>Lam, A. J.</dc:creator>
<dc:creator>Rao, L.</dc:creator>
<dc:creator>Anazawa, Y.</dc:creator>
<dc:creator>Okada, K.</dc:creator>
<dc:creator>Chiba, K.</dc:creator>
<dc:creator>Niwa, S.</dc:creator>
<dc:creator>Gennerich, A.</dc:creator>
<dc:creator>Nowakowski, D. W.</dc:creator>
<dc:creator>McKenney, R. J.</dc:creator>
<dc:date>2020-09-22</dc:date>
<dc:identifier>doi:10.1101/2020.09.22.308320</dc:identifier>
<dc:title><![CDATA[A Highly Conserved 310-Helix Within the Kinesin Motor Domain is Critical for Kinesin Function and Human Health.]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-09-22</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.09.29.318121v1?rss=1">
<title>
<![CDATA[
TRIM5α restriction of HIV-1-N74D viruses in lymphocytes is caused by a loss of cyclophilin A protection 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.09.29.318121v1?rss=1</link>
<description><![CDATA[
The core of HIV-1 viruses bearing the capsid change N74D (HIV-1-N74D) do not bind the human protein cleavage and polyadenylation specificity factor subunit 6 (CPSF6). In addition, HIV-1-N74D viruses have altered patterns of integration site preference in human cell lines. In primary human CD4+ T cells, HIV-1-N74D viruses exhibit infectivity defects when compared to wild type. The reason for this loss of infectivity in primary cells is unknown. We first investigated whether loss of CPSF6 binding accounts for the loss of infectivity. Depletion of CPSF6 in human CD4+ T cells did not affect the early stages of wild-type HIV-1 replication, suggesting that defective infectivity in the case of HIV-1-N74D is not due to the loss of CPSF6 binding. Based on our previous result that cyclophilin A (Cyp A) protected HIV-1 from human tripartite motif-containing protein 5 (TRIM5hu) restriction in CD4+ T cells, we tested whether TRIM5hu was involved in the decreased infectivity observed for HIV-1-N74D. Depletion of TRIM5hu in CD4+ T cells rescued the infectivity of HIV-1-N74D, suggesting that HIV-1-N74D cores interacted with TRIM5hu. Accordingly, TRIM5hu binding to HIV-1-N74D cores was increased compared with that of wild-type cores, and consistently, HIV-1-N74D cores lost their ability to bind Cyp A. In conclusion, we showed that the decreased infectivity of HIV-1-N74D in CD4+ T cells is due to a loss of Cyp A protection from TRIM5hu restriction activity.
]]></description>
<dc:creator>Selyutina, A.</dc:creator>
<dc:creator>Simons, L. M.</dc:creator>
<dc:creator>Bulnes-Ramos, A.</dc:creator>
<dc:creator>Hultquist, J. F.</dc:creator>
<dc:creator>Diaz-Griffero, F.</dc:creator>
<dc:date>2020-09-29</dc:date>
<dc:identifier>doi:10.1101/2020.09.29.318121</dc:identifier>
<dc:title><![CDATA[TRIM5α restriction of HIV-1-N74D viruses in lymphocytes is caused by a loss of cyclophilin A protection]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-09-29</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.10.01.322594v1?rss=1">
<title>
<![CDATA[
The Phaeodactylum tricornutum Diaminopimelate Decarboxylase was Acquired via Horizontal Gene Transfer from Bacteria and Displays Substrate Promiscuity 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.10.01.322594v1?rss=1</link>
<description><![CDATA[
Diatoms are predicted to synthesize certain amino acids within the chloroplast, including L-lysine via a diaminopimelate-dependent pathway. Herein, we report that the model diatom, Phaeodactylum tricornutum, possesses a chimeric lysine biosynthetic pathway, which coalesces bacterial and plant genes, and is terminated by a chloroplast-localized diaminopimelate decarboxylase (DAPDC, PtLYSA). We show that while RNAi ablation of PtLYSA is either synthetically lethal or concomitant with a slower growth rate, Cas9-mediated mutagenesis of PtLYSA results in recovery of heterozygous cells lines, suggesting that PtLYSA is an essential gene. Previously characterized DAPDCs are unique within the PLP-dependent decarboxylases where catalysis occurs at the D-stereocenter of the substrate and display a strict stereochemical preference for a (D,L)- or meso-substrate and not the D,D- or L,L-isomers of diaminopimelate (DAP) to synthesize L-lysine. Using decarboxylation assays and differential scanning calorimetry analyses, we validate that PtLYSA is a bona fide DAPDC and uncover its unexpected stereopromiscuous behavior in substrate specificity. The crystal structure of PtLYSA confirms the enzyme is an obligate homodimer in which both protomers reciprocally participate in the active site. The structure underscores features unique to the PtLYSA clan of DAPDC and provides structural insight into the determinants responsible for the substrate-promiscuity observed in PtLYSA.
]]></description>
<dc:creator>Bielinski, V. A.</dc:creator>
<dc:creator>Brunson, J. K.</dc:creator>
<dc:creator>Ghosh, A.</dc:creator>
<dc:creator>Moosburner, M. A.</dc:creator>
<dc:creator>Garza, E. A.</dc:creator>
<dc:creator>Fussy, Z.</dc:creator>
<dc:creator>Bai, J.</dc:creator>
<dc:creator>McKinnie, S. M. K.</dc:creator>
<dc:creator>Moore, B.</dc:creator>
<dc:creator>Allen, A. E.</dc:creator>
<dc:creator>Almo, S. C.</dc:creator>
<dc:creator>Dupont, C. L.</dc:creator>
<dc:date>2020-10-02</dc:date>
<dc:identifier>doi:10.1101/2020.10.01.322594</dc:identifier>
<dc:title><![CDATA[The Phaeodactylum tricornutum Diaminopimelate Decarboxylase was Acquired via Horizontal Gene Transfer from Bacteria and Displays Substrate Promiscuity]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-10-02</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.10.04.325787v1?rss=1">
<title>
<![CDATA[
Sleeve gastrectomy promotes sustained weight loss while increasing heat production in middle aged, obese female mice 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.10.04.325787v1?rss=1</link>
<description><![CDATA[
BackgroundSleeve gastrectomy (SG) is currently the most frequently performed bariatric surgery in the United States. The majority of patients undergoing SG are middle aged women. Most preclinical models of bariatric surgery, however, utilize juvenile male mice. A long-term characterization of the response of mature wild type, obese female mice to SG has not been performed. Thus, we set out to characterize the response of middle aged obese female mice to SG.

MethodsTen-month old C57bl/6J obese female mice were randomized to undergo SG, sham surgery without caloric restriction (SH) or sham surgery with caloric restriction to match body weight to the SG group (SWM). Body weight, body composition and glucose tolerance were matched at baseline. Mice were followed for 60 days following their respective surgeries.

ResultsThe SG group had a more pronounced percent weight loss than the SH and SWM control groups (p<0.05), while consuming more calories than the SWM group (p<0.05). The SG group had a significant improvement in glucose tolerance compared to the SH control group (p<0.05). Plasma leptin was significantly decreased in the SG and SWM group, compared to the SH group (p<0.01). Unexpectedly, FGF-21 was increased in the SH group compared to the SG and SWM groups (p<0.01), while there was no difference in plasma insulin among the three groups. Heat production was increased in the SG group compared to SWM and SH groups (p<0.001). SG also had a significantly increased mRNA expression of Uncoupling Protein 1 (UCP-1), Adiponectin and Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha (PGC1-alpha) in brown adipose tissue (BAT), compared to SWM and SH groups. Both SG and SWM groups had increased fecal lipid excretion (p<0.05), compared to the SH group.

ConclusionsSG in obese, middle aged female mice leads to sustained weight loss and blood glucose improvement. It appears that increased metabolism in BAT may be linked to these effects.
]]></description>
<dc:creator>Emiliano, A. B.</dc:creator>
<dc:creator>He, Y.</dc:creator>
<dc:creator>Higuchi, S.</dc:creator>
<dc:creator>Lopatinsky, N.</dc:creator>
<dc:creator>Nemr, R.</dc:creator>
<dc:creator>Schwartz, G. J.</dc:creator>
<dc:date>2020-10-05</dc:date>
<dc:identifier>doi:10.1101/2020.10.04.325787</dc:identifier>
<dc:title><![CDATA[Sleeve gastrectomy promotes sustained weight loss while increasing heat production in middle aged, obese female mice]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-10-05</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.10.05.326785v1?rss=1">
<title>
<![CDATA[
Fat Mass Regain in Middle-Aged Mice after Sleeve Gastrectomy is divergent from plasma leptin levels 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.10.05.326785v1?rss=1</link>
<description><![CDATA[
BackgroundSome degree of weight regain is typically observed in human patients who undergo Sleeve Gastrectomy (SG), even if the majority of them do not return to their presurgical body weight. Although the majority of bariatric surgery patients are middle aged, most preclinical models of bariatric surgery utilize juvenile male mice. A long-term characterization of the response of mature, wild type, obese male mice to SG has not been performed.

MethodsEight-month old C57bl/6J obese male mice were randomized to undergo SG, sham surgery without caloric restriction (SH) or sham surgery with caloric restriction to match body weight to the SG group (SWM). Body weight, body composition and glucose tolerance were matched at baseline. Mice were followed for 60 days following their respective surgeries.

ResultsSG mice had a more pronounced percent weight loss than the SH group in the first post-operative month (p<0.05), along with fat mass loss (p<0.01). By the second post-operative month, the SG group started to regain fat mass, although it continued to be statistically lower than the SH group (p<0.05). Cumulative food intake was significantly lower in the SG group compared to SH group only in the first post-operative week (p<0.05), with both groups having similar cumulative food intake thereafter (p>0.05). SWM group had a significantly lower cumulative food intake throughout the study, except for week 1 (p<0.01). Glucose tolerance was only demonstrably better in the SG group compared to SH group at 8 weeks post-operatively (p<0.01). Plasma leptin was significantly lower in the SG group compared to both SWM and SH groups group by the second post-operative month (p<0.01), in spite of SGs increasing fat mass accumulation. In the second post-operative month, both FGF-21 and GDF-15 were increased in the SH group compared to the SG and SWM groups (p<0.05), while there was no difference in plasma insulin among the three groups. Heat production was surprisingly higher in the SH group compared to the other two groups (p<0.05), even though brown adipose tissue Peroxisome Proliferator-Activated Receptor Gamma (PPARg) and Cidea mRNA expression were significantly higher in SG and SWM compared to SH (p<0.01). There was no change in BAT UCP-1 mRNA expression among the groups (p>0.05). There was also no change in fecal lipid content among the groups (p>0.05).

ConclusionsSG in obese, middle aged male mice leads is accompanied by fat mass regain in the second post-operative month, while plasma leptin levels continue to be significantly lower. This raises the question of whether the observed fat mass regain consists mostly of visceral adipose tissue.
]]></description>
<dc:creator>Emiliano, A.</dc:creator>
<dc:creator>He, Y.</dc:creator>
<dc:creator>Higuchi, S.</dc:creator>
<dc:creator>Nemr, R.</dc:creator>
<dc:creator>Lopatinsky, N.</dc:creator>
<dc:creator>Schwartz, G. J.</dc:creator>
<dc:date>2020-10-07</dc:date>
<dc:identifier>doi:10.1101/2020.10.05.326785</dc:identifier>
<dc:title><![CDATA[Fat Mass Regain in Middle-Aged Mice after Sleeve Gastrectomy is divergent from plasma leptin levels]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-10-07</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.10.09.324939v1?rss=1">
<title>
<![CDATA[
The Drosophila histone demethylase KDM5 is required during early neurodevelopment for proper mushroom body formation and cognitive function 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.10.09.324939v1?rss=1</link>
<description><![CDATA[
Mutations in the lysine demethylase 5 (KDM5) family of transcriptional regulators are associated with intellectual disability, yet little is known regarding the spatiotemporal requirements or neurodevelopmental contributions of KDM5 proteins. Utilizing the mushroom body (MB), a major learning and memory center within the Drosophila brain, we demonstrate that KDM5 is specifically required within ganglion mother cells and immature neurons for proper neurodevelopment and cognitive function. Within this cellular subpopulation, we identify a core network of KDM5-regulated genes that are critical modulators of neurodevelopment. Significantly, we find that a majority of these genes are direct targets of Prospero (Pros), a transcription factor with well-established roles in neurodevelopment in other neuronal contexts. We demonstrate that Pros is essential for MB development and functions downstream of KDM5 to regulate MB morphology. We therefore provide evidence for a KDM5-Pros axis that orchestrates a transcriptional program critical for proper axonal development and cognitive function.
]]></description>
<dc:creator>Hatch, H. A. M.</dc:creator>
<dc:creator>Belalcazar, H. M.</dc:creator>
<dc:creator>Marshall, O. J.</dc:creator>
<dc:creator>Secombe, J.</dc:creator>
<dc:date>2020-10-09</dc:date>
<dc:identifier>doi:10.1101/2020.10.09.324939</dc:identifier>
<dc:title><![CDATA[The Drosophila histone demethylase KDM5 is required during early neurodevelopment for proper mushroom body formation and cognitive function]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-10-09</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.10.12.331975v1?rss=1">
<title>
<![CDATA[
Vulnerability of ARID1A deficient cancer cells to pyrimidine synthesis blockade 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.10.12.331975v1?rss=1</link>
<description><![CDATA[
Here we report the discovery and preclinical validation of a novel precision medicine strategy for ARID1A-mutated cancer. Unbiased proteomics reveals for the first time that ARID1A protein (BAF250a) binds aspartate transcarbamoylase (ATCase), a key regulatory enzyme of the de novo pyrimidine synthesis pathway. Using isogenic paired ARID1A proficient/deficient cancer cell lines, we show that ARID1A protein deficiency (as occurs in ARID1A mutant cancers) leads to metabolic reprogramming and pyrimidine synthesis dependency. Pyrimidine synthesis blockade using the FDA-approved drug teriflunomide (a DHODH inhibitor) suppresses tumor growth and selectively induces DNA damage in ARID1A-deficient tumor models. Combining pyrimidine synthesis inhibition with DNA damage repair blockade, using teriflunomide and AZD6738 (an ATR inhibitor), achieves potent synergy and induces sustained tumor regression in ARID1A-mutant ovarian cancer patient-derived xenografts (PDX). These compelling preclinical data support the evaluation of this novel combination treatment in patients with ARID1A-mutated cancers.

SIGNIFICANCEWe identified that ARID1A-deficient cells are selectively vulnerable to pyrimidine synthesis blockade. Preclinical studies demonstrate the in vivo efficacy of a synergistic drug combination that concurrently inhibits the de novo pyrimidine synthesis pathway and DNA damage repair to induce regression in patient-derived xenograft models of ARID1A-mutated cancer.
]]></description>
<dc:creator>Li, Z.</dc:creator>
<dc:creator>Mi, S.</dc:creator>
<dc:creator>Osagie, O. I.</dc:creator>
<dc:creator>Ji, J.</dc:creator>
<dc:creator>Yang, C.-P. H.</dc:creator>
<dc:creator>Schwartz, M.</dc:creator>
<dc:creator>Hui, P.</dc:creator>
<dc:creator>Huang, G. S.</dc:creator>
<dc:date>2020-10-12</dc:date>
<dc:identifier>doi:10.1101/2020.10.12.331975</dc:identifier>
<dc:title><![CDATA[Vulnerability of ARID1A deficient cancer cells to pyrimidine synthesis blockade]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-10-12</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.10.12.335711v1?rss=1">
<title>
<![CDATA[
The histone demethylase KDM5 is required for synaptic structure and function at the Drosophila neuromuscular junction 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.10.12.335711v1?rss=1</link>
<description><![CDATA[
Mutations in the genes encoding the KDM5 family of histone demethylases are observed in individuals with intellectual disability (ID). Despite clear evidence linking KDM5 function to neurodevelopmental pathways, how this family of proteins impacts transcriptional programs to mediate synaptic structure and activity remains unclear. Using the Drosophila larval neuromuscular junction (NMJ), we show that KDM5 is required for neuroanatomical development and synaptic function. The JmjC-domain encoded histone demethylase activity of KDM5, which is expected to be diminished by many ID-associated alleles and required for appropriate synaptic morphology and neurotransmission. The C5HC2 zinc finger of KDM5 is also involved, as an ID-associated mutation in this motif reduces NMJ bouton number but increases bouton size. KDM5 therefore uses demethylase-dependent and independent mechanisms to regulate NMJ structure and activity, highlighting the complex nature by which this chromatin modifier carries out its neuronal gene regulatory programs.
]]></description>
<dc:creator>Secombe, J.</dc:creator>
<dc:creator>Belalcazar, H. M.</dc:creator>
<dc:creator>Hicks, E. L.</dc:creator>
<dc:creator>Zamurrad, S.</dc:creator>
<dc:creator>Liebl, F. L. W.</dc:creator>
<dc:date>2020-10-12</dc:date>
<dc:identifier>doi:10.1101/2020.10.12.335711</dc:identifier>
<dc:title><![CDATA[The histone demethylase KDM5 is required for synaptic structure and function at the Drosophila neuromuscular junction]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-10-12</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.10.14.338954v1?rss=1">
<title>
<![CDATA[
Neuronal NOX4 knockdown alleviates pathological tau-related alterations in a humanized mouse model of tauopathy 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.10.14.338954v1?rss=1</link>
<description><![CDATA[
Approximately 44 million people worldwide live with Alzheimers disease (AD) or a related form of dementia. Aggregates of the microtubule-associated protein tau are a common marker of these neurodegenerative diseases collectively termed as tauopathies. However, all therapeutic attempts based on tau have failed, suggesting that tau may only indicate a higher-level causal mechanism. For example, increasing levels of reactive oxygen species (ROS) may trigger protein aggregation or modulate protein degradation. Here we show that type 4 NADPH oxidase (NOX), the most abundant isoform of the only dedicated reactive oxygen producing enzyme family, is upregulated in dementia and AD patients and in a humanized mouse model of tauopathy. Both global knockout and neuronal knockdown of the Nox4 gene in mice, diminished the accumulation of pathological tau and positively modified established tauopathy by a mechanism that implicates modulation of the autophagy-lysosomal pathway (ALP). Moreover, neuronal-targeted NOX4 knockdown was sufficient to reduce neurotoxicity and prevented cognitive decline, suggesting a direct and causal role for neuronal NOX4. Thus, NOX4 is a previously unrecognized causal, mechanism-based target in tauopathies and blood-brain barrier permeable specific NOX4 inhibitors could have therapeutic potential even in established disease.

Graphical abstract

O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=83 SRC="FIGDIR/small/338954v1_ufig1.gif" ALT="Figure 1">
View larger version (26K):
org.highwire.dtl.DTLVardef@1dac496org.highwire.dtl.DTLVardef@1a07dd5org.highwire.dtl.DTLVardef@1a5653aorg.highwire.dtl.DTLVardef@198f3e4_HPS_FORMAT_FIGEXP  M_FIG C_FIG
]]></description>
<dc:creator>Luengo, E.</dc:creator>
<dc:creator>Trigo-Alonso, P.</dc:creator>
<dc:creator>Fernandez-Mendivil, C.</dc:creator>
<dc:creator>Nunez, A.</dc:creator>
<dc:creator>del Campo, M.</dc:creator>
<dc:creator>Porrero, C.</dc:creator>
<dc:creator>Garcia-Magro, N.</dc:creator>
<dc:creator>Negredo, P.</dc:creator>
<dc:creator>Sanchez, C.</dc:creator>
<dc:creator>Bernal, J. A.</dc:creator>
<dc:creator>Rabano, A.</dc:creator>
<dc:creator>Hoozemans, J.</dc:creator>
<dc:creator>Casas, A. I.</dc:creator>
<dc:creator>Schmidt, H. H.</dc:creator>
<dc:creator>Cuervo, A. M.</dc:creator>
<dc:creator>Lopez, M. G.</dc:creator>
<dc:date>2020-10-14</dc:date>
<dc:identifier>doi:10.1101/2020.10.14.338954</dc:identifier>
<dc:title><![CDATA[Neuronal NOX4 knockdown alleviates pathological tau-related alterations in a humanized mouse model of tauopathy]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-10-14</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.10.22.349514v1?rss=1">
<title>
<![CDATA[
NG2+/Nestin+ mesenchymal stem cells dictate DTC dormancy in the bone marrow through TGFβ2 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.10.22.349514v1?rss=1</link>
<description><![CDATA[
In the bone marrow (BM) microenvironment, NG2+/Nestin+ mesenchymal stem cells (MSCs) promote hematopoietic stem cell (HSC) quiescence1,2. Importantly, the BM can also harbour disseminated tumour cells (DTCs) from multiple cancers, which, like HSCs, can remain dormant3. The BM signals are so growth-restrictive that dormant BM DTCs can persist for years to decades only to awaken and fuel lethal metastasis3-10. The mechanisms and niche components regulating DTC dormancy remain largely unknown. Here, we reveal that periarteriolar BM-resident NG2+/Nestin+ MSCs can instruct breast cancer (BC) DTCs to enter dormancy. NG2+/Nestin+ MSCs produce TGF{beta}2 and BMP7 and activate a quiescence pathway dependent on TGFBRIII and BMPRII, which via p38-kinase result in p27-CDK inhibitor induction. Importantly, genetic depletion of the NG2+/Nestin+ MSCs or conditional knock-out of TGF{beta}2 in the NG2+/Nestin+ MSCs led to awakening and bone metastatic expansion of otherwise dormant p27+/Ki67- DTCs. Our results provide a direct proof that HSC dormancy niches control BC DTC dormancy. Given that aged NG2+/Nestin+ MSCs can lose homeostatic control of HSC dormancy, our results suggest that aging or extrinsic factors that affect the NG2+/Nestin+ MSC niche may result in a break from dormancy and BC bone relapse.
]]></description>
<dc:creator>Nobre, A. R.</dc:creator>
<dc:creator>Risson, E.</dc:creator>
<dc:creator>Singh, D. K.</dc:creator>
<dc:creator>Di Martino, J. S.</dc:creator>
<dc:creator>Cheung, J. F.</dc:creator>
<dc:creator>Wang, J.</dc:creator>
<dc:creator>Johnson, J.</dc:creator>
<dc:creator>Russnes, H. G.</dc:creator>
<dc:creator>Bravo-Cordero, J. J.</dc:creator>
<dc:creator>Birbrair, A.</dc:creator>
<dc:creator>Naume, B.</dc:creator>
<dc:creator>Azhar, M.</dc:creator>
<dc:creator>Frenette, P. S.</dc:creator>
<dc:creator>Aguirre-Ghiso, J. A.</dc:creator>
<dc:date>2020-10-22</dc:date>
<dc:identifier>doi:10.1101/2020.10.22.349514</dc:identifier>
<dc:title><![CDATA[NG2+/Nestin+ mesenchymal stem cells dictate DTC dormancy in the bone marrow through TGFβ2]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-10-22</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.10.22.351403v1?rss=1">
<title>
<![CDATA[
A Transgenic System for Targeted Ablation of Reproductive and Maternal-Effect genes 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.10.22.351403v1?rss=1</link>
<description><![CDATA[
Maternally provided gene products regulate the earliest events of embryonic life, including formation of the oocyte that will develop into an egg, and eventually an embryo. Forward genetic screens have provided invaluable insights into the molecular regulation of embryonic development, including essential contributions of some genes whose products must be provided to the transcriptionally silent early embryo for normal embryogenesis, maternal-effect genes. However, other maternal-effect genes are not accessible due to their essential zygotic functions during embryonic development. Identifying these regulators is essential to fill the large gaps in our understanding of the mechanisms and molecular pathways contributing to fertility and maternally regulated developmental processes. To identify these maternal factors, it is necessary to bypass the earlier requirement for these genes so that their potential later functions can be investigated. Here we report reverse genetic systems to identify genes with essential roles in reproductive and maternal-effect processes, as proof of principal and to assess the efficiency and robustness of mutagenesis we used these transgenic systems to disrupt two genes with known maternal-effect functions, kif5Ba and bucky ball.

Summary StatementWe report reverse genetic systems to identify essential regulators of reproductive and maternal-effect processes, as proof of principal we used these transgenic systems to disrupt genes with known maternal-effect functions.
]]></description>
<dc:creator>Bertho, S.</dc:creator>
<dc:creator>Kaufman, O.</dc:creator>
<dc:creator>Lee, K.</dc:creator>
<dc:creator>Santos-Ledo, A.</dc:creator>
<dc:creator>Dellal, D.</dc:creator>
<dc:creator>Marlow, F. L.</dc:creator>
<dc:date>2020-10-23</dc:date>
<dc:identifier>doi:10.1101/2020.10.22.351403</dc:identifier>
<dc:title><![CDATA[A Transgenic System for Targeted Ablation of Reproductive and Maternal-Effect genes]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-10-23</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.10.23.352377v1?rss=1">
<title>
<![CDATA[
Retrograde suppression of post-tetanic potentiation at the mossy fiber-CA3 pyramidal cell synapse 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.10.23.352377v1?rss=1</link>
<description><![CDATA[
In the hippocampus, the excitatory synapse between dentate granule cell axons - or mossy fibers (MF) - and CA3 pyramidal cells (MF-CA3) expresses robust forms of short-term plasticity, such as frequency facilitation and post-tetanic potentiation (PTP). These forms of plasticity are due to increases in neurotransmitter release, and can be engaged when dentate granule cells fire in bursts (e.g. during exploratory behaviors) and bring CA3 pyramidal neurons above threshold. While frequency facilitation at this synapse is limited by endogenous activation of presynaptic metabotropic glutamate receptors, whether MF-PTP can be regulated in an activity-dependent manner is unknown. Here, using physiologically relevant patterns of mossy fiber stimulation in acute mouse hippocampal slices, we found that disrupting postsynaptic Ca2+ dynamics increases MF-PTP, strongly suggesting a form of Ca2+-dependent retrograde suppression of this form of plasticity. PTP suppression requires a few seconds of MF bursting activity and Ca2+ release from internal stores. Our findings raise the possibility that the powerful MF-CA3 synapse can negatively regulate its own strength not only during PTP-inducing activity typical of normal exploratory behaviors, but also during epileptic activity.

SIGNIFICANCE STATEMENTThe powerful mossy fiber-CA3 synapse exhibits strong forms of plasticity that are engaged during location-specific exploration, when dentate granule cells fire in bursts. While this synapse is well-known for its presynaptically-expressed LTP and LTD, much less is known about the robust changes that occur on a shorter time scale. How such short-term plasticity is regulated, in particular, remains poorly understood. Unexpectedly, an in vivo-like pattern of presynaptic activity induced robust post-tetanic potentiation (PTP) only when the postsynaptic cell was loaded with a high concentration of Ca2+ buffer, indicating a form of Ca2+-dependent retrograde suppression of PTP. Such suppression may have profound implications for how environmental cues are encoded into neural assemblies, and for limiting network hyperexcitability during seizures.
]]></description>
<dc:creator>Makani, S.</dc:creator>
<dc:creator>Lutzu, S.</dc:creator>
<dc:creator>Lituma, P. J.</dc:creator>
<dc:creator>Hunt, D. L.</dc:creator>
<dc:creator>Castillo, P. E.</dc:creator>
<dc:date>2020-10-24</dc:date>
<dc:identifier>doi:10.1101/2020.10.23.352377</dc:identifier>
<dc:title><![CDATA[Retrograde suppression of post-tetanic potentiation at the mossy fiber-CA3 pyramidal cell synapse]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-10-24</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.10.29.359851v1?rss=1">
<title>
<![CDATA[
Regulation of intracellular signaling and neuron function by Bardet-Biedl Syndrome proteins in patient-specific iPSC-derived neurons 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.10.29.359851v1?rss=1</link>
<description><![CDATA[
Bardet-Biedl Syndrome (BBS) is a rare autosomal recessive disorder caused by mutations in genes encoding components of the primary cilium and characterized by hyperphagic obesity. We developed a cellular model of BBS using induced pluripotent stem cell (iPSCs)-derived hypothalamic arcuate-like neurons. BBS mutations BBS1M390R and BBS10C91fsX95 did not affect neuron differentiation efficiency but caused morphological defects including impaired neurite outgrowth and longer primary cilia. Expression of intact BBS10 normalized cilia length. Single-cell RNA sequencing (scRNA-seq) of BBS1M390R hypothalamic neurons identified several down regulated pathways including insulin and cAMP signaling, and axon guidance. In agreement with scRNA-seq data, insulin-induced AKT phosphorylation at Thr308 was reduced in BBS1M390R and BBS10c91fsX95 human fibroblasts and iPSC-derived neurons, as well as in BBS10 knockdown iPSC-derived neurons. Overexpression of intact BBS10 fully restored insulin receptor tyrosine phosphorylation in BBS10c91fsX95 neurons. Mutations in BBS1 and BBS10 impaired leptin-mediated p-STAT3 activation in both human primary fibroblasts and iPSC-derived hypothalamic neurons. Correction of the BBS mutation by CRISPR rescued leptin signaling. POMC expression in BBS1M390R and BBS10 C91fsX95 iPSC-derived hypothalamic neurons was downregulated, as was hypothalamic Pomc in BBS1M390R knockin (KI) mice. In the aggregate, these data provide insights into the anatomic and functional mechanisms by which components of the BBsome in CNS primary cilia mediate effects on energy homeostasis.
]]></description>
<dc:creator>Wang, L.</dc:creator>
<dc:creator>Liu, Y.</dc:creator>
<dc:creator>Stratigopoulos, G.</dc:creator>
<dc:creator>Panigrahi, S.</dc:creator>
<dc:creator>Sui, L.</dc:creator>
<dc:creator>Leduc, C. A.</dc:creator>
<dc:creator>Glover, H. J.</dc:creator>
<dc:creator>De Rosa, M. C.</dc:creator>
<dc:creator>Burnett, L. C.</dc:creator>
<dc:creator>Williams, D. J.</dc:creator>
<dc:creator>Shang, L.</dc:creator>
<dc:creator>Goland, R.</dc:creator>
<dc:creator>Tsang, S. H.</dc:creator>
<dc:creator>Wardlaw, S.</dc:creator>
<dc:creator>Egli, D.</dc:creator>
<dc:creator>Zheng, D.</dc:creator>
<dc:creator>Doege, C. A.</dc:creator>
<dc:creator>Leibel, R. L.</dc:creator>
<dc:date>2020-10-29</dc:date>
<dc:identifier>doi:10.1101/2020.10.29.359851</dc:identifier>
<dc:title><![CDATA[Regulation of intracellular signaling and neuron function by Bardet-Biedl Syndrome proteins in patient-specific iPSC-derived neurons]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-10-29</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.11.02.365783v1?rss=1">
<title>
<![CDATA[
The G protein-Coupled Metabotropic Glutamate Receptor 1 controls neuronal macroautophagy 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.11.02.365783v1?rss=1</link>
<description><![CDATA[
Autophagy is an evolutionarily conserved, highly regulated catabolic process critical to neuronal homeostasis, function and survival throughout organismal lifespan. However, the external factors and signals that control autophagy in neurons are still poorly understood. Here we report that the G protein-coupled metabotropic glutamate receptor 1 (mGlu1) contributes to control basal autophagy in the brain. Autophagy is upregulated in the brain of adult mGlu1 knockout mice and genetic deletion or pharmacological inhibition of native mGlu1 receptors enhances autophagy flux in neurons. The evolutionarily conserved adaptor protein FEZ1, identified by a genome-wide screen as mGlu1 receptor interacting partner, was found to participate in the regulation of neuronal autophagy and to be required for repression of autophagy flux by the mGlu1 receptor. Furthermore, FEZ1 appears to enable association of mGlu1 with Ulk1, a core component of the autophagy pathway. Thus, we propose that the mGlu1 receptor contributes to restrain constitutive autophagy in neurons.
]]></description>
<dc:creator>Donoso, M.</dc:creator>
<dc:creator>Speranza, L.</dc:creator>
<dc:creator>Kalinowska, M.</dc:creator>
<dc:creator>Castillo, C.</dc:creator>
<dc:creator>De Sanctis, C.</dc:creator>
<dc:creator>Francesconi, A.</dc:creator>
<dc:date>2020-11-02</dc:date>
<dc:identifier>doi:10.1101/2020.11.02.365783</dc:identifier>
<dc:title><![CDATA[The G protein-Coupled Metabotropic Glutamate Receptor 1 controls neuronal macroautophagy]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-11-02</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.11.04.368472v1?rss=1">
<title>
<![CDATA[
Comparative molecular and immunoregulatory analysis of extracellular vesicles from Candida albicans and Candida auris. 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.11.04.368472v1?rss=1</link>
<description><![CDATA[
Candida auris is a recently described multidrug-resistant pathogenic fungus that is increasingly responsible for healthcare associated outbreaks across the world. Bloodstream infections of this fungus cause death in up to 70% of the cases. Aggravating this scenario, C. auris disease-promoting mechanisms are poorly understood. Fungi release extracellular vesicles (EVs) carrying a broad range of molecules including proteins, lipids, carbohydrates, pigments, and RNA, many of which are virulence factors. Here, we carried out a comparative molecular characterization of C. auris and C. albicans EVs and evaluated their capacity to modulate effector mechanisms of host immune defense. Using proteomics, lipidomics, and transcriptomics, we found that C. auris released EVs with payloads that were strikingly different from EVs released by C. albicans. EVs released by C. auris potentiated the adhesion of this yeast to an epithelial cell monolayer. C. auris EVs also induced the expression of surface activation markers and cytokines by bone marrow-derived dendritic cells. Altogether, our findings show distinct profiles and properties of EVs released by C. auris and by C. albicans, and highlight the potential contribution of C. auris EVs to the pathogenesis of this emerging pathogen.
]]></description>
<dc:creator>Zamith-Miranda, D.</dc:creator>
<dc:creator>Heyman, H. M.</dc:creator>
<dc:creator>Couvillion, S. P.</dc:creator>
<dc:creator>Cordero, R. J. B.</dc:creator>
<dc:creator>Rodrigues, M.</dc:creator>
<dc:creator>Nimrichter, L.</dc:creator>
<dc:creator>Casadevall, A.</dc:creator>
<dc:creator>Amatuzzi, R.</dc:creator>
<dc:creator>Alves, L. R.</dc:creator>
<dc:creator>Nakayasu, E. S.</dc:creator>
<dc:creator>Nosanchuk, J. D.</dc:creator>
<dc:date>2020-11-04</dc:date>
<dc:identifier>doi:10.1101/2020.11.04.368472</dc:identifier>
<dc:title><![CDATA[Comparative molecular and immunoregulatory analysis of extracellular vesicles from Candida albicans and Candida auris.]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-11-04</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.11.05.369827v1?rss=1">
<title>
<![CDATA[
Modelling the neural code in large populations of correlated neurons 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.11.05.369827v1?rss=1</link>
<description><![CDATA[
Neurons respond selectively to stimuli, and thereby define a code that associates stimuli with population response patterns. Certain correlations within population responses (noise correlations) significantly impact the information content of the code, especially in large populations. Understanding the neural code thus necessitates response models that quantify the coding properties of modelled populations, while fitting large-scale neural recordings and capturing noise correlations. In this paper we propose a class of response model based on mixture models and exponential families. We show how to fit our models with expectation-maximization, and that they capture diverse variability and covariability in recordings of macaque primary visual cortex. We also show how they facilitate accurate Bayesian decoding, provide a closed-form expression for the Fisher information, and are compatible with theories of probabilistic population coding. Our framework could allow researchers to quantitatively validate the predictions of neural coding theories against both large-scale neural recordings and cognitive performance.
]]></description>
<dc:creator>Sokoloski, S.</dc:creator>
<dc:creator>Aschner, A.</dc:creator>
<dc:creator>Coen-Cagli, R.</dc:creator>
<dc:date>2020-11-06</dc:date>
<dc:identifier>doi:10.1101/2020.11.05.369827</dc:identifier>
<dc:title><![CDATA[Modelling the neural code in large populations of correlated neurons]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-11-06</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.11.08.371922v1?rss=1">
<title>
<![CDATA[
TSC1 loss-of-function increases risk for tauopathy by inducing tau acetylation and preventing autophagy-mediated tau clearance 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.11.08.371922v1?rss=1</link>
<description><![CDATA[
Age-associated neurodegenerative disorders demonstrating tau-laden intracellular inclusions, including Alzheimers disease (AD), frontotemporal lobar degeneration (FTLD) and progressive supranuclear palsy (PSP), are collectively known as tauopathies. The vast majority of human tauopathies accumulate non-mutant tau rather than mutant forms of the protein, yet cell and animal models for non-mutant tauopathies are lacking. We previously linked a monoallelic mutation in the TSC1 gene to tau accumulation and FTLD. Now, we have identified new variants in TSC1 that predisposed to other tauopathies such as AD and PSP. These new TSC1 risk variants significantly decreased the half-life of TSC1/hamartin in vitro. Cellular and murine models of TSC1 haploinsufficiency (TSC1+/-) accumulated tau protein that exhibited aberrant acetylation on six lysine residues. Tau acetylation hindered its lysosomal degradation via chaperone-mediated autophagy leading to neuronal tau accumulation. Enhanced tau acetylation in TSC1+/- models was achieved through both an increase in p300 acetyltransferase activity and a decrease in SIRT1 deacetylase levels. Pharmacological modulation of either enzyme restored tau levels. Together, these studies substantiate TSC1 as a novel tauopathy risk gene and advance TSC1 haploinsufficiency as a new genetic model for tauopathy. In addition, these results promote acetylated tau as a rational target for diagnostic and therapeutic modalities in multiple tauopathies.
]]></description>
<dc:creator>Alquezar, C.</dc:creator>
<dc:creator>Schoch, K. M.</dc:creator>
<dc:creator>Geier, E. G.</dc:creator>
<dc:creator>Ramos, E. M.</dc:creator>
<dc:creator>Scrivo, A.</dc:creator>
<dc:creator>Li, K.</dc:creator>
<dc:creator>Argouarch, A. R.</dc:creator>
<dc:creator>Mlynarski, E. E.</dc:creator>
<dc:creator>Dombroski, B.</dc:creator>
<dc:creator>Yokoyama, J. S.</dc:creator>
<dc:creator>Cuervo, A. M.</dc:creator>
<dc:creator>Burlingame, A. L.</dc:creator>
<dc:creator>Schellenberg, G. D.</dc:creator>
<dc:creator>Miller, T. M.</dc:creator>
<dc:creator>Miller, B. L.</dc:creator>
<dc:creator>Kao, A. W.</dc:creator>
<dc:date>2020-11-08</dc:date>
<dc:identifier>doi:10.1101/2020.11.08.371922</dc:identifier>
<dc:title><![CDATA[TSC1 loss-of-function increases risk for tauopathy by inducing tau acetylation and preventing autophagy-mediated tau clearance]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-11-08</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.11.11.378331v1?rss=1">
<title>
<![CDATA[
Mechanistic Dissection of Spatial Organization in NF-κB Signaling Pathways by Hybrid Simulations 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.11.11.378331v1?rss=1</link>
<description><![CDATA[
The nuclear factor kappa-light-chain-enhancer of activated B cells (NF-{kappa}B) is one of the most important transcription factors involved in the regulation of inflammatory signaling pathways. Inappropriate activation of these pathways has been linked to autoimmunity and cancers. Emerging experimental evidences have been showing the existence of elaborate spatial organizations for various molecular components in the pathways. One example is the scaffold protein tumor necrosis factor receptor associated factor (TRAF). While most TRAF proteins form trimeric quaternary structure through their coiled-coil regions, the N-terminal region of some members in the family can further be dimerized. This dimerization of TRAF trimers can drive them into higher-order clusters as a response to receptor stimulation, which functions as a spatial platform to mediate the downstream poly-ubiquitination. However, the molecular mechanism underlying the TRAF protein clustering and its functional impacts are not well-understood. In this article, we developed a hybrid simulation method to tackle this problem. The assembly of TRAF-based signaling platform at the membrane-proximal region is modeled with spatial resolution, while the dynamics of downstream signaling network, including the negative feedbacks through various signaling inhibitors, is simulated as stochastic chemical reactions. These two algorithms are further synchronized under a multiscale simulation framework. Using this computational model, we illustrated that the formation of TRAF signaling platform can trigger an oscillatory NF-{kappa}B response. We further demonstrated that the temporal patterns of downstream signal oscillations are closely regulated by the spatial factors of TRAF clustering, such as the geometry and energy of dimerization between TRAF trimers. In general, our study sheds light on the basic mechanism of NF-{kappa}B signaling pathway and highlights the functional importance of spatial regulation within the pathway. The simulation framework also showcases its potential of application to other signaling pathways in cells.
]]></description>
<dc:creator>Wu, Y.</dc:creator>
<dc:creator>Dhusia, K.</dc:creator>
<dc:creator>Su, Z.</dc:creator>
<dc:date>2020-11-11</dc:date>
<dc:identifier>doi:10.1101/2020.11.11.378331</dc:identifier>
<dc:title><![CDATA[Mechanistic Dissection of Spatial Organization in NF-κB Signaling Pathways by Hybrid Simulations]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-11-11</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.11.11.378497v1?rss=1">
<title>
<![CDATA[
The regulation of liver gene expression by carbohydrates is mouse strain specific 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.11.11.378497v1?rss=1</link>
<description><![CDATA[
C57BL/6J and BALB/cJ mouse strains were analyzed by deep mRNA sequencing of the liver in the fasted state and following ingestion of standard laboratory mouse chow supplemented with plain drinking water or water containing 20% glucose, sucrose or fructose. Supplementation with these carbohydrates induced unique extents and temporal changes in gene expressions in a strain specific manner. Fructose and sucrose stimulated gene changes peaked at 3 h postprandial, whereas glucose effects peaked at 12 h postprandial in C57BL/6J mice and at 6 h postprandial in BABL/cJ mice. Network analyses revealed that fructose changed genes were primarily involved in lipid metabolism and were more complex in C57BL/6J than in BALB/cJ mice. These data demonstrate that there are qualitative and quantitative differences in the normal physiological responses of the liver between these two strains of mice and C57BL/6J is more sensitive to sugar intake than BALB/cJ.
]]></description>
<dc:creator>Chi, Y.</dc:creator>
<dc:creator>Youn, D. Y.</dc:creator>
<dc:creator>Xiaoli, A. M.</dc:creator>
<dc:creator>Liu, L.</dc:creator>
<dc:creator>Pessin, J. B.</dc:creator>
<dc:creator>Yang, F.</dc:creator>
<dc:creator>Pessin, J. E.</dc:creator>
<dc:date>2020-11-11</dc:date>
<dc:identifier>doi:10.1101/2020.11.11.378497</dc:identifier>
<dc:title><![CDATA[The regulation of liver gene expression by carbohydrates is mouse strain specific]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-11-11</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.11.11.378570v1?rss=1">
<title>
<![CDATA[
The structural basis of fatty acid elongation by the ELOVL elongases 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.11.11.378570v1?rss=1</link>
<description><![CDATA[
Very long chain fatty acids (VLCFAs) are essential building blocks for synthesis of the ceramides and sphingolipids required for nerve, skin and retina function and 3-keto acyl-CoA synthases (ELOVL elongases) perform the first step in the FA elongation cycle. Although ELOVLs are implicated in common diseases including insulin resistance, hepatic steatosis and Parkinsons, their underlying molecular mechanisms are unknown. Here we report the structure of the human ELOVL7 elongase, which includes an inverted transmembrane barrel structure surrounding a 35 [A] long tunnel containing a covalently-attached product analogue. The structure reveals the substrate binding sites in the tunnel and an active site deep in the membrane including the canonical ELOVL HxxHH sequence. This indicates a ping-pong mechanism for catalysis, involving unexpected covalent histidine adducts. The unusual substrate-binding arrangement and chemistry suggest mechanisms for selective ELOVL inhibition, relevant for diseases where VLCFAs accumulate such as X-linked adrenoleukodystrophy.
]]></description>
<dc:creator>Nie, L.</dc:creator>
<dc:creator>Pike, A. C.</dc:creator>
<dc:creator>Pascoa, T. C.</dc:creator>
<dc:creator>Bushell, S. R.</dc:creator>
<dc:creator>Quigley, A.</dc:creator>
<dc:creator>Ruda, G. F.</dc:creator>
<dc:creator>Chu, A.</dc:creator>
<dc:creator>Cole, V.</dc:creator>
<dc:creator>Speedman, D.</dc:creator>
<dc:creator>Moreira, T.</dc:creator>
<dc:creator>Shrestha, L.</dc:creator>
<dc:creator>Mukhopadhyay, S. M.</dc:creator>
<dc:creator>Burgess-Brown, N. A.</dc:creator>
<dc:creator>Love, J. D.</dc:creator>
<dc:creator>Brennan, P. E.</dc:creator>
<dc:creator>Carpenter, E. P.</dc:creator>
<dc:date>2020-11-11</dc:date>
<dc:identifier>doi:10.1101/2020.11.11.378570</dc:identifier>
<dc:title><![CDATA[The structural basis of fatty acid elongation by the ELOVL elongases]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-11-11</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.11.11.378893v1?rss=1">
<title>
<![CDATA[
Glia actively sculpt sensory neurons by controlled phagocytosis to tune animal behavior 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.11.11.378893v1?rss=1</link>
<description><![CDATA[
Glia in the central nervous system engulf neuron fragments during synapse remodeling and recycling of photoreceptor outer-segments. Whether glia passively clear shed neuronal debris, or actively remove neuron fragments is unknown. How pruning of single-neuron endings impacts animal behavior is also unclear. Here we report that adult C. elegans AMsh glia engulf sensory endings of the AFD thermosensory neuron. Engulfment is regulated by temperature, AFDs sensory input, and tracks AFD activity. Phosphatidylserine (PS) flippase TAT-1/ATP8A, functions with glial PS-receptor PSR-1/PSR and PAT-2/-integrin to initiate engulfment. Glial CED-10/Rac1 GTPase, acting through a conserved GEF complex, executes phagocytosis using the actin-remodeler WSP-1/nWASp and the membrane-sealing factor EFF-1 fusogen. CED-10 levels determine engulfment rates, and engulfment-defective mutants exhibit altered AFD-ending shape and thermosensory behavior. Our findings reveal a molecular pathway underpinning glia-dependent phagocytosis in a peripheral sense-organ, and demonstrate that glia actively engulf neuron-fragments, with profound consequences on neuron shape and animal behavior.
]]></description>
<dc:creator>Raiders, S.</dc:creator>
<dc:creator>Black, E. C.</dc:creator>
<dc:creator>Bae, A.</dc:creator>
<dc:creator>MacFarlane, S.</dc:creator>
<dc:creator>Shaham, S.</dc:creator>
<dc:creator>Singhvi, A.</dc:creator>
<dc:date>2020-11-12</dc:date>
<dc:identifier>doi:10.1101/2020.11.11.378893</dc:identifier>
<dc:title><![CDATA[Glia actively sculpt sensory neurons by controlled phagocytosis to tune animal behavior]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-11-12</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.11.13.381756v1?rss=1">
<title>
<![CDATA[
Upregulated functionality of mitochondria-associated ER membranes in a mouse model of traumatic brain injury 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.11.13.381756v1?rss=1</link>
<description><![CDATA[
Traumatic brain injury (TBI) can lead to neurodegenerative diseases such as Alzheimers disease (AD) through mechanisms that remain incompletely characterized. Similar to AD, TBI models present with cellular metabolic alterations and modulated cleavage of amyloid precursor protein (APP). Specifically, AD and TBI tissues display increases in amyloid-{beta} as well as its precursor, APP C-terminal fragment of 99 a.a. (C99). Our recent data in cell models of AD indicate that C99, due to its affinity for cholesterol, induces the formation of transient lipid raft domains in the ER known as mitochondria-associated ER membranes ("MAM" domains). The formation of these domains recruits and activates specific lipid metabolic enzymes that regulate cellular cholesterol trafficking and sphingolipid turnover. Increased C99 levels in AD cell models promote MAM formation and significantly modulate cellular lipid homeostasis. Here, these phenotypes were recapitulated in the controlled cortical impact (CCI) model of TBI in adult mice. Specifically, the injured cortex and hippocampus displayed significant increases in C99 and MAM activity, as measured by phospholipid synthesis, sphingomyelinase activity and cholesterol turnover. In addition, our cell type-specific lipidomics analyses revealed significant changes in microglial lipid composition that are consistent with the observed alterations in MAM-resident enzymes. Altogether, we propose that alterations in the regulation of MAM and relevant lipid metabolic pathways could contribute to the epidemiological connection between TBI and AD.



O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=128 SRC="FIGDIR/small/381756v2_ufig1.gif" ALT="Figure 1">
View larger version (40K):
org.highwire.dtl.DTLVardef@12d0989org.highwire.dtl.DTLVardef@1cd1eb2org.highwire.dtl.DTLVardef@19a56caorg.highwire.dtl.DTLVardef@1b7f3e1_HPS_FORMAT_FIGEXP  M_FIG C_FIG
]]></description>
<dc:creator>Agrawal, R. R.</dc:creator>
<dc:creator>Larrea, D.</dc:creator>
<dc:creator>Shi, L.</dc:creator>
<dc:creator>Song, D.</dc:creator>
<dc:creator>Xu, Y.</dc:creator>
<dc:creator>Yun, T. D.</dc:creator>
<dc:creator>Emmanuele, V.</dc:creator>
<dc:creator>Cummins, L. G.</dc:creator>
<dc:creator>Macaluso, F. P.</dc:creator>
<dc:creator>Kernie, S. G.</dc:creator>
<dc:creator>Min, W.</dc:creator>
<dc:creator>Deckelbaum, R. J.</dc:creator>
<dc:creator>Area-Gomez, E.</dc:creator>
<dc:date>2020-11-15</dc:date>
<dc:identifier>doi:10.1101/2020.11.13.381756</dc:identifier>
<dc:title><![CDATA[Upregulated functionality of mitochondria-associated ER membranes in a mouse model of traumatic brain injury]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-11-15</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.11.17.386821v1?rss=1">
<title>
<![CDATA[
Temporal dynamics of implicit memory underlying serial dependence 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.11.17.386821v1?rss=1</link>
<description><![CDATA[
Serial dependence is the effect in which the immediately preceding trial influences participants' responses to the current stimulus. But for how long does this bias last in the absence of interference from other stimuli? Here, we had 20 healthy young adult participants (12 women) perform a coincident timing task using different inter-trial intervals to characterize the serial dependence effect as the time between trials increases. Our results show that serial dependence abruptly decreases from 0.1 s to 1 s inter-trial interval, but it remains pronounced after that for up to 8 s. In addition, participants' response variability slightly decreases over longer intervals. We discuss these results in light of recent models suggesting that serial dependence might rely on a short-term memory trace kept through changes in synaptic weights, which might explain its long duration and apparent stability over time.
]]></description>
<dc:creator>Bilacchi, C. M.</dc:creator>
<dc:creator>Sirius, E. V. P.</dc:creator>
<dc:creator>Cravo, A. M.</dc:creator>
<dc:creator>de Azevedo Neto, R. M.</dc:creator>
<dc:date>2020-11-19</dc:date>
<dc:identifier>doi:10.1101/2020.11.17.386821</dc:identifier>
<dc:title><![CDATA[Temporal dynamics of implicit memory underlying serial dependence]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-11-19</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.11.17.386854v1?rss=1">
<title>
<![CDATA[
TC10 regulates breast cancer invasion and metastasis by controlling membrane type-1 matrix metalloproteinase at invadopodia 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.11.17.386854v1?rss=1</link>
<description><![CDATA[
During breast cancer metastasis, cancer cell invasion is driven by actin-rich protrusions called invadopodia, which mediate the extracellular matrix degradation required for the success of the invasive cascade. In this study, we demonstrated that TC10, a member of a Cdc42 subfamily of p21 small GTPases, regulates the membrane type 1 matrix metalloproteinase (MT1-MMP)-driven extracellular matrix degradation at invadopodia. We show that TC10 is required for the plasma membrane surface exposure of MT1-MMP at invadopodia. By utilizing our new Forster resonance energy transfer (FRET) biosensor, we demonstrated the p190RhoGAP-dependent regulation of spatiotemporal TC10 activity at invadopodia. We identified a pathway that regulates TC10 activity and function at invadopodia through the activation of p190RhoGAP and the downstream interacting effector Exo70 at the invadopodia sites. Our findings reveal the role of a previously unknown regulator of vesicular fusion at invadopodia, TC10, on the invasive potential of breast cancer cells during invasion and metastasis.
]]></description>
<dc:creator>Hülsemann, M.</dc:creator>
<dc:creator>Donnelly, S. K.</dc:creator>
<dc:creator>Verkhusha, P. V.</dc:creator>
<dc:creator>Mao, S. S. P. H.</dc:creator>
<dc:creator>Segall, J. E.</dc:creator>
<dc:creator>Hodgson, L.</dc:creator>
<dc:date>2020-11-17</dc:date>
<dc:identifier>doi:10.1101/2020.11.17.386854</dc:identifier>
<dc:title><![CDATA[TC10 regulates breast cancer invasion and metastasis by controlling membrane type-1 matrix metalloproteinase at invadopodia]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-11-17</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.11.18.389288v1?rss=1">
<title>
<![CDATA[
Type I PRMTs and PRMT5 Independently Regulate Both snRNP Arginine Methylation and Post-Transcriptional Splicing 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.11.18.389288v1?rss=1</link>
<description><![CDATA[
Protein arginine methyltransferases (PRMTs) methylate histones, splicing factors, and many other nuclear proteins. Type I enzymes (PRMT1-4,6,8) catalyze mono- (Rme1/MMA) and asymmetric (Rme2a/ADMA) dimethylation; Type II enzymes (PRMT5,9) catalyze mono- and symmetric (Rme2s/SDMA) dimethylation. Misregulation of PRMTs in multiple types of cancers is associated with aberrant gene expression and RNA splicing. To understand the specific mechanisms of PRMT activity in splicing regulation, we treated cells with the PRMT5 inhibitor GSK591 and the Type I inhibitor MS023 and probed their transcriptomic consequences. We discovered that Type I PRMTs and PRMT5 inversely regulate core spliceosomal Sm protein Rme2s and intron retention. Loss of Sm Rme2s is associated with the accumulation of polyadenylated RNA containing retained introns and snRNPs on chromatin. Conversely, increased Sm Rme2s correlates with decreased intron retention and chromatin-association of intron-containing polyadenylated RNA. Using the newly developed SKaTER-seq model, comprehensive and quantitative analysis of co-transcriptional splicing revealed that either Type I PRMT or PRMT5 inhibition resulted in slower splicing rates. Surprisingly, altered co-transcriptional splicing kinetics correlated poorly with ultimate changes in alternatively spliced mRNA. Quantitation of retained intron decay following inhibition of nascent transcription revealed that Type I PRMTs and PRMT5 reciprocally regulate post-transcriptional splicing efficiency.
]]></description>
<dc:creator>Maron, M. I.</dc:creator>
<dc:creator>Burgos, E. S.</dc:creator>
<dc:creator>Gupta, V.</dc:creator>
<dc:creator>Casill, A. D.</dc:creator>
<dc:creator>Kosmyna, B.</dc:creator>
<dc:creator>Chen, H.</dc:creator>
<dc:creator>Gamble, M. J.</dc:creator>
<dc:creator>Query, C. C.</dc:creator>
<dc:creator>Shechter, D.</dc:creator>
<dc:date>2020-11-19</dc:date>
<dc:identifier>doi:10.1101/2020.11.18.389288</dc:identifier>
<dc:title><![CDATA[Type I PRMTs and PRMT5 Independently Regulate Both snRNP Arginine Methylation and Post-Transcriptional Splicing]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-11-19</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.11.23.394296v1?rss=1">
<title>
<![CDATA[
find-tfbs: a tool to identify functional non-coding variants associated with complex human traits using open chromatin maps and phased whole-genome sequences 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.11.23.394296v1?rss=1</link>
<description><![CDATA[
MotivationWhole-genome DNA sequencing (WGS) enables the discovery of non-coding variants, but tools are lacking to prioritize the subset that functionally impacts human phenotypes. DNA sequence variants that disrupt or create transcription factor binding sites (TFBS) can modulate gene expression. find-tfbs efficiently scans phased WGS in large cohorts to identify and count TFBSs in regulatory sequences. This information can then be used in association testing to find putatively functional non-coding variants associated with complex human diseases or traits.

ResultsWe applied find-tfbs to discover functional non-coding variants associated with hematological traits in the NHLBI Trans-Omics for Precision Medicine (TOPMed) WGS dataset (Nmax=44,709). We identified >2000 associations at P<1x10-9, implicating specific blood cell-types, transcription factors and causal genes. The vast majority of these associations are captured by variants identified in large genome-wide association studies (GWAS) for blood-cell traits. find-tfbs is computationally efficient and robust, allowing for the rapid identification of non-coding variants associated with multiple human phenotypes in very large sample size.

Availabilityhttps://github.com/Helkafen/find-tfbs and https://github.com/Helkafen/find-tfbs-demo

Contactssebastian.meric.de.bellefon@umontreal.ca and guillaume.lettre@umontreal.ca

Supplementary informationSupplementary data are available.
]]></description>
<dc:creator>Meric de Bellefon, S.</dc:creator>
<dc:creator>Thibord, F.</dc:creator>
<dc:creator>Auer, P. L.</dc:creator>
<dc:creator>Blangero, J.</dc:creator>
<dc:creator>Coban-Akdemir, Z. H.</dc:creator>
<dc:creator>Floyd, J. S.</dc:creator>
<dc:creator>Fornage, M.</dc:creator>
<dc:creator>Johnsen, J. M.</dc:creator>
<dc:creator>Lange, L. A.</dc:creator>
<dc:creator>Lewis, J. P.</dc:creator>
<dc:creator>Mathias, R. A.</dc:creator>
<dc:creator>McHugh, C. P.</dc:creator>
<dc:creator>Moon, J.-Y.</dc:creator>
<dc:creator>Reiner, A. P.</dc:creator>
<dc:creator>Stilp, A. M.</dc:creator>
<dc:creator>NHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium,</dc:creator>
<dc:creator>Lettre, G.</dc:creator>
<dc:date>2020-11-23</dc:date>
<dc:identifier>doi:10.1101/2020.11.23.394296</dc:identifier>
<dc:title><![CDATA[find-tfbs: a tool to identify functional non-coding variants associated with complex human traits using open chromatin maps and phased whole-genome sequences]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-11-23</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.11.24.396390v1?rss=1">
<title>
<![CDATA[
SUN-MKL1 crosstalk regulates nuclear deformation and fast motility of breast carcinoma cells in fibrillar ECM micro-environment 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.11.24.396390v1?rss=1</link>
<description><![CDATA[
Aligned collagen fibers provide topography for the rapid migration of single tumor cells (streaming migration) to invade the surrounding stroma, move within tumor nests towards blood vessels to intravasate and form distant metastases. Mechanisms of tumor cell motility have been studied extensively in the 2D context, but the mechanistic understanding of rapid single tumor cell motility in the in vivo context is still lacking. Here, we show that streaming tumor cells in vivo use collagen fibers with diameters below 3 m. Employing 1D migration assays with matching in vivo fiber dimensions, we found a dependence of tumor cell motility on 1D substrate width, with cells moving the fastest and the most persistently on the narrowest 1D fibers (700 nm - 2.5 m). Interestingly, we also observed nuclear deformation in the absence of restricting extracellular matrix pores during high speed carcinoma cell migration in 1D, similar to the nuclear deformation observed in tumor cells in vivo. Further, we found that actomyosin machinery is aligned along the 1D axis and actomyosin contractility synchronously regulates cell motility and nuclear deformation. To further investigate the link between cell speed and nuclear deformation, we focused on the Linker of Nucleoskeleton and Cytoskeleton (LINC) complex proteins and SRF-MKL1 signaling, key regulators of mechanotransduction, actomyosin contractility and actin-based cell motility. Analysis of The Cancer Genome Atlas dataset showed a dramatic decrease in the LINC complex proteins SUN1 and SUN2 in primary tumor compared to the normal tissue. Disruption of LINC complex by SUN1+2 KD led to multi-lobular elongated nuclei, increased tumor cell motility and concomitant increase in F-actin, without affecting Lamin proteins. Mechanistically, we found that MKL1, an effector of changes in cellular G-actin to F-actin ratio, is required for increased 1D motility seen in SUN1+2 KD cells. Thus, we demonstrate a previously unrecognized crosstalk between SUN proteins and MKL1 transcription factor in modulating nuclear shape and carcinoma cell motility in an in vivo relevant 1D microenvironment.
]]></description>
<dc:creator>Sharma, V. P.</dc:creator>
<dc:creator>Williams, J.</dc:creator>
<dc:creator>Leung, E.</dc:creator>
<dc:creator>Sanders, J.</dc:creator>
<dc:creator>Eddy, R.</dc:creator>
<dc:creator>Castracane, J.</dc:creator>
<dc:creator>Oktay, M. H.</dc:creator>
<dc:creator>Entenberg, D.</dc:creator>
<dc:creator>Condeelis, J. S.</dc:creator>
<dc:date>2020-11-24</dc:date>
<dc:identifier>doi:10.1101/2020.11.24.396390</dc:identifier>
<dc:title><![CDATA[SUN-MKL1 crosstalk regulates nuclear deformation and fast motility of breast carcinoma cells in fibrillar ECM micro-environment]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-11-24</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.11.25.395806v1?rss=1">
<title>
<![CDATA[
The HSPG Syndecan is a core organizer of cholinergic synapses in C. elegans 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.11.25.395806v1?rss=1</link>
<description><![CDATA[
The extracellular matrix has emerged as an active component of chemical synapses regulating synaptic formation, maintenance and homeostasis. The heparan sulfate proteoglycan syndecans are known to regulate cellular and axonal migration in the brain. They are also enriched at synapses, but their synaptic functions remain more elusive. Here we show that SDN-1, the sole ortholog of syndecan in C. elegans, is absolutely required for the synaptic clustering of homomeric 7-like N-acetylcholine receptors (AChR) and regulates the synaptic content of heteromeric L-AChRs. SDN-1 is concentrated at neuromuscular junctions (NMJs) by the neurally-secreted synaptic organizer Ce-Punctin/MADD-4, which also activates the transmembrane netrin receptor DCC. Those cooperatively recruit the FARP and CASK orthologues that localize N-AChRs at cholinergic NMJs through physical interactions. Therefore, SDN-1 stands at the core of the cholinergic synapse organization by bridging the extracellular synaptic determinants to the intracellular synaptic scaffold that controls the postsynaptic receptor content.
]]></description>
<dc:creator>Zhou, X.</dc:creator>
<dc:creator>Vachon, C.</dc:creator>
<dc:creator>Cizeron, M.</dc:creator>
<dc:creator>Romatif, O.</dc:creator>
<dc:creator>Buelow, H.</dc:creator>
<dc:creator>Jospin, M.</dc:creator>
<dc:creator>Bessereau, J.-L.</dc:creator>
<dc:date>2020-11-26</dc:date>
<dc:identifier>doi:10.1101/2020.11.25.395806</dc:identifier>
<dc:title><![CDATA[The HSPG Syndecan is a core organizer of cholinergic synapses in C. elegans]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-11-26</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.11.25.397596v1?rss=1">
<title>
<![CDATA[
Fat Tissue Regulates the Pathogenesis and Severity of Cardiomyopathy in Murine Chagas Disease 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.11.25.397596v1?rss=1</link>
<description><![CDATA[
Chronic Chagas cardiomyopathy (CCC) caused by a parasite Trypanosoma cruzi is a life-threatening disease in Latin America, for which there is no effective drug or vaccine. The pathogenesis of CCC is complex and multifactorial. Previously, we demonstrated T. cruzi infected mice lose a significant amount of fat tissue which correlates with progression of CCC. Based on this an investigation was undertaken during both acute and chronic T. cruzi infection utilizing the FAT-ATTAC murine model (that allows modulation of fat mass) to understand the consequences of the loss of adipocytes in the regulation of cardiac parasite load, parasite persistence, inflammation, mitochondrial stress, ER stress, survival, CCC progression and CCC severity. Mice were infected intraperitoneally with 5x104 and 103 trypomastigotes to generate acute and chronic Chagas models, respectively. Ablation of adipocytes was carried out in uninfected and infected mice by treatment with AP21087 for 10 days starting at 15DPI (acute infection) and at 65DPI (indeterminate infection). During acute infection, cardiac ultrasound imaging, histological, and biochemical analyses demonstrated that fat ablation increased cardiac parasite load, cardiac pathology and right ventricular dilation and decreased survival. During chronic indeterminate infection ablation of fat cells increased cardiac pathology and caused bi-ventricular dilation. These data demonstrate that dysfunctional adipose tissue not only affects cardiac metabolism but also the inflammatory status, morphology and physiology of the myocardium and increases the risk of progression and severity of CCC in murine Chagas disease.

AUTHOR SUMMARYAn estimated eight million individuals worldwide are chronically infected with Trypanosoma cruzi, the causative agent of Chagas disease (CD). Of these infected individuals, 30% will develop chronic Chagas cardiomyopathy (CCC), a major cause of morbidity and mortality in CD endemic regions for which there is currently no effective drug or vaccine. The molecular mechanisms underlying CCC pathogenesis, progression and severity are complex, multi-factorial and not completely understood. Earlier, it was demonstrated that T. cruzi persists in adipose tissue, alters adipocyte physiology, and causes loss of body fat mass in T. cruzi infected mice with CCC. In this study, the authors examined the role of visceral fat pad (adipose tissue) in regulating the pathogenic signalling in the development and progression of CCC using a fat mass modulatable transgenic mouse CD model. Loss of fat cells increased cardiac lipid load and deregulated cardiac lipid metabolism leading to mitochondrial oxidative stress and endoplasmic reticulum stress and severe CCC. In addition, loss of fat cells increased cardiac parasite load during acute infection and altered immune signalling in the hearts of infected mice during chronic infection. These discoveries underscore the importance of adipose tissue in the development of CCC.
]]></description>
<dc:creator>Nagajyothi, J. F.</dc:creator>
<dc:creator>Lizardo, K.</dc:creator>
<dc:creator>Ayyappan, J. P.</dc:creator>
<dc:creator>Oswal, N.</dc:creator>
<dc:creator>Weiss, L. M.</dc:creator>
<dc:creator>Scherer, P. E.</dc:creator>
<dc:date>2020-11-26</dc:date>
<dc:identifier>doi:10.1101/2020.11.25.397596</dc:identifier>
<dc:title><![CDATA[Fat Tissue Regulates the Pathogenesis and Severity of Cardiomyopathy in Murine Chagas Disease]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-11-26</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.11.30.404178v1?rss=1">
<title>
<![CDATA[
DIETARY MONOTERPENOIDS AS A NEW CLASS OF ALLOSTERIC HUMAN ARYL HYDROCARBON RECEPTOR ANTAGONISTS 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.11.30.404178v1?rss=1</link>
<description><![CDATA[
Carvones, the constituents of essential oils of dill, caraway, and spearmint, were reported to antagonize the human aryl hydrocarbon receptor (AhR); however, the exact molecular mechanism remains elusive. We show that carvones are non-competitive allosteric antagonists of the AhR that inhibit the induction of AhR target genes in a ligand-selective and cell type-specific manner. Carvones do not displace radiolabeled ligand from binding at the AhR, but they bind allosterically within the bHLH/PAS-A region of the AhR. Carvones did not influence a translocation of ligand-activated AhR into the nucleus. Carvones inhibited the heterodimerization of the AhR with its canonical partner ARNT and subsequent binding of the AhR to the promotor of CYP1A1. Interaction of carvones with potential off-targets, including ARNT and protein kinases, was refuted. This is the first report of a small dietary monoterpenoids as a new class of AhR non-competitive allosteric antagonists with the potential preventive and therapeutic application.
]]></description>
<dc:creator>Poulikova, K.</dc:creator>
<dc:creator>Zuvalova, I.</dc:creator>
<dc:creator>Vyhlidalova, B.</dc:creator>
<dc:creator>Krasulova, K.</dc:creator>
<dc:creator>Jiskrova, E.</dc:creator>
<dc:creator>Vrzal, R.</dc:creator>
<dc:creator>Kortagere, S.</dc:creator>
<dc:creator>Kopecna, M.</dc:creator>
<dc:creator>Kopecny, D.</dc:creator>
<dc:creator>Sebela, M.</dc:creator>
<dc:creator>Rolfes, K. M.</dc:creator>
<dc:creator>Haarmann-Stemmann, T.</dc:creator>
<dc:creator>Mani, S.</dc:creator>
<dc:creator>Dvorak, Z.</dc:creator>
<dc:date>2020-12-01</dc:date>
<dc:identifier>doi:10.1101/2020.11.30.404178</dc:identifier>
<dc:title><![CDATA[DIETARY MONOTERPENOIDS AS A NEW CLASS OF ALLOSTERIC HUMAN ARYL HYDROCARBON RECEPTOR ANTAGONISTS]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-12-01</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.12.03.410696v1?rss=1">
<title>
<![CDATA[
Electrical synaptic transmission requires a postsynaptic scaffolding protein 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.12.03.410696v1?rss=1</link>
<description><![CDATA[
Electrical synaptic transmission relies on neuronal gap junctions containing channels constructed by Connexins. While at chemical synapses neurotransmitter-gated ion channels are critically supported by scaffolding proteins, it is unknown if channels at electrical synapses require similar scaffold support. Here we investigated the functional relationship between neuronal Connexins and Zonula Occludens 1 (ZO1), an intracellular scaffolding protein localized to electrical synapses. Using model electrical synapses in zebrafish Mauthner cells, we demonstrated that ZO1 is required for robust synaptic Connexin localization, but Connexins are dispensable for ZO1 localization. Disrupting this hierarchical ZO1/Connexin relationship abolishes electrical transmission and disrupts Mauthner-cell-initiated escape responses. We found that ZO1 is asymmetrically localized exclusively postsynaptically at neuronal contacts where it functions to assemble intercellular channels. Thus, forming functional neuronal gap junctions requires a postsynaptic scaffolding protein. The critical function of a scaffolding molecule reveals an unanticipated complexity of molecular and functional organization at electrical synapses.
]]></description>
<dc:creator>Lasseigne, A. M.</dc:creator>
<dc:creator>Echeverry, F. A. A.</dc:creator>
<dc:creator>Ijaz, S.</dc:creator>
<dc:creator>Michel, J. C.</dc:creator>
<dc:creator>Martin, E. A.</dc:creator>
<dc:creator>Marsh, A. J.</dc:creator>
<dc:creator>Trujillo, E.</dc:creator>
<dc:creator>Marsden, K. C.</dc:creator>
<dc:creator>Pereda, A. E.</dc:creator>
<dc:creator>Miller, A. C.</dc:creator>
<dc:date>2020-12-04</dc:date>
<dc:identifier>doi:10.1101/2020.12.03.410696</dc:identifier>
<dc:title><![CDATA[Electrical synaptic transmission requires a postsynaptic scaffolding protein]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-12-04</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.12.04.411843v1?rss=1">
<title>
<![CDATA[
Integrated transcriptional analysis of the cellular and extracellular vesicle RNA content of Candida auris in response to caspofungin 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.12.04.411843v1?rss=1</link>
<description><![CDATA[
Candida auris has emerged as a serious worldwide threat by causing invasive infections in humans that are frequently resistant to one or more conventional antifungal medications, resulting in high mortality rates. Against this backdrop, health warnings around the world have focused efforts on understanding C. auris fungal biology and effective treatment approaches to combat this fungus. To date, there is little information about C. auris gene expression regulation in response to antifungal treatment. Our integrated analyses focused on the comparative transcriptomics of C. auris in the presence and absence of caspofungin as well as a detailed analysis of the yeasts extracellular vesicle (EV)-RNA composition. The results showed that genes coding oxidative stress response, ribosomal proteins, cell wall, and cell cycle were significantly upregulated in the presence of caspofungin, whereas transcriptional regulators and proteins related to the nucleus were downregulated. The mRNAs in the EVs were associated with stress responses induced by caspofungin and the ncRNA content of the EVs shifted during caspofungin treatment. Altogether, the results provide further insights into the fungal response to caspofungin and demonstrate that analyses of C. auris growth under antifungal stress can elucidate resistance and survival mechanisms of this fungus in response to medical therapy.
]]></description>
<dc:creator>Zamith Miranda, D.</dc:creator>
<dc:creator>Amatuzzi, R. F.</dc:creator>
<dc:creator>Martins, S. T.</dc:creator>
<dc:creator>Vieira, A. Z.</dc:creator>
<dc:creator>Munhoz da Rocha, I. F.</dc:creator>
<dc:creator>Rodrigues, M.</dc:creator>
<dc:creator>Trentin, G.</dc:creator>
<dc:creator>Almeida, F.</dc:creator>
<dc:creator>Nakayasu, E. S.</dc:creator>
<dc:creator>Nosanchuk, J. D.</dc:creator>
<dc:creator>Alves, L. R.</dc:creator>
<dc:date>2020-12-05</dc:date>
<dc:identifier>doi:10.1101/2020.12.04.411843</dc:identifier>
<dc:title><![CDATA[Integrated transcriptional analysis of the cellular and extracellular vesicle RNA content of Candida auris in response to caspofungin]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-12-05</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.12.04.412593v1?rss=1">
<title>
<![CDATA[
Deletion of PI3-Kinase Promotes Myelodysplasia Through Dysregulation of Autophagy in Hematopoietic Stem Cells 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.12.04.412593v1?rss=1</link>
<description><![CDATA[
Hematopoietic stem cells (HSCs) maintain the blood system through a delicate equilibrium between self-renewal and differentiation. Most hematopoietic growth factors and cytokines signal through phosphoinositide 3-kinase (PI3K) via three Class IA catalytic PI3K isoforms (P110, {beta}, and {delta}), encoded by Pik3ca, Pik3cb, and Pik3cd, respectively. The PI3K/AKT pathway is commonly activated in acute myeloid leukemia (AML), and PI3K is a common therapeutic target in cancer. However, it is not known whether PI3K is required for HSC differentiation or self-renewal. We previously demonstrated that individual PI3K isoforms are dispensable in HSCs1,2. To determine the redundant roles of PI3K isoforms in HSCs, we generated a triple knockout (TKO) mouse model with deletion of all three Class IA PI3K isoforms in the hematopoietic system. Surprisingly, we observed significant expansion of TKO HSCs after transplantation, with decreased differentiation capacity and impaired multilineage repopulation. Additionally, the bone marrow of TKO mice exhibited myelodysplastic features with chromosomal abnormalities. Interestingly, we found that macroautophagy (thereafter autophagy) is impaired in TKO HSCs, and that pharmacologic induction of autophagy improves their differentiation. Therefore, we have uncovered important roles for PI3K in autophagy regulation in HSCs to maintain the balance between self-renewal and differentiation.
]]></description>
<dc:creator>Ames, K.</dc:creator>
<dc:creator>Kaur, I.</dc:creator>
<dc:creator>Shi, Y.</dc:creator>
<dc:creator>Tong, M. M.</dc:creator>
<dc:creator>Sinclair, T.</dc:creator>
<dc:creator>Hemmati, S.</dc:creator>
<dc:creator>Glushakow-Smith, S. G.</dc:creator>
<dc:creator>Tein, E. E.</dc:creator>
<dc:creator>Gurska, L.</dc:creator>
<dc:creator>Dubin, R.</dc:creator>
<dc:creator>Shan, J.</dc:creator>
<dc:creator>Pradhan, K.</dc:creator>
<dc:creator>Verma, A.</dc:creator>
<dc:creator>Montagna, C.</dc:creator>
<dc:creator>Gritsman, K.</dc:creator>
<dc:date>2020-12-06</dc:date>
<dc:identifier>doi:10.1101/2020.12.04.412593</dc:identifier>
<dc:title><![CDATA[Deletion of PI3-Kinase Promotes Myelodysplasia Through Dysregulation of Autophagy in Hematopoietic Stem Cells]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-12-06</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.12.09.418590v1?rss=1">
<title>
<![CDATA[
Developmental loss of ErbB4 in PV interneurons disrupts state-dependent cortical circuit dynamics. 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.12.09.418590v1?rss=1</link>
<description><![CDATA[
GABAergic inhibition plays an important role in the establishment and maintenance of cortical circuits during development. Neuregulin 1 (Nrg1) and its interneuron-specific receptor ErbB4 are key elements of a signaling pathway critical for the maturation and proper synaptic connectivity of interneurons. Using conditional deletions of the ERBB4 gene in mice, we tested the role of this signaling pathway at two developmental timepoints in parvalbumin-expressing (PV) interneurons, the largest subpopulation of cortical GABAergic cells. Loss of ErbB4 in PV interneurons during embryonic, but not late postnatal, development leads to alterations in the activity of excitatory and inhibitory cortical neurons, along with severe disruption of cortical temporal organization. These impairments emerge by the end of the second postnatal week, prior to the complete maturation of the PV interneurons themselves. Early loss of ErbB4 in PV interneurons also results in profound dysregulation of excitatory pyramidal neuron dendritic architecture and a redistribution of spine density at the apical dendritic tuft. In association with these deficits, excitatory cortical neurons exhibit normal tuning for sensory inputs, but a loss of state-dependent modulation of the gain of sensory responses. Together these data support a key role for early developmental Nrg1/ErbB4 signaling in PV interneurons as powerful mechanism underlying the maturation of both the inhibitory and excitatory components of cortical circuits.
]]></description>
<dc:creator>Batista-Brito, R.</dc:creator>
<dc:creator>Majumdar, A.</dc:creator>
<dc:creator>Nuno, A.</dc:creator>
<dc:creator>Vinck, M.</dc:creator>
<dc:creator>Cardin, J. A.</dc:creator>
<dc:date>2020-12-10</dc:date>
<dc:identifier>doi:10.1101/2020.12.09.418590</dc:identifier>
<dc:title><![CDATA[Developmental loss of ErbB4 in PV interneurons disrupts state-dependent cortical circuit dynamics.]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-12-10</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.12.09.418657v1?rss=1">
<title>
<![CDATA[
Defective oligodendrocyte development and function in an RNA polymerase III mutant leukodystrophic mouse 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.12.09.418657v1?rss=1</link>
<description><![CDATA[
RNA polymerase (Pol) III synthesizes abundant short non-coding RNAs that have essential functions in protein synthesis, secretion and other processes. Despite the ubiquitous functions of these RNAs, mutations in Pol III subunits cause Pol III-related leukodystrophy, an early-onset neurodegenerative disease. The basis of this neural sensitivity and the mechanisms of disease pathogenesis are unknown. Here we show that mice expressing pathogenic mutations in the largest Pol III subunit, Polr3a, specifically in Olig2-expressing cells, have impaired growth and developmental delay, deficits in cognitive, sensory and fine sensorimotor function, and hypomyelination in multiple regions of the cerebrum and spinal cord. In contrast, the gross motor defects and cerebellar hypomyelination that are common features of severely affected patients are absent in the mice, suggesting a relatively mild form of the disease in this conditional model. Our results show that disease pathogenesis in the mice involves defects that reduce both the number of mature myelinating oligodendrocytes and the ability of these cells to produce a myelin sheath of normal thickness. Thus, the findings suggest cell-specific roles for Pol III in the development and/or survival of oligodendrocytes as well as their function in myelination.

Significance StatementPathogenic mutations in subunits of RNA polymerase (Pol) III cause a prevalent autosomal recessive form of leukodystrophy. However, understanding of the mechanisms of pathogenesis, including how ubiquitously-expressed Pol III mutations affect primarily the central nervous system, has been limited by the absence of an animal model of the disease. We show that conditional knock-in of pathogenic Polr3a mutations in the Olig2 lineage in mice results in growth, neurobehavioral and hypomyelination phenotypes reflecting a subset of clinical features of Pol III-related leukodystrophy patients. Myelination defects in the mice identify neural-specific roles for Pol III transcription. The phenotypes of Pol III-related leukodystrophic mice enable genetic and pharmacological approaches aimed at mitigating the consequences of this disease in humans.
]]></description>
<dc:creator>Merheb, E.</dc:creator>
<dc:creator>Cui, M.-H.</dc:creator>
<dc:creator>DuBois, J. C.</dc:creator>
<dc:creator>Branch, C. A.</dc:creator>
<dc:creator>Gulinello, M.</dc:creator>
<dc:creator>Shafit-Zagardo, B.</dc:creator>
<dc:creator>Moir, R. D.</dc:creator>
<dc:creator>Willis, I. M.</dc:creator>
<dc:date>2020-12-10</dc:date>
<dc:identifier>doi:10.1101/2020.12.09.418657</dc:identifier>
<dc:title><![CDATA[Defective oligodendrocyte development and function in an RNA polymerase III mutant leukodystrophic mouse]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-12-10</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.12.14.421529v1?rss=1">
<title>
<![CDATA[
The SEQC2 Epigenomics Quality Control (EpiQC) Study: Comprehensive Characterization of Epigenetic Methods, Reproducibility, and Quantification 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.12.14.421529v1?rss=1</link>
<description><![CDATA[
Cytosine modifications in DNA such as 5-methylcytosine (5mC) underlie a broad range of developmental processes, maintain cellular lineage specification, and can define or stratify cancer and other diseases. However, the wide variety of approaches available to interrogate these modifications has created a need for harmonized materials, methods, and rigorous benchmarking to improve genome-wide methylome sequencing applications in clinical and basic research. Here, we present a multi-platform assessment and a global resource for epigenetics research from the FDAs Epigenomics Quality Control (EpiQC) Group. The study design leverages seven human cell lines that are designated as reference materials and publicly available from the National Institute of Standards and Technology (NIST) and Genome in a Bottle (GIAB) consortium. These samples were subject to a variety of genome-wide methylation interrogation approaches across six independent laboratories, with a primary focus was on 5-methylcytosine modifications. Each sample was processed in two or more technical replicates by three whole-genome bisulfite sequencing (WGBS) protocols (TruSeq DNA methylation, Accel-NGS MethylSeq, and SPLAT), oxidative bisulfite sequencing (TrueMethyl), one enzymatic deamination method (EMseq), targeted methylation sequencing (Illumina Methyl Capture EPIC), and single-molecule long-read nanopore sequencing from Oxford Nanopore Technologies. After rigorous quality assessment and comparison to Illumina EPIC methylation microarrays and testing on a range of algorithms (Bismark, BitmapperBS, BWAMeth, and GemBS), we found overall high concordance between assays (R=0.87-R0.93), differences in efficency of read mapping and CpG capture and coverage, and platform performance. The data provided herein can guide continued used of these reference materials in epigenomics assays, as well as provide best practices for epigenomics research and experimental design in future studies.
]]></description>
<dc:creator>Foox, J.</dc:creator>
<dc:creator>Nordlund, J.</dc:creator>
<dc:creator>Lalancette, C.</dc:creator>
<dc:creator>Gong, T.</dc:creator>
<dc:creator>Lacey, M.</dc:creator>
<dc:creator>Lent, S.</dc:creator>
<dc:creator>Langhorst, B. W.</dc:creator>
<dc:creator>Ponnaluri, V. K. C.</dc:creator>
<dc:creator>Williams, L.</dc:creator>
<dc:creator>Padmamabhan, K.</dc:creator>
<dc:creator>Cavalcante, R. G.</dc:creator>
<dc:creator>Lundmark, A.</dc:creator>
<dc:creator>Butler, D.</dc:creator>
<dc:creator>Gurvitch, J. M.</dc:creator>
<dc:creator>Greally, J. M.</dc:creator>
<dc:creator>Suzuki, M.</dc:creator>
<dc:creator>Menor, M.</dc:creator>
<dc:creator>Nasu, M.</dc:creator>
<dc:creator>Alonso, A.</dc:creator>
<dc:creator>Sheridan, C.</dc:creator>
<dc:creator>Scherer, A.</dc:creator>
<dc:creator>Bruinsma, S.</dc:creator>
<dc:creator>Golda, G.</dc:creator>
<dc:creator>Muszynska, A.</dc:creator>
<dc:creator>Łabaj, P. P.</dc:creator>
<dc:creator>Campbell, M. A.</dc:creator>
<dc:creator>Wos, F.</dc:creator>
<dc:creator>Raine, A.</dc:creator>
<dc:creator>Liljedahl, U.</dc:creator>
<dc:creator>Axelsson, T.</dc:creator>
<dc:creator>Wang, C.</dc:creator>
<dc:creator>Chen, Z.</dc:creator>
<dc:creator>Yang, Z.</dc:creator>
<dc:creator>Li, J.</dc:creator>
<dc:creator>Yang, X.</dc:creator>
<dc:creator>Wang, H.</dc:creator>
<dc:creator>Melnick, A.</dc:creator>
<dc:creator>Guo, S.</dc:creator>
<dc:creator>Blume, A.</dc:creator>
<dc:creator>Franke, V.</dc:creator>
<dc:creator>Ibanez de Caceres, I.</dc:creator>
<dc:creator>Rodriguez-Antolin, C.</dc:creator>
<dc:creator>Rosas, R.</dc:creator>
<dc:creator>Davis, J. W.</dc:creator>
<dc:creator>Ishii, J.</dc:creator>
<dc:creator>Megh</dc:creator>
<dc:date>2020-12-14</dc:date>
<dc:identifier>doi:10.1101/2020.12.14.421529</dc:identifier>
<dc:title><![CDATA[The SEQC2 Epigenomics Quality Control (EpiQC) Study: Comprehensive Characterization of Epigenetic Methods, Reproducibility, and Quantification]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-12-14</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.12.16.422727v1?rss=1">
<title>
<![CDATA[
Methylation of Dual Specificity Phosphatase 4 Controls Cell Differentiation 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.12.16.422727v1?rss=1</link>
<description><![CDATA[
A collection of signaling and epigenetic events needs to be orchestrated for normal development of hematopoietic lineages. While mitogen-activated protein (MAP) kinases (MAPKs) and multiple epigenetic modulators have been implicated in the megakaryocytic (Mk) cell differentiation, the underlying molecular mechanisms of signaling-epigenetic crosstalk remain unclear. MAPKs are in general inactivated by dual specificity phosphatases (DUSPs), whose activities are tightly regulated by various posttranslational modifications. Using knockdown screening and single-cell transcriptional analysis, we determined that DUSP4 is the phosphatase that inactivates p38 MAPK in hematopoietic cells and serves as a key regulator to promote Mk differentiation. With the nextgeneration Bioorthogonal Profiling of Protein Methylation technology for live cells, we identified DUSP4 as a PRMT1 substrate. Mechanistically, PRMT1-mediated Arg351 methylation of DUSP4 triggers its ubiquitinylation by HUWE1 (an E3 ligase) and then degradation, which results in p38 MAPK activation and inhibition of Mk differentiation in vitro and in vivo. Interestingly, the mechanistic axis of the DUSP4 degradation and p38 activation is also associated with a transcriptional signature of immune activation and thus argues immunological roles of Mk cells. Collectively, these results demonstrate a critical role of PRMT1-mediated posttranslational modification of DUSP4 in regulation of Mk differentiation and maturation. In the context of thrombocytopenia observed in myelodysplastic syndromes (MDS), we demonstrated that high levels of p38 MAPK and PRMT1 are associated with low platelet counts and adverse prognosis, while pharmacological inhibition of p38 MAPK or PRMT1 stimulates megakaryopoiesis in MDS samples. These findings provide novel mechanistic insights into the role of the PRMT1-DUSP4-p38 axis on Mk differentiation and present a targeting strategy for treatment of thrombocytopenia associated with myeloid malignancies such as MDS.
]]></description>
<dc:creator>Su, H.</dc:creator>
<dc:creator>Jiang, M.</dc:creator>
<dc:creator>Senevirathne, C.</dc:creator>
<dc:creator>Aluri, S.</dc:creator>
<dc:creator>Zhang, T.</dc:creator>
<dc:creator>Guo, H.</dc:creator>
<dc:creator>Xavier-Ferrucio, J.</dc:creator>
<dc:creator>Jin, S.</dc:creator>
<dc:creator>Tran, N.-T.</dc:creator>
<dc:creator>Liu, S.-M.</dc:creator>
<dc:creator>Sun, C.-W.</dc:creator>
<dc:creator>Zhu, Y.</dc:creator>
<dc:creator>Zhao, Q.</dc:creator>
<dc:creator>Chen, Y.</dc:creator>
<dc:creator>Cable, L.</dc:creator>
<dc:creator>Shen, Y.</dc:creator>
<dc:creator>Liu, J.</dc:creator>
<dc:creator>Qu, C.-K.</dc:creator>
<dc:creator>Han, X.</dc:creator>
<dc:creator>Klug, C. A.</dc:creator>
<dc:creator>Bhatia, R.</dc:creator>
<dc:creator>Chen, Y.</dc:creator>
<dc:creator>Nimer, S. D.</dc:creator>
<dc:creator>Zheng, Y. G.</dc:creator>
<dc:creator>Iancu-Rubin, C.</dc:creator>
<dc:creator>Jin, J.</dc:creator>
<dc:creator>Deng, H.</dc:creator>
<dc:creator>Krause, D. S.</dc:creator>
<dc:creator>Xiang, J.</dc:creator>
<dc:creator>Verma, A.</dc:creator>
<dc:creator>Luo, M.</dc:creator>
<dc:creator>Zhao, X.</dc:creator>
<dc:date>2020-12-16</dc:date>
<dc:identifier>doi:10.1101/2020.12.16.422727</dc:identifier>
<dc:title><![CDATA[Methylation of Dual Specificity Phosphatase 4 Controls Cell Differentiation]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-12-16</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.12.22.423783v1?rss=1">
<title>
<![CDATA[
Rare coding variants in 35 genes associate with circulating lipid levels: a multi-ancestry analysis of 170,000 exomes 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.12.22.423783v1?rss=1</link>
<description><![CDATA[
Large-scale gene sequencing studies for complex traits have the potential to identify causal genes with therapeutic implications. We performed gene-based association testing of blood lipid levels with rare (minor allele frequency<1%) predicted damaging coding variation using sequence data from >170,000 individuals from multiple ancestries: 97,493 European, 30,025 South Asian, 16,507 African, 16,440 Hispanic/Latino, 10,420 East Asian, and 1,182 Samoan. We identified 35 genes associated with circulating lipid levels. Ten of these: ALB, SRSF2, JAK2, CREB3L3, TMEM136, VARS, NR1H3, PLA2G12A, PPARG and STAB1 have not been implicated for lipid levels using rare coding variation in population-based samples. We prioritize 32 genes identified in array-based genome-wide association study (GWAS) loci based on gene-based associations, of which three: EVI5, SH2B3, and PLIN1, had no prior evidence of rare coding variant associations. Most of the associated genes showed evidence of association in multiple ancestries. Also, we observed an enrichment of gene-based associations for low-density lipoprotein cholesterol drug target genes, and for genes closest to GWAS index single nucleotide polymorphisms (SNP). Our results demonstrate that gene-based associations can be beneficial for drug target development and provide evidence that the gene closest to the array-based GWAS index SNP is often the functional gene for blood lipid levels.
]]></description>
<dc:creator>Hindy, G.</dc:creator>
<dc:creator>Dornbos, P.</dc:creator>
<dc:creator>Chaffin, M. D.</dc:creator>
<dc:creator>Liu, D. J.</dc:creator>
<dc:creator>Wang, M. X.</dc:creator>
<dc:creator>Aguilar-Salinas, C. A.</dc:creator>
<dc:creator>Antonacci-Fulton, L.</dc:creator>
<dc:creator>Ardissino, D.</dc:creator>
<dc:creator>Arnett, D. K.</dc:creator>
<dc:creator>Aslibekyan, S.</dc:creator>
<dc:creator>Atzmon, G.</dc:creator>
<dc:creator>Ballantyne, C. M.</dc:creator>
<dc:creator>Barajas-Olmos, F.</dc:creator>
<dc:creator>Barzilai, N.</dc:creator>
<dc:creator>Becker, L. C.</dc:creator>
<dc:creator>Bielak, L. F.</dc:creator>
<dc:creator>Bis, J. C.</dc:creator>
<dc:creator>Blangero, J.</dc:creator>
<dc:creator>Boerwinkle, E.</dc:creator>
<dc:creator>Bonnycastle, L. L.</dc:creator>
<dc:creator>Bottinger, E.</dc:creator>
<dc:creator>Bowden, D. W.</dc:creator>
<dc:creator>Bown, M. J.</dc:creator>
<dc:creator>Brody, J. A.</dc:creator>
<dc:creator>Broome, J. G.</dc:creator>
<dc:creator>Burtt, N. P.</dc:creator>
<dc:creator>Cade, B. E.</dc:creator>
<dc:creator>Centeno-Cruz, F.</dc:creator>
<dc:creator>Chan, E.</dc:creator>
<dc:creator>Chang, Y.-C.</dc:creator>
<dc:creator>Chen, Y.-D. I.</dc:creator>
<dc:creator>Cheng, C.-Y.</dc:creator>
<dc:creator>Choi, W. J.</dc:creator>
<dc:creator>Chowdhury, R.</dc:creator>
<dc:creator>Contreras-Cubas, C.</dc:creator>
<dc:creator>Cordova, E. J.</dc:creator>
<dc:creator>Correa, A.</dc:creator>
<dc:creator>Cupples, L. A.</dc:creator>
<dc:creator>Curran, J. E.</dc:creator>
<dc:creator>Danesh,</dc:creator>
<dc:date>2020-12-23</dc:date>
<dc:identifier>doi:10.1101/2020.12.22.423783</dc:identifier>
<dc:title><![CDATA[Rare coding variants in 35 genes associate with circulating lipid levels: a multi-ancestry analysis of 170,000 exomes]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-12-23</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.12.24.424342v1?rss=1">
<title>
<![CDATA[
Single cell multi-omic analysis identifies a Tbx1-dependent multilineage primed population in the murine cardiopharyngeal mesoderm 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.12.24.424342v1?rss=1</link>
<description><![CDATA[
The poles of the heart and branchiomeric muscles of the face and neck are formed from the cardiopharyngeal mesoderm (CPM) within the pharyngeal apparatus. The formation of the cardiac outflow tract and branchiomeric muscles are disrupted in patients with 22q11.2 deletion syndrome (22q11.2DS), due to haploinsufficiency of TBX1, encoding a T-box transcription factor. Here, using single cell RNA-sequencing, we identified a multilineage primed population (MLP) within the CPM, marked by the Tbx1 lineage, which has bipotent properties to form cardiac and skeletal muscle cells. The MLPs are localized within the nascent mesoderm of the caudal lateral pharyngeal apparatus and provide a continuous source of progenitors that undergo TBX1-dependent progression towards maturation. Tbx1 also regulates the balance between MLP maintenance and maturation while restricting ectopic non-mesodermal gene expression. We further show that TBX1 confers this balance by direct regulation of MLP enriched genes and downstream pathways, partly through altering chromatin accessibility. Our study thus uncovers a new cell population and reveals novel mechanisms by which Tbx1 directs the development of the pharyngeal apparatus, which is profoundly altered in 22q11.2DS.
]]></description>
<dc:creator>Nomaru, H.</dc:creator>
<dc:creator>Liu, Y.</dc:creator>
<dc:creator>De Bono, C.</dc:creator>
<dc:creator>Righelli, D.</dc:creator>
<dc:creator>Cirino, A.</dc:creator>
<dc:creator>Wang, W.</dc:creator>
<dc:creator>Racedo, S. E.</dc:creator>
<dc:creator>Dantas, A.</dc:creator>
<dc:creator>Cai, C.</dc:creator>
<dc:creator>Angelini, C.</dc:creator>
<dc:creator>Christiaen, L.</dc:creator>
<dc:creator>Kelly, R.</dc:creator>
<dc:creator>Baldini, A.</dc:creator>
<dc:creator>Zheng, D.</dc:creator>
<dc:creator>Morrow, B. E.</dc:creator>
<dc:date>2020-12-24</dc:date>
<dc:identifier>doi:10.1101/2020.12.24.424342</dc:identifier>
<dc:title><![CDATA[Single cell multi-omic analysis identifies a Tbx1-dependent multilineage primed population in the murine cardiopharyngeal mesoderm]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-12-24</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.12.28.424504v1?rss=1">
<title>
<![CDATA[
GENERATION AND CHARACTERIZATION OF IMMORTALIZED MOUSE CORTICAL ASTROCYTES FROM WILDTYPE AND CONNEXIN43 KNOCKOUT MICE 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.12.28.424504v1?rss=1</link>
<description><![CDATA[
We transduced mouse cortical astrocytes cultured from four litters of embryonic wildtype (WT) and connexin43 (Cx43) null mouse pups with lentiviral vector encoding hTERT and measured expression of astrocyte-specific markers up to passage 10 (p10). The immortalized cell lines thus generated (designated IWCA and IKOCA, respectively) expressed biomarkers consistent with those of neonatal astrocytes, including Cx43 from wildtype but not from Cx43-null mice, lack of Cx30, and presence of Cx26. AQP4, the water channel that is found in high abundance in astrocyte end-feet, was expressed at moderately high levels in early passages, and its mRNA and protein declined to low but still detectable levels by p10. The mRNA levels of the astrocyte biomarkers aldehyde dehydrogenase 1 (ALDH1), glutamine synthetase (GS) and glial fibrillary acidic protein (GFAP) remained relatively constant during successive passages. GS protein expression was maintained while GFAP declined with cell passaging but was still detectable at p10. Both mRNA and protein levels of glutamate transporter 1 (GLT-1) declined with passage number. Immunostaining at corresponding times was consistent with the data from Western blots and provided evidence that these proteins were expressed at appropriate intracellular locations. Consistent with our goal of generating immortalized cell lines in which Cx43 was either functionally expressed or absent, IWCA cells were found to be well coupled with respect to intercellular dye transfer and similar to primary astrocyte cultures in terms of time course of junction formation, electrical coupling strength and voltage sensitivity. Moreover, barrier function was enhanced in co-culture of the IWCA cell line with bEnd.3 microvascular endothelial cells. In addition, immunostaining revealed oblate endogenous Cx43 gap junction plaques in IWCA that were similar in appearance to those plaques obtained following transfection of IKOCA cells with fluorescent protein tagged Cx43. Re-expression of Cx43 in IKOCA cells allows experimental manipulation of connexins and live imaging of interactions between connexins and other proteins. We conclude that properties of these cell lines resemble those of primary cultured astrocytes, and they may provide useful tools in functional studies by facilitating genetic and pharmacological manipulations in the context of an astrocyte-appropriate cellular environment.
]]></description>
<dc:creator>Cibelli, A.</dc:creator>
<dc:creator>Lopez-Quintero, S. V.</dc:creator>
<dc:creator>McCutcheon, S.</dc:creator>
<dc:creator>Scemes, E.</dc:creator>
<dc:creator>Spray, D. C.</dc:creator>
<dc:creator>Stout, R. F.</dc:creator>
<dc:creator>Suadicani, S. O.</dc:creator>
<dc:creator>Thi, M. M.</dc:creator>
<dc:creator>Urban-Maldonado, M.</dc:creator>
<dc:date>2020-12-29</dc:date>
<dc:identifier>doi:10.1101/2020.12.28.424504</dc:identifier>
<dc:title><![CDATA[GENERATION AND CHARACTERIZATION OF IMMORTALIZED MOUSE CORTICAL ASTROCYTES FROM WILDTYPE AND CONNEXIN43 KNOCKOUT MICE]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2020-12-29</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2020.12.30.424861v1?rss=1">
<title>
<![CDATA[
Genetic depletion studies define receptor usage by virulent hantaviruses in human endothelial cells 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2020.12.30.424861v1?rss=1</link>
<description><![CDATA[
Hantaviruses are a large group of RNA viruses that include known epidemic threats and other agents poised for emergence. Several rodent-borne hantaviruses cause zoonoses accompanied by severe illness and death. However, assessments of zoonotic risk and the development of countermeasures alike are challenged by our limited knowledge of the molecular mechanisms of hantavirus infection, including the identities of cell entry receptors and their roles in influencing viral host range and virulence. Previous work has implicated several cell-surface molecules, most notably {beta}3- and {beta}1-containing integrin heterodimers, decay-accelerating factor (DAF), and the cadherin superfamily protein protocadherin-1 (PCDH1), in hantavirus entry in endothelial cells, the major targets of viral infection in humans. Despite the fact that {beta}3/{beta}1 integrins have been presumed to be the major hantavirus entry receptors for over two decades, rigorous genetic evidence supporting their requirement, and that of DAF as an entry cofactor, is lacking. Here, we used CRISPR/Cas9 engineering to knock out four candidate hantaviral receptors, singly and in combination, in a human endothelial cell line that recapitulates the properties of primary microvascular endothelial cells. PCDH1 loss substantially reduced entry and infection by a subset of hantaviruses endemic to the Americas. In contrast, the loss of {beta}3 integrin, {beta}1 integrin, and/or DAF had little or no effect on entry by any of a large panel of hantaviruses tested. We conclude that the major host molecules necessary for endothelial cell entry by PCDH1-independent hantaviruses remain to be discovered.
]]></description>
<dc:creator>Dieterle, M. E.</dc:creator>
<dc:creator>Sola-Riera, C.</dc:creator>
<dc:creator>Jangra, R. K.</dc:creator>
<dc:creator>Ye, C.</dc:creator>
<dc:creator>Goodfellow, S. M.</dc:creator>
<dc:creator>Mittler, E.</dc:creator>
<dc:creator>Kasikci, E.</dc:creator>
<dc:creator>Bradfute, S. B.</dc:creator>
<dc:creator>Klingström, J.</dc:creator>
<dc:creator>Chandran, K.</dc:creator>
<dc:date>2021-01-04</dc:date>
<dc:identifier>doi:10.1101/2020.12.30.424861</dc:identifier>
<dc:title><![CDATA[Genetic depletion studies define receptor usage by virulent hantaviruses in human endothelial cells]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-01-04</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.01.05.425447v1?rss=1">
<title>
<![CDATA[
MAVERICC: Efficient marker-free rescue of vaccinia virus recombinants by in vitro CRISPR-Cas9 engineering 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.01.05.425447v1?rss=1</link>
<description><![CDATA[
Vaccinia virus (VACV)-based vectors are in extensive use as vaccines and cancer immunotherapies. VACV engineering has traditionally relied on homologous recombination between a parental viral genome and a transgene-bearing transfer plasmid, a highly inefficient process that necessitates the use of a selection or screening marker to isolate recombinants. Recent extensions of this approach have sought to enhance the recovery of transgene-bearing viruses through the use of CRISPR-Cas9 engineering to cleave the viral genome in infected cells. However, these methods do not completely eliminate the generation of WT viral progeny and thus continue to require multiple rounds of viral propagation and plaque purification. Here, we describe MAVERICC (marker-free vaccinia virus engineering of recombinants through in vitro CRISPR/Cas9 cleavage), a new strategy to engineer recombinant VACVs in a manner that overcomes current limitations. MAVERICC also leverages the CRISPR/Cas9 system but requires no markers and yields essentially pure preparations of the desired recombinants in a single step. We used this approach to rapidly introduce point mutations, insertions, and deletions at multiple locations in the VACV genome, both singly and in combination. The efficiency and versatility of MAVERICC make it an ideal choice for generating mutants and mutant libraries at arbitrarily selected locations in the viral genome to build complex VACV vectors, effect vector improvements, and facilitate the study of poxvirus biology.

Graphical Abstract

O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=81 SRC="FIGDIR/small/425447v1_ufig1.gif" ALT="Figure 1">
View larger version (19K):
org.highwire.dtl.DTLVardef@17151cborg.highwire.dtl.DTLVardef@b0f480org.highwire.dtl.DTLVardef@184166corg.highwire.dtl.DTLVardef@dc177d_HPS_FORMAT_FIGEXP  M_FIG C_FIG Overview of MAVERICC. Conceptual overview of the approach outlined in this manuscript. To make VACV recombinants, the parental virus is first purified and vDNA is isolated with phenol:chloroform extraction. This purified vDNA is then treated with Cas9 enzyme and sgRNAs that are directed to a specific locus in the VACV genome. The cleaved vDNA is then transfected into FWPV-infected BSC-40 cells along with a transfer amplicon containing an insertion or mutation of interest flanked by homologous sequences. Recombination is allowed to occur for 5-7 days, during which time the cleaved vDNA is healed by the transfer amplicon, thus editing the VACV genome, and packaged into infectious viral particles. Individual plaques are grown up and rVACVs are isolated after a single round of plaque purification. Image was created with Biorender.com.
]]></description>
<dc:creator>Laudermilch, E.</dc:creator>
<dc:creator>Chandran, K.</dc:creator>
<dc:date>2021-01-05</dc:date>
<dc:identifier>doi:10.1101/2021.01.05.425447</dc:identifier>
<dc:title><![CDATA[MAVERICC: Efficient marker-free rescue of vaccinia virus recombinants by in vitro CRISPR-Cas9 engineering]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-01-05</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.01.12.425739v1?rss=1">
<title>
<![CDATA[
Nucleus accumbens neurons encode initiation and vigor of reward approach behavior 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.01.12.425739v1?rss=1</link>
<description><![CDATA[
The nucleus accumbens (NAc) is considered an interface between motivation and action, with NAc neurons playing an important role in promoting reward approach. However, the encoding by NAc neurons that contribute to this role remains unknown. Here, we trained male rats to find rewards in an 8-arm radial maze. The activity of 62 neurons, mostly in the shell of the NAc, were recorded while rats ran towards each reward place. General linear model (GLM) analysis showed that variables related to the vigor of the locomotor approach, like speed and acceleration, and the fraction of the approach run completed were the best predictors of the firing rate for most NAc neurons. Nearly 23% of the recorded neurons, here named locomotion-off cells, were inhibited during the entire approach run, suggesting that reduction in firing of these neurons promotes initiation of locomotor approach. Another 24% of the neurons presented a peak of activity during acceleration followed by a valley during deceleration (peak-valley cells). Together, these neurons accounted for most of the speed and acceleration encoding identified in the GLM analysis. Cross-correlations between firing and speed indicated that the spikes of peak-valley cells were followed by increases in speed, suggesting that the activity of these neurons drives acceleration. In contrast, a further 19% of neurons presented a valley during acceleration followed by a peak just prior to or after reaching reward (valley-peak cells). These findings suggest that these three classes of NAc neurons control the initiation and vigor of the locomotor approach to reward.

Significance StatementDeciphering the mechanisms by which the NAc controls the vigor of motivated behavior is critical to better understand and treat psychiatric conditions in which motivation is dysregulated. Manipulations of the NAc profoundly impair subjects ability to spontaneously approach reward-associated locations, preventing them from exerting effort to obtain reward. Here, we identify for the first time specific activity of NAc neurons in relation to spontaneous approach behavior. We discover three classes of neurons that could control initiation of movement and the speed vs. time trajectory during locomotor approach. These results suggest a prominent but heretofore unknown role for the NAc in regulating the kinematics of reward approach locomotion.
]]></description>
<dc:creator>Levcik, D.</dc:creator>
<dc:creator>Sugi, A. H.</dc:creator>
<dc:creator>Pochapski, J. A.</dc:creator>
<dc:creator>Baltazar, G.</dc:creator>
<dc:creator>Pulido, L. N.</dc:creator>
<dc:creator>Villas-Boas, C.</dc:creator>
<dc:creator>Aguilar-Rivera, M.</dc:creator>
<dc:creator>Fuentes-Flores, R.</dc:creator>
<dc:creator>Nicola, S. M.</dc:creator>
<dc:creator>Da Cunha, C.</dc:creator>
<dc:date>2021-01-12</dc:date>
<dc:identifier>doi:10.1101/2021.01.12.425739</dc:identifier>
<dc:title><![CDATA[Nucleus accumbens neurons encode initiation and vigor of reward approach behavior]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-01-12</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.01.14.426721v1?rss=1">
<title>
<![CDATA[
Variational autoencoders learn universal latent representations of metabolomics data 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.01.14.426721v1?rss=1</link>
<description><![CDATA[
Dimensionality reduction approaches are commonly used for the deconvolution of high-dimensional metabolomics datasets into underlying core metabolic processes. However, current state-of-the-art methods are widely incapable of detecting nonlinearities in metabolomics data. Variational Autoencoders (VAEs) are a deep learning method designed to learn nonlinear latent representations which generalize to unseen data. Here, we trained a VAE on a large-scale metabolomics population cohort of human blood samples consisting of over 4,500 individuals. We analyzed the pathway composition of the latent space using a global feature importance score, which showed that latent dimensions represent distinct cellular processes. To demonstrate model generalizability, we generated latent representations of unseen metabolomics datasets on type 2 diabetes, schizophrenia, and acute myeloid leukemia and found significant correlations with clinical patient groups. Taken together, we demonstrate for the first time that the VAE is a powerful method that learns biologically meaningful, nonlinear, and universal latent representations of metabolomics data.
]]></description>
<dc:creator>Gomari, D. P.</dc:creator>
<dc:creator>Schweickart, A.</dc:creator>
<dc:creator>Cerchietti, L.</dc:creator>
<dc:creator>Paietta, E.</dc:creator>
<dc:creator>Fernandez, H.</dc:creator>
<dc:creator>Al-Amin, H.</dc:creator>
<dc:creator>Suhre, K.</dc:creator>
<dc:creator>Krumsiek, J.</dc:creator>
<dc:date>2021-01-17</dc:date>
<dc:identifier>doi:10.1101/2021.01.14.426721</dc:identifier>
<dc:title><![CDATA[Variational autoencoders learn universal latent representations of metabolomics data]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-01-17</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.01.21.427696v1?rss=1">
<title>
<![CDATA[
Extracellular vesicles regulate yeast growth, biofilm formation, and yeast-to-hypha differentiation in Candida albicans 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.01.21.427696v1?rss=1</link>
<description><![CDATA[
The ability to undergo morphological changes during adaptation to distinct environments is exploited by Candida albicans and has a direct impact on virulence. In this study, we investigated the influence of fungal extracellular vesicles (EVs) during yeast growth, biofilm formation, and morphogenesis in C. albicans. Addition of C. albicans EVs (Ca EVs) to the culture medium positively affected yeast growth. Using crystal violet staining and scanning electron microscopy (SEM), we demonstrated that Ca EVs inhibited biofilm formation by C. albicans in vitro. By time-lapse microscopy and SEM, we showed that Ca EV-treatment stops filamentation promoting pseudohyphae formation with multiple sites for yeast budding. The ability of Ca EVs to regulate dimorphism was further compared to EVs isolated from different C. albicans strains, Saccharomyces cerevisiae, and Histoplasma capsulatum. Ca EVs from distinct strains robustly inhibited yeast-to-hyphae differentiation with morphological changes occurring in less than 4 hours. A minor inhibitory effect was promoted by EVs from S. cerevisiae and H. capsulatum only after 24 hours of incubation. The inhibitory effect of Ca EVs was promoted by a combination of lipid compounds identified by gas chromatography-tandem mass spectrometry analysis as sesquiterpenes, diterpenes, and fatty acids. Remarkably, Ca EVs were also able to reverse filamentation, transforming hyphal growth to yeast forms. Transcriptomic analysis demonstrated that treatment with Ca EVs modified the expression of more than 300 genes. The most effectively upregulated pathways were related to DNA metabolism. The downregulated genes were mostly associated with extracellular and adhesion proteins. Finally, yeast cells treated with Ca EVs for 24 hours lost their agar invasive ability and were avirulent when inoculated in Galleria mellonella larvae. In summary, our results indicate that fungal EVs can profoundly modify C. albicans growth and regulate yeast-to-hypha differentiation inhibiting biofilm formation and virulence.
]]></description>
<dc:creator>Honorato, L.</dc:creator>
<dc:creator>Demetrio, J. F.</dc:creator>
<dc:creator>Ellis, C. C.</dc:creator>
<dc:creator>Piffer, A. C.</dc:creator>
<dc:creator>Pereira, Y.</dc:creator>
<dc:creator>Frases, S.</dc:creator>
<dc:creator>Araujo, G.</dc:creator>
<dc:creator>Pontes, B.</dc:creator>
<dc:creator>Mendes, M. T.</dc:creator>
<dc:creator>Pereira, M. D.</dc:creator>
<dc:creator>Guimaraes, A. J.</dc:creator>
<dc:creator>da Silva, N. M.</dc:creator>
<dc:creator>Vargas, G.</dc:creator>
<dc:creator>Joffe, L.</dc:creator>
<dc:creator>Del Poeta, M.</dc:creator>
<dc:creator>Nosanchuk, J. D.</dc:creator>
<dc:creator>Zamith Miranda, D.</dc:creator>
<dc:creator>Reis, F.</dc:creator>
<dc:creator>Rodrigues, M. L.</dc:creator>
<dc:creator>Martins, S.</dc:creator>
<dc:creator>Alves, L. R.</dc:creator>
<dc:creator>Almeida, I. C.</dc:creator>
<dc:creator>Nimrichter, L.</dc:creator>
<dc:date>2021-01-22</dc:date>
<dc:identifier>doi:10.1101/2021.01.21.427696</dc:identifier>
<dc:title><![CDATA[Extracellular vesicles regulate yeast growth, biofilm formation, and yeast-to-hypha differentiation in Candida albicans]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-01-22</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.01.25.428086v1?rss=1">
<title>
<![CDATA[
Genome-wide analysis of mitochondrial DNA copy number reveals multiple loci implicated in nucleotide metabolism, platelet activation, and megakaryocyte proliferation 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.01.25.428086v1?rss=1</link>
<description><![CDATA[
Mitochondrial DNA copy number (mtDNA-CN) measured from blood specimens is a minimally invasive marker of mitochondrial function that exhibits both inter-individual and intercellular variation. To identify genes involved in regulating mitochondrial function, we performed a genome-wide association study (GWAS) in 465,809 White individuals from the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) consortium and the UK Biobank (UKB). We identified 133 SNPs with statistically significant, independent effects associated with mtDNA-CN across 100 loci. A combination of fine-mapping, variant annotation, and co-localization analyses were used to prioritize genes within each of the 133 independent sites. Putative causal genes were enriched for known mitochondrial DNA depletion syndromes (p = 3.09 x 10-15) and the gene ontology (GO) terms for mtDNA metabolism (p = 1.43 x 10-8) and mtDNA replication (p = 1.2 x 10-7). A clustering approach leveraged pleiotropy between mtDNA-CN associated SNPs and 41 mtDNA-CN associated phenotypes to identify functional domains, revealing three distinct groups, including platelet activation, megakaryocyte proliferation, and mtDNA metabolism. Finally, using mitochondrial SNPs, we establish causal relationships between mitochondrial function and a variety of blood cell related traits, kidney function, liver function and overall (p = 0.044) and non-cancer mortality (p = 6.56 x 10-4).
]]></description>
<dc:creator>Longchamps, R. J.</dc:creator>
<dc:creator>Yang, S. Y.</dc:creator>
<dc:creator>Castellani, C. A.</dc:creator>
<dc:creator>Shi, W.</dc:creator>
<dc:creator>Lane, J.</dc:creator>
<dc:creator>Grove, M. L.</dc:creator>
<dc:creator>Bartz, T. M.</dc:creator>
<dc:creator>Sarnowski, C.</dc:creator>
<dc:creator>Burrows, K.</dc:creator>
<dc:creator>Guyatt, A. L.</dc:creator>
<dc:creator>Gaunt, T. R.</dc:creator>
<dc:creator>Kacprowski, T.</dc:creator>
<dc:creator>Yang, J.</dc:creator>
<dc:creator>De, P. L.</dc:creator>
<dc:creator>Yu, L.</dc:creator>
<dc:creator>CHARGE Aging and Longevity Group,</dc:creator>
<dc:creator>Bergman, A.</dc:creator>
<dc:creator>Xia, R.</dc:creator>
<dc:creator>Fornage, M.</dc:creator>
<dc:creator>Feitosa, M. F.</dc:creator>
<dc:creator>Wojczynski, M. K.</dc:creator>
<dc:creator>Kraja, A. T.</dc:creator>
<dc:creator>Province, M. A.</dc:creator>
<dc:creator>Amin, N.</dc:creator>
<dc:creator>Rivadeneira, F.</dc:creator>
<dc:creator>Tiemeier, H.</dc:creator>
<dc:creator>Uitterlinden, A. G.</dc:creator>
<dc:creator>Broer, L.</dc:creator>
<dc:creator>Van, J.</dc:creator>
<dc:creator>Van, C.</dc:creator>
<dc:creator>Raffield, L. M.</dc:creator>
<dc:creator>Lange, L.</dc:creator>
<dc:creator>Rich, S. S.</dc:creator>
<dc:creator>Lemaitre, R. N.</dc:creator>
<dc:creator>Goodarzi, M. O.</dc:creator>
<dc:creator>Sitlani, C. M.</dc:creator>
<dc:creator>Mak, A. C.</dc:creator>
<dc:creator>Bennett, D. A.</dc:creator>
<dc:creator>Rodriguez, S.</dc:creator>
<dc:creator>Murabito, J. M.</dc:creator>
<dc:creator>Lunetta, K. L.</dc:creator>
<dc:creator>Soto</dc:creator>
<dc:date>2021-01-28</dc:date>
<dc:identifier>doi:10.1101/2021.01.25.428086</dc:identifier>
<dc:title><![CDATA[Genome-wide analysis of mitochondrial DNA copy number reveals multiple loci implicated in nucleotide metabolism, platelet activation, and megakaryocyte proliferation]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-01-28</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.01.28.428713v1?rss=1">
<title>
<![CDATA[
Spatial organization of transcript elongation and splicing kinetics 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.01.28.428713v1?rss=1</link>
<description><![CDATA[
The organization of the genome in three-dimensional space has been shown to play an important role in gene expression. Specifically, facets of genomic interaction such as topologically associated domains (TADs) have been shown to regulate transcription by bringing regulatory elements into close proximity1. mRNA production is an intricate process with multiple control points including regulation of Pol II elongation and the removal of non-coding sequences via pre-mRNA splicing2. The connection between genomic compartments and the kinetics of RNA biogenesis and processing has been largely unexplored. Here, we measure Pol II elongation and splicing kinetics genome-wide using a novel technique that couples nascent RNA-seq with a mathematical model of transcription and co-transcriptional RNA processing. We uncovered multiple layers of spatial organization of these rates: the rate of splicing is coordinated across introns within individual genes, and both elongation and splicing rates are coordinated within TADs, as are alternative splicing outcomes. Overall, our work establishes that the kinetics of transcription and splicing are coordinated by the spatial organization of the genome and suggests that TADs are a major platform for coordination of alternative splicing.
]]></description>
<dc:creator>Casill, A. D.</dc:creator>
<dc:creator>Haimowitz, A. J.</dc:creator>
<dc:creator>Kosmyna, B.</dc:creator>
<dc:creator>Query, C. C.</dc:creator>
<dc:creator>Ye, K.</dc:creator>
<dc:creator>Gamble, M. J.</dc:creator>
<dc:date>2021-01-29</dc:date>
<dc:identifier>doi:10.1101/2021.01.28.428713</dc:identifier>
<dc:title><![CDATA[Spatial organization of transcript elongation and splicing kinetics]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-01-29</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.02.02.429412v1?rss=1">
<title>
<![CDATA[
Comparing synaptic proteomes across seven mouse models for autism reveals molecular subtypes and deficits in Rho GTPase signaling 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.02.02.429412v1?rss=1</link>
<description><![CDATA[
Impaired synaptic function is a common phenotype in animal models for autism spectrum disorder (ASD), and ASD risk genes are enriched for synaptic function. Here we leverage the availability of multiple ASD mouse models exhibiting synaptic deficits and behavioral correlates of ASD and use quantitative mass spectrometry with isobaric tandem mass tagging (TMT) to compare the hippocampal synaptic proteomes from 7 mouse models. We identified common altered cellular and molecular pathways at the synapse, including changes in Rho family small GTPase signaling, suggesting that it may be a point of convergence in ASD. Comparative analyses also revealed clusters of synaptic profiles, with similarities observed among models for Fragile X syndrome (Fmr1 knockout), PTEN hamartoma tumor syndrome (Pten haploinsufficiency), and the BTBR+ model of idiopathic ASD. Opposing changes were found in models for cortical dysplasia focal epilepsy syndrome (Cntnap2 knockout), Phelan McDermid syndrome (Shank3 InsG3680), Timothy syndrome (Cacna1c G406R), and ANKS1B syndrome (Anks1b haploinsufficiency), which were similar to each other. We propose that these clusters of synaptic profiles form the basis for molecular subtypes that explain genetic heterogeneity in ASD despite a common clinical diagnosis. Drawn from an internally controlled survey of the synaptic proteome across animal models, our findings support the notion that synaptic dysfunction in the hippocampus is a shared mechanism of disease in ASD, and that Rho GTPase signaling may be an important pathway leading to disease phenotypes in autism.
]]></description>
<dc:creator>Carbonell, A. U.</dc:creator>
<dc:creator>Freire-Cobo, C.</dc:creator>
<dc:creator>Deyneko, I. V.</dc:creator>
<dc:creator>Erdjument-Bromage, H.</dc:creator>
<dc:creator>Clipperton-Allen, A.</dc:creator>
<dc:creator>Rasmusson, R.</dc:creator>
<dc:creator>Page, D. T.</dc:creator>
<dc:creator>Neubert, T. A.</dc:creator>
<dc:creator>Jordan, B. A.</dc:creator>
<dc:date>2021-02-02</dc:date>
<dc:identifier>doi:10.1101/2021.02.02.429412</dc:identifier>
<dc:title><![CDATA[Comparing synaptic proteomes across seven mouse models for autism reveals molecular subtypes and deficits in Rho GTPase signaling]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-02-02</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.02.08.430346v1?rss=1">
<title>
<![CDATA[
Feedforward and feedback interactions between visual cortical areas use different population activity patterns 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.02.08.430346v1?rss=1</link>
<description><![CDATA[
Brain function relies on the coordination of activity across multiple, recurrently connected, brain areas. For instance, sensory information encoded in early sensory areas is relayed to, and further processed by, higher cortical areas and then fed back. However, the way in which feedforward and feedback signaling interact with one another is incompletely understood. Here we investigate this question by leveraging simultaneous neuronal population recordings in early and midlevel visual areas (V1-V2 and V1-V4). Using a dimensionality reduction approach, we find that population interactions are feedforward-dominated shortly after stimulus onset and feedback-dominated during spontaneous activity. The population activity patterns most correlated across areas were distinct during feedforward- and feedback-dominated periods. These results suggest that feedforward and feedback signaling rely on separate "channels", such that feedback signaling does not directly affect activity that is fed forward.
]]></description>
<dc:creator>Semedo, J.</dc:creator>
<dc:creator>Jasper, A. I.</dc:creator>
<dc:creator>Zandvakili, A.</dc:creator>
<dc:creator>Aschner, A.</dc:creator>
<dc:creator>Machens, C.</dc:creator>
<dc:creator>Kohn, A.</dc:creator>
<dc:creator>Yu, B. M.</dc:creator>
<dc:date>2021-02-10</dc:date>
<dc:identifier>doi:10.1101/2021.02.08.430346</dc:identifier>
<dc:title><![CDATA[Feedforward and feedback interactions between visual cortical areas use different population activity patterns]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-02-10</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.02.10.430690v1?rss=1">
<title>
<![CDATA[
Human retinal organoids release extracellular vesicles that regulate gene expression in target human retinal progenitors 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.02.10.430690v1?rss=1</link>
<description><![CDATA[
The mechanisms underlying retinal development have not been completely elucidated. Extracellular vesicles (EVs) are novel essential mediators of cell-to-cell communication with emerging roles in developmental processes. Nevertheless, the identification of EVs in human retinal tissue, characterization of their cargo, and analysis of their potential role in retina development has not been accomplished. Three-dimensional retinal tissue derived from human induced pluripotent stem cells (hiPSC) provide an ideal developmental system to achieve this goal. Here we report that hiPSC-derived retinal organoids release exosomes and microvesicles with small noncoding RNA cargo. EV miRNA cargo-predicted targetome correlates with GO pathways involved in mechanisms of retinogenesis relevant to specific developmental stages corresponding to hallmarks of native human retina development. Furthermore, uptake of EVs by human retinal progenitor cells leads to changes in gene expression correlated with EV miRNA cargo predicted gene targets, and mechanisms involved in retinal development, ganglion cell and photoreceptor differentiation and function.
]]></description>
<dc:creator>Zhou, J.</dc:creator>
<dc:creator>Flores-Bellver, M.</dc:creator>
<dc:creator>Pan, J.</dc:creator>
<dc:creator>Benito-Martin, A.</dc:creator>
<dc:creator>Shi, C.</dc:creator>
<dc:creator>Onwumere, O.</dc:creator>
<dc:creator>Mighty, J.</dc:creator>
<dc:creator>Qian, J.</dc:creator>
<dc:creator>Zhong, X.</dc:creator>
<dc:creator>Hogue, T.</dc:creator>
<dc:creator>Amponsah-Antwi, B.</dc:creator>
<dc:creator>Einbond, L.</dc:creator>
<dc:creator>Gharbaran, R.</dc:creator>
<dc:creator>Wu, H.</dc:creator>
<dc:creator>Chen, B.-J.</dc:creator>
<dc:creator>Zheng, Z.</dc:creator>
<dc:creator>Tchaikovskaya, T.</dc:creator>
<dc:creator>Zhang, X.</dc:creator>
<dc:creator>Peinado, H.</dc:creator>
<dc:creator>Canto-Soler, V.</dc:creator>
<dc:creator>Redenti, S.</dc:creator>
<dc:date>2021-02-11</dc:date>
<dc:identifier>doi:10.1101/2021.02.10.430690</dc:identifier>
<dc:title><![CDATA[Human retinal organoids release extracellular vesicles that regulate gene expression in target human retinal progenitors]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-02-11</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.02.11.430747v1?rss=1">
<title>
<![CDATA[
Hyper-connectivity between the left motor cortex and prefrontal cortex is associated with the severity of dysfunction of the descending pain modulatory system in fibromyalgia 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.02.11.430747v1?rss=1</link>
<description><![CDATA[
The impaired cortical function likely plays a critical role in chronic pain maintenance and fibromyalgia symptoms. Functional connectivity (FC), as assessed by functional near-infrared spectroscopy (fNIRS), is a promising approach that evaluates cortical activation through hemodynamic response estimation. This study compared the FC of bilateral motor and prefrontal cortices between responders and nonresponders to the conditioned pain modulation test (CPM-test) induced by hand immersion in cold water (0-1{degrees}C). We included 37 women with fibromyalgia according to the American College of Rheumatology diagnoses criteria (n = 23 responders to CPM-test and n = 14 nonresponders). After the adjustment for multiple comparisons, we found that nonresponders relative to responders showed higher FC between the left motor cortex (LMC) with the left prefrontal cortex (LPFC) and right prefrontal cortex (RPFC). The psychiatric diagnoses were also positively associated with a higher FC in LMC-LPFC and LMC-RPFC. These results indicate that the increased connectivity between the left motor and bilateral prefrontal cortex might be a neural marker of DPMS dysfunction and an intermediate in the interplay between fibromyalgia and psychiatric disorders.
]]></description>
<dc:creator>Caumo, W.</dc:creator>
<dc:creator>Oliveira Franco, A.</dc:creator>
<dc:creator>Fernandes, C.</dc:creator>
<dc:creator>Vicunha, P.</dc:creator>
<dc:creator>Bandeira, J.</dc:creator>
<dc:creator>Aratanha, M. A.</dc:creator>
<dc:creator>Torres, I. L.</dc:creator>
<dc:creator>Fregni, F.</dc:creator>
<dc:date>2021-02-11</dc:date>
<dc:identifier>doi:10.1101/2021.02.11.430747</dc:identifier>
<dc:title><![CDATA[Hyper-connectivity between the left motor cortex and prefrontal cortex is associated with the severity of dysfunction of the descending pain modulatory system in fibromyalgia]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-02-11</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.02.18.431802v1?rss=1">
<title>
<![CDATA[
Disrupting short-term memory in premotor but not visual cortex affects serial dependence in visuomotor integration 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.02.18.431802v1?rss=1</link>
<description><![CDATA[
Human behavior is biased by past experience. For example, when intercepting a moving target, the speed of previous targets will bias responses in future trials. Neural mechanisms underlying this so-called serial dependence are still under debate. Here, we tested the hypothesis that the previous trial leaves a neural trace in brain regions associated with encoding task-relevant information in visual and/or motor regions. We reasoned that injecting noise by means of transcranial magnetic stimulation (TMS) over premotor and visual areas would degrade such memory traces and hence reduce serial dependence. To test this hypothesis, we applied bursts of TMS pulses to right visual motion processing region hV5/MT+ and to left dorsal premotor cortex during inter-trial intervals of a coincident timing task performed by twenty healthy human participants (15 female). Without TMS, participants presented a bias towards the speed of the previous trial when intercepting moving targets. TMS over dorsal premotor cortex decreased serial dependence in comparison to the control Vertex stimulation, whereas TMS applied over hV5/MT+ did not. In addition, TMS seems to have specifically affected the memory trace that leads to serial dependence, as we found no evidence that participants behavior worsened after applying TMS. These results provide causal evidence that an implicit short-term memory mechanism in premotor cortex keeps information from one trial to the next, and that this information is blended with current trial information so that it biases behavior in a visuomotor integration task with moving objects.

Significance StatementHuman perception and action are biased by the recent past. The origin of such serial bias is still not fully understood, but a few components seem to be fundamental for its emergence: the brain needs to keep previous trial information in short-term memory and blend it with incoming information. Here, we present evidence that a premotor area has a potential role in storing previous trial information in short-term memory in a visuomotor task, and that this information is responsible for biasing ongoing behavior. These results corroborate the perspective that areas associated with processing information of a stimulus or task also participate in maintaining that information in short-term memory even when this information is no longer relevant for current behavior.
]]></description>
<dc:creator>de Azevedo Neto, R. M.</dc:creator>
<dc:creator>Bartels, A.</dc:creator>
<dc:date>2021-02-18</dc:date>
<dc:identifier>doi:10.1101/2021.02.18.431802</dc:identifier>
<dc:title><![CDATA[Disrupting short-term memory in premotor but not visual cortex affects serial dependence in visuomotor integration]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-02-18</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.02.18.431924v1?rss=1">
<title>
<![CDATA[
BTBD9 is a novel component of IGF signaling and regulates manganese-induced dopaminergic dysfunction 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.02.18.431924v1?rss=1</link>
<description><![CDATA[
Restless legs syndrome (RLS) is a common neurological disorder associated with iron deficiency and dopaminergic (DAergic) neuronal dysfunction. BTBD9 is a genetic risk factor for RLS. However, its molecular function remains largely unknown. Here, we report the interaction between BTBD9, manganese (Mn) and insulin/insulin-like growth factor (IGF) signaling in Caenorhabditis elegans, mouse Neuro2a cells and humans. We found that elevated Mn downregulated BTBD9 mRNA levels; in turn, BTBD9 expression attenuated Mn-induced cellular stress and dopaminergic neurodegeneration. As Mn is a known co-factor for insulin receptor and IGF-1 receptor, which activates IGF signaling, we posited that BTBD9 negatively regulates IGF signaling. Our results showed that the protective effects of BTBD9 against Mn toxicity were dependent on the forkhead box O (FOXO) protein. Furthermore, BTBD9 overexpression significantly elevated FOXO level and decreased PKB level, while phosphoinositide-dependent kinase-1 (PDK1) level remained unchanged. We conclude that BTBD9 acts as a key component in the IGF signaling pathway. Meanwhile, the roles of Mn in DAergic neurotoxicity and regulating BTBD9 shed new light on the etiology of RLS.
]]></description>
<dc:creator>Chen, P.</dc:creator>
<dc:creator>Zheng, F.</dc:creator>
<dc:creator>Li, S.</dc:creator>
<dc:creator>Cheng, H.</dc:creator>
<dc:creator>Bornhorst, J.</dc:creator>
<dc:creator>Li, Y.</dc:creator>
<dc:creator>Yang, B.</dc:creator>
<dc:creator>Lee, K. H.</dc:creator>
<dc:creator>Ke, T.</dc:creator>
<dc:creator>Schwerdtle, T.</dc:creator>
<dc:creator>Yang, X.</dc:creator>
<dc:creator>Bowman, A. B.</dc:creator>
<dc:creator>Aschner, M.</dc:creator>
<dc:date>2021-02-22</dc:date>
<dc:identifier>doi:10.1101/2021.02.18.431924</dc:identifier>
<dc:title><![CDATA[BTBD9 is a novel component of IGF signaling and regulates manganese-induced dopaminergic dysfunction]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-02-22</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.02.23.432516v1?rss=1">
<title>
<![CDATA[
VAL genes regulate vegetative phase change via miR156-dependent and independent mechanisms 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.02.23.432516v1?rss=1</link>
<description><![CDATA[
How organisms control when to transition between different stages of development is a key question in biology. In plants, epigenetic silencing by Polycomb repressive complex 1 (PRC1) and PRC2 plays a crucial role in promoting developmental transitions, including from juvenile-to-adult phases of vegetative growth. PRC1/2 are known to repress the master regulator of vegetative phase change, miR156, leading to the transition to adult growth, but how this process is regulated temporally is unknown. Here we investigate whether transcription factors in the VIVIPAROUS/ABI3-LIKE (VAL) gene family provide the temporal signal for the epigenetic repression of miR156. Exploiting a novel val1 allele, we found that VAL1 and VAL2 redundantly regulate vegetative phase change by controlling the overall level, rather than temporal dynamics, of miR156 expression. Furthermore, we discovered that VAL1 and VAL2 also act independently of miR156 to control this important developmental transition.
]]></description>
<dc:creator>Fouracre, J. P.</dc:creator>
<dc:creator>He, J.</dc:creator>
<dc:creator>Chen, V. J.</dc:creator>
<dc:creator>Sidoli, S.</dc:creator>
<dc:creator>Poethig, R. S.</dc:creator>
<dc:date>2021-02-24</dc:date>
<dc:identifier>doi:10.1101/2021.02.23.432516</dc:identifier>
<dc:title><![CDATA[VAL genes regulate vegetative phase change via miR156-dependent and independent mechanisms]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-02-24</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.02.23.432582v1?rss=1">
<title>
<![CDATA[
Widespread ripples synchronize human cortical activity 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.02.23.432582v1?rss=1</link>
<description><![CDATA[
Declarative memory encoding, consolidation, and retrieval require the integration of elements encoded in widespread cortical locations. The mechanism whereby such  binding of different components of mental events into unified representations occurs is unknown. The  binding-bysynchrony theory proposes that distributed encoding areas are bound by synchronous oscillations enabling enhanced communication. However, evidence for such oscillations is sparse. Brief high-frequency oscillations ( ripples) occur in the hippocampus and cortex, and help organize memory recall and consolidation. Here, using intracranial recordings in humans, we report that these ~70ms duration 90Hz ripples often couple (within {+/-}500ms), co-occur ([&ge;]25ms overlap), and crucially, phase-lock (have consistent phase-lags) between widely distributed focal cortical locations during both sleep and waking, even between hemispheres. Cortical ripple co-occurrence is facilitated through activation across multiple sites, and phaselocking increases with more cortical sites co-rippling. Ripples in all cortical areas co-occur with hippocampal ripples but do not phase-lock with them, further suggesting that cortico-cortical synchrony is mediated by cortico-cortical connections. Ripple phase-lags vary across sleep nights, consistent with participation in different networks. During waking, we show that hippocampo-cortical and cortico-cortical co-ripples increase preceding successful delayed memory recall, when binding between the cue and response is essential. Ripples increase and phase-modulate unit firing, and co-ripples increase high-frequency correlations between areas, suggesting synchronized unit-spiking facilitating information exchange. Co-occurrence, phasesynchrony, and high-frequency correlation are maintained with little decrement over very long distances (25cm). Hippocampo-cortico-cortical co-ripples appear to possess the essential properties necessary to support binding-by-synchrony during memory retrieval, and perhaps generally in cognition.

Significance StatementDifferent elements of a memory, or any mental event, are encoded in locations distributed across the cortex. A prominent hypothesis proposes that widespread networks are integrated with bursts of synchronized high-frequency oscillations called  ripples, but evidence is limited. Here, using recordings inside the human brain, we show that ripples occur simultaneously in multiple lobes in both cortical hemispheres, and the hippocampus, generally during sleep and waking, and especially during memory recall. Ripples phase-lock local cell firing, and phase-synchronize with little decay between locations separated by up to 25cm, enabling long-distance integration. Indeed, co-rippling sites have increased correlation of very high-frequency activity which reflects cell firing. Thus, ripples may help bind information across the cortex in memory and other mental events.
]]></description>
<dc:creator>Dickey, C. W.</dc:creator>
<dc:creator>Verzhbinsky, I. A.</dc:creator>
<dc:creator>Jiang, X.</dc:creator>
<dc:creator>Rosen, B. Q.</dc:creator>
<dc:creator>Kajfez, S.</dc:creator>
<dc:creator>Stedelin, B.</dc:creator>
<dc:creator>Shih, J. J.</dc:creator>
<dc:creator>Ben-Haim, S.</dc:creator>
<dc:creator>Raslan, A. M.</dc:creator>
<dc:creator>Madsen, J. R.</dc:creator>
<dc:creator>Eskandar, E. N.</dc:creator>
<dc:creator>Gonzalez-Martinez, J.</dc:creator>
<dc:creator>Cash, S. S.</dc:creator>
<dc:creator>Halgren, E.</dc:creator>
<dc:date>2021-02-24</dc:date>
<dc:identifier>doi:10.1101/2021.02.23.432582</dc:identifier>
<dc:title><![CDATA[Widespread ripples synchronize human cortical activity]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-02-24</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.02.27.433204v1?rss=1">
<title>
<![CDATA[
Donor-derived vasculature is required to support neocortical cell grafts after stroke 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.02.27.433204v1?rss=1</link>
<description><![CDATA[
Neural precursor cells (NPCs) transplanted into the adult neocortex generate neurons that synaptically integrate with host neurons, supporting the possibility of achieving functional tissue repair. However, poor survival of transplanted NPCs greatly limits efficient engraftment. Here, we test the hypothesis that combining blood vessel-forming vascular cells with neuronal precursors improves engraftment. By transplanting mixed embryonic neocortical cells into adult mice with neocortical strokes, we show that transplant-derived neurons synapse with appropriate targets while donor vascular cells form vessels that fuse with the host vasculature to perfuse blood within the graft. Although all grafts became vascularized, larger grafts had greater contributions of donor-derived vessels that increased as a function of their distance from the host-graft border. Moreover, excluding vascular cells from the donor cell population strictly limited graft size. Thus, inclusion of vessel-forming vascular cells with NPCs is required for more efficient engraftment and ultimately for tissue repair.
]]></description>
<dc:creator>Krzyspiak, J.</dc:creator>
<dc:creator>Yan, J.</dc:creator>
<dc:creator>Ghosh, H.</dc:creator>
<dc:creator>Galinski, B.</dc:creator>
<dc:creator>Lituma, P. J.</dc:creator>
<dc:creator>Alvina, K.</dc:creator>
<dc:creator>Washburn, S.</dc:creator>
<dc:creator>Gronska-Peski, M.</dc:creator>
<dc:creator>Tai, Y. D.</dc:creator>
<dc:creator>McDermott, K.</dc:creator>
<dc:creator>Zukin, S.</dc:creator>
<dc:creator>Weiser, D.</dc:creator>
<dc:creator>Castillo, P. E.</dc:creator>
<dc:creator>Khodakhah, K.</dc:creator>
<dc:creator>Hebert, J.</dc:creator>
<dc:date>2021-02-28</dc:date>
<dc:identifier>doi:10.1101/2021.02.27.433204</dc:identifier>
<dc:title><![CDATA[Donor-derived vasculature is required to support neocortical cell grafts after stroke]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-02-28</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.03.01.433468v1?rss=1">
<title>
<![CDATA[
Memory CD8+ T cells mediate early pathogen-specific protection through localized delivery of chemokines and IFNγ to clusters of inflammatory monocytes 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.03.01.433468v1?rss=1</link>
<description><![CDATA[
While cognate antigen drives clonal expansion of memory CD8+ T cells to achieve sterilizing immunity in immunized hosts, not much is known on how cognate antigen contributes to early mechanisms of protection before clonal expansion occurs. Herein, using distinct models of immunization, we establish that cognate antigen recognition by CD8+ TM cells on dendritic cells initiates their rapid and coordinated production of a burst of CCL3, CCL4 and XCL1 chemokines under the transcriptional control of IRF4. Using intravital microscopy imaging and in vivo monoclonal antibody labelling, we reveal that memory CD8+ T cells undergo antigen-mediated arrest in splenic red pulp clusters of CCR2+ monocytes where they locally deliver both IFN{gamma}- and chemokine-potentiating microbicidal activities to achieve early protection. Thus, rapid and effective memory CD8+ T cell responses require a complex series of spatially and temporally coordinated stepwise molecular and cellular events that quickly restrict microbial pathogen growth and optimize the local delivery of effector molecules before clonal expansion occurs.
]]></description>
<dc:creator>Boutet, M.</dc:creator>
<dc:creator>Benet, Z.</dc:creator>
<dc:creator>Guillen, E.</dc:creator>
<dc:creator>Koch, C.</dc:creator>
<dc:creator>SOUDJA, S. M.</dc:creator>
<dc:creator>Delahaye, F.</dc:creator>
<dc:creator>Fooksman, D.</dc:creator>
<dc:creator>Lauvau, G.</dc:creator>
<dc:date>2021-03-02</dc:date>
<dc:identifier>doi:10.1101/2021.03.01.433468</dc:identifier>
<dc:title><![CDATA[Memory CD8+ T cells mediate early pathogen-specific protection through localized delivery of chemokines and IFNγ to clusters of inflammatory monocytes]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-03-02</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.03.03.432938v1?rss=1">
<title>
<![CDATA[
Lamp1 mediates lipid transport, but is dispensable for autophagy in Drosophila 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.03.03.432938v1?rss=1</link>
<description><![CDATA[
The endolysosomal system not only is an integral part of the cellular catabolic machinery that processes and recycles nutrients for synthesis of biomaterials, but also acts as signaling hub to sense and coordinate the energy state of cells with growth and differentiation. Lysosomal dysfunction adversely influences vesicular transport-dependent macromolecular degradation and thus causes serious problems for human health. In mammalian cells, loss of the lysosome associated membrane proteins LAMP1/2 strongly impacts autophagy and cholesterol trafficking. Here we show that the previously uncharacterized Drosophila Lamp1 is a bona fide homolog of vertebrate LAMP1/2. Surprisingly and in contrast to Lamp1/2 double mutant mice, Drosophila Lamp1 is not required for viability or autophagy, suggesting that autophagy defects in Lamp1/2 mutants may have indirect causes. However, Lamp1 deficiency results in an expansion of the acidic compartment in flies. Furthermore, we find that Lamp1 mutant larvae have defects in lipid metabolism as they show elevated levels of sterols and diacylglycerols (DAGs). Since DAGs are the main lipid species used for transport though the hemolymph (blood) in insects, our results indicate broader functions of Lamp1 in lipid transport. Our findings make Drosophila an ideal model to study the role of LAMP proteins in lipid assimilation without the confounding effects of their storage and without interfering with autophagic processes.
]]></description>
<dc:creator>Chaudrhy, N.</dc:creator>
<dc:creator>Sica, M.</dc:creator>
<dc:creator>Surabhi, S.</dc:creator>
<dc:creator>Sanchez Hernandez, D.</dc:creator>
<dc:creator>Mesquita, A.</dc:creator>
<dc:creator>Selimovic, A.</dc:creator>
<dc:creator>Riaz, A.</dc:creator>
<dc:creator>Bai, H.</dc:creator>
<dc:creator>Macintosh, G. C.</dc:creator>
<dc:creator>Jenny, A.</dc:creator>
<dc:date>2021-03-03</dc:date>
<dc:identifier>doi:10.1101/2021.03.03.432938</dc:identifier>
<dc:title><![CDATA[Lamp1 mediates lipid transport, but is dispensable for autophagy in Drosophila]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-03-03</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.03.04.433962v1?rss=1">
<title>
<![CDATA[
Induction of Bdnf from promoter I following electroconvulsive seizures contributes to structural plasticity in neurons of the piriform cortex 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.03.04.433962v1?rss=1</link>
<description><![CDATA[
The efficacy of electroconvulsive therapy (ECT) as a treatment for psychiatric disorders, including major depressive disorder (MDD) is hypothesized to depend on induction of molecular and cellular events that trigger structural plasticity in neurons. Electroconvulsive seizures (ECS) in animal models can help to inform our understanding of how electroconvulsive therapy (ECT) impacts the brain. ECS induces structural plasticity in neuronal dendrites in many brain regions, including the piriform cortex, a highly epileptogenic region that has also been implicated in depression. ECS-induced structural plasticity is associated with differential expression of unique isoforms encoding the neurotrophin, brain-derived neurotrophic factor (BDNF), but the functional significance of these transcripts in dendritic plasticity is not clear. Here, we demonstrate that different Bdnf isoforms are expressed non-stochastically across neurons of the piriform cortex following ECS. Specifically, cells expressing Bdnf exon 1-containing transcripts show a unique spatial recruitment pattern in response to ECS. We further demonstrate that Bdnf Ex1 expression in these cells is necessary for ECS-induced dendritic spine plasticity.
]]></description>
<dc:creator>Ramnauth, A. D.</dc:creator>
<dc:creator>Maynard, K.</dc:creator>
<dc:creator>Kardian, A. S.</dc:creator>
<dc:creator>Phan, B. N.</dc:creator>
<dc:creator>Tippani, M.</dc:creator>
<dc:creator>Rajpurohit, S.</dc:creator>
<dc:creator>Hobbs, J. W.</dc:creator>
<dc:creator>Page, S. C.</dc:creator>
<dc:creator>Jaffe, A. E.</dc:creator>
<dc:creator>Martinowich, K.</dc:creator>
<dc:date>2021-03-04</dc:date>
<dc:identifier>doi:10.1101/2021.03.04.433962</dc:identifier>
<dc:title><![CDATA[Induction of Bdnf from promoter I following electroconvulsive seizures contributes to structural plasticity in neurons of the piriform cortex]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-03-04</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.03.05.433802v1?rss=1">
<title>
<![CDATA[
Cell competition removes segmental aneuploid cells from Drosophila imaginal disc-derived tissues based on ribosomal protein gene dose 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.03.05.433802v1?rss=1</link>
<description><![CDATA[
Aneuploidy causes birth defects and miscarriages, occurs in nearly all cancers, and is a hallmark of aging. Individual aneuploid cells can be eliminated from developing tissues by unknown mechanisms. Cells with ribosomal protein (Rp) gene mutations are also eliminated, by cell competition with normal cells. Because Rp genes are spread across the genome, their copy number is a marker for chromosome aberrations. Elimination of imaginal disc cells with irradiation-induced genome damage often required cell competition genes. When defined chromosome regions were deleted, segmentally-aneuploid cells were eliminated by the RpS12-Xrp1 cell competition pathway in an apoptosis- dependent manner when they differed from neighboring cells in Rp gene dose. Cells with normal doses of the Rp (and eIF2{gamma}) genes survived and differentiated adult tissues. Thus, cell competition, triggered by differences in Rp gene dose between cells, is a significant mechanism for the elimination of aneuploid somatic cells, likely to contribute to preventing cancer.
]]></description>
<dc:creator>ji, z.</dc:creator>
<dc:creator>Chuen, J.</dc:creator>
<dc:creator>Kiparaki, M.</dc:creator>
<dc:creator>baker, n. e.</dc:creator>
<dc:date>2021-03-06</dc:date>
<dc:identifier>doi:10.1101/2021.03.05.433802</dc:identifier>
<dc:title><![CDATA[Cell competition removes segmental aneuploid cells from Drosophila imaginal disc-derived tissues based on ribosomal protein gene dose]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-03-06</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.03.07.434271v1?rss=1">
<title>
<![CDATA[
Increased disease burden in Interleukin-3 deficient mice after Mycobacterium tuberculosis and herpes simplex virus infections 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.03.07.434271v1?rss=1</link>
<description><![CDATA[
Interleukin-3 (IL-3) is produced during infections caused by parasites, bacteria and viruses, but its contribution to immunity in this context remains largely unknown. In mouse models of parasitic infections, in which the effects of IL-3 have been most extensively studied, IL-3 has been variously reported as protective, detrimental or inconsequential. Similarly, mixed results have been reported in viral and bacterial infection models. Here, we investigated the effects of IL-3 in mouse models of Mycobacterium tuberculosis and herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) infections by assessing the pathogen burden, disease manifestations and survival following infection. After infection with M. tuberculosis, IL-3 deficient mice showed higher bacillary burden, increased lung pathology and reduced survival compared to wild type mice. After infection with HSV-1 through cutaneous route and HSV-2 through vaginal route, IL-3 deficient mice showed higher viral burden, increased disease manifestations and reduced survival compared to wild type mice. Our results show that IL-3 makes a subtle but significant contribution to protective immunity in these mouse models of bacterial and viral infections.
]]></description>
<dc:creator>Kunnath-Velayudhan, S.</dc:creator>
<dc:creator>Ng, T. W.</dc:creator>
<dc:creator>Saini, N. K.</dc:creator>
<dc:creator>Goldberg, M. F.</dc:creator>
<dc:creator>Arora, P.</dc:creator>
<dc:creator>Xu, J.</dc:creator>
<dc:creator>Kim, J.</dc:creator>
<dc:creator>Herold, B. C.</dc:creator>
<dc:creator>Chan, J.</dc:creator>
<dc:creator>Jacobs, W. R.</dc:creator>
<dc:creator>Porcelli, S. A.</dc:creator>
<dc:date>2021-03-08</dc:date>
<dc:identifier>doi:10.1101/2021.03.07.434271</dc:identifier>
<dc:title><![CDATA[Increased disease burden in Interleukin-3 deficient mice after Mycobacterium tuberculosis and herpes simplex virus infections]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-03-08</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.03.08.434304v1?rss=1">
<title>
<![CDATA[
Expansion-Assisted Iterative-FISH defines lateral hypothalamus spatio-molecular organization 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.03.08.434304v1?rss=1</link>
<description><![CDATA[
Determining the spatial organization and morphological characteristics of molecularly defined cell types is a major bottleneck for characterizing the architecture underpinning brain function. We developed Expansion-Assisted Iterative Fluorescence In Situ Hybridization (EASI-FISH) to survey gene expression in brain tissue, as well as a turnkey computational pipeline to rapidly process large EASI-FISH image datasets. EASI-FISH was optimized for thick brain sections (300 {micro}m) to facilitate reconstruction of spatio-molecular domains that generalize across brains. Using the EASI-FISH pipeline, we investigated the spatial distribution of dozens of molecularly defined cell types in the lateral hypothalamic area (LHA), a brain region with poorly defined anatomical organization. Mapping cell types in the LHA revealed nine novel spatially and molecularly defined subregions. EASI-FISH also facilitates iterative re-analysis of scRNA-Seq datasets to determine marker-genes that further dissociated spatial and morphological heterogeneity. The EASI-FISH pipeline democratizes mapping molecularly defined cell types, enabling discoveries about brain organization.

Highlights- EASI-FISH enables robust gene expression profiling in thick brain slices
- A turnkey analysis pipeline for facile analysis of large EASI-FISH image datasets
- EASI-FISH reveals novel subregions of the lateral hypothalamus
- Identification of rare cell types based on morphological and spatial heterogeneity
]]></description>
<dc:creator>Wang, Y.</dc:creator>
<dc:creator>Eddison, M.</dc:creator>
<dc:creator>Fleishman, G.</dc:creator>
<dc:creator>Weigert, M.</dc:creator>
<dc:creator>Xu, S.</dc:creator>
<dc:creator>Henry, F. E.</dc:creator>
<dc:creator>Wang, T.</dc:creator>
<dc:creator>Lemire, A. L.</dc:creator>
<dc:creator>Schmidt, U.</dc:creator>
<dc:creator>Yang, H.</dc:creator>
<dc:creator>Rokicki, K.</dc:creator>
<dc:creator>Goina, C.</dc:creator>
<dc:creator>Svoboda, K.</dc:creator>
<dc:creator>Myers, E. W.</dc:creator>
<dc:creator>Saalfeld, S.</dc:creator>
<dc:creator>Korff, W.</dc:creator>
<dc:creator>Sternson, S. M.</dc:creator>
<dc:creator>Tillberg, P. W.</dc:creator>
<dc:date>2021-03-08</dc:date>
<dc:identifier>doi:10.1101/2021.03.08.434304</dc:identifier>
<dc:title><![CDATA[Expansion-Assisted Iterative-FISH defines lateral hypothalamus spatio-molecular organization]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-03-08</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.03.10.434729v1?rss=1">
<title>
<![CDATA[
The CATP-8/P5A-type ATPase functions in multiple pathways during neuronal patterning 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.03.10.434729v1?rss=1</link>
<description><![CDATA[
The assembly of neuronal circuits involves the migrations of neurons from their place of birth to their final location in the nervous system, as well as the coordinated growth and patterning of axons and dendrites. In screens for genes required for patterning of the nervous system, we identified the catp-8/P5A-ATPase as an important regulator of neural patterning. P5A-ATPases are part of the P-type ATPases, a family of proteins known to serve a conserved function as transporters of ions, lipids and polyamines in unicellular eukaryotes, plants, and humans. While the function of many P-type ATPases is relatively well understood, the function of P5A-ATPases in metazoans remained elusive. We show here, that the Caenorhabditis elegans ortholog catp-8/P5A-ATPase is required for specific aspects of nervous system development. Specifically, the catp-8/P5A-ATPase serves functions in shaping the elaborately sculpted dendritic trees of somatosensory PVD neurons. Moreover, catp-8/P5A-ATPase is required for axonal guidance and repulsion at the midline, as well as embryonic and postembryonic neuronal migrations. Interestingly, not all axons at the midline require catp-8/P5A-ATPase, although the axons run in the same fascicles and navigate the same space. Similarly, not all neuronal migrations require catp-8/P5A-ATPase. A CATP-8/P5A-ATPase reporter is localized to the ER in most if not all tissues and catp-8/P5A-ATPase can function both cell-autonomously and non-autonomously to regulate neuronal development. Genetic analyses establish that catp-8/P5A-ATPase can function in multiple pathways, including the Menorin pathway, previously shown to control dendritic patterning in PVD, and Wnt signaling, which functions to control neuronal migrations. Lastly, we show that catp-8/P5A-ATPase is required for localizing select transmembrane proteins necessary for dendrite morphogenesis. Collectively, our studies suggest that catp-8/P5A-ATPase serves diverse, yet specific roles in different genetic pathways, and may be involved in the regulation or localization of transmembrane proteins to specific subcellular compartments.

AUTHOR SUMMARYP-type ATPases are a large family of transporters that are conserved from unicellular eukaryotes and plants to metazoans. Structurally and functionally, they fall into five subfamilies, P1 to P5, of which the latter is further divided into P5A and P5B-type ATPases. Unlike for other P-type ATPases, no mutant phenotypes for the P5A-type ATPases have been described in metazoans. Here, we show that the catp-8/P5A-ATPase in the nematode Caenorhabditis elegans is involved in multiple aspects of neuronal patterning, including neuronal migrations as well as axon guidance and dendrite patterning. A functional fluorescent reporter fusion shows the CATP-8/P5A-ATPase is expressed in most, if not all, tissues in the endoplasmic reticulum and catp-8 can function both in neurons and surrounding tissues from where it orchestrates neuronal development. Genetically, catp-8 acts in multiple pathways during these processes, including the Wnt signaling and the Menorin pathway. Imaging studies suggest that the catp-8/P5A-ATPase is necessary for proper localization of cell-surface transmembrane molecules to dendrites of sensory neurons, but likely not for their trafficking. In summary, we propose that CATP-8/P5A-ATPase serves a function in the ER during development of select neurons, by localizing certain transmembrane, and possibly, secreted proteins
]]></description>
<dc:creator>Tang, L.</dc:creator>
<dc:creator>Trivedi, M.</dc:creator>
<dc:creator>Freund, J.</dc:creator>
<dc:creator>Salazar, C.</dc:creator>
<dc:creator>Ramirez-Suarez, N.</dc:creator>
<dc:creator>Lee, G.</dc:creator>
<dc:creator>Rahman, M.</dc:creator>
<dc:creator>Wang, Y.</dc:creator>
<dc:creator>Grant, B.</dc:creator>
<dc:creator>Bülow, H. E.</dc:creator>
<dc:date>2021-03-10</dc:date>
<dc:identifier>doi:10.1101/2021.03.10.434729</dc:identifier>
<dc:title><![CDATA[The CATP-8/P5A-type ATPase functions in multiple pathways during neuronal patterning]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-03-10</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.03.12.435067v1?rss=1">
<title>
<![CDATA[
A Fragment-based approach to assess the ligandability of ArgB, ArgC, ArgD and ArgF in the L-arginine biosynthetic pathway of Mycobacterium tuberculosis. 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.03.12.435067v1?rss=1</link>
<description><![CDATA[
The L-arginine biosynthesis pathway consists of eight enzymes that catalyse the conversion of L-glutamate to L-arginine, appears to be attractive target for anti-Tuberculosis (TB) drug discovery. Starvation of M. tuberculosis deleted for either argB or argF genes led to rapid sterilization of these strains in mice while Chemical inhibition of ArgJ with Pranlukast was also found to clear chronic M. tuberculosis infection in animal models. In this work, the ligandability of four enzymes of the pathway ArgB, ArgC, ArgD and ArgF is explored using a fragment-based approach. We reveal several hits for these enzymes validated with biochemical and biophysical assays, and X-ray crystallographic data, which in the case of ArgB were further confirmed to have on-target activity against M. tuberculosis. These results demonstrate the potential of more enzymes in this pathway to be targeted with dedicated drug discovery programmes.
]]></description>
<dc:creator>Gupta, P.</dc:creator>
<dc:creator>Thomas, S. E.</dc:creator>
<dc:creator>Cory-Wright, J.</dc:creator>
<dc:creator>Sebastián-Pérez, V.</dc:creator>
<dc:creator>Burgess, A.</dc:creator>
<dc:creator>Cattermole, E.</dc:creator>
<dc:creator>Meghir, C.</dc:creator>
<dc:creator>Abell, C.</dc:creator>
<dc:creator>Coyne, A. G.</dc:creator>
<dc:creator>Jacobs, W. R.</dc:creator>
<dc:creator>Blundell, T. L.</dc:creator>
<dc:creator>Tiwari, S.</dc:creator>
<dc:creator>Mendes, V.</dc:creator>
<dc:date>2021-03-12</dc:date>
<dc:identifier>doi:10.1101/2021.03.12.435067</dc:identifier>
<dc:title><![CDATA[A Fragment-based approach to assess the ligandability of ArgB, ArgC, ArgD and ArgF in the L-arginine biosynthetic pathway of Mycobacterium tuberculosis.]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-03-12</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.03.25.434787v1?rss=1">
<title>
<![CDATA[
The Hox transcription factor Ultrabithorax binds RNA and regulates co-transcriptional splicing through an interplay with RNA polymerase II 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.03.25.434787v1?rss=1</link>
<description><![CDATA[
Transcription Factors (TFs) play a pivotal role in cell fate decision by coordinating distinct gene expression programs. Although most TFs act at the DNA regulatory layer, few TFs can bind RNA and modulate mRNA splicing. Yet, the mechanistic cues underlying TFs function in splicing remain elusive. Focusing on the Drosophila Hox TF Ultrabithorax (Ubx), our work shed light on a novel layer of Ubx function at the RNA level. Transcriptome and genome-wide binding profiles in embryonic mesoderm and Drosophila cells indicate that Ubx regulates mRNA expression and splicing to promote distinct functions in defined cellular contexts. Ubx modulates splicing via its DNA-binding domain, the Homeodomain (HD). Our results demonstrate a new RNA-binding ability of Ubx in cells and in vitro. Notably, the N51 amino acid of the HD, which mediates Ubx-DNA interaction, is non-essential for Ubx-RNA interaction in vitro but is required in vivo. We find that the N51 amino acid is necessary to mediate interaction between Ubx and the active form of the RNA Polymerase II (Pol II S2Phos) in Drosophila cells. By combining molecular and imaging approaches, our results reveal that Ubx mediates elongation-coupled splicing via a dynamic interplay with active Pol II and chromatin binding. Overall, our work uncovered a novel role of the Hox TFs at the mRNA regulatory layer. This could be an essential function for other classes of TFs to control cell diversity.
]]></description>
<dc:creator>Carnesecchi, J.</dc:creator>
<dc:creator>Boumpas, P.</dc:creator>
<dc:creator>van Nierop y Sanchez, P.</dc:creator>
<dc:creator>Domsch, K.</dc:creator>
<dc:creator>Pinto, H. D.</dc:creator>
<dc:creator>Borges Pinto, P.</dc:creator>
<dc:creator>Lohmann, I.</dc:creator>
<dc:date>2021-03-25</dc:date>
<dc:identifier>doi:10.1101/2021.03.25.434787</dc:identifier>
<dc:title><![CDATA[The Hox transcription factor Ultrabithorax binds RNA and regulates co-transcriptional splicing through an interplay with RNA polymerase II]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-03-25</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.03.26.437262v1?rss=1">
<title>
<![CDATA[
Gene structure, differential exon usage, and expression of the testis long intergenic non-protein coding RNA 1016 in humans reveals isoform-specific roles in controlling biological processes 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.03.26.437262v1?rss=1</link>
<description><![CDATA[
Long noncoding RNAs (lncRNAs) have emerged as critical regulators of biological processes. The constant expansion of newly-identified lncRNA genes requires that each one be comprehensively annotated to understand its molecular functions. Here, we describe a detailed characterization of the gene which encodes long intergenic non-protein coding RNA 01016 (LINC01016, a.k.a., LncRNA1195) with a focus on its structure, exon usage, and expression in human and macaque tissues. In this study, we show that it is exclusively conserved among non-human primates, suggesting its recent evolution and is expressed and processed into 12 distinct RNAs in testis, cervix, and uterus tissues. Further, we integrate de novo annotation of expressed LINC01016 transcripts and isoform-dependent gene expression analyses to show that human LINC01016 is a multi-exon gene, processed through differential exon usage with isoform-specific functions. Furthermore, in gynecological cancers, such as cervical squamous cell carcinoma and uterine corpus endometrial carcinoma, LINC01016 is downregulated; however, its higher expression is predictive of relapse-free survival in these cancers. Collectively, these analyses reveal that, unlike coding RNAs, lncRNA isoforms are differentially regulated and precisely processed in specific tissues to perform distinct biological roles.

One sentence summaryThe distinct molecular role of LINC01016 isoforms reveals intricate biology associated with lncRNA transcription and processing.
]]></description>
<dc:creator>Ramos, E. I.</dc:creator>
<dc:creator>Yang, B.</dc:creator>
<dc:creator>Vasquez, Y. M.</dc:creator>
<dc:creator>Lin, K. Y.</dc:creator>
<dc:creator>Choudhari, R.</dc:creator>
<dc:creator>Gadad, S. S.</dc:creator>
<dc:date>2021-03-28</dc:date>
<dc:identifier>doi:10.1101/2021.03.26.437262</dc:identifier>
<dc:title><![CDATA[Gene structure, differential exon usage, and expression of the testis long intergenic non-protein coding RNA 1016 in humans reveals isoform-specific roles in controlling biological processes]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-03-28</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.03.29.437581v1?rss=1">
<title>
<![CDATA[
Tbx1, a 22q11.2-encoded gene, is a link between alterations in fimbria myelination and cognitive speed in mice 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.03.29.437581v1?rss=1</link>
<description><![CDATA[
Copy number variants (CNVs) have provided a reliable entry point to identify structural correlates of atypical cognitive development. Hemizygous deletion of human chromosome 22q11.2 is associated with impaired cognitive function; however, the mechanisms by which numerous genes encoded in this CNV contribute to cognitive deficits via diverse structural alterations in the brain remain unclear. This study aimed to determine the cellular basis of the link between alterations in brain structure and cognitive functions in a mouse model. The heterozygosity of Tbx1, a 22q11.2 gene, altered the composition of myelinated axons in the fimbria, reduced oligodendrocyte production capacity, and slowed the acquisition of spatial memory and cognitive flexibility. Our findings provide a cellular basis for specific cognitive dysfunctions that occur in patients with loss-of-function TBX1 variants and 22q11.2 hemizygous deletion.

TeaserA risk gene for autism alters myelin composition in the hippocampal connection and slows cognitive speed.
]]></description>
<dc:creator>Hiramoto, T.</dc:creator>
<dc:creator>Sumiyoshi, A.</dc:creator>
<dc:creator>Yamauchi, T.</dc:creator>
<dc:creator>Tanigaki, K.</dc:creator>
<dc:creator>Shi, Q.</dc:creator>
<dc:creator>Kang, G.</dc:creator>
<dc:creator>Ryoke, R.</dc:creator>
<dc:creator>Nonaka, H.</dc:creator>
<dc:creator>Enomoto, S.</dc:creator>
<dc:creator>Izumi, T.</dc:creator>
<dc:creator>Bhat, M. A.</dc:creator>
<dc:creator>Kawashima, R.</dc:creator>
<dc:creator>Hiroi, N.</dc:creator>
<dc:date>2021-03-30</dc:date>
<dc:identifier>doi:10.1101/2021.03.29.437581</dc:identifier>
<dc:title><![CDATA[Tbx1, a 22q11.2-encoded gene, is a link between alterations in fimbria myelination and cognitive speed in mice]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-03-30</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.03.31.437836v1?rss=1">
<title>
<![CDATA[
Candida albicans enhances the progression of oral squamous cell cancrinoma in vitro and in vivo 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.03.31.437836v1?rss=1</link>
<description><![CDATA[
Oral squamous cell carcinoma (OSCC) is a serious health issue worldwide. OSCC is highly associated with oral candidiasis, although it is unclear whether the fungus promotes the genesis and progression of OSCC or cancer facilitates the growth of the fungus. Therefore, we investigated whether Candida could directly influence OSCC development and progression. Our in vitro results suggest that the presence of live C. albicans, but not C. parapsilosis, enhances the progression of OSCC by stimulating the production of matrix metalloproteinases, oncometabolites, pro-tumor signaling routes, and overexpression of prognostic marker genes associated with metastatic events. We also found that oral candidiasis triggered by C. albicans enhanced the progression of OSCC in vivo through the induction of inflammation and overexpression of metastatic genes and markers of epithelial-mesenchymal transition. Taken together, these results suggest that C. albicans actively participates in the complex process of OSCC progression.
]]></description>
<dc:creator>Vadovics, M.</dc:creator>
<dc:creator>Igaz, N.</dc:creator>
<dc:creator>Alfoldi, R.</dc:creator>
<dc:creator>Rakk, D.</dc:creator>
<dc:creator>Veres, E.</dc:creator>
<dc:creator>Szucs, B.</dc:creator>
<dc:creator>Horvath, M.</dc:creator>
<dc:creator>Toth, R.</dc:creator>
<dc:creator>Szucs, A.</dc:creator>
<dc:creator>Horvath, P.</dc:creator>
<dc:creator>Tiszlavicz, L.</dc:creator>
<dc:creator>Vagvolgyi, C.</dc:creator>
<dc:creator>Nosanchuk, J.</dc:creator>
<dc:creator>Szekeres, A.</dc:creator>
<dc:creator>Kiricsi, M.</dc:creator>
<dc:creator>Puskas, L.</dc:creator>
<dc:creator>Gacser, A.</dc:creator>
<dc:date>2021-03-31</dc:date>
<dc:identifier>doi:10.1101/2021.03.31.437836</dc:identifier>
<dc:title><![CDATA[Candida albicans enhances the progression of oral squamous cell cancrinoma in vitro and in vivo]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-03-31</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.03.31.437867v1?rss=1">
<title>
<![CDATA[
Cellular variability of nonsense-mediated mRNA decay 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.03.31.437867v1?rss=1</link>
<description><![CDATA[
Nonsense-mediated mRNA decay (NMD) is an mRNA degradation pathway that eliminates transcripts containing premature termination codons (PTCs). Half-lives of the mRNAs containing PTCs demonstrate that a small percent escape surveillance and do not degrade. It is not known whether this escape represents variable mRNA degradation within cells or, alternatively cells within the population are resistant. Here we demonstrate a single-cell approach with a bi-directional reporter, which expresses two {beta}-globin genes with or without a PTC in the same cell, to characterize the efficiency of NMD in individual cells. We found a broad range of NMD efficiency in the population; some cells degraded essentially all of the mRNAs, while others escaped NMD almost completely. Characterization of NMD efficiency together with NMD regulators in single cells showed cell-to-cell variability of NMD reflects the differential level of surveillance factors, SMG1 and phosphorylated UPF1. A single-cell fluorescent reporter system that enabled detection of NMD using flow cytometry revealed that this escape occurred either by translational readthrough at the PTC or by a failure of mRNA degradation after successful translation termination at the PTC.
]]></description>
<dc:creator>Sato, H.</dc:creator>
<dc:creator>Singer, R. H.</dc:creator>
<dc:date>2021-03-31</dc:date>
<dc:identifier>doi:10.1101/2021.03.31.437867</dc:identifier>
<dc:title><![CDATA[Cellular variability of nonsense-mediated mRNA decay]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-03-31</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.04.08.438992v1?rss=1">
<title>
<![CDATA[
Radiation Exposure of the Base of the Heart Accelerates Coronary Atherosclerosis 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.04.08.438992v1?rss=1</link>
<description><![CDATA[
Clinical studies have identified cardiac exposure as an independent predictor for cardiovascular mortality in patients treated with radiation therapy (RT) for thoracic malignancies. Although the mechanisms are not completely understood, the available evidence indicate that direct injury to the coronary arteries endothelium is implicated. In these studies we tested the hypothesis that different areas of the heart are more sensitive to the effects of RT on the formation of atherosclerotic plaque in apolipoprotein E deficient (ApoE-/-) mice, a well validated model of atherosclerosis.

MethodsApoE-/- mice on a high fat diet (HFD) received 16Gy cardiac irradiation targeted to the whole or partial (apical or basal) region of the heart at 9 weeks or 16 weeks of age. Atherosclerotic lesions and inflammatory changes in the hearts as compared to control unirradiated mice were assessed eight weeks following radiation.

ResultsAfter either basal or whole heart RT at 9 weeks of age the number of subendocardial atherosclerotic lesions at the heart base was higher as compared to unirradiated mice. Irradiation of the apex did not increase the number of subendocardial atherosclerotic lesions in any region. After basal RT at 16 weeks of age the number of coronary and subendocardial atherosclerotic lesions was higher as compared to controls. Neither apical or whole heart RT had an impact on the development or acceleration of lesions in the basal region of the hearts of 16 week old mice, thus demonstrating the adverse impact of basal irradiation. Infiltration of inflammatory cells (CD45+ and CD3+) and enhanced expression of endothelial adhesion molecules (CD31), were differentially and locally regulated based upon the site of irradiation. In support of a role of eicosanoid mediators for base or whole heart atherogenic irradiation effects, apex irradiation eicosanoid mediators are not clearly atherogenic, in contrast to eicosanoid mediators detected in serum after base heart irradiation. These results indicate that the base of the heart is significantly more prone to the development of atherosclerotic lesions in the coronary arteries post-RT.

ConclusionOur results indicate that the base of the heart is more susuceptible to development of RT-induced atherosclerotic lesions and therefore avoidance from RT direct exposure to this area may reduce the risk for atherosclerotic disease in patients undergoing RT.
]]></description>
<dc:creator>Nepali, P. R.</dc:creator>
<dc:creator>Mathieu, M.</dc:creator>
<dc:creator>Kitz, S.</dc:creator>
<dc:creator>Nakauchi, C.</dc:creator>
<dc:creator>Gabriels, K.</dc:creator>
<dc:creator>Russell, J.</dc:creator>
<dc:creator>Monette, S.</dc:creator>
<dc:creator>te Poele, J. A.</dc:creator>
<dc:creator>Heeneman, S.</dc:creator>
<dc:creator>Rimner, A.</dc:creator>
<dc:creator>Qiu, Y.</dc:creator>
<dc:creator>Kurland, I. J.</dc:creator>
<dc:creator>Stewart, F. A.</dc:creator>
<dc:creator>Jaimes, E. A.</dc:creator>
<dc:creator>Haimovitz-Friedman, A.</dc:creator>
<dc:date>2021-04-09</dc:date>
<dc:identifier>doi:10.1101/2021.04.08.438992</dc:identifier>
<dc:title><![CDATA[Radiation Exposure of the Base of the Heart Accelerates Coronary Atherosclerosis]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-04-09</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.04.13.439720v1?rss=1">
<title>
<![CDATA[
Non-clinical evidence supports anti-inflammatories as more effective medication than antihistamines against tarantula local effects envenomation 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.04.13.439720v1?rss=1</link>
<description><![CDATA[
BackgroundTarantulas are the most common invertebrates pets, especially in North America and Europe. The most commercialized genera are from Southern Asia and tropical Americas, represented by Vitalius, found in Southeastern Brazil, and Brachypelma, common in Mexican desert. Bites by these spiders in humans occurs during manipulation and generally result in clinical manifestations such local pain, erythema and oedema, with the possibility of secondary local infection. Hence, the cases are usually treated with prescription free drugs such as antihistamines and anti-inflammatories.

MethodsIn this work, we investigated the post treatment with commercial nonsteroidal and steroidal anti-inflammatories and anti-histamines administered by oral and intraperitoneal routes on rat paw oedema induced by venoms of V. dubius and B. smithi. Hydroplethysmometer standard oedema measurement and Evans blue extravasation were performed. Dose standardization experiments showed that the V. dubius is more potent than B. smithi, and doses were established at 30 g/paw and 60 g/paw respectively.

ResultsThe oral post-administration of ketoprofen (non-selective cyclooxygenase inhibitor) and prednisolone (steroidal anti-inflammatory) markedly reduced a paw oedema evoked by only V. dubius venom, but loratadine (H1-antihistamine) had negligible effect on rat paw oedema induced by both venoms. Intraperitoneal administration, ketoprofen (20 mg Kg-1) and loratadine (5 mg Kg-1) reduced the rat paw oedema induced by V. dubius and B. smithi while methylprednisolone (10 mg Kg-1) only inhibited the oedema induced by V. dubius.

ConclusionThese results suggest that the pos-treatment with nonsteroidal and steroidal anti-inflammatory drugs are more potent than antihistamines in attenuating the local effect induced by V. dubius and B. smithi venoms.
]]></description>
<dc:creator>Alves, B. R.</dc:creator>
<dc:creator>Sutti, R.</dc:creator>
<dc:creator>Silva, P. I.</dc:creator>
<dc:creator>Bertani, R.</dc:creator>
<dc:creator>Santos-Junior, J. G.</dc:creator>
<dc:creator>Rocha e Silva, T. A.</dc:creator>
<dc:creator>Linardi, A.</dc:creator>
<dc:date>2021-04-14</dc:date>
<dc:identifier>doi:10.1101/2021.04.13.439720</dc:identifier>
<dc:title><![CDATA[Non-clinical evidence supports anti-inflammatories as more effective medication than antihistamines against tarantula local effects envenomation]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-04-14</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.04.20.440666v1?rss=1">
<title>
<![CDATA[
Continuous multiplexed population representations of task context in the mouse primary visual cortex 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.04.20.440666v1?rss=1</link>
<description><![CDATA[
Primary visual cortex (V1) neurons integrate motor and multisensory information with visual inputs during sensory processing. However, whether V1 neurons also integrate and encode higher-order cognitive variables is less understood. We trained mice to perform a context-dependent cross-modal decision task where the interpretation of identical audio-visual stimuli depends on task context. We performed silicon probe population recordings of neuronal activity in V1 during task performance and showed that task context (whether the animal should base its decision on visual or auditory stimuli) can be decoded during both intertrial intervals and stimulus presentations. Context and visual stimuli were represented in overlapping populations but were orthogonal in the population activity space. Context representation was not static but displayed distinctive dynamics upon stimulus onset and offset. Thus, activity patterns in V1 independently represent visual stimuli and cognitive variables relevant to task execution.
]]></description>
<dc:creator>Hajnal, M. A.</dc:creator>
<dc:creator>Tran, D.</dc:creator>
<dc:creator>Einstein, M.</dc:creator>
<dc:creator>Martelo, M. V.</dc:creator>
<dc:creator>Safaryan, K.</dc:creator>
<dc:creator>Polack, P.-O.</dc:creator>
<dc:creator>Golshani, P.</dc:creator>
<dc:creator>Orban, G.</dc:creator>
<dc:date>2021-04-20</dc:date>
<dc:identifier>doi:10.1101/2021.04.20.440666</dc:identifier>
<dc:title><![CDATA[Continuous multiplexed population representations of task context in the mouse primary visual cortex]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-04-20</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.04.23.441023v1?rss=1">
<title>
<![CDATA[
Altered synaptic connectivity and brain function in mice lacking microglial adapter protein Iba1 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.04.23.441023v1?rss=1</link>
<description><![CDATA[
Growing evidence indicates that microglia impact brain function by regulating synaptic pruning and formation, as well as synaptic transmission and plasticity. Iba1 (Ionized Ca+2-binding adapter protein 1), encoded by the Allograft inflammatory factor 1 (Aif1) gene, is an actin-interacting protein in microglia. Although Iba1 has long been used as a cellular marker for microglia, its functional role remains unknown. Here, we used global Iba1-deficient (Aif1-/-) mice to characterize microglial activity, synaptic function and behavior. Microglial imaging in acute hippocampal slices and fixed tissues from juvenile mice revealed that Aif1-/- microglia display reductions in ATP-induced motility and ramification, respectively. Biochemical assays further demonstrated that Aif1-/- brain tissues exhibit an altered expression of microglial-enriched proteins associated with synaptic pruning. Consistent with these changes, juvenile Aif1-/- mice displayed deficits in excitatory synapse number and synaptic transmission assessed by neuronal labeling and whole-cell patch-clamp recording in acute hippocampal slices. Unexpectedly, microglial synaptic engulfment capacity was diminished in juvenile Aif1-/- mice. During early postnatal development when synapse formation is a predominant event in the hippocampus, excitatory synapse number was still reduced in Aif1-/- mice. Together these findings support an overall role of Iba1 in excitatory synaptic growth in juvenile mice. Lastly, postnatal synaptic deficits persisted in the adulthood and correlated with significant behavioral changes in adult Aif1-/- mice, which exhibited impairments in object recognition memory and social interaction. These results suggest that Iba1 critically contributes to microglial activity underlying essential neuro-glia developmental processes that may deeply influence behavior.

SignificanceAbnormal microglia-neuron interaction is increasingly implicated in neurodevelopmental and neuropsychiatric conditions such as autism spectrum disorders and schizophrenia, as well as in neurodegenerative disorders such as Alzheimers disease. This study demonstrates that deletion of the microglia-specific protein Iba1, which has long been utilized as a selective microglial marker but whose role has remained unidentified, results in microglial structural and functional impairments that significantly impact synaptic development and behavior. These findings not only highlight the importance of microglia in brain function but may also suggest that modifying microglial function could provide a therapeutic strategy for treatment of neurodevelopmental, neuropsychiatric and neurodegenerative disorders.
]]></description>
<dc:creator>Lituma, P. J.</dc:creator>
<dc:creator>Woo, E.</dc:creator>
<dc:creator>O'Hara, B. F.</dc:creator>
<dc:creator>Castillo, P. E.</dc:creator>
<dc:creator>Sibinga, N. E. S.</dc:creator>
<dc:creator>Nandi, S.</dc:creator>
<dc:date>2021-04-23</dc:date>
<dc:identifier>doi:10.1101/2021.04.23.441023</dc:identifier>
<dc:title><![CDATA[Altered synaptic connectivity and brain function in mice lacking microglial adapter protein Iba1]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-04-23</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.04.26.441524v1?rss=1">
<title>
<![CDATA[
Redundancy between spectral and higher-order texture statistics for natural image segmentation 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.04.26.441524v1?rss=1</link>
<description><![CDATA[
Visual texture, defined by local image statistics, provides important information to the human visual system for perceptual segmentation. Second-order or spectral statistics (equivalent to the Fourier power spectrum) are a well-studied segmentation cue. However, the role of higher-order statistics (HOS) in segmentation remains unclear, particularly for natural images. Recent experiments indicate that, in peripheral vision, the HOS of the widely adopted Portilla-Simoncelli texture model are a weak segmentation cue compared to spectral statistics, despite the fact that both are necessary to explain other perceptual phenomena and to support high-quality texture synthesis. Here we test whether this discrepancy reflects a property of natural image statistics. First, we observe that differences in spectral statistics across segments of natural images are redundant with differences in HOS. Second, using linear and nonlinear classifiers, we show that each set of statistics individually affords high performance in natural scenes and texture segmentation tasks, but combining spectral statistics and HOS produces relatively small improvements. Third, we find that HOS improve segmentation for a subset of images, although these images are difficult to identify. We also find that different subsets of HOS improve segmentation to a different extent, in agreement with previous physiological and perceptual work. These results show that the HOS add modestly to spectral statistics for natural image segmentation. We speculate that tuning to natural image statistics under resource constraints could explain the weak contribution of HOS to perceptual segmentation in human peripheral vision.
]]></description>
<dc:creator>Herrera-Esposito, D.</dc:creator>
<dc:creator>Gomez-Sena, L.</dc:creator>
<dc:creator>Coen-Cagli, R.</dc:creator>
<dc:date>2021-04-27</dc:date>
<dc:identifier>doi:10.1101/2021.04.26.441524</dc:identifier>
<dc:title><![CDATA[Redundancy between spectral and higher-order texture statistics for natural image segmentation]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-04-27</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.04.29.441821v1?rss=1">
<title>
<![CDATA[
Nopp140-chaperoned 2'-O-methylation of small nuclear RNAs in Cajal bodies ensures splicing fidelity 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.04.29.441821v1?rss=1</link>
<description><![CDATA[
Spliceosomal small nuclear RNAs (snRNAs) are modified by small Cajal body (CB) specific ribonucleoproteins (scaRNPs) to ensure snRNP biogenesis and pre-mRNA splicing. However, the function and subcellular site of snRNA modification are largely unknown. We show that CB localization of the protein Nopp140 is essential for concentration of scaRNPs in that nuclear condensate; and that phosphorylation by casein kinase 2 (CK2) at some 80 serines targets Nopp140 to CBs. Transiting through CBs, snRNAs are apparently modified by scaRNPs. Indeed, Nopp140 knockdown-mediated release of scaRNPs from CBs severely compromises 2-O-methylation of spliceosomal snRNAs, identifying CBs as the site of scaRNP catalysis. Additionally, alternative splicing patterns change indicating that these modifications in U1, U2, U5, and U12 snRNAs safeguard splicing fidelity. Given the importance of CK2 in this pathway, compromised splicing could underlie the mode of action of small molecule CK2 inhibitors currently considered for therapy in cholangiocarcinoma, hematological malignancies, and COVID-19.
]]></description>
<dc:creator>Bizarro, J.</dc:creator>
<dc:creator>Deryusheva, S.</dc:creator>
<dc:creator>Wacheul, L.</dc:creator>
<dc:creator>Gupta, V.</dc:creator>
<dc:creator>Ernst, F. G.</dc:creator>
<dc:creator>Lafontaine, D. L.</dc:creator>
<dc:creator>Gall, J. G.</dc:creator>
<dc:creator>Meier, U. T.</dc:creator>
<dc:date>2021-04-29</dc:date>
<dc:identifier>doi:10.1101/2021.04.29.441821</dc:identifier>
<dc:title><![CDATA[Nopp140-chaperoned 2'-O-methylation of small nuclear RNAs in Cajal bodies ensures splicing fidelity]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-04-29</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.04.29.441865v1?rss=1">
<title>
<![CDATA[
Cerebellar neuronal dysfunction accompanies early motor symptoms in Spinocerebellar Ataxia Type 3 and is partially alleviated upon chronic citalopram treatment 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.04.29.441865v1?rss=1</link>
<description><![CDATA[
Spinocerebellar Ataxia Type 3 (SCA3) is an adult-onset, progressive ataxia. SCA3 presents with ataxia before any gross neuropathology. A feature of many cerebellar ataxias is aberrant cerebellar output that contributes to motor dysfunction. We examined whether abnormal cerebellar output was present in the CMVMJD135 SCA3 mouse model and, if so, whether it correlated with the disease onset and progression. In vivo recordings showed that the activity of deep cerebellar nuclei neurons, the main output of the cerebellum, was altered. The aberrant activity correlated with the onset of ataxia. However, although the severity of ataxia increased with age, the severity of the aberrant cerebellar output was not progressive. The abnormal cerebellar output, however, was accompanied with non-progressive abnormal activity of their upstream synaptic inputs, the Purkinje cells. In vitro recordings indicated that alterations in both intrinsic Purkinje cell pacemaking and in their synaptic inputs contributed to abnormal Purkinje cell activity. These findings implicate abnormal cerebellar physiology as an early, consistent contributor to pathophysiology in SCA3, and suggest that the aberrant cerebellar output could be an appropriate therapeutic target in SCA3.

Summary StatementIn a mouse model of Spinocerebellar ataxia type 3 aberrant cerebellar physiology is apparent early in disease, before overt neuronal pathology or neuronal death.
]]></description>
<dc:creator>Palarz, K.</dc:creator>
<dc:creator>Neves-Carvalho, A.</dc:creator>
<dc:creator>Duarte-Silva, S.</dc:creator>
<dc:creator>Maciel, P.</dc:creator>
<dc:creator>Khodakhah, K.</dc:creator>
<dc:date>2021-04-29</dc:date>
<dc:identifier>doi:10.1101/2021.04.29.441865</dc:identifier>
<dc:title><![CDATA[Cerebellar neuronal dysfunction accompanies early motor symptoms in Spinocerebellar Ataxia Type 3 and is partially alleviated upon chronic citalopram treatment]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-04-29</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.04.30.442050v1?rss=1">
<title>
<![CDATA[
Single-molecule imaging of microRNA-mediated gene silencing in cells 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.04.30.442050v1?rss=1</link>
<description><![CDATA[
MicroRNAs (miRNAs) are small non-coding RNAs, which regulate the expression of thousands of genes; miRNAs silence gene expression from complementary mRNAs through translational repression and mRNA decay. For decades, the function of miRNAs has been studied primarily by ensemble methods, where a bulk collection of molecules is measured outside cells. Thus, the behavior of individual molecules during miRNA-mediated gene silencing, as well as their spatiotemporal regulation inside cells, remains mostly unknown. Here we report single-molecule methods to visualize each step of miRNA-mediated gene silencing in situ inside cells. Simultaneous visualization of single mRNAs, translation, and miRNA-binding revealed that miRNAs preferentially bind to translated mRNAs rather than untranslated mRNAs. Spatiotemporal analysis based on our methods uncovered that miRNAs bind to mRNAs immediately after nuclear export. Subsequently, miRNAs induced translational repression and mRNA decay within 30 and 60 min, respectively, after the binding to mRNAs. This methodology provides a framework for studying mRNA regulation at the single-molecule level with spatiotemporal information inside cells.
]]></description>
<dc:creator>Kobayashi, H.</dc:creator>
<dc:creator>Singer, R. H.</dc:creator>
<dc:date>2021-04-30</dc:date>
<dc:identifier>doi:10.1101/2021.04.30.442050</dc:identifier>
<dc:title><![CDATA[Single-molecule imaging of microRNA-mediated gene silencing in cells]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-04-30</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.05.01.442200v1?rss=1">
<title>
<![CDATA[
Activation of extrasynaptic kainate receptors drives hilar mossy cell activity 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.05.01.442200v1?rss=1</link>
<description><![CDATA[
Mossy cells (MCs) of the dentate gyrus (DG) are key components of an excitatory associative circuit established by reciprocal connections with dentate granule cells (GCs). MCs are implicated in place field encoding, pattern separation and novelty detection, as well as in brain disorders such as temporal lobe epilepsy and depression. Despite their functional relevance, little is known about the determinants that control MC activity. Here, we examined whether MCs express functional kainate receptors (KARs), a subtype of glutamate receptors involved in neuronal development, synaptic transmission and epilepsy. Using mouse hippocampal slices, we found that bath application of submicromolar and micromolar concentrations of the KAR agonist kainic acid induced inward currents and robust MC firing. These effects were abolished in GluK2 KO mice, indicating the presence of functional GluK2-containing KARs in MCs. In contrast to CA3 pyramidal cells, which are structurally and functionally similar to MCs, and express synaptic KARs at mossy fiber (MF) inputs (i.e., GC axons), we found no evidence for KAR-mediated transmission at MF-MC synapses, indicating that most KARs at MCs are extrasynaptic. Immunofluorescence and immunoelectron microscopy analyses confirmed the extrasynaptic localization of GluK2-containing KARs in MCs. Finally, blocking glutamate transporters, a manipulation that increases extracellular levels of endogenous glutamate, was sufficient to induce KAR-mediated inward currents in MCs, suggesting that MC-KARs can be activated by increases in ambient glutamate. Our findings provide the first direct evidence of functional extrasynaptic KARs at a critical excitatory neuron of the hippocampus.

Significance StatementHilar mossy cells (MCs) are an understudied population of hippocampal neurons that form an excitatory loop with dentate granule cells. MCs have been implicated in pattern separation, spatial navigation, and epilepsy. Despite their importance in hippocampal function and disease, little is known about how MC activity is recruited. Here, we show for the first time that MCs express extrasynaptic kainate receptors (KARs), a subtype of glutamate receptors critically involved in neuronal function and epilepsy. While we found no evidence for synaptic KARs in MCs, KAR activation induced strong action potential firing of MCs, raising the possibility that extracellular KARs regulate MC excitability in vivo and may also promote dentate gyrus hyperexcitability and epileptogenesis.
]]></description>
<dc:creator>Ramos, C. C.</dc:creator>
<dc:creator>Lutzu, S.</dc:creator>
<dc:creator>Yamasaki, M.</dc:creator>
<dc:creator>Yanagawa, Y.</dc:creator>
<dc:creator>Watanabe, M.</dc:creator>
<dc:creator>Sakimura, K.</dc:creator>
<dc:creator>Tomita, S.</dc:creator>
<dc:creator>Castillo, P. E.</dc:creator>
<dc:date>2021-05-01</dc:date>
<dc:identifier>doi:10.1101/2021.05.01.442200</dc:identifier>
<dc:title><![CDATA[Activation of extrasynaptic kainate receptors drives hilar mossy cell activity]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-05-01</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.05.02.442359v1?rss=1">
<title>
<![CDATA[
Definitive Hematopoietic Stem Cells Minimally Contribute to Embryonic Hematopoiesis 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.05.02.442359v1?rss=1</link>
<description><![CDATA[
Hematopoietic stem cells (HSCs) are rare cells that arise in the embryo and sustain adult hematopoiesis. Although the functional potential of nascent HSCs is detectable by transplantation, their native contribution during development is unknown, in part due to the overlapping genesis and marker gene expression with other embryonic blood progenitors. Using single cell transcriptomics, we defined gene signatures that distinguish nascent HSCs from embryonic blood progenitors. Applying a new lineage tracing approach, we selectively tracked HSC output in situ and discovered significantly delayed lymphomyeloid contribution. Using a novel inducible HSC injury model, we demonstrated a negligible impact on larval lymphomyelopoiesis following HSC depletion. HSCs are not merely dormant at this developmental stage as they showed robust regeneration after injury. Combined, our findings illuminate that nascent HSCs self-renew but display differentiation latency, while HSC-independent embryonic progenitors sustain developmental hematopoiesis. Understanding the differences among embryonic HSC and progenitor populations will guide improved de novo generation and expansion of functional HSCs.
]]></description>
<dc:creator>Ulloa, B. A.</dc:creator>
<dc:creator>Habbsa, S. S.</dc:creator>
<dc:creator>Potts, K. S.</dc:creator>
<dc:creator>Lewis, A.</dc:creator>
<dc:creator>McKinstry, M.</dc:creator>
<dc:creator>Payne, S. G.</dc:creator>
<dc:creator>Flores, J.</dc:creator>
<dc:creator>Nizhnik, A.</dc:creator>
<dc:creator>Feliz Norberto, M.</dc:creator>
<dc:creator>Mosimann, C.</dc:creator>
<dc:creator>Bowman, T. V.</dc:creator>
<dc:date>2021-05-03</dc:date>
<dc:identifier>doi:10.1101/2021.05.02.442359</dc:identifier>
<dc:title><![CDATA[Definitive Hematopoietic Stem Cells Minimally Contribute to Embryonic Hematopoiesis]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-05-03</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.05.04.442585v1?rss=1">
<title>
<![CDATA[
Haploinsufficiency of the essential gene RpS12 causes defects in erythropoiesis and hematopoietic stem cell maintenance 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.05.04.442585v1?rss=1</link>
<description><![CDATA[
Ribosomal protein (Rp) gene haploinsufficiency can result in Diamond-Blackfan Anemia (DBA), characterized by defective erythropoiesis and skeletal defects. Some mouse Rp mutations recapitulate DBA phenotypes, although others lack erythropoietic or skeletal defects. We generated a conditional knockout mouse to partially delete RpS12, which results in homozygous embryonic lethality. Rps12+/- mice have growth and morphological defects, pancytopenia and impaired erythropoiesis. A striking reduction in hematopoietic stem cells (HSCs) and progenitors in the bone marrow (BM) was associated with decreased ability to repopulate the blood system after competitive and non-competitive BM transplantation. The mutants exhibited loss of HSC quiescence, which was associated with ERK and MTOR activation and increased global translation in HSC and progenitors. Thus, RpS12 has a very strong requirement in maintaining HSC quiescence and function, in addition to erythropoiesis that is affected in DBA patients.
]]></description>
<dc:creator>Folgado Marco, V.</dc:creator>
<dc:creator>Ames, K.</dc:creator>
<dc:creator>Gritsman, K.</dc:creator>
<dc:creator>Baker, N. E.</dc:creator>
<dc:date>2021-05-04</dc:date>
<dc:identifier>doi:10.1101/2021.05.04.442585</dc:identifier>
<dc:title><![CDATA[Haploinsufficiency of the essential gene RpS12 causes defects in erythropoiesis and hematopoietic stem cell maintenance]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-05-04</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.05.10.443464v1?rss=1">
<title>
<![CDATA[
The terminal heme synthetic enzyme, Coproheme Decarboxylase, coordinates heme synthesis and uptake in response to iron in Mycobacteria 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.05.10.443464v1?rss=1</link>
<description><![CDATA[
Heme is both an essential cofactor and an abundant source of nutritional iron for the human pathogen Mycobacterium tuberculosis (Mtb). While heme is required for Mtb survival and virulence, it is also potentially cytotoxic. Since Mtb has the ability to both make and uptake heme, the de novo synthesis of heme and its acquisition from the host must be balanced in order to mitigate heme toxicity. However, the mechanisms employed by Mtb to regulate heme uptake, synthesis, and bioavailability are poorly understood. By integrating ratiometric heme sensors with mycobacterial genetics, cell biology, and biochemistry, we determined that the terminal heme biosynthetic enzyme, coproheme decarboxylase (ChdC), plays a role in regulating both heme bioavailability and uptake in Mtb. Moreover, we found that Mtb has a preference for scavenging reduced ferrous heme and exhibits a cell surface heme reductase activity that is regulated by ChdC. In Mtb, ChdC expression is down-regulated when iron is limiting, which in-turn increases both heme import and bioavailability. Such a mechanism may serve to protect cells from heme toxicity while trying to meet the nutritional demand for iron. Our results demonstrate that heme synthesis and uptake are tightly integrated in mycobacteria and represent the first example of a heme synthetic enzyme playing a role in controlling heme uptake.

Significance StatementHeme is an essential but potentially cytotoxic cofactor and iron source for the pathogen, Mycobacterium tuberculosis (Mtb). To understand how Mtb coordinates heme uptake and synthesis to mitigate heme toxicity, we integrated heme sensors with mycobacterial genetics and biochemical approaches to probe the interplay between heme synthesis and scavenging. We discovered that the terminal heme synthetic enzyme, coproheme decarboxylase (ChdC), negatively regulates heme uptake and utilization in response to iron availability through a mechanism involving control of a ferric heme reductase. During iron limitation, ChdC is downregulated, thereby enhancing exogenous heme reduction, uptake and utilization while simultaneously suppressing heme synthesis, which allows Mtb to avoid heme toxicity. Our results highlight the close coordination between heme synthesis and uptake in mycobacteria.

ClassificationBiological sciences : Biochemistry
]]></description>
<dc:creator>Donegan, R. K.</dc:creator>
<dc:creator>Copeland, J.</dc:creator>
<dc:creator>Edgha, S.</dc:creator>
<dc:creator>Brown, G.</dc:creator>
<dc:creator>Hale, O. F.</dc:creator>
<dc:creator>Mitra, A.</dc:creator>
<dc:creator>Yang, H.</dc:creator>
<dc:creator>Dailey, H. A.</dc:creator>
<dc:creator>Niederweis, M.</dc:creator>
<dc:creator>Jain, P.</dc:creator>
<dc:creator>Reddi, A. R.</dc:creator>
<dc:date>2021-05-10</dc:date>
<dc:identifier>doi:10.1101/2021.05.10.443464</dc:identifier>
<dc:title><![CDATA[The terminal heme synthetic enzyme, Coproheme Decarboxylase, coordinates heme synthesis and uptake in response to iron in Mycobacteria]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-05-10</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.05.11.443328v1?rss=1">
<title>
<![CDATA[
Kinesin-3 mediated delivery of presynaptic neurexin stabilizes growing dendritic spines and postsynaptic components in vivo 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.05.11.443328v1?rss=1</link>
<description><![CDATA[
The functional properties of neural circuits are defined by the patterns of synaptic connections between their partnering neurons, but the mechanisms that stabilize circuit connectivity are poorly understood. We systemically examined this question at synapses onto newly characterized dendritic spines of C. elegans GABAergic motor neurons. We show that the presynaptic adhesion protein, neurexin/NRX-1, is required for stabilization of postsynaptic structure. We find that early postsynaptic developmental events proceed without a strict requirement for synaptic activity and are not disrupted by deletion of neurexin/nrx-1. However, in the absence of presynaptic NRX-1, dendritic spines and receptor clusters become destabilized and collapse prior to adulthood. We demonstrate that kinesin-3/UNC-104 delivers NRX-1 to presynaptic terminals and show that ongoing delivery is required for postsynaptic maintenance in mature animals. By defining the dynamics and temporal order of synapse formation events in vivo, we describe a mechanism for stabilizing mature circuit connectivity through neurexin-based adhesion.
]]></description>
<dc:creator>Oliver, D.</dc:creator>
<dc:creator>Ramachandran, S.</dc:creator>
<dc:creator>Philbrook, A.</dc:creator>
<dc:creator>Lambert, C. M.</dc:creator>
<dc:creator>Nguyen, K. C. Q.</dc:creator>
<dc:creator>Hall, D. H.</dc:creator>
<dc:creator>Francis, M.</dc:creator>
<dc:date>2021-05-11</dc:date>
<dc:identifier>doi:10.1101/2021.05.11.443328</dc:identifier>
<dc:title><![CDATA[Kinesin-3 mediated delivery of presynaptic neurexin stabilizes growing dendritic spines and postsynaptic components in vivo]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-05-11</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.05.11.443637v1?rss=1">
<title>
<![CDATA[
Cortical ripples provide the conditions for consolidation during NREM sleep in humans 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.05.11.443637v1?rss=1</link>
<description><![CDATA[
Hippocampal ripples index the reconstruction of spatiotemporal neuronal firing patterns essential for the consolidation of memories in the cortex during non-rapid eye movement sleep (NREM). Recently, cortical ripples in humans have been shown to enfold the replay of neuron firing patterns during cued recall. Here, using intracranial recordings from 18 patients (12 female), we show that cortical ripples also occur during NREM in humans, with similar density, oscillation frequency ([~]90 Hz), duration, and amplitude to waking. Ripples occurred in all cortical regions with similar characteristics, unrelated to putative hippocampal connectivity, and were less dense and robust in higher association areas. Putative pyramidal and interneuron spiking phase-locked to cortical ripples during NREM, with phase delays consistent with ripple generation through pyramidal-interneuron feedback. Cortical ripples were smaller in amplitude than hippocampal ripples, but were similar in density, frequency, and duration. Cortical ripples during NREM typically occurred just prior to the upstate peak, often during spindles. Upstates and spindles have previously been associated with memory consolidation, and we found that cortical ripples grouped co-firing between units within the window of spike-timing-dependent plasticity. Thus, human NREM cortical ripples are: ubiquitous and stereotyped with a tightly focused oscillation frequency; similar to hippocampal ripples; associated with upstates and spindles; and associated with unit co-firing. These properties are consistent with cortical ripples possibly contributing to memory consolidation and other functions during NREM in humans.

Significance StatementIn rodents, hippocampal ripples organize replay during sleep to promote memory consolidation in the cortex, where ripples also occur. However, evidence for cortical ripples in human sleep is limited, and their anatomical distribution and physiological properties are unexplored. Here, using human intracranial recordings, we demonstrate that ripples occur throughout the cortex during waking and sleep with highly stereotyped characteristics. During sleep, cortical ripples tend to occur during spindles on the down-to-upstate transition, and thus participate in a sequence of sleep waves that is important for consolidation. Furthermore, cortical ripples organize single unit spiking with timing optimal to facilitate plasticity. Therefore, cortical ripples in humans possess essential physiological properties to support memory and other cognitive functions.
]]></description>
<dc:creator>Dickey, C. W.</dc:creator>
<dc:creator>Verzhbinsky, I. A.</dc:creator>
<dc:creator>Jiang, X.</dc:creator>
<dc:creator>Rosen, B. Q.</dc:creator>
<dc:creator>Kajfez, S.</dc:creator>
<dc:creator>Eskandar, E. N.</dc:creator>
<dc:creator>Gonzalez-Martinez, J.</dc:creator>
<dc:creator>Cash, S. S.</dc:creator>
<dc:creator>Halgren, E.</dc:creator>
<dc:date>2021-05-13</dc:date>
<dc:identifier>doi:10.1101/2021.05.11.443637</dc:identifier>
<dc:title><![CDATA[Cortical ripples provide the conditions for consolidation during NREM sleep in humans]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-05-13</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.05.27.445969v1?rss=1">
<title>
<![CDATA[
Ancestral diversity improves discovery and fine-mapping of genetic loci for anthropometric traits - the Hispanic/Latino Anthropometry Consortium 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.05.27.445969v1?rss=1</link>
<description><![CDATA[
Hispanic/Latinos have been underrepresented in genome-wide association studies (GWAS) for anthropometric traits despite notable anthropometric variability with ancestry proportions, and a high burden of growth stunting and overweight/obesity in Hispanic/Latino populations. This address this knowledge gap, we analyzed densely-imputed genetic data in a sample of Hispanic/Latino adults, to identify and fine-map common genetic variants associated with body mass index (BMI), height, and BMI-adjusted waist-to-hip ratio (WHRadjBMI). We conducted a GWAS of 18 studies/consortia as part of the Hispanic/Latino Anthropometry (HISLA) Consortium (Stage 1, n=59,769) and validated our findings in 9 additional studies (HISLA Stage 2, n=9,336). We conducted a trans-ethnic GWAS with summary statistics from HISLA Stage 1 and existing consortia of European and African ancestries. In our HISLA Stage 1+2 analyses, we discovered one novel BMI locus, as well two novel BMI signals and another novel height signal, each within established anthropometric loci. In our trans-ethnic meta- analysis, we identified three additional novel BMI loci, one novel height locus, and one novel WHRadjBMI locus. We also identified three secondary signals for BMI, 28 for height, and two for WHRadjBMI. We replicated >60 established anthropometric loci in Hispanic/Latino populations at genome-wide significance--representing up to 30% of previously-reported index SNP anthropometric associations. Trans-ethnic meta-analysis of the three ancestries showed a small-to-moderate impact of uncorrected population stratification on the resulting effect size estimates. Our novel findings demonstrate that future studies may also benefit from leveraging differences in linkage disequilibrium patterns to discover novel loci and additional signals with less residual population stratification.
]]></description>
<dc:creator>Fernandez-Rhodes, L.</dc:creator>
<dc:creator>Graff, M.</dc:creator>
<dc:creator>Buchanan, V. L.</dc:creator>
<dc:creator>Justice, A. E.</dc:creator>
<dc:creator>Highland, H. M.</dc:creator>
<dc:creator>Guo, X.</dc:creator>
<dc:creator>Young, K. L.</dc:creator>
<dc:creator>Adhikari, K.</dc:creator>
<dc:creator>Allred, N. P.</dc:creator>
<dc:creator>Below, J. E.</dc:creator>
<dc:creator>Bradfield, J.</dc:creator>
<dc:creator>Pereira, A. C.</dc:creator>
<dc:creator>Glover, L.</dc:creator>
<dc:creator>Kim, D.</dc:creator>
<dc:creator>Lilly, A. G.</dc:creator>
<dc:creator>Shrestha, P.</dc:creator>
<dc:creator>Thomas, A. G.</dc:creator>
<dc:creator>Zhang, X.</dc:creator>
<dc:creator>Chen, M.</dc:creator>
<dc:creator>Chiang, C.</dc:creator>
<dc:creator>Pulit, S.</dc:creator>
<dc:creator>Horimoto, A.</dc:creator>
<dc:creator>Krieger, J. E.</dc:creator>
<dc:creator>Guindo-Martinez, M.</dc:creator>
<dc:creator>Preuss, M.</dc:creator>
<dc:creator>Schumann, C.</dc:creator>
<dc:creator>Smit, R. A. J.</dc:creator>
<dc:creator>Torres-Mejia, G.</dc:creator>
<dc:creator>Acuna-Alonzo, V.</dc:creator>
<dc:creator>Bedoya, G.</dc:creator>
<dc:creator>Bortolini, M.-C.</dc:creator>
<dc:creator>Canizales-Quinteros, S.</dc:creator>
<dc:creator>Gallo, C.</dc:creator>
<dc:creator>Gonzalez-Jose, R.</dc:creator>
<dc:creator>Poletti, G.</dc:creator>
<dc:creator>Rothhammer, F.</dc:creator>
<dc:creator>Hakonarson, H.</dc:creator>
<dc:creator>Adler, S. G.</dc:creator>
<dc:creator>Igo, R.</dc:creator>
<dc:creator>Iyengar, S.</dc:creator>
<dc:creator>Nicholas, S. B.</dc:creator>
<dc:creator></dc:creator>
<dc:date>2021-05-29</dc:date>
<dc:identifier>doi:10.1101/2021.05.27.445969</dc:identifier>
<dc:title><![CDATA[Ancestral diversity improves discovery and fine-mapping of genetic loci for anthropometric traits - the Hispanic/Latino Anthropometry Consortium]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-05-29</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.05.31.446382v1?rss=1">
<title>
<![CDATA[
Micro-Meta App: an interactive software tool to facilitate the collection of microscopy metadata based on community-driven specifications 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.05.31.446382v1?rss=1</link>
<description><![CDATA[
For the information content of microscopy images to be appropriately interpreted, reproduced, and meet FAIR (Findable Accessible Interoperable and Reusable) principles, they should be accompanied by detailed descriptions of microscope hardware, image acquisition settings, image pixel and dimensional structure, and instrument performance. Nonetheless, the thorough documentation of imaging experiments is significantly impaired by the lack of community-sanctioned easy-to-use software tools to facilitate the extraction and collection of relevant microscopy metadata. Here we present Micro-Meta App, an intuitive open-source software designed to tackle these issues that was developed in the context of nascent global bioimaging community organizations, including BioImaging North America (BINA) and QUAlity Assessment and REProducibility in Light Microscopy (QUAREP-LiMi), whose goal is to improve reproducibility, data quality and sharing value for imaging experiments. The App provides a user-friendly interface for building comprehensive descriptions of the conditions utilized to produce individual microscopy datasets as specified by the recently proposed 4DN-BINA-OME tiered-system of Microscopy Metadata model. To achieve this goal the App provides a visual guide for a microscope-user to: 1) interactively build diagrammatic representations of hardware configurations of given microscopes that can be easily reused and shared with colleagues needing to document similar instruments. 2) Automatically extracts relevant metadata from image files and facilitates the collection of missing image acquisition settings and calibration metrics associated with a given experiment. 3) Output all collected Microscopy Metadata to interoperable files that can be used for documenting imaging experiments and shared with the community. In addition to significantly lowering the burden of quality assurance, the visual nature of Micro-Meta App makes it particularly suited for training users that have limited knowledge of the intricacies of light microscopy experiments. To ensure wide-adoption by microscope-users with different needs Micro-Meta App closely interoperates with MethodsJ2 and OMERO.mde, two complementary tools described in parallel manuscripts.
]]></description>
<dc:creator>Rigano, A.</dc:creator>
<dc:creator>Ehmsen, S.</dc:creator>
<dc:creator>Ozturk, S. U.</dc:creator>
<dc:creator>Ryan, J.</dc:creator>
<dc:creator>Balashov, A.</dc:creator>
<dc:creator>Hammer, M.</dc:creator>
<dc:creator>Kirli, K.</dc:creator>
<dc:creator>Bellve, K.</dc:creator>
<dc:creator>Boehm, U.</dc:creator>
<dc:creator>Brown, C. M.</dc:creator>
<dc:creator>Chambers, J. J.</dc:creator>
<dc:creator>Coleman, R. A.</dc:creator>
<dc:creator>Cosolo, A.</dc:creator>
<dc:creator>Faklaris, O.</dc:creator>
<dc:creator>Fogarty, K.</dc:creator>
<dc:creator>Guilbert, T.</dc:creator>
<dc:creator>Hamacher, A. B.</dc:creator>
<dc:creator>Itano, M. S.</dc:creator>
<dc:creator>Keeley, D. P.</dc:creator>
<dc:creator>Kunis, S.</dc:creator>
<dc:creator>Lacoste, J.</dc:creator>
<dc:creator>Laude, A.</dc:creator>
<dc:creator>Ma, W.</dc:creator>
<dc:creator>Marcello, M.</dc:creator>
<dc:creator>Montero-Llopis, P.</dc:creator>
<dc:creator>Nelson, G.</dc:creator>
<dc:creator>Nitschke, R.</dc:creator>
<dc:creator>Pimentel, J. A.</dc:creator>
<dc:creator>Weidtkamp-Peters, S.</dc:creator>
<dc:creator>Park, P. J.</dc:creator>
<dc:creator>Alver, B.</dc:creator>
<dc:creator>Grunwald, D.</dc:creator>
<dc:creator>Strambio-De-Castillia, C.</dc:creator>
<dc:date>2021-05-31</dc:date>
<dc:identifier>doi:10.1101/2021.05.31.446382</dc:identifier>
<dc:title><![CDATA[Micro-Meta App: an interactive software tool to facilitate the collection of microscopy metadata based on community-driven specifications]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-05-31</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.06.01.446628v1?rss=1">
<title>
<![CDATA[
Transcriptomic changes highly similar to Alzheimer's disease are observed in a subpopulation of individuals during normal brain aging 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.06.01.446628v1?rss=1</link>
<description><![CDATA[
Aging is a major risk factor for late-onset Alzheimers disease (LOAD). How aging contributes to the development of LOAD remains elusive. In this study, we examined multiple large-scale transcriptomic data from both normal aging and LOAD brains to understand the molecular interconnection between aging and LOAD. We found that shared gene expression changes between aging and LOAD are mostly seen in the hippocampal and several cortical regions. In the hippocampus, the expression of phosphoprotein, alternative splicing and cytoskeleton genes are commonly changed in both aging and AD, while synapse, ion transport, and synaptic vesicle genes are commonly down-regulated. Aging-specific changes are associated with acetylation and methylation, while LOAD-specific changes are more related to glycoprotein (both up- and down-regulations), inflammatory response (up-regulation), myelin sheath and lipoprotein (down-regulation). We also found that normal aging brain transcriptomes from relatively young donors (45-70 years old) clustered into several subgroups and some subgroups showed gene expression changes highly similar to those seen in LOAD brains. Using brain transcriptomic data from another cohort of older individuals (> 70 years), we found that samples from cognitively normal older individuals clustered with the "healthy aging" subgroup while AD samples mainly clustered with the "AD similar" subgroups. This may imply that individuals in the healthy aging subgroup will likely remain cognitively normal when they become older and vice versa. In summary, our results suggest that on the transcriptome level, aging and LOAD have strong interconnections in some brain regions in a subpopulation of cognitively normal aging individuals. This supports the theory that the initiation of LOAD occurs decades earlier than the manifestation of clinical phenotype and it may be essential to closely study the "normal brain aging" to identify the very early molecular events that may lead to LOAD development.
]]></description>
<dc:creator>Peng, S.</dc:creator>
<dc:creator>Zeng, L.</dc:creator>
<dc:creator>Haure-mirande, J.-v.</dc:creator>
<dc:creator>Wang, M.</dc:creator>
<dc:creator>Huffman, D. M.</dc:creator>
<dc:creator>Haroutunian, V.</dc:creator>
<dc:creator>Ehrlich, M.</dc:creator>
<dc:creator>Zhang, B.</dc:creator>
<dc:creator>Tu, Z.</dc:creator>
<dc:date>2021-06-02</dc:date>
<dc:identifier>doi:10.1101/2021.06.01.446628</dc:identifier>
<dc:title><![CDATA[Transcriptomic changes highly similar to Alzheimer's disease are observed in a subpopulation of individuals during normal brain aging]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-06-02</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.06.02.446746v1?rss=1">
<title>
<![CDATA[
Mycobacterium tuberculosis H2S functions as a sink to modulate central metabolism, bioenergetics, and drug susceptibility 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.06.02.446746v1?rss=1</link>
<description><![CDATA[
H2S is a potent gasotransmitter in eukaryotes and bacteria. Host-derived H2S has been shown to profoundly alter M. tuberculosis (Mtb) energy metabolism and growth. However, compelling evidence for endogenous production of H2S and its role in Mtb physiology is lacking. We show that multidrug-resistant and drug-susceptible clinical Mtb strains produce H2S, whereas H2S production in non-pathogenic M. smegmatis is barely detectable. We identified Rv3684 (Cds1) as an H2S-producing enzyme in Mtb and show that cds1 disruption reduces, but does not eliminate, H2S production, suggesting the involvement of multiple genes in H2S production. We identified endogenous H2S to be an effector molecule that maintains bioenergetic homeostasis by stimulating respiration primarily via cytochrome bd. Importantly, H2S plays a key role in central metabolism by modulating the balance between oxidative phosphorylation and glycolysis, and functions as a sink to recycle sulfur atoms back to cysteine to maintain sulfur homeostasis. Lastly, Mtb-generated H2S regulates redox homeostasis and susceptibility to anti-TB drugs clofazimine and rifampicin. These findings reveal previously unknown facets of Mtb physiology and have implications for routine laboratory culturing, understanding drug susceptibility, and improved diagnostics.
]]></description>
<dc:creator>Kunota, T. T. R.</dc:creator>
<dc:creator>Rahman, M. A.</dc:creator>
<dc:creator>Truebody, B. E.</dc:creator>
<dc:creator>Mackenzie, J. S.</dc:creator>
<dc:creator>Saini, V.</dc:creator>
<dc:creator>Lamprecht, D. A.</dc:creator>
<dc:creator>Adamson, J. H.</dc:creator>
<dc:creator>Sevalkar, R. R.</dc:creator>
<dc:creator>Lancaster, J. R.</dc:creator>
<dc:creator>Berney, M.</dc:creator>
<dc:creator>Glasgow, J. N.</dc:creator>
<dc:creator>Steyn, A. J.</dc:creator>
<dc:date>2021-06-02</dc:date>
<dc:identifier>doi:10.1101/2021.06.02.446746</dc:identifier>
<dc:title><![CDATA[Mycobacterium tuberculosis H2S functions as a sink to modulate central metabolism, bioenergetics, and drug susceptibility]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-06-02</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.06.06.447265v1?rss=1">
<title>
<![CDATA[
Resource-efficient pooled sequencing expands translational impact in solid tumors 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.06.06.447265v1?rss=1</link>
<description><![CDATA[
Intratumoral genetic heterogeneity (ITH) poses a significant challenge to utilizing sequencing for decision making in the management of cancer. Although sequencing of multiple tumor regions can address the pitfalls of ITH, it does so at a significant increase in cost and resource utilization. We propose a pooled multiregional sequencing strategy, whereby DNA aliquots from multiple tumor regions are mixed prior to sequencing, as a cost-effective strategy to boost translational value by addressing ITH while preserving valuable residual tissue for secondary analysis. Focusing on kidney cancer, we demonstrate that DNA pooling from as few as two regions significantly increases mutation detection while reducing clonality misattribution. This leads to an increased fraction of patients identified with therapeutically actionable mutations, improved patient risk stratification, and improved inference of evolutionary trajectories with an accuracy comparable to bona fide multiregional sequencing. The same approach applied to non-small-cell lung cancer data substantially improves tumor mutational burden (TMB) detection. Our findings demonstrate that pooled DNA sequencing strategies are a cost-effective alternative to address intrinsic genetic heterogeneity in clinical settings.
]]></description>
<dc:creator>DiNatale, R. G.</dc:creator>
<dc:creator>Mano, R.</dc:creator>
<dc:creator>Makarov, V.</dc:creator>
<dc:creator>Rusk, N.</dc:creator>
<dc:creator>Drill, E.</dc:creator>
<dc:creator>Winer, A.</dc:creator>
<dc:creator>Sankin, A.</dc:creator>
<dc:creator>Yoo, A.</dc:creator>
<dc:creator>Freeman, B. A.</dc:creator>
<dc:creator>Hsieh, J. J.</dc:creator>
<dc:creator>Chen, Y.-B.</dc:creator>
<dc:creator>Coleman, J. A.</dc:creator>
<dc:creator>Berger, M. G.</dc:creator>
<dc:creator>Ostrovnaya, I.</dc:creator>
<dc:creator>Chan, T. A.</dc:creator>
<dc:creator>Russo, P.</dc:creator>
<dc:creator>Reznik, E.</dc:creator>
<dc:creator>Hakimi, A. A.</dc:creator>
<dc:date>2021-06-07</dc:date>
<dc:identifier>doi:10.1101/2021.06.06.447265</dc:identifier>
<dc:title><![CDATA[Resource-efficient pooled sequencing expands translational impact in solid tumors]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-06-07</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.06.07.447454v1?rss=1">
<title>
<![CDATA[
Presynaptic FMRP and local protein synthesis support structural and functional plasticity of glutamatergic axon terminals 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.06.07.447454v1?rss=1</link>
<description><![CDATA[
Learning and memory critically rely on long-lasting, synapse-specific modifications. While postsynaptic forms of plasticity typically require local protein synthesis, whether and how local protein synthesis contributes to presynaptic changes remains unclear. Here, we examined the hippocampal mossy fiber (MF)-CA3 synapse which expresses both structural and functional presynaptic plasticity. We report that MF boutons synthesize protein locally and contain ribosomes. Long-term potentiation of MF-CA3 synaptic transmission (MF-LTP) was associated with translation-dependent enlargement of MF boutons. Moreover, increasing in vitro and in vivo MF activity enhanced protein synthesis in MFs. Remarkably, deletion of presynaptic Fragile X mental retardation protein (FMRP), an RNA-binding protein expressed in MF boutons and previously implicated in local postsynaptic protein synthesis-dependent plasticity, blocked structural and functional MF-LTP, suggesting that FMRP is a critical regulator of presynaptic function. Thus, presynaptic FMRP and protein synthesis dynamically control presynaptic structure and function in the mature brain.

HighlightsO_LIMossy fiber boutons (MFBs) synthesize protein locally and contain ribosomes
C_LIO_LILocal presynaptic translation is increased by in vitro and in vivo GC activity
C_LIO_LIMFB structural plasticity relies on de novo protein synthesis.
C_LIO_LIPresynaptic FMRP is required for MF-CA3 structural and functional plasticity
C_LI

In BriefMonday et al. report that FMRP and protein synthesis in hippocampal mossy fiber boutons mediate functional and structural presynaptic plasticity.
]]></description>
<dc:creator>Monday, H. R.</dc:creator>
<dc:creator>Kharod, S. C.</dc:creator>
<dc:creator>Yoon, Y. J.</dc:creator>
<dc:creator>Singer, R. H.</dc:creator>
<dc:creator>Castillo, P. E.</dc:creator>
<dc:date>2021-06-08</dc:date>
<dc:identifier>doi:10.1101/2021.06.07.447454</dc:identifier>
<dc:title><![CDATA[Presynaptic FMRP and local protein synthesis support structural and functional plasticity of glutamatergic axon terminals]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-06-08</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.06.10.447999v1?rss=1">
<title>
<![CDATA[
A combination of RBD and NTD neutralizing antibodies limits the generation of SARS-CoV-2 spike neutralization-escape mutants 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.06.10.447999v1?rss=1</link>
<description><![CDATA[
Most known SARS-CoV-2 neutralizing antibodies (nAbs), including those approved by the FDA for emergency use, inhibit viral infection by targeting the receptor-binding domain (RBD) of the spike (S) protein. Variants of concern (VOC) carrying mutations in the RBD or other regions of S reduce the effectiveness of many nAbs and vaccines by evading neutralization. Therefore, therapies that are less susceptible to resistance are urgently needed. Here, we characterized the memory B-cell repertoire of COVID-19 convalescent donors and analyzed their RBD and non-RBD nAbs. We found that many of the non-RBD-targeting nAbs were specific to the N-terminal domain (NTD). Using neutralization assays with authentic SARS-CoV-2 and a recombinant vesicular stomatitis virus carrying SARS-CoV-2 S protein (rVSV-SARS2), we defined a panel of potent RBD and NTD nAbs. Next, we used a combination of neutralization-escape rVSV-SARS2 mutants and a yeast display library of RBD mutants to map their epitopes. The most potent RBD nAb competed with hACE2 binding and targeted an epitope that includes residue F490. The most potent NTD nAb epitope included Y145, K150 and W152. As seen with some of the natural VOC, the neutralization potencies of COVID-19 convalescent sera were reduced by 4-16-fold against rVSV-SARS2 bearing Y145D, K150E or W152R spike mutations. Moreover, we found that combining RBD and NTD nAbs modestly enhanced their neutralization potential. Notably, the same combination of RBD and NTD nAbs limited the development of neutralization-escape mutants in vitro, suggesting such a strategy may have higher efficacy and utility for mitigating the emergence of VOC.

ImportanceThe US FDA has issued emergency use authorizations (EUAs) for multiple investigational monoclonal antibody (mAb) therapies for the treatment of mild to moderate COVID-19. These mAb therapeutics are solely targeting the receptor binding domain of the SARS-CoV-2 spike protein. However, the N-terminal domain of the spike protein also carries crucial neutralizing epitopes. Here, we show that key mutations in the N-terminal domain can reduce the neutralizing capacity of convalescent COVID-19 sera. We report that a combination of two neutralizing antibodies targeting the receptor binding and N-terminal domains may have higher efficacy and is beneficial to combat the emergence of virus variants.
]]></description>
<dc:creator>Haslwanter, D.</dc:creator>
<dc:creator>Dieterle, M. E.</dc:creator>
<dc:creator>Wec, A. Z.</dc:creator>
<dc:creator>O'Brien, C. M.</dc:creator>
<dc:creator>Sakharkar, M.</dc:creator>
<dc:creator>Florez, C.</dc:creator>
<dc:creator>Tong, K.</dc:creator>
<dc:creator>Rappazzo, C. G.</dc:creator>
<dc:creator>Lasso, G.</dc:creator>
<dc:creator>Vergnolle, O.</dc:creator>
<dc:creator>Wirchnianski, A. S.</dc:creator>
<dc:creator>Bortz, R. H.</dc:creator>
<dc:creator>Laudermilch, E.</dc:creator>
<dc:creator>Fels, J. M.</dc:creator>
<dc:creator>Mengotto, A.</dc:creator>
<dc:creator>Malonis, R. J.</dc:creator>
<dc:creator>Georgiev, G. I.</dc:creator>
<dc:creator>Quiroz, J.</dc:creator>
<dc:creator>Wrapp, D.</dc:creator>
<dc:creator>Wang, N.</dc:creator>
<dc:creator>Dye, K. E.</dc:creator>
<dc:creator>Barnhill, J.</dc:creator>
<dc:creator>Dye, J. M.</dc:creator>
<dc:creator>McLellan, J. S.</dc:creator>
<dc:creator>Daily, J. P.</dc:creator>
<dc:creator>Lai, J. R.</dc:creator>
<dc:creator>Herbert, A. S.</dc:creator>
<dc:creator>Walker, L.</dc:creator>
<dc:creator>Chandran, K.</dc:creator>
<dc:creator>Jangra, R. K.</dc:creator>
<dc:date>2021-06-11</dc:date>
<dc:identifier>doi:10.1101/2021.06.10.447999</dc:identifier>
<dc:title><![CDATA[A combination of RBD and NTD neutralizing antibodies limits the generation of SARS-CoV-2 spike neutralization-escape mutants]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-06-11</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.06.16.448617v1?rss=1">
<title>
<![CDATA[
HVEM structures and mutants reveal distinct functions of binding to LIGHT and BTLA/CD160 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.06.16.448617v1?rss=1</link>
<description><![CDATA[
HVEM is a TNF (tumor necrosis factor) receptor contributing to a broad range of immune functions involving diverse cell types. It interacts with a TNF ligand, LIGHT, and immunoglobulin (Ig) superfamily members BTLA and CD160. Assessing the functional impact of HVEM binding to specific ligands in different settings has been complicated by the multiple interactions of HVEM and HVEM binding partners. To dissect the molecular basis for multiple functions, we determined crystal structures that reveal the distinct HVEM surfaces that engage LIGHT or BTLA/CD160, including the human HVEM:LIGHT:CD160 ternary complex, with HVEM interacting simultaneously with both binding partners. Based on these structures, we generated mouse HVEM mutants that selectively recognized either the TNF or Ig ligands in vitro. Knock-in mice expressing these muteins maintain expression of all the proteins in the HVEM network, yet they demonstrate selective functions for LIGHT in the clearance of bacteria in the intestine and for the Ig ligands in the amelioration of liver inflammation.
]]></description>
<dc:creator>Liu, W.</dc:creator>
<dc:creator>Chou, T.-F.</dc:creator>
<dc:creator>Garrett-Thomson, S. C.</dc:creator>
<dc:creator>Seo, G.-Y.</dc:creator>
<dc:creator>Fedorov, E.</dc:creator>
<dc:creator>Ramagopa, U. A.</dc:creator>
<dc:creator>Bonanno, J. B.</dc:creator>
<dc:creator>Kakugawa, K.</dc:creator>
<dc:creator>Cheroutre, H.</dc:creator>
<dc:creator>Kronenberg, M.</dc:creator>
<dc:creator>Almo, S. C.</dc:creator>
<dc:date>2021-06-16</dc:date>
<dc:identifier>doi:10.1101/2021.06.16.448617</dc:identifier>
<dc:title><![CDATA[HVEM structures and mutants reveal distinct functions of binding to LIGHT and BTLA/CD160]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-06-16</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.06.17.448790v1?rss=1">
<title>
<![CDATA[
Alzheimer's disease-associated P460L mutation in ephrin receptor type A1 (EphA1) leads to dysregulated Rho-GTPase signaling 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.06.17.448790v1?rss=1</link>
<description><![CDATA[
Recently, late onset AD (LOAD) genome-wide association studies identified EphA1, a member of receptor tyrosine kinase family (RTK) as a disease associated loci. In the follow-up study where 3 independent LOAD cohorts were performed, a P460L coding mutation in EphA1 loci showed a significant association with LOAD. However, the role of EphA1 and P460L mutant EphA1 in AD is not fully understood. We have characterized this mutation biophysically and biochemically. Our structural in silico model and in vitro biochemical analysis demonstrate that EphA1-P460L mutation makes the receptor constitutively active suggesting a gain-of-toxic function leading to chronic EphA1 signaling in the brain. Moreover, we report that the EphA1 P460L variant triggers Rho-GTPase signaling dysregulation that could potentially contribute to spine morphology abnormalities and synaptic dysfunction observed in AD pathology.
]]></description>
<dc:creator>Kim, Y.</dc:creator>
<dc:creator>Lasso, G.</dc:creator>
<dc:creator>Patel, H.</dc:creator>
<dc:creator>Vardarajan, B.</dc:creator>
<dc:creator>Santa-Maria, I.</dc:creator>
<dc:creator>Lefort, R.</dc:creator>
<dc:date>2021-06-18</dc:date>
<dc:identifier>doi:10.1101/2021.06.17.448790</dc:identifier>
<dc:title><![CDATA[Alzheimer's disease-associated P460L mutation in ephrin receptor type A1 (EphA1) leads to dysregulated Rho-GTPase signaling]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-06-18</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.06.27.449121v1?rss=1">
<title>
<![CDATA[
Resolving the structure of phage-bacteria interactions in the context of natural diversity 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.06.27.449121v1?rss=1</link>
<description><![CDATA[
Microbial communities are shaped by viral predators1. Yet, resolving which viruses (phages) and bacteria are interacting is a major challenge in the context of natural levels of microbial diversity2. Thus, fundamental features of how phage-bacteria interactions are structured and evolve in "the wild" remain poorly resolved3, 4. Here we use large-scale isolation of environmental marine Vibrio bacteria and their phages to obtain quantitative estimates of strain-level phage predator loads, and use all-by-all host range assays to discover how phage and host genomic diversity shape interactions. We show that killing in environmental interaction networks is sparse - with phage predator loads low for most bacterial strains and phages host-strain-specific in their killing. Paradoxically, we also find that although overlap in killing is generally rare between phages, recombination is common. Together, these results indicate that the number of hosts that phages infect is often larger than the number that they kill and suggest that recombination during cryptic co-infections is an important mode of phage evolution in microbial communities. In the development of phages for bioengineering and therapeutics it will be important to consider that nucleic acids of introduced phages may spread into local phage populations through recombination, and that the likelihood of transfer is not predictable based on killing host range.
]]></description>
<dc:creator>Kauffman, K. M.</dc:creator>
<dc:creator>Chang, W. K.</dc:creator>
<dc:creator>Brown, J. M.</dc:creator>
<dc:creator>Hussain, F. A.</dc:creator>
<dc:creator>Yang, J. Y.</dc:creator>
<dc:creator>Polz, M. F.</dc:creator>
<dc:creator>Kelly, L.</dc:creator>
<dc:date>2021-06-27</dc:date>
<dc:identifier>doi:10.1101/2021.06.27.449121</dc:identifier>
<dc:title><![CDATA[Resolving the structure of phage-bacteria interactions in the context of natural diversity]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-06-27</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.06.27.450024v1?rss=1">
<title>
<![CDATA[
Inhibition of cancer cells in culture. The effects of treatment with ketone bodies and/or rapamycin treatment 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.06.27.450024v1?rss=1</link>
<description><![CDATA[
BackgroundThe potential for ketogenic diets or administration of exogenous ketone bodies to treat or prevent to cancer remains encouraging. Of particular interest is the possibility that, whatever the effect of a nutritional intervention alone, the diet might enhance the effect of existing cancer drugs, thereby requiring lower doses and a reduction in toxicity and side effects.

MethodsSW480, a human cell line derived from colon, was treated with ketone bodies (sodium 3-hydroxy butyrate (common name, {square}-hydroxy butyrate) or with sodium acetoacetate in the presence or absence of rapamycin. Cells were incubated for 96 hours in DMEM with 10 mM glucose medium. HSF2617, a human epithelial fibroblast line served as control and cells were subjected to similar treatment as the SW480 cells. Cell proliferation and glucose consumption were determined with standard reagents.

ResultsThe ketone bodies inhibited proliferation of SW480 cells in culture. Rapamycin also inhibited proliferation and its action was enhanced by the ketone bodies although there was little synergistic effect under these conditions. Human fibroblast controls were not inhibited by the ketone bodies. Both SW480 and control lines showed consumption of glucose during a 96 hour incubation period, suggesting that normal controls can switch to ketogenic metabolism while the cancer cells, which proliferate poorly, cannot. Results are consistent with recent reports of a mouse model showing the synergy of rapamycin and a ketogenic diet (Zou Y, et al. (2020) PLoS ONE 15 (5)) as well as earlier publications describing additive or synergistic effects of ketogenic diets with other modalities of cancer treatment.

ConclusionsThe results show that the growth of a cancer cell line in culture can be inhibited by the addition of ketone bodies or rapamycin to the growth medium. The combination of treatments was found to be additive, consistent with results from a previously published mouse model. The data demonstrate the potential for a strategy whereby doses of anti-cancer agents that have detrimental or toxic side-effects can be reduced if coupled to an appropriate source of ketone bodies.
]]></description>
<dc:creator>Miller, A.</dc:creator>
<dc:creator>Lin, B.</dc:creator>
<dc:creator>Pincus, M. R.</dc:creator>
<dc:creator>Fine, E. J.</dc:creator>
<dc:creator>Feinman, R. D.</dc:creator>
<dc:date>2021-06-28</dc:date>
<dc:identifier>doi:10.1101/2021.06.27.450024</dc:identifier>
<dc:title><![CDATA[Inhibition of cancer cells in culture. The effects of treatment with ketone bodies and/or rapamycin treatment]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-06-28</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.06.30.450628v1?rss=1">
<title>
<![CDATA[
Activity-dependent LTP in the dentate gyrus promotes epileptic seizures 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.06.30.450628v1?rss=1</link>
<description><![CDATA[
Epilepsy is a devastating brain disorder whose cellular mechanisms remain poorly understood. Excitatory mossy cells (MCs) in the dentate gyrus of the hippocampus are implicated in temporal lobe epilepsy, the most common form of focal epilepsy in adults. However, the role of MCs during initial seizures, before MC loss occurs, is unclear. Here, we show that initial seizures induced with kainic acid (KA) intraperitoneal injection in adult mice, a well-established model of experimental epilepsy, not only increased MC and granule cell (GC) activity in vivo, but also triggered a BDNF-dependent long-term potentiation at MC-GC synapses (MC-GC LTP). In vivo induction of MC-GC LTP worsened KA-induced seizures, whereas selective MC silencing and Bdnf genetic removal from GCs, which abolishes LTP, were both anti-epileptic. Thus, initial seizures strengthen MC-GC synaptic transmission, thereby promoting epileptic activity. Our findings reveal a potential mechanism of epileptogenesis that may help develop therapeutic strategies for early intervention.
]]></description>
<dc:creator>Nasrallah, K.</dc:creator>
<dc:creator>Frechou, M. A.</dc:creator>
<dc:creator>Yoon, Y. J.</dc:creator>
<dc:creator>Persaud, S.</dc:creator>
<dc:creator>Goncalves, T.</dc:creator>
<dc:creator>Castillo, P. E.</dc:creator>
<dc:date>2021-06-30</dc:date>
<dc:identifier>doi:10.1101/2021.06.30.450628</dc:identifier>
<dc:title><![CDATA[Activity-dependent LTP in the dentate gyrus promotes epileptic seizures]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-06-30</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.07.07.451518v1?rss=1">
<title>
<![CDATA[
Anti-tumor efficacy of an MMAE conjugated antibody targeting cell surface TACE/ADAM17-cleaved Amphiregulin in breast cancer 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.07.07.451518v1?rss=1</link>
<description><![CDATA[
The Epidermal Growth Factor Receptor ligand, Amphiregulin, is a key proliferative effector of estrogen receptor signaling in breast cancer and also plays a role in other malignancies. Amphiregulin is a single-pass transmembrane protein proteolytically processed by TACE/ADAM17 to release the soluble EGFR ligand, leaving a residual transmembrane stalk that is subsequently internalized. Here, we report the development of an antibody drug conjugate, GMF-1A3-MMAE, targeting an AREG neo-epitope revealed following ADAM17-mediated cleavage. The antibody does not interact with uncleaved Amphiregulin, providing a novel means of targeting cells with high rates of Amphiregulin shedding. Using fluorescent dye conjugation, we demonstrated that the antibody is internalized by cancer cells in a manner dependent on the presence of cell surface cleaved Amphiregulin. Antibodies conjugated with monomethyl auristatin E (MMAE) were cytotoxic in vitro and induced rapid regression of established breast tumor xenografts in immunocompromised mice. We further demonstrate that these antibodies recognize the Amphiregulin neo-epitope in formalin fixed paraffin embedded tumor tissue, suggesting their utility as a companion diagnostic for patient selection.
]]></description>
<dc:creator>Lofgren, K. A.</dc:creator>
<dc:creator>Sreekumar, S.</dc:creator>
<dc:creator>Jenkins, E. C.</dc:creator>
<dc:creator>Ernzen, K. J.</dc:creator>
<dc:creator>Kenny, P. A.</dc:creator>
<dc:date>2021-07-08</dc:date>
<dc:identifier>doi:10.1101/2021.07.07.451518</dc:identifier>
<dc:title><![CDATA[Anti-tumor efficacy of an MMAE conjugated antibody targeting cell surface TACE/ADAM17-cleaved Amphiregulin in breast cancer]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-07-08</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.07.12.452023v1?rss=1">
<title>
<![CDATA[
The transcription factor Xrp1 orchestrates both reduced translation and cell competition upon defective ribosome assembly or function 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.07.12.452023v1?rss=1</link>
<description><![CDATA[
Ribosomal Protein (Rp) gene haploinsufficiency affects overall translation rate, leads to cell elimination by competition with wild type cells in mosaic tissues, and sometimes leads to accumulation of protein aggregates. The changes in ribosomal subunit levels observed are not sufficient for these effects, which all depend on the AT-hook, bZip domain protein Xrp1. In Rp+/- cells, Xrp1 reduced global translation through PERK-dependent phosphorylation of eIF2. eIF2 phosphorylation was sufficient to reduce translation in, and also enable cell competition of, otherwise wild type cells. Unexpectedly, however, many other defects reducing ribosome biogenesis or function (depletion of TAF1B, eIF2, eIF4G, eIF6, eEF2, eEF11, or eIF5A), also increased eIF2 phosphorylation and enabled cell competition. In all cases this was through the Xrp1 expression that was induced, placing Xrp1 as the downstream instigator of cell competition that also contributed to overall translation deficits. In the absence of Xrp1, translation differences between cells were not themselves sufficient to trigger cell competition. Thus, Xrp1, which is shown here to be a sequence-specific transcription factor, is the master regulator that triggers cell competition and other consequences of multiple ribosomal stresses.
]]></description>
<dc:creator>Kiparaki, M.</dc:creator>
<dc:creator>Khan, C.</dc:creator>
<dc:creator>Folgado Marco, V.</dc:creator>
<dc:creator>Chuen, J.</dc:creator>
<dc:creator>Baker, N. E.</dc:creator>
<dc:date>2021-07-12</dc:date>
<dc:identifier>doi:10.1101/2021.07.12.452023</dc:identifier>
<dc:title><![CDATA[The transcription factor Xrp1 orchestrates both reduced translation and cell competition upon defective ribosome assembly or function]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-07-12</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.07.14.452351v1?rss=1">
<title>
<![CDATA[
Transcriptional regulation of neural stem cell expansion in adult hippocampus 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.07.14.452351v1?rss=1</link>
<description><![CDATA[
Experience governs neurogenesis from radial-glial neural stem cells (RGLs) in the adult hippocampus to support memory. Transcription factors in RGLs integrate physiological signals to dictate self-renewal division mode. Whereas asymmetric RGL divisions drive neurogenesis during favorable conditions, symmetric divisions prevent premature neurogenesis while amplifying RGLs to anticipate future neurogenic demands. The identities of transcription factors regulating RGL symmetric self-renewal, unlike those that regulate RGL asymmetric self-renewal, are not known. Here, we show that the transcription factor Kruppel-like factor 9 (Klf9) is elevated in quiescent RGLs and inducible, deletion of Klf9 promotes RGL activation state. Clonal analysis and longitudinal intravital 2-photon imaging directly demonstrate that Klf9 functions as a brake on RGL symmetric self-renewal. In vivo translational profiling of RGLs lacking Klf9 generated a blueprint of RGL symmetric self-renewal for stem cell community. Together, these observations identify Klf9 as a transcriptional regulator of neural stem cell expansion in the adult hippocampus.
]]></description>
<dc:creator>Guo, N.</dc:creator>
<dc:creator>McDermott, K.</dc:creator>
<dc:creator>Shih, Y.-T.</dc:creator>
<dc:creator>Zanga, H.</dc:creator>
<dc:creator>Ghosh, D.</dc:creator>
<dc:creator>Goncalves, T.</dc:creator>
<dc:creator>Sahay, A.</dc:creator>
<dc:date>2021-07-14</dc:date>
<dc:identifier>doi:10.1101/2021.07.14.452351</dc:identifier>
<dc:title><![CDATA[Transcriptional regulation of neural stem cell expansion in adult hippocampus]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-07-14</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.07.19.452879v1?rss=1">
<title>
<![CDATA[
A dynamic and combinatorial histone code drives malaria parasite asexual and sexual development 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.07.19.452879v1?rss=1</link>
<description><![CDATA[
A  histone code defines system-level crosstalk between histone post-translational modifications (PTMs) to induce specific biological outcomes. Proteome-scale information of co-existing PTM across the entire chromatin landscape of the malaria parasite, Plasmodium falciparum, was lacking. Here, we used advanced quantitative middle-down proteomics to identify combinations of PTMs in both the proliferative, asexual stages and transmissible, sexual gametocyte stages of P. falciparum. We provide an updated, high-resolution compendium of 72 PTMs on H3 and H3.3, of which 30 are novel to the parasite. Co-existing PTMs with unique stage distinction was identified, indicating a dynamic and complex histone code with increased connectivity of novel PTMs seen in gametocytes. Chromatin proteomics of a gametocyte-specific combination, H3R17me2K18acK23ac, identified a SAGA-like effector complex (including the transcription factor AP2-G2) tied to this combination to regulate gene expression in mature gametocytes. Ultimately, this study unveils previously undiscovered histone PTMs and their functional relationship with co-existing partners. These results highlight that investigating chromatin regulation in the parasite using single histone PTM assays might overlook higher order gene regulation for distinct proliferation and differentiation processes.
]]></description>
<dc:creator>von Grüning, H.</dc:creator>
<dc:creator>Coradin, M.</dc:creator>
<dc:creator>Mendoza, M.</dc:creator>
<dc:creator>Reader, J.</dc:creator>
<dc:creator>Sidoli, S.</dc:creator>
<dc:creator>Garcia, B.</dc:creator>
<dc:creator>Birkholtz, L.-M.</dc:creator>
<dc:date>2021-07-20</dc:date>
<dc:identifier>doi:10.1101/2021.07.19.452879</dc:identifier>
<dc:title><![CDATA[A dynamic and combinatorial histone code drives malaria parasite asexual and sexual development]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-07-20</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.07.21.453261v1?rss=1">
<title>
<![CDATA[
Toxoplasma gondii subverts the host ESCRT machinery for parasite uptake of host cytosolic proteins 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.07.21.453261v1?rss=1</link>
<description><![CDATA[
Toxoplasma gondii is a master manipulator capable of effectively siphoning the resources from the host cell for its intracellular subsistence. However, the molecular underpinnings of how the parasite gains resources from its host remain largely unknown. Residing within a non-fusogenic parasitophorous vacuole, the parasite must acquire resources across the limiting membrane of its replicative niche, which is decorated with parasite proteins including those secreted from dense granules. We discovered a role for the Endosomal Sorting Complex Required for Transport (ESCRT) machinery in host cytosolic protein uptake by T. gondii by disrupting host ESCRT function. We identified the transmembrane dense granule protein TgGRA14, which contains motifs homologous to the late domain motifs of HIV-1 Gag, as a candidate for the recruitment of the host ESCRT machinery to the PV membrane. Using an HIV virus-like particle (VLP) release assay, we found that the motif-containing portion of TgGRA14 is sufficient to substitute for HIV Gag late domain to mediate ESCRT-dependent VLP budding. We also show that TgGRA14 is proximal to and interacts with host ESCRT components and other dense granule proteins during infection. Furthermore, analysis of GRA14-deficient parasites revealed a marked reduction in ingestion of a host cytosolic protein compared to WT parasites. Thus, we propose a model in which T. gondii recruits the host ESCRT machinery to the PV where it can interact with TgGRA14 for the internalization of host cytosolic proteins across the PVM. These findings provide new insight into how T. gondii accesses contents of the host cytosol by exploiting a key pathway for vesicular budding and membrane scission.

Author summaryIntracellular pathogens exploit their host to gain the resources necessary to sustain infection; however, precisely how the intracellular parasite Toxoplasma gondii acquires essential nutrients from its host remains poorly understood. Previous work showed that T. gondii is capable of internalizing host derived cytosolic proteins and delivering them to its lysosome-like compartment for degradation. However, the mechanism by which the material is trafficked across the membrane delimiting the replicative vacuole in which the parasite resides remained unclear. Here, we report a role for the parasite effector protein TgGRA14 in the recruitment of the host ESCRT machinery for the uptake of host cytosolic proteins. Important human pathogens have developed strategies for exploiting the host ESCRT machinery for intracellular subsistence. Our study sheds lights on the strategy used by a eukaryotic pathogen in subverting the host ESCRT machinery for the internalization of resources from its host cells.
]]></description>
<dc:creator>Rivera-Cuevas, Y.</dc:creator>
<dc:creator>Mayoral, J.</dc:creator>
<dc:creator>Di Cristina, M.</dc:creator>
<dc:creator>Lawrence, A.-L. E.</dc:creator>
<dc:creator>Olafsson, E. B.</dc:creator>
<dc:creator>Thornhill, D.</dc:creator>
<dc:creator>Waldman, B. S.</dc:creator>
<dc:creator>Ono, A.</dc:creator>
<dc:creator>Sexton, J.</dc:creator>
<dc:creator>Lourido, S.</dc:creator>
<dc:creator>Weiss, L. M.</dc:creator>
<dc:creator>Carruthers, V. B.</dc:creator>
<dc:date>2021-07-21</dc:date>
<dc:identifier>doi:10.1101/2021.07.21.453261</dc:identifier>
<dc:title><![CDATA[Toxoplasma gondii subverts the host ESCRT machinery for parasite uptake of host cytosolic proteins]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-07-21</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.07.21.453277v1?rss=1">
<title>
<![CDATA[
Cytolytic memory CD4+ T cell clonotypes are expanded during Plasmodium falciparum infection 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.07.21.453277v1?rss=1</link>
<description><![CDATA[
Plasmodium falciparum (Pf) malaria causes high rates of morbidity and mortality and lacks a sufficiently effective vaccine. Clinical immunity develops in residents of malaria endemic regions which confers reduced clinical symptoms during infection and protection against severe disease. We hypothesized that understanding the immune mechanisms of clinical immunity could inform vaccine design to improve efficacy. We compared the peripheral blood cellular and humoral immune responses during a mild episode of Pf malaria infection. Participants were classified as either clinically susceptible or clinically protected, based on the number of recurrent clinical infections over an 18-month longitudinal study in a malaria endemic region in Malawi. Susceptible participants had three or more recurrent clinical episodes while clinically immune individuals had one or none. Protected participants exhibited higher plasma immunoglobulin G (IgG) breadth and titers against Pf antigens, and greater antibody (Ab)-dependent Pf opsonization compared to susceptible participants. Using high dimensional mass cytometry (CyTOF), spectral flow cytometry and single-cell transcriptomic analyses, we identified expanded memory CD4+ T cell clones sharing identical T cell receptor clonotypes in the blood of protected participants during malaria infection. These cells express a strong cytolytic T helper 1 effector program with transcripts encoding granzymes (A, B, H, M), granulysin, NKG7 and the Zeb2 master transcriptional regulator of terminally differentiated effector T cells. Memory CD4+ T cells expressing Zeb2+ were CD39hiTIGIThi and expressed multiple chemotactic and checkpoint inhibitory receptors, although the cellular levels of several of these receptors were reduced in protected compared to susceptible individuals. We propose that clonally expanded Zeb2+ cytolytic memory CD4+ Th1 cells could represent essential contributors to clinical immunity against Pf malaria.

One Sentence SummaryA population of cytolytic memory CD4+ T cells is clonally expanded in patients with Plasmodium falciparum malaria and has reduced chemotactic and inhibitory receptor expression in patients with naturally acquired clinical malaria immunity.
]]></description>
<dc:creator>Furtado, R.</dc:creator>
<dc:creator>Delahaye, F.</dc:creator>
<dc:creator>Zhang, J.</dc:creator>
<dc:creator>Sung, J.</dc:creator>
<dc:creator>Karell, P.</dc:creator>
<dc:creator>Kim, R. S.</dc:creator>
<dc:creator>Caillat-Zucman, S.</dc:creator>
<dc:creator>Liang, L.</dc:creator>
<dc:creator>Felgner, P.</dc:creator>
<dc:creator>Bauleni, A.</dc:creator>
<dc:creator>Gama, S.</dc:creator>
<dc:creator>Buchwald, A.</dc:creator>
<dc:creator>Taylor, T.</dc:creator>
<dc:creator>Seydel, K.</dc:creator>
<dc:creator>Laufer, M.</dc:creator>
<dc:creator>Daily, J.</dc:creator>
<dc:creator>Lauvau, G.</dc:creator>
<dc:date>2021-07-23</dc:date>
<dc:identifier>doi:10.1101/2021.07.21.453277</dc:identifier>
<dc:title><![CDATA[Cytolytic memory CD4+ T cell clonotypes are expanded during Plasmodium falciparum infection]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-07-23</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.07.28.453719v1?rss=1">
<title>
<![CDATA[
Uncovering the Bromodomain Interactome using Site-Specific Azide-Acetyllysine Photochemistry, Proteomic Profiling and Structural Characterization 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.07.28.453719v1?rss=1</link>
<description><![CDATA[
Protein-protein interactions mediated by acetyllysines and bromodomains are essential for the regulation of eukaryotic gene expression. Diagramming the bromodomain interactome network and molecular characterization of these interactions are key to unraveling context-dependent signaling pathways. Herein, we employ a chemoproteomic platform, called interaction-based protein profiling (IBPP), to map the acetylome of the bromodomain and extra terminal domain (BET) family of bromodomains. We developed photo-responsive bromodomain analogues to carry out UV light-induced azide-acetyllysine crosslinking within the recognition cavity of the domain to capture transient interacting partners present in human cells. Subsequent proteomic and biochemical analyses lead to the identification of an array of acetylated interacting factors, which extend the potential function of BET family proteins beyond transcription. We present here eight high-resolution crystal structures of interactome-bound bromodomains that underscore the atypical binding modes and sequence motifs by which BET members recognize an expanded repertoire of acetylated proteins. In addition, we report an acetyllysine-dependent interaction between BRD4 and interleukin enhancer binding factor 3 (ILF3) in human cells, and uncover its role in recruiting transcriptional regulators to the promoter of the Survivin gene, an anti-apoptotic factor overexpressed in a wide range of human neoplasia. Collectively, our work provides a blueprint for engineering bromodomains, establishes IBPP as a robust chemoproteomic tool to characterize bromodomain interactome, and reveals distinctive recognition modes by which such associations may take place in order to modulate signaling pathways. Furthermore, these structural snapshots offer clues to design specific small-molecule inhibitors against the novel BET interactions and paves the path for exploring the biological significance of this newly identified signaling network.
]]></description>
<dc:creator>Islam, K.</dc:creator>
<dc:creator>Wagner, S.</dc:creator>
<dc:creator>Ghosh, A.</dc:creator>
<dc:creator>Sudhamalla, B.</dc:creator>
<dc:creator>Jnawali, H. N.</dc:creator>
<dc:creator>Debiec, R.</dc:creator>
<dc:creator>Fedorov, E.</dc:creator>
<dc:date>2021-07-28</dc:date>
<dc:identifier>doi:10.1101/2021.07.28.453719</dc:identifier>
<dc:title><![CDATA[Uncovering the Bromodomain Interactome using Site-Specific Azide-Acetyllysine Photochemistry, Proteomic Profiling and Structural Characterization]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-07-28</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.08.02.454639v1?rss=1">
<title>
<![CDATA[
Targeted in silico characterization of fusion transcripts in tumor and normal tissues via FusionInspector 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.08.02.454639v1?rss=1</link>
<description><![CDATA[
MotivationGene fusions play a key role as driver oncogenes in tumors, and their reliable discovery and detection are important for cancer research, diagnostics, prognostics and guiding personalized therapy. While discovering gene fusions from genome sequencing can be laborious and costly, the resulting "fusion transcripts" can be recovered from RNA-seq data of tumor and normal samples. However, alleged and putative fusion transcripts can also arise from multiple sources other than chromosomal rearrangements, including cis- or trans-splicing events, experimental artifacts during RNA-seq or computational errors of transcriptome reconstruction methods. Understanding how to discern, interpret, categorize, and verify predicted fusion transcripts is essential for consideration in clinical settings and prioritization for further research.

SummaryHere, we present FusionInspector for in silico characterization and interpretation of candidate fusion transcripts from RNA-seq and exploration of their sequence and expression characteristics. We applied FusionInspector to thousands of tumor and normal transcriptomes, and identified statistical and experimental features enriched among biologically impactful fusions. Through clustering and machine learning, we identified large collections of fusions potentially relevant to tumor and normal biological processes. We show that biologically relevant fusions are enriched for relatively high expression of the fusion transcript, imbalanced fusion allelic ratios, and canonical splicing patterns, and are deficient in sequence microhomologies detected between partner genes. We demonstrate that FusionInspector accurately validates fusion transcripts in silico, and helps identify and characterize numerous understudied fusions in tumor and normal tissues samples. FusionInspector is freely available as open source for screening, characterization, and visualization of candidate fusions via RNA-seq, and helps with transparent explanation and interpretation of machine learning predictions and their experimental sources.

HighlightsO_LIFusionInspector software for supervised analysis of candidate fusion transcripts
C_LIO_LIClustering of recurrent fusion transcripts resolves biologically relevant fusions
C_LIO_LIIdentification of distinguishing characteristics of known and novel fusion transcripts in tumor and normal tissues
C_LI
]]></description>
<dc:creator>Haas, B.</dc:creator>
<dc:creator>Dobin, A.</dc:creator>
<dc:creator>Ghandi, M.</dc:creator>
<dc:creator>Van Arsdale, A.</dc:creator>
<dc:creator>Tickle, T. L.</dc:creator>
<dc:creator>Robinson, J. T.</dc:creator>
<dc:creator>Gilliani, R.</dc:creator>
<dc:creator>Kasif, S.</dc:creator>
<dc:creator>Regev, A.</dc:creator>
<dc:date>2021-08-04</dc:date>
<dc:identifier>doi:10.1101/2021.08.02.454639</dc:identifier>
<dc:title><![CDATA[Targeted in silico characterization of fusion transcripts in tumor and normal tissues via FusionInspector]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-08-04</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.08.02.454853v1?rss=1">
<title>
<![CDATA[
Isolation and characterization of human monoclonal antibodies to pneumococcal capsular polysaccharide 3 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.08.02.454853v1?rss=1</link>
<description><![CDATA[
The current pneumococcal capsular polysaccharide (PPS) conjugate vaccine (PCV13) is less effective against Streptococcus pneumoniae serotype 3 (ST3), which remains a major cause of pneumococcal disease and mortality. Therefore, dissecting structure-function relationships of human PPS3 antibodies may reveal characteristics of protective antibodies. Using flow cytometry, we isolated PPS3-binding memory B cells from pneumococcal vaccine recipients and generated seven human PPS3-specific monoclonal antibodies (humAbs). Five humAbs displayed ST3 opsonophagocytic activity, four induced ST3 agglutination in vitro, and four mediated both activities. For two humAbs, C10 and C27, that used the same variable heavy (VH) and light (VL) chain domains (VH3-9*01/VL2-14*03), C10 had fewer VL somatic mutations, higher PPS3 affinity, more ST3 opsonophagocytic and agglutinating activity, whilst both humAbs altered ST3 gene expression in vitro. After VL swaps, C10VH/C27VL exhibited reduced ST3 binding and agglutination, but C27VH/C10VL binding was unchanged. In C57Bl/6 mice, C10 and C27 reduced nasopharyngeal colonization with ST3 A66 and a clinical strain, B2, and prolonged survival following lethal A66 intraperitoneal infection, but only C10 protected against lethal intranasal infection with the clinical strain. Our findings, associate efficacy of PPS3-specific humAbs with ST3 agglutination and opsonophagocytic activity and reveal an unexpected role for the VL in functional activity in vitro and in vivo. These findings also provide insights that may inform antibody-based therapy and identification of surrogates of vaccine efficacy against ST3.

IMPORTANCEDespite the global success of pneumococcal conjugate vaccination, serotype 3 (ST3) pneumococcus remains a leading cause of morbidity and mortality. In comparison to other vaccine-included serotypes, the ST3 pneumococcal capsular polysaccharide (PPS3) induces a weaker opsonophagocytic response, which is considered a correlate of vaccine efficacy. Previous studies of mouse PPS3 monoclonal antibodies identified ST3 agglutination as a correlate of reduced ST3 nasopharyngeal colonization in mice, however neither the agglutinating ability of human vaccine-elicited PPS3 antibodies nor their ability to prevent experimental murine nasopharyngeal colonization has been studied. We generated and analysed the functional and in vivo efficacy of human vaccine-elicited PPS3 monoclonal antibodies and found that ST3 agglutination associated with antibody affinity, protection in vivo, and limited somatic mutations in the light chain variable region. These findings provide new insights that may inform the development of antibody-based therapies and next generation vaccines for ST3.
]]></description>
<dc:creator>Babb, R.</dc:creator>
<dc:creator>Doyle, C. R.</dc:creator>
<dc:creator>Pirofski, L.-a.</dc:creator>
<dc:date>2021-08-03</dc:date>
<dc:identifier>doi:10.1101/2021.08.02.454853</dc:identifier>
<dc:title><![CDATA[Isolation and characterization of human monoclonal antibodies to pneumococcal capsular polysaccharide 3]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-08-03</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.08.03.454947v1?rss=1">
<title>
<![CDATA[
Cytoplasmic labile iron accumulates in aging stem cells perturbing a key rheostat for identity control 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.08.03.454947v1?rss=1</link>
<description><![CDATA[
Bone marrow resident and rarely dividing haematopoietic stem cells (HSC) harbour an extensive self-renewal capacity to sustain life-long blood formation;1-5 albeit their function declines during ageing.6, 7 Various molecular mechanisms confer stem cell identity, ensure long-term maintenance and are known to be deregulated in aged stem cells.8, 9 How these programs are coordinated, particularly during cell division, and what triggers their ageing-associated dysfunction has been unknown. Here, we demonstrate that HSC, containing the lowest amount of cytoplasmic chelatable iron (labile iron pool)10 among hematopoietic cells, activate a limited iron response during mitosis. Engagement of this iron homeostasis pathway elicits mobilization and {beta}-oxidation of arachidonic acid and enhances stem cell-defining transcriptional programs governed by histone acetyl transferase Tip60/KAT5. We further find an age-associated expansion of the labile iron pool, along with loss of Tip60/KAT5-dependent gene regulation to contribute to the functional decline of ageing HSC, which can be mitigated by iron chelation. Together, our work reveals cytoplasmic redox active iron as a novel rheostat in adult stem cells; it demonstrates a role for the intracellular labile iron pool in coordinating a cascade of molecular events which reinforces HSC identity during cell division and to drive stem cell ageing when perturbed. As loss of iron homeostasis is commonly observed in the elderly, we anticipate these findings to trigger further studies into understanding and therapeutic mitigation of labile iron pool-dependent stem cell dysfunction in a wide range of degenerative and malignant pathologies.
]]></description>
<dc:creator>Kao, Y.-R.</dc:creator>
<dc:creator>Chen, J.</dc:creator>
<dc:creator>Kumari, R.</dc:creator>
<dc:creator>Tatiparthy, M.</dc:creator>
<dc:creator>Ma, Y.</dc:creator>
<dc:creator>Aivalioti, M.</dc:creator>
<dc:creator>Zintiridou, A.</dc:creator>
<dc:creator>Thiruthuvanathan, V.</dc:creator>
<dc:creator>Reisz, J.</dc:creator>
<dc:creator>Stransky, S.</dc:creator>
<dc:creator>Sidoli, S.</dc:creator>
<dc:creator>Steidl, U.</dc:creator>
<dc:creator>D'Alessandro, A.</dc:creator>
<dc:creator>Will, B.</dc:creator>
<dc:date>2021-08-05</dc:date>
<dc:identifier>doi:10.1101/2021.08.03.454947</dc:identifier>
<dc:title><![CDATA[Cytoplasmic labile iron accumulates in aging stem cells perturbing a key rheostat for identity control]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-08-05</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.08.07.455522v1?rss=1">
<title>
<![CDATA[
Adrenergic Attenuation of Immune Activity is Associated with Anhedonia in Adolescents 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.08.07.455522v1?rss=1</link>
<description><![CDATA[
While inflammation has been implicated in psychopathology, relationships between immune-suppressing processes and psychiatric constructs remain elusive. This study sought to assess whether {beta}2-agonist clenbuterol (CBL) would attenuate immune activation in adolescents with mood and anxiety symptoms following ex vivo exposure of whole blood to lipopolysaccharide (LPS). Our focus on adolescents aimed to target a critical developmental period when psychiatric conditions often emerge and prior to chronicity effects. To capture a diverse range of immunologic and symptomatologic phenotypes, we included 97 psychotropic-medication free adolescents with mood and anxiety symptoms and 33 healthy controls. All participants had comprehensive evaluations and dimensional assessments of psychiatric symptoms. Fasting whole-blood samples were collected and stimulated with LPS in the presence and absence of CBL for 6 hours, then analyzed for 41 cytokines, chemokines, and hematopoietic growth factors. Comparison analyses used Bonferroni-corrected nonparametric tests. Levels of nine immune biomarkers--including IL-1RA, IL-1{beta}, IL-6, IP-10, MCP-1, MIP-1, MIP-1{beta}, TGF-, and TNF---were significantly reduced by CBL treatment compared to LPS alone. Exploratory factor analysis reduced 41 analytes into 5 immune factors in each experimental condition, and their relationships with psychiatric symptoms were examined as a secondary aim. CBL+LPS Factor 4--comprising EGF, PDGF-AA, PDGF-AB/BB, sCD40L, and GRO--significantly correlated with anticipatory and consummatory anhedonia, even after controlling for depression severity. This study supports the possible inhibitory effect of CBL on immune activation. Using a data-driven method, distinctive relationships between CBL-affected immune biomarkers and dimensional anhedonia were reported, further elucidating the role of {beta}2-agonism in adolescent affective symptomatology.
]]></description>
<dc:creator>Nguyen, T. N. B.</dc:creator>
<dc:creator>Ely, B. A.</dc:creator>
<dc:creator>Kim-Schulze, S.</dc:creator>
<dc:creator>Gabbay, V.</dc:creator>
<dc:date>2021-08-09</dc:date>
<dc:identifier>doi:10.1101/2021.08.07.455522</dc:identifier>
<dc:title><![CDATA[Adrenergic Attenuation of Immune Activity is Associated with Anhedonia in Adolescents]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-08-09</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.08.10.455684v1?rss=1">
<title>
<![CDATA[
Cleavage of histone H2A during embryonic stem cell differentiation destabilizes nucleosomes to counteract gene activation 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.08.10.455684v1?rss=1</link>
<description><![CDATA[
Histone proteolysis is a poorly understood phenomenon in which the N-terminal tails of histones are irreversibly cleaved by intracellular proteases. During development, histone post-translational modifications are known to orchestrate gene expression patterns that ultimately drive cell fate decisions. Therefore, deciphering the mechanisms of histone proteolysis is necessary to enhance the understanding of cellular differentiation. Here we show that H2A is cleaved by the lysosomal protease Cathepsin L during ESCs differentiation. Using quantitative mass spectrometry (MS), we identified L23 to be the primary cleavage site that gives rise to the clipped form of H2A (cH2A), which reaches a maximum level of ~1% of total H2A after four days of differentiation. Using ChIP-seq, we found that preventing proteolysis leads to an increase in acetylated H2A at promoter regions in differentiated ES cells. We also identified novel readers of different acetylated forms of H2A in pluripotent ES cells, such as members of the PBAF remodeling complex. Finally, we showed that H2A proteolysis abolishes this recognition. Altogether, our data suggests that proteolysis serves as an efficient mechanism to silence pluripotency genes and destabilize the nucleosome core particle.
]]></description>
<dc:creator>Coradin, M.</dc:creator>
<dc:creator>Cesare, J.</dc:creator>
<dc:creator>Lan, Y.</dc:creator>
<dc:creator>Zhu, Z.</dc:creator>
<dc:creator>Lund, P. J.</dc:creator>
<dc:creator>Sidoli, S.</dc:creator>
<dc:creator>Kori, Y.</dc:creator>
<dc:creator>Lu, C.</dc:creator>
<dc:creator>Porter, E. G.</dc:creator>
<dc:creator>Robert, C. W. M.</dc:creator>
<dc:creator>Garcia, B. A.</dc:creator>
<dc:date>2021-08-10</dc:date>
<dc:identifier>doi:10.1101/2021.08.10.455684</dc:identifier>
<dc:title><![CDATA[Cleavage of histone H2A during embryonic stem cell differentiation destabilizes nucleosomes to counteract gene activation]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-08-10</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.08.17.456680v1?rss=1">
<title>
<![CDATA[
Arf6 anchors Cdr2 nodes at the cell cortex to control cell size at division 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.08.17.456680v1?rss=1</link>
<description><![CDATA[
Fission yeast cells prevent mitotic entry until a threshold cell surface area is reached. The protein kinase Cdr2 contributes to this size control system by forming multiprotein nodes that inhibit Wee1 at the medial cell cortex. Cdr2 node anchoring at the cell cortex is not fully understood. Through a genomic screen, we identified the conserved GTPase Arf6 as a component of Cdr2 signaling. Cells lacking Arf6 failed to divide at a threshold surface area and instead shifted to volume-based divisions at increased overall size. Arf6 stably localized to Cdr2 nodes in its GTP-bound but not GDP-bound state, and its GEF (guanine nucleotide exchange factor) Syt22 was required for both Arf6 node localization and proper size at division. In arf6{Delta} mutants, Cdr2 nodes detached from the membrane and exhibited increased dynamics. These defects were enhanced when arf6{Delta} was combined with other node mutants. Our work identifies a regulated anchor for Cdr2 nodes that is required for cells to sense surface area.
]]></description>
<dc:creator>Opalko, H. E.</dc:creator>
<dc:creator>Miller, K. E.</dc:creator>
<dc:creator>Kim, H.-S.</dc:creator>
<dc:creator>Vargas-Garcia, C. A.</dc:creator>
<dc:creator>Singh, A.</dc:creator>
<dc:creator>Keogh, M.-C.</dc:creator>
<dc:creator>Moseley, J. B.</dc:creator>
<dc:date>2021-08-17</dc:date>
<dc:identifier>doi:10.1101/2021.08.17.456680</dc:identifier>
<dc:title><![CDATA[Arf6 anchors Cdr2 nodes at the cell cortex to control cell size at division]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-08-17</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.08.19.457035v1?rss=1">
<title>
<![CDATA[
Modeling Neural Variability in Deep Networks with Dropout 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.08.19.457035v1?rss=1</link>
<description><![CDATA[
Computational neuroscience studies have shown that the structure of neural variability to an unchanged stimulus affects the amount of information encoded. Some artificial deep neural networks, e.g. those with Monte Carlo dropout layers, also have variable responses when the input is fixed. However, the structure of the trial-by-trial neural co-variance in neural networks with dropout has not been studied and its role in decoding accuracy is unknown. We studied the above questions in a convolutional neural network model with dropout in both the training and testing phase. We found that trial-by-trial correlation between neurons, i.e. noise correlation, is positive and low-dimensional. Neurons that are close in a feature map have larger noise correlation. These properties are surprisingly similar to the findings in the visual cortex. We further analyzed the alignment of the main axes of the covariance matrix. We found that different images share a common trial-by-trial noise covariance subspace, and they are aligned with the global signal covariance. The above evidence that the noise covariance is aligned with signal covariance suggests that noise covariance in dropout neural networks reduces network accuracy, which we further verified directly with a trial-shuffling procedure commonly used in neuroscience. These findings highlight a previously overlooked as-pect of dropout layers that can affect network performance. Such dropout networks could also potentially be a computational model of neural variability.
]]></description>
<dc:creator>Pan, X.</dc:creator>
<dc:creator>Coen-Cagli, R.</dc:creator>
<dc:creator>Schwartz, O.</dc:creator>
<dc:date>2021-08-19</dc:date>
<dc:identifier>doi:10.1101/2021.08.19.457035</dc:identifier>
<dc:title><![CDATA[Modeling Neural Variability in Deep Networks with Dropout]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-08-19</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.08.20.457069v1?rss=1">
<title>
<![CDATA[
Type I PRMTs and PRMT5 Inversely Regulate Post-Transcriptional Intron Detention 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.08.20.457069v1?rss=1</link>
<description><![CDATA[
Protein arginine methyltransferases (PRMTs) are required for the regulation of RNA processing factors. Type I enzymes catalyze mono- and asymmetric dimethylation; Type II enzymes catalyze mono- and symmetric dimethylation. To understand the specific mechanisms of PRMT activity in splicing regulation, we inhibited Type I and II PRMTs and probed their transcriptomic consequences. Using the newly developed SKaTER-seq method, analysis of co-transcriptional splicing revealed that PRMT inhibition resulted in slower splicing rates. Surprisingly, altered co-transcriptional splicing kinetics correlated poorly with ultimate changes in alternative splicing of polyadenylated RNA--particularly intron retention (RI). Investigation of RI following inhibition of nascent transcription demonstrated that PRMTs inversely regulate RI post-transcriptionally. Subsequent proteomic analysis of chromatin-associated polyadenylated RNA identified aberrant binding of the Type I substrate, CHTOP, and the Type II substrate, SmB. Targeted mutagenesis of all methylarginine sites in SmD3, SmB, and SmD1 recapitulated splicing changes seen with Type II PRMT inhibition. Conversely, mutagenesis of all methylarginine sites in CHTOP recapitulated the splicing changes seen with Type I PRMT inhibition. Closer examination of subcellular fractions indicated that RI were isolated to the nucleoplasm and chromatin. Together, these data demonstrate that PRMTs regulate the post-transcriptional processing of nuclear, detained introns through Sm and CHTOP arginine methylation.
]]></description>
<dc:creator>Maron, M. I.</dc:creator>
<dc:creator>Casill, A. D.</dc:creator>
<dc:creator>Gupta, V.</dc:creator>
<dc:creator>Sidoli, S.</dc:creator>
<dc:creator>Query, C. C.</dc:creator>
<dc:creator>Gamble, M. J.</dc:creator>
<dc:creator>Shechter, D.</dc:creator>
<dc:date>2021-08-20</dc:date>
<dc:identifier>doi:10.1101/2021.08.20.457069</dc:identifier>
<dc:title><![CDATA[Type I PRMTs and PRMT5 Inversely Regulate Post-Transcriptional Intron Detention]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-08-20</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.08.22.457235v1?rss=1">
<title>
<![CDATA[
Genotype-specific Features Reduce the Susceptibility of South American Yellow Fever Virus Strains to Vaccine-Induced Antibodies 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.08.22.457235v1?rss=1</link>
<description><![CDATA[
The resurgence of yellow fever in South America has prompted mitigation through vaccination against the etiologic agent, yellow fever virus (YFV). Current vaccines are based on a virulent African isolate, and their capacity to induce neutralizing antibodies against the vaccine strain is widely used as a surrogate for protection. However, the sensitivity of genetically distinct South American strains to vaccine-induced antibodies is unknown. Here, we show that antiviral potency of the polyclonal antibody response in both U.S. and Brazilian vaccinees is attenuated against an emergent Brazilian strain. This reduction was attributable to genetic changes at two sites in the central domain II of the glycoprotein E, including the acquisition of an N-linked glycosylation site, which are unique to and shared among most South American YFV strains. Our findings call for a reevaluation of current approaches to YFV immunological surveillance in South America and suggest approaches for designing updated vaccines.
]]></description>
<dc:creator>Haslwanter, D.</dc:creator>
<dc:creator>Lasso, G.</dc:creator>
<dc:creator>Wec, A. Z.</dc:creator>
<dc:creator>Furtado, N. D.</dc:creator>
<dc:creator>Raphael, L. M. S.</dc:creator>
<dc:creator>Sun, Y.</dc:creator>
<dc:creator>Stransky, S.</dc:creator>
<dc:creator>Pedreno-Lopez, N.</dc:creator>
<dc:creator>Tse, A.</dc:creator>
<dc:creator>Correia, C. A.</dc:creator>
<dc:creator>Bornholdt, Z. A.</dc:creator>
<dc:creator>Sakharkar, M.</dc:creator>
<dc:creator>Avelino-Silva, V. I.</dc:creator>
<dc:creator>Moyer, C. L.</dc:creator>
<dc:creator>Watkins, D. I.</dc:creator>
<dc:creator>Kallas, E. G.</dc:creator>
<dc:creator>Sidoli, S.</dc:creator>
<dc:creator>Walker, L. M.</dc:creator>
<dc:creator>Bonaldo, M. C.</dc:creator>
<dc:creator>Chandran, K.</dc:creator>
<dc:date>2021-08-22</dc:date>
<dc:identifier>doi:10.1101/2021.08.22.457235</dc:identifier>
<dc:title><![CDATA[Genotype-specific Features Reduce the Susceptibility of South American Yellow Fever Virus Strains to Vaccine-Induced Antibodies]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-08-22</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.08.24.457582v1?rss=1">
<title>
<![CDATA[
JAK2V617F mutant megakaryocytes contribute to hematopoietic aging in a murine model of myeloproliferative neoplasm 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.08.24.457582v1?rss=1</link>
<description><![CDATA[
Megakaryocytes (MKs) is an important component of the hematopoietic niche. Abnormal MK hyperplasia is a hallmark feature of myeloproliferative neoplasms (MPNs). The JAK2V617F mutation is present in hematopoietic cells in a majority of patients with MPNs. Using a murine model of MPN in which the human JAK2V617F gene is expressed specifically in the MK lineage, we show that the JAK2V617F-bearing MKs promote hematopoietic stem cell (HSC) aging, manifesting as myeloid-skewed hematopoiesis with an expansion of CD41+ HSCs, a reduced engraftment and self-renewal capacity, and a reduced differentiation capacity. HSCs from 2yr old mice with JAK2V617F-bearing MKs were more proliferative and less quiescent than HSCs from age-matched control mice. Examination of the marrow hematopoietic niche reveals that the JAK2V617F-bearing MKs not only have decreased direct interactions with hematopoietic stem/progenitor cells during aging, but also suppress the vascular niche function during aging. Unbiased RNA expression profiling reveals that HSC aging has a profound effect on MK transcriptomic profiles, while targeted cytokine array shows that the JAK2V617F-bearing MKs can alter the hematopoietic niche through increased levels of pro-inflammatory and anti-angiogenic factors. Therefore, as a hematopoietic niche cell, MKs represent an important connection between the extrinsic and intrinsic mechanisms for HSC aging.

Significance StatementThe relative contribution of intrinsic and extrinsic mechanisms to HSC aging remains debated. We find that JAK2V617F mutant MKs can accelerate hematopoietic aging both directly (via decreased MK-HSC interaction) and indirectly (via suppressing vascular niche function). We also show that HSC aging has a profound effect on MK function. Our data suggest that, as a hematopoietic niche cell, MKs represent an important connection between HSC-intrinsic and HSC-extrinsic aging mechanisms.
]]></description>
<dc:creator>Lee, S.</dc:creator>
<dc:creator>Wong, H.</dc:creator>
<dc:creator>Castiglione, M.</dc:creator>
<dc:creator>Murphy, M.</dc:creator>
<dc:creator>Kaushansky, K.</dc:creator>
<dc:creator>Zhan, H.</dc:creator>
<dc:date>2021-08-27</dc:date>
<dc:identifier>doi:10.1101/2021.08.24.457582</dc:identifier>
<dc:title><![CDATA[JAK2V617F mutant megakaryocytes contribute to hematopoietic aging in a murine model of myeloproliferative neoplasm]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-08-27</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.08.24.457589v1?rss=1">
<title>
<![CDATA[
Cell competition between wild-type and JAK2V617F mutant cells prevents disease relapse after stem cell transplantation in a murine model of myeloproliferative neoplasm 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.08.24.457589v1?rss=1</link>
<description><![CDATA[
Disease relapse after allogeneic stem cell transplantation is a major cause of treatment-related morbidity and mortality in patients with myeloproliferative neoplasms (MPNs). The cellular and molecular mechanisms for MPN relapse are not well understood. Here, we established a murine model of MPN relapse, in which [~]60% of the MPN recipient mice develop disease relapse after receiving stem cell transplantation with wild-type marrow donor. Using this model, we find that impaired wild-type cell function is associated with MPN disease relapse. We also show that competition between wild-type and JAK2V617F mutant cells can modulate the immune cell composition and PD-L1 expression induced by the JAK2V617F oncogene. These results suggest that cell competition between wild-type donor cells and JAK2V617F mutant recipient cells can prevent MPN disease relapse after stem cell transplantation.
]]></description>
<dc:creator>Zhang, H.</dc:creator>
<dc:creator>Castiglione, M.</dc:creator>
<dc:creator>Zheng, L.</dc:creator>
<dc:creator>Zhan, H.</dc:creator>
<dc:date>2021-08-26</dc:date>
<dc:identifier>doi:10.1101/2021.08.24.457589</dc:identifier>
<dc:title><![CDATA[Cell competition between wild-type and JAK2V617F mutant cells prevents disease relapse after stem cell transplantation in a murine model of myeloproliferative neoplasm]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-08-26</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.08.30.458230v1?rss=1">
<title>
<![CDATA[
Disentangling the flow of signals between populations of neurons 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.08.30.458230v1?rss=1</link>
<description><![CDATA[
Technological advances now allow us to record from large populations of neurons across multiple brain areas. These recordings may illuminate how communication between areas contributes to brain function, yet a substantial barrier remains: How do we disentangle the concurrent, bidirectional flow of signals between populations of neurons? We therefore propose here a novel dimensionality reduction framework: Delayed Latents Across Groups (DLAG). DLAG disentangles signals relayed in each direction, identifies how these signals are represented by each population, and characterizes how they evolve within and across trials. We demonstrate that DLAG performs well on synthetic datasets similar in scale to current neurophysiological recordings. Then we study simultaneously recorded populations in primate visual areas V1 and V2, where DLAG reveals signatures of bidirectional yet selective communication. Our framework lays a foundation for dissecting the intricate flow of signals across populations of neurons, and how this signaling contributes to cortical computation.
]]></description>
<dc:creator>Gokcen, E.</dc:creator>
<dc:creator>Jasper, A. I.</dc:creator>
<dc:creator>Semedo, J. D.</dc:creator>
<dc:creator>Zandvakili, A.</dc:creator>
<dc:creator>Kohn, A.</dc:creator>
<dc:creator>Machens, C. K.</dc:creator>
<dc:creator>Yu, B. M.</dc:creator>
<dc:date>2021-09-01</dc:date>
<dc:identifier>doi:10.1101/2021.08.30.458230</dc:identifier>
<dc:title><![CDATA[Disentangling the flow of signals between populations of neurons]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-09-01</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.08.31.458429v1?rss=1">
<title>
<![CDATA[
Multi-omic profiling of histone variant H3.3 lysine 27 methylation reveals a distinct role from canonical H3 in stem cell differentiation 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.08.31.458429v1?rss=1</link>
<description><![CDATA[
Histone variants, such as histone H3.3, replace canonical histones within the nucleosome to alter chromatin accessibility and gene expression. Although the biological roles of selected histone post-translational modifications (PTMs) have been extensively characterized, the potential differences in the function of a given PTM on different histone variants is almost always elusive. By applying proteomics and genomics techniques, we investigate the role of lysine 27 tri-methylation specifically on the histone variant H3.3 (H3.3K27me3) in the context of mouse embryonic stem cell pluripotency and differentiation as a model system for development. We demonstrate that while the steady state overall levels of methylation on both H3K27 and H3.3K27 decrease during differentiation, methylation dynamics studies indicate that methylation on H3.3K27 is maintained more than on H3K27. Using a custom-made antibody, we identify a unique enrichment of H3.3K27me3 at lineage-specific genes, such as olfactory receptor genes, and at binding motifs for the transcription factors FOXJ2/3. REST, a predicted FOXJ2/3 target that acts as a transcriptional repressor of terminal neuronal genes, was identified with H3.3K27me3 at its promoter region. H3.3K27A mutant cells confirmed an upregulation of FOXJ2/3 targets upon the loss of methylation at H3.3K27. Thus, while canonical H3K27me3 has been characterized to regulate the expression of transcription factors that play a general role in differentiation, our work suggests H3.3K27me3 is essential for regulating distinct terminal differentiation genes. This work highlights the importance of understanding the effects of PTMs not only on canonical histones but also on specific histone variants, as they may exhibit distinct roles.
]]></description>
<dc:creator>Kori, Y.</dc:creator>
<dc:creator>Lund, P. J.</dc:creator>
<dc:creator>Trovato, M.</dc:creator>
<dc:creator>Sidoli, S.</dc:creator>
<dc:creator>Yuan, Z.-F.</dc:creator>
<dc:creator>Noh, K.-M.</dc:creator>
<dc:creator>Garcia, B. A.</dc:creator>
<dc:date>2021-09-02</dc:date>
<dc:identifier>doi:10.1101/2021.08.31.458429</dc:identifier>
<dc:title><![CDATA[Multi-omic profiling of histone variant H3.3 lysine 27 methylation reveals a distinct role from canonical H3 in stem cell differentiation]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-09-02</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.09.03.458092v1?rss=1">
<title>
<![CDATA[
Silencing of hippocampal synaptic transmission impairs spatial reward search on a head-fixed tactile treadmill task 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.09.03.458092v1?rss=1</link>
<description><![CDATA[
Head-fixed linear treadmill tasks have been used to study hippocampal physiology in mice. Although some hippocampal neurons establish place fields along linear treadmills, it is not clear if the hippocampus is required for spatial memory on this task. Using a Designer Receptors Exclusively Activated by Designer Drugs (DREADDs) approach, we found that silencing hippocampal output on rewarded treadmill tasks impaired search for rewards signaled by spatial cues but did not impair search for rewards signaled by local cues, recapitulating findings from other behavior tasks. These findings serve to contextualize data on hippocampal physiology from mice performing this task.
]]></description>
<dc:creator>Jordan, J. T.</dc:creator>
<dc:creator>Goncalves, J. T.</dc:creator>
<dc:date>2021-09-05</dc:date>
<dc:identifier>doi:10.1101/2021.09.03.458092</dc:identifier>
<dc:title><![CDATA[Silencing of hippocampal synaptic transmission impairs spatial reward search on a head-fixed tactile treadmill task]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-09-05</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.09.03.458915v1?rss=1">
<title>
<![CDATA[
Reovirus sensitizes microsatellite stable colorectal cancer to anti-PD-1 treatment via cross-talk in innate and adaptive immune systems 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.09.03.458915v1?rss=1</link>
<description><![CDATA[
BackgroundMicrosatellite stable (MSS) colorectal cancer (CRC) represents ~85% of all CRCs. These tumors are poorly immunogenic and largely resistant to immunotherapy, necessitating a need to develop new immune enhancing strategies. Oncolytic reovirus has a high propensity to replicate in KRAS mutant tumors which account for ~50% of MSS CRCs. Current study explores the ability of reovirus to potentiate the effect of immune checkpoint inhibition in MSS CRC.

MethodsEffectiveness of reovirus infection was quantified through MTT assay for cell viability, and expression of immune-response genes by flow cytometry, RT-qPCR, and microarray. Computational analysis of differentially expressed genes was performed by TAC, DAVID and STRING. Combinatorial approach using anti-PD-1 monoclonal antibody was assessed in ex vivo and in vivo models. Live-cell imaging, tumor volume and survival were measured for quantification of anti-tumor activity. Expression of pattern recognition receptors (PRRs), cell surface and activation markers of immune cells, and PD-1/PD-L1 axis were studied using multi-color flow cytometry, immunoblotting, immunohistochemistry, and immunofluorescence.

ResultsReovirus infection exerted growth arrest and expression of immune-response genes in CRCs cell lines in a KRAS-dependent manner. However, microsatellite instability, rather than KRAS status determined immune-repose pathways, functionalities and biological processes post-reovirus infection. Furthermore, reovirus significantly enhanced the anti-tumor activity of anti-human PD-1 [nivolumab] treatment in MSS CRC cell lines ex vivo. Similarly, reovirus increased the activity of anti-mouse PD-1 treatment in the CT26 [MSS, KRASMut], but not the MC38 [MSI, KRASWt] syngeneic mouse model of CRC. Combinatorial treatment has reduced the proliferative index, increased apoptosis and differentially altered PD-L1/PD-1 signaling among CT26 and MC38 tumors. Activation of innate immune system and expression of PRRs and antigen presentation markers were observed under reovirus and anti-PD-1 treatment that additionally reduced immunosuppressive macrophages. This led to an increase in T cell subsets, increase in effector T cell activation, and decrease in exhaustion markers specifically within CT26 microenvironment.

ConclusionThe current study systematically evaluates immune characteristics and immune microenvironment of CRC under reovirus/anti-PD-1 combination treatment that proves increased effectiveness among MSS compared to MSI CRCs. This is a promising regimen warranting translation into clinical trials.

One Sentence SummaryOncolytic reovirus alters innate and adaptive immune system and potentiates MSS type colorectal cancer to checkpoint inhibition therapy.
]]></description>
<dc:creator>Augustine, T.</dc:creator>
<dc:creator>John, P.</dc:creator>
<dc:creator>Friedman, T.</dc:creator>
<dc:creator>Jiffry, J.</dc:creator>
<dc:creator>Guzik, H.</dc:creator>
<dc:creator>Mannan, R.</dc:creator>
<dc:creator>Gupta, R.</dc:creator>
<dc:creator>Delano, C.</dc:creator>
<dc:creator>Mariadason, J.</dc:creator>
<dc:creator>Zang, X.</dc:creator>
<dc:creator>Maitra, R.</dc:creator>
<dc:creator>Goel, S.</dc:creator>
<dc:date>2021-09-04</dc:date>
<dc:identifier>doi:10.1101/2021.09.03.458915</dc:identifier>
<dc:title><![CDATA[Reovirus sensitizes microsatellite stable colorectal cancer to anti-PD-1 treatment via cross-talk in innate and adaptive immune systems]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-09-04</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.09.14.460352v1?rss=1">
<title>
<![CDATA[
Stabilization of spine Synaptopodin by mGluR1 is required for mGluR-LTD 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.09.14.460352v1?rss=1</link>
<description><![CDATA[
Dendritic spines, actin-rich protrusions forming the postsynaptic sites of excitatory synapses, undergo activity-dependent molecular and structural remodeling. Activation of group 1 metabotropic glutamate receptors - mGluR1 and mGluR5 - by synaptic or pharmacological stimulation, induces LTD but whether this is accompanied with spine elimination remains unresolved. A subset of telencephalic mushroom spines contains the spine apparatus (SA), an enigmatic organelle composed of stacks of smooth endoplasmic reticulum, whose formation depends on the expression of the actin-bundling protein Synaptopodin. Allocation of Synaptopodin to spines appears governed by cell-intrinsic mechanisms as the relative frequency of spines harboring Synaptopodin is conserved in vivo and in vitro. Here we show that expression of Synaptopodin/SA in spines is required for induction of mGluR-LTD at Schaffer collateral-CA1 synapses. Post-mGluR-LTD, mushroom spines lacking Synaptopodin/SA are selectively lost whereas spines harboring it are preserved, a process dependent on activation of mGluR1 but not mGluR5. Mechanistically, we find that mGluR1 supports physical retention of Synaptopodin within excitatory spine synapses during LTD while triggering lysosome-dependent degradation of the protein residing in dendritic shafts. Together, these results reveal a cellular mechanism, dependent on mGluR1, which enables selective preservation of stronger spines containing Synaptopodin/SA while eliminating weaker ones and potentially countering spurious strengthening by de novo recruitment of Synaptopodin. Overall our results identify spines with Synaptopodin/SA as the locus of mGluR-LTD and underscore the importance of the molecular microanatomy of spines in synaptic plasticity.
]]></description>
<dc:creator>Speranza, L.</dc:creator>
<dc:creator>Inglebert, Y.</dc:creator>
<dc:creator>De Sanctis, C.</dc:creator>
<dc:creator>Wu, P. Y.</dc:creator>
<dc:creator>Kalinowska, M.</dc:creator>
<dc:creator>McKinney, R. A.</dc:creator>
<dc:creator>Francesconi, A.</dc:creator>
<dc:date>2021-09-17</dc:date>
<dc:identifier>doi:10.1101/2021.09.14.460352</dc:identifier>
<dc:title><![CDATA[Stabilization of spine Synaptopodin by mGluR1 is required for mGluR-LTD]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-09-17</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.09.22.461415v1?rss=1">
<title>
<![CDATA[
Peptide fusion improves prime editing efficiency 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.09.22.461415v1?rss=1</link>
<description><![CDATA[
Prime editing enables search-and-replace genome editing but is limited by low editing efficiency. We present a high-throughput approach, PepSEq, to measure how fusion of 12,000 85-amino acid peptides derived from human DNA repair-related proteins influences prime editing efficiency. We show that peptide fusion can enhance prime editing, prime-enhancing peptides combine productively, and a top dual peptide-prime editor increases prime editing significantly in multiple cell lines across dozens of target sites.
]]></description>
<dc:creator>Velimirovic, M.</dc:creator>
<dc:creator>Zanetti, L.</dc:creator>
<dc:creator>Shen, M. W.</dc:creator>
<dc:creator>Fife, J. D.</dc:creator>
<dc:creator>Lin, L.</dc:creator>
<dc:creator>Cha, M.</dc:creator>
<dc:creator>Akinci, E.</dc:creator>
<dc:creator>Barnum, D.</dc:creator>
<dc:creator>Yu, T.</dc:creator>
<dc:creator>Sherwood, R. I.</dc:creator>
<dc:date>2021-09-23</dc:date>
<dc:identifier>doi:10.1101/2021.09.22.461415</dc:identifier>
<dc:title><![CDATA[Peptide fusion improves prime editing efficiency]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-09-23</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.09.27.462002v1?rss=1">
<title>
<![CDATA[
Reovirus infection is regulated by NPC1 and endosomal cholesterol homeostasis 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.09.27.462002v1?rss=1</link>
<description><![CDATA[
Cholesterol homeostasis is required for the replication of many viruses, including Ebola virus, hepatitis C virus, and human immunodeficiency virus-1. Niemann-Pick C1 (NPC1) is an endosomal-lysosomal membrane protein involved in cholesterol trafficking from late endosomes and lysosomes to the endoplasmic reticulum. We identified NPC1 in CRISPR and RNA interference screens as a putative host factor for infection by mammalian orthoreovirus (reovirus). Following internalization via clathrin-mediated endocytosis, the reovirus outer capsid is proteolytically removed, the endosomal membrane is disrupted, and the viral core is released into the cytoplasm where viral transcription, genome replication, and assembly take place. We found that reovirus infection is significantly impaired in cells lacking NPC1, but infection is restored by treatment of cells with hydroxypropyl-{beta}-cyclodextrin, which binds and solubilizes cholesterol. Absence of NPC1 did not dampen infection by infectious subvirion particles, which are reovirus disassembly intermediates that bypass the endocytic pathway for infection of target cells. NPC1 is not required for reovirus attachment to the plasma membrane, internalization into cells, or uncoating within endosomes. Instead, NPC1 is required for delivery of transcriptionally active reovirus core particles into the cytoplasm. These findings suggest that cholesterol homeostasis, ensured by NPC1 transport activity, is required for reovirus penetration into the cytoplasm, pointing to a new function for NPC1 and cholesterol homeostasis in viral infection.

Author summaryGenetic screens are useful strategies to identify host factors required for viral infection. NPC1 was identified in independent CRISPR and RNA interference screens as a putative host factor required for reovirus replication. We discovered that NPC1-mediated cholesterol transport is dispensable for reovirus attachment, internalization, and disassembly but required for penetration of the viral disassembly intermediate from late endosomes into the cytoplasm. These findings pinpoint an essential function for cholesterol in the entry of reovirus and raise the possibility that cholesterol homeostasis regulates the entry of other viruses that penetrate late endosomes to initiate replication.
]]></description>
<dc:creator>Ortega Gonzalez, P.</dc:creator>
<dc:creator>Taylor, G. M.</dc:creator>
<dc:creator>Jangra, R.</dc:creator>
<dc:creator>Tenorio Vela, R.</dc:creator>
<dc:creator>Fernandez de Castro Martin, I.</dc:creator>
<dc:creator>Mainou, B.</dc:creator>
<dc:creator>Orchard, R.</dc:creator>
<dc:creator>Wilen, C. B.</dc:creator>
<dc:creator>Brigleb, P. A.</dc:creator>
<dc:creator>Sojati, J.</dc:creator>
<dc:creator>Chandran, K.</dc:creator>
<dc:creator>Risco, C.</dc:creator>
<dc:creator>Dermody, T. S.</dc:creator>
<dc:date>2021-09-28</dc:date>
<dc:identifier>doi:10.1101/2021.09.27.462002</dc:identifier>
<dc:title><![CDATA[Reovirus infection is regulated by NPC1 and endosomal cholesterol homeostasis]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-09-28</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.09.28.462124v1?rss=1">
<title>
<![CDATA[
Neuronal glucose metabolism sets cholinergic tone and controls thermo-regulated signaling at the neuromuscular junction 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.09.28.462124v1?rss=1</link>
<description><![CDATA[
Cholinergic and sympathetic counter-regulatory networks control numerous physiologic functions including learning/memory/cognition, stress responsiveness, blood pressure, heart rate and energy balance. As neurons primarily utilize glucose as their primary metabolic energy source, we generated mice with increased glycolysis in cholinergic neurons by specific deletion of the fructose-2,6-phosphatase protein TIGAR. Steady-state and stable isotope flux analyses demonstrated increased rates of glycolysis, acetyl-CoA production, acetylcholine levels and density of neuromuscular synaptic junction clusters with enhanced acetylcholine release. The increase in cholinergic signaling reduced blood pressure and heart rate with a remarkable resistance to cold-induced hypothermia. These data directly demonstrate that increased cholinergic signaling through the modulation of glycolysis has several metabolic benefits particularly to increase energy expenditure and heat production upon cold exposure.

HighlightsO_LIDeficiency of a negative regulator of glycolysis (TIGAR) in cholinergic neurons increases the biosynthesis and content of the neurotransmitter acetylcholine.
C_LIO_LIIncreased cholinergic tone reduces blood pressure and heart rate while enhancing signaling at neuromuscular junction.
C_LIO_LIUpregulation of neuromuscular junction activation provides protection against the paralytic curare and cold-induced hypothermia.
C_LIO_LIModulation of cholinergic neuron glycolysis may provide a novel therapeutic approach for treatment of diseases stemming from reduced acetylcholine signaling such as myasthenia gravis and sarcopenic pre-synaptic dysfunction.
C_LI
]]></description>
<dc:creator>Tang, Y.</dc:creator>
<dc:creator>Zong, H.</dc:creator>
<dc:creator>Kwon, H.</dc:creator>
<dc:creator>Qiu, Y.</dc:creator>
<dc:creator>Pessin, J. B.</dc:creator>
<dc:creator>Wu, L.</dc:creator>
<dc:creator>Buddo, K. A.</dc:creator>
<dc:creator>Boykov, I.</dc:creator>
<dc:creator>Schmidt, C.</dc:creator>
<dc:creator>Lin, C.-T.</dc:creator>
<dc:creator>Neufer, P. D.</dc:creator>
<dc:creator>Schwartz, G. J.</dc:creator>
<dc:creator>Kurland, I. J.</dc:creator>
<dc:creator>Pessin, J. E.</dc:creator>
<dc:date>2021-09-30</dc:date>
<dc:identifier>doi:10.1101/2021.09.28.462124</dc:identifier>
<dc:title><![CDATA[Neuronal glucose metabolism sets cholinergic tone and controls thermo-regulated signaling at the neuromuscular junction]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-09-30</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.09.30.462547v1?rss=1">
<title>
<![CDATA[
Cx43 carboxyl terminal domain determines AQP4 and Cx30 endfoot organization and blood brain barrier permeability 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.09.30.462547v1?rss=1</link>
<description><![CDATA[
The neurovascular unit (NVU) consists of cells intrinsic to the vessel wall, the endothelial cells and pericytes, and astrocyte endfeet that surround the vessel but are separated from it by basement membrane. Endothelial cells are primarily responsible for creating and maintaining blood-brain-barrier (BBB) tightness, but astrocytes contribute to the barrier through paracrine signaling to the endothelial cells and by forming the glia limitans. Gap junctions (GJs) between astrocyte endfeet are composed of connexin 43 (Cx43) and Cx30, which form plaques between cells. GJ plaques formed of Cx43 do not diffuse laterally in the plasma membrane and thus potentially provide stable organizational features to the endfoot domain, whereas GJ plaques formed of other connexins and of Cx43 lacking a large portion of its cytoplasmic carboxyl terminus are quite mobile. In order to examine the organizational features that immobile GJs impose on the endfoot, we have used super-resolution confocal microscopy to map number and sizes of GJ plaques and aquaporin (AQP)-4 channel clusters in the perivascular endfeet of mice in which astrocyte GJs (Cx30, Cx43) were deleted or the carboxyl terminus of Cx43 was truncated. To determine if blood-brain-barrier integrity was compromised in these transgenic mice, we conducted perfusion studies under elevated hydrostatic pressure using horseradish peroxide as a molecular probe enabling detection of micro-hemorrhages in brain sections. These studies revealed that microhemorrhages were more numerous in mice lacking Cx43 or its carboxyl terminus. In perivascular domains of cerebral vessels, we found that density of Cx43 GJs was higher in the truncation mutant, while GJ size was smaller. Density of perivascular particles formed by AQP4 and its extended isoform AQP4ex was inversely related to the presence of full length Cx43, whereas the ratio of sizes of the particles of the AQP4ex isoform to total AQP4 was directly related to the presence of full length Cx43. Confocal analysis showed that Cx43 and Cx30 were substantially colocalized in astrocyte domains near vasculature of truncation mutant mice. These results showing altered distribution of some astrocyte nexus components (AQP4 and Cx30) in Cx43 null mice and in a truncation mutant, together with leakier cerebral vasculature, support the hypothesis that localization and mobility of gap junction proteins and their binding partners influences organization of astrocyte endfeet which in turn impacts BBB integrity of the NVU.
]]></description>
<dc:creator>Cibelli, A.</dc:creator>
<dc:creator>Stout, R.</dc:creator>
<dc:creator>Timmermann, A.</dc:creator>
<dc:creator>de Menezes, L.</dc:creator>
<dc:creator>Guo, P.</dc:creator>
<dc:creator>Maass, K.</dc:creator>
<dc:creator>Seifert, G.</dc:creator>
<dc:creator>Steinhaeuser, C.</dc:creator>
<dc:creator>Spray, D. C.</dc:creator>
<dc:creator>Scemes, E.</dc:creator>
<dc:date>2021-10-01</dc:date>
<dc:identifier>doi:10.1101/2021.09.30.462547</dc:identifier>
<dc:title><![CDATA[Cx43 carboxyl terminal domain determines AQP4 and Cx30 endfoot organization and blood brain barrier permeability]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-10-01</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.10.01.462432v1?rss=1">
<title>
<![CDATA[
Natural and designed proteins inspired by extremotolerant organisms can form condensates and attenuate apoptosis in human cells 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.10.01.462432v1?rss=1</link>
<description><![CDATA[
Many organisms can survive extreme conditions and successfully recover to normal life. This extremotolerant behavior has been attributed in part to repetitive, amphipathic, and intrinsically disordered proteins that are upregulated in the protected state. Here, we assemble a library of approximately 300 naturally-occurring and designed extremotolerance-associated proteins to assess their ability to protect human cells from chemically-induced apoptosis. We show that several proteins from tardigrades, nematodes, and the Chinese giant salamander are apoptosis protective. Notably, we identify a region of the human ApoE protein with similarity to extremotolerance-associated proteins that also protects against apoptosis. This region mirrors the phase separation behavior seen with such proteins, like the tardigrade protein CAHS2. Moreover, we identify a synthetic protein, DHR81, that shares this combination of elevated phase separation propensity and apoptosis protection. Finally, we demonstrate that driving protective proteins into the condensate state increases apoptosis protection, and highlight the ability for DHR81 condensates to sequester caspase-7. Taken together, this work draws a link between extremotolerance-associated proteins, condensate formation, and designing human cellular protection.
]]></description>
<dc:creator>Veling, M. T.</dc:creator>
<dc:creator>Nguyen, D. T.</dc:creator>
<dc:creator>Thadani, N. N.</dc:creator>
<dc:creator>Oster, M. E.</dc:creator>
<dc:creator>Rollins, N. J.</dc:creator>
<dc:creator>Brock, K. P.</dc:creator>
<dc:creator>Bethel, N. P.</dc:creator>
<dc:creator>Baker, D.</dc:creator>
<dc:creator>Way, J. C.</dc:creator>
<dc:creator>Marks, D. S.</dc:creator>
<dc:creator>Chang, R. L.</dc:creator>
<dc:creator>Silver, P. A.</dc:creator>
<dc:date>2021-10-01</dc:date>
<dc:identifier>doi:10.1101/2021.10.01.462432</dc:identifier>
<dc:title><![CDATA[Natural and designed proteins inspired by extremotolerant organisms can form condensates and attenuate apoptosis in human cells]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-10-01</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.10.01.462786v1?rss=1">
<title>
<![CDATA[
Chi3l1 is a modulator of glioma stem cell states and a therapeutic vulnerability for glioblastoma 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.10.01.462786v1?rss=1</link>
<description><![CDATA[
Chi3l1 (Chitinase 3-like 1) is a secreted protein highly expressed in glioblastoma. Here, we show that exposure of glioma stem cells (GSCs) to Chi3l1 reduces the CD133+/SOX2+ cells and increases the CD44+/Chi3l1+ cells. Chi3l1 binds to CD44 and induces phosphorylation and nuclear translocation of beta-catenin, Akt and STAT3. Single cell RNA-seq and RNA velocity following incubation of GSCs with Chi3l1 show significant changes in GSC state dynamics driving GSCs towards a mesenchymal expression profile and reducing transition probabilities towards terminal cellular states. ATAC-seq reveals that Chi3l1 increases accessibility of promoters containing MAZ transcription factor footprint. Inhibition of MAZ directly regulates genes with highest expression in cellular clusters exhibiting significant cell state transitions. Finally, targeting Chi3l1 in vivo with a blocking antibody, resets the transcriptomic profile of glioblastoma and inhibits tumor growth. Our work implicates Chi3l1 as modulator of GSC cellular states and demonstrates pre-clinical efficacy of anti-Chi3l1 antibody treatment.
]]></description>
<dc:creator>Guetta-Terrier, C.</dc:creator>
<dc:creator>Karambizi, D.</dc:creator>
<dc:creator>Akosman, B.</dc:creator>
<dc:creator>Chen, J.-S.</dc:creator>
<dc:creator>Kamle, S.</dc:creator>
<dc:creator>Fajardo, J. E.</dc:creator>
<dc:creator>Fiser, A.</dc:creator>
<dc:creator>Singh, R.</dc:creator>
<dc:creator>Toms, S. A.</dc:creator>
<dc:creator>Lee, C. G.</dc:creator>
<dc:creator>Elias, J. A.</dc:creator>
<dc:creator>Tapinos, N.</dc:creator>
<dc:date>2021-10-01</dc:date>
<dc:identifier>doi:10.1101/2021.10.01.462786</dc:identifier>
<dc:title><![CDATA[Chi3l1 is a modulator of glioma stem cell states and a therapeutic vulnerability for glioblastoma]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-10-01</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.10.02.462895v1?rss=1">
<title>
<![CDATA[
SUMM4 complex couples insulator function and DNA replication timingcontrol 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.10.02.462895v1?rss=1</link>
<description><![CDATA[
AbstractAsynchronous replication of chromosome domains during S phase is essential for eukaryotic genome function, but the mechanisms establishing which domains replicate early versus late in different cell types remain incompletely understood. Drosophila SNF2-related factor SUUR imparts under- replication of late-replicating intercalary heterochromatin in polytene chromosomes. SUUR negatively regulates DNA replication fork progression; however, its mechanism of action remains obscure. Here we developed a novel method termed MS-Enabled Rapid protein Complex Identification (MERCI) to isolate a stable stoichiometric native complex SUMM4 that comprises SUUR and a chromatin boundary protein Mod(Mdg4)-67.2. Mod(Mdg4) stimulates SUUR ATPase activity and is required for a normal spatiotemporal distribution of SUUR in vivo. SUUR and Mod(Mdg4)-67.2 together mediate the activities of gypsy insulator that prevent certain enhancer-promoter interactions and establish euchromatin-heterochromatin barriers in the genome. Furthermore, SuUR or mod(mdg4) mutations reverse under-replication of intercalary heterochromatin. Thus, SUMM4 can impart late replication of intercalary heterochromatin by attenuating the progression of replication forks through euchromatin/heterochromatin boundaries. Our findings reveal that DNA replication can be delayed by a chromatin barrier and uncover a critical role for architectural proteins in replication control. They suggest a mechanism for replication timing that does not depend on an asynchronous firing of replication origins.
]]></description>
<dc:creator>Andreyeva, E. N.</dc:creator>
<dc:creator>Emelyanov, A. V.</dc:creator>
<dc:creator>Nevil, M.</dc:creator>
<dc:creator>Sun, L.</dc:creator>
<dc:creator>Vershilova, E.</dc:creator>
<dc:creator>Hill, C. A.</dc:creator>
<dc:creator>Keogh, M. C.</dc:creator>
<dc:creator>Duronio, R. J.</dc:creator>
<dc:creator>Skoultchi, A. I.</dc:creator>
<dc:creator>Fyodorov, D. V.</dc:creator>
<dc:date>2021-10-03</dc:date>
<dc:identifier>doi:10.1101/2021.10.02.462895</dc:identifier>
<dc:title><![CDATA[SUMM4 complex couples insulator function and DNA replication timingcontrol]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-10-03</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.10.03.462893v1?rss=1">
<title>
<![CDATA[
Neutrophil reverse migration from liver fuels neutrophilic inflammation to tissue injury in Nonalcoholic Steatohepatitis. 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.10.03.462893v1?rss=1</link>
<description><![CDATA[
Inflammation is a hallmark in the progression of nonalcoholic-fatty liver disease (NAFLD) to non-alcoholic steatohepatitis (NASH). Patients with NAFLD are characterized by a chronic low-grade systemic metabolic inflammation (i.e., metainflammation), which contributes to exacerbated however dysfunctional immune response. Neutrophils play an important pathological role in NAFLD progression to NASH; however, how NASH and associated chronic systemic inflammation impact overall the neutrophil response to injury is completely unexplored. Here, we investigated how neutrophil response to tissue injury is altered by the presence of NASH. We used a diet-induced NASH zebrafish model combined with tailfin transection in transgenic zebrafish larvae to study neutrophilic inflammation. Live non-invasive confocal microscopy was used to investigate neutrophil recruitment to tailfin injury through time. Photoconvertion of neutrophils at the liver area followed by time-lapse microscopy was performed to evaluate migration of neutrophils from liver to tailfin injury. Metformin and Pentoxifylline were used to pharmacologically reduce NASH and liver inflammation. We found that larvae with NASH display systemic inflammation and increased myelopoiesis. NASH larvae display a dysfunctional and exacerbated neutrophil response to tailfin injury, characterized by increased neutrophil recruitment, and delayed resolution of inflammation. Interestingly, we showed that neutrophils undergo reverse migration from the NASH liver to the wounded tailfin area. Finally, pharmacological treatment of NASH with Pentoxifylline and Metformin significantly reduced systemic chronic inflammation and the exacerbated recruitment of neutrophils to tissue injury. Taken together, our findings suggest that NASH exacerbates neutrophilic inflammation probably via neutrophil priming at the liver, which can further undergo reverse migration and respond to secondary inflammatory triggers such as tissue injury. Reverse migration of primed neutrophils from the liver might be an important mechanism that fuels the exacerbated neutrophil response observed in NASH conditions and associated metainflammation contributing to poor prognosis and increasing death in patients with metabolic syndrome.
]]></description>
<dc:creator>Feliz Norberto, M.</dc:creator>
<dc:creator>Michael, C.</dc:creator>
<dc:creator>de Oliveira, S.</dc:creator>
<dc:date>2021-10-04</dc:date>
<dc:identifier>doi:10.1101/2021.10.03.462893</dc:identifier>
<dc:title><![CDATA[Neutrophil reverse migration from liver fuels neutrophilic inflammation to tissue injury in Nonalcoholic Steatohepatitis.]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-10-04</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.10.03.462944v1?rss=1">
<title>
<![CDATA[
PAX3-FOXO1 coordinates enhancer architecture, eRNA transcription, andRNA polymerase pause release at select gene targets 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.10.03.462944v1?rss=1</link>
<description><![CDATA[
Transcriptional control is a highly dynamic process that changes rapidly in response to various cellular and extracellular cues1. Thus, it is difficult to achieve a mechanistic understanding of transcription factor function using traditional genetic deletion or RNAi methods, because these slow approaches make it challenging to distinguish direct from indirect transcriptional effects. Here, we used a chemical-genetic approach to rapidly degrade a canonical transcriptional activator, PAX3-FOXO12-6 to define how the t(2;13)(q35;q14) disrupts normal gene expression programs to trigger cancer. By coupling rapid protein degradation with the analysis of nascent transcription over short time courses, we identified a core transcriptional network that rapidly collapsed upon PAX3-FOXO1 degradation. Moreover, loss of PAX3-FOXO1 impaired RNA polymerase pause release and transcription elongation at regulated gene targets. The activity of PAX3-FOXO1 at enhancers controlling this core network was surprisingly selective and often only a single element within a complex super-enhancer was affected. In addition, fusion of the endogenous PAX3-FOXO1 with APEX2 identified proteins in close proximity with PAX3-FOXO1, including ARID1A and MYOD1. We found that continued expression of PAX3-FOXO1 was required to maintain chromatin accessibility and allow neighboring DNA binding proteins and chromatin remodeling complexes to associate with this small number of regulated enhancers. Overall, this work provides a detailed mechanism by which PAX3-FOXO1 maintains an oncogenic transcriptional regulatory network.
]]></description>
<dc:creator>Zhang, S.</dc:creator>
<dc:creator>Wang, J.</dc:creator>
<dc:creator>Liu, Q.</dc:creator>
<dc:creator>McDonald, W. H.</dc:creator>
<dc:creator>Bomber, M.</dc:creator>
<dc:creator>Layden, H.</dc:creator>
<dc:creator>Ellis, J.</dc:creator>
<dc:creator>Borinstein, S.</dc:creator>
<dc:creator>Hiebert, S. W.</dc:creator>
<dc:creator>Stengel, K. R.</dc:creator>
<dc:date>2021-10-04</dc:date>
<dc:identifier>doi:10.1101/2021.10.03.462944</dc:identifier>
<dc:title><![CDATA[PAX3-FOXO1 coordinates enhancer architecture, eRNA transcription, andRNA polymerase pause release at select gene targets]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-10-04</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.10.05.463200v1?rss=1">
<title>
<![CDATA[
Role of EXO1 nuclease activity in genome maintenance, the immune response and tumor suppression in Exo1D173A mice 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.10.05.463200v1?rss=1</link>
<description><![CDATA[
DNA damage response pathways rely extensively on nuclease activity to process DNA intermediates. Exonuclease 1 (EXO1) is a pleiotropic evolutionary conserved DNA exonuclease involved in various DNA repair pathways, replication, antibody diversification, and meiosis. But, whether EXO1 facilitates these DNA metabolic processes through its enzymatic or scaffolding functions remains unclear. Here we dissect the contribution of EXO1 enzymatic versus scaffolding activity by comparing Exo1DA/DA mice expressing a proven nuclease-dead mutant form of EXO1 to entirely EXO1-deficient Exo1-/- and EXO1 wild type Exo1+/+ mice. We show that Exo1DA/DA and Exo1-/- mice are compromised in canonical DNA repair processing, suggesting that the EXO1 enzymatic role is important for error-free DNA mismatch and double-strand break repair pathways. However, in non-canonical repair pathways, EXO1 appears to have a more nuanced function. Next-generation sequencing of heavy chain V region in B cells showed the mutation spectra of Exo1DA/DA mice to be intermediate between Exo1+/+ and Exo1-/- mice, suggesting that both catalytic and scaffolding roles of EXO1 are important for somatic hypermutation. Similarly, while overall class switch recombination in Exo1DA/DA and Exo1-/- mice was comparably defective, switch-switch junction analysis suggests that EXO1 might fulfill an additional scaffolding function downstream of class switching. In contrast to Exo1-/- mice that are infertile, meiosis progressed normally in Exo1DA/DA and Exo1+/+ cohorts, indicating that a structural but not the nuclease function of EXO1 is critical for meiosis. However, both Exo1DA/DA and Exo1-/- mice displayed similar mortality and cancer predisposition profiles. Taken together, these data demonstrate that EXO1 has both scaffolding and enzymatic functions in distinct DNA repair processes and suggest a more composite and intricate role for EXO1 in DNA metabolic processes and disease.
]]></description>
<dc:creator>Wang, S.</dc:creator>
<dc:creator>Lee, K.</dc:creator>
<dc:creator>Gray, S.</dc:creator>
<dc:creator>Zhang, Y.</dc:creator>
<dc:creator>Tangcatherin, C.</dc:creator>
<dc:creator>Morrish, R.</dc:creator>
<dc:creator>Tosti, E.</dc:creator>
<dc:creator>van Oers, J.</dc:creator>
<dc:creator>Cohen, P.</dc:creator>
<dc:creator>MacCarthy, T.</dc:creator>
<dc:creator>Roa, S.</dc:creator>
<dc:creator>Scharff, M. D.</dc:creator>
<dc:creator>Edelmann, W.</dc:creator>
<dc:creator>Chahwan, R.</dc:creator>
<dc:date>2021-10-05</dc:date>
<dc:identifier>doi:10.1101/2021.10.05.463200</dc:identifier>
<dc:title><![CDATA[Role of EXO1 nuclease activity in genome maintenance, the immune response and tumor suppression in Exo1D173A mice]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-10-05</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.10.07.463512v1?rss=1">
<title>
<![CDATA[
Retrograde adenosine/A2A receptor signaling mediates presynaptic hippocampal LTP and facilitates epileptic seizures 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.10.07.463512v1?rss=1</link>
<description><![CDATA[
Retrograde signaling at the synapse is a fundamental way by which neurons communicate and neuronal circuit function is fine-tuned upon activity. While long-term changes in neurotransmitter release commonly rely on retrograde signaling, the mechanisms remain poorly understood. Here, we identified adenosine/A2A receptor (A2AR) as a novel retrograde signaling pathway underlying presynaptic long-term potentiation (LTP) at a hippocampal excitatory circuit critically involved in memory and epilepsy. Transient burst activity of a single dentate granule cell induced LTP of mossy cell synaptic inputs, a BDNF/TrkB-dependent form of plasticity that facilitates seizures. Postsynaptic TrkB activation released adenosine from granule cells, uncovering a non-conventional BDNF/TrkB signaling mechanism. Moreover, presynaptic A2ARs were necessary and sufficient for LTP. Lastly, seizure induction released adenosine in a TrkB-dependent manner, while removing A2ARs or TrkB from the dentate gyrus had anti-convulsant effects. By mediating presynaptic LTP, adenosine/A2AR retrograde signaling may modulate dentate gyrus-dependent learning and promote epileptic activity.

HighlightsO_LIPostsynaptic firing induces presynaptic LTP at mossy cell to granule cell synapses
C_LIO_LIPostsynaptic TrkB activation induces adenosine release from granule cells
C_LIO_LIPresynaptic adenosine A2A receptors are necessary and sufficient to induce LTP
C_LIO_LIAdenosine/A2AR signaling within the dentate gyrus is pro-convulsant
C_LI

In BriefNasrallah et al. report a novel retrograde signaling pathway at hippocampal synapses that involves postsynaptic TrkB-dependent release of adenosine and the activation of presynaptic A2A receptors. This pathway mediates presynaptic long-term potentiation at a key hippocampal excitatory synapse and can also promote epileptic seizures.
]]></description>
<dc:creator>Nasrallah, K.</dc:creator>
<dc:creator>Berthoux, C.</dc:creator>
<dc:creator>Hashimotodani, Y.</dc:creator>
<dc:creator>Chavez, A. E.</dc:creator>
<dc:creator>Gulfo, M.</dc:creator>
<dc:creator>Lujan, R.</dc:creator>
<dc:creator>Castillo, P. E.</dc:creator>
<dc:date>2021-10-09</dc:date>
<dc:identifier>doi:10.1101/2021.10.07.463512</dc:identifier>
<dc:title><![CDATA[Retrograde adenosine/A2A receptor signaling mediates presynaptic hippocampal LTP and facilitates epileptic seizures]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-10-09</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.10.07.463524v1?rss=1">
<title>
<![CDATA[
Impact of stimulation location relative to grey and white matter on single pulse electrical stimulation responses in the human brain 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.10.07.463524v1?rss=1</link>
<description><![CDATA[
BackgroundElectrical neuromodulation is an increasingly common therapy for a wide variety of neuropsychiatric diseases. Unfortunately, therapeutic efficacy is inconsistent, possibly a result of our limited understanding of the mechanisms and the massive stimulation parameter space.

Objective/HypothesisTo better understand the role different parameters play in inducing a response, we systematically examined single pulse-induced cortico-cortico evoked potentials (CCEP) as a function of stimulation amplitude, duration and location in the brain and relative to grey and white matter.

MethodsWe measured voltage peak amplitudes and area under the curve of intracranially recorded stimulation responses as a function of distance from the stimulation site, pulse width, current injected, location relative to grey and white matter, and brain region stimulated (N=52, n=719 stimulation sites).

ResultsIncreasing stimulation pulse width increased response values near the stimulation location. Increasing stimulation amplitude (current) increased responses nonlinearly. Locally (<15 mm from the stimulation site), stimulation closer to the grey matter-white matter boundary induced larger responses. In contrast, for distant sites (>15 mm), white matter stimulation consistently produced larger responses than stimulation in or near grey matter. These relationships were different between cingulate, lateral prefrontal, and lateral temporal cortical stimulation.

ConclusionThese results demonstrate the importance of location and stimulation parameters in inducing a specific output and indicate that a stronger local response may require stimulation in the grey-white boundary while stimulation in the white matter may be needed for network activation, suggesting that stimulation location can be tailored for a specific outcome, key to informed neuromodulatory therapy.

HighlightsO_LIIntracranial single pulse electrical stimulation (SPES) response increases with increased pulse duration mostly near the stimulation site
C_LIO_LISPES response varies nonlinearly with injected current with an effect of distance from the stimulation site.
C_LIO_LISPES near the grey-white boundary and 90{degrees} to the nearest cortical axis induces larger local responses, but white matter stimulation produces larger distant responses.
C_LIO_LIThe relationship between SPES location and responses depends on brain region stimulated
C_LI
]]></description>
<dc:creator>Paulk, A. C.</dc:creator>
<dc:creator>Zelmann, R.</dc:creator>
<dc:creator>Crocker, B.</dc:creator>
<dc:creator>Widge, A. S.</dc:creator>
<dc:creator>Dougherty, D. D.</dc:creator>
<dc:creator>Eskandar, E. N.</dc:creator>
<dc:creator>Weisholtz, D. S.</dc:creator>
<dc:creator>Richardson, M.</dc:creator>
<dc:creator>Cosgrove, R.</dc:creator>
<dc:creator>Cash, S. S.</dc:creator>
<dc:date>2021-10-09</dc:date>
<dc:identifier>doi:10.1101/2021.10.07.463524</dc:identifier>
<dc:title><![CDATA[Impact of stimulation location relative to grey and white matter on single pulse electrical stimulation responses in the human brain]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-10-09</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.10.11.463514v1?rss=1">
<title>
<![CDATA[
Whole genome sequence analysis of blood lipid levels in >66,000 individuals 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.10.11.463514v1?rss=1</link>
<description><![CDATA[
Plasma lipids are heritable modifiable causal factors for coronary artery disease, the leading cause of death globally. Despite the well-described monogenic and polygenic bases of dyslipidemia, limitations remain in discovery of lipid-associated alleles using whole genome sequencing, partly due to limited sample sizes, ancestral diversity, and interpretation of potential clinical significance. Increasingly larger whole genome sequence datasets with plasma lipids coupled with methodologic advances enable us to more fully catalog the allelic spectrum for lipids. Here, among 66,329 ancestrally diverse (56% non-European ancestry) participants, we associate 428M variants from deep-coverage whole genome sequences with plasma lipids. Approximately 400M of these variants were not studied in prior lipids genetic analyses. We find multiple lipid-related genes strongly associated with plasma lipids through analysis of common and rare coding variants. We additionally discover several significantly associated rare non-coding variants largely at Mendelian lipid genes. Notably, we detect rare LDLR intronic variants associated with markedly increased LDL-C, similar to rare LDLR exonic variants. In conclusion, we conducted a systematic whole genome scan for plasma lipids expanding the alleles linked to lipids for multiple ancestries and characterize a clinically-relevant rare non-coding variant model for lipids.
]]></description>
<dc:creator>Selvaraj, M. S.</dc:creator>
<dc:creator>Li, X.</dc:creator>
<dc:creator>Li, Z.</dc:creator>
<dc:creator>Pampana, A.</dc:creator>
<dc:creator>Zhang, D. Y.</dc:creator>
<dc:creator>Park, J.</dc:creator>
<dc:creator>Aslibekyan, S.</dc:creator>
<dc:creator>Bis, J. C.</dc:creator>
<dc:creator>Brody, J. A.</dc:creator>
<dc:creator>Cade, B. E.</dc:creator>
<dc:creator>Chuang, L.-M.</dc:creator>
<dc:creator>Chung, R.-H.</dc:creator>
<dc:creator>Curran, J. E.</dc:creator>
<dc:creator>de las Fuentes, L.</dc:creator>
<dc:creator>de Vries, P. S.</dc:creator>
<dc:creator>Duggirala, R.</dc:creator>
<dc:creator>Freedman, B. I.</dc:creator>
<dc:creator>Graff, M.</dc:creator>
<dc:creator>Guo, X.</dc:creator>
<dc:creator>Heard-Costa, N.</dc:creator>
<dc:creator>Hidalgo, B.</dc:creator>
<dc:creator>Hwu, C.-M.</dc:creator>
<dc:creator>Irvin, M. R.</dc:creator>
<dc:creator>Kelly, T. N.</dc:creator>
<dc:creator>Kral, B. G.</dc:creator>
<dc:creator>Lange, L.</dc:creator>
<dc:creator>Li, X.</dc:creator>
<dc:creator>Lisa, M.</dc:creator>
<dc:creator>Lubitz, S. A.</dc:creator>
<dc:creator>Manichaikul, A. W.</dc:creator>
<dc:creator>Michael, P.</dc:creator>
<dc:creator>Montasser, M. E.</dc:creator>
<dc:creator>Morrison, A. C.</dc:creator>
<dc:creator>Naseri, T.</dc:creator>
<dc:creator>O'Connell, J. R.</dc:creator>
<dc:creator>Palmer, N. D.</dc:creator>
<dc:creator>Peyser, P. A.</dc:creator>
<dc:creator>Reupena, M. S.</dc:creator>
<dc:creator>Smith, J. A.</dc:creator>
<dc:creator>Sun, X.</dc:creator>
<dc:creator>Taylor, K. D.</dc:creator>
<dc:creator>Tracy, R. P.</dc:creator>
<dc:creator>Tsai, M. Y.</dc:creator>
<dc:creator>Wang,</dc:creator>
<dc:date>2021-10-12</dc:date>
<dc:identifier>doi:10.1101/2021.10.11.463514</dc:identifier>
<dc:title><![CDATA[Whole genome sequence analysis of blood lipid levels in >66,000 individuals]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-10-12</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.10.11.464022v1?rss=1">
<title>
<![CDATA[
Specific N-glycans regulate an extracellular adhesion complex during somatosensory dendrite patterning 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.10.11.464022v1?rss=1</link>
<description><![CDATA[
N-glycans are molecularly diverse sugars borne by over 70% of proteins transiting the secretory pathway and have been implicated in protein folding, stability, and localization. Mutations in genes important for N-glycosylation result in congenital disorders of glycosylation that are often associated with intellectual disability. Here, we show that structurally distinct N-glycans regulate the activity of an extracellular protein complex involved in patterning of somatosensory dendrites in Caenorhabditis elegans. Specifically, aman-2/Golgi alpha-mannosidase II, a conserved key enzyme in the biosynthesis of specific N-glycans regulates the activity of the Menorin adhesion complex without obviously affecting protein stability and localization of its components. AMAN-2 functions cell-autonomously to ensure decoration of the neuronal transmembrane receptor DMA-1/LRR-TM with high-mannose/hybrid N-glycans. Moreover, distinct types of N-glycans on specific N-glycosylation sites regulate the DMA-1/LRR-TM receptor, which together with three other extracellular proteins forms the Menorin adhesion complex. In summary, specific N-glycan structures regulate dendrite patterning by coordinating the activity of an extracellular adhesion complex suggesting that the molecular diversity of N-glycans can contribute to developmental specificity in the nervous system.
]]></description>
<dc:creator>Bülow, H. E.</dc:creator>
<dc:creator>Rahman, M.</dc:creator>
<dc:creator>Ramirez-Suarez, N. J.</dc:creator>
<dc:creator>Diaz-Balzac, C. A.</dc:creator>
<dc:date>2021-10-13</dc:date>
<dc:identifier>doi:10.1101/2021.10.11.464022</dc:identifier>
<dc:title><![CDATA[Specific N-glycans regulate an extracellular adhesion complex during somatosensory dendrite patterning]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-10-13</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.10.15.464577v1?rss=1">
<title>
<![CDATA[
Characterization of Cell-cell Communication in Autistic Brains with Single Cell Transcriptomes 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.10.15.464577v1?rss=1</link>
<description><![CDATA[
Autism spectrum disorder is a neurodevelopmental disorder, affecting 1-2% of children. Studies have revealed genetic and cellular abnormalities in the brains of affected individuals, leading to both regional and distal cell communication deficits. Recent application of single cell technologies, especially single cell transcriptomics, has significantly expanded our understanding of brain cell heterogeneity and further demonstrated that multiple cell types and brain layers or regions are perturbed in autism. The underlying high-dimensional single cell data provides opportunities for multi-level computational analysis that collectively can better deconvolute the molecular and cellular events altered in autism. Here, we apply advanced computation and pattern recognition approaches on single cell RNA-seq data to infer and compare inter-cell-type signaling communications in autism brains and controls. Our results indicate that at a global level there are cell-cell communication differences in autism in comparison to controls, largely involving neurons as both signaling senders and receivers, but glia also contribute to the communication disruption. Although the magnitude of change is moderate, we find that excitatory and inhibitor neurons are involved in multiple intercellular signaling that exhibit increased strengths in autism, such as NRXN and CNTN signaling. Not all genes in the intercellular signaling pathways are differentially expressed, but genes in the pathways are enriched for axon guidance, synapse organization, neuron migration, and other critical cellular functions. Furthermore, those genes are highly connected to and enriched for genes previously associated with autism risks. Overall, our proof-of-principle computational study using single cell data uncovers key intercellular signaling pathways that are potentially disrupted in the autism brains, suggesting that more studies examining cross-cell type affects can be valuable for understanding autism pathogenesis.
]]></description>
<dc:creator>Astorkia, M.</dc:creator>
<dc:creator>Lachman, H.</dc:creator>
<dc:creator>Zheng, D.</dc:creator>
<dc:date>2021-10-15</dc:date>
<dc:identifier>doi:10.1101/2021.10.15.464577</dc:identifier>
<dc:title><![CDATA[Characterization of Cell-cell Communication in Autistic Brains with Single Cell Transcriptomes]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-10-15</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.10.15.464608v1?rss=1">
<title>
<![CDATA[
Kernel-based genetic association analysis for microbiome phenotypes identifies host genetic drivers of beta-diversity 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.10.15.464608v1?rss=1</link>
<description><![CDATA[
Understanding human genetic influences on the gut microbiota helps elucidate the mechanisms by which genetics affects health outcomes. We propose a novel approach, the covariate-adjusted kernel RV (KRV) framework, to map genetic variants associated with microbiome beta-diversity, which focuses on overall shifts in the microbiota. The proposed KRV framework improves statistical power by capturing intrinsic structure within the genetic and microbiome data while reducing the multiple-testing burden. We apply the covariate-adjusted KRV test to the Hispanic Community Health Study/Study of Latinos in a genome-wide association analysis (first gene-level, then variant-level) for microbiome beta-diversity. We have identified an immunity-related gene, IL23R, reported in previous association studies and discovered 3 other novel genes, 2 of which are involved in immune functions or autoimmune disorders. Our findings highlight the value of the KRV as a powerful microbiome GWAS approach and support an important role of immunity-related genes in shaping the gut microbiome composition.
]]></description>
<dc:creator>Liu, H.</dc:creator>
<dc:creator>Ling, W.</dc:creator>
<dc:creator>Hua, X.</dc:creator>
<dc:creator>Moon, J.-Y.</dc:creator>
<dc:creator>Williams-Nguyen, J. S.</dc:creator>
<dc:creator>Zhan, X.</dc:creator>
<dc:creator>Plantinga, A. M.</dc:creator>
<dc:creator>Zhao, N.</dc:creator>
<dc:creator>Zhang, A.</dc:creator>
<dc:creator>Knight, R.</dc:creator>
<dc:creator>Qi, Q.</dc:creator>
<dc:creator>Burk, R. D.</dc:creator>
<dc:creator>Kaplan, R. C.</dc:creator>
<dc:creator>Wu, M. C.</dc:creator>
<dc:date>2021-10-16</dc:date>
<dc:identifier>doi:10.1101/2021.10.15.464608</dc:identifier>
<dc:title><![CDATA[Kernel-based genetic association analysis for microbiome phenotypes identifies host genetic drivers of beta-diversity]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-10-16</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.10.19.464978v1?rss=1">
<title>
<![CDATA[
T cell receptor and IL-2 signaling strength control memory CD8+ T cell functional fitness via chromatin remodeling 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.10.19.464978v1?rss=1</link>
<description><![CDATA[
Cognate antigen signal controls CD8+ T cell priming, expansion size and effector versus memory cell fates, but it is not known if and how it modulates the functional features of memory CD8+ T cells. Here we show that the strength of T cell receptor (TCR) signaling determines the requirement for interleukin-2 (IL-2) signals to form a pool of memory CD8+ T cells that competitively re-expand upon secondary antigen encounter. Combining strong TCR and intact IL-2 signaling synergistically induces genome-wide chromatin accessibility in regions targeting a wide breadth of biological processes, consistent with their greater functional fitness. Chromatin accessibility in promoters of genes encoding for stem cell, cell cycle and calcium-related proteins correlated with faster intracellular calcium accumulation, initiation of cell cycle and more robust expansion. High-dimensional flow-cytometry analysis also highlights higher subset diversity and phenotypes. These results formally establish that epitope selection in vaccine design strongly impacts memory CD8+ T cell epigenetic programming and functions.

One Sentence SummaryThe strength of antigenic and interleukin 2 signals received by CD8+ T cells during vaccination epigenetically programs their ability to form functional memory.
]]></description>
<dc:creator>Chin, S. S.</dc:creator>
<dc:creator>Guillen, E.</dc:creator>
<dc:creator>Chorro, L.</dc:creator>
<dc:creator>Achar, S.</dc:creator>
<dc:creator>Oberle, S.</dc:creator>
<dc:creator>Ng, K.</dc:creator>
<dc:creator>Alfei, F.</dc:creator>
<dc:creator>Zehn, D.</dc:creator>
<dc:creator>Altan-Bonnet, G.</dc:creator>
<dc:creator>DELAHAYE, F.</dc:creator>
<dc:creator>Lauvau, G.</dc:creator>
<dc:date>2021-10-20</dc:date>
<dc:identifier>doi:10.1101/2021.10.19.464978</dc:identifier>
<dc:title><![CDATA[T cell receptor and IL-2 signaling strength control memory CD8+ T cell functional fitness via chromatin remodeling]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-10-20</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.10.21.465350v1?rss=1">
<title>
<![CDATA[
Feature representation under crowding in V1 and V4 neuronal populations 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.10.21.465350v1?rss=1</link>
<description><![CDATA[
Visual perception depends strongly on spatial context. A profound example is visual crowding, whereby the presence of nearby stimuli impairs discriminability of object features. Despite extensive work on both perceptual crowding and the spatial integrative properties of visual cortical neurons, the link between these two aspects of visual processing remains unclear. To understand better the neural basis of crowding, we recorded simultaneously from neuronal populations in V1 and V4 of fixating macaque monkeys. We assessed the information about the orientation of a visual target available from the measured responses, both for targets presented in isolation and amid distractors. Both single neuron and population responses had less information about target orientation when distractors were present. Information loss was moderate in V1 and more substantial in V4. Information loss could be traced to systematic divisive and additive changes in neuronal tuning. Tuning changes were more severe in V4; in addition, tuning exhibited greater context-dependent distortions in V4, further restricting the ability of a fixed sensory readout strategy to extract accurate feature information across changing environments. Our results provide a direct test of crowding effects at different stages of the visual hierarchy, reveal how these effects alter the spiking activity of cortical populations by which sensory stimuli are encoded, and connect these changes to established mechanisms of neuronal spatial integration.
]]></description>
<dc:creator>Henry, C. A.</dc:creator>
<dc:creator>Kohn, A.</dc:creator>
<dc:date>2021-10-23</dc:date>
<dc:identifier>doi:10.1101/2021.10.21.465350</dc:identifier>
<dc:title><![CDATA[Feature representation under crowding in V1 and V4 neuronal populations]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-10-23</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.10.22.465419v1?rss=1">
<title>
<![CDATA[
Excessive fetal growth affects HSC quiescence maintenance through epigenetic programming of EGR1 transcriptional network 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.10.22.465419v1?rss=1</link>
<description><![CDATA[
Excessive fetal growth is associated with DNA methylation alterations in human hematopoietic stem and progenitor cells (HSPC), but their functional impact remains elusive. We implemented an integrative analysis combining single-cell epigenomics, single-cell transcriptomics, and in vitro analyses to functionally link DNA methylation changes to putative alterations of HSPC functions. We showed in hematopoietic stem cells (HSC) from large for gestational age neonates that both DNA hypermethylation and chromatin rearrangement target a specific network of transcription factors known to sustain stem cell quiescence. In parallel, we found a decrease expression of key genes regulating HSC differentiation including EGR1, KLF2, SOCS3, and JUNB. Our functional analyses showed that this epigenetic programming was associated with a decreased ability for HSCs to stay quiescent. Taken together, our multimodal approach using single-cell (epi)genomics showed that human fetal overgrowth affects hematopoietic stem cells quiescence maintenance via epigenetic programming.
]]></description>
<dc:creator>Pelletier, A.</dc:creator>
<dc:creator>Carrier, A.</dc:creator>
<dc:creator>Zhao, Y.</dc:creator>
<dc:creator>Canouil, M.</dc:creator>
<dc:creator>Derhourhi, M.</dc:creator>
<dc:creator>Durand, E.</dc:creator>
<dc:creator>Berberian-Ferrato, L.</dc:creator>
<dc:creator>Greally, J.</dc:creator>
<dc:creator>Hughes, F.</dc:creator>
<dc:creator>Froguel, P.</dc:creator>
<dc:creator>Bonnefond, A.</dc:creator>
<dc:creator>Delahaye, F.</dc:creator>
<dc:date>2021-10-24</dc:date>
<dc:identifier>doi:10.1101/2021.10.22.465419</dc:identifier>
<dc:title><![CDATA[Excessive fetal growth affects HSC quiescence maintenance through epigenetic programming of EGR1 transcriptional network]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-10-24</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.10.26.465924v1?rss=1">
<title>
<![CDATA[
Chronic stroke sensorimotor impairment is related to smaller hippocampal volumes: An ENIGMA analysis 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.10.26.465924v1?rss=1</link>
<description><![CDATA[
Persistent sensorimotor impairments after stroke can negatively impact quality of life. The hippocampus is involved in sensorimotor behavior but has not been widely studied within the context of post-stroke upper limb sensorimotor impairment. The hippocampus is vulnerable to secondary degeneration after stroke, and damage to this region could further weaken sensorimotor circuits, leading to greater chronic sensorimotor impairment. The purpose of this study was to investigate the cross-sectional association between non-lesioned hippocampal volume and upper limb sensorimotor impairment in people with chronic stroke. We hypothesized that smaller ipsilesional hippocampal volumes would be associated with worse upper-limb sensorimotor impairment.

Cross-sectional T1-weighted brain MRIs were pooled from 357 participants at the chronic stage after stroke (>180 days post-stroke) compiled from 18 research cohorts worldwide in the ENIGMA Stroke Recovery Working Group (age: median = 61 years, interquartile range = 18, range = 23-93; 135 women and 222 men). Sensorimotor impairment was estimated from the Fugl-Meyer Assessment of Upper Extremity scores. Robust mixed-effects linear models were used to test associations between post-stroke sensorimotor impairment and hippocampal volumes (ipsilesional and contralesional separately; Bonferroni-corrected, p-value < 0.025), controlling for age, sex, lesion volume, and lesioned hemisphere. We also performed an exploratory analysis to test whether sex differences influence the relationship between sensorimotor impairment and hippocampal volume.

Upper limb sensorimotor impairment was positively associated with ipsilesional (p = 0.005; d = 0.33) but not contralesional (p = 0.96; d = 0.01) hippocampal volume, such that impairment was worse for participants with smaller ipsilesional hippocampal volume. This association remained significant independent of lesion volume or other covariates (p = 0.001; d = 0.36). Evidence indicates an interaction between sensorimotor impairment and sex for both ipsilesional (p = 0.008; d = -0.29) and contralesional (p = 0.006; d = -0.30) hippocampal volumes, whereby women showed progressively worsening sensorimotor impairment with smaller hippocampal volumes compared to men.

The present study has identified a novel association between chronic post-stroke sensorimotor impairment and ipsilesional, but not contralesional, hippocampal volume. This finding was not due to lesion size and may be stronger in women. We also provide supporting evidence that smaller hippocampal volume post-stroke is likely a consequence of ipsilesional damage, which could provide a link between vascular disease and other disorders, such as dementia.
]]></description>
<dc:creator>Zavaliangos-Petropulu, A.</dc:creator>
<dc:creator>Lo, B.</dc:creator>
<dc:creator>Donnelly, M. R.</dc:creator>
<dc:creator>Schweighofer, N.</dc:creator>
<dc:creator>Lohse, K.</dc:creator>
<dc:creator>Jahanshad, N.</dc:creator>
<dc:creator>Barisano, G.</dc:creator>
<dc:creator>Banaj, N.</dc:creator>
<dc:creator>Borich, M. R.</dc:creator>
<dc:creator>Boyd, L. A.</dc:creator>
<dc:creator>Buetefisch, C. M.</dc:creator>
<dc:creator>Byblow, W. D.</dc:creator>
<dc:creator>Cassidy, J. M.</dc:creator>
<dc:creator>Charalambous, C. C.</dc:creator>
<dc:creator>Conforto, A. B.</dc:creator>
<dc:creator>DiCarlo, J. A.</dc:creator>
<dc:creator>Dula, A. N.</dc:creator>
<dc:creator>Egorova-Brumley, N.</dc:creator>
<dc:creator>Etherton, M. R.</dc:creator>
<dc:creator>Feng, W.</dc:creator>
<dc:creator>Fercho, K. A.</dc:creator>
<dc:creator>Geranmayeh, F.</dc:creator>
<dc:creator>Hanlon, C. A.</dc:creator>
<dc:creator>Hayward, K. S.</dc:creator>
<dc:creator>Hordacre, B.</dc:creator>
<dc:creator>Kautz, S. A.</dc:creator>
<dc:creator>Khlif, M. S.</dc:creator>
<dc:creator>Kim, H.</dc:creator>
<dc:creator>Kuceyeski, A.</dc:creator>
<dc:creator>Lin, D. J.</dc:creator>
<dc:creator>Lotze, M.</dc:creator>
<dc:creator>Liu, J.</dc:creator>
<dc:creator>MacIntosh, B. J.</dc:creator>
<dc:creator>Margetis, J. L.</dc:creator>
<dc:creator>Piras, F.</dc:creator>
<dc:creator>Ramos-Murguialday, A.</dc:creator>
<dc:creator>Revill, K. P.</dc:creator>
<dc:creator>Roberts, P. S.</dc:creator>
<dc:creator>Robertson, A. D.</dc:creator>
<dc:creator>Schambra</dc:creator>
<dc:date>2021-10-28</dc:date>
<dc:identifier>doi:10.1101/2021.10.26.465924</dc:identifier>
<dc:title><![CDATA[Chronic stroke sensorimotor impairment is related to smaller hippocampal volumes: An ENIGMA analysis]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-10-28</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.10.29.466479v1?rss=1">
<title>
<![CDATA[
Cycles of transcription and local translation consolidate Arc protein at dendritic sites 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.10.29.466479v1?rss=1</link>
<description><![CDATA[
Long-term memory requires transcription and translation of activity-regulated genes. Many of these are immediate early genes (IEGs) with short-lived mRNAs and proteins, decaying rapidly after stimulation. It remains unknown how an IEG with rapid mRNA and protein turnover can impact long-lasting changes at the synapses. Using fluorescently tagged endogenous Arc, an IEG important for memory consolidation, we performed high-resolution imaging of transcription and translation in individual neurons to identify the long-term gene dynamics after stimulation. Unexpectedly, once induced, Arc underwent transcriptional reactivation often at the same allele. Cycles of transcription were coordinated with localized translation. This cyclical regulation of an IEG, dependent on protein synthesis, reactivates subsequent transcription for maintaining mRNA supply to dendrites. The ensuing Arc mRNAs were preferentially localized at sites marked by previous Arc protein, thereby consolidating local "hubs" of dendritic Arc. These findings revealed the spatio-temporal dynamics of transcription-translation coupling of an IEG and provide a mechanism by which short-lived synaptic proteins can be sustained over the long-time scales of memory consolidation.
]]></description>
<dc:creator>Das, S.</dc:creator>
<dc:creator>Lituma, P. J.</dc:creator>
<dc:creator>Castillo, P. E.</dc:creator>
<dc:creator>Singer, R. H.</dc:creator>
<dc:date>2021-11-01</dc:date>
<dc:identifier>doi:10.1101/2021.10.29.466479</dc:identifier>
<dc:title><![CDATA[Cycles of transcription and local translation consolidate Arc protein at dendritic sites]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-11-01</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.10.31.466715v1?rss=1">
<title>
<![CDATA[
Transcriptional burst kinetics are linked to short term transcriptional memory 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.10.31.466715v1?rss=1</link>
<description><![CDATA[
Transcriptional bursting is thought to be a stochastic process that allows the dynamic regulation of most genes. The random telegraph model assumes the existence of two states, ON and OFF. However recent studies indicate the presence of additional ON states, suggesting that bursting kinetics and their regulation can be quite complex. We have developed a system to study transcriptional bursting in the context of p53 biology using the endogenous p21 gene tagged with MS2 in human cells. Remarkably, we find that transcriptional bursts from the p21 gene contain multiple ON and OFF states that can be regulated by elevation of p53 levels. Distinct ON states are characterized by differences in burst duration, classified as Short and Long, with long bursts associated with higher Pol II initiation rates. Importantly, the different ON states display memory effects that allow us to predict the likelihood of properties of future bursting events. Long bursting events result in faster re-activation, longer subsequent bursts and higher transcriptional output in the future compared to short bursts. Bursting memory persists up to 2 hours suggesting a stable inheritable promoter architecture. Bursting memory at the p21 gene is the strongest under basal conditions and is suppressed by UV and inhibition of H3K9me1/2, which also increase transcriptional noise. Stabilization of p53 by Nutlin-3a partially reverses suppression of bursting memory suggesting that higher p53 levels may be a key in enforcing memory under conditions of cellular stress. Overall our data uncover a new found bursting property termed Short-Term Transcriptional Memory (STTM) that has the potential to fine-tune transcriptional output at the p21 gene.
]]></description>
<dc:creator>Senecal, A.</dc:creator>
<dc:creator>Singer, R. H.</dc:creator>
<dc:creator>Coleman, R. A.</dc:creator>
<dc:date>2021-11-02</dc:date>
<dc:identifier>doi:10.1101/2021.10.31.466715</dc:identifier>
<dc:title><![CDATA[Transcriptional burst kinetics are linked to short term transcriptional memory]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-11-02</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.11.02.467042v1?rss=1">
<title>
<![CDATA[
Dense granule protein, GRA64 interacts with host cell ESCRT proteins during Toxoplasma gondii infection 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.11.02.467042v1?rss=1</link>
<description><![CDATA[
The intracellular parasite Toxoplasma gondii adapts to diverse host cell environments within a replicative compartment that is heavily decorated by secreted proteins. In attempts to identify novel parasite secreted proteins that influence host cell activity, we identified and characterized a trans-membrane dense granule protein dubbed GRA64 (TGME49_202620). We found that GRA64 is on the parasitophorous vacuolar membrane (PVM) and is partially exposed to the host cell cytoplasm in both tachyzoite and bradyzoite parasitophorous vacuoles. Using co-immunoprecipitation and proximity-based biotinylation approaches, we demonstrate that GRA64 appears to interact with certain components of the host Endosomal Sorting Complexes Required for Transport (ESCRT). Genetic disruption of GRA64 does not affect acute Toxoplasma virulence in mice nor encystation as observed via tissue cyst burdens in mice during chronic infection. However, ultrastructural analysis of {Delta}gra64 tissue cysts using electron tomography revealed enlarged vesicular structures underneath the cyst membrane, suggesting a role for GRA64 in organizing the recruitment of ESCRT proteins and subsequent intracystic vesicle formation. This study uncovers a novel host-parasite interaction that contributes to an emerging paradigm in which specific host ESCRT proteins are recruited to the limiting membranes (PVMs) of tachyzoite and bradyzoite vacuoles formed during acute and chronic Toxoplasma infection.

IMPORTANCEToxoplasma gondii is a widespread foodborne parasite that causes congenital disease and life-threatening complications in immune compromised individuals. Part of this parasites success lies in its ability to infect diverse organisms and host cells, as well as to persist as a latent infection within parasite constructed structures called tissue cysts. In this study, we characterized a protein secreted by T. gondii into its parasitophorous vacuole during intracellular infection, which we dub GRA64. On the vacuole, this protein is exposed to the host cell and interacts with specific host ESCRT proteins. Parasites lacking the GRA64 protein exhibit ultrastructural changes in tissue cysts during chronic infection. This study lays the foundation for future studies on the mechanics and consequences of host ESCRT-parasite protein interactions.
]]></description>
<dc:creator>Mayoral, J.</dc:creator>
<dc:creator>Guevara, R. B.</dc:creator>
<dc:creator>Rivera-Cuevas, Y.</dc:creator>
<dc:creator>Tu, V.</dc:creator>
<dc:creator>Tomita, T.</dc:creator>
<dc:creator>Romano, J. D.</dc:creator>
<dc:creator>Gunther-Cummins, L.</dc:creator>
<dc:creator>Sidoli, S.</dc:creator>
<dc:creator>Coppens, I.</dc:creator>
<dc:creator>Carruthers, V. B.</dc:creator>
<dc:creator>Weiss, L. M.</dc:creator>
<dc:date>2021-11-03</dc:date>
<dc:identifier>doi:10.1101/2021.11.02.467042</dc:identifier>
<dc:title><![CDATA[Dense granule protein, GRA64 interacts with host cell ESCRT proteins during Toxoplasma gondii infection]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-11-03</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.11.09.467887v1?rss=1">
<title>
<![CDATA[
Maf1, a repressor of RNA polymerase III-dependent transcription, regulates bone mass 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.11.09.467887v1?rss=1</link>
<description><![CDATA[
Maf1, a key repressor of RNA polymerase III-mediated transcription, has been shown to promote mesoderm formation in vitro. Here, we show, for the first time, that Maf1 plays a critical role in the regulation of osteoblast differentiation and bone mass. A high bone mass phenotype was noted in mice with global deletion of Maf1 (Maf1-/- mice), as well as paradoxically, in mice that overexpressed MAF1 in cells of the osteoblast lineage (Prx1-Cre;LSL-Maf1 mice). Osteoblasts isolated from Maf1-/- mice showed reduced osteoblastogenesis ex vivo. Prx1-Cre;LSL-MAF1 mice showed enhanced osteoblastogenesis concordant with their high bone mass phenotype. Thus, the high bone mass phenotype in Maf1-/- mice is likely due to the confounding effects of the global absence of Maf1 in Maf1-/- mice. Expectedly, MAF1 overexpression promoted osteoblast differentiation and shRNA-mediated Maf1 downregulation inhibited differentiation of ST2 cells, overall indicating Maf1 enhances osteoblast formation. We also found that, in contrast to MAF1 overexpression, other perturbations that repress RNA pol III transcription, including Brf1 knockdown and the chemical inhibition of RNA pol III by ML-60218, inhibited osteoblast differentiation. All perturbations that decrease RNA pol III transcription, however, enhanced adipogenesis in ST2 cell cultures. RNA-seq was used to determine the basis for these opposing actions on osteoblast differentiation. The modalities used to alter RNA pol III transcription resulted in distinct changes gene expression, indicating that this transcription process is highly sensitive to perturbations and triggers diverse gene expression programs and phenotypic outcomes. Specifically, Maf1 induced genes in ST2 cells known to promote osteoblast differentiation. Furthermore, genes that are induced during osteoblast differentiation displayed codon bias. Together, these results reveal a novel role for Maf1 and RNA pol III-mediated transcription in osteoblast fate determination and differentiation and bone mass regulation.
]]></description>
<dc:creator>Busschers, E.</dc:creator>
<dc:creator>Ahmad, N.</dc:creator>
<dc:creator>Sun, L.</dc:creator>
<dc:creator>Iben, J. R.</dc:creator>
<dc:creator>Walkey, C. J.</dc:creator>
<dc:creator>Rusin, A.</dc:creator>
<dc:creator>Yuen, T.</dc:creator>
<dc:creator>J. Rosen, C.</dc:creator>
<dc:creator>Willis, I. M.</dc:creator>
<dc:creator>Zaidi, M.</dc:creator>
<dc:creator>Johnson, D. L.</dc:creator>
<dc:date>2021-11-11</dc:date>
<dc:identifier>doi:10.1101/2021.11.09.467887</dc:identifier>
<dc:title><![CDATA[Maf1, a repressor of RNA polymerase III-dependent transcription, regulates bone mass]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-11-11</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.11.12.468452v1?rss=1">
<title>
<![CDATA[
Transcriptional regulation of neonatal neural stem cells is a determinant of social behavior 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.11.12.468452v1?rss=1</link>
<description><![CDATA[
Rare gene variants confer a high level of penetrance to neurodevelopmental disorders, but their developmental origin and cellular substrates remain poorly understood. To address this limitation, we explored the role of TBX1, a gene encoded in a rare copy number variant, in cell and mouse models. Here, we report that neonatal Tbx1 deficiency contributes to defective peripubertal social behavior and impairs the proliferation of neonatal neural stem/progenitor cells. Moreover, TBX1 transcriptionally regulates genes linked to post-embryonic neurogenesis and neurodevelopmental disorders associated with other rare gene variants. Our data indicate a precise time window and cell type through which the social dimension is altered by a gene encoded in a rare CNV and provide a potential common mechanistic basis for a group of neurodevelopmental disorders.

One-Sentence SummaryTbx1, a gene affecting neonatal stem cell proliferation, influences peripubertal social behavior.
]]></description>
<dc:creator>Hiramoto, T.</dc:creator>
<dc:creator>Boku, S.</dc:creator>
<dc:creator>Kang, G.</dc:creator>
<dc:creator>Abe, S.</dc:creator>
<dc:creator>Barbachan e Silva, M.</dc:creator>
<dc:creator>Tanigaki, K.</dc:creator>
<dc:creator>Nagashima, M.</dc:creator>
<dc:creator>Ye, K.</dc:creator>
<dc:creator>Yamauchi, T.</dc:creator>
<dc:creator>Michurina, T. V.</dc:creator>
<dc:creator>O Broin, P.</dc:creator>
<dc:creator>Enikolopov, G.</dc:creator>
<dc:creator>Hiroi, N.</dc:creator>
<dc:date>2021-11-13</dc:date>
<dc:identifier>doi:10.1101/2021.11.12.468452</dc:identifier>
<dc:title><![CDATA[Transcriptional regulation of neonatal neural stem cells is a determinant of social behavior]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-11-13</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.11.15.468657v1?rss=1">
<title>
<![CDATA[
Learning a new class of multisensory associations: High-density electrophysiological mapping of the temporal course of audio-visual object processing. 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.11.15.468657v1?rss=1</link>
<description><![CDATA[
Multisensory objects that are frequently encountered in the natural environment lead to strong associations across a distributed sensory cortical network, with the end result experience of a unitary percept. Remarkably little is known, however, about the cortical processes sub-serving multisensory object formation and recognition. To advance our understanding in this important domain, the present study investigated the brain processes involved in learning and identification of novel visual-auditory objects. Specifically, we introduce and test a rudimentary three-stage model of multisensory object-formation and processing. Thirty adults were remotely trained for a week to recognize a novel class of multisensory objects (3D shapes paired to complex sounds), and high-density event related potentials (ERPs) were recorded to the corresponding unisensory (shapes or sounds only) and multisensory (shapes and sounds) stimuli, before and after intensive training. We identified three major stages of multisensory processing: 1) an early, multisensory, automatic effect (<100 ms) in occipital areas, related to the detection of simultaneous audiovisual signals and not related to multisensory learning 2) an intermediate object-processing stage (100-200 ms) in occipital and parietal areas, sensitive to the learned multisensory associations and 3) a late multisensory processing stage (>250 ms) that appears to be involved in both object recognition and possibly memory consolidation. Results from this study provide support for multiple stages of multisensory object learning and recognition that are subserved by an extended network of cortical areas.
]]></description>
<dc:creator>Vercillo, T.</dc:creator>
<dc:creator>Freedman, E. G.</dc:creator>
<dc:creator>Ewen, J. B.</dc:creator>
<dc:creator>Molholm, S.</dc:creator>
<dc:creator>Foxe, J. J.</dc:creator>
<dc:date>2021-11-15</dc:date>
<dc:identifier>doi:10.1101/2021.11.15.468657</dc:identifier>
<dc:title><![CDATA[Learning a new class of multisensory associations: High-density electrophysiological mapping of the temporal course of audio-visual object processing.]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-11-15</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.11.17.468943v1?rss=1">
<title>
<![CDATA[
SARS-CoV-2 papain-like protease PLpro in complex with natural compounds reveal allosteric sites for antiviral drug design 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.11.17.468943v1?rss=1</link>
<description><![CDATA[
SARS-CoV-2 papain-like protease (PLpro) covers multiple functions. Beside the cysteine-protease activity, PLpro has the additional and vital function of removing ubiquitin and ISG15 (Interferon-stimulated gene 15) from host-cell proteins to aid coronaviruses in evading the hosts innate immune responses. We established a high-throughput X-ray screening to identify inhibitors by elucidating the native PLpro structure refined to 1.42 [A] and performing co-crystallization utilizing a diverse library of selected natural compounds. We identified three phenolic compounds as potential inhibitors. Crystal structures of PLpro inhibitor complexes, obtained to resolutions between 1.7-1.9 [A], show that all three compounds bind at the ISG15/Ub-S2 allosteric binding site, preventing the essential ISG15-PLpro molecular interactions. All compounds demonstrate clear inhibition in a deISGylation assay, two exhibit distinct antiviral activity and one inhibited a cytopathic effect in a non-cytotoxic concentration range. These results highlight the druggability of the rarely explored ISG15/Ub-S2 PLpro allosteric binding site to identify new and effective antiviral compounds. Importantly, in the context of increasing PLpro mutations in the evolving new variants of SARS-CoV-2, the natural compounds we identified may also reinstate the antiviral immune response processes of the host that are down-regulated in COVID-19 infections.
]]></description>
<dc:creator>Srinivasan, V.</dc:creator>
<dc:creator>Brognaro, H.</dc:creator>
<dc:creator>Prabhu, P. R.</dc:creator>
<dc:creator>de Souza, E. E.</dc:creator>
<dc:creator>Guenther, S.</dc:creator>
<dc:creator>Reinke, P. Y. A.</dc:creator>
<dc:creator>J. Lane, T.</dc:creator>
<dc:creator>Ginn, H.</dc:creator>
<dc:creator>Han, H.</dc:creator>
<dc:creator>Ewert, W.</dc:creator>
<dc:creator>Sprenger, J.</dc:creator>
<dc:creator>Koua, F. H. M.</dc:creator>
<dc:creator>Falke, S.</dc:creator>
<dc:creator>Werner, N.</dc:creator>
<dc:creator>Andaleeb, H.</dc:creator>
<dc:creator>Ullah, N.</dc:creator>
<dc:creator>Alves Franca, B.</dc:creator>
<dc:creator>Wang, M.</dc:creator>
<dc:creator>Luana C Barra, A.</dc:creator>
<dc:creator>Perbandt, M.</dc:creator>
<dc:creator>Schwinzer, M.</dc:creator>
<dc:creator>Schmidt, C.</dc:creator>
<dc:creator>Brings, L.</dc:creator>
<dc:creator>Lorenzen, K.</dc:creator>
<dc:creator>Schubert, R.</dc:creator>
<dc:creator>Rahal Guaragna Machado, R.</dc:creator>
<dc:creator>Donizette Candido, E.</dc:creator>
<dc:creator>Bruna Leal Oliveira, D.</dc:creator>
<dc:creator>Luiz Durigon, E.</dc:creator>
<dc:creator>Yefanov, O.</dc:creator>
<dc:creator>Lieske, J.</dc:creator>
<dc:creator>Gelisio, L.</dc:creator>
<dc:creator>Domaracky, M.</dc:creator>
<dc:creator>Middendorf, P.</dc:creator>
<dc:creator>Groessler, M.</dc:creator>
<dc:creator>Trost, F.</dc:creator>
<dc:creator>Galchenkova, M.</dc:creator>
<dc:creator>Saouane, S.</dc:creator>
<dc:creator>Hakanpaeae, J.</dc:creator>
<dc:creator>Wolf, M.</dc:creator>
<dc:creator>Turk, D.</dc:creator>
<dc:creator>P</dc:creator>
<dc:date>2021-11-22</dc:date>
<dc:identifier>doi:10.1101/2021.11.17.468943</dc:identifier>
<dc:title><![CDATA[SARS-CoV-2 papain-like protease PLpro in complex with natural compounds reveal allosteric sites for antiviral drug design]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-11-22</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.11.20.469295v1?rss=1">
<title>
<![CDATA[
A dual voltage clamp technique to study gap junction hemichannels in astrocytes cultured from neonatal rodent spinal cords 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.11.20.469295v1?rss=1</link>
<description><![CDATA[
Astrocytes express surface channels involved in purinergic signaling, and among these channels, pannexin-1 (Px1) and connexin-43 (Cx43) hemichannels (HCs) mediate ATP release that acts directly, or through its derivatives, on neurons and glia via purinergic receptors. Although HCs are functional, i.e., open and close, under physiological and pathological conditions, single channel conductance of Px1 HCs is not well defined. Here, we developed a dual voltage clamp technique in HeLa cells overexpressing human Px1-YFP, and then applied this system to rodent spinal astrocytes. Single channels were recorded in cell attached patches and evoked with ramp cycles of 2 s duration and -/+ 80-100 mV amplitude through another pipette in whole cell clamp. Conductance of Px1 HC openings recorded during ramp stimuli ranged 25-110 pS. Based on their single channel conductances, Px1 HCs could be distinguished from Cx43 HCs and P2X7 receptors (P2X7Rs) in spinal astrocytes during dual voltage clamp experiments. Furthermore, we found that single channel activity of Cx43 HCs and P2X7Rs was increased, and that of Px1 HCs was decreased, in spinal astrocytes treated for 7 h with FGF-1, a growth factor implicated in neurodevelopment, repair and inflammation.
]]></description>
<dc:creator>Garre, J. M.</dc:creator>
<dc:creator>Bukauskas, F. F.</dc:creator>
<dc:creator>Bennett, M. V.</dc:creator>
<dc:date>2021-11-22</dc:date>
<dc:identifier>doi:10.1101/2021.11.20.469295</dc:identifier>
<dc:title><![CDATA[A dual voltage clamp technique to study gap junction hemichannels in astrocytes cultured from neonatal rodent spinal cords]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-11-22</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.11.26.470028v1?rss=1">
<title>
<![CDATA[
Meisosomes, folded membrane platforms, link the epidermis to the cuticle in C. elegans 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.11.26.470028v1?rss=1</link>
<description><![CDATA[
Apical extracellular matrices (aECMs) form a physical barrier to the environment. In C. elegans, the epidermal aECM, the cuticle, is composed mainly of different types of collagen, associated in circumferential ridges separated by furrows. Here, we show that in mutants lacking furrows, the normal intimate connection between the epidermis and the cuticle is lost, specifically at the lateral epidermis, where, in contrast to the dorsal and ventral epidermis, there are no hemidesmosomes. At the ultrastructural level, there is a profound alteration of structures that we term "meisosomes", in reference to eisosomes in yeast. We show that meisosomes are composed of stacked parallel folds of the epidermal plasma membrane, alternately filled with cuticle. We propose that just as hemidesmosomes connect the dorsal and ventral epidermis, above the muscles, to the cuticle, meisosomes connect the lateral epidermis to it. Moreover, furrow mutants present marked modifications of the biomechanical properties of their skin and exhibit a constitutive damage response in the epidermis. As meisosomes co-localise to macrodomains enriched in phosphatidylinositol (4,5) bisphosphate, they might act, like eisosomes, as signalling platforms, to relay tensile information from the aECM to the underlying epidermis, as part of an integrated stress response to damage.
]]></description>
<dc:creator>Aggad, D.</dc:creator>
<dc:creator>Omi, S.</dc:creator>
<dc:creator>Essmann, C. L.</dc:creator>
<dc:creator>Brouilly, N.</dc:creator>
<dc:creator>Richard, F.</dc:creator>
<dc:creator>Cazevieille, C.</dc:creator>
<dc:creator>Politi, K. A.</dc:creator>
<dc:creator>Hall, D. D.</dc:creator>
<dc:creator>Ewbank, J.</dc:creator>
<dc:creator>Pujol, R.</dc:creator>
<dc:creator>Pujol, N.</dc:creator>
<dc:date>2021-11-26</dc:date>
<dc:identifier>doi:10.1101/2021.11.26.470028</dc:identifier>
<dc:title><![CDATA[Meisosomes, folded membrane platforms, link the epidermis to the cuticle in C. elegans]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-11-26</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.11.28.470233v1?rss=1">
<title>
<![CDATA[
Global analysis of human-to-mouse intercellular RNA transfer in cell culture 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.11.28.470233v1?rss=1</link>
<description><![CDATA[
Full-length mRNAs can transfer between adjacent mammalian cells via direct cell-to-cell connections called tunneling nanotubes (TNTs). However, the extent of mRNA transfer at the transcriptome-wide level (the transferome) is unknown. Here, we analyzed whole transcriptome mRNA and lncRNA transfer between heterogeneous human-mouse cell populations in in vitro co-culture using RNA-sequencing. Our data indicate that mRNA transfer is non-selective, prevalent across the human transcriptome, and that the amount of transfer to mouse embryonic fibroblasts (MEFs) strongly correlates with the endogenous level of gene expression in donor human breast cancer cells (MCF7). These results were validated by both quantitative RT-PCR and in situ hybridization, and analysis shows that typically <1% of endogenous mRNAs and lncRNAs undergo transfer. Non-selective expression-dependent RNA transfer was further validated using synthetic RNA reporters. Notably, significant differential changes in the native MEF transcriptome were observed in response to co-culture, including the upregulation of multiple cancer and cancer-associated fibroblast-related genes and pathways. Together, these results lead us to suggest that TNT-mediated RNA transfer could be a phenomenon of physiological importance under both normal and pathogenic conditions.

O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=183 SRC="FIGDIR/small/470233v2_ufig1.gif" ALT="Figure 1">
View larger version (44K):
org.highwire.dtl.DTLVardef@13a7176org.highwire.dtl.DTLVardef@1ef1c75org.highwire.dtl.DTLVardef@1355eeforg.highwire.dtl.DTLVardef@ebc275_HPS_FORMAT_FIGEXP  M_FIG C_FIG
]]></description>
<dc:creator>Dasgupta, S.</dc:creator>
<dc:creator>Dyagi, D. Y.</dc:creator>
<dc:creator>Haimovich, G.</dc:creator>
<dc:creator>Wyler, E.</dc:creator>
<dc:creator>Olender, T.</dc:creator>
<dc:creator>Singer, R. H.</dc:creator>
<dc:creator>Landthaler, M.</dc:creator>
<dc:creator>Gerst, J. E.</dc:creator>
<dc:date>2021-11-28</dc:date>
<dc:identifier>doi:10.1101/2021.11.28.470233</dc:identifier>
<dc:title><![CDATA[Global analysis of human-to-mouse intercellular RNA transfer in cell culture]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-11-28</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.11.29.470444v1?rss=1">
<title>
<![CDATA[
Bet-hedging antimicrobial strategies in macrophage phagosome acidification drive the dynamics of Cryptococcus neoformans intracellular escape mechanisms 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.11.29.470444v1?rss=1</link>
<description><![CDATA[
The fungus Cryptococcus neoformans is a major human pathogen with a remarkable intracellular survival strategy that includes exiting macrophages through non-lytic exocytosis (Vomocytosis) and transferring between macrophages (Dragotcytosis) by a mechanism that involves sequential events of non-lytic exocytosis and phagocytosis. Vomocytosis and Dragotcytosis are fungal driven processes, but their triggers are not understood. We hypothesized that the dynamics of Dragotcytosis could inherit the stochasticity of phagolysosome acidification and that Dragotcytosis was triggered by fungal cell stress. Consistent with this view, fungal cells involved in Dragotcytosis reside in phagolysosomes characterized by low pH and/or high oxidative stress. Using fluorescent microscopy, qPCR, live cell video microscopy, and fungal growth assays we found that the that mitigating pH or oxidative stress abrogated Dragotcytosis frequency, that ROS susceptible mutants of C. neoformans underwent Dragotcytosis more frequently. Dragotcytosis initiation was linked to phagolysosomal pH and oxidative stresses and correlated with the macrophage polarization state. Dragotcytosis manifested stochastic dynamics thus paralleling the dynamics of phagosomal acidification, which correlated with the inhospitality of phagolysosomes in differently polarized macrophages. Hence, randomness in phagosomal acidification randomly created a population of inhospitable phagosomes where fungal cell stress triggered stochastic C. neoformans non-lytic exocytosis dynamics to escape a non-permissive intracellular macrophage environment.
]]></description>
<dc:creator>Dragotakes, Q.</dc:creator>
<dc:creator>Jacobs, E.</dc:creator>
<dc:creator>Ramirez, L. S.</dc:creator>
<dc:creator>Yoon, O. I.</dc:creator>
<dc:creator>Perez-Stable, C.</dc:creator>
<dc:creator>Eden, H.</dc:creator>
<dc:creator>Pagnotta, J.</dc:creator>
<dc:creator>Vij, R.</dc:creator>
<dc:creator>Bergman, A.</dc:creator>
<dc:creator>D'Alessio, F.</dc:creator>
<dc:creator>Casadevall, A.</dc:creator>
<dc:date>2021-11-29</dc:date>
<dc:identifier>doi:10.1101/2021.11.29.470444</dc:identifier>
<dc:title><![CDATA[Bet-hedging antimicrobial strategies in macrophage phagosome acidification drive the dynamics of Cryptococcus neoformans intracellular escape mechanisms]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-11-29</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.12.07.471603v1?rss=1">
<title>
<![CDATA[
Using coexpression to explore cell-type diversity with the fcoex package 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.12.07.471603v1?rss=1</link>
<description><![CDATA[
Here, we present the fcoex package, which infers coexpression from scRNA-seq data and yields multiple, overlapping classes of cells based on coexpression modules. The tool extends the current scRNA-seq toolbox, providing a multi-hierarchy view on cell functionality and enabling the development of more complete cell atlases. Single-cell RNA sequencing (scRNA-seq) captures details of the cellular landscape, basing a fine-grained view on biological processes. Current pipelines, however, are restricted to single-label perspectives, missing details of the classification landscape. In the pbmc3k blood cell dataset, fcoex detects known classes, like antigen-presenting cells and a new theoretical group of cells, marked by the expression of FCGR3A (CD16). Fcoex extends the current scRNA-seq toolbox, providing a multi-hierarchy view on cell functions as a tool to develop complete cell type atlases.

Availability and ImplementationFcoex is written in R and openly available in Bioconductor (https://bioconductor.org/packages/fcoex/).

Supplementary informationSupplementary data is available at the end of the manuscript. Source code for analysis is available at https://github.com/csbl-inovausp/fcoex_analysis;
]]></description>
<dc:creator>Lubiana, T.</dc:creator>
<dc:creator>Nakaya, H.</dc:creator>
<dc:date>2021-12-09</dc:date>
<dc:identifier>doi:10.1101/2021.12.07.471603</dc:identifier>
<dc:title><![CDATA[Using coexpression to explore cell-type diversity with the fcoex package]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-12-09</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.12.07.471619v1?rss=1">
<title>
<![CDATA[
MacroH2A impedes metastatic growth by enforcing a discrete dormancy program in disseminated cancer cells 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.12.07.471619v1?rss=1</link>
<description><![CDATA[
AO_SCPLOWBSTRACTC_SCPLOWMacroH2A variants have been associated with tumor suppression through inhibition of proliferation and metastasis, as well as their role in cellular senescence. However, their role in regulating the dormant state of disseminated cancer cells (DCCs) remains unclear. Here we reveal that solitary dormant DCCs display increased levels of macroH2A variants in head and neck squamous cell carcinoma PDX models and patient samples compared to proliferating primary or metastatic lesions. We further demonstrate that microenvironmental and stress adaptive signals such as TGF{beta}2 and p38/{beta}, which induce DCC dormancy, upregulate macroH2A expression. Functionally, we find that overexpression of macroH2A variants is sufficient to induce tumor cells into dormancy and notably, inducible expression of the macroH2A2 variant suppresses the growth of DCCs into overt metastasis. However, this dormant state does not require well-characterized dormancy factors such as DEC2 and NR2F1, suggesting alternate pathways. Our transcriptomic analyses reveal that macroH2A2 overexpression inhibits E2F, RAS and MYC signaling programs, while upregulating inflammatory cytokines commonly secreted by senescent cells. Taken together, our results demonstrate that macroH2A2 enforces a stable dormant phenotype in DCCs by activating a select subset of dormancy and senescence genes that limit metastasis initiation.
]]></description>
<dc:creator>Sun, D.</dc:creator>
<dc:creator>Filipescu, D.</dc:creator>
<dc:creator>Hasson, D.</dc:creator>
<dc:creator>Singh, D. K.</dc:creator>
<dc:creator>Carcamo, S.</dc:creator>
<dc:creator>Khalil, B.</dc:creator>
<dc:creator>Miles, B.</dc:creator>
<dc:creator>Westra, W.</dc:creator>
<dc:creator>Sproll, K. C.</dc:creator>
<dc:creator>Bernstein, E.</dc:creator>
<dc:creator>Aguirre-Ghiso, J. A.</dc:creator>
<dc:date>2021-12-07</dc:date>
<dc:identifier>doi:10.1101/2021.12.07.471619</dc:identifier>
<dc:title><![CDATA[MacroH2A impedes metastatic growth by enforcing a discrete dormancy program in disseminated cancer cells]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-12-07</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.12.07.471632v1?rss=1">
<title>
<![CDATA[
Modeling diverse genetic subtypes of lung adenocarcinoma with a next-generation alveolar type 2 organoid platform 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.12.07.471632v1?rss=1</link>
<description><![CDATA[
Lung cancer is the leading cause of cancer-related death worldwide. Lung adenocarcinoma (LUAD), the most common histological subtype, accounts for 40% of all cases. While genetically engineered mouse models (GEMMs) recapitulate the histological progression and transcriptional evolution of human LUAD, they are slow and technically demanding. In contrast, cell line transplant models are fast and flexible, but are often derived from clonal idiosyncratic tumors that fail to capture the full spectrum of clinical disease. Organoid technologies provide a means to create next-generation cancer models that integrate the most relevant features of autochthonous and transplant-based systems, yet robust and faithful LUAD organoid platforms are currently lacking. Here, we describe optimized conditions to continuously expand murine alveolar type 2 cells (AT2), a prominent cell-of-origin for LUAD, in organoid culture. These organoids display canonical features of AT2 cells, including marker gene expression, the presence of lamellar bodies, and an ability to differentiate into the AT1 lineage. We used this system to develop flexible and versatile immunocompetent organoid-based models of KRAS and ALK-mutant LUAD. Notably, the resultant tumors closely resemble their autochthonous murine counterparts and human LUAD. In contrast to comparable organoid platforms, our system supports long-term maintenance of the AT2 cellular identity, providing unprecedented ease and reliability to study AT2 and LUAD biology in vitro and in vivo.
]]></description>
<dc:creator>Naranjo, S.</dc:creator>
<dc:creator>Cabana, C. M.</dc:creator>
<dc:creator>LaFave, L. M.</dc:creator>
<dc:creator>Westcott, P. M.</dc:creator>
<dc:creator>Romero, R.</dc:creator>
<dc:creator>Ghosh, A.</dc:creator>
<dc:creator>Liao, L. Z.</dc:creator>
<dc:creator>Schenkel, J. M.</dc:creator>
<dc:creator>Del Priore, I.</dc:creator>
<dc:creator>Bhutkar, A.</dc:creator>
<dc:creator>Yang, D.</dc:creator>
<dc:creator>Jacks, T.</dc:creator>
<dc:date>2021-12-07</dc:date>
<dc:identifier>doi:10.1101/2021.12.07.471632</dc:identifier>
<dc:title><![CDATA[Modeling diverse genetic subtypes of lung adenocarcinoma with a next-generation alveolar type 2 organoid platform]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-12-07</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.12.08.471650v1?rss=1">
<title>
<![CDATA[
Antagonism of D1, but not D2, dopamine receptors inhibits cued sucrose seeking by decreasing arousal 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.12.08.471650v1?rss=1</link>
<description><![CDATA[
Dopamine facilitates approach to reward via its actions on dopamine receptors in the nucleus accumbens. For example, blocking either D1 or D2 dopamine receptors in the accumbens reduces the proportion of reward-predictive cues to which rats respond with cued approach. Recent evidence indicates that accumbens dopamine also promotes wakefulness and arousal, but the relationship between dopamines roles in arousal and reward seeking remains unexplored. Here, we show that the ability of systemic or intra-accumbens injections of the D1 antagonist SCH23390 to reduce cued approach to reward depends on the animals state of arousal. Handling the animal, a manipulation known to increase arousal, was sufficient to reverse the behavioral effects of the antagonist. In addition, SCH23390 reduced spontaneous locomotion and increased time spent in sleep postures, both consistent with reduced arousal, but also increased time spent immobile in postures inconsistent with sleep. In contrast, the ability of the D2 antagonist haloperidol to reduce cued approach was not reversible by handling. Haloperidol reduced spontaneous locomotion but did not increase sleep postures, instead increasing immobility in non-sleep postures. We place these results in the context of the extensive literature on dopamines contributions to behavior, and propose the arousal-motor hypothesis. This novel synthesis, which proposes that two main functions of dopamine are to promote arousal and facilitate motor behavior, accounts both for our findings and many previous behavioral observations that have led to disparate and conflicting conclusions.
]]></description>
<dc:creator>Kazmierczak, M.</dc:creator>
<dc:creator>Nicola, S. M.</dc:creator>
<dc:date>2021-12-09</dc:date>
<dc:identifier>doi:10.1101/2021.12.08.471650</dc:identifier>
<dc:title><![CDATA[Antagonism of D1, but not D2, dopamine receptors inhibits cued sucrose seeking by decreasing arousal]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-12-09</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.12.09.471942v1?rss=1">
<title>
<![CDATA[
A genetic disorder reveals a hematopoietic stem cell regulatory network co-opted in leukemia 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.12.09.471942v1?rss=1</link>
<description><![CDATA[
The molecular regulation of human hematopoietic stem cell (HSC) maintenance is therapeutically important, but limitations in experimental systems and interspecies variation have constrained our knowledge of this process. Here, we have studied a rare genetic disorder due to MECOM haploinsufficiency, characterized by an early-onset absence of HSCs in vivo. By generating a faithful model of this disorder in primary human HSCs and coupling functional studies with integrative single-cell genomic analyses, we uncover a key transcriptional network involving hundreds of genes that is required for HSC maintenance. Through our analyses, we nominate cooperating transcriptional regulators and identify how MECOM prevents the CTCF-dependent genome reorganization that occurs as HSCs differentiate. Strikingly, we show that this transcriptional network is co-opted in high-risk leukemias, thereby enabling these cancers to acquire stem cell properties. Collectively, we illuminate a regulatory network necessary for HSC self-renewal through the study of a rare experiment of nature.
]]></description>
<dc:creator>Voit, R. A.</dc:creator>
<dc:creator>Tao, L.</dc:creator>
<dc:creator>Yu, F.</dc:creator>
<dc:creator>Cato, L. D.</dc:creator>
<dc:creator>Cohen, B.</dc:creator>
<dc:creator>Liao, X.</dc:creator>
<dc:creator>Fiorini, C.</dc:creator>
<dc:creator>Nandakumar, S. K.</dc:creator>
<dc:creator>Wahlster, L.</dc:creator>
<dc:creator>Teichert, K.</dc:creator>
<dc:creator>Regev, A.</dc:creator>
<dc:creator>Sankaran, V. G.</dc:creator>
<dc:date>2021-12-09</dc:date>
<dc:identifier>doi:10.1101/2021.12.09.471942</dc:identifier>
<dc:title><![CDATA[A genetic disorder reveals a hematopoietic stem cell regulatory network co-opted in leukemia]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-12-09</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.12.10.471810v1?rss=1">
<title>
<![CDATA[
Clonal hematopoiesis is driven by aberrant activation of TCL1A 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.12.10.471810v1?rss=1</link>
<description><![CDATA[
A diverse set of driver genes, such as regulators of DNA methylation, RNA splicing, and chromatin remodeling, have been associated with pre-malignant clonal expansion of hematopoietic stem cells (HSCs). The factors mediating expansion of these mutant clones remain largely unknown, partially due to a paucity of large cohorts with longitudinal blood sampling. To circumvent this limitation, we developed and validated a method to infer clonal expansion rate from single timepoint data called PACER (passenger-approximated clonal expansion rate). Applying PACER to 5,071 persons with clonal hematopoiesis accurately recapitulated the known fitness effects due to different driver mutations. A genome-wide association study of PACER revealed that a common inherited polymorphism in the TCL1A promoter was associated with slower clonal expansion. Those carrying two copies of this protective allele had up to 80% reduced odds of having driver mutations in TET2, ASXL1, SF3B1, SRSF2, and JAK2, but not DNMT3A. TCL1A was not expressed in normal or DNMT3A-mutated HSCs, but the introduction of mutations in TET2 or ASXL1 by CRISPR editing led to aberrant expression of TCL1A and expansion of HSCs in vitro. These effects were abrogated in HSCs from donors carrying the protective TCL1A allele. Our results indicate that the fitness advantage of multiple common driver genes in clonal hematopoiesis is mediated through TCL1A activation. PACER is an approach that can be widely applied to uncover genetic and environmental determinants of pre-malignant clonal expansion in blood and other tissues.
]]></description>
<dc:creator>Weinstock, J. S.</dc:creator>
<dc:creator>Gopakumar, J.</dc:creator>
<dc:creator>Burugula, B. B.</dc:creator>
<dc:creator>Uddin, M. M.</dc:creator>
<dc:creator>Jahn, N.</dc:creator>
<dc:creator>Belk, J. A.</dc:creator>
<dc:creator>Daniel, B.</dc:creator>
<dc:creator>Ly, N.</dc:creator>
<dc:creator>Mack, T. M.</dc:creator>
<dc:creator>Laurie, C. A.</dc:creator>
<dc:creator>Broome, J. G.</dc:creator>
<dc:creator>Taylor, K. D.</dc:creator>
<dc:creator>Guo, X.</dc:creator>
<dc:creator>Sinner, M. F.</dc:creator>
<dc:creator>von Falkenhausen, A. S.</dc:creator>
<dc:creator>Kaab, S.</dc:creator>
<dc:creator>Shuldiner, A. R.</dc:creator>
<dc:creator>O'Connell, J. R.</dc:creator>
<dc:creator>Lewis, J. P.</dc:creator>
<dc:creator>Boerwinkle, E.</dc:creator>
<dc:creator>Barnes, K. C.</dc:creator>
<dc:creator>Chami, N.</dc:creator>
<dc:creator>Kenny, E. E.</dc:creator>
<dc:creator>Loos, R. J. F.</dc:creator>
<dc:creator>Fornage, M.</dc:creator>
<dc:creator>Hou, L.</dc:creator>
<dc:creator>Lloyd-Jones, D. M.</dc:creator>
<dc:creator>Redline, S.</dc:creator>
<dc:creator>Cade, B. E.</dc:creator>
<dc:creator>Psaty, B. M.</dc:creator>
<dc:creator>Bis, J. C.</dc:creator>
<dc:creator>Brody, J. A.</dc:creator>
<dc:creator>Silverman, E. K.</dc:creator>
<dc:creator>Yun, J. H.</dc:creator>
<dc:creator>Qiao, D.</dc:creator>
<dc:creator>Palmer, N. D.</dc:creator>
<dc:creator>Freedman, B. I.</dc:creator>
<dc:creator>Bowden, D. W.</dc:creator>
<dc:creator>Cho, M. H.</dc:creator>
<dc:creator>DeMeo, D. L.</dc:creator>
<dc:creator>Vasan, R. S.</dc:creator>
<dc:creator>Johnson, A. D.</dc:creator>
<dc:creator>Mat</dc:creator>
<dc:date>2021-12-13</dc:date>
<dc:identifier>doi:10.1101/2021.12.10.471810</dc:identifier>
<dc:title><![CDATA[Clonal hematopoiesis is driven by aberrant activation of TCL1A]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-12-13</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.12.10.472114v1?rss=1">
<title>
<![CDATA[
Evolution of plasmid mobility: origin and fate of non-conjugative plasmids 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.12.10.472114v1?rss=1</link>
<description><![CDATA[
Conjugation drives horizontal gene transfer of many adaptive traits across prokaryotes. Yet, only a fourth of the plasmids encode the functions necessary to conjugate autonomously, others being non-mobile or mobilizable by other elements. How these different plasmids evolve is poorly understood. Here, we studied plasmid evolution in terms of their gene repertoires and relaxases. We observed that gene content in plasmid varies rapidly in relation to the rate of evolution of relaxases, such that plasmids with 95% identical relaxases have on average fewer than 50% of homologs. The identification of 249 recent transitions in terms of mobility types revealed that they are associated with even greater changes in gene repertoires, possibly mediated by transposable elements that are more abundant in such plasmids. These changes include pseudogenization of the conjugation locus, exchange of replication initiators, and extensive gene loss. In some instances, the transition between mobility types also leads to the genesis of novel plasmid taxonomic units. Most of these transitions are short-lived, suggesting a source-sink dynamic, where conjugative plasmids constantly generate mobilizable and putatively non-mobilizable plasmids by gene deletion. Yet, in few cases such transitions resulted in the emergence of large clades of relaxases present only in mobilizable plasmids, suggesting successful specialization of these families in the hijacking of diverse conjugative systems. Our results shed further light on the huge plasticity of plasmids, suggest that many non-conjugative plasmids emerged recently from conjugative elements and allowed to quantify how changes in plasmid mobility shape the variation of their gene repertoires.
]]></description>
<dc:creator>Coluzzi, C.</dc:creator>
<dc:creator>Garcillan-Barcia, M. d. P.</dc:creator>
<dc:creator>de la Cruz, F.</dc:creator>
<dc:creator>Rocha, E. P. C.</dc:creator>
<dc:date>2021-12-11</dc:date>
<dc:identifier>doi:10.1101/2021.12.10.472114</dc:identifier>
<dc:title><![CDATA[Evolution of plasmid mobility: origin and fate of non-conjugative plasmids]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-12-11</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.12.13.472381v1?rss=1">
<title>
<![CDATA[
A rare human centenarian variant of SIRT6 enhances genome stability and interaction with Lamin A 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.12.13.472381v1?rss=1</link>
<description><![CDATA[
Sirtuin 6 (SIRT6) is a deacylase and mono-ADP ribosyl transferase (mADPr) enzyme involved in multiple cellular pathways implicated in the regulation of aging and metabolism. Targeted sequencing identified a SIRT6 allele containing two linked substitutions (N308K/A313S) as enriched in Ashkenazi Jewish (AJ) centenarians as compared to AJ control individuals. Characterization of this SIRT6 (centSIRT6) allele demonstrated it to be a stronger suppressor of LINE1 retrotransposons, confer enhanced stimulation of DNA double strand break repair, and more robust cancer cell killing compared to the wild type. Surprisingly, centSIRT6 displayed weaker deacetylase activity, but stronger mADPr activity, over a range of NAD+ concentrations and substrates. Additionally, centSIRT6 displayed a stronger interaction with Lamin A/C (LMNA), which correlated with enhanced ribosylation of LMNA. Our results suggest that enhanced SIRT6 function contributes to human longevity by improving genome maintenance via increased mADPr activity and enhanced interaction with LMNA.
]]></description>
<dc:creator>Gorbunova, V.</dc:creator>
<dc:creator>Simon, M.</dc:creator>
<dc:creator>Trombline, G.</dc:creator>
<dc:creator>Yang, J.</dc:creator>
<dc:creator>Earley, E. J.</dc:creator>
<dc:creator>Zhang, L.</dc:creator>
<dc:creator>Gigas, J.</dc:creator>
<dc:creator>Zagorulya, M.</dc:creator>
<dc:creator>Gilbert, M.</dc:creator>
<dc:creator>Robbins, P. D.</dc:creator>
<dc:creator>Vijg, J.</dc:creator>
<dc:creator>Seluanov, A.</dc:creator>
<dc:creator>Suh, Y.</dc:creator>
<dc:creator>Garcia, B.</dc:creator>
<dc:creator>Thomas, D. D.</dc:creator>
<dc:creator>Yuen, S. L.</dc:creator>
<dc:creator>Pope, A.</dc:creator>
<dc:creator>Van Meter, M.</dc:creator>
<dc:creator>Emmrich, S.</dc:creator>
<dc:creator>Moody, K.</dc:creator>
<dc:creator>Barzilai, N.</dc:creator>
<dc:creator>Wolfe, A.</dc:creator>
<dc:creator>Atzmon, G.</dc:creator>
<dc:creator>Schaff, T. M.</dc:creator>
<dc:date>2021-12-13</dc:date>
<dc:identifier>doi:10.1101/2021.12.13.472381</dc:identifier>
<dc:title><![CDATA[A rare human centenarian variant of SIRT6 enhances genome stability and interaction with Lamin A]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-12-13</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.12.16.472826v1?rss=1">
<title>
<![CDATA[
Neural signature of everyday function in older adults at-risk of cognitive impairment 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.12.16.472826v1?rss=1</link>
<description><![CDATA[
Assessment of everyday activities are central to the diagnosis of pre-dementia and dementia. Yet, little is known about the brain substrates and processes that contribute to everyday functional impairment, particularly during early stages of cognitive decline. We investigated everyday function using a complex gait task in normal older adults stratified by risk of cognitive impairment. We applied a novel EEG approach, which combines electroencephalographic with 3D-body tracking technology to measure brain-gait dynamics with millisecond precision while participants are in motion. Twenty-six participants (mean age = 74.9 years) with cognitive and everyday functional profiles within the normal range for their age and sex were ranked for risk of cognitive impairment. We used the Montreal Cognitive Assessment battery, a global index of cognition with a range from 0 to 30, to classify individuals as being at higher (22-26) and lower risk (27+). Individuals walking on a treadmill were exposed to visual perturbation designed to destabilize gait. Assuming that brain changes precede behavioral decline, we predicted that older adults increase step width to gain stability, yet the underlying neural signatures would be different for lower versus higher risk individuals. When pooling across risk groups, we found that step width increased and fronto-parietal activation shifted from transient, during swing phases, to sustained across the gait cycle during visually perturbed input. As predicted, step width increased in both groups but underlying neural signatures were different. Fronto-medial theta (3-7Hz) power of gait-related brain oscillations were increased in higher risk individuals during both perturbed and unperturbed inputs. On the other hand, left central gyri beta (13-28Hz) power was decreased in lower risk individuals, specifically during visually perturbed input. Finally, relating MoCA scores to spectral power pooled across fronto-parietal regions, we found associations between increased theta power and worse MoCA scores and between decreased beta power and better MoCA scores.Able-bodied older adults at-risk of cognitive impairment are characterized by unique neural signatures of mobility. Stronger reliance on frontomedial theta activation in at-risk individuals may reflect higher-order compensatory responses for deterioration of basic sensorimotor processes. Region and spectral-specific signatures of mobility may provide brain targets for early intervention against everyday functional decline.
]]></description>
<dc:creator>De Sanctis, P.</dc:creator>
<dc:creator>Wagner, J.</dc:creator>
<dc:creator>Molholm, S.</dc:creator>
<dc:creator>Foxe, J. J.</dc:creator>
<dc:creator>Blumen, H.</dc:creator>
<dc:creator>Horsthuis, D.</dc:creator>
<dc:date>2021-12-17</dc:date>
<dc:identifier>doi:10.1101/2021.12.16.472826</dc:identifier>
<dc:title><![CDATA[Neural signature of everyday function in older adults at-risk of cognitive impairment]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-12-17</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.12.16.472958v1?rss=1">
<title>
<![CDATA[
Real-time imaging of Arc/Arg3.1 transcription ex vivo reveals input-specific immediate early gene dynamics 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.12.16.472958v1?rss=1</link>
<description><![CDATA[
The ability of neurons to process and store salient environmental features underlies information processing in the brain. Long-term information storage requires synaptic plasticity and regulation of gene expression. While distinct patterns of activity have been linked to synaptic plasticity, their impact on immediate early gene (IEG) expression remains poorly understood. The activity regulated cytoskeleton associated (Arc) gene has received wide attention as an IEG implicated in synaptic plasticity and memory. Yet, to date, the transcriptional dynamics of Arc in response to compartment and input-specific activity is unclear. By developing a knock-in mouse to fluorescently tag Arc alleles, we studied real-time transcription dynamics after stimulation of dentate granule cells (GCs) in acute hippocampal slices. To our surprise, we found that Arc transcription displayed distinct temporal kinetics depending on the activation of excitatory inputs that convey functionally distinct information, i.e. medial and lateral perforant paths (MPP and LPP, respectively). Moreover, the transcriptional dynamics of Arc after synaptic stimulation was similar to direct activation of GCs, although the contribution of ionotropic glutamate receptors, L-type voltage gated calcium channel, and the endoplasmic reticulum (ER) differed. Specifically, we observed an ER-mediated synapse-to-nucleus signal that supported elevations in nuclear calcium, and rapid induction of Arc transcription following MPP stimulation. However, activation of LPP inputs displayed lower nuclear calcium rise, which could underlie the delayed transcriptional onset of Arc. Our findings highlight how input-specific activity distinctly impacts transcriptional dynamics of an IEG linked to learning and memory.

Significance statementEnvironmental experiences trigger neuronal activity that elicits gene expression in the nervous system. Rapid induction of specific genes known as immediate early genes (IEGs) supports activity-dependent changes of neuronal circuits to ultimately influence animal behavior. However, the cellular and molecular mechanisms controlling how distinct forms of neuronal activity modulate IEG expression remains unclear. The activity regulated cytoskeleton associated (Arc) gene is a critical IEG linked to memory. By imaging Arc transcription in real-time after neuronal activity, we identified how different receptors and signaling pathways influence transcriptional induction and dynamics of an IEG. Our findings provide insights into how information received by distinct synaptic inputs could be encoded by modulating IEG dynamics.
]]></description>
<dc:creator>Lituma, P. J.</dc:creator>
<dc:creator>Singer, R. H.</dc:creator>
<dc:creator>Das, S.</dc:creator>
<dc:creator>Castillo, P. E.</dc:creator>
<dc:date>2021-12-17</dc:date>
<dc:identifier>doi:10.1101/2021.12.16.472958</dc:identifier>
<dc:title><![CDATA[Real-time imaging of Arc/Arg3.1 transcription ex vivo reveals input-specific immediate early gene dynamics]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-12-17</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.12.28.474388v1?rss=1">
<title>
<![CDATA[
Interleukin 4 controls the role of macrophages in pulmonary metastatic tumor cell seeding and growth 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.12.28.474388v1?rss=1</link>
<description><![CDATA[
Metastasis is the systemic manifestation of cancer and the main cause of death from breast cancer. In mouse models of lung metastases, recruitment of classical monocytes from blood to the lung and their differentiation to metastasis-associated macrophages (MAMs) facilitate cancer cell extravasation, survival, and growth. Ablation of MAMs or their monocytic progenitors inhibits metastasis. We hypothesized that factors controlling macrophage polarization modulate tumor cell extravasation in the lung. We evaluated whether signaling by Th1 or Th2 cytokines in macrophages affected trans-endothelial migration of tumor cells in vitro. Interferon {gamma} and LPS inhibited macrophage-dependent tumor cell extravasation while the Th2 cytokine interleukin-4 (IL4) enhanced this process. We demonstrated that IL4 receptor (IL4r) null mice develop fewer and smaller lung metastasis. Adoptive transfer of wild type monocytes to IL4r deficient mice rescued this phenotype. IL4 signaling in macrophages controls the expression of the chemokine receptor CXCR2, necessary for IL4-mediated tumor cell extravasation in vitro. Furthermore, IL4 signaling in macrophages transcriptionally regulates several other genes already causally associated with lung metastasis including CCL2, CSF1, CCR1, HGF and FLT1. The central role for IL4 signaling in MAMs was confirmed by high-resolution intravital imaging of the lung in mice at the time of metastatic seeding, which showed reduced physical interaction between tumor cells and IL4r-deficient macrophages. This interaction enhances tumor cell survival. These data indicate that IL4 signaling in monocytes and macrophages is key during seeding and growth of breast metastasis in the lung as it regulates pro-tumoral paracrine signaling between cancer cells and macrophages.
]]></description>
<dc:creator>Rodriguez-Tirado, C. A.</dc:creator>
<dc:creator>Entenberg, D.</dc:creator>
<dc:creator>Li, J.</dc:creator>
<dc:creator>Qian, B.-Z.</dc:creator>
<dc:creator>Condeelis, J. S.</dc:creator>
<dc:creator>Pollard, J. W.</dc:creator>
<dc:date>2021-12-29</dc:date>
<dc:identifier>doi:10.1101/2021.12.28.474388</dc:identifier>
<dc:title><![CDATA[Interleukin 4 controls the role of macrophages in pulmonary metastatic tumor cell seeding and growth]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-12-29</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.12.28.474392v1?rss=1">
<title>
<![CDATA[
A transient apical extracellular matrix relays cytoskeletal patterns to shape permanent acellular ridges on the surface of adult C. elegans 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.12.28.474392v1?rss=1</link>
<description><![CDATA[
Apical extracellular matrices can form protruding structures such as denticles, ridges, scales, or teeth on the surfaces of epithelia. The mechanisms that shape these structures remain poorly understood. Here, we show how the actin cytoskeleton and a provisional matrix work together to sculpt acellular longitudinal alae ridges in the cuticle of adult C. elegans. Transient actomyosin-dependent constriction of the underlying lateral epidermis accompanies deposition of the provisional matrix at the earliest stages of alae formation. Actin is required to pattern the provisional matrix into longitudinal bands that are initially offset from the pattern of longitudinal actin filaments. These bands appear ultrastructurally as alternating regions of adhesion and separation within laminated provisional matrix layers. The provisional matrix is required to establish these demarcated zones of adhesion and separation, which ultimately give rise to alae ridges and their intervening valleys, respectively. Provisional matrix proteins shape the alae ridges and valleys but are not present within the final structure. We propose a morphogenetic mechanism wherein cortical actin patterns are relayed mechanically to the laminated provisional matrix to set up distinct zones of matrix layer separation and accretion that shape a permanent and acellular matrix structure.
]]></description>
<dc:creator>Katz, S. S.</dc:creator>
<dc:creator>Barker, T. J.</dc:creator>
<dc:creator>Maul-Newby, H. M.</dc:creator>
<dc:creator>Sparacio, A. P.</dc:creator>
<dc:creator>Nguyen, K. C. Q.</dc:creator>
<dc:creator>Maybrun, C. L.</dc:creator>
<dc:creator>Belfi, A.</dc:creator>
<dc:creator>Cohen, J. D.</dc:creator>
<dc:creator>Hall, D. H.</dc:creator>
<dc:creator>Sundaram, M. V.</dc:creator>
<dc:creator>Frand, A. R.</dc:creator>
<dc:date>2021-12-29</dc:date>
<dc:identifier>doi:10.1101/2021.12.28.474392</dc:identifier>
<dc:title><![CDATA[A transient apical extracellular matrix relays cytoskeletal patterns to shape permanent acellular ridges on the surface of adult C. elegans]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-12-29</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.12.30.474558v1?rss=1">
<title>
<![CDATA[
BDNF-induced BDNF release mediates presynaptic LTP and is regulated by cannabinoids 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.12.30.474558v1?rss=1</link>
<description><![CDATA[
The brain-derived neurotrophic factor (BDNF) and its effector Tropomyosin receptor kinase B (TrkB) mediate diverse forms of activity-dependent synaptic plasticity implicated in learning, neural circuit refinement, and brain diseases, including epilepsy and mood disorders. Here, we report that activity-dependent release of presynaptic BDNF elicits the release of postsynaptic BDNF in a TrkB- and calcium-dependent manner. This BDNF-induced BDNF release was required for the induction of presynaptic long-term potentiation (LTP) of excitatory transmission in the mouse dentate gyrus. Tonic and phasic activity of presynaptic type-1 cannabinoid receptors suppressed BDNF release and dampened LTP, while exposure to enriched environment elicited BDNF-mediated LTP. In addition to mediating presynaptic plasticity, BDNF-induced BDNF release could be an important mechanism in synaptic stabilization during the maturation and refinement of neuronal connections.

One-Sentence SummaryThe brain-derived neurotrophic factor induces its own release to mediate long-lasting increase in neurotransmitter release.
]]></description>
<dc:creator>Berthoux, C.</dc:creator>
<dc:creator>Nasrallah, K.</dc:creator>
<dc:creator>Castillo, P. E.</dc:creator>
<dc:date>2021-12-30</dc:date>
<dc:identifier>doi:10.1101/2021.12.30.474558</dc:identifier>
<dc:title><![CDATA[BDNF-induced BDNF release mediates presynaptic LTP and is regulated by cannabinoids]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2021-12-30</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2021.12.30.474568v1?rss=1">
<title>
<![CDATA[
The synaptic organization in the  C. elegans neural network suggests significant local compartmentalized computations 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2021.12.30.474568v1?rss=1</link>
<description><![CDATA[
Neurons are characterized by elaborate tree-like dendritic structures that support local computations by integrating multiple inputs from upstream presynaptic neurons. It is less clear if simple neurons, consisting of a few or even a single neurite, may perform local computations as well. To address this question, we focused on the compact neural network of C. elegans animals for which the full wiring diagram is available, including the coordinates of individual synapses. We find that the positions of the chemical synapses along the neurites are not randomly distributed, nor can they be explained by anatomical constraints. Instead, synapses tend to form clusters, an organization that supports local compartmentalized computations. In mutually-synapsing neurons, connections of opposite polarity cluster separately, suggesting that positive and negative feedback dynamics may be implemented in discrete compartmentalized regions along neurites. In triple-neuron circuits, the non-random synaptic organization may facilitate local functional roles, such as signal integration and coordinated activation of functionally-related downstream neurons. These clustered synaptic topologies emerge as a guiding principle in the network presumably to facilitate distinct parallel functions along a single neurite, effectively increasing the computational capacity of the neural network.
]]></description>
<dc:creator>Ruach, R.</dc:creator>
<dc:creator>Ratner, N.</dc:creator>
<dc:creator>Emmons, S. W.</dc:creator>
<dc:creator>Zaslaver, A.</dc:creator>
<dc:date>2022-01-01</dc:date>
<dc:identifier>doi:10.1101/2021.12.30.474568</dc:identifier>
<dc:title><![CDATA[The synaptic organization in the  C. elegans neural network suggests significant local compartmentalized computations]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-01-01</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.01.11.475775v1?rss=1">
<title>
<![CDATA[
Glutamine is required for M1-like polarization in response to Mycobacterium tuberculosis infection 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.01.11.475775v1?rss=1</link>
<description><![CDATA[
In response to Mycobacterium tuberculosis infection, macrophages mount early proinflammatory and antimicrobial responses similar to those observed in M1 macrophages classically activated by LPS and IFN-{gamma}. A metabolic reprogramming to HIF-1-mediated uptake of glucose and its metabolism by glycolysis is required for M1-like polarization, but little is known about other metabolic programs driving M1-like polarization during M. tuberculosis infection. Identification and quantification of labeling patterns of U13C glutamine and U13C glucose-derived metabolites demonstrated that glutamine, rather than glucose, is catabolized in both the oxidative and reductive TCA cycle of M1-like macrophages, thereby generating signaling molecules that include succinate, biosynthetic precursors such as aspartate, and the antimicrobial metabolite itaconate. This conclusion is corroborated by diminished M1 polarization via chemical inhibition of glutaminase (GLS), the key enzyme of the glutaminolysis pathway, and by genetic deletion of GLS in infected macrophages. Furthermore, characterization of the labeling distribution pattern of U15N glutamine in M1-like macrophages indicates that glutamine serves as a nitrogen source for the synthesis of intermediates of purine and pyrimidine metabolism plus amino acids including aspartate. Thus, the catabolism of glutamine, as an integral component of metabolic reprogramming in activating macrophages, fulfills the cellular demand for bioenergetic and biosynthetic precursors of M1-like macrophages. Knowledge of these new immunometabolic features of M1-like macrophages is expected to advance the development of host-directed therapies that will enhance bacterial clearance and prevent immunopathology during tuberculosis.

SummaryRecent advances in immunometabolism have stimulated increasing interest in understanding the specific cellular metabolic states of immune cells associated with the various disease states of tuberculosis. As the primary target of Mycobacterium tuberculosis (Mtb) infection, macrophages play essential roles in dictating the progression and final outcome of infection. Previous studies, including our own, show that the upregulation of hypoxia-inducible-factor 1 alpha (HIF-1) and a metabolic reprogramming to the Warburg effect-like state are general features of the host immune cell response to Mtb infection. They are also critical for macrophage polarization to the M1-like phenotype characterized by high-level expression of proinflammatory and antimicrobial molecules against Mtb infection. However, our knowledge about the immunometabolic features of M1-like macrophages is poor. Using widely targeted small metabolite (WTSM) screening (600+ small polar metabolites) and stable isotope tracing of U13 glutamine, U13 glucose, and N15 glutamine, as well as therapeutic and genetic approaches, we report that, in addition to elevated glucose catabolism by glycolysis, glutamine serves as an important carbon and nitrogen source for the generation of building blocks, signaling molecules, and antimicrobial metabolite during macrophage polarization to the M1-like phenotype. The study adds novel insights into the immunometabolic properties of Mtb-infected macrophages.
]]></description>
<dc:creator>Shi, L.</dc:creator>
<dc:creator>Jiang, Q.</dc:creator>
<dc:creator>Qiu, Y.</dc:creator>
<dc:creator>Kurland, I. J.</dc:creator>
<dc:creator>Drlica, K.</dc:creator>
<dc:creator>Subbian, S.</dc:creator>
<dc:creator>Tyagi, S.</dc:creator>
<dc:date>2022-01-11</dc:date>
<dc:identifier>doi:10.1101/2022.01.11.475775</dc:identifier>
<dc:title><![CDATA[Glutamine is required for M1-like polarization in response to Mycobacterium tuberculosis infection]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-01-11</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.01.12.475944v1?rss=1">
<title>
<![CDATA[
Epigenetic dysregulation from chromosomal transit in micronuclei 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.01.12.475944v1?rss=1</link>
<description><![CDATA[
Chromosomal instability (CIN) and epigenetic alterations are characteristics of advanced and metastatic cancers [1-4], yet whether they are mechanistically linked is unknown. Here we show that missegregation of mitotic chromosomes, their sequestration in micronuclei [5, 6], and subsequent micronuclear envelope rupture [7] profoundly disrupt normal histone post-translational modifications (PTMs), a phenomenon conserved across humans and mice as well as cancer and non-transformed cells. Some of the changes to histone PTMs occur due to micronuclear envelope rupture whereas others are inherited from mitotic abnormalities prior to micronucleus formation. Using orthogonal techniques, we show that micronuclei exhibit extensive differences in chromatin accessibility with a strong positional bias between promoters and distal or intergenic regions. Finally, we show that inducing CIN engenders widespread epigenetic dysregulation and that chromosomes which transit in micronuclei experience durable abnormalities in their accessibility long after they have been reincorporated into the primary nucleus. Thus, in addition to genomic copy number alterations, CIN can serve as a vehicle for epigenetic reprogramming and heterogeneity in cancer.
]]></description>
<dc:creator>Agustinus, A.</dc:creator>
<dc:creator>Raviram, R.</dc:creator>
<dc:creator>Dameracharla, B.</dc:creator>
<dc:creator>Luebeck, J.</dc:creator>
<dc:creator>Stransky, S.</dc:creator>
<dc:creator>Scipioni, L.</dc:creator>
<dc:creator>Myers, R.</dc:creator>
<dc:creator>DiBona, M.</dc:creator>
<dc:creator>Duran, M.</dc:creator>
<dc:creator>Weigelt, B.</dc:creator>
<dc:creator>Yomtoubian, S.</dc:creator>
<dc:creator>Toufektchan, E.</dc:creator>
<dc:creator>Mischel, P.</dc:creator>
<dc:creator>Mittal, V.</dc:creator>
<dc:creator>Shah, S.</dc:creator>
<dc:creator>Maciejowski, J.</dc:creator>
<dc:creator>Gratton, E.</dc:creator>
<dc:creator>Ly, P.</dc:creator>
<dc:creator>Bakhoum, M.</dc:creator>
<dc:creator>Landau, D.</dc:creator>
<dc:creator>Bafna, V.</dc:creator>
<dc:creator>Sidoli, S.</dc:creator>
<dc:creator>David, Y.</dc:creator>
<dc:creator>Bakhoum, S. F.</dc:creator>
<dc:date>2022-01-12</dc:date>
<dc:identifier>doi:10.1101/2022.01.12.475944</dc:identifier>
<dc:title><![CDATA[Epigenetic dysregulation from chromosomal transit in micronuclei]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-01-12</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.01.12.476040v1?rss=1">
<title>
<![CDATA[
Heterosynaptic NMDA Receptor Plasticity in Hippocampal Dentate Granule Cells 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.01.12.476040v1?rss=1</link>
<description><![CDATA[
The dentate gyrus is a key relay station that controls information transfer from the entorhinal cortex to the hippocampus proper. This process heavily relies on dendritic integration by dentate granule cells (GCs) of excitatory synaptic inputs from medial and lateral entorhinal cortex via medial and lateral perforant paths (MPP and LPP, respectively). N-methyl-D-aspartate receptors (NMDARs) can contribute significantly to the integrative properties of neurons. While early studies reported that excitatory inputs from entorhinal cortex onto GCs can undergo activity-dependent long-term plasticity of NMDAR-mediated transmission, the input-specificity of this plasticity along the dendritic axis remains unknown. Here, we examined the NMDAR plasticity rules at MPP-GC and LPP-GC synapses using physiologically relevant patterns of stimulation in acute rat hippocampal slices. We found that MPP-GC, but not LPP-GC synapses, expressed homosynaptic NMDAR-LTP. In addition, induction of NMDAR-LTP at MPP-GC synapses heterosynaptically potentiated distal LPP-GC NMDAR plasticity. The same stimulation protocol induced homosynaptic -amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR)-LTP at MPP-GC but heterosynaptic AMPAR-LTD at distal LPP synapses, demonstrating that NMDAR and AMPAR are governed by different plasticity rules. Remarkably, heterosynaptic but not homosynaptic NMDAR-LTP required Ca2+ release from intracellular, ryanodine-dependent Ca2+ stores. Lastly, the induction and maintenance of both homo- and heterosynaptic NMDAR-LTP were blocked by GluN2D antagonism, suggesting the recruitment of GluN2D-containing receptors to the synapse. Our findings uncover a mechanism by which distinct inputs to the dentate gyrus may interact functionally and contribute to hippocampal-dependent memory formation.

Significance StatementNMDARs are key players in synaptic plasticity. In addition to their classical role as coincidence detectors and triggers of AMPAR plasticity, there is compelling evidence that NMDARs can undergo activity-dependent plasticity independent of AMPAR plasticity. However, whether NMDAR-plasticity is expressed heterosynaptically remains unclear. Here, in the dentate gyrus of the hippocampus, we show that the induction of burst timing-dependent LTP of NMDAR-mediated transmission at proximal medial perforant path synapses is accompanied by heterosynaptic NMDAR-LTP at lateral perforant path synapses. These findings provide the first evidence for heterosynaptic NMDAR plasticity, which may have important consequences on the dendritic integration of functionally distinct excitatory inputs by dentate granule cells.
]]></description>
<dc:creator>Rodenas-Ruano, A.</dc:creator>
<dc:creator>Nasrallah, K.</dc:creator>
<dc:creator>Lutzu, S.</dc:creator>
<dc:creator>Castillo, M.</dc:creator>
<dc:creator>Castillo, P. E.</dc:creator>
<dc:date>2022-01-12</dc:date>
<dc:identifier>doi:10.1101/2022.01.12.476040</dc:identifier>
<dc:title><![CDATA[Heterosynaptic NMDA Receptor Plasticity in Hippocampal Dentate Granule Cells]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-01-12</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.01.18.476783v1?rss=1">
<title>
<![CDATA[
Phenotypic Pliancy and the Breakdown of Epigenetic Polycomb Mechanisms 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.01.18.476783v1?rss=1</link>
<description><![CDATA[
Epigenetic regulatory mechanisms allow multicellular organisms to develop distinct specialized cell identities despite having the same total genome. Cell-fate choices are based on gene expression programs and environmental cues that cells experience during embryonic development, and are usually maintained throughout the life of the organism despite new environmental cues. The evolutionarily conserved Polycomb group (PcG) proteins form Polycomb Repressive Complexes that help orchestrate these developmental choices. Post-development, these complexes actively maintain the resulting cell fate, even in the face of environmental perturbations. Given the crucial role of these polycomb mechanisms in providing phenotypic fidelity (i.e. maintenance of cell fate), we hypothesize that their dysregulation after development will lead to decreased phenotypic fidelity allowing dysregulated cells to sustainably switch their phenotype in response to environmental changes. We call this abnormal phenotypic switching phenotypic pliancy. We introduce a general computational evolutionary model that allows us to test our systems-level phenotypic pliancy hypothesis in-silico and in a context-independent manner. We find that 1) phenotypic fidelity is an emergent systems-level property of PcG-like mechanism evolution, and 2) phenotypic pliancy is an emergent systems-level property resulting from this mechanisms dysregulation. Since there is evidence that metastatic cells behave in a phenotypically pliant manner, we hypothesize that progression to metastasis is driven by the emergence of phenotypic pliancy in cancer cells as a result of PcG mechanism dysregulation. We corroborate our hypothesis using single-cell RNA-sequencing data from metastatic cancers. We find that metastatic cancer cells are phenotypically pliant in the same manner as predicted by our model.

Significance StatementWe introduce the concept of cellular phenotypic pliancy- sustained abnormal phenotypic switching in response to environmental changes- and demonstrate that such behavior can be caused by dysregulation of Polycomb mechanisms. To overcome the incomplete knowledge about these mechanisms in higher organisms, we develop an abstract computational model to study the emergence of phenotypic pliancy from a general systems-level view by confirming our hypothesis over a wide range of simulated gene-regulatory networks and Polycomb mechanism patterns. We corroborate our hypothesis and model predictions using single-cell RNA-seq metastatic cancer datasets. Our hypothesis has the potential to shed light on a general phenomenon for complex diseases where abnormal phenotypic switching is relevant.
]]></description>
<dc:creator>Lambros, L.</dc:creator>
<dc:creator>Sella, Y.</dc:creator>
<dc:creator>Bergman, A.</dc:creator>
<dc:date>2022-01-20</dc:date>
<dc:identifier>doi:10.1101/2022.01.18.476783</dc:identifier>
<dc:title><![CDATA[Phenotypic Pliancy and the Breakdown of Epigenetic Polycomb Mechanisms]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-01-20</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.01.25.477803v1?rss=1">
<title>
<![CDATA[
Replicative Aging Remodels Cell Wall and is Associated with Increased Intracellular Trafficking in Human Pathogenic Yeasts 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.01.25.477803v1?rss=1</link>
<description><![CDATA[
Replicative aging is an underexplored field of research in medical mycology. Cryptococcus neoformans (Cn) and Candida glabrata (Cg) are dreaded fungal pathogens that cause fatal invasive infections. The fungal cell wall is essential for yeast viability and pathogenesis. In this study, we provide data characterizing age-associated modifications to the cell wall of Cn and Cg. Here, we report that old yeast cells upregulate genes of cell wall biosynthesis, leading to cell wall reorganization, and increased levels of all major components, including glucan, chitin and its derivatives, as well as mannan. This results in a significant thickening of the cell wall in aged cells. Old generation yeast cells exhibited drastic ultrastructural changes, including the presence of abundant vesicle-like particles in the cytoplasm, and enlarged vacuoles with altered pH homeostasis. Our findings suggest that the cell wall modifications could be enabled by augmented intracellular trafficking. This work furthers our understanding of the cell phenotype that emerges during aging. It highlights differences in these two fungal pathogens and elucidates mechanisms that explain the enhanced resistance of old cells to antifungals and phagocytic attacks.

IMPORTANCECryptococcus neoformans and Candida glabrata are two opportunistic human fungal pathogens that cause life-threatening diseases. During infection, both microorganisms have the ability to persist for long periods, and treatment failure can occur even if standard testing identifies the yeasts to be sensitive to antifungals. Replicative lifespan is a trait that is measured by the number of divisions a cell undergoes before death. Aging in fungi is associated with enhanced tolerance to antifungals and resistance to phagocytosis, and characterization of old cells may help identify novel antifungal targets. The cell wall remains an attractive target for new therapies because it is essential for fungi and is not present in humans. This study shows that the organization of the fungal cell wall changes remarkably during aging and becomes thicker and is associated with increased intracellular trafficking as well as the alteration of vacuole morphology and pH homeostasis.
]]></description>
<dc:creator>Silva, V. K. A.</dc:creator>
<dc:creator>Bhattacharya, S.</dc:creator>
<dc:creator>Oliveira, N. K.</dc:creator>
<dc:creator>Savitt, A. G.</dc:creator>
<dc:creator>Zamith-Miranda, D.</dc:creator>
<dc:creator>Nosanchuk, J. D.</dc:creator>
<dc:creator>Fries, B. C.</dc:creator>
<dc:date>2022-01-26</dc:date>
<dc:identifier>doi:10.1101/2022.01.25.477803</dc:identifier>
<dc:title><![CDATA[Replicative Aging Remodels Cell Wall and is Associated with Increased Intracellular Trafficking in Human Pathogenic Yeasts]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-01-26</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.01.28.478161v1?rss=1">
<title>
<![CDATA[
Blood flow modeling under LVAD physiology. From global circulation to local hemodynamics 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.01.28.478161v1?rss=1</link>
<description><![CDATA[
This document presents the modeling strategy to address the in-silico study of different LVAD patho-physiological scenarios. The proposed approach employs a closed-loop lumped-parameter compartmental representation of the global circulation in the cardiovascular system (CVS). The CVS is coupled to a HeartMate 3 LVAD, and different cardiovascular conditions are proposed by modification of model parameters. Once the simulation for these conditions are performed, the cardiac function is analyzed in detail, and the global circulation model delivers flow rate waveforms which are employed as boundary conditions in a 3D hemodynamic simulation. This local circulation model is built using a patient-specific geometry of the aortic arch, containing 7 inlet/outlet boundaries, namely: LVAD cannula, aortic root, left and right subclavian arteries, left and right common carotid arteries and thoracic aorta. This model is exploited to investigate the impact of global cardiovascular conditions in the local hemodynamic features, particularly the wall shear stress (WSS) in different spatial regions.
]]></description>
<dc:creator>Blanco, P. J.</dc:creator>
<dc:creator>Grinstein, J.</dc:creator>
<dc:creator>Bulant, C. A.</dc:creator>
<dc:creator>Torii, R.</dc:creator>
<dc:creator>Bourantas, C.</dc:creator>
<dc:creator>Lemos, P.</dc:creator>
<dc:creator>Garcia-Garcia, H.</dc:creator>
<dc:date>2022-01-28</dc:date>
<dc:identifier>doi:10.1101/2022.01.28.478161</dc:identifier>
<dc:title><![CDATA[Blood flow modeling under LVAD physiology. From global circulation to local hemodynamics]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-01-28</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.01.29.478329v1?rss=1">
<title>
<![CDATA[
Making sense of disorder: Investigating intrinsically disordered proteins in the tardigrade proteome via a computational approach 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.01.29.478329v1?rss=1</link>
<description><![CDATA[
Tardigrades, also known as water bears, are a phylum of microscopic metazoans with the extraordinary ability to endure environmental extremes. When threatened by suboptimal habitat conditions, these creatures enter a suspended animation-like state called cryptobiosis, in which metabolism is diminished, similar to hibernation. In this state, tardigrades benefit from enhanced extremotolerance, withstanding dehydration efficiently for years at a time in a type of cryptobiosis called anhydrobiosis. Recent studies have demonstrated that the tardigrade proteome is at the heart of cryptobiosis. Principally, intrinsically disordered proteins (IDPs) and tardigrade-specific intrinsically disordered proteins (TDPs) are known to help protect cell function in the absence of water. Importantly, TDPs have been successfully expressed in cells of other species experimentally, even protecting human tissue against stress in vitro. However, previous work has failed to address how to strategically identify TDPs in the tardigrade proteome holistically. The overarching purpose of this current study, consequently, was to generate a list of IDPs/TDPs associated with tardigrade cryptobiosis that are high-priority for further investigation. Firstly, a novel database containing 44,836 tardigrade proteins from 338 different species was constructed to consolidate and standardize publicly available data. Secondly, a support vector machine (SVM) was created to sort the newly constructed database entries on the binary basis of disorder (i.e., IDP versus non-IDP). Features of this model draw from disorder metrics and literature curation, correctly classifying 160 of the 171 training set proteins (~93.6%). Of the 5,415 putative IDPs/TDPs our SVM identified, we present 82 (30 having confident subclass prediction and 52 having experimental detection in previous studies). Subsequently, the role each protein might play in tardigrade resilience is discussed. By and large, this supervised machine learning classifier represents a promising new approach for identifying IDPs/TDPs, opening doors to harness the tardigrades remarkable faculties for biomaterial preservation, genetic engineering, astrobiological research, and ultimately, the benefit of humankind.
]]></description>
<dc:creator>Lowe, N. E.</dc:creator>
<dc:creator>Chang, R. L.</dc:creator>
<dc:date>2022-01-31</dc:date>
<dc:identifier>doi:10.1101/2022.01.29.478329</dc:identifier>
<dc:title><![CDATA[Making sense of disorder: Investigating intrinsically disordered proteins in the tardigrade proteome via a computational approach]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-01-31</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.02.05.479257v1?rss=1">
<title>
<![CDATA[
An improved MS2-MCP imaging system with minimal perturbation of mRNA stability 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.02.05.479257v1?rss=1</link>
<description><![CDATA[
The MS2-MCP imaging system is widely used to study the mRNA spatial distribution in living cells. Here, we report that the MS2-MCP system may destabilize the tagged mRNA by targeting it to the nonsense-mediated mRNA decay pathway. We introduce an improved version, which has minimal perturbation of the mRNA stability.
]]></description>
<dc:creator>Li, W.</dc:creator>
<dc:creator>Maekiniemi, A.</dc:creator>
<dc:creator>Sato, H.</dc:creator>
<dc:creator>Osman, C.</dc:creator>
<dc:creator>Singer, R. H.</dc:creator>
<dc:date>2022-02-06</dc:date>
<dc:identifier>doi:10.1101/2022.02.05.479257</dc:identifier>
<dc:title><![CDATA[An improved MS2-MCP imaging system with minimal perturbation of mRNA stability]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-02-06</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.02.06.479292v1?rss=1">
<title>
<![CDATA[
Functional geometry of auditory cortical resting state networks derived from intracranial electrophysiology 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.02.06.479292v1?rss=1</link>
<description><![CDATA[
Understanding central auditory processing critically depends on defining underlying auditory cortical networks and their relationship to the rest of the brain. We addressed these questions using resting state functional connectivity derived from human intracranial electroencephalography. Mapping recording sites into a low-dimensional space where proximity represents functional similarity revealed a hierarchical organization. At fine scale, a group of auditory cortical regions excluded several higher order auditory areas and segregated maximally from prefrontal cortex. On mesoscale, the proximity of limbic structures to auditory cortex suggested a limbic stream that parallels the classically described ventral and dorsal auditory processing streams. Identities of global hubs in anterior temporal and cingulate cortex depended on frequency band, consistent with diverse roles in semantic and cognitive processing. On a macro scale, observed hemispheric asymmetries were not specific for speech and language networks. This approach can be applied to multivariate brain data with respect to development, behavior, and disorders.

BlurbWe describe the organization of human neocortex on multiple spatial scalesbased on resting state intracranial electrophysiology. We focus on cortical regions involved in auditory processing and examine inter-regional hierarchical relationships, network topology, and hemispheric lateralization. This work introduces a powerful analytical tool to examine mechanisms of altered arousal states, brain development, and neuropsychiatric disorders.
]]></description>
<dc:creator>Banks, M. I.</dc:creator>
<dc:creator>Krause, B. M.</dc:creator>
<dc:creator>Berger, D. G.</dc:creator>
<dc:creator>Campbell, D. I.</dc:creator>
<dc:creator>Boes, A. D.</dc:creator>
<dc:creator>Bruss, J. E.</dc:creator>
<dc:creator>Kovach, C. K.</dc:creator>
<dc:creator>Kawasaki, H.</dc:creator>
<dc:creator>Steinschneider, M.</dc:creator>
<dc:creator>Nourski, K. V.</dc:creator>
<dc:date>2022-02-09</dc:date>
<dc:identifier>doi:10.1101/2022.02.06.479292</dc:identifier>
<dc:title><![CDATA[Functional geometry of auditory cortical resting state networks derived from intracranial electrophysiology]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-02-09</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.02.07.479472v1?rss=1">
<title>
<![CDATA[
Neurobeachin controls the asymmetric subcellular distribution of electrical synapse proteins 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.02.07.479472v1?rss=1</link>
<description><![CDATA[
The subcellular positioning of synapses and their specialized molecular compositions form the fundamental basis of neural circuits. Like chemical synapses, electrical synapses are constructed from an assortment of adhesion, scaffolding, and regulatory molecules, yet little is known about how these molecules localize at specified subcellular neuronal compartments. Here we investigated the relationship between the autism- and epilepsy-associated gene Neurobeachin, neuronal gap junction channelforming Connexins, and the scaffold ZO1. Using the zebrafish Mauthner circuit we found Neurobeachin localizes to the electrical synapse independent of ZO1 and Connexins. By contrast, we show Neurobeachin is required postsynaptically for the robust localization of ZO1 and Connexins. We demonstrate Neurobeachin binds ZO1 but not Connexins. Finally, we find Neurobeachin is required to restrict postsynaptic electrical synapse proteins to dendrites. These findings reveal a mechanism for the asymmetric synaptic localization of electrical synapse components providing a basis for the subcellular specialization of neuronal gap junctions.
]]></description>
<dc:creator>Martin, E. A.</dc:creator>
<dc:creator>Michel, J. C.</dc:creator>
<dc:creator>Kissinger, J. S.</dc:creator>
<dc:creator>Echeverry, F. A.</dc:creator>
<dc:creator>Lin, Y.-P.</dc:creator>
<dc:creator>O'Brien, J.</dc:creator>
<dc:creator>Pereda, A. E.</dc:creator>
<dc:creator>Miller, A. C.</dc:creator>
<dc:date>2022-02-10</dc:date>
<dc:identifier>doi:10.1101/2022.02.07.479472</dc:identifier>
<dc:title><![CDATA[Neurobeachin controls the asymmetric subcellular distribution of electrical synapse proteins]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-02-10</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.02.11.480113v1?rss=1">
<title>
<![CDATA[
Neurophysiological Measures Of Auditory Sensory Processing Are Associated With Adaptive Behavior In Children With Autism Spectrum Disorder 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.02.11.480113v1?rss=1</link>
<description><![CDATA[
BackgroundAtypical auditory cortical processing is consistently found in scalp electrophysiological and magnetoencephalographic studies of Autism Spectrum Disorder (ASD), and may provide a marker of neuropathological brain development. However, the relationship between atypical cortical processing of auditory information and adaptive behavior in ASD is not yet well understood.

MethodsWe sought to test the hypothesis that early auditory processing in ASD is related to everyday adaptive behavior through the examination of auditory event-related potentials (AEPs) in response to simple tones and Vineland Adaptive Behavior Scales in a large cohort of children with ASD (N=89), aged 6-17, and in age- and IQ-matched neurotypically (NT) developing controls (N=120).

ResultsStatistical analyses revealed significant group differences in early AEPs over temporal scalp regions. Whereas the expected rightward lateralization of the AEP to tonal stimuli occurred in both groups, lateralization of the AEP was only significantly associated with adaptive functioning, in the domains of communication and daily living, in the ASD group.

ConclusionsThese results lend support to the hypothesis that atypical processing of sensory information is related to everyday adaptive behavior in autism.
]]></description>
<dc:creator>Cotter, M.</dc:creator>
<dc:creator>Tikir, S.</dc:creator>
<dc:creator>Francisco, A. A.</dc:creator>
<dc:creator>Oakes, L.</dc:creator>
<dc:creator>Crosse, M. J.</dc:creator>
<dc:creator>Foxe, J. J.</dc:creator>
<dc:creator>Molholm, S.</dc:creator>
<dc:date>2022-02-14</dc:date>
<dc:identifier>doi:10.1101/2022.02.11.480113</dc:identifier>
<dc:title><![CDATA[Neurophysiological Measures Of Auditory Sensory Processing Are Associated With Adaptive Behavior In Children With Autism Spectrum Disorder]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-02-14</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.02.13.480299v1?rss=1">
<title>
<![CDATA[
scShapes: A statistical framework for identifying distribution shapes in single-cell RNA-sequencing data 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.02.13.480299v1?rss=1</link>
<description><![CDATA[
BackgroundSingle cell RNA sequencing (scRNA-seq) methods have been advantageous for quantifying cell-to-cell variation by profiling the transcriptomes of individual cells. For scRNA-seq data, variability in gene expression reflects the degree of variation in gene expression from one cell to another. Analyses that focus on cell-cell variability therefore are useful for going beyond changes based on average expression and instead, identifying genes with homogenous expression versus those that vary widely from cell to cell.

ResultsWe present a novel statistical framework scShapes for identifying differential distributions in single-cell RNA-sequencing data using generalized linear models. Most approaches for differential gene expression detect shifts in the mean value. However, as single cell data are driven by over-dispersion and dropouts, moving beyond means and using distributions that can handle excess zeros is critical. scShapes quantifies gene-specific cell-to-cell variability by testing for differences in the expression distribution while flexibly adjusting for covariates if required. We demonstrate that scShapes identifies subtle variations that are independent of altered mean expression and detects biologically-relevant genes that were not discovered through standard approaches.

ConclusionsThis analysis also draws attention to genes that switch distribution shapes from a unimodal distribution to a zero-inflated distribution and raises open questions about the plausible biological mechanisms that may give rise to this, such as transcriptional bursting. Overall, the results from scShapes helps to expand our understanding of the role that gene expression plays in the transcriptional regulation of a specific perturbation or cellular phenotype. Our framework scShapes is incorporated into Bioconductor R package (https://github.com/Malindrie/scShapes).
]]></description>
<dc:creator>Dharmaratne, M.</dc:creator>
<dc:creator>Kulkarni, A. S.</dc:creator>
<dc:creator>Taherian Fard, A.</dc:creator>
<dc:creator>Mar, J. C.</dc:creator>
<dc:date>2022-02-15</dc:date>
<dc:identifier>doi:10.1101/2022.02.13.480299</dc:identifier>
<dc:title><![CDATA[scShapes: A statistical framework for identifying distribution shapes in single-cell RNA-sequencing data]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-02-15</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.02.14.480408v1?rss=1">
<title>
<![CDATA[
Neural correlates of multisensory enhancement in audiovisual narrative speech perception: a fMRI investigation 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.02.14.480408v1?rss=1</link>
<description><![CDATA[
This fMRI study investigated the effect of seeing articulatory movements of a speaker while listening to a naturalistic narrative stimulus. It had the goal to identify regions of the language network showing multisensory enhancement under synchronous audiovisual conditions. We expected this enhancement to emerge in regions known to underlie the integration of auditory and visual information such as the posterior superior temporal gyrus as well as parts of the broader language network, including the semantic system. To this end we presented 53 participants with a continuous narration of a story in auditory alone, visual alone, and both synchronous and asynchronous audiovisual speech conditions while recording brain activity using BOLD fMRI. We found multisensory enhancement in an extensive network of regions underlying multisensory integration and parts of the semantic network as well as extralinguistic regions not usually associated with multisensory integration, namely the primary visual cortex and the bilateral amygdala. Analysis also revealed involvement of thalamic brain regions along the visual and auditory pathways more commonly associated with early sensory processing. We conclude that under natural listening conditions, multisensory enhancement not only involves sites of multisensory integration but many regions of the wider semantic network and includes regions associated with extralinguistic sensory, perceptual and cognitive processing.
]]></description>
<dc:creator>Ross, L. A.</dc:creator>
<dc:creator>Molholm, S.</dc:creator>
<dc:creator>Butler, J. S.</dc:creator>
<dc:creator>Del Bene, V. A.</dc:creator>
<dc:creator>Foxe, J. J.</dc:creator>
<dc:date>2022-02-15</dc:date>
<dc:identifier>doi:10.1101/2022.02.14.480408</dc:identifier>
<dc:title><![CDATA[Neural correlates of multisensory enhancement in audiovisual narrative speech perception: a fMRI investigation]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-02-15</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.02.15.480601v1?rss=1">
<title>
<![CDATA[
Highly efficient generation of isogenic pluripotent stem cell models using prime editing 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.02.15.480601v1?rss=1</link>
<description><![CDATA[
The recent development of prime editing (PE) genome engineering technologies has the potential to significantly simplify the generation of human pluripotent stem cell (hPSC)-based disease models. PE is a multi-component editing system that uses a Cas9-nickase fused to a reverse transcriptase (nCas9-RT) and an extended PE guide RNA (pegRNA). Once reverse transcribed, the pegRNA extension functions as a repair template to introduce precise designer mutations at the target site. Here, we systematically compared the editing efficiencies of PE to conventional gene editing methods in hPSCs. This analysis revealed that PE is overall more efficient and precise than homology-directed repair (HDR) of site-specific nuclease-induced double-strand breaks (DSBs). Specifically, PE is more effective in generating heterozygous editing events to create autosomal dominant disease-associated mutations. By stably integrating the nCas9-RT into hPSCs we achieved editing efficiencies equal to those reported for cancer cells, suggesting that the expression of the PE components, rather than cell-intrinsic features, limit PE in hPSCs. To improve the efficiency of PE in hPSCs, we optimized the delivery modalities for the PE components. Delivery of the nCas9-RT as mRNA combined with synthetically generated chemically-modified pegRNAs and nicking guide RNAs (ngRNAs) improved editing efficiencies up to 13-fold compared to transfecting the prime editing components as plasmids or ribonucleoprotein particles (RNPs). Finally, we demonstrated that this mRNA-based delivery approach can be used repeatedly to yield editing efficiencies exceeding 60% and to correct or introduce familial mutations causing Parkinsons disease in hPSCs.
]]></description>
<dc:creator>Li, H.</dc:creator>
<dc:creator>Busquets, O.</dc:creator>
<dc:creator>Verma, Y.</dc:creator>
<dc:creator>Syed, K. M.</dc:creator>
<dc:creator>Kutnowski, N.</dc:creator>
<dc:creator>Pangilinan, G. R.</dc:creator>
<dc:creator>Gilbert, L.</dc:creator>
<dc:creator>Bateup, H.</dc:creator>
<dc:creator>Rio, D. C.</dc:creator>
<dc:creator>Hockemeyer, D.</dc:creator>
<dc:creator>Soldner, F.</dc:creator>
<dc:date>2022-02-15</dc:date>
<dc:identifier>doi:10.1101/2022.02.15.480601</dc:identifier>
<dc:title><![CDATA[Highly efficient generation of isogenic pluripotent stem cell models using prime editing]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-02-15</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.02.18.480594v1?rss=1">
<title>
<![CDATA[
Increased Relative Biological Effectiveness of Orthovoltage X-rays Compared to γ-rays in Preclinical Irradiation 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.02.18.480594v1?rss=1</link>
<description><![CDATA[
PurposeRadionuclide irradiators (137Cs and 60Co) are commonly used in preclinical studies ranging from cancer therapy to stem cell biology. There are institutional initiatives to replace radionuclide sources with lower-energy X-ray sources amidst concerns of radiological terrorism. As researchers transition, there are questions whether the biological effects of {gamma}-rays may be recapitulated with orthovoltage X-rays, since different energy may cause different biological effects. We, therefore, sought to compare the effects of orthovoltage X-rays and 137Cs {gamma}-rays using mouse models of acute radiation syndrome.

Experimental Design137Cs {gamma}-rays were compared with Orthovoltage X-rays, generated at 300 kVp, 10 mA with 1 mm Cu or Thoraeus filtration. We assessed 30-day overall survival following whole-body irradiation and calculated LD50 by logistic regression. Comparing equivalent doses delivered with different average energies ([E]), we assessed bone marrow, spleen, and intestinal histology and flow cytometry.

ResultsThe LD50 doses are 6.7 Gy, 7.4 Gy and 8.1 Gy with 1 mm Cu filtered ([E]=120 keV), and Thoraeus filtered X-rays ([E]=160 keV), and 137Cs (E=662 keV), respectively. At constant dose, hematopoietic injury was most severe with 1 mm Cu filtered X-rays with the greatest reduction in bone marrow cellularity, stem and progenitor populations, and intestinal crypts and OLFM4+ intestinal stem cells. Thoraeus filtered X-rays provoked an intermediate phenotype, with 137Cs showing the least damage.

ConclusionsOur study reveals a dichotomy between physical dose and biological effect relevant as researchers transition to orthovoltage X-rays. With decreasing energy, there is increasing hematopoietic and intestinal injury, necessitating dose-reduction to achieve comparable biological effects.

Statement of Translational RelevanceRadiation is used in translational studies in fields ranging from hematopoiesis and stem cell biology to cancer radiotherapy, with 137Cs and 60Co radionuclide sources serving as the most common irradiators. Due to the threat of radiological terrorism using stolen radionuclides, there are institutional initiatives to replace these sources with orthovoltage X-ray irradiators. Yet, as shown in this study, the biological effects of radiation are highly dependent on radiation energy. Lower energy orthovoltage X-rays are absorbed differently than higher energy radionuclide {gamma}-rays, provoking more severe hematopoietic, immunologic, and gastrointestinal radiation injury. Thus, an identical physical dose delivered with beams of differing energy does not produce the same biologic effect. As researchers transition between these sources, it is critical that we appreciate that radiation doses are not interchangeable between them. Understanding the significance of physical dose delivered using different methods will allow us to contextualize past results with future studies.
]]></description>
<dc:creator>Bell, B. I.</dc:creator>
<dc:creator>Vercellino, J.</dc:creator>
<dc:creator>Brodin, N. P.</dc:creator>
<dc:creator>Velten, C.</dc:creator>
<dc:creator>Nanduri, L. S. Y.</dc:creator>
<dc:creator>Tanaka, K. E.</dc:creator>
<dc:creator>Fang, Y.</dc:creator>
<dc:creator>Wang, Y.</dc:creator>
<dc:creator>Macedo, R.</dc:creator>
<dc:creator>English, J.</dc:creator>
<dc:creator>Schumacher, M. M.</dc:creator>
<dc:creator>Duddempudi, P. K.</dc:creator>
<dc:creator>Asp, P.</dc:creator>
<dc:creator>Koba, W.</dc:creator>
<dc:creator>Shajahan, S.</dc:creator>
<dc:creator>Liu, L.</dc:creator>
<dc:creator>Tome, W.</dc:creator>
<dc:creator>Yang, W.-L.</dc:creator>
<dc:creator>Kolesnick, R.</dc:creator>
<dc:creator>Guha, C.</dc:creator>
<dc:date>2022-02-20</dc:date>
<dc:identifier>doi:10.1101/2022.02.18.480594</dc:identifier>
<dc:title><![CDATA[Increased Relative Biological Effectiveness of Orthovoltage X-rays Compared to γ-rays in Preclinical Irradiation]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-02-20</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.02.19.481074v1?rss=1">
<title>
<![CDATA[
Urocortin-3 neurons in the perifornical area mediate the impact of chronic stress on female infant-directed behavior 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.02.19.481074v1?rss=1</link>
<description><![CDATA[
Infant avoidance and aggression are promoted by activation of the Urocortin-3 expressing neurons of the perifornical area of hypothalamus (PeFAUcn3) in male and female mice. PeFAUcn3 neurons have been implicated in stress, and stress is known to reduce maternal behavior. We asked how chronic restraint stress (CRS) affects infant-directed behavior in virgin and lactating females and what role PeFAUcn3 neurons play in this process. Here we show that infant-directed behavior increases activity in the PeFAUcn3 neurons in virgin and lactating females. Chemogenetic inhibition of PeFAUcn3 neurons facilitates pup retrieval in virgin females. CRS reduces pup retrieval in virgin females and increases activity of PeFAUcn3 neurons but does not affect maternal behavior in mothers. Inhibition of PeFAUcn3 neurons blocks stress-induced deficits in pup-directed behavior in virgin females. Together, these data illustrate the critical role for PeFAUcn3 neuronal activity in mediating the impact of chronic stress on female infant-directed behavior.

Significance statementWhile a large body of research has studied the impact of maternal stress on offspring, few studies have focused on the neural circuitry underlying reduced maternal behavior in stressed mothers. In this study, we examine the neural substrates involved in reduced infant-directed behavior caused by chronic stress. We find that perifornical area neurons expressing the neuropeptide urocortin-3 are critical mediators of the impact of stress on infant-directed behavior in females.
]]></description>
<dc:creator>Autry, A. E.</dc:creator>
<dc:creator>Abdelmesih, B.</dc:creator>
<dc:creator>Carta, I.</dc:creator>
<dc:creator>Anderson, R.</dc:creator>
<dc:date>2022-02-20</dc:date>
<dc:identifier>doi:10.1101/2022.02.19.481074</dc:identifier>
<dc:title><![CDATA[Urocortin-3 neurons in the perifornical area mediate the impact of chronic stress on female infant-directed behavior]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-02-20</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.02.21.481325v1?rss=1">
<title>
<![CDATA[
Granulocyte Colony Stimulating Factor causes cerebellar deficits and anxiety in a mouse model of CSF-1 receptor-related leukoencephalopathy 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.02.21.481325v1?rss=1</link>
<description><![CDATA[
Colony stimulating factor (CSF) receptor-1 (CSF-1R)-related leukoencephalopathy (CRL) is an adult-onset, demyelinating neurodegenerative disease caused by autosomal dominant mutations in CSF1R, modeled by the Csf1r+/- mouse. The expression of Csf2, encoding granulocyte- macrophage CSF (GM-CSF) and of Csf3, encoding granulocyte CSF (G-CSF), are elevated in both mouse and human CRL brains. While monoallelic targeting of Csf2 has been shown to attenuate many behavioral and histological deficits of mouse CRL, including cognitive dysfunction and demyelination, the contribution of Csf3 has not been explored. In this manuscript, we investigate the behavioral, electrophysiological and histopathological phenotypes of CRL mice following monoallelic targeting of Csf3. We show that Csf3 heterozygosity normalized the Csf3 levels in Csf1r+/- mouse brains and ameliorated anxiety-like behavior, motor coordination and social interaction deficits, but not their cognitive impairment. Consistent with this, Csf3 heterozygosity attenuated microglial activation in the cerebellum and in the ventral but not in the dorsal hippocampus. Csf3 heterozygosity also failed to prevent demyelination. Csf1r+/- mice exhibited altered synaptic activity in the deep cerebellar nuclei (DCN) associated with increased deposition of the complement factor C1q on glutamatergic synapses and with increased engulfment of glutamatergic synapses by DCN microglia. These phenotypes were significantly ameliorated by monoallelic deletion of Csf3. Our findings indicate that G-CSF and GM-CSF play non-overlapping roles in mouse CRL development and suggest that G-CSF could be an additional therapeutic target in CRL.
]]></description>
<dc:creator>Stanley, E. R.</dc:creator>
<dc:creator>Biundo, F.</dc:creator>
<dc:creator>Chitu, V.</dc:creator>
<dc:creator>Tindi, J.</dc:creator>
<dc:creator>Burghardt, N. S.</dc:creator>
<dc:creator>Shlager, G. G. L.</dc:creator>
<dc:creator>Ketchum, H. C.</dc:creator>
<dc:creator>DeTure, M. A.</dc:creator>
<dc:creator>Dickson, D. W.</dc:creator>
<dc:creator>Wszolek, Z. K.</dc:creator>
<dc:creator>Khodakhah, K.</dc:creator>
<dc:date>2022-02-22</dc:date>
<dc:identifier>doi:10.1101/2022.02.21.481325</dc:identifier>
<dc:title><![CDATA[Granulocyte Colony Stimulating Factor causes cerebellar deficits and anxiety in a mouse model of CSF-1 receptor-related leukoencephalopathy]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-02-22</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.02.21.481385v1?rss=1">
<title>
<![CDATA[
Activity of the manganese efflux transporter SLC30A10 in dopaminergic but not GABAergic neurons protects against neurotoxicity 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.02.21.481385v1?rss=1</link>
<description><![CDATA[
Metals such as copper, iron, and manganese (Mn) are essential for life, but induce neurotoxicity at elevated levels. Yet, the neuronal mechanisms of metal-induced neurological disease are largely unclear. A primary limitation has been an inability to selectively alter metal levels in specific neurons, so that the role of the targeted neurons in disease biology can be isolated. Here, we show that neuron-specific depletion of metal efflux transporters provides the feasibility to overcome this limitation by focusing on Mn, which accumulates in the basal ganglia and induces motor disease, and the Mn-specific efflux transporter SLC30A10. Pan-neuronal/glial Slc30a10 knockout mice exhibited increased basal ganglia Mn levels and hypolocomotor deficits in early-life (pre-adulthood), which were exacerbated by Mn exposure. The locomotor deficits of the pan-neuronal/glial strain was associated with a reduction in evoked striatal dopamine release without dopaminergic (DAergic) neurodegeneration or changes in striatal tissue dopamine levels. Furthermore, DAergic-specific, but not GABAergic-specific, Slc30a10 knockout mice recapitulated the hypolocomotor phenotype of the pan-neuronal/glial knockouts in early-life although Mn levels were elevated in the targeted basal ganglia regions of both the neuron-specific strains. Put together, our results imply that (1) activity of SLC30A10 in DAergic neurons is necessary to protect against early-life Mn neurotoxicity; (2) increasing Mn levels in DAergic neurons is sufficient to induce early-life motor disease, suggesting that Mn targets DAergic neurons in the early-life period to induce motor deficits; and (3) neuron-specific knockout of metal efflux transporters may be a widely applicable strategy to elucidate mechanisms of metal-induced neurotoxicity.
]]></description>
<dc:creator>Taylor, C. A.</dc:creator>
<dc:creator>Grant, S.</dc:creator>
<dc:creator>Jursa, T.</dc:creator>
<dc:creator>Aschner, M.</dc:creator>
<dc:creator>Smith, D. R.</dc:creator>
<dc:creator>Gonzales, R.</dc:creator>
<dc:creator>Mukhopadhyay, S.</dc:creator>
<dc:date>2022-02-22</dc:date>
<dc:identifier>doi:10.1101/2022.02.21.481385</dc:identifier>
<dc:title><![CDATA[Activity of the manganese efflux transporter SLC30A10 in dopaminergic but not GABAergic neurons protects against neurotoxicity]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-02-22</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.02.28.480783v1?rss=1">
<title>
<![CDATA[
Kinesin-8-specific loop-2 controls the dual activities of the motor domain according to tubulin protofilament shape 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.02.28.480783v1?rss=1</link>
<description><![CDATA[
Kinesin-8s are dual-activity motor proteins that can move processively on microtubules and depolymerize microtubule plus-ends, but their mechanism of combining these distinct activities remains unclear. We addressed this by obtaining cryo-EM structures (2.6-3.9 [A]) of Candida albicans Kip3 in different catalytic states on the microtubule lattice and on a curved microtubule end mimic, as well as a microtubule-unbound CaKip3-ADP crystal structure (2.0 [A]). Together with biochemical analyses of CaKip3 and kinesin-1 mutants, we define a model that explains the kinesin-8 mechanism. The microtubule depolymerization activity originates in conformational changes of the kinesin-8 motor core that are amplified by its dynamic loop-2. On curved microtubule ends, loop-1 assists depolymerization by inserting into preceding motor domains, forming head-to-tail arrays of kinesin-8s that complement loop-2 contacts with curved tubulin. On straight tubulin protofilaments in the microtubule lattice, extended loop-2-tubulin contacts inhibit conformational changes in the motor core, but in the ADP-Pi state these contacts are relaxed, allowing neck-linker docking for motility. These tubulin shape-induced alternations between pro-microtubule-depolymerization and pro-motility kinesin states, regulated by loop-2, are the key to the dual activity of kinesin-8 motors.
]]></description>
<dc:creator>Hunter, B.</dc:creator>
<dc:creator>Benoit, M. P. M. H.</dc:creator>
<dc:creator>Asenjo, A. B.</dc:creator>
<dc:creator>Doubleday, C.</dc:creator>
<dc:creator>Daria, T.</dc:creator>
<dc:creator>Sosa, H. S.</dc:creator>
<dc:creator>Allingham, J. S.</dc:creator>
<dc:date>2022-02-28</dc:date>
<dc:identifier>doi:10.1101/2022.02.28.480783</dc:identifier>
<dc:title><![CDATA[Kinesin-8-specific loop-2 controls the dual activities of the motor domain according to tubulin protofilament shape]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-02-28</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.03.01.481833v1?rss=1">
<title>
<![CDATA[
Cyclin CLB2 mRNA localization determines efficient protein synthesis to orchestrate bud growth and cell cycle progression 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.03.01.481833v1?rss=1</link>
<description><![CDATA[
Clb2 is a conserved B-type cyclin essential for mitotic progression in Saccharomyces cerevisiae, with expression tightly regulated at transcriptional and proteolytic levels. However, it remains unclear whether Clb2 protein synthesis is regulated and responsive to cell growth. Here, we show that CLB2 mRNA localizes to the bud via the She2/She3 complex, while Clb2 protein accumulates in the mother nucleus. This mRNA localization enhances translation without affecting protein localization. A structured RNA element, a ZIP-code, is located within the coding sequence and is required, but not sufficient, for both mRNA transport and protein expression. Mutation of this ZIP code disrupts mRNA localization, reduces Clb2 synthesis, increases budded phase duration and daughter cell size. In wild-type cells, Clb2 protein levels scale with bud growth, a coupling lost in ZIP code mutants. These findings reveal a mechanism by which mRNA localization and translation are coordinated to link cell growth with cell cycle progression.
]]></description>
<dc:creator>Tutucci, E.</dc:creator>
<dc:creator>Maekiniemi, A.</dc:creator>
<dc:creator>Snoep, J. L.</dc:creator>
<dc:creator>Seiler, M.</dc:creator>
<dc:creator>van Rossum, K.</dc:creator>
<dc:creator>van Niekerk, D. D.</dc:creator>
<dc:creator>Savakis, P.</dc:creator>
<dc:creator>Zarnack, K.</dc:creator>
<dc:creator>Singer, R. H.</dc:creator>
<dc:date>2022-03-02</dc:date>
<dc:identifier>doi:10.1101/2022.03.01.481833</dc:identifier>
<dc:title><![CDATA[Cyclin CLB2 mRNA localization determines efficient protein synthesis to orchestrate bud growth and cell cycle progression]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-03-02</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.03.09.483595v1?rss=1">
<title>
<![CDATA[
Activation of targetable inflammatory immune signaling is seen in Myelodysplastic Syndromes with SF3B1 mutations 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.03.09.483595v1?rss=1</link>
<description><![CDATA[
BackgroundMutations in the SF3B1 splicing factor are commonly seen in Myelodysplastic syndromes (MDS) and Acute Myeloid Leukemia (AML), yet the specific oncogenic pathways activated by missplicing have not been fully elucidated. Inflammatory immune pathways have been shown to play roles in pathogenesis of MDS, though the exact mechanisms of their activation in splicing mutant cases are not well understood.

MethodsRNA-seq data from SF3B1 mutant samples was analyzed and functional roles of IRAK4 isoforms were determined. Efficacy of IRAK4 inhibition was evaluated in pre-clinical models of MDS/AML

ResultsRNA-seq splicing analysis of innate immune mediators in SF3B1 mutant MDS samples revealed retention of full-length exon 6 of interleukin-1 receptor-associated kinase 4 (IRAK4), a critical downstream mediator that links the Myddosome to inflammatory NF-kB activation. Exon 6 retention leads to a longer isoform, encoding a protein (IRAK4-Long) that contains the entire death domain and kinase domain, leading to maximal activation of NF-kB. Cells with wild-type SF3B1 contain smaller IRAK4 isoforms that are targeted for proteosomal degradation. Expression of IRAK4-Long in SF3B1 mutant cells induces TRAF6 activation leading to K63-linked ubiquitination of CDK2, associated with a block in hematopoietic differentiation. Inhibition of IRAK4 with CA-4948, leads to reduction in NF-kB activation, inflammatory cytokine production, enhanced myeloid differentiation in vitro and reduced leukemic growth in xenograft models.

ConclusionsSF3B1 mutation leads to expression of a therapeutically targetable, longer, oncogenic IRAK4 isoform in AML/MDS models.
]]></description>
<dc:creator>Choudhary, G.</dc:creator>
<dc:creator>Pellagatti, A.</dc:creator>
<dc:creator>Agianian, B.</dc:creator>
<dc:creator>Smith, M.</dc:creator>
<dc:creator>Bhagat, T. D.</dc:creator>
<dc:creator>Gordon-Mitchell, S.</dc:creator>
<dc:creator>Pandey, S.</dc:creator>
<dc:creator>Shah, N.</dc:creator>
<dc:creator>Aluri, S.</dc:creator>
<dc:creator>Schwartz, L.</dc:creator>
<dc:creator>Steeples, V.</dc:creator>
<dc:creator>Booher, R.</dc:creator>
<dc:creator>Ramachandra, M.</dc:creator>
<dc:creator>Samson, M.</dc:creator>
<dc:creator>Carbajal, M.</dc:creator>
<dc:creator>Pradhan, K.</dc:creator>
<dc:creator>Bowman, T.</dc:creator>
<dc:creator>Pillai, M. M.</dc:creator>
<dc:creator>Will, B.</dc:creator>
<dc:creator>Wickrema, A.</dc:creator>
<dc:creator>Shastri, A.</dc:creator>
<dc:creator>Bradley, R. K.</dc:creator>
<dc:creator>Martell, R. E.</dc:creator>
<dc:creator>Steidl, U.</dc:creator>
<dc:creator>Gavathiotis, E.</dc:creator>
<dc:creator>Boultwood, J.</dc:creator>
<dc:creator>Starczynowski, D. T.</dc:creator>
<dc:creator>Verma, A.</dc:creator>
<dc:date>2022-03-09</dc:date>
<dc:identifier>doi:10.1101/2022.03.09.483595</dc:identifier>
<dc:title><![CDATA[Activation of targetable inflammatory immune signaling is seen in Myelodysplastic Syndromes with SF3B1 mutations]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-03-09</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.03.10.483848v1?rss=1">
<title>
<![CDATA[
Characterization of Morreton Virus (MORV) as a Novel Oncolytic Virotherapy Platform for Liver Cancers 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.03.10.483848v1?rss=1</link>
<description><![CDATA[
Morreton virus (MORV) is a novel oncolytic Vesiculovirus, genetically distinct from vesicular stomatitis virus (VSV). we report that MORV induced potent cytopathic effects in a panel of cholangiocarcinoma (CCA) and hepatocellular carcinoma (HCC) cell lines. In addition, high intranasal doses of MORV were not associated with significant adverse effects and were well tolerated in mice bearing liver tumor xenografts and syngeneic liver cancers. Furthermore, single intratumoral treatments with MORV (1 x 107 TCID50) triggered a robust antitumor immune response leading to substantial tumor regression and disease control in a syngeneic CCA model, using 10-fold lower dose compared to VSV (1 x 108 TCID50). In addition, MORV and VSV both induced prominent tumor growth delay in immunodeficient mice bearing Hep3B hepatocellular carcinoma (HCC) but not in mice bearing HuCCT-1 CCA xenografts. Our findings indicate that wild-type MORV is safe and can induce potent tumor regression in HCC and CCA animal models without adverse events via immune-mediated and immune-independent mechanisms. Further development and clinical translation of MORV as virotherapy for liver cancers are warranted.
]]></description>
<dc:creator>Nagalo, B. M.</dc:creator>
<dc:creator>Zhou, Y.</dc:creator>
<dc:creator>Loeuillard, E. L.</dc:creator>
<dc:creator>Dumbauld, C.</dc:creator>
<dc:creator>Barro, O.</dc:creator>
<dc:creator>Elliott, N.</dc:creator>
<dc:creator>Baker, A. T.</dc:creator>
<dc:creator>Arora, M.</dc:creator>
<dc:creator>Bogenberger, J. M.</dc:creator>
<dc:creator>Meurice, N.</dc:creator>
<dc:creator>Petit, J.</dc:creator>
<dc:creator>Uson Junior, P. L. S.</dc:creator>
<dc:creator>Aslam, F.</dc:creator>
<dc:creator>Chamcheu, J. C.</dc:creator>
<dc:creator>Simoes, C. C.</dc:creator>
<dc:creator>Cannon, M.</dc:creator>
<dc:creator>Basnakian, A. G.</dc:creator>
<dc:creator>Post, S. R.</dc:creator>
<dc:creator>Barrett, M. T.</dc:creator>
<dc:creator>Duda, D. G.</dc:creator>
<dc:creator>Jacobs, B.</dc:creator>
<dc:creator>Vile, R.</dc:creator>
<dc:creator>Barry, M. A.</dc:creator>
<dc:creator>Roberts, L.</dc:creator>
<dc:creator>Lyas, S. I.</dc:creator>
<dc:creator>Borad, M.</dc:creator>
<dc:date>2022-03-11</dc:date>
<dc:identifier>doi:10.1101/2022.03.10.483848</dc:identifier>
<dc:title><![CDATA[Characterization of Morreton Virus (MORV) as a Novel Oncolytic Virotherapy Platform for Liver Cancers]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-03-11</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/206110v1?rss=1">
<title>
<![CDATA[
Enhanced Astrocyte Responses are Driven by a Genetic Risk Allele Associated with Multiple Sclerosis 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/206110v1?rss=1</link>
<description><![CDATA[
Epigenetic annotation studies of genetic risk variants for multiple sclerosis (MS) implicate dysfunctional lymphocytes in MS susceptibility; however, the role of central nervous system (CNS) cells remains unclear. We investigated the effect of the risk variant, rs7665090G, located near NFKB1, on astrocytes. We demonstrated that chromatin is accessible at the risk locus, a prerequisite for its impact on astroglial function. The risk variant was associated with increased NF-{kappa}B signaling and target gene expression driving lymphocyte recruitment in cultured human astrocytes and astrocytes within MS lesions, and with increased lesional lymphocytic infiltrates. In MS patients, the risk genotype was associated with increased lesion volumes on MRI. Thus, we established that the rs7665090G variant perturbs astrocyte function resulting in increased CNS access for peripheral immune cells. MS may thus result from variant-driven dysregulation of the peripheral immune system and the CNS, where perturbed CNS cell function aids in establishing local autoimmune inflammation.nnOne Sentence SummaryThe NF-{kappa}B relevant multiple sclerosis risk variant, rs7665090G, drives astrocyte responses that promote lesion formation.
]]></description>
<dc:creator>Ponath, G.</dc:creator>
<dc:creator>Lincoln, M. R.</dc:creator>
<dc:creator>Dahlawi, S.</dc:creator>
<dc:creator>Mubarak, M.</dc:creator>
<dc:creator>Sumida, T.</dc:creator>
<dc:creator>Arias, L.</dc:creator>
<dc:creator>Zhang, S.</dc:creator>
<dc:creator>Isitan, C.</dc:creator>
<dc:creator>Nguyen, T. D.</dc:creator>
<dc:creator>Raine, C. S.</dc:creator>
<dc:creator>Hafler, D. A.</dc:creator>
<dc:creator>Pitt, D.</dc:creator>
<dc:date>2017-10-19</dc:date>
<dc:identifier>doi:10.1101/206110</dc:identifier>
<dc:title><![CDATA[Enhanced Astrocyte Responses are Driven by a Genetic Risk Allele Associated with Multiple Sclerosis]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2017-10-19</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/206268v1?rss=1">
<title>
<![CDATA[
Cryo-EM Reveals the Structural Basis of Microtubule Depolymerization by Kinesin-13s 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/206268v1?rss=1</link>
<description><![CDATA[
Kinesin-13s constitute a distinct group within the kinesin superfamily of motor proteins that promotes microtubule depolymerization and lacks motile activity. The molecular mechanism by which the kinesins depolymerize microtubules and are adapted to perform a seemingly very different activity from other kinesins is still unclear. To address this issue we obtained near atomic resolution cryo-electron microscopy (cryo-EM) structures of Drosophila melanogaster kinesin-13 KLP10A constructs bound to curved or straight tubulin in different nucleotide states. The structures show how nucleotide induced conformational changes near the catalytic site are coupled with kinesin-13-specific structural elements to induce tubulin curvature leading to microtubule depolymerization. The data highlight a modular structure that allows similar kinesin core motor-domains to be used for different functions, such as motility or microtubule depolymerization.
]]></description>
<dc:creator>Benoit, M. P. M. H.</dc:creator>
<dc:creator>Asenjo, A. B.</dc:creator>
<dc:creator>Sosa, H.</dc:creator>
<dc:date>2017-10-19</dc:date>
<dc:identifier>doi:10.1101/206268</dc:identifier>
<dc:title><![CDATA[Cryo-EM Reveals the Structural Basis of Microtubule Depolymerization by Kinesin-13s]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2017-10-19</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/207274v1?rss=1">
<title>
<![CDATA[
Integrin alpha 4/beta 1 (CD49d/CD29) is a component of the murine IgG3 receptor 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/207274v1?rss=1</link>
<description><![CDATA[
Antibodies exert several of their effector functions by binding to cell surface receptors. For murine IgG3 (mIgG3) the identity of its receptors (and the very existence of a receptor) is still under debate, as not all mIgG3 functions can be explained by interaction with Fc{gamma}-receptor I (Fc{gamma}RI). This implies the existence of an alternate receptor, whose identity we sought to pinpoint. We found that blockage of the alpha4/beta1 integrin (Itga4/Itgb1) selectively hampered binding of mIgG3 to macrophages and mIgG3-mediated phagocytosis. Manganese, an integrin activator, increased mIgG3 binding to macrophages. Blockage of Fc{gamma}RI or Itgb1 inhibited binding of different mIgG3 antibodies to variable extents. Our results indicate an integrin component in the mIgG3 receptor. Given the more ancient origin of integrins in comparison with Fc{gamma}R, this observation could have far ranging implications for our understanding of the evolution of antibody-mediated immunity, as well as in immunity to microorganisms, pathogenesis of autoimmune diseases and antibody engineering.
]]></description>
<dc:creator>Hawk, C. S.</dc:creator>
<dc:creator>Coelho, C.</dc:creator>
<dc:creator>de Oliveira, D. S. L.</dc:creator>
<dc:creator>Paredes, V.</dc:creator>
<dc:creator>Albuquerque, P.</dc:creator>
<dc:creator>Bocca, A. L.</dc:creator>
<dc:creator>dos Santos, A. C.</dc:creator>
<dc:creator>Rusakova, V.</dc:creator>
<dc:creator>Holemon, H.</dc:creator>
<dc:creator>Felipe, M. S. S.</dc:creator>
<dc:creator>Yagita, H.</dc:creator>
<dc:creator>Nicola, A. M.</dc:creator>
<dc:creator>Casadevall, A.</dc:creator>
<dc:date>2017-10-21</dc:date>
<dc:identifier>doi:10.1101/207274</dc:identifier>
<dc:title><![CDATA[Integrin alpha 4/beta 1 (CD49d/CD29) is a component of the murine IgG3 receptor]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2017-10-21</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/210906v1?rss=1">
<title>
<![CDATA[
Listeria monocytogenes virulence factors are secreted in biologically active Extracellular Vesicles 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/210906v1?rss=1</link>
<description><![CDATA[
Outer membrane vesicles produced by Gram-negative bacteria have been studied for half a century but the possibility that Gram-positive bacteria secreted extracellular vesicles (EVs) was not pursued due to the assumption that the thick peptidoglycan cell wall would prevent their release to the environment. However, following discovery in fungi, which also have cell walls, EVs have now been described for a variety of Gram-positive bacteria. EVs purified from Gram-positive bacteriaare implicated in virulence, toxin release and transference to host cells, eliciting immune responses, and spread of antibiotic resistance. Listeria monocytogenes is a Gram-positive bacterium that is the etiological agent of listeriosis. Here we report that L. monocytogenes produces EVs with diameter ranging from 20-200 nm, containing the pore-forming toxin listeriolysin O(LLO) and phosphatidylinositol-specific phospholipase C (PI-PLC). Using simultaneous metabolite, protein, and lipid extraction (MPLEx) multi-omics we characterized protein, lipid and metabolite composition of bacterial cells and secreted EVs and found that EVs carry the majority of listerial virulence proteins. Cell-free EV preparations were toxic to the murine macrophage cell line J774.16, in a LLO-dependent manner, evidencing EV biological activity. The deletion of plcA increased EV toxicity, suggesting PI-PLC can restrain LLO activity. Using immunogold electron microscopy we detect LLO localization at several organelles within infected human epithelial cells and with high-resolution fluorescence imaging we show that dynamic lipid structures are released from L. monocytogenes that colocalize with LLO during infection. Our findings demonstrate that L. monocytogenes utilize EVs for toxin release and implicate these structures in mammalian cytotoxicity.
]]></description>
<dc:creator>Coelho, C.</dc:creator>
<dc:creator>Brown, L.</dc:creator>
<dc:creator>Maryam, M.</dc:creator>
<dc:creator>Burnet, M. C.</dc:creator>
<dc:creator>Kyle, J. E.</dc:creator>
<dc:creator>Heyman, H. M.</dc:creator>
<dc:creator>Prados-Rosales, R.</dc:creator>
<dc:creator>Lauvau, G.</dc:creator>
<dc:creator>Nakayasu, E. S.</dc:creator>
<dc:creator>Brady, N. R.</dc:creator>
<dc:creator>Brady, A.</dc:creator>
<dc:creator>Coppens, I.</dc:creator>
<dc:creator>Casadevall, A.</dc:creator>
<dc:date>2017-10-29</dc:date>
<dc:identifier>doi:10.1101/210906</dc:identifier>
<dc:title><![CDATA[Listeria monocytogenes virulence factors are secreted in biologically active Extracellular Vesicles]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2017-10-29</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/218685v1?rss=1">
<title>
<![CDATA[
Intestinal crypts recover rapidly from focal damage with coordinated motion of stem cells that is impaired by aging 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/218685v1?rss=1</link>
<description><![CDATA[
Despite the continuous renewal and turnover of the small intestinal epithelium, the intestinal stem cell niche maintains a  soccer ball-like, alternating pattern of stem and Paneth cells in the crypt. To study the robustness of the niche pattern, we used intravital two-photon microscopy in mice with fluorescently-labeled Lgr5+ intestinal stem cells and precisely perturbed the mosaic pattern with femtosecond laser ablation. Ablation of one to three cells initiated rapid motion of niche cells that restored the alternation in the crypt pattern within about two hours without any cell proliferation. Crypt cells then performed a coordinated dilation of the crypt lumen, which resulted in peristalsis-like motion that forced damaged cells out of the niche. Crypt cell motion was reduced with inhibition of the ROCK pathway and attenuated with old age, and both resulted in incomplete pattern recovery. This suggests that in addition to proliferation and self-renewal, motility of stem cells is critical for maintaining homeostasis. Reduction of this novel behavior of stem cells could contribute to disease and age-related changes.
]]></description>
<dc:creator>Choi, J.</dc:creator>
<dc:creator>Rakhilin, N.</dc:creator>
<dc:creator>Gadamsetty, P.</dc:creator>
<dc:creator>Joe, D. J.</dc:creator>
<dc:creator>Tabrizian, T.</dc:creator>
<dc:creator>Lipkin, S. M.</dc:creator>
<dc:creator>Huffman, D.</dc:creator>
<dc:creator>Shen, X.</dc:creator>
<dc:creator>Nishimura, N.</dc:creator>
<dc:date>2017-11-13</dc:date>
<dc:identifier>doi:10.1101/218685</dc:identifier>
<dc:title><![CDATA[Intestinal crypts recover rapidly from focal damage with coordinated motion of stem cells that is impaired by aging]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2017-11-13</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/242404v1?rss=1">
<title>
<![CDATA[
Generalizing Genetic Risk Scores from Europeans to Hispanics/Latinos 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/242404v1?rss=1</link>
<description><![CDATA[
Genetic risk scores (GRSs) are weighted sums of risk allele counts of single nucleotide polymorphisms (SNPs) associated with a disease or trait. Construction of GRSs is typically based on published results from Genome-Wide Association Studies (GWASs), the majority of which have been performed in large populations of European ancestry (EA) individuals. While many genotype-trait associations have been shown to generalize from EA populations to other populations, such as Hispanics/Latinos, the optimal choice of SNPs and weights for GRSs may differ between populations due to different linkage disequilibrium (LD) and allele frequency patterns. This is further complicated by the fact that different Hispanic/Latino populations may have different admixture patterns, so that LD and allele frequency patterns may not be the same among non-EA populations. Here, we compare various approaches for GRS construction, using GWAS results from both large EA studies and a smaller study in Hispanics/Latinos, the Hispanic Community Health Study/Study of Latinos (HCHS/SOL, n = 12, 803). We consider multiple ways to select SNPs from association regions and to calculate the SNP weights. We study the performance of the resulting GRSs in an independent study of Hispanics/Latinos from the Woman Health Initiative (WHI, n = 3, 582). We support our investigation with simulation studies of potential genetic architectures in a single locus. We observed that selecting variants based on EA GWASs generally performs well, as long as SNP weights are calculated using Hispanics/Latinos GWASs, or using the meta-analysis of EA and Hispanics/Latinos GWASs. The optimal approach depends on the genetic architecture of the trait.
]]></description>
<dc:creator>Grinde, K. E.</dc:creator>
<dc:creator>Qi, Q.</dc:creator>
<dc:creator>Thornton, T. A.</dc:creator>
<dc:creator>Liu, S.</dc:creator>
<dc:creator>Shadyab, A. H.</dc:creator>
<dc:creator>Chan, K. H. K.</dc:creator>
<dc:creator>Reiner, A. P.</dc:creator>
<dc:creator>Sofer, T.</dc:creator>
<dc:date>2018-01-04</dc:date>
<dc:identifier>doi:10.1101/242404</dc:identifier>
<dc:title><![CDATA[Generalizing Genetic Risk Scores from Europeans to Hispanics/Latinos]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-01-04</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/254441v1?rss=1">
<title>
<![CDATA[
Insights from deconvolution of cell subtype proportions enhance the interpretation of functional genomic data. 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/254441v1?rss=1</link>
<description><![CDATA[
Cell subtype proportional differences between samples significantly contribute to variation of functional genomic properties such as gene expression or DNA methylation. Current analytical approaches typically deal with cell subtype proportion influences as a nuisance variable to be eliminated. Here we demonstrate how harvesting information about cell subtype proportions from functional genomics data provides insights into the cellular events in human phenotypes. We note a striking concordance between cell subtype proportions estimated from orthogonal genome-wide assays, and demonstrate the potential for single-cell RNA-seq data to be used in tissues for which reference cell subtype functional genomic datasets are not available. Taken together, our results confirm the importance of estimating cell subtype proportions when testing a model of cellular reprogramming in human phenotypic association studies, and the value of simultaneously testing for systematic cell subtype proportional alterations as a separate phenotypic association, gaining extra insights from functional genomic studies.
]]></description>
<dc:creator>Kong, Y.</dc:creator>
<dc:creator>Rastogi, D.</dc:creator>
<dc:creator>Seoighe, C.</dc:creator>
<dc:creator>Greally, J. M.</dc:creator>
<dc:creator>Suzuki, M.</dc:creator>
<dc:date>2018-01-26</dc:date>
<dc:identifier>doi:10.1101/254441</dc:identifier>
<dc:title><![CDATA[Insights from deconvolution of cell subtype proportions enhance the interpretation of functional genomic data.]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-01-26</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/259275v1?rss=1">
<title>
<![CDATA[
Aberrant mast cell activation promotes chronic recurrent multifocal osteomyelitis 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/259275v1?rss=1</link>
<description><![CDATA[
Chronic nonbacterial osteomyelitis (CNO) is an autoinflammatory bone disease. While some patients exhibit bone lesions at single sites, most patients develop chronically active or recurrent bone inflammation at multiple sites, and are then diagnosed with recurrent multifocal osteomyelitis (CRMO). Chronic multifocal osteomyelitis (CMO) mice develop IL-1{beta}-driven sterile bone lesions reminscent of severe CRMO. Mechanistically, CMO disease arises due to loss of PSTPIP2, a negative regulator of macrophages, osteoclasts and neutrophils. The goal of this study was to evaluate the potential involvement of mast cells in CMO/CRMO disease pathophysiology. Here, we show that mast cells accumulate in the inflamed tissues from CMO mice, and mast cell protease Mcpt1 was detected in the peripheral blood. The role of mast cells in CMO disease was investigated using a transgenic model of connective tissue mast cell depletion (Mcpt5-Cre:Rosa26-Stopfl/fl-DTa) that was crossed with CMO mice. The resulting CMO/MC-mice showed a significant delay in disease onset compared to age-matched CMO mice. At 5-6 months of age, CMO/MC- mice had fewer bone lesions and immune infiltration in the popliteal lymph nodes that drain the affected tail and paw tissues. To test the relevance of mast cells to human CRMO, we tested serum samples from a cohort of healthy controls or CRMO patients at diagnosis. Interestingly, mast cell chymase was elevated in CRMO patients as well as patients with oligoclonal juvenile arthritis. Tryptase-positive mast cells were also detected in bone lesions from CRMO patients as well as patients with bacterial osteomyelitis. Taken together, our results identify mast cells as cellular contributors to bone inflammation in CMO/CRMO. Observations of this study promise potential for mast cells and derived mediators as future biomarkers and/or therapeutic targets.
]]></description>
<dc:creator>Lee, J. H. P.</dc:creator>
<dc:creator>Sharma, N.</dc:creator>
<dc:creator>Young, S.</dc:creator>
<dc:creator>Chitu, V.</dc:creator>
<dc:creator>Henkelman, M.</dc:creator>
<dc:creator>Neumeister, V.</dc:creator>
<dc:creator>Sohr, E.</dc:creator>
<dc:creator>Stanley, E. R.</dc:creator>
<dc:creator>Hedrich, C. M.</dc:creator>
<dc:creator>Craig, A.</dc:creator>
<dc:date>2018-02-16</dc:date>
<dc:identifier>doi:10.1101/259275</dc:identifier>
<dc:title><![CDATA[Aberrant mast cell activation promotes chronic recurrent multifocal osteomyelitis]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-02-16</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/264531v1?rss=1">
<title>
<![CDATA[
HLA-B*39:06 Efficiently Mediates Type 1 Diabetes in a Mouse Model Incorporating Reduced Thymic Insulin Expression 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/264531v1?rss=1</link>
<description><![CDATA[
Type 1 diabetes (T1D) is characterized by T cell-mediated destruction of the insulin-producing {beta}cells of the pancreatic islets. Among the loci associated with T1D risk, those most predisposing are found in the MHC region. HLA-B*39:06 is the most predisposing class I MHC allele and is associated with an early age of onset. To establish an NOD mouse model for the study of HLA-B*39:06, we expressed it in the absence of murine class I MHC. HLA-B*39:06 was able to mediate the development of CD8 T cells, support lymphocytic infiltration of the islets, and confer T1D susceptibility. Because reduced thymic insulin expression is associated with increased T1D risk in patients, we incorporated this in our model as well, finding that HLA-B*39:06-transgenic NOD mice with reduced thymic insulin expression have an earlier age of disease onset and a higher overall prevalence as compared to littermates with typical thymic insulin expression. This was despite virtually indistinguishable blood insulin levels, T cell subset percentages, and TCR V{beta} family usage, indicating that reduced thymic insulin expression does not impact T cell development on a global scale. Rather, we propose that it allows the thymic escape of insulin-reactive HLA-B*39:06-restricted T cells which participate in {beta} cell destruction. We also found that in mice expressing either HLA-B*39:06 or HLA-A*02:01 in the absence of murine class I MHC, HLA transgene identity alters TCR V{beta} usage, which may contribute to varying diabetogenic CD8 T cell repertoires in the presence of different HLA class I alleles.
]]></description>
<dc:creator>Schloss, J.</dc:creator>
<dc:creator>Ali, R.</dc:creator>
<dc:creator>Racine, J. J.</dc:creator>
<dc:creator>Chapman, H.</dc:creator>
<dc:creator>Serreze, D.</dc:creator>
<dc:creator>DiLorenzo, T.</dc:creator>
<dc:date>2018-02-13</dc:date>
<dc:identifier>doi:10.1101/264531</dc:identifier>
<dc:title><![CDATA[HLA-B*39:06 Efficiently Mediates Type 1 Diabetes in a Mouse Model Incorporating Reduced Thymic Insulin Expression]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-02-13</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/267369v1?rss=1">
<title>
<![CDATA[
Serum-mediated cleavage of Bacillus anthracis Protective Antigen is a two-step process that involves a serum carboxypeptidase 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/267369v1?rss=1</link>
<description><![CDATA[
Much our understanding of the activity of anthrax toxin is based on in-vitro systems, which delineate the interaction between B. anthracis toxins and the cell surface. These systems however, fail to account for the intimate association of B. anthracis with the circulatory system, including the contribution of serum proteins to the host response and processing of anthrax toxins. Using variety immunologic techniques to inhibit serum processing of B. anthracis Protective Antigen (PA) along with mass spectrometry analysis, we demonstrate that serum digests PA via 2 distinct reactions. In the first reaction, serum cleaves PA83 into 2 fragments to produce PA63 and PA20 fragments, similar to that observed following furin digestion. This is followed by carboxypeptidase-mediated removal of the carboxy-terminal arginine and lysine residues from PA20.
]]></description>
<dc:creator>Goldman, D. L.</dc:creator>
<dc:creator>Nieves, E.</dc:creator>
<dc:creator>Nakouzi, A.</dc:creator>
<dc:creator>Rivera, J.</dc:creator>
<dc:creator>Phyu, E. E.</dc:creator>
<dc:creator>Win, T. H.</dc:creator>
<dc:creator>Achkar, J.</dc:creator>
<dc:creator>Casadevall, A.</dc:creator>
<dc:date>2018-02-18</dc:date>
<dc:identifier>doi:10.1101/267369</dc:identifier>
<dc:title><![CDATA[Serum-mediated cleavage of Bacillus anthracis Protective Antigen is a two-step process that involves a serum carboxypeptidase]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-02-18</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/269365v1?rss=1">
<title>
<![CDATA[
SMARTcleaner: identify and clean off-target signals in SMART ChIP-seq analysis 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/269365v1?rss=1</link>
<description><![CDATA[
BackgroundNoises and artifacts may arise in several steps of the next-generation sequencing (NGS) process. Recently, a NGS library preparation method called SMART, or Switching Mechanism At the 5 end of the RNA Transcript, is introduced to prepare ChIP-seq (chromatin immunoprecipitation and deep sequencing) libraries from small amount of DNA material. The protocol adds Ts to the 3 end of DNA templates, which is subsequently recognized and used by SMART poly(dA) primers for reverse transcription and then addition of PCR primers and sequencing adapters. The poly(dA) primers, however, can anneal to poly(T) sequences in a genome and amplify DNA fragments that are not enriched in the immunoprecipitated DNA templates. This off-target amplification results in false signals in the ChIP-seq data.nnResultsHere, we show that the off-target ChIP-seq reads derived from false amplification of poly(T/A) genomic sequences have unique and strand-specific features. Accordingly, we develop a tool (called "SMARTcleaner") that can exploit the features to remove SMART ChIP-seq artifacts. Application of SMARTcleaner to several SMART ChIP-seq datasets demonstrates that it can remove reads from off-target amplification effectively, leading to improved ChIP-seq peaks and results.nnConclusionsSMARTcleaner could identify and clean the false signals in SMART-based ChIP-seq libraries, leading to improvement in peak calling, and downstream data analysis and interpretation.
]]></description>
<dc:creator>Zhao, D.</dc:creator>
<dc:creator>Zheng, D.</dc:creator>
<dc:date>2018-02-21</dc:date>
<dc:identifier>doi:10.1101/269365</dc:identifier>
<dc:title><![CDATA[SMARTcleaner: identify and clean off-target signals in SMART ChIP-seq analysis]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-02-21</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/277111v1?rss=1">
<title>
<![CDATA[
Intermediate filaments EXC-2 and IFA-4 Maintain Luminal Structure of the Tubular Excretory Canals in Caenorhabditis elegans 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/277111v1?rss=1</link>
<description><![CDATA[
The excretory canals of Caenorhabditis elegans are a model for understanding the maintenance of apical morphology in narrow single-celled tubes. Light and electron microscopy shows that mutants in exc-2 start to form canals normally, but these swell to develop large fluid-filled cysts that lack a complete terminal web at the apical surface, and accumulate filamentous material in the canal lumen. Here, whole-genome sequencing and gene rescue show that exc-2 encodes intermediate filament protein IFC-2. EXC-2/IFC-2 protein, fluorescently tagged via CRISPR/Cas9, is located at the apical surface of the canals independently of other intermediate filament proteins. EXC-2 is also located in several other tissues, though the tagged isoforms are not seen in the larger intestinal tube. Tagged EXC-2 binds via pulldown to intermediate filament protein IFA-4, which is also shown to line the canal apical surface. Overexpression of either protein results in narrow but shortened canals. These results are consistent with a model whereby three intermediate filaments in the canals, EXC-2, IFA-4, and IFB-1, restrain swelling of narrow tubules in concert with actin filaments that guide the extension and direction of tubule outgrowth, while allowing the tube to bend as the animal moves.nnArticle SummaryThe C. elegans excretory canals form a useful model for understanding formation of narrow tubes. exc-2 mutants start to form normal canals that then swell into fluid-filled cysts. We show that exc-2 encodes a large intermediate filament (IF) protein previously not thought to be located in the canals. EXC-2 is located at the apical (luminal) membrane, binds to another IF protein, and appears to be one of three IF proteins that form a flexible meshwork to maintain the thin canal diameter. This work provides a genetically useful model for understanding the interactions of IF proteins with other cytoskeletal elements to regulate tube size and growth.
]]></description>
<dc:creator>Al-Hashimi, H. I.</dc:creator>
<dc:creator>Hall, D. H.</dc:creator>
<dc:creator>Ackley, B. D.</dc:creator>
<dc:creator>Lundquist, E. A.</dc:creator>
<dc:creator>Buechner, M.</dc:creator>
<dc:date>2018-03-06</dc:date>
<dc:identifier>doi:10.1101/277111</dc:identifier>
<dc:title><![CDATA[Intermediate filaments EXC-2 and IFA-4 Maintain Luminal Structure of the Tubular Excretory Canals in Caenorhabditis elegans]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-03-06</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/277137v1?rss=1">
<title>
<![CDATA[
Heparan sulfate molecules mediate synapse formation and function of male mating neural circuits in C. elegans 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/277137v1?rss=1</link>
<description><![CDATA[
The nervous system regulates complex behaviors through a network of neurons interconnected by synapses. How specific synaptic connections are genetically determined is still unclear. Male mating is the most complex behavior in C. elegans. It is composed of sequential steps that are governed by more than 3,000 chemical connections. Here we show that heparan sulfates (HS) play a role in the formation and function of the male neural network. Cell-autonomous and non-autonomous 3-O sulfation by the HS modification enzyme HST-3.1/HS 3-O-sulfotransferase, localized to the HSPG glypicans LON-2/glypican and GPN-1/glypican, was specifically required for response to hermaphrodite contact during mating. Loss of 3-O sulfation resulted in the presynaptic accumulation of RAB-3, a molecule that localizes to synaptic vesicles, disrupting the formation of synapses in a component of the mating circuits. We also show that neural cell adhesion protein neurexin promotes and neural cell adhesion protein neuroligin inhibits formation of the same set of synapses in a parallel pathway. Thus, neural cell adhesion proteins and extracellular matrix components act together in the formation of synaptic connections.nnAuthor SummaryThe formation of the nervous system requires the function of several genetically-encoded proteins to form complex networks. Enzymatically-generated modifications of these proteins play a crucial role during this process. These authors analyzed the role of heparan sulfates in the process of synaptogenesis in the male tail of C. elegans. A modification of heparan sulfate is required for the formation of specific synapses between neurons by acting cell-autonomously and non-autonomously. Could it be that heparan sulfates and their diverse modifications are a component of the specification factor that neurons use to make such large numbers of connections unique?
]]></description>
<dc:creator>Lazaro-Pena, M. I.</dc:creator>
<dc:creator>Diaz-Balzac, C. A.</dc:creator>
<dc:creator>Buelow, H. E.</dc:creator>
<dc:creator>Emmons, S.</dc:creator>
<dc:date>2018-03-06</dc:date>
<dc:identifier>doi:10.1101/277137</dc:identifier>
<dc:title><![CDATA[Heparan sulfate molecules mediate synapse formation and function of male mating neural circuits in C. elegans]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-03-06</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/279240v1?rss=1">
<title>
<![CDATA[
Single-step Enzymatic Glycoengineering for the Construction of Antibody-cell Conjugates 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/279240v1?rss=1</link>
<description><![CDATA[
Employing live cells as therapeutics is a direction of future drug discovery. An easy and robust method to modify the surfaces of cells directly to incorporate novel functionalities is highly desirable. However, many current methods for cell-surface engineering interfere with cells endogenous properties. Here we report an enzymatic approach that enables the transfer of biomacromolecules, such as a full length IgG antibody, to the glycocalyx on the surfaces of live cells when the antibody is conjugated to the enzymes natural donor substrate GDP-fucose. This method is fast and biocompatible with little interference to cells endogenous functions. We applied this method to construct two antibody-cell conjugates (ACCs) using different immune cells, and the modified cells exhibited specific tumor targeting and resistance to inhibitory signals produced by tumor cells, respectively. Remarkably, Herceptin-NK-92MI conjugates exhibits enhanced activities to induce the lysis of HER2+ cancer cells both ex vivo and in a murine tumor model, indicating its potential for further development as a clinical candidate.
]]></description>
<dc:creator>Li, J.</dc:creator>
<dc:creator>Chen, M.</dc:creator>
<dc:creator>Liu, Z.</dc:creator>
<dc:creator>Zhang, L.</dc:creator>
<dc:creator>Felding, B. H.</dc:creator>
<dc:creator>Lauvau, G.</dc:creator>
<dc:creator>Abadier, M.</dc:creator>
<dc:creator>Ley, K.</dc:creator>
<dc:creator>Wu, P.</dc:creator>
<dc:date>2018-03-10</dc:date>
<dc:identifier>doi:10.1101/279240</dc:identifier>
<dc:title><![CDATA[Single-step Enzymatic Glycoengineering for the Construction of Antibody-cell Conjugates]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-03-10</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/285320v1?rss=1">
<title>
<![CDATA[
A direct glia-to-neuron natural transdifferentiation ensures nimble sensory-motor coordination of male mating behaviour 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/285320v1?rss=1</link>
<description><![CDATA[
The coordinated execution of innate, stereotyped sexual behaviours, such as courtship and mating, requires sexually dimorphic sensory-motor circuits that are genetically specified during development (reviewed in [1-3]). Studies in the nematode Caenorhabditis elegans, in which the development and function of neural circuits can be interrogated with single cell resolution, have revealed two general developmental mechanisms underlying sexual dimorphism in the nervous system. The first involves the acquisition of sexually dimorphic features in sex-shared neurons during sexual maturation, which include changes in terminal gene expression, such as odorant receptors, neurotransmitters and synaptic regulators [4-10]. The second mechanism involves the generation of sex-specific neurons [11-13]. This requires sex-specific cell death [14]or neurogenesis events resulting from extensive sex differences in the cell division patterns and neurodevelopmental programmes of post-embryonic cell lineages (reviewed in [3]). Here we identify a third, novel way to generate sexual dimorphism in the nervous system. We find that during sexual maturation (L4 stage), a class of sex-shared glial cells acquires sexually dimorphic function by undergoing a direct glia-to-neuron transdifferentiation that results in the production of male-specific neurons. This plasticity is regulated cell-intrinsically by the sex-determination pathway. These previously unnoticed neurons, which we term PHDs, are putative proprioceptors that regulate male locomotion during specific steps of mating. One of these steps is a novel readjustment movement performed when intromission becomes difficult to achieve. Our results reveal sex-specific direct transdifferentiation as a novel mechanism for generating sex-specific neurons and also show the importance of proprioceptive feedback during the complex steps of mating for successful reproduction.
]]></description>
<dc:creator>Molina-Garcia, L.</dc:creator>
<dc:creator>Cook, S. J.</dc:creator>
<dc:creator>Kim, B.</dc:creator>
<dc:creator>Bonnington, R.</dc:creator>
<dc:creator>Sammut, M.</dc:creator>
<dc:creator>O'Shea, J.</dc:creator>
<dc:creator>Elliott, D.</dc:creator>
<dc:creator>Hall, D. H.</dc:creator>
<dc:creator>Emmons, S.</dc:creator>
<dc:creator>Barrios, A.</dc:creator>
<dc:creator>Poole, R. J.</dc:creator>
<dc:date>2018-03-21</dc:date>
<dc:identifier>doi:10.1101/285320</dc:identifier>
<dc:title><![CDATA[A direct glia-to-neuron natural transdifferentiation ensures nimble sensory-motor coordination of male mating behaviour]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-03-21</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/290106v1?rss=1">
<title>
<![CDATA[
Processing of Auditory Novelty Across the Cortical Hierarchy: An Intracranial Electrophysiology Study 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/290106v1?rss=1</link>
<description><![CDATA[
Under the predictive coding hypothesis, specific spatiotemporal patterns of cortical activation are postulated to occur during sensory processing as expectations generate feedback predictions and prediction errors generate feedforward signals. Establishing experimental evidence for this information flow within cortical hierarchy has been difficult, especially in humans, due to spatial and temporal limitations of non-invasive measures of cortical activity. This study investigated cortical responses to auditory novelty using the local/global deviant paradigm, which engages the hierarchical network underlying auditory predictive coding over short ( local deviance; LD) and long ( global deviance; GD) time scales. Electrocorticographic responses to auditory stimuli were obtained in neurosurgical patients from regions of interest (ROIs) including auditory, auditory-related and prefrontal cortex. LD and GD effects were assayed in averaged evoked potential (AEP) and high gamma (70-150 Hz) signals, the former likely dominated by local synaptic currents and the latter largely reflecting local spiking activity. AEP LD effects were distributed across all ROIs, with greatest percentage of significant sites in core and non-core auditory cortex. High gamma LD effects were localized primarily to auditory cortex in the superior temporal plane and on the lateral surface of the superior temporal gyrus (STG). LD effects exhibited progressively longer latencies in core, non-core, auditory-related and prefrontal cortices, consistent with feedforward signaling. The spatial distribution of AEP GD effects overlapped that of LD effects, but high gamma GD effects were more restricted to non-core areas. High gamma GD effects had shortest latencies in STG and preceded AEP GD effects in most ROIs. This latency profile, along with the paucity of high gamma GD effects in the superior temporal plane, suggest that the STG plays a prominent role in initiating novelty detection signals over long time scales. Thus, the data demonstrate distinct patterns of information flow in human cortex associated with auditory novelty detection over multiple time scales.
]]></description>
<dc:creator>Nourski, K. V.</dc:creator>
<dc:creator>Steinschneider, M.</dc:creator>
<dc:creator>Rhone, A. E.</dc:creator>
<dc:creator>Kawasaki, H.</dc:creator>
<dc:creator>Howard, M. A.</dc:creator>
<dc:creator>Banks, M. I.</dc:creator>
<dc:date>2018-03-27</dc:date>
<dc:identifier>doi:10.1101/290106</dc:identifier>
<dc:title><![CDATA[Processing of Auditory Novelty Across the Cortical Hierarchy: An Intracranial Electrophysiology Study]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-03-27</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/297804v1?rss=1">
<title>
<![CDATA[
The histone demethylase KDM5 is essential for larval growth in Drosophila 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/297804v1?rss=1</link>
<description><![CDATA[
Regulated gene expression is necessary for developmental and homeostatic processes. The KDM5 family of proteins are histone H3 lysine 4 demethylases that can regulate transcription through both demethylase-dependent and independent mechanisms. While loss and overexpression of KDM5 proteins are linked to intellectual disability and cancer, respectively, their normal developmental functions remain less characterized. Drosophila melanogaster provides an ideal system to investigate KDM5 function, as it encodes a single ortholog in contrast to the four paralogs found in mammalian cells. To examine the consequences of complete loss of KDM5, we generated a null allele of Drosophila kdm5, also known as little imaginal discs (lid), and show that it is essential for development. Animals lacking KDM5 die during late pupal development but show a dramatically delayed larval development that coincides with decreased proliferation and increased cell death in imaginal discs. Interestingly, this developmental delay is independent of the well-characterized Jumonji C (JmjC) domain-encoded histone demethylase activity and plant homedomain (PHD) motif-mediated chromatin binding activities of KDM5, suggesting key functions for less characterized domains. Consistent with the phenotypes observed, transcriptome analyses of kdm5 null mutant wing imaginal discs revealed the dysregulation of genes involved in several cellular processes, including cell cycle progression and DNA repair. Together, our data provide the first description of complete loss of KDM5 function in a metazoan and offer an invaluable tool for defining the biological activities of KDM5 family proteins.
]]></description>
<dc:creator>Secombe, J.</dc:creator>
<dc:creator>Drelon, C.</dc:creator>
<dc:creator>Belalcazar, H. M.</dc:creator>
<dc:date>2018-04-09</dc:date>
<dc:identifier>doi:10.1101/297804</dc:identifier>
<dc:title><![CDATA[The histone demethylase KDM5 is essential for larval growth in Drosophila]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-04-09</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/301713v1?rss=1">
<title>
<![CDATA[
Direct Small Molecule Activation of Mitofusins 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/301713v1?rss=1</link>
<description><![CDATA[
Mitochondrial fusion is a physiological process that is regulated by mitofusins on the outer mitochondrial membrane. Conformational plasticity between anti- and pro-tethering conformations of mitofusins permits mitochondrial tethering and subsequent fusion. Here we developed a pharmacophore-based model to rationally manipulate the conformational plasticity of mitofusin 2 and perfomed an in silico small-molecule screen. This enabled the discovery of a direct activator of mitofusins, MASM7, capable of potently promoting mitochondrial fusion. The specificity of the MASM7-mitofusin 2 interaction is highlighted by structure-activity relationships of MASM7 analogues, FRET, NMR and mitochondrial fusion studies using mitofusin mutants. Our study identified the first-in-class direct activator of mitofusins, demonstrating a new paradigm for chemical modulation of mitochondrial fusion and downstream processes.
]]></description>
<dc:creator>Zacharioudakis, E.</dc:creator>
<dc:creator>Biris, N.</dc:creator>
<dc:creator>Garner, T.</dc:creator>
<dc:creator>Chen, Y.</dc:creator>
<dc:creator>Pekson, R.</dc:creator>
<dc:creator>Dhingra, R.</dc:creator>
<dc:creator>Santulli, G.</dc:creator>
<dc:creator>Kirshenbaum, L.</dc:creator>
<dc:creator>Kitsis, R.</dc:creator>
<dc:creator>Gavathiotis, E.</dc:creator>
<dc:date>2018-04-17</dc:date>
<dc:identifier>doi:10.1101/301713</dc:identifier>
<dc:title><![CDATA[Direct Small Molecule Activation of Mitofusins]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-04-17</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/302968v1?rss=1">
<title>
<![CDATA[
A novel sialylation site on Neisseria gonorrhoeae lipooligosaccharide links heptose II lactose expression with pathogenicity 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/302968v1?rss=1</link>
<description><![CDATA[
Sialylation of lacto-W-neotetraose (LNnT) extending from heptose I (HepI) of gonococcal lipooligosaccharide (LOS) contributes to pathogenesis. Previously, gonococcal LOS sialyltransterase (Lst) was shown to sialylate LOS in Triton X-100 extracts of strain 15253, which expresses lactose from both HepI and HepII, the minimal structure required for mAb 2C7 binding. Ongoing work has shown that growth of 15253 in cytidine monophospho-W-acetylneuraminic acid (CMP-Neu5Ac)-containing media enables binding to CD33/Siglec-3, a cell surface receptor that binds sialic acid, suggesting that lactose termini on LOS of intact gonococci can be sialylated. Neu5Ac was detected on LOSs of strains 15253 and a MS11 mutant with only lactose from HepI and HepII by mass spectrometry; deleting HepII lactose rendered Neu5Ac undetectable. Resistance of HepII lactose Neu5Ac to desialylation by 2-3-specific neuraminidase suggested an 2-6-linkage. Although not associated with increased factor H binding, HepII lactose sialylation inhibited complement C3 deposition on gonococci. 15253 mutants that lacked Lst or HepII lactose were significantly attenuated in mice, confirming the importance of HepII Neu5Ac in virulence. All 75 minimally passaged clinical isolates from Nanjing, China, expressed HepII lactose, evidenced by reactivity with mAb 2C7; mAb 2C7 was bactericidal against the first 62 (of 75) isolates that had been collected sequentially and were sialylated before testing. mAb 2C7 effectively attenuated 15253 vaginal colonization in mice. In conclusion, this novel sialylation site could explain the ubiquity of gonococcal HepII lactose in vivo. Our findings reiterate the candidacy of the 2C7 epitope as a vaccine antigen and mAb 2C7 as an immunotherapeutic antibody.
]]></description>
<dc:creator>Ram, S.</dc:creator>
<dc:creator>Gulati, S.</dc:creator>
<dc:creator>Lewis, L. A.</dc:creator>
<dc:creator>Chakraborti, S.</dc:creator>
<dc:creator>Zheng, B.</dc:creator>
<dc:creator>DeOliveira, R. B.</dc:creator>
<dc:creator>Reed, G. W.</dc:creator>
<dc:creator>Cox, A. D.</dc:creator>
<dc:creator>Li, J.</dc:creator>
<dc:creator>St. Michael, F.</dc:creator>
<dc:creator>Stupak, J.</dc:creator>
<dc:creator>Su, X.-H.</dc:creator>
<dc:creator>Saha, S.</dc:creator>
<dc:creator>Landig, C. S.</dc:creator>
<dc:creator>Varki, A.</dc:creator>
<dc:creator>RICE, P. A.</dc:creator>
<dc:date>2018-04-17</dc:date>
<dc:identifier>doi:10.1101/302968</dc:identifier>
<dc:title><![CDATA[A novel sialylation site on Neisseria gonorrhoeae lipooligosaccharide links heptose II lactose expression with pathogenicity]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-04-17</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/303396v1?rss=1">
<title>
<![CDATA[
A novel approach to modeling transcriptional heterogeneity identifies the oncogene candidate CBX2 in invasive breast carcinoma 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/303396v1?rss=1</link>
<description><![CDATA[
Oncogenes promote the development of and serve as therapeutic targets against subsets of cancers. Here, a new statistical approach that captures transcriptional heterogeneity in tumor and adjacent normal (i.e. tumor-free) mRNA expression profiles was developed to identify oncogene candidates that were overexpressed in a subset of breast tumors. Intronic DNA methylation was strongly associated with the overexpression of chromobox 2 (CBX2), an oncogene candidate that was identified using our method but not through prior analytical approaches. CBX2 overexpression in breast tumors was associated with the upregulation of genes involved in cell cycle progression and is associated with poorer 5-year survival. The predicted function of CBX2 was confirmed in vitro providing the first experimental evidence that CBX2 promotes breast cancer cell growth. Modeling mRNA expression heterogeneity in tumors is a novel powerful approach with the potential to uncover therapeutic targets that benefit subsets of cancer patients.
]]></description>
<dc:creator>Pique, D.</dc:creator>
<dc:creator>Montagna, C.</dc:creator>
<dc:creator>Greally, J.</dc:creator>
<dc:creator>Mar, J.</dc:creator>
<dc:date>2018-04-20</dc:date>
<dc:identifier>doi:10.1101/303396</dc:identifier>
<dc:title><![CDATA[A novel approach to modeling transcriptional heterogeneity identifies the oncogene candidate CBX2 in invasive breast carcinoma]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-04-20</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/314922v1?rss=1">
<title>
<![CDATA[
Synthesis and degradation of FtsZ determines the first cell division in starved bacteria 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/314922v1?rss=1</link>
<description><![CDATA[
In natural environments, microbes are typically non-dividing. Such quiescent cells manage fleeting nutrients and gauge when intra- and extracellular resources permit division. Quantitative prediction of the division event as a function of nutritional status is currently achieved through phenomenological models for nutrient-rich, exponentially growing cultures. Such models, however, cannot predict the first division of cells under limiting nutrient availability. To address this, we analyzed the metabolic capability of starved Escherichia coli that were fed pulsed glucose at defined frequencies. Real-time metabolomics and microfluidic single-cell microscopy revealed unexpected, rapid protein and nucleic acid synthesis already in non-dividing cells. Additionally, the lag time to first division shortened as pulsing frequency increased. Here, we demonstrate that the first division from a non-dividing state occurs when the facilitating protein FtsZ reaches division-supporting concentration. A dynamic model quantitatively relates lag time to FtsZ synthesis from nutrient pulses and its protease-dependent degradation. Consistent with model predictions, lag time shortened when FtsZ synthesis was supplemented or protease inhibitors were added. Lag time prolonged when ftsZ was repressed or FtsZ degradation rate was increased. Thus, we provide a basis to quantitatively predict bacterial division using information about molecular determinants and the nutrient input.
]]></description>
<dc:creator>Sekar, K.</dc:creator>
<dc:creator>Rusconi, R.</dc:creator>
<dc:creator>Fuhrer, T.</dc:creator>
<dc:creator>Noor, E.</dc:creator>
<dc:creator>Nguyen, J.</dc:creator>
<dc:creator>Fernandez, V. I.</dc:creator>
<dc:creator>Buffing, M. F.</dc:creator>
<dc:creator>Berney, M.</dc:creator>
<dc:creator>Stocker, R.</dc:creator>
<dc:creator>Sauer, U.</dc:creator>
<dc:date>2018-05-04</dc:date>
<dc:identifier>doi:10.1101/314922</dc:identifier>
<dc:title><![CDATA[Synthesis and degradation of FtsZ determines the first cell division in starved bacteria]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-05-04</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/319509v1?rss=1">
<title>
<![CDATA[
Clustering of Type 2 Diabetes Genetic Loci by Multi-Trait Associations Identifies Disease Mechanisms and Subtypes 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/319509v1?rss=1</link>
<description><![CDATA[
BackgroundType 2 diabetes (T2D) is a heterogeneous disease for which 1) disease-causing pathways are incompletely understood and 2) sub-classification may improve patient management. Unlike other biomarkers, germline genetic markers do not change with disease progression or treatment. In this paper we test whether a germline genetic approach informed by physiology can be used to deconstruct T2D heterogeneity. First, we aimed to categorize genetic loci into groups representing likely disease mechanistic pathways. Second, we asked whether the novel clusters of genetic loci we identified have any broad clinical consequence, as assessed in four independent cohorts of individuals with T2D.nnMethods and FindingsIn an effort to identify mechanistic pathways driven by established T2D genetic loci, we applied Bayesian nonnegative matrix factorization clustering to genome-wide association results for 94 independent T2D genetic loci and 47 diabetes-related traits. We identified five robust clusters of T2D loci and traits, each with distinct tissue-specific enhancer enrichment based on analysis of epigenomic data from 28 cell types. Two clusters contained variant-trait associations indicative of reduced beta-cell function, differing from each other by high vs. low proinsulin levels. The three other clusters displayed features of insulin resistance: obesity-mediated (high BMI, waist circumference), "lipodystrophy-like" fat distribution (low BMI, adiponectin, HDL-cholesterol, and high triglycerides), and disrupted liver lipid metabolism (low triglycerides). Increased cluster GRSs were associated with distinct clinical outcomes, including increased blood pressure, coronary artery disease, and stroke risk. We evaluated the potential for clinical impact of these clusters in four studies containing participants with T2D (METSIM, N=487; Ashkenazi, N=509; Partners Biobank, N=2,065; UK Biobank N=14,813). Individuals with T2D in the top genetic risk score decile for each cluster reproducibly exhibited the predicted cluster-associated phenotypes, with ~30% of all participants assigned to just one cluster top decile.nnConclusionOur approach identifies salient T2D genetically anchored and physiologically informed pathways, and supports use of genetics to deconstruct T2D heterogeneity. Classification of patients by these genetic pathways may offer a step toward genetically informed T2D patient management.
]]></description>
<dc:creator>Udler, M. S.</dc:creator>
<dc:creator>Kim, J.</dc:creator>
<dc:creator>von Grotthuss, M.</dc:creator>
<dc:creator>Bonas-Guarch, S.</dc:creator>
<dc:creator>Mercader, J. M.</dc:creator>
<dc:creator>Cole, J. B.</dc:creator>
<dc:creator>Chiou, J.</dc:creator>
<dc:creator>Anderson, C. D.</dc:creator>
<dc:creator>Boehnke, M.</dc:creator>
<dc:creator>Laakso, M.</dc:creator>
<dc:creator>Atzmon, G.</dc:creator>
<dc:creator>Glaser, B.</dc:creator>
<dc:creator>Gaulton, K.</dc:creator>
<dc:creator>Flannick, J.</dc:creator>
<dc:creator>Getz, G.</dc:creator>
<dc:creator>Florez, J. C.</dc:creator>
<dc:date>2018-05-10</dc:date>
<dc:identifier>doi:10.1101/319509</dc:identifier>
<dc:title><![CDATA[Clustering of Type 2 Diabetes Genetic Loci by Multi-Trait Associations Identifies Disease Mechanisms and Subtypes]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-05-10</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/322404v1?rss=1">
<title>
<![CDATA[
Discovery of a novel stereospecific β-hydroxyacyl-CoA lyase/thioesterase shared by three metabolic pathways in Mycobacterium tuberculosis 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/322404v1?rss=1</link>
<description><![CDATA[
The vast number of poorly characterised enzymes in Mycobacterium tuberculosis (Mtb) is one of the key barriers precluding a better understanding of the biology that underpins pathogenesis. Here, we investigated the Mtb orphan enzyme Rv2498c to delineate its physiological role. Our results from in vitro enzymatic assays, phylogenetic analysis, X-ray crystallography and in vivo Mtb experiments, de-orphan Rv2498c as a multi-functional {beta}-hydroxyacyl-CoA lyase/thioesterase ({beta}-HAClyase/thioesterase) that participates in three different metabolic pathways: L-leucine catabolism, itaconate dissimilation, and glyoxylate shunt. Moreover, the deletion of the rv2498c gene from the Mtb genome resulted in attenuation in the mouse model compared to infection with the parent strain. To the best of our knowledge, this is the first report of an (R)-3-hydroxyl-3-methylglutaryl-CoA for leucine catabolism and an itaconate-specific resistance mechanism in Mtb.
]]></description>
<dc:creator>Wang, H.</dc:creator>
<dc:creator>Fedorov, A. A.</dc:creator>
<dc:creator>Fedorov, E. V.</dc:creator>
<dc:creator>Hunt, D. M.</dc:creator>
<dc:creator>Rodgers, A.</dc:creator>
<dc:creator>Garza-Garcia, A.</dc:creator>
<dc:creator>Bonanno, J. B.</dc:creator>
<dc:creator>Almo, S. C.</dc:creator>
<dc:creator>Carvalho, L. P.</dc:creator>
<dc:date>2018-05-15</dc:date>
<dc:identifier>doi:10.1101/322404</dc:identifier>
<dc:title><![CDATA[Discovery of a novel stereospecific β-hydroxyacyl-CoA lyase/thioesterase shared by three metabolic pathways in Mycobacterium tuberculosis]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-05-15</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/326231v1?rss=1">
<title>
<![CDATA[
Regulated nuclear accumulation of a histone methyltransferase times the onset of heterochromatin formation in C. elegans embryos 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/326231v1?rss=1</link>
<description><![CDATA[
Heterochromatin formation during early embryogenesis is timed precisely, but it has been elusive how this process is regulated. Here we report the discovery of a histone methyltransferase complex whose nuclear accumulation and activation establishes the onset of heterochromatin formation in C. elegans embryos. We find that the inception of heterochromatin generation coincides with the accumulation of the Histone H3 Lysine 9 (H3K9) methyltransferase MET-2 (SETDB) into nuclear hubs. The absence of MET-2 results in delayed and disturbed heterochromatin formation, whereas accelerated nuclear localization of the methyltransferase leads to precocious H3K9 methylation. We identify two factors that bind to and function with MET-2: LIN-65, which resembles ATF7IP, localizes MET-2 into nuclear hubs, and ARLE-14, orthologous to ARL14EP, promotes stable association of MET-2 with chromatin. These data reveal that nuclear accumulation of MET-2 in conjunction with LIN-65 and ARLE-14 regulates timing of heterochromatin domains during embryogenesis.nnONE SENTENCE SUMMARYMET-2/SETDB1 and interactors LIN-65/ATF7IP and ARLE-14/ARL14EP initiate heterochromatin formation during embryogenesis.
]]></description>
<dc:creator>Mutlu, B.</dc:creator>
<dc:creator>Chen, H.-M.</dc:creator>
<dc:creator>Moresco, J. J.</dc:creator>
<dc:creator>Orelo, B. D.</dc:creator>
<dc:creator>Yang, B.</dc:creator>
<dc:creator>Gaspar, J. M.</dc:creator>
<dc:creator>Keppler-Ross, S.</dc:creator>
<dc:creator>Yates, J. R.</dc:creator>
<dc:creator>Hall, D. H.</dc:creator>
<dc:creator>Maine, E. M.</dc:creator>
<dc:creator>Mango, S. E.</dc:creator>
<dc:date>2018-05-18</dc:date>
<dc:identifier>doi:10.1101/326231</dc:identifier>
<dc:title><![CDATA[Regulated nuclear accumulation of a histone methyltransferase times the onset of heterochromatin formation in C. elegans embryos]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-05-18</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/326264v1?rss=1">
<title>
<![CDATA[
A novel approach of human geroprotector discovery by targeting the converging subnetworks of aging and age-related diseases 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/326264v1?rss=1</link>
<description><![CDATA[
A key goal of geroscience research is to discover effective interventions to extend human healthspan, the years of healthy life. Currently, majority of the geroprotectors are found by testing compounds in model organisms; whether these compounds will be effective in humans is largely unknown. Here we present a novel strategy called ANDRU (aging network based drug discovery) to help the discovery of human geroprotectors. Instead of relying on model organisms, this approach is driven by human genomic and pharmacogenomic data. It first identifies human aging subnetworks that putatively function at the interface between aging and age-related diseases; it then screens for pharmacological or genetic interventions that may "reverse" the age-associated transcriptional changes seen in these subnetworks. We applied ANDRU to human adipose and artery tissues. In adipose tissue, PTPN1, a target for diabetes treatment and APOE, a known genetic factor for human longevity and diseases like Alzheimers disease, were ranked at the top. For small molecules, conjugated linoleic acid and metformin, a drug commonly used to treat type 2 diabetes, were ranked among the top compounds. In artery tissue, N-methyl-D-aspartate antagonists and curcumin were ranked at the top. In summary, ANDRU represents a promising human data-driven strategy that may speed up the discovery of interventions to extend human healthspan.
]]></description>
<dc:creator>Yang, J.</dc:creator>
<dc:creator>Zhang, B.</dc:creator>
<dc:creator>Houten, S.</dc:creator>
<dc:creator>Schadt, E.</dc:creator>
<dc:creator>Zhu, J.</dc:creator>
<dc:creator>Suh, Y.</dc:creator>
<dc:creator>Tu, Z.</dc:creator>
<dc:date>2018-05-19</dc:date>
<dc:identifier>doi:10.1101/326264</dc:identifier>
<dc:title><![CDATA[A novel approach of human geroprotector discovery by targeting the converging subnetworks of aging and age-related diseases]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-05-19</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/330894v1?rss=1">
<title>
<![CDATA[
Susceptibility to Neutralization by Broadly Neutralizing Antibodies Correlates with Infected Cell Binding for a Panel of Clade B HIV Reactivated from Latent Reservoirs 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/330894v1?rss=1</link>
<description><![CDATA[
Efforts to HIV cure are obstructed by reservoirs of latently infected CD4+ T-cells that can re-establish viremia. Broadly neutralizing HIV-specific antibodies (bNAbs), defined by unusually high neutralization breadths against globally diverse viruses, may contribute to the elimination of these reservoirs by binding to reactivated cells, targeting them for immune clearance. However, the relationship between neutralization of reservoir isolates and binding to corresponding infected primary CD4+ T-cells has not been determined. Thus, the extent to which neutralization breadths and potencies can be used to infer the corresponding parameters of infected-cell binding is currently unknown. We assessed the breadths and potencies of bNAbs against 36 viruses reactivated from peripheral blood CD4+ T-cells of ARV-treated HIV-infected individuals, using paired neutralization and infected-cell binding assays. Single antibody breadths ranged from 0-64% for neutralization (IC80[&le;]10g/ml) and 0-89% for binding, with two-antibody combinations reaching 0-83% and 50-100%, respectively. Infected-cell binding correlated with virus neutralization for 10 out of 14 antibodies (e.g. 3BNC117, r=0.87, p<0.0001). Heterogeneity was observed, however, with a lack of significant correlations for 2G12, CAP256.VRC26.25, 2F5, and 4E10. Our results provide guidance on the selection of bNAbs for interventional cure studies; both by providing a direct assessment of intra-and inter-individual variability in neutralization and infected cell binding in a novel cohort, and by defining the relationships between these parameters for a panel of bNAbs.nnImportanceAlthough anti-retroviral therapies have improved the lives of people who are living with HIV, they do not cure infection. Efforts are being directed towards harnessing the immune system to eliminate the virus that persists, potentially resulting in virus-free remission without medication. HIV-specific antibodies hold promise for such therapies owing to their abilities to both prevent the infection of new cells (neutralization), and also to direct the killing of infected cells. We isolated 36 HIV strains from individuals whose virus was suppressed by medication, and tested 14 different antibodies for neutralization of these viruses and for binding to cells infected with the same viruses (critical for engaging natural killer cells). For both neutralization and infected-cell binding, we observed variation both between individuals, and amongst different viruses within an individual. For most antibodies, neutralization activity correlated with infected cell binding. These data provide guidance on the selection of antibodies for clinical trials.
]]></description>
<dc:creator>Ren, Y.</dc:creator>
<dc:creator>Korom, M.</dc:creator>
<dc:creator>Truong, R.</dc:creator>
<dc:creator>Chan, D.</dc:creator>
<dc:creator>Huang, S.-h.</dc:creator>
<dc:creator>Kovacs, C.</dc:creator>
<dc:creator>Benko, E.</dc:creator>
<dc:creator>Safrit, J. T.</dc:creator>
<dc:creator>Lee, J.</dc:creator>
<dc:creator>Garban, H.</dc:creator>
<dc:creator>Apps, R.</dc:creator>
<dc:creator>Goldstein, H.</dc:creator>
<dc:creator>Lynch, R. M.</dc:creator>
<dc:creator>Jones, R. B.</dc:creator>
<dc:date>2018-05-25</dc:date>
<dc:identifier>doi:10.1101/330894</dc:identifier>
<dc:title><![CDATA[Susceptibility to Neutralization by Broadly Neutralizing Antibodies Correlates with Infected Cell Binding for a Panel of Clade B HIV Reactivated from Latent Reservoirs]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-05-25</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/333468v1?rss=1">
<title>
<![CDATA[
Re-targeting of macroH2A following mitosis to cytogenetic-scale heterochromatic domains 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/333468v1?rss=1</link>
<description><![CDATA[
The heritability of chromatin states through cell division is a potential contributor to the epigenetic maintenance of cellular memory of prior states. The macroH2A histone variant has properties of a regulator of epigenetic cell memory, including roles controlling gene silencing and cell differentiation. Its mechanisms of regional genomic targeting and maintenance through cell division are unknown. Here we combined in vivo imaging with biochemical and genomic approaches to show that human macroH2A is incorporated into chromatin in the G1 phase of the cell cycle following DNA replication. The newly-incorporated macroH2A re-targets the same, large heterochromatic domains where macroH2A was already enriched in the previous cell cycle. It remains heterotypic, targeting individual nucleosomes that do not already contain a macroH2A molecule. The pattern observed resembles that of new deposition of centromeric histone variants during the cell cycle, indicating mechanistic similarities for macrodomain-scale regulation of epigenetic properties of the cell.
]]></description>
<dc:creator>Sato, H.</dc:creator>
<dc:creator>Wu, B.</dc:creator>
<dc:creator>Delahaye, F.</dc:creator>
<dc:creator>Singer, R. H.</dc:creator>
<dc:creator>Greally, J.</dc:creator>
<dc:date>2018-05-29</dc:date>
<dc:identifier>doi:10.1101/333468</dc:identifier>
<dc:title><![CDATA[Re-targeting of macroH2A following mitosis to cytogenetic-scale heterochromatic domains]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-05-29</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/347567v1?rss=1">
<title>
<![CDATA[
TIAM-1/GEF can shape somatosensory dendrites independently of its GEF activity by regulating F-actin localization 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/347567v1?rss=1</link>
<description><![CDATA[
Development of dendritic arbors is crucial for nervous system assembly, but the intracellular mechanisms that govern these processes remain incompletely understood. Here we show that the complex dendritic trees of PVD somatosensory neurons in Caenorhabditis elegans are patterned by distinct pathways downstream of the DMA-1 leucine rich transmembrane (LRR-TM) receptor. The guanine nucleotide exchange factor tiam-1/GEF and act-4/Actin function with the DMA-1/LRR-TM to pattern 4{degrees} higher order branches by localizing F-actin to the distal ends of developing dendrites. Biochemical experiments show that DMA-1/LRR-TM is part of a biochemical complex with TIAM-1/GEF and ACT-4/Actin. Surprisingly, TIAM-1/GEF appears to function independently of Rac1 guanine nucleotide exchange factor activity. Additionally, another pathway dependent on HPO-30/Claudin and TIAM-1/GEF is required for formation of 2{degrees} and 3{degrees} branches. Collectively, our experiments suggest that the DMA-1/LRR-TM receptor on PVD dendrites may control aspects of dendrite patterning by directly modulating F-actin dynamics, independently of TIAM-1/GEF enzymatic activity.
]]></description>
<dc:creator>Tang, L. T. H.</dc:creator>
<dc:creator>Diaz-Balzac, C. A.</dc:creator>
<dc:creator>Rahman, M.</dc:creator>
<dc:creator>Ramirez-Suarez, N. J.</dc:creator>
<dc:creator>Salzberg, Y.</dc:creator>
<dc:creator>Lazaro-Pena, M. I.</dc:creator>
<dc:creator>Bülow, H. E.</dc:creator>
<dc:date>2018-06-14</dc:date>
<dc:identifier>doi:10.1101/347567</dc:identifier>
<dc:title><![CDATA[TIAM-1/GEF can shape somatosensory dendrites independently of its GEF activity by regulating F-actin localization]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-06-14</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/349993v1?rss=1">
<title>
<![CDATA[
Spatiotemporal Gene Coexpression and Regulation in Mouse Cardiomyocytes of Early Cardiac Morphogenesis 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/349993v1?rss=1</link>
<description><![CDATA[
Cardiac looping is an early morphogenic process critical for the formation of four-chambered mammalian hearts. To study the roles of signaling pathways, transcription factors (TFs) and genetic networks in the process, we constructed gene co-expression networks and identified gene modules highly activated in individual cardiomyocytes (CMs) at multiple anatomical regions and developmental stages. Function analyses of the module genes uncovered major pathways important for spatiotemporal CM differentiation. Interestingly, about half of the pathways were highly active in cardiomyocytes at outflow tract (OFT) and atrioventricular canal (AVC), including many well-known signaling pathways for cardiac development and several newly identified ones. Most of the OFT-AVC pathways were predicted to be regulated by 6 6 transcription factors (TFs) actively expressed at the OFT-AVC locations, with the prediction supported by motif enrichment analysis of the TF targets, including 10 TFs that have not been previously associated with cardiac development, e.g., Etv5, Rbpms, and Baz2b. Finally, our study showed that the OFT-AVC TF targets were significantly enriched with genes associated with mouse heart developmental abnormalities and human congenital heart defects.
]]></description>
<dc:creator>Liu, Y.</dc:creator>
<dc:creator>Lu, P.</dc:creator>
<dc:creator>Wang, Y.</dc:creator>
<dc:creator>Morrow, B. E.</dc:creator>
<dc:creator>Zhou, B.</dc:creator>
<dc:creator>Zheng, D.</dc:creator>
<dc:date>2018-06-19</dc:date>
<dc:identifier>doi:10.1101/349993</dc:identifier>
<dc:title><![CDATA[Spatiotemporal Gene Coexpression and Regulation in Mouse Cardiomyocytes of Early Cardiac Morphogenesis]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-06-19</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/356055v1?rss=1">
<title>
<![CDATA[
Two point mutations in the Hantaan virus glycoproteins afford the generation of a highly infectious recombinant vesicular stomatitis virus vector 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/356055v1?rss=1</link>
<description><![CDATA[
Rodent-to-human transmission of hantaviruses is associated with severe disease. Currently, no FDA-approved, specific antivirals or vaccines are available, and the requirement for high biocontainment (BSL3) laboratories limits hantavirus research. To study hantavirus entry in a BSL-2 laboratory, we set out to generate replication-competent, recombinant vesicular stomatitis viruses (rVSVs) bearing the Gn/Gc entry glycoproteins. As previously reported, rVSVs bearing New World hantavirus Gn/Gc were readily rescued from cDNAs, but their counterparts bearing Gn/Gc from the Old World hantavirus, Hantaan virus (HTNV), were refractory to rescue and only grew to low titers. However, serial passage of the rescued rVSV-HTNV Gn/Gc virus markedly increased its infectivity and capacity for cell-to-cell spread. This gain in viral fitness was associated with the acquisition of two point mutations; I532K in the cytoplasmic tail of Gn, and S1094L in the membrane-proximal stem of Gc. Follow-up experiments with rVSVs and single-cycle VSV pseudotypes confirmed these results. Mechanistic studies revealed that both mutations were determinative and contributed to viral infectivity in a synergistic manner. Our findings indicate that the primary mode of action of these mutations is to relocalize HTNV Gn/Gc from the Golgi complex to the cell surface, thereby affording significantly enhanced Gn/Gc incorporation into budding VSV particles. Our results suggest that enhancements in cell-surface expression of hantaviral glycoprotein(s) through incorporation of cognate mutations could afford the generation of rVSVs that are otherwise challenging to rescue. The robust replication-competent rVSV-HTNV Gn/Gc reported herein may also have utility as a vaccine.nnImportanceHuman hantavirus infections cause pulmonary syndrome in the Americas and hemorrhagic fever with renal syndrome (HFRS) in Eurasia. No FDA-approved vaccines and therapeutics exist for these deadly viruses, and their development is limited by the requirement for high biocontainment. In this study, we identified and characterized key amino acid changes in the surface glycoproteins of HFRS-causing Hantaan virus that enhance their incorporation into recombinant vesicular stomatitis virus (rVSV) particles. The replication-competent rVSV genetically encoding Hantaan virus glycoproteins described in this work provides a powerful and facile system to study hantavirus entry under lower biocontainment and may have utility as a hantavirus vaccine.
]]></description>
<dc:creator>Slough, M. M.</dc:creator>
<dc:creator>Chandran, K.</dc:creator>
<dc:creator>Jangra, R. K.</dc:creator>
<dc:date>2018-06-26</dc:date>
<dc:identifier>doi:10.1101/356055</dc:identifier>
<dc:title><![CDATA[Two point mutations in the Hantaan virus glycoproteins afford the generation of a highly infectious recombinant vesicular stomatitis virus vector]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-06-26</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/363051v1?rss=1">
<title>
<![CDATA[
The immune cell landscape in kidneys of lupus nephritis patients 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/363051v1?rss=1</link>
<description><![CDATA[
Lupus nephritis is a potentially fatal autoimmune disease, whose current treatment is ineffective and often toxic. To gain insights into disease mechanisms, we analyzed kidney samples from lupus nephritis patients and healthy controls using single-cell RNA-seq. Our analysis revealed 21 subsets of leukocytes active in disease, including multiple populations of myeloid, T, NK and B cells, demonstrating both pro-inflammatory and resolving responses. We found evidence of local activation of B cells correlated with an age-associated B cell signature, and of progressive stages of monocyte differentiation within the kidney. A clear interferon response was observed in most cells. Two chemokine receptors, CXCR4 and CX3CR1, were broadly expressed, pointing to potential therapeutic targets. Gene expression of immune cells in urine and kidney was highly correlated, suggesting urine may be a surrogate for kidney biopsies. Our results provide a first comprehensive view of the complex network of leukocytes active in lupus nephritis kidneys.
]]></description>
<dc:creator>Arazi, A.</dc:creator>
<dc:creator>Rao, D. A.</dc:creator>
<dc:creator>Berthier, C. C.</dc:creator>
<dc:creator>Davidson, A.</dc:creator>
<dc:creator>Liu, Y.</dc:creator>
<dc:creator>Hoover, P. J.</dc:creator>
<dc:creator>Chicoine, A.</dc:creator>
<dc:creator>Eisenhaure, T. M.</dc:creator>
<dc:creator>Jonsson, A. H.</dc:creator>
<dc:creator>Li, S.</dc:creator>
<dc:creator>Lieb, D. J.</dc:creator>
<dc:creator>Browne, E. P.</dc:creator>
<dc:creator>Noma, A.</dc:creator>
<dc:creator>Sutherby, D.</dc:creator>
<dc:creator>Steelman, S.</dc:creator>
<dc:creator>Smilek, D. E.</dc:creator>
<dc:creator>Tosta, P.</dc:creator>
<dc:creator>Apruzzese, W.</dc:creator>
<dc:creator>Massarotti, E.</dc:creator>
<dc:creator>Dall'Era, M.</dc:creator>
<dc:creator>Park, M.</dc:creator>
<dc:creator>Kamen, D. L.</dc:creator>
<dc:creator>Furie, R. A.</dc:creator>
<dc:creator>Payan-Schober, F.</dc:creator>
<dc:creator>Buyon, J. P.</dc:creator>
<dc:creator>Petri, M. A.</dc:creator>
<dc:creator>Putterman, C.</dc:creator>
<dc:creator>Kalunian, K. C.</dc:creator>
<dc:creator>Woodle, E. S.</dc:creator>
<dc:creator>Lederer, J. A.</dc:creator>
<dc:creator>Hildeman, D. A.</dc:creator>
<dc:creator>Nusbaum, C.</dc:creator>
<dc:creator>Wofsy, D.</dc:creator>
<dc:creator>Kretzler, M.</dc:creator>
<dc:creator>Anolik, J. H.</dc:creator>
<dc:creator>Brenner, M. B.</dc:creator>
<dc:creator>The Accelerating Medicines Partnership in RA/SLE network,</dc:creator>
<dc:creator>Hacohen, N.</dc:creator>
<dc:creator>Diamond, B.</dc:creator>
<dc:date>2018-07-07</dc:date>
<dc:identifier>doi:10.1101/363051</dc:identifier>
<dc:title><![CDATA[The immune cell landscape in kidneys of lupus nephritis patients]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-07-07</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/374124v1?rss=1">
<title>
<![CDATA[
Repeated Measures Regression In Laboratory, Clincal And Enviromental Research - Different Between/Within Subject Slopes And Common Misconceptions 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/374124v1?rss=1</link>
<description><![CDATA[
When using repeated measures linear regression models to make causal inference in laboratory, clinical and environmental research, it is often assumed that the Within Subject association of differences (or changes) in predictor value across replicates is the same as the Between Subject association of differences in those predictor values. But this is often false, for example with body weight as the predictor and blood cholesterol the outcome i) a 10 pound weight increase in the same adult more greatly a higher increase in cholesterol in that adult than does ii) one adult weighing 10 pounds more than a second reflect increased cholesterol levels in the first adult as the weigh difference in i) more closely tracks higher body fat while that in ii) is also influenced by heavier adults being taller. Hence to make causal inferences, different Within and Between subject slopes should be separately modeled. A related misconception commonly made using generalized estimation equations (GEE) and mixed models (MM) on repeated measures (i.e. for fitting Cross Sectional Regression) is that the working correlation structure used only influences variance of model parameter estimates. But only independence working correlation guarantees the modeled parameters have any interpretability. We illustrate this with an example where changing working correlation from independence to equicorrelation qualitatively biases parameters of GEE models and show this happens because Between and Within Subject slopes for the predictor variables differ. We then describe several common mechanisms that cause Within and Between Subject slopes to differ as; change effects, lag/reverse lag and spillover causality, shared within subject measurement bias or confounding, and predictor variable measurement error. The misconceptions noted here should be better publicized in laboratory, clinical and environmental research. Repeated measures analyses should compare Within and Between subject slopes of predictors and when they differ, investigate the reasons this has happened.nnHIGHLIGHTSWhen using repeated measures with time varying predictors variables in laboratory, clinical and environmental research: O_LICross sectional regressions with any working correlation structure other than independence often give non-meaningful resultsnC_LIO_LIBetween/Within subject decomposition of slopes should be undertaken when making causal inferencesnC_LIO_LIInvestigators should investigate the reasons Between and Within Subject slopes differ if this occursnC_LI
]]></description>
<dc:creator>Hoover, D. R.</dc:creator>
<dc:creator>Shi, Q.</dc:creator>
<dc:creator>Anastos, K.</dc:creator>
<dc:date>2018-07-25</dc:date>
<dc:identifier>doi:10.1101/374124</dc:identifier>
<dc:title><![CDATA[Repeated Measures Regression In Laboratory, Clincal And Enviromental Research - Different Between/Within Subject Slopes And Common Misconceptions]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-07-25</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/376152v1?rss=1">
<title>
<![CDATA[
Extracellular matrix regulates morphogenesis and function of ciliated sensory organs in Caenorhabditis elegans 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/376152v1?rss=1</link>
<description><![CDATA[
Cilia and extracellular vesicles (EVs) are signaling organelles that play important roles in human health and disease. In C. elegans and mammals, the Autosomal Dominant Polycystic Kidney Disease (ADPKD) gene products polycystin-1 and polycystin-2 localize to both cilia and EVs, act in the same genetic pathway, and function in a sensory capacity, suggesting ancient conservation. Hence, the nematode offers an excellent system in which to address central questions regarding the biology of cilia, EVs, and the polycystins. We discovered an unexpected role of the mec-1, mec-5, and mec-9 genes encoding extracellular matrix (ECM) components. We determined that these ECM encoding genes regulate polycystin localization and function, ciliary EV release, cilia length, dendritic morphology, and neuron-glia interactions. Abnormal ECM and fibrosis are observed in ciliopathies such as ADPKD, nephronophthisis, and Bardet-Biedl Syndrome. Our studies reveal multifaceted roles for ECM proteins in the ciliated nervous system of the worm and provide a powerful new in vivo model to study the relationship between ECM, the polycystins, and ciliopathies.
]]></description>
<dc:creator>Barr, M. M.</dc:creator>
<dc:creator>De Vore, D. M.</dc:creator>
<dc:creator>Knobel, K. M.</dc:creator>
<dc:creator>Nguyen, K. C. Q.</dc:creator>
<dc:creator>Hall, D. H.</dc:creator>
<dc:date>2018-07-24</dc:date>
<dc:identifier>doi:10.1101/376152</dc:identifier>
<dc:title><![CDATA[Extracellular matrix regulates morphogenesis and function of ciliated sensory organs in Caenorhabditis elegans]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-07-24</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/377556v1?rss=1">
<title>
<![CDATA[
COMPASS: An Open-Source, General-Purpose Software Toolkit for Computational Psychiatry 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/377556v1?rss=1</link>
<description><![CDATA[
Mathematical modeling of behavior during psychophysical tasks, referred to as "computational psychiatry", could greatly improve our understanding of mental disorders. One barrier to broader adoption of computational methods is that they often require advanced programming skills. We developed the Computational Psychiatry Adaptive State-Space (COMPASS) toolbox, an open-source MATLAB-based software package. After specifying a few parameters in a small set of user-friendly functions, COMPASS allows the user to efficiently fit of a wide range of computational behavioral models. The model output can be analyzed as an experimental outcome or used as a regressor for neural data, and can be tested using goodness-of-fit methods. Here, we demonstrate that COMPASS can replicate two computational behavior analyses from different groups. COMPASS replicates and, in one case, slightly improves on the original modeling results. This flexible, general-purpose toolkit should accelerate the use of computational modeling in psychiatric neuroscience.
]]></description>
<dc:creator>Yousefi, A.</dc:creator>
<dc:creator>Paulk, A. C.</dc:creator>
<dc:creator>Basu, I.</dc:creator>
<dc:creator>Dougherty, D. D.</dc:creator>
<dc:creator>Eskandar, E. N.</dc:creator>
<dc:creator>Eden, U. T.</dc:creator>
<dc:creator>Widge, A. S.</dc:creator>
<dc:date>2018-07-27</dc:date>
<dc:identifier>doi:10.1101/377556</dc:identifier>
<dc:title><![CDATA[COMPASS: An Open-Source, General-Purpose Software Toolkit for Computational Psychiatry]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-07-27</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/378182v1?rss=1">
<title>
<![CDATA[
Tbx1 and Foxi3 genetically interact in the third pharyngeal pouch endoderm required for thymus and parathyroid development 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/378182v1?rss=1</link>
<description><![CDATA[
The mechanisms required for segmentation of the pharyngeal apparatus to individual arches are not precisely delineated in mammalian species. Here, using conditional mutagenesis, we found that two transcription factor genes, Tbx1, the gene for 22q11.2 deletion syndrome and Foxi3, genetically interact in the third pharyngeal pouch endoderm for thymus and parathyroid gland development. We found that Tbx1 is autonomously required for the endoderm to form a temporary multilayered epithelium while invaginating. E-cadherin for adherens junctions remains expressed and cells in the apical boundary express ZO-1. Foxi3 is required autonomously to modulate proliferation and promote later restoration of the endoderm to a monolayer once the epithelia meet after invagination. Completion of this process cooccurs with expression of Alcam needed to stabilize adherens junctions and extracellular, Fibronectin. These processes are required in the third pharyngeal pouch to form the thymus and parathyroid glands, disrupted in 22q11.2 deletion syndrome patients.
]]></description>
<dc:creator>Hasten, E.</dc:creator>
<dc:creator>MORROW, B. E.</dc:creator>
<dc:date>2018-07-26</dc:date>
<dc:identifier>doi:10.1101/378182</dc:identifier>
<dc:title><![CDATA[Tbx1 and Foxi3 genetically interact in the third pharyngeal pouch endoderm required for thymus and parathyroid development]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-07-26</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/379461v1?rss=1">
<title>
<![CDATA[
High efficiency genomic editing in Epstein-Barr virus-transformed lymphoblastoid B cells. 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/379461v1?rss=1</link>
<description><![CDATA[
While lymphoblastoid cell lines (LCLs) represent a valuable resource for population genetic studies, they are usually regarded as difficult for CRISPR-mediated genomic editing. It would be valuable to be able to take the results of their functional variant studies and test them in the same LCLs. We describe a protocol using a single-stranded donor oligonucleotide (ssODN) strategy for  scarless editing in LCLs. The protocol involves optimized transfection, flow cytometric sorting of transfected cells to single cells in multi-well plates and growth in conditioned, serum-rich medium, followed by characterization of the clones. Amplicon sequencing reveals the relative proportions of alleles with different editing events, with sequencing of DNA from clones showing the frequencies of events in individual cells. We find 12/60 (20%) of clones selected in this manner to have the desired ssODN-mediated recombination event. Long-range PCR of DNA at the edited locus and of RT-PCR products for the gene traversing the edited locus reveals 3/6 characterized clones (50%) to have large structural mutations of the region that are missed by sequencing just the edited site. The protocol does not require the use of lentiviruses or stable transfection, and makes LCLs a realistic cell type for consideration for CRISPR-mediated genomic targeting.
]]></description>
<dc:creator>Johnston, A. D.</dc:creator>
<dc:creator>Simoes-Pires, C.</dc:creator>
<dc:creator>Suzuki, M.</dc:creator>
<dc:creator>Greally, J.</dc:creator>
<dc:date>2018-07-29</dc:date>
<dc:identifier>doi:10.1101/379461</dc:identifier>
<dc:title><![CDATA[High efficiency genomic editing in Epstein-Barr virus-transformed lymphoblastoid B cells.]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-07-29</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/382689v1?rss=1">
<title>
<![CDATA[
Cell type-specific structural plasticity of the ciliary transition zone in C. elegans 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/382689v1?rss=1</link>
<description><![CDATA[
Background informationThe current consensus on cilia development posits that the ciliary transition zone (TZ) is formed via extension of nine centrosomal microtubules. In this model, TZ structure remains unchanged in microtubule number throughout the cilium life cycle. This model does not however explain structural variations of TZ structure seen in nature, and could also lend itself to the misinterpretation that deviations from nine-doublet microtubule ultrastructure represent an abnormal phenotype. Thus, a better understanding of events that occur at the TZ in vivo during metazoan development is required.nnResultsTo address this issue, we characterized ultrastructure of two types of sensory cilia in developing Caenorhabditis elegans. We discovered that, in cephalic male (CEM) and inner labial quadrant (IL2Q) sensory neurons, ciliary TZs are structurally plastic and remodel from one structure to another during animal larval development. The number of microtubules doublets forming the TZ can be increased or decreased over time, depending on cilia type. Both cases result in structural TZ intermediates different from TZ in adult cilia. In CEM cilia, axonemal extension and maturation occurs concurrently with TZ structural maturation.nnConclusions and SignificanceOur work extends the current model to include the structural plasticity of metazoan transition zone, which can be structurally delayed, maintained or remodeled in cell type-specific manner.
]]></description>
<dc:creator>Akella, J. S.</dc:creator>
<dc:creator>Silva, M. S.</dc:creator>
<dc:creator>Morsci, N. S.</dc:creator>
<dc:creator>Nguyen, K. C. Q.</dc:creator>
<dc:creator>Rice, W.</dc:creator>
<dc:creator>Hall, D. H.</dc:creator>
<dc:creator>Barr, M. M.</dc:creator>
<dc:date>2018-08-01</dc:date>
<dc:identifier>doi:10.1101/382689</dc:identifier>
<dc:title><![CDATA[Cell type-specific structural plasticity of the ciliary transition zone in C. elegans]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-08-01</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/382697v1?rss=1">
<title>
<![CDATA[
The allergic response mediated by fire ant venom proteins 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/382697v1?rss=1</link>
<description><![CDATA[
Fire ants are widely studied, invasive and venomous arthropod pests. There is significant biomedical interest in immunotherapy against fire ant stings. However, mainly due to practical reasons, the physiological effects of envenomation has remained poorly characterized. The present study takes advantage of a recently-described venom protein extract to delineate the immunological pathways underlying the allergic reaction to fire ant venom toxins. Mice were injected with controlled doses of venom protein extract. Following sensitization and a second exposure, a marked footpad swelling was observed. Based on eosinophil recruitment and production of Th2 cytokines, we hereby establish that fire ant proteins per se can lead to an allergic response, which casts a new light into the mechanism of action of these toxins.
]]></description>
<dc:creator>Zamith-Miranda, D.</dc:creator>
<dc:creator>Fox, E. G. P.</dc:creator>
<dc:creator>Monteiro, A. P.</dc:creator>
<dc:creator>Gama, D.</dc:creator>
<dc:creator>Poublan, L. E.</dc:creator>
<dc:creator>Araujo, A. F. d.</dc:creator>
<dc:creator>Araujo, M. F. C.</dc:creator>
<dc:creator>Atella, G. C.</dc:creator>
<dc:creator>Machado, E. A.</dc:creator>
<dc:creator>Diaz, B. L.</dc:creator>
<dc:date>2018-08-01</dc:date>
<dc:identifier>doi:10.1101/382697</dc:identifier>
<dc:title><![CDATA[The allergic response mediated by fire ant venom proteins]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-08-01</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/388215v1?rss=1">
<title>
<![CDATA[
Transposable Element Expression In Tumors Is Associated With Immune Infiltration And Increased Antigenicity 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/388215v1?rss=1</link>
<description><![CDATA[
Profound loss of DNA methylation is a well-recognized hallmark of cancer. Given its role in silencing transposable elements (TEs), we hypothesized that extensive TE expression occurs in tumors with highly demethylated DNA. We developed REdiscoverTE, a computational method for quantifying genome-wide TE expression in RNA sequencing data. Using The Cancer Genome Atlas database, we observed increased expression of over 400 TE subfamilies, of which 262 appeared to result from a proximal loss of DNA methylation. The most recurrent TEs were among the evolutionarily youngest in the genome, predominantly expressed from intergenic loci, and associated with antiviral or DNA damage responses. Treatment of glioblastoma cells with a demethylation agent resulted in both increased TE expression and de novo presentation of TE-derived peptides on MHC class I molecules. Therapeutic reactivation of tumor-specific TEs may synergize with immunotherapy by inducing both inflammation and the display of potentially immunogenic neoantigens.nnOne Sentence SummaryTransposable element expression in tumors is associated with increased immune response and provides tumor-associated antigens
]]></description>
<dc:creator>Kong, Y.</dc:creator>
<dc:creator>Rose, C.</dc:creator>
<dc:creator>Cass, A. A.</dc:creator>
<dc:creator>Darwish, M.</dc:creator>
<dc:creator>Lianoglou, S.</dc:creator>
<dc:creator>Haverty, P. M.</dc:creator>
<dc:creator>Tong, A.-J.</dc:creator>
<dc:creator>Blanchette, C.</dc:creator>
<dc:creator>Mellman, I.</dc:creator>
<dc:creator>Bourgon, R.</dc:creator>
<dc:creator>John, G.</dc:creator>
<dc:creator>Jhunjhunwala, S.</dc:creator>
<dc:creator>Albert, M. L.</dc:creator>
<dc:creator>Chen-Harris, H.</dc:creator>
<dc:date>2018-08-09</dc:date>
<dc:identifier>doi:10.1101/388215</dc:identifier>
<dc:title><![CDATA[Transposable Element Expression In Tumors Is Associated With Immune Infiltration And Increased Antigenicity]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-08-09</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/394502v1?rss=1">
<title>
<![CDATA[
Structural Basis of Broad Ebolavirus Neutralization by a Human Survivor Antibody 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/394502v1?rss=1</link>
<description><![CDATA[
The structural features that govern broad-spectrum activity of broadly neutralizing, anti-ebolavirus antibodies (Abs) are currently unknown. Here we describe the first structure of a broadly neutralizing human Ab, ADI-15946, in complex with cleaved Ebola virus glycoprotein (EBOV GPCL). We find that ADI-15946 employs structural mimicry of a conserved interaction between the GP core and the glycan cap {beta}17-{beta}18 loop to inhibit infection. Both endosomal proteolysis of EBOV GP and binding of monoclonal Ab (mAb) FVM09 displace this loop, increase exposure of ADI-15946s conserved epitope and potentiate neutralization. Our work also illuminated the determinants of ADI-15946s reduced activity against Sudan virus (SUDV), and enabled rational, structure-guided engineering to enhance binding and neutralization against SUDV while retaining the parental breadth of activity.nnOne Sentence SummaryThe first crystal structure of a broadly active antibody against surface glycoproteins of ebolaviruses identifies a highly conserved epitope beneath the glycan cap and highlights the molecular requirements for broad ebolavirus neutralization.
]]></description>
<dc:creator>West, B. R.</dc:creator>
<dc:creator>Wec, A. Z.</dc:creator>
<dc:creator>Moyer, C. L.</dc:creator>
<dc:creator>Fusco, M. L.</dc:creator>
<dc:creator>Illinykh, P. A.</dc:creator>
<dc:creator>Huang, K.</dc:creator>
<dc:creator>James, R.</dc:creator>
<dc:creator>Herbert, A.</dc:creator>
<dc:creator>Hui, S.</dc:creator>
<dc:creator>Wirchnianski, A. S.</dc:creator>
<dc:creator>Goodwin, E.</dc:creator>
<dc:creator>Aman, M. J.</dc:creator>
<dc:creator>Walker, L. M.</dc:creator>
<dc:creator>Dye, J. M.</dc:creator>
<dc:creator>Bukreyev, A.</dc:creator>
<dc:creator>Chandran, K.</dc:creator>
<dc:creator>Saphire, E. O.</dc:creator>
<dc:date>2018-08-19</dc:date>
<dc:identifier>doi:10.1101/394502</dc:identifier>
<dc:title><![CDATA[Structural Basis of Broad Ebolavirus Neutralization by a Human Survivor Antibody]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-08-19</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/395525v1?rss=1">
<title>
<![CDATA[
Human antibody cocktail deploys multiple functions to confer pan-ebolavirus protection 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/395525v1?rss=1</link>
<description><![CDATA[
During the unprecedented 2013-2016 Ebola virus disease (EVD) epidemic in Western Africa and in its aftermath, the passive administration of monoclonal antibodies (mAbs) emerged as a promising treatment approach1-7. However, all antibody-based therapeutics currently in advanced development are specific for a single member of the Ebolavirus genus, Ebola virus (EBOV), and ineffective against divergent outbreak-causing ebolaviruses, including Bundibugyo virus (BDBV) and Sudan virus (SUDV)2,3,5,7. Here we advance MBP134, a cocktail of two broadly neutralizing human mAbs targeting the filovirus surface glycoprotein, GP, as a candidate pan-ebolavirus therapeutic. One component of this cocktail is a pan-ebolavirus neutralizing mAb, ADI-15878, isolated from a human EVD survivor8,9. The second, ADI-23774, was derived by affinity maturation of a human mAb8,9 via yeast display to enhance its potency against SUDV. MBP134 afforded exceptionally potent pan-ebolavirus neutralization in vitro and demonstrated greater protective efficacy than ADI-15878 alone in the guinea pig model of lethal EBOV challenge. A second-generation cocktail, MBP134AF, engineered to effectively harness natural killer (NK) cells afforded additional, unprecedented improvements in protective efficacy against EBOV and SUDV in guinea pigs relative to both its precursor and to any mAbs or mAb cocktails tested previously. MBP134AF is a best-in-class mAb cocktail suitable for evaluation as a pan-ebolavirus therapeutic in nonhuman primates.
]]></description>
<dc:creator>Wec, A. Z.</dc:creator>
<dc:creator>Bornholdt, Z. A.</dc:creator>
<dc:creator>He, S.</dc:creator>
<dc:creator>Herbert, A. S.</dc:creator>
<dc:creator>Goodwin, E.</dc:creator>
<dc:creator>Wirchnianski, A. S.</dc:creator>
<dc:creator>Gunn, B. M.</dc:creator>
<dc:creator>Zhang, Z.</dc:creator>
<dc:creator>Zhu, W.</dc:creator>
<dc:creator>Liu, G.</dc:creator>
<dc:creator>Abelson, D. M.</dc:creator>
<dc:creator>Moyer, C. L.</dc:creator>
<dc:creator>Jangra, R. K.</dc:creator>
<dc:creator>James, R. M.</dc:creator>
<dc:creator>Bakken, R. R.</dc:creator>
<dc:creator>Bohorova, N.</dc:creator>
<dc:creator>Bohorov, O.</dc:creator>
<dc:creator>Kim, D. H.</dc:creator>
<dc:creator>Pauly, M. H.</dc:creator>
<dc:creator>Velasco, J.</dc:creator>
<dc:creator>Bortz, R. H.</dc:creator>
<dc:creator>Whaley, K. J.</dc:creator>
<dc:creator>Goldstein, T.</dc:creator>
<dc:creator>Anthony, S. J.</dc:creator>
<dc:creator>Alter, G.</dc:creator>
<dc:creator>Walker, L. M.</dc:creator>
<dc:creator>Dye, J. M.</dc:creator>
<dc:creator>Zeitlin, L.</dc:creator>
<dc:creator>Qiu, X.</dc:creator>
<dc:creator>Chandran, K.</dc:creator>
<dc:date>2018-08-20</dc:date>
<dc:identifier>doi:10.1101/395525</dc:identifier>
<dc:title><![CDATA[Human antibody cocktail deploys multiple functions to confer pan-ebolavirus protection]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-08-20</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/395533v1?rss=1">
<title>
<![CDATA[
Two-antibody pan-ebolavirus cocktail confers broad therapeutic protection in ferrets and nonhuman primates 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/395533v1?rss=1</link>
<description><![CDATA[
All available experimental vaccines and immunotherapeutics1,2 against Ebola virus (EBOV), including rVSV-ZEBOV3 and ZMappTM4, lack activity against other ebolaviruses associated with human disease outbreaks. This year, two separate outbreaks of EBOV in the Democratic Republic of Congo underscored the unpredictable nature of ebolavirus reemergence in a region that has historically experienced outbreaks of the divergent ebolaviruses Sudan virus (SUDV) and Bundibugyo virus (BDBV)5. Here we show that MBP134AF, a pan-ebolavirus therapeutic comprising two broadly neutralizing human antibodies (bNAbs)6,7(see companion manuscript, Wec et al.) could protect against lethal EBOV, SUDV, and BDBV infection in ferrets and nonhuman primates (NHPs). MBP134AF not only not only establishes a viable therapeutic countermeasure to outbreaks caused by antigenically diverse ebolaviruses but also affords unprecedented effectiveness and potency--a single 25-mg/kg dose was fully protective in NHPs. This best-in-class antibody cocktail is the culmination of an intensive collaboration spanning academia, industry and government in response to the 2013-2016 EBOV epidemic6,7 and provides a translational research model for the rapid development of immunotherapeutics targeting emerging infectious diseases.
]]></description>
<dc:creator>Bornholdt, Z. A.</dc:creator>
<dc:creator>Herbert, A. S.</dc:creator>
<dc:creator>Mire, C. E.</dc:creator>
<dc:creator>He, S.</dc:creator>
<dc:creator>Cross, R. W.</dc:creator>
<dc:creator>Wec, A. Z.</dc:creator>
<dc:creator>Abelson, D. M.</dc:creator>
<dc:creator>Geisbert, J. B.</dc:creator>
<dc:creator>James, R. M.</dc:creator>
<dc:creator>Rahim, M. N.</dc:creator>
<dc:creator>Zhu, W.</dc:creator>
<dc:creator>Borisevich, V.</dc:creator>
<dc:creator>Banadyga, L.</dc:creator>
<dc:creator>Gunn, B. M.</dc:creator>
<dc:creator>Agans, K. N.</dc:creator>
<dc:creator>Goodwin, E.</dc:creator>
<dc:creator>Tierney, K.</dc:creator>
<dc:creator>Shestowsky, W. S.</dc:creator>
<dc:creator>Bohorov, O.</dc:creator>
<dc:creator>Bohorova, N.</dc:creator>
<dc:creator>Velasco, J.</dc:creator>
<dc:creator>Ailor, E.</dc:creator>
<dc:creator>Kim, D. H.</dc:creator>
<dc:creator>Pauly, M. H.</dc:creator>
<dc:creator>Whaley, K. J.</dc:creator>
<dc:creator>Alter, G.</dc:creator>
<dc:creator>Walker, L. M.</dc:creator>
<dc:creator>Chandran, K.</dc:creator>
<dc:creator>Zeitlin, L.</dc:creator>
<dc:creator>Qiu, X.</dc:creator>
<dc:creator>Geisbert, T. W.</dc:creator>
<dc:creator>Dye, J. M.</dc:creator>
<dc:date>2018-08-19</dc:date>
<dc:identifier>doi:10.1101/395533</dc:identifier>
<dc:title><![CDATA[Two-antibody pan-ebolavirus cocktail confers broad therapeutic protection in ferrets and nonhuman primates]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-08-19</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/396671v1?rss=1">
<title>
<![CDATA[
Pericentromeric hypomethylation elicits an interferon response in an animal model of ICF syndrome 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/396671v1?rss=1</link>
<description><![CDATA[
Pericentromeric satellite repeats are enriched in 5-methylcytosine (5mC). Loss of 5mC at these sequences is common in cancer and is a hallmark of Immunodeficiency, Centromere and Facial abnormalities (ICF) syndrome. While the general importance of 5mC is well-established, the specific functions of 5mC at pericentromeres are less clear. To address this deficiency, we generated a viable animal model of pericentromeric hypomethylation through mutation of the ICF-gene ZBTB24. Deletion of zebrafish zbtb24 caused a progressive loss of 5mC at pericentromeres and ICF-like phenotypes. Hypomethylation of these repeats triggered derepression of pericentromeric transcripts and activation of an interferon-based innate immune response. Injection of pericentromeric RNA is sufficient to elicit this response in wild-type embryos, and mutation of the MDA5-MAVS dsRNA-sensing machinery blocks the response in mutants. These findings identify activation of the innate immune system as an early consequence of pericentromeric hypomethylation, implicating derepression of pericentromeric transcripts as a trigger of autoimmunity.
]]></description>
<dc:creator>Rajshekar, S.</dc:creator>
<dc:creator>Yao, J.</dc:creator>
<dc:creator>Arnold, P. K.</dc:creator>
<dc:creator>Payne, S. G.</dc:creator>
<dc:creator>Zhang, Y.</dc:creator>
<dc:creator>Bowman, T. V.</dc:creator>
<dc:creator>Schmitz, R. J.</dc:creator>
<dc:creator>Edwards, J. R.</dc:creator>
<dc:creator>Goll, M. G.</dc:creator>
<dc:date>2018-08-23</dc:date>
<dc:identifier>doi:10.1101/396671</dc:identifier>
<dc:title><![CDATA[Pericentromeric hypomethylation elicits an interferon response in an animal model of ICF syndrome]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-08-23</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/403873v1?rss=1">
<title>
<![CDATA[
The 22q11 low copy repeats are characterized by unprecedented size and structure variability 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/403873v1?rss=1</link>
<description><![CDATA[
AbstractLow copy repeats (LCRs) are recognized as a significant source of genomic instability, driving genome variability and evolution. The chromosome 22 LCRs (LCR22s) are amongst the most complex regions in the genome and their structure remains unresolved. These LCR22s mediate non-allelic homologous recombination (NAHR) leading to the 22q11 deletion syndrome (22q11DS), causing the most frequent genomic disorder. Using fiber FISH optical mapping, we have de novo assembled the LCR22s in 33 cell lines. We observed a high level of variation in LCR22 structures, including 26 different haplotypes of LCR22A with alleles ranging from 250 Kb to over 2,000 Kb. An additional four haplotypes were detected using Bionano mapping. Further, Bionano maps generated from 154 individuals from different populations suggested significantly different LCR22 haplotype frequencies between populations. Furthermore, haplotype analysis in nine 22q11DS patients resulted in the localization of the NAHR site to a 160 Kb paralog between LCR22A and -D in seven patients and to a 31 Kb region in two individuals with a rearrangement between LCR22A and -B.. This 31 Kb region contains a palindromic AT-rich repeat known to be a driver of chromosomal rearrangements. Our study highlights an unprecedented level of polymorphism in the structure of LCR22s, which are likely still evolving. We present the most comprehensive map of LCR22 variation to date, paving the way towards investigating the role of LCR variation as a driver of 22q11 rearrangements and the phenotypic variability in 22q11DS patients as well as in the general population.
]]></description>
<dc:creator>Demaerel, W.</dc:creator>
<dc:creator>Mostovoy, Y.</dc:creator>
<dc:creator>Yilmaz, F.</dc:creator>
<dc:creator>Vervoort, L.</dc:creator>
<dc:creator>Pastor, S.</dc:creator>
<dc:creator>Hestand, M. S.</dc:creator>
<dc:creator>Swillen, A.</dc:creator>
<dc:creator>Vergaelen, E.</dc:creator>
<dc:creator>Geiger, E. A.</dc:creator>
<dc:creator>Coughlin, C. R.</dc:creator>
<dc:creator>Chow, S. K.</dc:creator>
<dc:creator>McDonald-McGinn, D.</dc:creator>
<dc:creator>Morrow, B.</dc:creator>
<dc:creator>Kwok, P.-Y.</dc:creator>
<dc:creator>Xiao, M.</dc:creator>
<dc:creator>Emanuel, B. S.</dc:creator>
<dc:creator>Shaikh, T. H.</dc:creator>
<dc:creator>Vermeesch, J. R.</dc:creator>
<dc:date>2018-09-12</dc:date>
<dc:identifier>doi:10.1101/403873</dc:identifier>
<dc:title><![CDATA[The 22q11 low copy repeats are characterized by unprecedented size and structure variability]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-09-12</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/405589v1?rss=1">
<title>
<![CDATA[
β-actin mRNA interactome mapping by proximity biotinylation 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/405589v1?rss=1</link>
<description><![CDATA[
The molecular function and fate of mRNAs are controlled by RNA binding proteins (RBPs). However, identification of the interacting proteome of a specific mRNA in vivo is still very challenging. Based on the widely-used RNA tagging with MS2 aptamers for RNA visualization, we developed a novel RNA proximity biotinylation (RNA-BioID) method by tethering biotin ligase (BirA*) via MS2 coat protein (MCP) at the 3UTR of endogenously MS2 tagged {beta}-actin mRNA in mouse embryonic fibroblasts (MEFs). We demonstrate the dynamics of the {beta}-actin mRNA interactome by characterizing its changes upon serum-induced localization of the mRNA. Apart from the previously known interactors, we identified over 60 additional {beta}-actin associated RBPs by RNA-BioID, among them the KH-domain containing protein FUBP3/MARTA2 has shown to be required for {beta}-actin mRNA localization. This protein binds to the 3-untranslated region of {beta}-actin mRNA, is essential for {beta}-actin mRNA localization but does not interact with the characterized {beta}-actin zipcode element. RNA-BioID provides a tool to identify new mRNA interactors and to study the dynamic view of the interacting proteome of endogenous mRNAs in space and time.
]]></description>
<dc:creator>Mukherjee, J.</dc:creator>
<dc:creator>Hermesh, O.</dc:creator>
<dc:creator>Nalpas, N.</dc:creator>
<dc:creator>Franz-Wachtel, M.</dc:creator>
<dc:creator>Macek, B.</dc:creator>
<dc:creator>Jansen, R.-P.</dc:creator>
<dc:date>2018-08-31</dc:date>
<dc:identifier>doi:10.1101/405589</dc:identifier>
<dc:title><![CDATA[β-actin mRNA interactome mapping by proximity biotinylation]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-08-31</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/413757v1?rss=1">
<title>
<![CDATA[
AptCompare: optimized de novo motif discovery of RNA aptamers via HTS-SELEX 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/413757v1?rss=1</link>
<description><![CDATA[
SummaryHigh-Throughput Sequencing can enhance the analysis of aptamer libraries generated by the Systematic Evolution of Ligands by EXponential enrichment (HTS-SELEX). Robust analysis of the resulting sequenced rounds is best implemented by determining a ranked consensus of reads following the processing by multiple aptamer detection algorithms. Whilst several such approaches have been developed to this end, their installation and implementation is problematic. We developed AptCompare, a cross-platform program that combines six of the most widely used analytical approaches for the identification of RNA aptamer motifs and uses a simple weighted ranking to order the candidate aptamers, all driven within the same GUI- enabled environment. We demonstrate AptCompares performance by identifying the top-ranked candidate aptamers from a previously published selection experiment in our laboratory, with follow-up bench assays demonstrating good correspondence between the sequences rankings and their binding affinities.nnAvailability and ImplementationThe source code and pre-built virtual machine images are freely available at https://bitbucket.org/shiehk/aptcompare.
]]></description>
<dc:creator>Shieh, K. R.</dc:creator>
<dc:creator>Kratschmer, C.</dc:creator>
<dc:creator>Maier, K. E.</dc:creator>
<dc:creator>Greally, J. M.</dc:creator>
<dc:creator>Levy, M.</dc:creator>
<dc:creator>Golden, A.</dc:creator>
<dc:date>2018-09-12</dc:date>
<dc:identifier>doi:10.1101/413757</dc:identifier>
<dc:title><![CDATA[AptCompare: optimized de novo motif discovery of RNA aptamers via HTS-SELEX]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-09-12</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/418640v1?rss=1">
<title>
<![CDATA[
Tau Secretion and Propagation Is Regulated by p300/CBP via Autophagy-Lysosomal Pathway in Tauopathy 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/418640v1?rss=1</link>
<description><![CDATA[
The trans-neuronal propagation of tau has been implicated in the progression of tau-mediated neurodegeneration. Tau secretion from neurons is the first step in tau transmission, but little is known about the cellular mechanism. Here, we report that p300/CBP, the lysine acetyltransferase that acetylates tau and regulates its homeostasis and toxicity, serves as a key regulator of tau secretion by inhibiting the autophagy-lysosomal pathway (ALP). Increased p300/CBP activity was associated with impaired function of this pathway in a tau transgenic mouse model. p300/CBP hyperactivation increased tau secretion by blocking autophagic flux. Conversely, inhibiting p300/CBP genetically or pharmacologically promoted autophagic flux, and reduced tau accumulation, tau secretion, and tau propagation in fibril-induced tau spreading models in vitro and in vivo. Our findings show that p300/CBP-induced impairment in the ALP underlies excessive unconventional secretion and pathogenic spread of tau.
]]></description>
<dc:creator>Chen, X.</dc:creator>
<dc:creator>Li, Y.</dc:creator>
<dc:creator>Wang, C.</dc:creator>
<dc:creator>Tang, Y.</dc:creator>
<dc:creator>Mok, S.-A.</dc:creator>
<dc:creator>Tsai, R. M.</dc:creator>
<dc:creator>Rojas, J. C.</dc:creator>
<dc:creator>Karydas, A.</dc:creator>
<dc:creator>Miller, B. L.</dc:creator>
<dc:creator>Boxer, A. L.</dc:creator>
<dc:creator>Gestwicki, J. E.</dc:creator>
<dc:creator>Cuervo, A. M.</dc:creator>
<dc:creator>Arkin, M.</dc:creator>
<dc:creator>Gan, L.</dc:creator>
<dc:date>2018-09-14</dc:date>
<dc:identifier>doi:10.1101/418640</dc:identifier>
<dc:title><![CDATA[Tau Secretion and Propagation Is Regulated by p300/CBP via Autophagy-Lysosomal Pathway in Tauopathy]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-09-14</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/420026v1?rss=1">
<title>
<![CDATA[
Individual response to mTOR inhibition in delaying replicative senescence of mesenchymal stromal cells 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/420026v1?rss=1</link>
<description><![CDATA[
Background aimsDelaying replicative senescence and extending lifespan of human mesenchymal stromal cells (MSCs) may enhance their potential for tissue engineering and cell based therapies. Accumulating evidence suggests that inhibitors of the mTOR signaling pathway, such as rapamycin, constitute promising pharmacological agents to retard senescence and extend stemness properties of various progenitor cell types. Here, we investigated whether the ability of rapamycin to postpone replicative senescence varies among bone marrow MSC samples (BM-MSCs) derived from different healthy donors, and explored the molecular mechanisms that drive rapamycin-mediated lifespan increment.nnMethodsBM-MSCs at early passages were serially passaged either in absence or continuous presence of rapamycin and the number of cell population doublings until growth arrest was measured. The inhibition of mTOR signaling was assessed by the phosphorylation status of the downstream target RPS6. The expression levels of several senescence and pluripotency markers at early and late/senescent passages were analyzed by RT-qPCR, flow cytometry and western blot.nnResultsWe found that the lifespan extension in response to the continuous rapamycin treatment was highly variable among samples, but effective in most BM-MSCs. Despite all rapamycin-treated cells secreted significantly reduced levels of IL6, a major SASP cytokine, and expressed significantly higher levels of the pluripotency marker NANOG, the expression patterns of these markers were not correlated with the rapamycin-mediated increase in lifespan. Interestingly, rapamycin-mediated life-span extension was significantly associated only with repression of p16INK4A protein accumulation.nnConclusionsTaken together, our results suggest that some, but not all, BM-MSC samples would benefit from using rapamycin to postpone replicative arrest and reinforce a critical role of p16INK4A protein downregulation in this process.
]]></description>
<dc:creator>Antonioli, E.</dc:creator>
<dc:creator>Torres, N.</dc:creator>
<dc:creator>Ferretti, M.</dc:creator>
<dc:creator>Piccinato, C. d. A.</dc:creator>
<dc:creator>Sertie, A. L.</dc:creator>
<dc:date>2018-09-17</dc:date>
<dc:identifier>doi:10.1101/420026</dc:identifier>
<dc:title><![CDATA[Individual response to mTOR inhibition in delaying replicative senescence of mesenchymal stromal cells]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-09-17</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/427385v1?rss=1">
<title>
<![CDATA[
Genetic variability and potential effects on clinical trial outcomes: perspectives in Parkinson’s disease 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/427385v1?rss=1</link>
<description><![CDATA[
BackgroundImproper randomization in clinical trials can result in the failure of the trial to meet its primary end-point. The last [~]10 years have revealed that common and rare genetic variants are an important disease factor and sometimes account for a substantial portion of disease risk variance. However, the burden of common genetic risk variants is not often considered in the randomization of clinical trials and can therefore lead to additional unwanted variance between trial arms. We simulated clinical trials to estimate false negative and false positive rates and investigated differences in single variants and mean genetic risk scores (GRS) between trial arms to investigate the potential effect of genetic variance on clinical trial outcomes at different sample sizes.nnMethodsSingle variant and genetic risk score analyses were conducted in a clinical trial simulation environment using data from 5851 Parkinsons Disease patients as well as two simulated virtual cohorts based on public data. The virtual cohorts included a GBA variant cohort and a two variant interaction cohort. Data was resampled at different sizes (n = 200-5000 for the Parkinsons Disease cohort) and (n = 50-800 and n = 50-2000 for virtual cohorts) for 1000 iterations and randomly assigned to the two arms of a trial. False negative and false positive rates were estimated using simulated clinical trials, and percent difference in genetic risk score and allele frequency was calculated to quantify disparity between arms.nnFindingsSignificant genetic differences between the two arms of a trial are found at all sample sizes. Approximately 90% of the iterations had at least one statistically significant difference in individual risk SNPs between each trial arm. Approximately 10% of iterations had a statistically significant difference between trial arms in polygenic risk score mean or variance. For significant iterations at sample size 200, the average percent difference for mean GRS between trial arms was 130.87%, decreasing to 29.87% as sample size reached 5000. In the GBA only simulations we see an average 18.86% difference in GRS scores between trial arms at n = 50, decreasing to 3.09% as sample size reaches 2000. Balancing patients by genotype reduced mean percent difference in GRS between arms to 36.71% for the main cohort and 2.00% for the GBA cohort at n = 200. When adding a drug effect to the simulations, we found that unbalanced genetics with an effect on the chosen measurable clinical outcome can result in high false negative rates among trials, especially at small sample sizes. At a sample size of n = 50 and a targeted drug effect of -0.5 points in UPDRS per year, we discovered 33.9% of trials resulted in false negatives.nnInterpretationsOur data support the hypothesis that within genetically unmatched clinical trials, particularly those below 1000 participants, heterogeneity could confound true therapeutic effects as expected. This is particularly important in the changing environment of drug approvals. Clinical trials should undergo pre-trial genetic adjustment or, at the minimum, post-trial adjustment and analysis for failed trials. Clinical trial arms should be balanced on genetic risk variants, as well as cumulative variant distributions represented by GRS, in order to ensure the maximum reduction in trial arm disparities. The reduction in variance after balancing allows smaller sample sizes to be utilized without risking the large disparities between trial arms witnessed in typical randomized trials. As the cost of genotyping will likely be far less than greatly increasing sample size, genetically balancing trial arms can lead to more cost-effective clinical trials as well as better outcomes.
]]></description>
<dc:creator>Leonard, H.</dc:creator>
<dc:creator>Blauwendraat, C.</dc:creator>
<dc:creator>Krohn, L.</dc:creator>
<dc:creator>Faghri, F.</dc:creator>
<dc:creator>Iwaki, H.</dc:creator>
<dc:creator>Furgeson, G.</dc:creator>
<dc:creator>Day-Williams, A. G.</dc:creator>
<dc:creator>Stone, D. J.</dc:creator>
<dc:creator>International Parkinson's Disease Genomics Consortium (IPDGC),</dc:creator>
<dc:creator>Singleton, A. B.</dc:creator>
<dc:creator>Nalls, M. A.</dc:creator>
<dc:creator>Gan-Or, Z.</dc:creator>
<dc:date>2018-10-05</dc:date>
<dc:identifier>doi:10.1101/427385</dc:identifier>
<dc:title><![CDATA[Genetic variability and potential effects on clinical trial outcomes: perspectives in Parkinson’s disease]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-10-05</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/429902v1?rss=1">
<title>
<![CDATA[
MET-2, a SETDB1 family methyltransferase, coordinates embryo events through distinct histone H3 methylation states 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/429902v1?rss=1</link>
<description><![CDATA[
During the first hours of embryogenesis, formation of higher-order heterochromatin coincides with the loss of developmental potential. Here we examine the relationship between these two processes, and we probe the determinants that contribute to their onset. Mutations that disrupt histone H3 lysine 9 (H3K9) methyltransferases reveal that the methyltransferase MET-2 helps terminate developmental plasticity, likely through mono- and di- methylation of H3K9 (me1/me2), and promotes heterochromatin formation, likely through H3K9me3. We examine how MET-2 is regulated and find that methylated H3K9 appears gradually and depends on the accumulated time of embryogenesis. H3K9me is independent of zygotic genome activation or cell counting. These data reveal how central events are synchronized during embryogenesis and distinguish distinct roles for different H3K9 methylation states.nnSummary StatementDuring early embryogenesis, heterochromatin formation and loss of developmental plasticity are coordinately regulated by distinct Histone H3 Lysine 9 (H3K9) methylation states, by the methyltransferase MET-2.
]]></description>
<dc:creator>Mutlu, B.</dc:creator>
<dc:creator>Chen, H.-M. M.</dc:creator>
<dc:creator>Hall, D. H.</dc:creator>
<dc:creator>Mango, S. E.</dc:creator>
<dc:date>2018-09-28</dc:date>
<dc:identifier>doi:10.1101/429902</dc:identifier>
<dc:title><![CDATA[MET-2, a SETDB1 family methyltransferase, coordinates embryo events through distinct histone H3 methylation states]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-09-28</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/431213v1?rss=1">
<title>
<![CDATA[
Single-cell microRNA/mRNA co-sequencing reveals non-genetic heterogeneity and novel regulatory mechanisms 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/431213v1?rss=1</link>
<description><![CDATA[
Co-measurement of multiple omic profiles from the same single cells opens up the opportunity to decode molecular regulation that underlie intercellular heterogeneity in development and disease. Here, we present co-sequencing of microRNAs and mRNAs in the same single cells using a half-cell genomics approach. This method demonstrates good robustness (~95% success rate) and reproducibility (R2=0.93 for both miRNAs and mRNAs), and yields paired half-cell miRNA and mRNA profiles that could be independently validated. Linking the level of miRNAs to the expression of predicted target mRNAs across 19 single cells that are phenotypically identical, we observe that the predicted targets are significantly anti-correlated with the variation of abundantly expressed miRNAs, suggesting that miRNA expression variability alone may lead to non-genetic cell-to-cell heterogeneity. Genome-scale analysis of paired miRNA-mRNA co-profiles further allows us to derive and validate new regulatory relationships of cellular pathways controlling miRNA expression and variability.
]]></description>
<dc:creator>Wang, N.</dc:creator>
<dc:creator>Zheng, J.</dc:creator>
<dc:creator>Chen, Z.</dc:creator>
<dc:creator>Liu, Y.</dc:creator>
<dc:creator>Dura, B.</dc:creator>
<dc:creator>Kwak, M.</dc:creator>
<dc:creator>Xavier-Ferrucio, J.</dc:creator>
<dc:creator>Lu, Y.-C.</dc:creator>
<dc:creator>Zhang, M.</dc:creator>
<dc:creator>Roden, C.</dc:creator>
<dc:creator>Cheng, J.</dc:creator>
<dc:creator>Krauss, D.</dc:creator>
<dc:creator>Ding, Y.</dc:creator>
<dc:creator>Fan, R.</dc:creator>
<dc:creator>Lu, J.</dc:creator>
<dc:date>2018-09-30</dc:date>
<dc:identifier>doi:10.1101/431213</dc:identifier>
<dc:title><![CDATA[Single-cell microRNA/mRNA co-sequencing reveals non-genetic heterogeneity and novel regulatory mechanisms]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-09-30</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/432211v1?rss=1">
<title>
<![CDATA[
Genetic variants influence on the placenta regulatory landscape 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/432211v1?rss=1</link>
<description><![CDATA[
BackgroundFrom genomic association studies, quantitative trait loci analysis, and epigenomic mapping, it is evident that significant efforts are necessary to define genetic-epigenetic interactions and understand their role in disease susceptibility and progression. For this reason, an analysis of the effects of genetic variation on gene expression and DNA methylation in human placentas at high resolution and whole-genome coverage will have multiple mechanistic and practical implications.nnResultsBy producing and analyzing DNA sequence variation (n=303), DNA methylation (n=303) and mRNA expression data (n=80) from placentas from healthy women, we investigate the regulatory landscape of the human placenta and offer analytical approaches to integrate different types of genomic data and address some potential limitations of current platforms. We distinguish two profiles of interaction between expression and DNA methylation, revealing linear or bimodal effects, reflecting differences in genomic context, transcription factor recruitment, and possibly cell subpopulations.nnConclusionsThese findings help to clarify the interactions of genetic, epigenetic, and transcriptional regulatory mechanisms in normal human placentas. They also provide strong evidence for genotype-driven modifications of transcription and DNA methylation in normal placentas. In addition to these mechanistic implications, the data and analytical methods presented here will improve the interpretability of genome-wide and epigenome-wide association studies for human traits and diseases that involve placental functions.nnAuthor summaryThe placenta is a critical organ playing multiple roles including oxygen and metabolite transfer from mother to fetus, hormone production, and vascular perfusion. With this study, we aimed to deliver a placenta-specific regulatory map based on a combination of publicly available and newly generated data. To complete this reference, we obtained genotype information (n=303), DNA methylation (n=303) and expression data (n=80) for placentas from healthy women. Our analysis of methylation and expression quantitative trait loci (QTLs) and correlations between methylation and expression data were designed to identify fundamental associations between genome, transcriptome, and epigenome in this key fetal organ. The results provide high-resolution genetic and epigenetic maps specific to the placenta based on a representative ethnically diverse cohort. As interest and efforts are growing to better understand the etiology of placental disease and the impact of the environment on placental function these data will provide a reference and enhance future investigations.
]]></description>
<dc:creator>Delahaye, F.</dc:creator>
<dc:creator>Do, C.</dc:creator>
<dc:creator>Kong, Y.</dc:creator>
<dc:creator>Ashkar, R.</dc:creator>
<dc:creator>Salas, M.</dc:creator>
<dc:creator>Tycko, B.</dc:creator>
<dc:creator>Wapner, R.</dc:creator>
<dc:creator>Hughes, F.</dc:creator>
<dc:date>2018-10-03</dc:date>
<dc:identifier>doi:10.1101/432211</dc:identifier>
<dc:title><![CDATA[Genetic variants influence on the placenta regulatory landscape]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-10-03</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/433755v1?rss=1">
<title>
<![CDATA[
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/433755v1?rss=1</link>
<description><![CDATA[
Genomic amplification of the androgen receptor (AR) is an established mechanism of antiandrogen resistance in prostate cancer. Here we show that the magnitude of AR signaling output, independent of AR genomic alteration or expression level, also contributes to antiandrogen resistance, through upregulation of the coactivator GREB1. We demonstrate 100-fold heterogeneity in AR output within cell lines and show that cells with high AR output have reduced sensitivity to enzalutamide. Through transcriptomic and shRNA knockdown studies, together with analysis of clinical datasets, we identify GREB1 as a gene responsible for high AR output. We show that GREB1 is an AR target gene that amplifies AR output by enhancing AR DNA binding and promoting p300 recruitment. GREB1 knockdown in high AR output cells restores enzalutamide sensitivity in vivo. Thus, GREB1 is a candidate driver of enzalutamide resistance through a novel feed forward mechanism.
]]></description>
<dc:creator>Sawyers, C. L.</dc:creator>
<dc:creator>Lee, E.</dc:creator>
<dc:creator>Wongvipat, J.</dc:creator>
<dc:creator>Choi, D.</dc:creator>
<dc:creator>Wang, P.</dc:creator>
<dc:creator>Zheng, D.</dc:creator>
<dc:creator>Watson, P. A.</dc:creator>
<dc:creator>Gopalan, A.</dc:creator>
<dc:date>2018-10-02</dc:date>
<dc:identifier>doi:10.1101/433755</dc:identifier>
<dc:title><![CDATA[GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-10-02</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/441923v1?rss=1">
<title>
<![CDATA[
The ULK1-FBXW5-SEC23B nexus controls autophagy 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/441923v1?rss=1</link>
<description><![CDATA[
In response to nutrient deprivation, the cell needs to mobilize an extensive amount of membrane to form and grow the autophagosome, allowing the progression of autophagy. By providing membranes and a source for LC3 lipidation, COPII (Coat Protein Complex II) localizes to the endoplasmic reticulum (ER)-Golgi intermediate compartment (ERGIC) and promotes autophagosome biogenesis. However, the molecular mechanisms that, in response to starvation, divert COPII from the secretory pathway to the autophagic pathway are largely unknown. Here, we show that the F-box protein FBXW5 targets SEC23B, a component of COPII, for proteasomal degradation and that this event limits the autophagic flux in the presence of nutrients. In response to starvation, ULK1 phosphorylates SEC23B on Serine 186, preventing the interaction of SEC23B with FBXW5 and, therefore, inhibiting its degradation. Phosphorylated and stabilized SEC23B associates with SEC24A and SEC24B, but not SEC24C and SEC24D, and they re-localize to the ERGIC, promoting autophagic flux. Induction of autophagy and localization of both SEC23B and SEC24B to the ERGIC in response to nutrient deprivation are significantly reduced in SEC23B(S186A) knock-in cells. We propose that, in the presence of nutrients, FBXW5 limits COPII-mediated autophagosome biogenesis. Inhibition of this event by ULK1 ensures efficient execution of the autophagic cascade in response to nutrient starvation.
]]></description>
<dc:creator>Pagano, M.</dc:creator>
<dc:creator>Jeong, Y.-T.</dc:creator>
<dc:creator>Simoneschi, D.</dc:creator>
<dc:creator>Keegan, S.</dc:creator>
<dc:creator>Melville, D.</dc:creator>
<dc:creator>Adler, N.</dc:creator>
<dc:creator>Saraf, A.</dc:creator>
<dc:creator>Florens, L.</dc:creator>
<dc:creator>Washburn, M. P.</dc:creator>
<dc:creator>Cavasotto, C.</dc:creator>
<dc:creator>Fenyö, D.</dc:creator>
<dc:creator>Cuervo, A. M.</dc:creator>
<dc:creator>Rossi, M.</dc:creator>
<dc:date>2018-10-12</dc:date>
<dc:identifier>doi:10.1101/441923</dc:identifier>
<dc:title><![CDATA[The ULK1-FBXW5-SEC23B nexus controls autophagy]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-10-12</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/441980v1?rss=1">
<title>
<![CDATA[
The mRNA export adaptor Yra1 contributes to DNA double-strand break repair through its C-box domain 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/441980v1?rss=1</link>
<description><![CDATA[
Yra1 is an mRNA export adaptor involved in mRNA biogenesis and export in S. cerevisiae. Yra1 overexpression was recently shown to promote accumulation of DNA:RNA hybrids favoring DNA double strand breaks (DSB), cell senescence and telomere shortening, via an unknown mechanism. Yra1 was also identified at an HO-induced DSB and Yra1 depletion causes defects in DSB repair. Previous work from our laboratory showed that Yra1 ubiquitination by Tom1 is important for mRNA export. Interestingly, we found that Yra1 is also ubiquitinated by the SUMO-targeted ubiquitin ligases Slx5-Slx8 implicated in the interaction of irreparable DSB with nuclear pores. Here we show that Yra1 binds an HO-induced irreparable DSB. Importantly, a Yra1 mutant lacking the evolutionarily conserved C-box is not recruited to an HO-induced irreparable DSB and becomes lethal under DSB induction in a HO-cut reparable system. Together, the data provide evidence that Yra1 plays a crucial role in DSB repair via homologous recombination. Unexpectedly, while the Yra1 C-box is essential, Yra1 sumoylation and/or ubiquitination are dispensable in this process.
]]></description>
<dc:creator>Stutz, F.</dc:creator>
<dc:creator>Infantino, V.</dc:creator>
<dc:creator>Tutucci, E.</dc:creator>
<dc:creator>Yeh Martin, N.</dc:creator>
<dc:creator>Zihlmann, A.</dc:creator>
<dc:creator>Garcia-Molinero, V.</dc:creator>
<dc:creator>Silvano, G.</dc:creator>
<dc:creator>Palancade, B.</dc:creator>
<dc:date>2018-10-12</dc:date>
<dc:identifier>doi:10.1101/441980</dc:identifier>
<dc:title><![CDATA[The mRNA export adaptor Yra1 contributes to DNA double-strand break repair through its C-box domain]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-10-12</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/459735v1?rss=1">
<title>
<![CDATA[
Aneuvis: Web-based exploration of numerical chromosomal variation in single cells 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/459735v1?rss=1</link>
<description><![CDATA[
MotivationAberrations in chromosomal copy number are one of the most common molecular features observed in cancer. Quantifying the degree of numerical chromosomal variation in single cells across a population of cells is of interest to researchers studying whole chromosomal instability (W-CIN). W-CIN, a state of high numerical chromosomal variation, contributes to treatment resistance in cancer.nnResultsHere, we introduce aneuvis, a web application that allows users to determine whether numerical chromosomal variation exists between experimental treatment groups. The web interface allows users to upload molecular cytogenetic or processed whole-genome sequencing data in a cell-by-chromosome matrix format and automatically generates visualizations and summary statistics that reflect the degree of numeric chromosomal variability. Aneuvis is the first user-friendly web application to help researchers identify the genetic and environmental perturbations that promote numerical chromosomal variation.nnAvailability and ImplementationAneuvis is freely available as a web application at https://dpique.shinyapps.io/aneuvis/. Website implemented using Shiny version 1.0.5 with all major browsers supported. All source code for the application is available at https://github.com/dpique/aneuvis.
]]></description>
<dc:creator>Pique, D. G.</dc:creator>
<dc:creator>Andriani, G. A.</dc:creator>
<dc:creator>Maggi, E.</dc:creator>
<dc:creator>Zimmerman, S. E.</dc:creator>
<dc:creator>Greally, J. M.</dc:creator>
<dc:creator>Montagna, C.</dc:creator>
<dc:creator>Mar, J. C.</dc:creator>
<dc:date>2018-11-01</dc:date>
<dc:identifier>doi:10.1101/459735</dc:identifier>
<dc:title><![CDATA[Aneuvis: Web-based exploration of numerical chromosomal variation in single cells]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-11-01</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/466011v1?rss=1">
<title>
<![CDATA[
Evidence of a noncoding transcript of the RIPK2 gene overexpressed in head and neck tumor 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/466011v1?rss=1</link>
<description><![CDATA[
Receptor-interacting proteins are a family of serine/threonine kinases, which integrate extra and intracellular stress signals caused by different factors, including infections, inflammation and DNA damage. Receptor-interacting serine/threonine-protein kinase 2 (RIP-2) is a member of this family and an important component of the nuclear factor NF-kappa-B signaling pathway. The corresponding human gene RIPK2 generates two transcripts by alternative splicing, the full-length and a short transcript. The short transcript has a truncated 5 sequence, which results in a predicted isoform with a partial kinase domain but able to transduce signals through its caspase recruitment domain. In this study, the expression of RIPK2 was investigated in human tissue samples and, in order to determine if both transcripts are similarly regulated at the transcriptional level, cancer cell lines were submitted to temperature and acid stresses. We observed that both transcripts are expressed in all tissues analyzed, with higher expression of the short one in tumor samples, and they are differentially regulated following temperature stress. Despite transcription, no corresponding protein for the short transcript was detected in tissues and cell lines analyzed. We propose that the shorter transcript is a noncoding RNA and that its presence in the cell may play regulatory roles and affect inflammation and other biological processes related to the kinase activity of RIP-2.
]]></description>
<dc:creator>Tajara, E. H.</dc:creator>
<dc:creator>Villagra, U. M.</dc:creator>
<dc:creator>da Cunha, B. R.</dc:creator>
<dc:creator>Polachini, G. M.</dc:creator>
<dc:creator>Henrique, T.</dc:creator>
<dc:creator>da Silva, C. H. T. P.</dc:creator>
<dc:creator>Feitosa, O. A.</dc:creator>
<dc:creator>Erica E. Fukuyama, E. E.</dc:creator>
<dc:creator>Lopez, R. V. M.</dc:creator>
<dc:creator>Dias-Neto, E.</dc:creator>
<dc:creator>Nunes, F. D.</dc:creator>
<dc:creator>Severino, P.</dc:creator>
<dc:date>2018-11-08</dc:date>
<dc:identifier>doi:10.1101/466011</dc:identifier>
<dc:title><![CDATA[Evidence of a noncoding transcript of the RIPK2 gene overexpressed in head and neck tumor]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-11-08</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/470286v1?rss=1">
<title>
<![CDATA[
Tobacco exposure associated with oral microbiota oxygen utilization in the New York City Health and Nutrition Examination Study 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/470286v1?rss=1</link>
<description><![CDATA[
PurposeThe effect of tobacco exposure on the oral microbiome has not been established.

MethodsWe performed amplicon sequencing of the 16S ribosomal RNA gene V4 variable region to estimate bacterial community characteristics in 259 oral rinse samples, selected based on self-reported smoking and serum cotinine levels, from the 2013-14 New York City Health and Nutrition Examination Study. We identified differentially abundant operational taxonomic units (OTUs) by primary and secondhand tobacco exposure, and employed "microbe set enrichment analysis" to assess shifts in microbial oxygen utilization.

ResultsCigarette smoking was associated with depletion of aerobic OTUs (Enrichment Score test statistic ES = -0.75, p = 0.002) with a minority (29%) of aerobic OTUs enriched in current smokers compared to never smokers. Consistent shifts in the microbiota were observed for current cigarette smokers as for non-smokers with secondhand exposure as measured by serum cotinine levels. Differential abundance findings were similar in crude and adjusted analyses.

ConclusionResults support a plausible link between tobacco exposure and shifts in the oral microbiome at the population level through three lines of evidence: 1) a shift in microbiota oxygen utilization associated with primary tobacco smoke exposure, 2) consistency of abundance fold-changes associated with current smoking and shifts along the gradient of secondhand smoke exposure among non-smokers, and 3) consistency after adjusting for a priori hypothesized confounders.

HighlightsO_LICigarette smoke was associated with microbial anaerobiosis in oral rinse specimens
C_LIO_LIThe microbiome shifts associated with smoking and secondhand exposure were correlated
C_LIO_LIShifts in oral bacterial oxygen utilization may mediate smoking and health outcomes
C_LIO_LIWe propose "microbe set enrichment analysis" for interpreting shifts in the microbiome
C_LI
]]></description>
<dc:creator>Beghini, F.</dc:creator>
<dc:creator>Renson, A.</dc:creator>
<dc:creator>Zolnik, C.</dc:creator>
<dc:creator>Geistlinger, L.</dc:creator>
<dc:creator>Usyk, M.</dc:creator>
<dc:creator>Moody, T. U.</dc:creator>
<dc:creator>Thorpe, L.</dc:creator>
<dc:creator>Dowd, J. B.</dc:creator>
<dc:creator>Burk, R.</dc:creator>
<dc:creator>Segata, N.</dc:creator>
<dc:creator>Jones, H. E.</dc:creator>
<dc:creator>Waldron, L. D.</dc:creator>
<dc:date>2018-11-14</dc:date>
<dc:identifier>doi:10.1101/470286</dc:identifier>
<dc:title><![CDATA[Tobacco exposure associated with oral microbiota oxygen utilization in the New York City Health and Nutrition Examination Study]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-11-14</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/470617v1?rss=1">
<title>
<![CDATA[
Chance is an important element in phagolysosomal acidification that favors the macrophage 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/470617v1?rss=1</link>
<description><![CDATA[
Microbial ingestion by a macrophage results in the formation of an acidic phagolysosome but the host cell has no information on the pH susceptibility of the ingested organism. This poses a problem for the macrophage and raises the fundamental question of how the phagocytic cell optimizes the acidification process to prevail. We analyzed the dynamical distribution of phagolysosomal pH in murine and human macrophages that had ingested live or dead Cryptococcus neoformans cells, or inert beads. Phagolysosomal acidification produced a range of pH values that approximated normal distributions, but these differed from normality depending on ingested particle type. Analysis of the increments of pH reduction revealed no forbidden ordinal patterns, implying that phagosomal acidification process was a stochastic dynamical system. Using simulation modeling, we determined that by stochastically acidifying a phagolysosome to a pH within the observed distribution, macrophages sacrificed a small amount of overall fitness to gain the benefit of reduced variation in fitness. Hence, chance in the final phagosomal pH introduces unpredictability to the outcome of the macrophage-microbe, which implies a bet-hedging strategy that benefits the macrophage. While bet hedging is common in biological systems at the organism level, our results show its use at the organelle and cellular level.
]]></description>
<dc:creator>Dragotakes, Q.</dc:creator>
<dc:creator>Stouffer, K.</dc:creator>
<dc:creator>Fu, M. S.</dc:creator>
<dc:creator>Leon-Rodriguez, C. M.</dc:creator>
<dc:creator>Freij, J. B.</dc:creator>
<dc:creator>Bergman, A.</dc:creator>
<dc:creator>Casadevall, A.</dc:creator>
<dc:date>2018-11-15</dc:date>
<dc:identifier>doi:10.1101/470617</dc:identifier>
<dc:title><![CDATA[Chance is an important element in phagolysosomal acidification that favors the macrophage]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-11-15</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/472258v1?rss=1">
<title>
<![CDATA[
C. elegans granulins promote an age-associated decline in protein homeostasis via lysosomal protease inhibition 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/472258v1?rss=1</link>
<description><![CDATA[
The progressive failure of protein homeostasis is a hallmark of aging and a common feature in neurodegenerative disease. As the enzymes executing the final stages of autophagy, lysosomal proteases (or cathepsins) are key contributors to maintenance of protein homeostasis with age. Here, we identify the cysteine-rich granulin peptides as a new class of regulators of lysosomal aspartyl protease activity. Granulins are produced in an age and stress-dependent manner through cleavage of the neurodegenerative disease protein, progranulin. Once liberated, granulins selectively interact with the aspartyl protease ASP-3/cathepsin D to impair enzymatic activity. Consequently, protein homeostasis and lysosome function is disrupted, prompting cells to activate a compensatory transcriptional program. Our results support a model in which granulin production modulates a critical transition between the normal, physiological regulation of protease activity and the impairment of lysosomal function that can occur with age and disease.
]]></description>
<dc:creator>Butler, V. J.</dc:creator>
<dc:creator>Cortopassi, W. A.</dc:creator>
<dc:creator>Argouarch, A. R.</dc:creator>
<dc:creator>Pierce, O. M.</dc:creator>
<dc:creator>Vohra, M.</dc:creator>
<dc:creator>Oses-Prieto, J. A.</dc:creator>
<dc:creator>Gao, F.</dc:creator>
<dc:creator>Caballero, B.</dc:creator>
<dc:creator>Chand, S.</dc:creator>
<dc:creator>Seeley, W. W.</dc:creator>
<dc:creator>Miller, B. L.</dc:creator>
<dc:creator>Coppola, G.</dc:creator>
<dc:creator>Burlingame, A. L.</dc:creator>
<dc:creator>Ashrafi, K.</dc:creator>
<dc:creator>Cuervo, A. M.</dc:creator>
<dc:creator>Jacobson, M.</dc:creator>
<dc:creator>Kao, A. W.</dc:creator>
<dc:date>2018-11-17</dc:date>
<dc:identifier>doi:10.1101/472258</dc:identifier>
<dc:title><![CDATA[C. elegans granulins promote an age-associated decline in protein homeostasis via lysosomal protease inhibition]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-11-17</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/480830v1?rss=1">
<title>
<![CDATA[
Neural circuit robustness to acute, global physiological perturbations 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/480830v1?rss=1</link>
<description><![CDATA[
Neural function depends on underlying physiological processes that are highly sensitive to physical variables such as temperature. However, some robustness to perturbations in these variables manifests at the circuit level, suggesting that circuit properties are organized to tolerate consistent changes in underlying parameters. We show that a crustacean pacemaker circuit is robust to two global perturbations - temperature and pH - that differentially alter circuit properties. Consistent with high variability in underlying circuit parameters, we find that the critical temperatures and pH values where circuit activity breaks down vary widely across animals. Despite variability in critical points the network state transitions at these critical points are consistent, implying that qualitative circuit dynamics are preserved across animals, in spite of high quantitative parameter variability. Surprisingly, robustness perturbations in pH only moderately affect temperature robustness. Thus, robustness to a global perturbation does not necessarily imply sensitivity to other global perturbations.
]]></description>
<dc:creator>Ratliff, J.</dc:creator>
<dc:creator>Marder, E.</dc:creator>
<dc:creator>O'Leary, T.</dc:creator>
<dc:date>2018-11-29</dc:date>
<dc:identifier>doi:10.1101/480830</dc:identifier>
<dc:title><![CDATA[Neural circuit robustness to acute, global physiological perturbations]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-11-29</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/483297v1?rss=1">
<title>
<![CDATA[
RISC: robust integration of single-cell RNA-seq datasets with different extents of cell cluster overlap 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/483297v1?rss=1</link>
<description><![CDATA[
Single cell RNA-seq (scRNA-seq) has remarkably advanced our understanding of cellular heterogeneity and dynamics in tissue development, diseases, and cancers. Integrated data analysis can often uncover molecular and cellular links among individual datasets and thus provide new biological insights, such as developmental relationship. Due to differences in experimental platforms and biological sample batches, the integration of multiple scRNA-seq datasets is challenging. To address this, we developed a novel computational method for robust integration of scRNA-seq (RISC) datasets using principal component regression (PCR). Because of the natural compatibility of eigenvectors between PCR model and dimension reduction, RISC can accurately integrate scRNA-seq datasets and avoid over-integration. Compared to existing software, RISC shows particular improvement in integrating datasets that contain cells of the same types (more accurately clusters) but at distinct functional states. To demonstrate the value of RISC in finding small groups of cells common between otherwise heterogenous datasets, we applied it to scRNA-seq datasets of normal and malignant cells and successfully identified small clusters of cells in healthy kidney tissues that may be related to the origin of renal tumors.
]]></description>
<dc:creator>Liu, Y.</dc:creator>
<dc:creator>Wang, T.</dc:creator>
<dc:creator>Zheng, D.</dc:creator>
<dc:date>2018-11-29</dc:date>
<dc:identifier>doi:10.1101/483297</dc:identifier>
<dc:title><![CDATA[RISC: robust integration of single-cell RNA-seq datasets with different extents of cell cluster overlap]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-11-29</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/485771v1?rss=1">
<title>
<![CDATA[
Volumetric reconstruction of main Caenorhabditis elegans neuropil at two different time points 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/485771v1?rss=1</link>
<description><![CDATA[
Detailed knowledge of both synaptic connectivity and the spatial proximity of neurons is crucial for understanding wiring specificity in the nervous system. Here, we volumetrically reconstructed the C. elegans nerve ring from legacy serial-sectioned electron micrographs at two distinct time points: the L4 and young adult. The new volumetric reconstructions provide detailed spatial and morphological information of neural processes in the nerve ring. Our analysis suggests that the nerve ring exhibits three levels of wiring specificity: spatial, synaptic and subcellular. Neuron classes innervate well defined neighborhoods and aggregate functionally similar synapses to support distinct computational pathways. Connectivity fractions vary based on neuron class and synapse type. We find that the variability in process placement accounts for less than 20% of the variability in synaptic connectivity and models based only on spatial information cannot account for the reproducibility of synaptic connections among homologous neurons. This suggests that additional, non-spatial factors also contribute to synaptic and subcellular specificity. With this in mind, we conjecture that a spatially constrained, genetic model could provide sufficient synaptic specificity. Using a model of cell-specific combinatorial genetic expression, we show that additional specificity, such as sub-cellular domains or alternative splicing, would be required to reproduce the wiring specificity in the nerve ring.
]]></description>
<dc:creator>Brittin, C. A.</dc:creator>
<dc:creator>Cook, S. J.</dc:creator>
<dc:creator>Hall, D. H.</dc:creator>
<dc:creator>Emmons, S. W.</dc:creator>
<dc:creator>Cohen, N.</dc:creator>
<dc:date>2018-12-04</dc:date>
<dc:identifier>doi:10.1101/485771</dc:identifier>
<dc:title><![CDATA[Volumetric reconstruction of main Caenorhabditis elegans neuropil at two different time points]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-12-04</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/500801v1?rss=1">
<title>
<![CDATA[
Farnesyl Transferase Inhibition for the Treatment of Tauopathies 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/500801v1?rss=1</link>
<description><![CDATA[
Tau inclusions are a shared feature of many neurodegenerative conditions and tau mutations lead to frontotemporal dementia. Approaches to treatment of these conditions have focused directly on the tau protein by targeting its post-translational modifications, its levels and its tendency to aggregate. We discovered a novel regulatory pathway for tau degradation that operates through the Rhes protein, a GTPase. Rhes is farnesylated and treatment with the farnesyl transferase inhibitor, lonafarnib, reduced Rhes, attenuated behavioral abnormalities, significantly reduced atrophy, tau inclusions, sumoylation and ubiquitination, as well as microgliosis in the rTg4510 tauopathy mouse. Direct reduction of Rhes levels reproduced the results observed with lonafarnib. The mechanism of lonafarnib action, as mediated by Rhes to reduce tau pathology, operates through the lysosome without involvement of the proteasome. Finally we show that the developmental increase in Rhes levels can be homeostatically regulated in the presence of tau mutations as a protective mechanism through which cells sense abnormal tau before any pathology is present. The extensive human trials of lonafarnib for other conditions, makes this drug ideal for repurposing to treat tauopathies.nnOne-sentence summaryVia a mechanism that involves targeting Rhes, lonafarnib can induce lysosomal-mediated tau degradation and prevent pathology in a tau mouse model
]]></description>
<dc:creator>Hernandez, I.</dc:creator>
<dc:creator>Luna, G.</dc:creator>
<dc:creator>Rauch, J. N.</dc:creator>
<dc:creator>Giroux, M.</dc:creator>
<dc:creator>Karch, C. M.</dc:creator>
<dc:creator>Boctor, D.</dc:creator>
<dc:creator>Storm, N. J.</dc:creator>
<dc:creator>Diaz, A.</dc:creator>
<dc:creator>Zekanowski, C.</dc:creator>
<dc:creator>Kang, A. A.</dc:creator>
<dc:creator>Hinman, C.</dc:creator>
<dc:creator>Cerovac, V.</dc:creator>
<dc:creator>Guzman, E.</dc:creator>
<dc:creator>Zhou, H.</dc:creator>
<dc:creator>Goate, A.</dc:creator>
<dc:creator>Fisher, S. K.</dc:creator>
<dc:creator>Cuervo, A. M.</dc:creator>
<dc:creator>Kosik, K. S.</dc:creator>
<dc:date>2018-12-18</dc:date>
<dc:identifier>doi:10.1101/500801</dc:identifier>
<dc:title><![CDATA[Farnesyl Transferase Inhibition for the Treatment of Tauopathies]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-12-18</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/507350v1?rss=1">
<title>
<![CDATA[
Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible to Tibrovirus Particle Cell Entry 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/507350v1?rss=1</link>
<description><![CDATA[
In 2012, the genome of a novel rhabdovirus, Bas-Congo virus, was discovered in the acute-phase serum of a Congolese patient with presumed viral hemorrhagic fever. In the absence of a replicating virus isolate, fulfilling Kochs postulates to determine whether Bas-Congo virus is indeed a human virus and/or pathogen has been impossible. However, experiments with vesiculoviral particles pseudotyped with Bas-Congo glycoprotein suggested that Bas-Congo virus particles can enter cells from multiple animals, including humans. In 2015, genomes of two related viruses, Ekpoma virus 1 and Ekpoma virus 2, were detected in human sera in Nigeria. Isolates could not be obtained. Phylogenetic analyses led to the classification of Bas-Congo virus, Ekpoma virus 1, and Ekpoma virus 2 in the same genus, Tibrovirus, together with five biting midge-borne rhabdoviruses (i.e., Beatrice Hill virus, Bivens Arm virus, Coastal Plains virus, Sweetwater Branch virus, and Tibrogargan virus) not known to infect humans. Using individual recombinant vesiculoviruses expressing the glycoproteins of all eight known tibroviruses and more than 75 cell lines representing different animal species, we demonstrate that the glycoproteins of all tibroviruses can mediate vesiculovirus particle entry into human, bat, nonhuman primate, cotton rat, boa constrictor, and Asian tiger mosquito cells. Using four of five isolated authentic tibroviruses (i.e., Bivens Arm virus, Coastal Plains virus, Sweetwater Branch virus, and Tibrogargan virus), our experiments indicate that many cell types may be partially resistant to tibrovirus replication after virion cell entry. Consequently, experimental data solely obtained from experiments using tibrovirus surrogate systems (e.g., vesiculoviral pseudotypes, recombinant vesiculoviruses) cannot be used to predict whether Bas-Congo virus, or any other tibrovirus, infects humans.
]]></description>
<dc:creator>Cai, Y.</dc:creator>
<dc:creator>Yu, S.</dc:creator>
<dc:creator>Jangra, R.</dc:creator>
<dc:creator>Postnikova, E.</dc:creator>
<dc:creator>Wada, J.</dc:creator>
<dc:creator>Tesh, R.</dc:creator>
<dc:creator>Whelan, S.</dc:creator>
<dc:creator>Lauck, M.</dc:creator>
<dc:creator>Wiley, M.</dc:creator>
<dc:creator>Finch, C.</dc:creator>
<dc:creator>Radoshitzky, S.</dc:creator>
<dc:creator>O'Connor, D.</dc:creator>
<dc:creator>Palacios, G.</dc:creator>
<dc:creator>Chandran, K.</dc:creator>
<dc:creator>Chiu, C.</dc:creator>
<dc:creator>Kuhn, J.</dc:creator>
<dc:date>2018-12-27</dc:date>
<dc:identifier>doi:10.1101/507350</dc:identifier>
<dc:title><![CDATA[Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible to Tibrovirus Particle Cell Entry]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-12-27</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/508838v1?rss=1">
<title>
<![CDATA[
Neural response variability and divisive normalization 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/508838v1?rss=1</link>
<description><![CDATA[
Cortical responses to repeated presentations of a stimulus are variable. This variability is sensitive to experimental manipulations that are also known to engage divisive normalization: a widespread description of neural activity as the ratio of a numerator (the excitatory stimulus drive) and denominator (the normalization signal). Yet, we lack a framework to quantify the effects of normalization on response variability. We extended the standard normalization model, treating the numerator and denominator as stochastic quantities, and derived a method to infer the single-trial normalization strength, which cannot be measured directly. The model revealed a general reduction of response variability in macaque primary visual cortex for neurons that were more strongly normalized, and during trials in which normalization was inferred to be strong. This framework could enable a direct quantification of the impact of single-trial normalization on perceptual judgments, and can readily be applied to other sensory and non-sensory factors.
]]></description>
<dc:creator>Coen-Cagli, R.</dc:creator>
<dc:creator>Solomon, S. S.</dc:creator>
<dc:date>2018-12-31</dc:date>
<dc:identifier>doi:10.1101/508838</dc:identifier>
<dc:title><![CDATA[Neural response variability and divisive normalization]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-12-31</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/520072v1?rss=1">
<title>
<![CDATA[
Kinesin-5 promotes microtubule nucleation and assembly by stabilizing a lattice-competent conformation of tubulin 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/520072v1?rss=1</link>
<description><![CDATA[
Besides sliding apart antiparallel microtubules during spindle elongation, the mitotic kinesin-5, Eg5 promotes microtubule polymerization, emphasizing its importance in mitotic spindle length control. Here, we characterize the Eg5 microtubule polymerase mechanism by assessing motor-induced changes in the longitudinal and lateral tubulin-tubulin bonds that form the microtubule lattice. Isolated Eg5 motor domains promote microtubule nucleation, growth and stability. Eg5 binds preferentially to microtubules over free tubulin, and colchicine-like inhibitors that stabilize the bent conformation of tubulin allosterically inhibit Eg5 binding, consistent with a model in which Eg5 induces a curved-to-straight transition in tubulin. Domain swap experiments establish that the family-specific Loop11, which resides near the nucleotide-sensing Switch-II domain, is necessary and sufficient for the polymerase activity of Eg5. Thus, we propose a microtubule polymerase mechanism in which Eg5 at the plus-end promotes a curved-to-straight transition in tubulin that enhances lateral bond formation and thereby promotes microtubule growth and stability.
]]></description>
<dc:creator>Chen, G.-Y.</dc:creator>
<dc:creator>Asenjo, A. B.</dc:creator>
<dc:creator>Chen, Y.</dc:creator>
<dc:creator>Mascaro, J.</dc:creator>
<dc:creator>Arginteanu, D. F. J.</dc:creator>
<dc:creator>Sosa, H. J.</dc:creator>
<dc:creator>Hancock, W. O.</dc:creator>
<dc:date>2019-01-14</dc:date>
<dc:identifier>doi:10.1101/520072</dc:identifier>
<dc:title><![CDATA[Kinesin-5 promotes microtubule nucleation and assembly by stabilizing a lattice-competent conformation of tubulin]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-01-14</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/528232v1?rss=1">
<title>
<![CDATA[
Candida auris: multi-omics signature of an emerging and multidrug-resistant pathogen 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/528232v1?rss=1</link>
<description><![CDATA[
Candida auris is a recently described pathogenic fungus that is causing invasive outbreaks on all continents. The fungus is of high concern given the numbers of multidrug-resistant strains that have been isolated in distinct sites across the globe. The fact that its diagnosis is still problematic suggests that the spreading of the pathogen remains underestimated. Notably, the molecular mechanisms of virulence and antifungal resistance employed by this new species are largely unknown. In the present work, we compared two clinical isolates of C. auris with distinct drug susceptibility profiles and a Candida albicans reference strain using a multi-omics approach. Our results show that, despite the distinct drug-resistance profile, both C. auris strains appear to be very similar, albeit with a few notable differences. However, when compared to C. albicans both C. auris strains have major differences regarding their carbon utilization and downstream lipid and protein content, suggesting a multi-factorial mechanism of drug resistance. The molecular profile displayed by C. auris helps to explain the antifungal resistance and virulence phenotypes of this new emerging pathogen.

ImportanceCandida auris was firstly described in Japan in 2009 and has now been the cause of significant outbreaks across the globe. The high number of isolates that are resistant to one or more antifungals, as well as the high mortality rates from patients with bloodstream infections, has caught the attention of the medical mycology, infectious disease and public health communities to this pathogenic fungus. In the current work, we performed a broad multi-omics approach on two clinical isolates isolated in New York, the most affected area in the USA and found that the omic profile of C. auris differs significantly from C. albicans. Besides our insights into C. auris carbon utilization and lipid and protein content, we believe that the availability of these data will enhance our ability to combat this rapidly emerging pathogenic yeast.
]]></description>
<dc:creator>Zamith-Miranda, D.</dc:creator>
<dc:creator>Heyman, H. M.</dc:creator>
<dc:creator>Cleare, L. G.</dc:creator>
<dc:creator>Couvillion, S. P.</dc:creator>
<dc:creator>Clair, G. C.</dc:creator>
<dc:creator>Bredeweg, E. L.</dc:creator>
<dc:creator>Gacser, A.</dc:creator>
<dc:creator>Nimrichter, L.</dc:creator>
<dc:creator>Nakayasu, E. S.</dc:creator>
<dc:creator>Nosanchuk, J. D.</dc:creator>
<dc:date>2019-01-23</dc:date>
<dc:identifier>doi:10.1101/528232</dc:identifier>
<dc:title><![CDATA[Candida auris: multi-omics signature of an emerging and multidrug-resistant pathogen]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-01-23</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/529289v1?rss=1">
<title>
<![CDATA[
Mitochondrial volume fraction controls translation of nuclear-encoded mitochondrial proteins 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/529289v1?rss=1</link>
<description><![CDATA[
Mitochondria are dynamic in their size and morphology yet must also precisely control their protein composition according to cellular energy demand. This control is particularly complicated for mitochondria, as they must coordinate gene expression from both the nuclear and mitochondrial genome. We have found that cells are able to use this dynamic morphology to post-transcriptionally coordinate protein expression with the metabolic demands of the cell through enhanced mRNA localization to the mitochondria. As yeast switch to respiratory metabolism, they increase their mitochondrial volume fraction that is, the ratio of mitochondrial volume to intracellular volume which drives the localization of nuclear-encoded mitochondrial mRNAs to the surface of the mitochondria. Through artificial tethering experiments, we show that this mitochondrial localization is sufficient to increase protein production, whereas sequestering mRNAs away from the mitochondrial surface decreases protein production, and those cells are deficient in growth in respiratory conditions. Furthermore, we find that this mRNA sensitivity to mitochondrial volume fraction is driven by the speed of translation downstream of the mitochondrial targeting sequence (MTS), as local ribosome stalling through a stretch of polyprolines in the nascent peptide can drive constitutive localization of mRNAs to the mitochondria. This points to a mechanism by which organelle volume fraction provides feedback to regulate organelle-specific gene expression through mRNA localization while potentially circumventing the need to directly coordinate with the nuclear genome.
]]></description>
<dc:creator>Tsuboi, T.</dc:creator>
<dc:creator>Viana, M. P.</dc:creator>
<dc:creator>Xu, F.</dc:creator>
<dc:creator>Yu, J.</dc:creator>
<dc:creator>Chanchani, R.</dc:creator>
<dc:creator>Arceo, X. G.</dc:creator>
<dc:creator>Tutucci, E.</dc:creator>
<dc:creator>Choi, J.</dc:creator>
<dc:creator>Chen, Y. S.</dc:creator>
<dc:creator>Singer, R. H.</dc:creator>
<dc:creator>Rafelski, S. M.</dc:creator>
<dc:creator>Zid, B. M.</dc:creator>
<dc:date>2019-01-25</dc:date>
<dc:identifier>doi:10.1101/529289</dc:identifier>
<dc:title><![CDATA[Mitochondrial volume fraction controls translation of nuclear-encoded mitochondrial proteins]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-01-25</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/535807v1?rss=1">
<title>
<![CDATA[
SCCNV: a software tool for identifying copy number variation from single-cell whole-genome sequencing 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/535807v1?rss=1</link>
<description><![CDATA[
BackgroundIdentification of de novo mutations from cell populations requires single-cell whole-genome sequencing (SCWGS). Although many experimental protocols of SCWGS have been developed, few computational tools are available for downstream analysis of different types of somatic mutations, including copy number variation (CNV).

ResultsWe developed SCCNV, a software tool for detecting CNVs from whole genome-amplified single cells. SCCNV is a read-depth based approach with adjustment for the whole-genome amplification bias.

ConclusionsWe demonstrate its performance by analyzing data collected from most of the single-cell amplification methods, including DOP-PCR, MDA, MALBAC and LIANTI. SCCNV is freely available at https://github.com/biosinodx/SCCNV.
]]></description>
<dc:creator>Dong, X.</dc:creator>
<dc:creator>Zhang, L.</dc:creator>
<dc:creator>Hao, X.</dc:creator>
<dc:creator>Wang, T.</dc:creator>
<dc:creator>Vijg, J.</dc:creator>
<dc:date>2019-01-31</dc:date>
<dc:identifier>doi:10.1101/535807</dc:identifier>
<dc:title><![CDATA[SCCNV: a software tool for identifying copy number variation from single-cell whole-genome sequencing]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-01-31</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/535906v1?rss=1">
<title>
<![CDATA[
Single-cell whole-genome sequencing reveals the functional landscape of somatic mutations in B lymphocytes across the human lifespan 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/535906v1?rss=1</link>
<description><![CDATA[
Introductory paragraphThe accumulation of mutations in somatic cells have been implicated as a cause of ageing since the 1950s1,2. Yet, attempts to establish a causal relationship between somatic mutations and ageing have been constrained by the lack of methods to directly identify mutational events in primary human tissues. Here we provide detailed, genome-wide mutation frequencies and spectra of human B lymphocytes from healthy individuals across the entire human lifespan, from newborns to centenarians, using a recently developed, highly accurate single-cell whole-genome sequencing method3. We found that the number of somatic mutations increases from <500 per cell in newborns to >3,000 per cell in centenarians. We discovered mutational hotspot regions, some of which, as expected, located at immunoglobulin genes associated with somatic hypermutation. B cell-specific mutation signatures were observed associated with development, ageing or somatic hypermutation (SHM). The SHM signature strongly correlated with the signature found in human chronic lymphocytic leukemia and malignant B-cell lymphomas4, indicating that even in B cells of healthy individuals the potential cancer-causing events are already present. We also identified multiple mutations in sequence features relevant to cellular function, i.e., transcribed genes and gene regulatory regions. Such mutations increased significantly during ageing, but only at approximately half the rate of the genome average, indicating selection against mutations that impact B cell function. This first full characterization of the landscape of somatic mutations in human B lymphocytes indicates that spontaneous somatic mutations accumulating with age can be deleterious and may contribute to both the increased risk for leukemia and the functional decline of B lymphocytes in the elderly.
]]></description>
<dc:creator>Zhang, L.</dc:creator>
<dc:creator>Dong, X.</dc:creator>
<dc:creator>Lee, M.</dc:creator>
<dc:creator>Maslov, A. Y.</dc:creator>
<dc:creator>Wang, T.</dc:creator>
<dc:creator>Vijg, J.</dc:creator>
<dc:date>2019-01-31</dc:date>
<dc:identifier>doi:10.1101/535906</dc:identifier>
<dc:title><![CDATA[Single-cell whole-genome sequencing reveals the functional landscape of somatic mutations in B lymphocytes across the human lifespan]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-01-31</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/536896v1?rss=1">
<title>
<![CDATA[
Spontaneous retrotranspositions in normal tissues are rare and associated with cell-type-specific differentiation 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/536896v1?rss=1</link>
<description><![CDATA[
Activation of retrotransposons and their insertions into new genomic locations, i.e., retrotranspositions (RTs), have been identified in about 50% of tumors. However, the landscape of RTs in different, normal somatic cell types in humans remains largely unknown. Using single-cell whole-genome sequencing we identified 528 RT events, including LINE-1 (L1), and Alu, in 164 single cells and clones of fibroblasts, neurons, B lymphocytes, hepatocytes and liver stem cells, of 29 healthy human subjects aged from 0 to 106 years. The frequency of RTs was found to vary from <1 on average per cell in primary fibroblasts to 7.8 per cell in hepatocytes. Somewhat surprisingly, RT frequency does not increase with age, which is in contrast to other types of spontaneous mutation. RTs were found significantly more likely to insert in or close to target genes of the Polycomb Repressive Complex 2 (PRC2), which represses most of the genes encoding developmental regulators through H3K27me3 histone modification in embryonic stem cells. Indeed, when directly comparing RT frequency between differentiated liver hepatocytes with liver stem cells, the latter were almost devoid of RTs. These results indicate that spontaneous RTs are associated with cellular differentiation and occur, possibly, as a consequence of the transient chromatin transition of differentiation-specific genes from a transcriptionally repressed to activated state during the differentiation process.
]]></description>
<dc:creator>Dong, X.</dc:creator>
<dc:creator>Zhang, L.</dc:creator>
<dc:creator>Brazhnik, K.</dc:creator>
<dc:creator>Lee, M.</dc:creator>
<dc:creator>Hao, X.</dc:creator>
<dc:creator>Maslov, A. Y.</dc:creator>
<dc:creator>Zhang, Z.</dc:creator>
<dc:creator>Wang, T.</dc:creator>
<dc:creator>Vijg, J.</dc:creator>
<dc:date>2019-01-31</dc:date>
<dc:identifier>doi:10.1101/536896</dc:identifier>
<dc:title><![CDATA[Spontaneous retrotranspositions in normal tissues are rare and associated with cell-type-specific differentiation]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-01-31</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/546010v1?rss=1">
<title>
<![CDATA[
Mutation of the ATPase domain of MutS homolog-5 (MSH5) reveals a requirement for a functional MutSγ complex for all crossovers in mammalian meiosis 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/546010v1?rss=1</link>
<description><![CDATA[
During meiosis, induction of DNA double strand breaks (DSB) leads to recombination between homologous chromosomes, resulting in crossovers (CO) and non-crossovers (NCO). Only 10% DSBs resolve as COs, mostly through a class I pathway dependent on MutS{gamma} (MSH4/ MSH5). Class II CO events represent a minor proportion of the total CO count and also arise from DSBs, but are not thought to involve MutS{gamma}. However, loading of MutS{gamma} occurs very early in prophase I at a frequency that far exceeds the final number of class I COs found in late prophase I. Moreover, loss of MutS{gamma} in mouse results in apoptosis before CO formation, preventing analysis of its CO function. We generated a mutation in the ATP binding domain of Msh5 (Msh5GA). While this mutation was not expected to affect MutS{gamma} complex formation, MutS{gamma} foci do not accumulate during prophase I. Nevertheless, while some spermatocytes from Msh5-/- animals progress into pachynema, most spermatocytes from Msh5GA/GA mice progress to late pachynema and beyond. Some spermatocytes from Msh5GA/GA mice complete prophase I entirely, allowing for the first time an assessment of MSH5 function in CO formation. At pachynema, Msh5GA/GA spermatocytes show persistent DSBs, incomplete homolog pairing, and fail to accumulate MutL{gamma} (MLH1/MLH3). Unexpectedly, Msh5GA/GA diakinesis-staged spermatocytes have no chiasmata at all from any CO pathway, indicating that a functional MutS{gamma} complex in early prophase I is a pre-requisite for all COs.

ARTICLE SUMMARYMSH4/MSH5 are critical components of the class I crossover (CO) machinery, which is responsible for >90% of the COs that arise in mammalian meiosis. We generated a point mutation in the ATP binding motif of Msh5, and found that mutant spermatocytes lose all COs, not just those arising from the class I pathway.
]]></description>
<dc:creator>Milano, C. R.</dc:creator>
<dc:creator>Holloway, J. K.</dc:creator>
<dc:creator>Zhang, Y.</dc:creator>
<dc:creator>Jin, B.</dc:creator>
<dc:creator>Bergman, A.</dc:creator>
<dc:creator>Edelmann, W.</dc:creator>
<dc:creator>Cohen, P. E.</dc:creator>
<dc:date>2019-02-10</dc:date>
<dc:identifier>doi:10.1101/546010</dc:identifier>
<dc:title><![CDATA[Mutation of the ATPase domain of MutS homolog-5 (MSH5) reveals a requirement for a functional MutSγ complex for all crossovers in mammalian meiosis]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-02-10</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/547893v1?rss=1">
<title>
<![CDATA[
Single-cell analysis reveals different age-related somatic mutation profiles between stem and differentiated cells in human liver 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/547893v1?rss=1</link>
<description><![CDATA[
Accumulating somatic mutations have been implicated in age-related cellular degeneration and death. Because of their random nature and low abundance, somatic mutations are difficult to detect except in single cells or clonal lineages. Here we show that in single hepatocytes from human liver, an organ normally exposed to high levels of genotoxic stress, somatic mutation frequencies are high and increase substantially with age. Significantly lower mutation frequencies were observed in liver stem cells and organoids derived from them. These results could explain the increased age-related incidence of liver disease in humans and stress the importance of stem cells in maintaining genome integrity.
]]></description>
<dc:creator>Brazhnik, K.</dc:creator>
<dc:creator>Sun, S.</dc:creator>
<dc:creator>Alani, O.</dc:creator>
<dc:creator>Kinkhabwala, M.</dc:creator>
<dc:creator>Wolkoff, A. W.</dc:creator>
<dc:creator>Maslov, A. Y.</dc:creator>
<dc:creator>Dong, X.</dc:creator>
<dc:creator>Vijg, J.</dc:creator>
<dc:date>2019-02-14</dc:date>
<dc:identifier>doi:10.1101/547893</dc:identifier>
<dc:title><![CDATA[Single-cell analysis reveals different age-related somatic mutation profiles between stem and differentiated cells in human liver]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-02-14</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/553982v1?rss=1">
<title>
<![CDATA[
The Process Pathway Model of bacterial growth 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/553982v1?rss=1</link>
<description><![CDATA[
The growth profile of microorganisms in an enclosed environment, such as a bioreactor or flask, is a well studied and characterized system. Despite a long history of examination, there are still many competing mathematical models used to describe an output of the microorganisms, namely the number of bacteria as a function of time. However, these descriptions are either purely phenomenological and give no intuition as to the biological mechanisms underlying the growth curves, or extremely complex and become computationally unfeasible at the population level. In this paper, we develop the Process Pathway Model by modifying a model of sequential processes, which was first used to model robustness in metabolic pathways, and demonstrate that the Process Pathway Model encapsulates many features and temperature dependence of bacterial growth. We verify the predictions of the model against growth data for multiple species of microorganisms, and confirm that the model generates accurate predictions on temperature dependence of bacterial growth. The model has five free parameters, and the simplifying assumptions used to build the model are built upon biologically realistic notions. The Process Pathway Model accurately models a microorganisms growth profile at an intermediate level of complexity that is computationally feasible. This model can be used as both an conceptual model for thinking about systems of bacterial growth, as well as a computational model that operates at level of complexity that is amenable to large scale simulation. This balance in accuracy and intuitiveness was accomplished by using realistic biological assumptions to simplify the underlying biology, which may point the way forward for future models of this type.
]]></description>
<dc:creator>Biro, D.</dc:creator>
<dc:creator>Pechuan, X.</dc:creator>
<dc:creator>Bergman, A.</dc:creator>
<dc:creator>Lambros, M.</dc:creator>
<dc:date>2019-02-19</dc:date>
<dc:identifier>doi:10.1101/553982</dc:identifier>
<dc:title><![CDATA[The Process Pathway Model of bacterial growth]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-02-19</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/554048v1?rss=1">
<title>
<![CDATA[
Cryptococcus neoformans secretes small molecules that inhibit IL-1β inflammasome-dependent secretion 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/554048v1?rss=1</link>
<description><![CDATA[
Cryptococcus neoformans is an encapsulated yeast that causes disease mainly in immunosuppressed hosts. It is considered a facultative intracellular pathogen because of its capacity to survive and replicate inside phagocytes, especially macrophages. This capacity is heavily dependent on various virulence factors, particularly the glucuronoxylomannan (GXM) component of the polysaccharide capsule, that render the non- or poorly-activated macrophage ineffective against phagocytosed yeast. Strategies utilized by macrophages to prevent this scenario include pyroptosis (a rapid highly inflammatory cell death) and vomocytosis (the expulsion of the pathogen from the intracellular environment without lysis). Inflammasome activation in phagocytes is usually protective against fungal infections, including cryptococcosis. Nevertheless, recognition of C. neoformans by inflammasome receptors requires specific changes in morphology or the opsonization of the yeast, impairing a proper inflammasome function. In this context, we analyzed the impact of molecules secreted by C. neoformans B3501 strain and its acapsular mutant{Delta} cap67 in an inflammasome activation in vitro model. Our results showed that conditioned media derived from B3501 was capable of inhibiting inflammasome dependent events (i. e. IL-1{beta} secretion and LDH release via pyroptosis) more strongly than conditioned media from{Delta} cap67, regardless of GXM presence. We also demonstrated that macrophages treated with conditioned media were less responsive against infection with the virulent strain H99, exhibiting lower rates of phagocytosis, increased fungal burdens and enhanced vomocytosis. Moreover, we showed that the aromatic metabolite DL-Indole-3-lactic acid (ILA) was present in B3501s conditioned media and that this fungal metabolite is involved in the regulation of inflammasome activation by C. neoformans. Overall, the results presented show that conditioned media from a wild-type strain can inhibit an important recognition pathway and subsequent fungicidal functions of macrophages, contributing to fungal survival in vitro and suggesting that this serves as an important role for secreted molecules during cryptococcal infections.

Authors SummaryCryptococcus neoformans is the agent of cryptococcal meningitis, a disease that can be life-threatening in immunocompromised hosts such as those infected with HIV. The infection thrives in hosts that poorly activate their immune system, mainly because of the yeasts ability to survive inside macrophages and migrate towards the central nervous system. Emerging data indicate that cryptococci modulate the host immune response, but the underlying mechanisms remain largely uncharacterized. Here we show that secreted molecules from a wild-type strain of C. neoformans impair inflammatory responses driven by inflammasome activation, which in turn impact the macrophage antifungal activity. We further show that this inhibition does not involve GXM, the main constituent of the fungal capsule, but rather is partially dependent on DL-Indole-3-lactic acid (ILA), a metabolite not previously implicated in fungal virulence.
]]></description>
<dc:creator>Bürgel, P. H.</dc:creator>
<dc:creator>Marina, C. L.</dc:creator>
<dc:creator>Saavedra, P. H. V.</dc:creator>
<dc:creator>Albuquerque, P.</dc:creator>
<dc:creator>Holanda, P. H.</dc:creator>
<dc:creator>Castro, R. d. A.</dc:creator>
<dc:creator>Heyman, H.</dc:creator>
<dc:creator>Coelho, C.</dc:creator>
<dc:creator>Cordero, R. J. B.</dc:creator>
<dc:creator>Casadevall, A.</dc:creator>
<dc:creator>Nosanchuk, J.</dc:creator>
<dc:creator>Nakayasu, E.</dc:creator>
<dc:creator>May, R. C.</dc:creator>
<dc:creator>Tavares, A. H.</dc:creator>
<dc:creator>Bocca, A.</dc:creator>
<dc:date>2019-02-19</dc:date>
<dc:identifier>doi:10.1101/554048</dc:identifier>
<dc:title><![CDATA[Cryptococcus neoformans secretes small molecules that inhibit IL-1β inflammasome-dependent secretion]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-02-19</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/554410v1?rss=1">
<title>
<![CDATA[
Chromosomal rearrangements at hypomethylated Satellite 2 sequences are associated with impaired replication efficiency and increased fork stalling 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/554410v1?rss=1</link>
<description><![CDATA[
Cancer cells, aging cells, and cells from patients with the developmental disorder Immunodeficiency, Centromeric instability, and Facial anomalies (ICF) syndrome frequently display a striking loss of DNA methylation (hypomethylation) that is accompanied by increased DNA damage and chromosomal rearrangements. Despite the robust link, the mechanism by which hypomethylation leads to genomic instability is poorly understood. We report that the human pericentromeric repeat sequence Satellite 2 (SAT2) poses challenges to the DNA replication machinery when hypomethylated. Loss of methylation at SAT2 is associated with increased frequencies of chromosomal abnormalities and DNA damage. Hypomethylation of SAT2 is associated with elevated levels of replication stress signaling, and chromosomal abnormalities involving SAT2 are enhanced by low levels of aphidicolin-induced replication stress. To investigate the basis for these chromosomal abnormalities, we developed a single-molecule approach employing DNA combing to examine the progress of replication forks through SAT2 at the resolution of a single DNA molecule. Our analysis of replicating SAT2 molecules provides in vivo evidence that hypomethylation of SAT2 strongly decreases the efficiency of replicating these sequences suggesting that hypomethylation results in the formation of barriers to the replication machinery. Consistent with increased frequency of fork stalling at these sequences, we find increased levels of single-stranded DNA (ssDNA) binding protein RPA2 as well as asymmetric progression of sister replication forks within hypomethylated SAT2 sequences. Together these findings indicate that impaired replication triggers the formation of chromosomal aberrations observed at hypomethylated SAT2 sequences and also suggests a mechanistic basis for how the loss of DNA methylation may contribute to genomic instability in diverse pathological conditions.
]]></description>
<dc:creator>Delpu, Y.</dc:creator>
<dc:creator>McNamara, T. F.</dc:creator>
<dc:creator>Griffin, P.</dc:creator>
<dc:creator>Kaleem, S.</dc:creator>
<dc:creator>Narayan, S.</dc:creator>
<dc:creator>Schildkraut, C.</dc:creator>
<dc:creator>Miga, K. H.</dc:creator>
<dc:creator>Tahiliani, M.</dc:creator>
<dc:date>2019-02-19</dc:date>
<dc:identifier>doi:10.1101/554410</dc:identifier>
<dc:title><![CDATA[Chromosomal rearrangements at hypomethylated Satellite 2 sequences are associated with impaired replication efficiency and increased fork stalling]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-02-19</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/563858v1?rss=1">
<title>
<![CDATA[
Cancer-type specific aneuploidies hard-wire chromosome-wide gene expression patterns of their tissue of origin 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/563858v1?rss=1</link>
<description><![CDATA[
Most carcinomas have characteristic chromosomal aneuploidies specific to the tissue of tumor origin. The reason for this specificity is unknown. As aneuploidies directly affect gene expression, we hypothesized that cancer-type specific aneuploidies, which emerge at early stages of tumor evolution, confer adaptive advantages to the physiological requirements of the tissue of origin. To test this hypothesis, we compared chromosomal aneuploidies reported in the TCGA database to chromosome arm-wide gene expression levels of normal tissues from the GTEx database. We find that cancer-type specific chromosomal aneuploidies mirror differential gene expression levels specific to the respective normal tissues which cannot be explained by copy number alterations of resident cancer driver genes. We propose that cancer-type specific aneuploidies "hard-wire" chromosome arm-wide gene expression levels present in normal tissues, favoring clonal expansion and tumorigenesis.

One sentence summaryThe clonal evolution of cancer is initiated by tissue-specific transcriptional requirements
]]></description>
<dc:creator>Auslander, N.</dc:creator>
<dc:creator>Heselmeyer-Haddad, K.</dc:creator>
<dc:creator>Patkar, S.</dc:creator>
<dc:creator>Hirsch, D.</dc:creator>
<dc:creator>Camps, J.</dc:creator>
<dc:creator>Brown, M.</dc:creator>
<dc:creator>Bronder, D.</dc:creator>
<dc:creator>Chen, W.-D.</dc:creator>
<dc:creator>Lokanga, R.</dc:creator>
<dc:creator>Wangsa, D.</dc:creator>
<dc:creator>Wangsa, D.</dc:creator>
<dc:creator>Hu, Y.</dc:creator>
<dc:creator>Lischka, A.</dc:creator>
<dc:creator>Braun, R.</dc:creator>
<dc:creator>Emons, G.</dc:creator>
<dc:creator>Ghadimi, B. M.</dc:creator>
<dc:creator>Gaedcke, J.</dc:creator>
<dc:creator>Grade, M.</dc:creator>
<dc:creator>Montagna, C.</dc:creator>
<dc:creator>Lazebnik, Y.</dc:creator>
<dc:creator>Difilippantonio, M. J.</dc:creator>
<dc:creator>Habermann, J. K.</dc:creator>
<dc:creator>Auer, G.</dc:creator>
<dc:creator>Ruppin, E.</dc:creator>
<dc:creator>ried, t.</dc:creator>
<dc:date>2019-03-01</dc:date>
<dc:identifier>doi:10.1101/563858</dc:identifier>
<dc:title><![CDATA[Cancer-type specific aneuploidies hard-wire chromosome-wide gene expression patterns of their tissue of origin]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-03-01</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/565333v1?rss=1">
<title>
<![CDATA[
Developmental Recovery of Impaired Multisensory Processing in Autism and the Cost of Switching Sensory Modality 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/565333v1?rss=1</link>
<description><![CDATA[
Children with autism spectrum disorder (ASD) are often impaired in their ability to cope with and process multisensory information, which may contribute to some of the social and communicative deficits that are prevalent in this population. Amelioration of such deficits in adolescence has been observed for ecologically-relevant stimuli such as speech. However, it is not yet known if this recovery generalizes to the processing of nonsocial stimuli such as more basic beeps and flashes, typically used in cognitive neuroscience research. We hypothesize that engagement of different neural processes and lack of environmental exposure to such artificial stimuli leads to protracted developmental trajectories in both neurotypical (NT) individuals and individuals with ASD, thus delaying the age at which we observe this "catch up". Here, we test this hypothesis using a bisensory detection task by measuring human response times to randomly presented auditory, visual and audiovisual stimuli. By measuring the behavioral gain afforded by an audiovisual signal, we show that the multisensory deficit previously reported in children with ASD recovers in adulthood by the mid-twenties. In addition, we examine the effects of switching between sensory modalities and show that teenagers with ASD incur less of a behavioral cost than their NT peers. Computational modelling reveals that multisensory information interacts according to different rules in children and adults, and that sensory evidence is weighted differently too. In ASD, weighting of sensory information and allocation of attention during multisensory processing differs to that of NT individuals. Based on our findings, we propose a theoretical framework of multisensory development in NT and ASD individuals.
]]></description>
<dc:creator>Crosse, M. J.</dc:creator>
<dc:creator>Foxe, J. J.</dc:creator>
<dc:creator>Molholm, S.</dc:creator>
<dc:date>2019-03-01</dc:date>
<dc:identifier>doi:10.1101/565333</dc:identifier>
<dc:title><![CDATA[Developmental Recovery of Impaired Multisensory Processing in Autism and the Cost of Switching Sensory Modality]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-03-01</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/565473v1?rss=1">
<title>
<![CDATA[
The Marginal Cells of the Caenorhabditis elegans Pharynx Scavenge Cholesterol and Other Hydrophobic Small Molecules 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/565473v1?rss=1</link>
<description><![CDATA[
The nematode worm Caenorhabditis elegans is a bacterivore filter feeder. Through the contraction of the worms pharynx, a bacterial suspension is sucked into the pharynxs lumen. Excess liquid is then shunted out of the buccal cavity through ancillary channels that are made from specialized pharyngeal cells called marginal cells. Through the characterization of our library of worm-bioactive small molecules (a.k.a. wactives), we found that more than one third of wactives visibly accumulate inside of the marginal cells as crystals or globular spheres. Wactives that visibly accumulate are typically more hydrophobic than those that do not. To understand why wactives accumulate specifically in marginal cells, we performed a forward genetic screen for mutants that resist the lethality associated with one crystallizing wactive. We identified a presumptive sphingomyelin-synthesis pathway that is necessary for crystal and sphere accumulation. Sphingomyelin is a phospholipid that is enriched in the outer leaflet of the plasma membranes of most metazoans. We find that the predicted terminal enzyme of this pathway, sphingomyelin synthase 5 (SMS-5), is expressed in the pharynx, contributes to sphingomyelin abundance, and that its expression in marginal cells is sufficient for wactive accumulation. We also find that the expression of SMS-5 in the marginal cells is necessary for the proper absorption of exogenous cholesterol, without which C. elegans cannot develop. We conclude that the sphingomyelin-rich plasma membrane of the marginal cells acts as a sink to scavenge important hydrophobic nutrients from the filtered liquid that might otherwise be shunted back into the environment.

One sentence summaryThe anterior pharynx of C. elegans is a Sink for Hydrophobic Small Molecules
]]></description>
<dc:creator>Kamal, M.</dc:creator>
<dc:creator>Moshiri, H.</dc:creator>
<dc:creator>Magomedova, L.</dc:creator>
<dc:creator>Han, D.</dc:creator>
<dc:creator>Nguyen, K. C.</dc:creator>
<dc:creator>Yeo, M.</dc:creator>
<dc:creator>Knox, J.</dc:creator>
<dc:creator>Bagg, R.</dc:creator>
<dc:creator>Won, A. M.</dc:creator>
<dc:creator>Szlapa, K.</dc:creator>
<dc:creator>Yip, C.</dc:creator>
<dc:creator>Cummins, C. L.</dc:creator>
<dc:creator>Hall, D. H.</dc:creator>
<dc:creator>Roy, P. J.</dc:creator>
<dc:date>2019-03-03</dc:date>
<dc:identifier>doi:10.1101/565473</dc:identifier>
<dc:title><![CDATA[The Marginal Cells of the Caenorhabditis elegans Pharynx Scavenge Cholesterol and Other Hydrophobic Small Molecules]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-03-03</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/565507v1?rss=1">
<title>
<![CDATA[
Temporal Metrics of Multisensory Processing Change in the Elderly 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/565507v1?rss=1</link>
<description><![CDATA[
Older adults exhibit greater multisensory response time (RT) facilitation by violating the race model more than younger adults; this is commonly interpreted as an enhancement in perception. Older adults typically exhibit wider temporal binding windows (TBWs) and points of subjective simultaneity (PSS) that are farther from true simultaneity as compared to younger adults when simultaneity judgment (SJ) and temporal order judgment (TOJ) tasks are utilized; this is commonly interpreted as an impairment in perception. Here we explore the relation between the three tasks in younger and older adults in order to better understand the underlying mechanisms that subserve audiovisual multisensory temporal processing. Our results confirm previous reports showing that audiovisual RT, TBWs and PSSs change with age, and we show for the first time a significant positive relation between the magnitude of race model violation in younger adults as a function of the PSS obtained from the audiovisual TOJ task with (r: 0.49, p: 0.007), that is absent among the elderly (r: 0.13, p: 0.58). Furthermore, we find no evidence for the relation between race model violation as a function of the PSS obtained from the audiovisual SJ task in both younger (r: -0.01, p: 0.94) and older adults (r: 0.1, p: 0.66). Our results confirm previous reports that i) audiovisual temporal processing changes with age; ii) there is evidence for distinct neural networks involved in simultaneity and temporal order perception; and iii) common processing between race model violation and temporal order judgment is impaired in the elderly.
]]></description>
<dc:creator>Basharat, A.</dc:creator>
<dc:creator>Barnett-Cowan, M.</dc:creator>
<dc:creator>Mahoney, J. R.</dc:creator>
<dc:date>2019-03-01</dc:date>
<dc:identifier>doi:10.1101/565507</dc:identifier>
<dc:title><![CDATA[Temporal Metrics of Multisensory Processing Change in the Elderly]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-03-01</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/566513v1?rss=1">
<title>
<![CDATA[
Proteomic profiling of the oncogenic septin 9 reveals isoform-specific interactions in breast cancer cells 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/566513v1?rss=1</link>
<description><![CDATA[
Septins are a family of multimeric GTP-binding proteins, which are abnormally expressed in cancer. Septin 9 (SEPT9) is an essential and ubiquitously expressed septin with multiple isoforms, which have differential expression patterns and effects in breast cancer cells. It is unknown, however, if SEPT9 isoforms associate with different molecular networks and functions. Here, we performed a proteomic screen in MCF-7 breast cancer cells to identify the interactome of GFP-SEPT9 isoforms 1, 4 and 5, which vary significantly in their N-terminal extensions. While all three isoforms associated with SEPT2 and SEPT7, the truncated SEPT9_i4 and SEPT9_i5 interacted with septins of the SEPT6 group more promiscuously than SEPT9_i1, which bound predominately SEPT8. Spatial mapping and functional clustering of non-septin partners showed isoform-specific differences in interactions with proteins of distinct subcellular organelles (e.g., nuclei, centrosomes, cilia) and functions such as cell signaling and ubiquitination. Notably, the interactome of the full length SEPT9_i1 was more enriched in cytoskeletal regulators, while the truncated SEPT9_i4 and SEPT9_i5 exhibited preferential and isoform-specific interactions with nuclear, signaling and ubiquitinating proteins. These data provide evidence for isoform-specific interactions, which arise from truncations in the N-terminal extensions of SEPT9, and point to novel roles in the pathogenesis of breast cancer.
]]></description>
<dc:creator>Devlin, L.</dc:creator>
<dc:creator>Perkins, G.</dc:creator>
<dc:creator>Bowen, J. R.</dc:creator>
<dc:creator>Montagna, C.</dc:creator>
<dc:creator>Spiliotis, E. T.</dc:creator>
<dc:date>2019-03-05</dc:date>
<dc:identifier>doi:10.1101/566513</dc:identifier>
<dc:title><![CDATA[Proteomic profiling of the oncogenic septin 9 reveals isoform-specific interactions in breast cancer cells]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-03-05</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/566802v1?rss=1">
<title>
<![CDATA[
HILPDA uncouples lipid storage in adipose tissue macrophages from inflammation and metabolic dysregulation 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/566802v1?rss=1</link>
<description><![CDATA[
Obesity promotes accumulation of lipid-laden macrophages in adipose tissue. Here, we determined the role of macrophage lipid accumulation in the development of obesity-induced adipose tissue inflammation, using mice with myeloid-specific deficiency of the lipid-inducible HILPDA protein. HILPDA deficiency in bone marrow-derived macrophages markedly reduced intracellular lipid levels and accumulation of fluorescently-labeled fatty acids in lipid droplets. Decreased lipid storage in HILPDA-deficient macrophages could be almost completely rescued by inhibition of adipose triglyceride lipase (ATGL) and was associated with increased oxidative metabolism. In diet-induced obese mice, HILPDA deficiency did not alter inflammatory or metabolic parameters, despite markedly reducing lipid storage in adipose tissue macrophages. Our data indicate that HILPDA is a lipid-induced physiological inhibitor of ATGL-mediated lipolysis that uncouples lipid storage in adipose tissue macrophages from inflammation and metabolic dysregulation. Overall, our data question the importance of lipid storage in adipose tissue macrophages in obesity-induced inflammation and metabolic dysregulation.
]]></description>
<dc:creator>van Dierendonck, X. A. M. H.</dc:creator>
<dc:creator>de la Rosa Rodriguez, M. A.</dc:creator>
<dc:creator>Georgiadi, A.</dc:creator>
<dc:creator>Mattijssen, F.</dc:creator>
<dc:creator>Dijk, W.</dc:creator>
<dc:creator>van Weeghel, M.</dc:creator>
<dc:creator>Singh, R.</dc:creator>
<dc:creator>Borst, J. W.</dc:creator>
<dc:creator>Stienstra, R.</dc:creator>
<dc:creator>Kersten, S.</dc:creator>
<dc:date>2019-03-05</dc:date>
<dc:identifier>doi:10.1101/566802</dc:identifier>
<dc:title><![CDATA[HILPDA uncouples lipid storage in adipose tissue macrophages from inflammation and metabolic dysregulation]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-03-05</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/568832v1?rss=1">
<title>
<![CDATA[
Auditory sensory memory span for duration is severely curtailed in females with Rett Syndrome. 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/568832v1?rss=1</link>
<description><![CDATA[
Rett syndrome (RTT), a rare neurodevelopmental disorder caused by mutations in the MECP2 gene, is typified by profound cognitive impairment and severe language impairment, rendering it very difficult to accurately measure auditory processing capabilities behaviorally in this population. Here we leverage the mismatch negativity (MMN) component of the event-related potential to measure the ability of RTT patients to decode and store occasional duration deviations in a stream of auditory stimuli. Sensory memory for duration, crucial for speech comprehension, has not been studied in RTT.nnHigh-density EEG was successfully recorded in 18 females with RTT and 27 age-matched typically developing (TD) controls (aged 6-22 years). Data from 7 RTT and 3 TD participants were excluded for excessive noise. Stimuli were 1kHz tones with a standard duration of 100ms and deviant duration of 180ms. To assess the sustainability of sensory memory, stimulus presentation rate was varied with stimulus onset asynchronies (SOAs) of 450, 900 and 1800ms. MMNs with maximum negativity over fronto-central scalp and a latency of 220-230ms were clearly evident for each presentation rate in the TD group, but only for the shortest SOA in the RTT group. Repeated-measures ANOVA revealed a significant group by SOA interaction. MMN amplitude correlated with age in the TD group only. MMN amplitude was not correlated with the Rett Syndrome Severity Scale. This study indicates that while RTT patients can decode deviations in auditory duration, the span of this sensory memory system is severely foreshortened, with likely implications for speech decoding abilities.
]]></description>
<dc:creator>Brima, T. J.</dc:creator>
<dc:creator>Molholm, S.</dc:creator>
<dc:creator>Molloy, C. J.</dc:creator>
<dc:creator>Sysoeva, O. V.</dc:creator>
<dc:creator>Nicholas, E.</dc:creator>
<dc:creator>Djukic, A.</dc:creator>
<dc:creator>Freedman, E.</dc:creator>
<dc:creator>Foxe, J. J.</dc:creator>
<dc:date>2019-03-05</dc:date>
<dc:identifier>doi:10.1101/568832</dc:identifier>
<dc:title><![CDATA[Auditory sensory memory span for duration is severely curtailed in females with Rett Syndrome.]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-03-05</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/570291v1?rss=1">
<title>
<![CDATA[
Extracellular vesicle-mediated RNA release in Histoplasma capsulatum 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/570291v1?rss=1</link>
<description><![CDATA[
Eukaryotic cells, including fungi, release extracellular vesicles (EVs). These lipid bilayered compartments play essential roles in cellular communication and pathogenesis. EV composition is complex and includes proteins, glycans, pigments, and RNA. RNA classes with putative roles in pathogenesis have been described in EVs produced by fungi. Here we describe the RNA content in EVs produced by the G186AR and G217B strains of Histoplasma capsulatum, an important human fungal pathogen. A total of 124 mRNA were identified in both strains. In this set of RNA classes, 93 transcripts were enriched in EVs from the G217B strain, while 31 enriched in EVs produced by the G186AR strain. This result suggests that there are important strain-specific properties in the mRNA composition of fungal EVs. We also identified short fragments (25-40 long) that were strain-specific, with a greater number of them identified in EVs produced by the G217B strain. Remarkably, the most enriched processes were stress responses and translation. Half of these fragments aligned to the reverse strand of the transcript, suggesting the occurrence of miRNA-like molecules in fungal EVs. We also compared the transcriptome profiles of H. capsulatum with the RNA composition of EVs and no correlation was observed. Altogether, our study provided information about the RNA molecules present in H. capsulatum EVs, and the differences in composition between the G186AR and G217B strains. In addition, we showed that the correlation between the most expressed transcripts in the cell and their presence in the EVs, reinforcing the idea that the RNAs were directed to the EVs by a regulated mechanism.nnImportanceExtracellular vesicles (EVs) play important roles in cellular communication and pathogenesis. The RNA molecules in EVs have been implicated in a variety of processes. In pathogenic fungi, EV-associated RNA classes have recently been described; however, only a few studies describing the RNA in fungal EVs are available. An improved knowledge on EV-associated RNA will contribute to the understanding of their role during infection. In this study, we described the RNA content in EVs produced by two isolates of Histoplasma capsulatum. Our results add this important pathogen to the current short list of fungal species with the ability to use EVs for the extracellular release of RNA.
]]></description>
<dc:creator>Alves, L. R.</dc:creator>
<dc:creator>Peres da Silva, R.</dc:creator>
<dc:creator>Sanchez, D. A.</dc:creator>
<dc:creator>Zamith-Miranda, D.</dc:creator>
<dc:creator>Rodrigues, M. L.</dc:creator>
<dc:creator>Goldenberg, S.</dc:creator>
<dc:creator>Puccia, R.</dc:creator>
<dc:creator>Nosanchuk, J. D.</dc:creator>
<dc:date>2019-03-07</dc:date>
<dc:identifier>doi:10.1101/570291</dc:identifier>
<dc:title><![CDATA[Extracellular vesicle-mediated RNA release in Histoplasma capsulatum]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-03-07</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/571000v1?rss=1">
<title>
<![CDATA[
Mortality among adults living with HIV treated for tuberculosis based on positive, negative, or no bacteriologic test results for tuberculosis: the IeDEA consortium 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/571000v1?rss=1</link>
<description><![CDATA[
BackgroundIn resource-constrained settings, people living with HIV (PLWH) treated for tuberculosis (TB) despite negative bacteriologic tests have a higher mortality than those treated with positive tests. Many PLWH are treated without bacteriologic testing; their mortality compared to those with bacteriologic testing is uncertain.nnMethodsWe conducted an observational cohort study among PLWH [&ge;] 15 years of age who initiated TB treatment at clinical sites affiliated with four regions of the International epidemiology Databases to Evaluate AIDS (IeDEA) consortium from 2012-2014: Caribbean, Central and South America, and Central, East, and West Africa. The primary exposure of interest was the TB bacteriologic test status at TB treatment initiation: positive, negative, or no test result. The hazard for death in the 12 months following TB treatment initiation was estimated using the Cox proportional hazard model, adjusted for patient- and site-level factors. Missing covariates were multiply imputed.nnResultsAmong 2,091 PLWH included, the median age at TB treatment initiation was 36 years, 44% were female, 53% had CD4 counts [&le;] 200 cells/mm3, and 52% were on antiretroviral treatment (ART). Compared to patients with positive bacteriologic tests, the adjusted hazard for death was higher among patients with no test results (HR 1.56, 95% CI 1.08-2.26) but not different than those with negative tests (HR 1.28, 95% CI 0.91-1.81). Older age was also associated with a higher hazard for death, while being on ART, having a higher CD4 count, West Africa region, and tertiary facility level were associated with lower hazards for death.nnConclusionPLWH treated for TB with no bacteriologic test results were more likely to die than those treated with positive tests, underscoring the importance of TB bacteriologic diagnosis in resource-constrained settings. Research is needed to understand the causes of death among PLWH treated for TB in the absence of positive bacteriologic tests.
]]></description>
<dc:creator>Humphrey, J. M.</dc:creator>
<dc:creator>Mpofu, P.</dc:creator>
<dc:creator>Pettit, A. C.</dc:creator>
<dc:creator>Musick, B.</dc:creator>
<dc:creator>Carter, E. J.</dc:creator>
<dc:creator>Messou, E.</dc:creator>
<dc:creator>Marcy, O.</dc:creator>
<dc:creator>Crabtree-Ramirez, B.</dc:creator>
<dc:creator>Yotebieng, M.</dc:creator>
<dc:creator>Anastos, K.</dc:creator>
<dc:creator>Sterling, T. R.</dc:creator>
<dc:creator>Yiannoutsos, C.</dc:creator>
<dc:creator>Diero, L.</dc:creator>
<dc:creator>Wools-Kaloustian, K.</dc:creator>
<dc:creator>See S8 Table,</dc:creator>
<dc:date>2019-03-08</dc:date>
<dc:identifier>doi:10.1101/571000</dc:identifier>
<dc:title><![CDATA[Mortality among adults living with HIV treated for tuberculosis based on positive, negative, or no bacteriologic test results for tuberculosis: the IeDEA consortium]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-03-08</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/572693v1?rss=1">
<title>
<![CDATA[
The shape of gene expression distributions matter: how incorporating distribution shape improves the interpretation of cancer transcriptomic data 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/572693v1?rss=1</link>
<description><![CDATA[
In genomics, we often impose the assumption that gene expression data follows a specific distribution. However, rarely do we stop to question this assumption or consider its applicability to all genes in the transcriptome. Our study investigated the prevalence of genes with expression distributions that are non-Normal in three different tumor types from the Cancer Genome Atlas (TCGA). Surprisingly, less than 50% of all genes were Normally-distributed, with other distributions including Gamma, Bimodal, Cauchy, and Lognormal were represented. Relevant information about cancer biology was captured by the genes with non-Normal gene expression. When used for classification, the set of non-Normal genes were able to discriminate between cancer patients with poor versus good survival status. Our results highlight the value of studying a genes distribution shape to model heterogeneity of transcriptomic data. These insights would have been overlooked when using standard approaches that assume all genes follow the same type of distribution in a patient cohort.
]]></description>
<dc:creator>de Torrente, L.</dc:creator>
<dc:creator>Zimmerman, S.</dc:creator>
<dc:creator>Suzuki, M.</dc:creator>
<dc:creator>Christopeit, M.</dc:creator>
<dc:creator>Greally, J. M.</dc:creator>
<dc:creator>Mar, J.</dc:creator>
<dc:date>2019-03-09</dc:date>
<dc:identifier>doi:10.1101/572693</dc:identifier>
<dc:title><![CDATA[The shape of gene expression distributions matter: how incorporating distribution shape improves the interpretation of cancer transcriptomic data]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-03-09</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/581777v1?rss=1">
<title>
<![CDATA[
Dissociable neural circuits underlie the resolution of three discrete sources of competition during task-switching. 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/581777v1?rss=1</link>
<description><![CDATA[
Humans perform sub-optimally when juggling more than one task, but are nonetheless required to multitask during many daily activities. Rapidly and effectively switching attentional focus between tasks is fundamental to navigating complex environments. Task-switching paradigms in conjunction with neuroimaging have identified brain networks underpinning flexible reallocation of cognitive resources and a core network of neural regions is repeatedly implicated (i.e., posterior parietal, inferior frontal, anterior cingulate, and middle frontal cortex). Performance costs such as reduced accuracy and slowed responses accompany the first execution of a task following a task-switch. These costs stem from three main sources of competition: 1) the need to reconfigure task-rules, 2) the immediate history of motor responding, and 3) whether inputs to be acted upon provide congruent or incongruent information regarding the appropriate motor response, relative to the recently "switched-away-from" task. Here, we asked whether both common (domain-general) and non-overlapping (dissociable) neural circuits were involved in resolving these three distinct sources of competition under high-demand task-switching conditions. Dissociable neural circuits were active in resolving each of the three sources of competition. No domain-general regions were implicated in all three. Rather, two regions were common across rule-switching and stimulus incongruence, and five regions to incongruence and response-switching. Each source of conflict elicited activation from many regions including the posterior cingulate, thalamus, and cerebellum, regions not commonly implicated in the task-switching literature. These results suggest that dissociable neural networks are principally responsible for resolving different sources of competition, but with partial interaction of some overlapping domain-general circuitry.
]]></description>
<dc:creator>Burke, K. M.</dc:creator>
<dc:creator>Molholm, S.</dc:creator>
<dc:creator>Butler, J. S.</dc:creator>
<dc:creator>Ross, L. A.</dc:creator>
<dc:creator>Foxe, J. J.</dc:creator>
<dc:date>2019-03-18</dc:date>
<dc:identifier>doi:10.1101/581777</dc:identifier>
<dc:title><![CDATA[Dissociable neural circuits underlie the resolution of three discrete sources of competition during task-switching.]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-03-18</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/582346v1?rss=1">
<title>
<![CDATA[
Dietary intake regulates the circulating inflammatory monocyte pool 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/582346v1?rss=1</link>
<description><![CDATA[
Caloric restriction is known to improve inflammatory and autoimmune diseases. However, the mechanisms by which reduced caloric intake modulates inflammation are poorly understood. Here we show that short-term fasting reduced monocyte metabolic and inflammatory activity and drastically reduced the number of circulating monocytes. Regulation of peripheral monocyte numbers was dependent on dietary glucose and protein levels. Specifically, we found that activation of the low-energy sensor 5-AMP-activated protein kinase (AMPK) in hepatocytes and suppression of systemic CCL2 production by peroxisome proliferator-activator receptor alpha (PPAR) reduced monocyte mobilization from the bone marrow. Importantly, while caloric restriction improves chronic inflammatory diseases, fasting did not compromise monocyte emergency mobilization during acute infectious inflammation and tissue repair. These results reveal that caloric intake and liver energy sensors dictate the blood and tissue immune tone and link dietary habits to inflammatory disease outcome.nnHighlightsO_LIFasting reduces the numbers of peripheral pro-inflammatory monocytes in healthy humans and mice.nC_LIO_LIA hepatic AMPK-PPAR energy-sensing axis controls homeostatic monocyte numbers via regulation of steady-state CCL2 production.nC_LIO_LIFasting reduces monocyte metabolic and inflammatory activity.nC_LIO_LIFasting improves chronic inflammatory diseases but does not compromise monocyte emergency mobilization during acute infectious inflammation and tissue repair.nC_LI
]]></description>
<dc:creator>Jordan, S.</dc:creator>
<dc:creator>Tung, N.</dc:creator>
<dc:creator>Casanova-Acebes, M.</dc:creator>
<dc:creator>Chang, C.</dc:creator>
<dc:creator>Cantoni, C.</dc:creator>
<dc:creator>Zhang, D.</dc:creator>
<dc:creator>Wirtz, T. H.</dc:creator>
<dc:creator>Naik, S.</dc:creator>
<dc:creator>Rose, S. A.</dc:creator>
<dc:creator>Brocker, C. N.</dc:creator>
<dc:creator>Gainullina, A.</dc:creator>
<dc:creator>Maier, B. B.</dc:creator>
<dc:creator>LeRoith, D.</dc:creator>
<dc:creator>Gonzalez, F. J.</dc:creator>
<dc:creator>Meissner, F.</dc:creator>
<dc:creator>Ochando, J.</dc:creator>
<dc:creator>Rahman, A.</dc:creator>
<dc:creator>Chipuk, J. E.</dc:creator>
<dc:creator>Artyomov, M. N.</dc:creator>
<dc:creator>Frenette, P. S.</dc:creator>
<dc:creator>Piccio, L.</dc:creator>
<dc:creator>Berres, M.-L.</dc:creator>
<dc:creator>Gallagher, E. J.</dc:creator>
<dc:creator>Merad, M.</dc:creator>
<dc:date>2019-03-21</dc:date>
<dc:identifier>doi:10.1101/582346</dc:identifier>
<dc:title><![CDATA[Dietary intake regulates the circulating inflammatory monocyte pool]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-03-21</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/584201v1?rss=1">
<title>
<![CDATA[
Inferring the quasipotential landscape of microbial ecosystems with topological data analysis 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/584201v1?rss=1</link>
<description><![CDATA[
Microbiome dynamics influence the health and functioning of human physiology and the environment and are driven in part by interactions between large numbers of microbial taxa, making large-scale prediction and modeling a challenge. Here, using topological data analysis, we identify states and dynamical features relevant to macroscopic processes.We show that gut disease processes and marine geochemical events are associated with transitions between community states, defined as topological features of the data density. We find a reproducible two-state succession during recovery from cholera in the gut microbiomes of multiple patients, evidence of dynamic stability in the gut microbiome of a healthy human after experiencing diarrhea during travel, and periodic state transitions in a marine Prochlorococcus community driven by water column cycling. Our approach bridges small-scale fluctuations in microbiome composition and large-scale changes in phenotype without details of underlying mechanisms, and provides a novel assessment of microbiome stability and its relation to human and environmental health.
]]></description>
<dc:creator>Chang, W. K.</dc:creator>
<dc:creator>Kelly, L.</dc:creator>
<dc:date>2019-03-21</dc:date>
<dc:identifier>doi:10.1101/584201</dc:identifier>
<dc:title><![CDATA[Inferring the quasipotential landscape of microbial ecosystems with topological data analysis]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-03-21</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/584516v1?rss=1">
<title>
<![CDATA[
Leveraging non-human primate multisensory neurons and circuits in assessing consciousness theory 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/584516v1?rss=1</link>
<description><![CDATA[
Both the Global Neuronal Workspace (GNW) and Integrated Information Theory (IIT) posit that highly complex and interconnected networks engender perceptual awareness. GNW specifies that activity recruiting fronto-parietal networks will elicit a subjective experience, while IIT is more concerned with the functional architecture of networks than with activity within it. Here, we argue that according to IIT mathematics, circuits converging on integrative vs. convergent yet non-integrative neurons should support a greater degree of consciousness. We test this hypothesis by analyzing a dataset of neuronal responses collected simultaneously from primary somatosensory cortex (S1) and ventral premotor cortex (vPM) in non-human primates presented with auditory, tactile, and audio-tactile stimuli as they are progressively anesthetized with Propofol. We first describe the multisensory (audio-tactile) characteristics of S1 and vPM neurons (mean and dispersion tendencies, as well as noise-correlations), and functionally label these neurons as convergent or integrative according to their spiking responses. Then, we characterize how these different pools of neurons behave as a function of consciousness. At odds with the IIT mathematics, results suggest that convergent neurons more readily exhibit properties of consciousness (neural complexity and noise correlation) and are more impacted during the loss of consciousness than integrative neurons. Lastly, we provide support for the GNW by showing that neural ignition (i.e., same trial co-activation of S1 and vPM) was more frequent in conscious than unconscious states. Overall, we contrast GNW and IIT within the same single-unit activity dataset, and support the GNW.
]]></description>
<dc:creator>Noel, J.-P.</dc:creator>
<dc:creator>Ishizawa, Y.</dc:creator>
<dc:creator>Patel, S.</dc:creator>
<dc:creator>Eskandar, E.</dc:creator>
<dc:creator>Wallace, M.</dc:creator>
<dc:date>2019-03-21</dc:date>
<dc:identifier>doi:10.1101/584516</dc:identifier>
<dc:title><![CDATA[Leveraging non-human primate multisensory neurons and circuits in assessing consciousness theory]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-03-21</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/593285v1?rss=1">
<title>
<![CDATA[
Transcriptional maintenance of cortical somatostatin interneuron subtype identity during migration 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/593285v1?rss=1</link>
<description><![CDATA[
Recent work suggests that cortical interneuron diversity arises from genetic mechanisms guided by the interplay of intrinsic developmental patterning and local extrinsic cues. Individual genetic programs underlying subtype identity are at least partly established in postmitotic neural precursors, prior to their tangential migration and integration in the cortical circuitry. Nevertheless, it is unclear how distinct interneuron identities are maintained during their migration and maturation. Sox6 is a transcription factor with an established role in MGE-derived interneuron maturation and positional identity. To determine its role in maintaining somatostatin (Sst)-expressing interneurons subtype identity, we conditionally removed Sox6 in migrating Sst interneurons and assessed the effects on their mature identity using single-cell RNA-sequencing (scRNAseq), in situ hybridization and electrophysiology. Sox6 removal prior to migration in Sst-expressing neurons reduced subtype diversity without affecting overall number of neurons. Seven out of nine Sst-expressing molecular subtypes were absent in the mature primary somatosensory cortex of Sox6-cKO mice, including the Chodl-Nos1-expressing type which has been shown to be specified at, or shortly after, cell cycle exit. The remaining Sst-expressing subtypes in the Sox6-cKO cortex comprised three molecular subtypes, Crh-C1ql3 and Hpse-Cbln4, and a third subtype that seemed to be a molecular hybrid of these subtypes. Moreover, Sox6-cKO cells still expressed genes enriched within the entire class of Sst-expressing neurons, such as Sst, Lhx6, Satb1, Elfn1 and Mafb. Removal of Sox6 at P7, after cells have reached their final destination and begin integration into the network, did not disrupt Chodl-Nos1 marker expression. Our findings suggest that expression of Sox6 during the migratory phase of cortical interneurons is necessary for maintenance of Sst+ subtype identity, indicating that subtype maintenance during migration requires active transcriptional programs.
]]></description>
<dc:creator>Munguba, H.</dc:creator>
<dc:creator>Nikouei, K.</dc:creator>
<dc:creator>Hochgerner, H.</dc:creator>
<dc:creator>Oberst, P.</dc:creator>
<dc:creator>Kouznetsova, A.</dc:creator>
<dc:creator>Ryge, J.</dc:creator>
<dc:creator>Bastista-Brito, R.</dc:creator>
<dc:creator>Munoz-Manchado, A. B.</dc:creator>
<dc:creator>Close, J.</dc:creator>
<dc:creator>Linnarsson, S.</dc:creator>
<dc:creator>Hjerling Leffler, J.</dc:creator>
<dc:date>2019-03-31</dc:date>
<dc:identifier>doi:10.1101/593285</dc:identifier>
<dc:title><![CDATA[Transcriptional maintenance of cortical somatostatin interneuron subtype identity during migration]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-03-31</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/598995v1?rss=1">
<title>
<![CDATA[
Evolutionary contingency’s impact on laboratory evolution of Escherichia coli under fluctuating environments 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/598995v1?rss=1</link>
<description><![CDATA[
1The adaptation of biological organisms to fluctuating environments is one major determinant of their structural and dynamical complexity. Organisms have evolved devoted adaptations to ensure the robust performance of physiological functions under environmental fluctuations. To further our understanding of particular adaptation strategies to different environmental fluctuations, we perform laboratory evolution experiments of Escherichia coli under three temperature fluctuation regimes alternating between 15{degrees}C and 43{degrees}C. Two of these regimes are determined by the populations growth, while the third regime switches stochastically. To address evolutionary contingencies, the experiments are performed on two lineages departing from different genetic backgrounds. The two lineages display distinct evolutionary trajectories, demonstrating dependency on the starting strains genetic background. Several genes exhibit a high degree of parallelism, suggesting their potential adaptive nature. The growth increase of the representative clones from each final population relative to their ancestor at 15{degrees}C and 43{degrees}C demonstrated no correlation between both temperatures, insinuating an absence of a strong trade-off between these two temperatures. Some had a growth rate decrease at 15{degrees}C unless exposed to a 43{degrees}C epoch, indicating some degree of internalization of the structure of the environment fluctuations. The phenotypic response of the evolved clones at 15{degrees}C and 43{degrees}C was assessed by a phenotype array method. The resulting responses reveal a general tendency to move closer to the phenotypic response of our starting strains at the optimum of 37{degrees}C. This observation expands the documented restorative responses, even when facing complex environmental conditions.nn2 Author SummaryLaboratory evolution experiments have been widely employed to test hypotheses from evolutionary theory. To assess the dynamics of adaptation under environmental fluctuations, we evolved 24 Escherichia coli populations under different regimes of temperature switching between 15{degrees}C and 43{degrees}C for about 600 generations. At the final point of the evolution experiment, the evolved populations were genome sequenced and clones were isolated and sequenced for phenotypic characterization. Fitness measurements revealed adaptation to both environmental conditions and some strains internalized the environmental fluctuation. Array phenotypic measurements showed that the majority of evolved strains tended to restore the phenotypic signature of the perturbed environments to that of the optimal temperature condition. This observation expands the documented restorative responses, even when facing complex environmental conditions.
]]></description>
<dc:creator>Pechuan, X.</dc:creator>
<dc:creator>Biro, D.</dc:creator>
<dc:creator>Lambros, M.</dc:creator>
<dc:creator>Bergman, A.</dc:creator>
<dc:date>2019-04-05</dc:date>
<dc:identifier>doi:10.1101/598995</dc:identifier>
<dc:title><![CDATA[Evolutionary contingency’s impact on laboratory evolution of Escherichia coli under fluctuating environments]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-04-05</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/600106v1?rss=1">
<title>
<![CDATA[
A new immunotherapeutic concept for pancreatic cancer using childhood vaccine recall antigens and Listeria 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/600106v1?rss=1</link>
<description><![CDATA[
Pancreatic ductal adenocarcinoma is highly metastatic, poorly immunogenic, and immune suppression prevents T cell activation in the tumor microenvironment. We developed a microbial-based immunotherapeutic concept for selective delivery of a highly immunogenic tetanus toxoid protein (TT856-1313), into tumor cells by attenuated Listeria monocytogenes, and reactivation of pre-existing TT-specific memory T cells (generated during childhood) to kill infected tumor cells. Thus, TT here functions as an alternative for neoantigens. Treatment of KPC mice with Listeria-TT resulted in TT accumulation in tumors and inside tumor cells, and attraction of predominantly TT-specific memory CD4 T cells. Moreover, gemcitabine (GEM) combined with Listeria-TT significantly improved the migration of CD4 T cells into tumors and the production of perforin and granzyme B, turning cold tumors into immunological hot tumors. In vivo depletion of T cells in Listeria-TT+GEM-treated mice demonstrated CD4 T cell-mediated eradication of tumors and metastases (Mann-Whitney p<0.05). In addition, peritumoral lymph node like structures (LNS) were observed in close contact with the pancreatic tumors displaying CD4 T cells and CD8 T cells of KPC mice treated with Listeria-TT or Listeria-TT+GEM. The production of perforin and granzyme B was observed in LNS of KPC mice that received Listeria-TT+GEM. This combination not only reduced tumor burden (80%) and metastases (87%) significantly (p<0.05, Mann-Whitney), but also improved the survival time of KPC mice with advanced pancreatic cancer substantially (Mantel-Cox p<0.0001). Our results unveil new mechanisms of Listeria and GEM improving immunotherapy for PDAC.
]]></description>
<dc:creator>Selvanesan, B. C.</dc:creator>
<dc:creator>Chandra, D.</dc:creator>
<dc:creator>Quispe-Tintaya, W.</dc:creator>
<dc:creator>Jahangir, A.</dc:creator>
<dc:creator>Patel, A.</dc:creator>
<dc:creator>Meena, K.</dc:creator>
<dc:creator>Alberto Alves Da Silva, R.</dc:creator>
<dc:creator>Libutti, S. K.</dc:creator>
<dc:creator>Yuan, Z.</dc:creator>
<dc:creator>Beck, A.</dc:creator>
<dc:creator>Tesfa, L.</dc:creator>
<dc:creator>Koba, W.</dc:creator>
<dc:creator>Chuy, J.</dc:creator>
<dc:creator>McAuliffe, J. C.</dc:creator>
<dc:creator>Jafari, R.</dc:creator>
<dc:creator>Entenberg, D.</dc:creator>
<dc:creator>Wang, Y.</dc:creator>
<dc:creator>Condeelis, J.</dc:creator>
<dc:creator>Gravekamp, C.</dc:creator>
<dc:date>2019-04-05</dc:date>
<dc:identifier>doi:10.1101/600106</dc:identifier>
<dc:title><![CDATA[A new immunotherapeutic concept for pancreatic cancer using childhood vaccine recall antigens and Listeria]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-04-05</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/610097v1?rss=1">
<title>
<![CDATA[
Oleocanthal and oleocanthal-rich olive oils induce lysosomal membrane permeabilization in cancer cells 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/610097v1?rss=1</link>
<description><![CDATA[
Oleocanthal is a phenolic compound found in varying concentrations in extra virgin olive oil Oleocanthal has been shown to be active physiologically, benefiting several diseased states by conferring anti-inflammatory and neuroprotective benefits. Recently, we and other groups have demonstrated its specific and selective toxicity toward cancer cells; however, the mechanism leading to cancer cell death is still disputed. The current study demonstrates that oleocanthal, as well as naturally oleocanthal-rich extra virgin olive oils, induced damage to cancer cells lysosomes leading to cellular toxicity in vitro and in vivo. Lysosomal membrane permeabilization following oleocanthal treatment in various cell lines was assayed via three complementary methods. Additionally, we found oleocanthal treatment reduced tumor burden and extended lifespan of mice engineered to develop pancreatic neuroendocrine tumors. Finally, following-up on numerous correlative studies demonstrating consumption of olive oil reduces cancer incidence and morbidity, we observed that extra virgin olive oils naturally rich in oleocanthal sharply reduced cancer cell viability and induced lysosomal membrane permeabilization while oleocanthal-poor oils did not. Our results are especially encouraging since tumor cells often have larger and more numerous lysosomes, making them especially vulnerable to lysosomotropic agents such as oleocanthal.
]]></description>
<dc:creator>Goren, L.</dc:creator>
<dc:creator>Zhang, G.</dc:creator>
<dc:creator>Kaushik, S.</dc:creator>
<dc:creator>Breslin, P. A.</dc:creator>
<dc:creator>Du, Y.-C. N.</dc:creator>
<dc:creator>Foster, D. A.</dc:creator>
<dc:date>2019-04-15</dc:date>
<dc:identifier>doi:10.1101/610097</dc:identifier>
<dc:title><![CDATA[Oleocanthal and oleocanthal-rich olive oils induce lysosomal membrane permeabilization in cancer cells]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-04-15</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/616748v1?rss=1">
<title>
<![CDATA[
PSC-RED, an Albumin-Free Robust Erythroid Differentiation Method to Produce Enucleated Red Blood Cells from Human Pluripotent Stem Cells 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/616748v1?rss=1</link>
<description><![CDATA[
Cultured red blood cells (cRBCs) have many potential applications in transfusion medicine and drug delivery. We report that we have developed chemically defined, albumin-free Robust Erythroid Differentiation (RED) methods to produce enucleated cRBCs from human induced pluripotent stem cells (iPSCs). Human iPSC-derived cRBCs produced with either the short or long variation of the RED protocol respectively express embryonic/fetal or a mixture of fetal and adult hemoglobins. The long version of the protocol produces up to 50% of enucleated cells at an unprecedented yield. RED is scalable and relies on inexpensive components and therefore dramatically increases the feasibility and economic viability of all translational applications of cRBCs.nnHighlightsO_LIPSC-RED: A chemically-defined, albumin-free Robust Erythroid Differentiation (RED) methods to produce cRBCs from human induced pluripotent stem cells.nC_LIO_LIPSC-RED produces up to 50% enucleated cells at an unprecedented yield.nC_LIO_LIPSC-RED is scalable and relies on inexpensive components and therefore increases the feasibility and economic viability of translational applications of cRBCs.nC_LI
]]></description>
<dc:creator>Olivier, E. E.</dc:creator>
<dc:creator>Zhang, S.</dc:creator>
<dc:creator>Yan, Z.</dc:creator>
<dc:creator>Suzuka, S.</dc:creator>
<dc:creator>Roberts, K. E.</dc:creator>
<dc:creator>Wang, K. E.</dc:creator>
<dc:creator>Bouhassira, E. E.</dc:creator>
<dc:date>2019-04-23</dc:date>
<dc:identifier>doi:10.1101/616748</dc:identifier>
<dc:title><![CDATA[PSC-RED, an Albumin-Free Robust Erythroid Differentiation Method to Produce Enucleated Red Blood Cells from Human Pluripotent Stem Cells]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-04-23</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/616755v1?rss=1">
<title>
<![CDATA[
MNC-RED a Chemically Defined Method to Produce Enucleated Red Blood Cells from Adult Peripheral Blood Mononuclear Cells 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/616755v1?rss=1</link>
<description><![CDATA[
Many methods have been developed to produce red blood cells in vitro but translational applications have been hampered by the high cost of production. We have developed R6, a chemically-defined, albumin-free, low-transferrin culture medium, and MNC-RED, a protocol to differentiate peripheral blood mononuclear cells into enucleated erythroid cells that does not require any albumin or any animal components. Erythropoiesis requires large amounts of iron for hemoglobin synthesis. In all existing protocols, these large iron needs are met by increasing the concentration of holo-transferrin. This is necessary because transferrin recycling does not take place in existing erythroid culture conditions. In the R6 medium, iron is provided to the differentiating erythroblasts by small amounts of recombinant transferrin supplemented with FeIII-EDTA, an iron chelator that allows transferrin recycling to take place in cell culture. As a result of the absence of albumin and the use of low amounts of transferrin, the production of cultured red blood cells using the MNC-RED protocol is much less expensive than with existing protocols. The MNC-RED protocol should therefore help make the many translational applications of cultured RBCs economically more feasible.nnHighlightsWe have developed R6, a chemically-defined, albumin-free low-transferrin culture medium, and MNC-RED, a protocol to differentiate peripheral blood mononuclear cells into enucleated erythroid EnnR6 is suitable for red blood cell culture despite the low transferrin amounts because of the presence of FeIII-EDTA, an iron chelator that allows transferrin recycling to take place in cell culture.nnThe MNC-RED protocol should help make the many translational applications of cultured RBCs more economically feasible.
]]></description>
<dc:creator>Zhang, S. E.</dc:creator>
<dc:creator>Olivier, E. E.</dc:creator>
<dc:creator>Yan, Z. E.</dc:creator>
<dc:creator>Suzuka, S. E.</dc:creator>
<dc:creator>Roberts, K. E.</dc:creator>
<dc:creator>Wang, K. E.</dc:creator>
<dc:creator>Bouhassira, E. E.</dc:creator>
<dc:date>2019-04-25</dc:date>
<dc:identifier>doi:10.1101/616755</dc:identifier>
<dc:title><![CDATA[MNC-RED a Chemically Defined Method to Produce Enucleated Red Blood Cells from Adult Peripheral Blood Mononuclear Cells]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-04-25</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/617985v1?rss=1">
<title>
<![CDATA[
The histone demethylase KDM5 controls developmental timing in Drosophila by promoting prothoracic gland endocycles. 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/617985v1?rss=1</link>
<description><![CDATA[
In Drosophila, the larval prothoracic gland integrates nutritional status with developmental signals to regulate growth and maturation through the secretion of the steroid hormone ecdysone. While the nutritional signals and cellular pathways that regulate prothoracic gland function are relatively well studied, the transcriptional regulators that orchestrate the activity of this tissue remain largely unknown. Here we show that lysine demethylase 5 (KDM5) is essential for prothoracic gland function. Indeed, restoring kdm5 expression only in the prothoracic gland in an otherwise kdm5 mutant animal is sufficient to rescue both the larval developmental delay and the pupal lethality caused by loss of KDM5. Molecularly, our studies show that KDM5 functions by promoting the endoreplication of prothoracic gland cells, a process that increases ploidy and is rate-limiting for the expression of ecdysone biosynthetic genes. This occurs through KDM5-mediated regulation of the receptor tyrosine kinase torso, which in in turn promotes polyploidization and growth through activation of the MAPK signaling pathway. Taken together, our studies provide key insights into the biological processes regulated by KDM5 and the molecular mechanisms that govern the transcriptional regulation of animal development.
]]></description>
<dc:creator>Drelon, C.</dc:creator>
<dc:creator>Belalcazar, H. M.</dc:creator>
<dc:creator>Secombe, J.</dc:creator>
<dc:date>2019-04-24</dc:date>
<dc:identifier>doi:10.1101/617985</dc:identifier>
<dc:title><![CDATA[The histone demethylase KDM5 controls developmental timing in Drosophila by promoting prothoracic gland endocycles.]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-04-24</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/618587v1?rss=1">
<title>
<![CDATA[
The structural basis for RNA selectivity by the IMP family of RNA binding proteins 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/618587v1?rss=1</link>
<description><![CDATA[
The Igf2 mRNA binding proteins (ZBP1/IMP1, IMP2, IMP3) are highly conserved post-transcriptional regulators of RNA stability, localization and translation. They play important roles in cell migration, neural development, metabolism and cancer cell survival. The knockout phenotypes of individual IMP proteins suggest that each family member regulates a unique pool of RNAs, yet evidence and an underlying mechanism for this is lacking. Here, we combine SELEX and NMR spectroscopy to demonstrate that the major RNA binding domains of the two most distantly related IMPs (ZBP1 and IMP2) bind to different consensus sequences and regulate targets consistent with their knockout phenotypes and roles in disease. We find that the targeting specificity of each IMP is determined by few amino acids in their variable loops. As variable loops often differ amongst KH domain paralogs, we hypothesize that this is a general mechanism for evolving specificity and regulation of the transcriptome.
]]></description>
<dc:creator>Biswas, J.</dc:creator>
<dc:creator>Patel, V. L.</dc:creator>
<dc:creator>Bhaskar, V.</dc:creator>
<dc:creator>Chao, J. A.</dc:creator>
<dc:creator>Singer, R. H.</dc:creator>
<dc:creator>Eliscovich, C.</dc:creator>
<dc:date>2019-04-25</dc:date>
<dc:identifier>doi:10.1101/618587</dc:identifier>
<dc:title><![CDATA[The structural basis for RNA selectivity by the IMP family of RNA binding proteins]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-04-25</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/626846v1?rss=1">
<title>
<![CDATA[
Screening human embryos for polygenic traits has limited utility 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/626846v1?rss=1</link>
<description><![CDATA[
Genome-wide association studies have led to the development of polygenic score (PS) predictors that explain increasing proportions of the variance in human complex traits. In parallel, progress in preimplantation genetic testing now allows genome-wide genotyping of embryos generated via in vitro fertilization (IVF). Jointly, these developments suggest the possibility of screening embryos for polygenic traits such as height or cognitive function. There are clear ethical, legal, and societal concerns regarding such a procedure, but these cannot be properly discussed in the absence of data on the expected outcomes of screening. Here, we use theory, simulations, and real data to evaluate the potential gain of PS-based embryo selection, defined as the expected difference in trait value between the top-scoring embryo and an average, unselected embryo. We observe that the gain increases very slowly with the number of embryos, but more rapidly with increased variance explained by the PS. Given currently available polygenic predictors and typical IVF yields, the average gain due to selection would be {approx}2.5cm if selecting for height, and {approx}2.5 IQ (intelligence quotient) points if selecting for cognitive function. These mean values are accompanied by wide confidence intervals; in real data drawn from nuclear families with up to 20 offspring each, we observe that the offspring with the highest PS for height was the tallest only in 25% of the families. We discuss prospects and limitations of PS-based embryo selection for the foreseeable future.
]]></description>
<dc:creator>Karavani, E.</dc:creator>
<dc:creator>Zuk, O.</dc:creator>
<dc:creator>Zeevi, D.</dc:creator>
<dc:creator>Atzmon, G.</dc:creator>
<dc:creator>Barzilai, N.</dc:creator>
<dc:creator>Stefanis, N. C.</dc:creator>
<dc:creator>Hatzimanolis, A.</dc:creator>
<dc:creator>Smyrnis, N.</dc:creator>
<dc:creator>Avramopoulos, D.</dc:creator>
<dc:creator>Kruglyak, L.</dc:creator>
<dc:creator>Lam, M.</dc:creator>
<dc:creator>Lencz, T.</dc:creator>
<dc:creator>Carmi, S.</dc:creator>
<dc:date>2019-05-05</dc:date>
<dc:identifier>doi:10.1101/626846</dc:identifier>
<dc:title><![CDATA[Screening human embryos for polygenic traits has limited utility]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-05-05</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/634857v1?rss=1">
<title>
<![CDATA[
Insertional oncogenesis by HPV70 revealed by multiple genomic analyses in a clinically HPV-negative cervical cancer 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/634857v1?rss=1</link>
<description><![CDATA[
Cervical carcinogenesis, the second leading cause of cancer death in women worldwide, is caused by multiple types of human papillomaviruses (HPVs). To investigate a possible role for HPV in a cervical carcinoma that was HPV-negative by PCR testing, we performed HPV DNA hybridization capture plus massively parallel sequencing. This detected a subgenomic, URR- E6-E7-E1 segment of HPV70 DNA, a type not generally associated with cervical cancer, inserted in an intron of the B-cell lymphoma/leukemia 11B (BCL11B) gene in the human genome. Long range DNA sequencing confirmed the virus and flanking BCL11B DNA structures including both insertion junctions. Global transcriptomic analysis detected multiple, alternatively spliced, HPV70-BCL11B, fusion transcripts with fused open reading frames. The insertion and fusion transcripts were present in an intraepithelial precursor phase of tumorigenesis. These results suggest oncogenicity of HPV70, identify novel BCL11B variants with potential oncogenic implications, and underscore the advantages of thorough genomic analyses to elucidate insights into HPV-associated tumorigenesis.nnStatement of SignificanceMultiple HPV types have been defined as high risk for cancer causation. However, genomic analyses applied here detected a non-high risk HPV in a carcinoma that was HPV negative, and elucidated virally-associated tumorigenic genetic events. This stresses the importance of thorough genomic analyses for elucidating genetic processes in HPV-associated tumorigenesis.nnAuthor SummaryCervical cancer is the second leading cause of cancer death in women worldwide. Most cervical cancers are caused by one of 15 high risk types of human papilloma viruses (HPVs), although hundreds of types of HPVs exist. We used a series of contemporary genomics analyses to examine a cervical cancer that was clinically determined to be HPV-negative. These detected DNA of HPV70, an HPV type not considered to be high risk, in the tumor. Approximately half of the HPV70 DNA genome was present including the viral E6 and E7 oncogenes. Moreover, the viral DNA was inserted into the BCL11B gene in the human genome. BCL11B is known to be mutated in certain human cancers. The HPV70 DNA interacted with the human BCL11B gene to produce altered forms of RNA encoding unusual, truncated forms of the BCL11B protein. These results strongly implicate HPV70 as being oncogenic, suggest that this tumor was caused by a combination of viral oncogenes plus the virally-activated human BCL11B gene, demonstrate novel truncated BCL11B variants with oncogenic implications, and underscore the advantages of thorough genomic analyses to elucidate HPV tumorigenesis insights
]]></description>
<dc:creator>Van Arsdale, A.</dc:creator>
<dc:creator>Patterson, N. E.</dc:creator>
<dc:creator>Maggi, E. C.</dc:creator>
<dc:creator>Agoni, L.</dc:creator>
<dc:creator>Van Doorslaer, K.</dc:creator>
<dc:creator>Harmon, B.</dc:creator>
<dc:creator>Nevadunsky, N.</dc:creator>
<dc:creator>Kuo, D. Y. S.</dc:creator>
<dc:creator>Einstein, M. H.</dc:creator>
<dc:creator>Lenz, J.</dc:creator>
<dc:creator>Montagna, C.</dc:creator>
<dc:date>2019-05-10</dc:date>
<dc:identifier>doi:10.1101/634857</dc:identifier>
<dc:title><![CDATA[Insertional oncogenesis by HPV70 revealed by multiple genomic analyses in a clinically HPV-negative cervical cancer]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-05-10</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/639526v1?rss=1">
<title>
<![CDATA[
Disruption of the CSF-1-CSF-1R axis alters cerebellar microglia and is associated with motor and social interaction defects 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/639526v1?rss=1</link>
<description><![CDATA[
Microglia, the brain resident macrophages, critically shape forebrain neuronal circuits. However, their precise function in the cerebellum is unknown. Here we show that human and mouse cerebellar microglia express a unique molecular program distinct from forebrain microglia. Cerebellar microglial identity was driven by the CSF-1R ligand CSF-1, independently of the alternate CSF-1R ligand, IL-34. Accordingly, CSF-1 depletion from Nestin+ cells led to severe depletion and transcriptional alterations of cerebellar microglia, while microglia in the forebrain remained intact. Strikingly, CSF-1 deficiency and alteration of cerebellar microglia were associated with reduced Purkinje cells, altered neuronal function, and defects in motor learning and social novelty interactions. These findings reveal a novel CSF-1-CSF-1R signaling-mediated mechanism that contributes to motor function and social behavior.nnSummaryMicroglia are a heterogeneous population whose identity and function are dictated by signals from their microenvironment. Kana et al. show that CSF-1 signaling is critical for maintaining cerebellar microglial transcriptional identity and homeostasis, and that altering the CSF-1 - CSF-1R axis leads to motor and behavioral defects.
]]></description>
<dc:creator>Kana, V.</dc:creator>
<dc:creator>Desland, F. A.</dc:creator>
<dc:creator>Casanova-Acebes, M.</dc:creator>
<dc:creator>Ayata, P.</dc:creator>
<dc:creator>Badimon, A.</dc:creator>
<dc:creator>Nabel, E.</dc:creator>
<dc:creator>Yamamuro, K.</dc:creator>
<dc:creator>Sneeboer, M.</dc:creator>
<dc:creator>Tan, I.-L.</dc:creator>
<dc:creator>Flanigan, M.</dc:creator>
<dc:creator>Rose, S. A.</dc:creator>
<dc:creator>Chang, C.</dc:creator>
<dc:creator>Leader, A.</dc:creator>
<dc:creator>LeBourhis, H.</dc:creator>
<dc:creator>Sweet, E.</dc:creator>
<dc:creator>Tung, N.</dc:creator>
<dc:creator>Wroblewska, A.</dc:creator>
<dc:creator>Lavin, Y.</dc:creator>
<dc:creator>See, P.</dc:creator>
<dc:creator>Baccarini, A.</dc:creator>
<dc:creator>Ginhoux, F.</dc:creator>
<dc:creator>Chitu, V.</dc:creator>
<dc:creator>Stanley, E. R.</dc:creator>
<dc:creator>Russo, S.</dc:creator>
<dc:creator>Yue, Z.</dc:creator>
<dc:creator>Brown, B.</dc:creator>
<dc:creator>Joyner, A. L.</dc:creator>
<dc:creator>De Witte, L.</dc:creator>
<dc:creator>Morishita, H.</dc:creator>
<dc:creator>Schaefer, A.</dc:creator>
<dc:creator>Merad, M.</dc:creator>
<dc:date>2019-05-17</dc:date>
<dc:identifier>doi:10.1101/639526</dc:identifier>
<dc:title><![CDATA[Disruption of the CSF-1-CSF-1R axis alters cerebellar microglia and is associated with motor and social interaction defects]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-05-17</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/643098v1?rss=1">
<title>
<![CDATA[
Relationship between footshock intensity, post-training corticosterone release and contextual fear memory specificity over time 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/643098v1?rss=1</link>
<description><![CDATA[
Overgeneralized fear has long been implicated in generalized anxiety and post-traumatic stress disorder, however, time-dependent mechanisms underlying memory retrieval are still not completely understood. Previous studies have revealed that stronger fear conditioning training protocols are associated with both increased post-training corticosterone (CORT) levels and fear responses at later retrieval tests. Here we used discriminative contextual fear conditioning (CFC) to investigate the relationship between post-training CORT levels and memory specificity in different retrieval timepoints. Wistar rats were exposed to CFC training with increasing footshock intensities (0.3, 0.6 or 1.0mA) and had their blood collected 30 min afterwards to measure post-training plasma CORT. After 2, 14 or 28 days, rats were tested for memory specificity either in the training or in the novel context. Regression analysis was used to verify linear and non-linear interactions between CORT levels and freezing. Higher footshock intensities increased post-training CORT levels and freezing times during tests in all timepoints. Moreover, stronger trainings elicited faster memory generalization, which was associated with higher CORT levels during memory consolidation. The 0.3mA training maintained memory specificity up to 28 days. Additionally, linear regressions suggest that the shift from specific to generalized memories is underway at 14 days after training. These results are consistent with the hypotheses that stronger training protocols elicit a faster generalization rate, and that this process is associated with increased post-training CORT release.nnHIGHLIGHTSStronger contextual fear conditioning (CFC) elicits higher plasma corticosterone (CORT).nnStrong CFC and high CORT levels increase the rate of memory generalization.nnWeak CFC and low CORT levels retain memory specificity up to 28 days.nnPost-training plasma CORT is linearly associated with remote generalized fear.
]]></description>
<dc:creator>dos Santos Correa, M.</dc:creator>
<dc:creator>dos Santos Vaz, B.</dc:creator>
<dc:creator>Grisanti, G. D. V.</dc:creator>
<dc:creator>de Paiva, J. P. Q.</dc:creator>
<dc:creator>Tiba, P. A.</dc:creator>
<dc:creator>Fornari, R. V.</dc:creator>
<dc:date>2019-05-24</dc:date>
<dc:identifier>doi:10.1101/643098</dc:identifier>
<dc:title><![CDATA[Relationship between footshock intensity, post-training corticosterone release and contextual fear memory specificity over time]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-05-24</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/651141v1?rss=1">
<title>
<![CDATA[
Single-cell analysis of Non-CpG methylation dynamics and gene expression in human oocyte maturation 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/651141v1?rss=1</link>
<description><![CDATA[
Oocyte maturation is a coordinated process that is tightly linked to reproductive potential. A better understanding of gene regulation during human oocyte maturation will not only answer an important question in biology, but also facilitate the development of in vitro maturation technology as a fertility treatment. We generated single-cell transcriptome and use previously published single-cell methylome data from human oocytes at different maturation stages to investigate how genes are regulated during oocyte maturation, focusing on the potential regulatory role of non-CG methylation. DNMT3B, a gene encoding a key non-CG methylation enzyme, is one of the 1000 genes upregulated in mature oocytes, which may be at least partially responsible for the increased non-CG methylation as oocytes mature. Non-CG differentially methylated regions (DMRs) between mature and immature oocytes have multiple binding motifs for transcription factors, some of which bind with DNMT3B and may be important regulators of oocyte maturation through non-CG methylation. Over 98% of non-CG DMRs locate in transposable elements, and these DMRs are correlated with expression changes of the nearby genes. Taken together, this data indicates that global non-CG hypermethylation during oocyte maturation may play an active role in gene expression regulation, potentially through the interaction with transcription factors.
]]></description>
<dc:creator>Yu, B.</dc:creator>
<dc:creator>Doni Jayavelu, N.</dc:creator>
<dc:creator>Battle, S.</dc:creator>
<dc:creator>Smith, T.</dc:creator>
<dc:creator>Zimmerman, S. E.</dc:creator>
<dc:creator>Mar, J. C.</dc:creator>
<dc:creator>Schimmel, T.</dc:creator>
<dc:creator>Cohen, J.</dc:creator>
<dc:creator>Hawkins, R. D.</dc:creator>
<dc:date>2019-05-27</dc:date>
<dc:identifier>doi:10.1101/651141</dc:identifier>
<dc:title><![CDATA[Single-cell analysis of Non-CpG methylation dynamics and gene expression in human oocyte maturation]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-05-27</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/652966v1?rss=1">
<title>
<![CDATA[
Whole-Genome Association Analyses of Sleep-disordered Breathing Phenotypes in the NHLBI TOPMed Program 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/652966v1?rss=1</link>
<description><![CDATA[
Sleep-disordered breathing (SDB) is a common disorder associated with significant morbidity. Through the NHLBI Trans-Omics for Precision Medicine (TOPMed) program we report the first whole-genome sequence analysis of SDB. We identified 4 rare gene-based associations with SDB traits in 7,988 individuals of diverse ancestry and 4 replicated common variant associations with inclusion of additional samples (n=13,257). We identified a multi-ethnic set-based rare-variant association (p = 3.48 x 10-8) on chromosome X with ARMCX3. Transcription factor binding site enrichment identified associations with genes implicated with respiratory and craniofacial traits. Results highlighted associations in genes that modulate lung development, inflammation, respiratory rhythmogenesis and HIF1A-mediated hypoxic response.
]]></description>
<dc:creator>Cade, B. E.</dc:creator>
<dc:creator>Lee, J.</dc:creator>
<dc:creator>Sofer, T.</dc:creator>
<dc:creator>Wang, H.</dc:creator>
<dc:creator>Zhang, M.</dc:creator>
<dc:creator>Chen, H.</dc:creator>
<dc:creator>Gharib, S. A.</dc:creator>
<dc:creator>Gottlieb, D. J.</dc:creator>
<dc:creator>Guo, X.</dc:creator>
<dc:creator>Lane, J. M.</dc:creator>
<dc:creator>Liang, J.</dc:creator>
<dc:creator>Lin, X.</dc:creator>
<dc:creator>Mei, H.</dc:creator>
<dc:creator>Patel, S. R.</dc:creator>
<dc:creator>Purcell, S. M.</dc:creator>
<dc:creator>Saxena, R.</dc:creator>
<dc:creator>Shah, N. A.</dc:creator>
<dc:creator>Evans, D. S.</dc:creator>
<dc:creator>Hanis, C. L.</dc:creator>
<dc:creator>Hillman, D. R.</dc:creator>
<dc:creator>Mukherjee, S.</dc:creator>
<dc:creator>Palmer, L. J.</dc:creator>
<dc:creator>Stone, K. L.</dc:creator>
<dc:creator>Tranah, G. J.</dc:creator>
<dc:creator>NHLBI Trans-Omics for Precision Medicine (TOPMed),</dc:creator>
<dc:creator>Abecasis, G.</dc:creator>
<dc:creator>Boerwinkle, E.</dc:creator>
<dc:creator>Correa, A.</dc:creator>
<dc:creator>Cupples, L. A.</dc:creator>
<dc:creator>Kaplan, R. C.</dc:creator>
<dc:creator>Nickerson, D. A.</dc:creator>
<dc:creator>North, K. E.</dc:creator>
<dc:creator>Psaty, B. M.</dc:creator>
<dc:creator>Rotter, J. I.</dc:creator>
<dc:creator>Rich, S. S.</dc:creator>
<dc:creator>Tracy, R. P.</dc:creator>
<dc:creator>Vasan, R. S.</dc:creator>
<dc:creator>Wilson, J. G.</dc:creator>
<dc:creator>Zhu, X.</dc:creator>
<dc:creator>Redline, S.</dc:creator>
<dc:creator>TOPMed Sleep Working Group,</dc:creator>
<dc:date>2019-06-03</dc:date>
<dc:identifier>doi:10.1101/652966</dc:identifier>
<dc:title><![CDATA[Whole-Genome Association Analyses of Sleep-disordered Breathing Phenotypes in the NHLBI TOPMed Program]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-06-03</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/653246v1?rss=1">
<title>
<![CDATA[
Auditory processing atypicalities for pure tones and complex speech sounds in Rett Syndrome: towards neuromarkers of disease progression. 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/653246v1?rss=1</link>
<description><![CDATA[
Due to severe motor impairments and the lack of expressive language abilities seen in most patients with Rett Syndrome (RTT), it has proven extremely difficult to obtain accurate measures of auditory processing capabilities in this population. Here, we examined early auditory cortical processing of pure tones and more complex phonemes females with confirmed mutation of the MECP2 gene. We recorded high-density auditory evoked potentials (AEP), which allow for objective evaluation of the timing and severity of processing deficits along the auditory processing hierarchy. We compared AEPs of 12 females with RTT to those of 21 typically developing (TD) peers aged 4-21 years, interrogating the first four major components of the AEP (P1: 60-90ms; N1: 100-130ms; P2: 135-165ms; N2: 245-275ms). Atypicalities were evident in RTT at the initial stage of processing. Whereas the initial P1 showed increased amplitude to phonemic inputs relative to tones in TD participants, this modulation by stimulus complexity was absent in RTT. Interestingly, the subsequent N1 did not differ between groups, whereas the following P2 was hugely diminished in RTT, regardless of stimulus complexity. The N2 was similarly smaller in RTT, and did not differ as a function of stimulus type. The P2 effect was remarkably robust in differentiating between groups with near perfect separation between the two groups despite the wide age range of our samples. Given this robustness, along with the observation that P2 amplitude was significantly associated with RTT symptom severity, the P2 has the potential to serve as a biomarker of treatment efficacy.nnSignificance statementOur study points to dramatic reduction of the P2 component of the auditory evoked potential (AEP) as a potentially reliable biomarker of Rett Syndrome severity, with prospective applicability as an objective readout (neuromarker) of change in functional brain activity following therapeutic interventions administered in the context of clinical trials. Compellingly, the reduction of P2 amplitude in patients with RTT mimics findings in animal models of RTT, providing a translational bridge between pre-clinical and human research.
]]></description>
<dc:creator>Sysoeva, O. V.</dc:creator>
<dc:creator>Molholm, S.</dc:creator>
<dc:creator>Djukic, A.</dc:creator>
<dc:creator>Frey, H.-P.</dc:creator>
<dc:creator>Foxe, J. J.</dc:creator>
<dc:date>2019-05-30</dc:date>
<dc:identifier>doi:10.1101/653246</dc:identifier>
<dc:title><![CDATA[Auditory processing atypicalities for pure tones and complex speech sounds in Rett Syndrome: towards neuromarkers of disease progression.]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-05-30</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/654012v1?rss=1">
<title>
<![CDATA[
Multi-ethnic genome-wide association study of decomposed cardioelectric phenotypes illustrates strategies to identify and characterize evidence of shared genetic effects for complex traits 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/654012v1?rss=1</link>
<description><![CDATA[
BackgroundPublished genome-wide association studies (GWAS) are mainly European-centric, examine a narrow view of phenotypic variation, and infrequently interrogate genetic effects shared across traits. We therefore examined the extent to which a multi-ethnic, combined trait GWAS of phenotypes that map to well-defined biology can enable detection and characterization of complex trait loci.nnMethodsWith 1000 Genomes Phase 3 imputed data in 34,668 participants (15% African American; 3% Chinese American; 51% European American; 30% Hispanic/Latino), we performed covariate-adjusted univariate GWAS of six contiguous electrocardiogram (ECG) traits that decomposed an average heartbeat and two commonly reported composite ECG traits that summed contiguous traits. Combined phenotype testing was performed using the adaptive sum of powered scores test (aSPU).nnResultsWe identified six novel and 87 known ECG trait loci (aSPU p-value < 5E-9). Lead SNP rs3211938 at novel locus CD36 was common in African Americans (minor allele frequency=10%) and near-monomorphic in European Americans, with effect sizes for the composite trait, QT interval, among the largest reported. Only one novel locus was detected for the composite traits, due to opposite directions of effects across contiguous traits that summed to near-zero. Combined phenotype testing did not detect novel loci unapparent by univariate testing. However, this approach aided locus characterization, particularly when loci harbored multiple independent signals that differed by trait.nnConclusionsDespite including one-third as few participants as the largest published GWAS of ECG traits, our study identifies multiple novel ECG genetic loci, emphasizing the importance of ancestral diversity and phenotype measurement in this era of ever-growing GWAS.nnAUTHOR SUMMARYWe leveraged a multiethnic cohort with precise measures of cardioelectric function to identify novel genetic loci affecting this complex, multifaceted phenotype. The success of our approach stresses the importance of phenotypic precision and participant diversity for future locus discovery and characterization efforts, and cautions against compromises made in genome-wide association studies to pursue ever-growing sample sizes.
]]></description>
<dc:creator>Baldassari, A. R.</dc:creator>
<dc:creator>Avery, C. L.</dc:creator>
<dc:creator>Highland, H. M.</dc:creator>
<dc:creator>Arking, D. R.</dc:creator>
<dc:creator>Buyske, S.</dc:creator>
<dc:creator>Darbar, D.</dc:creator>
<dc:creator>Gondalia, R.</dc:creator>
<dc:creator>Graff, M. R.</dc:creator>
<dc:creator>Guo, X. R.</dc:creator>
<dc:creator>Heckbert, S. R.</dc:creator>
<dc:creator>Hindorff, L. A.</dc:creator>
<dc:creator>Hodonsky, C. J.</dc:creator>
<dc:creator>Ida Chen, Y.-D.</dc:creator>
<dc:creator>Kaplan, R. C.</dc:creator>
<dc:creator>Peters, U.</dc:creator>
<dc:creator>Post, W.</dc:creator>
<dc:creator>Reiner, A. P.</dc:creator>
<dc:creator>Shohet, R. V.</dc:creator>
<dc:creator>Sotoodehnia, N.</dc:creator>
<dc:creator>Tao, R.</dc:creator>
<dc:creator>Taylor, K. D.</dc:creator>
<dc:creator>Yao, J. D.</dc:creator>
<dc:creator>Kenny, E. D.</dc:creator>
<dc:creator>Lin, H. J.</dc:creator>
<dc:creator>Soliman, E. Z.</dc:creator>
<dc:creator>Whitsel, E. A.</dc:creator>
<dc:creator>North, K. E.</dc:creator>
<dc:creator>Kooperberg, C.</dc:creator>
<dc:creator>Rotters, j.</dc:creator>
<dc:creator>Seyerle, A. A.</dc:creator>
<dc:date>2019-05-31</dc:date>
<dc:identifier>doi:10.1101/654012</dc:identifier>
<dc:title><![CDATA[Multi-ethnic genome-wide association study of decomposed cardioelectric phenotypes illustrates strategies to identify and characterize evidence of shared genetic effects for complex traits]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-05-31</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/655969v1?rss=1">
<title>
<![CDATA[
Modeling missing cases and transmission links in networks of extensively drug-resistant tuberculosis in KwaZulu-Natal, South Africa 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/655969v1?rss=1</link>
<description><![CDATA[
The transmission patterns of drug-resistant tuberculosis (TB) remain poorly understood, despite over half a million incident cases in 2017. Modeling TB transmission networks can provide insight into the nature and drivers of transmission, but incomplete and non-random sampling of TB cases can pose challenges to making inferences from epidemiologic and molecular data. We conducted a quantitative bias analysis to assess the effect of missing cases on a transmission network inferred from Mtb sequencing data on extensively drug-resistant (XDR) TB cases in South Africa. We tested scenarios in which cases were missing at random, differentially by clinical characteristics, or differentially by transmission (i.e., cases with many links were under or over-sampled). Under the assumption cases were missing at random, cases in the complete, modeled network would have had a mean of 20 or more transmission links, which is far higher than expected, in order to reproduce the observed, partial network. Instead, we found that the most likely scenario involved undersampling of high-transmitting cases, and further models provided evidence for superspreading behavior. This is, to our knowledge, the first study to define and assess the support for different mechanisms of missingness in a study of TB transmission. Our findings should caution interpretation of results of future studies of TB transmission in high-incidence settings, given the potential for biased sampling, and should motivate further research aimed at identifying the specific host, pathogen, or environmental factors contributing to superspreading.
]]></description>
<dc:creator>Nelson, K. N.</dc:creator>
<dc:creator>Gandhi, N. R.</dc:creator>
<dc:creator>Mathema, B.</dc:creator>
<dc:creator>Lopman, B.</dc:creator>
<dc:creator>Brust, J. C.</dc:creator>
<dc:creator>Auld, S. C.</dc:creator>
<dc:creator>Ismail, N.</dc:creator>
<dc:creator>Omar, S. V.</dc:creator>
<dc:creator>Brown, T. S.</dc:creator>
<dc:creator>Allana, S.</dc:creator>
<dc:creator>Campbell, A.</dc:creator>
<dc:creator>Moodley, P.</dc:creator>
<dc:creator>Mlisana, K.</dc:creator>
<dc:creator>Shah, N. S.</dc:creator>
<dc:creator>Jenness, S. M.</dc:creator>
<dc:date>2019-06-07</dc:date>
<dc:identifier>doi:10.1101/655969</dc:identifier>
<dc:title><![CDATA[Modeling missing cases and transmission links in networks of extensively drug-resistant tuberculosis in KwaZulu-Natal, South Africa]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-06-07</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/659466v1?rss=1">
<title>
<![CDATA[
Distinct neural mechanisms for the prosocial and rewarding properties of MDMA 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/659466v1?rss=1</link>
<description><![CDATA[
The extensively abused recreational drug MDMA has shown promise as an adjunct to psychotherapy for treatment-resistant psychiatric disease. It is unknown, however, whether the mechanisms underlying its prosocial therapeutic effects and abuse potential are distinct. We demonstrate in mice that MDMA acting at the serotonin transporter within the nucleus accumbens is necessary and sufficient for MDMAs prosocial effect. MDMAs acute rewarding properties, in contrast, require dopaminergic signaling. MDMAs prosocial effect requires 5-HT1b receptor activation and is mimicked by d-fenfluramine, a selective serotonin-releasing compound. By dissociating the mechanisms of MDMAs prosocial effects from its addictive properties, we provide evidence for a conserved neuronal pathway, which can be leveraged to develop novel therapeutics with limited abuse liability.nnOne Sentence SummaryMDMA, which has both therapeutic and abuse potential, engages a brain region-specific serotonergic pathway to produce its prosocial effect.
]]></description>
<dc:creator>Heifets, B. D.</dc:creator>
<dc:creator>Salgado, J. S.</dc:creator>
<dc:creator>Taylor, M. D.</dc:creator>
<dc:creator>Hoerbelt, P.</dc:creator>
<dc:creator>Cardozo Pinto, D. F.</dc:creator>
<dc:creator>Walsh, J. J.</dc:creator>
<dc:creator>Steinberg, E. E.</dc:creator>
<dc:creator>Sze, J. Y.</dc:creator>
<dc:creator>Malenka, R. C.</dc:creator>
<dc:date>2019-06-03</dc:date>
<dc:identifier>doi:10.1101/659466</dc:identifier>
<dc:title><![CDATA[Distinct neural mechanisms for the prosocial and rewarding properties of MDMA]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-06-03</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/668467v1?rss=1">
<title>
<![CDATA[
Single-cell whole-genome sequencing reveals mutational landscapes of DNA mismatch repair deficiency in mouse primary fibroblasts 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/668467v1?rss=1</link>
<description><![CDATA[
DNA Mismatch repair (MMR) deficiency is a major cause of hereditary non-polyposis colorectal cancer, and is also associated with increased risk of several other cancers. This is generally ascribed to the role of MMR in avoiding mutations by correcting DNA replication errors. In MMR knockout mice very high frequencies of somatic mutations, up until 100-fold of background, have been reported. However, these results have been obtained using bacterial reporter transgenes, which are not representative for the genome overall, and mutational patterns of MMR deficiency remain largely unknown. To fill this knowledge gap, we performed single-cell whole-genome sequencing of lung fibroblasts of Msh2-/- and wild-type mice. We observed a 4-fold increase of somatic single nucleotide variants (SNVs) in the fibroblasts of Msh2-/- mice compared to those of wild-type mice. The SNV signature of Msh2 deficiency was found to be driven by C>T and T>C transitions. By comparing it to human cancer signatures, we not only confirmed the inferred MMR-deficiency-related etiology of several cancer signatures but also suggested that MMR deficiency is likely the cause of a cancer signature with its etiology previously unknown. We also observed a 7-fold increase of somatic small insertions and deletions (INDELs) in the Msh2-/- mice. An elevated INDEL frequency has also been found in human MMR-related cancers. INDELs and SNVs distributed differently across genomic features in the Msh2-/- and control cells, with evidence of selection pressure and repair preference. These results provide insights into the landscape of somatic mutations in normal somatic cells caused by MMR deficiency.nnSignificanceOur results show that MMR deficiency in the mouse is associated with a much lower elevation of somatic mutation rates than previously reported and provides the first MMR whole-genome mutational landscapes in normal somatic cells in vivo.
]]></description>
<dc:creator>Zhang, L.</dc:creator>
<dc:creator>Dong, X.</dc:creator>
<dc:creator>Hao, X.</dc:creator>
<dc:creator>Lee, M.</dc:creator>
<dc:creator>Chi, Z.</dc:creator>
<dc:creator>Jin, B.</dc:creator>
<dc:creator>Maslov, A. Y.</dc:creator>
<dc:creator>Edelmann, W.</dc:creator>
<dc:creator>Vijg, J.</dc:creator>
<dc:date>2019-06-12</dc:date>
<dc:identifier>doi:10.1101/668467</dc:identifier>
<dc:title><![CDATA[Single-cell whole-genome sequencing reveals mutational landscapes of DNA mismatch repair deficiency in mouse primary fibroblasts]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-06-12</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/678037v1?rss=1">
<title>
<![CDATA[
Cyclophilin A Prevents HIV-1 Restriction in Lymphocytes by Blocking Human TRIM5α Binding to the viral Core 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/678037v1?rss=1</link>
<description><![CDATA[
Disruption of cyclophilin A (CypA)-capsid interactions affects HIV-1 replication in human lymphocytes. To understand the mechanism, we used Jurkat cells, human PBMCs, and human CD4+ T cells. Our results showed that the inhibition of HIV-1 infection caused by disrupting CypA-capsid interactions is dependent on human TRIM5 (TRIM5hu), suggesting that TRIM5hu restricts HIV-1. Accordingly, we found that TRIM5hu binds to the HIV-1 core. Disruption of CypA-capsid interactions failed to affect HIV-1-A92E infection, correlating with the loss of TRIM5hu binding to HIV-1-A92E cores. Disruption of CypA-capsid interactions in PBMCs and CD4+ T cells had a greater inhibitory effect on HIV-1 when compared to Jurkat cells. HIV-1-A92E infection of PBMCs and CD4+ T cells was unaffected by disruption of CypA-capsid interactions. Consistent with TRIM5 restriction, disruption of CypA-capsid interactions in CD4+ T cells inhibited reverse transcription. Overall, our results showed that CypA binding to the core protects HIV-1 from TRIM5hu restriction.
]]></description>
<dc:creator>Selyutina, A.</dc:creator>
<dc:creator>Persaud, M.</dc:creator>
<dc:creator>Bulnes-Ramos, A.</dc:creator>
<dc:creator>Buffone, C.</dc:creator>
<dc:creator>Scoca, V.</dc:creator>
<dc:creator>Di Nunzio, F.</dc:creator>
<dc:creator>Hiatt, J.</dc:creator>
<dc:creator>Krogan, N. J.</dc:creator>
<dc:creator>Hultquist, J. F.</dc:creator>
<dc:creator>Diaz-Griffero, F.</dc:creator>
<dc:date>2019-06-21</dc:date>
<dc:identifier>doi:10.1101/678037</dc:identifier>
<dc:title><![CDATA[Cyclophilin A Prevents HIV-1 Restriction in Lymphocytes by Blocking Human TRIM5α Binding to the viral Core]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-06-21</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/682476v1?rss=1">
<title>
<![CDATA[
Synergistic interplay between PHF8 and HER2 signaling contributes to breast cancer development and drug resistance 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/682476v1?rss=1</link>
<description><![CDATA[
HER2 plays a critical role in tumorigenesis and is associated with poor prognosis of HER2-positive breast cancers. Although, anti-HER2 drugs show benefits in breast cancer therapy, de novo or acquired resistance often develop. Epigenetic factors have been increasingly targeted for therapeutic purposes, however, such mechanisms interacting with HER2 signaling are poorly understood. This study reports the synergistic interplay between histone demethylase PHF8 and HER2 signaling, i.e. PHF8 is elevated in HER2-positive breast cancers and is upregulated by HER2; PHF8 plays coactivator roles in regulating HER2 expression and HER2-driven epithelial-to-mesenchymal transition (EMT) markers and cytokines. The HER2-PHF8-IL-6 regulatory axis was proved both in cell lines and in the newly established MMTV-Her2/MMTV-Cre/Phf8flox/flox models, with which the oncogenic function of Phf8 in breast cancer in vivo was revealed for the first time. Furthermore, PHF8-IL-6 axis contributes to the resistance of Trastuzumab in vitro and may play a critical role in the infiltration of T-cells in HER2-driven breast cancers. This study reveals novel epigenetic mechanisms underlying HER2-driven cancer development and anti-HER2 drug resistance.
]]></description>
<dc:creator>Qi, H. H.</dc:creator>
<dc:creator>Liu, Q.</dc:creator>
<dc:creator>Borcherding, N.</dc:creator>
<dc:creator>Shao, P.</dc:creator>
<dc:creator>Maina, P. K.</dc:creator>
<dc:creator>Zhang, W.</dc:creator>
<dc:date>2019-06-25</dc:date>
<dc:identifier>doi:10.1101/682476</dc:identifier>
<dc:title><![CDATA[Synergistic interplay between PHF8 and HER2 signaling contributes to breast cancer development and drug resistance]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-06-25</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/686840v1?rss=1">
<title>
<![CDATA[
Regulation of Numb during planar cell polarity establishment in the Drosophila eye 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/686840v1?rss=1</link>
<description><![CDATA[
The establishment of planar cell polarity (PCP) in the Drosophila eye requires correct specification of the R3/R4 pair of photoreceptor cells, determined by a Frizzled mediated signaling event that specifies R3 and induces Delta to activate Notch signaling in the neighboring cell, specifying it as R4. Here, we investigated the role of the Notch signaling negative regulator Numb in the specification of R3/R4 fates and PCP establishment in the Drosophila eye. We observed that Numb is transiently upregulated in R3 at the time of R3/R4 specification. This regulation of Numb levels in developing photoreceptors occurs at the post-transcriptional level and is dependent on Dishevelled, an effector of Frizzled signaling, and Lethal Giant Larva. We detected PCP defects in cells homozygous for numb15, but these defects were due to a loss of function mutation in fat (fatQ805*) being present in the numb15 chromosome. However, mosaic overexpression of Numb in R4 precursors (only) caused PCP defects and numb loss-of-function had a modifying effect on the defects found in a hypomorphic dishevelled mutation. Our results suggest that Numb levels are upregulated to reinforce the bias of Notch signaling activation in the R3/R4 pair, two post-mitotic cells that are not specified by asymmetric cell division.
]]></description>
<dc:creator>Domingos, P. M.</dc:creator>
<dc:creator>Jenny, A.</dc:creator>
<dc:creator>del Alamo, D.</dc:creator>
<dc:creator>Mlodzik, M.</dc:creator>
<dc:creator>Steller, H.</dc:creator>
<dc:creator>Mollereau, B.</dc:creator>
<dc:date>2019-06-28</dc:date>
<dc:identifier>doi:10.1101/686840</dc:identifier>
<dc:title><![CDATA[Regulation of Numb during planar cell polarity establishment in the Drosophila eye]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-06-28</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/688010v1?rss=1">
<title>
<![CDATA[
High-throughput phenotyping reveals expansive genetic and structural underpinnings of immune variation 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/688010v1?rss=1</link>
<description><![CDATA[
By developing a high-density murine immunophenotyping platform compatible with high-throughput genetic screening, we have established profound contributions of genetics and structure to immune variation. Specifically, high-throughput phenotyping of 530 knockout mouse lines identified 140 monogenic "hits" (>25%), most of which had never hitherto been implicated in immunology. Furthermore, they were conspicuously enriched in genes for which humans show poor tolerance to loss-of-function. The immunophenotyping platform also exposed dense correlation networks linking immune parameters with one another and with specific physiologic traits. By limiting the freedom of individual immune parameters, such linkages impose genetically regulated "immunological structures", whose integrity was found to be associated with immunocompetence. Hence, our findings provide an expanded genetic resource and structural perspective for understanding and monitoring immune variation in health and disease.
]]></description>
<dc:creator>Abeler-Dörner, L.</dc:creator>
<dc:creator>Laing, A.</dc:creator>
<dc:creator>Lorenc, A.</dc:creator>
<dc:creator>Ushakov, D. S.</dc:creator>
<dc:creator>Clare, S.</dc:creator>
<dc:creator>Speak, A.</dc:creator>
<dc:creator>Duque, M.</dc:creator>
<dc:creator>White, J. K.</dc:creator>
<dc:creator>Ramirez-Solis, R.</dc:creator>
<dc:creator>Saran, N.</dc:creator>
<dc:creator>Bull, K. R.</dc:creator>
<dc:creator>Moron, B.</dc:creator>
<dc:creator>Iwasaki, J.</dc:creator>
<dc:creator>Barton, P. R.</dc:creator>
<dc:creator>Caetano, S.</dc:creator>
<dc:creator>Hng, K. I.</dc:creator>
<dc:creator>Cambridge, E.</dc:creator>
<dc:creator>Forman, S.</dc:creator>
<dc:creator>Crockford, T. L.</dc:creator>
<dc:creator>Griffiths, M.</dc:creator>
<dc:creator>Kane, L.</dc:creator>
<dc:creator>Harcourt, K.</dc:creator>
<dc:creator>Brandt, C.</dc:creator>
<dc:creator>Notley, G.</dc:creator>
<dc:creator>Babalola, K. O.</dc:creator>
<dc:creator>Warren, J.</dc:creator>
<dc:creator>Mason, J. C.</dc:creator>
<dc:creator>Meeniga, A.</dc:creator>
<dc:creator>Karp, N. A.</dc:creator>
<dc:creator>Melvin, D.</dc:creator>
<dc:creator>Cawthorne, E.</dc:creator>
<dc:creator>Weinrick, B.</dc:creator>
<dc:creator>Rahim, A.</dc:creator>
<dc:creator>Drissler, S.</dc:creator>
<dc:creator>Meskas, J.</dc:creator>
<dc:creator>Yue, A.</dc:creator>
<dc:creator>Lux, M.</dc:creator>
<dc:creator>Song-Zhao, G.</dc:creator>
<dc:creator>Chan, A.</dc:creator>
<dc:creator>Ballesteros Reviriego, C.</dc:creator>
<dc:creator>Abeler, J.</dc:creator>
<dc:creator>Wilson, H.</dc:creator>
<dc:creator>Przemska-Kosicka, A.</dc:creator>
<dc:creator>Edmans, M.</dc:creator>
<dc:creator>Stre</dc:creator>
<dc:date>2019-07-02</dc:date>
<dc:identifier>doi:10.1101/688010</dc:identifier>
<dc:title><![CDATA[High-throughput phenotyping reveals expansive genetic and structural underpinnings of immune variation]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-07-02</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/696021v1?rss=1">
<title>
<![CDATA[
Assessing auditory processing endophenotypes associated with Schizophrenia in individuals with 22q11.2 Deletion Syndrome 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/696021v1?rss=1</link>
<description><![CDATA[
Background22q11.2 Deletion Syndrome (22q11.2DS) is the strongest known molecular risk factor for schizophrenia. Brain responses to auditory stimuli have been studied extensively in schizophrenia and described as potential biomarkers of vulnerability to psychosis. We sought to understand whether these responses might aid in differentiating individuals with 22q11.2DS as a function of psychotic symptoms, and ultimately serve as signals of risk for schizophrenia.nnMethodsA duration oddball paradigm and high-density electrophysiology were used to test auditory processing in 26 individuals with 22q11.2DS (13-35 years old, 17 females) with varying degrees of psychotic symptomatology and in 26 age- and sex-matched neurotypical controls (NT). Presentation rate varied across three levels, to examine the effect of increasing demands on memory and the integrity of sensory adaptation. We tested whether N1 and mismatch negativity (MMN), typically reduced in schizophrenia, related to clinical/cognitive measures, and how they were affected by presentation rate.nnResultsN1 adaptation effects interacted with psychotic symptomatology: Compared to an NT group, individuals with 22q11.2DS but no psychotic symptomatology presented larger adaptation effects, whereas those with psychotic symptomatology presented smaller effects. In contrast, individuals with 22q11.2DS showed increased effects of presentation rate on MMN amplitude, regardless of the presence of symptoms. While IQ and working memory were lower in the 22q11.2DS group, these measures did not correlate with the electrophysiological data.nnConclusionsThese findings suggest the presence of two distinct mechanisms: One intrinsic to 22q11.2DS resulting in increased N1 and MMN responses; another related to psychosis leading to a decreased N1 response.
]]></description>
<dc:creator>A Francisco, A.</dc:creator>
<dc:creator>J Foxe, J.</dc:creator>
<dc:creator>J Horsthuis, D.</dc:creator>
<dc:creator>DeMaio, D.</dc:creator>
<dc:creator>Molholm, S.</dc:creator>
<dc:date>2019-07-09</dc:date>
<dc:identifier>doi:10.1101/696021</dc:identifier>
<dc:title><![CDATA[Assessing auditory processing endophenotypes associated with Schizophrenia in individuals with 22q11.2 Deletion Syndrome]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-07-09</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/696195v1?rss=1">
<title>
<![CDATA[
Within-host dynamics of virulent viruses in bat reservoirs for emerging zoonotic disease 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/696195v1?rss=1</link>
<description><![CDATA[
Bats host virulent zoonotic viruses without experiencing disease. A mechanistic understanding of the impact of bats virus hosting capacities, including uniquely constitutive immune pathways, on cellular-scale viral dynamics is needed to elucidate zoonotic emergence. We carried out virus infectivity assays on bat cell lines expressing induced and constitutive immune phenotypes, then developed a theoretical model of our in vitro system, which we fit to empirical data. Best fit models recapitulated expected immune phenotypes for representative cell lines, supporting robust antiviral defenses in bat cells that correlated with higher estimates for within-host viral propagation rates. In general, heightened immune responses limit pathogen-induced cellular morbidity, which can facilitate the establishment of rapidly-propagating persistent infections within-host. Rapidly-replicating viruses that have evolved with bat immune systems will likely cause enhanced virulence following emergence into secondary hosts with immune systems that diverge from those unique to bats.
]]></description>
<dc:creator>Brook, C. E.</dc:creator>
<dc:creator>Boots, M.</dc:creator>
<dc:creator>Chandran, K.</dc:creator>
<dc:creator>Dobson, A. P.</dc:creator>
<dc:creator>Drosten, C.</dc:creator>
<dc:creator>Graham, A. L.</dc:creator>
<dc:creator>Grenfell, B.</dc:creator>
<dc:creator>Müller, M. A.</dc:creator>
<dc:creator>Ng, M.</dc:creator>
<dc:creator>Wang, L.-F.</dc:creator>
<dc:creator>van Leeuwen, A.</dc:creator>
<dc:date>2019-07-08</dc:date>
<dc:identifier>doi:10.1101/696195</dc:identifier>
<dc:title><![CDATA[Within-host dynamics of virulent viruses in bat reservoirs for emerging zoonotic disease]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-07-08</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/697334v1?rss=1">
<title>
<![CDATA[
Perifornical Area Urocortin-3 Neurons Promote Infant-directed Neglect and Aggression 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/697334v1?rss=1</link>
<description><![CDATA[
While recent studies have uncovered dedicated neural pathways mediating the positive control of parenting, the regulation of infant-directed aggression and how it relates to adult-adult aggression is poorly understood. Here we show that urocortin-3 (Ucn3)-expressing neurons in the hypothalamic perifornical area (PeFAUcn3) are activated during infant-directed attacks in males and females, but not other behaviors. Functional manipulations of PeFAUcn3 neurons demonstrate the role of this population in the negative control of parenting in both sexes. PeFAUcn3 neurons receive input from areas associated with vomeronasal sensing, stress, and parenting, and send projections to hypothalamic and limbic areas. Optogenetic activation of PeFAUcn3 axon terminals in these regions triggers various aspects of infant-directed agonistic responses, such as neglect, repulsion and aggression. Thus, PeFAUcn3 neurons emerge as a dedicated circuit component controlling infant-directed neglect and aggression, providing a new framework to understand the positive and negative regulation of parenting in health and disease.
]]></description>
<dc:creator>Autry, A. E.</dc:creator>
<dc:creator>Wu, Z.</dc:creator>
<dc:creator>Kohl, J.</dc:creator>
<dc:creator>Bambah-Mukku, D.</dc:creator>
<dc:creator>Rubinstein, N. D.</dc:creator>
<dc:creator>Marin-Rodriguez, B.</dc:creator>
<dc:creator>Carta, I.</dc:creator>
<dc:creator>Sedwick, V.</dc:creator>
<dc:creator>Dulac, C.</dc:creator>
<dc:date>2019-07-09</dc:date>
<dc:identifier>doi:10.1101/697334</dc:identifier>
<dc:title><![CDATA[Perifornical Area Urocortin-3 Neurons Promote Infant-directed Neglect and Aggression]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-07-09</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/715730v1?rss=1">
<title>
<![CDATA[
A ciliary BBSome-ARL-6-PDE6D pathway trafficks RAB-28, a negative regulator of extracellular vesicle biogenesis 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/715730v1?rss=1</link>
<description><![CDATA[
Cilia both receive and send information, the latter in the form of extracellular vesicles (EVs). EVs are nano-communication devices that cells shed to influence cell, tissue, and organism behavior. Mechanisms driving ciliary EV biogenesis and environment release are almost entirely unknown. Here, we show that the ciliary G-protein RAB28, associated with human autosomal recessive cone-rod dystrophy, negatively regulates EV levels in the sensory organs of Caenorhabditis elegans. We also find that sequential targeting of lipidated RAB28 to periciliary and ciliary membranes is highly dependent on the BBSome and PDE6D, respectively, and that BBSome loss causes excessive and ectopic EV production. Our data indicate that RAB28 and the BBSome are key in vivo regulators of EV production at the periciliary membrane. Our findings also suggest that EVs control sensory organ homeostasis by mediating communication between ciliated neurons and glia, and that defects in ciliary EV biogenesis may contribute to human ciliopathies.
]]></description>
<dc:creator>Akella, J. S.</dc:creator>
<dc:creator>Carter, S. P.</dc:creator>
<dc:creator>Rizvi, F.</dc:creator>
<dc:creator>Nguyen, K. C. Q.</dc:creator>
<dc:creator>Tsiropoulou, S.</dc:creator>
<dc:creator>Moran, A. L.</dc:creator>
<dc:creator>Silva, M.</dc:creator>
<dc:creator>Kennedy, B. N.</dc:creator>
<dc:creator>Hall, D. H.</dc:creator>
<dc:creator>Barr, M. M.</dc:creator>
<dc:creator>Blacque, O. E.</dc:creator>
<dc:date>2019-07-25</dc:date>
<dc:identifier>doi:10.1101/715730</dc:identifier>
<dc:title><![CDATA[A ciliary BBSome-ARL-6-PDE6D pathway trafficks RAB-28, a negative regulator of extracellular vesicle biogenesis]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-07-25</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/723585v1?rss=1">
<title>
<![CDATA[
The generation of plasma cells and CD27-IgD- B cells during Hantavirus infection are associated with distinct pathological findings 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/723585v1?rss=1</link>
<description><![CDATA[
Human hantavirus infections can cause hemorrhagic fever with renal syndrome (HFRS), major signs of the disease being thrombocytopenia and transient kidney dysfunction. By a comprehensive and longitudinal study of circulating B cells, we demonstrate that these two pathologies associate with distinct effects on the humoral immune system during HFRS. Low thrombocyte counts strongly associated with an abnormal frequency of plasmablasts in circulation, whereas kidney dysfunction was indicative of an accumulation of CD27- B cells and plasmablasts. Finally, we provide evidence that high levels of extracellular ATP in circulation during HFRS correlates with shedding of surface CD27 on B cells via a metallomatrix proteinase-8-mediated mechanism. Since extracellular ATP is known to regulate kidney function, our study reveals a link between kidney dysfunction and the generation of CD27-IgD- B cells, and a potential molecular target for treatment of the symptomatic phase of HFRS.
]]></description>
<dc:creator>Kerkman, P. F.</dc:creator>
<dc:creator>Dernstedt, A.</dc:creator>
<dc:creator>Tadala, L.</dc:creator>
<dc:creator>Mittler, E.</dc:creator>
<dc:creator>Dannborg, M.</dc:creator>
<dc:creator>Sundling, C.</dc:creator>
<dc:creator>Maleki, K. T.</dc:creator>
<dc:creator>Tauriainen, J.</dc:creator>
<dc:creator>Tuiskunen-Back, A.</dc:creator>
<dc:creator>Wigren Bystrom, J.</dc:creator>
<dc:creator>Ocaya, P.</dc:creator>
<dc:creator>Thunberg, T.</dc:creator>
<dc:creator>Jangra, R.</dc:creator>
<dc:creator>Roman-Sosa, G.</dc:creator>
<dc:creator>Guardado-Calvo, P.</dc:creator>
<dc:creator>Rey, F. A.</dc:creator>
<dc:creator>Klingstrom, J.</dc:creator>
<dc:creator>Chandran, K.</dc:creator>
<dc:creator>Puhar, A.</dc:creator>
<dc:creator>Ahlm, C.</dc:creator>
<dc:creator>Forsell, M.</dc:creator>
<dc:date>2019-08-02</dc:date>
<dc:identifier>doi:10.1101/723585</dc:identifier>
<dc:title><![CDATA[The generation of plasma cells and CD27-IgD- B cells during Hantavirus infection are associated with distinct pathological findings]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-08-02</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/726612v1?rss=1">
<title>
<![CDATA[
In situ Fucosylation for Modulating Wnt Signaling in Live Cells 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/726612v1?rss=1</link>
<description><![CDATA[
Wnt/{beta}-catenin signaling, also known as canonical Wnt signaling, regulates critical, context-dependent transcription in numerous (patho) physiological events. Amongst the well-documented mechanisms of canonical Wnt signaling, modification of N-glycans by L-fucose (Fuc) is the newest and the least understood. Using a combination of Chinese Hamster Ovary (CHO) cell mutants with different fucosylation levels and in situ cell-surface Fuc editing (ISF), we report that (1-3)-fucosylation of N-acetylglucosamine in the LacNAc (Gal{beta}(1-4)-GlcNAc) sequences of complex N-glycans modulates Wnt signaling by regulating the endocytosis of low density lipoprotein receptor-related protein 6 (LRP6). Pulse-chase experiments reveal that increasing N-glycan LacNAc fucosylation elevates endocytosis of lipid-raft-localized LRP6, leading to the suppression of Wnt-{beta}-catenin signaling. Inhibiting endocytosis by inhibiting dynamin 1, a GTPase responsible for endocytosis in eukaryotic cells, partially rescues Wnt signaling. Remarkably, inhibition of Wnt signaling by N-glycan LacNAc fucosylation is fully rescued by the addition of free Fuc to the medium, suggesting that endocytosis of N-glycan fucosylated LRP6 may be mediated by a receptor that recognizes the bound (1-3)-Fuc. This work provides the first evidence that in situ cell-surface fucosylation can be exploited to regulate a specific signaling pathway via endocytosis, revealing a novel regulatory mechanism linking glycosylation of a cell surface receptor with its intracellular signaling.
]]></description>
<dc:creator>Hong, S.</dc:creator>
<dc:creator>Feng, L.</dc:creator>
<dc:creator>Jiang, H.</dc:creator>
<dc:creator>Hou, X.</dc:creator>
<dc:creator>Guo, P.</dc:creator>
<dc:creator>Marlow, F.</dc:creator>
<dc:creator>Stanley, P.</dc:creator>
<dc:creator>Wu, P.</dc:creator>
<dc:date>2019-08-09</dc:date>
<dc:identifier>doi:10.1101/726612</dc:identifier>
<dc:title><![CDATA[In situ Fucosylation for Modulating Wnt Signaling in Live Cells]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-08-09</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/726901v1?rss=1">
<title>
<![CDATA[
Multiclass Disease Classification from Microbial Whole-Community Metagenomes using Graph Convolutional Neural Networks. 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/726901v1?rss=1</link>
<description><![CDATA[
There is a wealth of information contained within ones microbiome regarding their physiology and environment, and this is a promising avenue for developing non-invasive diagnostic tools. Here, we utilize 5643 aggregated, annotated whole-community metagenomes from 19 different diseases to implement the first multiclass microbiome disease classifier of this scale. We compared three different machine learning models: random forests, deep neural nets, and a novel graph convolutional architecture which exploits the graph structure of phylogenetic trees as its input. We show that the graph convolutional model outperforms deep neural nets in terms of accuracy (achieving 75% average test-set accuracy), receiver-operator-characteristics (92.1% average AUC), and precision-recall (50% average AUPR). Additionally, the convolutional nets performance complements that of the random forest, achieving similar accuracy but better receiver-operator-characteristics and lower area under precision-recall. Lastly, we are able to achieve over 90% average top-3 accuracy across all of our models. Together, these results indicate that there are predictive, disease specific signatures across microbiomes which could potentially be used for diagnostic purposes.
]]></description>
<dc:creator>Khan, S.</dc:creator>
<dc:creator>Kelly, L.</dc:creator>
<dc:date>2019-08-09</dc:date>
<dc:identifier>doi:10.1101/726901</dc:identifier>
<dc:title><![CDATA[Multiclass Disease Classification from Microbial Whole-Community Metagenomes using Graph Convolutional Neural Networks.]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-08-09</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/729491v1?rss=1">
<title>
<![CDATA[
Post-EMT: Cadherin-11 mediates cancer hijacking fibroblasts 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/729491v1?rss=1</link>
<description><![CDATA[
Current prevailing knowledge on EMT (epithelial mesenchymal transition) deems epithelial cells acquire the characters of mesenchymal cells to be capable of invading and metastasizing on their own. One of the signature events of EMT is called "cadherin switch", e.g. the epithelial E-cadherin switching to the mesenchymal Cadherin-11. Here, we report the critical events after EMT that cancer cells utilize cadherin-11 to hijack the endogenous cadherin-11 positive fibroblasts. Numerous 3-D cell invasion assays with high-content live cell imaging methods reveal that cadherin-11 positive cancer cells adhere to and migrate back and forth dynamically on the cell bodies of fibroblasts. By adhering to fibroblasts for co-invasion through 3-D matrices, cancer cells acquire higher invasion speed and velocity, as well as significantly elevated invasion persistence, which are exclusive characteristics of fibroblast invasion. Silencing cadherin-11 in cancer cells or in fibroblasts, or in both, significantly decouples such physical co-invasion. Additional bioinformatics studies and PDX (patient derived xenograft) studies link such cadherin-11 mediated cancer hijacking fibroblasts to the clinical cancer progression in human such as triple-negative breast cancer patients. Further animal studies confirm cadherin-11 mediates cancer hijacking fibroblasts in vivo and promotes significant solid tumor progression and distant metastasis. Moreover, overexpression of cadherin-11 strikingly protects 4T1-luc cells from implant rejection against firefly luciferase in immunocompetent mice. Overall, our findings report and characterize the critical post-EMT event of cancer hijacking fibroblasts in cancer progression and suggest cadherin-11 can be a therapeutic target for solid tumors with stroma. Our studies hence provide significant updates on the "EMT" theory that EMT cancer cells can hijack fibroblasts to achieve full mesenchymal behaviors in vivo for efficient homing, growth, metastasis and evasion of immune surveillance. Our studies also reveal that cadherin-11 is the key molecule that helps link cancer cells to stromal fibroblasts in the "Seed & Soil" theory.

Graphical Abstract

O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=117 SRC="FIGDIR/small/729491v2_ufig1.gif" ALT="Figure 1">
View larger version (40K):
org.highwire.dtl.DTLVardef@11317f1org.highwire.dtl.DTLVardef@88fffaorg.highwire.dtl.DTLVardef@5da692org.highwire.dtl.DTLVardef@62f6ed_HPS_FORMAT_FIGEXP  M_FIG C_FIG
]]></description>
<dc:creator>Kang, W.</dc:creator>
<dc:creator>Fan, Y.</dc:creator>
<dc:creator>Du, Y.</dc:creator>
<dc:creator>Tonkova, E. A.</dc:creator>
<dc:creator>Hsu, Y.-H.</dc:creator>
<dc:creator>Tan, K. V.</dc:creator>
<dc:creator>Alexander, S.</dc:creator>
<dc:creator>Wong, B. S.</dc:creator>
<dc:creator>Yang, H.</dc:creator>
<dc:creator>Luo, J.</dc:creator>
<dc:creator>Yao, K.</dc:creator>
<dc:creator>Yang, J.</dc:creator>
<dc:creator>Hu, X.</dc:creator>
<dc:creator>Liu, T.</dc:creator>
<dc:creator>Gan, Y.</dc:creator>
<dc:creator>Zhang, J.</dc:creator>
<dc:creator>Zhao, J. J.</dc:creator>
<dc:creator>Konstantopoulos, K.</dc:creator>
<dc:creator>Friedl, P.</dc:creator>
<dc:creator>Khong, P. L.</dc:creator>
<dc:creator>Lu, A.</dc:creator>
<dc:creator>Hung, M.-C.</dc:creator>
<dc:creator>Brenner, M. B.</dc:creator>
<dc:creator>Segall, J. E.</dc:creator>
<dc:creator>Gu, Z.</dc:creator>
<dc:date>2019-08-09</dc:date>
<dc:identifier>doi:10.1101/729491</dc:identifier>
<dc:title><![CDATA[Post-EMT: Cadherin-11 mediates cancer hijacking fibroblasts]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-08-09</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/730135v1?rss=1">
<title>
<![CDATA[
Targeting EZH2 Increases Therapeutic Efficacy of Check-Point Blockade in Models of Prostate Cancer 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/730135v1?rss=1</link>
<description><![CDATA[
Prostate cancers are considered immunologically  cold tumors given the very few patients who respond to checkpoint inhibitor therapy (CPI). Recently, enrichment of interferon (IFN) response genes predicts a favorable response to CPI across various disease sites. The enhancer of zeste homolog-2 (EZH2) is over-expressed in prostate cancer and is known to negatively regulate IFN response genes. Here, we demonstrate that inhibition of EZH2 catalytic activity in prostate cancer models derepresses expression of double-strand RNA (dsRNA), associated with upregulation of genes involved in antigen presentation, Th-1 chemokine signaling, and interferon (IFN) response, including PD-L1. Similarly, application of a novel EZH2 derived gene signature to human prostate sample analysis indicated an inverse correlation between tumor EZH2 activity/expression with T-cell inflamed and IFN gene signatures and PD-L1 expression. EZH2 inhibition combined with PD-1 CPI significantly enhances antitumor response that is dependent on up-regulation of tumor PD-L1 expression. Further, combination therapy significantly increases intratumoral trafficking of activated CD8+ T-cells and M1 tumor associated macrophages (TAMs) with concurrent loss of M2 TAMs. Our study identifies EZH2 as a potent inhibitor of antitumor immunity and responsiveness to CPI. This data suggests EZH2 inhibition as a novel therapeutic direction to enhance prostate cancer response to PD-1 CPI.
]]></description>
<dc:creator>Sheahan, A. V.</dc:creator>
<dc:creator>Morel, K. L.</dc:creator>
<dc:creator>Burkhart, D. L.</dc:creator>
<dc:creator>Baca, S. C.</dc:creator>
<dc:creator>Labbe, D. P.</dc:creator>
<dc:creator>Roehle, K.</dc:creator>
<dc:creator>Heckler, M.</dc:creator>
<dc:creator>Calagua, C.</dc:creator>
<dc:creator>Ye, H.</dc:creator>
<dc:creator>Galbo, P.</dc:creator>
<dc:creator>Panja, S.</dc:creator>
<dc:creator>Mitrofanova, A.</dc:creator>
<dc:creator>Hamid, A. A.</dc:creator>
<dc:creator>Kibel, A. S.</dc:creator>
<dc:creator>Choudhury, A. D.</dc:creator>
<dc:creator>Pomerantz, M. M.</dc:creator>
<dc:creator>Freedman, M. L.</dc:creator>
<dc:creator>Sweeney, C. J.</dc:creator>
<dc:creator>Dougan, S. K.</dc:creator>
<dc:creator>Sowalsky, A.</dc:creator>
<dc:creator>Loda, M.</dc:creator>
<dc:creator>Olson, B. M.</dc:creator>
<dc:creator>Ellis, L.</dc:creator>
<dc:date>2019-08-08</dc:date>
<dc:identifier>doi:10.1101/730135</dc:identifier>
<dc:title><![CDATA[Targeting EZH2 Increases Therapeutic Efficacy of Check-Point Blockade in Models of Prostate Cancer]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-08-08</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/739458v1?rss=1">
<title>
<![CDATA[
Deconstructing glucose-mediated catabolite repression of the lac operon of Escherichia coli: I. Inducer exclusion, by itself, cannot account for the repression. 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/739458v1?rss=1</link>
<description><![CDATA[
The lac operon of Escherichia coli is repressed several 100-fold in the presence of glucose. This repression has been attributed to CRP-mediated transcriptional inhibition and EIIAGlc-mediated inducer exclusion. The growing evidence against the first mechanism has led to the postulate that the repression is driven by inducer exclusion. The literature shows that in fully induced cells, inducer exclusion reduces the permease activity only 2-fold. However, it is conceivable that inducer exclusion drastically reduces the permease activity in partially induced cells. We measured the decline of lactose permease activity due to inducer exclusion in partially induced cells, but found that the permease activity decreased no more than 6-fold. We show that the repression is small because these experiments are performed in the presence of chloramphenicol. Indeed, when glucose is added to a culture growing on glycerol and TMG, but no chloramphenicol, lac is repressed 900-fold. This repression is primarily due to reversal of the positive feedback loop, i.e., the decline of the intracellular TMG level leads to a lower permease level, which reduces the intracellular TMG level even further. The repression in the absence of chloramphenicol is therefore primarily due to positive feedback, which does not exist during measurements of inducer exclusion.Competing Interest StatementThe authors have declared no competing interest.ABBREVIATIONS AND NOTATIONScAMP3’,5’-cyclic adenosine monophosphateCGSCColi Genetic Stock Centre, Yale UniversityCRPcAMP receptor proteinEIIAGlcEnzyme III of glucose transport system, PTS (Previously EIIIGlc)gdwGrams of cell dry weight, gIPTGIsopropyl β-D-thiogalactopyranoside or MeSHLBLuria-Bertani brothMUMiller unitsOD600Optical density at 600 nmONPGortho-nitrophenol-β-D-galactopyranosideRNAPRibonucleic acid (RNA) polymeraseTMGMethyl- β-D-1-thiogalactopyranoside[14C]TMGCarbon-14 labelled isotope of TMGUVUltraviolet (radiation)X-gal5-bromo-4-chloro-3-indolyl-β-D-galactopyranosideNOTATIONSIntracellular concentration of phosphorylated EIIAglc in the absence of glucoseIntracellular concentration of dephosphorylated EIIAglc in the presence of glucoseEgSpecific activity of β-galactosidaseSteady state specific activity of β-galactosidase in the presence of glucoseSteady state specific activity of β-galactosidase in the presence of glycerolEpSpecific activity of Lac permeaseSteady state specific activity of Lac permeaseEp,tSpecific activity of free Lac permease in the absence of glucoseφpFractional reduction of permease activity in the presence of glucose, 1 - Ep/Ep,tk1, k2Proportionality constantsKdDissociation constant for complex OD600Optical density at 600 nmSp. rate of β-galactosidase synthesis in the presence of glucose + glycerol + TMGSp. rate of β-galactosidase synthesis in the presence of glycerol + TMGSpecific rate of diffusive efflux of TMGTIntracellular TMG concentrationSteady-state intracellular TMG concentrationSteady-state intracellular TMG concentration in the presence of glucoseSteady-state intracellular TMG concentration in the presence of glucoseTeExtracellular TMG concentrationµglcSpecific growth rate of E. coli cells on glucoseµglySpecific growth rate of E. coli cells on glycerolXBiomass or cell density, gdw l-1View Full Text
]]></description>
<dc:creator>Aggarwal, R. K.</dc:creator>
<dc:creator>Narang, A.</dc:creator>
<dc:date>2019-08-20</dc:date>
<dc:identifier>doi:10.1101/739458</dc:identifier>
<dc:title><![CDATA[Deconstructing glucose-mediated catabolite repression of the lac operon of Escherichia coli: I. Inducer exclusion, by itself, cannot account for the repression.]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-08-20</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/743005v1?rss=1">
<title>
<![CDATA[
Tri-4C: efficient identification of cis-regulatory loops at hundred base pair resolution 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/743005v1?rss=1</link>
<description><![CDATA[
The resolution limit of chromatin conformation capture methodologies (3Cs) has restrained their application in detection of fine-level chromatin structure mediated by cis-regulatory elements (CREs). Here we report two 3C-derived methods, Tri-4C and Tri-HiC, which utilize mult-restriction enzyme digestions for ultrafine mapping of targeted and genome-wide chromatin interaction, respectively, at up to one hundred basepair resolution. Tri-4C identified CRE loop interaction networks and quantifatively revealed their alterations underlying dynamic gene control. Tri-HiC uncovered global fine-gage regulatory interaction networks, identifying > 20-fold more enhancer:promoter (E:P) loops than in situ HiC. In addition to vasly improved identification of subkilobase-sized E:P loops, Tri-HiC also uncovered interaction stripes and contact domain insulation from promoters and enhancers, revealing their loop extrusion behaviors resembling the topologically-associated domain (TAD) boundaries. Tri-4C and Tri-HiC provide robust approaches to achieve the high resolution interactome maps required for characterizing fine-gage regulatory chromatin interactions in analysis of development, homeostasis and disease.
]]></description>
<dc:creator>Zhu, Y.</dc:creator>
<dc:creator>Suh, Y.</dc:creator>
<dc:date>2019-08-22</dc:date>
<dc:identifier>doi:10.1101/743005</dc:identifier>
<dc:title><![CDATA[Tri-4C: efficient identification of cis-regulatory loops at hundred base pair resolution]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-08-22</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/743328v1?rss=1">
<title>
<![CDATA[
Mobile Brain/Body Imaging of cognitive-motor impairment in multiple sclerosis: deriving EEG-based neuro-markers during a dual-task walking study 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/743328v1?rss=1</link>
<description><![CDATA[
Individuals with a diagnosis of multiple sclerosis (MS) often present with deficits in the cognitive as well as the motor domain. The ability to perform tasks that rely on both domains may therefore be particularly impaired. Yet, behavioral studies designed to measure costs associated with performing two tasks at the same time such as dual-task walking have yielded mixed results. Patients may mobilize additional brain resources to sustain good levels of performance. To test this hypothesis, we acquired event-related potentials (ERP) in thirteen individuals with MS and fifteen healthy control (HC) participants performing a Go/NoGo response inhibition task while sitting (i.e., single task) or walking on a treadmill (i.e., dual-task). In previous work, we showed that the nogo-N2 elicited by the cognitive task was reduced when healthy adults are also asked to walk, and that nogo-N2 reduction was accompanied by sustained dual-task performance. We predicted that some MS patients, similar to their healthy peers, may mobilize N2-indexed brain resources and thereby reduce costs. Somewhat to our surprise, the HC group performed the Go/NoGo task more accurately while walking, thus showing a dual-task benefit, whereas, in line with expectation, the MS group showed a trend towards dual-task costs. The expected nogo-N2 reduction during dual-task walking was found in the HC group, but was not present at the group level in the MS group, suggesting that this group did not modulate the nogo-N2 process in response to higher task load. Regression analysis for the pooled sample revealed a robust link between nogo-N2 reduction and better dual-task performance. We conclude that impaired nogo-N2 adaptation reflects a neurophysiological marker of cognitive-motor dysfunction in MS.
]]></description>
<dc:creator>De Sanctis, P.</dc:creator>
<dc:creator>Malcolm, B. R.</dc:creator>
<dc:creator>Mabie, P. C.</dc:creator>
<dc:creator>Francisco, A. A.</dc:creator>
<dc:creator>Mowrey, W. B.</dc:creator>
<dc:creator>Joshi, S.</dc:creator>
<dc:creator>Molholm, S.</dc:creator>
<dc:creator>Foxe, J. J.</dc:creator>
<dc:date>2019-08-31</dc:date>
<dc:identifier>doi:10.1101/743328</dc:identifier>
<dc:title><![CDATA[Mobile Brain/Body Imaging of cognitive-motor impairment in multiple sclerosis: deriving EEG-based neuro-markers during a dual-task walking study]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-08-31</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/743625v1?rss=1">
<title>
<![CDATA[
Arfgef1 haploinsufficiency in mice alters neuronal endosome composition and decreases membrane surface postsynaptic GABAA receptors 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/743625v1?rss=1</link>
<description><![CDATA[
ARFGEF1 encodes a guanine exchange factor involved in intracellular vesicle trafficking, and is a candidate gene for childhood genetic epilepsies. To model ARFGEF1 haploinsufficiency observed in a recent Lennox Gastaut Syndrome patient, we studied a frameshift mutation (Arfgef1fs) in mice. Arfgef1fs/+ pups exhibit signs of developmental delay, and Arfgef1fs/+ adults have a significantly decreased threshold to induced seizures but do not experience spontaneous seizures. Histologically, the Arfgef1fs/+ brain exhibits a disruption in the apical lining of the dentate gyrus and altered spine morphology of deep layer neurons. In primary hippocampal neuron culture, dendritic surface and synaptic but not total GABAA receptors (GABAAR) are reduced in Arfgef1fs/+ neurons with an accompanying decrease in GABAAR-containing recycling endosomes in cell body. Arfgef1fs/+ neurons also display differences in the relative ratio of Arf6+:Rab11+:TrfR+ recycling endosomes. Although the GABAAR-containing early endosomes in Arfgef1fs/+ neurons are comparable to wildtype, Arfgef1fs/+ neurons show an increase in GABAAR-containing lysosomes in dendrite and cell body. Together, the altered endosome composition and decreased neuronal surface GABAAR results suggests a mechanism whereby impaired neuronal inhibition leads to seizure susceptibility.nnHighlightsO_LIArfgef1fs/+ mice have lower seizure threshold but no spontaneous seizure.nC_LIO_LIArfgef1fs/+ neurons show reduced dendritic surface GABAAR.nC_LIO_LIArfgef1fs/+ neurons have decreased GABAAR-containing recycling endosome accompanied with an increase in GABAAR-containing lysosomes.nC_LI
]]></description>
<dc:creator>Teoh, J. J.</dc:creator>
<dc:creator>Subramanian, N.</dc:creator>
<dc:creator>Pero, M. E.</dc:creator>
<dc:creator>Bartolini, F.</dc:creator>
<dc:creator>Amador, A.</dc:creator>
<dc:creator>Kanber, A.</dc:creator>
<dc:creator>Williams, D.</dc:creator>
<dc:creator>Petri, S.</dc:creator>
<dc:creator>Yang, M.</dc:creator>
<dc:creator>Allen, A. S.</dc:creator>
<dc:creator>Beal, J.</dc:creator>
<dc:creator>Haut, S. R.</dc:creator>
<dc:creator>Frankel, W.</dc:creator>
<dc:date>2019-09-08</dc:date>
<dc:identifier>doi:10.1101/743625</dc:identifier>
<dc:title><![CDATA[Arfgef1 haploinsufficiency in mice alters neuronal endosome composition and decreases membrane surface postsynaptic GABAA receptors]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-09-08</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/746602v1?rss=1">
<title>
<![CDATA[
Inhibition of Microbial Beta-Glucuronidase Does Not Prevent Breast Carcinogenesis in the Polyoma Middle T Mouse 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/746602v1?rss=1</link>
<description><![CDATA[
PurposeTo demonstrate whether inhibition of intestinal microbial beta ({beta})-glucuronidase (BGUS) abrogates tumor formation in a MMTV-PyMT mouse breast cancer model.nnMethodsFemale MMTV-PyMT heterozygote mice (4 weeks old) were randomized to oral gavage with vehicle or UNC10201652 (20 g/day), a microbial BGUS inhibitor, for 9 weeks. The entire animal carcass was assessed for tumor deposits by histology and immunohistochemical staining for tumor (Ki67, PCNA) and breast specific (ER, PR, Cyclin D1, aSMA, Integrin {beta}1) markers.nnResultsThe MMTV-PyMT breast pathology in our study simulates prior published reports of tumor incidence and aggressiveness. There was no significant difference in the tumor histology, number of tumors (lesions), and patterns of spread of tumors in the UNC10201652 versus the vehicle treated mice. Similarly, there were no significant differences in the semi-quantitative scores for expression of ER, PR, Ki67, PCNA, or Integrin {beta}1. There were also no major differences seen in qualitative screening of Cyclin D1 and aSMA.nnConclusionsMMTV-PyMT mice administered UNC10201652, when compared to vehicle treated mice, show a similar abundance of breast tumor (and tumor initiating) lesions ranging from hyperplasia to frank carcinoma. There is a trend, however small, that the incidence of hyperplastic and adenomas may be decreased in UNC10201652 treated mice. Further refined dosing strategies in MMTV-PyMT are planned to clarify its biological significance. To our knowledge this is the first report of use of any BGUS inhibitor in chemoprevention of breast tumors using a genetic model simulating human breast cancer.
]]></description>
<dc:creator>Mani, A.</dc:creator>
<dc:creator>Li, H.</dc:creator>
<dc:creator>Evrin, S.</dc:creator>
<dc:creator>Redinbo, M. R.</dc:creator>
<dc:creator>Mani, S.</dc:creator>
<dc:date>2019-08-24</dc:date>
<dc:identifier>doi:10.1101/746602</dc:identifier>
<dc:title><![CDATA[Inhibition of Microbial Beta-Glucuronidase Does Not Prevent Breast Carcinogenesis in the Polyoma Middle T Mouse]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-08-24</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/747642v1?rss=1">
<title>
<![CDATA[
Electrophysiological evidence for impaired auditory sensory memory in Cystinosis despite typical sensory processing: An MMN investigation 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/747642v1?rss=1</link>
<description><![CDATA[
Cystinosis, a genetic rare disease characterized by cystine accumulation and crystallization, results in significant damage in a multitude of tissues and organs, such as the kidney, thyroid, eye, and brain. While Cystinosis impact on brain function is relatively mild compared to its effects on other organs, the increased lifespan of this population and thus potential for productive societal contributions have led to increased interest on the effects on brain function. Nevertheless, and despite some evidence of structural brain differences, the neural impact of the mutation is still not well characterized.nnHere, using a passive duration oddball paradigm (with different stimulus onset asynchronies (SOAs), representing different levels of demand on memory) and high-density electrophysiology, we tested basic auditory processing in a group of 22 children and adolescents diagnosed with Cystinosis (age range: 6-17 years old) and in neurotypical age-matched controls (N=24). We examined whether the N1 and mismatch negativity (MMN) significantly differed between the groups and if those neural measures correlated with verbal and non-verbal IQ. Individuals diagnosed with Cystinosis presented similar N1 responses to their age-matched peers, indicating typical basic auditory processing in this population. However, whereas both groups showed similar MMN responses for the shortest (450ms) SOA, suggesting intact change detection and sensory memory, individuals diagnosed with Cystinosis presented clearly reduced responses for the longer (900ms and 1800ms) SOAs. This could indicate reduced duration auditory sensory memory traces, and thus sensory memory impairment, in children and adolescents diagnosed with Cystinosis. Future work addressing other aspects of sensory and working memory is needed to understand the underlying bases of the differences described here, and their implication for higher order processing.
]]></description>
<dc:creator>Alves Francisco, A.</dc:creator>
<dc:creator>Foxe, J. J.</dc:creator>
<dc:creator>Horsthuis, D. J.</dc:creator>
<dc:creator>Molholm, S.</dc:creator>
<dc:date>2019-08-28</dc:date>
<dc:identifier>doi:10.1101/747642</dc:identifier>
<dc:title><![CDATA[Electrophysiological evidence for impaired auditory sensory memory in Cystinosis despite typical sensory processing: An MMN investigation]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-08-28</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/747956v1?rss=1">
<title>
<![CDATA[
Transcriptome analysis reveals the difference between \"healthy\" and \"common\" aging and their connection with age-related diseases 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/747956v1?rss=1</link>
<description><![CDATA[
A key goal of aging research is to understand mechanisms underlying healthy aging and use them to develop methods to promote the human healthspan. One approach is to identify gene regulations differentiating healthy aging from aging in the general population (i.e., "common" aging). In this study, we leveraged GTEx (Genotype-Tissue Expression) project data to investigate "healthy" and "common" aging in humans and their interconnection with diseases.nnWe selected GTEx donors who were not annotated with diseases to approximate a "healthy" aging cohort. We then compared the age-associated genes derived from this cohort with age-associated genes from our "common" aging cohort which included all GTEx donors; we also compared the "healthy" and "common" aging gene expressions with various disease-associated gene expression to elucidate the relationships among "healthy", "common" aging and disease. Our analyses showed that 1. "healthy" and "common" aging shared a large number of gene regulations; 2. Despite the substantial commonality, "healthy" and "common" aging genes also showed distinct function enrichment, and "common" aging genes had a higher enrichment for disease genes; 3. Disease-associated gene regulations were overall different from aging gene regulations. However, for genes regulated by both, their regulation directions were largely consistent, implying some aging processes could increase the susceptibility to disease development; and 4. Possible protective mechanisms were associated with the "healthy" aging gene regulations.nnIn summary, our work highlights several unique features of human "healthy" aging program. This new knowledge can be used for the development of therapeutics to promote human healthspan.
]]></description>
<dc:creator>Zeng, L.</dc:creator>
<dc:creator>Yang, J.</dc:creator>
<dc:creator>Peng, S.</dc:creator>
<dc:creator>Zhu, J.</dc:creator>
<dc:creator>Zhang, B.</dc:creator>
<dc:creator>Suh, Y.</dc:creator>
<dc:creator>Tu, Z.</dc:creator>
<dc:date>2019-08-28</dc:date>
<dc:identifier>doi:10.1101/747956</dc:identifier>
<dc:title><![CDATA[Transcriptome analysis reveals the difference between \"healthy\" and \"common\" aging and their connection with age-related diseases]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-08-28</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/749010v1?rss=1">
<title>
<![CDATA[
Novel genetic determinants of telomere length from a multi-ethnic analysis of 75,000 whole genome sequences in TOPMed 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/749010v1?rss=1</link>
<description><![CDATA[
Telomeres shorten in replicating somatic cells, and telomere length (TL) is associated with age-related diseases 1,2. To date, 17 genome-wide association studies (GWAS) have identified 25 loci for leukocyte TL 3-19, but were limited to European and Asian ancestry individuals and relied on laboratory assays of TL. In this study from the NHLBI Trans-Omics for Precision Medicine (TOPMed) program, we used whole genome sequencing (WGS) of whole blood for variant genotype calling and the bioinformatic estimation of TL in n=109,122 trans-ethnic (European, African, Asian and Hispanic/Latino) individuals. We identified 59 sentinel variants (p-value <5x10-9) from 36 loci (20 novel, 13 replicated in external datasets). There was little evidence of effect heterogeneity across populations, and 10 loci had >1 independent signal. Fine-mapping at OBFC1 indicated the independent signals colocalized with cell-type specific eQTLs for OBFC1 (STN1). We further identified two novel genes, DCLRE1B (SNM1B) and PARN, using a multi-variant gene-based approach.
]]></description>
<dc:creator>Taub, M. A.</dc:creator>
<dc:creator>Weinstock, J. S.</dc:creator>
<dc:creator>Iyer, K. R.</dc:creator>
<dc:creator>Yanek, L. R.</dc:creator>
<dc:creator>Conomos, M. P.</dc:creator>
<dc:creator>NHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium,</dc:creator>
<dc:creator>Reiner, A. P.</dc:creator>
<dc:creator>Mathias, R. A.</dc:creator>
<dc:date>2019-09-04</dc:date>
<dc:identifier>doi:10.1101/749010</dc:identifier>
<dc:title><![CDATA[Novel genetic determinants of telomere length from a multi-ethnic analysis of 75,000 whole genome sequences in TOPMed]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-09-04</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/751115v1?rss=1">
<title>
<![CDATA[
Undulating changes in human plasma proteome across lifespan are linked to disease 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/751115v1?rss=1</link>
<description><![CDATA[
Aging is the predominant risk factor for numerous chronic diseases that limit healthspan. Mechanisms of aging are thus increasingly recognized as therapeutic targets. Blood from young mice reverses aspects of aging and disease across multiple tissues, pointing to the intriguing possibility that age-related molecular changes in blood can provide novel insight into disease biology. We measured 2,925 plasma proteins from 4,331 young adults to nonagenarians and developed a novel bioinformatics approach which uncovered profound non-linear alterations in the human plasma proteome with age. Waves of changes in the proteome in the fourth, seventh, and eighth decades of life reflected distinct biological pathways, and revealed differential associations with the genome and proteome of age-related diseases and phenotypic traits. This new approach to the study of aging led to the identification of unexpected signatures and pathways of aging and disease and offers potential pathways for aging interventions.
]]></description>
<dc:creator>Lehallier, B.</dc:creator>
<dc:creator>Gate, D.</dc:creator>
<dc:creator>Schaum, N.</dc:creator>
<dc:creator>Nanasi, T.</dc:creator>
<dc:creator>Lee, S. E.</dc:creator>
<dc:creator>Yousef, H.</dc:creator>
<dc:creator>Moran Losada, P.</dc:creator>
<dc:creator>Berdnik, D.</dc:creator>
<dc:creator>Keller, A.</dc:creator>
<dc:creator>Verghese, J.</dc:creator>
<dc:creator>Sathyan, S.</dc:creator>
<dc:creator>Franceschi, C.</dc:creator>
<dc:creator>Milman, S.</dc:creator>
<dc:creator>Barzilai, N.</dc:creator>
<dc:creator>Wyss-Coray, T.</dc:creator>
<dc:date>2019-09-01</dc:date>
<dc:identifier>doi:10.1101/751115</dc:identifier>
<dc:title><![CDATA[Undulating changes in human plasma proteome across lifespan are linked to disease]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-09-01</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/758557v1?rss=1">
<title>
<![CDATA[
A metabolic pathway for bile acid dehydroxylation by the gut microbiome 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/758557v1?rss=1</link>
<description><![CDATA[
The gut microbiota synthesize hundreds of molecules, many of which are known to impact host physiology. Among the most abundant metabolites are the secondary bile acids deoxycholic acid (DCA) and lithocholic acid (LCA), which accumulate at ~500 M and are known to block C. difficile growth1, promote hepatocellular carcinoma2, and modulate host metabolism via the GPCR TGR53. More broadly, DCA, LCA and their derivatives are a major component of the recirculating bile acid pool4; the size and composition of this pool are a target of therapies for primary biliary cholangitis and nonalcoholic steatohepatitis. Despite the clear impact of DCA and LCA on host physiology, incomplete knowledge of their biosynthetic genes and a lack of genetic tools in their native producer limit our ability to modulate secondary bile acid levels in the host. Here, we complete the pathway to DCA/LCA by assigning and characterizing enzymes for each of the steps in its reductive arm, revealing a strategy in which the A-B rings of the steroid core are transiently converted into an electron acceptor for two reductive steps carried out by Fe-S flavoenzymes. Using anaerobic in vitro reconstitution, we establish that a set of six enzymes is necessary and sufficient for the 8-step conversion of cholic acid to DCA. We then engineer the pathway into Clostridium sporogenes, conferring production of DCA and LCA on a non-producing commensal and demonstrating that a microbiome-derived pathway can be expressed and controlled heterologously. These data establish a complete pathway to two central components of the bile acid pool, and provide a road map for deorphaning and engineering pathways from the microbiome as a critical step toward controlling the metabolic output of the gut microbiota.
]]></description>
<dc:creator>Funabashi, M.</dc:creator>
<dc:creator>Grove, T.</dc:creator>
<dc:creator>Pascal, V.</dc:creator>
<dc:creator>Varma, Y.</dc:creator>
<dc:creator>McFadden, M.</dc:creator>
<dc:creator>Brown, L.</dc:creator>
<dc:creator>Guo, C.</dc:creator>
<dc:creator>Medema, M. H.</dc:creator>
<dc:creator>Almo, S.</dc:creator>
<dc:creator>Fischbach, M. A.</dc:creator>
<dc:date>2019-09-05</dc:date>
<dc:identifier>doi:10.1101/758557</dc:identifier>
<dc:title><![CDATA[A metabolic pathway for bile acid dehydroxylation by the gut microbiome]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-09-05</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/759886v1?rss=1">
<title>
<![CDATA[
Bacterial Hyperswarming as a Protective Response to Intestinal Stress 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/759886v1?rss=1</link>
<description><![CDATA[
Bacterial swarming, a collective movement on a surface, has rarely been associated with human pathophysiology. Here, we report for the first time that bacterial swarmers are associated with protection against intestinal inflammation. We show that bacterial swarmers are highly predictive of intestinal stress in mice and humans. We isolated a novel Enterobacter swarming strain, SM3, from mouse feces. SM3 and other known commensal swarmers contrast to their respective swarming-deficient, but swimming-competent isogenic strains abrogated intestinal inflammation in mice. Treatment of colitic mice with SM3, but not its mutants, enriched beneficial fecal anaerobes belonging to the family, Bacteroidales S24-7. We observed SM3 swarming associated pathways in the in vivo fecal metatranscriptomes. In vitro growth of S24-7 was enriched in presence of SM3 or its mutants conjecturing that bacterial swarming in vivo might influence SM3s access to S24-7 in the intestines. Overall, our work identifies a new paradigm in which intestinal stress allows for the emergence of swarming bacteria, which can counterintuitively heal intestinal inflammation.
]]></description>
<dc:creator>Chen, W.</dc:creator>
<dc:creator>De, A.</dc:creator>
<dc:creator>Li, H.</dc:creator>
<dc:creator>Lukin, D. J.</dc:creator>
<dc:creator>Szymczak, W.</dc:creator>
<dc:creator>Sun, K.</dc:creator>
<dc:creator>Kelly, L.</dc:creator>
<dc:creator>Wright, J. R.</dc:creator>
<dc:creator>Lamendella, R.</dc:creator>
<dc:creator>Ghosh, S.</dc:creator>
<dc:creator>Kearns, D. B.</dc:creator>
<dc:creator>He, Z.</dc:creator>
<dc:creator>Jobin, C.</dc:creator>
<dc:creator>Luo, X.</dc:creator>
<dc:creator>Byju, A.</dc:creator>
<dc:creator>Chatterjee, S.</dc:creator>
<dc:creator>Yeoh, B. S.</dc:creator>
<dc:creator>Vijay-Kumar, M.</dc:creator>
<dc:creator>Tang, J. X.</dc:creator>
<dc:creator>Mani, S.</dc:creator>
<dc:date>2019-09-08</dc:date>
<dc:identifier>doi:10.1101/759886</dc:identifier>
<dc:title><![CDATA[Bacterial Hyperswarming as a Protective Response to Intestinal Stress]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-09-08</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/763482v1?rss=1">
<title>
<![CDATA[
Linker Histone H1 subtypes specifically regulate neutrophil differentiation 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/763482v1?rss=1</link>
<description><![CDATA[
Neutrophils are important innate immune cells that tackle invading pathogens with different effector mechanisms. They acquire this antimicrobial potential during their maturation in the bone marrow, where they differentiate from hematopoietic stem cells in a process called granulopoiesis. Mature neutrophils are terminally differentiated and short-lived with a high turnover rate. Here, we show a critical role for linker histone H1 on the differentiation and function of neutrophils using a genome-wide CRISPR/Cas9 screen in the human cell line PLB-985. We systematically disrupted expression of somatic H1 subtypes to show that individual H1 subtypes affect PLB-985 maturation in opposite ways. Importantly, H1 subtypes also affect neutrophil differentiation of murine bone marrow stem cells, demonstrating an unexpected subtype-specific role for H1 in granulopoiesis.
]]></description>
<dc:creator>Sollberger, G.</dc:creator>
<dc:creator>Streeck, R.</dc:creator>
<dc:creator>Caffrey, B. E.</dc:creator>
<dc:creator>Zychlinsky, A.</dc:creator>
<dc:date>2019-09-09</dc:date>
<dc:identifier>doi:10.1101/763482</dc:identifier>
<dc:title><![CDATA[Linker Histone H1 subtypes specifically regulate neutrophil differentiation]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-09-09</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/770743v1?rss=1">
<title>
<![CDATA[
Microscale physiological events on the human cortical surface detected with PEDOT:PSS Electrodes 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/770743v1?rss=1</link>
<description><![CDATA[
Despite ongoing advancements in our understanding of the local single-cellular and network-level activity of neuronal populations in the human brain, extraordinarily little is known about their  intermediate microscale local circuit dynamics. Here, we utilized ultrahigh density microelectrode arrays and a rare opportunity to perform intracranial recordings across multiple cortical areas in human participants to discover three distinct classes of cortical activity that are not locked to ongoing natural brain rhythmic activity. The first included fast waveforms similar to extracellular single unit activity. The other two types were discrete events with slower waveform dynamics and were found preferentially in upper layers of the grey matter. They were also observed in rodents, non-human primates, and semi-chronic recordings in humans via laminar and Utah array microelectrodes. The rates of all three events were selectively modulated by auditory and electrical stimuli, pharmacological manipulation, and cold saline application and had small causal co-occurrences. These results suggest that with the proper combination of high resolution microelectrodes and analytic techniques it is possible to capture neuronal dynamics that lay between somatic action potentials and aggregate population activity and that understanding these intermediate microscale dynamics may reveal important details of the full circuit behavior in human cognition.
]]></description>
<dc:creator>Paulk, A. C.</dc:creator>
<dc:creator>Yang, J. C.</dc:creator>
<dc:creator>Cleary, D. R.</dc:creator>
<dc:creator>Soper, D. J.</dc:creator>
<dc:creator>Lee, S. H.</dc:creator>
<dc:creator>Ganji, M.</dc:creator>
<dc:creator>Ro, Y. G.</dc:creator>
<dc:creator>Oh, H.</dc:creator>
<dc:creator>Hossain, L.</dc:creator>
<dc:creator>Rogers, N.</dc:creator>
<dc:creator>Kilic, K.</dc:creator>
<dc:creator>Ryu, S. B.</dc:creator>
<dc:creator>Lee, S. W.</dc:creator>
<dc:creator>Hermiz, J.</dc:creator>
<dc:creator>Gilja, V.</dc:creator>
<dc:creator>Lee, J. W.</dc:creator>
<dc:creator>Maus, D.</dc:creator>
<dc:creator>Devor, A.</dc:creator>
<dc:creator>Fried, S. I.</dc:creator>
<dc:creator>Jones, P. S.</dc:creator>
<dc:creator>Nahed, B. V.</dc:creator>
<dc:creator>Ben-Haim, S.</dc:creator>
<dc:creator>Raslan, A. M. T.</dc:creator>
<dc:creator>Siler, D. A.</dc:creator>
<dc:creator>Cahill, D. P.</dc:creator>
<dc:creator>Williams, Z. M.</dc:creator>
<dc:creator>Cosgrove, G. R.</dc:creator>
<dc:creator>Dayeh, S. A.</dc:creator>
<dc:creator>Cash, S. S.</dc:creator>
<dc:date>2019-09-18</dc:date>
<dc:identifier>doi:10.1101/770743</dc:identifier>
<dc:title><![CDATA[Microscale physiological events on the human cortical surface detected with PEDOT:PSS Electrodes]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-09-18</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/775353v1?rss=1">
<title>
<![CDATA[
Chronic repression by MAF1 supports futile RNA cycling as a mechanism for obesity resistance 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/775353v1?rss=1</link>
<description><![CDATA[
Maf1-/- mice are lean, obesity-resistant and metabolically inefficient. Their increased energy expenditure is thought to be driven by a futile RNA cycle that reprograms metabolism to meet an increased demand for nucleotides stemming from the deregulation of RNA polymerase (pol) III transcription. Metabolic changes consistent with this model have been reported in both fasted and refed mice, however the impact of the fasting-refeeding-cycle on pol III function has not been examined. Here we show that changes in pol III occupancy in the liver of fasted versus refed wild-type mice are largely confined to low and intermediate occupancy genes; high occupancy genes are unchanged. However, in Maf1-/- mice, pol III occupancy of the vast majority of active loci in liver and the levels of specific precursor tRNAs in this tissue and other organs are higher than wild-type in both fasted and refed conditions. Thus, MAF1 functions as a chronic repressor of active pol III loci and can modulate transcription under different conditions. Our findings support the futile RNA cycle hypothesis, elaborate the mechanism of pol III repression by MAF1 and demonstrate a modest effect of MAF1 on global translation via reduced mRNA levels and translation efficiencies for several ribosomal proteins.
]]></description>
<dc:creator>Bonhoure, N.</dc:creator>
<dc:creator>Praz, V.</dc:creator>
<dc:creator>Moir, R. D.</dc:creator>
<dc:creator>Willemin, G.</dc:creator>
<dc:creator>Mange, F.</dc:creator>
<dc:creator>Moret, C.</dc:creator>
<dc:creator>Willis, I. M.</dc:creator>
<dc:creator>Hernandez, N.</dc:creator>
<dc:date>2019-09-19</dc:date>
<dc:identifier>doi:10.1101/775353</dc:identifier>
<dc:title><![CDATA[Chronic repression by MAF1 supports futile RNA cycling as a mechanism for obesity resistance]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-09-19</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/780668v1?rss=1">
<title>
<![CDATA[
Towards a Fine-scale Population Health Monitoring System 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/780668v1?rss=1</link>
<description><![CDATA[
Understanding population health disparities is an essential component of equitable precision health efforts. Epidemiology research often relies on definitions of race and ethnicity, but these population labels may not adequately capture disease burdens specific to sub-populations. Here we propose a framework for repurposing data from Electronic Health Records (EHRs) in concert with genomic data to explore enrichment of disease within sub-populations. Using data from a diverse biobank in New York City, we genetically identified 17 sub-populations, and noted the presence of genetic founder effects in 7. By then linking community membership to the EHR, we were able to identify over 600 health outcomes that were statistically enriched within a specific population, with many representing known associations, and many others being novel. This work reinforces the utility of linking genomic data to EHRs, and provides a framework towards fine-scale monitoring of population health.
]]></description>
<dc:creator>Belbin, G. M.</dc:creator>
<dc:creator>Wenric, S.</dc:creator>
<dc:creator>Cullina, S.</dc:creator>
<dc:creator>Glicksberg, B. S.</dc:creator>
<dc:creator>Moscati, A.</dc:creator>
<dc:creator>Wojcik, G. L.</dc:creator>
<dc:creator>Shemirani, R.</dc:creator>
<dc:creator>Beckmann, N. D.</dc:creator>
<dc:creator>Cohain, A.</dc:creator>
<dc:creator>Sorokin, E. P.</dc:creator>
<dc:creator>Park, D. S.</dc:creator>
<dc:creator>Ambite, J.-L.</dc:creator>
<dc:creator>Ellis, S.</dc:creator>
<dc:creator>Auton, A.</dc:creator>
<dc:creator>CBIPM Genomics Team,</dc:creator>
<dc:creator>Regeneron Genetics Center,</dc:creator>
<dc:creator>Bottinger, E. P.</dc:creator>
<dc:creator>Cho, J. H.</dc:creator>
<dc:creator>Loos, R. J.</dc:creator>
<dc:creator>Abul-Husn, N. S.</dc:creator>
<dc:creator>Zaitlen, N. A.</dc:creator>
<dc:creator>Gignoux, C. R.</dc:creator>
<dc:creator>Kenny, E. E.</dc:creator>
<dc:date>2019-09-24</dc:date>
<dc:identifier>doi:10.1101/780668</dc:identifier>
<dc:title><![CDATA[Towards a Fine-scale Population Health Monitoring System]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-09-24</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/781005v1?rss=1">
<title>
<![CDATA[
Acute cerebellar knockdown of Sgce reproduces salient features of Myoclonus-dystonia (DYT11) in mice 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/781005v1?rss=1</link>
<description><![CDATA[
Myoclonus dystonia (DYT11) is a movement disorder caused by loss-of-function mutations in SGCE and characterized by involuntary jerking and dystonia that frequently improve after drinking alcohol. Existing transgenic mouse models of DYT11 exhibit only mild motor symptoms, possibly due to rodent-specific developmental compensation mechanisms, which have limited the study of neural mechanisms underlying DYT11. To circumvent potential compensation, we used short hairpin RNA (shRNA) to acutely knock down Sgce in the adult mouse and found that this approach produced dystonia and repetitive, myoclonic-like movements in mice that improved after administration of ethanol. Acute knockdown of Sgce in the cerebellum, but not the basal ganglia, produced motor symptoms, likely due to aberrant cerebellar activity. The acute knockdown model described here reproduces the salient features of DYT11 and provides a platform to study the mechanisms underlying symptoms of the disorder, and to explore potential therapeutic options.
]]></description>
<dc:creator>Khodakhah, K.</dc:creator>
<dc:creator>Washburn, S.</dc:creator>
<dc:creator>Freemont, R.</dc:creator>
<dc:creator>Moreno-Escobar, M. C.</dc:creator>
<dc:creator>Angueyra, C.</dc:creator>
<dc:date>2019-09-25</dc:date>
<dc:identifier>doi:10.1101/781005</dc:identifier>
<dc:title><![CDATA[Acute cerebellar knockdown of Sgce reproduces salient features of Myoclonus-dystonia (DYT11) in mice]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-09-25</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/782748v1?rss=1">
<title>
<![CDATA[
Inherited Causes of Clonal Hematopoiesis of Indeterminate Potential in TOPMed Whole Genomes 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/782748v1?rss=1</link>
<description><![CDATA[
Age is the dominant risk factor for most chronic human diseases; yet the mechanisms by which aging confers this risk are largely unknown.1 Recently, the age-related acquisition of somatic mutations in regenerating hematopoietic stem cell populations was associated with both hematologic cancer incidence2-4 and coronary heart disease prevalence.5 Somatic mutations with leukemogenic potential may confer selective cellular advantages leading to clonal expansion, a phenomenon termed  Clonal Hematopoiesis of Indeterminate Potential (CHIP).6 Simultaneous germline and somatic whole genome sequence analysis now provides the opportunity to identify root causes of CHIP. Here, we analyze high-coverage whole genome sequences from 97,691 participants of diverse ancestries in the NHLBI TOPMed program and identify 4,229 individuals with CHIP. We identify associations with blood cell, lipid, and inflammatory traits specific to different CHIP genes. Association of a genome-wide set of germline genetic variants identified three genetic loci associated with CHIP status, including one locus at TET2 that was African ancestry specific. In silico-informed in vitro evaluation of the TET2 germline locus identified a causal variant that disrupts a TET2 distal enhancer. Aggregates of rare germline loss-of-function variants in CHEK2, a DNA damage repair gene, predisposed to CHIP acquisition. Overall, we observe that germline genetic variation altering hematopoietic stem cell function and the fidelity of DNA-damage repair increase the likelihood of somatic mutations leading to CHIP.
]]></description>
<dc:creator>Bick, A. G.</dc:creator>
<dc:creator>Weinstock, J.</dc:creator>
<dc:creator>Nandakumar, S. K.</dc:creator>
<dc:creator>Fulco, C. P.</dc:creator>
<dc:creator>Leventhal, M. J.</dc:creator>
<dc:creator>Bao, E. L.</dc:creator>
<dc:creator>Nasser, J.</dc:creator>
<dc:creator>Zekavat, S. M.</dc:creator>
<dc:creator>Szeto, M. D.</dc:creator>
<dc:creator>Laurie, C.</dc:creator>
<dc:creator>Taub, M.</dc:creator>
<dc:creator>Mitchell, B.</dc:creator>
<dc:creator>Barnes, K.</dc:creator>
<dc:creator>Moscati, A.</dc:creator>
<dc:creator>Fornage, M.</dc:creator>
<dc:creator>Redline, S.</dc:creator>
<dc:creator>Psaty, B. M.</dc:creator>
<dc:creator>Silverman, E.</dc:creator>
<dc:creator>Weiss, S.</dc:creator>
<dc:creator>Palmer, N.</dc:creator>
<dc:creator>Ramachandran, V.</dc:creator>
<dc:creator>Burchard, E.</dc:creator>
<dc:creator>Kardia, S.</dc:creator>
<dc:creator>He, J.</dc:creator>
<dc:creator>Kaplan, R.</dc:creator>
<dc:creator>Smith, N. L.</dc:creator>
<dc:creator>Arnett, D.</dc:creator>
<dc:creator>Schwartz, D.</dc:creator>
<dc:creator>Correa, A.</dc:creator>
<dc:creator>de Andrade, M.</dc:creator>
<dc:creator>Guo, X.</dc:creator>
<dc:creator>Konkle, B. A.</dc:creator>
<dc:creator>Custer, B.</dc:creator>
<dc:creator>Peralta, J.</dc:creator>
<dc:creator>Gui, H.</dc:creator>
<dc:creator>Meyers, D.</dc:creator>
<dc:creator>McGarvey, S. T.</dc:creator>
<dc:creator>Chen, I.</dc:creator>
<dc:creator>Shoemaker, M. B.</dc:creator>
<dc:creator>Peyser, P. A.</dc:creator>
<dc:creator>Broome, J.</dc:creator>
<dc:creator>Gogarten, S.</dc:creator>
<dc:creator>Wang, F. F.</dc:creator>
<dc:creator>Wong, Q.</dc:creator>
<dc:creator>Montasser, M.</dc:creator>
<dc:creator>Da</dc:creator>
<dc:date>2019-09-27</dc:date>
<dc:identifier>doi:10.1101/782748</dc:identifier>
<dc:title><![CDATA[Inherited Causes of Clonal Hematopoiesis of Indeterminate Potential in TOPMed Whole Genomes]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-09-27</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/784009v1?rss=1">
<title>
<![CDATA[
Age-dependent neuroprotective effect of an SK3. channel agonist on excitotoxityto dopaminergic neurons in organotypic culture 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/784009v1?rss=1</link>
<description><![CDATA[
We evaluated the age-dependency of the neuroprotective effect of an small-conductance calcium activated potassium channel 3 (SK3) agonist, 1-EBIO, on AMPA excitoxicity to dopaminergic neurons (DN) in organotypic cultures. Most TH+ neurons were also SK3+. SK3+/TH-cells (DN+) were common at each developmental stage but more prominently at day in vitro (DIV) 8. Young DN+ neurons were small bipolar and fusiform, whereas mature ones were large and multipolar. Exposure of organotypic cultures to AMPA (100 m, 16 h) had no effect on the survival of DN+ at DIV 8, but caused significant toxicity at DIV 15 (n=15, p=0.005) and DIV 22 (n=15, p<<0.001). These results indicate that susceptibility of DN to AMPA excitotoxicity is developmental stage-dependent in embryonic VM organotypic cultures. Immature DN+ (small, bipolar) were increased after AMPA (100 m, 16 h) at DIV 8, at the expense of the number of differentiated (large, multipolar) DN+ (p=0.039). This effect was larger at DIV 15 (p<<<0.0001) and at DIV 22 (p<<<0.0001). At DIV 8, 30 M 1-EBIO resulted in a large increase in DN+. At DIV 15, AMPA toxicity was prevented by exposure to 30 M, but not 100 M 1-EBIO. At DIV 22, excitotoxicity was unaffected by 30 M 1-EBIO, and partially reduced by 100 M 1-EBIO. The effects of the SK3. channel agonist 1-EBIO on the survival of SK3.-expressing dopaminergic neurons were concentrationdependent and influenced by neuronal developmental stage.
]]></description>
<dc:creator>Maldonado, O.</dc:creator>
<dc:creator>Jenkins, A.</dc:creator>
<dc:creator>Belalcazar, H. M.</dc:creator>
<dc:creator>Hernandez-Cuervo, H.</dc:creator>
<dc:creator>Ladaga, G.</dc:creator>
<dc:creator>Padilla, L.</dc:creator>
<dc:creator>de Erausquin, G. A.</dc:creator>
<dc:date>2019-09-26</dc:date>
<dc:identifier>doi:10.1101/784009</dc:identifier>
<dc:title><![CDATA[Age-dependent neuroprotective effect of an SK3. channel agonist on excitotoxityto dopaminergic neurons in organotypic culture]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-09-26</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/785931v1?rss=1">
<title>
<![CDATA[
Comparative single-cell transcriptomics of complete insect nervous systems 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/785931v1?rss=1</link>
<description><![CDATA[
Molecular profiles of neurons influence information processing, but bridging the gap between genes, circuits, and behavior has been very difficult. Furthermore, the behavioral state of an animal continuously changes across development and as a result of sensory experience. How behavioral state influences molecular cell state is poorly understood. Here we present a complete atlas of the Drosophila larval central nervous system composed of over 200,000 single cells across four developmental stages. We develop polyseq, a python package, to perform cell-type analyses. We use single-molecule RNA-FISH to validate our scRNAseq findings. To investigate how internal state affects cell state, we optogentically altered internal state with high-throughput behavior protocols designed to mimic wasp sting and over activation of the memory system. We found nervous system-wide and neuron-specific gene expression changes. This resource is valuable for developmental biology and neuroscience, and it advances our understanding of how genes, neurons, and circuits generate behavior.
]]></description>
<dc:creator>Cocanougher, B. T.</dc:creator>
<dc:creator>Wittenbach, J. D.</dc:creator>
<dc:creator>Long, X.</dc:creator>
<dc:creator>Kohn, A. B.</dc:creator>
<dc:creator>Norekian, T. P.</dc:creator>
<dc:creator>Yan, J.</dc:creator>
<dc:creator>Colonell, J.</dc:creator>
<dc:creator>Masson, J.-B.</dc:creator>
<dc:creator>Truman, J. W.</dc:creator>
<dc:creator>Cardona, A.</dc:creator>
<dc:creator>Turaga, S.</dc:creator>
<dc:creator>Singer, R. H.</dc:creator>
<dc:creator>Moroz, L. L.</dc:creator>
<dc:creator>Zlatic, M.</dc:creator>
<dc:date>2019-09-30</dc:date>
<dc:identifier>doi:10.1101/785931</dc:identifier>
<dc:title><![CDATA[Comparative single-cell transcriptomics of complete insect nervous systems]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-09-30</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/792671v1?rss=1">
<title>
<![CDATA[
Targeting the Pregnane X Receptor Using Microbial Metabolite Mimicry 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/792671v1?rss=1</link>
<description><![CDATA[
The human pregnane X receptor (PXR), a master regulator of drug metabolism, has important roles in intestinal homeostasis and abrogating inflammation. Existing PXR ligands have substantial off-target toxicity. Based on prior work that established microbial (indole) metabolites as PXR ligands, we proposed microbial metabolite mimicry as a novel strategy for drug discovery that allows to exploit previously unexplored parts of chemical space. Here we report functionalized indole-derivatives as first-in-class non-cytotoxic PXR agonists, as a proof-of-concept for microbial metabolite mimicry. The lead compound, FKK6, binds directly to PXR protein in solution, induces PXR specific target gene expression in, cells, human organoids, and mice. FKK6 significantly represses pro-inflammatory cytokine production cells and abrogates inflammation in mice expressing the human PXR gene. The development of FKK6 demonstrates for the first time that microbial metabolite mimicry is a viable strategy for drug discovery and opens the door to mine underexploited regions of chemical space.
]]></description>
<dc:creator>Dvorak, Z.</dc:creator>
<dc:creator>Felix Kopp, F.</dc:creator>
<dc:creator>Costello, C. M.</dc:creator>
<dc:creator>Kemp, J. S.</dc:creator>
<dc:creator>Li, H.</dc:creator>
<dc:creator>Vrzalova, A.</dc:creator>
<dc:creator>Stepankova, M.</dc:creator>
<dc:creator>Iveta Bartonkov, I.</dc:creator>
<dc:creator>Poulikova, K.</dc:creator>
<dc:creator>Vyhlidalova, B.</dc:creator>
<dc:creator>Nordstroem, L. U.</dc:creator>
<dc:creator>Karunaratne, C.</dc:creator>
<dc:creator>Ranhotra, H.</dc:creator>
<dc:creator>Mun, K. S.</dc:creator>
<dc:creator>Naren, A. P.</dc:creator>
<dc:creator>Murray, I.</dc:creator>
<dc:creator>Perdew, G. H.</dc:creator>
<dc:creator>Brtko, J.</dc:creator>
<dc:creator>Toporova, L.</dc:creator>
<dc:creator>Schon, A.</dc:creator>
<dc:creator>Wallace, B.</dc:creator>
<dc:creator>Walton, W. G.</dc:creator>
<dc:creator>Redinbo, M. R.</dc:creator>
<dc:creator>Sun, K.</dc:creator>
<dc:creator>Beck, A.</dc:creator>
<dc:creator>Kortagere, S.</dc:creator>
<dc:creator>Neary, M. C.</dc:creator>
<dc:creator>Chandran, A.</dc:creator>
<dc:creator>Vishveshwara, S.</dc:creator>
<dc:creator>Cavalluzzi, M. M.</dc:creator>
<dc:creator>Lentini, G.</dc:creator>
<dc:creator>Cui, J. Y.</dc:creator>
<dc:creator>Gu, H.</dc:creator>
<dc:creator>March, J. C.</dc:creator>
<dc:creator>Chaterjee, S.</dc:creator>
<dc:creator>Matson, A.</dc:creator>
<dc:creator>Wright, D.</dc:creator>
<dc:creator>Flannigan, K. L.</dc:creator>
<dc:creator>Hirota, S. A.</dc:creator>
<dc:creator>Mani, S.</dc:creator>
<dc:date>2019-10-04</dc:date>
<dc:identifier>doi:10.1101/792671</dc:identifier>
<dc:title><![CDATA[Targeting the Pregnane X Receptor Using Microbial Metabolite Mimicry]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-10-04</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/793380v1?rss=1">
<title>
<![CDATA[
Human hepatic tryptophan 2,3-dioxygenase ubiquitin-dependent protein degradation: The critical role of its exosite as the molecular lynchpin of its substrate-mediated protein stabilization 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/793380v1?rss=1</link>
<description><![CDATA[
Hepatic tryptophan 2,3-dioxygenase (TDO) is a cytoplasmic homotetrameric hemoprotein and the rate-limiting enzyme in the irreversible degradation of the essential amino acid L-tryptophan (L-Trp) to N-formylkynurenine, thus controlling the flux of L-Trp into its serotonergic and kynureninic/NAD pathways. TDO has long been recognized to be substrate-inducible via protein stabilization, but the molecular mechanism of this stabilization has remained elusive. Recent elucidation of human TDO (hTDO) crystal structure has identified a high-affinity (Kd {approx} 0.5 M) Trp-binding exosite in each of its 4 monomeric subunits. Mutation of the Glu105, Trp208 and Arg211 comprising this exosite not only abolished the high-affinity L-Trp binding, but also accelerated the ubiquitin-dependent proteasomal degradation of hTDO. We have further characterized this hTDO degradation by documenting that its ubiquitination by gp78/AMFR and CHIP E2/E3 ligase complexes occurs on external Lys-residues within or vicinal to acidic Asp/Glu and phosphorylated pSer/pThr (DEpSpT)-clusters. Furthermore, we have identified the unstructured hTDO N- and C-termini as imparting relatively high proteolytic instability, as their deletion ({Delta}NC) markedly prolonged hTDO t1/2. Additionally, although previous studies reported that upon hepatic heme-depletion, the heme-free apoTDO turns over with a t1/2 {approx} 2.2 h relative to the t1/2 of 7.7 h of holoTDO, mutating the axial heme-ligating His328 to Ala has the opposite effect of prolonging hTDO t1/2. Most importantly, introducing the exosite mutation into the {Delta}NC-deleted or H328A-mutant completely abolished their prolonged half-lives irrespective of L-Trp presence or absence, thereby revealing that the exosite is the molecular lynchpin that defines L-Trp-mediated TDO induction via protein stabilization.
]]></description>
<dc:creator>Kim, S.-M.</dc:creator>
<dc:creator>Liu, Y.</dc:creator>
<dc:creator>Wang, Y.</dc:creator>
<dc:creator>Karkashon, S.</dc:creator>
<dc:creator>Lewis-Ballester, A.</dc:creator>
<dc:creator>Yeh, S.-R.</dc:creator>
<dc:creator>Correia, M. A.</dc:creator>
<dc:date>2019-10-04</dc:date>
<dc:identifier>doi:10.1101/793380</dc:identifier>
<dc:title><![CDATA[Human hepatic tryptophan 2,3-dioxygenase ubiquitin-dependent protein degradation: The critical role of its exosite as the molecular lynchpin of its substrate-mediated protein stabilization]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-10-04</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/794487v1?rss=1">
<title>
<![CDATA[
Optimizing a human fecal assay that elicits bacterial swarming 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/794487v1?rss=1</link>
<description><![CDATA[
A distinct property of many bacteria is swarming: swift movement across a surface through flagella propulsion. Early research indicates that bacterial swarming can be a protective host response to intestinal inflammation. Central to the further study of bacterial swarming in human health is an effective and replicable assay for swarming that can accommodate complex material, such as fecal matter. To date, nearly all swarming assays described in the literature are specific for bacteria grown in culture, most often Pseudomonas. In this paper, we describe a protocol for discerning swarming of bacteria from frozen human fecal samples. Moreover, we tested 4 variables that may influence the effectiveness of the assay: the method by which frozen samples were thawed, the concentration of agar used in the Lysogenic broth (LB) agar plate, the volume of LB agar poured in the plate, and the volume of sample inoculated. We found that while the type of thaw and volume of LB agar had little to no effect on swarming, greater concentrations of agar were negatively correlated with swarming and greater volumes of the sample were positively correlated with swarming.
]]></description>
<dc:creator>Byju, A.</dc:creator>
<dc:creator>Patel, D.</dc:creator>
<dc:creator>Chen, W.</dc:creator>
<dc:creator>Mani, S.</dc:creator>
<dc:date>2019-10-07</dc:date>
<dc:identifier>doi:10.1101/794487</dc:identifier>
<dc:title><![CDATA[Optimizing a human fecal assay that elicits bacterial swarming]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-10-07</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/802710v1?rss=1">
<title>
<![CDATA[
Distinct spatiotemporal mechanisms underlie extra-classical receptive field modulation in macaque V1 microcircuits 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/802710v1?rss=1</link>
<description><![CDATA[
Complex scene perception depends upon the interaction between signals from the classical receptive field (CRF) and the extra-classical receptive field (eCRF) in primary visual cortex (V1) neurons. While much is known about V1 eCRF properties, it remains unknown how the underlying mechanisms map onto the cortical microcircuit. We probed the spatio-temporal dynamics of eCRF modulation using a reverse correlation paradigm, and found three principal eCRF mechanisms: tuned-facilitation, untuned-suppression, and tuned-suppression. Each mechanism had a distinct timing and spatial profile. Laminar analysis showed that the timing, orientation-tuning, and strength of eCRF mechanisms had distinct signatures within magnocellular and parvocellular processing streams in the V1 microcircuit. The existence of multiple eCRF mechanisms provides new insights into how V1 responds to spatial context. Modeling revealed that the differences in timing and scale of these mechanisms predicted distinct patterns of net modulation, reconciling many previous disparate physiological and psychophysical findings.
]]></description>
<dc:creator>Henry, C. A.</dc:creator>
<dc:creator>Jazayeri, M.</dc:creator>
<dc:creator>Shapley, R. M.</dc:creator>
<dc:creator>Hawken, M. J.</dc:creator>
<dc:date>2019-10-13</dc:date>
<dc:identifier>doi:10.1101/802710</dc:identifier>
<dc:title><![CDATA[Distinct spatiotemporal mechanisms underlie extra-classical receptive field modulation in macaque V1 microcircuits]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-10-13</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/808170v1?rss=1">
<title>
<![CDATA[
Viral manipulation of functionally distinct neurons from mice to humans 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/808170v1?rss=1</link>
<description><![CDATA[
Recent success in identifying gene regulatory elements in the context of recombinant adeno-associated virus vectors have enabled cell type-restricted gene expression. However, within the cerebral cortex these tools are presently limited to broad classes of neurons. To overcome this limitation, we developed a strategy that led to the identification of multiple novel enhancers to target functionally distinct neuronal subtypes. By investigating the regulatory landscape of the disease gene Scn1a, we identified enhancers that target the breadth of its expression, including two that are selective for parvalbumin and vasoactive intestinal peptide cortical interneurons. Demonstrating the functional utility of these elements, we found that the PV-specific enhancer allowed for the selective targeting and manipulation of these neurons across species, from mice to humans. Finally, we demonstrate that our selection method is generalizable to other genes and characterize four additional PV-specific enhancers with exquisite specificity for distinct regions of the brain. Altogether, these viral tools can be used for cell-type specific circuit manipulation and hold considerable promise for use in therapeutic interventions.
]]></description>
<dc:creator>Vormstein-Schneider, D. C.</dc:creator>
<dc:creator>Lin, J. D.</dc:creator>
<dc:creator>Pelkey, K. A.</dc:creator>
<dc:creator>Chittajallu, R.</dc:creator>
<dc:creator>Guo, B.</dc:creator>
<dc:creator>Arias Garcia, M.</dc:creator>
<dc:creator>Sakopoulos, S.</dc:creator>
<dc:creator>Stevenson, O.</dc:creator>
<dc:creator>Schneider, G.</dc:creator>
<dc:creator>Zhang, Q.</dc:creator>
<dc:creator>Sharma, J.</dc:creator>
<dc:creator>Franken, T. P.</dc:creator>
<dc:creator>Smith, J.</dc:creator>
<dc:creator>Vogel, I.</dc:creator>
<dc:creator>Sanchez, V.</dc:creator>
<dc:creator>Ibrahim, L. A.</dc:creator>
<dc:creator>Burbridge, T.</dc:creator>
<dc:creator>Favuzzi, E.</dc:creator>
<dc:creator>Saldi, G. A.</dc:creator>
<dc:creator>Xu, Q.</dc:creator>
<dc:creator>Guo, L.</dc:creator>
<dc:creator>Yuan, X.</dc:creator>
<dc:creator>Zaghloul, K. A.</dc:creator>
<dc:creator>Sabri, E.</dc:creator>
<dc:creator>Goldberg, E. M.</dc:creator>
<dc:creator>Devinsky, O.</dc:creator>
<dc:creator>Batista-Brito, R.</dc:creator>
<dc:creator>Reynolds, J.</dc:creator>
<dc:creator>Feng, G.</dc:creator>
<dc:creator>Fu, Z.</dc:creator>
<dc:creator>McBain, C. J.</dc:creator>
<dc:creator>Fishell, G. J.</dc:creator>
<dc:creator>Dimidschstein, J.</dc:creator>
<dc:date>2019-10-18</dc:date>
<dc:identifier>doi:10.1101/808170</dc:identifier>
<dc:title><![CDATA[Viral manipulation of functionally distinct neurons from mice to humans]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-10-18</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/809145v1?rss=1">
<title>
<![CDATA[
Expressional artifact caused by a co-injection marker rol-6 in C. elegans 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/809145v1?rss=1</link>
<description><![CDATA[
In transgenic research, selection markers have greatly facilitated the generation of transgenic animals. A prerequisite for a suitable selection marker to be used along with a test gene of interest is that the marker should not affect the phenotype of interest in transformed animals. One of the most common selection markers used in C. elegans transgenic approaches is the rol-6 co-injection marker, which induces a behavioral roller phenotype due to a cuticle defect but is not known to have other side effects. However, we found that the rol-6 co-injection marker can cause expression of GFP in the test sequence in a male-specific interneuron called CP09. We found that the rol-6 gene sequence included in the marker plasmid is responsible for this unwanted expression. Accordingly, the use of the rol-6 co-injection marker is not recommended when researchers intend to examine precise expression or perform functional studies especially targeting male C. elegans neurons. The rol-6 sequence region we identified can be used to drive a specific expression in CP09 neuron for future research.
]]></description>
<dc:creator>Jin, H.</dc:creator>
<dc:creator>Emmons, S. W.</dc:creator>
<dc:creator>Kim, B.</dc:creator>
<dc:date>2019-10-17</dc:date>
<dc:identifier>doi:10.1101/809145</dc:identifier>
<dc:title><![CDATA[Expressional artifact caused by a co-injection marker rol-6 in C. elegans]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-10-17</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/813279v1?rss=1">
<title>
<![CDATA[
Impact of intensive care unit admission during handover on mortality: a propensity matched cohort study 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/813279v1?rss=1</link>
<description><![CDATA[
IntroductionHandover is a process of transferring information, responsibility and authority for providing care of critically ill patients from a departing intensivist to an oncoming intensivist. The effect of i admission during a medical handover on clinical outcomes is unknown.

ObjectivesOur purpose was to evaluate the impact of ICU admission during a medical handover on clinical outcomes.

MethodsPost hoc analysis of a cohort study addressing the effect of ICU admissions during the handover on outcomes. This retrospective, single center, propensity matched cohort study was conducted in a 41-bed open general ICU located in a private tertiary care hospital in Sao Paulo, Brazil. Based on time of ICU admission, patients were categorized into two cohorts: handover group (ICU admission between 6:30 am to 7:30 or 6:30 pm to 7:30 pm) or control group (admission between 7:31 am to 6:29 pm or 7:31 pm to 6:29 am). Patients in the handover group were propensity matched to patients in the control group at 1:2 ratio. Our primary outcome was hospital mortality.

ResultsBetween June 1, 2013 and May 31, 2015, 6,650 adult patients were admitted to the ICU. Following exclusion of ineligible participants, 5,779 patients [389 (6.7%) in handover group and 5390 (93.3%) in control group] were eligible for propensity score matching, of whom 1,166 were successfully matched [389 (33.4%) handover group and 777 (66.6%) in control group]. Before matching, hospital mortality was 14.1% (55/389 patients) in handover group compared to 11.7% (628/5,390) in control group (p=0.142). After propensity-score matching, ICU admission during handover was not associated with increased risk of ICU (OR, 1.40; 95% CI, 0.92 to 2.11; p=0.11) and hospital (OR, 1.23; 95%CI, 0.85 to 1.75; p=0.26) mortality. ICU and hospital length of stay did not differ between the groups.

ConclusionIn this propensity-matched single center cohort study, ICU admission during medical handover did not affect clinical outcomes.
]]></description>
<dc:creator>Midega, T. D.</dc:creator>
<dc:creator>Filho, N. C. V. L.</dc:creator>
<dc:creator>Nassar, A. P.</dc:creator>
<dc:creator>Alencar, R. M.</dc:creator>
<dc:creator>Neto, A. C.</dc:creator>
<dc:creator>Ferraz, L. R.</dc:creator>
<dc:creator>Correa, T. D.</dc:creator>
<dc:date>2019-10-21</dc:date>
<dc:identifier>doi:10.1101/813279</dc:identifier>
<dc:title><![CDATA[Impact of intensive care unit admission during handover on mortality: a propensity matched cohort study]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-10-21</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/818195v1?rss=1">
<title>
<![CDATA[
The Golgi Glycoprotein MGAT4D Protects Testicular Germ Cells From Mild Heat Stress 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/818195v1?rss=1</link>
<description><![CDATA[
Male germ cells are sensitive to heat stress and testes must be maintained outside the body for optimal fertility. However, no germ cell intrinsic mechanism that protects from heat has been reported. Here, we identify the germ cell specific Golgi glycoprotein MGAT4D as a protector of male germ cells from heat stress. Mgat4d is highly expressed in spermatocytes and spermatids. Unexpectedly, when the Mgat4d gene was inactivated globally or conditionally in spermatogonia, or mis-expressed in spermatogonia, spermatocytes or spermatids, neither spermatogenesis nor fertility were affected. On the other hand, when males were subjected to mild heat stress of the testis (43{degrees}C for 25 min), germ cells with inactivated Mgat4d were markedly more sensitive to the effects of heat stress, and transgenic mice expressing Mgat4d were partially protected from heat stress. Germ cells lacking Mgat4d generally mounted a similar heat shock response to control germ cells, but could not maintain that response. Several pathways activated by heat stress in wild type were induced to a lesser extent in Mgat4d[-/-] heat-stressed germ cells (NF{kappa}B response, TNF and TGF{beta} signaling, Hif1 and Myc genes). Thus, the Golgi glycoprotein MGAT4D is a novel, intrinsic protector of male germ cells from heat stress.
]]></description>
<dc:creator>Akintayo, A.</dc:creator>
<dc:creator>Liang, M.</dc:creator>
<dc:creator>Bartholdy, B.</dc:creator>
<dc:creator>Batista, F.</dc:creator>
<dc:creator>Aguilan, J.</dc:creator>
<dc:creator>Prendergast, J.</dc:creator>
<dc:creator>Sundaram, S.</dc:creator>
<dc:creator>Stanley, P.</dc:creator>
<dc:date>2019-10-28</dc:date>
<dc:identifier>doi:10.1101/818195</dc:identifier>
<dc:title><![CDATA[The Golgi Glycoprotein MGAT4D Protects Testicular Germ Cells From Mild Heat Stress]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-10-28</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/822007v1?rss=1">
<title>
<![CDATA[
4-state model for simulating kinetic and steady-state voltage-dependent gating of gap junctions 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/822007v1?rss=1</link>
<description><![CDATA[
Gap junction (GJ) channels, formed of connexin (Cx) proteins, provide a direct pathway for metabolic and electrical cell-to-cell communication. These specialized channels are not just passive conduits for the passage of ions and metabolites, but have been shown to gate robustly in response to transjunctional voltage, Vj, the voltage difference between two coupled cells and are regulated by various chemical factors. Voltage gating of GJs may play a physiological role, particularly in excitable cells which can exhibit large transients in membrane potential during the generation of an action potential. We present a mathematical/computational model of GJ channel voltage gating to assess properties of GJ channels that takes into account contingent gating of two series hemichannels and the distribution of Vj across each hemichannel. From electrophysiological recordings in cell cultures transfected with Cx43 and Cx45, isoforms that are expressed in cardiac tissue, data sets were fit simultaneously using global optimization. The results showed that the model is capable of describing both steady-state and kinetic properties of homotypic and heterotypic GJ channels composed of these connexins. Moreover, mathematical analyses showed that the model can be simplified to a reversible two-state system and solved analytically, using a rapid equilibrium assumption. Given that excitable cells are arranged in interconnected networks, the equilibrium assumption allows for a substantial reduction in computation time, which is useful in simulations of large clusters of coupled cells. Overall, this model can serve not just as a modeling tool, but also to provide a means of testing GJ channel gating behavior.nnSignificanceGap junction (GJ) channels gate in response to transjunctional voltage which provides the capacity for dynamic regulation of intercellular coupling. Kinetic properties of GJs in modeling studies have been infrequently addressed and we present a computational model of voltage gating that can account for both kinetic and steady-state changes in junctional conductance, gj. Although GJs possess two gating mechanisms, our analysis indicates that changes in gj for each voltage polarity can be adequately described by a kinetic scheme describing a single mechanism in each of the hemichannels, suggesting functional dominance of one mechanism over a substantial voltage range. This property allowed for model simplification that can be applied for efficient simulation of sizeable cell clusters and analyses of electrophysiological data.
]]></description>
<dc:creator>Snipas, M.</dc:creator>
<dc:creator>Kraujalis, T.</dc:creator>
<dc:creator>Maciunas, K.</dc:creator>
<dc:creator>Kraujaliene, L.</dc:creator>
<dc:creator>Gudaitis, L.</dc:creator>
<dc:creator>Verselis, V. K.</dc:creator>
<dc:date>2019-10-29</dc:date>
<dc:identifier>doi:10.1101/822007</dc:identifier>
<dc:title><![CDATA[4-state model for simulating kinetic and steady-state voltage-dependent gating of gap junctions]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-10-29</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/829606v1?rss=1">
<title>
<![CDATA[
MS2-TRIBE evaluates protein-RNA interactions and nuclear organization of transcription by RNA editing 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/829606v1?rss=1</link>
<description><![CDATA[
Nearly every step of RNA regulation is mediated by binding proteins (RBPs). The most common method to identify specific RBP target transcripts in vivo is by crosslinking ("CLIP" and its variants), which rely on protein-RNA crosslinking and specific antibodies. Another recently introduced method exploits RNA editing, with the catalytic domain of ADAR covalently attached to a specific RBP ("TRIBE"). Both approaches suffer from difficulties in distinguishing real RNA targets from false negative and especially false positive signals. To critically evaluate this problem, we used fibroblasts from a mouse where every endogenous {beta}-actin mRNA molecule was tagged with the bacteriophage MS2 RNA stem loops; hence there is only a single bona fide target mRNA for the MS2 capsid protein (MCP). CLIP and TRIBE could both detect the single RNA target, albeit with some false positives (transcripts lacking the MS2 stem loops). Consistent false positive CLIP signals could be attributed to nonspecific antibody crosslinking. To our surprise, the supposed false positive TRIBE targets correlated with the location of genes spatially proximal to the {beta}-actin gene. This result indicates that MCP-ADAR bound to {beta}-actin mRNA contacted and edited nearby nascent transcripts, as evidenced by frequent intronic editing. Importantly, nascent transcripts on nearby chromosomes were also edited, agreeing with the interchromosomal contacts observed in chromosome paint and Hi-C. The identification of nascent RNA-RNA contacts imply that RNA-regulatory proteins such as splicing factors can associate with multiple nascent transcripts and thereby form domains of post-transcriptional activity, which increase their local concentrations. These results more generally indicate that TRIBE combined with the MS2 system, MS2-TRIBE, is a new tool to study nuclear RNA organization and regulation.
]]></description>
<dc:creator>Biswas, J.</dc:creator>
<dc:creator>Rahman, R.</dc:creator>
<dc:creator>Gupta, V.</dc:creator>
<dc:creator>Rosbash, M.</dc:creator>
<dc:creator>Singer, R.</dc:creator>
<dc:date>2019-11-04</dc:date>
<dc:identifier>doi:10.1101/829606</dc:identifier>
<dc:title><![CDATA[MS2-TRIBE evaluates protein-RNA interactions and nuclear organization of transcription by RNA editing]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-11-04</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/833582v1?rss=1">
<title>
<![CDATA[
Varstation: a complete and efficient tool to support NGS data analysis 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/833582v1?rss=1</link>
<description><![CDATA[
SummaryVarstation is a cloud-based NGS data processor and analyzer for human genetic variation. This resource provides a customizable, centralized, safe and clinically validated environment aiming to improve and optimize the flow of NGS analyses and reports related with clinical and research genetics.nnAvailability and implementationVarstation is freely available at http://varstation.com, for academic use.nnContactcontact@varstation.comnnSupplementary informationSupplementary data are available at Bioinformatics online.
]]></description>
<dc:creator>Faria, A. C. O.</dc:creator>
<dc:creator>Caraciolo, M.</dc:creator>
<dc:creator>Minillo, R. M.</dc:creator>
<dc:creator>Almeida, T. F.</dc:creator>
<dc:creator>Pereira, S. M.</dc:creator>
<dc:creator>Cervato, M. C.</dc:creator>
<dc:creator>Oliveira, J. B.</dc:creator>
<dc:date>2019-11-07</dc:date>
<dc:identifier>doi:10.1101/833582</dc:identifier>
<dc:title><![CDATA[Varstation: a complete and efficient tool to support NGS data analysis]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-11-07</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/835793v1?rss=1">
<title>
<![CDATA[
Paradoxical role of AT-rich interactive domain 1A in restraining pancreatic carcinogenesis 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/835793v1?rss=1</link>
<description><![CDATA[
Background & AimsARID1A is postulated to be a tumor suppressor gene owing to loss-of-function mutations in human pancreatic ductal adenocarcinomas (PDAC). However, its role in pancreatic pathogenesis is not clear despite recent studies using genetically engineered mouse (GEM) models. We aimed at further understanding of its direct functional role in PDAC, using a combination of GEM model, PDAC cell lines.

MethodsPancreas-specific mutant Arid1a-driven GEM model (Ptf1a-Cre;KrasG12D;Arid1af/f or "KAC") was generated by crossing Ptf1a-Cre;KrasG12D ("KC") mice with Arid1af/f mice and characterized histologically with timed necropsies. Arid1a was also deleted using CRISPR-Cas9 system in established PDAC cell lines to study the immediate effects of Arid1a loss in isogenic models. Cells lines with or without Arid1a expression were developed from respective autochthonous PDAC GEM models, compared functionally using various culture assays, and subjected to RNA-sequencing for comparative gene expression analysis. DNA damage repair was analyzed in cultured cells using immunofluorescence and COMET assay.

ResultsArid1a is critical for early progression of mutant Kras-driven pre-malignant lesions into PDAC, as evident by lower Ki-67 and higher apoptosis staining in "KAC" as compared to "KC" mice. Enforced deletion of Arid1a in established PDAC cell lines caused suppression of cellular growth and migration, accompanied by compromised DNA damage repair. Despite early development of relatively indolent cystic precursor lesions called intraductal papillary mucinous neoplasms (IPMNs), a subset of "KAC" mice developed aggressive PDAC in later ages. PDAC cells obtained from older autochthonous "KAC" mice revealed epigenetic changes underlying the various compensatory mechanisms to overcome the growth suppressive effects of Arid1a loss.

ConclusionsArid1a is an essential survival gene whose loss impairs cellular growth, and thus, its expression is critical during early stages of pancreatic tumorigenesis in mouse models.
]]></description>
<dc:creator>Ferri-Borgogno, S.</dc:creator>
<dc:creator>Barui, S.</dc:creator>
<dc:creator>McGee, A. M.</dc:creator>
<dc:creator>Griffiths, T.</dc:creator>
<dc:creator>Singh, P. K.</dc:creator>
<dc:creator>Piett, C. G.</dc:creator>
<dc:creator>Ghosh, B.</dc:creator>
<dc:creator>Bhattacharyya, S.</dc:creator>
<dc:creator>Singhi, A.</dc:creator>
<dc:creator>Pradhan, K.</dc:creator>
<dc:creator>Verma, A.</dc:creator>
<dc:creator>Nagel, Z.</dc:creator>
<dc:creator>Maitra, A.</dc:creator>
<dc:creator>Gupta, S.</dc:creator>
<dc:date>2019-11-08</dc:date>
<dc:identifier>doi:10.1101/835793</dc:identifier>
<dc:title><![CDATA[Paradoxical role of AT-rich interactive domain 1A in restraining pancreatic carcinogenesis]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-11-08</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/836288v1?rss=1">
<title>
<![CDATA[
Inhibiting the prostaglandin transporter PGT induces non-canonical thermogenesis at thermoneutrality 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/836288v1?rss=1</link>
<description><![CDATA[
ABSTRACT / SUMMARYProstaglandins play fundamental roles in adipose tissue function. While prostaglandin F2 inhibits adipogenesis, prostaglandin E2 promotes adipose beiging. PGF2 and PGE2 are both inactivated through uptake by the plasma membrane transporter (PGT). We hypothesized that inhibiting PGT would increase PGF2 and PGE2 levels, thereby reducing white fat expansion and inducing beiging. Consistent with this hypothesis, inhibiting PGT in mice on high fat diet via genetic knockout or pharmacological blockade reduced body fat stores and induced thermogenesis at thermoneutrality. Inguinal white adipose tissue (iWAT) of these mice exhibited robust UCP1-independent thermogenesis characterized by mitochondrial expansion, coupling of O2 consumption to ATP synthesis, and induction of the creatine pathway. Enhanced coupled respiration persisted in PGT-KO iWAT adipocytes in a creatine shuttle-dependent manner. Thus, inhibiting PGT increases mitochondrial biogenesis and coupled respiration--each supported by the creatine pathway in a system lacking UCP1 expression--revealing PGT as a promising drug target against obesity.
]]></description>
<dc:creator>Pai, V. J.</dc:creator>
<dc:creator>Lu, R.</dc:creator>
<dc:creator>Wu, L.</dc:creator>
<dc:creator>Garcia-Macia, M.</dc:creator>
<dc:creator>Koba, W. R.</dc:creator>
<dc:creator>Chi, Y.</dc:creator>
<dc:creator>Singh, R.</dc:creator>
<dc:creator>Schwartz, G. J.</dc:creator>
<dc:creator>Schuster, V. L.</dc:creator>
<dc:date>2019-11-09</dc:date>
<dc:identifier>doi:10.1101/836288</dc:identifier>
<dc:title><![CDATA[Inhibiting the prostaglandin transporter PGT induces non-canonical thermogenesis at thermoneutrality]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-11-09</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/842724v1?rss=1">
<title>
<![CDATA[
Strong information-limiting correlations in early visual areas 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/842724v1?rss=1</link>
<description><![CDATA[
If the brain processes incoming data efficiently, information should degrade little between early and later neural processing stages, and so information in early stages should match behavioral performance. For instance, if there is enough information in a visual cortical area to determine the orientation of a grating to within 1 degree, and the code is simple enough to be read out by downstream circuits, then animals should be able to achieve that performance behaviourally. Despite over 30 years of research, it is still not known how efficient the brain is. For tasks involving a large number of neurons, the amount of information encoded by neural circuits is limited by differential correlations. Therefore, determining how much information is encoded requires quantifying the strength of differential correlations. Detecting them, however, is difficult. We report here a new method, which requires on the order of 100s of neurons and trials. This method relies on computing the alignment of the neural stimulus encoding direction, f', with the eigenvectors of the noise covariance matrix,{Sigma} . In the presence of strong differential correlations, f' must be spanned by a small number of the eigenvectors with largest eigenvalues. Using simulations with a leaky-integrate-and-fire neuron model of the LGN-V1 circuit, we confirmed that this method can indeed detect differential correlations consistent with those that would limit orientation discrimination thresholds to 0.5-3 degrees. We applied this technique to V1 recordings in awake monkeys and found signatures of differential correlations, consistent with a discrimination threshold of 0.47-1.20 degrees, which is not far from typical discrimination thresholds (1-2 deg). These results suggest that, at least in macaque monkeys, V1 contains about as much information as is seen in behaviour, implying that downstream circuits are efficient at extracting the information available in V1.
]]></description>
<dc:creator>Montijn, J. S.</dc:creator>
<dc:creator>Liu, R. G.</dc:creator>
<dc:creator>Aschner, A.</dc:creator>
<dc:creator>Kohn, A.</dc:creator>
<dc:creator>Latham, P. E.</dc:creator>
<dc:creator>Pouget, A.</dc:creator>
<dc:date>2019-11-15</dc:date>
<dc:identifier>doi:10.1101/842724</dc:identifier>
<dc:title><![CDATA[Strong information-limiting correlations in early visual areas]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-11-15</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/843177v1?rss=1">
<title>
<![CDATA[
Phenotypic size heterogeneity is a viral mechanism of persistence 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/843177v1?rss=1</link>
<description><![CDATA[
Assembly of many enveloped animal viruses yields a mixture of particle morphologies, from small, essentially isometric forms to vastly longer, filamentous forms. Selective advantage of pleomorphic virus structure is apparent only in vivo, hindering functional characterization of distinct particle shapes. Here we sought to mimic the in vivo pressures on virus entry in cultured cells and in single-particle experiments of membrane fusion for influenza virus preparations enriched in spherical or filamentous particles. We show that filamentous shape confers functional advantage in the presence of neutralizing antibodies or fusion inhibitors and in cases of only limited fusion-protein activation. For very long particles, inactivation of >95% of associated fusion proteins still permits enough active-protein cooperation to induce membrane merger. Experiments with Ebola virus-like particles show that resistance to antibody pressure is a conserved feature of filamentous particles. Our results offer a strategy for averting drug resistance or immune evasion by targeting filamentous virus particles.
]]></description>
<dc:creator>Li, T.</dc:creator>
<dc:creator>Li, Z.</dc:creator>
<dc:creator>Liu, M.</dc:creator>
<dc:creator>Deans, E. E.</dc:creator>
<dc:creator>Ivanovic, T.</dc:creator>
<dc:date>2019-11-15</dc:date>
<dc:identifier>doi:10.1101/843177</dc:identifier>
<dc:title><![CDATA[Phenotypic size heterogeneity is a viral mechanism of persistence]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-11-15</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/859132v1?rss=1">
<title>
<![CDATA[
Structural basis of RNA Polymerase III transcription repression by Maf1 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/859132v1?rss=1</link>
<description><![CDATA[
Maf1 is a highly conserved central regulator of transcription by RNA polymerase III (Pol III), and Maf1 activity influences a wide range of phenotypes from metabolic efficiency to lifespan. Here, we present a 3.3 [A] cryo-EM structure of yeast Maf1 bound to Pol III, which establishes how Maf1 achieves transcription repression. In the Maf1-bound state, Pol III elements that are involved in transcription initiation are sequestered, and the active site is sealed off due to ordering of the mobile C34 winged helix 2 domain. Specifically, the Maf1 binding site overlaps with the binding site of the Pol III transcription factor TFIIIB and DNA in the pre-initiation complex, rationalizing that binding of Maf1 and TFIIIB to Pol III are mutually exclusive. We validate our structure using variants of Maf1 with impaired transcription-inhibition activity. These results reveal the exact mechanism of Pol III inhibition by Maf1, and rationalize previous biochemical data.
]]></description>
<dc:creator>Vorländer, M. K.</dc:creator>
<dc:creator>Baudin, F.</dc:creator>
<dc:creator>Moir, R. D.</dc:creator>
<dc:creator>Wetzel, R.</dc:creator>
<dc:creator>Hagen, W. J. H.</dc:creator>
<dc:creator>Willis, I. M.</dc:creator>
<dc:creator>Müller, C. W.</dc:creator>
<dc:date>2019-11-29</dc:date>
<dc:identifier>doi:10.1101/859132</dc:identifier>
<dc:title><![CDATA[Structural basis of RNA Polymerase III transcription repression by Maf1]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-11-29</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/868513v1?rss=1">
<title>
<![CDATA[
The connectome of the Caenorhabditis elegans pharynx 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/868513v1?rss=1</link>
<description><![CDATA[
Detailed anatomical maps of individual organs and entire animals have served as invaluable entry points for ensuing dissection of their evolution, development, and function. The pharynx of the nematode Caenorhabditis elegans is a simple neuromuscular organ with a self-contained, autonomously acting nervous system, composed of 20 neurons that fall into 14 anatomically distinct types. Using serial EM reconstruction, we re-evaluate here the connectome of the pharyngeal nervous system, providing a novel and more detailed view of its structure and predicted function. Contrasting the previous classification of pharyngeal neurons into distinct inter- and motorneuron classes, we provide evidence that most pharyngeal neurons are also likely sensory neurons and most, if not all, pharyngeal neurons also classify as motorneurons. Together with the extensive cross-connectivity among pharyngeal neurons, which is more widespread than previously realized, the sensory-motor characteristics of most neurons define a shallow network architecture of the pharyngeal connectome. Network analysis reveals that the patterns of neuronal connections are organized into putative computational modules that reflect the known functional domains of the pharynx. Compared to the somatic nervous system, pharyngeal neurons both physically associate with a larger fraction of their neighbors and create synapses with a greater proportion of their neighbors. We speculate that the overall architecture of the pharyngeal nervous system may be reminiscent of the architecture of ancestral, primitive nervous systems.
]]></description>
<dc:creator>Cook, S. J.</dc:creator>
<dc:creator>Crouse, C. M.</dc:creator>
<dc:creator>Yemini, E.</dc:creator>
<dc:creator>Hall, D. H.</dc:creator>
<dc:creator>Emmons, S. W.</dc:creator>
<dc:creator>Hobert, O.</dc:creator>
<dc:date>2019-12-08</dc:date>
<dc:identifier>doi:10.1101/868513</dc:identifier>
<dc:title><![CDATA[The connectome of the Caenorhabditis elegans pharynx]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-12-08</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.03.17.484800v1?rss=1">
<title>
<![CDATA[
Dietary Induced Dynamic Plasticity of Intestinal Stem Cells and the Mucosa in Elevating Risk for Tumor Development 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.03.17.484800v1?rss=1</link>
<description><![CDATA[
NWD1, a purified rodent diet establishing mouse exposure to key nutrients recapitulating levels that increase risk for intestinal cancer, reproducibly causes sporadic intestinal and colonic tumors in the mouse, reflecting human etiology, incidence, frequency and lag with developmental age. Complex NWD1 reprogramming of stem cells and lineages was deconvolved by bulk and scRNAseq, scATACseq, functional genomics and imaging. NWD1 extensively, rapidly, and reversibly reprogrammed Lgr5hi stem cells, epigenetically down-regulating Ppargc1a expression, altering mitochondrial structure and function. This suppressed Lgr5hi stem cell functions and developmental maturation of Lgr5hi cell progeny as cells progressed through progenitor cell compartments, recapitulated by Ppargc1a genetic inactivation in Lgr5hi cells in vivo. Mobilized Bmi1+, Ascl2hi cells adapted lineages to the nutritional environment and elevated antigen processing and presentation pathways, especially in mature enterocytes, causing chronic, pro-tumorigenic low-level inflammation. There were multiple parallels between NWD1 remodeling of stem cells and lineages with pathogenic mechanisms in human inflammatory bowel disease, also pro-tumorigenic. Moreover, the shift to alternate stem cells reflects that the balance between Lg5 positive and negative stem cells in supporting human colon tumors is determined by environmental influences. Stem cell and lineage plasticity in response to nutrients supports historic concepts of homeostasis as a continual adaptation to environment, with the human mucosa likely in constant flux in response to changing nutrient exposures. Thus, although oncogenic mutations provide a competitive advantage to intestinal epithelial cells in clonal expansion, the competition is on a playing field dynamically sculpted by the nutritional environment, influencing which cells dominate in mucosal maintenance and tumorigenesis.
]]></description>
<dc:creator>Choi, J.</dc:creator>
<dc:creator>Zhang, X.</dc:creator>
<dc:creator>Li, W.</dc:creator>
<dc:creator>Houston, M.</dc:creator>
<dc:creator>Peregrina, K.</dc:creator>
<dc:creator>Dubin, R.</dc:creator>
<dc:creator>Ye, K.</dc:creator>
<dc:creator>Augenlicht, L.</dc:creator>
<dc:date>2022-03-19</dc:date>
<dc:identifier>doi:10.1101/2022.03.17.484800</dc:identifier>
<dc:title><![CDATA[Dietary Induced Dynamic Plasticity of Intestinal Stem Cells and the Mucosa in Elevating Risk for Tumor Development]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-03-19</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.03.21.485194v1?rss=1">
<title>
<![CDATA[
Synergistic Regulation of Notch Signaling by Different O-Glycans Promotes Hematopoiesis 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.03.21.485194v1?rss=1</link>
<description><![CDATA[
Glycosylation of Notch receptors by O-fucose glycans regulates Notch ligand binding and Notch signaling during hematopoiesis. However, roles in hematopoiesis for other O-glycans that modify Notch receptors have not been determined. Here we show that the EGF domain-specific GlcNAc transferase EOGT is required in mice for the optimal production of lymphoid and myeloid cells. The phenotype of Eogt null mice was largely cell-autonomous, and Notch target gene expression was reduced in T cell progenitors. Moreover, EOGT supported residual Notch signaling following conditional deletion of Pofut1 in hematopoietic stem cells (HSC). Eogt:Pofut1 double mutant HSC had more severe defects in bone marrow, and in T and B cell development in thymus and spleen, compared to deletion of Pofut1 alone. The combined results show that EOGT and O-GlcNAc glycans are required for optimal hematopoiesis and T and B cell development, and that they act synergistically with POFUT1 and O-fucose glycans to promote Notch signaling in lymphoid and myeloid differentiation.

Key pointsO_LIO-GlcNAc glycans and EOGT promote lymphopoiesis and myelopoiesis
C_LIO_LIEOGT supports Notch signaling in the absence of POFUT1 and O-fucose glycans
C_LI
]]></description>
<dc:creator>Tanwar, A.</dc:creator>
<dc:creator>Stanley, P.</dc:creator>
<dc:date>2022-03-21</dc:date>
<dc:identifier>doi:10.1101/2022.03.21.485194</dc:identifier>
<dc:title><![CDATA[Synergistic Regulation of Notch Signaling by Different O-Glycans Promotes Hematopoiesis]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-03-21</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.03.23.485508v1?rss=1">
<title>
<![CDATA[
Cyb5r3-based mechanism and reversal of secondary failure to sulfonylurea 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.03.23.485508v1?rss=1</link>
<description><![CDATA[
Sulfonylureas (SU) are effective and affordable anti-diabetic drugs. But chronic use leads to secondary failure, limiting their utilization. The mechanism of secondary failure is unknown. Here we identify Cyb5r3 downregulation as a mechanism of SU failure and successfully reverse it. Chronic exposure to SU impairs Cyb5r3 levels and reduces islet glucose utilization with a metabolomics signature characterized by low acetyl-CoA and amino acid levels. Cyb5r3 engages in a glucose-dependent interaction that stabilizes glucokinase (Gck) to maintain glucose utilization. Accordingly, activating Gck mutations in patients with hyperinsulinemia reduce Cyb5r3 binding, whereas inactivating MODY mutations increase it, providing evidence for a role of Cyb5r3 in determining flux through Gck. The Cyb5r3 activator tetrahydroindenoindole (THII) rescues secondary failure to SU in an animal model of chronic SU treatment and restores insulin secretion from ex vivo islets. We conclude that Cyb5r3 loss-of-function is a key factor in the secondary failure to SU and a potential target for its prevention, which may lead to a rehabilitation of SU use in diabetes.
]]></description>
<dc:creator>Watanabe, H.</dc:creator>
<dc:creator>Du, W.</dc:creator>
<dc:creator>Son, J.</dc:creator>
<dc:creator>Sui, L.</dc:creator>
<dc:creator>Asahara, S.-i.</dc:creator>
<dc:creator>Kurland, I. J.</dc:creator>
<dc:creator>Kuo, T.</dc:creator>
<dc:creator>Kitamoto, T.</dc:creator>
<dc:creator>Miyachi, Y.</dc:creator>
<dc:creator>de Cabo, R.</dc:creator>
<dc:creator>Accili, D.</dc:creator>
<dc:date>2022-03-26</dc:date>
<dc:identifier>doi:10.1101/2022.03.23.485508</dc:identifier>
<dc:title><![CDATA[Cyb5r3-based mechanism and reversal of secondary failure to sulfonylurea]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-03-26</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.03.31.485431v1?rss=1">
<title>
<![CDATA[
Hippocampal CA1 represents action and reward events instantly compared to the superficial and deep layers of the lateral entorhinal cortex 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.03.31.485431v1?rss=1</link>
<description><![CDATA[
The entorhinal cortex (EC) is the main interface between the hippocampus and the neocortex. The EC plays a critical role in learning and memory. We investigated the neuronal representation of behavioral events during operant learning in the hippocampal-entorhinal circuit of head-fixed rats. Both CA1 and lateral entorhinal cortex (LEC) neurons develop task-related activities after learning. Among diverse task-related activities, we compared the transient peak activities that represent action and reward and found a distinct difference in the timing of behavioral event representation between CA1 and LEC. CA1 represents action and reward events in close to real-time, whereas both the superficial and deep layers of the LEC showed delayed representation of those events. Our results suggest that subpopulations exist within which CA1 and LEC neurons process the information in a different order from the anatomically defined hippocampal-entorhinal circuit.
]]></description>
<dc:creator>Soma, S.</dc:creator>
<dc:creator>Ohara, S.</dc:creator>
<dc:creator>Nonomura, S.</dc:creator>
<dc:creator>Yoshida, J.</dc:creator>
<dc:creator>Suematsu, N.</dc:creator>
<dc:creator>Pastalkova, E.</dc:creator>
<dc:creator>Sakai, Y.</dc:creator>
<dc:creator>Tsutsui, K.-I.</dc:creator>
<dc:creator>Isomura, Y.</dc:creator>
<dc:date>2022-04-01</dc:date>
<dc:identifier>doi:10.1101/2022.03.31.485431</dc:identifier>
<dc:title><![CDATA[Hippocampal CA1 represents action and reward events instantly compared to the superficial and deep layers of the lateral entorhinal cortex]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-04-01</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.04.03.486895v1?rss=1">
<title>
<![CDATA[
CD169+ macrophages orchestrate plasmacytoid dendritic cell arrest and retention for optimal priming in the bone marrow of malaria-infected mice 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.04.03.486895v1?rss=1</link>
<description><![CDATA[
Plasmacytoid dendritic cells (pDC) are the most potent producer of type I interferon (IFN), but how pDC are primed in vivo is poorly defined. Using a mouse model of severe malaria, we have previously established that upon priming by CD169+ macrophages (MP), pDC initiate type I IFN-I secretion in the bone marrow (BM) of infected mice via cell-intrinsic TLR7 sensing and cell-extrinsic STING sensing. Herein we show that CD169+ MP and TLR7-sensing are both required for pDC arrest during priming, suggesting CD169+ MP are the source of TLR7 ligands. We establish that TLR7 sensing in pDC and chemotaxis are both required for pDC arrest and functional clustering with CD169+ MP in the BM. Lastly, we demonstrate that STING-sensing in CD169+ MP control pDC initiation of type I IFN production while also regulating pDC clustering and egress from the BM. Collectively, these results link pDC acquisition of type I IFN secreting capacity with changes in their motility, homing and interactions with CD169+ MP during infection. Thus, targeting this cellular interaction may help modulate type I IFN to improve outcomes of microbial infections and autoimmune diseases.
]]></description>
<dc:creator>Fried, J.</dc:creator>
<dc:creator>Paul, M.</dc:creator>
<dc:creator>Jing, Z.</dc:creator>
<dc:creator>Fooksman, D.</dc:creator>
<dc:creator>Lauvau, G.</dc:creator>
<dc:date>2022-04-03</dc:date>
<dc:identifier>doi:10.1101/2022.04.03.486895</dc:identifier>
<dc:title><![CDATA[CD169+ macrophages orchestrate plasmacytoid dendritic cell arrest and retention for optimal priming in the bone marrow of malaria-infected mice]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-04-03</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.04.01.486754v1?rss=1">
<title>
<![CDATA[
An open-source, ready-to-use and validated ripple detector plugin for the Open Ephys GUI 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.04.01.486754v1?rss=1</link>
<description><![CDATA[
Sharp wave-ripples (SWRs, 100-250 Hz) are oscillatory events extracellularly recorded in the CA1 subfield of the hippocampus during sleep and quiet wakefulness. SWRs are thought to be involved in the dialogue between the hippocampus and cortical regions to promote memory consolidation during sleep and memory-guided decision making. Many studies employed closed-loop strategies to either detect and abolish SWRs within the hippocampus or manipulate other relevant areas upon ripple detection. However, the code and schematics necessary to replicate the detection system are not always available, which hinders the reproducibility of experiments among different research groups. Furthermore, information about performance is not usually reported. Here, we present the development and validation of an open-source, real-time ripple detection plugin integrated into the Open Ephys GUI. It contains a built-in movement detector based on accelerometer or electromyogram data that prevents false ripple events (due to chewing, grooming, or moving, for instance) from triggering the stimulation/manipulation device. To determine the accuracy of the detection algorithm, we first carried out simulations in Matlab with synthetic and real ripple recordings. Using a specific combination of detection parameters (amplitude threshold of 5 standard deviations above the mean, time threshold of 10 ms, and RMS block size of 7 samples), we obtained a 97% true positive rate and 2.48 false positives per minute on the real data. Next, an Open Ephys plugin based on the same detection algorithm was developed, and a closed-loop system was set up to evaluate the round trip (ripple onset-to-stimulation) latency over synthetic data. The lowest latency obtained was 34.5 {+/-} 0.5 ms. Besides contributing to increased reproducibility, we anticipate that the developed ripple detector plugin will be helpful for many closed-loop applications in the field of systems neuroscience.
]]></description>
<dc:creator>Sousa, B. M. d.</dc:creator>
<dc:creator>de Oliveira, E. F.</dc:creator>
<dc:creator>Beraldo, I. J. d. S.</dc:creator>
<dc:creator>Polanczyk, R. S.</dc:creator>
<dc:creator>Leite, J. P.</dc:creator>
<dc:creator>Lopes Aguiar, C.</dc:creator>
<dc:date>2022-04-05</dc:date>
<dc:identifier>doi:10.1101/2022.04.01.486754</dc:identifier>
<dc:title><![CDATA[An open-source, ready-to-use and validated ripple detector plugin for the Open Ephys GUI]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-04-05</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.04.04.487043v1?rss=1">
<title>
<![CDATA[
The strength of feedback processing is associated with resistance to visual backward masking during illusory contour processing in adult humans. 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.04.04.487043v1?rss=1</link>
<description><![CDATA[
Re-entrant feedback processing is a key mechanism of visual object-recognition, especially under compromised viewing conditions where only sparse information is available and object features must be interpolated. Illusory contour stimuli are commonly used in conjunction with visual evoked potentials (VEP) to study these filling-in processes, with characteristic modulation of the VEP in the ~100-150ms timeframe associated with this re-entrant processing. Substantial inter-individual variability in timing and amplitude of feedback-related VEP modulation is observed, raising the question whether this variability might underlie inter-individual differences in the ability to form strong perceptual gestalts. Backward masking paradigms have been used to study inter-individual variance in the ability to form robust object perceptions before processing of the mask interferes with object-recognition. Some individuals recognize objects when the time between target object and mask is extremely short, whereas others struggle to do so even at longer target-to-mask intervals. We asked whether timing and amplitude of feedback-related VEP modulations were associated with individual differences in resistance to backward masking. Participants (N=40) showed substantial performance variability in detecting illusory contours at intermediate target-to-mask intervals (67ms and 117ms), allowing us to use kmeans clustering to divide the population into four performance groups (poor, low-average, high-average, superior). There was a clear relationship between the amplitude (but not the timing) of feedback-related VEP modulation and illusory contour detection during backward masking. We conclude that individual differences in the strength of feedback processing in neurotypical humans lead to differences in the ability to quickly establish perceptual awareness of incomplete visual objects.
]]></description>
<dc:creator>Foxe, J. J.</dc:creator>
<dc:creator>Knight, E. J.</dc:creator>
<dc:creator>Myers, E. J.</dc:creator>
<dc:creator>Cao, C. Z.</dc:creator>
<dc:creator>Molholm, S.</dc:creator>
<dc:creator>Freedman, E. G.</dc:creator>
<dc:date>2022-04-07</dc:date>
<dc:identifier>doi:10.1101/2022.04.04.487043</dc:identifier>
<dc:title><![CDATA[The strength of feedback processing is associated with resistance to visual backward masking during illusory contour processing in adult humans.]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-04-07</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.04.05.487190v1?rss=1">
<title>
<![CDATA[
Propofol disrupts alpha dynamics in distinct thalamocortical networks underlying sensory and cognitive function during loss of consciousness 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.04.05.487190v1?rss=1</link>
<description><![CDATA[
During propofol-induced general anesthesia, alpha rhythms undergo a striking shift from posterior to anterior, termed anteriorization. We combined human intracranial recordings with diffusion imaging to show that anteriorization occurs with opposing dynamics in two distinct thalamocortical subnetworks. The cortical and thalamic anatomy involved, as well as their known functional roles, suggest multiple means by which propofol dismantles sensory and cognitive processes to achieve loss of consciousness.
]]></description>
<dc:creator>Weiner, V. S.</dc:creator>
<dc:creator>Zhou, D. W.</dc:creator>
<dc:creator>Kahali, P.</dc:creator>
<dc:creator>Stephen, E. P.</dc:creator>
<dc:creator>Peterfreund, R. A.</dc:creator>
<dc:creator>Aglio, L. S.</dc:creator>
<dc:creator>Szabo, M. D.</dc:creator>
<dc:creator>Eskandar, E. N.</dc:creator>
<dc:creator>Salazar-Gomez, A. F.</dc:creator>
<dc:creator>Sampson, A. L.</dc:creator>
<dc:creator>Cash, S. S.</dc:creator>
<dc:creator>Brown, E. N.</dc:creator>
<dc:creator>Purdon, P. L.</dc:creator>
<dc:date>2022-04-08</dc:date>
<dc:identifier>doi:10.1101/2022.04.05.487190</dc:identifier>
<dc:title><![CDATA[Propofol disrupts alpha dynamics in distinct thalamocortical networks underlying sensory and cognitive function during loss of consciousness]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-04-08</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.04.06.487297v1?rss=1">
<title>
<![CDATA[
A novel Pyk2-derived peptide inhibits invadopodia-mediated breast cancer metastasis 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.04.06.487297v1?rss=1</link>
<description><![CDATA[
The non-receptor tyrosine kinase Pyk2 is highly expressed in breast cancer, where it mediates invadopodia formation and function via interaction with the actin-nucleation promoting factor cortactin. Here, we designed a cell-permeable peptide inhibitor that contains the second proline-rich region (PRR2) sequence of Pyk2, which binds to the SH3 domain of cortactin and blocks spontaneous lung metastasis in immune-competent mice by inhibiting invadopodia maturation and function. The native structure of the Pyk2-PRR2:cortactin-SH3 complex was determined using nuclear magnetic resonance (NMR), revealing an extended class II interaction surface spanning the canonical binding groove and a second hydrophobic surface which significantly contributes to ligand affinity. Using structure-guided design, we created a mutant peptide lacking critical residues involved in binding that failed to inhibit invadopodia maturation and function and consequent metastatic dissemination in mice. Our findings shed light on the specific molecular interactions between Pyk2 and cortactin and suggest that their inhibition may be used as a novel strategy for blocking breast cancer metastasis.
]]></description>
<dc:creator>Twafra, S.</dc:creator>
<dc:creator>Sokolik, C.</dc:creator>
<dc:creator>Sneh, T.</dc:creator>
<dc:creator>Srikanth, K.</dc:creator>
<dc:creator>Meirson, T.</dc:creator>
<dc:creator>Genna, A.</dc:creator>
<dc:creator>Chill, J.</dc:creator>
<dc:creator>Gil-Henn, H.</dc:creator>
<dc:date>2022-04-08</dc:date>
<dc:identifier>doi:10.1101/2022.04.06.487297</dc:identifier>
<dc:title><![CDATA[A novel Pyk2-derived peptide inhibits invadopodia-mediated breast cancer metastasis]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-04-08</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.04.07.487495v1?rss=1">
<title>
<![CDATA[
Functional Contribution of Cancer-Associated Fibroblasts in Glioblastoma 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.04.07.487495v1?rss=1</link>
<description><![CDATA[
The abundance and biological contribution of cancer associated fibroblasts (CAFs) in glioblastoma are poorly understood. Here, we applied single-cell RNA sequencing and spatial transcriptomics analyses to identify and characterize CAFs in human glioblastoma tumors and then performed functional enrichment analysis and in vitro assays to investigate their interactions with malignant glioblastoma cells. We found that CAF abundance was significantly correlated with tumor grade, poor clinical outcome, and activation of extracellular matrix remodeling, using three large databases containing bulk RNA-sequencing data and clinical information. Proteomic analysis of the CAFs and their secretome revealed fibronectin (FN1) as a strong candidate mediating CAF functions. This was validated using in vitro cellular models, which demonstrated that CAF conditioned media and recombinant FN1 could facilitate the migration and invasion of glioblastoma cells. In addition, we showed that CAFs were more abundant in the mesenchymal-like state (or subtype) than in other states of glioblastomas, while cell lines resembling the proneural-state responded to the CAF signaling better in terms of the migratory and invasive phenotypes. Investigating the in-situ expression of gene markers specifically associated with CAFs and mesenchymal malignant cells further indicated that CAFs were enriched in the perinecrotic and pseudopalisading zones of human tumors, where mesenchymal-like glioblastoma cells co-resided and thus likely interacted. Overall, this study characterized the molecular features and functional impacts of CAFs in glioblastoma, alluding to a novel cell-to-cell interaction axis mediated by CAFs in the glioblastoma microenvironment.
]]></description>
<dc:creator>Galbo, P. M.</dc:creator>
<dc:creator>Liu, Y.</dc:creator>
<dc:creator>Peng, M.</dc:creator>
<dc:creator>Wei, Y.</dc:creator>
<dc:creator>Madsen, A. T.</dc:creator>
<dc:creator>Graff, S.</dc:creator>
<dc:creator>Montagna, C.</dc:creator>
<dc:creator>Segall, J. E.</dc:creator>
<dc:creator>Sidoli, S.</dc:creator>
<dc:creator>Zang, X.</dc:creator>
<dc:creator>Zheng, D.</dc:creator>
<dc:date>2022-04-08</dc:date>
<dc:identifier>doi:10.1101/2022.04.07.487495</dc:identifier>
<dc:title><![CDATA[Functional Contribution of Cancer-Associated Fibroblasts in Glioblastoma]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-04-08</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.04.08.487404v1?rss=1">
<title>
<![CDATA[
Autophagic state prospectively identifies facultative stem cells in the intestinal epithelium 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.04.08.487404v1?rss=1</link>
<description><![CDATA[
The intestinal epithelium exhibits a rapid and efficient regenerative response to injury. Emerging evidence supports a model where plasticity of differentiated cells, particularly those in the secretory lineages, contributes to epithelial regeneration upon ablation of injury-sensitive stem cells. However, such facultative stem cell activity is rare within secretory populations. Here we ask whether specific functional properties predict facultative stem cell activity. We utilize in vivo labeling combined with ex vivo organoid formation assays to evaluate how cell age and autophagic state contribute to facultative stem cell activity within secretory lineages. Strikingly, we find that cell age (time elapsed since cell cycle exit) does not correlate with secretory cell plasticity. Instead, high autophagic activity predicts plasticity and resistance to DNA damaging injury independently of cell lineage. Our findings indicate that autophagic status prior to injury serves as a lineageagnostic marker for the prospective identification of facultative stem cells.
]]></description>
<dc:creator>Johnson, N. M.</dc:creator>
<dc:creator>Parham, L. R.</dc:creator>
<dc:creator>Na, J.</dc:creator>
<dc:creator>Monaghan, K. E.</dc:creator>
<dc:creator>Kolev, H. M.</dc:creator>
<dc:creator>Klochkova, A.</dc:creator>
<dc:creator>Kim, M. S.</dc:creator>
<dc:creator>Danan, C. H.</dc:creator>
<dc:creator>Cramer, Z.</dc:creator>
<dc:creator>Simon, L. A.</dc:creator>
<dc:creator>Naughton, K. E.</dc:creator>
<dc:creator>Adams-Tzivelekidis, S.</dc:creator>
<dc:creator>Tian, Y.</dc:creator>
<dc:creator>Williams, P. A.</dc:creator>
<dc:creator>Leu, N. A.</dc:creator>
<dc:creator>Sidoli, S.</dc:creator>
<dc:creator>Whelan, K. A.</dc:creator>
<dc:creator>Li, N.</dc:creator>
<dc:creator>Lengner, C. J.</dc:creator>
<dc:creator>Hamilton, K. E.</dc:creator>
<dc:date>2022-04-10</dc:date>
<dc:identifier>doi:10.1101/2022.04.08.487404</dc:identifier>
<dc:title><![CDATA[Autophagic state prospectively identifies facultative stem cells in the intestinal epithelium]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-04-10</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.04.11.487923v1?rss=1">
<title>
<![CDATA[
Toxoplasma scavenges mammalian host organelles through usurpation of host ESCRT-III and Vps4 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.04.11.487923v1?rss=1</link>
<description><![CDATA[
Intracellular pathogens exploit cellular resources through host cell manipulation. Within its nonfusogenic parasitophorous vacuole (PV), Toxoplasma targets host nutrient-filled organelles and sequesters them into the PV through deep invaginations of the PV membrane (PVM) that ultimately detach from this membrane. Some of these invaginations are generated by an intravacuolar network (IVN) of parasite-derived tubules fusing with the PVM. Here, we examine the parasite usurpation of host ESCRT-III and Vps4 to create PVM buds and vesicles. CHMP4B associates with the PVM/IVN and dominant negative (DN) CHMP4B forms many long PVM invaginations containing CHMP4B filaments; the invaginations are shorter in IVN-deficient parasites, suggesting cooperation between IVN and ESCRT. In infected cells expressing Vps4-DN, enlarged intra-PV structures containing host endo-lysosomes accumulate, reflecting defects in PVM scission. Parasite mutants lacking TgGRA14 or TgGRA64 that interact with ESCRT have reduced CHMP4B-DN-induced PVM invaginations and intra-PV host organelles, with greater defects in a double-knockout, revealing the exploitation of ESCRT to scavenge host organelles by Toxoplasma.

SummaryThe parasite Toxoplasma sequesters host nutrient-filled organelles into its parasitophorous vacuole through its exploitation of host ESCRT-III and Vps4 for vacuolar membrane-remodeling and fission processes utilizing the parasite proteins TgGRA14 and TgGRA64 that interact with ESCRT.
]]></description>
<dc:creator>Coppens, I.</dc:creator>
<dc:creator>Romano, J. D.</dc:creator>
<dc:creator>Mayoral, J. A.</dc:creator>
<dc:creator>Guevara, R.</dc:creator>
<dc:creator>Rivera-Cuevas, Y.</dc:creator>
<dc:creator>Carruthers, V. B.</dc:creator>
<dc:creator>Weiss, L. M.</dc:creator>
<dc:date>2022-04-11</dc:date>
<dc:identifier>doi:10.1101/2022.04.11.487923</dc:identifier>
<dc:title><![CDATA[Toxoplasma scavenges mammalian host organelles through usurpation of host ESCRT-III and Vps4]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-04-11</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.04.11.487937v1?rss=1">
<title>
<![CDATA[
Pharmacological Interrogation of the C. elegans Pharyngeal Cuticle Reveals Small Molecule Amyloid Disruptors 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.04.11.487937v1?rss=1</link>
<description><![CDATA[
Amyloids are associated with over 50 human diseases and have inspired significant effort to identify small molecule remedies. Here, we present a novel in vivo platform that efficiently yields small molecule disruptors of amyloid formation. We previously identified small molecules that kill the nematode C. elegans by forming membrane-piercing crystals in the pharynx cuticle, which is rich in amyloid-like material. We show here that many of these molecules are known amyloid-binders whose crystal-formation in the pharynx can be blocked by amyloid-binding dyes. Furthermore, we found that amyloid fibrils can seed small molecule crystal formation in vitro. These observations suggest that small molecule crystals are seeded by the cuticles amyloid-like material. We asked whether this phenomenon could be exploited to identify additional molecules that interfere with the ability of amyloids to seed higher-order structures. We screened 2560 compounds and identified 85 crystal suppressors, which we found to be 10-fold enriched in known amyloid disruptors relative to a random set. Of the uncharacterized suppressors, we found 25% to inhibit Ab42 fibril nucleation and/or extension in vitro, which is a hit rate that far exceeds other screening methodologies. Hence, screens for suppressors of crystal formation can efficiently reveal small molecules with amyloid-disrupting potential.
]]></description>
<dc:creator>Kamal, M.</dc:creator>
<dc:creator>Knox, J.</dc:creator>
<dc:creator>Han, D.</dc:creator>
<dc:creator>Burns, A.</dc:creator>
<dc:creator>Nguyen, K. C.</dc:creator>
<dc:creator>Hall, D. H.</dc:creator>
<dc:creator>Roy, P. J.</dc:creator>
<dc:date>2022-04-12</dc:date>
<dc:identifier>doi:10.1101/2022.04.11.487937</dc:identifier>
<dc:title><![CDATA[Pharmacological Interrogation of the C. elegans Pharyngeal Cuticle Reveals Small Molecule Amyloid Disruptors]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-04-12</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.04.12.487930v1?rss=1">
<title>
<![CDATA[
Human and murine Cryptococcus neoformans infection selects for common genomic changes in an environmental isolate. 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.04.12.487930v1?rss=1</link>
<description><![CDATA[
A pet cockatoo was the suspected source of Cryptococcus neoformans recovered from the cerebral spinal fluid (CSF) of an immunocompromised patient with cryptococcosis based on the molecular analyses available in 2000. Here we report whole genome sequence analysis of the clinical and cockatoo strains. Both are closely related MAT strains belonging to the VNII lineage, confirming that the human infection likely originated from pet bird exposure. The two strains differ by 61 single nucleotide polymorphisms, including 8 nonsynonymous changes involving 7 genes. To ascertain whether changes in these genes are selected during mammalian infection, we passaged the cockatoo strain in mice. Remarkably, isolates obtained from mouse tissue possess a frame-shift mutation in one of the seven genes altered in the human sample, a gene predicted to encode a SWI-SNF chromatin-remodeling complex protein. Both cockatoo and patient strains as well as mouse passaged isolates obtained from brain tissue had a premature stop codon in a homolog of ZFC3, a predicted single-zinc finger containing protein, which is associated with larger capsules when deleted and appears to have reverted to a full-length protein in the mouse passaged isolates obtained from lung tissue. The patient strain and mouse passaged isolates show variability in the expression of virulence factors, with differences in capsule size, melanization, and rates on non-lytic expulsion from macrophages observed. Our results establish that environmental strains undergo genomic and phenotypic changes during mammalian passage, suggesting that animal virulence can be a mechanism for genetic change and that the genomes of clinical isolates may provide a readout of mutations acquired during infection.
]]></description>
<dc:creator>Sephton-Clark, P.</dc:creator>
<dc:creator>McConnell, S. A.</dc:creator>
<dc:creator>Grossman, N.</dc:creator>
<dc:creator>Baker, R.</dc:creator>
<dc:creator>Dragotakes, Q.</dc:creator>
<dc:creator>Fan, Y.</dc:creator>
<dc:creator>Fu, M. S.</dc:creator>
<dc:creator>Gerbig, G.</dc:creator>
<dc:creator>Greengo, S.</dc:creator>
<dc:creator>Hardwick, J. M.</dc:creator>
<dc:creator>Kulkarni, M.</dc:creator>
<dc:creator>Levitz, S. M.</dc:creator>
<dc:creator>Nosanchuk, J. D.</dc:creator>
<dc:creator>Shoham, S.</dc:creator>
<dc:creator>Smith, D.</dc:creator>
<dc:creator>Stempinski, P.</dc:creator>
<dc:creator>Wear, M.</dc:creator>
<dc:creator>Cuomo, C. A.</dc:creator>
<dc:creator>Casadevall, A.</dc:creator>
<dc:date>2022-04-12</dc:date>
<dc:identifier>doi:10.1101/2022.04.12.487930</dc:identifier>
<dc:title><![CDATA[Human and murine Cryptococcus neoformans infection selects for common genomic changes in an environmental isolate.]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-04-12</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.04.25.489405v1?rss=1">
<title>
<![CDATA[
Epigenetic Control of Hundreds of Chromosome-Associated lncRNA Genes Essential for Replication and Stability 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.04.25.489405v1?rss=1</link>
<description><![CDATA[
ASARs are long noncoding RNA genes that control replication timing of entire human chromosomes in cis. The three known ASAR genes are located on human chromosomes 6 and 15, and are essential for chromosome integrity. To identify ASARs on all human chromosomes we utilized a set of distinctive ASAR characteristics that allowed for the identification of hundreds of autosomal loci with epigenetically controlled, allele-restricted behavior in expression and replication timing of coding and noncoding genes, and is distinct from genomic imprinting. Disruption of noncoding RNA genes at five of five tested loci resulted in chromosome-wide delayed replication and chromosomal instability, validating their ASAR activity. In addition to the three known essential cis-acting chromosomal loci, origins, centromeres, and telomeres, we propose that all mammalian chromosomes also contain "Inactivation/Stability Centers" that display allele-restricted epigenetic regulation of protein coding and noncoding ASAR genes that are essential for replication and stability of each chromosome.
]]></description>
<dc:creator>Heskett, M. B.</dc:creator>
<dc:creator>Vouzas, A. E.</dc:creator>
<dc:creator>Smith, L. G.</dc:creator>
<dc:creator>Yates, P. A.</dc:creator>
<dc:creator>Boniface, C.</dc:creator>
<dc:creator>Bouhassira, E. E.</dc:creator>
<dc:creator>Spellman, P. T.</dc:creator>
<dc:creator>Gilbert, D. M.</dc:creator>
<dc:creator>Thayer, M. J.</dc:creator>
<dc:date>2022-04-25</dc:date>
<dc:identifier>doi:10.1101/2022.04.25.489405</dc:identifier>
<dc:title><![CDATA[Epigenetic Control of Hundreds of Chromosome-Associated lncRNA Genes Essential for Replication and Stability]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-04-25</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.04.20.488954v1?rss=1">
<title>
<![CDATA[
Histone H2A serine-1 phosphorylation is a chaperone-dependent signal for dimerization with H2B and for enhanced deposition 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.04.20.488954v1?rss=1</link>
<description><![CDATA[
Multiple histone chaperones and histone modifications are involved in the folding, transport, and re-lease of histones onto newly replicated DNA. Little is known about histone H2A-H2B pre-deposition his-tone modifications and their regulation of histone deposition. We previously showed that H2A serine 1 phosphorylation (H2AS1ph) is enriched on the soluble egg histones and on zygotic chromatin in Xenopus embryos. Here, we demonstrate that H2AS1 phosphorylation is required for a timely incorporation of H2A-H2B into the pronuclear chromatin. Our analysis revealed that exogenous H2AS1A-H2B dimers were poorly incorporated into pronuclei in egg extract compared with wildtype and H2AS1E-H2B dimers. Chaperone-mediated deposition using histones purified from pronuclei showed that neither Nap1 nor Nucleoplasmin (Npm2) histone deposition was directly affected by endogenous histone posttranslational modification. We further demonstrate that H2AS1 phosphorylation was dependent on Npm2 and required H2B. Surprisingly, Nap1 was incapable of promoting H2AS1 phosphorylation. These results suggest that serine 1 phosphorylation signals a specific state of H2A-H2B dimer bound by Nucleoplasmin. Neither Npm2 nor Nap1 exhibited preference for binding H2AS1A or H2AS1E mutant histones or dimers with H2B in vitro. We propose that H2AS1 phosphorylation is a pre-deposition modification that signals for the proper dimerization of H2A-H2B, which in turn activates downstream effectors leading to H2A-H2B deposition.
]]></description>
<dc:creator>Onikubo, T.</dc:creator>
<dc:creator>Wang, W.-l.</dc:creator>
<dc:creator>Shechter, D. M.</dc:creator>
<dc:date>2022-04-26</dc:date>
<dc:identifier>doi:10.1101/2022.04.20.488954</dc:identifier>
<dc:title><![CDATA[Histone H2A serine-1 phosphorylation is a chaperone-dependent signal for dimerization with H2B and for enhanced deposition]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-04-26</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.04.26.489611v1?rss=1">
<title>
<![CDATA[
Isthmal stem cells sustain intestinal homeostasis and regeneration 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.04.26.489611v1?rss=1</link>
<description><![CDATA[
The currently accepted intestinal epithelial cell organization model proposes that crypt base columnar (CBC) cells marked by high levels of Lgr5 expression represent the sole intestinal stem cell (ISC) compartment. However, previous studies have indicated that Lgr5+ cells are dispensable for intestinal regeneration, leading to two major hypotheses: one favoring the presence of a quiescent reserve stem cell population, the other calling for differentiated cell plasticity. To investigate these possibilities, we studied crypt epithelial cell organization, during homeostasis and regeneration, in unbiased fashion, via high-resolution single-cell profiling. These studies, combined with in vivo lineage tracing, show that Lgr5 is not a specific ISC marker and that stemness potential exists beyond the crypt base in the isthmus region, whose cells, contrary to differentiated cells, participate in tissue homeostasis and support intestinal regeneration. Our results provide a novel model of organization for the intestinal crypt epithelium in which stemness potential is not restricted to CBC cells and suggesting that neither de-differentiation nor reserve stem cell populations are drivers of intestinal regeneration.
]]></description>
<dc:creator>Malagola, E.</dc:creator>
<dc:creator>Vasciaveo, A.</dc:creator>
<dc:creator>Ochiai, Y.</dc:creator>
<dc:creator>Kim, W.</dc:creator>
<dc:creator>Middelhoff, M.</dc:creator>
<dc:creator>Nienhuser, H.</dc:creator>
<dc:creator>Belin, B.</dc:creator>
<dc:creator>LaBella, J.</dc:creator>
<dc:creator>Zamechek, L.</dc:creator>
<dc:creator>Wong, M.</dc:creator>
<dc:creator>Li, L.</dc:creator>
<dc:creator>Guha, C.</dc:creator>
<dc:creator>Yan, K.</dc:creator>
<dc:creator>Califano, A.</dc:creator>
<dc:creator>Wang, T.</dc:creator>
<dc:date>2022-04-28</dc:date>
<dc:identifier>doi:10.1101/2022.04.26.489611</dc:identifier>
<dc:title><![CDATA[Isthmal stem cells sustain intestinal homeostasis and regeneration]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-04-28</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.05.02.490330v1?rss=1">
<title>
<![CDATA[
EGR2 promoter antisense RNA coordinates chromatin remodeling and spatial genome organization in Schwann cells. 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.05.02.490330v1?rss=1</link>
<description><![CDATA[
The EGR2 promoter antisense RNA (AS-RNA) recruits chromatin remodeling complexes to inhibit EGR2 transcription following peripheral nerve injury. Here we show that the EGR2-AS-RNA modulates chromatin accessibility and interacts with two distinct histone modification complexes. It binds to EZH2 and WDR5 and enables targeting of H3K27me3 and H3K4me3 to promoters of EGR2and C-JUN respectively. Expression of the AS-RNA results in reorganization of the global chromatin landscape and quantitative changes in loop formation and in contact frequency at domain boundaries exhibiting enrichment for AP-1 genes. In addition, the EGR2-AS-RNA induces changes in hierarchical TADs and increases transcription factor occupancy on an inter-TAD loop between a super-enhancer regulatory hub and the promoter of mTOR. Our results show that the EGR2-AS-RNA may serve as regulator of chromatin remodeling and spatial genome organization in Schwann cells.
]]></description>
<dc:creator>Moreno, M.-M.</dc:creator>
<dc:creator>Karambizi, D.</dc:creator>
<dc:creator>Hwang, H.</dc:creator>
<dc:creator>Fregoso, K.</dc:creator>
<dc:creator>Chen, J.-S.</dc:creator>
<dc:creator>Fajardo, J. E.</dc:creator>
<dc:creator>Fiser, A.</dc:creator>
<dc:creator>Tapinos, N.</dc:creator>
<dc:date>2022-05-02</dc:date>
<dc:identifier>doi:10.1101/2022.05.02.490330</dc:identifier>
<dc:title><![CDATA[EGR2 promoter antisense RNA coordinates chromatin remodeling and spatial genome organization in Schwann cells.]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-05-02</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.05.02.490333v1?rss=1">
<title>
<![CDATA[
Characterizing ketamine-induced dissociation using human intracranial neurophysiology: brain dynamics, network activity, and interactions with propofol 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.05.02.490333v1?rss=1</link>
<description><![CDATA[
Subanesthetic doses of ketamine produce rapid and sustained anti-depressant effects in patients with treatment-resistant depression. Unfortunately, the usefulness of ketamine as a treatment is limited by its potential for abuse because of psychotropic side effects such as dissociation. Understanding the brain dynamics and the neural circuits involved in ketamines effects could lend insight into improved therapies for depression with fewer adverse effects. It is believed that ketamine acts via NMDA receptor and hyperpolarization-activated cyclic nucleotide-gated 1 (HCN1) channels to produce changes in oscillatory brain dynamics. Here we show, in humans, a detailed description of the principal oscillatory changes in cortical and subcortical structures by administration of a subanesthetic dose of ketamine. Using recordings from intracranial electrodes, we found that ketamine increased gamma oscillations within prefrontal cortical areas and the hippocampus--structures previously implicated in ketamines antidepressant effects. Furthermore, our studies provide direct evidence of a ketamine-induced 3 Hz oscillation in posteromedial cortex that has been proposed as a mechanism for its dissociative effects. By analyzing changes in neural oscillations after the addition of propofol, whose GABAergic activity antagonizes ketamines NMDA-mediated disinhibition alongside a shared HCN1 inhibitory effect, we identified brain dynamics that could be attributed to NMDA-mediated disinhibition versus HCN1 inhibition. Overall, our results imply that ketamine engages different neural circuits in distinct frequency-dependent patterns of activity to produce its antidepressant and dissociative sensory effects. These insights may help guide the development of novel brain dynamic biomarkers and therapeutics for depression.
]]></description>
<dc:creator>Tian, F.</dc:creator>
<dc:creator>Lewis, L. D.</dc:creator>
<dc:creator>Zhou, D. W.</dc:creator>
<dc:creator>Villegas, G. B.</dc:creator>
<dc:creator>Paulk, A. C.</dc:creator>
<dc:creator>Zelmann, R.</dc:creator>
<dc:creator>Peled, N.</dc:creator>
<dc:creator>Soper, D.</dc:creator>
<dc:creator>Mercado, L. A. S. C.</dc:creator>
<dc:creator>Peterfreund, R. A.</dc:creator>
<dc:creator>Aglio, L. S.</dc:creator>
<dc:creator>Eskandar, E. N.</dc:creator>
<dc:creator>Cosgrove, G. R.</dc:creator>
<dc:creator>Williams, Z. M.</dc:creator>
<dc:creator>Richardson, R. M.</dc:creator>
<dc:creator>Brown, E. N.</dc:creator>
<dc:creator>Akeju, O.</dc:creator>
<dc:creator>Cash, S. S.</dc:creator>
<dc:creator>Purdon, P. L.</dc:creator>
<dc:date>2022-05-04</dc:date>
<dc:identifier>doi:10.1101/2022.05.02.490333</dc:identifier>
<dc:title><![CDATA[Characterizing ketamine-induced dissociation using human intracranial neurophysiology: brain dynamics, network activity, and interactions with propofol]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-05-04</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.05.03.490527v1?rss=1">
<title>
<![CDATA[
Hybrid offspring of C57BL/6J mice exhibit improved properties for neurobehavioral research 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.05.03.490527v1?rss=1</link>
<description><![CDATA[
C57BL/6 is the most commonly used mouse strain in neurobehavioral research, serving as a background for multiple transgenic lines. However, C57BL/6 exhibit behavioral and sensorimotor disadvantages that worsen with age. We bred FVB/NJ females and C57BL/6J males to generate first-generation hybrid offspring, (FVB/NJ x C57BL/6J)F1. The hybrid mice exhibit reduced anxiety-like behavior, improved learning, and enhanced long-term spatial memory. In contrast to both progenitors, older hybrids maintain sensorimotor performance and exhibit improved long-term memory. The hybrids are larger than C57BL/6J, exhibiting enhanced running behavior on a linear track during freely-moving electrophysiological recordings. Hybrids exhibit typical rate and phase coding of space by CA1 pyramidal cells. Hybrids generated by crossing FVB/NJ females with transgenic males of a C57BL/6 background support optogenetic neuronal control in neocortex and hippocampus. The hybrid mice provide an improved model for neurobehavioral studies combining complex behavior, electrophysiology, and genetic tools readily available in C57BL/6 mice.
]]></description>
<dc:creator>Sloin, H. E.</dc:creator>
<dc:creator>Bikovski, L.</dc:creator>
<dc:creator>Levi, A.</dc:creator>
<dc:creator>Amber-Vitos, O.</dc:creator>
<dc:creator>Katz, T.</dc:creator>
<dc:creator>Spivak, L.</dc:creator>
<dc:creator>Someck, S.</dc:creator>
<dc:creator>Gattegno, R.</dc:creator>
<dc:creator>Sivroni, S.</dc:creator>
<dc:creator>Sjulson, L.</dc:creator>
<dc:creator>Stark, E.</dc:creator>
<dc:date>2022-05-04</dc:date>
<dc:identifier>doi:10.1101/2022.05.03.490527</dc:identifier>
<dc:title><![CDATA[Hybrid offspring of C57BL/6J mice exhibit improved properties for neurobehavioral research]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-05-04</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.05.05.490697v1?rss=1">
<title>
<![CDATA[
TMEM106B is increased in Multiple Sclerosis plaques, and deletion causes accumulation of lipid after demyelination 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.05.05.490697v1?rss=1</link>
<description><![CDATA[
During inflammatory, demyelinating diseases such as multiple sclerosis (MS) axonal damage is prevalent early in the disease course. Axonal damage includes swellings, defects in transport, and failure to clear damaged intracellular proteins, all of which affect recovery and compromise the integrity of neurons and remyelination. Autophagy and the clearance of damaged cell components by the proteasome are important for the maintenance of normal cellular turnover; and the restoration of cellular homeostasis. The gradual accumulation of insoluble proteins in the brain is known to impair recovery from several neurodegenerative diseases. In this study, we used mass spectrometry to identify insoluble proteins within high-speed, mercaptoethanol/sarcosyl-insoluble pellets from purified white matter plaques isolated from the brains of individuals with MS. We determined that insoluble transmembrane protein106B (TMEM106B), expressed in neurons and glia and normally lysosomal-associated, is increased in MS plaques relative to normal-appearing white matter from individuals with Alzheimers disease and non-neurologic controls. We found that decreased TMEM106B protein in mice results in significant axonal damage and lipid droplet accumulation in the spinal cord following chronic myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis. When TMEM106Bt/t mice were treated with cuprizone to experimentally induce demyelination, a significant increase in lipid deposition was observed in the corpus callosum of TMEM106Bt/t mice post-cuprizone withdrawal. Our study shows that the brain and spinal cord from challenged TMEM106Bt/t mice accumulate OilRedO+/Perilipin2+ lipid droplets. We postulate that increased insolubility of TMEM106B in MS plaques limits debris clearance by the lysosome which over time contributes to failed remyelination and axonal defects.

Abbreviated AbstractTransmembrane protein106B (TMEM106B), a lysosome-associated protein, is significantly less soluble in multiple sclerosis plaques than in white matter controls. Decreased TMEM106B produces significant axonal damage and lipid accumulation in mouse models of demyelinating diseases. TMEM106B insolubility and likely loss of function may limit lysosome transport and contribute to CNS pathology.
]]></description>
<dc:creator>Shafit-Zagardo, B.</dc:creator>
<dc:creator>Sidoli, S.</dc:creator>
<dc:creator>Goldman, J. E.</dc:creator>
<dc:creator>DuBois, J. C.</dc:creator>
<dc:creator>Corboy, J. R.</dc:creator>
<dc:creator>Strittmatter, S. M.</dc:creator>
<dc:creator>Guzik, H.</dc:creator>
<dc:creator>Graff, S.</dc:creator>
<dc:creator>Nagra, R. M.</dc:creator>
<dc:date>2022-05-05</dc:date>
<dc:identifier>doi:10.1101/2022.05.05.490697</dc:identifier>
<dc:title><![CDATA[TMEM106B is increased in Multiple Sclerosis plaques, and deletion causes accumulation of lipid after demyelination]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-05-05</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.05.10.491435v1?rss=1">
<title>
<![CDATA[
Bacterial strain-dependent dissociation of cell recruitment and cell-to-cell spread in early M. tuberculosis infection 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.05.10.491435v1?rss=1</link>
<description><![CDATA[
In the initial stage of respiratory infection, Mycobacterium tuberculosis traverses from alveolar macrophages to phenotypically diverse monocyte-derived phagocytes and neutrophils in the lung parenchyma. Here, we compare the in vivo kinetics of early bacterial growth and cell-to-cell spread of two strains of M. tuberculosis: a lineage 2 strain, 4334, and the widely studied lineage 4 strain H37Rv. Using flow cytometry, live cell sorting of phenotypic subsets, and quantitation of bacteria in cells of the distinct subsets, we found that 4334 induces less leukocyte influx into the lungs but demonstrates earlier population expansion and cell-to-cell spread. The earlier spread of 4334 to recruited cells, including monocyte-derived dendritic cells, is accompanied by earlier and greater magnitude of CD4+ T cell activation. The results provide evidence that strain-specific differences in interactions with lung leukocytes can shape adaptive immune responses in vivo.

IMPORTANCETuberculosis is a leading infectious disease killer world-wide and is caused by Mycobacterium tuberculosis. After exposure to M. tuberculosis, outcomes range from apparent elimination to active disease. Early innate immune responses may contribute to differences in outcomes, yet it is not known how bacterial strains alter the early dynamics of innate immune and T cell responses. We infected mice with distinct strains of M. tuberculosis and discovered striking differences in innate cellular recruitment, cell- to-cell spread of bacteria in the lungs, and kinetics of initiation of antigen-specific CD4 T cell responses. We also found that M. tuberculosis can spread beyond alveolar macrophages even before a large influx of inflammatory cells. These results provide evidence that distinct strains of M. tuberculosis can exhibit differential kinetics in cell-to- cell spread which is not directly linked to early recruitment of phagocytes but is subsequently linked to adaptive immune responses.
]]></description>
<dc:creator>Zha, B. S.</dc:creator>
<dc:creator>Desvignes, L.</dc:creator>
<dc:creator>Fergus, T.</dc:creator>
<dc:creator>Cornelius, A.</dc:creator>
<dc:creator>Cheng, T.-Y.</dc:creator>
<dc:creator>Moody, D. B.</dc:creator>
<dc:creator>Ernst, J.</dc:creator>
<dc:date>2022-05-11</dc:date>
<dc:identifier>doi:10.1101/2022.05.10.491435</dc:identifier>
<dc:title><![CDATA[Bacterial strain-dependent dissociation of cell recruitment and cell-to-cell spread in early M. tuberculosis infection]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-05-11</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.05.13.491805v1?rss=1">
<title>
<![CDATA[
Genome-wide data from medieval German Jews show that the Ashkenazi founder event pre-dated the 14th century 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.05.13.491805v1?rss=1</link>
<description><![CDATA[
We report genome-wide data for 33 Ashkenazi Jews (AJ), dated to the 14th century, following a salvage excavation at the medieval Jewish cemetery of Erfurt, Germany. The Erfurt individuals are genetically similar to modern AJ and have substantial Southern European ancestry, but they show more variability in Eastern European-related ancestry than modern AJ. A third of the Erfurt individuals carried the same nearly-AJ-specific mitochondrial haplogroup and eight carried pathogenic variants known to affect AJ today. These observations, together with high levels of runs of homozygosity, suggest that the Erfurt community had already experienced the major reduction in size that affected modern AJ. However, the Erfurt bottleneck was more severe, implying substructure in medieval AJ. Together, our results suggest that the AJ founder event and the acquisition of the main sources of ancestry pre-dated the 14th century and highlight late medieval genetic heterogeneity no longer present in modern AJ.
]]></description>
<dc:creator>Waldman, S.</dc:creator>
<dc:creator>Backenroth, D.</dc:creator>
<dc:creator>Harney, E.</dc:creator>
<dc:creator>Flohr, S.</dc:creator>
<dc:creator>Neff, N. C.</dc:creator>
<dc:creator>Buckley, G. M.</dc:creator>
<dc:creator>Fridman, H.</dc:creator>
<dc:creator>Akbari, A.</dc:creator>
<dc:creator>Rohland, N.</dc:creator>
<dc:creator>Mallick, S.</dc:creator>
<dc:creator>Nistal, J. C.</dc:creator>
<dc:creator>Yu, J.</dc:creator>
<dc:creator>Barzilai, N.</dc:creator>
<dc:creator>Peter, I.</dc:creator>
<dc:creator>Atzmon, G.</dc:creator>
<dc:creator>Ostrer, H.</dc:creator>
<dc:creator>Lencz, T.</dc:creator>
<dc:creator>Maruvka, Y. E.</dc:creator>
<dc:creator>Lämmerhirt, M.</dc:creator>
<dc:creator>Rutgers, L. V.</dc:creator>
<dc:creator>Renson, V.</dc:creator>
<dc:creator>Prufer, K. M.</dc:creator>
<dc:creator>Schiffels, S.</dc:creator>
<dc:creator>Ringbauer, H.</dc:creator>
<dc:creator>Sczech, K.</dc:creator>
<dc:creator>Carmi, S.</dc:creator>
<dc:creator>Reich, D.</dc:creator>
<dc:date>2022-05-16</dc:date>
<dc:identifier>doi:10.1101/2022.05.13.491805</dc:identifier>
<dc:title><![CDATA[Genome-wide data from medieval German Jews show that the Ashkenazi founder event pre-dated the 14th century]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-05-16</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.05.18.491827v1?rss=1">
<title>
<![CDATA[
Intermittent systemic exposure to lipopolysaccharide-induced inflammation disrupts hippocampal long-term potentiation and impairs cognition in aging male mice 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.05.18.491827v1?rss=1</link>
<description><![CDATA[
Age-related cognitive decline, a common component of the brain aging process, is associated with significant impairment in daily functioning and quality of life among geriatric adults. While the complexity of mechanisms underlying cognitive aging are still being elucidated, microbial exposure and the multifactorial inflammatory cascades associated with systemic infections is emerging as a potential driver of neurological senescence. The negative cognitive and neurobiological consequences of a single pathogen-associated inflammatory experience, such as that modeled through treatment with lipopolysaccharide (LPS), are well documented. Yet, the brain aging impacts of repeated, intermittent inflammatory challenges are less well studied. To extend the emerging literature assessing the impact of infection burden on cognitive function among normally aging mice, here, we repeatedly exposed adult mice to intermittent LPS challenges during the aging period. Male 10-month-old C57BL6 mice were systemically administered escalating doses of LPS once every two weeks for 2.5 months. We evaluated cognitive consequences using the non-spatial step-through inhibitory avoidance task and both spatial working and reference memory versions of the Morris water maze. We also probed several potential mechanisms, including cortical and hippocampal cytokine/chemokine gene expression as well as hippocampal neuronal function via extracellular field potential recordings. Though there was limited evidence for an ongoing inflammatory state in cortex and hippocampus, we observed impaired learning and memory and a disruption of hippocampal long-term potentiation. These data suggest that a history of intermittent exposure to LPS-induced inflammation is associated with a subtle but significantly accelerated trajectory of cognitive decline. The broader impact of these findings may have important implications for standard of care involving infections in aging individuals or populations at-risk for dementia.
]]></description>
<dc:creator>Engler-Chiurazzi, E. B.</dc:creator>
<dc:creator>Russell, A. E.</dc:creator>
<dc:creator>Povroznik, J. M.</dc:creator>
<dc:creator>McDonald, K. O.</dc:creator>
<dc:creator>Porter, K.</dc:creator>
<dc:creator>Wang, D.</dc:creator>
<dc:creator>Billig, B.</dc:creator>
<dc:creator>Felton, C.</dc:creator>
<dc:creator>Hammock, J.</dc:creator>
<dc:creator>Schreurs, B. G.</dc:creator>
<dc:creator>O'Callghan, J.</dc:creator>
<dc:creator>Zwezdaryk, K.</dc:creator>
<dc:creator>Simpkins, J. W.</dc:creator>
<dc:date>2022-05-18</dc:date>
<dc:identifier>doi:10.1101/2022.05.18.491827</dc:identifier>
<dc:title><![CDATA[Intermittent systemic exposure to lipopolysaccharide-induced inflammation disrupts hippocampal long-term potentiation and impairs cognition in aging male mice]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-05-18</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.05.20.492532v1?rss=1">
<title>
<![CDATA[
Cerebellum Directly Modulates the Substantia Nigra Dopaminergic Activity 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.05.20.492532v1?rss=1</link>
<description><![CDATA[
Evidence of direct reciprocal connections between the cerebellum and basal ganglia has challenged the long-held notion that these structures function independently. While anatomical studies have suggested the presence of cerebellar projections to the substantia nigra pars compacta (SNc), the nature and function of these connections (Cb-SNc) is unknown. Here we show that the Cb-SNc form monosynaptic glutamatergic synapses with both dopaminergic and non-dopaminergic neurons in the SNc. Optogenetic activation Cb-SNc axons in the SNc rapidly increases SNc activity, elevates striatal dopamine levels, and increases the probability of locomotion. During ongoing behavior, Cb-SNc axons are bilaterally activated prior to ambulation and unilateral lever manipulation. The Cb-SNc axons show prominent activation to water reward, and higher activation for sweet water, suggesting that the pathway also encodes reward value. Thus, the cerebellum directly, rapidly, and effectively modulates basal ganglia dopamine levels and conveys information related to movement initiation, vigor, and possibly reward processing.
]]></description>
<dc:creator>Washborn, S.</dc:creator>
<dc:creator>Nadim, F.</dc:creator>
<dc:creator>Onate, M.</dc:creator>
<dc:creator>Vera, J.</dc:creator>
<dc:creator>Yoshida, J.</dc:creator>
<dc:creator>K.B., R.</dc:creator>
<dc:creator>Khatami, L.</dc:creator>
<dc:creator>Khodakhah, K.</dc:creator>
<dc:date>2022-05-21</dc:date>
<dc:identifier>doi:10.1101/2022.05.20.492532</dc:identifier>
<dc:title><![CDATA[Cerebellum Directly Modulates the Substantia Nigra Dopaminergic Activity]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-05-21</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.05.27.493507v1?rss=1">
<title>
<![CDATA[
Tumor-intrinsic PRC2 inactivation drives a context-dependent immune-desert tumor microenvironment and confers resistance to immunotherapy 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.05.27.493507v1?rss=1</link>
<description><![CDATA[
Immune checkpoint blockade (ICB) has demonstrated clinical success in "inflamed" tumors with significant T-cell infiltrates, but tumors with an immune-desert tumor microenvironment (TME) fail to benefit. The tumor cell-intrinsic molecular mechanisms of the immune-desert phenotype remain poorly understood. Here, we demonstrate that inactivation of the Polycomb-repressive complex 2 (PRC2) core components, EED or SUZ12, a prevalent genetic event in malignant peripheral nerve sheath tumor (MPNST) and sporadically in other cancer types, drives a context-dependent immune-desert TME. PRC2 inactivation reprograms the chromatin landscape that leads to a cell-autonomous shift from primed baseline signaling-dependent cellular responses (e.g., interferon {gamma}) to PRC2-regulated development and cellular differentiation transcriptional programs. Further, PRC2 inactivation reprograms the TME, leads to diminished tumor immune infiltrates and immune evasion through reduced chemokine production and impaired antigen presentation and T-cell priming, and confers ICB primary resistance through blunted T-cell recruitment in vivo. We demonstrate that strategies that enhancing innate immunity via intratumoral delivery of inactivated modified vaccinia virus Ankara (MVA) leads to increased tumor immune infiltrates and sensitizes PRC2-loss tumors to ICB. Our results provide novel molecular mechanisms of context-dependent dysfunctional epigenetic reprogramming that underline the immune-desert phenotype in MPNST and other cancers with PRC2 inactivation. Importantly, our findings highlight genetic-inactivation of PRC2 as a novel context-dependent ICB therapeutic resistance biomarker in cancer, and caution that therapeutic strategies that non-selectively target PRC2 in the host may lead to undesirable context-dependent immune evasion and ICB resistance in tumors. Our studies also point to intratumoral delivery of immunogenic therapeutic viruses as an initial strategy to modulate the immune-desert TME and capitalize on the clinical benefit of ICB.
]]></description>
<dc:creator>Yan, J.</dc:creator>
<dc:creator>Chen, Y.</dc:creator>
<dc:creator>Patel, A. J.</dc:creator>
<dc:creator>Warda, S.</dc:creator>
<dc:creator>Nixon, B. G.</dc:creator>
<dc:creator>Wong, E. W. P.</dc:creator>
<dc:creator>Miranda-Roman, M. A.</dc:creator>
<dc:creator>Lee, C. J.</dc:creator>
<dc:creator>Yang, N.</dc:creator>
<dc:creator>Wang, Y.</dc:creator>
<dc:creator>Sher, J.</dc:creator>
<dc:creator>Giff, E.</dc:creator>
<dc:creator>Tang, F.</dc:creator>
<dc:creator>Khurana, E.</dc:creator>
<dc:creator>Singer, S.</dc:creator>
<dc:creator>Liu, Y.</dc:creator>
<dc:creator>Galbo, P. M.</dc:creator>
<dc:creator>Maag, J. L.</dc:creator>
<dc:creator>Koche, R. P.</dc:creator>
<dc:creator>Zheng, D.</dc:creator>
<dc:creator>Deng, L.</dc:creator>
<dc:creator>Antonescu, C. R.</dc:creator>
<dc:creator>Li, M.</dc:creator>
<dc:creator>Chen, Y.</dc:creator>
<dc:creator>Chi, P.</dc:creator>
<dc:date>2022-05-27</dc:date>
<dc:identifier>doi:10.1101/2022.05.27.493507</dc:identifier>
<dc:title><![CDATA[Tumor-intrinsic PRC2 inactivation drives a context-dependent immune-desert tumor microenvironment and confers resistance to immunotherapy]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-05-27</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.05.28.493429v1?rss=1">
<title>
<![CDATA[
PRC2 Inactivating Mutations in Cancer are Synthetic Lethal with DNMT1 Targeted Therapy via Enhanced Viral Mimicry 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.05.28.493429v1?rss=1</link>
<description><![CDATA[
Polycomb Repressive Complex 2 (PRC2) establishes and maintains di- and tri-methylation at histone 3 at lysine 27 (H3K27me2/3) in the genome and plays oncogenic and tumor suppressor roles in context-dependent cancer pathogenesis. While there is clinical success of therapeutically targeting PRC2 core component, EZH2, in PRC2-dependent cancers (e.g., follicular lymphoma, epithelioid sarcoma), it remains an unmet therapeutic bottleneck in PRC2-inactivated cancer. Biallelic inactivating mutations in PRC2 core components are a hallmark feature of high-grade malignant peripheral nerve sheath tumor (MPNST), an aggressive subtype of sarcoma with poor prognosis and no effective targeted therapeutics. Using a custom RNAi-based drop out screen, we observed that PRC2-inactivation is synthetic lethal with DNA methyltransferase 1 (DNMT1) downregulation; we further observed that small molecule DNMT inhibitors (DNMTis) resulted in enhanced cytotoxicity and antitumor response in PRC2-loss cancer context in vitro and in vivo. Mechanistically, DNMTi-mediated de-repression of retrotransposons (e.g., endogenous retroviral elements (ERVs)/LTR, LINE, SINE) and gene targets is partly restricted by PRC2, which potentially contributes to limited therapeutic activity in PRC2-wild-type (wt) cancer context. In contrast, DNMTi treatment synergizes with PRC2 inactivation and cooperatively amplifies the expression of retrotransposons (e.g., ERV/LTR, LINE, SINE), and subsequent viral mimicry response that promotes robust cell death in part through PKR-dependent double stranded-RNA (dsRNA) sensing. Collectively, our observations posit DNA methylation as a safeguard against anti-tumorigenic cell fate decisions in the context of PRC2-inactivation to promote cancer pathogenesis. Further, they identified a novel targeted therapeutic strategy in PRC2-inactivated MPNST and delineated the PRC2-inactivated cancer context for future preclinical exploration and clinical investigation of DNMT1-targeted therapies in cancer.

SIGNIFICANCEPRC2-inactivation drives oncogenesis in various cancers but therapeutically targeting PRC2-loss has remained challenging. Here we show that PRC2 inactivating mutations sets up a tumor context-specific liability for synthetic lethal interaction with genetic and therapeutic inhibition of DNMT1. DNMT1 inhibitor-induced cytotoxicity in PRC2-loss cancer context is accompanied by innate immune signaling signature through PKR-mediated sensing of endogenous retrotransposons. These observations posit a therapeutic window via direct anti-tumor effect by DNMT1 inhibitors in PRC2-loss cancers, and point to potentials to be combined with innovative immunotherapeutic strategies to capitalize on innate immune signaling activation.
]]></description>
<dc:creator>Patel, A. J.</dc:creator>
<dc:creator>Warda, S.</dc:creator>
<dc:creator>Maag, J. L. V.</dc:creator>
<dc:creator>Misra, R.</dc:creator>
<dc:creator>Miranda-Roman, M. A.</dc:creator>
<dc:creator>Pachai, M. R.</dc:creator>
<dc:creator>Lee, C. J.</dc:creator>
<dc:creator>Li, D.</dc:creator>
<dc:creator>Wang, N.</dc:creator>
<dc:creator>Bayshtok, G.</dc:creator>
<dc:creator>Meng, Y.</dc:creator>
<dc:creator>Wong, E. W. P.</dc:creator>
<dc:creator>Yan, J.</dc:creator>
<dc:creator>Giff, E.</dc:creator>
<dc:creator>Pappalardi, M. B.</dc:creator>
<dc:creator>McCabe, M. T.</dc:creator>
<dc:creator>Fletcher, J. A.</dc:creator>
<dc:creator>Scandura, J. M.</dc:creator>
<dc:creator>Koche, R. P.</dc:creator>
<dc:creator>Glass, J. L.</dc:creator>
<dc:creator>Antonescu, C. R.</dc:creator>
<dc:creator>Zheng, D.</dc:creator>
<dc:creator>Chen, Y.</dc:creator>
<dc:creator>Chi, P.</dc:creator>
<dc:date>2022-05-29</dc:date>
<dc:identifier>doi:10.1101/2022.05.28.493429</dc:identifier>
<dc:title><![CDATA[PRC2 Inactivating Mutations in Cancer are Synthetic Lethal with DNMT1 Targeted Therapy via Enhanced Viral Mimicry]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-05-29</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.06.01.494383v1?rss=1">
<title>
<![CDATA[
Prefrontal cortex melanocortin 4 receptors (MC4R) mediate food intake behavior in mice 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.06.01.494383v1?rss=1</link>
<description><![CDATA[
BackgroundMelanocortin 4 receptor (MC4R) activity in the hypothalamus is crucial for regulation of metabolism and food intake. The peptide ligands for the MC4R are associated with feeding, energy expenditure, and also with complex behaviors that orchestrate energy intake and expenditure, but the downstream neuroanatomical and neurochemical targets associated with these behaviors are elusive. In addition to strong expression in the hypothalamus, the MC4R is highly expressed in the medial prefrontal cortex, a region involved in executive function and decision-making.

MethodsUsing viral techniques in genetically modified mice combined with molecular techniques, we identify and describe the neuronal dynamics, and define the effects on feeding behavior of a novel population of MC4R expressing neurons in the infralimbic region of the cortex.

ResultsHere, we describe a novel population of MC4R-expressing neurons in the infralimbic (IL) region of the mouse prefrontal cortex that are glutamatergic, receive input from melanocortinergic neurons of the arcuate hypothalamus, and project to multiple regions that coordinate appetitive responses to food-related stimuli. The neurons are depolarized by application of MC4R-specific peptidergic agonist, THIQ. Deletion of MC4R from the IL neurons causes increased food intake and body weight gain and impaired executive function in simple food-related behavior tasks.

ConclusionTogether, these data suggest that MC4R neurons of the IL play a critical role in the regulation of food intake.
]]></description>
<dc:creator>Ross, R. A.</dc:creator>
<dc:creator>Kim, A.</dc:creator>
<dc:creator>Das, P.</dc:creator>
<dc:creator>Li, Y.</dc:creator>
<dc:creator>Choi, Y. K.</dc:creator>
<dc:creator>Thompson, A. T.</dc:creator>
<dc:creator>Douglas, E.</dc:creator>
<dc:creator>Subramanian, S.</dc:creator>
<dc:creator>Ramos, K.</dc:creator>
<dc:creator>Callahan, K.</dc:creator>
<dc:creator>Bolshakov, V. Y.</dc:creator>
<dc:creator>Ressler, K. J.</dc:creator>
<dc:date>2022-06-02</dc:date>
<dc:identifier>doi:10.1101/2022.06.01.494383</dc:identifier>
<dc:title><![CDATA[Prefrontal cortex melanocortin 4 receptors (MC4R) mediate food intake behavior in mice]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-06-02</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.06.06.494998v1?rss=1">
<title>
<![CDATA[
The DNA Damage response and cell competition are p53- and Xrp1-dependent processes that suppress hyperplastic aneuploidy 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.06.06.494998v1?rss=1</link>
<description><![CDATA[
Model organisms may help understand how p53 suppresses tumorigenesis in mammals. In Drosophila, the primary transcriptional target of p53 is the gene encoding the bZip AT-hook protein Xrp1, which is another transcription factor. We report that Xrp1 mediated multiple functions of p53 in the DNA damage response (DDR), contributing to p53-dependent gene transcription and DNA damage-induced apoptosis. In addition to this role as a p53 effector, a p53-independent role for Xrp1 in cell competition has been described. Cell competition can remove cells whose genome has been altered by DNA damage and repair. During cell competition, Xrp1 is induced by RpS12, which acts as a sensor of defective ribosome biogenesis. RpS12-dependent cell competition began as the DDR wound down, and was even more prominent if p53 function was reduced. Such p53 inhibition resulted in persistence of DNA damage revealed by {gamma}H2Av accumulation. Thus, Xrp1 limited the accumulation of abnormal cells resulting from genotoxicity through both the acute, p53-dependent DDR, and also from subsequent cell competition that removes cells where DNA repair did not restore the normal genome. Both these processes might contribute to the tumor suppressor function of p53 in mammals.
]]></description>
<dc:creator>Baker, N.</dc:creator>
<dc:creator>Khan, C.</dc:creator>
<dc:date>2022-06-08</dc:date>
<dc:identifier>doi:10.1101/2022.06.06.494998</dc:identifier>
<dc:title><![CDATA[The DNA Damage response and cell competition are p53- and Xrp1-dependent processes that suppress hyperplastic aneuploidy]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-06-08</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.06.08.495145v1?rss=1">
<title>
<![CDATA[
Modeling the Diverse Effects of Divisive Normalization on Noise Correlations 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.06.08.495145v1?rss=1</link>
<description><![CDATA[
Divisive normalization, a prominent descriptive model of neural activity, is employed by theories of neural coding across many different brain areas. Yet, the relationship between normalization and the statistics of neural responses beyond single neurons remains largely unexplored. Here we focus on noise correlations, a widely studied pairwise statistic, because its stimulus and state dependence plays a central role in neural coding. Existing models of covariability typically ignore normalization despite empirical evidence suggesting it affects correlation structure in neural populations. We therefore propose a pairwise stochastic divisive normalization model that accounts for the effects of normalization and other factors on covariability. We first show that normalization modulates noise correlations in qualitatively different ways depending on whether normalization is shared between neurons, and we discuss how to infer when normalization signals are shared. We then apply our model to calcium imaging data from mouse primary visual cortex (V1), and find that it accurately fits the data, often outperforming a popular alternative model of correlations. Our analysis indicates that normalization signals are often shared between V1 neurons in this dataset. Our model will enable quantifying the relation between normalization and covariability in a broad range of neural systems, which could provide new constraints on circuit mechanisms of normalization and their role in information transmission and representation.

Author SummaryCortical responses are often variable across identical experimental conditions, and this variability is shared between neurons (noise correlations). These noise correlations have been studied extensively to understand how they impact neural coding and what mechanisms determine their properties. Here we show how correlations relate to divisive normalization, a mathematical operation widely adopted to describe how the activity of a neuron is modulated by other neurons via divisive gain control. We introduce the first statistical model of this relation. We extensively validate the model and investigate parameter inference in synthetic data. We find that our model, when applied to data from mouse visual cortex, outperforms a popular model of noise correlations that does not include normalization, and it reveals diverse influences of normalization on correlations. Our work demonstrates a framework to measure the relation between noise correlations and the parameters of the normalization model, which could become an indispensable tool for quantitative investigations of noise correlations in the wide range of neural systems that exhibit normalization.
]]></description>
<dc:creator>Weiss, O.</dc:creator>
<dc:creator>Bounds, H. A.</dc:creator>
<dc:creator>Adesnik, H.</dc:creator>
<dc:creator>Coen-Cagli, R.</dc:creator>
<dc:date>2022-06-10</dc:date>
<dc:identifier>doi:10.1101/2022.06.08.495145</dc:identifier>
<dc:title><![CDATA[Modeling the Diverse Effects of Divisive Normalization on Noise Correlations]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-06-10</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.06.10.495710v1?rss=1">
<title>
<![CDATA[
Off-manifold coding in visual cortex revealed by sleep 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.06.10.495710v1?rss=1</link>
<description><![CDATA[
Low-dimensional neural manifolds are controversial in part because it is unclear how to reconcile them with high-dimensional representations observed in areas such as primary visual cortex (V1). We addressed this by recording neuronal activity in V1 during slow-wave sleep, enabling us to identify internally-generated low-dimensional manifold structure and evaluate its role during visual processing. We found that movements and visual stimuli were both encoded in the "on-manifold" subspace preserved during sleep. However, only stimuli were encoded in the "off-manifold" subspace, which contains activity patterns that are less likely than chance to occur spontaneously during sleep. This off-manifold activity comprises sparse firing in neurons with the strongest low-dimensional modulation by movement, which paradoxically prevents movement-evoked activity from interfering with stimulus representations. These results reveal an unexpected link between low-dimensional dynamics and sparse coding, which together create a protected off-manifold coding space keeping high-dimensional representations separable from movement-evoked activity.
]]></description>
<dc:creator>de Oliveira, E. F.</dc:creator>
<dc:creator>Kim, S.</dc:creator>
<dc:creator>Qiu, T. S.</dc:creator>
<dc:creator>Peyrache, A.</dc:creator>
<dc:creator>Batista-Brito, R.</dc:creator>
<dc:creator>Sjulson, L.</dc:creator>
<dc:date>2022-06-13</dc:date>
<dc:identifier>doi:10.1101/2022.06.10.495710</dc:identifier>
<dc:title><![CDATA[Off-manifold coding in visual cortex revealed by sleep]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-06-13</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.06.14.496098v1?rss=1">
<title>
<![CDATA[
Laminar Distribution of stimulus- and task-related variables related to auditory streaming in core and belt auditory cortex 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.06.14.496098v1?rss=1</link>
<description><![CDATA[
Although previous studies have identified neural mechanisms that may underlie auditory scene analysis, the relationship between these mechanisms and behavior remains elusive. To fill these gaps, we recorded multiunit activity (MUA) from the posterior and anterior auditory fields while monkeys participated in an auditory streaming task. We found that MUA magnitude was reduced as the streaming stimulus unfolded over time, and this reduction depended on the frequency difference between the tone bursts comprising the streaming stimulus. We then examined whether this frequency-dependent reduction in activity could be utilized by downstream neurons to read out "one stream" versus "two streams" and found that, as the frequency difference increased, an ideal observer consistently classified neural activity as "two streams". However, because this classification was not modulated by the monkeys choices, it suggests that this activity may not reflect the segregation of stimuli into perceptually distinct auditory streams but may simply reflect bottom-up processes.
]]></description>
<dc:creator>Banno, T.</dc:creator>
<dc:creator>Shirley, H. W.</dc:creator>
<dc:creator>Fishman, Y. I.</dc:creator>
<dc:creator>Cohen, Y. E.</dc:creator>
<dc:date>2022-06-16</dc:date>
<dc:identifier>doi:10.1101/2022.06.14.496098</dc:identifier>
<dc:title><![CDATA[Laminar Distribution of stimulus- and task-related variables related to auditory streaming in core and belt auditory cortex]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-06-16</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.06.20.496902v1?rss=1">
<title>
<![CDATA[
POSTRE: a tool to predict the pathological effects of human structural variants 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.06.20.496902v1?rss=1</link>
<description><![CDATA[
Understanding the pathological impact of non-coding genetic variation is a major challenge in medical genetics. Accumulating evidences indicate that a significant fraction of genetic alterations, including structural variants (SVs), can cause human disease by altering the function of non-coding regulatory elements, such as enhancers. In the case of SVs, described pathomechanisms include changes in enhancer dosage and long-range enhancer-gene communication. However, there is still a clear gap between the need to predict and interpret the medical impact of non-coding variants, and the existence of tools to properly perform these tasks. To reduce this gap, we have developed POSTRE (Prediction Of STRuctural variant Effects), a computational tool to predict the pathogenicity of SVs implicated in a broad range of human congenital disorders. By considering disease-relevant cellular contexts, POSTRE identifies SVs with either coding or long-range pathological consequences with high specificity and sensitivity. Furthermore, POSTRE not only identifies pathogenic SVs, but also predicts the disease-causative genes and the underlying pathological mechanism (e.g, gene deletion, enhancer disconnection, enhancer adoption, etc.). POSTRE is available at https://github.com/vicsanga/Postre.
]]></description>
<dc:creator>Sanchez-Gaya, V.</dc:creator>
<dc:creator>Rada-Iglesias, A.</dc:creator>
<dc:date>2022-06-22</dc:date>
<dc:identifier>doi:10.1101/2022.06.20.496902</dc:identifier>
<dc:title><![CDATA[POSTRE: a tool to predict the pathological effects of human structural variants]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-06-22</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.06.24.497533v1?rss=1">
<title>
<![CDATA[
Cell-Type-Specific Epigenetic Priming of Gene Expression in Nucleus Accumbens by Cocaine 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.06.24.497533v1?rss=1</link>
<description><![CDATA[
A hallmark of addiction is the ability of drugs of abuse to trigger relapse after periods of prolonged abstinence. Here, we describe a novel epigenetic mechanism whereby chronic cocaine exposure causes lasting chromatin and downstream transcriptional modifications in the nucleus accumbens (NAc), a critical brain region controlling motivation. We link prolonged withdrawal from cocaine to the depletion of the histone variant H2A.Z, coupled to increased genome accessibility and latent priming of gene transcription, in D1 dopamine receptor-expressing medium spiny neurons (D1 MSNs) that relates to aberrant gene expression upon drug relapse. The histone chaperone ANP32E removes H2A.Z from chromatin, and we demonstrate that D1 MSN-selective Anp32e knockdown prevents cocaine-induced H2A.Z depletion and blocks cocaines rewarding actions. By contrast, very different effects of cocaine exposure, withdrawal, and relapse were found for D2-MSNs. These findings establish histone variant exchange as an important mechanism and clinical target engaged by drugs of abuse to corrupt brain function and behavior.
]]></description>
<dc:creator>Mews, P.</dc:creator>
<dc:creator>Van der Zee, Y.</dc:creator>
<dc:creator>Kronman, H.</dc:creator>
<dc:creator>Gurung, A.</dc:creator>
<dc:creator>Ramakrishnan, A.</dc:creator>
<dc:creator>Browne, C.</dc:creator>
<dc:creator>Futamura, R.</dc:creator>
<dc:creator>Ryan, M.</dc:creator>
<dc:creator>Reyes, A. A.</dc:creator>
<dc:creator>Garcia, B.</dc:creator>
<dc:creator>Sidoli, S.</dc:creator>
<dc:creator>Shen, L.</dc:creator>
<dc:creator>Nestler, E. J.</dc:creator>
<dc:date>2022-06-26</dc:date>
<dc:identifier>doi:10.1101/2022.06.24.497533</dc:identifier>
<dc:title><![CDATA[Cell-Type-Specific Epigenetic Priming of Gene Expression in Nucleus Accumbens by Cocaine]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-06-26</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.06.28.497908v1?rss=1">
<title>
<![CDATA[
Molecular genomic studies of the obesogenic effects of tributyltin during adipogenic differentiation implicate a primary role for cytoskeletal damage. 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.06.28.497908v1?rss=1</link>
<description><![CDATA[
Environmental obesogens are being studied for their potential role in the increasing prevalence of obesity globally. A major focus in this field of research has been on the mechanism by which these agents act. In this study we focused on the obesogenic organotin tributyltin (TBT), which is believed to act by binding to the PPAR{gamma} nuclear receptor in a heterodimer with RXR to alter gene regulation. To test whether this was the dominant mechanism for TBT activity, we performed time-course studies of transcription and chromatin accessibility in mesenchymal stem cells differentiating to adipocytes. We found limited evidence for PPAR{gamma} effects by TBT, but a strong response by Ras-related GTPases and evidence for the loss of TEAD transcription factor activity during differentiation. These observations combine to implicate a known property of organotins, to cause cytoskeletal cytoskeletal damage as the primary event in an updated model for TBT effects, leading to the loss of YAP co-regulator activity and the consequent failure of TEAD repression of adipogenesis.
]]></description>
<dc:creator>Thompson, T. V.</dc:creator>
<dc:creator>Greally, J. M.</dc:creator>
<dc:date>2022-06-28</dc:date>
<dc:identifier>doi:10.1101/2022.06.28.497908</dc:identifier>
<dc:title><![CDATA[Molecular genomic studies of the obesogenic effects of tributyltin during adipogenic differentiation implicate a primary role for cytoskeletal damage.]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-06-28</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.06.28.497777v1?rss=1">
<title>
<![CDATA[
NFATc1 negatively determines chondrocyte differentiation in articular cartilage progenitors 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.06.28.497777v1?rss=1</link>
<description><![CDATA[
The origin and differentiation mechanism of articular chondrocytes remain poorly understood. Broadly, the difference in developmental mechanisms of articular and growth-plate cartilage is still less elucidated. Here, we identified that the nuclear factor of activated T-cells cytoplasmic 1 (NFATc1) is a crucial regulator of articular, but not growth-plate, chondrocyte differentiation during development. At the early stage of mouse knee development (embryonic day 13.5), NFATc1-expressing cells were mainly located in the flanking region of the joint interzone. With development, NFATc1-expressing cells generated almost all articular chondrocytes, but not chondrocytes in limb growth-plate primordium. NFATc1-expressing cells displayed prominent capacities for colony formation and multipotent differentiation. Transcriptome analyses revealed a set of characteristic genes in NFATc1-enriched articular cartilage progenitors. Strikingly, the expression of NFATc1 was diminished with articular chondrocyte differentiation, and suppressing NFATc1 expression in articular cartilage progenitors was sufficient to induce spontaneous chondrogenesis while overexpressing NFATc1 suppresses chondrogenesis. Mechanistically, NFATc1 negatively regulated the transcriptional activity of the Col2a1 gene. Thus, our results reveal that NFATc1 characterizes articular, but not growth-plate, cartilage progenitors and negatively determines articular chondrocyte differentiation at least partly through regulating COL2A1 gene transcription.
]]></description>
<dc:creator>Zhang, F.</dc:creator>
<dc:creator>Zhao, Y.</dc:creator>
<dc:creator>Wang, M.</dc:creator>
<dc:creator>Zhou, B.</dc:creator>
<dc:creator>Zhou, B.</dc:creator>
<dc:creator>Ge, X.</dc:creator>
<dc:date>2022-06-29</dc:date>
<dc:identifier>doi:10.1101/2022.06.28.497777</dc:identifier>
<dc:title><![CDATA[NFATc1 negatively determines chondrocyte differentiation in articular cartilage progenitors]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-06-29</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.07.03.498624v1?rss=1">
<title>
<![CDATA[
Targeting C5aR1 signaling reduced neutrophil extracellular traps and ameliorates COVID-19 pathology 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.07.03.498624v1?rss=1</link>
<description><![CDATA[
Patients with severe COVID-19 develop acute respiratory distress syndrome (ARDS) that may progress to cytokine storm syndrome, organ dysfunction, and death. Considering that complement component 5a (C5a), through its cellular receptor C5aR1, has potent proinflammatory actions, and plays immunopathological roles in inflammatory diseases, we investigated whether C5a/C5aR1 pathway could be involved in COVID-19 pathophysiology. C5a/C5aR1 signaling increased locally in the lung, especially in neutrophils of critically ill COVID-19 patients compared to patients with influenza infection, as well as in the lung tissue of K18-hACE2 Tg mice (Tg mice) infected with SARS-CoV-2. Genetic and pharmacological inhibition of C5aR1 signaling ameliorated lung immunopathology in Tg-infected mice. Mechanistically, we found that C5aR1 signaling drives neutrophil extracellular trap (NET)s-dependent immunopathology. These data confirm the immunopathological role of C5a/C5aR1 signaling in COVID-19 and indicate that antagonist of C5aR1 could be useful for COVID-19 treatment.
]]></description>
<dc:creator>Silva, B. M.</dc:creator>
<dc:creator>Veras, F. P.</dc:creator>
<dc:creator>Gomes, G.</dc:creator>
<dc:creator>Cambier, S.</dc:creator>
<dc:creator>Silva, G.</dc:creator>
<dc:creator>Quadros, A.</dc:creator>
<dc:creator>Caetite, D.</dc:creator>
<dc:creator>Nascimento, D.</dc:creator>
<dc:creator>Silva, C.</dc:creator>
<dc:creator>Silva, J.</dc:creator>
<dc:creator>Damasceno, S.</dc:creator>
<dc:creator>Schneider, A.</dc:creator>
<dc:creator>Beretta, F.</dc:creator>
<dc:creator>Batah, S.</dc:creator>
<dc:creator>Castro, I.</dc:creator>
<dc:creator>Paiva, I.</dc:creator>
<dc:creator>Rodrigues, T.</dc:creator>
<dc:creator>Salina, A. C. G.</dc:creator>
<dc:creator>Martins, R.</dc:creator>
<dc:creator>Cebinelli, G.</dc:creator>
<dc:creator>Bibo, N.</dc:creator>
<dc:creator>Jorge, D.</dc:creator>
<dc:creator>Nakaya, H. I.</dc:creator>
<dc:creator>Zamboni, D. S.</dc:creator>
<dc:creator>Leiria, L.</dc:creator>
<dc:creator>Fabro, A.</dc:creator>
<dc:creator>Alves-Filho, J. C.</dc:creator>
<dc:creator>Arruda, E.</dc:creator>
<dc:creator>Louzada-Junior, P.</dc:creator>
<dc:creator>Oliveira, R.</dc:creator>
<dc:creator>Cunha, L. D.</dc:creator>
<dc:creator>Van-Mol, P.</dc:creator>
<dc:creator>Vanderbeke, L.</dc:creator>
<dc:creator>Feys, S.</dc:creator>
<dc:creator>Wauters, E.</dc:creator>
<dc:creator>Brandolini, L.</dc:creator>
<dc:creator>Cunha, F.</dc:creator>
<dc:creator>Kohl, J.</dc:creator>
<dc:creator>Allegretti, M.</dc:creator>
<dc:creator>Lambrechts, D.</dc:creator>
<dc:creator>Wauters, J.</dc:creator>
<dc:creator>Proost, P.</dc:creator>
<dc:creator>Cunha, T. M.</dc:creator>
<dc:date>2022-07-05</dc:date>
<dc:identifier>doi:10.1101/2022.07.03.498624</dc:identifier>
<dc:title><![CDATA[Targeting C5aR1 signaling reduced neutrophil extracellular traps and ameliorates COVID-19 pathology]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-07-05</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.07.07.499147v1?rss=1">
<title>
<![CDATA[
Pseudouridine-dependent ribosome biogenesis regulates translation of polyglutamine proteins during Drosophila oogenesis 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.07.07.499147v1?rss=1</link>
<description><![CDATA[
Stem cells in many systems, including Drosophila germline stem cells (GSCs), increase ribosome biogenesis and translation during terminal differentiation. Here, we show that pseudouridylation of ribosomal RNA (rRNA) mediated by the H/ACA box is required for ribosome biogenesis and oocyte specification. Reducing ribosome levels during differentiation decreased the translation of a subset of mRNAs that are enriched for CAG repeats and encode polyglutamine-containing proteins, including differentiation factors such as RNA-binding Fox protein 1. Moreover, ribosomes were enriched at CAG repeats within transcripts during oogenesis. Increasing TOR activity to elevate ribosome levels in H/ACA box-depleted germlines suppressed the GSC differentiation defects, whereas germlines treated with the TOR inhibitor rapamycin had reduced levels of polyglutamine-containing proteins. Thus, ribosome biogenesis and ribosome levels can control stem cell differentiation via selective translation of CAG repeat-containing transcripts.
]]></description>
<dc:creator>Breznak, S.</dc:creator>
<dc:creator>Peng, Y.</dc:creator>
<dc:creator>Deng, L.</dc:creator>
<dc:creator>Kotb, N. M.</dc:creator>
<dc:creator>Flamholz, Z.</dc:creator>
<dc:creator>Rapisarda, I. T.</dc:creator>
<dc:creator>Martin, E. T.</dc:creator>
<dc:creator>LaBarge, K. A.</dc:creator>
<dc:creator>Fabris, D.</dc:creator>
<dc:creator>Gavis, E. R.</dc:creator>
<dc:creator>Rangan, P.</dc:creator>
<dc:date>2022-07-08</dc:date>
<dc:identifier>doi:10.1101/2022.07.07.499147</dc:identifier>
<dc:title><![CDATA[Pseudouridine-dependent ribosome biogenesis regulates translation of polyglutamine proteins during Drosophila oogenesis]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-07-08</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.07.14.500134v1?rss=1">
<title>
<![CDATA[
Melanization of Candida auris is Associated with Alteration of Extracellular pH 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.07.14.500134v1?rss=1</link>
<description><![CDATA[
Candida auris is a recently emerged global fungal pathogen, which causes life-threatening infections, often in healthcare settings. C. auris infections are worrisome because the fungus is often resistant to multiple antifungal drug classes. Furthermore, C. auris forms durable and difficult to remove biofilms. Due to the relatively recent, resilient, and resistant nature of C. auris, we investigated whether it produces the common fungal virulence factor melanin. Melanin is a black-brown pigment typically produced following enzymatic oxidation of aromatic precursors, which promotes fungal virulence through oxidative stress resistance, mammalian immune response evasion, and antifungal peptide and pharmaceutical inactivation. We found that certain strains of C. auris oxidized L-DOPA and catecholamines into melanin. Melanization occurred extracellularly in a process mediated by alkalinization of the extracellular environment, resulting in granule-like structures that adhere to the fungus external surface. C. auris had relatively high cell surface hydrophobicity, but there was no correlation between hydrophobicity and melanization. Melanin protected the fungus from oxidative damage, but we did not observe a protective role during infection of macrophages or Galleria mellonella larvae. In summary, C. auris alkalinizes the extracellular medium, which promotes the non-enzymatic oxidation of L-DOPA to melanin that attaches to its surface, thus illustrating a novel mechanism for fungal melanization.
]]></description>
<dc:creator>Smith, D. F. Q.</dc:creator>
<dc:creator>Mudrak, N. J.</dc:creator>
<dc:creator>Zamith-Miranda, D.</dc:creator>
<dc:creator>Honorato, L.</dc:creator>
<dc:creator>Nimrichter, L.</dc:creator>
<dc:creator>Smith, B.</dc:creator>
<dc:creator>Gerfen, G. J.</dc:creator>
<dc:creator>Nosanchuk, J. D.</dc:creator>
<dc:creator>Casadevall, A.</dc:creator>
<dc:date>2022-07-15</dc:date>
<dc:identifier>doi:10.1101/2022.07.14.500134</dc:identifier>
<dc:title><![CDATA[Melanization of Candida auris is Associated with Alteration of Extracellular pH]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-07-15</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.07.19.500669v1?rss=1">
<title>
<![CDATA[
mTORC2 couples fasting to mitochondrial fission 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.07.19.500669v1?rss=1</link>
<description><![CDATA[
Fasting triggers diverse cellular and metabolic adaptations to facilitate organismal survival1,2. During nutrient deprivation, increases in circulating fatty acids support mitochondrial respiration2. The mechanisms driving mitochondrial adaptations and respiratory sufficiency during nutrient deprivation remain incompletely understood. Here we show that extended periods of fasting, or lipid availability stimulates mTORC2 activity. Activation of mTORC2 and phosphorylation of its target NDRG13 at S336 sustains mitochondrial fission and respiratory sufficiency. Timelapse imaging reveals that wildtype NDRG1, but not phosphorylation-deficient NDRG1S336A mutant, engages with mitochondria to facilitate its scission. Using proteomics, and an siRNA screen, we show that mTORC2-phosphorylated NDRG1 cooperates with the small GTPase Cdc424 and Cdc42-specific effectors and regulators to orchestrate fission. Accordingly, RictorKO, NDRG1S336A mutants, and Cdc42-deficient cells each display mitochondrial phenotypes reminiscent of fission failure. During nutrient surplus, mTOR complexes perform anabolic functions5; however, paradoxical reactivation of mTORC2 during fasting plays an unexpected role in driving mitochondrial fission and respiration.
]]></description>
<dc:creator>Martinez-Lopez, N.</dc:creator>
<dc:creator>Mattar, P.</dc:creator>
<dc:creator>Toledo, M.</dc:creator>
<dc:creator>Bains, H.</dc:creator>
<dc:creator>Kalyani, M.</dc:creator>
<dc:creator>Aoun, M. L.</dc:creator>
<dc:creator>Sharma, M.</dc:creator>
<dc:creator>McIntyre, L. B. J.</dc:creator>
<dc:creator>Gunther-Cummins, L.</dc:creator>
<dc:creator>Macaluso, F. P.</dc:creator>
<dc:creator>Aguilan, J. T.</dc:creator>
<dc:creator>Sidoli, S.</dc:creator>
<dc:creator>Bourdenx, M.</dc:creator>
<dc:creator>Singh, R.</dc:creator>
<dc:date>2022-07-20</dc:date>
<dc:identifier>doi:10.1101/2022.07.19.500669</dc:identifier>
<dc:title><![CDATA[mTORC2 couples fasting to mitochondrial fission]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-07-20</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.07.19.500682v1?rss=1">
<title>
<![CDATA[
Two point mutations in protocadherin-1 disrupt Andes hantavirus recognition and afford protection against lethal infection 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.07.19.500682v1?rss=1</link>
<description><![CDATA[
Andes virus and Sin Nombre virus are the etiologic agents of severe hantavirus cardiopulmonary syndrome (HCPS) in the Americas for which no FDA-approved countermeasures are available. Protocadherin-1 (PCDH1), a cadherin-superfamily protein recently identified as a critical host factor for ANDV and SNV, represents a new antiviral target; however, its precise role remains to be elucidated. Here, we used computational and experimental approaches to delineate the binding surface of the ANDV glycoprotein complex on PCDH1s first extracellular cadherin repeat domain. Strikingly, a single amino acid residue in this PCDH1 surface influenced the host species-specificity of SNV glycoprotein-PCDH1 interaction and cell entry. Mutation of this, and a neighboring residue, substantially protected Syrian hamsters from pulmonary disease and death caused by ANDV. We conclude that PCDH1 is a bona fide entry receptor for ANDV and SNV whose direct interaction with hantavirus glycoproteins could be targeted to develop new interventions against HCPS.
]]></description>
<dc:creator>Slough, M. M.</dc:creator>
<dc:creator>Li, R.</dc:creator>
<dc:creator>Herbert, A. S.</dc:creator>
<dc:creator>Lasso, G.</dc:creator>
<dc:creator>Kuehne, A. I.</dc:creator>
<dc:creator>Bakken, R. R.</dc:creator>
<dc:creator>Monticelli, S. R.</dc:creator>
<dc:creator>Liu, Y.</dc:creator>
<dc:creator>Ghosh, A.</dc:creator>
<dc:creator>Moreau, A. M.</dc:creator>
<dc:creator>Zeng, X.</dc:creator>
<dc:creator>Almo, S. C.</dc:creator>
<dc:creator>Dye, J. M.</dc:creator>
<dc:creator>Jangra, R. K.</dc:creator>
<dc:creator>Wang, Z.</dc:creator>
<dc:creator>Chandran, K.</dc:creator>
<dc:date>2022-07-20</dc:date>
<dc:identifier>doi:10.1101/2022.07.19.500682</dc:identifier>
<dc:title><![CDATA[Two point mutations in protocadherin-1 disrupt Andes hantavirus recognition and afford protection against lethal infection]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-07-20</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.07.20.500802v1?rss=1">
<title>
<![CDATA[
Multi-ancestry GWAS of major depression aids locus discovery, fine-mapping, gene prioritisation, and causal inference 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.07.20.500802v1?rss=1</link>
<description><![CDATA[
Most genome-wide association studies (GWAS) of major depression (MD) have been conducted in samples of European ancestry. Here we report a multi-ancestry GWAS of MD, adding data from 21 studies with 88,316 MD cases and 902,757 controls to previously reported data from individuals of European ancestry. This includes samples of African (36% of effective sample size), East Asian (26%) and South Asian (6%) ancestry and Hispanic/Latinx participants (32%). The multi-ancestry GWAS identified 190 significantly associated loci, 53 of them novel. For previously reported loci from GWAS in European ancestry the power-adjusted transferability ratio was 0.6 in the Hispanic/Latinx group and 0.3 in each of the other groups. Fine-mapping benefited from additional sample diversity: the number of credible sets with [&le;]5 variants increased from 3 to 12. A transcriptome-wide association study identified 354 significantly associated genes, 205 of them novel. Mendelian Randomisation showed a bidirectional relationship with BMI exclusively in samples of European ancestry. This first multi-ancestry GWAS of MD demonstrates the importance of large diverse samples for the identification of target genes and putative mechanisms.
]]></description>
<dc:creator>Meng, X.</dc:creator>
<dc:creator>Navoly, G.</dc:creator>
<dc:creator>Giannakopoulou, O.</dc:creator>
<dc:creator>DL, D.</dc:creator>
<dc:creator>Koller, D.</dc:creator>
<dc:creator>Pathak, G.</dc:creator>
<dc:creator>Koen, N.</dc:creator>
<dc:creator>Lin, K.</dc:creator>
<dc:creator>Renteria, M.</dc:creator>
<dc:creator>Feng, Y.</dc:creator>
<dc:creator>Gaziano, J. M.</dc:creator>
<dc:creator>Stein, D.</dc:creator>
<dc:creator>Zar, H.</dc:creator>
<dc:creator>Campbell, M.</dc:creator>
<dc:creator>van Heel, D.</dc:creator>
<dc:creator>Trivedi, B.</dc:creator>
<dc:creator>Finer, S.</dc:creator>
<dc:creator>McQuillin, A.</dc:creator>
<dc:creator>Bass, N.</dc:creator>
<dc:creator>Chundru, V. K.</dc:creator>
<dc:creator>Martin, H.</dc:creator>
<dc:creator>Huang, Q. Q.</dc:creator>
<dc:creator>Valkovskaya, M.</dc:creator>
<dc:creator>Kuo, P.-H.</dc:creator>
<dc:creator>Chen, H.-C.</dc:creator>
<dc:creator>Tsai, S.-J.</dc:creator>
<dc:creator>Liu, Y.-L.</dc:creator>
<dc:creator>Kendler, K.</dc:creator>
<dc:creator>Peterson, R.</dc:creator>
<dc:creator>Cai, N.</dc:creator>
<dc:creator>Fang, Y.</dc:creator>
<dc:creator>Sen, S.</dc:creator>
<dc:creator>Scott, L.</dc:creator>
<dc:creator>Burmeister, M.</dc:creator>
<dc:creator>Loos, R.</dc:creator>
<dc:creator>Preuss, M.</dc:creator>
<dc:creator>Actkins, K.</dc:creator>
<dc:creator>Davis, L.</dc:creator>
<dc:creator>Uddin, M.</dc:creator>
<dc:creator>Wani, A.</dc:creator>
<dc:creator>Wildman, D.</dc:creator>
<dc:creator>Ursano, R.</dc:creator>
<dc:creator>Kessler, R.</dc:creator>
<dc:creator>Kanai, M.</dc:creator>
<dc:creator>Okada, Y.</dc:creator>
<dc:creator>Sakaue, S.</dc:creator>
<dc:creator>Rabinowitz, J.</dc:creator>
<dc:creator>Maher, B.</dc:creator>
<dc:creator>Uhl, G.</dc:creator>
<dc:creator>Eato</dc:creator>
<dc:date>2022-07-21</dc:date>
<dc:identifier>doi:10.1101/2022.07.20.500802</dc:identifier>
<dc:title><![CDATA[Multi-ancestry GWAS of major depression aids locus discovery, fine-mapping, gene prioritisation, and causal inference]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-07-21</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.07.28.501875v1?rss=1">
<title>
<![CDATA[
ATM and MSH2 control blunt DNA end joining in immunoglobulin class switch recombination 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.07.28.501875v1?rss=1</link>
<description><![CDATA[
Class switch recombination (CSR) produces secondary immunoglobulin isotypes and requires AID-dependent DNA deamination of intronic switch (S) regions within the immunoglobulin heavy chain (Igh) gene locus. Non-canonical repair of deaminated DNA by mismatch repair (MMR) or base excision repair (BER) creates DNA breaks that permit recombination between distal S regions. ATM-dependent phosphorylation of AID at serine-38 (pS38-AID) promotes its interaction with APE1, a BER protein, suggesting that ATM regulates CSR through BER. However, pS38-AID may also function in MMR during CSR, although the mechanism remains unknown. To examine whether ATM modulates BER- and/or MMR-dependent CSR, Atm-/- mice were bred to mice deficient for the MMR gene Msh2. Surprisingly, the predicted Mendelian frequencies of Atm-/-Msh2-/- adult mice were not obtained. To generate ATM and MSH2-deficient B cells, Atm was conditionally deleted on an Msh2-/- background using a floxed ATM allele [Atmf] and B cell-specific Cre recombinase expression (CD23-cre) to produce a deleted ATM allele (AtmD). As compared to AtmD/Dand Msh2-/- mice and B cells, AtmD/DMsh2-/- mice and B cells display a reduced CSR phenotype. Interestingly, S-S{gamma}1 junctions from AtmD/DMsh2-/-B cells that were induced to switch to IgG1 in vitro showed a significant loss of blunt end joins and an increase in insertions as compared to wildtype, AtmD/D, or Msh2-/- B cells. This data indicates that the absence of both ATM and MSH2 blocks non-homologous end joining (NHEJ), leading to inefficient CSR. We propose a model whereby ATM and MSH2 function cooperatively to regulate end-joining during CSR through pS38-AID.

SummaryLoss of the DNA repair genes Atm and Msh2 produces a novel synthetic lethality in mice. B cell specific deletion of Atm on an Msh2-/- background reduces Ig CSR and inhibits NHEJ.
]]></description>
<dc:creator>Sible, E.</dc:creator>
<dc:creator>Attaway, M.</dc:creator>
<dc:creator>Fiorica, G.</dc:creator>
<dc:creator>Michel, G.</dc:creator>
<dc:creator>Chaudhuri, J.</dc:creator>
<dc:creator>Vuong, B. Q.</dc:creator>
<dc:date>2022-07-30</dc:date>
<dc:identifier>doi:10.1101/2022.07.28.501875</dc:identifier>
<dc:title><![CDATA[ATM and MSH2 control blunt DNA end joining in immunoglobulin class switch recombination]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-07-30</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.07.28.501930v1?rss=1">
<title>
<![CDATA[
Collective invasion of the basement membrane in breast cancer driven by forces from cell volume expansion and local contractility 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.07.28.501930v1?rss=1</link>
<description><![CDATA[
Breast cancer becomes invasive when carcinoma cells collectively invade through the basement membrane (BM), a nanoporous layer of matrix that physically separates the primary tumor from the stroma, in a first step towards metastasis. Single cells can invade through nanoporous three-dimensional (3D) matrices via protease-mediated degradation or, when the matrix exhibits sufficient mechanical plasticity, force-mediated widening of pores. However, how cells invade collectively through physiological BM layers in cancer remains unclear. Here, we developed a 3D in vitro model of collective invasion of the BM during breast cancer. We show that cells utilize both proteases and forces to breach the BM. Forces are generated from a combination of global cell volume expansion that stretch the BM with local contractile forces that act in the plane of the BM to breach it, allowing invasion. These results uncover a mechanism by which cells collectively interact to overcome a critical barrier to metastasis.
]]></description>
<dc:creator>Chang, J.</dc:creator>
<dc:creator>Saraswathibhatla, A.</dc:creator>
<dc:creator>Song, Z.</dc:creator>
<dc:creator>Varma, S.</dc:creator>
<dc:creator>Sanchez, C.</dc:creator>
<dc:creator>Srivastava, S.</dc:creator>
<dc:creator>Liu, K.</dc:creator>
<dc:creator>Bassik, M. C.</dc:creator>
<dc:creator>Marinkovich, M. P.</dc:creator>
<dc:creator>Hodgson, L.</dc:creator>
<dc:creator>Shenoy, V.</dc:creator>
<dc:creator>West, R. B.</dc:creator>
<dc:creator>Chaudhuri, O.</dc:creator>
<dc:date>2022-07-31</dc:date>
<dc:identifier>doi:10.1101/2022.07.28.501930</dc:identifier>
<dc:title><![CDATA[Collective invasion of the basement membrane in breast cancer driven by forces from cell volume expansion and local contractility]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-07-31</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.07.31.502194v1?rss=1">
<title>
<![CDATA[
Large vesicle extrusion from C. elegans neurons requires phagocytic interaction via the ARF-6 and CED-1/DRAPER pathways 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.07.31.502194v1?rss=1</link>
<description><![CDATA[
C. elegans neurons under stress can produce giant vesicles, several microns in diameter, called exophers. Current models suggest that exophers are neuroprotective, providing a mechanism for stressed neurons to eject toxic protein aggregates and organelles. However, little is known of the fate of the exopher once it leaves the neuron. We found that exophers produced by mechanosensory neurons in C. elegans are engulfed by surrounding hypodermal skin cells and are then broken up into numerous smaller vesicles that acquire hypodermal phagosome maturation markers, with vesicular contents gradually degraded by hypodermal lysosomes. Consistent with the hypodermis acting as an exopher phagocyte, we found that exopher removal requires hypodermal actin and Arp2/3, and the hypodermal plasma membrane adjacent to newly formed exophers accumulates dynamic F-actin during budding. Efficient fission of engulfed exopher-phagosomes to produce smaller vesicles and degrade their contents requires phagosome maturation factors SAND-1/Mon1, GTPase RAB-35, the CNT-1 ARF-GAP, and microtubule motor associated GTPase ARL-8, suggesting a close coupling of phagosome fission and phagosome maturation. Lysosome activity was required to degrade exopher contents in the hypodermis but not for exopher-phagosome resolution into smaller vesicles. Importantly, we found that GTPase ARF-6 and effector SEC-10/Exocyst activity in the hypodermis, along with the CED-1 phagocytic receptor, is required for efficient production of exophers by the neuron. Our results indicate that the neuron requires specific interaction with the phagocyte for an efficient exopher response, a mechanistic feature potentially conserved with mammalian exophergenesis, and similar to neuronal pruning by phagocytic glia that influences neurodegenerative disease.
]]></description>
<dc:creator>Wang, Y.</dc:creator>
<dc:creator>Arnold, M. L.</dc:creator>
<dc:creator>Smart, A. J.</dc:creator>
<dc:creator>Wang, G.</dc:creator>
<dc:creator>Morera, A.</dc:creator>
<dc:creator>Nguyen, K. C.</dc:creator>
<dc:creator>Schweinsberg, P. J.</dc:creator>
<dc:creator>Bai, G.</dc:creator>
<dc:creator>Cooper, J.</dc:creator>
<dc:creator>Hall, D. H.</dc:creator>
<dc:creator>Driscoll, M.</dc:creator>
<dc:creator>Grant, B.</dc:creator>
<dc:date>2022-08-01</dc:date>
<dc:identifier>doi:10.1101/2022.07.31.502194</dc:identifier>
<dc:title><![CDATA[Large vesicle extrusion from C. elegans neurons requires phagocytic interaction via the ARF-6 and CED-1/DRAPER pathways]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-08-01</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.08.01.502156v1?rss=1">
<title>
<![CDATA[
Cold-induced expression of a truncated Adenylyl Cyclase 3 acts as rheostat to brown fat function. 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.08.01.502156v1?rss=1</link>
<description><![CDATA[
Promoting brown adipose tissue (BAT) activity has been recognized as innovative therapeutic approach to improve obesity and metabolic disease. Whilst the molecular circuitry underlying thermogenic activation of BAT is well understood, the processes underlying rheostatic regulation of BAT to maintain homeostasis and avoid excessive energy dissipation remain ill-defined. Increasing cyclic AMP (cAMP) biosynthesis is key for BAT activation. Here, we demonstrate that ADCY3, an adenylyl cyclase whose expression is induced during cold exposure and regulates cAMP homeostasis in thermogenic fat, is dispensable for BAT function in lean mice, but becomes critical during obesity. Furthermore, by combining RNA-seq with epigenomic H3K4me3 profiling, we detected a novel, cold-inducible promoter that generates a 5 truncated Adcy3-at mRNA isoform, Adcy3-at. Mice lacking only Adcy3-at, but not full-length Adcy3, displayed increased energy expenditure already under lean conditions and were protected against obesity and ensuing metabolic imbalances. Subcellularly, translated ADCY3-AT proteins are retained in the endoplasmic reticulum (ER), did not translocate to the cell membrane, and lacked enzymatic activity. By interacting with ADCY3, ADCY3-AT retained ADCY3 in the ER and, thereby, reduced the plasma membrane pool of ADCYs available for G-protein mediated cAMP synthesis. Thereby, ADCY3-AT acts as a signaling rheostat in BAT, limiting adverse consequences of uncurbed cAMP activity after long-term BAT activation. Adcy3-at induction was driven by a cold-induced, truncated isoform of the transcriptional cofactor PPARGC1A (PPARG Coactivator 1 Alpha, PPARGC1A-AT). Expression of Ppargc1a-at and Adcy3-at are evolutionary conserved, indicating that transcriptional rewiring by commissioning of alternative promoters is key for thermogenic fat function.
]]></description>
<dc:creator>Khani, S.</dc:creator>
<dc:creator>Topel, H.</dc:creator>
<dc:creator>Josephrajan, A.</dc:creator>
<dc:creator>Larsen, B. D. M.</dc:creator>
<dc:creator>Tavanez, A. R. A. d. A.</dc:creator>
<dc:creator>Gaudry, M. J.</dc:creator>
<dc:creator>Leyendecker, P.</dc:creator>
<dc:creator>Stanic, N.</dc:creator>
<dc:creator>Gaziano, I.</dc:creator>
<dc:creator>Hansmeier, N. R.</dc:creator>
<dc:creator>Schmidt, E.</dc:creator>
<dc:creator>Klemm, P.</dc:creator>
<dc:creator>Vagliano, L.-M.</dc:creator>
<dc:creator>Engelhard, C. A.</dc:creator>
<dc:creator>Nielsen, S.</dc:creator>
<dc:creator>Jespersen, N. Z.</dc:creator>
<dc:creator>Rehimi, R.</dc:creator>
<dc:creator>Gohlke, S.</dc:creator>
<dc:creator>Frommolt, P.</dc:creator>
<dc:creator>Gnad, T.</dc:creator>
<dc:creator>Rada-Iglesias, A.</dc:creator>
<dc:creator>Pradas-Juni, M.</dc:creator>
<dc:creator>Schulz, T. J.</dc:creator>
<dc:creator>Wunderlich, F. T.</dc:creator>
<dc:creator>Pfeifer, A.</dc:creator>
<dc:creator>Jastroch, M.</dc:creator>
<dc:creator>Wachten, D.</dc:creator>
<dc:creator>Kornfeld, J.-W.</dc:creator>
<dc:date>2022-08-01</dc:date>
<dc:identifier>doi:10.1101/2022.08.01.502156</dc:identifier>
<dc:title><![CDATA[Cold-induced expression of a truncated Adenylyl Cyclase 3 acts as rheostat to brown fat function.]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-08-01</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.08.01.502391v1?rss=1">
<title>
<![CDATA[
Single cell transcriptomics uncovers a non-autonomous Tbx1-dependent genetic program controlling cardiac neural crest cell deployment and progression 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.08.01.502391v1?rss=1</link>
<description><![CDATA[
Disruption of cardiac neural crest cells (CNCCs) results in congenital heart disease, yet we do not understand the cell fate dynamics as these cells differentiate to vascular smooth muscle cells. Here we utilized single-cell RNA-sequencing of NCCs from the pharyngeal apparatus with heart in control mouse embryos and when Tbx1, the gene for 22q11.2 deletion syndrome, is inactivated. We uncovered three dynamic transitions of pharyngeal NCCs expressing Tbx2 and Tbx3 through differentiated CNCCs expressing cardiac transcription factors with smooth muscle genes, and that these transitions are altered non-autonomously by loss of Tbx1. Further, inactivation of Tbx2 and Tbx3 in early CNCCs resulted in aortic arch branching defects due to failed smooth muscle differentiation. Loss of Tbx1 interrupted mesoderm to CNCC cell-cell communication with upregulation of BMP signaling with reduced MAPK signaling and failed dynamic transitions of CNCCs leading to disruption of aortic arch artery formation and cardiac outflow tract septation.
]]></description>
<dc:creator>De Bono, C.</dc:creator>
<dc:creator>Liu, Y.</dc:creator>
<dc:creator>Ferrena, A.</dc:creator>
<dc:creator>Valentine, A.</dc:creator>
<dc:creator>Zheng, D.</dc:creator>
<dc:creator>Morrow, B.</dc:creator>
<dc:date>2022-08-02</dc:date>
<dc:identifier>doi:10.1101/2022.08.01.502391</dc:identifier>
<dc:title><![CDATA[Single cell transcriptomics uncovers a non-autonomous Tbx1-dependent genetic program controlling cardiac neural crest cell deployment and progression]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-08-02</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.08.03.501714v1?rss=1">
<title>
<![CDATA[
Intermediate Filaments Associate with Aggresome-like Structures and Influence Rate of Cellular Expulsion of Neuronal Disease Aggregates 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.08.03.501714v1?rss=1</link>
<description><![CDATA[
Under conditions of proteostasis disequilibrium, neurons can enhance intracellular and extracellular protective mechanisms to guard against neurotoxicity. In mammals, an intracellular response to severe proteostasis imbalance that results from proteosome inhibition is the formation of juxtanuclear intermediate filament-surrounded, aggregate-filled aggresomes, which sequester threatening aggregates for later disposal via lysosomal degradation. Highly proteo-stressed neurons can also engage the assistance of neighboring cells in aggregate removal by loading threatening materials into large exopher vesicles that are transferred to neighboring cells for remote degradation of contents, a process that has been suggested to be analogous to the process that enables aggregate spreading in the human brain in neurodegenerative disease. In C. elegans these large extruded vesicles are called exophers.

Here we document that players involved in aggresome biology are required for the elimination of potentially deleterious materials in neuronal exophers. We show that in proteostressed C. elegans touch receptor neurons, intermediate filament proteins IFD-1 and IFD-2 can assemble into juxtanuclear structures with multiple molecular and cellular characteristics of mammalian aggresomes. IFD-concentrating structures depend upon orthologs of mammalian adapter proteins, dynein motors, and microtubule integrity for aggregate collection into juxtanuclear compartments where they associate with ubiquitinated and neurotoxic polyglutamine expansion proteins. Strikingly, disruption of aggresome-decoration genes encoding IFDs or disruption of the BAG/14-3-3/Hsc70 adapter that promote aggregate loading of aggresome-like organelles, lowers exopher production via a cell autonomous mechanism. Although aggresome-like structures are not mandatory exopher cargo, IFD compartments can be extruded from neurons in exophers, revealing a previously unreported strategy to eliminate neuronal aggresome-like organelles via transfer to neighboring cells. Human IF neurofilament light chain hNFL can partially substitute for C. elegans IFD-2 proteins in promoting exopher production, indicating conservation of the capacity of intermediate filaments to influence neuronal aggregate extrusions across phyla. In sum, we identify a requirement for specific intermediate filaments, counterparts of human biomarkers of neuronal injury and disease and major components of Parkinsons disease Lewy bodies, in C. elegans neuronal aggresome-like organelle formation and large vesicle exopher extrusion from stressed neurons.
]]></description>
<dc:creator>Arnold, M. L.</dc:creator>
<dc:creator>Cooper, J. F.</dc:creator>
<dc:creator>Androwski, R.</dc:creator>
<dc:creator>Ardeshna, S.</dc:creator>
<dc:creator>Melentijevic, I.</dc:creator>
<dc:creator>Smart, A. J.</dc:creator>
<dc:creator>Guasp, R. J.</dc:creator>
<dc:creator>Nguyen, K. C.</dc:creator>
<dc:creator>Bai, G.</dc:creator>
<dc:creator>Hall, D. H.</dc:creator>
<dc:creator>Grant, B. D.</dc:creator>
<dc:creator>Driscoll, M.</dc:creator>
<dc:date>2022-08-05</dc:date>
<dc:identifier>doi:10.1101/2022.08.03.501714</dc:identifier>
<dc:title><![CDATA[Intermediate Filaments Associate with Aggresome-like Structures and Influence Rate of Cellular Expulsion of Neuronal Disease Aggregates]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-08-05</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.08.04.502541v1?rss=1">
<title>
<![CDATA[
Neuronal SNAP-23 scales hippocampal synaptic plasticity and memory 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.08.04.502541v1?rss=1</link>
<description><![CDATA[
Soluble NSF Attachment protein REceptor (SNARE)-mediated membrane fusion plays a crucial role not only in presynaptic vesicle exocytosis but also in postsynaptic receptor delivery. The latter is considered particularly important for long-term synaptic plasticity and learning and memory, yet underlying mechanisms including the identity of the key SNARE proteins remain elusive. Here, we investigate the role of neuronal Synaptosomal-Associated Protein-23 (SNAP-23) by analyzing pyramidal-neuron specific SNAP-23 conditional knockout (cKO) mice. SNAP-23 immunostaining in postsynaptic spines was effectively decreased in the SNAP-23 cKO hippocampus. Electrophysiological analysis of SNAP-23 deficient neurons using acute hippocampal slices showed normal basal neurotransmission in CA3-CA1 synapses with unchanged AMPA and NMDA currents. Nevertheless, we found theta-burst stimulation induced long-term potentiation (LTP) was vastly diminished in SNAP-23 cKO. Moreover, unlike syntaxin-4 cKO mice in which both basal neurotransmission and LTP decrease manifested changes in a broad set of behavioral tasks, deficits of SNAP-23 cKO is more limited to spatial memory. Our data reveal that neuronal SNAP-23 is selectively crucial for synaptic plasticity and spatial memory without affecting basal glutamate receptor function.
]]></description>
<dc:creator>Huang, M.</dc:creator>
<dc:creator>Bin, N.-R.</dc:creator>
<dc:creator>Rai, J.</dc:creator>
<dc:creator>Ma, K.</dc:creator>
<dc:creator>Chow, C. H.</dc:creator>
<dc:creator>Eide, S.</dc:creator>
<dc:creator>Harada, H.</dc:creator>
<dc:creator>Xiao, J.</dc:creator>
<dc:creator>Feng, D.</dc:creator>
<dc:creator>Sun, H.-S.</dc:creator>
<dc:creator>Feng, Z.-P.</dc:creator>
<dc:creator>Gaisano, H. Y.</dc:creator>
<dc:creator>Pessin, J.</dc:creator>
<dc:creator>Monnier, P. P.</dc:creator>
<dc:creator>Okamoto, K.</dc:creator>
<dc:creator>Zhang, L.</dc:creator>
<dc:creator>Sugita, S.</dc:creator>
<dc:date>2022-08-06</dc:date>
<dc:identifier>doi:10.1101/2022.08.04.502541</dc:identifier>
<dc:title><![CDATA[Neuronal SNAP-23 scales hippocampal synaptic plasticity and memory]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-08-06</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.08.10.503449v1?rss=1">
<title>
<![CDATA[
Doublecortin and JIP3 are neural-specific counteracting regulators of dynein-mediated retrograde trafficking 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.08.10.503449v1?rss=1</link>
<description><![CDATA[
Mutations in the microtubule (MT)-binding protein doublecortin (DCX) or in the MT- based molecular motor dynein result in lissencephaly. However, a functional link between DCX and dynein has not been defined. Here, we demonstrate that DCX negatively regulates dynein-mediated retrograde transport by reducing dyneins association with MTs and by disrupting the composition of the dynein motor complex. Previous work showed an increased binding of the adaptor protein C-Jun-amino-terminal kinase-interacting protein 3 (JIP3) to dynein in the absence of DCX. Using purified components, we demonstrate that JIP3 forms an active motor complex with dynein and its cofactor dynactin with two dyneins per complex. DCX competes with the binding of the second dynein, resulting in a velocity reduction of the complex. We conclude that DCX negatively regulates dynein-mediated retrograde transport through two critical interactions by regulating dynein binding to MTs and by regulating the association of JIP3 to the dynein motor complex.
]]></description>
<dc:creator>Rao, L.</dc:creator>
<dc:creator>Li, P.</dc:creator>
<dc:creator>Liu, X.</dc:creator>
<dc:creator>Wang, Q.</dc:creator>
<dc:creator>Son, A. I.</dc:creator>
<dc:creator>Gennerich, A.</dc:creator>
<dc:creator>Shih-Hwa Liu, J.</dc:creator>
<dc:creator>Fu, X.</dc:creator>
<dc:date>2022-08-11</dc:date>
<dc:identifier>doi:10.1101/2022.08.10.503449</dc:identifier>
<dc:title><![CDATA[Doublecortin and JIP3 are neural-specific counteracting regulators of dynein-mediated retrograde trafficking]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-08-11</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.08.14.503914v1?rss=1">
<title>
<![CDATA[
Destabilized 3UTR ARE therapeutically degrades ERBB2 in drug-resistant ERBB2+ cancer models 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.08.14.503914v1?rss=1</link>
<description><![CDATA[
Breast, lung, and colorectal cancer resistance to molecular targeted therapy is a major challenge and unfavorably impacts clinical outcomes, leading to hundreds of thousands of deaths yearly. In ERBB2+ cancers regardless of the tissue of origin, ERBB2 is the driver oncogene of resistance. We discovered that the ERBB2+ cancers are enriched with poly U sequences on their 3UTR AU rich elements which are mRNA stabilizing sequences. We developed a novel technology, in which we engineered these ERBB2 mRNA stabilizing sequences to unstable forms and specifically controlled and degraded ERBB2 transcript and protein across multiple cancer types both in the wildtype and drug resistance settings in vitro and in vivo, offering a unique novel modality to control ERBB2 and other pervasive oncogenic signals where other therapies fail.

One-Sentence SummaryEngineered destabilized 3UTR ARE of ERBB2 degrades ERBB2 in many cancer types and controlled resistance.

Graphical abstract

O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=163 SRC="FIGDIR/small/503914v1_ufig1.gif" ALT="Figure 1">
View larger version (34K):
org.highwire.dtl.DTLVardef@139d8dborg.highwire.dtl.DTLVardef@cc1fd3org.highwire.dtl.DTLVardef@13d9086org.highwire.dtl.DTLVardef@db69bf_HPS_FORMAT_FIGEXP  M_FIG A. Depiction represents multiple ERBB2 expressing cancer cells with stable 3UTR ARE and the signaling cascade known to cause chemo resistance. B. Depiction of the engineered destabilized 3UTR ARE of ERBB2 and the destabilization and degradation of the ERBB2 transcript, protein and kinases involved in mediation of drug resistance

C_FIG
]]></description>
<dc:creator>Awah, C.</dc:creator>
<dc:creator>Glemaud, Y.</dc:creator>
<dc:creator>Levine, F.</dc:creator>
<dc:creator>Yang, K.</dc:creator>
<dc:creator>Ansary, A.</dc:creator>
<dc:creator>Dong, F.</dc:creator>
<dc:creator>Ash, L.</dc:creator>
<dc:creator>Zhang, J.</dc:creator>
<dc:creator>Weiser, D.</dc:creator>
<dc:creator>Ogunwobi, O. O.</dc:creator>
<dc:date>2022-08-15</dc:date>
<dc:identifier>doi:10.1101/2022.08.14.503914</dc:identifier>
<dc:title><![CDATA[Destabilized 3UTR ARE therapeutically degrades ERBB2 in drug-resistant ERBB2+ cancer models]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-08-15</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.08.20.504665v1?rss=1">
<title>
<![CDATA[
Addressing Structural Mentoring Barriers in Postdoctoral Training: A Qualitative Study 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.08.20.504665v1?rss=1</link>
<description><![CDATA[
BackgroundStructural mentoring barriers are policies, practices, and cultural norms that collectively disadvantage marginalized groups and perpetuate disparities in mentoring. While these mentoring barriers can be found early in the training pathway, failure to address or overcome these barriers at the postdoctoral training stage has a direct impact on faculty diversity and national efforts to retain underrepresented groups in research careers.

MethodsTo better understand the mentoring barriers faced by postdoctoral trainees, and possible ways to address them, a diverse sample of postdoctoral scholars ("postdocs") from across the United States were asked to participate in focus groups to discuss their training experiences. We conducted five 90-minute focus groups with 32 biomedical postdocs, including 20 (63%) women and 15 (47%) individuals from underrepresented racial/ethnic groups (URG). Participants were well-represented across years of training, and 65% were at least somewhat likely to pursue a research-intensive faculty career, similar to previously reported national averages.

ResultsA social ecological framework was used to examine both the upstream and downstream manifestations of structural mentoring barriers, as well as mentor barriers, overall. Themes were categorized on four broad levels: Individual (attitudes, beliefs, knowledge, or behaviors that inform mentoring barriers), Interpersonal (mentoring barriers arising from dyadic, peer, or network relationships), Institutional (departmental, institutional, organizational mentoring barriers), or Systemic (mentoring barriers originating from policies or broad social and cultural norms). Notable structural barriers included (1) academic politics and scientific hierarchy, (2) inequalities resulting from mentor prestige, (3) the (over) reliance on one mentor, (4) the lack of formal training for academic and non-academic careers, and (5) the lack of institutional diversity and institutional mentor training. These structural barriers foster mentoring practices and behaviors that lead to poor work-life balance, poor communication, and research career attrition. To overcome these barriers, postdocs strongly encouraged developing a network or team of mentors and recommended institutional interventions that create more comprehensive professional development, mentorship, and belonging.

ConclusionsFor postdoctoral scientists, structural mentoring barriers can permeate down to institutional, interpersonal, and individual levels, impeding a successful transition to an independent research career. It has become clear that large-scale changes in mentoring must come from addressing the policies, practices, and cultural norms that perpetuate poor mentoring. This work provides strong evidence for promoting mentorship networks and cultivating a "mentoring milieu" that fosters a supportive community and a strong culture of mentorship at all levels.
]]></description>
<dc:creator>Lambert, W. M.</dc:creator>
<dc:creator>Nana, N.</dc:creator>
<dc:creator>Afonja, S.</dc:creator>
<dc:creator>Saeed, A.</dc:creator>
<dc:creator>Amado, A. C.</dc:creator>
<dc:creator>Golightly, L. M.</dc:creator>
<dc:date>2022-08-23</dc:date>
<dc:identifier>doi:10.1101/2022.08.20.504665</dc:identifier>
<dc:title><![CDATA[Addressing Structural Mentoring Barriers in Postdoctoral Training: A Qualitative Study]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-08-23</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.08.22.504849v1?rss=1">
<title>
<![CDATA[
Frataxin deficiency disrupts mitochondrial respiration and pulmonary endothelial cell function 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.08.22.504849v1?rss=1</link>
<description><![CDATA[
Deficiency of iron-sulfur (Fe-S) clusters promotes metabolic rewiring of the endothelium and the development of pulmonary hypertension (PH) in vivo. Joining a growing number of Fe-S biogenesis proteins critical to pulmonary endothelial function, recent data highlighted that frataxin (FXN) reduction drives Fe-S-dependent genotoxic stress and senescence across multiple types of pulmonary vascular disease. Trinucleotide repeat mutations in the FXN gene cause Friedreichs ataxia, a disease characterized by cardiomyopathy and neurodegeneration. These tissue-specific phenotypes have historically been attributed to mitochondrial reprogramming and oxidative stress. Whether FXN coordinates both nuclear and mitochondrial processes in the endothelium is unknown. Here, we aim to identify the mitochondria-specific effects of FXN deficiency in the endothelium that predispose to pulmonary hypertension. Our data highlight an Fe-S-driven metabolic shift separate from previously described replication stress whereby FXN knockdown diminished mitochondrial respiration and increased glycolysis and oxidative species production. In turn, FXN-deficient endothelial cells exhibited a vasoconstrictive phenotype consistent with PH. These data were observed in both primary pulmonary endothelial cells after pharmacologic inhibition of FXN and inducible pluripotent stem cell-derived endothelial cells from patients with FXN mutations. Altogether, this study defines FXN as a shared upstream driver of pathologic aberrations in both metabolism and genomic stability. Moreover, our study highlights FXN-specific vasoconstriction, suggesting available and future therapies may be beneficial and targeted for PH subtypes with FXN deficiency.

Graphical Abstract

O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=166 SRC="FIGDIR/small/504849v1_ufig1.gif" ALT="Figure 1">
View larger version (58K):
org.highwire.dtl.DTLVardef@12c5568org.highwire.dtl.DTLVardef@19b5f0borg.highwire.dtl.DTLVardef@17d0157org.highwire.dtl.DTLVardef@1e323a0_HPS_FORMAT_FIGEXP  M_FIG C_FIG
]]></description>
<dc:creator>Culley, M. K.</dc:creator>
<dc:creator>Mehta, M.</dc:creator>
<dc:creator>Zhao, J.</dc:creator>
<dc:creator>Perk, D.</dc:creator>
<dc:creator>Tai, Y. Y.</dc:creator>
<dc:creator>Tang, Y.</dc:creator>
<dc:creator>Shiva, S.</dc:creator>
<dc:creator>Rabinovitch, M.</dc:creator>
<dc:creator>Gu, M.</dc:creator>
<dc:creator>Bertero, T.</dc:creator>
<dc:creator>Chan, S. Y.</dc:creator>
<dc:date>2022-08-23</dc:date>
<dc:identifier>doi:10.1101/2022.08.22.504849</dc:identifier>
<dc:title><![CDATA[Frataxin deficiency disrupts mitochondrial respiration and pulmonary endothelial cell function]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-08-23</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.08.24.505085v1?rss=1">
<title>
<![CDATA[
MicroRNA-218 instructs proper assembly of hippocampal networks 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.08.24.505085v1?rss=1</link>
<description><![CDATA[
The assembly of the mammalian brain is orchestrated by temporally coordinated waves of gene expression. A key aspect of this developmental program is mediated at the post-transcriptional level by microRNAs (miRNAs). Deletion of neuronal enriched miRNAs induces strong developmental phenotypes, and multiple reports have found altered levels of miRNAs in patients with neurodevelopmental disorders. However, cellular and molecular mechanisms used by miRNAs to instruct proper brain development remain largely unexplored.

Here, through multiple screens, we identified miR-218 as a critical regulator of hippocampal assembly in mice. MiR-218 is highly expressed in the hippocampus and enriched in both excitatory principal neurons and GABAergic inhibitory interneurons. Transient inhibition of miR-218 in early life results in an adult brain with heightened network activity and a predisposition to seizures. We used RNA-seq and FACS-seq (fluorescence-activated cell sorting followed by RNA-seq) to identify global and cell type-specific changes in gene expression in the absence of miR-218 and narrow down which altered developmental processes would lead to long-term network instability. We find that miR-218 inhibition results in the disruption of early depolarizing GABAergic signaling, structural defects in dendritic spines, and altered intrinsic membrane excitability. Finally, conditional knockout of miR-218 in interneurons, but not pyramidal neurons is sufficient to recapitulate the effects on long-term stability. Taken together, the data suggest that miR-218 orchestrates hippocampal network assembly to produce a stable network in the adult, primarily by regulating interneuron function in early postnatal life.
]]></description>
<dc:creator>Taylor, S.</dc:creator>
<dc:creator>Kobayashi, M.</dc:creator>
<dc:creator>Vilella, A.</dc:creator>
<dc:creator>Tiwari, D.</dc:creator>
<dc:creator>Zolboot, N.</dc:creator>
<dc:creator>Hartzell, A.</dc:creator>
<dc:creator>Girgiss, C.</dc:creator>
<dc:creator>Abaci, Y.</dc:creator>
<dc:creator>De Sanctis, C.</dc:creator>
<dc:creator>Bellenchi, G. C.</dc:creator>
<dc:creator>Darnell, R. B.</dc:creator>
<dc:creator>Gross, C.</dc:creator>
<dc:creator>Zoli, M.</dc:creator>
<dc:creator>Berg, D. K.</dc:creator>
<dc:creator>Lippi, G.</dc:creator>
<dc:date>2022-08-25</dc:date>
<dc:identifier>doi:10.1101/2022.08.24.505085</dc:identifier>
<dc:title><![CDATA[MicroRNA-218 instructs proper assembly of hippocampal networks]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-08-25</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.08.29.503508v1?rss=1">
<title>
<![CDATA[
Redox signaling regulates breast cancer metastasis via HIF1alpha-stimulated EMT dynamics and metabolic reprogramming 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.08.29.503508v1?rss=1</link>
<description><![CDATA[
Metastasis is orchestrated by phenotypic and metabolic reprogramming underlying tumor aggressiveness. Redox signaling by mammary tumor knockdown (KD) of the antioxidant glutathione peroxidase 2 (GPx2) enhanced metastasis via dynamic changes in epithelial-to-mesenchymal transition. Single cell RNA sequencing (scRNA-seq) of the control and PyMT/GPx2 KD mammary tumor revealed six luminal and one basal/mesenchymal like (cluster 3) subpopulations. Remarkably, GPx2 KD enhanced the size and basal/mesenchymal gene signature of cluster 3 as well as induced epithelial/mesenchymal (E/M) clusters which expressed markers of oxidative phosphorylation and glycolysis, indicative of hybrid metabolism. These data were validated in human breast cancer xenografts and were supported by pseudotime cell trajectory analysis. Moreover, the E/M and M states were both attenuated by GPx2 gain of function or HIF1 inhibition, leading to metastasis suppression. Collectively, these results demonstrate that redox/HIF1 signaling promotes mesenchymal gene expression, resulting in E/M clusters and a mesenchymal root subpopulation, driving phenotypic and metabolic heterogeneity underlying metastasis.

SignificanceBy leveraging single cell RNA analysis, we were able to demonstrate that redox signaling by GPx2 loss in mammary tumors results in HIF1 signaling, which promotes partial and full EMT conversions, represented by distinct tumor cell subpopulations, which in turn express hybrid and binary metabolic states. These data underscore a phenotypic and metabolic co-adaptation in cancer, arguing in favor of the GPx2-HIF1 axis as a therapeutic platform for targeting tumor cell metastasis.
]]></description>
<dc:creator>Ren, Z.</dc:creator>
<dc:creator>Dharmaratne, M.</dc:creator>
<dc:creator>Liang, H.</dc:creator>
<dc:creator>Benard, O.</dc:creator>
<dc:creator>Morales-Gallego, M.</dc:creator>
<dc:creator>Suyama, K.</dc:creator>
<dc:creator>Fard, A. T.</dc:creator>
<dc:creator>Mar, J. C.</dc:creator>
<dc:creator>Prystowsky, M.</dc:creator>
<dc:creator>Norton, L.</dc:creator>
<dc:creator>Hazan, R. B.</dc:creator>
<dc:date>2022-08-30</dc:date>
<dc:identifier>doi:10.1101/2022.08.29.503508</dc:identifier>
<dc:title><![CDATA[Redox signaling regulates breast cancer metastasis via HIF1alpha-stimulated EMT dynamics and metabolic reprogramming]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-08-30</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.08.31.505869v1?rss=1">
<title>
<![CDATA[
Intestinal stem cell aging at single-cell resolution: functional perturbations alter cell developmental trajectory reversed by gerotherapeutics 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.08.31.505869v1?rss=1</link>
<description><![CDATA[
The intestinal epithelium is consists of cells derived from continuously cycling Lgr5hi intestinal stem cells (Lgr5hi ISCs) that mature developmentally in an order fashion as the cells progress along the crypt-luminal axis. Perturbed function of Lgr5hi ISCs with aging is well documented but the consequent impact on overall mucosal homeostasis has not been defined. Using single-cell RNA sequencing, the progressive maturation of progeny was dissected in mouse intestine, which revealed that transcriptional reprogramming with aging in Lgr5hi ISCs retarded cell maturation in their progression along the crypt-luminal axis. Importantly, treatment with metformin or rapamycin at a late stage of mouse lifespan reversed the effects of aging on function of Lgr5hi ISCs and subsequent maturation of progenitors. The effects of metformin and rapamycin overlapped in reversing changes of transcriptional profiles, but were also complementary, with metformin more efficient than rapamycin in correcting the developmental trajectory. Therefore, our data identify novel effects of aging on stem cells and the maturation of their daughter cells contributing to the decline of functional Lgr5hi ISCs and the correction by geroprotectors.
]]></description>
<dc:creator>Choi, J.</dc:creator>
<dc:creator>Houston, M.</dc:creator>
<dc:creator>Wang, R.</dc:creator>
<dc:creator>Ye, K.</dc:creator>
<dc:creator>Li, W.</dc:creator>
<dc:creator>Zhang, X.</dc:creator>
<dc:creator>Huffman, D. M.</dc:creator>
<dc:creator>Augenlicht, L. H.</dc:creator>
<dc:date>2022-09-01</dc:date>
<dc:identifier>doi:10.1101/2022.08.31.505869</dc:identifier>
<dc:title><![CDATA[Intestinal stem cell aging at single-cell resolution: functional perturbations alter cell developmental trajectory reversed by gerotherapeutics]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-09-01</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.08.30.505945v1?rss=1">
<title>
<![CDATA[
Spatial analysis of the metastatic brain tumor immune and extracellular matrix microenvironment 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.08.30.505945v1?rss=1</link>
<description><![CDATA[
Metastatic cancer is responsible for the overwhelming majority of cancer-related deaths with metastatic tumors being the most common neoplasms affecting the central nervous system. One of the major factors regulating tumor biology is the tumor microenvironment. However, little is known about the cellular and non-cellular composition of metastatic brain tumors and how tumor cell ontogeny influences the metastatic brain tumor microenvironment. By integrating multiplex immunohistochemistry and histopathological analysis to investigate composition and the spatial relationship between neoplastic cells, infiltrating and brain resident immune cells and the extracellular matrix, we demonstrate that metastatic brain tumors exhibit differences in ECM deposition, compared with the most common primary brain tumor type, glioblastoma, and that the dominant immune cell types in metastatic brain tumors are immunosuppressive macrophages, which preferentially localize to ECM-rich stromal regions.
]]></description>
<dc:creator>Widodo, S. S.</dc:creator>
<dc:creator>Dinevska, M.</dc:creator>
<dc:creator>Cuzcano, L. R.</dc:creator>
<dc:creator>Papanicolaou, M.</dc:creator>
<dc:creator>Cox, T. R.</dc:creator>
<dc:creator>Stylli, S. S.</dc:creator>
<dc:creator>Mantamadiotis, T.</dc:creator>
<dc:date>2022-09-02</dc:date>
<dc:identifier>doi:10.1101/2022.08.30.505945</dc:identifier>
<dc:title><![CDATA[Spatial analysis of the metastatic brain tumor immune and extracellular matrix microenvironment]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-09-02</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.09.01.506123v1?rss=1">
<title>
<![CDATA[
Chemoenzymatic Measurement of Cell-surface Glycan in Single-cell Multiomics: LacNAc as an Example 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.09.01.506123v1?rss=1</link>
<description><![CDATA[
Despite the rich information of a cells physiological state encoded in the dynamic changes of cell-surface glycans, methods of capturing glycosylation states at the single-cell level are quite limited. Here we report a chemoenzymatic single-cell N-acetyllactosamine (LacNAc) detection method via tagging the LacNAc with a specific DNA barcode. Compared to the lectin-based glycan detection, the chemoenzymatic labeling does not change the transcriptional status of immune cells and is more compatible with scRNA-seq. Integrated analysis of LacNAc and transcriptome of T cells at a single-cell level reveals that the quantity of cell-surface LacNAc is significantly upregulated in activated CD8+ T cells but maintained at the basal level in quiescent CD8+ T cells (i.e., naive and central memory T cells). Further analysis confirms that the LacNAc level is positively correlated to the glycolytic activity of CD8+ T cells at all statues. Taken together, our study demonstrates the feasibility of chemoenzymatic detection of cell-surface glycan in single-cell RNA sequencing-based multiomics with information of TCR sequence and cell-surface epitopes (i.e., scTCR and CITE-seq) and offers a new way to characterize the biological role of glycan in diversified physiological states.
]]></description>
<dc:creator>Yu, W.</dc:creator>
<dc:creator>Zhao, X.</dc:creator>
<dc:creator>Jalloh, A. S.</dc:creator>
<dc:creator>Zhao, Y.</dc:creator>
<dc:creator>Dinner, B.</dc:creator>
<dc:creator>Yang, Y.</dc:creator>
<dc:creator>Ouyang, S.</dc:creator>
<dc:creator>Li, Y.</dc:creator>
<dc:creator>Tian, T.</dc:creator>
<dc:creator>Zhao, Z.</dc:creator>
<dc:creator>Yang, R.</dc:creator>
<dc:creator>Chen, M.</dc:creator>
<dc:creator>Lauvau, G.</dc:creator>
<dc:creator>Guo, Z.</dc:creator>
<dc:creator>Wu, P.</dc:creator>
<dc:creator>Li, J. P.</dc:creator>
<dc:date>2022-09-04</dc:date>
<dc:identifier>doi:10.1101/2022.09.01.506123</dc:identifier>
<dc:title><![CDATA[Chemoenzymatic Measurement of Cell-surface Glycan in Single-cell Multiomics: LacNAc as an Example]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-09-04</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.09.08.507190v1?rss=1">
<title>
<![CDATA[
Locus-specific proteomics identifies new aspects of the chromatin context involved in V region somatic hypermutation 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.09.08.507190v1?rss=1</link>
<description><![CDATA[
Activation-induced cytidine deaminase (AID) somatically hypermutates the immunoglobulin heavy chain variable region (IGHV) gene to create the antibody diversity required to resist infections. This hypermutational process involves many pathways including transcription, DNA structural change and repair. While many of the proteins involved have been identified, their relative abundance, organization and regulation have not been resolved and additional factors and pathways need to be identified. To identify the proteome occupying IGHV, we have utilized dCas9-APEX targeted by guide RNAs to biotinylate and enrich the proteins associated with the mutating V region chromatin in the Ramos human B cell line and compared them to the non-mutating downstream constant region (C) chromatin. We identified hundreds of proteins specifically enriched on the V or C region. We confirmed the functionality of selected factors by examining the changes in the V region-specific proteome after inhibiting transcriptional elongation and somatic mutation with the Dot1L inhibitor EPZ004777.

SummaryLocus-specific proteomics using dCas9-APEX identifies new aspects of the chromatin context involved in V region somatic hypermutation (SHM) in the human Ramos B cell line. An inhibitor of Dot1L which participates in SHM is used to identify functional SHM-related factors.
]]></description>
<dc:creator>Yu, G.</dc:creator>
<dc:creator>Duan, Z.</dc:creator>
<dc:creator>Zhang, Y.</dc:creator>
<dc:creator>Aguilan, J.</dc:creator>
<dc:creator>Sidoli, S.</dc:creator>
<dc:creator>Scharff, M. D.</dc:creator>
<dc:date>2022-09-12</dc:date>
<dc:identifier>doi:10.1101/2022.09.08.507190</dc:identifier>
<dc:title><![CDATA[Locus-specific proteomics identifies new aspects of the chromatin context involved in V region somatic hypermutation]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-09-12</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.09.12.507584v1?rss=1">
<title>
<![CDATA[
Function of cell adhesion molecules in differentiation of ray sensory neurons in C. elegans. 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.09.12.507584v1?rss=1</link>
<description><![CDATA[
For proper functioning of the nervous system, it is crucial that neurons find their appropriate partners and build the correct neural connection patterns. Although cell adhesion molecules (CAMs) have been studied for many years as essential players in neural connections, we have yet to unravel the code by which CAMs encode synaptic specificity. We analyzed the effects of mutations in CAM genes on the morphology and synapses of a set of sensory neurons in the C. elegans male tail. B-type ray sensory neurons express ten genes encoding CAMs. We examined the effect on axon trajectory and localization of presynaptic components in viable mutants of nine of these. We found axon trajectory defects in mutants of UNC-40/DCC, SAX-3/ROBO, and FMI-1/Flamingo/Celsr1. In none of the mutants was presence of presynaptic components in axons lost, and in several the level appeared to increase, suggesting possible accumulation. B-type sensory neurons fasciculate with a second type of ray sensory neuron, the A-type, in axon commissures. We found cell non-autonomous effects consistent with each promoting the trajectory of the other. Overall, single and multiple mutants of CAM genes had limited effects on ray neuron trajectories and accumulation of synaptic components.
]]></description>
<dc:creator>Sakai, N.</dc:creator>
<dc:creator>Sun, P.</dc:creator>
<dc:creator>Kim, B.</dc:creator>
<dc:creator>Emmons, S. W.</dc:creator>
<dc:date>2022-09-14</dc:date>
<dc:identifier>doi:10.1101/2022.09.12.507584</dc:identifier>
<dc:title><![CDATA[Function of cell adhesion molecules in differentiation of ray sensory neurons in C. elegans.]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-09-14</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.09.15.508149v1?rss=1">
<title>
<![CDATA[
WikiGOA: Gene set enrichment analysis based on Wikipedia and the Gene Ontology 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.09.15.508149v1?rss=1</link>
<description><![CDATA[
O_LIGene sets curated to Gene Ontology terms are widely used by the transcriptomics community
C_LIO_LIPresence in Wikipedia is a common proxy for the relevance of a concept.
C_LIO_LIIn this work, we describe the use of Wikidata to generate a dataset comprising only gene sets with a corresponding Wikipedia page.
C_LIO_LIWe refer to the dataset as "WikiGOA", standing for "Wikipedia Gene Ontology Annotations"
C_LIO_LIWe use the dataset to analyze gene expression data and show that it provides readily understandable results.
C_LIO_LIWe envision WikiGOA to be useful for exploring complex biological datasets both in academic research and educational contexts.
C_LI

NoteThis report was written in a non-standard, experimental format, where assertions are expressed in bullet points. This was done to clarify statements and assumptions, simplify reading and pave the way for conversion to structured formats (e.g., nanopublications). [1]
]]></description>
<dc:creator>Lubiana, T.</dc:creator>
<dc:creator>Dias, T. L.</dc:creator>
<dc:creator>Peixe, D. G.</dc:creator>
<dc:creator>Nakaya, H. T. I.</dc:creator>
<dc:date>2022-09-17</dc:date>
<dc:identifier>doi:10.1101/2022.09.15.508149</dc:identifier>
<dc:title><![CDATA[WikiGOA: Gene set enrichment analysis based on Wikipedia and the Gene Ontology]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-09-17</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.09.18.508392v1?rss=1">
<title>
<![CDATA[
Photocycle characterization of a blue-orange cyanobacteriochrome from Synechococcus sp. PCC 7002 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.09.18.508392v1?rss=1</link>
<description><![CDATA[
Cyanobacteria employ photoreceptors called cyanobacteriochromes (CBCRs) to sense the colour and intensity of light. The information extracted from the solar spectrum is used for adaptive responses such as optimizing photosynthesis, phototaxis and cell aggregation. cGMP-phosphodiesterase/adenlylate cyclase/FhlA (GAF) domains are the principal light sensors in cyanobacteriochromes. They contain a conjugated bilin chromophore and boast an impressive spectral diversity. Characterizing the spectral characteristics of GAF domains in model strains, such as Synechococcus sp. PCC 7002, can open new avenues for optogenetics and biotechnology. Based on sequence analysis we predicted several different GAF domains in this strain. The SynPCC7002_a0852 gene encodes a single GAF domain with two cysteine residues: one in the conserved 3 helix and one in the conserved DXCF motif. Spectral analysis of recombinant SynPCC7002_A0852 with phycocyanobilin (PCB) showed that the protein cycles between two states, Po and Pb, which absorb orange and blue light, respectively. Measurements of kinetics identified Po as the dark state of the protein. Acid-denaturation analysis suggested that the 15E isomer of PCB is bound in the (dark) Po state, whereas 15Z is bound the (photoproduct) Pb state. Site-directed mutagenesis and iodoacetamide treatments showed that Cys73 in the DXCF motif is essential for the conversion from Po to Pb. Future experiments dark-purified protein/chromophore versions are required to establish the sequence of events in the photocycle. In summary, SynPCC7002_A0852 enables orange/blue colour perception in Synechococcus sp. PCC 7002 as other CBRCs of this protein family but might contain the energetically higher chromophore isoform in its dark state. Such photocycle has previously been found in  bathy bacteriophytochromes but not in CBCRs.
]]></description>
<dc:creator>Mihnev, A.</dc:creator>
<dc:creator>Amtmann, A.</dc:creator>
<dc:creator>Cogdell, R.</dc:creator>
<dc:creator>McKenzie, D.</dc:creator>
<dc:date>2022-09-18</dc:date>
<dc:identifier>doi:10.1101/2022.09.18.508392</dc:identifier>
<dc:title><![CDATA[Photocycle characterization of a blue-orange cyanobacteriochrome from Synechococcus sp. PCC 7002]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-09-18</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.09.16.508266v1?rss=1">
<title>
<![CDATA[
Analysis of somatic mutations in senescent cells using single-cell whole-genome sequencing 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.09.16.508266v1?rss=1</link>
<description><![CDATA[
SO_SCPLOWUMMARYC_SCPLOWSomatic mutations accumulate in multiple organs and tissues during aging and are a known cause of cancer. Here we tested whether mutations accumulate during replicative senescence. Cellular senescence is also a possible cause of functional decline in aging, yet also acts as an anti-cancer mechanism in vivo. Using single-cell whole-genome sequencing, we compared mutation burdens between early passage and deeply senescent human fibroblasts. The results showed that single-nucleotide variations and small insertions and deletions increased in senescent cells by about two-fold, but have the same spectrum as early passage cells, while it has been known that particular mutational signatures are found in tumor cells. In contrast, aneuploidies were observed in half the senescent cells, but largely absent in early passage cells. Thus, the patterns of mutations among senescent, normal-aged and tumor cells differ significantly.
]]></description>
<dc:creator>Zhang, L.</dc:creator>
<dc:creator>De Cecco, M.</dc:creator>
<dc:creator>Lee, M.</dc:creator>
<dc:creator>Hao, X.</dc:creator>
<dc:creator>Maslov, A. Y.</dc:creator>
<dc:creator>Montagna, C.</dc:creator>
<dc:creator>Campisi, J.</dc:creator>
<dc:creator>Dong, X.</dc:creator>
<dc:creator>Sedivy, J. M.</dc:creator>
<dc:creator>Vijg, J.</dc:creator>
<dc:date>2022-09-19</dc:date>
<dc:identifier>doi:10.1101/2022.09.16.508266</dc:identifier>
<dc:title><![CDATA[Analysis of somatic mutations in senescent cells using single-cell whole-genome sequencing]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-09-19</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.09.20.508746v1?rss=1">
<title>
<![CDATA[
CDKL5 regulates p62-mediated selective autophagy and host antiviral defense 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.09.20.508746v1?rss=1</link>
<description><![CDATA[
Virophagy, the selective autophagosomal engulfment and degradation of viral components, is crucial for antiviral immunity. However, the mechanisms leading to viral antigen recognition and autophagy induction remain poorly understood. Here, we identify a novel kinase, Cyclin-dependent kinase-like 5 (CDKL5), as an essential regulator of virophagy. Deletion of CDKL5 or abrogation of its kinase activity reduced virophagy of Sindbis virus (SINV), a neurotropic RNA virus, and increased intracellular accumulation of SINV capsid proteins and cellular cytotoxicity. Mechanistically, through direct phosphorylation of the selective autophagy receptor p62, CDKL5 promoted formation of p62 inclusion bodies that bound capsid. Loss of CDKL5 disrupted the capsid-p62 interaction, and a p62 phosphomimetic mutant rescued the interaction. CDKL5 knockout mice demonstrated increased neuronal cell death after SINV infection and enhanced lethality after infection with several human viruses. Overall, these findings identify a cell-autonomous innate immune mechanism for autophagy activation to clear toxic viral capsid aggregates during infection.
]]></description>
<dc:creator>Thinwa, J. W.</dc:creator>
<dc:creator>Zou, Z.</dc:creator>
<dc:creator>Parks, E.</dc:creator>
<dc:creator>Sebti, S.</dc:creator>
<dc:creator>Hui, K.</dc:creator>
<dc:creator>Singh, V.</dc:creator>
<dc:creator>Wei, Y.</dc:creator>
<dc:creator>Urquhart, G.</dc:creator>
<dc:creator>Jewell, J. L.</dc:creator>
<dc:creator>Pfeiffer, J. K.</dc:creator>
<dc:creator>Levine, B.</dc:creator>
<dc:creator>Reese, T. A.</dc:creator>
<dc:creator>Shiloh, M. U.</dc:creator>
<dc:date>2022-09-20</dc:date>
<dc:identifier>doi:10.1101/2022.09.20.508746</dc:identifier>
<dc:title><![CDATA[CDKL5 regulates p62-mediated selective autophagy and host antiviral defense]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-09-20</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.09.20.508741v1?rss=1">
<title>
<![CDATA[
Combined DiI and antibody labeling reveals complex dysgenesis of hippocampal spine synapses in a mouse model of Fragile X Syndrome. 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.09.20.508741v1?rss=1</link>
<description><![CDATA[
Structural, functional, and molecular alterations in excitatory spine synapses are a common hall-mark of many neurodevelopmental disorders including intellectual disability and autism. Here, we describe an optimized methodology, based on combined use of DiI and immunofluorescence, for rapid and sensitive characterization of the structure and composition of spine synapses in native brain tissue. We successfully demonstrate the applicability of this approach by examining the properties of hippocampal spine synapses in juvenile Fmr1 KO mice, a mouse model of Fragile X Syndrome. We find that mutant mice display pervasive dysgenesis of spine synapses evidenced by an overabundance of both abnormally elongated thin spines and cup-shaped spines, in combination with reduced density of mushroom spines. We further find that mushroom spines expressing the actin-binding protein Synaptopodin - a marker for spine apparatus - are more prevalent in mutant mice. Previous work identified spines with Synaptopodin/spine apparatus as the locus of mGluR-LTD, which is abnormally elevated in Fmr1 KO mice. Altogether, our data suggest this enhancement may be linked to the preponderance of this subset of spines in the mutant. Overall, these findings demonstrate the sensitivity and versatility of the optimized methodology by uncovering a novel facet of spine dysgenesis in Fmr1 KO mice.
]]></description>
<dc:creator>Speranza, L.</dc:creator>
<dc:creator>Filiz, K. D.</dc:creator>
<dc:creator>Goebel, S.</dc:creator>
<dc:creator>Perrone-Capano, C.</dc:creator>
<dc:creator>Pulcrano, S.</dc:creator>
<dc:creator>Volpicelli, F.</dc:creator>
<dc:creator>Francesconi, A.</dc:creator>
<dc:date>2022-09-22</dc:date>
<dc:identifier>doi:10.1101/2022.09.20.508741</dc:identifier>
<dc:title><![CDATA[Combined DiI and antibody labeling reveals complex dysgenesis of hippocampal spine synapses in a mouse model of Fragile X Syndrome.]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-09-22</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.09.22.509050v1?rss=1">
<title>
<![CDATA[
In-silico analysis of cyanobacteriochrome architectures and spectral diversity 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.09.22.509050v1?rss=1</link>
<description><![CDATA[
The cyanobacteriochrome GAF domains represent a trove of spectral diversity. These proteins are endemic to cyanobacteria and sense the color and power of light. Multiple mechanisms are used to tune the natural absorbance spectrum of the bound bilin chromophore. In practice, these are difficult to identify from the predicted amino acid sequence. Their individual presence rarely yields a consistent and predictable outcome. The absorbance characteristics of the GAF domain are a complex function of many such tuning mechanisms. This implies that a more combinatoric approach to characterizing the diversity of GAF domains would better to predict spectral tunes. We reviewed the literature and constructed a dataset of predicted/confirmed cyanobacteriochrome GAF domains. This dataset was subjected to multiple sequence alignments and 18 GAF domain families were defined. The amino acid sequence similarity correlated well with known spectral characteristics but there were exceptions. A second approach to predict chromotype involved using Principal Component Analysis to characterize the whole domain architectures of cyanobacteriochrome. This approach identified 7 conserved domain architectures, with some variations. These also offered a correlation to the spectral tune of the GAF domains therein, in addition to the 18 GAF families. The three-dimensional structures of 98 spectrally characterized GAF domains were predicted using Phyre2. Subsequent grouping based on distance maps offered an insight into how the general spectral position of the domain is set. Finer tuning is likely to be achieved by means of six key residues within the binding pocket. Taken together, these insights allowed us to carry out a Multiple Correlation Analysis serving as a mathematical summary of the diversity of cyanobacteriochrome GAF domains. This summary or "cyanobacteriochrome atlas" can be used to make spectral predictions on uncharacterized GAF domains.
]]></description>
<dc:creator>Mihnev, A.</dc:creator>
<dc:creator>Amtmann, A.</dc:creator>
<dc:date>2022-09-23</dc:date>
<dc:identifier>doi:10.1101/2022.09.22.509050</dc:identifier>
<dc:title><![CDATA[In-silico analysis of cyanobacteriochrome architectures and spectral diversity]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-09-23</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.09.22.509080v1?rss=1">
<title>
<![CDATA[
Investigation of reversible histone acetylation and dynamics in gene expression regulation using 3D liver spheroid model 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.09.22.509080v1?rss=1</link>
<description><![CDATA[
BackgroundThree-dimensional (3D) cell culture has emerged as an alternative approach to 2D flat culture to model more accurately the phenotype of solid tissue in laboratories. Culturing cells in 3D more precisely recapitulates physiological conditions of tissues, as these cells reduce activities related to proliferation, focusing their energy consumption towards metabolism and homeostasis.

ResultsHere, we demonstrate that 3D liver spheroids are a suitable system to model chromatin dynamics and response to epigenetics inhibitors. To delay necrotic tissue formation despite proliferation arrest, we utilize rotating bioreactors that apply active media diffusion and low shearing forces. We demonstrate that the proteome and the metabolome of our model resemble typical liver functions. We prove that spheroids respond to sodium butyrate (NaBut) treatment, an inhibitor of histone deacetylases (HDACi), by upregulating histone acetylations and transcriptional activation. As expected, NaBut treatment impaired specific cellular functions, including the energy metabolism. More importantly, we demonstrate that spheroids reestablish their original proteome and transcriptome, including pre-treatment levels of histone acetylation, metabolism, and protein expression once the standard culture condition is restored after treatment. Given the slow replication rate (>40 days) of cells in 3D spheroids, our model enables to monitor the recovery of approximately the same cells that underwent treatment, demonstrating that NaBut does not have long-lasting effects on histone acetylation and gene expression. These results suggest that histone acetylation has minimal epigenetics memory in our spheroids culture.

ConclusionTogether, we established an innovative cell culture system that can be used to model anomalously decondensing chromatin in physiological cell growth and rule out epigenetics inheritance if cells recover the original phenotype after treatment. The transient epigenetics effects demonstrated here highlights the relevance of using a 3D culture model system that could be very useful in studies requiring long term drug treatment conditions that would not be possible using a 2D cell monolayer system.
]]></description>
<dc:creator>Stransky, S.</dc:creator>
<dc:creator>Cutler, R.</dc:creator>
<dc:creator>Aguilan, J.</dc:creator>
<dc:creator>Nieves, E.</dc:creator>
<dc:creator>Sidoli, S.</dc:creator>
<dc:date>2022-09-23</dc:date>
<dc:identifier>doi:10.1101/2022.09.22.509080</dc:identifier>
<dc:title><![CDATA[Investigation of reversible histone acetylation and dynamics in gene expression regulation using 3D liver spheroid model]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-09-23</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.09.27.509791v1?rss=1">
<title>
<![CDATA[
In vivo proximity ligation reveals endogenous candidate interactors of Neurexin's intracellular domain 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.09.27.509791v1?rss=1</link>
<description><![CDATA[
Neurexins are highly-spliced transmembrane cell adhesion molecules that bind an array of partners via their extracellular domains. However, much less is known about the signaling pathways downstream of neurexins largely-invariant intracellular domain. C. elegans contains a single neurexin gene that we have previously shown is required for presynaptic assembly and stabilization. To gain insight into the signaling pathways mediating neurexins presynaptic functions, we employed a proximity ligation method, endogenously tagging neurexins intracellular domain with the promiscuous biotin ligase TurboID, allowing us to isolate adjacent biotinylated proteins by streptavidin pull-down and mass spectrometry. We compared our experimental strain to a control strain in which neurexin, endogenously tagged with TurboID, was dispersed from presynaptic active zones by the deletion of its C-terminal PDZ-binding motif. Using this approach we identified both known and novel intracellular interactors of neurexin, including active zone scaffolds, actin-binding proteins (including almost every member of the Arp2/3 complex), signaling molecules, and mediators of RNA trafficking, protein synthesis and degradation, among others. Characterization of mutants for candidate neurexin interactors revealed that they recapitulate aspects of the nrx-1 mutant phenotype, suggesting they may be involved in neurexin signaling. Finally, to investigate a possible role for neurexin in local actin assembly, we endogenously tagged its intracellular domain with actin depolymerizing and sequestering peptides (DeActs), and found that this led to defects in active zone assembly.
]]></description>
<dc:creator>Schaan Profes, M.</dc:creator>
<dc:creator>Tiroumalechetty, A.</dc:creator>
<dc:creator>Patel, N.</dc:creator>
<dc:creator>Lauar, S. S.</dc:creator>
<dc:creator>Sidoli, S.</dc:creator>
<dc:creator>Kurshan, P.</dc:creator>
<dc:date>2022-09-28</dc:date>
<dc:identifier>doi:10.1101/2022.09.27.509791</dc:identifier>
<dc:title><![CDATA[In vivo proximity ligation reveals endogenous candidate interactors of Neurexin's intracellular domain]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-09-28</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.09.29.510116v1?rss=1">
<title>
<![CDATA[
Development shaped by cue reliability in the barn owl's auditory midbrain 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.09.29.510116v1?rss=1</link>
<description><![CDATA[
Sensory systems display capability to preferentially choose stimuli based on their reliability at conveying accurate information. While previous reports have shown the ability of the brain to reweigh cues based on ongoing or dynamic changes in reliability, how the brain may learn and maintain neural responses to sensory statistics expected to be stable over longer time periods remain significant open questions of potential mechanisms underlying naturalistic biased perception. This study provides evidence that the barn owls midbrain is shaped by permanent statistics experienced during development. The barn owls midbrain features a topographic map of auditory space where neurons compute horizontal sound location from the interaural time difference (ITD). Previous work has shown that frequency tuning of these midbrain map neurons is correlated with the pattern of most reliable frequencies for the neurons preferred ITD. This pattern of ITD reliability is due to the filtering properties of the head, primarily determined by the facial ruff in the barn owl. In this study, we found that the absence of a facial ruff led to a decrease in the reliability of high frequencies originating from frontal space. To test if the owls frequency tuning of midbrain map neurons is driven by permanent changes in the pattern of ITD reliability, these neurons were recorded from adult owls, who had the facial ruff removed as juveniles, and from juvenile owls, before the facial ruff developed. In both groups, we found that frontally-tuned neurons displayed tunings to frequencies lower than reported in normal adult owls, consistent with the difference in ITD reliability between the normal and ruff removed conditions. Juvenile owls also exhibited more heterogeneous frequency tuning, suggesting developmental processes that refine tuning to match the pattern of ITD reliability. Additional recordings immediately upstream of the midbrain map displayed ITD tuned neural responses for all frequencies across the owls normal hearing range. Broader analysis of the effects of ruff-removal on the acoustical properties of spatial cues indicated a dominant role of ITD reliability in driving the adaptive changes in frequency tuning. These results support the hypothesis that frequency tuning in the midbrain map is developmentally adapted to permanent statistics of spatial cues, implementing probabilistic coding for sound localization.
]]></description>
<dc:creator>Shadron, K. K.</dc:creator>
<dc:creator>Pena, J. L.</dc:creator>
<dc:date>2022-09-29</dc:date>
<dc:identifier>doi:10.1101/2022.09.29.510116</dc:identifier>
<dc:title><![CDATA[Development shaped by cue reliability in the barn owl's auditory midbrain]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-09-29</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.09.30.507111v1?rss=1">
<title>
<![CDATA[
Chromatin regulators in the TBX1 network confer risk for conotruncal heart defects in 22q11.2DS and sporadic congenital heart disease 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.09.30.507111v1?rss=1</link>
<description><![CDATA[
BackgroundCongenital heart disease (CHD) affecting the conotruncal region of the heart, occur in half of patients with 22q11.2 deletion syndrome. This syndrome is a rare disorder with relative genetic homogeneity that can facilitate identification of genetic modifiers. Haploinsufficiency of TBX1, mapped to the 22q11.2 region, encoding a T-box transcription factor, is one of the main genes for the etiology of the syndrome. We suggest that genetic modifiers of CHD in patients with 22q11.2 deletion syndrome may be in the TBX1 gene network.

MethodsTo identify genetic modifiers of 22q11.2 deletion syndrome, we analyzed whole genome sequence of subjects with 22q11.2DS, of which 456 were cases with conotruncal heart defects and 537 were controls with normal cardiac structures. We retained the most damaging rare coding variants and examined 19 functional gene sets for association that were weighted upon expression of genes in cardiac progenitor cells in mouse embryos identified by RNA-sequencing.

ResultsWe identified rare damaging coding variants in chromatin regulatory genes as modifiers of conotruncal heart defects in 22q11.2DS. Chromatin genes with recurrent damaging variants include EP400, KAT6A, KMT2C, KMT2D, NSD1, CHD7 and PHF21A. In total, we identified 37 chromatin regulatory genes, that may increase risk for conotruncal heart defects in 8.5% of 22q11.2 deletion syndrome cases. Many of these genes were identified as risk factors for sporadic CHD in the general population increasing the likelihood that these genes are medically important contributors for CHD. These genes are co-expressed in cardiac progenitor cells with TBX1, suggesting that they may be in the same genetic network. Some of the genes identified, such as KAT6A, KMT2C, CHD7 and EZH2, have been previously shown to genetically interact with TBX1 in mouse models, providing mechanistic validation of these genes found.

ConclusionsOur findings indicate that disturbance of chromatin regulatory genes impact a TBX1 gene network serving as genetic modifiers of 22q11.2 deletion syndrome. Since some of these chromatin regulatory genes were found in individuals with sporadic CHD, we suggest that there are shared mechanisms involving the TBX1 gene network in the etiology of CHD.
]]></description>
<dc:creator>Zhao, Y.</dc:creator>
<dc:creator>Wang, Y.</dc:creator>
<dc:creator>Shi, L.</dc:creator>
<dc:creator>McDonald-McGinn, D. M.</dc:creator>
<dc:creator>Crowley, T. B.</dc:creator>
<dc:creator>McGinn, D. E.</dc:creator>
<dc:creator>Tran, O. T.</dc:creator>
<dc:creator>Miller, D.</dc:creator>
<dc:creator>Zackai, E.</dc:creator>
<dc:creator>Johnston, H. R.</dc:creator>
<dc:creator>Chow, E.</dc:creator>
<dc:creator>Vorstman, J. A. S.</dc:creator>
<dc:creator>Vingerhoets, C.</dc:creator>
<dc:creator>van Amelsvoort, T.</dc:creator>
<dc:creator>Gothelf, D.</dc:creator>
<dc:creator>Swillen, A.</dc:creator>
<dc:creator>Breckpot, J.</dc:creator>
<dc:creator>Vermeesch, J. R.</dc:creator>
<dc:creator>Eliez, S.</dc:creator>
<dc:creator>Schneider, M.</dc:creator>
<dc:creator>van den Bree, M. B.</dc:creator>
<dc:creator>Owen, M. J.</dc:creator>
<dc:creator>Kates, W.</dc:creator>
<dc:creator>Repetto, G. M.</dc:creator>
<dc:creator>Shashi, V.</dc:creator>
<dc:creator>Schoch, K.</dc:creator>
<dc:creator>Bearden, C. E.</dc:creator>
<dc:creator>Digilio, M. C. E.</dc:creator>
<dc:creator>Unolt, M.</dc:creator>
<dc:creator>Putotto, C.</dc:creator>
<dc:creator>Marino, B.</dc:creator>
<dc:creator>Pontillo, M.</dc:creator>
<dc:creator>Armando, M.</dc:creator>
<dc:creator>Vicari, S.</dc:creator>
<dc:creator>Angkustsiri, K.</dc:creator>
<dc:creator>Campbell, L.</dc:creator>
<dc:creator>Busa, T.</dc:creator>
<dc:creator>Heine-Suner, D.</dc:creator>
<dc:creator>Murphy, K. C.</dc:creator>
<dc:creator>Murphy, D.</dc:creator>
<dc:creator>Garcia-Minaur, S.</dc:creator>
<dc:creator>Fernandez, L</dc:creator>
<dc:date>2022-10-03</dc:date>
<dc:identifier>doi:10.1101/2022.09.30.507111</dc:identifier>
<dc:title><![CDATA[Chromatin regulators in the TBX1 network confer risk for conotruncal heart defects in 22q11.2DS and sporadic congenital heart disease]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-10-03</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.10.02.510540v1?rss=1">
<title>
<![CDATA[
Loss of the MLL3 tumor suppressor accelerates breast tumor onset via HIF1a-induced CCL2-mediated recruitment of CCR2+ regulatory T cells 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.10.02.510540v1?rss=1</link>
<description><![CDATA[
While essential gatekeepers of immune homeostasis, Foxp3+ regulatory T (Treg) cells infiltrating tumors acquire distinct phenotypes and become highly immunosuppressive, promoting tumor immune escape and growth. How this occurs and relates to tumor-driver mutations is largely uncharacterized. Herein, we created a mouse mammary stem cell-based tumor model using CRISPR gene editing in which we introduced known human cancer-driver mutations. These included functional loss of the MLL3 histone methyltransferase and p53, and constitutive PI3-kinase activation, recapitulating the genetic makeup of aggressive breast cancers. We show that MLL3 loss fosters tumorigenesis by promoting the rapid establishment of an immunosuppressive microenvironment through induction of HIF1, which increases the secretion of the chemokine CCL2 by tumor cells and the recruitment of higher numbers of Foxp3+ Treg cells via CCR2. Greater infiltration of Treg cells also correlates with MLL3 downregulation and mutations in human breast cancer biopsies. Interestingly, HIF1 enforces the differentiation of tumor-infiltrating Treg cells into highly immunosuppressive ICOShiGITRhi Blimp-1hi effector Treg cells that enable rapid tumor escape. Monoclonal antibody targeting of ICOS or GITR inhibits tumorigenesis in most mice even two months after the cessation of treatment as well as the growth of established tumors, suggesting possible therapeutic opportunities for MLL3-mutant breast cancers.
]]></description>
<dc:creator>Boutet, M.</dc:creator>
<dc:creator>Erler, P.</dc:creator>
<dc:creator>Nishitani, K.</dc:creator>
<dc:creator>Couturier, N.</dc:creator>
<dc:creator>Zhang, Z.</dc:creator>
<dc:creator>Barbieux, E.</dc:creator>
<dc:creator>Guillen, E.</dc:creator>
<dc:creator>Suzuki, M.</dc:creator>
<dc:creator>Lauvau, G.</dc:creator>
<dc:creator>Guo, W.</dc:creator>
<dc:date>2022-10-05</dc:date>
<dc:identifier>doi:10.1101/2022.10.02.510540</dc:identifier>
<dc:title><![CDATA[Loss of the MLL3 tumor suppressor accelerates breast tumor onset via HIF1a-induced CCL2-mediated recruitment of CCR2+ regulatory T cells]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-10-05</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.10.03.510675v1?rss=1">
<title>
<![CDATA[
Polycomb Repressive Complex 1 subunit Cbx4 positively regulates effector responses in CD8 T cells 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.10.03.510675v1?rss=1</link>
<description><![CDATA[
CD8 T cell differentiation is controlled by the crosstalk of various transcription factors and epigenetic modulators. Uncovering the different players in regulating this process is fundamental to improving immunotherapy and designing novel therapeutic approaches. Here, we show that Polycomb Repressive Complex (PRC)1 subunit Chromobox (Cbx)4 favors differentiation to effector CD8 T cells. Cbx4 deficiency in CD8 T cells induced transcriptional signature and phenotype of memory cells, increasing the formation of memory population during acute viral infection. It has been previously shown that besides chromodomain-mediated binding to H3K27me3, Cbx4 function as a SUMO E3 ligase in a SUMO interacting motifs (SIM)-dependent way. The overexpression of Cbx4 mutants in distinct domains showed that this protein regulates CTL differentiation primarily in a SIM-dependent way and partially through its chromodomain. Our data revealed a novel role of a Polycomb group protein Cbx4 controlling CD8 T lymphocyte differentiation and indicates the SUMOylation process as a key molecular mechanism connected to chromatin modification in this process.

SummaryUnderstanding the epigenetic control of CTL differentiation is critical for the manipulation of these cells in immunotherapy protocols. This article demonstrates a novel role for Cbx4, a Polycomb-group protein, in supporting CD8 T cell commitment to an effector cell phenotype.
]]></description>
<dc:creator>Melo, G. A.</dc:creator>
<dc:creator>Xu, T.</dc:creator>
<dc:creator>Caloba, C.</dc:creator>
<dc:creator>Schutte, A. W.</dc:creator>
<dc:creator>Brum, G.</dc:creator>
<dc:creator>Passos, T. O.</dc:creator>
<dc:creator>Higa, L.</dc:creator>
<dc:creator>Goncalves, A. N. A.</dc:creator>
<dc:creator>Tanuri, A.</dc:creator>
<dc:creator>Viola, J. P. B.</dc:creator>
<dc:creator>Werneck, M. B. F.</dc:creator>
<dc:creator>Nakaya, H.</dc:creator>
<dc:creator>Pipkin, M. E.</dc:creator>
<dc:creator>Martinez, G. J.</dc:creator>
<dc:creator>Pereira, R. M.</dc:creator>
<dc:date>2022-10-07</dc:date>
<dc:identifier>doi:10.1101/2022.10.03.510675</dc:identifier>
<dc:title><![CDATA[Polycomb Repressive Complex 1 subunit Cbx4 positively regulates effector responses in CD8 T cells]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-10-07</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.10.05.510967v1?rss=1">
<title>
<![CDATA[
Iron Chelation Improves Ineffective Erythropoiesis and Iron Overload in Myelodysplastic Syndrome Mice 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.10.05.510967v1?rss=1</link>
<description><![CDATA[
Myelodysplastic syndrome (MDS) is a heterogeneous group of bone marrow stem cell disorders characterized by ineffective hematopoiesis and cytopenias, most commonly anemia. Red cell transfusion therapy for anemia in MDS results in iron overload, correlating with reduced overall survival. Whether treatment of iron overload benefits MDS patients remains controversial. We evaluate underlying iron-related pathophysiology and the effect of iron chelation using deferiprone on erythropoiesis in NUP98-HOXD13 transgenic mice, a highly penetrant well-established MDS mouse model. Our results characterize an iron overload phenotype with aberrant erythropoiesis in these mice which was reversed by deferiprone-treatment. Serum erythropoietin level decreased while erythroblast erythropoietin receptor expression increased in deferiprone-treated MDS mice. We demonstrate, for the first time, normalized expression of the iron chaperones Pcbp1 and Nco4 and increased ferritin stores in late stage erythroblasts from deferiprone-treated MDS mice, evidence of aberrant iron trafficking in MDS erythroblasts. Importantly, erythroblast ferritin is increased in response to deferiprone, correlating with decreased erythroblast ROS. Finally, we confirmed increased expression of genes involved in iron uptake, sensing, and trafficking in stem and progenitor cells from MDS patients. Taken together, our findings provide evidence that erythroblast-specific iron metabolism is a novel potential therapeutic target to reverse ineffective erythropoiesis in MDS.

BRIEF SUMMARYIneffective erythropoiesis in MDS mice correlates with aberrant iron trafficking within bone marrow erythroblasts, consistent with findings in MDS patient progenitors, reversed after iron chelation.
]]></description>
<dc:creator>An, W.</dc:creator>
<dc:creator>Feola, M.</dc:creator>
<dc:creator>Aluri, S.</dc:creator>
<dc:creator>Ruiz-Martinez, M.</dc:creator>
<dc:creator>Sridharan, A.</dc:creator>
<dc:creator>Levy, M.</dc:creator>
<dc:creator>Fibach, E.</dc:creator>
<dc:creator>Zhu, X.</dc:creator>
<dc:creator>Verma, A. K.</dc:creator>
<dc:creator>Ginzburg, Y.</dc:creator>
<dc:date>2022-10-07</dc:date>
<dc:identifier>doi:10.1101/2022.10.05.510967</dc:identifier>
<dc:title><![CDATA[Iron Chelation Improves Ineffective Erythropoiesis and Iron Overload in Myelodysplastic Syndrome Mice]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-10-07</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.10.14.512324v1?rss=1">
<title>
<![CDATA[
SARS-CoV-2 multi-antigen protein microarray for detailed characterization of antibody responses in COVID-19 patients 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.10.14.512324v1?rss=1</link>
<description><![CDATA[
Antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) target multiple epitopes on different domains of the spike protein, and other SARS-CoV-2 proteins. We developed a SARS-CoV-2 multi-antigen protein microarray with the nucleocapsid, spike and its domains (S1, S2), and variants with single (D614G, E484K, N501Y) or double substitutions (N501Y/Deletion69/70), allowing a more detailed high-throughput analysis of the antibody repertoire following infection. The assay was demonstrated to be reliable and comparable to ELISA. We analyzed antibodies from 18 COVID-19 patients and 12 recovered convalescent donors. S IgG level was higher than N IgG in most of the COVID-19 patients, receptor-binding domain of S1 showed high reactivity, but no antibodies were detected against heptad repeat domain 2 of S2. Furthermore, antibodies were detected against S variants with single and double substitutions in COVID-19 patients who were infected with SARS-CoV-2 early in the pandemic. Here we demonstrated that SARS-CoV-2 multi-antigen protein microarray is a powerful tool for detailed characterization of antibody responses, with potential utility in understanding the disease progress and assessing current vaccines and therapies against evolving SARS-CoV-2.
]]></description>
<dc:creator>Celikgil, A.</dc:creator>
<dc:creator>Massimi, A. B.</dc:creator>
<dc:creator>Nakouzi, A.</dc:creator>
<dc:creator>Herrera, N. G.</dc:creator>
<dc:creator>Morano, N. C.</dc:creator>
<dc:creator>Lee, J. H.</dc:creator>
<dc:creator>Yoon, H. a.</dc:creator>
<dc:creator>Garforth, S. J.</dc:creator>
<dc:creator>Almo, S. C.</dc:creator>
<dc:date>2022-10-16</dc:date>
<dc:identifier>doi:10.1101/2022.10.14.512324</dc:identifier>
<dc:title><![CDATA[SARS-CoV-2 multi-antigen protein microarray for detailed characterization of antibody responses in COVID-19 patients]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-10-16</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.10.17.512615v1?rss=1">
<title>
<![CDATA[
DISRUPTION OF SYMPATHETIC OUTFLOW TO INTRA-ABDOMINAL ORGANS EMULATES THE METABOLIC EFFECTS OF SLEEVE GASTRECTOMY IN OBESE MICE 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.10.17.512615v1?rss=1</link>
<description><![CDATA[
Although sleeve gastrectomy (SG) is the most commonly performed bariatric surgery in the US, its mechanistic underpinnings have not been fully determined. Thus, we set out to investigate whether SGs effects on the peripheral sympathetic system could mediate the metabolic effects of SG. The celiac-superior mesenteric ganglia (CSMG) lie juxtaposed to the stomach and supply the sympathetic innervation of the stomach, as well as to numerous intra-abdominal organs relevant to metabolism. Here we investigated the effects of SG on the CSMG. SG led to the degeneration of neurons in the CSMG, as evidenced by chromatolysis, which was not found in control mice. Furthermore, CSMG ablation (CGX) completely recapitulated the glycemic and weight loss effects of SG, promoting weight loss at the expense of fat mass in both males and females. Glycemic improvement was robust in males but much more modest in female mice. Norepinephrine tissue content measurement by high performance liquid chromatography revealed that liver, duodenum, and ileum were organs where both SG and CGX displayed evidence of significant sympathetic denervation. Both SG and CGX were associated with increased levels of glucagon-like peptide 1 (GLP-1) and high free fatty acid content in the stools. In conclusion, CSMG neuronal degeneration caused by SG appears to be a mediator of the metabolic effects of this type of bariatric surgery.
]]></description>
<dc:creator>Emiliano, A.</dc:creator>
<dc:creator>Kraljevic, M.</dc:creator>
<dc:creator>Lopatinsky, N. R.</dc:creator>
<dc:creator>Batista, R.</dc:creator>
<dc:creator>Jiang, C.</dc:creator>
<dc:creator>Schwartz, G. J.</dc:creator>
<dc:date>2022-10-21</dc:date>
<dc:identifier>doi:10.1101/2022.10.17.512615</dc:identifier>
<dc:title><![CDATA[DISRUPTION OF SYMPATHETIC OUTFLOW TO INTRA-ABDOMINAL ORGANS EMULATES THE METABOLIC EFFECTS OF SLEEVE GASTRECTOMY IN OBESE MICE]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-10-21</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.10.28.514255v1?rss=1">
<title>
<![CDATA[
Spatiotemporal coordination of stem cell behavior following alveolar injury 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.10.28.514255v1?rss=1</link>
<description><![CDATA[
Tissue repair requires a highly coordinated cellular response to injury. In the lung, alveolar type 2 (AT2) cells act as stem cells and can replace both themselves and alveolar type 1 cells (AT1); however, the complex orchestration of AT2 stem cell activity following lung injury is poorly understood owing to the inability of tracking individual stem cells and their dynamic behavior over time. Here, we apply live time lapse imaging to ex vivo mouse precision cut lung slice (PCLS) culture and in vivo mouse lung to track individual GFP-labeled AT2 cells following induction of alveolar injury by bleomycin. We observe highly dynamic movement of AT2 cells, including migration within and between alveoli. To map the dynamic evolution of AT2 cell behavior, we introduce Live Cell Encoder (LCE-PHATE), a novel method for converting static snapshots from time lapse imaging into single points representative of entire, dynamic cellular trajectories. Applying LCE-PHATE, we observe the emergence of at least three distinct morphokinetic AT2 cell states associated with AT2 stem cell injury response. Finally, small molecule-based inhibition of Rho-associated protein kinase (ROCK) pathway significantly reduced motility of AT2 stem cells following injury and reduced expression of Krt8, a marker of intermediate progenitor cells. Together, our results uncover motility of alveolar stem cells as a new injury response mechanism in the lung and reveal properties of stem cell motility at high cellular resolution.
]]></description>
<dc:creator>Chioccioli, M.</dc:creator>
<dc:creator>Magruder, S.</dc:creator>
<dc:creator>McDonough, J. E.</dc:creator>
<dc:creator>Nouws, J.</dc:creator>
<dc:creator>Gonzalez, D.</dc:creator>
<dc:creator>Borriello, L.</dc:creator>
<dc:creator>Traub, B.</dc:creator>
<dc:creator>Ye, X.</dc:creator>
<dc:creator>Hendry, C. E.</dc:creator>
<dc:creator>Entenberg, D.</dc:creator>
<dc:creator>Kaminski, N.</dc:creator>
<dc:creator>Krishnaswamy, S.</dc:creator>
<dc:creator>Sauler, M.</dc:creator>
<dc:date>2022-10-30</dc:date>
<dc:identifier>doi:10.1101/2022.10.28.514255</dc:identifier>
<dc:title><![CDATA[Spatiotemporal coordination of stem cell behavior following alveolar injury]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-10-30</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.11.02.514812v1?rss=1">
<title>
<![CDATA[
Structural insights into 3Fe-4S ferredoxins diversity in M.tuberculosis highlighted by a first redox complex with P450. 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.11.02.514812v1?rss=1</link>
<description><![CDATA[
Ferredoxins are small iron-sulfur proteins and key players in essential metabolic pathways. Among all types, 3Fe-4S ferredoxins are less studied mostly due to anaerobic requirements. Their complexes with cytochrome P450 redox partners have not been structurally characterized. In the present work, we solved the structures of both 3Fe-4S ferredoxins from M. tuberculosis - Fdx alone and the fusion FdxE-CYP143. Our SPR analysis demonstrated a high affinity binding of FdxE to CYP143. According to SAXS data, the same complex is present in solution. The structure reveals extended multipoint interactions and the shape/charge complementarity of redox partners. Furthermore, FdxE binding induced conformational changes in CYP143 as evident from the solved CYP143 structure alone. The comparison of FdxE-CYP143 and modeled Fdx-CYP51 complexes further revealed the specificity of ferredoxins. Our results illuminate the diversity of electron transfer complexes for the production of different secondary metabolites.
]]></description>
<dc:creator>Gilep, A.</dc:creator>
<dc:creator>Varaksa, T.</dc:creator>
<dc:creator>Bukhdruker, S.</dc:creator>
<dc:creator>Kavaleuski, A.</dc:creator>
<dc:creator>Ryzhykau, Y.</dc:creator>
<dc:creator>Smolskaya, S.</dc:creator>
<dc:creator>Sushko, T.</dc:creator>
<dc:creator>Tsumoto, K.</dc:creator>
<dc:creator>Grabovec, I.</dc:creator>
<dc:creator>Kapranov, I.</dc:creator>
<dc:creator>Okhrimenko, I.</dc:creator>
<dc:creator>Marin, E.</dc:creator>
<dc:creator>Shevtsov, M.</dc:creator>
<dc:creator>Mishin, A.</dc:creator>
<dc:creator>Kovalev, K.</dc:creator>
<dc:creator>Kuklin, A.</dc:creator>
<dc:creator>Gordeliy, V.</dc:creator>
<dc:creator>Kaluzhskiy, L.</dc:creator>
<dc:creator>Gnedenko, O.</dc:creator>
<dc:creator>Yablokov, E.</dc:creator>
<dc:creator>Ivanov, A.</dc:creator>
<dc:creator>Borshchevskiy, V.</dc:creator>
<dc:creator>Strushkevich, N.</dc:creator>
<dc:date>2022-11-02</dc:date>
<dc:identifier>doi:10.1101/2022.11.02.514812</dc:identifier>
<dc:title><![CDATA[Structural insights into 3Fe-4S ferredoxins diversity in M.tuberculosis highlighted by a first redox complex with P450.]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-11-02</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.11.10.515925v1?rss=1">
<title>
<![CDATA[
Nucleotide-free structures of Kif20A illuminate the atypical allostery in this mitotic kinesin-6 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.11.10.515925v1?rss=1</link>
<description><![CDATA[
KIF20A is a critical kinesin for cell division and a promising anti-cancer drug target. The mechanisms underlying its cellular roles remain elusive. Interestingly, unusual coupling between the nucleotide- and microtubule-binding sites of this kinesin-6 has been reported but little is known about how its divergent sequence leads to atypical motility properties. We present here the first high-resolution structure of its motor domain that delineates the highly unusual structural features of this motor, including a long L6 insertion that integrates into the core of the motor domain and that drastically affects allostery and ATPase activity. Together with the high-resolution cryo-EM microtubule-bound KIF20A structure that reveal the microtubule-binding interface, we dissect the peculiarities of the KIF20A sequence that work to favor fast dissociation of ADP, particularly in contrast to other kinesins. Structural and functional insights from the KIF20A pre-power stroke conformation thus highlight the role of extended insertions in shaping the motor mechanochemical cycle. Essential for force production and processivity is the length of the neck linker in kinesins. We highlight here the role of the sequence preceding the neck linker in controlling its backward docking and show that a neck linker 4-times longer than kinesin-1 is required for the activity of this motor.
]]></description>
<dc:creator>Ranaivoson, F. M.</dc:creator>
<dc:creator>Crozet, V.</dc:creator>
<dc:creator>Benoit, M.</dc:creator>
<dc:creator>Mohammed Khalid, A. A.</dc:creator>
<dc:creator>Kikuti, C.</dc:creator>
<dc:creator>Sirkia, H.</dc:creator>
<dc:creator>El Marjou, A.</dc:creator>
<dc:creator>Asenjo, A.</dc:creator>
<dc:creator>Sosa, H.</dc:creator>
<dc:creator>Schmidt, C.</dc:creator>
<dc:creator>Rosenfeld, S.</dc:creator>
<dc:creator>Houdusse, A.</dc:creator>
<dc:date>2022-11-10</dc:date>
<dc:identifier>doi:10.1101/2022.11.10.515925</dc:identifier>
<dc:title><![CDATA[Nucleotide-free structures of Kif20A illuminate the atypical allostery in this mitotic kinesin-6]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-11-10</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.11.14.516438v1?rss=1">
<title>
<![CDATA[
Expression of retrotransposons contributes to aging in Drosophila 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.11.14.516438v1?rss=1</link>
<description><![CDATA[
Retrotransposons are a class of transposable elements capable of self-replication and insertion into new genomic locations. Across species, the mobilization of retrotransposons in somatic cells has been suggested to contribute to the cell and tissue functional decline that occurs during aging. Retrotransposon expression generally increases with age, and de novo insertions have been observed to occur during tumorigenesis. However, the extent to which new retrotransposon insertions occur during normal aging and their effect on cellular and animal function remains understudied. Here we use a single nucleus whole genome sequencing approach in Drosophila to directly test whether transposon insertions increase with age in somatic cells. Analyses of nuclei from thoraces and indirect flight muscles using a newly developed pipeline, Retrofind, revealed no significant increase in the number of transposon insertions with age. Despite this, reducing the expression of two different retrotransposons, 412 and Roo, extends lifespan, without increasing stress resistance. This suggests a key role for transposon expression and not insertion in regulating longevity. Transcriptomic analyses revealed similar changes to gene expression in 412 and Roo knockdown flies and highlighted potential changes to genes involved in proteolysis and immune function as potential contributors to the observed changes in longevity. Combined, our data show a clear link between retrotransposon expression and aging.

Author SummaryWith the onset of modern medicine, the average age of the population has significantly increased, leading to more individuals living with chronic health issues. Rather than treat each age-associated disorder individually, one approach to target multiple health concerns simultaneously might to be target aging itself. Genomic instability is a hallmark of aging cells that has been proposed to be a key contributor to age-associated cellular decline. Transposons are mobile genetic elements capable of inserting into new genomic locations, thus having the potential to increase genomic instability. Consistent with this, transposon expression generally increases with age. However, the extent to which transposon insertions accumulate to disrupt the genome of cells within aging individuals has remained an open question. We specifically answer this through single cell whole genome sequencing and find that transposon insertions do not increase with age. Even though insertions did not increase, the expression of transposons is linked to aging, as reducing the expression of individual transposons extended lifespan. Transcriptome studies of these long-lived flies revealed increased expression of genes linked to proteolysis genes and to functioning of the immune system. Our study therefore establishes transposon expression, and not insertion, as a critical contributor to animal aging.
]]></description>
<dc:creator>Schneider, B. K.</dc:creator>
<dc:creator>Sun, S.</dc:creator>
<dc:creator>Lee, M.</dc:creator>
<dc:creator>Li, W.</dc:creator>
<dc:creator>Skvir, N.</dc:creator>
<dc:creator>Neretti, N.</dc:creator>
<dc:creator>Vijg, J.</dc:creator>
<dc:creator>Secombe, J.</dc:creator>
<dc:date>2022-11-15</dc:date>
<dc:identifier>doi:10.1101/2022.11.14.516438</dc:identifier>
<dc:title><![CDATA[Expression of retrotransposons contributes to aging in Drosophila]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-11-15</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.11.17.516919v1?rss=1">
<title>
<![CDATA[
All-or-None Evaluation of Prediction Certainty in Autism 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.11.17.516919v1?rss=1</link>
<description><![CDATA[
The brain generates predictions to prepare for upcoming events. As life is not always 100% predictable, it also estimates a level of certainty for these predictions. Given that autistic individuals resist even small changes in everyday life, we hypothesized impaired tuning of prediction certainty in autism. To study this, EEG was recorded from adolescents and young adults with autism while they performed a probabilistic prediction task in which cue validity was parametrically manipulated. A fully predictable condition (100% cue validity) was contrasted with less predictable conditions (84, 67 and 33% cue validity). Well characterized brain potentials were examined to assess the influence of cue validity on target anticipation (contingent negative variation; CNV), the evaluation of target statistics (P3), and prediction model updating (slow wave; SW). As expected, cue validity systematically influenced the amplitudes of the CNV, P3 and SW in controls. In contrast, cue-validity effects on CNV and SW were substantially reduced in autism. This suggests that although target statistics are accurately registered in autism, as indicated by intact modulation of the P3, they are not effectively applied to generate expectations for upcoming input or model updating. Contrasting the fully predictable with the less predictable conditions, our data suggest that autistic individuals adopted an all-or-none evaluation of certainty of their environment, rather than adjusting certainty of predictions to different levels of environmental statistics. Social responsiveness scores were associated with flexibility in representing prediction certainty, suggesting that impaired representation and updating of prediction certainty may contribute to social difficulties in autism.

SIGNIFICANCE STATEMENTThe ability to make predictions is integral to everyday life. Yet, as life is not always 100% predictable and it is also essential to adjust the certainty of these predictions based on the current context. This study reveals that individuals with autism are less efficient in adjusting the certainty of their predictions to the level of predictability of events. Instead, they may adopt an all-or-none evaluation of certainty. Our findings reveal novel insights into the processes underlying impaired predictive processing in autism, which may open the door to developing targeted behavioral interventions and/or non-invasive brain stimulation therapies that help autistic individuals make more accurate predictions to ease social- and rigidity-based symptoms.
]]></description>
<dc:creator>Reisli, S.</dc:creator>
<dc:creator>Crosse, M. J.</dc:creator>
<dc:creator>Molholm, S.</dc:creator>
<dc:date>2022-11-17</dc:date>
<dc:identifier>doi:10.1101/2022.11.17.516919</dc:identifier>
<dc:title><![CDATA[All-or-None Evaluation of Prediction Certainty in Autism]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-11-17</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.11.20.517232v1?rss=1">
<title>
<![CDATA[
Proximity labeling reveals a new in vivo network of interactors for the histone demethylase KDM5 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.11.20.517232v1?rss=1</link>
<description><![CDATA[
BackgroundKDM5 family proteins are multi-domain regulators of transcription that when dysregulated contribute to cancer and intellectual disability. KDM5 proteins can regulate transcription through their histone demethylase activity in addition to demethylase-independent gene regulatory functions that remain less characterized. To expand our understanding of the mechanisms that contribute to KDM5-mediated transcription regulation, we used TurboID proximity labeling to identify KDM5-interacting proteins.

ResultsUsing Drosophila melanogaster, we enriched for biotinylated proteins from KDM5-TurboID-expressing adult heads using a newly generated control for DNA-adjacent background in the form of dCas9:TurboID. Mass spectrometry analyses of biotinylated proteins identified both known and novel candidate KDM5 interactors, including members of the SWI/SNF and NURF chromatin remodeling complexes, the NSL complex, Mediator, and several insulator proteins.

ConclusionsCombined, our data shed new light on potential demethylase-independent activities of KDM5. In the context of KDM5 dysregulation, these interactions may play key roles in the alteration of evolutionarily conserved transcriptional programs implicated in human disorders.
]]></description>
<dc:creator>Yheskel, M.</dc:creator>
<dc:creator>Sidoli, S.</dc:creator>
<dc:creator>Secombe, J.</dc:creator>
<dc:date>2022-11-20</dc:date>
<dc:identifier>doi:10.1101/2022.11.20.517232</dc:identifier>
<dc:title><![CDATA[Proximity labeling reveals a new in vivo network of interactors for the histone demethylase KDM5]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-11-20</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.11.23.517621v1?rss=1">
<title>
<![CDATA[
Mapping the content of comments on bioRxiv and medRxiv preprints 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.11.23.517621v1?rss=1</link>
<description><![CDATA[
IntroductionPreprints have been increasingly used in biomedical sciences, providing the opportunity for research to be publicly assessed before journal publication. With the increase in attention over preprints during the COVID-19 pandemic, we decided to assess the content of comments left on preprint platforms.

MethodsPreprints posted on bioRxiv and medRxiv in 2020 were accessed through each platforms API, and a random sample of preprints that had received between 1 and 20 comments was analyzed. Comments were evaluated in triplicate by independent evaluators using an instrument that assessed their features and general content.

Results7.3% of preprints received at least 1 comment during a mean follow-up of 7.5 months. Analyzed comments had a median size of 43 words. Criticisms, corrections or suggestions were the most prevalent type of content, followed by compliments or positive appraisals and questions. Most critical comments regarded interpretation, data collection and methodological design, while compliments were usually about relevance and implications.

ConclusionsOnly a small percentage of preprints posted in 2020 in bioRxiv and medRxiv received comments in these platforms. When present, however, these comments address content that is similar to that analyzed by traditional peer review. A more precise taxonomy of peer review functions would be desirable to describe whether post-publication peer review fulfills these roles.
]]></description>
<dc:creator>Carneiro, C. F. D.</dc:creator>
<dc:creator>Costa, G.</dc:creator>
<dc:creator>Neves, K.</dc:creator>
<dc:creator>Abreu, M. B.</dc:creator>
<dc:creator>Tan, P. B.</dc:creator>
<dc:creator>Rayee, D.</dc:creator>
<dc:creator>Boos, F.</dc:creator>
<dc:creator>Andrejew, R.</dc:creator>
<dc:creator>Lubiana, T.</dc:creator>
<dc:creator>Malicki, M.</dc:creator>
<dc:creator>Amaral, O. B.</dc:creator>
<dc:date>2022-11-24</dc:date>
<dc:identifier>doi:10.1101/2022.11.23.517621</dc:identifier>
<dc:title><![CDATA[Mapping the content of comments on bioRxiv and medRxiv preprints]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-11-24</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.11.24.517880v1?rss=1">
<title>
<![CDATA[
Measuring cell-to-cell expression variability in single-cell RNA-sequencing data: a comparative analysis and applications to B cell ageing 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.11.24.517880v1?rss=1</link>
<description><![CDATA[
BackgroundSingle-cell RNA-sequencing (scRNA-seq) technologies enable the capture of gene expression heterogeneity and consequently cell-to-cell variability at the cell type level. Although different methods have been proposed to quantify cell-to-cell variability, it is unclear what the optimal statistical approach is, especially in light of challenging data structures that are unique to scRNA-seq data like zero inflation.

ResultsIn this study, we conducted a systematic evaluation of cell-to-cell gene expression variability using 14 different variability metrics that are commonly applied to transcriptomic data. Performance was evaluated with respect to data-specific features like sparsity and sequencing platform, biological properties like gene length, and the ability to recapitulate true levels of variability based on simulation and known biological gene sets like ribosomal genes and stably expressed genes. scran had the strongest all-round performance, and this metric was then applied to investigate the changes in cell-to-cell variability that occur during ageing. Studying ageing showcases the value of cell-to-cell variability as it is a genetically-regulated program that is influenced by stochastic processes.scRNA-seq datasets from hematopoietic stem cells (HSCs) and B lymphocytes and other cell types from this differentiation lineage were used with scran to identify the genes with consistent patterns of variable and stable expression profiles during differentiation. Furthermore, to understand the regulatory relationship for genes that were differentially-variable in their expression between young and old mice, we constructed networks using transcription factors and their known targets for HSC and B lymphocyte cells. Comparisons of these networks identified a shared TF Sfpi1 that although was seen to increase in gene expression variability in old mice versus young in both cell types, the corresponding targets were distinct and their gene expression variability had different directions between cell types.

ConclusionsThrough these analyses, we highlight the importance of capturing cell-to-cell gene expression variability in a complex biological process like differentiation and ageing, and emphasise the value and specificity of interpreting these findings at the level of individual cell types.
]]></description>
<dc:creator>Zheng, H.</dc:creator>
<dc:creator>Vijg, J.</dc:creator>
<dc:creator>Taherian Fard, A.</dc:creator>
<dc:creator>Mar, J. C.</dc:creator>
<dc:date>2022-11-25</dc:date>
<dc:identifier>doi:10.1101/2022.11.24.517880</dc:identifier>
<dc:title><![CDATA[Measuring cell-to-cell expression variability in single-cell RNA-sequencing data: a comparative analysis and applications to B cell ageing]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-11-25</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.12.06.519376v1?rss=1">
<title>
<![CDATA[
Pynapple: a toolbox for data analysis in neuroscience. 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.12.06.519376v1?rss=1</link>
<description><![CDATA[
Datasets collected in neuroscientific studies are of ever-growing complexity, often combining high dimensional time series data from multiple data acquisition modalities. Handling and manipulating these various data streams in an adequate programming environment is crucial to ensure reliable analysis, and to facilitate sharing of reproducible analysis pipelines. Here, we present Pynapple, the PYthon Neural Analysis Package, a lightweight python package designed to process a broad range of time-resolved data in systems neuroscience. The core feature of this package is a small number of versatile objects that support the manipulation of any data streams and task parameters. The package includes a set of methods to read common data formats and allows users to easily write their own. The resulting code is easy to read and write, avoids low-level data processing and other error-prone steps, and is open source. Libraries for higher-level analyses are developed within the Pynapple framework but are contained within in a collaborative repository of specialized and continuously updated analysis routines. This provides flexibility while ensuring long-term stability of the core package. In conclusion, Pynapple provides a common framework for data analysis in neuroscience.

HighlightsO_LIAn open-source framework for data analysis in systems neuroscience.
C_LIO_LIEasy-to-use object-oriented programming for data manipulation.
C_LIO_LIA lightweight and standalone package ensuring long-term backward compatibility.
C_LI
]]></description>
<dc:creator>Viejo, G.</dc:creator>
<dc:creator>Levenstein, D.</dc:creator>
<dc:creator>Carrasco, S. S.</dc:creator>
<dc:creator>Mehrotra, D.</dc:creator>
<dc:creator>Mahallati, S.</dc:creator>
<dc:creator>Vite, G. R.</dc:creator>
<dc:creator>Denny, H.</dc:creator>
<dc:creator>Sjulson, L.</dc:creator>
<dc:creator>Battaglia, F. P.</dc:creator>
<dc:creator>Peyrache, A.</dc:creator>
<dc:date>2022-12-07</dc:date>
<dc:identifier>doi:10.1101/2022.12.06.519376</dc:identifier>
<dc:title><![CDATA[Pynapple: a toolbox for data analysis in neuroscience.]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-12-07</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.12.09.519776v1?rss=1">
<title>
<![CDATA[
An in vivo platform for rebuilding functional neocortical tissue 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.12.09.519776v1?rss=1</link>
<description><![CDATA[
Recent progress in cortical stem cell transplantation has demonstrated its potential to repair the brain. However, current transplant models have yet to demonstrate that the circuitry of transplant-derived neurons can encode useful function to the host. This is likely due to missing cell types within the grafts, abnormal proportions of cell types, abnormal cytoarchitecture, and inefficient vascularization. Here, we devised a transplant platform for testing neocortical tissue prototypes. Dissociated mouse embryonic telencephalic cells in a liquid scaffold were transplanted into aspiration-lesioned adult mouse cortices. The donor neuronal precursors differentiated into upper and deep layer neurons that exhibited synaptic puncta, projected outside of the graft to appropriate brain areas, became electrophysiologically active within one month post-transplant, and responded to visual stimuli. Interneurons and oligodendrocytes were present at normal densities in grafts. Grafts became fully vascularized by 1-week post-transplant and vessels in grafts were perfused with blood. With this paradigm, we could also organize cells into layers. Overall, we have provided proof of concept for an in vivo platform that can be used for developing and testing neocortical-like tissue prototypes.
]]></description>
<dc:creator>Quezada, A.</dc:creator>
<dc:creator>Ward, C.</dc:creator>
<dc:creator>Bader, E. R.</dc:creator>
<dc:creator>Zolotavin, P.</dc:creator>
<dc:creator>Altun, E.</dc:creator>
<dc:creator>Hong, S.</dc:creator>
<dc:creator>Killian, N.</dc:creator>
<dc:creator>Xie, C.</dc:creator>
<dc:creator>Batista-Brito, R.</dc:creator>
<dc:creator>Hebert, J. M.</dc:creator>
<dc:date>2022-12-11</dc:date>
<dc:identifier>doi:10.1101/2022.12.09.519776</dc:identifier>
<dc:title><![CDATA[An in vivo platform for rebuilding functional neocortical tissue]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-12-11</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.12.10.517707v1?rss=1">
<title>
<![CDATA[
Visualization of early RNA replication kinetics of SARS-CoV-2 by using single molecule RNA-FISH 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.12.10.517707v1?rss=1</link>
<description><![CDATA[
SARS-CoV-2 infection has caused a major global burden. Despite intensive research, the mechanism and dynamics of early viral replication are not completely understood including the kinetics of formation of plus stranded genomic and subgenomic RNAs (gRNA and sgRNA) starting from the RNA from the first virus that enters the cell. We employed single-molecule RNA-fluorescence in situ hybridization (smRNA-FISH) to simultaneously detect viral gRNA and sgRNA in infected cells and carried out a time course analysis to determine the kinetics of their replication. We visualized the single molecules of gRNA within the cytoplasm of infected cells 30 minutes post-infection and detected the co-expression of gRNA and sgRNA within two hours post-infection. Furthermore, we observed the formation of a replication organelle (RO) from a single RNA, which led to the formation of multiple ROs within the same cells. Single molecule analysis indicated that while gRNA resided in the center of these ROs, the sgRNAs were found to radiate and migrate out of these structures. Our results also indicated that after the initial delay, there was a rapid but asynchronous replication, and the gRNA and sgRNAs dispersed throughout the cell within 4-5 hours post-infection forming multiple ROs that filled the entire cytoplasm. These results provide insight into the kinetics of early post-entry events of SARS-CoV-2 and the formation of RO, which will help to understand the molecular events associated with viral infection and facilitate the identification of new therapeutic targets that can curb the virus at a very early stage of replication to combat COVID-19.

Author SummarySARS-CoV-2 infection continues to be a global burden. Soon after the entry, SARS-CoV-2 replicates by an elaborate process, producing genomic and subgenomic RNAs (gRNA and sgRNAs) within specialized structures called replication organelles (RO). Many questions including the timing of multiplication of gRNA and sgRNA, the generation, subcellular localization, and function of the ROs, and the mechanism of vRNA synthesis within ROs is not completely understood. Here, we have developed probes and methods to simultaneously detect the viral gRNA and a sgRNA at single cell single molecule resolution and have employed a method to scan thousands of cells to visualize the early kinetics of gRNA and sgRNA synthesis soon after the viral entry into the cell. Our results reveal that the replication is asynchronous and ROs are rapidly formed from a single RNA that enters the cell within 2 hours, which multiply to fill the entire cell cytoplasm within ~4 hours after infection. Furthermore, our studies provide a first glimpse of the gRNA and sgRNA synthesis within ROs at single molecule resolution. Our studies may facilitate the development of drugs that inhibit the virus at the earliest possible stages of replication to minimize the pathogenic impact of viral infection.
]]></description>
<dc:creator>Pathak, R.</dc:creator>
<dc:creator>Eliscovich, C.</dc:creator>
<dc:creator>Mena, I.</dc:creator>
<dc:creator>Dixit, U.</dc:creator>
<dc:creator>Garcia-Sastre, A.</dc:creator>
<dc:creator>Singer, R.</dc:creator>
<dc:creator>Kalpana, G. V.</dc:creator>
<dc:date>2022-12-12</dc:date>
<dc:identifier>doi:10.1101/2022.12.10.517707</dc:identifier>
<dc:title><![CDATA[Visualization of early RNA replication kinetics of SARS-CoV-2 by using single molecule RNA-FISH]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-12-12</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.12.14.520402v1?rss=1">
<title>
<![CDATA[
Chaotic signatures in host-microbe interactions 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.12.14.520402v1?rss=1</link>
<description><![CDATA[
Host-microbe interactions constitute dynamical systems that can be represented by mathematical formulations that determine their dynamic nature, and are categorized as deterministic, stochastic, or chaotic. Knowing the type of dynamical interaction is essential for understanding the system under study. Very little experimental work has been done to determine the dynamical characteristics of host-microbe interactions and its study poses significant challenges. The most straightforward experimental outcome involves an observation of time to death upon infection. However, in measuring this outcome, the internal parameters, and the dynamics of each particular host-microbe interaction in a population of interactions are hidden from the experimentalist. To investigate whether a time-to-death (time to event) dataset provides adequate information for searching for chaotic signatures, we first determined our ability to detect chaos in simulated data sets of time-to-event measurements and successfully distinguished the time-to-event distribution of a chaotic process from a comparable stochastic one. To do so, we introduced an inversion measure to test for a chaotic signature in time-to-event distributions. Next, we searched for chaos, in time-to-death of Caenorhabditis elegans and Drosophila melanogaster infected with Pseudomonas aeruginosa or Pseudomonas entomophila, respectively. We found suggestions of chaotic signatures in both systems, but caution that our results are preliminary and highlight the need for more fine-grained and larger data sets in determining dynamical characteristics. If validated, chaos in host-microbe interactions would have important implications for the occurrence and outcome of infectious diseases, the reproducibility of experiments in the field of microbial pathogenesis and the prediction of microbial threats.

ImportanceIs microbial pathogenesis a predictable scientific field? At a time when we are dealing with Coronavirus Disease 2019 (COVID-19) there is intense interest in knowing about the epidemic potential of other microbial threats and new emerging infectious diseases. To know whether microbial pathogenesis will ever be a predictable scientific field requires knowing whether a host-microbe interaction follows deterministic, stochastic, or chaotic dynamics. If randomness and chaos are absent from virulence, there is the hope for prediction in the future regarding the outcome of microbe-host interactions. Chaotic systems are inherently unpredictable although it is possible to generate shortterm probabilistic models, as is done in applications of stochastic processes and machine learning to weather forecasting. Information on the dynamics of a system is also essential for understanding the reproducibility of experiments, a topic of great concern in biological sciences. Our study finds preliminary evidence for chaotic dynamics in infectious diseases.
]]></description>
<dc:creator>Sella, Y.</dc:creator>
<dc:creator>Broderick, N. A.</dc:creator>
<dc:creator>Stouffer, K.</dc:creator>
<dc:creator>McEwan, D. L.</dc:creator>
<dc:creator>Ausubel, F. M.</dc:creator>
<dc:creator>Casadevall, A.</dc:creator>
<dc:creator>Bergman, A.</dc:creator>
<dc:date>2022-12-14</dc:date>
<dc:identifier>doi:10.1101/2022.12.14.520402</dc:identifier>
<dc:title><![CDATA[Chaotic signatures in host-microbe interactions]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-12-14</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.12.15.520548v1?rss=1">
<title>
<![CDATA[
Cleavage of cFLIP restrains cell death during viral infection and tissue injury and favors tissue repair 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.12.15.520548v1?rss=1</link>
<description><![CDATA[
Cell death coordinates repair programs following pathogen attack and tissue injury. However, aberrant cell death can interfere with such programs and cause organ failure. cFLIP is a crucial regulator of cell death and a substrate of Caspase-8. Yet, the physiological role of cFLIP cleavage by Caspase-8 remains elusive. Here, we discovered an essential role for cFLIP cleavage in restraining cell death in different pathophysiological scenarios. Mice expressing a cleavage-resistant cFLIP mutant, CflipD377A, exhibited increased sensitivity to SARS-CoV-induced lethality, impaired skin wound healing and increased tissue damage caused by Sharpin deficiency. In vitro, abrogation of cFLIP cleavage sensitizes cells to TNF-induced necroptosis and apoptosis by favoring complex-II formation. Mechanistically, the cell death-sensitizing effect of the D377A mutation depends on Gln(Q)469. These results reveal a crucial role for cFLIP cleavage in controlling the amplitude of cell death responses occurring upon tissue stress, to ensure the execution of repair programs.
]]></description>
<dc:creator>Martinez Lagunas, K.</dc:creator>
<dc:creator>Savcigil, D. P.</dc:creator>
<dc:creator>Zrilic, M.</dc:creator>
<dc:creator>Carvajal Fraile, C.</dc:creator>
<dc:creator>Craxton, A.</dc:creator>
<dc:creator>Self, E.</dc:creator>
<dc:creator>Uranga, I.</dc:creator>
<dc:creator>de Miguel, D.</dc:creator>
<dc:creator>Arias, M.</dc:creator>
<dc:creator>Willenborg, S.</dc:creator>
<dc:creator>Piekarek, M.</dc:creator>
<dc:creator>Albert, M. C.</dc:creator>
<dc:creator>Nugraha, K.</dc:creator>
<dc:creator>Lisewski, I.</dc:creator>
<dc:creator>Janakova, E.</dc:creator>
<dc:creator>Igual, N.</dc:creator>
<dc:creator>Tonnus, W.</dc:creator>
<dc:creator>Hilendbrandt, X.</dc:creator>
<dc:creator>Ibrahim, M.</dc:creator>
<dc:creator>Ballegeer, M.</dc:creator>
<dc:creator>Saelens, X.</dc:creator>
<dc:creator>Kueh, A. J.</dc:creator>
<dc:creator>Meier, P.</dc:creator>
<dc:creator>Linkermann, A.</dc:creator>
<dc:creator>Pardo, J.</dc:creator>
<dc:creator>Eming, S.</dc:creator>
<dc:creator>Walczak, H.</dc:creator>
<dc:creator>MacFarlane, M.</dc:creator>
<dc:creator>Peltzer, N.</dc:creator>
<dc:creator>Annibaldi, A.</dc:creator>
<dc:date>2022-12-15</dc:date>
<dc:identifier>doi:10.1101/2022.12.15.520548</dc:identifier>
<dc:title><![CDATA[Cleavage of cFLIP restrains cell death during viral infection and tissue injury and favors tissue repair]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-12-15</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.12.21.521407v1?rss=1">
<title>
<![CDATA[
Laminar Neural Dynamics of Auditory Evoked Responses: Computational Modeling of Local Field Potentials in Auditory Cortex of Non-Human Primates 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.12.21.521407v1?rss=1</link>
<description><![CDATA[
Evoked neural responses to sensory stimuli have been extensively investigated in humans and animal models both to enhance our understanding of brain function and to aid in clinical diagnosis of neurological and neuropsychiatric conditions. Recording and imaging techniques such as electroencephalography (EEG), magnetoencephalography (MEG), local field potentials (LFPs), and calcium imaging provide complementary information about different aspects of brain activity at different spatial and temporal scales. Modeling and simulations provide a way to integrate these different types of information to clarify underlying neural mechanisms.

In this study, we aimed to shed light on the neural dynamics underlying auditory evoked responses by fitting a rate-based model to LFPs recorded via multi-contact electrodes which simultaneously sampled neural activity across cortical laminae. Recordings included neural population responses to best-frequency (BF) and non-BF tones at four representative sites in primary auditory cortex (A1) of awake monkeys. The model considered major neural populations of excitatory, parvalbumin-expressing (PV), and somatostatin-expressing (SOM) neurons across layers 2/3, 4, and 5/6. Unknown parameters, including the connection strength between the populations, were fitted to the data. Our results revealed similar population dynamics, fitted model parameters, predicted equivalent current dipoles (ECD), tuning curves, and lateral inhibition profiles across recording sites and animals, in spite of quite different extracellular current distributions. We found that PV firing rates were higher in BF than in non-BF responses, mainly due to different strengths of tonotopic thalamic input, whereas SOM firing rates were higher in non-BF than in BF responses due to lateral inhibition.

In conclusion, we demonstrate the feasibility of the model-fitting approach in identifying the contributions of cell-type specific population activity to stimulus-evoked LFPs across cortical laminae, providing a foundation for further investigations into the dynamics of neural circuits underlying cortical sensory processing.
]]></description>
<dc:creator>Chien, S.-C.</dc:creator>
<dc:creator>Wang, P.</dc:creator>
<dc:creator>Maess, B.</dc:creator>
<dc:creator>Fishman, Y.</dc:creator>
<dc:creator>Knoesche, T.</dc:creator>
<dc:date>2022-12-21</dc:date>
<dc:identifier>doi:10.1101/2022.12.21.521407</dc:identifier>
<dc:title><![CDATA[Laminar Neural Dynamics of Auditory Evoked Responses: Computational Modeling of Local Field Potentials in Auditory Cortex of Non-Human Primates]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-12-21</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2022.12.22.521637v1?rss=1">
<title>
<![CDATA[
An optimized approach for multiplexing single-nuclear ATAC-seq using oligonucleotide conjugated antibodies 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2022.12.22.521637v1?rss=1</link>
<description><![CDATA[
BackgroundSingle-cell technologies to analyze transcription and chromatin structure have been widely used in many research areas to reveal the functions and molecular properties of cells at single-cell resolution. Sample multiplexing techniques are valuable when performing single-cell analysis, reducing technical variation and permitting cost efficiencies. Several commercially available methods are available and have been used in many scRNA-seq studies. On the other hand, while several methods have been published, the multiplexing techniques for single nuclear Assay for Transposase-Accessible Chromatin (snATAC)-seq assays remain under development. We developed a simple nucleus hashing method using oligonucleotide conjugated antibodies recognizing nuclear pore complex proteins, NuHash, to perform snATAC-seq library preparations by multiplexing.

ResultsWe performed multiplexing snATAC-seq analyses on the mixture of human and mouse cell samples (two samples, 2-plex, and four samples, 4-plex) using NuHash. The demultiplexing accuracy of NuHash was high, and only ten out of 9,144 nuclei (2-plex) and 150 of 12,208 nuclei (4-plex) had discordant classifications between NuHash demultiplexing and discrimination using reference genome alignments. We compared results between snATAC-seq and deeply sequenced bulk ATAC-seq on the same samples and found that most of the peaks detected in snATAC-seq were also detected in deeply sequenced bulk ATAC-seq. The bulk ATAC-seq signal intensity was positively correlated with the number of cell subtype clusters detected in snATAC-seq, but not the subset of peaks detected in all clusters. These subsets of snATAC-seq peaks showed different distributions over different genomic features, suggesting that the peak intensities of bulk ATAC-seq can be used to identify different types of functional loci.

ConclusionsOur multiplexing method using oligo-conjugated anti-nuclear pore complex proteins, NuHash, permits high accuracy demultiplexing of samples. The NuHash protocol is straightforward, it works on frozen samples, and requires no modifications for snATAC-seq library preparation.
]]></description>
<dc:creator>Bera, B. S.</dc:creator>
<dc:creator>Thompson, T. V.</dc:creator>
<dc:creator>Sosa, E.</dc:creator>
<dc:creator>Nomaru, H.</dc:creator>
<dc:creator>Reynolds, D.</dc:creator>
<dc:creator>Dubin, R. A.</dc:creator>
<dc:creator>Maqbool, S. B.</dc:creator>
<dc:creator>Zheng, D.</dc:creator>
<dc:creator>Morrow, B. E.</dc:creator>
<dc:creator>Greally, J. M.</dc:creator>
<dc:creator>Suzuki, M.</dc:creator>
<dc:date>2022-12-22</dc:date>
<dc:identifier>doi:10.1101/2022.12.22.521637</dc:identifier>
<dc:title><![CDATA[An optimized approach for multiplexing single-nuclear ATAC-seq using oligonucleotide conjugated antibodies]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2022-12-22</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.01.03.522642v1?rss=1">
<title>
<![CDATA[
Cooperative NF-κB and Notch1 signaling promotes macrophage-mediated MenaINV expression in breast cancer 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.01.03.522642v1?rss=1</link>
<description><![CDATA[
Metastasis is a multistep process that leads to the formation of clinically detectable tumor foci at distant organs and frequently patient demise. Only a subpopulation of breast cancer cells within the primary tumor can disseminate systemically and cause metastasis. To disseminate, cancer cells must express MenaINV, an isoform of the actin-regulatory protein Mena encoded by the ENAH gene that endows tumor cells with transendothelial migration activity allowing them to enter and exit the blood circulation. We have previously demonstrated that MenaINV mRNA and protein expression is induced in cancer cells by macrophage contact. In this study, we discovered the precise mechanism by which macrophages induce MenaINV expression in tumor cells. We examined the promoter of the human and mouse ENAH gene and discovered a conserved NF-{kappa}B transcription factor binding site. Using live imaging of an NF-{kappa}B activity reporter and staining of fixed tissues from mouse and human breast cancer we further determined that for maximal induction of MenaINV in cancer cell NF-{kappa}B needs to cooperate with the Notch1 signaling pathway. Mechanistically, Notch1 signaling does not directly increase MenaINV expression, but it enhances and sustains NF-{kappa}B signaling through retention of p65, an NF-{kappa}B transcription factor, in the nucleus of tumor cells, leading to increased MenaINV expression. In mice, these signals are augmented following chemotherapy treatment and abrogated upon macrophage depletion. Targeting Notch1 signaling in vivo decreased NF-{kappa}B signaling and MenaINV expression in the primary tumor and decreased metastasis. Altogether, these data uncover mechanistic targets for blocking MenaINV induction that should be explored clinically to decrease cancer cell dissemination and improve survival of patients with metastatic disease.
]]></description>
<dc:creator>Duran, C. L.</dc:creator>
<dc:creator>Karagiannis, G. S.</dc:creator>
<dc:creator>Chen, X.</dc:creator>
<dc:creator>Sharma, V. P.</dc:creator>
<dc:creator>Entenberg, D.</dc:creator>
<dc:creator>Condeelis, J. S.</dc:creator>
<dc:creator>Oktay, M. H.</dc:creator>
<dc:date>2023-01-03</dc:date>
<dc:identifier>doi:10.1101/2023.01.03.522642</dc:identifier>
<dc:title><![CDATA[Cooperative NF-κB and Notch1 signaling promotes macrophage-mediated MenaINV expression in breast cancer]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-01-03</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.01.07.522490v1?rss=1">
<title>
<![CDATA[
Genetics of Latin American Diversity (GLAD) Project: insights into population genetics and association studies in recently admixed groups in the Americas 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.01.07.522490v1?rss=1</link>
<description><![CDATA[
Latin America is underrepresented in genetic studies, which can exacerbate disparities in personalized genomic medicine. However, genetic data of thousands of Latin Americans are already publicly available, but require a bureaucratic maze to navigate all the data access and consenting issues. We present the Genetics of Latin American Diversity (GLAD) Project, a platform that compiles genome-wide information of 54,077 Latin Americans from 39 studies representing 45 geographical regions. Through GLAD, we identified heterogeneous ancestry composition and recent gene-flow across the Americas. Also, we developed a simulated-annealing-based algorithm to match the genetic background of external samples to our database and share summary statistics without transferring individual-level data. Finally, we demonstrate the potential of GLAD as a critical resource for evaluating statistical genetic softwares in the presence of admixture. By making this resource available, we promote genomic research in Latin Americans and contribute to the promises of personalized medicine to more people.
]]></description>
<dc:creator>Borda, V.</dc:creator>
<dc:creator>Loesch, D. P.</dc:creator>
<dc:creator>Guo, B.</dc:creator>
<dc:creator>Laboulaye, R.</dc:creator>
<dc:creator>Veliz-Otani, D.</dc:creator>
<dc:creator>French-Kwawu, J. N.</dc:creator>
<dc:creator>Peixoto Leal, T.</dc:creator>
<dc:creator>Gogarten, S. M.</dc:creator>
<dc:creator>Ikpe, S.</dc:creator>
<dc:creator>Gouveia, M. H.</dc:creator>
<dc:creator>Mendes, M.</dc:creator>
<dc:creator>Abecasis, G. R.</dc:creator>
<dc:creator>Alvim, I.</dc:creator>
<dc:creator>Arboleda-Bustos, C. E.</dc:creator>
<dc:creator>Arboleda, G.</dc:creator>
<dc:creator>Arboleda, H.</dc:creator>
<dc:creator>Barreto, M. L.</dc:creator>
<dc:creator>Barwick, L.</dc:creator>
<dc:creator>Bezzera, M. A.</dc:creator>
<dc:creator>Blangero, J.</dc:creator>
<dc:creator>Borges, V.</dc:creator>
<dc:creator>Caceres, O.</dc:creator>
<dc:creator>Cai, J.</dc:creator>
<dc:creator>Chana-Cuevas, P.</dc:creator>
<dc:creator>Chen, Z.</dc:creator>
<dc:creator>Custer, B.</dc:creator>
<dc:creator>Dean, M.</dc:creator>
<dc:creator>Dinardo, C.</dc:creator>
<dc:creator>Domingos, I.</dc:creator>
<dc:creator>Duggirala, R.</dc:creator>
<dc:creator>Dieguez, E.</dc:creator>
<dc:creator>Fernandez, W.</dc:creator>
<dc:creator>Ferraz, H. B.</dc:creator>
<dc:creator>Gilliland, F. D.</dc:creator>
<dc:creator>Guio, H.</dc:creator>
<dc:creator>Horta, B.</dc:creator>
<dc:creator>Curran, J. E.</dc:creator>
<dc:creator>Johnsen, J. M.</dc:creator>
<dc:creator>Kaplan, R. C.</dc:creator>
<dc:creator>Kelly, S.</dc:creator>
<dc:creator>Kenny, E. E.</dc:creator>
<dc:creator>Kittner, S.</dc:creator>
<dc:creator>Konkle,</dc:creator>
<dc:date>2023-01-09</dc:date>
<dc:identifier>doi:10.1101/2023.01.07.522490</dc:identifier>
<dc:title><![CDATA[Genetics of Latin American Diversity (GLAD) Project: insights into population genetics and association studies in recently admixed groups in the Americas]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-01-09</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.01.12.523604v1?rss=1">
<title>
<![CDATA[
Restructuring of an asymmetric neural circuit during associative learning 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.01.12.523604v1?rss=1</link>
<description><![CDATA[
Asymmetric brain function is common across the animal kingdom and involved in language processing, and likely in learning and memory. What regulates asymmetric brain function remains elusive. Here, we show that the nematode Caenorhabditis elegans restructures an asymmetric salt sensing neural circuit during associative learning. Worms memorize and prefer the salt concentration at which they were raised in the presence of food through a left-biased network architecture. When conditioned at elevated salt concentrations, animals change the left-biased to a right-biased network, which explains the changed salt-seeking behavior. The changes in circuit architecture require new synapse formation induced through asymmetric, paracrine insulin-signaling. Therefore, experience-dependent changes in asymmetric network architecture rely on paracrine insulin signaling and are fundamental to learning and behavior.
]]></description>
<dc:creator>Tang, L. T. H.</dc:creator>
<dc:creator>Lee, G. A.</dc:creator>
<dc:creator>Cook, S. J.</dc:creator>
<dc:creator>Ho, J.</dc:creator>
<dc:creator>Potter, C. C.</dc:creator>
<dc:creator>Buelow, H. E.</dc:creator>
<dc:date>2023-01-13</dc:date>
<dc:identifier>doi:10.1101/2023.01.12.523604</dc:identifier>
<dc:title><![CDATA[Restructuring of an asymmetric neural circuit during associative learning]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-01-13</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.01.12.523842v1?rss=1">
<title>
<![CDATA[
Periosteal skeletal stem cells can migrate into the bone marrow and support hematopoiesis after injury 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.01.12.523842v1?rss=1</link>
<description><![CDATA[
Skeletal stem cells have been isolated from various tissues, including periosteum and bone marrow, where they exhibit key functions in bone biology and hematopoiesis, respectively. The role of periosteal skeletal stem cells in bone regeneration and healing has been extensively studied, but their ability to contribute to the bone marrow stroma is still under debate. In the present study, we characterized a whole bone transplantation model that mimics the initial bone marrow necrosis and fatty infiltration seen after injury. Using this model and a lineage tracing approach, we observed the migration of periosteal skeletal stem cells into the bone marrow after transplantation. Once in the bone marrow, periosteal skeletal stem cells are phenotypically and functionally reprogrammed into bone marrow mesenchymal stem cells that express high levels of hematopoietic stem cell niche factors such as Cxcl12 and Kitl. In addition, using ex vivo and in vivo approaches, we found that periosteal skeletal stem cells are more resistant to acute stress than bone marrow mesenchymal stem cells. These results highlight the plasticity of periosteal skeletal stem cells and their potential role in bone marrow regeneration after bone marrow injury.
]]></description>
<dc:creator>Marchand, T.</dc:creator>
<dc:creator>Akinnola, K. E.</dc:creator>
<dc:creator>Takeishi, S.</dc:creator>
<dc:creator>Maryanovich, M.</dc:creator>
<dc:creator>Pinho, S.</dc:creator>
<dc:creator>Saint-Vanne, J.</dc:creator>
<dc:creator>Birbrair, A.</dc:creator>
<dc:creator>Lamy, T.</dc:creator>
<dc:creator>Tarte, K.</dc:creator>
<dc:creator>Frenette, P.</dc:creator>
<dc:creator>Gritsman, K.</dc:creator>
<dc:date>2023-01-13</dc:date>
<dc:identifier>doi:10.1101/2023.01.12.523842</dc:identifier>
<dc:title><![CDATA[Periosteal skeletal stem cells can migrate into the bone marrow and support hematopoiesis after injury]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-01-13</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.01.18.524515v1?rss=1">
<title>
<![CDATA[
Excitation and inhibition delays within a feedforward inhibitory pathway modulate cerebellar Purkinje cell output in mice 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.01.18.524515v1?rss=1</link>
<description><![CDATA[
The cerebellar cortex computes sensorimotor information from many brain areas through a feedforward inhibitory (FFI) microcircuit between the input stage, the granule cell layer, and the output stage, the Purkinje cells. While in other brain areas FFI underlies a precise excitation vs inhibition temporal correlation, recent findings in the cerebellum highlighted more complex behaviors at the granule cell (GC) - molecular layer interneuron (MLI) - Purkinje cell (PC) FFI pathway. To dissect the temporal organization of the cerebellar FFI pathway, we combined ex vivo patch clamp recordings of PCs with a viral-based strategy to express Channelrhodopsin2 in a subset of mossy fibers (MFs), a major excitatory input to GCs. We show that light-mediated MF activation elicits excitatory and inhibitory currents in PCs with a wide range of temporal delays. Furthermore, in many recordings, excitation and inhibition were initiated by different groups of GCs, expanding PCs synaptic temporal integration. Using a computational model of the FFI pathway we demonstrated that this temporal expansion could strongly influence how PCs integrate MF inputs. Our findings suggest that MF inputs are also encoded by specific delays between excitation and inhibition in PCs.
]]></description>
<dc:creator>Binda, F.</dc:creator>
<dc:creator>Spaeth, L.</dc:creator>
<dc:creator>Kumar, A.</dc:creator>
<dc:creator>Isope, P.</dc:creator>
<dc:date>2023-01-18</dc:date>
<dc:identifier>doi:10.1101/2023.01.18.524515</dc:identifier>
<dc:title><![CDATA[Excitation and inhibition delays within a feedforward inhibitory pathway modulate cerebellar Purkinje cell output in mice]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-01-18</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.01.21.525021v1?rss=1">
<title>
<![CDATA[
Role of Gut Microbiome in Neoadjuvant Chemotherapy Response in Urothelial Carcinoma: A Multi-Institutional Prospective Cohort Evaluation 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.01.21.525021v1?rss=1</link>
<description><![CDATA[
Treatment with neoadjuvant chemotherapy (NAC) in muscle invasive bladder cancer (MIBC) is associated with clinical benefit in urothelial carcinoma. While extensive research evaluating role of tumor mutational expression profiles and clinicopathologic factors into chemoresponse has been published, the role of gut microbiome (GM) in bladder cancer in chemoresponse has not been thoroughly evaluated. A working knowledge of the microbiome and its effect on all forms of cancer therapy in BC is critical. Here we examine gut microbiome of bladder cancer patients undergoing NAC. Overall, there was no significant difference in alpha and beta diversity by responder status. However, analysis of fecal microbiome samples showed that a higher abundance of Bacteroides within both institutional cohorts during NAC was associated with residual disease at the time of radical cystectomy regardless of chemotherapy regimen. Group community analysis revealed presence of favorable microbial subtypes in complete responders. Finally, fecal microbial composition outperformed clinical variables in prediction of complete response (AUC 0.88 vs AUC 0.50), however, no single microbial species could be regarded as a fully consistent biomarker. Microbiome-based community signature as compared to single microbial species is more likely to be associated as the link between bacterial composition and NAC response.
]]></description>
<dc:creator>Bukavina, L.</dc:creator>
<dc:creator>Ginwala, R.</dc:creator>
<dc:creator>Sindhani, M.</dc:creator>
<dc:creator>Prunty, M.</dc:creator>
<dc:creator>Geynisman, D.</dc:creator>
<dc:creator>Pooja, G.</dc:creator>
<dc:creator>Valentine, H.</dc:creator>
<dc:creator>Calaway, A.</dc:creator>
<dc:creator>Brown, J. R.</dc:creator>
<dc:creator>Correa, A.</dc:creator>
<dc:creator>Mishra, K.</dc:creator>
<dc:creator>Pominville, R.</dc:creator>
<dc:creator>Plimack, E.</dc:creator>
<dc:creator>Kutikov, A.</dc:creator>
<dc:creator>Ghannoum, M.</dc:creator>
<dc:creator>ElShaer, M.</dc:creator>
<dc:creator>Retuerto, M.</dc:creator>
<dc:creator>Uzzo, R.</dc:creator>
<dc:creator>Ponsky, L.</dc:creator>
<dc:creator>Abbosh, P. H.</dc:creator>
<dc:date>2023-01-23</dc:date>
<dc:identifier>doi:10.1101/2023.01.21.525021</dc:identifier>
<dc:title><![CDATA[Role of Gut Microbiome in Neoadjuvant Chemotherapy Response in Urothelial Carcinoma: A Multi-Institutional Prospective Cohort Evaluation]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-01-23</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.01.25.525428v1?rss=1">
<title>
<![CDATA[
Structural variation across 138,134 samples in the TOPMed consortium 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.01.25.525428v1?rss=1</link>
<description><![CDATA[
Ever larger Structural Variant (SV) catalogs highlighting the diversity within and between populations help researchers better understand the links between SVs and disease. The identification of SVs from DNA sequence data is non-trivial and requires a balance between comprehensiveness and precision. Here we present a catalog of 355,667 SVs (59.34% novel) across autosomes and the X chromosome (50bp+) from 138,134 individuals in the diverse TOPMed consortium. We describe our methodologies for SV inference resulting in high variant quality and >90% allele concordance compared to long-read de-novo assemblies of well-characterized control samples. We demonstrate utility through significant associations between SVs and important various cardio-metabolic and hemotologic traits. We have identified 690 SV hotspots and deserts and those that potentially impact the regulation of medically relevant genes. This catalog characterizes SVs across multiple populations and will serve as a valuable tool to understand the impact of SV on disease development and progression.
]]></description>
<dc:creator>Jun, G.</dc:creator>
<dc:creator>English, A. C.</dc:creator>
<dc:creator>Metcalf, G. A.</dc:creator>
<dc:creator>Yang, J.</dc:creator>
<dc:creator>Chaisson, M. J.</dc:creator>
<dc:creator>Pankratz, N.</dc:creator>
<dc:creator>Menon, V. K.</dc:creator>
<dc:creator>Salerno, W. J.</dc:creator>
<dc:creator>Krasheninina, O.</dc:creator>
<dc:creator>Smith, A. V.</dc:creator>
<dc:creator>Lane, J. A.</dc:creator>
<dc:creator>Blackwell, T.</dc:creator>
<dc:creator>Kang, H. M.</dc:creator>
<dc:creator>Salvi, S.</dc:creator>
<dc:creator>Meng, Q.</dc:creator>
<dc:creator>Shen, H.</dc:creator>
<dc:creator>Pasham, D.</dc:creator>
<dc:creator>Bhamidipati, S.</dc:creator>
<dc:creator>Kottapalli, K.</dc:creator>
<dc:creator>Arnett, D. K.</dc:creator>
<dc:creator>Ashley-Koch, A.</dc:creator>
<dc:creator>Auer, P. L.</dc:creator>
<dc:creator>Beutel, K. M.</dc:creator>
<dc:creator>Bis, J. C.</dc:creator>
<dc:creator>Blangero, J.</dc:creator>
<dc:creator>Bowden, D. W.</dc:creator>
<dc:creator>Brody, J. A.</dc:creator>
<dc:creator>Cade, B. E.</dc:creator>
<dc:creator>Chen, Y.-D. I.</dc:creator>
<dc:creator>Cho, M. H.</dc:creator>
<dc:creator>Curran, J. E.</dc:creator>
<dc:creator>Fornage, M.</dc:creator>
<dc:creator>Freedman, B. I.</dc:creator>
<dc:creator>Fingerlin, T.</dc:creator>
<dc:creator>Gelb, B. D.</dc:creator>
<dc:creator>Hou, L.</dc:creator>
<dc:creator>Hung, Y.-J.</dc:creator>
<dc:creator>Kane, J. P.</dc:creator>
<dc:creator>Kaplan, R.</dc:creator>
<dc:creator>Kim, W.</dc:creator>
<dc:creator>Loos, R. J. F.</dc:creator>
<dc:creator>Marcus,, G. M.</dc:creator>
<dc:creator>Mathias, R. A.</dc:creator>
<dc:creator>McGarv</dc:creator>
<dc:date>2023-01-26</dc:date>
<dc:identifier>doi:10.1101/2023.01.25.525428</dc:identifier>
<dc:title><![CDATA[Structural variation across 138,134 samples in the TOPMed consortium]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-01-26</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.01.26.525812v1?rss=1">
<title>
<![CDATA[
Assessing the functional impact of protein binding site definition 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.01.26.525812v1?rss=1</link>
<description><![CDATA[
Many biomedical applications, such as classification of binding specificities or bioengineering, depend on the accurate definition of protein binding interfaces. Depending on the choice of method used, substantially different sets of residues can be classified as belonging to the interface of a protein. A typical approach used to verify these definitions is to mutate residues and measure the impact of these changes on binding. Besides the lack of exhaustive data this approach generates, it also suffers from the fundamental problem that a mutation introduces an unknown amount of alteration into an interface, which potentially alters the binding characteristics of the interface. In this study we explore the impact of alternative binding site definitions on the ability of a protein to recognize its cognate ligand using a pharmacophore approach, which does not affect the interface. The study also provides guidance on the minimum expected accuracy of interface definition that is required to capture the biological function of a protein.

AUTHOR SUMMARYThe residue level description or prediction of protein interfaces is a critical input for protein engineering and classification of function. However, different parametrizations of the same methods and especially alternative methods used to define the interface of a protein can return substantially different sets of residues. Typical experimental or computational methods employ mutational studies to verify interface definitions, but all these approaches inherently suffer from the problem that in order to probe the importance of any one position of an interface, an unknown amount of alteration is introduced into the very interface being studied. In this work, we employ a pharmacophore-based approach to computationally explore the consequences of defining alternative binding sites. The pharmacophore generates a hypothesis for the complementary protein binding interface, which then can be used in a search to identify the corresponding ligand from a library of candidates. The accurate ranking of cognate ligands can inform us about the biological accuracy of the interface definition. This study also provides a guideline about the minimum required accuracy of protein interface definitions that still provides a statistically significant recognition of cognate ligands above random expectation, which in turn sets a minimum expectation for interface prediction methods.
]]></description>
<dc:creator>Nandigrami, P.</dc:creator>
<dc:creator>Fiser, A.</dc:creator>
<dc:date>2023-01-27</dc:date>
<dc:identifier>doi:10.1101/2023.01.26.525812</dc:identifier>
<dc:title><![CDATA[Assessing the functional impact of protein binding site definition]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-01-27</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.01.31.526505v1?rss=1">
<title>
<![CDATA[
Genetic control of mRNA splicing as a potential mechanism for incomplete penetrance of rare coding variants 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.01.31.526505v1?rss=1</link>
<description><![CDATA[
Exonic variants present some of the strongest links between genotype and phenotype. However, these variants can have significant inter-individual pathogenicity differences, known as variable penetrance. In this study, we propose a model where genetically controlled mRNA splicing modulates the pathogenicity of exonic variants. By first cataloging exonic inclusion from RNA-seq data in GTEx v8, we find that pathogenic alleles are depleted on highly included exons. Using a large-scale phased WGS data from the TOPMed consortium, we observe that this effect may be driven by common splice-regulatory genetic variants, and that natural selection acts on haplotype configurations that reduce the transcript inclusion of putatively pathogenic variants, especially when limiting to haploinsufficient genes. Finally, we test if this effect may be relevant for autism risk using families from the Simons Simplex Collection, but find that splicing of pathogenic alleles has a penetrance reducing effect here as well. Overall, our results indicate that common splice-regulatory variants may play a role in reducing the damaging effects of rare exonic variants.
]]></description>
<dc:creator>Einson, J.</dc:creator>
<dc:creator>Glinos, D.</dc:creator>
<dc:creator>Boerwinkle, E.</dc:creator>
<dc:creator>Castaldi, P.</dc:creator>
<dc:creator>Darbar, D.</dc:creator>
<dc:creator>de Andrade, M.</dc:creator>
<dc:creator>Ellinor, P.</dc:creator>
<dc:creator>Fornage, M.</dc:creator>
<dc:creator>Gabriel, S.</dc:creator>
<dc:creator>Germer, S.</dc:creator>
<dc:creator>Gibbs, R.</dc:creator>
<dc:creator>Hersh, C.</dc:creator>
<dc:creator>Johnsen, J.</dc:creator>
<dc:creator>Kaplan, R.</dc:creator>
<dc:creator>Konkle, B.</dc:creator>
<dc:creator>Kooperberg, C.</dc:creator>
<dc:creator>Nassir, R.</dc:creator>
<dc:creator>Loos, R. J. F.</dc:creator>
<dc:creator>Meyers, D. A.</dc:creator>
<dc:creator>Mitchell, B. D.</dc:creator>
<dc:creator>Psaty, B.</dc:creator>
<dc:creator>Vasan, R. S.</dc:creator>
<dc:creator>Rich, S. S.</dc:creator>
<dc:creator>Rienstra, M.</dc:creator>
<dc:creator>Rotter, J. I.</dc:creator>
<dc:creator>Saferali, A.</dc:creator>
<dc:creator>Shoemaker, M. B.</dc:creator>
<dc:creator>Silverman, E.</dc:creator>
<dc:creator>Smith, A. V.</dc:creator>
<dc:creator>Mohammadi, P.</dc:creator>
<dc:creator>Castel, S. E.</dc:creator>
<dc:creator>Iossifov, I.</dc:creator>
<dc:creator>Lappalainen, T.</dc:creator>
<dc:date>2023-01-31</dc:date>
<dc:identifier>doi:10.1101/2023.01.31.526505</dc:identifier>
<dc:title><![CDATA[Genetic control of mRNA splicing as a potential mechanism for incomplete penetrance of rare coding variants]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-01-31</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.02.02.526913v1?rss=1">
<title>
<![CDATA[
High-Resolution structures of microtubule-bound KIF1A and its pathogenic variant P305L 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.02.02.526913v1?rss=1</link>
<description><![CDATA[
Mutations in the microtubule-associated motor protein KIF1A lead to severe neurological conditions known as KIF1A-associated neurological disorders (KAND). Despite insights into its molecular mechanism, high-resolution structures of KIF1A-microtubule complexes remain undefined. Here, we present 2.7-3.4 [A] resolution structures of dimeric microtubule-bound KIF1A, including the pathogenic P305L mutant, across various nucleotide states. Our structures reveal that KIF1A binds microtubules in one- and two-heads-bound configurations, with both heads exhibiting distinct conformations with tight inter-head connection. Notably, KIF1As class-specific loop 12 (K-loop) forms electrostatic interactions with the C-terminal tails of both - and {beta}-tubulin. The P305L mutation does not disrupt these interactions but alters loop-12s conformation, impairing strong microtubule-binding. Structure-function analysis reveals the K-loop and head-head coordination as major determinants of KIF1As superprocessive motility. Our findings advance the understanding of KIF1As molecular mechanism and provide a basis for developing structure-guided therapeutics against KAND.
]]></description>
<dc:creator>Benoit, M. P. M. H.</dc:creator>
<dc:creator>Rao, L.</dc:creator>
<dc:creator>Asenjo, A. B.</dc:creator>
<dc:creator>Gennerich, A.</dc:creator>
<dc:creator>Sosa, H. J.</dc:creator>
<dc:date>2023-02-03</dc:date>
<dc:identifier>doi:10.1101/2023.02.02.526913</dc:identifier>
<dc:title><![CDATA[High-Resolution structures of microtubule-bound KIF1A and its pathogenic variant P305L]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-02-03</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.02.13.528323v1?rss=1">
<title>
<![CDATA[
Chromatin remodeling enzyme Snf2h is essential for retinal cell proliferation and photoreceptor maintenance 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.02.13.528323v1?rss=1</link>
<description><![CDATA[
Chromatin remodeling complexes are required for many distinct nuclear processes such as transcription, DNA replication and DNA repair. However, how these complexes contribute to the development of complex tissues within an organism is poorly characterized. Imitation switch (ISWI) proteins are among the most evolutionarily conserved ATP-dependent chromatin remodeling factors and are represented by yeast Isw1/Isw2, and their vertebrate counterparts Snf2h (Smarca5) and Snf2l (Smarca1). In this study, we focused on the role of the Snf2h gene during development of the mammalian retina. We show that Snf2h is expressed in both retinal progenitors and post-mitotic retinal cells. Using Snf2h conditional knockout mice (Snf2h cKO), we found that when Snf2h is deleted the laminar structure of the adult retina is not retained, the overall thickness of the retina is significantly reduced compared with controls, and the outer nuclear layer (ONL) is completely missing. Depletion of Snf2h did not influence the ability of retinal progenitors to generate all of the differentiated retinal cell types. Instead, Snf2h function is critical for proliferation of retinal progenitor cells. Cells lacking Snf2h have a defective S-phase, leading to the entire cell division process impairments. Although, all retinal cell types appear to be specified in the absence of Snf2h function, cell cycle defects and concomitantly increased apoptosis in Snf2h cKO result in abnormal retina lamination, complete destruction of the photoreceptor layer and, consequently, in a physiologically non-functional retina.
]]></description>
<dc:creator>Kuzelova, A.</dc:creator>
<dc:creator>Dupacova, N.</dc:creator>
<dc:creator>Antosova, B.</dc:creator>
<dc:creator>Sunny, S. S.</dc:creator>
<dc:creator>Kozmik, Z.</dc:creator>
<dc:creator>Paces, J.</dc:creator>
<dc:creator>Skoultchi, A. I.</dc:creator>
<dc:creator>Stopka, T.</dc:creator>
<dc:creator>Kozmik, Z.</dc:creator>
<dc:date>2023-02-13</dc:date>
<dc:identifier>doi:10.1101/2023.02.13.528323</dc:identifier>
<dc:title><![CDATA[Chromatin remodeling enzyme Snf2h is essential for retinal cell proliferation and photoreceptor maintenance]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-02-13</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.02.13.528419v1?rss=1">
<title>
<![CDATA[
The SapM phosphatase arrests phagosome maturation in an ESX-1 independent manner in Mycobacterium tuberculosis and BCG 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.02.13.528419v1?rss=1</link>
<description><![CDATA[
Mycobacterium tuberculosis (Mtb) is an intracellular pathogen that survives and grows in macrophages. A mechanism used by Mtb to achieve intracellular survival is to secrete effector molecules that arrest the normal process of phagosome maturation. Through phagosome maturation arrest (PMA), Mtb remains in an early phagosome and avoids delivery to degradative phagolysosomes. One PMA effector of Mtb is the secreted SapM phosphatase. Because the host target of SapM, phosphatidylinositol-3-phosphate (PI3P), is located on the cytosolic face of the phagosome, SapM needs to be both released by the mycobacteria and escape the phagosome to carry out its function. To date, the only mechanism known for Mtb molecules to escape the phagosome is phagosome permeabilization by the ESX-1 secretion system. To understand this step of SapM function in PMA, we generated identical in-frame sapM mutants in both the attenuated Mycobacterium bovis bacille Calmette-Guerin (BCG) vaccine strain, which lacks the ESX-1 system, and Mtb. Characterization of these mutants demonstrated that SapM is required for PMA in both BCG and Mtb. Further, by establishing a role for SapM in PMA in BCG, and subsequently in a Mtb mutant lacking the ESX-1 system, we demonstrated that the role of SapM is ESX-1-independent. We further determined that ESX-2 or ESX-4 are also not required for SapM to function in PMA. These results indicate that SapM is a secreted effector of PMA in both BCG and Mtb and that it functions independent of the known mechanism for Mtb molecules to escape the phagosome.
]]></description>
<dc:creator>Xander, C.</dc:creator>
<dc:creator>Rajagopalan, S.</dc:creator>
<dc:creator>Jacobs, W. R.</dc:creator>
<dc:creator>Braunstein, M.</dc:creator>
<dc:date>2023-02-14</dc:date>
<dc:identifier>doi:10.1101/2023.02.13.528419</dc:identifier>
<dc:title><![CDATA[The SapM phosphatase arrests phagosome maturation in an ESX-1 independent manner in Mycobacterium tuberculosis and BCG]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-02-14</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.02.14.528512v1?rss=1">
<title>
<![CDATA[
A hyper-quiescent chromatin state formed during aging is reversed by regeneration 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.02.14.528512v1?rss=1</link>
<description><![CDATA[
Epigenetic alterations are a key hallmark of aging but have been limitedly explored in tissues. Here, using naturally aged murine liver as a model and extending to other quiescent tissues, we find that aging is driven by temporal chromatin alterations that promote a refractory cellular state and compromise cellular identity. Using an integrated multi-omics approach, and the first direct visualization of aged chromatin we find that globally, old cells show H3K27me3-driven broad heterochromatinization and transcription suppression. At the local level, site-specific loss of H3K27me3 over promoters of genes encoding developmental transcription factors leads to expression of otherwise non-hepatocyte markers. Interestingly, liver regeneration reverses H3K27me3 patterns and rejuvenates multiple molecular and physiological aspects of the aged liver.
]]></description>
<dc:creator>Yang, N.</dc:creator>
<dc:creator>Occean, J. R.</dc:creator>
<dc:creator>Melters, D. P.</dc:creator>
<dc:creator>Shi, C.</dc:creator>
<dc:creator>Wang, L.</dc:creator>
<dc:creator>Stransky, S.</dc:creator>
<dc:creator>Doyle, M. E.</dc:creator>
<dc:creator>Cui, C.-Y.</dc:creator>
<dc:creator>Delannoy, M.</dc:creator>
<dc:creator>Fan, J.</dc:creator>
<dc:creator>Slama, E.</dc:creator>
<dc:creator>Egan, J. M.</dc:creator>
<dc:creator>De, S.</dc:creator>
<dc:creator>Cunningham, S. C.</dc:creator>
<dc:creator>Cabo, R. d.</dc:creator>
<dc:creator>Sidoli, S.</dc:creator>
<dc:creator>Dalal, Y.</dc:creator>
<dc:creator>Sen, P.</dc:creator>
<dc:date>2023-02-15</dc:date>
<dc:identifier>doi:10.1101/2023.02.14.528512</dc:identifier>
<dc:title><![CDATA[A hyper-quiescent chromatin state formed during aging is reversed by regeneration]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-02-15</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.02.15.527913v1?rss=1">
<title>
<![CDATA[
Fine-tuning spatial-temporal dynamics and surface receptor expression support plasma cell-intrinsic longevity 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.02.15.527913v1?rss=1</link>
<description><![CDATA[
Durable serological memory following vaccination is critically dependent on the production and survival of long-lived plasma cells (LLPCs). Yet, the factors that control LLPC specification and survival remain poorly resolved. Using intra-vital two-photon imaging, we find that in contrast to most plasma cells in the bone marrow (BM), LLPCs are uniquely sessile and organized into clusters that are dependent on APRIL, an important survival factor. Using deep, bulk RNA sequencing, and surface protein flow-based phenotyping, we find that LLPCs express a unique transcriptome and phenotype compared to bulk PCs, fine tuning expression of key cell surface molecules, CD93, CD81, CXCR4, CD326, CD44 and CD48, important for adhesion and homing. Conditional deletion of Cxcr4 in PCs following immunization leads to rapid mobilization from the BM, reduced survival of antigen-specific PCs, and ultimately accelerated decay of antibody titer. In naive mice, the endogenous LLPCs BCR repertoire exhibits reduced diversity, reduced somatic mutations, and increased public clones and IgM isotypes, particularly in young mice, suggesting LLPC specification is non-random. As mice age, the BM PC compartment becomes enriched in LLPCs, which may outcompete and limit entry of new PCs into the LLPC niche and pool.

HIGHLIGHTSO_LILLPCs have reduced motility and increased clustering in the BM
C_LIO_LILLPCs accumulate in the BM PC pool, with mouse age
C_LIO_LILLPCs have unique surfaceome, transcriptome, and BCR clonality
C_LIO_LICXCR4 controls maintenance of PCs and antibody titers
C_LI
]]></description>
<dc:creator>Jing, Z.</dc:creator>
<dc:creator>Galbo, P.</dc:creator>
<dc:creator>Ovando, L.</dc:creator>
<dc:creator>Demouth, M.</dc:creator>
<dc:creator>Welte, S.</dc:creator>
<dc:creator>Park, R.</dc:creator>
<dc:creator>Chandran, K.</dc:creator>
<dc:creator>Wu, Y.</dc:creator>
<dc:creator>MacCarthy, T.</dc:creator>
<dc:creator>Zheng, D.</dc:creator>
<dc:creator>Fooksman, D.</dc:creator>
<dc:date>2023-02-15</dc:date>
<dc:identifier>doi:10.1101/2023.02.15.527913</dc:identifier>
<dc:title><![CDATA[Fine-tuning spatial-temporal dynamics and surface receptor expression support plasma cell-intrinsic longevity]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-02-15</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.02.15.528714v1?rss=1">
<title>
<![CDATA[
Gene body DNA hydroxymethylation restricts the magnitude of transcriptional changes during aging 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.02.15.528714v1?rss=1</link>
<description><![CDATA[
DNA hydroxymethylation (5hmC), the most abundant oxidative derivative of DNA methylation, is typically enriched at enhancers and gene bodies of transcriptionally active and tissue-specific genes. Although aberrant genomic 5hmC has been implicated in age-related diseases, its functional role in aging remains unknown. Here, using mouse liver and cerebellum as model organs, we show that 5hmC accumulates in gene bodies associated with tissue-specific function and restricts the magnitude of gene expression changes with age. Mechanistically, 5hmC decreases the binding of splicing associated factors and correlates with age-related alternative splicing events. We found that various age-related contexts, such as prolonged quiescence and senescence, drive the accumulation of 5hmC with age. We provide evidence that this age-related transcriptionally restrictive function is conserved in mouse and human tissues. Our findings reveal that 5hmC regulates tissue-specific function and may play a role in longevity.
]]></description>
<dc:creator>Occean, J. R.</dc:creator>
<dc:creator>Yang, N.</dc:creator>
<dc:creator>Sun, Y.</dc:creator>
<dc:creator>Dawkins, M. S.</dc:creator>
<dc:creator>Munk, R.</dc:creator>
<dc:creator>Belair, C.</dc:creator>
<dc:creator>Dar, S.</dc:creator>
<dc:creator>Anerillas, C.</dc:creator>
<dc:creator>Wang, L.</dc:creator>
<dc:creator>Shi, C.</dc:creator>
<dc:creator>Dunn, C.</dc:creator>
<dc:creator>Bernier, M.</dc:creator>
<dc:creator>Price, N. L.</dc:creator>
<dc:creator>Kim, J. S.</dc:creator>
<dc:creator>Cui, C.-Y.</dc:creator>
<dc:creator>Fan, J.</dc:creator>
<dc:creator>Bhattacharyya, M.</dc:creator>
<dc:creator>De, S.</dc:creator>
<dc:creator>Maragkakis, M.</dc:creator>
<dc:creator>Cabo, R. d.</dc:creator>
<dc:creator>Sidoli, S.</dc:creator>
<dc:creator>Sen, P.</dc:creator>
<dc:date>2023-02-15</dc:date>
<dc:identifier>doi:10.1101/2023.02.15.528714</dc:identifier>
<dc:title><![CDATA[Gene body DNA hydroxymethylation restricts the magnitude of transcriptional changes during aging]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-02-15</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.02.16.528161v1?rss=1">
<title>
<![CDATA[
Macrophages Promote Tumor Cell Extravasation across an Endothelial Barrier through Thin Membranous Connections 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.02.16.528161v1?rss=1</link>
<description><![CDATA[
Macrophages are important players involved in the progression of breast cancer, including in seeding the metastatic niche. However, the mechanism by which macrophages in the lung parenchyma interact with tumor cells in the vasculature to promote tumor cell extravasation at metastatic sites is not clear. To mimic macrophage-driven tumor cell extravasation, we used an in vitro assay (eTEM) in which an endothelial monolayer and a matrigel-coated filter separated tumor cells and macrophages from each other. The presence of macrophages promoted tumor cell extravasation while macrophage conditioned media was insufficient to stimulate tumor cell extravasation in vitro. This finding is consistent with a requirement for direct contact between macrophages and tumor cells. We observed the presence of Thin Membranous Connections (TMCs) resembling similar structures formed between macrophages and tumor cells called tunneling nanotubes which we previously demonstrated to be important in tumor cell invasion in vitro and in vivo (Hanna 2019). To determine if TMCs are important for tumor cell extravasation, we used macrophages with reduced levels of endogenous M-Sec (TNFAIP2), which causes a defect in tunneling nanotube formation. As predicted, these macrophages showed reduced macrophage-tumor cell TMCs. In both, human and murine breast cancer cell lines, there was also a concomitant reduction in tumor cell extravasation in vitro when co-cultured with M-Sec deficient macrophages compared to control macrophages. We also detected TMCs formed between macrophages and tumor cells through the endothelial layer in the eTEM assay. Furthermore, tumor cells were more frequently found in pores under the endothelium that contain macrophage protrusions. To determine the role of macrophage-tumor cell TMCs in vivo, we generated an M-Sec deficient mouse. Using an in vivo model of experimental metastasis, we detected a significant reduction in the number of metastatic lesions in M-Sec deficient mice compared to wild type mice. There was no difference in the size of the metastases, consistent with a defect specific to tumor cell extravasation and not metastatic outgrowth. Additionally, examination of time-lapse intravital-imaging (IVI) data sets of breast cancer cell extravasation in the lung, we could detect the presence of TMCs between extravascular macrophages and vascular tumor cells. Overall, our data indicate that macrophage TMCs play an important role in promoting the extravasation of circulating tumor cells in the lung.
]]></description>
<dc:creator>Genna, A.</dc:creator>
<dc:creator>Duran, C. L.</dc:creator>
<dc:creator>Entenberg, D.</dc:creator>
<dc:creator>Condeelis, J. S.</dc:creator>
<dc:creator>Cox, D.</dc:creator>
<dc:date>2023-02-16</dc:date>
<dc:identifier>doi:10.1101/2023.02.16.528161</dc:identifier>
<dc:title><![CDATA[Macrophages Promote Tumor Cell Extravasation across an Endothelial Barrier through Thin Membranous Connections]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-02-16</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.02.25.530019v1?rss=1">
<title>
<![CDATA[
Transcription elongation defects link oncogenic splicing factor mutations to targetable alterations in chromatin landscape 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.02.25.530019v1?rss=1</link>
<description><![CDATA[
Transcription and splicing of pre-messenger RNA are closely coordinated, but how this functional coupling is disrupted in human disease remains unexplored. Here, we investigated the impact of non-synonymous mutations in SF3B1 and U2AF1, two splicing factors commonly mutated in cancer, on transcription. We find that the mutations impair RNA Polymerase II (RNAPII) transcription elongation along gene bodies leading to transcription-replication conflicts, replication stress and altered chromatin organization. This elongation defect is linked to disrupted pre-spliceosome assembly due to impaired protein-protein interactions of mutant SF3B1. Through an unbiased screen, we identified epigenetic factors in the Sin3/HDAC complex, which, when modulated, normalize transcription defects and their downstream effects. Our findings shed light on the mechanisms by which oncogenic mutant spliceosomes impact chromatin organization through their effects on RNAPII transcription elongation and present a rationale for targeting the Sin3/HDAC complex as a potential therapeutic strategy.

HIGHLIGHTS- Oncogenic mutations in SF3B1 and U2AF1 cause a gene body RNAPII transcription elongation defect
- The elongation defect is linked to impaired assembly of early spliceosome complexes and leads to replication stress and changes to chromatin landscape
- RNAPII elongation defects in SF3B1K700E are normalized by modulating epigenetic factors but 3 cryptic splicing events are not reversed
- Targeting the Sin3/HDAC pathway to normalize RNAPII elongation defect is a potential therapeutic approach in these disorders


GRAPHICAL ABSTRACT

O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=139 SRC="FIGDIR/small/530019v3_ufig1.gif" ALT="Figure 1">
View larger version (50K):
org.highwire.dtl.DTLVardef@dc6d22org.highwire.dtl.DTLVardef@180f36borg.highwire.dtl.DTLVardef@ed341forg.highwire.dtl.DTLVardef@f8dfb2_HPS_FORMAT_FIGEXP  M_FIG C_FIG
]]></description>
<dc:creator>Boddu, P. C.</dc:creator>
<dc:creator>Gupta, A. K.</dc:creator>
<dc:creator>Roy, R.</dc:creator>
<dc:creator>De La Pena Avalos, B.</dc:creator>
<dc:creator>Olazabal Herrero, A.</dc:creator>
<dc:creator>Neuenkirchen, N.</dc:creator>
<dc:creator>Zimmer, J.</dc:creator>
<dc:creator>Chandhok, N. S.</dc:creator>
<dc:creator>King, D.</dc:creator>
<dc:creator>Nannya, Y.</dc:creator>
<dc:creator>Ogawa, S.</dc:creator>
<dc:creator>Lin, H.</dc:creator>
<dc:creator>Simon, M.</dc:creator>
<dc:creator>Dray, E.</dc:creator>
<dc:creator>Kupfer, G.</dc:creator>
<dc:creator>Verma, A. K.</dc:creator>
<dc:creator>Neugebauer, K. M.</dc:creator>
<dc:creator>Pillai, M. M.</dc:creator>
<dc:date>2023-02-26</dc:date>
<dc:identifier>doi:10.1101/2023.02.25.530019</dc:identifier>
<dc:title><![CDATA[Transcription elongation defects link oncogenic splicing factor mutations to targetable alterations in chromatin landscape]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-02-26</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.02.27.530366v1?rss=1">
<title>
<![CDATA[
Substrate stiffness facilitates improved induced pluripotent stem cell production through modulation of both early and late phases of cell reprogramming 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.02.27.530366v1?rss=1</link>
<description><![CDATA[
Cell reprogramming involves time-intensive, costly processes that ultimately produce low numbers of reprogrammed cells of variable quality. By screening a range of polyacrylamide hydrogels (pAAm gels) of varying stiffness (1 kPA - 1.3 MPa) we found that a gel of medium stiffness significantly increases the overall number of reprogrammed cells by up to ten-fold with accelerated reprogramming kinetics, as compared to the standard Tissue Culture PolyStyrene (TCPS)-based protocol. We observe that though the gel improves both early and late phases of reprogramming, improvement in the late (reprogramming prone population maturation) phase is more pronounced and produces iPSCs having different characteristics and lower remnant transgene expression than those produced on TCPS. Comparative RNA-Seq analyses coupled with experimental validation reveals that modulation of Bone Morphogenic Protein (BMP) signalling by a novel reprogramming regulator, Phactr3, upregulated in the gel at an earliest time-point without the influence of transcription factors used for reprogramming, plays a crucial role in the improvement in the early reprogramming kinetics and overall reprogramming outcomes. This study provides new insights into the mechanism via which substrate stiffness modulates reprogramming kinetics and iPSC quality outcomes, opening new avenues for producing higher numbers of quality iPSCs or other reprogrammed cells at shorter timescales.
]]></description>
<dc:creator>Chowdhury, M. M.</dc:creator>
<dc:creator>Samuel Zimmerman, S.</dc:creator>
<dc:creator>Leeson, H.</dc:creator>
<dc:creator>Nefzger, C.</dc:creator>
<dc:creator>Mar, J. C.</dc:creator>
<dc:creator>Laslett, A.</dc:creator>
<dc:creator>Polo, J. M.</dc:creator>
<dc:creator>Wolvetang, E. J.</dc:creator>
<dc:creator>Cooper-White, J. J.</dc:creator>
<dc:date>2023-03-01</dc:date>
<dc:identifier>doi:10.1101/2023.02.27.530366</dc:identifier>
<dc:title><![CDATA[Substrate stiffness facilitates improved induced pluripotent stem cell production through modulation of both early and late phases of cell reprogramming]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-03-01</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.03.03.531021v1?rss=1">
<title>
<![CDATA[
Delayed formation of neural representations of space in aged mice 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.03.03.531021v1?rss=1</link>
<description><![CDATA[
Aging is associated with cognitive deficits, with spatial memory being very susceptible to decline. The hippocampal dentate gyrus (DG) is important for processing spatial information in the brain and is particularly vulnerable to aging, yet its sparse activity has led to difficulties in assessing changes in this area. Using in vivo two-photon calcium imaging, we compared DG neuronal activity and representations of space in young and aged mice walking on an unfamiliar treadmill. We found that calcium activity was significantly higher and less tuned to location in aged mice, resulting in decreased spatial information encoded in the DG. However, with repeated exposure to the same treadmill, both spatial tuning and information levels in aged mice became similar to young mice, while activity remained elevated. Our results show that spatial representations of novel environments are impaired in the aged hippocampus and gradually improve with increased familiarity. Moreover, while the aged DG is hyperexcitable, this does not disrupt neural representations of familiar environments.
]]></description>
<dc:creator>McDermott, K. D.</dc:creator>
<dc:creator>Frechou, M. A.</dc:creator>
<dc:creator>Jordan, J. T.</dc:creator>
<dc:creator>Martin, S. S.</dc:creator>
<dc:creator>Goncalves, J. T.</dc:creator>
<dc:date>2023-03-06</dc:date>
<dc:identifier>doi:10.1101/2023.03.03.531021</dc:identifier>
<dc:title><![CDATA[Delayed formation of neural representations of space in aged mice]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-03-06</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.03.07.531569v1?rss=1">
<title>
<![CDATA[
Dynamic network-guided CRISPRi screen reveals CTCF loop-constrained nonlinear enhancer-gene regulatory activity in cell state transitions 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.03.07.531569v1?rss=1</link>
<description><![CDATA[
Comprehensive enhancer discovery is challenging because most enhancers, especially those affected in complex diseases, have weak effects on gene expression. Our network modeling revealed that nonlinear enhancer-gene regulation during cell state transitions can be leveraged to improve the sensitivity of enhancer discovery. Utilizing hESC definitive endoderm differentiation as a dynamic transition system, we conducted a mid-transition CRISPRi-based enhancer screen. The screen discovered a comprehensive set of enhancers (4 to 9 per locus) for each of the core endoderm lineage-specifying transcription factors, and many enhancers had strong effects mid-transition but weak effects post-transition. Through integrating enhancer activity measurements and three-dimensional enhancer-promoter interaction information, we were able to develop a CTCF loop-constrained Interaction Activity (CIA) model that can better predict functional enhancers compared to models that rely on Hi-C-based enhancer-promoter contact frequency. Our study provides generalizable strategies for sensitive and more comprehensive enhancer discovery in both normal and pathological cell state transitions.
]]></description>
<dc:creator>Luo, R.</dc:creator>
<dc:creator>Yan, J.</dc:creator>
<dc:creator>Oh, J. W.</dc:creator>
<dc:creator>Xi, W.</dc:creator>
<dc:creator>Shigaki, D.</dc:creator>
<dc:creator>Wong, W.</dc:creator>
<dc:creator>Cho, H.</dc:creator>
<dc:creator>Murphy, D.</dc:creator>
<dc:creator>Cutler, R.</dc:creator>
<dc:creator>Rosen, B. P.</dc:creator>
<dc:creator>Pulecio, J.</dc:creator>
<dc:creator>Yang, D.</dc:creator>
<dc:creator>Glenn, R.</dc:creator>
<dc:creator>Chen, T.</dc:creator>
<dc:creator>Li, Q. V.</dc:creator>
<dc:creator>Vierbuchen, T.</dc:creator>
<dc:creator>Sidoli, S.</dc:creator>
<dc:creator>Apostolou, E.</dc:creator>
<dc:creator>Huangfu, D.</dc:creator>
<dc:creator>Beer, M. A.</dc:creator>
<dc:date>2023-03-09</dc:date>
<dc:identifier>doi:10.1101/2023.03.07.531569</dc:identifier>
<dc:title><![CDATA[Dynamic network-guided CRISPRi screen reveals CTCF loop-constrained nonlinear enhancer-gene regulatory activity in cell state transitions]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-03-09</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.03.15.532613v1?rss=1">
<title>
<![CDATA[
Regulation of FMRP granule structure and function through phosphorylation 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.03.15.532613v1?rss=1</link>
<description><![CDATA[
Fragile X messenger ribonucleoprotein (FMRP) is an RNA-binding protein implicated in autism that suppresses translation and forms granules. While FMRP function has been well-studied, how phosphorylation regulates granule binding and function remains limited. Here, we found that Fragile X patient-derived I304N mutant FMRP could not stably bind granules, underscoring the essential nature of FMRP granule association for function. Next, phosphorylation on serine 499 (S499) led to differences in puncta size, intensity, contrast, and transport as shown by phospho-deficient (S499A) and phospho-mimic (S499D) mutant FMRP granules. Additionally, S499D exchanged slowly on granules relative to S499A, suggesting that phosphorylated FMRP can attenuate translation. Furthermore, the S499A mutant enhanced translation in presynaptic boutons of the mouse hippocampus. Thus, the phospho-state of FMRP altered the structure of individual granules with changes in transport and translation to achieve spatiotemporal regulation of local protein synthesis.

TeaserThe phosphorylation-state of S499 on FMRP can change FMRP granule structure and function to facilitate processive transport or local protein synthesis.
]]></description>
<dc:creator>Kharod, S. C.</dc:creator>
<dc:creator>Hwang, D.</dc:creator>
<dc:creator>Castillo, P. E.</dc:creator>
<dc:creator>Yoon, Y. J.</dc:creator>
<dc:date>2023-03-15</dc:date>
<dc:identifier>doi:10.1101/2023.03.15.532613</dc:identifier>
<dc:title><![CDATA[Regulation of FMRP granule structure and function through phosphorylation]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-03-15</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.03.18.533278v1?rss=1">
<title>
<![CDATA[
Host genetic variation guides hepacivirus clearance, chronicity, and liver fibrosis in mice 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.03.18.533278v1?rss=1</link>
<description><![CDATA[
Background & AimsHuman genetic variation is thought to guide the outcome of hepatitis C virus (HCV) infection but model systems within which to dissect these host genetic mechanisms are limited. Norway rat hepacivirus (NrHV), closely related to HCV, causes chronic liver infection in rats but causes acute self-limiting hepatitis in typical strains of laboratory mice, which resolves in two weeks. The Collaborative Cross (CC) is a robust mouse genetics resource comprised of a panel of recombinant inbred strains, which model the complexity of the human genome and provide a system within which to understand diseases driven by complex allelic variation.

Approach & ResultsWe infected a panel of CC strains with NrHV and identified several that failed to clear virus after 4 weeks. Strains displayed an array of virologic phenotypes ranging from delayed clearance (CC046) to chronicity (CC071, CC080) with viremia for at least 10 months. Body weight loss, hepatocyte infection frequency, viral evolution, T-cell recruitment to the liver, liver inflammation and the capacity to develop liver fibrosis varied among infected CC strains.

ConclusionsThese models recapitulate many aspects of HCV infection in humans and demonstrate that host genetic variation affects a multitude of virus and host phenotypes. These models can be used to better understand the molecular mechanisms that drive hepacivirus clearance and chronicity, the virus and host interactions that promote chronic disease manifestations like liver fibrosis, therapeutic and vaccine performance, and how these factors are affected by host genetic variation.
]]></description>
<dc:creator>Brown, A. J.</dc:creator>
<dc:creator>Won, J.</dc:creator>
<dc:creator>Wolfisberg, R.</dc:creator>
<dc:creator>Fanhoe, U.</dc:creator>
<dc:creator>Catanzaro, N.</dc:creator>
<dc:creator>West, A.</dc:creator>
<dc:creator>Moreira, F.</dc:creator>
<dc:creator>Nogeuira Batista, M.</dc:creator>
<dc:creator>Ferris, M. T.</dc:creator>
<dc:creator>Linnertz, C.</dc:creator>
<dc:creator>Leist, S. R.</dc:creator>
<dc:creator>Nguyen, C.</dc:creator>
<dc:creator>De la Cruz, G.</dc:creator>
<dc:creator>Midkiff, B.</dc:creator>
<dc:creator>Xia, Y.</dc:creator>
<dc:creator>Montgomery, S. A.</dc:creator>
<dc:creator>Billerbeck, E.</dc:creator>
<dc:creator>Bukh, J.</dc:creator>
<dc:creator>Scheel, T.</dc:creator>
<dc:creator>Rice, C. M.</dc:creator>
<dc:creator>Sheahan, T. P.</dc:creator>
<dc:date>2023-03-19</dc:date>
<dc:identifier>doi:10.1101/2023.03.18.533278</dc:identifier>
<dc:title><![CDATA[Host genetic variation guides hepacivirus clearance, chronicity, and liver fibrosis in mice]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-03-19</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.03.20.530986v1?rss=1">
<title>
<![CDATA[
Structural basis for functional properties of cytochrome c oxidase 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.03.20.530986v1?rss=1</link>
<description><![CDATA[
Cytochrome c oxidase (CcO) is an essential enzyme in mitochondrial and bacterial respiration. It catalyzes the four-electron reduction of molecular oxygen to water and harnesses the chemical energy to translocate four protons across biological membranes, thereby establishing the proton gradient required for ATP synthesis1. The full turnover of the CcO reaction involves an oxidative phase, in which the reduced enzyme (R) is oxidized by molecular oxygen to the metastable oxidized OH state, and a reductive phase, in which OH is reduced back to the R state. During each of the two phases, two protons are translocated across the membranes2. However, if OH is allowed to relax to the resting oxidized state (O), a redox equivalent to OH, its subsequent reduction to R is incapable of driving proton translocation2,3. How the O state structurally differs from OH remains an enigma in modern bioenergetics. Here, with resonance Raman spectroscopy and serial femtosecond X-ray crystallography (SFX)4, we show that the heme a3 iron and CuB in the active site of the O state, like those in the OH state5,6, are coordinated by a hydroxide ion and a water molecule, respectively. However, Y244, a residue covalently linked to one of the three CuB ligands and critical for the oxygen reduction chemistry, is in the neutral protonated form, which distinguishes O from OH, where Y244 is in the deprotonated tyrosinate form. These structural characteristics of O provide new insights into the proton translocation mechanism of CcO.
]]></description>
<dc:creator>Ishigami, I.</dc:creator>
<dc:creator>Sierra, R. G.</dc:creator>
<dc:creator>Su, Z.</dc:creator>
<dc:creator>Peck, A.</dc:creator>
<dc:creator>Wang, C.</dc:creator>
<dc:creator>Poitevin, F.</dc:creator>
<dc:creator>Lisova, S.</dc:creator>
<dc:creator>Hayes, B.</dc:creator>
<dc:creator>Moss, F. R.</dc:creator>
<dc:creator>Boutet, S.</dc:creator>
<dc:creator>Sublett, R. E.</dc:creator>
<dc:creator>Yoon, C. H.</dc:creator>
<dc:creator>Yeh, S.-R.</dc:creator>
<dc:creator>Rousseau, D. L.</dc:creator>
<dc:date>2023-03-22</dc:date>
<dc:identifier>doi:10.1101/2023.03.20.530986</dc:identifier>
<dc:title><![CDATA[Structural basis for functional properties of cytochrome c oxidase]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-03-22</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.03.23.533915v1?rss=1">
<title>
<![CDATA[
Mind of a dauer: Comparative connectomics reveals developmental plasticity 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.03.23.533915v1?rss=1</link>
<description><![CDATA[
A fundamental question in neurodevelopmental biology is how flexibly the nervous system changes during development. To address this, we reconstructed the complete connectome of dauer, an alternative developmental stage of nematodes with distinct behavioral characteristics, by volumetric reconstruction and automated synapse detection using deep learning. With the basic architecture of the nervous system preserved, structural changes in neurons, large or small, were closely associated with connectivity changes, which in turn evoked dauer-specific behaviors such as nictation. Graph theoretical analyses revealed significant dauer-specific rewiring of sensory neuron connectivity and increased clustering within motor neurons in the dauer connectome. We suggest that the nervous system in the nematode, probably animals in general, has evolved to respond to harsh environments by reversibly developing a quantitatively and qualitatively differentiated connectome.
]]></description>
<dc:creator>Yim, H.</dc:creator>
<dc:creator>Choe, D. T.</dc:creator>
<dc:creator>Bae, J. A.</dc:creator>
<dc:creator>Kang, H.-M.</dc:creator>
<dc:creator>Nguyen, K. C. Q.</dc:creator>
<dc:creator>Choi, M.-k.</dc:creator>
<dc:creator>Ahn, S.</dc:creator>
<dc:creator>Bahn, S.-k.</dc:creator>
<dc:creator>Yang, H.</dc:creator>
<dc:creator>Hall, D. H.</dc:creator>
<dc:creator>Kim, J. S.</dc:creator>
<dc:creator>Lee, J.</dc:creator>
<dc:date>2023-03-23</dc:date>
<dc:identifier>doi:10.1101/2023.03.23.533915</dc:identifier>
<dc:title><![CDATA[Mind of a dauer: Comparative connectomics reveals developmental plasticity]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-03-23</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.03.22.533827v1?rss=1">
<title>
<![CDATA[
Self-formation of concentric zones of telencephalic and ocular tissues and directional retinal ganglion cell axons 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.03.22.533827v1?rss=1</link>
<description><![CDATA[
The telencephalon and eye in mammals are originated from adjacent fields at the anterior neural plate. Morphogenesis of these fields generates telencephalon, optic-stalk, optic-disc, and neuroretina along a spatial axis. How these telencephalic and ocular tissues are specified coordinately to ensure directional retinal ganglion cell (RGC) axon growth is unclear. Here, we report the self-formation of human telencephalon-eye organoids comprising concentric zones of telencephalic, optic-stalk, optic-disc, and neuroretinal tissues along the center-periphery axis. Initially-differentiated RGCs grew axons towards and then along a path defined by adjacent PAX2+ optic-disc cells. Single-cell RNA sequencing of CONCEPT organoids not only confirmed telencephalic and ocular identities but also identified expression signatures of early optic-disc, optic-stalk, and RGCs. These signatures were similar to those in human fetal retinas. Optic-disc cells in CONCEPT organoids differentially expressed FGF8 and FGF9; FGFR inhibitions drastically decreased RGC differentiation and directional axon growth. Through the identified RGC-specific cell-surface marker CNTN2, electrophysiologically-excitable RGCs were isolated under a native condition. Our findings provide insight into the coordinated specification of early telencephalic and ocular tissues in humans and establish resources for studying RGC-related diseases such as glaucoma.

Impact statementA human telencephalon-eye organoid model that exhibited axon growth and pathfinding from retinal ganglion cell (RGC) axons is reported; via cell surface marker CNTN2 identified using scRNA-seq, early RGCs were isolated under a native condition.
]]></description>
<dc:creator>Liu, W.</dc:creator>
<dc:creator>Shrestha, R.</dc:creator>
<dc:creator>Lowe, A.</dc:creator>
<dc:creator>Zhang, X.</dc:creator>
<dc:creator>Spaeth, L.</dc:creator>
<dc:date>2023-03-24</dc:date>
<dc:identifier>doi:10.1101/2023.03.22.533827</dc:identifier>
<dc:title><![CDATA[Self-formation of concentric zones of telencephalic and ocular tissues and directional retinal ganglion cell axons]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-03-24</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.03.26.534293v1?rss=1">
<title>
<![CDATA[
A local ATR-dependent checkpoint pathway is activated by a site-specific replication fork block in human cells 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.03.26.534293v1?rss=1</link>
<description><![CDATA[
When replication forks encounter DNA lesions that cause polymerase stalling a checkpoint pathway is activated. The ATR-dependent intra-S checkpoint pathway mediates detection and processing of sites of replication fork stalling to maintain genomic integrity. Several factors involved in the global checkpoint pathway have been identified, but the response to a single replication fork barrier (RFB) is poorly understood. We utilized the E.coli-based Tus-Ter system in human MCF7 cells and showed that the Tus protein binding to TerB sequences creates an efficient site-specific RFB. The single fork RFB was sufficient to activate a local, but not global, ATR-dependent checkpoint response that leads to phosphorylation and accumulation of DNA damage sensor protein {gamma}H2AX, confined locally to within a kilobase of the site of stalling. These data support a model of local management of fork stalling, which allows global replication at sites other than the RFB to continue to progress without delay.
]]></description>
<dc:creator>Ahmed-Seghir, S.</dc:creator>
<dc:creator>Jalan, M.</dc:creator>
<dc:creator>Grimsley, H. E.</dc:creator>
<dc:creator>Sharma, A.</dc:creator>
<dc:creator>Twayana, S.</dc:creator>
<dc:creator>Kosiyatrakul, S. T.</dc:creator>
<dc:creator>Thompson, C.</dc:creator>
<dc:creator>Schildkraut, C. L.</dc:creator>
<dc:creator>Powell, S. N.</dc:creator>
<dc:date>2023-03-26</dc:date>
<dc:identifier>doi:10.1101/2023.03.26.534293</dc:identifier>
<dc:title><![CDATA[A local ATR-dependent checkpoint pathway is activated by a site-specific replication fork block in human cells]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-03-26</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.03.31.535145v1?rss=1">
<title>
<![CDATA[
Response inhibition and error-monitoring in cystinosis (CTNS gene mutations): Behavioral and electrophysiological evidence of a diverse set of difficulties 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.03.31.535145v1?rss=1</link>
<description><![CDATA[
Cystinosis, a rare lysosomal storage disease, is characterized by cystine crystallization and accumulation within tissues and organs, including the kidneys and brain. Its impact on neural function appears mild relative to its effects on other organs, but therapeutic advances have led to substantially increased life expectancy, necessitating deeper understanding of its impact on neurocognitive function. Behaviorally, some deficits in executive function have been noted in this population, but the underlying neural processes are not understood. Using standardized cognitive assessments and a Go/No-Go response inhibition task in conjunction with high-density electrophysiological recordings (EEG), we sought to investigate the behavioral and neural dynamics of inhibition of a prepotent response and of error monitoring (critical components of executive function) in individuals with cystinosis, when compared to age-matched controls. Thirty-seven individuals diagnosed with cystinosis (7-36 years old, 24 women) and 45 age-matched controls (27 women) participated in this study. Analyses focused on N2 and P3 No-Go responses and error-related positivity (Pe). Atypical inhibitory processing was shown behaviorally. Electrophysiological differences were additionally found between the groups, with individuals with cystinosis showing larger No-Go P3s. Error-monitoring was likewise different between the groups, with those with cystinosis showing reduced Pe amplitudes.
]]></description>
<dc:creator>Francisco, A. A.</dc:creator>
<dc:creator>Foxe, J. J.</dc:creator>
<dc:creator>Berruti, A.</dc:creator>
<dc:creator>Horsthuis, D. J.</dc:creator>
<dc:creator>Molholm, S.</dc:creator>
<dc:date>2023-04-02</dc:date>
<dc:identifier>doi:10.1101/2023.03.31.535145</dc:identifier>
<dc:title><![CDATA[Response inhibition and error-monitoring in cystinosis (CTNS gene mutations): Behavioral and electrophysiological evidence of a diverse set of difficulties]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-04-02</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.03.31.535154v1?rss=1">
<title>
<![CDATA[
Event-related potential (ERP) evidence of early visual processing differences in cystinosis 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.03.31.535154v1?rss=1</link>
<description><![CDATA[
Cystinosis, a rare lysosomal storage disease, is characterized by cystine crystallization and accumulation within tissues and organs, including the kidneys and brain. Its impact on neural function appears mild relative to its effects on other organs, but therapeutic advances have led to substantially increased life expectancy, necessitating deeper understanding of its impact on neurocognitive function.

Behavioral difficulties have been reported in cystinosis in the visual and visual-processing domain. Very little is known, however, about how the brains of people living with cystinosis process visual information, although cysteamine accumulation in the retina is a prominent feature of cystinosis. Here, electrophysiology was recorded during a Go/No-Go task to investigate early visual processing in cystinosis, compared to an age-matched control group. Analyses focused on early stages of cortical visual processing.

The groups differed in their initial cortical response, with individuals with cystinosis exhibiting a significantly larger visual evoked potential (VEP) in the 130 to 150 ms time window. The timing and topography of this response suggested an enhanced P1 in cystinosis that could be the result of cortical hyperexcitability and/or differences in attentional engagement and explain, at least partially, the visual and visual-spatial difficulties described in this population. The groups also differed in the associations between neural responses and verbal abilities: While controls with higher IQ scores presented larger neural responses, that relationship was not observed in cystinosis.
]]></description>
<dc:creator>Horsthuis, D. J.</dc:creator>
<dc:creator>Molholm, S.</dc:creator>
<dc:creator>Foxe, J. J.</dc:creator>
<dc:creator>Francisco, A. A.</dc:creator>
<dc:date>2023-04-02</dc:date>
<dc:identifier>doi:10.1101/2023.03.31.535154</dc:identifier>
<dc:title><![CDATA[Event-related potential (ERP) evidence of early visual processing differences in cystinosis]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-04-02</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.03.29.534846v1?rss=1">
<title>
<![CDATA[
Novel non hot spot modification in Fks1 of Candida auris confers echinocandin resistance 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.03.29.534846v1?rss=1</link>
<description><![CDATA[
We determined echinocandin susceptibility and FKS1 genotypes of thirteen clinical isolates of Candida auris recovered from four patients at a tertiary care center in Salvador, Brazil. Three isolates were categorized as echinocandin-resistant and harbored a novel FKS1 mutation leading to an amino acid change W691L located downstream from hot-spot 1. When introduced to echinocandin-susceptible C. auris strains by CRISPR/Cas9, Fks1 W691L induced elevated MIC values to all echinocandins (ANF 16-32x; CAS >64x; MCF >64x).
]]></description>
<dc:creator>Kordalewska, M.</dc:creator>
<dc:creator>Cancino-Prado, G.</dc:creator>
<dc:creator>Nobrega de Almeida, J.</dc:creator>
<dc:creator>Brasil Brandao, I.</dc:creator>
<dc:creator>Tigulini de Souza Peral, R.</dc:creator>
<dc:creator>Lopes Colombo, A.</dc:creator>
<dc:creator>Perlin, D. S.</dc:creator>
<dc:date>2023-04-03</dc:date>
<dc:identifier>doi:10.1101/2023.03.29.534846</dc:identifier>
<dc:title><![CDATA[Novel non hot spot modification in Fks1 of Candida auris confers echinocandin resistance]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-04-03</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.04.03.535418v1?rss=1">
<title>
<![CDATA[
The role of microglial LRRK2 in manganese-induced inflammatory neurotoxicity via NLRP3 inflammasome and RAB10-mediated autophagy dysfunction 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.04.03.535418v1?rss=1</link>
<description><![CDATA[
Chronic exposure to manganese (Mn) can lead to manganism, a neurological disorder sharing common symptoms with Parkinsons disease (PD). Studies have shown that Mn can increase the expression and activity of leucine-rich repeat kinase 2 (LRRK2), leading to inflammation and toxicity in microglia. LRRK2 G2019S mutation also elevates LRRK2 kinase activity. Thus, we tested if Mn-increased microglial LRRK2 kinase is responsible for Mn-induced toxicity, and exacerbated by G2019S mutation, using WT and LRRK2 G2019S knock-in mice, and BV2 microglia. Mn (30 mg/kg, nostril instillation, daily for 3 weeks) caused motor deficits, cognitive impairments, and dopaminergic dysfunction in WT mice, which were exacerbated in G2019S mice. Mn induced proapoptotic Bax, NLRP3 inflammasome, IL-1{beta} and TNF- in the striatum and midbrain of WT mice, and these effects were exacerbated in G2019S mice. BV2 microglia were transfected with human LRRK2 WT or G2019S, followed by Mn (250 M) exposure to better characterize its mechanistic action. Mn increased TNF-, IL-1{beta}, and NLRP3 inflammasome activation in BV2 cells expressing WT LRRK2, which was exacerbated in G2019S-expressing cells, while pharmacological inhibition of LRRK2 mitigated these effects in both genotypes. Moreover, the media from Mn-treated BV2 microglia expressing G2019S caused greater toxicity to cath.a-differentiated (CAD) neuronal cells compared to media from microglia expressing WT. Mn-LRRK2 activated RAB10, which was exacerbated in G2019S. RAB10 played a critical role in LRRK2-mediated Mn toxicity by dysregulating the autophagy-lysosome pathway, and NLRP3 inflammasome in microglia. Our novel findings suggest that microglial LRRK2 via RAB10 plays a critical role in Mn-induced neuroinflammation.
]]></description>
<dc:creator>Pajarillo, E.</dc:creator>
<dc:creator>Kim, S.</dc:creator>
<dc:creator>Digman, A.</dc:creator>
<dc:creator>Dutton, M.</dc:creator>
<dc:creator>Son, D.-S.</dc:creator>
<dc:creator>Aschner, M.</dc:creator>
<dc:creator>Lee, E.</dc:creator>
<dc:date>2023-04-04</dc:date>
<dc:identifier>doi:10.1101/2023.04.03.535418</dc:identifier>
<dc:title><![CDATA[The role of microglial LRRK2 in manganese-induced inflammatory neurotoxicity via NLRP3 inflammasome and RAB10-mediated autophagy dysfunction]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-04-04</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.04.06.535398v1?rss=1">
<title>
<![CDATA[
Histone Deacetylases (HDACs) maintain expression of the pluripotent gene network via recruitment of RNA polymerase II to coding and non-coding loci 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.04.06.535398v1?rss=1</link>
<description><![CDATA[
Histone acetylation is a dynamic modification regulated by the opposing actions of histone acetyltransferases (HATs) and histone deacetylases (HDACs). Deacetylation of histone tails results in chromatin tightening and therefore HDACs are generally regarded as transcriptional repressors. Counterintuitively, simultaneous deletion of Hdac1 and Hdac2 in embryonic stem cells (ESC) reduced expression of pluripotent transcription factors, Oct4, Sox2 and Nanog (OSN). By shaping global histone acetylation patterns, HDACs indirectly regulate the activity of acetyl-lysine readers, such as the transcriptional activator, BRD4. We used inhibitors of HDACs and BRD4 (LBH589 and JQ1 respectively) in combination with precision nuclear run-on and sequencing (PRO-seq) to examine their roles in defining the ESC transcriptome. Both LBH589 and JQ1 caused a marked reduction in the pluripotent network. However, while JQ1 treatment induced widespread transcriptional pausing, HDAC inhibition caused a reduction in both paused and elongating polymerase, suggesting an overall reduction in polymerase recruitment. Using enhancer RNA (eRNA) expression to measure enhancer activity we found that LBH589-sensitive eRNAs were preferentially associated with super-enhancers and OSN binding sites. These findings suggest that HDAC activity is required to maintain pluripotency by regulating the OSN enhancer network via the recruitment of RNA polymerase II.
]]></description>
<dc:creator>Kelly, R.</dc:creator>
<dc:creator>Stengel, K.</dc:creator>
<dc:creator>Chandru, A.</dc:creator>
<dc:creator>Johnson, L.</dc:creator>
<dc:creator>Hiebert, S. W.</dc:creator>
<dc:creator>Cowley, S. M.</dc:creator>
<dc:date>2023-04-06</dc:date>
<dc:identifier>doi:10.1101/2023.04.06.535398</dc:identifier>
<dc:title><![CDATA[Histone Deacetylases (HDACs) maintain expression of the pluripotent gene network via recruitment of RNA polymerase II to coding and non-coding loci]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-04-06</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.04.06.535886v1?rss=1">
<title>
<![CDATA[
StocSum: stochastic summary statistics for whole genome sequencing studies 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.04.06.535886v1?rss=1</link>
<description><![CDATA[
Genomic summary statistics, usually defined as single-variant test results from genome-wide association studies, have been widely used to advance the genetics field in a wide range of applications. Applications that involve multiple genetic variants also require their correlations or linkage disequilibrium (LD) information, often obtained from an external reference panel. In practice, it is usually difficult to find suitable external reference panels that represent the LD structure for underrepresented and admixed populations, or rare genetic variants from whole genome sequencing (WGS) studies, limiting the scope of applications for genomic summary statistics. Here we introduce StocSum, a novel reference-panel-free statistical framework for generating, managing, and analyzing stochastic summary statistics using random vectors. We develop various downstream applications using StocSum including single-variant tests, conditional association tests, gene-environment interaction tests, variant set tests, as well as meta-analysis and LD score regression tools. We demonstrate the accuracy and computational efficiency of StocSum using two cohorts from the Trans-Omics for Precision Medicine Program. StocSum will facilitate sharing and utilization of genomic summary statistics from WGS studies, especially for underrepresented and admixed populations.
]]></description>
<dc:creator>Wang, N.</dc:creator>
<dc:creator>Yu, B.</dc:creator>
<dc:creator>Jun, G.</dc:creator>
<dc:creator>Qi, Q.</dc:creator>
<dc:creator>Durazo-Arvizu, R. A.</dc:creator>
<dc:creator>Lindstroem, S.</dc:creator>
<dc:creator>Morrison, A.</dc:creator>
<dc:creator>Kaplan, R. C.</dc:creator>
<dc:creator>Boerwinkle, E.</dc:creator>
<dc:creator>Chen, H.</dc:creator>
<dc:date>2023-04-06</dc:date>
<dc:identifier>doi:10.1101/2023.04.06.535886</dc:identifier>
<dc:title><![CDATA[StocSum: stochastic summary statistics for whole genome sequencing studies]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-04-06</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.04.12.536581v1?rss=1">
<title>
<![CDATA[
Engineering GliaTrap: a biodegradable non-swelling hydrogel with tuned release of CXCL12 to attract migrating glioblastoma cells 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.04.12.536581v1?rss=1</link>
<description><![CDATA[
Glioblastoma is the most aggressive type of brain cancer with an average overall survival of 15-21 months after first diagnosis. The relapse is mainly caused by migrating glioblastoma cells that diffuse away from the tumor mass into the brain parenchyma and retain cancer stem cell (GSC) properties. Current therapeutic options are ineffective and inevitably result in relapse, indicating a high unmet medical need for innovative therapies in the treatment of invasive glioblastoma. To address this challenge, we propose a new therapeutic modality: GliaTrap, a biodegradable non-swelling, injectable hydrogel with sustained release of a chemoattractant for GSCs that lures and traps the migrating cells back to the tumor resection cavity. We developed a biodegradable and injectable hyaluronan/collagen II-based (HA/Col) hydrogel that does not swell in vivo. The hydrogel is embedded with CXCL12 loaded liposomes and is tuned for sustained release of CXCL12. The safety profile of liposome-embedded HA/Col hydrogel was determined in-vivo after stereotactic implantation in the mouse brain. The efficacy of GliaTrap to attract GSCs was determined ex vivo using a 3D tumor spheroid model and in-vivo using 3D light-sheet microscopy in orthotopic human glioblastoma xenografts. Our findings suggest that GliaTrap could represent a safe and efficacious new therapeutic approach for glioblastoma and potentially serve as a drug delivery platform to locally deliver tumor-killing agents.

One Sentence SummaryGliaTrap is a biodegradable non-swelling hydrogel with tuned release of a chemoattractant to attract invading glioma cells and serve as delivery platform for local therapeutics.
]]></description>
<dc:creator>Suita, Y.</dc:creator>
<dc:creator>Miriyala, S.</dc:creator>
<dc:creator>Merih-Toruner, D.</dc:creator>
<dc:creator>Yue, W.</dc:creator>
<dc:creator>Xie, L.</dc:creator>
<dc:creator>Akobundu, B.</dc:creator>
<dc:creator>Perch, N.</dc:creator>
<dc:creator>Fiser, A.</dc:creator>
<dc:creator>Fajardo, E.</dc:creator>
<dc:creator>Shen, J.</dc:creator>
<dc:creator>Tapinos, N.</dc:creator>
<dc:date>2023-04-13</dc:date>
<dc:identifier>doi:10.1101/2023.04.12.536581</dc:identifier>
<dc:title><![CDATA[Engineering GliaTrap: a biodegradable non-swelling hydrogel with tuned release of CXCL12 to attract migrating glioblastoma cells]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-04-13</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.04.12.536671v1?rss=1">
<title>
<![CDATA[
SARS-CoV-2 selectively induces the expression of unproductive splicing isoforms of interferon, class I MHC and splicing machinery genes 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.04.12.536671v1?rss=1</link>
<description><![CDATA[
Splicing is a highly conserved, intricate mechanism intimately linked to transcription elongation, serving as a pivotal regulator of gene expression. Alternative splicing may generate specific transcripts incapable of undergoing translation into proteins, designated as unproductive. A plethora of respiratory viruses, including Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), strategically manipulate the hosts splicing machinery to circumvent antiviral responses. During the infection, SARS-CoV-2 effectively suppresses interferon (IFN) expression, leading to B cell and CD8+ T cell leukopenia, while simultaneously increasing the presence of macrophages and neutrophils in patients with severe COVID-19. In this study, we integrated publicly available omics datasets to systematically analyze transcripts at the isoform level and delineate the nascent-peptide translatome landscapes of SARS-CoV-2-infected human cells. Our findings reveal a hitherto uncharacterized mechanism whereby SARS-CoV-2 infection induces the predominant expression of unproductive splicing isoforms in key IFN signaling genes, interferon-stimulated genes (ISGs), class I MHC genes, and splicing machinery genes, including IRF7, OAS3, HLA-B, and HNRNPH1. In stark contrast, cytokine and chemokine genes, such as IL6, CXCL8, and TNF, predominantly express productive (protein-coding) splicing isoforms in response to SARS-CoV-2 infection. We postulate that SARS-CoV-2 employs a previously unreported tactic of exploiting the host splicing machinery to bolster viral replication and subvert the immune response by selectively upregulating unproductive splicing isoforms from antigen presentation and antiviral response genes. Our study sheds new light on the molecular interplay between SARS-CoV-2 and the host immune system, offering a foundation for the development of novel therapeutic strategies to combat COVID-19.
]]></description>
<dc:creator>Lüscher Dias, T.</dc:creator>
<dc:creator>Mamede Costa Andrade da Conceicao, I.</dc:creator>
<dc:creator>Toledo, N. E.</dc:creator>
<dc:creator>Queiroz, L. R.</dc:creator>
<dc:creator>de Castro, I. M. S.</dc:creator>
<dc:creator>Polidoro, R. B.</dc:creator>
<dc:creator>Del-Bem, L.-E.</dc:creator>
<dc:creator>Nakaya, H.</dc:creator>
<dc:creator>Franco, G. R.</dc:creator>
<dc:date>2023-04-13</dc:date>
<dc:identifier>doi:10.1101/2023.04.12.536671</dc:identifier>
<dc:title><![CDATA[SARS-CoV-2 selectively induces the expression of unproductive splicing isoforms of interferon, class I MHC and splicing machinery genes]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-04-13</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.04.14.536788v1?rss=1">
<title>
<![CDATA[
EOGT Enables Residual Notch Signaling in Mouse Intestinal Cells Lacking POFUT1 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.04.14.536788v1?rss=1</link>
<description><![CDATA[
Notch signaling determines cell fates in mouse intestine. Notch receptors contain multiple epidermal growth factor-like (EGF) repeats modified by O-glycans that regulate Notch signaling. Conditional deletion of protein O-fucosyltransferase 1 (Pofut1) substantially reduces Notch signaling and markedly perturbs lineage development in mouse intestine. However, mice with inactivated Pofut1 are viable, whereas complete elimination of Notch signaling in intestine is lethal. Here we investigate whether residual Notch signaling enabled by EOGT permits mice lacking Pofut1 in intestine to survive. Mice globally lacking Eogt alone were grossly unaffected in intestinal development. In contrast, mice lacking both Eogt and Pofut1 died at [~]28 days after birth with greater loss of body weight, a greater increase in the numbers of goblet and Paneth cells, and greater downregulation of Notch target genes, compared to Pofut1 deletion alone. These data establish that both O-fucose and O-GlcNAc glycans are fundamental to Notch signaling in the intestine and provide new insights into roles for O-glycans in regulating Notch ligand binding. Finally, EOGT and O-GlcNAc glycans provide residual Notch signaling and support viability in mice lacking Pofut1 in the intestine.
]]></description>
<dc:creator>Nauman, M.</dc:creator>
<dc:creator>Varshney, S.</dc:creator>
<dc:creator>Choi, J.</dc:creator>
<dc:creator>Augenlicht, L. H.</dc:creator>
<dc:creator>Stanley, P.</dc:creator>
<dc:date>2023-04-14</dc:date>
<dc:identifier>doi:10.1101/2023.04.14.536788</dc:identifier>
<dc:title><![CDATA[EOGT Enables Residual Notch Signaling in Mouse Intestinal Cells Lacking POFUT1]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-04-14</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.04.14.536984v1?rss=1">
<title>
<![CDATA[
Early-life stress and ovarian hormones alter transcriptional regulation in the nucleus accumbens resulting in sex-specific responses to cocaine 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.04.14.536984v1?rss=1</link>
<description><![CDATA[
Early-life stress and ovarian hormones contribute to increased female vulnerability to cocaine addiction. Here we reveal molecular substrates in the key reward area, the nucleus accumbens, through which these female-specific factors affect immediate and conditioning responses to cocaine in mice. We find shared involvement of X chromosome and estrogen signaling gene regulation in enhanced conditioning responses seen after early-life stress and during the low-estrogenic state in females. During the low-estrogenic state, females respond to acute cocaine exposure by increasing the accessibility of neuronal chromatin enriched for the binding sites of {Delta}FosB, a transcription factor implicated in chronic cocaine response and addiction. Conversely, high-estrogenic females respond to cocaine by preferential closing of neuronal chromatin, providing a mechanism for limiting cocaine-driven chromatin and synaptic plasticity. We find that physiological estrogen withdrawal, exposure to early-life stress, and absence of the second X chromosome all nullify the protective effect of high-estrogenic state on cocaine conditioning in females. Our findings offer a molecular framework to understand sex-specific neuronal mechanisms underlying cocaine use disorder.
]]></description>
<dc:creator>Rocks, D.</dc:creator>
<dc:creator>Jaric, I.</dc:creator>
<dc:creator>Bellia, F.</dc:creator>
<dc:creator>Cham, H.</dc:creator>
<dc:creator>Greally, J. M.</dc:creator>
<dc:creator>Suzuki, M.</dc:creator>
<dc:creator>Kundakovic, M.</dc:creator>
<dc:date>2023-04-15</dc:date>
<dc:identifier>doi:10.1101/2023.04.14.536984</dc:identifier>
<dc:title><![CDATA[Early-life stress and ovarian hormones alter transcriptional regulation in the nucleus accumbens resulting in sex-specific responses to cocaine]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-04-15</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.04.17.537087v1?rss=1">
<title>
<![CDATA[
mRNA Localization and Local Translation of the Microtubule Severing Enzyme, Fidgetin-Like 2, in Polarization, Migration and Outgrowth 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.04.17.537087v1?rss=1</link>
<description><![CDATA[
Cell motility requires strict spatiotemporal control of protein expression. During cell migration, mRNA localization and local translation in subcellular areas like the leading edge and protrusions are particularly advantageous for regulating the reorganization of the cytoskeleton. Fidgetin-Like 2 (FL2), a microtubule severing enzyme (MSE) that restricts migration and outgrowth, localizes to the leading edge of protrusions where it severs dynamic microtubules. FL2 is primarily expressed during development but in adulthood, is spatially upregulated at the leading edge minutes after injury. Here, we show mRNA localization and local translation in protrusions of polarized cells are responsible for FL2 leading edge expression after injury. The data suggests that the RNA binding protein IMP1 is involved in the translational regulation and stabilization of FL2 mRNA, in competition with the miRNA let-7. These data exemplify the role of local translation in microtubule network reorganization during migration and elucidate an unexplored MSE protein localization mechanism.

Graphical Abstract

O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=83 SRC="FIGDIR/small/537087v1_ufig1.gif" ALT="Figure 1">
View larger version (20K):
org.highwire.dtl.DTLVardef@139f4e5org.highwire.dtl.DTLVardef@1fd1a4eorg.highwire.dtl.DTLVardef@1ca17b4org.highwire.dtl.DTLVardef@da2b56_HPS_FORMAT_FIGEXP  M_FIG C_FIG HighlightsO_LIThe microtubule severing enzyme FL2 RNA is localized to the leading edge
C_LIO_LIFL2 mRNA localization leads to FL2 translation within protrusions
C_LIO_LIThe IMP family works in concert with Let-7 miRNA to regulate FL2 mRNA
C_LI
]]></description>
<dc:creator>Birnbaum, R.</dc:creator>
<dc:creator>Biswas, J.</dc:creator>
<dc:creator>Singer, R.</dc:creator>
<dc:creator>Sharp, D.</dc:creator>
<dc:date>2023-04-17</dc:date>
<dc:identifier>doi:10.1101/2023.04.17.537087</dc:identifier>
<dc:title><![CDATA[mRNA Localization and Local Translation of the Microtubule Severing Enzyme, Fidgetin-Like 2, in Polarization, Migration and Outgrowth]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-04-17</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.04.19.537523v1?rss=1">
<title>
<![CDATA[
Transcription promotes the restoration of chromatin following DNA replication. 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.04.19.537523v1?rss=1</link>
<description><![CDATA[
DNA replication results in the transient eviction of nucleosomes, RNAPII and transcription regulators. How chromatin organization is duplicated on the two daughter strands is a central question in epigenetics. In mammals, transcription restarts on newly replicated DNA within a couple of hours, promoting chromatin accessibility. However, the role of transcription in the restoration of other chromatin determinants following DNA replication remains unclear. Here we have monitored protein re-association to newly replicated DNA upon inhibition of transcription using iPOND coupled to quantitative mass spectrometry. We show that nucleosome assembly and the re-establishment of most histone modifications are uncoupled from transcription restart. However, upon transcription inhibition, the re-association of many proteins was altered, including ATP-dependent remodellers, transcription regulators, the histone variant H2A.Z, histone modifiers as well as the restoration of H3.3K36me2. Finally, transcription also provoked the recruitment of several DNA repair proteins, revealing that transcription promotes chromatin reestablishment post-replication but is also a potential source of genotoxic stress.
]]></description>
<dc:creator>Bandau, S.</dc:creator>
<dc:creator>Alvarez, V.</dc:creator>
<dc:creator>Jiang, H.</dc:creator>
<dc:creator>Graff, S.</dc:creator>
<dc:creator>Sundaramoorthy, R.</dc:creator>
<dc:creator>Toman, M.</dc:creator>
<dc:creator>Owen-Hughes, T.</dc:creator>
<dc:creator>Sidoli, S.</dc:creator>
<dc:creator>Lamond, A. I.</dc:creator>
<dc:creator>Alabert, C.</dc:creator>
<dc:date>2023-04-20</dc:date>
<dc:identifier>doi:10.1101/2023.04.19.537523</dc:identifier>
<dc:title><![CDATA[Transcription promotes the restoration of chromatin following DNA replication.]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-04-20</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.04.24.538128v1?rss=1">
<title>
<![CDATA[
Identification of allele-specific KIV-2 repeats and impact on Lp(a) measurements for cardiovascular disease risk 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.04.24.538128v1?rss=1</link>
<description><![CDATA[
The abundance of Lp(a) protein holds significant implications for the risk of cardiovascular disease (CVD), which is directly impacted by the copy number (CN) of KIV-2, a 5.5 kbp sub-region. KIV-2 is highly polymorphic in the population and accurate analysis is challenging. In this study, we present the DRAGEN KIV-2 CN caller, which utilizes short reads. Data across 166 WGS show that the caller has high accuracy, compared to optical mapping and can further phase [~]50% of the samples. We compared KIV-2 CN numbers to 24 previously postulated KIV-2 relevant SNVs, revealing that many are ineffective predictors of KIV-2 copy number. Population studies, including USA-based cohorts, showed distinct KIV-2 CN, distributions for European-, African-, and Hispanic-American populations and further underscored the limitations of SNV predictors. We demonstrate that the CN estimates correlate significantly with the available Lp(a) protein levels and that phasing is highly important.
]]></description>
<dc:creator>Behera, S.</dc:creator>
<dc:creator>Belyeu, J.</dc:creator>
<dc:creator>Chen, X.</dc:creator>
<dc:creator>Paulin, L. F.</dc:creator>
<dc:creator>Nguyen, N. Q.</dc:creator>
<dc:creator>Newman, E.</dc:creator>
<dc:creator>Mahmoud, M.</dc:creator>
<dc:creator>Menon, V. K.</dc:creator>
<dc:creator>Qi, Q.</dc:creator>
<dc:creator>Joshi, P.</dc:creator>
<dc:creator>Marcovina, S.</dc:creator>
<dc:creator>Rossi, M.</dc:creator>
<dc:creator>Roller, E.</dc:creator>
<dc:creator>Han, J.</dc:creator>
<dc:creator>Onuchic, V.</dc:creator>
<dc:creator>Avery, C. L.</dc:creator>
<dc:creator>Ballantyne, C. M.</dc:creator>
<dc:creator>Rodriguez, C. J.</dc:creator>
<dc:creator>Kaplan, R. C.</dc:creator>
<dc:creator>Muzny, D. M.</dc:creator>
<dc:creator>Metcalf, G. A.</dc:creator>
<dc:creator>Gibbs, R.</dc:creator>
<dc:creator>Yu, B.</dc:creator>
<dc:creator>Boerwinkle, E.</dc:creator>
<dc:creator>Eberle, M. A.</dc:creator>
<dc:creator>Sedlazeck, F. J.</dc:creator>
<dc:date>2023-04-27</dc:date>
<dc:identifier>doi:10.1101/2023.04.24.538128</dc:identifier>
<dc:title><![CDATA[Identification of allele-specific KIV-2 repeats and impact on Lp(a) measurements for cardiovascular disease risk]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-04-27</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.05.05.539468v1?rss=1">
<title>
<![CDATA[
Dopamine D2 receptors in mossy cells reduce excitatory transmission and are essential for hippocampal function 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.05.05.539468v1?rss=1</link>
<description><![CDATA[
Hilar mossy cells (MCs) are principal excitatory neurons of the dentate gyrus (DG) that play critical roles in hippocampal function and have been implicated in brain disorders such as anxiety and epilepsy. However, the mechanisms by which MCs contribute to DG function and disease are poorly understood. Expression from the dopamine D2 receptor (D2R) gene (Drd2) promoter is a defining feature of MCs, and previous work indicates a key role for dopaminergic signaling in the DG. Additionally, the involvement of D2R signaling in cognition and neuropsychiatric conditions is well-known. Surprisingly, though, the function of MC D2Rs remain largely unexplored. In this study, we show that selective and conditional removal of Drd2 from MCs of adult mice impaired spatial memory, promoted anxiety-like behavior and was proconvulsant. To determine the subcellular expression of D2Rs in MCs, we used a D2R knockin mouse which revealed that D2Rs are enriched in the inner molecular layer of the DG, where MCs establish synaptic contacts with granule cells. D2R activation by exogenous and endogenous dopamine reduced MC to dentate granule cells (GC) synaptic transmission, most likely by a presynaptic mechanism. In contrast, removing Drd2 from MCs had no significant impact on MC excitatory inputs and passive and active properties. Our findings support that MC D2Rs are essential for proper DG function by reducing MC excitatory drive onto GCs. Lastly, impairment of MC D2R signaling could promote anxiety and epilepsy, therefore highlighting a potential therapeutic target.

SIGNIFICANCEGrowing evidence indicates that hilar mossy cells (MCs) of the dentate gyrus play critical but incompletely understood roles in memory and brain disorders, including anxiety and epilepsy. Dopamine D2 receptors (D2Rs), implicated in cognition and several psychiatric and neurological disorders, are considered to be characteristically expressed by MCs. Still, the subcellular localization and function of MC D2Rs are largely unknown. We report that removing the Drd2 gene specifically from MCs of adult mice impaired spatial memory and was anxiogenic and proconvulsant. We also found that D2Rs are enriched where MCs synaptically contact dentate granule cells (GC) and reduce MC-GC transmission. This work uncovered the functional significance of MC D2Rs, thus highlighting their therapeutic potential in D2R- and MC-associated pathologies.
]]></description>
<dc:creator>Gulfo, M. C.</dc:creator>
<dc:creator>Lebowitz, J. J.</dc:creator>
<dc:creator>Ramos, C.</dc:creator>
<dc:creator>Hwang, D.-W.</dc:creator>
<dc:creator>Nasrallah, K.</dc:creator>
<dc:creator>Castillo, P. E.</dc:creator>
<dc:date>2023-05-05</dc:date>
<dc:identifier>doi:10.1101/2023.05.05.539468</dc:identifier>
<dc:title><![CDATA[Dopamine D2 receptors in mossy cells reduce excitatory transmission and are essential for hippocampal function]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-05-05</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.05.04.539397v1?rss=1">
<title>
<![CDATA[
Reduced frequency of clonal hematopoiesis in Parkinson's disease 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.05.04.539397v1?rss=1</link>
<description><![CDATA[
To test if clonal hematopoiesis of indeterminate potential (CHIP) is associated with the incidence of Parkinsons Disease (PD), we analyzed blood whole exome sequencing data from 171 healthy controls and 335 PD subjects in the Parkinsons Progression Markers Initiative. We observed an age-related increase of CHIP carriers in the healthy controls. Surprisingly, the percentage of CHIP carriers was significantly lower in old PD patients than in age-matched controls.
]]></description>
<dc:creator>Sun, S.</dc:creator>
<dc:creator>Sproviero, D.</dc:creator>
<dc:creator>Payan-Gomez, C.</dc:creator>
<dc:creator>Huang, Z.</dc:creator>
<dc:creator>Hoeijmakers, J. H. J.</dc:creator>
<dc:creator>Maslov, A. Y.</dc:creator>
<dc:creator>Mastroberardino, P. G.</dc:creator>
<dc:creator>Vijg, J.</dc:creator>
<dc:date>2023-05-07</dc:date>
<dc:identifier>doi:10.1101/2023.05.04.539397</dc:identifier>
<dc:title><![CDATA[Reduced frequency of clonal hematopoiesis in Parkinson's disease]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-05-07</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.05.07.539748v1?rss=1">
<title>
<![CDATA[
DNA repair and anti-cancer mechanisms in the longest-living mammal: the bowhead whale 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.05.07.539748v1?rss=1</link>
<description><![CDATA[
At over 200 years, the maximum lifespan of the bowhead whale exceeds that of all other mammals. The bowhead is also the second-largest animal on Earth, reaching over 80,000 kg1. Despite its very large number of cells and long lifespan, the bowhead is not highly cancer-prone, an incongruity termed Petos Paradox2. This phenomenon has been explained by the evolution of additional tumor suppressor genes in other larger animals, supported by research on elephants demonstrating expansion of the p53 gene3-5. Here we show that bowhead whale fibroblasts undergo oncogenic transformation after disruption of fewer tumor suppressors than required for human fibroblasts. However, analysis of DNA repair revealed that bowhead cells repair double strand breaks (DSBs) and mismatches with uniquely high efficiency and accuracy compared to other mammals. The protein CIRBP, implicated in protection from genotoxic stress, was present in very high abundance in the bowhead whale relative to other mammals. We show that CIRBP and its downstream protein RPA2, also present at high levels in bowhead cells, increase the efficiency and fidelity of DNA repair in human cells. These results indicate that rather than possessing additional tumor suppressor genes as barriers to oncogenesis, the bowhead whale relies on more accurate and efficient DNA repair to preserve genome integrity. This strategy which does not eliminate damaged cells but repairs them may be critical for the long and cancer-free lifespan of the bowhead whale.
]]></description>
<dc:creator>Firsanov, D.</dc:creator>
<dc:creator>Zacher, M.</dc:creator>
<dc:creator>Tian, X.</dc:creator>
<dc:creator>Zhao, Y.</dc:creator>
<dc:creator>George, J. C.</dc:creator>
<dc:creator>Sformo, T. L.</dc:creator>
<dc:creator>Tombline, G.</dc:creator>
<dc:creator>Biashad, S. A.</dc:creator>
<dc:creator>Gilman, A.</dc:creator>
<dc:creator>Hamilton, N.</dc:creator>
<dc:creator>Patel, A.</dc:creator>
<dc:creator>Straight, M.</dc:creator>
<dc:creator>Lee, M.</dc:creator>
<dc:creator>Lu, J. Y.</dc:creator>
<dc:creator>Haseljic, E.</dc:creator>
<dc:creator>Williams, A.</dc:creator>
<dc:creator>Miller, N.</dc:creator>
<dc:creator>Gladyshev, V. N.</dc:creator>
<dc:creator>Zhang, Z.</dc:creator>
<dc:creator>Vijg, J.</dc:creator>
<dc:creator>Seluanov, A.</dc:creator>
<dc:creator>Gorbunova, V.</dc:creator>
<dc:date>2023-05-08</dc:date>
<dc:identifier>doi:10.1101/2023.05.07.539748</dc:identifier>
<dc:title><![CDATA[DNA repair and anti-cancer mechanisms in the longest-living mammal: the bowhead whale]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-05-08</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.05.08.539829v1?rss=1">
<title>
<![CDATA[
Monomethylation of Lysine 27 at Histone 3 Confers Lifelong Susceptibility to Stress 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.05.08.539829v1?rss=1</link>
<description><![CDATA[
Histone post-translational modifications are critical for mediating persistent alterations in gene expression. By combining unbiased proteomics profiling, and genome-wide approaches, we uncovered a role for mono-methylation of lysine 27 at histone H3 (H3K27me1) in the enduring effects of stress. Specifically, mice exposed to early life stress (ELS) or to chronic social defeat stress (CSDS) in adulthood displayed increased enrichment of H3K27me1, and transient decreases in H3K27me2, in the nucleus accumbens (NAc), a key brain-reward region. Stress induction of H3K27me1 was mediated by the VEFS domain of SUZ12, a core subunit of the polycomb repressive complex-2, which is induced by chronic stress and controls H3K27 methylation patterns. Overexpression of the VEFS domain led to social, emotional, and cognitive abnormalities, and altered excitability of NAc D1 mediums spiny neurons. Together, we describe a novel function of H3K27me1 in brain and demonstrate its role as a "chromatin scar" that mediates lifelong stress susceptibility.
]]></description>
<dc:creator>Torres-Berrio, A.</dc:creator>
<dc:creator>Estill, M.</dc:creator>
<dc:creator>Ramakrishnan, A.</dc:creator>
<dc:creator>Kronman, H.</dc:creator>
<dc:creator>Patel, V.</dc:creator>
<dc:creator>Minier-Toribio, A.</dc:creator>
<dc:creator>Issler, O.</dc:creator>
<dc:creator>Browne, C. J.</dc:creator>
<dc:creator>Parise, E.</dc:creator>
<dc:creator>van der Zee, Y.</dc:creator>
<dc:creator>Walker, D.</dc:creator>
<dc:creator>Martinez-Rivera, F. J.</dc:creator>
<dc:creator>Lardner, C. K.</dc:creator>
<dc:creator>Durand, R.</dc:creator>
<dc:creator>Russo, S.</dc:creator>
<dc:creator>Shen, L.</dc:creator>
<dc:creator>Sidoli, S.</dc:creator>
<dc:creator>Nestler, E. J.</dc:creator>
<dc:date>2023-05-08</dc:date>
<dc:identifier>doi:10.1101/2023.05.08.539829</dc:identifier>
<dc:title><![CDATA[Monomethylation of Lysine 27 at Histone 3 Confers Lifelong Susceptibility to Stress]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-05-08</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.05.08.539888v1?rss=1">
<title>
<![CDATA[
Detection of a geminate photoproduct of bovine cytochrome c oxidase by time-resolved serial femtosecond crystallography 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.05.08.539888v1?rss=1</link>
<description><![CDATA[
Cytochrome c oxidase (CcO) is a large membrane-bound hemeprotein that catalyzes the reduction of dioxygen to water. Unlike classical dioxygen binding hemeproteins with a heme b group in their active sites, CcO has a unique binuclear center (BNC) comprised of a copper atom (CuB) and a heme a3 iron, where O2 binds and is reduced to water. CO is a versatile O2 surrogate in ligand binding and escape reactions. Previous time-resolved spectroscopic studies of the CO complexes of bovine CcO (bCcO) revealed that photolyzing CO from the heme a3 iron leads to a metastable intermediate (CuB-CO), where CO is bound to CuB, before it escapes out of the BNC. Here, with a time-resolved serial femtosecond X-ray crystallography-based pump-probe method, we detected a geminate photoproduct of the bCcO-CO complex, where CO is dissociated from the heme a3 iron and moved to a temporary binding site midway between the CuB and the heme a3 iron, while the locations of the two metal centers and the conformation of the Helix-X, housing the proximal histidine ligand of the heme a3 iron, remain in the CO complex state. This new structure, combined with other reported structures of bCcO, allows the full definition of the ligand dissociation trajectory, as well as the associated protein dynamics.
]]></description>
<dc:creator>Yeh, S.-R.</dc:creator>
<dc:creator>Ishigami, I.</dc:creator>
<dc:creator>Rousseau, D. L.</dc:creator>
<dc:creator>Carbajo, S.</dc:creator>
<dc:creator>Zatsepin, N.</dc:creator>
<dc:creator>Coe, J.</dc:creator>
<dc:creator>Hikita, M.</dc:creator>
<dc:creator>Seaberg, M. H.</dc:creator>
<dc:creator>Sierra, R. G.</dc:creator>
<dc:creator>Hunter, M. S.</dc:creator>
<dc:creator>Fromme, P.</dc:creator>
<dc:creator>Fromme, R.</dc:creator>
<dc:creator>Nelson, G.</dc:creator>
<dc:creator>Grant, T.</dc:creator>
<dc:creator>Basu, S.</dc:creator>
<dc:creator>Conrad, C.</dc:creator>
<dc:date>2023-05-10</dc:date>
<dc:identifier>doi:10.1101/2023.05.08.539888</dc:identifier>
<dc:title><![CDATA[Detection of a geminate photoproduct of bovine cytochrome c oxidase by time-resolved serial femtosecond crystallography]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-05-10</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.05.09.540053v1?rss=1">
<title>
<![CDATA[
SKP2 knockout in Rb1/p53 deficient mouse models of osteosarcoma induces immune infiltration and drives a transcriptional program with a favorable prognosis 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.05.09.540053v1?rss=1</link>
<description><![CDATA[
PurposeOsteosarcoma (OS) is an aggressive bone malignancy with a poor prognosis. One putative proto-oncogene in OS is SKP2, encoding a substrate recognition factor of the SCF E3 ubiquitin ligase. We previously demonstrated that SKP2 knockout in murine OS improved survival and delayed tumorigenesis. Here we aim to define the SKP2 drives transcriptional program and its clinical implication in OS.

Experimental DesignWe performed RNA-sequencing (RNA-seq) on tumors from a transgenic OS mouse model with conditional Trp53 and Rb1 knockouts in the osteoblast lineage ("DKO": Osx1-Cre;Rb1lox/lox;p53lox/lox) and a triple-knockout model with additional Skp2 germline knockout ("TKO": Osx1-Cre;Rb1lox/lox;p53lox/lox;SKP2-/-). We validated our RNA-seq findings using qPCR and immunohistochemistry. To investigate the clinical implications of our results, we analyzed a human OS patient cohort ("NCI-TARGET OS") with RNA-seq and clinical data.

ResultsWe found large differences in gene expression after SKP2 knockout. Strikingly, we observed increased expression of genes related to immune microenvironment infiltration in TKO tumors. We observed significant increases in signature genes for macrophages and to a lesser extent, T cells, B cells and vascular cells. We also uncovered a set of relevant transcription factors that may mediate the changes. In OS patient cohorts, high expression of genes upregulated in TKO was correlated with favorable overall survival, which was largely explained by the macrophage gene signatures. This relationship was further supported by our finding that SKP2 expression was negatively correlated with macrophage infiltration in the NCI-TARGET OS and the TCGA Sarcoma cohort.

ConclusionOur findings indicate that SKP2 may mediate immune exclusion from the OS tumor microenvironment, suggesting that SKP2 modulation in OS may induce anti-tumor immune activation.

Translational RelevanceOsteosarcoma (OS) is an aggressive bone malignancy. Standard care treatment involving chemotherapy and surgery remains unchanged for decades. OS prognosis remains poor and targeted therapies are critically needed. Immunotherapy failed in clinical trials despite extensive genomic instability, suggesting OS tumors employ active immune exclusion. One putative oncogene in OS is SKP2, which activates cell proliferation. SKP2 is correlated with worse prognosis in patients and knockout of SKP2 improved survival in murine OS. Here, we performed comparative transcriptomic analysis between transgenic OS murine models with SKP2 knockout and controls. We showed that SKP2 knockout dramatic increased immune gene expression largely due to macrophage, and to a lesser extent lymphocytes, infiltration. Interestingly, we found that the increased gene program uncovered from our SKP2 knockout model was correlated with improved survival in OS patients. Our findings indicate a completely new function for SKP2 in mediating immune exclusion in sarcoma and suggest that SKP2 inhibition may lead to improved immune activation and potential treatment.
]]></description>
<dc:creator>Ferrena, A.</dc:creator>
<dc:creator>Wang, J.</dc:creator>
<dc:creator>Zhang, R.</dc:creator>
<dc:creator>Karadal-Ferrena, B.</dc:creator>
<dc:creator>al-Hardan, W.</dc:creator>
<dc:creator>Singh, S.</dc:creator>
<dc:creator>Borjihan, H.</dc:creator>
<dc:creator>Schwartz, E.</dc:creator>
<dc:creator>Zhao, H.</dc:creator>
<dc:creator>Yang, R.</dc:creator>
<dc:creator>Geller, D.</dc:creator>
<dc:creator>Hoang, B.</dc:creator>
<dc:creator>Zheng, D.</dc:creator>
<dc:date>2023-05-12</dc:date>
<dc:identifier>doi:10.1101/2023.05.09.540053</dc:identifier>
<dc:title><![CDATA[SKP2 knockout in Rb1/p53 deficient mouse models of osteosarcoma induces immune infiltration and drives a transcriptional program with a favorable prognosis]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-05-12</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.05.13.540637v1?rss=1">
<title>
<![CDATA[
Targeted inhibition of SCF-SKP2 confers anti-tumor activities resulting in a survival benefit in osteosarcoma 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.05.13.540637v1?rss=1</link>
<description><![CDATA[
Osteosarcoma(OS) is a highly aggressive bone cancer for which treatment has remained essentially unchanged for decades. Although OS is characterized by extensive genomic heterogeneity and instability, RB1 and TP53 have been shown to be the most commonly inactivated tumor suppressors in OS. We previously generated a mouse model with a double knockout (DKO) of Rb1 and Trp53 within cells of the osteoblastic lineage, which largely recapitulates human OS with nearly complete penetrance. SKP2 is a repression target of pRb and serves as a substrate recruiting subunit of the SCFSKP2 complex. In addition, SKP2 plays a central role in regulating the cell cycle by ubiquitinating and promoting the degradation of p27. We previously reported the DKOAA transgenic model, which harbored a knock-in mutation in p27 that impaired its binding to SKP2. Here, we generated a novel p53-Rb1-SKP2 triple-knockout model (TKO) to examine SKP2 function and its potential as a therapeutic target in OS. First, we observed that OS tumorigenesis was significantly delayed in TKO mice and their overall survival was markedly improved. In addition, the loss of SKP2 also promoted an apoptotic microenvironment and reduced the stemness of DKO tumors. Furthermore, we found that small-molecule inhibitors of SKP2 exhibited anti-tumor activities in vivo and in OS organoids as well as synergistic effects when combined with a standard chemotherapeutic agent. Taken together, our results suggest that SKP2 inhibitors may reduce the stemness plasticity of OS and should be leveraged as next-generation adjuvants in this cancer.
]]></description>
<dc:creator>Wang, J.</dc:creator>
<dc:creator>Ferrena, A.</dc:creator>
<dc:creator>Singh, S.</dc:creator>
<dc:creator>Viscarret, V.</dc:creator>
<dc:creator>Al-Hardan, W.</dc:creator>
<dc:creator>Aldahamsheh, O.</dc:creator>
<dc:creator>Borjihan, H.</dc:creator>
<dc:creator>Singla, A.</dc:creator>
<dc:creator>Yaguare, S.</dc:creator>
<dc:creator>Tingling, J.</dc:creator>
<dc:creator>Zi, X.</dc:creator>
<dc:creator>Lo, Y.</dc:creator>
<dc:creator>Gorlick, R.</dc:creator>
<dc:creator>Schwartz, E. L.</dc:creator>
<dc:creator>Zhao, H.</dc:creator>
<dc:creator>Yang, R.</dc:creator>
<dc:creator>Geller, D. S.</dc:creator>
<dc:creator>Zheng, D.</dc:creator>
<dc:creator>Hoang, B. H.</dc:creator>
<dc:date>2023-05-14</dc:date>
<dc:identifier>doi:10.1101/2023.05.13.540637</dc:identifier>
<dc:title><![CDATA[Targeted inhibition of SCF-SKP2 confers anti-tumor activities resulting in a survival benefit in osteosarcoma]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-05-14</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.05.10.540284v1?rss=1">
<title>
<![CDATA[
PROX1 inhibits PDGF-B expression to prevent myxomatous degeneration of heart valves 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.05.10.540284v1?rss=1</link>
<description><![CDATA[
BackgroundCardiac valve disease (CVD) is observed in 2.5% of the general population and 10% of the elderly people. Effective pharmacological treatments are currently not available, and patients with severe CVD require surgery. PROX1 and FOXC2 are transcription factors that are required for the development of lymphatic and venous valves. We found that PROX1 and FOXC2 are expressed in a subset of valvular endothelial cells (VECs) that are located on the downstream (fibrosa) side of cardiac valves. Whether PROX1 and FOXC2 regulate cardiac valve development and disease is not known.

MethodsWe used histology, electron microscopy and echocardiography to investigate the structure and functioning of heart valves from Prox1{Delta}VEC mice in which Prox1 was conditionally deleted from VECs. Isolated valve endothelial cells and valve interstitial cells were used to identify the molecular mechanisms in vitro, which were tested in vivo by RNAScope, additional mouse models and pharmacological approaches. The significance of our findings was tested by evaluation of human samples of mitral valve prolapse (MVP) and aortic valve insufficiency.

ResultsHistological analysis revealed that the aortic and mitral valves of Prox1{Delta}VEC mice become progressively thick and myxomatous. Echocardiography revealed that the aortic valves of Prox1{Delta}VEC mice are stenotic. FOXC2 was downregulated and platelet-derived growth factor-B (PDGF-B) was upregulated in the VECs of Prox1{Delta}VEC mice. Conditional knockdown of FOXC2 and conditional overexpression of PDGF-B in VECs recapitulated the phenotype of Prox1{Delta}VEC mice. PDGF-B was also increased in mice lacking FOXC2 and in human MVP and insufficient aortic valve samples. Pharmacological inhibition of PDGF-B signaling with imatinib partially ameliorated the valve defects of Prox1{Delta}VEC mice.

ConclusionPROX1 antagonizes PDGF-B signaling partially via FOXC2 to maintain the extracellular matrix composition and prevent myxomatous degeneration of cardiac valves.

Novelty and SignificanceWhat Is Known?

O_LIThe transcription factors PROX1 and FOXC2 are critical regulators of lymphatic and venous valve development.
C_LIO_LIPROX1 and FOXC2 are expressed in the downstream valvular endothelial cells of heart valves.
C_LI

What Is New?

O_LIDeletion of Prox1 from the valvular endothelial cells of mice results in enlarged and myxomatous aortic and mitral valves. Aortic valves of the mutant (Prox1{Delta}VEC) mice were stenotic.
C_LIO_LIFOXC2 is partially responsible for the phenotype of Prox1{Delta}VEC mice.
C_LIO_LIPROX1 and FOXC2 inhibit the expression of the cytokine PDGF-B in heart valves.
C_LIO_LIHyperactivation of PDGF-B signaling results in aortic and mitral valve thickening.
C_LIO_LIInhibition of PDGF-B signaling ameliorates aortic valve stenosis in Prox1{Delta}VEC mice.
C_LIO_LIPDGFB is overexpressed and PROX1 is downregulated in human mitral valve prolapse (MVP) samples.
C_LI

Our findings suggest that PROX1 is an inhibitor of myxomatous valve disease that afflicts ~10% of the elderly population. We have also identified PDGF-B as a potential target for treating myxomatous valve disease.
]]></description>
<dc:creator>Ho, Y.-C.</dc:creator>
<dc:creator>Geng, X.</dc:creator>
<dc:creator>O'Donnell, A.</dc:creator>
<dc:creator>Ibarrola, J.</dc:creator>
<dc:creator>Fernandez-Celis, A.</dc:creator>
<dc:creator>Varshney, R.</dc:creator>
<dc:creator>Subramani, K.</dc:creator>
<dc:creator>Azartash-Namin, Z. J.</dc:creator>
<dc:creator>Kim, J.</dc:creator>
<dc:creator>Silasi, R.</dc:creator>
<dc:creator>Wylie-Sears, J.</dc:creator>
<dc:creator>Alvandi, Z.</dc:creator>
<dc:creator>Chen, L.</dc:creator>
<dc:creator>Cha, B.</dc:creator>
<dc:creator>Chen, H.</dc:creator>
<dc:creator>Xia, L.</dc:creator>
<dc:creator>Zhou, B.</dc:creator>
<dc:creator>Lupu, F.</dc:creator>
<dc:creator>Burkhart, H.</dc:creator>
<dc:creator>Aikawa, E.</dc:creator>
<dc:creator>Olson, L.</dc:creator>
<dc:creator>Ahamed, J.</dc:creator>
<dc:creator>Lopez-Andres, N.</dc:creator>
<dc:creator>Bischoff, J.</dc:creator>
<dc:creator>Yutzey, K. E.</dc:creator>
<dc:creator>Srinivasan, R. S.</dc:creator>
<dc:date>2023-05-15</dc:date>
<dc:identifier>doi:10.1101/2023.05.10.540284</dc:identifier>
<dc:title><![CDATA[PROX1 inhibits PDGF-B expression to prevent myxomatous degeneration of heart valves]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-05-15</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.05.17.540984v1?rss=1">
<title>
<![CDATA[
Longevity-associated SMAD3 non-coding centenarian variant impairs a cell-type specific enhancer to reduce inflammation 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.05.17.540984v1?rss=1</link>
<description><![CDATA[
Given the pro and anti-geronic roles of the TGF-{beta} superfamily in aging, we hypothesized that human longevity involves genetic variation in TGF-{beta} signaling genes. Here we utilized a candidate functional genomic approach to identify and characterize functional variants in TGF- {beta} signaling associated with human longevity. Targeted sequencing of 113 genes involved in aging- associated TGF- {beta} signaling in an Ashkenazi Jewish centenarian cohort identified genetic variants robustly associated with human longevity. In particular, a centenarian-enriched intronic variant residing in a cell-type specific enhancer in SMAD3, a critical receptor-regulated TGF- {beta} signal transducer, was identified. This non-coding SMAD3 variant (rs8040709) altered binding of ELK1, a member of the ETS family of transcription factor important for enhancer activity in certain cell types, resulting in reduced SMAD3 expression. Analysis of the variant in cell types derived from gene edited iPSCs demonstrated the variant reduced SMAD3 expression, senescence and inflammation in endothelial cells. In addition, heterozygosity in SMAD3 improved healthspan and reduced senescence in the Ercc1-/{Delta} progeroid mouse model of accelerated aging. Taken together, these experiments demonstrate that variants in a cell type specific enhancer of SMAD3 resulted in reduced expression, senescence and inflammation and contributes to human longevity. Thus, SMAD3 represents a validated targeted for drug development for extending human healthspan.
]]></description>
<dc:creator>Yang, J.</dc:creator>
<dc:creator>Tare, A.</dc:creator>
<dc:creator>Zhang, L.</dc:creator>
<dc:creator>Kim, S.</dc:creator>
<dc:creator>Ryu, S.</dc:creator>
<dc:creator>Guo, Q.</dc:creator>
<dc:creator>Zhu, Y.</dc:creator>
<dc:creator>Wang, X.</dc:creator>
<dc:creator>Wang, X.</dc:creator>
<dc:creator>Hudgins, A. D.</dc:creator>
<dc:creator>Guan, D.</dc:creator>
<dc:creator>Jin, C.</dc:creator>
<dc:creator>Chang, H.-K.</dc:creator>
<dc:creator>Atzmon, G.</dc:creator>
<dc:creator>Milman, S.</dc:creator>
<dc:creator>Barzilai, N.</dc:creator>
<dc:creator>Vijg, J.</dc:creator>
<dc:creator>Niedernhofer, L.</dc:creator>
<dc:creator>Robbins, P. D.</dc:creator>
<dc:creator>Suh, Y.</dc:creator>
<dc:date>2023-05-18</dc:date>
<dc:identifier>doi:10.1101/2023.05.17.540984</dc:identifier>
<dc:title><![CDATA[Longevity-associated SMAD3 non-coding centenarian variant impairs a cell-type specific enhancer to reduce inflammation]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-05-18</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.05.19.541542v1?rss=1">
<title>
<![CDATA[
The regulation of Insulin/IGF-1 signaling by miR-142-3p associated with human longevity 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.05.19.541542v1?rss=1</link>
<description><![CDATA[
MicroRNAs (miRNAs) have been demonstrated to modulate life span in the invertebrates C. elegans and Drosophila by targeting conserved pathways of aging, such as insulin/IGF-1 signaling (IIS). However, a role for miRNAs in modulating human longevity has not been fully explored. Here we investigated novel roles of miRNAs as a major epigenetic component of exceptional longevity in humans. By profiling the miRNAs in B-cells from Ashkenazi Jewish centenarians and 70-year-old controls without a longevity history, we found that the majority of differentially expressed miRNAs were upregulated in centenarians and predicted to modulate the IIS pathway. Notably, decreased IIS activity was found in B cells from centenarians who harbored these upregulated miRNAs. miR-142-3p, the top upregulated miRNA, was verified to dampen the IIS pathway by targeting multiple genes including GNB2, AKT1S1, RHEB and FURIN. Overexpression of miR-142-3p improved the stress resistance under genotoxicity and induced the impairment of cell cycle progression in IMR90 cells. Furthermore, mice injected with a miR-142-3p mimic showed reduced IIS signaling and improved longevity-associated phenotypes including enhanced stress resistance, improved diet/aging-induced glucose intolerance, and longevity-associated change of metabolic profile. These data suggest that miR-142-3p is involved in human longevity through regulating IIS-mediated pro-longevity effects. This study provides strong support for the use of miR-142-3p as a novel therapeutic to promote longevity or prevent aging/aging-related diseases in human.
]]></description>
<dc:creator>Wang, X.</dc:creator>
<dc:creator>Jung, H. J.</dc:creator>
<dc:creator>Milholland, B.</dc:creator>
<dc:creator>Cui, J.</dc:creator>
<dc:creator>Tazearslan, C.</dc:creator>
<dc:creator>Atzmon, G.</dc:creator>
<dc:creator>Wang, X.</dc:creator>
<dc:creator>Yang, J.</dc:creator>
<dc:creator>Guo, Q.</dc:creator>
<dc:creator>Barzilai, N.</dc:creator>
<dc:creator>Robbins, P. D.</dc:creator>
<dc:creator>Suh, Y.</dc:creator>
<dc:date>2023-05-20</dc:date>
<dc:identifier>doi:10.1101/2023.05.19.541542</dc:identifier>
<dc:title><![CDATA[The regulation of Insulin/IGF-1 signaling by miR-142-3p associated with human longevity]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-05-20</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.05.18.541339v1?rss=1">
<title>
<![CDATA[
Identification and functional validation of an enhancer variant in the 9p21.3 locus associated with glaucoma risk and elevated expression of p16INK4a 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.05.18.541339v1?rss=1</link>
<description><![CDATA[
Glaucoma is a leading cause of irreversible blindness, with advanced age being the single most significant risk factor. However, the mechanisms underlying the relationship between aging and glaucoma remain unclear. Genome-wide association studies (GWAS) have successfully identified genetic variants strongly associated with increased glaucoma risk. Understanding how these variants function in pathogenesis is crucial for translating genetic associations into molecular mechanisms and, ultimately, clinical applications. The chromosome 9p21.3 locus is among the most replicated glaucoma risk loci discovered by GWAS. Nonetheless, the absence of protein-coding genes in the locus makes interpreting the disease association challenging, leaving the causal variant and molecular mechanism elusive. In this study, we report the identification of a functional glaucoma risk variant, rs6475604. By employing computational and experimental methods, we demonstrated that rs6475604 resides in a repressive regulatory element. Risk allele of rs6475604 disrupts the binding of YY1, a transcription factor known to repress the expression of a neighboring gene in 9p21.3, p16INK4A, which plays a crucial role in cellular senescence and aging. These findings suggest that the glaucoma disease variant contributes to accelerated senescence, providing a molecular link between glaucoma risk and an essential cellular mechanism for human aging.
]]></description>
<dc:creator>Zhu, Y.</dc:creator>
<dc:creator>Tazearslan, C.</dc:creator>
<dc:creator>Rosenfeld, M. G.</dc:creator>
<dc:creator>Fiser, A.</dc:creator>
<dc:creator>Suh, Y.</dc:creator>
<dc:date>2023-05-22</dc:date>
<dc:identifier>doi:10.1101/2023.05.18.541339</dc:identifier>
<dc:title><![CDATA[Identification and functional validation of an enhancer variant in the 9p21.3 locus associated with glaucoma risk and elevated expression of p16INK4a]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-05-22</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.05.23.541787v1?rss=1">
<title>
<![CDATA[
KDM5-mediated activation of genes required for mitochondrial biology is necessary for viability in Drosophila 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.05.23.541787v1?rss=1</link>
<description><![CDATA[
The precise coordination of gene expression is critical for developmental programs, and histone modifying proteins play important, conserved roles in fine-tuning transcription for these processes. One such family of proteins are KDM5 enzymes that interact with chromatin through demethylating H3K4me3 as well as demethylase-independent mechanisms that remain less understood. The single kdm5 ortholog in Drosophila is an essential gene that has crucial developmental roles in a neuroendocrine tissue, the prothoracic gland. To characterize the regulatory functions of KDM5, we examined its role in coordinating gene expression programs critical to cellular homeostasis and organismal viability in larval prothoracic gland cells. Utilizing targeted genetic experiments, we analyzed the relationship between critical cell signaling pathways, particularly MAPK, and the lethality caused by loss of kdm5. Integrating KDM5 genome binding and transcriptomic data revealed conserved and tissue-specific transcriptional programs regulated by KDM5. These experiments highlighted a role for KDM5 in regulating the expression of a set of genes critical for the function and maintenance of mitochondria. This gene expression program is key to the essential functions of KDM5, as expression of the mitochondrial biogenesis transcription factor Ets97D/Delg, the Drosophila homolog of GABP, in prothoracic gland cells suppressed the lethality of kdm5 null animals. Consistent with this, we observed morphological changes to mitochondria in the prothoracic gland of kdm5 null mutant animals. Together, these data establish KDM5-mediated cellular functions that are both important for normal development and could also contribute to KDM5-linked disorders when dysregulated.
]]></description>
<dc:creator>Rogers, M. F.</dc:creator>
<dc:creator>Marshall, O. J.</dc:creator>
<dc:creator>Secombe, J.</dc:creator>
<dc:date>2023-05-24</dc:date>
<dc:identifier>doi:10.1101/2023.05.23.541787</dc:identifier>
<dc:title><![CDATA[KDM5-mediated activation of genes required for mitochondrial biology is necessary for viability in Drosophila]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-05-24</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.05.30.542959v1?rss=1">
<title>
<![CDATA[
Ultrastructural analysis reveals mitochondrial placement independent of synapse placement in fine caliber C. elegans neurons 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.05.30.542959v1?rss=1</link>
<description><![CDATA[
Neurons rely on mitochondria for an efficient supply of ATP and other metabolites. However, while neurons are highly elongated, mitochondria are discrete and limited in number. Due to the slow rates of diffusion over long distances it follows that neurons would benefit from an ability to control the distribution of mitochondria to sites of high metabolic activity, such as synapses. It is assumed that neurons possess this capacity, but ultrastructural data over substantial portions of a neurons extent that would allow for tests of such hypotheses are scarce. Here, we mined the Caenorhabditis elegans electron micrographs of John White and Sydney Brenner and found systematic differences in average mitochondrial length (ranging from 1.3 to 2.4 m), volume density (3.7% to 6.5%) and diameter (0.18 to 0.24 m) between neurons of different neurotransmitter type and function, but found limited differences in mitochondrial morphometrics between axons and dendrites of the same neurons. Analyses of distance intervals found mitochondria to be distributed randomly with respect to presynaptic specializations, and an indication that mitochondria were displaced from postsynaptic specializations. Presynaptic specializations were primarily localized to varicosities, but mitochondria were no more likely to be found in synaptic varicosities than non-synaptic varicosities. Consistently, mitochondrial volume density was no greater in varicosities with synapses. Therefore, beyond the capacity to disperse mitochondria throughout their length, at least in C. elegans, fine caliber neurons manifest limited sub-cellular control of mitochondrial size and distribution.

SIGNIFICANCEBrain function is unequivocally reliant on mitochondrial function for its energy needs, and the mechanisms that cells use to control these organelles is an active field of enquiry. WormImage, a decades old electron microscopy database in the public domain, contains information about the ultrastructural disposition of mitochondria within the nervous system of C elegans over previously unexamined extents. In a largely remote format, a team of students mined this database over the course of the pandemic. They found differences in mitochondrial size and density between neurons, but limited differences between different compartments of the same neurons. Also, while neurons are clearly able to disperse mitochondria throughout their extent, they found little evidence that they "install" mitochondria at synaptic varicosities.
]]></description>
<dc:creator>Riboul, D. V.</dc:creator>
<dc:creator>Crill, S.</dc:creator>
<dc:creator>Oliva, C. D.</dc:creator>
<dc:creator>Restifo, M. G.</dc:creator>
<dc:creator>Joseph, R.</dc:creator>
<dc:creator>Joseph, K.</dc:creator>
<dc:creator>Nguyen, K. C.</dc:creator>
<dc:creator>Hall, D. H.</dc:creator>
<dc:creator>Fily, Y.</dc:creator>
<dc:creator>Macleod, G. T.</dc:creator>
<dc:date>2023-06-01</dc:date>
<dc:identifier>doi:10.1101/2023.05.30.542959</dc:identifier>
<dc:title><![CDATA[Ultrastructural analysis reveals mitochondrial placement independent of synapse placement in fine caliber C. elegans neurons]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-06-01</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.05.31.543132v1?rss=1">
<title>
<![CDATA[
Ribosomal protein control of hematopoietic stem cell transformation through direct, non-canonical regulation of metabolism 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.05.31.543132v1?rss=1</link>
<description><![CDATA[
We report here that expression of the ribosomal protein, RPL22, is frequently reduced in human myelodysplastic syndrome (MDS) and acute myelogenous leukemia (AML); and, reduced RPL22 expression is associated with worse outcomes. Mice null for Rpl22 display characteristics of an MDS-like syndrome and develop leukemia at an accelerated rate. Rpl22-deficient mice also display enhanced hematopoietic stem cell (HSC) self-renewal and obstructed differentiation potential, which arises not from reduced protein synthesis but from altered metabolism including increased fatty acid oxidation (FAO) and a striking induction of the stemness factor Lin28b in the resulting leukemia. Lin28b promotes a substantial increase in lipid content, upon which the survival of Rpl22-deficient leukemias depends. Altogether, these findings reveal that Rpl22 insufficiency enhances the leukemia potential of HSC through regulation of FAO and promotes leukemogenesis through Lin28b promotion of lipid synthesis.

HighlightsO_LIRPL22 insufficiency is observed in MDS/AML and is associated with reduced survival
C_LIO_LIRpl22-deficiency produces an MDS-like syndrome and facilitates leukemogenesis
C_LIO_LIRpl22-deficiency does not impair global protein synthesis by HSC
C_LIO_LIRpl22 controls leukemia survival through control of lipid synthesis
C_LI

eTOC: Rpl22 controls the function and transformation potential of hematopoietic stem cells through regulation of lipid metabolism.
]]></description>
<dc:creator>Harris, B.</dc:creator>
<dc:creator>Singh, D. K.</dc:creator>
<dc:creator>Verma, M.</dc:creator>
<dc:creator>Fahl, S. P.</dc:creator>
<dc:creator>Rhodes, M.</dc:creator>
<dc:creator>Sprinkle, S. R.</dc:creator>
<dc:creator>Wang, M.</dc:creator>
<dc:creator>Zhang, Y.</dc:creator>
<dc:creator>Perrigoue, J.</dc:creator>
<dc:creator>Kessel, R.</dc:creator>
<dc:creator>Peri, S.</dc:creator>
<dc:creator>West, J.</dc:creator>
<dc:creator>Giricz, O.</dc:creator>
<dc:creator>Boultwood, J.</dc:creator>
<dc:creator>Pellagatti, A.</dc:creator>
<dc:creator>Ramesh, K.</dc:creator>
<dc:creator>Montangna, C.</dc:creator>
<dc:creator>Pradhan, K.</dc:creator>
<dc:creator>Tyner, J.</dc:creator>
<dc:creator>Kennedy, B. K.</dc:creator>
<dc:creator>Holinstat, M.</dc:creator>
<dc:creator>Steidl, U.</dc:creator>
<dc:creator>Sykes, S.</dc:creator>
<dc:creator>Verma, A.</dc:creator>
<dc:creator>Wiest, D. L.</dc:creator>
<dc:date>2023-06-01</dc:date>
<dc:identifier>doi:10.1101/2023.05.31.543132</dc:identifier>
<dc:title><![CDATA[Ribosomal protein control of hematopoietic stem cell transformation through direct, non-canonical regulation of metabolism]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-06-01</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.06.07.544116v1?rss=1">
<title>
<![CDATA[
Understanding the General Principles of T Cell Engagement by Multiscale Computational Simulations 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.06.07.544116v1?rss=1</link>
<description><![CDATA[
The use of bispecific antibodies as T cell engagers can bypass the normal TCR-MHC interaction, redirect the cytotoxic activity of T-cells, and lead to highly efficient tumor cell killing. However, this immunotherapy also causes significant on-target off-tumor toxicologic effects, especially when they were used to treat solid tumors. In order to avoid these adverse events, it is necessary to understand the fundamental mechanisms during the physical process of T cell engagement. We developed a multiscale computational framework to reach this goal. The framework combines simulations on the intercellular and multicellular levels. On the intercellular level, we simulated the spatial-temporal dynamics of three-body interactions among bispecific antibodies, CD3 and TAA. The derived number of intercellular bonds formed between CD3 and TAA were further transferred into the multicellular simulations as the input parameter of adhesive density between cells. Through the simulations under various molecular and cellular conditions, we were able to gain new insights of how to adopt the most appropriate strategy to maximize the drug efficacy and avoid the off-target effect. For instance, we discovered that the low antibody binding affinity resulted in the formation of large clusters at the cell-cell interface, which could be important to control the downstream signaling pathways. We also tested different molecular architectures of the bispecific antibody and suggested the existence of an optimal length in regulating the T cell engagement. Overall, the current multiscale simulations serve as a prove-of-concept study to help the future design of new biological therapeutics.

SIGNIFICANCET-cell engagers are a class of anti-cancer drugs that can directly kill tumor cells by bringing T cells next to them. However, current treatments using T-cell engagers can cause serious side-effects. In order to reduce these effects, it is necessary to understand how T cells and tumor cells interact together through the connection of T-cell engagers. Unfortunately, this process is not well studied due to the limitations in current experimental techniques. We developed computational models on two different scales to simulate the physical process of T cell engagement. Our simulation results provide new insights into the general properties of T cell engagers. The new simulation methods can therefore serve as a useful tool to design novel antibodies for cancer immunotherapy.
]]></description>
<dc:creator>Su, Z.</dc:creator>
<dc:creator>Almo, S.</dc:creator>
<dc:creator>Wu, Y.</dc:creator>
<dc:date>2023-06-07</dc:date>
<dc:identifier>doi:10.1101/2023.06.07.544116</dc:identifier>
<dc:title><![CDATA[Understanding the General Principles of T Cell Engagement by Multiscale Computational Simulations]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-06-07</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.06.09.544415v1?rss=1">
<title>
<![CDATA[
Kinesin-14 HSET and KlpA are non-processive microtubule motors with load-dependent power strokes 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.06.09.544415v1?rss=1</link>
<description><![CDATA[
Accurate chromosome segregation during cell division relies on coordinated actions of microtubule (MT)-based motor proteins in the mitotic spindle. Kinesin-14 motors play vital roles in spindle assembly and maintenance by crosslinking antiparallel MTs at the spindle midzone and anchoring spindle MTs minus ends at the poles. We investigate the force generation and motility of the Kinesin-14 motors HSET and KlpA, revealing that both motors function as non-processive motors under load, producing single power strokes per MT encounter. Each homodimeric motor generates forces of [~]0.5 pN, but when assembled in teams, they cooperate to generate forces of 1 pN or more. Importantly, cooperative activity among multiple motors leads to increased MT-sliding velocities. Our findings deepen our understanding of the structure-function relationship of Kinesin-14 motors and underscore the significance of cooperative behavior in their cellular functions.
]]></description>
<dc:creator>Gennerich, A.</dc:creator>
<dc:creator>Liu, X.</dc:creator>
<dc:creator>Rao, L.</dc:creator>
<dc:creator>Qiu, W.</dc:creator>
<dc:date>2023-06-10</dc:date>
<dc:identifier>doi:10.1101/2023.06.09.544415</dc:identifier>
<dc:title><![CDATA[Kinesin-14 HSET and KlpA are non-processive microtubule motors with load-dependent power strokes]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-06-10</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.06.10.544474v1?rss=1">
<title>
<![CDATA[
RNA Helicase DDX3 Regulates RAD51 Localization and DNA Damage Repair in Ewing Sarcoma 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.06.10.544474v1?rss=1</link>
<description><![CDATA[
We previously demonstrated that RNA helicase DDX3X (DDX3) can be a therapeutic target in Ewing sarcoma (EWS), but its role in EWS biology remains unclear. The present work demonstrates that DDX3 plays a unique role in DNA damage repair (DDR). We show that DDX3 interacts with several proteins involved in homologous recombination, including RAD51, RECQL1, RPA32, and XRCC2. In particular, DDX3 colocalizes with RAD51 and RNA:DNA hybrid structures in the cytoplasm of EWS cells. Inhibition of DDX3 RNA helicase activity increases cytoplasmic RNA:DNA hybrids, sequestering RAD51 in the cytoplasm, which impairs nuclear translocation of RAD51 to sites of double-stranded DNA breaks thus increasing sensitivity of EWS to radiation treatment, both in vitro and in vivo. This discovery lays the foundation for exploring new therapeutic approaches directed at manipulating DDR protein localization in solid tumors.
]]></description>
<dc:creator>Randolph, M. E.</dc:creator>
<dc:creator>Afifi, M.</dc:creator>
<dc:creator>Gorthi, A.</dc:creator>
<dc:creator>Weil, R.</dc:creator>
<dc:creator>Wilky, B. A.</dc:creator>
<dc:creator>Weinreb, J.</dc:creator>
<dc:creator>Ciero, P.</dc:creator>
<dc:creator>ter Hoeve, N.</dc:creator>
<dc:creator>van Diest, P. J.</dc:creator>
<dc:creator>Raman, V.</dc:creator>
<dc:creator>Bishop, A. J.</dc:creator>
<dc:creator>Loeb, D. M.</dc:creator>
<dc:date>2023-06-10</dc:date>
<dc:identifier>doi:10.1101/2023.06.10.544474</dc:identifier>
<dc:title><![CDATA[RNA Helicase DDX3 Regulates RAD51 Localization and DNA Damage Repair in Ewing Sarcoma]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-06-10</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.06.18.545438v1?rss=1">
<title>
<![CDATA[
KATP channel mutation disrupts hippocampal network activity and nocturnal γ shifts 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.06.18.545438v1?rss=1</link>
<description><![CDATA[
ATP-sensitive potassium (KATP) channels enable ATP to control the membrane potential and insulin secretion. Humans affected by severe activating mutations in KATP channels suffer from developmental delay, epilepsy and neonatal diabetes (DEND syndrome). While the diabetes in DEND syndrome is well understood, the pathophysiology of the neurological symptoms remains unclear. We hypothesized that parvalbumin-positive interneurons (PV-INs) are key for the pathophysiology and found, by using electrophysiology, that expressing the DEND mutation Kir6.2-V59M selectively in PV-INs reduced intrinsic gamma frequency preference and short-term depression as well as disturbed cognition-associated gamma oscillations and hippocampal sharp waves. Furthermore, risk of seizures is increased and day-night shift in gamma activity disrupted. Thus, PV-INs play a key role in DEND syndrome and this provides a framework for establishing treatment options.

One Sentence SummaryOveractive KATP channels in PV-interneurons disturb cellular behaviour and cognition-associated network oscillations.
]]></description>
<dc:creator>Burkart, M.-E.</dc:creator>
<dc:creator>Kurzke, J.</dc:creator>
<dc:creator>Vera, J.</dc:creator>
<dc:creator>Ashcroft, F. M.</dc:creator>
<dc:creator>Eilers, J.</dc:creator>
<dc:creator>Lippmann, K.</dc:creator>
<dc:date>2023-06-21</dc:date>
<dc:identifier>doi:10.1101/2023.06.18.545438</dc:identifier>
<dc:title><![CDATA[KATP channel mutation disrupts hippocampal network activity and nocturnal γ shifts]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-06-21</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.06.24.546409v1?rss=1">
<title>
<![CDATA[
Intrarenal myeloid subsets associated with kidney injury are comparable in mice and patients with lupus nephritis 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.06.24.546409v1?rss=1</link>
<description><![CDATA[
Resident macrophages and infiltrating monocytes in kidneys of patients with lupus nephritis are altered both in frequency and function relative to their counterparts in healthy kidneys. The extent to which mouse models might be useful in developing approaches to target these cells for treating lupus nephritis is poorly understood. Here, we studied four common lupus mouse models that share clinical, serologic, and histopathologic kidney changes with humans. Using single-cell profiling and multiplex spatial imaging to analyze the intrarenal myeloid compartment with the onset of clinical disease in these models, we identified monocyte and macrophage subsets that expand or contract in kidneys with clinical nephritis. A unique subset of classical monocytes expanded with the onset of disease and expressed genes such as CD9, Spp1, Ctsd, Cd63, Apoe, and Trem2 that were previously shown to be induced by tissue injury and play a role in inflammation, lipid metabolism and tissue repair in other organs. Resident macrophages transitioned from a pro-inflammatory to a similar injury-associated state with onset of disease. To test whether these findings in mouse models were also observed in humans, we re-analyzed monocytes and macrophages in a single-cell RNAseq dataset of kidney biopsies from 155 patients with lupus nephritis and 30 healthy donors, collected by the NIH AMP RA/SLE consortium. Human monocytes and macrophages showed conserved changes in gene expression programs associated with lupus nephritis disease indices, and localized to similar kidney microenvironments as in mice. By identifying myeloid subsets and disease-associated alterations in biological processes that are conserved across species, we provide a strong rationale for functional studies of these cells and pathways in mice to uncover mechanisms and find targets relevant to human lupus nephritis.

One sentence summaryThis study characterizes intrarenal myeloid cells from four lupus mouse models and 155 patients with lupus nephritis using single-cell RNA-seq and imaging, and identifies novel infiltrating and resident myeloid subsets that are conserved between mouse and human lupus nephritis, thus providing a map and strong rationale for functional studies in mice with relevance to human disease.
]]></description>
<dc:creator>Hoover, P.</dc:creator>
<dc:creator>Lieb, D. J.</dc:creator>
<dc:creator>Kang, J.</dc:creator>
<dc:creator>Li, S.</dc:creator>
<dc:creator>Peters, M.</dc:creator>
<dc:creator>Raparia, C.</dc:creator>
<dc:creator>Arazi, A.</dc:creator>
<dc:creator>Eisenhaure, T.</dc:creator>
<dc:creator>Gurajala, S. S.</dc:creator>
<dc:creator>Xiao, Q.</dc:creator>
<dc:creator>Mishra, R.</dc:creator>
<dc:creator>Spurrell, M.</dc:creator>
<dc:creator>Menon, R.</dc:creator>
<dc:creator>Kretzler, M.</dc:creator>
<dc:creator>Chen, J.</dc:creator>
<dc:creator>Nieman, L.</dc:creator>
<dc:creator>Sonny, A.</dc:creator>
<dc:creator>Demeke, D.</dc:creator>
<dc:creator>Hodgin, J.</dc:creator>
<dc:creator>Guthridge, J.</dc:creator>
<dc:creator>Fava, A.</dc:creator>
<dc:creator>Clancy, R.</dc:creator>
<dc:creator>Putterman, C.</dc:creator>
<dc:creator>Izmirly, P.</dc:creator>
<dc:creator>Belmont, H. M.</dc:creator>
<dc:creator>Kalunian, K.</dc:creator>
<dc:creator>Kamen, D.</dc:creator>
<dc:creator>Wofsy, D.</dc:creator>
<dc:creator>Buyon, J.</dc:creator>
<dc:creator>James, J. A.</dc:creator>
<dc:creator>Petri, M.</dc:creator>
<dc:creator>Diamond, B.</dc:creator>
<dc:creator>Raychaudhuri, S.</dc:creator>
<dc:creator>The Kidney Precision Medicine Project,</dc:creator>
<dc:creator>The Accelerating Medicines Partnership: RA/SLE network,</dc:creator>
<dc:creator>Hacohen, N.</dc:creator>
<dc:creator>Davidson, A.</dc:creator>
<dc:date>2023-06-25</dc:date>
<dc:identifier>doi:10.1101/2023.06.24.546409</dc:identifier>
<dc:title><![CDATA[Intrarenal myeloid subsets associated with kidney injury are comparable in mice and patients with lupus nephritis]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-06-25</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.06.29.547010v1?rss=1">
<title>
<![CDATA[
The catalytic-independent function of LSD1 modulates the epigenetic landscape of mouse embryonic stem cells 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.06.29.547010v1?rss=1</link>
<description><![CDATA[
Lysine-specific histone demethylase 1 (LSD1), which demethylates mono- or di-methylated histone H3 on lysine 4 (H3K4me1/2), is essential for early embryogenesis and development. Here we show that LSD1 is dispensable for embryonic stem cell (ESC) self-renewal but is required for ESC growth and differentiation. Reexpression of a catalytically-dead LSD1 (LSD1MUT) recovers the proliferation capability of ESCs, yet the enzymatic activity of LSD1 is essential to ensure proper differentiation. Indeed, a gain of H3K4me1 in Lsd1 knockout (KO) ESCs does not lead to major changes in global gene expression programs related to stemness. However, ablation of LSD1 but not LSD1MUT results in decreased DNMT1 and UHRF1 proteins coupled to global hypomethylation. We show that both LSD1 and LSD1MUT control protein stability of UHRF1 and DNMT1 through interaction with the ubiquitin-specific peptidase 7 (USP7) and, consequently, inhibiting DNMT1 and UHRF1 ubiquitylation. Our studies elucidate for the first time a novel mechanism by which the scaffolding function of LSD1 controls DNA methylation in ESCs.
]]></description>
<dc:creator>Malla, S.</dc:creator>
<dc:creator>Kumari, K.</dc:creator>
<dc:creator>Martinez-Gamero, C.</dc:creator>
<dc:creator>Garcia-Prieto, C. A.</dc:creator>
<dc:creator>Stransky, S.</dc:creator>
<dc:creator>Caroli, J.</dc:creator>
<dc:creator>Alvarez-Errico, D.</dc:creator>
<dc:creator>Saiki, P. A.</dc:creator>
<dc:creator>Lai, W.</dc:creator>
<dc:creator>Lyu, C.</dc:creator>
<dc:creator>Gilthorpe, J. D.</dc:creator>
<dc:creator>Wang, H.</dc:creator>
<dc:creator>Sidoli, S.</dc:creator>
<dc:creator>Mattevi, A.</dc:creator>
<dc:creator>Mateus, A.</dc:creator>
<dc:creator>Esteller, M.</dc:creator>
<dc:creator>Roman, A.</dc:creator>
<dc:creator>Aguilo, F.</dc:creator>
<dc:date>2023-06-29</dc:date>
<dc:identifier>doi:10.1101/2023.06.29.547010</dc:identifier>
<dc:title><![CDATA[The catalytic-independent function of LSD1 modulates the epigenetic landscape of mouse embryonic stem cells]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-06-29</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.06.29.547114v1?rss=1">
<title>
<![CDATA[
Transcription factor Nrf1 regulates proteotoxic stress-induced autophagy 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.06.29.547114v1?rss=1</link>
<description><![CDATA[
Cells exposed to proteotoxic stress invoke adaptive responses aimed at restoring proteostasis. Our previous studies have established a firm role for the transcription factor Nuclear factor erythroid derived 2-related factor 1 (Nrf1, also called NFE2L1) in responding to proteotoxic stress elicited by inhibition of cellular proteasome. Following proteasome inhibition, Nrf1 mediates new proteasome synthesis, thus enabling the cells to mitigate the proteotoxic stress. Here we report that under similar circumstances, multiple components of the autophagy lysosomal pathway (ALP) are transcriptionally upregulated in an Nrf1-dependent fashion, thus providing the cells with an additional route to cope with proteasome insufficiency. In response to proteasome inhibitors, Nrf1-deficient cells displayed profound defects in invoking autophagy and clearance of aggresomes. This phenomenon was also recapitulated in NGLY1 knockout cells (a model for NGLY1 disease) where Nrf1 is known to be non-functional. Overall, our results significantly expand the role of Nrf1 in shaping the cellular response to proteotoxic stress.
]]></description>
<dc:creator>Kaya, H. E. K.</dc:creator>
<dc:creator>Ward, M. A.</dc:creator>
<dc:creator>Vangala, J. R.</dc:creator>
<dc:creator>Byers, H. A.</dc:creator>
<dc:creator>Diaz, A.</dc:creator>
<dc:creator>Kaushik, S.</dc:creator>
<dc:creator>Cuervo, A. M.</dc:creator>
<dc:creator>Radhakrishnan, S. K.</dc:creator>
<dc:date>2023-06-30</dc:date>
<dc:identifier>doi:10.1101/2023.06.29.547114</dc:identifier>
<dc:title><![CDATA[Transcription factor Nrf1 regulates proteotoxic stress-induced autophagy]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-06-30</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.07.03.547423v1?rss=1">
<title>
<![CDATA[
Intratumoral immune triads are required for adoptive T cell therapy-mediated elimination of solid tumors 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.07.03.547423v1?rss=1</link>
<description><![CDATA[
Tumor-reactive CD8 T cells found in cancer patients are frequently dysfunctional, unable to halt tumor growth. Adoptive T cell transfer (ACT), the administration of large numbers of in vitro-generated cytolytic tumor-reactive CD8 T cells, is an important cancer immune therapy being pursued. However, a limitation of ACT is that transferred CD8 T cells often rapidly lose effector function, and despite exciting results in certain malignancies, few ACT clinical trials have shown responses in solid tumors. Here, we developed preclinical cancer mouse models to investigate if and how tumor-specific CD4 T cells can be enlisted to overcome CD8 T cell dysfunction in the setting of ACT. In situ confocal microscopy of color-coded cancer cells, tumor-specific CD8 and CD4 T cells, and antigen presenting cells (APC), combined with functional studies, revealed that the spatial positioning and interactions of CD8 and CD4 T cells, but not their numbers, dictates ACT efficacy and anti-tumor responses. We uncover a new role of antigen-specific CD4 T cells in addition to the known requirement for CD4 T cells during priming/activation of naive CD8 T cells. CD4 T cells must co-engage with CD8 T cells and APC cross-presenting CD8-and CD4-tumor antigens during the effector phase, forming a three-cell-cluster (triad), to license CD8 T cell cytotoxicity and mediate cancer cell elimination. Triad formation transcriptionally and epigenetically reprogram CD8 T cells, prevent T cell dysfunction/exhaustion, and ultimately lead to the elimination of large established tumors and confer long-term protection from recurrence. When intratumoral triad formation was disrupted, adoptively transferred CD8 T cells could not be reprogrammed, and tumors progressed despite equal numbers of tumor-infiltrating CD8 and CD4 T cells. Strikingly, the formation of CD4 T cell::CD8 T cell::APC triads in tumors of patients with lung cancers treated with immune checkpoint blockade was associated with clinical responses, but not CD4::APC dyads or overall numbers of CD8 or CD4 T cells, demonstrating the importance of triads in non-ACT settings in humans. Our work uncovers intratumoral triads as a key requirement for anti-tumor immunity and a new role for CD4 T cells in CD8 T cell cytotoxicity and cancer cell eradication.
]]></description>
<dc:creator>Schietinger, A.</dc:creator>
<dc:creator>Espinosa-Carrasco, G.</dc:creator>
<dc:creator>Dave, A.</dc:creator>
<dc:creator>Scrivo, A.</dc:creator>
<dc:creator>Lee, H.-S.</dc:creator>
<dc:creator>Burt, B. M.</dc:creator>
<dc:creator>Zumbo, P.</dc:creator>
<dc:creator>Betel, D.</dc:creator>
<dc:creator>Hellmann, M.</dc:creator>
<dc:date>2023-07-03</dc:date>
<dc:identifier>doi:10.1101/2023.07.03.547423</dc:identifier>
<dc:title><![CDATA[Intratumoral immune triads are required for adoptive T cell therapy-mediated elimination of solid tumors]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-07-03</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.07.08.548192v1?rss=1">
<title>
<![CDATA[
Proteomics and phosphoproteomics profiling in glutamatergic neurons and microglia in an iPSC model of Jansen de Vries Syndrome 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.07.08.548192v1?rss=1</link>
<description><![CDATA[
BackgroundJansen de Vries Syndrome (JdVS) is a rare neurodevelopmental disorder (NDD) caused by gain-of-function (GOF) truncating mutations in PPM1D exons 5 or 6. PPM1D is a serine/threonine phosphatase that plays an important role in the DNA damage response (DDR) by negatively regulating TP53 (P53). JdVS-associated mutations lead to the formation of a truncated PPM1D protein that retains catalytic activity and has a GOF effect because of reduced degradation. Somatic PPM1D exons 5 and 6 truncating mutations are well-established factors in a number of cancers, due to excessive dephosphorylation and reduced function of P53 and other substrates involved in DDR. Children with JdVS have a variety of neurodevelopmental, psychiatric, and physical problems. In addition, a small fraction has acute neuropsychiatric decompensation apparently triggered by infection or severe non-infectious environmental stress factors.

MethodsTo understand the molecular basis of JdVS, we developed an induced pluripotent stem cell (iPSC) model system. iPSCs heterozygous for the truncating variant (PPM1D+/tr), were made from a patient, and control lines engineered using CRISPR-Cas9 gene editing. Proteomics and phosphoprotemics analyses were carried out on iPSC-derived glutamatergic neurons and microglia from three control and three PPM1D+/tr iPSC lines. We also analyzed the effect of the TLR4 agonist, lipopolysaccharide, to understand how activation of the innate immune system in microglia could account for acute behavioral decompensation.

ResultsOne of the major findings was the downregulation of POGZ in unstimulated microglia. Since loss-of-function variants in the POGZ gene are well-known causes of autism spectrum disorder, the decrease in PPM1D+/tr microglia suggests this plays a role in the neurodevelopmental aspects of JdVS. In addition, neurons, baseline, and LPS-stimulated microglia show marked alterations in the expression of several E3 ubiquitin ligases, most notably UBR4, and regulators of innate immunity, chromatin structure, ErbB signaling, and splicing. In addition, pathway analysis points to overlap with neurodegenerative disorders.

LimitationsOwing to the cost and labor-intensive nature of iPSC research, the sample size was small.

ConclusionsOur findings provide insight into the molecular basis of JdVS and can be extrapolated to understand neuropsychiatric decompensation that occurs in subgroups of patients with ASD and other NDDs.
]]></description>
<dc:creator>Aguilan, J.</dc:creator>
<dc:creator>Pedrosa, E.</dc:creator>
<dc:creator>Dolstra, H.</dc:creator>
<dc:creator>Nur Baykara, R.</dc:creator>
<dc:creator>Barnes, J.</dc:creator>
<dc:creator>Zhang, J.</dc:creator>
<dc:creator>Sidoli, S.</dc:creator>
<dc:creator>Lachman, H.</dc:creator>
<dc:date>2023-07-08</dc:date>
<dc:identifier>doi:10.1101/2023.07.08.548192</dc:identifier>
<dc:title><![CDATA[Proteomics and phosphoproteomics profiling in glutamatergic neurons and microglia in an iPSC model of Jansen de Vries Syndrome]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-07-08</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.07.12.548782v1?rss=1">
<title>
<![CDATA[
Crk/Crkl regulates early angiogenesis in mouse embryos by accelerating endothelial cell maturation 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.07.12.548782v1?rss=1</link>
<description><![CDATA[
RationaleUbiquitously expressed cytoplasmic adaptors CRK and CRKL mediate multiple signaling pathways in mammalian embryogenesis. They are also associated with cardiovascular defects occurring in Miller-Dieker syndrome and 22q11.2 deletion syndrome, respectively. The embryonic mesoderm contributes to the formation of the cardiovascular system, yet the roles that Crk and Crkl play there are not understood on a single cell level.

ObjectivesTo determine functions of Crk and Crkl in the embryonic mesoderm during early mouse vascular development. Secondly, we will examine the molecular mechanisms responsible for early embryonic endothelial cell (EC) defects by performing single cell RNA-sequencing (scRNA-seq) and in vivo validation experiments.

Methods and ResultsInactivation of both Crk and Crkl together using Mesp1Cre resulted embryonic lethality with severe vascular defects. Although vasculogenesis appeared normal, angiogenesis was disrupted both in the yolk sac and embryo proper, leading to disorganized vascular networks. We performed scRNA-seq of the Mesp1Cre mesodermal lineage and found that there was upregulation of a great number of angiogenesis and cell migration related genes in ECs in the mutants, including NOTCH signaling genes such as Dll4 and Hey1. Further bioinformatic analysis of EC subpopulations identified a relative increase in the number of more differentiated angiogenic ECs and decrease in EC progenitors. Consistent with this, we identified an expansion of Dll4 expressing cells within abnormal arteries, in vivo. Also, our bioinformatic data indicates that there is dysregulated expression of lineage genes that promote EC differentiation causing accelerated cell fate progression during EC differentiation.

ConclusionsOur results show that Crk and Crkl are crucial for regulating early embryonic angiogenesis. Combined inactivation of Crk/Crkl caused precocious EC maturation with an increase of atypical differentiated angiogenic ECs and failed vascular remodeling. This is in part due to increased NOTCH signaling and altered expression of cell migration genes.
]]></description>
<dc:creator>Morrow, B. E.</dc:creator>
<dc:creator>Shi, L.</dc:creator>
<dc:creator>Song, H.</dc:creator>
<dc:creator>Zhou, B.</dc:creator>
<dc:date>2023-07-13</dc:date>
<dc:identifier>doi:10.1101/2023.07.12.548782</dc:identifier>
<dc:title><![CDATA[Crk/Crkl regulates early angiogenesis in mouse embryos by accelerating endothelial cell maturation]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-07-13</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.07.12.548702v1?rss=1">
<title>
<![CDATA[
Validation of human telomere length trans-ancestry meta-analysis association signals identifies POP5 and KBTBD6 as novel human telomere length regulation genes 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.07.12.548702v1?rss=1</link>
<description><![CDATA[
Telomere length genome-wide association studies (GWAS) have become well-powered to detect novel genes in telomere length regulation. However, no prior work has validated these putative novel genes to confirm the contribution of GWAS loci to telomere length regulation. We conducted a trans-ancestry meta-analysis of 211,369 individuals. Through enrichment analyses of chromatin state and cell-type heritability we identified blood and immune cells as the most relevant cell type to examine telomere length association signals. We validated specific GWAS associations by overexpressing KBTBD6, a component of an E3 ubiquitin ligase complex, and POP5, a component of the Ribonuclease P/MRP complex, and demonstrating that both lengthened telomeres as predicted by our statistical analyses. CRISPR/Cas9 deletion of the predicted causal regions of these association peaks in K562 immortalized blood cells reduced expression of these genes, demonstrating that these loci are related to transcriptional regulation of KBTBD6 and POP5, respectively. Together our results demonstrate the utility of telomere length GWAS in the identification of novel telomere length regulation mechanisms and highlight the importance of the proteasome-ubiquitin pathway in telomere length regulation.
]]></description>
<dc:creator>Keener, R.</dc:creator>
<dc:creator>Chhetri, S. B.</dc:creator>
<dc:creator>Connelly, C. J.</dc:creator>
<dc:creator>Taub, M. A.</dc:creator>
<dc:creator>Conomos, M. P.</dc:creator>
<dc:creator>Weinstock, J. S.</dc:creator>
<dc:creator>Ni, B.</dc:creator>
<dc:creator>Strober, B. J.</dc:creator>
<dc:creator>Aslibekyan, S.</dc:creator>
<dc:creator>Auer, P. L.</dc:creator>
<dc:creator>Barwick, L.</dc:creator>
<dc:creator>Becker, L. C.</dc:creator>
<dc:creator>Blangero, J.</dc:creator>
<dc:creator>Bleecker, E. R.</dc:creator>
<dc:creator>Brody, J. A.</dc:creator>
<dc:creator>Cade, B. E.</dc:creator>
<dc:creator>Celedon, J. C.</dc:creator>
<dc:creator>Chang, Y.-C.</dc:creator>
<dc:creator>Cupples, L. A.</dc:creator>
<dc:creator>Custer, B.</dc:creator>
<dc:creator>Freedman, B. I.</dc:creator>
<dc:creator>Gladwin, M. T.</dc:creator>
<dc:creator>Heckbert, S. R.</dc:creator>
<dc:creator>Hou, L.</dc:creator>
<dc:creator>Irvin, M. R.</dc:creator>
<dc:creator>Isasi, C. R.</dc:creator>
<dc:creator>Johnsen, J. M.</dc:creator>
<dc:creator>Kenny, E. E.</dc:creator>
<dc:creator>Kooperberg, C.</dc:creator>
<dc:creator>Minster, R. L.</dc:creator>
<dc:creator>Nekhai, S.</dc:creator>
<dc:creator>Pankratz, N.</dc:creator>
<dc:creator>Peyser, P. A.</dc:creator>
<dc:creator>Rotter, J. I.</dc:creator>
<dc:creator>Taylor, K. D.</dc:creator>
<dc:creator>Telen, M. J.</dc:creator>
<dc:creator>Wu, B.</dc:creator>
<dc:creator>Yanek, L. R.</dc:creator>
<dc:creator>Yang, I. V.</dc:creator>
<dc:creator>Albert, C.</dc:creator>
<dc:creator>Arnett, D. K.</dc:creator>
<dc:creator>Ashley-Koch, A.</dc:creator>
<dc:date>2023-07-14</dc:date>
<dc:identifier>doi:10.1101/2023.07.12.548702</dc:identifier>
<dc:title><![CDATA[Validation of human telomere length trans-ancestry meta-analysis association signals identifies POP5 and KBTBD6 as novel human telomere length regulation genes]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-07-14</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.07.25.550347v1?rss=1">
<title>
<![CDATA[
The components of an electrical synapse as revealed by expansion microscopy of a single synaptic contact 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.07.25.550347v1?rss=1</link>
<description><![CDATA[
Most nervous systems combine both transmitter-mediated and direct cell-cell communication, known as  chemical and  electrical synapses, respectively. Chemical synapses can be identified by their multiple structural components. Electrical synapses are, on the other hand, generally defined by the presence of a  gap junction (a cluster of intercellular channels) between two neuronal processes. However, while gap junctions provide the communicating mechanism, it is unknown whether electrical transmission requires the contribution of additional cellular structures. We investigated this question at identifiable single synaptic contacts on the zebrafish Mauthner cells, at which gap junctions coexist with specializations for neurotransmitter release and where the contact defines the anatomical limits of a synapse. Expansion microscopy of these contacts revealed a detailed map of the incidence and spatial distribution of proteins pertaining to various synaptic structures. Multiple gap junctions of variable size were identified by the presence of their molecular components. Remarkably, most of the synaptic contacts surface was occupied by interleaving gap junctions and components of adherens junctions, suggesting a close functional association between these two structures. In contrast, glutamate receptors were confined to small peripheral portions of the contact, indicating that most of the synaptic area works as an electrical synapse. Thus, our results revealed the overarching organization of an electrical synapse that operates with not one, but multiple gap junctions, in close association with structural and signaling molecules known to be components of AJs. The relationship between these intercellular structures will aid in establishing the boundaries of electrical synapses found throughout animal connectomes and provide insight into the structural organization and functional diversity of electrical synapses.
]]></description>
<dc:creator>Cardenas- Garcia, S. P.</dc:creator>
<dc:creator>Ijaz, S.</dc:creator>
<dc:creator>Pereda, A. E.</dc:creator>
<dc:date>2023-07-28</dc:date>
<dc:identifier>doi:10.1101/2023.07.25.550347</dc:identifier>
<dc:title><![CDATA[The components of an electrical synapse as revealed by expansion microscopy of a single synaptic contact]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-07-28</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.08.01.551382v1?rss=1">
<title>
<![CDATA[
Lysosomal release of amino acids at ER three-way junctions regulates transmembrane and secretory protein mRNA translation 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.08.01.551382v1?rss=1</link>
<description><![CDATA[
One-third of the mammalian proteome is comprised of transmembrane and secretory proteins that are synthesized on endoplasmic reticulum (ER). Here, we investigate the spatial distribution and regulation of mRNAs encoding these membrane and secretory proteins (termed "secretome" mRNAs) through live cell, single molecule tracking to directly monitor the position and translation states of secretome mRNAs on ER and their relationship to other organelles. Notably, translation of secretome mRNAs occurred preferentially near lysosomes on ER marked by the ER junction-associated protein, Lunapark. Knockdown of Lunapark reduced the extent of secretome mRNA translation without affecting translation of other mRNAs. Less secretome mRNA translation also occurred when lysosome function was perturbed by raising lysosomal pH or inhibiting lysosomal proteases. Secretome mRNA translation near lysosomes was enhanced during amino acid deprivation. Addition of the integrated stress response inhibitor, ISRIB, reversed the translation inhibition seen in Lunapark knockdown cells, implying an eIF2 dependency. Altogether, these findings uncover a novel coordination between ER and lysosomes, in which local release of amino acids and other factors from ER-associated lysosomes patterns and regulates translation of mRNAs encoding secretory and membrane proteins.
]]></description>
<dc:creator>Choi, H.</dc:creator>
<dc:creator>Liao, Y.-C.</dc:creator>
<dc:creator>Yoon, Y. J.</dc:creator>
<dc:creator>Grimm, J. B.</dc:creator>
<dc:creator>Lavis, L.</dc:creator>
<dc:creator>Singer, R. H.</dc:creator>
<dc:creator>Lippincott-Schwartz, J.</dc:creator>
<dc:date>2023-08-03</dc:date>
<dc:identifier>doi:10.1101/2023.08.01.551382</dc:identifier>
<dc:title><![CDATA[Lysosomal release of amino acids at ER three-way junctions regulates transmembrane and secretory protein mRNA translation]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-08-03</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.08.02.551676v1?rss=1">
<title>
<![CDATA[
Loss of synaptopodin impairs mGluR5 and protein synthesis dependent mGluR-LTD at CA3-CA1 synapses 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.08.02.551676v1?rss=1</link>
<description><![CDATA[
Metabotropic glutamate receptor-dependent long-term depression (mGluR-LTD) is an important form of synaptic plasticity that occurs in many regions of the CNS and is the underlying mechanism for several learning paradigms. In the hippocampus, mGluR-LTD is manifested by the weakening of synaptic transmission and elimination of dendritic spines. Interestingly, not all spines respond or undergo plasticity equally in response to mGluR-LTD. A subset of dendritic spines containing synaptopodin (SP), an actin-associated protein, are critical for mGluR-LTD and protect spines from elimination through mGluR1 activity. The precise cellular function of SP is still enigmatic and it is still unclear how SP contributes to the functional aspect of mGluR-LTD despite of its modulation on the structural plasticity. In the present study, we show that the lack of SP impairs mGluR-LTD by negatively affecting the mGluR5-dependent activity. Such impairment of mGluR5 activity is accompanied by a significant decrease of surface mGluR5 level in SP knockout (SPKO) mice. Intriguingly, the remaining mGluR-LTD becomes a protein synthesis-independent process in the SPKO and is mediated instead by endocannabinoid signaling. These data show for the first time that the postsynaptic protein SP can regulate the locus of expression of mGluR-LTD and provide insight to our understanding of spine/synapse-specific plasticity.

Significance statementHippocampal group I metabotropic glutamate receptor dependent long-term depression (mGluR-LTD), a form of learning and memory, is misregulated in many murine models of neurodevelopmental disorders. Despite extensive studies there is a paucity of information on the molecular mechanism underlying mGluR-LTD. Previously, we reported that loss of synaptopodin, an actin-associated protein found in a subset of mature dendritic spines, impairs mGluR-LTD. In the current study, we uncover the molecular and cellular deficits involved. We find that synaptopodin is required for the mGluR5-Homer interaction and uncover synaptopodin as a molecular switch for mGluR-LTD expression, as mGluR-LTD becomes protein synthesis-independent and relies on endocannabinoid signaling in synaptopodin knock-out. This work provides insight into synaptopodin as a gatekeeper to regulate mGluR-LTD at hippocampal synapses.
]]></description>
<dc:creator>Wu, P. Y.</dc:creator>
<dc:creator>Ji, L.</dc:creator>
<dc:creator>De Sanctis, C.</dc:creator>
<dc:creator>Francesconi, A.</dc:creator>
<dc:creator>Inglebert, Y.</dc:creator>
<dc:creator>McKinney, R. A.</dc:creator>
<dc:date>2023-08-03</dc:date>
<dc:identifier>doi:10.1101/2023.08.02.551676</dc:identifier>
<dc:title><![CDATA[Loss of synaptopodin impairs mGluR5 and protein synthesis dependent mGluR-LTD at CA3-CA1 synapses]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-08-03</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.08.02.551681v1?rss=1">
<title>
<![CDATA[
Targeting the dependence on PIK3C3-mTORC1 signaling in dormancy-prone breast cancer cells blunts metastasis initiation 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.08.02.551681v1?rss=1</link>
<description><![CDATA[
Halting breast cancer metastatic relapses following primary tumor removal and the clinical dormant phase, remains challenging, due to a lack of specific vulnerabilities to target during dormancy. To address this, we conducted genome-wide CRISPR screens on two breast cancer cell lines with distinct dormancy properties: 4T1 (short-term dormancy) and 4T07 (prolonged dormancy). We discovered that loss of class-III PI3K, Pik3c3, revealed a unique vulnerability in 4T07 cells. Surprisingly, dormancy-prone 4T07 cells exhibited higher mTORC1 activity than 4T1 cells, due to lysosome-dependent signaling occurring at the cell periphery. Pharmacological inhibition of Pik3c3 counteracted this phenotype in 4T07 cells, and selectively reduced metastasis burden only in the 4T07 dormancy-prone model. This mechanism was also detected in human breast cancer cell lines in addition to a breast cancer patient-derived xenograft supporting that it may be relevant in humans. Our findings suggest dormant cancer cell-initiated metastasis may be prevented in patients carrying tumor cells that display PIK3C3-peripheral lysosomal signaling to mTORC1.

Statement of SignificanceWe reveal that dormancy-prone breast cancer cells depend on the class III PI3K to mediate a constant peripheral lysosomal positioning and mTORC1 hyperactivity. Targeting this pathway might blunt breast cancer metastasis.
]]></description>
<dc:creator>Elkholi, I. E.</dc:creator>
<dc:creator>Robert, A.</dc:creator>
<dc:creator>Kuasne, H.</dc:creator>
<dc:creator>Drapela, S.</dc:creator>
<dc:creator>Macleod, G.</dc:creator>
<dc:creator>Hebert, S.</dc:creator>
<dc:creator>Pacis, A.</dc:creator>
<dc:creator>Calderon, V.</dc:creator>
<dc:creator>Kleinman, C. L.</dc:creator>
<dc:creator>Gomes, A. P.</dc:creator>
<dc:creator>Aguirre-Ghiso, J. A.</dc:creator>
<dc:creator>Park, M.</dc:creator>
<dc:creator>Angers, S.</dc:creator>
<dc:creator>Cote, J.-F.</dc:creator>
<dc:date>2023-08-05</dc:date>
<dc:identifier>doi:10.1101/2023.08.02.551681</dc:identifier>
<dc:title><![CDATA[Targeting the dependence on PIK3C3-mTORC1 signaling in dormancy-prone breast cancer cells blunts metastasis initiation]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-08-05</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.08.05.552096v1?rss=1">
<title>
<![CDATA[
Sex-Specific Developmental Gene Expression Atlas Unveils Dimorphic Gene Networks in C. elegans 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.08.05.552096v1?rss=1</link>
<description><![CDATA[
Sex-specific traits and behaviors emerge during development by the acquisition of unique properties in the nervous system of each sex. However, the genetic events responsible for introducing these sex-specific features remain poorly understood. In this study, we created a comprehensive gene expression atlas for both sexes of the nematode Caenorhabditis elegans across development. By comparing the transcriptome of pure populations of hermaphrodites and males from early larval stages to adulthood, we discovered numerous differentially expressed genes, including neuronal gene families like transcription factors, neuropeptides, and GPCRs. We identified INS-39, an insulin-like peptide, as a prominent male-biased gene expressed specifically in ciliated sensory neurons. We show that INS-39 serves as an early-stage male marker, facilitating the effective isolation of males in high-throughput experiments. Through complex and sex-specific regulation, ins-39 plays pleiotropic sexually-dimorphic roles in temperature sensation, survival in cold temperatures, resilience against high hydrogen peroxide levels, and dauer entry, while also playing a shared, dimorphic role in early life stress. This study offers a comparative sexual and developmental gene expression database for C. elegans, which will facilitate research into the genetic regulation of the sexual development of other organisms. Furthermore, it highlights conserved candidate genes that may underlie the sexually-dimorphic manifestation of different human diseases.
]]></description>
<dc:creator>Haque, R.</dc:creator>
<dc:creator>Peedikayil-Kurien, S.</dc:creator>
<dc:creator>Setty, H.</dc:creator>
<dc:creator>Salzberg, Y.</dc:creator>
<dc:creator>Stelzer, G.</dc:creator>
<dc:creator>Litvak, E.</dc:creator>
<dc:creator>Gingold, H.</dc:creator>
<dc:creator>Rechavi, O.</dc:creator>
<dc:creator>Oren-Suissa, M.</dc:creator>
<dc:date>2023-08-06</dc:date>
<dc:identifier>doi:10.1101/2023.08.05.552096</dc:identifier>
<dc:title><![CDATA[Sex-Specific Developmental Gene Expression Atlas Unveils Dimorphic Gene Networks in C. elegans]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-08-06</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.08.03.551473v1?rss=1">
<title>
<![CDATA[
An oligodendrocyte silencer element underlies the pathogenic impact of lamin B1 structural variants 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.08.03.551473v1?rss=1</link>
<description><![CDATA[
The role of non-coding regulatory elements and how they might contribute to tissue type specificity of disease phenotypes is poorly understood. Autosomal Dominant Leukodystrophy (ADLD) is a fatal, adult-onset, neurological disorder that is characterized by extensive CNS demyelination. Most cases of ADLD are caused by tandem genomic duplications involving the lamin B1 gene (LMNB1) while a small subset are caused by genomic deletions upstream of the gene. Utilizing data from recently identified families that carry LMNB1 gene duplications but do not exhibit demyelination, ADLD patient tissues, CRISPR modified cell lines and mouse models, we have identified a novel silencer element that is lost in ADLD patients and that specifically targets overexpression to oligodendrocytes. This element consists of CTCF binding sites that mediate three-dimensional chromatin looping involving the LMNB1 and the recruitment of the PRC2 repressor complex. Loss of the silencer element in ADLD identifies a previously unknown role for silencer elements in tissue specificity and disease causation.
]]></description>
<dc:creator>Nmezi, B.</dc:creator>
<dc:creator>Bey, G. R.</dc:creator>
<dc:creator>Oranburg, T. D.</dc:creator>
<dc:creator>Dudnyk, K.</dc:creator>
<dc:creator>Morgan, S.</dc:creator>
<dc:creator>Herdman, N.</dc:creator>
<dc:creator>Jacko, A.</dc:creator>
<dc:creator>Rubio, S.</dc:creator>
<dc:creator>Alcocer, E. L.</dc:creator>
<dc:creator>Kofler, J.</dc:creator>
<dc:creator>Kim, D.</dc:creator>
<dc:creator>Rankin, J.</dc:creator>
<dc:creator>Kivuva, E.</dc:creator>
<dc:creator>Gutowski, N.</dc:creator>
<dc:creator>Schon, K.</dc:creator>
<dc:creator>van den Ameele, J.</dc:creator>
<dc:creator>Chinnery, P. F.</dc:creator>
<dc:creator>Sousa, S. B.</dc:creator>
<dc:creator>Palavra, F.</dc:creator>
<dc:creator>Toro, C.</dc:creator>
<dc:creator>Pinto e Vairo, F.</dc:creator>
<dc:creator>Saute, J.</dc:creator>
<dc:creator>Pan, L.</dc:creator>
<dc:creator>Alturkustani, M.</dc:creator>
<dc:creator>Hammond, R.</dc:creator>
<dc:creator>Gros-Louis, F.</dc:creator>
<dc:creator>Gold, M.</dc:creator>
<dc:creator>Park, Y.</dc:creator>
<dc:creator>Bernard, G.</dc:creator>
<dc:creator>Raininko, R.</dc:creator>
<dc:creator>Zhou, J.</dc:creator>
<dc:creator>Hainer, S.</dc:creator>
<dc:creator>Padiath, Q.</dc:creator>
<dc:date>2023-08-07</dc:date>
<dc:identifier>doi:10.1101/2023.08.03.551473</dc:identifier>
<dc:title><![CDATA[An oligodendrocyte silencer element underlies the pathogenic impact of lamin B1 structural variants]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-08-07</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.08.09.551369v1?rss=1">
<title>
<![CDATA[
Plasma Glycomic Markers of Accelerated Biological Aging During Chronic HIV Infection 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.08.09.551369v1?rss=1</link>
<description><![CDATA[
People with HIV (PWH) experience an increased vulnerability to premature aging and inflammation-associated comorbidities, even when HIV replication is suppressed by antiretroviral therapy (ART). However, the factors that contribute to or are associated with this vulnerability remain uncertain. In the general population, alterations in the glycomes of circulating IgGs trigger inflammation and precede the onset of aging-associated diseases. Here, we investigate the IgG glycomes of cross-sectional and longitudinal samples from 1,216 women and men, both living with virally suppressed HIV and those without HIV. Our glycan-based machine learning models indicate that living with chronic HIV significantly accelerates the accumulation of pro-aging-associated glycomic alterations. Consistently, PWH exhibit heightened expression of senescence-associated glycan-degrading enzymes compared to their controls. These glycomic alterations correlate with elevated markers of inflammatory aging and the severity of comorbidities, potentially preceding the development of such comorbidities. Mechanistically, HIV-specific antibodies glycoengineered with these alterations exhibit reduced anti-HIV IgG-mediated innate immune functions. These findings hold significant potential for the development of glycomic-based biomarkers and tools to identify and prevent premature aging and comorbidities in people living with chronic viral infections.
]]></description>
<dc:creator>Giron, L. B.</dc:creator>
<dc:creator>Liu, Q.</dc:creator>
<dc:creator>Adeniji, O. S.</dc:creator>
<dc:creator>Yin, X.</dc:creator>
<dc:creator>Kannan, T.</dc:creator>
<dc:creator>Ding, J.</dc:creator>
<dc:creator>Lu, D. Y.</dc:creator>
<dc:creator>Langan, S.</dc:creator>
<dc:creator>Zhang, J.</dc:creator>
<dc:creator>Azevedo, J. L. L. C.</dc:creator>
<dc:creator>Hanna, D. B.</dc:creator>
<dc:creator>Ofotokun, I.</dc:creator>
<dc:creator>Lazar, J.</dc:creator>
<dc:creator>Fischl, M. A.</dc:creator>
<dc:creator>Haberlen, S.</dc:creator>
<dc:creator>Macatangay, B.</dc:creator>
<dc:creator>Adimora, A. A.</dc:creator>
<dc:creator>Jamieson, B. D.</dc:creator>
<dc:creator>Rinaldo, C.</dc:creator>
<dc:creator>Merenstein, D.</dc:creator>
<dc:creator>Roan, N. R.</dc:creator>
<dc:creator>Kutsch, O.</dc:creator>
<dc:creator>Gange, S.</dc:creator>
<dc:creator>Wolinsky, S.</dc:creator>
<dc:creator>Witt, M.</dc:creator>
<dc:creator>Post, W. S.</dc:creator>
<dc:creator>Kossenkov, A.</dc:creator>
<dc:creator>Landay, A.</dc:creator>
<dc:creator>Frank, I.</dc:creator>
<dc:creator>Tien, P. C.</dc:creator>
<dc:creator>Gross, R.</dc:creator>
<dc:creator>Brown, T. T.</dc:creator>
<dc:creator>Mohsen, M. A.</dc:creator>
<dc:date>2023-08-10</dc:date>
<dc:identifier>doi:10.1101/2023.08.09.551369</dc:identifier>
<dc:title><![CDATA[Plasma Glycomic Markers of Accelerated Biological Aging During Chronic HIV Infection]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-08-10</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.08.09.552687v1?rss=1">
<title>
<![CDATA[
Brain Specific Estrogen Ameliorates Cognitive Effects of Surgical Menopause in Mice 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.08.09.552687v1?rss=1</link>
<description><![CDATA[
Menopause is a major endocrinological shift that leads to an increased vulnerability to the risk factors for cognitive impairment and dementia. This is thought to be due to the loss of circulating estrogens, which exert many potent neuroprotective effects in the brain. Systemic replacement of estrogen post-menopause has many limitations, including increased risk for estrogen-sensitive cancers. A more promising therapeutic approach therefore might be to deliver estrogen only to the brain thus limiting adverse peripheral side effects. We examined whether we could enhance cognitive performance by delivering estrogen exclusively to the brain in post-menopausal mice. We modeled surgical menopause via bilateral ovariectomy (OVX). We treated mice with the pro-drug 10{beta},17{beta}-dihydroxyestra-1,4-dien-3-one (DHED), which can be administered systemically but is converted to 17{beta}-estradiol only in the brain. Young (2.5-month) and middle-aged (11-month-old) female C57BL/6J mice received ovariectomy and a subcutaneous implant containing vehicle (cholesterol) or DHED. At 3.5 months old (young group) and 14.5 months old (middle-aged group), mice underwent behavior testing to assess memory. DHED did not significantly alter metabolic status in middle-aged, post-menopausal mice. In both young and middle-aged mice, the brain-specific estrogen DHED improved spatial memory. Additional testing in middle-aged mice also showed that DHED improved working and recognition memory. These promising results lay the foundation for future studies aimed at determining if this intervention is as efficacious in models of dementia that have comorbid risk factors.
]]></description>
<dc:creator>Salinero, A. E.</dc:creator>
<dc:creator>Abi-Ghanem, C.</dc:creator>
<dc:creator>Venkataganesh, H.</dc:creator>
<dc:creator>Sura, A.</dc:creator>
<dc:creator>Smith, R. M.</dc:creator>
<dc:creator>Thrasher, C. A.</dc:creator>
<dc:creator>Kelly, R. D.</dc:creator>
<dc:creator>Hatcher, K. M.</dc:creator>
<dc:creator>Nyblom, V.</dc:creator>
<dc:creator>Shamlian, V.</dc:creator>
<dc:creator>Kyaw, N.-R.</dc:creator>
<dc:creator>Belanger, K. M.</dc:creator>
<dc:creator>Gannon, O. J.</dc:creator>
<dc:creator>Stephens, S. B.</dc:creator>
<dc:creator>Zuloaga, D. G.</dc:creator>
<dc:creator>Zuloaga, K. L.</dc:creator>
<dc:date>2023-08-13</dc:date>
<dc:identifier>doi:10.1101/2023.08.09.552687</dc:identifier>
<dc:title><![CDATA[Brain Specific Estrogen Ameliorates Cognitive Effects of Surgical Menopause in Mice]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-08-13</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.09.04.556156v1?rss=1">
<title>
<![CDATA[
KAT2 paralogs prevent dsRNA accumulation and interferon signaling to maintain intestinal stem cells 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.09.04.556156v1?rss=1</link>
<description><![CDATA[
Histone acetyltransferases KAT2A and KAT2B are paralogs highly expressed in the intestinal epithelium, but their functions are not well understood. In this study, double knockout of murine Kat2 genes in the intestinal epithelium was lethal, resulting in robust activation of interferon signaling and interferon-associated phenotypes including the loss of intestinal stem cells. Use of pharmacological agents and sterile organoid cultures indicated a cell-intrinsic double-stranded RNA trigger for interferon signaling. Acetyl-proteomics and dsRIP-seq were employed to interrogate the mechanism behind this response, which identified mitochondria-encoded double-stranded RNA as the source of intrinsic interferon signaling. Kat2a and Kat2b therefore play an essential role in regulating mitochondrial functions as well as maintaining intestinal health.

Highlights of the workO_LIKat2a and Kat2b double knockout in the murine intestinal epithelium triggers activation of the interferon signaling pathway
C_LIO_LIKat2a/Kat2b knockout leads to intestinal stem cell loss and other mucosal phenotypes consistent with interferon activation
C_LIO_LIHistone PTM mass spec profiling reveals the first in vivo study showing H3K9ac-specific loss with Kat2a and Kat2b double knockout, yet without correlation to interferon signaling pathway genes
C_LIO_LIComprehensive proteomic analysis identifies non-histone acetyl-lysine targets of KAT2 in the mouse intestine in vivo, including mitochondrial proteins
C_LIO_LIMitochondrial function is compromised upon Kat2 loss
C_LIO_LIdsRIP-seq identifies double-stranded RNA from the mitochondria as a trigger for the intrinsic immune response upon Kat2 double knockout
C_LI
]]></description>
<dc:creator>Nguyen, M.-U. T.</dc:creator>
<dc:creator>Potgieter, S.</dc:creator>
<dc:creator>Huang, W.</dc:creator>
<dc:creator>Pfeffer, J.</dc:creator>
<dc:creator>Woo, S.</dc:creator>
<dc:creator>Zhao, C.</dc:creator>
<dc:creator>Lawlor, M.</dc:creator>
<dc:creator>Yang, R.</dc:creator>
<dc:creator>Halstead, A.</dc:creator>
<dc:creator>Dent, S.</dc:creator>
<dc:creator>Saenz, J.</dc:creator>
<dc:creator>Zheng, H.</dc:creator>
<dc:creator>Yuan, Z.-F.</dc:creator>
<dc:creator>Sidoli, S.</dc:creator>
<dc:creator>Ellison, C. E.</dc:creator>
<dc:creator>Verzi, M.</dc:creator>
<dc:date>2023-09-05</dc:date>
<dc:identifier>doi:10.1101/2023.09.04.556156</dc:identifier>
<dc:title><![CDATA[KAT2 paralogs prevent dsRNA accumulation and interferon signaling to maintain intestinal stem cells]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-09-05</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.09.05.556409v1?rss=1">
<title>
<![CDATA[
Conserved nucleocytoplasmic density homeostasis drives cellular organization across eukaryotes 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.09.05.556409v1?rss=1</link>
<description><![CDATA[
The packing and confinement of macromolecules in the cytoplasm and nucleoplasm has profound implications for cellular biochemistry. How intracellular density distributions vary and affect cellular physiology remains largely unknown. Here, we show that the nucleus is less dense than the cytoplasm and that living systems establish and maintain a constant density ratio between these compartments. Using label-free biophotonics and theory, we show that nuclear density is set by a pressure balance across the nuclear envelope in vitro, in vivo and during early development. Nuclear transport establishes a specific nuclear proteome that exerts a colloid osmotic pressure, which, assisted by entropic chromatin pressure, draws water into the nucleus. Using C. elegans, we show that while nuclear-to-cytoplasmic (N/C) volume ratios change during early development, the N/C density ratio is robustly maintained. We propose that the maintenance of a constant N/C density ratio is the biophysical driver of one of the oldest tenets of cell biology: the N/C volume ratio. In summary, this study reveals a previously unidentified homeostatic coupling of macromolecular densities that drives cellular organization with implications for pathophysiologies such as senescence and cancer.
]]></description>
<dc:creator>Biswas, A.</dc:creator>
<dc:creator>Munoz, O.</dc:creator>
<dc:creator>Kim, K.</dc:creator>
<dc:creator>Hoege, C.</dc:creator>
<dc:creator>Lorton, B. M.</dc:creator>
<dc:creator>Shechter, D.</dc:creator>
<dc:creator>Guck, J.</dc:creator>
<dc:creator>Zaburdaev, V.</dc:creator>
<dc:creator>Reber, S.</dc:creator>
<dc:date>2023-09-06</dc:date>
<dc:identifier>doi:10.1101/2023.09.05.556409</dc:identifier>
<dc:title><![CDATA[Conserved nucleocytoplasmic density homeostasis drives cellular organization across eukaryotes]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-09-06</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.09.08.556812v1?rss=1">
<title>
<![CDATA[
Encoding the Space of Protein-protein Binding Interfaces by Artificial Intelligence 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.09.08.556812v1?rss=1</link>
<description><![CDATA[
The physical interactions between proteins are largely determined by the structural properties at their binding interfaces. It was found that the binding interfaces in distinctive protein complexes are highly similar. The structural properties underlying different binding interfaces could be further captured by artificial intelligence. In order to test this hypothesis, we broke protein-protein binding interfaces into pairs of interacting fragments. We employed a generative model to encode these interface fragment pairs in a low-dimensional latent space. After training, new conformations of interface fragment pairs were generated. We found that, by only using a small number of interface fragment pairs that were generated by artificial intelligence, we were able to guide the assembly of protein complexes into their native conformations. These results demonstrate that the conformational space of fragment pairs at protein-protein binding interfaces is highly degenerate. Our study illustrates how artificial intelligence can be used to understand and characterize protein-protein binding interfaces. The method will be potentially useful to search for the conformation of unknown protein-protein interactions. This result demonstrated that the structural space of protein-protein interactions is highly degenerate under the representation of interface fragment pairs. Features in this degenerate space can be well characterized by artificial intelligence. In summary, our machine learning method will be potentially useful to search for and predict the conformations of unknown protein-protein interactions.
]]></description>
<dc:creator>Su, Z.</dc:creator>
<dc:creator>Dhusia, K.</dc:creator>
<dc:creator>Wu, Y.</dc:creator>
<dc:date>2023-09-10</dc:date>
<dc:identifier>doi:10.1101/2023.09.08.556812</dc:identifier>
<dc:title><![CDATA[Encoding the Space of Protein-protein Binding Interfaces by Artificial Intelligence]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-09-10</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.09.10.555215v1?rss=1">
<title>
<![CDATA[
Whole Genome Sequencing Based Analysis of Inflammation Biomarkers in the Trans-Omics for Precision Medicine (TOPMed) Consortium 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.09.10.555215v1?rss=1</link>
<description><![CDATA[
Inflammation biomarkers can provide valuable insight into the role of inflammatory processes in many diseases and conditions. Sequencing based analyses of such biomarkers can also serve as an exemplar of the genetic architecture of quantitative traits. To evaluate the biological insight, which can be provided by a multi-ancestry, whole-genome based association study, we performed a comprehensive analysis of 21 inflammation biomarkers from up to 38,465 individuals with whole-genome sequencing from the Trans-Omics for Precision Medicine (TOPMed) program. We identified 22 distinct single-variant associations across 6 traits - E-selectin, intercellular adhesion molecule 1, interleukin-6, lipoprotein-associated phospholipase A2 activity and mass, and P-selectin - that remained significant after conditioning on previously identified associations for these inflammatory biomarkers. We further expanded upon known biomarker associations by pairing the single-variant analysis with a rare variant set-based analysis that further identified 19 significant rare variant set-based associations with 5 traits. These signals were distinct from both significant single variant association signals within TOPMed and genetic signals observed in prior studies, demonstrating the complementary value of performing both single and rare variant analyses when analyzing quantitative traits. We also confirm several previously reported signals from semi-quantitative proteomics platforms. Many of these signals demonstrate the extensive allelic heterogeneity and ancestry-differentiated variant-trait associations common for inflammation biomarkers, a characteristic we hypothesize will be increasingly observed with well-powered, large-scale analyses of complex traits.
]]></description>
<dc:creator>Jiang, M.-Z.</dc:creator>
<dc:creator>Gaynor, S. M.</dc:creator>
<dc:creator>Li, X.</dc:creator>
<dc:creator>Van Buren, E.</dc:creator>
<dc:creator>Stilp, A.</dc:creator>
<dc:creator>Buth, E.</dc:creator>
<dc:creator>Wang, F. F.</dc:creator>
<dc:creator>Manansala, R.</dc:creator>
<dc:creator>Gogarten, S. M.</dc:creator>
<dc:creator>Li, Z.</dc:creator>
<dc:creator>Polfus, L. M.</dc:creator>
<dc:creator>Salimi, S.</dc:creator>
<dc:creator>Bis, J. C.</dc:creator>
<dc:creator>Pankratz, N.</dc:creator>
<dc:creator>Yanek, L. R.</dc:creator>
<dc:creator>Durda, P.</dc:creator>
<dc:creator>Tracy, R. P.</dc:creator>
<dc:creator>Rich, S. S.</dc:creator>
<dc:creator>Rotter, J. I.</dc:creator>
<dc:creator>Mitchell, B. D.</dc:creator>
<dc:creator>Lewis, J. P.</dc:creator>
<dc:creator>Psaty, B. M.</dc:creator>
<dc:creator>Pratte, K. A.</dc:creator>
<dc:creator>Silverman, E. K.</dc:creator>
<dc:creator>Kaplan, R. C.</dc:creator>
<dc:creator>Avery, C.</dc:creator>
<dc:creator>North, K.</dc:creator>
<dc:creator>Mathias, R. A.</dc:creator>
<dc:creator>Faraday, N.</dc:creator>
<dc:creator>Lin, H.</dc:creator>
<dc:creator>Wang, B.</dc:creator>
<dc:creator>Carson, A. P.</dc:creator>
<dc:creator>Norwood, A. F.</dc:creator>
<dc:creator>Gibbs, R. A.</dc:creator>
<dc:creator>Kooperberg, C.</dc:creator>
<dc:creator>Lundin, J.</dc:creator>
<dc:creator>Peters, U.</dc:creator>
<dc:creator>Dupuis, J.</dc:creator>
<dc:creator>Hou, L.</dc:creator>
<dc:creator>Fornage, M.</dc:creator>
<dc:creator>Benjamin, E. J.</dc:creator>
<dc:creator>Reiner, A. P.</dc:creator>
<dc:creator>Bowler, R. P.</dc:creator>
<dc:creator>Lin, X.</dc:creator>
<dc:creator>Auer, P. L.</dc:creator>
<dc:creator>Raf</dc:creator>
<dc:date>2023-09-12</dc:date>
<dc:identifier>doi:10.1101/2023.09.10.555215</dc:identifier>
<dc:title><![CDATA[Whole Genome Sequencing Based Analysis of Inflammation Biomarkers in the Trans-Omics for Precision Medicine (TOPMed) Consortium]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-09-12</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.09.11.557255v1?rss=1">
<title>
<![CDATA[
Prenatal vitamin D deficiency alters immune cell proportions of young adult offspring through alteration of long-term stem cell fates 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.09.11.557255v1?rss=1</link>
<description><![CDATA[
Vitamin D deficiency is a common deficiency worldwide, particularly among women of reproductive age. During pregnancy, it increases the risk of immune-related diseases in offspring later in life. However, exactly how the body remembers exposure to an adverse environment during development is poorly understood. Herein, we explore the effects of prenatal vitamin D deficiency on immune cell proportions in offspring using vitamin D deficient mice established by dietary manipulation. We found that prenatal vitamin D deficiency alters immune cell proportions in offspring by changing the transcriptional properties of genes downstream of vitamin D receptor signaling in hematopoietic stem and progenitor cells of both the fetus and adults. Our results suggest the role of cellular differentiation properties of the hematopoiesis as the long-term memories of prenatal exposure at the adult stage. Moreover, further investigations of the associations between maternal vitamin D levels and cord blood immune cell profiles from 75 healthy pregnant women and their term babies also confirm that maternal vitamin D levels in the second trimester significantly affect immune cell proportions in the babies. This highlights the importance of providing vitamin D supplementation at specific stages of pregnancy.
]]></description>
<dc:creator>Ueda, K.</dc:creator>
<dc:creator>Chin, S. S.</dc:creator>
<dc:creator>Sato, N.</dc:creator>
<dc:creator>NIshikawa, M.</dc:creator>
<dc:creator>Yasuda, K.</dc:creator>
<dc:creator>Miyasaka, N.</dc:creator>
<dc:creator>Bera, B. S.</dc:creator>
<dc:creator>Chorro, L.</dc:creator>
<dc:creator>Dona-Termine, R.</dc:creator>
<dc:creator>Koba, W. R.</dc:creator>
<dc:creator>Reynolds, D.</dc:creator>
<dc:creator>Steidl, U. G.</dc:creator>
<dc:creator>Lauvau, G.</dc:creator>
<dc:creator>Greally, J. M.</dc:creator>
<dc:creator>Suzuki, M.</dc:creator>
<dc:date>2023-09-13</dc:date>
<dc:identifier>doi:10.1101/2023.09.11.557255</dc:identifier>
<dc:title><![CDATA[Prenatal vitamin D deficiency alters immune cell proportions of young adult offspring through alteration of long-term stem cell fates]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-09-13</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.09.12.557337v1?rss=1">
<title>
<![CDATA[
Prediction of Interactions between Cell Surface Proteins by Machine Learning 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.09.12.557337v1?rss=1</link>
<description><![CDATA[
Cells detect changes of external environments or communicate with each other through proteins on their surfaces. These cell surface proteins form a complicated network of interactions in order to fulfill their functions. The interactions between cell surface proteins are highly dynamic and thus challenging to detect using traditional experimental techniques. Here we tackle this challenge by a computational framework. The primary focus of the framework is to develop new tools to identify interactions between domains in immunoglobulin (Ig) fold, which is the most abundant domain family in cell surface proteins. These interactions could be formed between ligands and receptors from different cells, or between proteins on the same cell surface. In practice, we collected all structural data of Ig domain interactions and transformed them into an interface fragment pair library. A high dimensional profile can be then constructed from the library for a given pair of query protein sequences. Multiple machine learning models were used to read this profile, so that the probability of interaction between the query proteins can be predicted. We tested our models to an experimentally derived dataset which contains 564 cell surface proteins in human. The cross-validation results show that we can achieve higher than 70% accuracy in identifying the PPIs within this dataset. We then applied this method to a group of 46 cell surface proteins in C elegans. We screened every possible interaction between these proteins. Many interactions recognized by our machine learning classifiers have been experimentally confirmed in the literatures. In conclusion, our computational platform serves a useful tool to help identifying potential new interactions between cell surface proteins in addition to current state-of-the-art experimental techniques. The tool is freely accessible for use by the scientific community. Moreover, the general framework of the machine learning classification can also be extended to study interactions of proteins in other domain superfamilies.
]]></description>
<dc:creator>Su, Z.</dc:creator>
<dc:creator>Griffin, B.</dc:creator>
<dc:creator>Emmons, S.</dc:creator>
<dc:creator>Wu, Y.</dc:creator>
<dc:date>2023-09-14</dc:date>
<dc:identifier>doi:10.1101/2023.09.12.557337</dc:identifier>
<dc:title><![CDATA[Prediction of Interactions between Cell Surface Proteins by Machine Learning]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-09-14</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.09.17.558139v1?rss=1">
<title>
<![CDATA[
Attractor dynamics reflect decision confidence in macaque prefrontal cortex 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.09.17.558139v1?rss=1</link>
<description><![CDATA[
Decisions are made with different degrees of consistency, and this consistency can be linked to the confidence that the best choice has been made. Theoretical work suggests that attractor dynamics in networks can account for choice consistency, but how this is implemented in the brain remains unclear. Here, we provide evidence that the energy landscape around attractor basins in population neural activity in prefrontal cortex reflects choice consistency. We trained two rhesus monkeys to make accept/reject decisions based on pretrained visual cues that signaled reward offers with different magnitudes and delays-to-reward. Monkeys made consistent decisions for very good and very bad offers, but decisions were less consistent for intermediate offers. Analysis of neural data showed that the attractor basins around patterns of activity reflecting decisions had steeper landscapes for offers that led to consistent decisions. Therefore, we provide neural evidence that energy landscapes predict decision consistency, which reflects decision confidence.
]]></description>
<dc:creator>Wang, S.</dc:creator>
<dc:creator>Falcone, R.</dc:creator>
<dc:creator>Richmond, B.</dc:creator>
<dc:creator>Averbeck, B.</dc:creator>
<dc:date>2023-09-17</dc:date>
<dc:identifier>doi:10.1101/2023.09.17.558139</dc:identifier>
<dc:title><![CDATA[Attractor dynamics reflect decision confidence in macaque prefrontal cortex]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-09-17</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.09.17.558147v1?rss=1">
<title>
<![CDATA[
Proximity labeling reveals new insights into the relationships between meiotic recombination proteins in S. cerevisiae 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.09.17.558147v1?rss=1</link>
<description><![CDATA[
Several protein ensembles facilitate MutS{gamma} crossover recombination and the associated process of synaptonemal complex (SC) assembly during meiosis, but the physical and functional relationships between the components involved remain obscure. We have employed proximity labeling as a phenotypic tool to discern functional relationships between meiotic recombination and SC proteins in S. cerevisiae, and to gain deeper insight into molecular deficits of crossover-defective mutants. We find that recombination initiation (Spo11) and the Mer3 helicase are dispensable for proximity labeling of the Zip3 E3 ligase by components of the ZZS ensemble (Zip2, Zip4 and Spo16) but are required for proximity labeling of Zip3 by Msh4, consistent with the possibility that MutS{gamma} joins Zip3 only after a specific recombination intermediate has been generated. Proximity labeling analysis of crossover-defective zip1 mutants suggests a key shared defect is a failure to assemble an early recombination ensemble where ZZS can properly engage Zip3. We furthermore discovered that Zip3s abundance within the meiotic cell is uniquely dependent on the presence of Zip1, and that the post-translational modification of Zip3 is promoted by most MutS{gamma} pathway proteins but countered by Zip1. Based on this and additional data, we propose a model whereby Zip1 stabilizes a functional, unmodified form of Zip3 until intermediate steps in recombination are complete. We also find that SC structural protein Ecm11 is proximity labeled by ZZS complex proteins in a Zip4-dependent manner, but by Zip3 and Msh4, at least in part, via a distinct pathway. Finally, streptavidin pulldowns followed by mass spectrometry on eleven different proximity labeling strains uncovers shared proximity targets of MutS{gamma}-associated proteins, some with known meiotic functions and others not yet implicated in a meiotic activity, highlighting the potential power of proximity labeling as a discovery tool.
]]></description>
<dc:creator>Voelkel-Meiman, K.</dc:creator>
<dc:creator>Poppel, A. J.</dc:creator>
<dc:creator>Liddle, J. C.</dc:creator>
<dc:creator>Balsbaugh, J. L.</dc:creator>
<dc:creator>MacQueen, A. J.</dc:creator>
<dc:date>2023-09-17</dc:date>
<dc:identifier>doi:10.1101/2023.09.17.558147</dc:identifier>
<dc:title><![CDATA[Proximity labeling reveals new insights into the relationships between meiotic recombination proteins in S. cerevisiae]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-09-17</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.09.18.558337v1?rss=1">
<title>
<![CDATA[
Glutamylation of Npm2 and Nap1 acidic disordered regions increases DNA charge mimicry to enhance chaperone efficiency 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.09.18.558337v1?rss=1</link>
<description><![CDATA[
Histone chaperones-structurally diverse, non-catalytic proteins enriched with acidic intrinsically disordered regions (IDRs)-protect histones from spurious nucleic acid interactions and guide their deposition into and out of nucleosomes. Despite their conservation and ubiquity, the function of the chaperone acidic IDRs remains unclear. Here, we show that the Xenopus laevis Npm2 and Nap1 acidic IDRs are substrates for TTLL4 (Tubulin Tyrosine Ligase Like 4)-catalyzed post-translational glutamate-glutamylation. We demonstrate that, to bind, stabilize, and deposit histones into nucleosomes, chaperone acidic IDRs function as DNA mimetics. Our biochemical, computational, and biophysical studies reveal that glutamylation of these chaperone polyelectrolyte acidic stretches functions to enhance DNA electrostatic mimicry, promoting the binding and stabilization of H2A/H2B heterodimers and facilitating nucleosome assembly. This discovery provides insights into both the previously unclear function of the acidic IDRs and the regulatory role of post-translational modifications in chromatin dynamics.
]]></description>
<dc:creator>Lorton, B. M.</dc:creator>
<dc:creator>Warren, C.</dc:creator>
<dc:creator>Ilyas, H.</dc:creator>
<dc:creator>Nandigrami, P.</dc:creator>
<dc:creator>Hegde, S.</dc:creator>
<dc:creator>Cahill, S.</dc:creator>
<dc:creator>Lehman, S. M.</dc:creator>
<dc:creator>Shabanowitz, J.</dc:creator>
<dc:creator>Hunt, D.</dc:creator>
<dc:creator>Fiser, A.</dc:creator>
<dc:creator>Cowburn, D.</dc:creator>
<dc:creator>Shechter, D.</dc:creator>
<dc:date>2023-09-19</dc:date>
<dc:identifier>doi:10.1101/2023.09.18.558337</dc:identifier>
<dc:title><![CDATA[Glutamylation of Npm2 and Nap1 acidic disordered regions increases DNA charge mimicry to enhance chaperone efficiency]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-09-19</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.09.19.558375v1?rss=1">
<title>
<![CDATA[
Isofagomine inhibits multiple TcdB variants and protects mice from Clostridioides difficile induced mortality 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.09.19.558375v1?rss=1</link>
<description><![CDATA[
Clostridioides difficile causes life-threatening diarrhea and is the leading cause of healthcare associated bacterial infections in the United States. During infection, C. difficile releases the gut-damaging toxins, TcdA and TcdB, the primary determinants of disease pathogenesis and are therefore therapeutic targets. TcdA and TcdB contain a glycosyltransferase domain that uses UDP-glucose to glycosylate host Rho GTPases, causing cytoskeletal changes that result in a loss of intestinal integrity. Isofagomine inhibits TcdA and TcdB as a mimic of the oxocarbenium ion transition state of the glycosyltransferase reaction. However, sequence variants of TcdA and TcdB across the clades of infective C. difficile continue to be identified and therefore, evaluation of isofagomine inhibition against multiple toxin variants are required. Here we show that Isofagomine inhibits the glycosyltransferase activity of multiple TcdB variants and also protects TcdB toxin-induced cell rounding of the most common full-length toxin variants. Further, isofagomine protects against C. difficile induced mortality in two murine models of C. difficile infection. Isofagomine treatment of mouse C. difficile infection permitted recovery of the gastrointestinal microbiota, an important barrier to prevent recurring C. difficile infection. The broad specificity of isofagomine supports its potential as a prophylactic to protect against C. difficile induced morbidity and mortality.
]]></description>
<dc:creator>Paparella, A. S.</dc:creator>
<dc:creator>Brew, I.</dc:creator>
<dc:creator>Hong, H. A.</dc:creator>
<dc:creator>Ferriera, W.</dc:creator>
<dc:creator>Cutting, S.</dc:creator>
<dc:creator>Lamiable-Oulaidi, F.</dc:creator>
<dc:creator>Popadynec, M.</dc:creator>
<dc:creator>Tyler, P. C.</dc:creator>
<dc:creator>Schramm, V. L.</dc:creator>
<dc:date>2023-09-19</dc:date>
<dc:identifier>doi:10.1101/2023.09.19.558375</dc:identifier>
<dc:title><![CDATA[Isofagomine inhibits multiple TcdB variants and protects mice from Clostridioides difficile induced mortality]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-09-19</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.09.27.559752v1?rss=1">
<title>
<![CDATA[
Molecular and network disruptions in neurodevelopment uncovered by single cell transcriptomics analysis of CHD8 heterozygous cerebral organoids 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.09.27.559752v1?rss=1</link>
<description><![CDATA[
About 100 genes have been associated with significantly increased risks of autism spectrum disorders (ASD) with an estimate of [~]1000 genes that may be involved. The new challenge now is to investigate the molecular and cellular functions of these genes during neural and brain development, and then even more challenging, to link the altered molecular and cellular phenotypes to the ASD clinical manifestations. In this study, we use single cell RNA-seq analysis to study one of the top risk gene, CHD8, in cerebral organoids, which models early neural development. We identify 21 cell clusters in the organoid samples, representing non-neuronal cells, neural progenitors, and early differentiating neurons at the start of neural cell fate commitment. Comparisons of the cells with one copy of the CHD8 knockout and their isogenic controls uncover thousands of differentially expressed genes, which are enriched with function related to neural and brain development, with genes and pathways previously implicated in ASD, but surprisingly not for Schizophrenia and intellectual disability risk genes. The comparisons also find cell composition changes, indicating potential altered neural differential trajectories upon CHD8 reduction. Moreover, we find that cell-cell communications are affected in the CHD8 knockout organoids, including the interactions between neural and glial cells. Taken together, our results provide new data for understanding CHD8 functions in the early stages of neural lineage development and interaction.
]]></description>
<dc:creator>Astorkia, M.</dc:creator>
<dc:creator>Liu, Y.</dc:creator>
<dc:creator>Pedrosa, E.</dc:creator>
<dc:creator>Lachman, H.</dc:creator>
<dc:creator>Zheng, D.</dc:creator>
<dc:date>2023-09-27</dc:date>
<dc:identifier>doi:10.1101/2023.09.27.559752</dc:identifier>
<dc:title><![CDATA[Molecular and network disruptions in neurodevelopment uncovered by single cell transcriptomics analysis of CHD8 heterozygous cerebral organoids]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-09-27</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.10.02.560432v1?rss=1">
<title>
<![CDATA[
The origin of intestinal cancer in the context of inflammation 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.10.02.560432v1?rss=1</link>
<description><![CDATA[
According to conventional views, colon cancer originates from stem cells. However, inflammation, a key risk factor for colon cancer, was shown to suppress intestinal stemness. Here, we employed Paneth cells (PCs) as a model to assess the capacity of differentiated lineages to trigger tumorigenesis in the context of inflammation. Upon inflammation, PC-specific Apc mutations led to intestinal tumors reminiscent not only of those arising in inflammatory bowel disease (IBD) patients but also of a larger fraction of sporadic colon cancers. The latter is likely due to the inflammatory consequences of Western-style dietary habits, the major colon cancer risk factor. Computational methods designed to predict the cell-of-origin of cancer confirmed that, in a substantial fraction of sporadic colon cancers the cells-of-origin are secretory lineages and not stem cells.

One-Sentence SummarySecretory cell lineages trigger tumor formation in the context of the major etiologic colon cancer risk factors.
]]></description>
<dc:creator>Verhagen, M. P.</dc:creator>
<dc:creator>Joosten, R.</dc:creator>
<dc:creator>Schmitt, M.</dc:creator>
<dc:creator>Valimaki, N.</dc:creator>
<dc:creator>Sacchetti, A.</dc:creator>
<dc:creator>Rajamaki, K.</dc:creator>
<dc:creator>Choi, J.</dc:creator>
<dc:creator>Procopio, P.</dc:creator>
<dc:creator>Silva, S.</dc:creator>
<dc:creator>van der Steen, B.</dc:creator>
<dc:creator>van den Bosch, T. P. P.</dc:creator>
<dc:creator>Seinstra, D.</dc:creator>
<dc:creator>Doukas, M.</dc:creator>
<dc:creator>Augenlicht, L. H.</dc:creator>
<dc:creator>Aaltonen, L. A.</dc:creator>
<dc:creator>Fodde, R.</dc:creator>
<dc:date>2023-10-04</dc:date>
<dc:identifier>doi:10.1101/2023.10.02.560432</dc:identifier>
<dc:title><![CDATA[The origin of intestinal cancer in the context of inflammation]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-10-04</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.10.04.560841v1?rss=1">
<title>
<![CDATA[
Extramacrochaetae regulates Notch signaling in the Drosophila eye through non-apoptotic caspase activity 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.10.04.560841v1?rss=1</link>
<description><![CDATA[
Many cell fate decisions are determined transcriptionally. Accordingly, some fate specification is prevented by Inhibitor of DNA binding (Id) proteins that interfere with DNA binding by master regulatory transcription factors. We show that the Drosophila Id protein Extra macrochaetae (Emc) also affects developmental decisions by regulating caspase activity. Emc, which prevents proneural bHLH transcription factors from specifying neural cell fate, also prevents homodimerization of another bHLH protein, Daughterless (Da), and thereby maintains expression of the Death-Associated Inhibitor of Apoptosis (diap1) gene. Accordingly, we found that multiple effects of emc mutations on cell growth and on eye development were all caused by activation of caspases. These effects included acceleration of the morphogenetic furrow, failure of R7 photoreceptor cell specification, and delayed differentiation of non-neuronal cone cells. Within emc mutant clones, Notch signaling was elevated in the morphogenetic furrow, increasing morphogenetic furrow speed. This was associated with caspase-dependent increase in levels of Delta protein, the transmembrane ligand for Notch. Posterior to the morphogenetic furrow, elevated Delta cis-inhibited Notch signaling that was required for R7 specification and cone cell differentiation. Growth inhibition of emc mutant clones in wing imaginal discs also depended on caspases. Thus, emc mutations reveal the importance of restraining caspase activity even in non-apoptotic cells to prevent abnormal development, in the Drosophila eye through effects on Notch signaling.
]]></description>
<dc:creator>Baker, N. E.</dc:creator>
<dc:creator>Nair, S.</dc:creator>
<dc:date>2023-10-04</dc:date>
<dc:identifier>doi:10.1101/2023.10.04.560841</dc:identifier>
<dc:title><![CDATA[Extramacrochaetae regulates Notch signaling in the Drosophila eye through non-apoptotic caspase activity]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-10-04</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.10.11.561880v1?rss=1">
<title>
<![CDATA[
Differential activation of mouse and human Panx1 channel variants. 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.10.11.561880v1?rss=1</link>
<description><![CDATA[
Pannexins are ubiquitously expressed in human and mouse tissues. Pannexin 1 (Panx1), the most thoroughly characterized isoform of this family, forms plasmalemmal membrane channels permeable to relatively large molecules, such as ATP. Although human and mouse Panx1 amino acid sequences are conserved in the presently known regulatory sites involved in trafficking and modulation of the channel, differences are reported in the N- and C-termini of the protein, and the mechanisms of channel activation by different stimuli remain controversial. Here we used a neuroblastoma cell line to study the activation properties of endogenous mPanx1 and exogenously expressed hPanx1. Dye uptake and electrophysiological recordings revealed that in contrast to mouse Panx1, the human ortholog is insensitive to stimulation with high extracellular [K+] but responds similarly to activation of the purinergic P2X7 receptor. The two most frequent Panx1 polymorphisms found in the human population, Q5H (rs1138800) and E390D (rs74549886), exogenously expressed in Panx1-null N2a cells revealed that regarding P2X7 receptor mediated Panx1 activation, the Q5H mutant is a gain of function whereas the E390D mutant is a loss of function variant. Collectively, we demonstrate differences in the activation between human and mouse Panx1 orthologs and suggest that these differences may have translational implications for studies where Panx1 has been shown to have significant impact.
]]></description>
<dc:creator>Cibelli, A.</dc:creator>
<dc:creator>Dohare, P.</dc:creator>
<dc:creator>Spray, D. C.</dc:creator>
<dc:creator>Scemes, E.</dc:creator>
<dc:date>2023-10-12</dc:date>
<dc:identifier>doi:10.1101/2023.10.11.561880</dc:identifier>
<dc:title><![CDATA[Differential activation of mouse and human Panx1 channel variants.]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-10-12</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.10.11.561944v1?rss=1">
<title>
<![CDATA[
Tumor-targeted delivery of Tetanus toxoid by Listeria improves immunotherapy against ovarian cancer in mice 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.10.11.561944v1?rss=1</link>
<description><![CDATA[
Ovarian cancer is known for its poor neoantigen expression and strong immunosuppression. Here, we utilized an attenuated non-pathogenic bacterium Listeria monocytogenes to deliver a highly immunogenic Tetanus Toxoid protein (Listeria-TT), as a neoantigen surrogate, into tumor cells through infection in a metastatic mouse ovarian cancer model (Id8p53-/-Luc). Gemcitabine (GEM) was added to reduce immune suppression. Listeria-TT+GEM treatments resulted in tumors expressing TT and reactivation of pre-existing CD4 and CD8 memory T cells to TT (generated early in life). These T cells were then attracted to the TT-expressing tumors now producing perforin and granzyme B. This correlated with a strong reduction in tumor burden, and significant improvement of the survival time compared to all control groups. Checkpoint inhibitors have little effect on ovarian cancer partly because of low neoantigen expression. Here we demonstrated that Listeria-TT+GEM+anti-PD1 was significantly more effective (efficacy and survival) than anti-PD1 or Listeria-TT+GEM alone. Of clinical interest, high doses of anti-PD1 (PD1H) (when added to Listeria-TT+GEM) were less effective than the low doses (PD1L). IHC and ELISPOT demonstrated that high doses of anti-PD1 inhibited T cell function in the TME. Using RNAseq, Differentially Expressed Genes (DEG) analysis and Genes Set Enrichment Analysis (GSEA) showed that gene expression levels and biological pathways were predominantly upregulated in the PD1H compared to the PD1L group, in correlation with low immune infiltration in tumors, more immune suppression, and more aggressive ovarian cancer. In summary, this study suggests that our approach may benefit ovarian cancer patients.



O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=101 SRC="FIGDIR/small/561944v3_ufig1.gif" ALT="Figure 1">
View larger version (24K):
org.highwire.dtl.DTLVardef@197942eorg.highwire.dtl.DTLVardef@8180d4org.highwire.dtl.DTLVardef@3113e6org.highwire.dtl.DTLVardef@116851_HPS_FORMAT_FIGEXP  M_FIG Graphical Abstract

Human concept: Childhood vaccinations with the highly immunogenic tetanus toxoid (TT) generate TT-specific memory T cells, which circulate in the blood for life. After appearance of ovarian cancer (late in life), the patients will receive one high dose with Listeria-TT to deliver TT into tumor cells, followed by multiple low doses of Listeria-TT over a period of 2 weeks to restimulate the pre-existing memory T cells to TT. MDSC are involved in the delivery of Listeria-TT to the TME. Reactivated memory T cells will in turn destroy the tumor cells expressing TT. Multiple low doses of GEM will be added after TT has been delivered at the tumor site, which reduce immune suppression by eliminating MDSC and TAM (not shown here). Since individuals have seen TT earlier in life (during childhood vaccinations) and since TT is highly immunogenic (attracting T cells to the TME) but not expressed in normal cells, TT functions here as a vaccine recall antigen and as a neoantigen surrogate, respectively.

C_FIG
]]></description>
<dc:creator>Scanlon, L. R.</dc:creator>
<dc:creator>Gabor, L.</dc:creator>
<dc:creator>Khouri, O. R.</dc:creator>
<dc:creator>Ahmad, S.</dc:creator>
<dc:creator>Levy, E.</dc:creator>
<dc:creator>Kuo, D. Y.-S.</dc:creator>
<dc:creator>Lin, K.</dc:creator>
<dc:creator>Nevadunsky, N.</dc:creator>
<dc:creator>Gravekamp, C.</dc:creator>
<dc:date>2023-10-12</dc:date>
<dc:identifier>doi:10.1101/2023.10.11.561944</dc:identifier>
<dc:title><![CDATA[Tumor-targeted delivery of Tetanus toxoid by Listeria improves immunotherapy against ovarian cancer in mice]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-10-12</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.10.11.561933v1?rss=1">
<title>
<![CDATA[
Regulatory Landscape Enrichment Analysis (RLEA) using gaiaAssociation 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.10.11.561933v1?rss=1</link>
<description><![CDATA[
MotivationTo understand whether sets of genomic loci are enriched at the regulatory loci of one or more cell types, we developed the gaiaAssociation package to perform Regulatory Landscape Enrichment Analysis (RLEA). RLEA is a novel analytical process that tests for enrichment of sets of loci in cell type-specific open chromatin regions (OCRs) in the genome.

ResultsWe demonstrate that the application of RLEA to genome-wide association study (GWAS) data reveals cell types likely to be mediating the phenotype studied, and clusters OCRs based on their shared regulatory profiles. GaiaAssociation is Python code that is freely available for use in functional genomics studies.

Availability and ImplementationGaia Association is available on PyPi (https://pypi.org/project/gaiaAssociation/0.6.0/#description) for pip download and use on the command line or as an inline Python package. Gaia Association can also be installed from GitHub at https://github.com/GreallyLab/gaiaAssociation.

Contactjohn.greally@einsteinmed.edu
]]></description>
<dc:creator>Sosa, E. A.</dc:creator>
<dc:creator>Rosean, S.</dc:creator>
<dc:creator>O'Shea, D.</dc:creator>
<dc:creator>Raj, S. M.</dc:creator>
<dc:creator>Seoighe, C.</dc:creator>
<dc:creator>Greally, J. M.</dc:creator>
<dc:date>2023-10-16</dc:date>
<dc:identifier>doi:10.1101/2023.10.11.561933</dc:identifier>
<dc:title><![CDATA[Regulatory Landscape Enrichment Analysis (RLEA) using gaiaAssociation]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-10-16</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.10.16.562559v1?rss=1">
<title>
<![CDATA[
The PDIM paradox of Mycobacterium tuberculosis: new solutions to a persistent problem 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.10.16.562559v1?rss=1</link>
<description><![CDATA[
Phthiocerol dimycocerosate (PDIM) is an essential virulence lipid of Mycobacterium tuberculosis. In vitro culturing rapidly selects for spontaneous mutations that cause PDIM loss leading to virulence attenuation and increased cell wall permeability. We discovered that PDIM loss is due to a metabolic deficiency of methylmalonyl-CoA that impedes the growth of PDIM-producing bacilli. This can be remedied by supplementation with odd-chain fatty acids, cholesterol, or vitamin B12. We developed a much-needed facile and scalable routine assay for PDIM production and show that propionate supplementation enhances the growth of PDIM-producing bacilli and selects against PDIM-negative mutants, analogous to in vivo conditions. Our results solve a major issue in tuberculosis research and exemplify how discrepancies between the host and in vitro nutrient environments can attenuate bacterial pathogenicity.
]]></description>
<dc:creator>Mulholland, C. V.</dc:creator>
<dc:creator>Wiggins, T. J.</dc:creator>
<dc:creator>Cui, J.</dc:creator>
<dc:creator>Vilcheze, C.</dc:creator>
<dc:creator>Rajagopalan, S.</dc:creator>
<dc:creator>Shultis, M. W.</dc:creator>
<dc:creator>Reyes-Fernandez, E. Z.</dc:creator>
<dc:creator>Jacobs, W. R.</dc:creator>
<dc:creator>Berney, M.</dc:creator>
<dc:date>2023-10-16</dc:date>
<dc:identifier>doi:10.1101/2023.10.16.562559</dc:identifier>
<dc:title><![CDATA[The PDIM paradox of Mycobacterium tuberculosis: new solutions to a persistent problem]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-10-16</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.10.18.563021v1?rss=1">
<title>
<![CDATA[
Identification of new markers of angiogenic sprouting using transcriptomics: New role for RND3 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.10.18.563021v1?rss=1</link>
<description><![CDATA[
BackgroundNew blood vessel formation requires endothelial cells to transition from a quiescent to an invasive phenotype. Transcriptional changes are vital for this switch, but a comprehensive genome-wide approach focused exclusively on endothelial cell sprout initiation has not been reported.

Approach and ResultsUsing a model of human endothelial cell sprout initiation, we developed a protocol to physically separate cells that initiate the process of new blood vessel formation (invading cells) from non-invading cells. We used this model to perform multiple transcriptomics analyses from multiple donors to monitor endothelial gene expression changes. Single-cell Population Analyses, single-cell Cluster Analyses, and bulk RNA sequencing were used to delineate transcriptomic changes in invading cells. The results revealed a 39 gene signature that was consistent with activation of signal transduction, morphogenesis, and immune responses. Many of the genes were previously shown to regulate angiogenesis, and include multiple tip cell markers. Upregulation of SNAI1, PTGS2, and JUNB protein expression was confirmed in invading cells, and silencing JunB and SNAI1 significantly reduced invasion responses. Separate studies investigated Rounding 3 (RND3), also known as RhoE, which has not yet been implicated in angiogenesis. Silencing RND3 reduced endothelial invasion distance as well as filopodia length, fitting with a pathfinding role for RND3 via regulation of filopodial extensions. Analysis of in vivo retinal angiogenesis in Rnd3 heterozygous mice confirmed a decrease in filopodial length compared to wild type littermates.

ConclusionValidation of multiple genes, including RND3, revealed a functional role for this gene signature early in the angiogenic process. This study expands the list of genes that are associated with the acquisition of a tip cell phenotype during endothelial cell sprout initiation.

HIGHLIGHTSO_LITranscriptomic analyses identified 39 candidate genes that were upregulated at the onset of endothelial sprouting
C_LIO_LIThe gene signature includes signal transduction, morphogenesis, and immune responses
C_LIO_LINewly-identified RND3 is associated with filopodial extension and pathfinding
C_LI

Graphical Abstract

O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=190 SRC="FIGDIR/small/563021v1_ufig1.gif" ALT="Figure 1">
View larger version (92K):
org.highwire.dtl.DTLVardef@1045439org.highwire.dtl.DTLVardef@1357703org.highwire.dtl.DTLVardef@1189cf2org.highwire.dtl.DTLVardef@e7d574_HPS_FORMAT_FIGEXP  M_FIG C_FIG
]]></description>
<dc:creator>Abbey, C. A.</dc:creator>
<dc:creator>Duran, C. L.</dc:creator>
<dc:creator>Chen, Z.</dc:creator>
<dc:creator>Chen, Y.</dc:creator>
<dc:creator>Roy, S.</dc:creator>
<dc:creator>Coffell, A.</dc:creator>
<dc:creator>Chakraborty, S.</dc:creator>
<dc:creator>Wells, G. B.</dc:creator>
<dc:creator>Chang, J.</dc:creator>
<dc:creator>Bayless, K.</dc:creator>
<dc:date>2023-10-19</dc:date>
<dc:identifier>doi:10.1101/2023.10.18.563021</dc:identifier>
<dc:title><![CDATA[Identification of new markers of angiogenic sprouting using transcriptomics: New role for RND3]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-10-19</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.10.21.563410v1?rss=1">
<title>
<![CDATA[
In Vitro Safety Signals for Potential Clinical Development of the Anti-Inflammatory Pregnane X Receptor Agonist FKK6 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.10.21.563410v1?rss=1</link>
<description><![CDATA[
Background and purposeBased on the mimicry of microbial metabolites, functionalized indoles were demonstrated as the ligands and agonists of the pregnane X receptor (PXR). The lead indole, FKK6, displayed PXR-dependent protective effects in DSS-induced colitis in mice and in vitro cytokine-treated intestinal organoid cultures. Here, we performed the initial in vitro pharmacological profiling of FKK6.

Experimental approachA complex series of cell-free and cell-based assays were employed. The organic synthesis, and advanced analytical chemistry methods were used.

Key resultsFKK6-PXR interactions were characterized by hydrogen-deuterium exchange mass spectrometry. Screening FKK6 against potential cellular off-targets revealed high PXR selectivity. FKK6 has poor aqueous solubility but was highly soluble in simulated gastric and intestinal fluids. FKK6 was bound to plasma proteins and chemically stable in plasma. The partition coefficient of FKK6 was 2.70, and FKK6 moderately partitioned into red blood cells. In Caco2 cells, FKK6 displayed high permeability (A-B: 22.8 x 10-6 cm.s-1) and no active efflux. These data are indicative of essentially complete in vivo absorption of FKK6. FKK6 was rapidly metabolized by cytochromes P450, notably by CYP3A4 in human liver microsomes. Two oxidized FKK6 derivatives, including N6-oxide and C19-phenol, were detected, and these metabolites had 5-7 x lower potency as PXR agonists than FKK6. This implies that despite high intestinal absorption, FKK6 is rapidly eliminated by the liver, and its PXR effects are predicted to be predominantly in the intestines.

Conclusion and implicationsThe PXR ligand and agonist FKK6 has a suitable pharmacological profile supporting its potential preclinical development.

BULLET POINT SUMMARYWhat is already known: O_LIMicrobial metabolite mimic FKK6 is a hPXR agonist with anti-inflammatory properties in mice and human.
C_LIO_LIThe in vitro PXR binding, absorption, and metabolism have not been completely characterized.
C_LI What this study adds: O_LIPXR selectivity with unique binding mode, high intestinal cell permeability, rapid and complex microsomal metabolism.
C_LIO_LIInitial testing for predicted metabolites shows reduced potency as PXR agonists.
C_LI Clinical significance: O_LIPXR effects of FKK6 are predicted to be predominantly in the intestines.
C_LIO_LIFKK6 has a suitable pharmacological profile supporting its potential preclinical development.
C_LI
]]></description>
<dc:creator>Dvorak, Z.</dc:creator>
<dc:creator>Vyhlidalov, B.</dc:creator>
<dc:creator>Pecinkov, P.</dc:creator>
<dc:creator>Li, H.</dc:creator>
<dc:creator>Anzenbacher, P.</dc:creator>
<dc:creator>spicakova, a.</dc:creator>
<dc:creator>anzenbacherova, e.</dc:creator>
<dc:creator>Chow, V.</dc:creator>
<dc:creator>LIU, J.</dc:creator>
<dc:creator>Krause, H.</dc:creator>
<dc:creator>Wilson, D. J.</dc:creator>
<dc:creator>Beres, T.</dc:creator>
<dc:creator>Tarkowski, P.</dc:creator>
<dc:creator>Chen, D.</dc:creator>
<dc:creator>Mani, S.</dc:creator>
<dc:date>2023-10-21</dc:date>
<dc:identifier>doi:10.1101/2023.10.21.563410</dc:identifier>
<dc:title><![CDATA[In Vitro Safety Signals for Potential Clinical Development of the Anti-Inflammatory Pregnane X Receptor Agonist FKK6]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-10-21</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.10.22.563475v1?rss=1">
<title>
<![CDATA[
Unique Binding and Stabilization Mechanisms Employed By and Engineered Into Nanobodies. 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.10.22.563475v1?rss=1</link>
<description><![CDATA[
Nanobodies are single domain antibody variants that bind an antigen with the precision and affinity of a conventional antibody at only a fraction of their size. In solving the crystal structures of our nanobody-GFP complexes and compared with other available structures, we uncover mechanism that enable nanobodies to function so efficiently and effectively as single-domain antibodies. We show that unlike conventional antibodies, a nanobody repertoire maximizes sampling of their antigen surface by binding a single antigen in at least three different orientations which can be predicted by their paratope composition. We also structurally reengineering these nanobodies to improve their antigen affinity, their stability, or both - results which also revealed the strong connection between nanobody stability and affinity. We achieved this by either directly modifying the paratope, or by altering a particular region within their third framework, which is a highly conserved area that we determined plays a role in controlling nanobody stability. Our study suggests that these unique characteristics of nanobodies allow them to interact with antigens as effectively as conventional antibodies, despite their smaller size. This understanding provides methods to facilitate optimizing, humanizing and functionalizing nanobodies, thus paving the way for their utilization in diverse areas such as research, diagnostics, and therapeutic development.

Significance StatementNanobodies are a unique type of antibody fragment found in select animals, containing all its antigen binding ability reduced to a single [~]15 kDa protein. There is increasing development of nanobodies for research, diagnostics, and therapeutics, yet how nanobodies function so effectively as single domain antigen binders with the precision and affinity of conventional antibodies is unclear. In this study, we present key observations to help answer this question, where one key finding is the strong relationship between nanobody stability and antigen affinity aided by the identification of a highly conserved region in nanobodies essential for maintaining nanobody stability. This region may have been retained in nanobodies in lieu of stabilizing mechanisms induced by dimerization as seen in conventional antibodies.
]]></description>
<dc:creator>Ketaren, N. E.</dc:creator>
<dc:creator>Fridy, P. C.</dc:creator>
<dc:creator>Malashkevich, V.</dc:creator>
<dc:creator>Sanyal, T.</dc:creator>
<dc:creator>Brilliantes, M.</dc:creator>
<dc:creator>Thompson, M. K.</dc:creator>
<dc:creator>Orens, D. A.</dc:creator>
<dc:creator>Bonanno, J. B.</dc:creator>
<dc:creator>Sali, a.</dc:creator>
<dc:creator>Almo, S. C.</dc:creator>
<dc:creator>Chait, B. T.</dc:creator>
<dc:creator>Rout, M. P.</dc:creator>
<dc:date>2023-10-22</dc:date>
<dc:identifier>doi:10.1101/2023.10.22.563475</dc:identifier>
<dc:title><![CDATA[Unique Binding and Stabilization Mechanisms Employed By and Engineered Into Nanobodies.]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-10-22</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.10.24.563841v1?rss=1">
<title>
<![CDATA[
Simulation-Driven Design of Stabilized SARS-CoV-2 Spike S2 Immunogens 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.10.24.563841v1?rss=1</link>
<description><![CDATA[
The full-length prefusion-stabilized SARS-CoV-2 spike (S) is the principal antigen of COVID-19 vaccines. Vaccine efficacy has been impacted by emerging variants of concern that accumulate most of the sequence modifications in the immunodominant S1 subunit. S2, in contrast, is the most evolutionarily conserved region of the spike and can elicit broadly neutralizing and protective antibodies. Yet, S2s usage as an alternative vaccine strategy is hampered by its general instability. Here, we use a simulation-driven approach to design S2-only immunogens stabilized in a closed prefusion conformation. Molecular simulations provide a mechanistic characterization of the S2 trimers opening, informing the design of tryptophan substitutions that impart kinetic and thermodynamic stabilization. Structural characterization via cryo-EM shows the molecular basis of S2 stabilization in the closed prefusion conformation. Informed by molecular simulations and corroborated by experiments, we report an engineered S2 immunogen that exhibits increased protein expression, superior thermostability, and preserved immunogenicity against sarbecoviruses.
]]></description>
<dc:creator>Nuqui, X.</dc:creator>
<dc:creator>Casalino, L.</dc:creator>
<dc:creator>Zhou, L.</dc:creator>
<dc:creator>Shehata, M.</dc:creator>
<dc:creator>Wang, A.</dc:creator>
<dc:creator>Tse, A. L.</dc:creator>
<dc:creator>Ojha, A.</dc:creator>
<dc:creator>Kearns, F. L.</dc:creator>
<dc:creator>Rosenfeld, M. A.</dc:creator>
<dc:creator>Miller, E. H.</dc:creator>
<dc:creator>Acreman, C. M.</dc:creator>
<dc:creator>Ahn, S.-H.</dc:creator>
<dc:creator>Chandran, K.</dc:creator>
<dc:creator>McLellan, J. S.</dc:creator>
<dc:creator>Amaro, R. E.</dc:creator>
<dc:date>2023-10-25</dc:date>
<dc:identifier>doi:10.1101/2023.10.24.563841</dc:identifier>
<dc:title><![CDATA[Simulation-Driven Design of Stabilized SARS-CoV-2 Spike S2 Immunogens]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-10-25</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.10.26.564164v1?rss=1">
<title>
<![CDATA[
A Toxoplasma gondii O-glycosyltransferase that modulates bradyzoite cyst wall rigidity is structurally and functionally distinct from host homologues 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.10.26.564164v1?rss=1</link>
<description><![CDATA[
Infection with the Apicomplexan protozoan Toxoplasma gondii can be life-threatening in immunocompromised hosts. Transmission frequently occurs through the oral ingestion of T. gondii bradyzoite cysts, which transition to tachyzoites, disseminate, and then form cysts containing bradyzoites in the central nervous system, resulting in latent infection. There are currently no effective treatments to cure latent infection. Bradyzoites are encapsulated by a cyst wall that is critical for immune evasion, survival, and transmission. Cyst wall rigidity is influenced by the O-glycosylation of the mucin domain of the cyst wall protein CST1 by mucin-type O-glycosyltransferases (GalNAc-Ts). Here, we report the first structures of a protozoan GalNAc-T, T.gondii-GalNAc-T3 in the apo state and in complex with glycopeptide substrates. The structures reveal features that are strictly conserved in Apicomplexan homologues of T.gondii-GalNAc-T3, including a unique 2nd metal binding site that is coupled to substrate binding and enzymatic activity in vitro and cyst wall O-glycosylation in T. gondii. Additional structural features illustrate the divergence of GalNAc-Ts from parasite to host and highlight multiple druggable sites in T.gondii-GalNAc-T3 and its homologues in Apicomplexa that are responsible for a wide range of parasitic diseases.
]]></description>
<dc:creator>Kumar, P.</dc:creator>
<dc:creator>Tomita, T.</dc:creator>
<dc:creator>Gerken, T. A.</dc:creator>
<dc:creator>Ballard, C. J.</dc:creator>
<dc:creator>Lee, Y. S.</dc:creator>
<dc:creator>Weiss, L. M.</dc:creator>
<dc:creator>Samara, N. L.</dc:creator>
<dc:date>2023-10-26</dc:date>
<dc:identifier>doi:10.1101/2023.10.26.564164</dc:identifier>
<dc:title><![CDATA[A Toxoplasma gondii O-glycosyltransferase that modulates bradyzoite cyst wall rigidity is structurally and functionally distinct from host homologues]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-10-26</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.10.24.563860v1?rss=1">
<title>
<![CDATA[
CD44 and β1-integrin are both engaged in cell traction force generation in hyaluronic acid-rich extracellular matrices 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.10.24.563860v1?rss=1</link>
<description><![CDATA[
Mechanical properties of the extracellular matrix (ECM) critically regulate a number of important cell functions including growth, differentiation and migration. Type I collagen and glycosaminoglycans (GAGs) are two primary components of ECMs that contribute to mammalian tissue mechanics, with the collagen fiber network sustaining tension, and GAGs withstanding compression. The architecture and stiffness of the collagen network are known to be important for cell-ECM mechanical interactions via integrin cell surface adhesion receptors. In contrast, studies of GAGs in modulating cell-ECM interactions are limited. Here, we present experimental studies on the roles of hyaluronic acid (HA, an unsulfated GAG) in single tumor cell traction force generation using a recently developed 3D cell traction force microscopy method. Our work reveals that CD44, a cell surface adhesion receptor to HA, is engaged in cell traction force generation in conjunction with {beta}1-integrin. We find that HA significantly modifies the architecture and mechanics of the collagen fiber network, decreasing tumor cells propensity to remodel the collagen network, attenuating traction force generation, transmission distance, and tumor invasion. Our findings point to a novel role for CD44 in traction force generation, which can be a potential therapeutic target for diseases involving HA rich ECMs such as breast cancer and glioblastoma.
]]></description>
<dc:creator>Cheung, B. C. H.</dc:creator>
<dc:creator>Chen, X.</dc:creator>
<dc:creator>Davis, H. J.</dc:creator>
<dc:creator>Toth, J.</dc:creator>
<dc:creator>Shenoy, V. B.</dc:creator>
<dc:creator>Segall, J. E.</dc:creator>
<dc:creator>Wu, M.</dc:creator>
<dc:date>2023-10-27</dc:date>
<dc:identifier>doi:10.1101/2023.10.24.563860</dc:identifier>
<dc:title><![CDATA[CD44 and β1-integrin are both engaged in cell traction force generation in hyaluronic acid-rich extracellular matrices]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-10-27</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.10.27.564212v1?rss=1">
<title>
<![CDATA[
FAK family proteins regulate in vivo breast cancer metastasis via distinct mechanisms. 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.10.27.564212v1?rss=1</link>
<description><![CDATA[
Breast cancer is the most commonly diagnosed malignancy and the major leading cause of tumor-related deaths in women. It is estimated that the majority of breast tumor-related deaths are a consequence of metastasis, to which no cure exists at present. The FAK family proteins Proline-rich tyrosine kinase (PYK2) and focal adhesion kinase (FAK) are highly expressed in breast cancer, but the exact cellular and signaling mechanisms by which they regulate in vivo tumor cell invasiveness and consequent metastatic dissemination are mostly unknown. Using a PYK2 and FAK knockdown xenograft model we show here, for the first time, that ablation of either PYK2 or FAK decreases primary tumor size and significantly reduces Tumor MicroEnvironment of Metastasis (TMEM) doorway activation, leading to decreased intravasation and reduced spontaneous lung metastasis. Intravital imaging analysis further demonstrates that PYK2, but not FAK, regulates a motility phenotype switch between focal adhesion-mediated fast motility and invadopodia-dependent, ECM-degradation associated slow motility within the primary tumor. Furthermore, we validate our in vivo and intravital imaging results with integrated transcriptomic and proteomic data analysis from xenograft knockdown tumors and reveal new and distinct pathways by which these two homologous kinases regulate breast tumor cell invasiveness and consequent metastatic dissemination. Our findings identify PYK2 and FAK as novel mediators of mammary tumor progression and metastasis and as candidate therapeutic targets for breast cancer metastasis.
]]></description>
<dc:creator>Genna, A.</dc:creator>
<dc:creator>Alter, J.</dc:creator>
<dc:creator>Poletti, M.</dc:creator>
<dc:creator>Meirson, T.</dc:creator>
<dc:creator>Sneh, T.</dc:creator>
<dc:creator>Gendler, M.</dc:creator>
<dc:creator>Saleev, N.</dc:creator>
<dc:creator>Karagiannis, G.</dc:creator>
<dc:creator>Wang, Y.</dc:creator>
<dc:creator>Cox, D.</dc:creator>
<dc:creator>Entenberg, D.</dc:creator>
<dc:creator>Oktay, M.</dc:creator>
<dc:creator>Korcsmaros, T.</dc:creator>
<dc:creator>Condeelis, J.</dc:creator>
<dc:creator>Gil-Henn, H.</dc:creator>
<dc:date>2023-10-29</dc:date>
<dc:identifier>doi:10.1101/2023.10.27.564212</dc:identifier>
<dc:title><![CDATA[FAK family proteins regulate in vivo breast cancer metastasis via distinct mechanisms.]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-10-29</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.10.28.564559v1?rss=1">
<title>
<![CDATA[
Haematopoietic stem cell numbers are not solely determined by niche availability 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.10.28.564559v1?rss=1</link>
<description><![CDATA[
Haematopoietic stem cells (HSCs) reside in specialized microenvironments, also referred to as niches, and it has been widely believed that HSC numbers are determined by the niche size alone1-5. However, the vast excess of the number of niche cells over that of HSCs raises questions about this model. We initially established a mathematical model of niche availability and occupancy, which predicted that HSC numbers are restricted at both systemic and local levels. To address this question experimentally, we developed a femoral bone transplantation system, enabling us to increase the number of available HSC niches. We found that the addition of niches does not alter total HSC numbers in the body, regardless of whether the endogenous (host) niche is intact or defective, suggesting that HSC numbers are limited at the systemic level. Additionally, HSC numbers in transplanted wild-type femurs did not increase beyond physiological levels when HSCs were mobilized from defective endogenous niches to the periphery, indicating that HSC numbers are also constrained at the local level. Our study demonstrates that HSC numbers are not solely determined by niche availability, thereby rewriting the long-standing model for the regulation of HSC numbers.
]]></description>
<dc:creator>Takeishi, S.</dc:creator>
<dc:creator>Marchand, T.</dc:creator>
<dc:creator>Koba, W. R.</dc:creator>
<dc:creator>Borger, D. K.</dc:creator>
<dc:creator>Xu, C.</dc:creator>
<dc:creator>Guha, C.</dc:creator>
<dc:creator>Bergman, A.</dc:creator>
<dc:creator>Frenette, P. S.</dc:creator>
<dc:creator>Gritsman, K.</dc:creator>
<dc:creator>Steidl, U.</dc:creator>
<dc:date>2023-10-29</dc:date>
<dc:identifier>doi:10.1101/2023.10.28.564559</dc:identifier>
<dc:title><![CDATA[Haematopoietic stem cell numbers are not solely determined by niche availability]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-10-29</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.10.30.564764v1?rss=1">
<title>
<![CDATA[
A statistical framework for powerful multi-trait rare variant analysis in large-scale whole-genome sequencing studies 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.10.30.564764v1?rss=1</link>
<description><![CDATA[
Large-scale whole-genome sequencing (WGS) studies have improved our understanding of the contributions of coding and noncoding rare variants to complex human traits. Leveraging association effect sizes across multiple traits in WGS rare variant association analysis can improve statistical power over single-trait analysis, and also detect pleiotropic genes and regions. Existing multi-trait methods have limited ability to perform rare variant analysis of large-scale WGS data. We propose MultiSTAAR, a statistical framework and computationally-scalable analytical pipeline for functionally-informed multi-trait rare variant analysis in large-scale WGS studies. MultiSTAAR accounts for relatedness, population structure and correlation among phenotypes by jointly analyzing multiple traits, and further empowers rare variant association analysis by incorporating multiple functional annotations. We applied MultiSTAAR to jointly analyze three lipid traits (low-density lipoprotein cholesterol, high-density lipoprotein cholesterol and triglycerides) in 61,861 multi-ethnic samples from the Trans-Omics for Precision Medicine (TOPMed) Program. We discovered new associations with lipid traits missed by single-trait analysis, including rare variants within an enhancer of NIPSNAP3A and an intergenic region on chromosome 1.
]]></description>
<dc:creator>Li, X.</dc:creator>
<dc:creator>Chen, H.</dc:creator>
<dc:creator>Selvaraj, M. S.</dc:creator>
<dc:creator>Van Buren, E.</dc:creator>
<dc:creator>Zhou, H.</dc:creator>
<dc:creator>Wang, Y.</dc:creator>
<dc:creator>Sun, R.</dc:creator>
<dc:creator>McCaw, Z. R.</dc:creator>
<dc:creator>Yu, Z.</dc:creator>
<dc:creator>Arnett, D. K.</dc:creator>
<dc:creator>Bis, J. C.</dc:creator>
<dc:creator>Blangero, J.</dc:creator>
<dc:creator>Boerwinkle, E.</dc:creator>
<dc:creator>Bowden, D. W.</dc:creator>
<dc:creator>Brody, J. A.</dc:creator>
<dc:creator>Cade, B. E.</dc:creator>
<dc:creator>Carson, A. P.</dc:creator>
<dc:creator>Carlson, J. C.</dc:creator>
<dc:creator>Chami, N.</dc:creator>
<dc:creator>Chen, Y.-D. I.</dc:creator>
<dc:creator>Curran, J. E.</dc:creator>
<dc:creator>de Vries, P. S.</dc:creator>
<dc:creator>Fornage, M.</dc:creator>
<dc:creator>Franceschini, N.</dc:creator>
<dc:creator>Freedman, B. I.</dc:creator>
<dc:creator>Gu, C.</dc:creator>
<dc:creator>Heard-Costa, N. L.</dc:creator>
<dc:creator>He, J.</dc:creator>
<dc:creator>Hou, L.</dc:creator>
<dc:creator>Hung, Y.-J.</dc:creator>
<dc:creator>Irvin, M. R.</dc:creator>
<dc:creator>Kaplan, R. C.</dc:creator>
<dc:creator>Kardia, S. L. R.</dc:creator>
<dc:creator>Kelly, T.</dc:creator>
<dc:creator>Konigsberg, I.</dc:creator>
<dc:creator>Kooperberg, C.</dc:creator>
<dc:creator>Kral, B. G.</dc:creator>
<dc:creator>Li, C.</dc:creator>
<dc:creator>Loos, R. J. F.</dc:creator>
<dc:creator>Mahaney, M. C.</dc:creator>
<dc:creator>Martin, L. W.</dc:creator>
<dc:creator>Mathias, R. A.</dc:creator>
<dc:creator>Minster, R. L.</dc:creator>
<dc:creator>Mitchell, B. D</dc:creator>
<dc:date>2023-11-02</dc:date>
<dc:identifier>doi:10.1101/2023.10.30.564764</dc:identifier>
<dc:title><![CDATA[A statistical framework for powerful multi-trait rare variant analysis in large-scale whole-genome sequencing studies]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-11-02</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.11.01.565151v1?rss=1">
<title>
<![CDATA[
Ciliary intrinsic mechanisms regulate dynamic ciliary extracellular vesicle release from sensory neurons 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.11.01.565151v1?rss=1</link>
<description><![CDATA[
Cilia-derived extracellular vesicles (EVs) contain signaling proteins and act in intercellular communication. Polycystin-2 (PKD-2), a transient receptor potential channel, is a conserved ciliary EVs cargo. Caenorhabditis elegans serves as a model for studying ciliary EV biogenesis and function. C. elegans males release EVs in a mechanically-induced manner and deposit PKD-2-labeled EVs onto the hermaphrodite vulva during mating, suggesting an active release process. Here, we study the dynamics of ciliary EV release using time-lapse imaging and find that cilia can sustain the release of PKD-2-labeled EVs for a two-hour duration. Intriguingly, this extended release doesnt require neuronal synaptic transmission. Instead, ciliary intrinsic mechanisms regulate PKD-2 ciliary membrane replenishment and dynamic EV release. The ciliary kinesin-3 motor KLP-6 is necessary for both initial and extended ciliary EV release, while the transition zone protein NPHP-4 is required only for sustained EV release. The dihydroceramide desaturase DEGS1/2 ortholog TTM-5 is highly expressed in the EV-releasing sensory neurons, localizes to cilia, and is required for sustained but not initial ciliary EV release, implicating ceramide in ciliary ectocytosis. The study offers a comprehensive portrait of real-time ciliary EV release, and mechanisms supporting cilia as proficient EV release platforms.
]]></description>
<dc:creator>Wang, J.</dc:creator>
<dc:creator>Saul, J.</dc:creator>
<dc:creator>Nikonorova, I. A.</dc:creator>
<dc:creator>Cruz, C. N.</dc:creator>
<dc:creator>Power, K. M.</dc:creator>
<dc:creator>Nguyen, K. C.</dc:creator>
<dc:creator>Hall, D. H.</dc:creator>
<dc:creator>Barr, M. M.</dc:creator>
<dc:date>2023-11-03</dc:date>
<dc:identifier>doi:10.1101/2023.11.01.565151</dc:identifier>
<dc:title><![CDATA[Ciliary intrinsic mechanisms regulate dynamic ciliary extracellular vesicle release from sensory neurons]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-11-03</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.11.03.565494v1?rss=1">
<title>
<![CDATA[
Ablation of parasympathetic cholinergic innervation of the liver prevents diet-induced obesity and hepatic steatosis in mice. 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.11.03.565494v1?rss=1</link>
<description><![CDATA[
Hepatic lipid metabolism is regulated by the autonomic nervous system of the liver, with the sympathetic innervation being extensively studied, while the parasympathetic efferent innervation is less understood despite its potential importance. In this study, we investigate the consequences of disrupted brain-liver communication on hepatic lipid metabolism in mice exposed to obesogenic conditions. We found that a subset of hepatocytes and cholangiocytes are innervated by parasympathetic nerve terminals originating from the dorsal motor nucleus of the vagus. The elimination of the brain-liver axis by deleting parasympathetic cholinergic neurons innervating the liver prevents hepatic steatosis and promotes browning of inguinal white adipose tissue (ingWAT). The loss of liver-innervating cholinergic neurons increases hepatic Cyp7b1 expression and fasting serum bile acid levels. Furthermore, knockdown of the G protein-coupled bile acid receptor 1 gene in ingWAT reverses the beneficial effects of the loss of liver-innervating cholinergic neurons, leading to the reappearance of hepatic steatosis. Deleting liver-innervating cholinergic neurons has a small but significant effect on body weight, which is accompanied by an increase in energy expenditure. Taken together, these data suggest that targeting the parasympathetic cholinergic innervation of the liver is a potential therapeutic approach for enhancing hepatic lipid metabolism in obesity and diabetes.
]]></description>
<dc:creator>JO, y.-h.</dc:creator>
<dc:creator>Hwang, J.</dc:creator>
<dc:creator>Okada, J.</dc:creator>
<dc:creator>Liu, L.</dc:creator>
<dc:creator>Pessin, J. E.</dc:creator>
<dc:creator>Schwartz, G. J.</dc:creator>
<dc:date>2023-11-05</dc:date>
<dc:identifier>doi:10.1101/2023.11.03.565494</dc:identifier>
<dc:title><![CDATA[Ablation of parasympathetic cholinergic innervation of the liver prevents diet-induced obesity and hepatic steatosis in mice.]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-11-05</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.11.06.565847v1?rss=1">
<title>
<![CDATA[
Methylation of histone H3 lysine 36 is a barrier for therapeutic interventions of head and neck squamous cell carcinoma. 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.11.06.565847v1?rss=1</link>
<description><![CDATA[
Approximately 20% of head and neck squamous cell carcinomas (HNSCC) exhibit reduced methylation on lysine 36 of histone H3 (H3K36me) due to mutations in histone methylase NSD1 or a lysine-to-methionine mutation in histone H3 (H3K36M). Whether such alterations of H3K36me can be exploited for therapeutic interventions is still unknown. Here, we show that HNSCC models expressing H3K36M can be divided into two groups: those that display aberrant accumulation of H3K27me3 and those that maintain steady levels of H3K27me3. The first group shows decreased proliferation, genome instability, and increased sensitivity to genotoxic agents, such as PARP1/2 inhibitors. In contrast, the H3K36M HNSCC models with steady H3K27me3 levels do not exhibit these characteristics unless H3K27me3 levels are elevated, either by DNA hypomethylating agents or by inhibiting the H3K27me3 demethylases KDM6A/B. Mechanistically, we found that H3K36M reduces H3K36me by directly impeding the activities of the histone methyltransferase NSD3 and the histone demethylase LSD2. Notably, we found that aberrant H3K27me3 levels induced by H3K36M expression is not a bona fide epigenetic mark in HNSCC since it requires continuous expression of H3K36M to be inherited. Moreover, increased sensitivity of H3K36M HNSCC models to PARP1/2 inhibitors solely depends on the increased H3K27me3 levels. Indeed, aberrantly high H3K27me3 levels decrease BRCA1 and FANCD2-dependent DNA repair, resulting in higher sensitivity to DNA breaks and replication stress. Finally, in support of our in vitro findings, a PARP1/2 inhibitor alone reduce tumor burden in a H3K36M HNSCC xenograft model with elevated H3K27me3, whereas in a H3K36M HNSCC xenograft model with consistent H3K27me3 levels, a combination of PARP1/2 inhibitors and agents that upregulate H3K27me3 proves to be successful. In conclusion, our findings underscore a delicate balance between H3K36 and H3K27 methylation, essential for maintaining genome stability. This equilibrium presents promising therapeutic opportunities for patients with H3K36me-deficient tumors.
]]></description>
<dc:creator>Caeiro, L.</dc:creator>
<dc:creator>Nakata, Y.</dc:creator>
<dc:creator>Borges, R. L.</dc:creator>
<dc:creator>Garcia-Martinez, L.</dc:creator>
<dc:creator>Banuelos, C.</dc:creator>
<dc:creator>Stransky, S.</dc:creator>
<dc:creator>Chan, H. L.</dc:creator>
<dc:creator>Brabson, J.</dc:creator>
<dc:creator>Dominguez, D.</dc:creator>
<dc:creator>Zhang, Y.</dc:creator>
<dc:creator>Lewis, P. W.</dc:creator>
<dc:creator>Benitah, S. A.</dc:creator>
<dc:creator>Cimmino, L.</dc:creator>
<dc:creator>Bilbao, D.</dc:creator>
<dc:creator>Sidoli, S.</dc:creator>
<dc:creator>Verdun, R.</dc:creator>
<dc:creator>Morey, L.</dc:creator>
<dc:date>2023-11-06</dc:date>
<dc:identifier>doi:10.1101/2023.11.06.565847</dc:identifier>
<dc:title><![CDATA[Methylation of histone H3 lysine 36 is a barrier for therapeutic interventions of head and neck squamous cell carcinoma.]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-11-06</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.11.06.565884v1?rss=1">
<title>
<![CDATA[
Astrocyte sensitivity to glymphatic shear stress is amplified by albumin and mediated by the interaction of sphingosine 1 phosphate with Piezo1 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.11.06.565884v1?rss=1</link>
<description><![CDATA[
Astrocyte endfeet enwrap brain vasculature, forming a boundary for perivascular glymphatic flow of fluid and solutes along and across the astrocyte endfeet into the brain parenchyma. To determine whether astrocytes may sense and respond to the shear forces generated by glymphatic flow, we examined intracellular calcium (Ca2+) changes evoked in astrocytes to brief fluid flow applied in calibrated microfluidic chambers. Shear stresses < 20 dyn/cm2 failed to evoke Ca2+ responses in the absence of albumin, but cells responded to shear stress below 1 dyn/cm2 when as little as 5 M albumin was present in flow medium. A role for extracellular matrix in mechanotransduction was indicated by reduced sensitivity after degradation of heparan sulfate proteoglycan. Sphingosine-1-phosphate (S1P) amplified shear responses in the absence of albumin, whereas mechanosensitivity was attenuated by the S1P receptor blocker fingolimod. Piezo1 participated in the transduction as revealed by blockade by the spider toxin GsMTX and amplification by the chemical modulator Yoda1, even in absence of albumin or S1P. Our findings that astrocytes are exquisitely sensitive to shear stress and that sensitivity is greatly amplified by albumin concentrations encountered in normal and pathological CSF predict that perivascular astrocytes are responsive to glymphatic shear stress and that responsiveness is augmented by elevated CSF protein. S1P receptor signaling thus establishes a setpoint for Piezo1 activation that is finely tuned to coincide with albumin level in CSF and to the low shear forces resulting from glymphatic flow.

Graphical abstract

O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=71 SRC="FIGDIR/small/565884v1_ufig1.gif" ALT="Figure 1">
View larger version (21K):
org.highwire.dtl.DTLVardef@17086e6org.highwire.dtl.DTLVardef@a89f32org.highwire.dtl.DTLVardef@6baed5org.highwire.dtl.DTLVardef@1a32f80_HPS_FORMAT_FIGEXP  M_FIG C_FIG Astrocyte endfoot responds to glymphatic shear stress when albumin is present. Mechanism involves sphingosine-1-phosphate (S1P) binding to its receptor (S1PR), activating phospholipase C (PLC) and thereby sensitizing the response of Piezo1 to flow. Ca2+ influx triggers Ca2+ release from intracellular stores and further downstream signaling, thereby modulating parenchymal perfusion. Illustration created using BioRender.com
]]></description>
<dc:creator>Ballesteros-Gomez, D.</dc:creator>
<dc:creator>McCutcheon, S.</dc:creator>
<dc:creator>Yang, G. L.</dc:creator>
<dc:creator>Cibelli, A.</dc:creator>
<dc:creator>Bispo, A.</dc:creator>
<dc:creator>Krawchuk, M.</dc:creator>
<dc:creator>Piedra, G.</dc:creator>
<dc:creator>Spray, D. C.</dc:creator>
<dc:date>2023-11-07</dc:date>
<dc:identifier>doi:10.1101/2023.11.06.565884</dc:identifier>
<dc:title><![CDATA[Astrocyte sensitivity to glymphatic shear stress is amplified by albumin and mediated by the interaction of sphingosine 1 phosphate with Piezo1]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-11-07</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.11.10.564562v1?rss=1">
<title>
<![CDATA[
Lipid metabolism drives allele-specific early-stage hypertrophic cardiomyopathy 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.11.10.564562v1?rss=1</link>
<description><![CDATA[
Hypertrophic cardiomyopathy (HCM) results from pathogenic variants in sarcomeric protein genes, that increase myocyte energy demand and lead to cardiac hypertrophy. But it is unknown whether a common metabolic trait underlies the cardiac phenotype at early disease stage. This study characterized two HCM mouse models (R92W-TnT, R403Q-MyHC) that demonstrate differences in mitochondrial function at early disease stage. Using a combination of cardiac phenotyping, transcriptomics, mass spectrometry-based metabolomics and computational modeling, we discovered allele-specific differences in cardiac structure/function and metabolic changes. TnT-mutant hearts had impaired energy substrate metabolism and increased phospholipid remodeling compared to MyHC-mutants. TnT-mutants showed increased incorporation of saturated fatty acid residues into ceramides, cardiolipin, and increased lipid peroxidation, that could underlie allele-specific differences in mitochondrial function and cardiomyopathy.

Graphical Abstract

O_FIG O_LINKSMALLFIG WIDTH=172 HEIGHT=200 SRC="FIGDIR/small/564562v1_ufig1.gif" ALT="Figure 1">
O_LINKSMALLFIG WIDTH=185 HEIGHT=200 SRC="FIGDIR/small/564562v1_ufig2.gif" ALT="Figure 1">
O_LINKSMALLFIG WIDTH=200 HEIGHT=74 SRC="FIGDIR/small/564562v1_ufig3.gif" ALT="Figure 1">
View larger version (90K):
org.highwire.dtl.DTLVardef@195b1d7org.highwire.dtl.DTLVardef@cead88org.highwire.dtl.DTLVardef@e2bf35org.highwire.dtl.DTLVardef@776765_HPS_FORMAT_FIGEXP  M_FIG C_FIG
]]></description>
<dc:creator>Vaniya, A.</dc:creator>
<dc:creator>Karlstaedt, A.</dc:creator>
<dc:creator>Ates Gulkok, D.</dc:creator>
<dc:creator>Thottakara, T.</dc:creator>
<dc:creator>Liu, Y.</dc:creator>
<dc:creator>Fan, S.</dc:creator>
<dc:creator>Eades, H.</dc:creator>
<dc:creator>Fukunaga, R.</dc:creator>
<dc:creator>Vernon, H. J.</dc:creator>
<dc:creator>Fiehn, O.</dc:creator>
<dc:creator>Abraham, M. R.</dc:creator>
<dc:date>2023-11-15</dc:date>
<dc:identifier>doi:10.1101/2023.11.10.564562</dc:identifier>
<dc:title><![CDATA[Lipid metabolism drives allele-specific early-stage hypertrophic cardiomyopathy]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-11-15</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.11.13.565361v1?rss=1">
<title>
<![CDATA[
Mechanical force of uterine occupation enables large vesicle extrusion from proteostressed maternal neurons 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.11.13.565361v1?rss=1</link>
<description><![CDATA[
Large vesicle extrusion from neurons may contribute to spreading pathogenic protein aggregates and promoting inflammatory responses, two mechanisms leading to neurodegenerative disease. Factors that regulate extrusion of large vesicles, such as exophers produced by proteostressed C. elegans touch neurons, are poorly understood. Here we document that mechanical force can significantly potentiate exopher extrusion from proteostressed neurons. Exopher production from the C. elegans ALMR neuron peaks at adult day 2 or 3, coinciding with the C. elegans reproductive peak. Genetic disruption of C. elegans germline, sperm, oocytes, or egg/early embryo production can strongly suppress exopher extrusion from the ALMR neurons during the peak period. Conversely, restoring egg production at the late reproductive phase through mating with males or inducing egg retention via genetic interventions that block egg-laying can strongly increase ALMR exopher production. Overall, genetic interventions that promote ALMR exopher production are associated with expanded uterus lengths and genetic interventions that suppress ALMR exopher production are associated with shorter uterus lengths. In addition to the impact of fertilized eggs, ALMR exopher production can be enhanced by filling the uterus with oocytes, dead eggs, or even fluid, supporting that distention consequences, rather than the presence of fertilized eggs, constitute the exopher-inducing stimulus. We conclude that the mechanical force of uterine occupation potentiates exopher extrusion from proximal proteostressed maternal neurons. Our observations draw attention to the potential importance of mechanical signaling in extracellular vesicle production and in aggregate spreading mechanisms, making a case for enhanced attention to mechanobiology in neurodegenerative disease.
]]></description>
<dc:creator>Wang, G.</dc:creator>
<dc:creator>Guasp, R.</dc:creator>
<dc:creator>Salam, S.</dc:creator>
<dc:creator>Chuang, E.</dc:creator>
<dc:creator>Morera, A.</dc:creator>
<dc:creator>Smart, A. J.</dc:creator>
<dc:creator>Jimenez, D.</dc:creator>
<dc:creator>Shekhar, S.</dc:creator>
<dc:creator>Melentijevic, I.</dc:creator>
<dc:creator>Nguyen, K. C.</dc:creator>
<dc:creator>Hall, D. H.</dc:creator>
<dc:creator>Grant, B. D.</dc:creator>
<dc:creator>Driscoll, M.</dc:creator>
<dc:date>2023-11-16</dc:date>
<dc:identifier>doi:10.1101/2023.11.13.565361</dc:identifier>
<dc:title><![CDATA[Mechanical force of uterine occupation enables large vesicle extrusion from proteostressed maternal neurons]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-11-16</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.11.16.567340v1?rss=1">
<title>
<![CDATA[
Cell-specific alpha-tubulin TBA-6 and pan-ciliary IFT cargo RAB-28 generate a non-canonical transition zone 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.11.16.567340v1?rss=1</link>
<description><![CDATA[
The transition zone (TZ) regulates cilia composition and function. Canonical TZs with 9 doublet microtubules (MTs) are common but non-canonical TZs that vary from 9 MT symmetry also occur and arise through unknown mechanisms. Cilia on the quadrant inner labial type 2 (IL2Q) neurons of C. elegans have a specialized non-canonical TZ with fewer than 9 doublet MTs. We previously showed that non-canonical TZs in IL2Q cilia arise via MT loss and reorganization of canonical TZs. Here, we identify structural events and mechanisms that generate non-canonical TZs. Cell-specific -tubulin TBA-6 and pan-ciliary IFT cargo RAB-28 regulate IL2QTZ MT loss without affecting ciliary assembly. Our results reveal a role for the tubulin code in generating non-canonical TZs and contribute towards understanding ciliary functional specialization.

Author summaryCiliary microtubules are exquisitely diverse in arrangements and composition. Studies on how ciliary ultrastructural diversity is generated are essential to our understanding of cilia function in diverse healthy and pathological contexts. Despite its clinical relevance, the ultrastructural diversity of the transition zone and its microtubules remains understudied. Here, we uncover mechanisms contributing to generating ultrastructural diversity in the transition zone and in cilia. A subset of sensory cilia in C. elegans contain a non-canonical transition zone with 7 and fewer doublet microtubules. We previously showed that this distinct transition zone is generated through microtubule loss in a canonical transition zone with 9 doublet microtubules, a process that occurs asynchronously during animal development. Here, we identify roles for the tubulin code and for an IFT cargo in generating a distinct transition zone. Sculpting of the distinct transition zone occurs in fully assembled cilia and transition zones and is independent of general ciliogenesis mechanisms. Our results demonstrate how specialized transition zones can be generated from canonical transition zones and provide insight into mechanisms of ciliary ultrastructural diversity and post-ciliogenesis restructuring. Such mechanisms hold the key to understanding ciliary function and to restoration of function in ciliopathies with ciliary ultrastructural defects.
]]></description>
<dc:creator>Akella, J. S.</dc:creator>
<dc:creator>Silva, M. S.</dc:creator>
<dc:creator>Nguyen, K. C. Q.</dc:creator>
<dc:creator>Hall, D. H.</dc:creator>
<dc:creator>Barr, M. M.</dc:creator>
<dc:date>2023-11-17</dc:date>
<dc:identifier>doi:10.1101/2023.11.16.567340</dc:identifier>
<dc:title><![CDATA[Cell-specific alpha-tubulin TBA-6 and pan-ciliary IFT cargo RAB-28 generate a non-canonical transition zone]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-11-17</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.11.17.567618v1?rss=1">
<title>
<![CDATA[
Protein-lipid interactions drive presynaptic assembly upstream of cell adhesion molecules 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.11.17.567618v1?rss=1</link>
<description><![CDATA[
Textbook models of synaptogenesis position cell adhesion molecules such as neurexin as initiators of synapse assembly. Here we discover a mechanism for presynaptic assembly that occurs prior to neurexin recruitment, while supporting a role for neurexin in synapse maintenance. We find that the cytosolic active zone scaffold SYD-1 interacts with membrane phospholipids to promote active zone protein clustering at the plasma membrane, and subsequently recruits neurexin to stabilize those clusters. Employing molecular dynamics simulations to model intrinsic interactions between SYD-1 and lipid bilayers followed by in vivo tests of these predictions, we find that PIP2-interacting residues in SYD-1s C2 and PDZ domains are redundantly necessary for proper active zone assembly. Finally, we propose that the uncharacterized yet evolutionarily conserved short {gamma} isoform of neurexin represents a minimal neurexin sequence that can stabilize previously assembled presynaptic clusters, potentially a core function of this critical protein.
]]></description>
<dc:creator>Frankel, E. B.</dc:creator>
<dc:creator>Tiroumalechetty, A. R.</dc:creator>
<dc:creator>Henry, P. S.</dc:creator>
<dc:creator>Su, Z.</dc:creator>
<dc:creator>Wu, Y.</dc:creator>
<dc:creator>Kurshan, P. T.</dc:creator>
<dc:date>2023-11-17</dc:date>
<dc:identifier>doi:10.1101/2023.11.17.567618</dc:identifier>
<dc:title><![CDATA[Protein-lipid interactions drive presynaptic assembly upstream of cell adhesion molecules]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-11-17</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.11.19.566520v1?rss=1">
<title>
<![CDATA[
Whole genome association testing in 333,100 individuals across three biobanks identifies rare non-coding single variant and genomic aggregate associations with height 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.11.19.566520v1?rss=1</link>
<description><![CDATA[
The role of rare non-coding variation in complex human phenotypes is still largely unknown. To elucidate the impact of rare variants in regulatory elements, we performed a whole-genome sequencing association analysis for height using 333,100 individuals from three datasets: UK Biobank (N=200,003), TOPMed (N=87,652) and All of Us (N=45,445). We performed rare (<0.1% minor-allele-frequency) single-variant and aggregate testing of non-coding variants in regulatory regions based on proximal, intergenic and deep-intronic annotation. We observed 29 independent variants associated with height at P < 6 x 10-10 after conditioning on previously reported variants, with effect sizes ranging from -7cm to +4.7cm. We also identified and replicated non-coding aggregate-based associations proximal to HMGA1 containing variants associated with a 5cm taller height and of highly-conserved variants in MIR497HG on chromosome 17. We have developed a novel approach for identifying non-coding rare variants in regulatory regions with large effects from whole-genome sequencing data associated with complex traits.
]]></description>
<dc:creator>Hawkes, G.</dc:creator>
<dc:creator>Beaumont, R. N.</dc:creator>
<dc:creator>Li, Z.</dc:creator>
<dc:creator>Mandla, R.</dc:creator>
<dc:creator>Li, X.</dc:creator>
<dc:creator>Albert, C. M.</dc:creator>
<dc:creator>Arnett, D. K.</dc:creator>
<dc:creator>Ashley-Koch, A. E.</dc:creator>
<dc:creator>Ashrani, A. A.</dc:creator>
<dc:creator>Barnes, K. C.</dc:creator>
<dc:creator>Boerwinkle, E.</dc:creator>
<dc:creator>Brody, J. A.</dc:creator>
<dc:creator>Carson, A. P.</dc:creator>
<dc:creator>Chami, N.</dc:creator>
<dc:creator>Chen, Y.-D. I.</dc:creator>
<dc:creator>Chung, M. K.</dc:creator>
<dc:creator>Curran, J. E.</dc:creator>
<dc:creator>Darbar, D.</dc:creator>
<dc:creator>Ellinor, P. T.</dc:creator>
<dc:creator>Fornage, M.</dc:creator>
<dc:creator>Gordeuk, V. R.</dc:creator>
<dc:creator>Guo, X.</dc:creator>
<dc:creator>He, J.</dc:creator>
<dc:creator>Hwu, C.-M.</dc:creator>
<dc:creator>Kalyani, R. R.</dc:creator>
<dc:creator>Kaplan, R.</dc:creator>
<dc:creator>Kardia, S. L. R.</dc:creator>
<dc:creator>Kooperberg, C.</dc:creator>
<dc:creator>Loos, R. J. F.</dc:creator>
<dc:creator>Lubitz, S. A.</dc:creator>
<dc:creator>Minster, R. L.</dc:creator>
<dc:creator>Mitchell, B. D.</dc:creator>
<dc:creator>Murabito, J. M.</dc:creator>
<dc:creator>Palmer, N. D.</dc:creator>
<dc:creator>Psaty, B. M.</dc:creator>
<dc:creator>Redline, S.</dc:creator>
<dc:creator>Shoemaker, M. B.</dc:creator>
<dc:creator>Silverman, E. K.</dc:creator>
<dc:creator>Telen, M. J.</dc:creator>
<dc:creator>Weiss, S. T.</dc:creator>
<dc:creator>Yanek, L. R.</dc:creator>
<dc:creator>Zhou, H.</dc:creator>
<dc:creator>NH</dc:creator>
<dc:date>2023-11-20</dc:date>
<dc:identifier>doi:10.1101/2023.11.19.566520</dc:identifier>
<dc:title><![CDATA[Whole genome association testing in 333,100 individuals across three biobanks identifies rare non-coding single variant and genomic aggregate associations with height]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-11-20</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.11.20.563492v1?rss=1">
<title>
<![CDATA[
Isolating Single Cycles of Neural Oscillations in Spiking Activity 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.11.20.563492v1?rss=1</link>
<description><![CDATA[
Neural oscillations are prominent features of brain activity, observable through frequency-specific power changes in electroencephalograms (EEG) and local field potentials (LFP). They also manifest as rhythmic coherence across brain regions. Although the identification of oscillations has primarily relied on EEG and LFP, the intrinsic relation between neural oscillations and neuronal spiking is noteworthy. We investigate the potential to detect individual cycles of neural rhythms solely through the spiking activity of neurons, leveraging recent advances in densely recording large populations of neurons within a local network. The numerous spikes from many neurons within a local network estimate the networks activity over time, enabling the identification of cyclic patterns. Here, we utilize a Long Short Term Memory (LSTM) network to effectively isolate and align individual cycles of neural oscillations from the spiking of a densely recorded population of neurons. We applied this network to robustly isolate specific cycles in different brain regions of mice across different time scales, from gamma to ultra-slow rhythms spanning durations of up to hundreds of seconds. These ultra-slow rhythms, which are usually cut off in the LFP, are also detected in behavioral measures of arousal, such as pupil size and mouse facial motion, and show delayed coherence with corresponding rhythms in the population spiking. We used the isolated neural cycles to investigate two questions: 1) With isolated gamma cycles driven by sensory input, we achieved a more precise alignment of the trials in sensory stimulation experiments in the primary visual cortex (V1) of mice. This alignment compensates for the biological variation in the transmission times of sensory signals from the retina to V1 across trials. As a result, we retrieve more accurate neural dynamics in response to sensory stimulation. 2) We used the distinct cycles in population spiking of simultaneously recorded regions to measure the correlated spiking across brain regions separately on different time scales. We observed that the delay in population spiking between brain regions varies according to brain regions and different time scales.
]]></description>
<dc:creator>Sabri, E.</dc:creator>
<dc:creator>Batista-Brito, R.</dc:creator>
<dc:date>2023-11-21</dc:date>
<dc:identifier>doi:10.1101/2023.11.20.563492</dc:identifier>
<dc:title><![CDATA[Isolating Single Cycles of Neural Oscillations in Spiking Activity]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-11-21</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.11.22.568065v1?rss=1">
<title>
<![CDATA[
More than expected: extracellular waveforms and functional responses in monkey LGN 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.11.22.568065v1?rss=1</link>
<description><![CDATA[
Unlike the exhaustive determination of cell types in the retina, key populations in the lateral geniculate nucleus of the thalamus (LGN) may have been missed. Here, we have begun to characterize the full range of extracellular neuronal responses in the LGN of awake monkeys using multi-electrodes during the presentation of colored noise visual stimuli to identify any previously overlooked signals. Extracellular spike waveforms of single units were classified into seven distinct classes, revealing previously unrecognized diversity: four negative-dominant classes that were narrow or broad, one triphasic class, and two positive-dominant classes. Based on their mapped receptive field (RF), these units were further categorized into either magnocellular (M), parvocellular (P), koniocellular (K), or non-RF (N). We found correlations between spike shape and mapped RF and response characteristics, with negative and narrow spiking waveform units predominantly associated with P and N RFs, and positive waveforms mostly linked to M RFs. Responses from positive waveforms exhibited shorter latencies, larger RF sizes, and were associated with larger eccentricities in the visual field than the other waveform classes. Additionally, N cells, those without an estimated RF, were consistently responsive to the visually presented mapping stimulus at a lower and more sustained rate than units with an RF. These findings suggest that the LGN cell population may be more diverse than previously believed.

Significance statementThis study uncovers evidence for an intricate diversity of neuronal responses within the lateral geniculate nucleus (LGN), challenging conventional classifications and revealing previously overlooked populations. By characterizing extracellular spike waveforms and revising receptive field classifications, we provide novel insights into LGN function. Our findings have significant implications for understanding early visual processing mechanisms and interpreting extracellular signals in neural circuits. Furthermore, we identify non-receptive field units, prompting exploration into their functional roles and broader implications for visual and non-visual computations. This study not only advances our understanding of LGN organization but also highlights the importance of considering recording biases in electrophysiological studies. Overall, our work opens new avenues for interdisciplinary research and contributes to advancing our knowledge of neural dynamics in the visual system.
]]></description>
<dc:creator>Sun, S. H.</dc:creator>
<dc:creator>Killian, N. J.</dc:creator>
<dc:creator>Pezaris, J. S.</dc:creator>
<dc:date>2023-11-23</dc:date>
<dc:identifier>doi:10.1101/2023.11.22.568065</dc:identifier>
<dc:title><![CDATA[More than expected: extracellular waveforms and functional responses in monkey LGN]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-11-23</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.11.30.569387v1?rss=1">
<title>
<![CDATA[
Structural mechanism of HP1-dependent transcriptional repression and chromatin compaction 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.11.30.569387v1?rss=1</link>
<description><![CDATA[
Heterochromatin protein 1 (HP1) plays a central role in establishing and maintaining constitutive heterochromatin. However, the mechanisms underlying HP1-nucleosome interactions and their contributions to heterochromatin functions remain elusive. In this study, we employed a multidisciplinary approach to unravel the interactions between human HP1 and nucleosomes. We have elucidated the cryo-EM structure of an HP1 dimer bound to an H2A.Z nucleosome, revealing that the HP1 dimer interfaces with nucleosomes at two distinct sites. The primary binding site is located at the N-terminus of histone H3, specifically at the trimethylated K9 (K9me3) region, while a novel secondary binding site is situated near histone H2B, close to nucleosome superhelical location 4 (SHL4). Our biochemical data further demonstrates that HP1 binding influences the dynamics of DNA on the nucleosome. It promotes DNA unwrapping near the nucleosome entry and exit sites while concurrently restricting DNA accessibility in the vicinity of SHL4. This study offers a model that explains how HP1 functions in heterochromatin maintenance and gene silencing, particularly in the context of H3K9me-dependent mechanisms. Additionally, it sheds light on the H3K9me-independent role of HP1 in responding to DNA damage.
]]></description>
<dc:creator>Sokolova, V.</dc:creator>
<dc:creator>Miratsky, J.</dc:creator>
<dc:creator>Svetlov, V.</dc:creator>
<dc:creator>Brenowitz, M.</dc:creator>
<dc:creator>Vant, J.</dc:creator>
<dc:creator>Lewis, T. S.</dc:creator>
<dc:creator>Dryden, K.</dc:creator>
<dc:creator>Lee, G. L.</dc:creator>
<dc:creator>Sarkar, S. L.</dc:creator>
<dc:creator>Nudler, E.</dc:creator>
<dc:creator>Singharoy, A.</dc:creator>
<dc:creator>Tan, D.</dc:creator>
<dc:date>2023-11-30</dc:date>
<dc:identifier>doi:10.1101/2023.11.30.569387</dc:identifier>
<dc:title><![CDATA[Structural mechanism of HP1-dependent transcriptional repression and chromatin compaction]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-11-30</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.11.30.569417v1?rss=1">
<title>
<![CDATA[
Lens Placode Modulates Extracellular Matrix Formation During Early Eye Development 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.11.30.569417v1?rss=1</link>
<description><![CDATA[
The role extracellular matrix (ECM) in multiple events of morphogenesis has been well described, little is known about its specific role in early eye development. One of the first morphogenic events in lens development is placodal thickening, which converts the presumptive lens ectoderm from cuboidal to pseudostratified epithelium. This process occurs in the anterior pre-placodal ectoderm when the optic vesicle approaches the cephalic ectoderm. Since cells and ECM have a dynamic relationship of interdependence and modulation, we hypothesized that the ECM evolves with cell shape changes during lens placode formation. This study investigates changes in optic ECM including both protein distribution deposition, extracellular gelatinase activity and gene expression patterns during early optic development using chicken and mouse models. In particular, the expression of Timp2, a metalloprotease inhibitor, corresponds with a decrease in gelatinase activity within the optic ECM. Furthermore, we demonstrate that optic ECM remodeling depends on BMP signaling in the placode. Together, our findings suggest that the lens placode plays an active role in remodeling the optic ECM during early eye development.
]]></description>
<dc:creator>de Magalhaes, C. G.</dc:creator>
<dc:creator>Cvekl, A.</dc:creator>
<dc:creator>Jaeger, R. G.</dc:creator>
<dc:creator>Yan, C. Y. I.</dc:creator>
<dc:date>2023-12-01</dc:date>
<dc:identifier>doi:10.1101/2023.11.30.569417</dc:identifier>
<dc:title><![CDATA[Lens Placode Modulates Extracellular Matrix Formation During Early Eye Development]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-12-01</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.12.06.570390v1?rss=1">
<title>
<![CDATA[
A proteogenomic surfaceome study identifies DLK1 as an immunotherapeutic target in neuroblastoma 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.12.06.570390v1?rss=1</link>
<description><![CDATA[
Cancer immunotherapies have produced remarkable results in B-cell malignancies; however, optimal cell surface targets for many solid cancers remain elusive. Here, we present an integrative proteomic, transcriptomic, and epigenomic analysis of tumor specimens along with normal tissues to identify biologically relevant cell surface proteins that can serve as immunotherapeutic targets for neuroblastoma, an often-fatal childhood cancer of the developing nervous system. We apply this approach to human-derived cell lines (N=9) and cell/patient-derived xenograft (N=12) models of neuroblastoma. Plasma membrane-enriched mass spectrometry identified 1,461 cell surface proteins in cell lines and 1,401 in xenograft models, respectively. Additional proteogenomic analyses revealed 60 high-confidence candidate immunotherapeutic targets and we prioritized Delta-like canonical notch ligand 1 (DLK1) for further study. High expression of DLK1 directly correlated with the presence of a super-enhancer spanning the DLK1 locus. Robust cell surface expression of DLK1 was validated by immunofluorescence, flow cytometry, and immunohistochemistry. Short hairpin RNA mediated silencing of DLK1 in neuroblastoma cells resulted in increased cellular differentiation. ADCT-701, a DLK1-targeting antibody-drug conjugate (ADC), showed potent and specific cytotoxicity in DLK1-expressing neuroblastoma xenograft models. Moreover, DLK1 is highly expressed in several adult cancer types, including adrenocortical carcinoma (ACC), pheochromocytoma/paraganglioma (PCPG), hepatoblastoma, and small cell lung cancer (SCLC), suggesting potential clinical benefit beyond neuroblastoma. Taken together, our study demonstrates the utility of comprehensive cancer surfaceome characterization and credentials DLK1 as an immunotherapeutic target.

HighlightsO_LIPlasma membrane enriched proteomics defines surfaceome of neuroblastoma
C_LIO_LIMulti-omic data integration prioritizes DLK1 as a candidate immunotherapeutic target in neuroblastoma and other cancers
C_LIO_LIDLK1 expression is driven by a super-enhancer
C_LIO_LIDLK1 silencing in neuroblastoma cells results in cellular differentiation
C_LIO_LIADCT-701, a DLK1-targeting antibody-drug conjugate, shows potent and specific cytotoxicity in DLK1-expressing neuroblastoma preclinical models
C_LI
]]></description>
<dc:creator>Weiner, A. K.</dc:creator>
<dc:creator>Radaoui, A. B.</dc:creator>
<dc:creator>Tsang, M.</dc:creator>
<dc:creator>Martinez, D.</dc:creator>
<dc:creator>Sidoli, S.</dc:creator>
<dc:creator>Conkrite, K. L.</dc:creator>
<dc:creator>Delaidelli, A.</dc:creator>
<dc:creator>Modi, A.</dc:creator>
<dc:creator>Rokita, J. L.</dc:creator>
<dc:creator>Patel, K.</dc:creator>
<dc:creator>Lane, M. V.</dc:creator>
<dc:creator>Zhang, B.</dc:creator>
<dc:creator>Zhong, C.</dc:creator>
<dc:creator>Ennis, B.</dc:creator>
<dc:creator>Miller, D. P.</dc:creator>
<dc:creator>Brown, M. A.</dc:creator>
<dc:creator>Rathi, K. S.</dc:creator>
<dc:creator>Raman, P.</dc:creator>
<dc:creator>Pogoriler, J.</dc:creator>
<dc:creator>Bhatti, T.</dc:creator>
<dc:creator>Pawel, B.</dc:creator>
<dc:creator>Glisovic-Aplenc, T.</dc:creator>
<dc:creator>Teicher, B.</dc:creator>
<dc:creator>Erickson, S. W.</dc:creator>
<dc:creator>Earley, E. J.</dc:creator>
<dc:creator>Bosse, K. R.</dc:creator>
<dc:creator>Sorensen, P. H.</dc:creator>
<dc:creator>Krytska, K.</dc:creator>
<dc:creator>Mosse, Y. P.</dc:creator>
<dc:creator>Havenith, K. E.</dc:creator>
<dc:creator>Zammarchi, F.</dc:creator>
<dc:creator>van Berkel, P. H.</dc:creator>
<dc:creator>Smith, M. A.</dc:creator>
<dc:creator>Garcia, B. A.</dc:creator>
<dc:creator>Maris, J. M.</dc:creator>
<dc:creator>Diskin, S. J.</dc:creator>
<dc:date>2023-12-08</dc:date>
<dc:identifier>doi:10.1101/2023.12.06.570390</dc:identifier>
<dc:title><![CDATA[A proteogenomic surfaceome study identifies DLK1 as an immunotherapeutic target in neuroblastoma]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-12-08</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.12.06.570397v1?rss=1">
<title>
<![CDATA[
Machine-learning-based Structural Analysis of Interactions between Antibodies and Antigens 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.12.06.570397v1?rss=1</link>
<description><![CDATA[
Computational analysis of paratope-epitope interactions between antibodies and their corresponding antigens can facilitate our understanding of the molecular mechanism underlying humoral immunity and boost the design of new therapeutics for many diseases. The recent breakthrough in artificial intelligence has made it possible to predict protein-protein interactions and model their structures. Unfortunately, detecting antigen-binding sites associated with a specific antibody is still a challenging problem. To tackle this challenge, we implemented a deep learning model to characterize interaction patterns between antibodies and their corresponding antigens. With high accuracy, our model can distinguish between antibody-antigen complexes and other types of protein-protein complexes. More intriguingly, we can identify antigens from other common protein binding regions with an accuracy of higher than 70% even if we only have the epitope information. This indicates that antigens have distinct features on their surface that antibodies can recognize. Additionally, our model was unable to predict the partnerships between antibodies and their particular antigens. This result suggests that one antigen may be targeted by more than one antibody and that antibodies may bind to previously unidentified proteins. Taken together, our results support the precision of antibody-antigen interactions while also suggesting positive future progress in the prediction of specific pairing.
]]></description>
<dc:creator>Zhang, G.</dc:creator>
<dc:creator>Su, Z.</dc:creator>
<dc:creator>Zhang, T.</dc:creator>
<dc:creator>Wu, Y.</dc:creator>
<dc:date>2023-12-08</dc:date>
<dc:identifier>doi:10.1101/2023.12.06.570397</dc:identifier>
<dc:title><![CDATA[Machine-learning-based Structural Analysis of Interactions between Antibodies and Antigens]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-12-08</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.12.11.571163v1?rss=1">
<title>
<![CDATA[
Boosting bactericidal immunity of a recombinant Mycobacterium smegmatis strain via zinc-dependent ribosomal proteins 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.12.11.571163v1?rss=1</link>
<description><![CDATA[
Tuberculosis (TB) continues to be a major global health burden and kills over a million people annually. New immunization strategies are required for the development of an efficacious TB vaccine that can potentially induce sterilizing immunity. In this study, we first confirmed that various strains of the IKEPLUS vaccine confer a higher survival benefit than BCG in a murine model of intravenous Mycobacterium tuberculosis (Mtb) infection. We have shown that there was a significant increase in the expression of the Rv0282 when IKEPLUS was grown in low zinc and iron containing Sauton medium. We confirmed on biofilm assays that zinc plays a vital role in the growth and formation of Mycobacterium smegmatis (M. smegmatis) biofilms. IKEPLUS grown in low zinc media led to better protection of mice after intravenous challenge with very high dosage of Mtb. We also showed that various variants of IKEPLUS induced apoptotic cell-death of infected macrophages at a higher rate than wild type M. smegmatis. We next attempted to determine if zinc containing ribosomal proteins such as rpmb2 could contribute to protective efficacy against Mtb infection. Since BCG has an established role in anti-mycobacterial efficacy, we boosted BCG vaccinated mice with rmpb2 but this did not lead to an increment in the protection mediated by BCG.
]]></description>
<dc:creator>Singh, S.</dc:creator>
<dc:creator>Kanzin, D.</dc:creator>
<dc:creator>Chavez, S.</dc:creator>
<dc:creator>Saavedra-Avila, N. A.</dc:creator>
<dc:creator>Ng, T.</dc:creator>
<dc:creator>Lukos, R.</dc:creator>
<dc:creator>Mayer, O.</dc:creator>
<dc:creator>Kim, J.</dc:creator>
<dc:creator>Chen, B.</dc:creator>
<dc:creator>Chen, M.</dc:creator>
<dc:creator>Porcelli, S.</dc:creator>
<dc:creator>Jacobs, W. R.</dc:creator>
<dc:creator>Tiwari, S.</dc:creator>
<dc:date>2023-12-12</dc:date>
<dc:identifier>doi:10.1101/2023.12.11.571163</dc:identifier>
<dc:title><![CDATA[Boosting bactericidal immunity of a recombinant Mycobacterium smegmatis strain via zinc-dependent ribosomal proteins]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-12-12</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.12.12.571293v1?rss=1">
<title>
<![CDATA[
Mechanism of Dimer Selectivity and Binding Cooperativity of BRAF inhibitors 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.12.12.571293v1?rss=1</link>
<description><![CDATA[
Aberrant signaling of BRAFV600E is a major cancer driver. Current FDA-approved RAF inhibitors selectively inhibit the monomeric BRAFV600E and suffer from tumor resistance. Recently, dimer-selective and equipotent RAF inhibitors have been developed; however, the mechanism of dimer selectivity is poorly understood. Here, we report extensive molecular dynamics (MD) simulations of the monomeric and dimeric BRAFV600E in the apo form or in complex with one or two dimer-selective (PHI1) or equipotent (LY3009120) inhibitor(s). The simulations uncovered the unprecedented details of the remarkable allostery in BRAFV600E dimerization and inhibitor binding. Specifically, dimerization retrains and shifts the C helix inward and increases the flexibility of the DFG motif; dimer compatibility is due to the promotion of the C-in conformation, which is stabilized by a hydrogen bond formation between the inhibitor and the C Glu501. A more stable hydrogen bond further restrains and shifts the C helix inward, which incurs a larger entropic penalty that disfavors monomer binding. This mechanism led us to propose an empirical way based on the co-crystal structure to assess the dimer selectivity of a BRAFV600E inhibitor. Simulations also revealed that the positive cooperativity of PHI1 is due to its ability to preorganize the C and DFG conformation in the opposite protomer, priming it for binding the second inhibitor. The atomically detailed view of the interplay between BRAF dimerization and inhibitor allostery as well as cooperativity has implications for understanding kinase signaling and contributes to the design of protomer selective RAF inhibitors.
]]></description>
<dc:creator>Clayton, J.</dc:creator>
<dc:creator>Romany, A.</dc:creator>
<dc:creator>Matenoglou, E.</dc:creator>
<dc:creator>Gavathiotis, E.</dc:creator>
<dc:creator>Poulikakos, P. I.</dc:creator>
<dc:creator>Shen, J.</dc:creator>
<dc:date>2023-12-12</dc:date>
<dc:identifier>doi:10.1101/2023.12.12.571293</dc:identifier>
<dc:title><![CDATA[Mechanism of Dimer Selectivity and Binding Cooperativity of BRAF inhibitors]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-12-12</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.12.12.571310v1?rss=1">
<title>
<![CDATA[
Molecular basis of neurodegeneration in a mouse model of Polr3-related disease 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.12.12.571310v1?rss=1</link>
<description><![CDATA[
Pathogenic variants in subunits of RNA polymerase (Pol) III cause a spectrum of Polr3-related neurodegenerative diseases including 4H leukodystrophy. Disease onset occurs from infancy to early adulthood and is associated with a variable range and severity of neurological and non-neurological features. The molecular basis of Polr3-related disease pathogenesis is unknown. We developed a postnatal whole-body mouse model expressing pathogenic Polr3a mutations to examine the molecular mechanisms by which reduced Pol III transcription results primarily in central nervous system phenotypes. Polr3a mutant mice exhibit behavioral deficits, cerebral pathology and exocrine pancreatic atrophy. Transcriptome and immunohistochemistry analyses of cerebra during disease progression show a reduction in most Pol III transcripts, induction of innate immune and integrated stress responses and cell type-specific gene expression changes reflecting neuron and oligodendrocyte loss and microglial activation. Earlier in the disease when integrated stress and innate immune responses are minimally induced, mature tRNA sequencing revealed a global reduction in tRNA levels and an altered tRNA profile but no changes in other Pol III transcripts. Thus, changes in the size and/or composition of the tRNA pool have a causal role in disease initiation. Our findings reveal different tissue- and brain region-specific sensitivities to a defect in Pol III transcription.
]]></description>
<dc:creator>Moir, R. D.</dc:creator>
<dc:creator>Merheb, E.</dc:creator>
<dc:creator>Chitu, V.</dc:creator>
<dc:creator>Stanley, E. R.</dc:creator>
<dc:creator>Willis, I. M.</dc:creator>
<dc:date>2023-12-12</dc:date>
<dc:identifier>doi:10.1101/2023.12.12.571310</dc:identifier>
<dc:title><![CDATA[Molecular basis of neurodegeneration in a mouse model of Polr3-related disease]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-12-12</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.12.14.571774v1?rss=1">
<title>
<![CDATA[
Metacell-based differential expression analysis identifies cell type specific temporal gene response programs in COVID-19 patient PBMCs 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.12.14.571774v1?rss=1</link>
<description><![CDATA[
BackgroundBy resolving cellular heterogeneity in a biological sample, single cell RNA sequencing (scRNA-seq) can detect gene expression and its dynamics in different cell types. Its application to time-series samples can thus identify temporal genetic programs active in different cell types, for example, immune cells responses to viral infection. However, current scRNA-seq analysis need improvement. Two issues are related to data generation. One is that the number of genes detected in each cell is relatively low especially when currently popular dropseq-based technology is used for analyzing thousands of cells or more. The other is the lack of sufficient replicates (often 1-2) due to high cost of library preparation and sequencing. The third issue lies in the data analysis --usage of individual cells as independent sampling data points leads to inflated statistics.

MethodsTo address these issues, we explore a new data analysis framework, specifically whether "metacells" that are carefully constructed to maintain cellular heterogeneity within individual cell types (or clusters) can be used as "replicates" for statistical methods requiring multiple replicates. Toward this, we applied SEACells to a time-series scRNA-seq dataset from peripheral blood mononuclear cells (PBMCs) after SARS-Cov-2 infection to construct metacells, which were then used in maSigPro for quadratic regression to find significantly differentially expressed genes (DEGs) over time, followed by clustering analysis of the expression velocity trends.

ResultsWe found that metacells generated using the SEACells algorithm retained greater between-cell variance and produced more biologically meaningful results compared to metacells generated from random cells. Quadratic regression revealed significant DEGs through time that have been previously annotated in the SARS-CoV2 infection response pathway. It also identified significant genes that have not been annotated in this pathway, which were compared to baseline expression and showed unique expression patterns through time.

ConclusionsThe results demonstrated that this strategy could overcome the limitation of 1-2 replicates, as it correctly identified the known ISG15 interferon response program in almost all PBMC cell types. Its application further led to the uncovering of additional and more cell type-specific gene expression programs that potentially modulate different levels of host response after infection.
]]></description>
<dc:creator>O'Leary, K.</dc:creator>
<dc:creator>Zheng, D.</dc:creator>
<dc:date>2023-12-15</dc:date>
<dc:identifier>doi:10.1101/2023.12.14.571774</dc:identifier>
<dc:title><![CDATA[Metacell-based differential expression analysis identifies cell type specific temporal gene response programs in COVID-19 patient PBMCs]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-12-15</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.12.15.571088v1?rss=1">
<title>
<![CDATA[
A CAG repeat threshold for therapeutics targeting somatic instability in Huntington's disease 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.12.15.571088v1?rss=1</link>
<description><![CDATA[
The Huntingtons disease mutation is a CAG repeat expansion in the huntingtin gene that results in an expanded polyglutamine tract in the huntingtin protein. The CAG repeat is unstable, and expansions of hundreds of CAGs have been detected in Huntingtons disease post-mortem brains. The age of disease onset can be predicted partially from the length of the CAG repeat as measured in blood. Onset age is also determined by genetic modifiers, which in six cases involve variation in DNA mismatch repair pathways genes. Knocking-out specific mismatch repair genes in mouse models of Huntingtons disease prevents somatic CAG repeat expansion. Taken together, these results have led to the hypothesis that somatic CAG repeat expansion in Huntingtons disease brains is required for pathogenesis. Therefore, the pathogenic repeat threshold in brain is longer than (CAG)40, as measured in blood, and is currently unknown.

The mismatch repair gene MSH3 has become a major focus for therapeutic development, as unlike other mismatch repair genes, nullizygosity for MSH3 does not cause malignancies associated with mismatch repair deficiency. Potential treatments targeting MSH3 currently under development include gene therapy, biologics and small molecules, which will be assessed for efficacy in mouse models of Huntingtons disease. The zQ175 knock-in model carries a mutation of approximately (CAG)185 and develops early molecular and pathological phenotypes that have been extensively characterised. Therefore, we crossed the mutant huntingtin allele onto heterozygous and homozygous Msh3 knock-out backgrounds to determine the maximum benefit of targeting Msh3 in this model. Ablation of Msh3 prevented somatic expansion throughout the brain and periphery, and reduction of Msh3 by 50% decreased the rate of expansion. This had no effect on the deposition of huntingtin aggregation in the nuclei of striatal neurons, nor on the dysregulated striatal transcriptional profile. This contrasts with ablating Msh3 in knock-in models with shorter CAG repeat expansions. Therefore, further expansion of a (CAG)185 repeat in striatal neurons does not accelerate the onset of molecular and neuropathological phenotypes. It is striking that highly expanded CAG repeats of a similar size in humans cause disease onset before 2 years of age, indicating that somatic CAG repeat expansion in the brain is not required for pathogenesis. Given that the trajectory for somatic CAG expansion in the brains of Huntingtons disease mutation carriers is unknown, our study underlines the importance of administering treatments targeting somatic instability as early as possible.
]]></description>
<dc:creator>Aldous, S. G.</dc:creator>
<dc:creator>Smith, E. J.</dc:creator>
<dc:creator>Landles, C.</dc:creator>
<dc:creator>Osborne, G. F.</dc:creator>
<dc:creator>Canibano-Pico, M.</dc:creator>
<dc:creator>Nita, I. M.</dc:creator>
<dc:creator>Phillips, J.</dc:creator>
<dc:creator>Zhang, Y.</dc:creator>
<dc:creator>Jin, B.</dc:creator>
<dc:creator>Hirst, M. B.</dc:creator>
<dc:creator>Benn, C. L.</dc:creator>
<dc:creator>Bond, B. C.</dc:creator>
<dc:creator>Edelmann, W.</dc:creator>
<dc:creator>Greene, J. R.</dc:creator>
<dc:creator>Bates, G. P.</dc:creator>
<dc:date>2023-12-15</dc:date>
<dc:identifier>doi:10.1101/2023.12.15.571088</dc:identifier>
<dc:title><![CDATA[A CAG repeat threshold for therapeutics targeting somatic instability in Huntington's disease]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-12-15</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.12.15.571909v1?rss=1">
<title>
<![CDATA[
Targetable leukemia dependency on noncanonical PI3Kγ signaling 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.12.15.571909v1?rss=1</link>
<description><![CDATA[
Phosphoinositide 3-kinase gamma (PI3K{gamma}) is implicated as a target to repolarize tumor-associated macrophages and promote anti-tumor immune responses in solid cancers. However, cancer cell-intrinsic roles of PI3K{gamma} are unclear. Here, by integrating unbiased genome-wide CRISPR interference screening with functional analyses across acute leukemias, we define a selective dependency on the PI3K{gamma} complex in a high-risk subset that includes myeloid, lymphoid, and dendritic lineages. This dependency is characterized by innate inflammatory signaling and activation of phosphoinositide 3-kinase regulatory subunit 5 (PIK3R5), which encodes a regulatory subunit of PI3K{gamma} and stabilizes the active enzymatic complex. Mechanistically, we identify p21 (RAC1) activated kinase 1 (PAK1) as a noncanonical substrate of PI3K{gamma} that mediates this cell-intrinsic dependency independently of Akt kinase. PI3K{gamma} inhibition dephosphorylates PAK1, activates a transcriptional network of NF{kappa}B-related tumor suppressor genes, and impairs mitochondrial oxidative phosphorylation. We find that treatment with the selective PI3K{gamma} inhibitor eganelisib is effective in leukemias with activated PIK3R5, either at baseline or by exogenous inflammatory stimulation. Notably, the combination of eganelisib and cytarabine prolongs survival over either agent alone, even in patient-derived leukemia xenografts with low baseline PIK3R5 expression, as residual leukemia cells after cytarabine treatment have elevated G protein-coupled purinergic receptor activity and PAK1 phosphorylation. Taken together, our study reveals a targetable dependency on PI3K{gamma}/PAK1 signaling that is amenable to near-term evaluation in patients with acute leukemia.
]]></description>
<dc:creator>Luo, Q.</dc:creator>
<dc:creator>Raulston, E. G.</dc:creator>
<dc:creator>Prado, M. A.</dc:creator>
<dc:creator>Wu, X.</dc:creator>
<dc:creator>Gritsman, K.</dc:creator>
<dc:creator>Booth, C. A. G.</dc:creator>
<dc:creator>Xu, R.</dc:creator>
<dc:creator>van Galen, P.</dc:creator>
<dc:creator>Doench, J. G.</dc:creator>
<dc:creator>Shimony, S.</dc:creator>
<dc:creator>Long, H. W.</dc:creator>
<dc:creator>Neuberg, D. S.</dc:creator>
<dc:creator>Paulo, J. A.</dc:creator>
<dc:creator>Lane, A. A.</dc:creator>
<dc:date>2023-12-15</dc:date>
<dc:identifier>doi:10.1101/2023.12.15.571909</dc:identifier>
<dc:title><![CDATA[Targetable leukemia dependency on noncanonical PI3Kγ signaling]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-12-15</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.12.15.571760v1?rss=1">
<title>
<![CDATA[
Synergistic insulation of regulatory domains by developmental genes and clusters of CTCF sites 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.12.15.571760v1?rss=1</link>
<description><![CDATA[
The specificity of gene expression during development requires the insulation of regulatory domains to avoid inappropriate enhancer-gene interactions. In vertebrates, this insulator function is mostly attributed to clusters of CTCF sites located at topologically associating domain (TAD) boundaries. However, TAD boundaries allow a certain level of physical crosstalk across regulatory domains, which is at odds with the highly specific and precise expression of developmental genes. Here we show that developmental genes and nearby clusters of CTCF sites synergistically foster the robust insulation of regulatory domains. Firstly, we found that the TADs containing developmental genes have distinctive features, including the sequential organization of developmental genes and CTCF clusters near TAD boundaries. Most importantly, by genetically dissecting representative loci in mouse embryonic stem cells, we showed that developmental genes and CTCF sites synergistically strengthened the insulation capacity of nearby boundaries through different mechanisms. Namely, while CTCF sites prevent undesirable enhancer-gene contacts (i.e. physical insulation), developmental genes preferentially contribute to regulatory insulation through non-structural mechanisms involving promoter competition rather than enhancer blocking. Overall, our work provides important insights into the specificity of gene regulation, which in turn might help interpreting the pathological consequences of certain structural variants.
]]></description>
<dc:creator>Ealo, T.</dc:creator>
<dc:creator>Sanchez-Gaya, V.</dc:creator>
<dc:creator>Respuela, P.</dc:creator>
<dc:creator>Munoz-San Martin, M.</dc:creator>
<dc:creator>Martin-Batista, E.</dc:creator>
<dc:creator>Haro, E.</dc:creator>
<dc:creator>Rada-Iglesias, A.</dc:creator>
<dc:date>2023-12-16</dc:date>
<dc:identifier>doi:10.1101/2023.12.15.571760</dc:identifier>
<dc:title><![CDATA[Synergistic insulation of regulatory domains by developmental genes and clusters of CTCF sites]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-12-16</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.12.27.573459v1?rss=1">
<title>
<![CDATA[
Common genetic variation impacts molecular stress response in the brain 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.12.27.573459v1?rss=1</link>
<description><![CDATA[
To explain why individuals exposed to identical stressors experience divergent clinical outcomes, we determine how molecular encoding of stress modifies genetic risk for brain disorders. Analysis of post-mortem brain (n=304) revealed 8557 stress-interactive expression quantitative trait loci (eQTLs) that dysregulate expression of 915 eGenes in response to stress, and lie in stress-related transcription factor binding sites. Response to stress is robust across experimental paradigms: up to 50% of stress-interactive eGenes validate in glucocorticoid treated hiPSC-derived neurons (n=39 donors). Stress-interactive eGenes show brain region- and cell type-specificity, and, in post-mortem brain, implicate glial and endothelial mechanisms. Stress dysregulates long-term expression of disorder risk genes in a genotype-dependent manner; stress-interactive transcriptomic imputation uncovered 139 novel genes conferring brain disorder risk only in the context of traumatic stress. Molecular stress-encoding explains individualized responses to traumatic stress; incorporating trauma into genomic studies of brain disorders is likely to improve diagnosis, prognosis, and drug discovery.

Graphical Abstract

O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=71 SRC="FIGDIR/small/573459v1_ufig1.gif" ALT="Figure 1">
View larger version (25K):
org.highwire.dtl.DTLVardef@1e07fa9org.highwire.dtl.DTLVardef@1dd530forg.highwire.dtl.DTLVardef@17822a5org.highwire.dtl.DTLVardef@2a889f_HPS_FORMAT_FIGEXP  M_FIG C_FIG
]]></description>
<dc:creator>Seah, C.</dc:creator>
<dc:creator>Singer, R.</dc:creator>
<dc:creator>Deans, P. M.</dc:creator>
<dc:creator>Bader, H.</dc:creator>
<dc:creator>Rusielewicz, T.</dc:creator>
<dc:creator>Hicks, E. M.</dc:creator>
<dc:creator>Young, H.</dc:creator>
<dc:creator>Cote, A.</dc:creator>
<dc:creator>Townsley, K.</dc:creator>
<dc:creator>Xu, C.</dc:creator>
<dc:creator>Hunter, C. J.</dc:creator>
<dc:creator>McCarthy, B.</dc:creator>
<dc:creator>Goldberg, J.</dc:creator>
<dc:creator>Dobariya, S.</dc:creator>
<dc:creator>Holtzherimer, P. E.</dc:creator>
<dc:creator>Young, K. A.</dc:creator>
<dc:creator>NYSCF Global Stem Cell Array Team,</dc:creator>
<dc:creator>Traumatic Stress Brain Research Group,</dc:creator>
<dc:creator>Noggle, S. A.</dc:creator>
<dc:creator>Krystal, J. H.</dc:creator>
<dc:creator>Paull, D.</dc:creator>
<dc:creator>Girgenti, M. J.</dc:creator>
<dc:creator>Yehuda, R.</dc:creator>
<dc:creator>Brennand, K.</dc:creator>
<dc:creator>Huckins, L.</dc:creator>
<dc:date>2023-12-28</dc:date>
<dc:identifier>doi:10.1101/2023.12.27.573459</dc:identifier>
<dc:title><![CDATA[Common genetic variation impacts molecular stress response in the brain]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-12-28</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2023.12.28.573568v1?rss=1">
<title>
<![CDATA[
A single-cell transposable element atlas of human cell identity 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2023.12.28.573568v1?rss=1</link>
<description><![CDATA[
Single cell RNA sequencing (scRNA-seq) is revolutionizing the study of complex biological systems. However, most sequencing studies overlook the contribution of transposable element (TE) expression to the transcriptome. In both scRNA-seq and bulk tissue RNA sequencing (RNA-seq), quantification of TE expression is challenging due to repetitive sequence content and poorly characterized TE gene models. Here, we developed a tool and analysis pipeline for Single cell Transposable Element Locus Level Analysis of scRNA Sequencing (Stellarscope) that reassigns multi-mapped reads to specific genomic loci using an expectation-maximization algorithm. Using Stellarscope, we built an atlas of TE expression in human PBMCs. We found that locus-specific TEs delineate cell types and define new cell subsets not identified by standard mRNA expression profiles. Altogether, this study provides comprehensive insights into the influence of transposable elements in human biology.
]]></description>
<dc:creator>Reyes-Gopar, H.</dc:creator>
<dc:creator>Marston, J. L.</dc:creator>
<dc:creator>Singh, B.</dc:creator>
<dc:creator>Greenig, M.</dc:creator>
<dc:creator>Lin, J.</dc:creator>
<dc:creator>Ostrowski, M. A.</dc:creator>
<dc:creator>Randall, K. N.</dc:creator>
<dc:creator>Sandoval-Motta, S.</dc:creator>
<dc:creator>Dopkins, N.</dc:creator>
<dc:creator>Lawrence, E.</dc:creator>
<dc:creator>O'Mara, M. M.</dc:creator>
<dc:creator>Fei, T.</dc:creator>
<dc:creator>Duarte, R. R. R.</dc:creator>
<dc:creator>Powell, T. R.</dc:creator>
<dc:creator>Hernandez-Lemus, E.</dc:creator>
<dc:creator>Iniguez, L. P.</dc:creator>
<dc:creator>Nixon, D. F.</dc:creator>
<dc:creator>Bendall, M. L.</dc:creator>
<dc:date>2023-12-28</dc:date>
<dc:identifier>doi:10.1101/2023.12.28.573568</dc:identifier>
<dc:title><![CDATA[A single-cell transposable element atlas of human cell identity]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2023-12-28</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.01.14.575609v1?rss=1">
<title>
<![CDATA[
Blood immunophenotyping identifies distinct kidney histopathology and outcomes in patients with lupus nephritis 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.01.14.575609v1?rss=1</link>
<description><![CDATA[
Lupus nephritis (LN) is a frequent manifestation of systemic lupus erythematosus, and fewer than half of patients achieve complete renal response with standard immunosuppressants. Identifying non-invasive, blood-based pathologic immune alterations associated with renal injury could aid therapeutic decisions. Here, we used mass cytometry immunophenotyping of peripheral blood mononuclear cells in 145 patients with biopsy-proven LN and 40 healthy controls to evaluate the heterogeneity of immune activation in patients with LN and to identify correlates of renal parameters and treatment response. Unbiased analysis identified 3 immunologically distinct groups of patients with LN that were associated with different patterns of histopathology, renal cell infiltrates, urine proteomic profiles, and treatment response at one year. Patients with enriched circulating granzyme B+ T cells at baseline showed more severe disease and increased numbers of activated CD8 T cells in the kidney, yet they had the highest likelihood of treatment response. A second group characterized primarily by a high type I interferon signature had a lower likelihood of response to therapy, while a third group appeared immunologically inactive by immunophenotyping at enrollment but with chronic renal injuries. Main immune profiles could be distilled down to 5 simple cytometric parameters that recapitulate several of the associations, highlighting the potential for blood immune profiling to translate to clinically useful non-invasive metrics to assess immune-mediated disease in LN.
]]></description>
<dc:creator>Horisberger, A.</dc:creator>
<dc:creator>Griffith, A.</dc:creator>
<dc:creator>Keegan, J.</dc:creator>
<dc:creator>Arazi, A.</dc:creator>
<dc:creator>Pulford, J.</dc:creator>
<dc:creator>Murzin, E.</dc:creator>
<dc:creator>Howard, K.</dc:creator>
<dc:creator>Hancock, B.</dc:creator>
<dc:creator>Fava, A.</dc:creator>
<dc:creator>Sasaki, T.</dc:creator>
<dc:creator>Ghosh, T.</dc:creator>
<dc:creator>Inamo, J.</dc:creator>
<dc:creator>Beuschel, R.</dc:creator>
<dc:creator>Cao, Y.</dc:creator>
<dc:creator>Preisinger, K.</dc:creator>
<dc:creator>Gutierrez-Arcelus, M.</dc:creator>
<dc:creator>Eisenhaure, T. M.</dc:creator>
<dc:creator>Guthridge, J.</dc:creator>
<dc:creator>Hoover, P. J.</dc:creator>
<dc:creator>Dall'Era, M.</dc:creator>
<dc:creator>Wofsy, D.</dc:creator>
<dc:creator>Kamen, D. L.</dc:creator>
<dc:creator>Kalunian, K. C.</dc:creator>
<dc:creator>Furie, R.</dc:creator>
<dc:creator>Belmont, M.</dc:creator>
<dc:creator>Izmirly, P.</dc:creator>
<dc:creator>Clancy, R.</dc:creator>
<dc:creator>Hildeman, D.</dc:creator>
<dc:creator>Woodle, E. S.</dc:creator>
<dc:creator>Apruzzese, W.</dc:creator>
<dc:creator>McMahon, M. A.</dc:creator>
<dc:creator>Grossman, J.</dc:creator>
<dc:creator>Barnas, J. L.</dc:creator>
<dc:creator>Payan-Schober, F.</dc:creator>
<dc:creator>Ishimori, M.</dc:creator>
<dc:creator>Weisman, M.</dc:creator>
<dc:creator>Kretzler, M.</dc:creator>
<dc:creator>Berthier, C. C.</dc:creator>
<dc:creator>Hodgin, J. B.</dc:creator>
<dc:creator>Demeke, D. S.</dc:creator>
<dc:creator>Putterman, C.</dc:creator>
<dc:creator>Accelerating Medicines Pa</dc:creator>
<dc:date>2024-01-16</dc:date>
<dc:identifier>doi:10.1101/2024.01.14.575609</dc:identifier>
<dc:title><![CDATA[Blood immunophenotyping identifies distinct kidney histopathology and outcomes in patients with lupus nephritis]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-01-16</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.01.23.576931v1?rss=1">
<title>
<![CDATA[
BETA-HYDROXYBUTYRATE COUNTERACTS THE DELETERIOUS EFFECTS OF A SATURATED HIGH-FAT DIET ON SYNAPTIC AMPA RECEPTORS AND COGNITIVE PERFORMANCE 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.01.23.576931v1?rss=1</link>
<description><![CDATA[
The ketogenic diet, characterized by high fat and low carbohydrates, has gained popularity not only as a strategy for managing body weight but also for its efficacy in delaying cognitive decline associated with neurodegenerative diseases and the aging process. Since this dietary approach stimulates the livers production of ketone bodies, primarily {beta}-hydroxybutyrate (BHB), which serves as an alternative energy source for neurons, we investigated whether BHB could mitigate impaired AMPA receptor trafficking, synaptic dysfunction, and cognitive decline induced by metabolic challenges such as saturated fatty acids. Here, we observe that, in cultured primary cortical neurons, exposure to palmitic acid (200M) decreased surface levels of glutamate GluA1-containing AMPA receptors, whereas unsaturated fatty acids, such as oleic acid and {omega}-3 docosahexaenoic acid (200M), and BHB (5mM) increased them. Furthermore, BHB countered the adverse effects of palmitic acid on synaptic GluA1 levels in hippocampal neurons, as well as excitability and plasticity in hippocampal slices. Additionally, daily intragastric administration of BHB (100 mg/kg/day) for two months reversed cognitive impairment induced by a saturated high-fat diet (49% of calories from fat) in a mouse experimental model of obesity. In summary, our findings underscore the significant impact of fatty acids and ketone bodies on AMPA receptors abundance, synaptic function and neuroplasticity, shedding light on the potential use of BHB to delay cognitive impairments associated with metabolic diseases.
]]></description>
<dc:creator>Rojas, R.</dc:creator>
<dc:creator>Grinan-Ferre, C.</dc:creator>
<dc:creator>Castellanos, A.</dc:creator>
<dc:creator>Griego, E.</dc:creator>
<dc:creator>Martinez, M.</dc:creator>
<dc:creator>Navarro-Lopez, J. d. D.</dc:creator>
<dc:creator>Jimenez-Diaz, L.</dc:creator>
<dc:creator>Rodriguez-Alvarez, J.</dc:creator>
<dc:creator>Soto del Cerro, D.</dc:creator>
<dc:creator>Castillo, P. E.</dc:creator>
<dc:creator>Pallas, M.</dc:creator>
<dc:creator>Fado, R.</dc:creator>
<dc:creator>Casals, N.</dc:creator>
<dc:date>2024-01-24</dc:date>
<dc:identifier>doi:10.1101/2024.01.23.576931</dc:identifier>
<dc:title><![CDATA[BETA-HYDROXYBUTYRATE COUNTERACTS THE DELETERIOUS EFFECTS OF A SATURATED HIGH-FAT DIET ON SYNAPTIC AMPA RECEPTORS AND COGNITIVE PERFORMANCE]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-01-24</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.01.24.577010v1?rss=1">
<title>
<![CDATA[
Nr4a2 blocks oAbeta-mediated synaptic plasticity dysfunction and ameliorates spatial memory deficits in the APPSw,Ind mouse 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.01.24.577010v1?rss=1</link>
<description><![CDATA[
Alzheimers disease AD is associated with disruptions in neuronal communication, especially in brain regions crucial for learning and memory, such as the hippocampus. The amyloid hypothesis suggests that the accumulation of amyloid-beta oligomers (oA{beta}) contributes to synaptic dysfunction by internalisation of synaptic AMPA receptors. Recently, it has been reported that Nr4a2, a member of the Nr4a family of orphan nuclear receptors, plays a role in hippocampal synaptic plasticity by regulating BDNF and synaptic AMPA receptors. Here, we demonstrate that oA{beta} inhibits activity-dependent Nr4a2 activation in hippocampal neurons, indicating a potential link between oA{beta} and Nr4a2 down-regulation. Furthermore, we have observed a reduction in Nr4a2 protein levels in postmortem hippocampal tissue samples from early AD stages. Pharmacological activation of Nr4a2 proves effective in preventing oA{beta}-mediated synaptic depression in the hippocampus. Notably, Nr4a2 overexpression in the hippocampus of AD mouse models ameliorates spatial learning and memory deficits. In conclusion, the findings suggest that oA{beta} may contribute to early cognitive impairment in AD by blocking Nr4a2 activation, leading to synaptic dysfunction. Thus, our results further support that Nr4a2 activation is a potential therapeutic target to mitigate oA{beta}-induced synaptic and cognitive impairments in the early stages of Alzheimers disease.
]]></description>
<dc:creator>Catala Solsona, J.</dc:creator>
<dc:creator>Lutzu, S.</dc:creator>
<dc:creator>Lituma, P. J.</dc:creator>
<dc:creator>Fabregas Ordonez, C.</dc:creator>
<dc:creator>Siedlecki, D.</dc:creator>
<dc:creator>Gimenez-Llort, L.</dc:creator>
<dc:creator>Minano-Molina, A. J.</dc:creator>
<dc:creator>Saura, C. A.</dc:creator>
<dc:creator>Castillo, P. E.</dc:creator>
<dc:creator>Rodriguez Alvarez, J.</dc:creator>
<dc:date>2024-01-24</dc:date>
<dc:identifier>doi:10.1101/2024.01.24.577010</dc:identifier>
<dc:title><![CDATA[Nr4a2 blocks oAbeta-mediated synaptic plasticity dysfunction and ameliorates spatial memory deficits in the APPSw,Ind mouse]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-01-24</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.02.01.578272v1?rss=1">
<title>
<![CDATA[
A hierarchical Bayesian interaction model to estimate cell-type-specific methylation quantitative trait loci incorporating priors from cell-sorted bisulfite sequencing data 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.02.01.578272v1?rss=1</link>
<description><![CDATA[
BackgroundMethylation Quantitative Trait Loci (meQTLs) are chromosomal regions that harbor genetic variants affecting DNA methylation levels. The identification of meQTLs can be accomplished through quantifying the effects of single nucleotide polymorphisms (SNPs) on DNA methylation levels, and these inferred meQTLs can shed light on the complex interplay between the genome and methylome. However, most meQTL studies to date utilize bulk methylation datasets composed of different cell types that may have distinct methylation patterns in each cell type. Current technological challenges hinder the comprehensive collection of large-scale, cell-type-specific (CTS) methylation data, which limits our understanding of CTS methylation regulation. To address this challenge, we propose a hierarchical Bayesian interaction model (HBI) to infer CTS meQTLs from bulk methylation data.

ResultsOur HBI method integrates bulk methylations data from a large number of samples and CTS methylation data from a small number of samples to estimate CTS meQTLs. Through simulations, we show that HBI improves the estimation (accuracy and power) of CTS genetic effects on DNA methylation. To systematically characterize genome-wide SNP-methylation level associations in multiple cell types, we apply HBI to bulk methylation data measured in peripheral blood mononuclear cells (PBMC) from a cohort of 431 individuals together with flow-sorted cell-derived methylation sequencing (MC-seq) data measured in isolated white blood cells (CD4+ T-cells, CD8+ T-cells, CD16+ monocytes) for 47 individuals. We demonstrate that HBI can identify CTS meQTLs and improve the functional annotation of SNPs.

ConclusionsHBI can incorporate strong and robust signals from MC-seq data to improve the estimation of CTS meQTLs. Applying HBI to link the methylome and genome data helps to identify biologically relevant cell types for complex traits.
]]></description>
<dc:creator>Cheng, Y.</dc:creator>
<dc:creator>Cai, B.</dc:creator>
<dc:creator>Li, H.</dc:creator>
<dc:creator>Zhang, X.</dc:creator>
<dc:creator>D'Souza, G.</dc:creator>
<dc:creator>Shrestha, S.</dc:creator>
<dc:creator>Edmonds, A.</dc:creator>
<dc:creator>Meyers, J.</dc:creator>
<dc:creator>Fischl, M.</dc:creator>
<dc:creator>Kassaye, S.</dc:creator>
<dc:creator>Anastos, K.</dc:creator>
<dc:creator>Cohen, M.</dc:creator>
<dc:creator>Aouizerat, B. E.</dc:creator>
<dc:creator>Xu, K.</dc:creator>
<dc:creator>Zhao, H.</dc:creator>
<dc:date>2024-02-02</dc:date>
<dc:identifier>doi:10.1101/2024.02.01.578272</dc:identifier>
<dc:title><![CDATA[A hierarchical Bayesian interaction model to estimate cell-type-specific methylation quantitative trait loci incorporating priors from cell-sorted bisulfite sequencing data]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-02-02</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.02.06.578742v1?rss=1">
<title>
<![CDATA[
αKG-mediated carnitine synthesis promotes homologous recombination via histone acetylation 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.02.06.578742v1?rss=1</link>
<description><![CDATA[
Homologous recombination (HR) deficiency enhances sensitivity to DNA damaging agents commonly used to treat cancer. In HR-proficient cancers, metabolic mechanisms driving response or resistance to DNA damaging agents remain unclear. Here we identified that depletion of alpha-ketoglutarate (KG) sensitizes HR-proficient cells to DNA damaging agents by metabolic regulation of histone acetylation. KG is required for the activity of KG-dependent dioxygenases (KGDDs), and prior work has shown that changes in KGDD affect demethylases. Using a targeted CRISPR knockout library consisting of 64 KGDDs, we discovered that Trimethyllysine Hydroxylase Epsilon (TMLHE), the first and rate-limiting enzyme in de novo carnitine synthesis, is necessary for proliferation of HR-proficient cells in the presence of DNA damaging agents. Unexpectedly, KG-mediated TMLHE-dependent carnitine synthesis was required for histone acetylation, while histone methylation was affected but dispensable. The increase in histone acetylation via KG-dependent carnitine synthesis promoted HR-mediated DNA repair through site- and substrate-specific histone acetylation. These data demonstrate for the first time that HR-proficiency is mediated through KG directly influencing histone acetylation via carnitine synthesis and provide a metabolic avenue to induce HR-deficiency and sensitivity to DNA damaging agents.
]]></description>
<dc:creator>Uboveja, A.</dc:creator>
<dc:creator>Huang, Z.</dc:creator>
<dc:creator>Buj, R.</dc:creator>
<dc:creator>Amalric, A.</dc:creator>
<dc:creator>Wang, H.</dc:creator>
<dc:creator>Tangudu, N. K.</dc:creator>
<dc:creator>Cole, A. R.</dc:creator>
<dc:creator>Megill, E.</dc:creator>
<dc:creator>Kantner, D.</dc:creator>
<dc:creator>Chatoff, A.</dc:creator>
<dc:creator>Ahmad, H.</dc:creator>
<dc:creator>Marcinkiewicz, M. M.</dc:creator>
<dc:creator>Disharoon, J. A.</dc:creator>
<dc:creator>Graff, S.</dc:creator>
<dc:creator>Dahl, E. S.</dc:creator>
<dc:creator>Hempel, N.</dc:creator>
<dc:creator>Stallaert, W.</dc:creator>
<dc:creator>Sidoli, S.</dc:creator>
<dc:creator>Bitler, B. G.</dc:creator>
<dc:creator>Long, D. T.</dc:creator>
<dc:creator>Snyder, N. W.</dc:creator>
<dc:creator>Aird, K. M.</dc:creator>
<dc:date>2024-02-07</dc:date>
<dc:identifier>doi:10.1101/2024.02.06.578742</dc:identifier>
<dc:title><![CDATA[αKG-mediated carnitine synthesis promotes homologous recombination via histone acetylation]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-02-07</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.02.12.579917v1?rss=1">
<title>
<![CDATA[
iSCORE-PD: an isogenic stem cell collection to research Parkinson Disease 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.02.12.579917v1?rss=1</link>
<description><![CDATA[
Parkinsons disease (PD) is a neurodegenerative disorder caused by complex genetic and environmental factors. Genome-edited human pluripotent stem cells (hPSCs) offer a unique experimental platform to advance our understanding of PD etiology by enabling the generation of disease-relevant cell types carrying patient mutations along with isogenic control cells. To facilitate this approach, we generated a collection of 65 human stem cell lines genetically engineered to harbor high risk or causal variants in genes associated with PD (SNCA A53T, SNCA A30P, PRKN Ex3del, PINK1 Q129X, DJ1/PARK7 Ex1-5del, LRRK2 G2019S, ATP13A2 FS, FBXO7 R498X/FS, DNAJC6 c.801 A>G/FS, SYNJ1 R258Q/FS, VPS13C A444P/FS, VPS13C W395C/FS, GBA1 IVS2+1/FS). All mutations were introduced into a fully characterized and sequenced female human embryonic stem cell (hESC) line (WIBR3; NIH approval number NIHhESC-10-0079) using different genome editing techniques. To ensure the genetic integrity of these cell lines, we implemented rigorous quality controls, including whole-genome sequencing of each line. Our analysis of the genetic variation in this cell line collection revealed that while genome editing, particularly using CRISPR/Cas9, can introduce rare off-target mutations, the predominant source of genetic variants arises from routine cell culture and are fixed in cell lines during clonal isolation. The observed genetic variation was minimal compared to that typically found in patient-derived iPSC experiments and predominantly affected non-coding regions of the genome. Importantly, our analysis outlines strategies for effectively managing genetic variation through stringent quality control measures and careful experimental design. This systematic approach ensures the high quality of our stem cell collection, highlights advantages of prime editing over conventional CRISPR/Cas9 methods and provides a roadmap for the generation of gene-edited hPSC collections at scale in an academic setting. Our iSCORE-PD collection represents an easily accessible and valuable platform to study PD, which can be used by investigators to understand the molecular pathophysiology of PD in a human cellular setting.
]]></description>
<dc:creator>Busquets, O.</dc:creator>
<dc:creator>Li, H.</dc:creator>
<dc:creator>Syed, K. M.</dc:creator>
<dc:creator>Jerez, P. A.</dc:creator>
<dc:creator>Dunnack, J.</dc:creator>
<dc:creator>Bu, R. L.</dc:creator>
<dc:creator>Verma, Y.</dc:creator>
<dc:creator>Pangilinan, G. R.</dc:creator>
<dc:creator>Martin, A.</dc:creator>
<dc:creator>Straub, J.</dc:creator>
<dc:creator>Du, Y.</dc:creator>
<dc:creator>Simon, V. M.</dc:creator>
<dc:creator>Poser, S.</dc:creator>
<dc:creator>Bush, Z.</dc:creator>
<dc:creator>Diaz, J.</dc:creator>
<dc:creator>Sahagun, A.</dc:creator>
<dc:creator>Gao, J.</dc:creator>
<dc:creator>Hernandez, D.</dc:creator>
<dc:creator>Levine, K. S.</dc:creator>
<dc:creator>Booth, E. O.</dc:creator>
<dc:creator>Bateup, H.</dc:creator>
<dc:creator>Rio, D.</dc:creator>
<dc:creator>Hockemeyer, D.</dc:creator>
<dc:creator>Blauwendraat, C.</dc:creator>
<dc:creator>Soldner, F.</dc:creator>
<dc:date>2024-02-13</dc:date>
<dc:identifier>doi:10.1101/2024.02.12.579917</dc:identifier>
<dc:title><![CDATA[iSCORE-PD: an isogenic stem cell collection to research Parkinson Disease]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-02-13</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.02.19.581109v1?rss=1">
<title>
<![CDATA[
Maternal Immune Activation Alters Temporal Precision of Spike Generation of CA1 Pyramidal Neurons by Unbalancing GABAergic Inhibition in the Offspring 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.02.19.581109v1?rss=1</link>
<description><![CDATA[
Maternal immune activation (MIA) represents a risk factor for neuropsychiatric disorders associated with neurodevelopmental alterations. A growing body of evidence from rodents and non-human primates shows that MIA induced by viral or bacterial infections results in several neurobiological alterations in the offspring. These changes may play an important role in the pathophysiology of psychiatric disorders like schizophrenia and autism spectrum disorders, whose clinical features include impairments in cognitive processing and social performance. Such alterations are causally associated with the maternal inflammatory response to infection rather than with the infection itself. Previously, we reported that CA1 pyramidal neurons of mice exposed to MIA exhibit increased excitability accompanied by a reduction in dendritic complexity. However, potential alterations in cellular and synaptic rules that shape the neuronal computational properties of the offspring remain to be determined. In this study, using mice as subjects, we identified a series of cellular and synaptic alterations endured by CA1 pyramidal neurons of the dorsal hippocampus in a lipopolysaccharide-induced MIA model. Our data provide evidence that MIA reshapes the excitation-inhibition balance by decreasing the perisomatic GABAergic inhibition impinging on CA1 pyramidal neurons. These alterations yield a dysregulated amplification of the temporal and spatial synaptic integration. In addition, MIA-exposed offspring displayed social and anxiety-like abnormalities. Collectively, these findings contribute to the understanding of the cellular and synaptic alterations underlying the behavioral symptoms present in neurodevelopmental disorders associated with MIA.

HighlightsO_LILPS injection during pregnancy (MIA) increases cytokine production and decreases litter size.
C_LIO_LIMIA increases the temporal summation of EPSPs in hippocampal neurons.
C_LIO_LIMIA alters spatial summation and increases the probability of action potential discharge.
C_LIO_LIMIA alters the inhibitory/excitatory balance of CA1 pyramidal cells.
C_LIO_LIMIA alters the expression of GAD-positive interneurons.
C_LIO_LIMIA alters the performance of several behavioral tests in offspring.
C_LI
]]></description>
<dc:creator>Griego, E.</dc:creator>
<dc:creator>Cerna, C.</dc:creator>
<dc:creator>Sollozo-Dupont, I.</dc:creator>
<dc:creator>Fuenzalida, M.</dc:creator>
<dc:creator>Galvan, E. J.</dc:creator>
<dc:date>2024-02-22</dc:date>
<dc:identifier>doi:10.1101/2024.02.19.581109</dc:identifier>
<dc:title><![CDATA[Maternal Immune Activation Alters Temporal Precision of Spike Generation of CA1 Pyramidal Neurons by Unbalancing GABAergic Inhibition in the Offspring]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-02-22</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.02.20.581228v1?rss=1">
<title>
<![CDATA[
Liver-innervating vagal sensory neurons play an indispensable role in the development of hepatic steatosis in mice fed a high-fat diet. 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.02.20.581228v1?rss=1</link>
<description><![CDATA[
The visceral organ-brain axis, mediated by vagal sensory neurons, is essential for maintaining various physiological functions. Here, we investigate the impact of liver-projecting vagal sensory neurons on energy balance, hepatic steatosis, and anxiety-like behavior in mice under obesogenic conditions. A small subset of vagal sensory neurons in both the left and right ganglia innervate the liver and project centrally to the nucleus of the tractus solitarius, area postrema, and dorsal motor nucleus of the vagus, and peripherally to the periportal areas in the liver. Surprisingly, the loss of liver-projecting vagal sensory neurons via caspase-induced selective destruction of advillin-positive neurons prevents diet-induced obesity, and these outcomes are associated with increased energy expenditure. Although males and females exhibit improved glucose homeostasis following disruption of liver-projecting vagal sensory neurons, only male mice display increased insulin sensitivity. Furthermore, the loss of liver-projecting vagal sensory neurons limits the progression of hepatic steatosis in mice fed a steatogenic diet. Intriguingly, mice lacking liver-innervating vagal sensory neurons also exhibit less anxiety-like behavior compared to control mice. Therefore, modulation of the liver-brain axis may aid in designing effective treatments for both psychiatric and metabolic disorders associated with obesity and MAFLD.
]]></description>
<dc:creator>JO, y.-h.</dc:creator>
<dc:creator>Hwang, J.</dc:creator>
<dc:creator>jo, W.</dc:creator>
<dc:creator>Chua, S.</dc:creator>
<dc:creator>Schwartz, G. J.</dc:creator>
<dc:date>2024-02-23</dc:date>
<dc:identifier>doi:10.1101/2024.02.20.581228</dc:identifier>
<dc:title><![CDATA[Liver-innervating vagal sensory neurons play an indispensable role in the development of hepatic steatosis in mice fed a high-fat diet.]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-02-23</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.02.21.581451v1?rss=1">
<title>
<![CDATA[
Development of novel tools for dissection of central versus peripheral dopamine D2-like receptor signaling in dysglycemia 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.02.21.581451v1?rss=1</link>
<description><![CDATA[
Dopamine (DA) D2-like receptors in both the central nervous system (CNS) and the periphery are key modulators of metabolism. Moreover, disruption of D2-like receptor signaling is implicated in dysglycemia. Yet, the respective metabolic contributions of CNS versus peripheral D2-like receptors including D2 (D2R) and D3 (D3R) receptors remain poorly understood. To address this, we developed new pharmacological tools, D2-like receptor agonists with diminished and delayed blood-brain barrier capability, to selectively manipulate D2R/D3R signaling in the periphery. We designated bromocriptine methiodide (BrMeI), a quaternary methiodide analogue of D2/3R agonist and diabetes drug bromocriptine, as our lead compound based on preservation of D2R/D3R binding and functional efficacy. We then used BrMeI and unmodified bromocriptine to dissect relative contributions of CNS versus peripheral D2R/D3R signaling in treating dysglycemia. Systemic administration of bromocriptine, with unrestricted access to CNS and peripheral targets, significantly improved both insulin sensitivity and glucose tolerance in obese, dysglycemic mice in vivo. In contrast, metabolic improvements were attenuated when access to bromocriptine was restricted either to the CNS through intracerebroventricular administration or delayed access to the CNS via BrMeI. Our findings demonstrate that the coordinated actions of both CNS and peripheral D2-like receptors are required for correcting dysglycemia. Ultimately, the development of a first-generation of drugs designed to selectively target the periphery provides a blueprint for dissecting mechanisms of central versus peripheral DA signaling and paves the way for novel strategies to treat dysglycemia.
]]></description>
<dc:creator>Bonifazi, A.</dc:creator>
<dc:creator>Ellenberger, M.</dc:creator>
<dc:creator>Farino, Z. J.</dc:creator>
<dc:creator>Aslanoglou, D.</dc:creator>
<dc:creator>Rais, R.</dc:creator>
<dc:creator>Pereira, S.</dc:creator>
<dc:creator>Mantilla-Rivas, J. O.</dc:creator>
<dc:creator>Boateng, C. A.</dc:creator>
<dc:creator>Eshleman, A. J.</dc:creator>
<dc:creator>Janowsky, A.</dc:creator>
<dc:creator>Hahn, M. K.</dc:creator>
<dc:creator>Schwartz, G. J.</dc:creator>
<dc:creator>Slusher, B. S.</dc:creator>
<dc:creator>Freyberg, Z.</dc:creator>
<dc:date>2024-02-23</dc:date>
<dc:identifier>doi:10.1101/2024.02.21.581451</dc:identifier>
<dc:title><![CDATA[Development of novel tools for dissection of central versus peripheral dopamine D2-like receptor signaling in dysglycemia]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-02-23</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.03.02.583110v1?rss=1">
<title>
<![CDATA[
Crimean-Congo Hemorrhagic Fever Survivors Elicit Protective Non-Neutralizing Antibodies that Target 11 Overlapping Regions on Viral Glycoprotein GP38 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.03.02.583110v1?rss=1</link>
<description><![CDATA[
Crimean-Congo hemorrhagic fever virus can cause lethal disease in humans yet there are no approved medical countermeasures. Viral glycoprotein GP38, unique to Nairoviridae, is a target of protective antibodies, but extensive mapping of the human antibody response to GP38 has not been previously performed. Here, we isolated 188 GP38-specific antibodies from human survivors of infection. Competition experiments showed that these antibodies bind across five distinct antigenic sites, encompassing eleven overlapping regions. Additionally, we reveal structures of GP38 bound with nine of these antibodies targeting different antigenic sites. Although GP38-specific antibodies were non-neutralizing, several antibodies were found to have protection equal to or better than murine antibody 13G8 in two highly stringent rodent models of infection. Together, these data expand our understanding regarding this important viral protein and inform the development of broadly effective CCHFV antibody therapeutics.
]]></description>
<dc:creator>Shin, O. S.</dc:creator>
<dc:creator>Monticelli, S. R.</dc:creator>
<dc:creator>Hjorth, C. K.</dc:creator>
<dc:creator>Hornet, V.</dc:creator>
<dc:creator>Doyle, M.</dc:creator>
<dc:creator>Abelson, D.</dc:creator>
<dc:creator>Kuehne, A. I.</dc:creator>
<dc:creator>Wang, A.</dc:creator>
<dc:creator>Bakken, R. R.</dc:creator>
<dc:creator>Mishra, A. K.</dc:creator>
<dc:creator>Middlecamp, M.</dc:creator>
<dc:creator>Champney, E.</dc:creator>
<dc:creator>Stuart, L.</dc:creator>
<dc:creator>Maurer, D. P.</dc:creator>
<dc:creator>Li, J.</dc:creator>
<dc:creator>Berrigan, J. L.</dc:creator>
<dc:creator>Balinandi, S.</dc:creator>
<dc:creator>Lutwama, J. J.</dc:creator>
<dc:creator>Lobel, L.</dc:creator>
<dc:creator>Zeitlin, L.</dc:creator>
<dc:creator>Walker, L. M.</dc:creator>
<dc:creator>Dye, J. M.</dc:creator>
<dc:creator>Chandran, K.</dc:creator>
<dc:creator>Herbert, A. S.</dc:creator>
<dc:creator>Pauli, N. T.</dc:creator>
<dc:creator>McLellan, J. S.</dc:creator>
<dc:date>2024-03-06</dc:date>
<dc:identifier>doi:10.1101/2024.03.02.583110</dc:identifier>
<dc:title><![CDATA[Crimean-Congo Hemorrhagic Fever Survivors Elicit Protective Non-Neutralizing Antibodies that Target 11 Overlapping Regions on Viral Glycoprotein GP38]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-03-06</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.03.04.583378v1?rss=1">
<title>
<![CDATA[
Damage sensing through TLR9 Promotes Viral Clearance and Recovery During Influenza Infection 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.03.04.583378v1?rss=1</link>
<description><![CDATA[
Host response aimed at eliminating the infecting pathogen, as well as the pathogen itself, can cause tissue injury. Tissue injury leads to the release of a myriad of cellular components including mitochondrial DNA, which the host senses through pattern recognition receptors. How the sensing of tissue injury by the host shapes the anti-pathogen response remains poorly understood. In this study, we utilized mice that are deficient in toll-like receptor-9 (TLR9), which binds to unmethylated CpG DNA sequences such as those present in bacterial and mitochondrial DNA. To avoid direct pathogen sensing by TLR9, we utilized the influenza virus, which lacks ligands for TLR9, to determine how damage sensing by TLR9 contributes to anti-influenza immunity. Our data show that TLR9-mediated sensing of tissue damage promotes an inflammatory response during early infection, driven by the epithelial and myeloid cells. Along with the diminished inflammatory response, the absence of TLR9 led to impaired viral clearance manifested as a higher and prolonged influenza components in myeloid cells including monocytes and macrophages rendering them highly inflammatory. The persistent inflammation driven by infected myeloid cells led to persistent lung injury and impaired recovery in influenza-infected TLR9-/-mice. Further, we show elevated TLR9 activation in the plasma samples of patients with influenza and its association with the disease severity in hospitalized patients, demonstrating its clinical relevance. Overall, we demonstrate an essential role of damage sensing through TLR9 in promoting anti-influenza immunity and inflammatory response.

Author SummaryTissue damage is an inevitable outcome of clinically relevant lung infections, but the host mechanisms for detecting such damage during infection are not well understood. We investigated the role of Toll-like receptor 9 (TLR9) in sensing tissue damage caused by influenza. Since influenza lacks TLR9 ligands, we hypothesized that TLR9 signaling is driven by tissue damage molecules like mitochondrial DNA (mtDNA). Our data indicate that TLR9 reduces early inflammatory lung injury but impairs viral clearance, resulting in extensive immune cell infection, persistent inflammation, and delayed recovery. Myeloid-specific TLR9 deletion ameliorated late-stage inflammatory responses. In humans, influenza-infected individuals exhibited elevated TLR9 activity and mtDNA levels in plasma compared to healthy controls, with higher TLR9 activation potential correlating with severe disease requiring ICU admission. These findings suggest that TLR9-mediated damage sensing triggers both inflammatory tissue injury and viral clearance. These data indicate that TLR9 activity can serve as a crucial biomarker and therapeutic target to limit influenza induced tissue injury.
]]></description>
<dc:creator>Kim, J.</dc:creator>
<dc:creator>Yuan, Y.</dc:creator>
<dc:creator>Agaronyan, K.</dc:creator>
<dc:creator>Zhao, A.</dc:creator>
<dc:creator>Wang, V. D.</dc:creator>
<dc:creator>Gupta, G.</dc:creator>
<dc:creator>Essayas, H.</dc:creator>
<dc:creator>Kaminski, A.</dc:creator>
<dc:creator>McGovern, J.</dc:creator>
<dc:creator>Yu, S.</dc:creator>
<dc:creator>Woo, S.</dc:creator>
<dc:creator>Lee, C. J.</dc:creator>
<dc:creator>Saleh, T.</dc:creator>
<dc:creator>Hu, B.</dc:creator>
<dc:creator>Sun, Y.</dc:creator>
<dc:creator>Ishikawa, G.</dc:creator>
<dc:creator>Bain, W.</dc:creator>
<dc:creator>Evankovich, J.</dc:creator>
<dc:creator>Herzog, E.</dc:creator>
<dc:creator>Dela Cruz, C. S.</dc:creator>
<dc:creator>Ryu, C.</dc:creator>
<dc:creator>Sharma, L.</dc:creator>
<dc:date>2024-03-06</dc:date>
<dc:identifier>doi:10.1101/2024.03.04.583378</dc:identifier>
<dc:title><![CDATA[Damage sensing through TLR9 Promotes Viral Clearance and Recovery During Influenza Infection]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-03-06</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.03.05.583565v1?rss=1">
<title>
<![CDATA[
Lineage commitment pathways epigenetically oppose oncogenic Gαq/11-YAP signaling in dormant disseminated uveal melanoma 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.03.05.583565v1?rss=1</link>
<description><![CDATA[
Uveal melanoma (UM) can remain in clinical dormancy for decades only to later produce lethal metastases. Using Gq/11mut/BAP1wt UM xenograft models and human metastatic samples, we identified NR2F1 as a key inducer of UM disseminated cancer cell (DCC) dormancy. Dormant UM DCCs upregulate NR2F1, neural crest genes and, along with suppression of proliferation programs, NR2F1 silences YAP1/TEAD1 transcription by altering histone H3 activation marks. YAP1 can reciprocally repress NR2F1, but inhibiting Gq/11 signaling or activating NR2F1 can arrest UM growth. NR2F1 knockout led to dormant DCC awakening and liver metastatic growth. NR2F1 and YAP1 inverse expression was confirmed in human livers carrying UM solitary, small DCC clusters as well as large metastases. Intriguingly, RNA-seq and Cut&Run analysis revealed that NR2F1 short-circuits oncogene signaling by repressing multiple G-protein signaling components. Our work provides previously unrecognized mechanistic insight into UM DCC dormancy and potential pathways for interception.

Statement of significanceNR2F1 epigenetically suppresses genes associated with G-protein signaling, cell cycle, and YAP1/TEAD1 pathways, inducing dormancy in uveal melanoma (UM) disseminated cancer cells. This study unveils novel markers for UM dormancy and reactivation, positioning NR2F1 as a promising target for intercepting residual and UM metastatic disease.
]]></description>
<dc:creator>Kadamb, R.</dc:creator>
<dc:creator>Anton, M. L.</dc:creator>
<dc:creator>Purwin, T. J.</dc:creator>
<dc:creator>Chua, V.</dc:creator>
<dc:creator>Seeneevassen, L.</dc:creator>
<dc:creator>Teh, J.</dc:creator>
<dc:creator>Nieto, M. A.</dc:creator>
<dc:creator>Sato, T.</dc:creator>
<dc:creator>Terai, M.</dc:creator>
<dc:creator>Roman, S.</dc:creator>
<dc:creator>de Koning, L.</dc:creator>
<dc:creator>Zheng, D.</dc:creator>
<dc:creator>Aplin, A. E.</dc:creator>
<dc:creator>Aguirre-Ghiso, J.</dc:creator>
<dc:date>2024-03-08</dc:date>
<dc:identifier>doi:10.1101/2024.03.05.583565</dc:identifier>
<dc:title><![CDATA[Lineage commitment pathways epigenetically oppose oncogenic Gαq/11-YAP signaling in dormant disseminated uveal melanoma]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-03-08</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.03.08.584145v1?rss=1">
<title>
<![CDATA[
Function of C. elegans neurons from synaptic connectivity 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.03.08.584145v1?rss=1</link>
<description><![CDATA[
Despite decades of research on the C. elegans nervous system based on an anatomical description of synaptic connectivity, the circuits underlying behavior remain incompletely described and the functions of many neurons are still unknown. Updated and more complete chemical and gap junction connectomes of both adult sexes covering the entire animal including the muscle end organ have become available recently. Here these are analyzed to gain insight into the overall structure of the connectivity network and to suggest functions of individual neuron classes. Modularity analysis divides the connectome graph into ten communities that can be correlated with broad categories of behavior. A significant role of the body wall musculature end organ is emphasized as both a site of significant information convergence and as a source of sensory input in a feedback loop. Convergence of pathways for multisensory integration occurs throughout the network -- most interneurons have similar indegrees and outdegrees and hence disperse information as much as they aggregate it. New insights include description of a set of high degree interneurons connected by many gap junctions running through the ventral cord that may represent a previously unrecognized locus of information processing. There is an apparent mechanosensory and proprioceptive field covering the entire body formed by connectivity of the many mechanosensory neurons of multiple types to two interneurons with output connections across the nervous system. Several additional significant, previously unrecognized circuits and pathways are uncovered, some involving unstudied neurons. The insights are valuable for guiding theoretical investigation of network properties as well as experimental studies of the functions of individual neurons, groups of neurons, and circuits.
]]></description>
<dc:creator>Emmons, S. W.</dc:creator>
<dc:date>2024-03-13</dc:date>
<dc:identifier>doi:10.1101/2024.03.08.584145</dc:identifier>
<dc:title><![CDATA[Function of C. elegans neurons from synaptic connectivity]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-03-13</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.03.11.584509v1?rss=1">
<title>
<![CDATA[
Morphometric Analysis of the Thymic Epithelial Cell (TEC) Network Using Integrated and Orthogonal Digital Pathology Approaches 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.03.11.584509v1?rss=1</link>
<description><![CDATA[
The thymus, a central primary lymphoid organ of the immune system, plays a key role in T cell development. Surprisingly, the thymus is quite neglected with regards to standardized pathology approaches and practices for assessing structure and function. Most studies use multispectral flow cytometry to define the dynamic composition of the thymus at the cell population level, but they are limited by lack of contextual insight. This knowledge gap hinders our understanding of various thymic conditions and pathologies, particularly how they affect thymic architecture, and subsequently, immune competence. Here, we introduce a digital pathology pipeline to address these challenges. Our approach can be coupled to analytical algorithms and utilizes rationalized morphometric assessments of thymic tissue, ranging from tissue-wide down to microanatomical and ultrastructural levels. This pipeline enables the quantitative assessment of putative changes and adaptations of thymic structure to stimuli, offering valuable insights into the pathophysiology of thymic disorders. This versatile pipeline can be applied to a wide range of conditions that may directly or indirectly affect thymic structure, ranging from various cytotoxic stimuli inducing acute thymic involution to autoimmune diseases, such as myasthenia gravis. Here, we demonstrate applicability of the method in a mouse model of age-dependent thymic involution, both by confirming established knowledge, and by providing novel insights on intrathymic remodeling in the aged thymus. Our orthogonal pipeline, with its high versatility and depth of analysis, promises to be a valuable and practical toolset for both basic and translational immunology laboratories investigating thymic function and disease.
]]></description>
<dc:creator>Lagou, M. K.</dc:creator>
<dc:creator>Argyris, D. G.</dc:creator>
<dc:creator>Vodopyanov, S.</dc:creator>
<dc:creator>Gunther-Cummins, L.</dc:creator>
<dc:creator>Hardas, A.</dc:creator>
<dc:creator>Poutahidis, T.</dc:creator>
<dc:creator>Panorias, C.</dc:creator>
<dc:creator>DesMarais, S.</dc:creator>
<dc:creator>Entenberg, C.</dc:creator>
<dc:creator>Carpenter, R. S.</dc:creator>
<dc:creator>Guzik, H.</dc:creator>
<dc:creator>Nishku, X.</dc:creator>
<dc:creator>Churaman, J.</dc:creator>
<dc:creator>Maryanovich, M.</dc:creator>
<dc:creator>DesMarais, V.</dc:creator>
<dc:creator>Macaluso, F. P.</dc:creator>
<dc:creator>Karagiannis, G. S.</dc:creator>
<dc:date>2024-03-14</dc:date>
<dc:identifier>doi:10.1101/2024.03.11.584509</dc:identifier>
<dc:title><![CDATA[Morphometric Analysis of the Thymic Epithelial Cell (TEC) Network Using Integrated and Orthogonal Digital Pathology Approaches]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-03-14</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.03.12.584656v1?rss=1">
<title>
<![CDATA[
Heterochromatin spreading in cancer cells through HDAC7 mediated histone H3.3 landscape reprogramming. 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.03.12.584656v1?rss=1</link>
<description><![CDATA[
Class IIa histone deacetylases (HDACs) are a family of enzymes with minimal histone deacetylase activity but can function as multi-protein interaction hubs. Here we demonstrate the expression of HDAC7, a Class IIa HDAC family member, in glioblastoma tumor tissue from 84 patients, patient-derived glioma stem cells (GSCs) from six patients, and pediatric diffuse pontine glioma (DIPG) cells from three patients. HDAC7 binds to Histone H3.3 and interacts with H3.3 and HIRA on chromatin. Targeted downregulation of HDAC7 expression with a subtype-specific siRNA inhibits the interaction of H3.3 with HIRA while increasing the association of H3.3 with DAXX and H3K9me3. This results in H3.3 being deposited on H3K9me3+/DAPI+ heterochromatin nuclear foci. Inhibition of HDAC7 triggers H3K9me3+ heterochromatin spreading, increased H3K9me3 binding in the cancer genome, and significant alterations in gene expression. Using single molecule DNA fiber approach, we show that HDAC7 inhibition results in a significant increase in replication fork speed without affecting fork symmetry. This altered replication fork speed leads to replication stress, evidenced by phosphorylation of RPA2 and impact on global DNA synthesis, resulting in reduced EdU incorporation. Finally, HDAC7 depletion leads to reduced BRCA2 expression and increased sensitivity of cancer cells to DNA damaging agents. Taken together, these studies uncover the involvement of HDAC7 in the euchromatic H3.3 chaperone network and the effect of HDAC7 depletion on chromatin dynamics, inducing epigenetic restriction and DNA damage in cancer cells.
]]></description>
<dc:creator>Hassan, O.</dc:creator>
<dc:creator>Pizzagalli, M.</dc:creator>
<dc:creator>Wu, L. J.</dc:creator>
<dc:creator>Karambizi, D.</dc:creator>
<dc:creator>Zepecki, J. P.</dc:creator>
<dc:creator>Fajardo, E.</dc:creator>
<dc:creator>Fiser, A.</dc:creator>
<dc:creator>Tapinos, N.</dc:creator>
<dc:date>2024-03-14</dc:date>
<dc:identifier>doi:10.1101/2024.03.12.584656</dc:identifier>
<dc:title><![CDATA[Heterochromatin spreading in cancer cells through HDAC7 mediated histone H3.3 landscape reprogramming.]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-03-14</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.03.12.584663v1?rss=1">
<title>
<![CDATA[
A longevity-specific bank of induced pluripotent stem cells from centenarians and their offspring 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.03.12.584663v1?rss=1</link>
<description><![CDATA[
Centenarians provide a unique lens through which to study longevity, healthy aging, and resiliency. Moreover, models of human aging and resilience to disease that allow for the testing of potential interventions are virtually non-existent. We obtained and characterized over 50 centenarian and offspring peripheral blood samples including those connected to functional independence data highlighting resistance to disability and cognitive impairment. Targeted methylation arrays were used in molecular aging clocks to compare and contrast differences between biological and chronological age in these specialized subjects. Isolated peripheral blood mononuclear cells (PBMCs) were then successfully reprogrammed into high-quality induced pluripotent stem cell (iPSC) lines which were functionally characterized for pluripotency, genomic stability, and the ability to undergo directed differentiation. The result of this work is a one-of-a-kind resource for studies of human longevity and resilience that can fuel the discovery and validation of novel therapeutics for aging-related disease.
]]></description>
<dc:creator>Dowrey, T. W.</dc:creator>
<dc:creator>Cranston, S. F.</dc:creator>
<dc:creator>Skvir, N.</dc:creator>
<dc:creator>Lok, Y.</dc:creator>
<dc:creator>Gould, B.</dc:creator>
<dc:creator>Petrowitz, B.</dc:creator>
<dc:creator>Villar, D.</dc:creator>
<dc:creator>Shan, J.</dc:creator>
<dc:creator>James, M.</dc:creator>
<dc:creator>Dodge, M.</dc:creator>
<dc:creator>Belkina, A. C.</dc:creator>
<dc:creator>Giadone, R. M.</dc:creator>
<dc:creator>Sebastiani, P.</dc:creator>
<dc:creator>Perls, T. T.</dc:creator>
<dc:creator>Andersen, S. L.</dc:creator>
<dc:creator>Murphy, G. J.</dc:creator>
<dc:date>2024-03-14</dc:date>
<dc:identifier>doi:10.1101/2024.03.12.584663</dc:identifier>
<dc:title><![CDATA[A longevity-specific bank of induced pluripotent stem cells from centenarians and their offspring]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-03-14</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.03.14.584861v1?rss=1">
<title>
<![CDATA[
PRMT5 is required for full-length HTT expression by repressing multiple proximal intronic polyadenylation sites 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.03.14.584861v1?rss=1</link>
<description><![CDATA[
Expansion of the CAG trinucleotide repeat tract in exon 1 of the Huntingtin (HTT) gene above a threshold of [~]36 repeats causes Huntingtons disease (HD) through the expression of a polyglutamine-expanded form of the HTT protein. This mutation triggers wide-ranging cellular and biochemical pathologies leading to cognitive, motor, and psychiatric symptoms in HD patients. As accurate splicing is required to produce the full-length HTT protein of [~]348 kDa, targeting HTT splicing with small molecule drugs is a compelling approach to lower HTT protein levels to treat HD, and splice modulators are being tested in the clinic. Here, we identify PRMT5 as a novel regulator of HTT mRNA splicing and alternative polyadenylation. PRMT5 inhibition disrupts the splicing of HTT introns 9 and 10, leading to activation of multiple proximal intronic polyadenylation sites within these introns and promoting premature termination, cleavage and polyadenylation (PCPA) of the HTT mRNA, thus lowering total HTT protein levels. We also detected increasing levels of these truncated, intron-containing HTT transcripts across a series of neuronal differentiation samples which correlated with lower PRMT5 expression. Notably, PRMT5 inhibition in glioblastoma (GBM) stem cells potently induced neuronal differentiation. We posit that PRMT5-mediated regulation of intronic polyadenylation, premature termination and cleavage of the HTT mRNA modulates HTT expression and plays an important role during embryonic development and neuronal differentiation.
]]></description>
<dc:creator>ALQAZZAZ, M.</dc:creator>
<dc:creator>Ciamponi, F. E.</dc:creator>
<dc:creator>Ho, J. C.</dc:creator>
<dc:creator>Maron, M. I.</dc:creator>
<dc:creator>Yadav, M.</dc:creator>
<dc:creator>Sababi, A. M.</dc:creator>
<dc:creator>Macleod, G.</dc:creator>
<dc:creator>Ahmadi, M.</dc:creator>
<dc:creator>Bullivant, G.</dc:creator>
<dc:creator>Tano, V.</dc:creator>
<dc:creator>Langley, S. R.</dc:creator>
<dc:creator>Osuna, M. S.</dc:creator>
<dc:creator>Sachamitr, P.</dc:creator>
<dc:creator>Kushida, M.</dc:creator>
<dc:creator>Richards, L. M.</dc:creator>
<dc:creator>Bardile, C. F.</dc:creator>
<dc:creator>Pouladi, M.</dc:creator>
<dc:creator>Pugh, T.</dc:creator>
<dc:creator>Tyers, M.</dc:creator>
<dc:creator>Angers, S.</dc:creator>
<dc:creator>Dirks, P. B.</dc:creator>
<dc:creator>Bader, G.</dc:creator>
<dc:creator>Massirer, K. B.</dc:creator>
<dc:creator>Barsyte-Lovejoy, D.</dc:creator>
<dc:creator>Shechter, D.</dc:creator>
<dc:creator>Harding, R. J.</dc:creator>
<dc:creator>Arrowsmith, C.</dc:creator>
<dc:creator>Prinos, P.</dc:creator>
<dc:date>2024-03-14</dc:date>
<dc:identifier>doi:10.1101/2024.03.14.584861</dc:identifier>
<dc:title><![CDATA[PRMT5 is required for full-length HTT expression by repressing multiple proximal intronic polyadenylation sites]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-03-14</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.03.18.585626v1?rss=1">
<title>
<![CDATA[
Estrogen regulation and functional role of FGFR4 in estrogen receptor positive breast cancer 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.03.18.585626v1?rss=1</link>
<description><![CDATA[
BackgroundResistance to endocrine therapy is a major challenge of managing estrogen receptor positive (ER+) breast cancer. We previously reported frequent overexpression of FGFR4 in endocrine resistant cell lines and breast cancers that recurred and metastasized following endocrine therapy, suggesting FGFR4 as a potential driver of endocrine resistance. In this study, we investigated the role of FGFR4 in mediating endocrine resistance and explored the therapeutic potential of targeting FGFR4 in advanced breast cancer.

MethodsA gene expression signature of FGFR4 activity was examined in ER+ breast cancer pre- and post-neoadjuvant endocrine therapy and the association between FGFR4 expression and patient survival was examined. A correlation analysis was used to uncover potential regulators of FGFR4 overexpression. To investigate if FGFR4 is necessary to drive endocrine resistance, we tested response to FGFR4 inhibition in long term estrogen deprived (LTED) cells and their paired parental cells. Doxycycline inducible FGFR4 overexpression and knockdown cell models were generated to examine if FGFR4 was sufficient to confer endocrine resistance. Finally, we examined response to FGFR4 monotherapy or combination therapy with fulvestrant in breast cancer cell lines to explore the potential of FGFR4 targeted therapy for advanced breast cancer and assessed the importance of PAM50 subtype in response to FGFR4 inhibition.

ResultsA FGFR4 activity gene signature was significantly upregulated post neoadjuvant aromatase inhibitor treatment, and high FGFR4 expression predicted poorer survival in patients with ER+ breast cancer. Gene expression association analysis using TCGA, METABRIC and SCAN-B datasets uncovered ER as the most significant gene negatively correlated with FGFR4 expression. ER negatively regulates FGFR4 expression at both the mRNA and protein level across multiple ER+ breast cancer cell lines. Despite robust overexpression of FGFR4, LTED cells did not show enhanced responses to FGFR4 inhibition compared to parental cells. Similarly, FGFR4 overexpression, knockdown or hotspot mutations did not significantly alter response to endocrine treatment in ER+ cell lines, nor did FGFR4 and fulvestrant combination treatment show synergistic effects. The HER2-like subtype of breast cancer showed elevated expression of FGFR4 and an increased response to FGFR4 inhibition relative to other breast cancer subtypes.

ConclusionsDespite ER-mediated upregulation of FGFR4 post endocrine therapy, our study does not support a general role of FGFR4 in mediating endocrine resistance in ER+ breast cancer. Our data suggests that specific genomic backgrounds such as HER2 expression may be required for FGFR4 function in breast cancer and should be further explored.
]]></description>
<dc:creator>Ding, K.</dc:creator>
<dc:creator>Chen, L.</dc:creator>
<dc:creator>Levine, K. M.</dc:creator>
<dc:creator>Sikora, M. J.</dc:creator>
<dc:creator>Tasdemir, N.</dc:creator>
<dc:creator>Dabbs, D.</dc:creator>
<dc:creator>Jankowitz, R.</dc:creator>
<dc:creator>Hazan, R. S.</dc:creator>
<dc:creator>Shah, O. S.</dc:creator>
<dc:creator>Xavier, J. M.</dc:creator>
<dc:creator>LEE, A. V.</dc:creator>
<dc:creator>Oesterreich, S.</dc:creator>
<dc:date>2024-03-20</dc:date>
<dc:identifier>doi:10.1101/2024.03.18.585626</dc:identifier>
<dc:title><![CDATA[Estrogen regulation and functional role of FGFR4 in estrogen receptor positive breast cancer]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-03-20</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.03.20.585881v1?rss=1">
<title>
<![CDATA[
Co-translational sorting enables a single mRNA to generate distinct polysomes with different localizations and protein fates 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.03.20.585881v1?rss=1</link>
<description><![CDATA[
{beta}-catenin is a multi-functional protein playing essential roles in tissue homeostasis and cancer. It bridges E-cadherin to the cytoskeleton and also activates transcription in response to Wnt. Plasma membrane {beta}-catenin is stable whereas without Wnt, cytoplasmic {beta}-catenin is degraded by the destruction complex, composed of APC and Axin. Here, we show that APC and Axin associate with many mRNAs and that this occurs via the nascent protein chains. Notably, APC and Axin bind {beta}-catenin mRNAs present as either single polysome or polysome condensates, and co-translational interactions constitute the major fraction of their binding to the {beta}-catenin protein. Remarkably, E-cadherin also binds {beta}-catenin co-translationally, and {beta}-catenin mRNAs localize either with APC in the cytosol or E-cadherin at the plasma membrane. Thus, co-translational interactions sort {beta}-catenin mRNAs into distinct polysome populations that spatially segregate in cells and synthesize proteins with different functions. Co-translational polysome sorting provides a mechanism to regulate the fate of multi-functional proteins.
]]></description>
<dc:creator>Salloum, S.</dc:creator>
<dc:creator>Seveno, M.</dc:creator>
<dc:creator>El-koulali, K.</dc:creator>
<dc:creator>Rialle, S.</dc:creator>
<dc:creator>George, S.</dc:creator>
<dc:creator>Lemmers, B.</dc:creator>
<dc:creator>Zibara, K.</dc:creator>
<dc:creator>Eliscovich, C.</dc:creator>
<dc:creator>Hahne, M.</dc:creator>
<dc:creator>Bertrand, E.</dc:creator>
<dc:date>2024-03-20</dc:date>
<dc:identifier>doi:10.1101/2024.03.20.585881</dc:identifier>
<dc:title><![CDATA[Co-translational sorting enables a single mRNA to generate distinct polysomes with different localizations and protein fates]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-03-20</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.03.28.587307v1?rss=1">
<title>
<![CDATA[
Exhaustion profile on classical monocytes after LPS stimulation in patients with Crohn's disease. 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.03.28.587307v1?rss=1</link>
<description><![CDATA[
Crohns disease is an inflammatory bowel disease that induces diarrhea, abdominal pain, weight loss, and even susceptibility to developing tumors. The immune system is pivotal in the gastrointestinal tract, promoting tolerance against commensal antigens and food. However, Crohns disease manifests by a breakdown in the mechanism of immune tolerance and the consequent development of exacerbated chronic inflammatory responses. The involvement of the immune system is pivotal in Crohns disease, with a wide range of immune cells being altered, which may include monocytes. Taking the lack of knowledge regarding monocytes in Crohns disease, we ought to elucidate the cytokine production and activation profile of monocyte subsets in the pathophysiology. We used multiparametric flow cytometry, quantified gene expression using qPCR, and made a correlation matrix regarding flow cytometry data and qPCR using a bioinformatic approach to examine monocyte status. The Corhns patients show a decrease in all subsets of monocytes.

In contrast, classical monocytes show an exhaustion profile with increased expression of CD38 and decreased production of IL-1{beta} after LPS stimulation in the patients group. These results indicate that monocyte subsets are differentially involved in the pathophysiology. These findings may suggest that monocytes favor disease chronicity and lack immune response resolution.
]]></description>
<dc:creator>Oliveira, L. P.</dc:creator>
<dc:creator>Xavier, R. G.</dc:creator>
<dc:creator>Nora, C. C.</dc:creator>
<dc:creator>Mangueira, C. L.</dc:creator>
<dc:creator>Rosseto, E. A.</dc:creator>
<dc:creator>Aloia, T.</dc:creator>
<dc:creator>Gil, J. Z.</dc:creator>
<dc:creator>Scavanini Neto, A.</dc:creator>
<dc:creator>Lopes, F. B.</dc:creator>
<dc:creator>Carvalho, K. I.</dc:creator>
<dc:date>2024-03-29</dc:date>
<dc:identifier>doi:10.1101/2024.03.28.587307</dc:identifier>
<dc:title><![CDATA[Exhaustion profile on classical monocytes after LPS stimulation in patients with Crohn's disease.]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-03-29</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.04.10.588915v1?rss=1">
<title>
<![CDATA[
Inhibition of Cyp1a Protects Mice against Anthracycline Cardiomyopathy 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.04.10.588915v1?rss=1</link>
<description><![CDATA[
BackgroundAnthracyclines such as doxorubicin (Dox) are highly effective anti-tumor agents, but their use is limited by dose-dependent cardiomyopathy and heart failure. Our laboratory previously reported that induction of cytochrome P450 family 1 (Cyp1) enzymes contributes to acute Dox cardiotoxicity in zebrafish and in mice, and that potent Cyp1 inhibitors prevent cardiotoxicity. However, the role of Cyp1 enzymes in chronic Dox cardiomyopathy, as well as the mechanisms underlying cardioprotection associated with Cyp1 inhibition, have not been fully elucidated.

MethodsThe Cyp1 pathway was evaluated using a small molecule Cyp1 inhibitor in wild-type (WT) mice, or Cyp1-null mice (Cyp1a1/1a2-/-, Cyp1b1-/-, and Cyp1a1/1a2/1b1-/-). Low-dose Dox was administered by serial intraperitoneal or intravenous injections, respectively. Expression of Cyp1 isoforms was measured by RT-qPCR, and myocardial tissue was isolated from the left ventricle for RNA sequencing. Cardiac function was evaluated by transthoracic echocardiography.

ResultsIn WT mice, Dox treatment was associated with a decrease in Cyp1a2 and increase in Cyp1b1 expression in the heart and in the liver. Co-treatment of WT mice with Dox and the novel Cyp1 inhibitor YW-130 protected against cardiac dysfunction compared to Dox treatment alone. Cyp1a1/1a2-/- and Cyp1a1/1a2/1b1-/- mice were protected from Dox cardiomyopathy compared to WT mice. Male, but not female, Cyp1b1-/- mice had increased cardiac dysfunction following Dox treatment compared to WT mice. RNA sequencing of myocardial tissue showed upregulation of Fundc1 and downregulation of Ccl21c in Cyp1a1/1a2-/- mice treated with Dox, implicating changes in mitophagy and chemokine-mediated inflammation as possible mechanisms of Cyp1a-mediated cardioprotection.

ConclusionsTaken together, this study highlights the potential therapeutic value of Cyp1a inhibition in mitigating anthracycline cardiomyopathy.
]]></description>
<dc:creator>Liu, J.</dc:creator>
<dc:creator>Curtin, C.</dc:creator>
<dc:creator>Lall, R.</dc:creator>
<dc:creator>Lane, S.</dc:creator>
<dc:creator>Wieke, J.</dc:creator>
<dc:creator>Ariza, A.</dc:creator>
<dc:creator>Sejour, L.</dc:creator>
<dc:creator>Vlachos, I.</dc:creator>
<dc:creator>Zordoky, B.</dc:creator>
<dc:creator>Peterson, R.</dc:creator>
<dc:creator>Asnani, A.</dc:creator>
<dc:date>2024-04-11</dc:date>
<dc:identifier>doi:10.1101/2024.04.10.588915</dc:identifier>
<dc:title><![CDATA[Inhibition of Cyp1a Protects Mice against Anthracycline Cardiomyopathy]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-04-11</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.04.20.590419v1?rss=1">
<title>
<![CDATA[
Engineering, structure, and immunogenicity of a Crimean-Congo hemorrhagic fever virus pre-fusion heterotrimeric glycoprotein complex 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.04.20.590419v1?rss=1</link>
<description><![CDATA[
Crimean-Congo hemorrhagic fever virus (CCHFV) is a tick-borne virus that can cause severe disease in humans with case fatality rates of 10-40%. Although structures of CCHFV glycoproteins GP38 and Gc have provided insights into viral entry and defined epitopes of neutralizing and protective antibodies, the structure of glycoprotein Gn and its interactions with GP38 and Gc have remained elusive. Here, we used structure-guided protein engineering to produce a stabilized GP38-Gn-Gc heterotrimeric glycoprotein complex (GP38-GnH-DS-Gc). A cryo-EM structure of this complex provides the molecular basis for GP38s association on the viral surface, reveals the structure of Gn, and demonstrates that GP38-Gn restrains the Gc fusion loops in the prefusion conformation, facilitated by an N-linked glycan attached to Gn. Immunization with GP38-GnH-DS-Gc conferred 40% protection against lethal IbAr10200 challenge in mice. These data define the architecture of a GP38-Gn-Gc protomer and provide a template for structure-guided vaccine antigen development.
]]></description>
<dc:creator>McFadden, E.</dc:creator>
<dc:creator>Monticelli, S.</dc:creator>
<dc:creator>Wang, A.</dc:creator>
<dc:creator>Ramamohan, A.</dc:creator>
<dc:creator>Batchelor, T.</dc:creator>
<dc:creator>Kuehne, A.</dc:creator>
<dc:creator>Bakken, R.</dc:creator>
<dc:creator>Tse, A.</dc:creator>
<dc:creator>Chandran, K.</dc:creator>
<dc:creator>Herbert, A.</dc:creator>
<dc:creator>McLellan, J.</dc:creator>
<dc:date>2024-04-21</dc:date>
<dc:identifier>doi:10.1101/2024.04.20.590419</dc:identifier>
<dc:title><![CDATA[Engineering, structure, and immunogenicity of a Crimean-Congo hemorrhagic fever virus pre-fusion heterotrimeric glycoprotein complex]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-04-21</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.04.30.591319v1?rss=1">
<title>
<![CDATA[
Functional selection in SH3-mediated activation of the PI3 kinase 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.04.30.591319v1?rss=1</link>
<description><![CDATA[
The phosphoinositide-3 kinase (PI3K), a heterodimeric enzyme, plays a pivotal role in cellular metabolism and survival. Its deregulation is associated with major human diseases, particularly cancer. The p85 regulatory subunit of PI3K binds to the catalytic p110 subunit via its C-terminal domains, stabilising it in an inhibited state. Certain Src homology 3 (SH3) domains can activate p110 by binding to the proline-rich (PR) 1 motif located at the N-terminus of p85. However, the mechanism by which this N-terminal interaction activates the C-terminally bound p110 remains elusive. Moreover, the intrinsically poor ligand selectivity of SH3 domains raises the question of how they can control PI3K. Combining structural, biophysical, and functional methods, we demonstrate that the answers to both these unknown issues are linked: PI3K-activating SH3 domains engage in additional "tertiary" interactions with the C-terminal domains of p85, thereby relieving their inhibition of p110. SH3 domains lacking these tertiary interactions may still bind to p85 but cannot activate PI3K. Thus, p85 uses a functional selection mechanism that precludes nonspecific activation rather than nonspecific binding. This separation of binding and activation may provide a general mechanism for how biological activities can be controlled by promiscuous protein-protein interaction domains.
]]></description>
<dc:creator>Aljedani, S. S.</dc:creator>
<dc:creator>Aldehaiman, A.</dc:creator>
<dc:creator>Sandholu, A.</dc:creator>
<dc:creator>Alharb, S.</dc:creator>
<dc:creator>Mak, V. C. Y.</dc:creator>
<dc:creator>Wu, H.</dc:creator>
<dc:creator>Lugari, A.</dc:creator>
<dc:creator>Jaremko, M.</dc:creator>
<dc:creator>Morelli, X.</dc:creator>
<dc:creator>Backer, J.</dc:creator>
<dc:creator>Ladbury, J. E.</dc:creator>
<dc:creator>Nowakowski, M.</dc:creator>
<dc:creator>Cheung, L. W. T.</dc:creator>
<dc:creator>Arold, S. T.</dc:creator>
<dc:date>2024-04-30</dc:date>
<dc:identifier>doi:10.1101/2024.04.30.591319</dc:identifier>
<dc:title><![CDATA[Functional selection in SH3-mediated activation of the PI3 kinase]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-04-30</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.05.01.592114v1?rss=1">
<title>
<![CDATA[
Design of High Affinity Binders to Convex Protein Target Sites 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.05.01.592114v1?rss=1</link>
<description><![CDATA[
While there has been progress in the de novo design of small globular miniproteins (50-65 residues) to bind to primarily concave regions of a target protein surface, computational design of minibinders to convex binding sites remains an outstanding challenge due to low level of overall shape complementarity. Here, we describe a general approach to generate computationally designed proteins which bind to convex target sites that employ geometrically matching concave scaffolds. We used this approach to design proteins binding to TGF{beta}RII, CTLA-4 and PD-L1 which following experimental optimization have low nanomolar to picomolar affinities and potent biological activity. Co-crystal structures of the TGF{beta}RII and CTLA-4 binders in complex with the receptors are in close agreement with the design models. Our approach provides a general route to generating very high affinity binders to convex protein target sites.
]]></description>
<dc:creator>Baker, D.</dc:creator>
<dc:creator>Yang, W.</dc:creator>
<dc:creator>Hicks, D. R.</dc:creator>
<dc:creator>Ghosh, A.</dc:creator>
<dc:creator>Schwartze, T. A.</dc:creator>
<dc:creator>Coventry, B.</dc:creator>
<dc:creator>Goreshnik, I.</dc:creator>
<dc:creator>Allen, A.</dc:creator>
<dc:creator>Halabiya, S.</dc:creator>
<dc:creator>Kim, C.</dc:creator>
<dc:creator>Hinck, C. S.</dc:creator>
<dc:creator>Lee, D. S.</dc:creator>
<dc:creator>Bera, A.</dc:creator>
<dc:creator>Li, Z.</dc:creator>
<dc:creator>Wang, Y.</dc:creator>
<dc:creator>Schlichthaerle, T.</dc:creator>
<dc:creator>Cao, L.</dc:creator>
<dc:creator>Huang, B.</dc:creator>
<dc:creator>Garrett, S.</dc:creator>
<dc:creator>Gerben, S. R.</dc:creator>
<dc:creator>Rettie, S.</dc:creator>
<dc:creator>Heine, P.</dc:creator>
<dc:creator>Edman, N.</dc:creator>
<dc:creator>Murray, A. N.</dc:creator>
<dc:creator>Carter, L. P.</dc:creator>
<dc:creator>Stewart, L.</dc:creator>
<dc:creator>Almo, S.</dc:creator>
<dc:creator>Hinck, A. P.</dc:creator>
<dc:date>2024-05-03</dc:date>
<dc:identifier>doi:10.1101/2024.05.01.592114</dc:identifier>
<dc:title><![CDATA[Design of High Affinity Binders to Convex Protein Target Sites]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-05-03</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.05.04.592535v1?rss=1">
<title>
<![CDATA[
Negative Selection Allows DNA Mismatch Repair-Deficient Mouse Fibroblasts In Vitro to Tolerate High Levels of Somatic Mutations 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.05.04.592535v1?rss=1</link>
<description><![CDATA[
Substantial numbers of somatic mutations have been found to accumulate with age in different human tissues. Clonal cellular amplification of some of these mutations can cause cancer and other diseases. However, it is as yet unclear if and to what extent an increased burden of random mutations can affect cellular function without clonal amplification. We tested this in cell culture, which avoids the limitation that an increased mutation burden in vivo typically leads to cancer. We performed single-cell whole-genome sequencing of primary fibroblasts from DNA mismatch repair (MMR) deficient Msh2-/- mice and littermate control animals after long-term passaging. Apart from analyzing somatic mutation burden we analyzed clonality, mutational signatures, and hotspots in the genome, characterizing the complete landscape of somatic mutagenesis in normal and MMR-deficient mouse primary fibroblasts during passaging. While growth rate of Msh2-/-fibroblasts was not significantly different from the controls, the number of de novo single-nucleotide variants (SNVs) increased linearly up until at least 30,000 SNVs per cell, with the frequency of small insertions and deletions (INDELs) plateauing in the Msh2-/- fibroblasts to about 10,000 INDELS per cell. We provide evidence for negative selection and large-scale mutation-driven population changes, including significant clonal expansion of preexisting mutations and widespread cell-strain-specific hotspots. Overall, our results provide evidence that increased somatic mutation burden drives significant cell evolutionary changes in a dynamic cell culture system without significant effects on growth. Since similar selection processes against mutations preventing organ and tissue dysfunction during aging are difficult to envision, these results suggest that increased somatic mutation burden can play a causal role in aging and diseases other than cancer.
]]></description>
<dc:creator>Zhang, L.</dc:creator>
<dc:creator>Lee, M.</dc:creator>
<dc:creator>Hao, X.</dc:creator>
<dc:creator>Ehlert, J.</dc:creator>
<dc:creator>Chi, Z.</dc:creator>
<dc:creator>Jin, B.</dc:creator>
<dc:creator>Maslov, A. Y.</dc:creator>
<dc:creator>Barabasi, A.-L.</dc:creator>
<dc:creator>Hoeijmakers, J. H. J.</dc:creator>
<dc:creator>Edelmann, W.</dc:creator>
<dc:creator>Vijg, J.</dc:creator>
<dc:creator>Dong, X.</dc:creator>
<dc:date>2024-05-07</dc:date>
<dc:identifier>doi:10.1101/2024.05.04.592535</dc:identifier>
<dc:title><![CDATA[Negative Selection Allows DNA Mismatch Repair-Deficient Mouse Fibroblasts In Vitro to Tolerate High Levels of Somatic Mutations]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-05-07</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.05.06.592684v1?rss=1">
<title>
<![CDATA[
ELONGATED HYPOCOTYL 5 (HY5) and POPEYE (PYE) Regulate Intercellular Iron Transport in Plants. 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.05.06.592684v1?rss=1</link>
<description><![CDATA[
Plants maintain iron (Fe) homeostasis under varying environmental conditions by balancing processes such as Fe uptake, transport, and storage. In Arabidopsis, POPEYE (PYE), a basic helix-loop-helix (bHLH) transcription factor (TF), has been shown to play a crucial role in regulating this balance. In recent years, the mechanisms regulating Fe uptake have been well established but the upstream transcriptional regulators of Fe transport and storage are still poorly understood. In this study, we report that ELONGATED HYPOCOTYL5 (HY5), a basic leucine zipper (bZIP) TF which has recently been shown to play a crucial role in Fe homeostasis, interacts with PYE. Molecular, genetic and biochemical approaches revealed that PYE and HY5 have overlapping as well as some distinct roles in regulation of Fe deficiency response. We found that HY5 and PYE both act as a repressor of Fe transport genes such as YSL3, FRD3 NPF5.9, YSL2, NAS4, and OPT3. HY5 was found to directly bind on the promoter of these genes and regulate intercellular Fe transport. Further analysis revealed that HY5 and PYE directly interact at the same region on PYE and NAS4 promoter. Overall, this study revealed that HY5 regulates Fe homeostasis by physically interacting with PYE as well as independently.
]]></description>
<dc:creator>Mankotia, S.</dc:creator>
<dc:creator>Dubey, A.</dc:creator>
<dc:creator>Jakhar, P.</dc:creator>
<dc:creator>Satbhai, S. B.</dc:creator>
<dc:date>2024-05-07</dc:date>
<dc:identifier>doi:10.1101/2024.05.06.592684</dc:identifier>
<dc:title><![CDATA[ELONGATED HYPOCOTYL 5 (HY5) and POPEYE (PYE) Regulate Intercellular Iron Transport in Plants.]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-05-07</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.05.06.592708v1?rss=1">
<title>
<![CDATA[
scDAPP: a comprehensive single-cell transcriptomics analysis pipeline optimized for cross-group comparison 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.05.06.592708v1?rss=1</link>
<description><![CDATA[
Single-cell transcriptomics profiling has increasingly been used to evaluate cross-group differences in cell population and cell-type gene expression. This often leads to large datasets with complex experimental designs that need advanced comparative analysis. Concurrently, bioinformatics software and analytic approaches also become more diverse and constantly undergo improvement. Thus, there is an increased need for automated and standardized data processing and analysis pipelines, which should be efficient and flexible too. To address these, we develop the single-cell Differential Analysis and Processing Pipeline (scDAPP), a R-based workflow for comparative analysis of single cell (or nucleus) transcriptomic data between two or more groups and at the levels of single cells or "pseudobulking" samples. The pipeline automates many steps of pre-processing using data-learnt parameters, uses previously benchmarked software, and generates comprehensive intermediate data and final results that are valuable for both beginners and experts of scRNA-seq analysis. Moreover, the analytic reports, augmented by extensive data visualization, increase the transparency of computational analysis and parameter choices, while facilitate users to go seamlessly from raw data to biological interpretation.

Availability and ImplementationscDAPP is freely available for non-commercial usage as an R package under the MIT license. Source code, documentation and sample data are available at the GitHub (https://github.com/bioinfoDZ/scDAPP).
]]></description>
<dc:creator>Ferrena, A.</dc:creator>
<dc:creator>Zheng, X. Y.</dc:creator>
<dc:creator>Jackson, K.</dc:creator>
<dc:creator>Hoang, B.</dc:creator>
<dc:creator>Morrow, B. E.</dc:creator>
<dc:creator>Zheng, D.</dc:creator>
<dc:date>2024-05-09</dc:date>
<dc:identifier>doi:10.1101/2024.05.06.592708</dc:identifier>
<dc:title><![CDATA[scDAPP: a comprehensive single-cell transcriptomics analysis pipeline optimized for cross-group comparison]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-05-09</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.05.08.593231v1?rss=1">
<title>
<![CDATA[
Improved accuracy for estrous cycle staging using supervised object detection 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.05.08.593231v1?rss=1</link>
<description><![CDATA[
The estrous cycle regulates reproductive events and hormone changes in female mammals and is analogous to the menstrual cycle in humans. Monitoring this cycle is necessary as it serves as a biomarker for overall health and is crucial for interpreting study results. The estrous cycle comprises four stages influenced by fluctuating levels of hormones, mainly estradiol and progesterone. Tracking the cycle traditionally relies on vaginal cytology, which categorizes stages based on three epithelial cell concentrations. However, this method has limitations, including time-consuming training and variable accuracy among researchers. To address these challenges, this study assessed the feasibility and reliability of two machine learning methods. An object detection-based machine learning model, Object Detection Estrous Staging (ODES), was employed to identify cell types throughout the estrous cycle in mice. A dataset of 555 vaginal cytology images with four different stains was annotated, with 335 images for training, 45 for validation, and 175 for testing. A novel, accurate set of rules for classification was derived by analyzing training images. ODES achieved an average accuracy of 87% in classifying cycle stages and took only 3.9 minutes to analyze 175 test images. The use of object detection machine learning significantly improved accuracy and efficiency compared to previously derived supervised image classification models (33-45% accuracy) and human accuracy (66% accuracy), refining research practices for female studies. These findings facilitate the integration of the estrous cycle into research, enhancing the quality of scientific results by allowing for efficient and accurate identification of the cycle stage.
]]></description>
<dc:creator>Babaev, B.</dc:creator>
<dc:creator>Goyal, S.</dc:creator>
<dc:creator>Ross, R. A.</dc:creator>
<dc:date>2024-05-09</dc:date>
<dc:identifier>doi:10.1101/2024.05.08.593231</dc:identifier>
<dc:title><![CDATA[Improved accuracy for estrous cycle staging using supervised object detection]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-05-09</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.05.15.594435v1?rss=1">
<title>
<![CDATA[
A linear sensorimotor transformation accounts for response range-dependent biases in human heading estimation 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.05.15.594435v1?rss=1</link>
<description><![CDATA[
Accurate estimation of heading direction from optic flow is a crucial aspect of human spatial perception. Previous psychophysical studies have shown that humans are typically biased in their estimates of heading directions, but the reported results are inconsistent. While some studies found that humans generally underestimate heading direction (central bias), others find the opposite, an overestimation of heading direction (peripheral bias). We conducted three psychophysical experiments showing that these conflicting findings do not reflect inherent differences in heading perception but are caused by the different sizes of the response range that participants were allowed to utilize when reporting their estimates. Notably, we show that participants heading estimates monotonically scale with the size of the response range, leading to underestimation for small and overestimation for large response ranges. Additionally, neither the speed profile of the optic flow pattern nor the response method (mouse vs. keyboard) significantly affected participants estimates.

Furthermore, we introduce a Bayesian heading estimation model that can quantitatively account for participants heading reports. The model assumes an efficient sensory encoding of heading direction according to a prior inferred from human heading discrimination data. In addition, the model assumes a response mapping that linearly scales the perceptual estimate with a scaling factor that monotonically depends on the size of the response range. This simple perception-action model accurately predicts participants estimates both in terms of mean and variance across all experimental conditions. Our findings underscore that human heading perception follows efficient Bayesian inference; differences in participants reported estimates can be parsimoniously explained as differences in mapping percept to probe response.

Author summaryHumans can estimate the direction of their self-motion (heading) from the associated visual motion pattern (optic flow) on their retinae. While these heading estimates are typically biased, previous studies have found quite conflicting bias patterns despite using very similar optic flow stimuli. Our findings demonstrate that these differences in participants reported estimates can be attributed to differences in the response range within which participants were able to move their cursor to report their estimates. We introduce an efficient Bayesian observer model to quantitatively analyze these conflicting bias patterns. The model assumes that perceived heading directions are identical for identical optical flow patterns, yet the reported heading directions are the result of an additional response mapping that linearly maps the percept to the reported estimate. This model fits the data well and demonstrate that participants reported perceptual estimates can be substantially modulated by post-perceptual response transformations, in particular under conditions where they do not receive feedback. Our study is a reminder that psychophysical measurements necessarily provide only an indirect account of perception. Full explanations of such data require the inclusion of appropriate post-perceptual transformations that describe the mapping from perception to action.
]]></description>
<dc:creator>Sun, Q.</dc:creator>
<dc:creator>Xu, L.-H.</dc:creator>
<dc:creator>Stocker, A. A.</dc:creator>
<dc:date>2024-05-16</dc:date>
<dc:identifier>doi:10.1101/2024.05.15.594435</dc:identifier>
<dc:title><![CDATA[A linear sensorimotor transformation accounts for response range-dependent biases in human heading estimation]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-05-16</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.05.23.595578v1?rss=1">
<title>
<![CDATA[
Antibodies targeting Crimean-Congo hemorrhagic fever virus GP38 limit vascular leak and viral spread 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.05.23.595578v1?rss=1</link>
<description><![CDATA[
Crimean-Congo hemorrhagic fever virus (CCHFV) is a priority pathogen transmitted by tick bites, with no vaccines or specific therapeutics approved to date. Severe disease manifestations include hemorrhage, endothelial dysfunction, and multiorgan failure. Infected cells secrete the viral glycoprotein GP38, whose extracellular function is presently unknown. GP38 is considered an important target for vaccine and therapeutic design as GP38-specific antibodies can protect against severe disease in animal models, albeit through a currently unknown mechanism of action. Here, we show that GP38 induces endothelial barrier dysfunction in vitro, and that CCHFV infection, and GP38 alone, can trigger vascular leak in a mouse model. Protective antibodies that recognize specific antigenic sites on GP38, but not a protective neutralizing antibody binding the structural protein Gc, potently inhibit endothelial hyperpermeability in vitro and vascular leak in vivo during CCHFV infection. This work uncovers a function of the secreted viral protein GP38 as a viral toxin in CCHFV pathogenesis and elucidates the mode of action of non-neutralizing GP38-specific antibodies.
]]></description>
<dc:creator>Pahmeier, F.</dc:creator>
<dc:creator>Monticelli, S. R.</dc:creator>
<dc:creator>Feng, X.</dc:creator>
<dc:creator>Hjorth, C. K.</dc:creator>
<dc:creator>Wang, A.</dc:creator>
<dc:creator>Kuehne, A. I.</dc:creator>
<dc:creator>Bakken, R. R.</dc:creator>
<dc:creator>Batchelor, T. G.</dc:creator>
<dc:creator>Lee, S. E.</dc:creator>
<dc:creator>Middlecamp, M.</dc:creator>
<dc:creator>Stuart, L.</dc:creator>
<dc:creator>Abelson, D. M.</dc:creator>
<dc:creator>McLellan, J. S.</dc:creator>
<dc:creator>Biering, S. B.</dc:creator>
<dc:creator>Herbert, A. S.</dc:creator>
<dc:creator>Chandran, K.</dc:creator>
<dc:creator>Harris, E.</dc:creator>
<dc:date>2024-05-23</dc:date>
<dc:identifier>doi:10.1101/2024.05.23.595578</dc:identifier>
<dc:title><![CDATA[Antibodies targeting Crimean-Congo hemorrhagic fever virus GP38 limit vascular leak and viral spread]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-05-23</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.05.31.596845v1?rss=1">
<title>
<![CDATA[
TAD hierarchy restricts poised LTR activation and loss of TAD hierarchy promotes LTR co-option in cancer 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.05.31.596845v1?rss=1</link>
<description><![CDATA[
Transposable elements (TEs) are abundant in the human genome, and they provide the sources for genetic and functional diversity. The regulation of TEs expression and their functional consequences in physiological conditions and cancer development remain to be fully elucidated. Previous studies suggested TEs are repressed by DNA methylation and chromatin modifications. The effect of 3D chromatin topology on TE regulation remains elusive. Here, by integrating transcriptome and 3D genome architecture studies, we showed that haploinsufficient loss of NIPBL selectively activates alternative promoters at the long terminal repeats (LTRs) of the TE subclasses. This activation occurs through the reorganization of topologically associating domain (TAD) hierarchical structures and recruitment of proximal enhancers. These observations indicate that TAD hierarchy restricts transcriptional activation of LTRs that already possess open chromatin features. In cancer, perturbation of the hierarchical chromatin topology can lead to co-option of LTRs as functional alternative promoters in a context-dependent manner and drive aberrant transcriptional activation of novel oncogenes and other divergent transcripts. These data uncovered a new layer of regulatory mechanism of TE expression beyond DNA and chromatin modification in human genome. They also posit the TAD hierarchy dysregulation as a novel mechanism for alternative promoter-mediated oncogene activation and transcriptional diversity in cancer, which may be exploited therapeutically.
]]></description>
<dc:creator>Wong, E. W. P.</dc:creator>
<dc:creator>Sahin, M.</dc:creator>
<dc:creator>Yang, R.</dc:creator>
<dc:creator>Lee, U.</dc:creator>
<dc:creator>Zhan, Y. A.</dc:creator>
<dc:creator>Misra, R.</dc:creator>
<dc:creator>Tomas, F.</dc:creator>
<dc:creator>Alomran, N.</dc:creator>
<dc:creator>Polyzos, A.</dc:creator>
<dc:creator>Lee, C. J.</dc:creator>
<dc:creator>Trieu, T.</dc:creator>
<dc:creator>Fundichely, A. M.</dc:creator>
<dc:creator>Wiesner, T.</dc:creator>
<dc:creator>Rosowicz, A.</dc:creator>
<dc:creator>Cheng, S.</dc:creator>
<dc:creator>Liu, C. L.</dc:creator>
<dc:creator>Lallo, M.</dc:creator>
<dc:creator>Merghoub, T.</dc:creator>
<dc:creator>Hamard, P.-J.</dc:creator>
<dc:creator>Koche, R.</dc:creator>
<dc:creator>Khurana, E.</dc:creator>
<dc:creator>Apostolou, E.</dc:creator>
<dc:creator>Zheng, D.</dc:creator>
<dc:creator>Chen, Y.</dc:creator>
<dc:creator>Leslie, C. S.</dc:creator>
<dc:creator>Chi, P.</dc:creator>
<dc:date>2024-06-06</dc:date>
<dc:identifier>doi:10.1101/2024.05.31.596845</dc:identifier>
<dc:title><![CDATA[TAD hierarchy restricts poised LTR activation and loss of TAD hierarchy promotes LTR co-option in cancer]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-06-06</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.06.04.597347v1?rss=1">
<title>
<![CDATA[
Comprehensive single cell transcriptomics analysis of murine osteosarcoma uncovers Skp2 function in metastasis, genomic instability and immune activation and reveals additional target pathways 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.06.04.597347v1?rss=1</link>
<description><![CDATA[
Osteosarcoma (OS) is the most common primary pediatric bone malignancy. One promising new therapeutic target is SKP2, encoding a substrate recognition factor of the SCF E3 ubiquitin ligase responsible for ubiquitination and proteasome degradation of substrate p27, thus driving cellular proliferation. We have shown previously that knockout of Skp2 in an immunocompetent transgenic mouse model of OS improved survival, drove apoptosis, and induced tumor inflammation. Here, we applied single-cell RNA-sequencing (scRNA-seq) to study primary OS tumors derived from Osx-Cre driven conditional knockout of Rb1 and Trp53. We showed that murine OS models recapitulate the tumor heterogeneity and microenvironment complexity observed in patient tumors. We further compared this model with OS models with functional disruption of Skp2: one with Skp2 knockout and the other with the Skp2-p27 interaction disrupted (resulting in p27 overexpression). We found reduction of T cell exhaustion and upregulation of interferon activation, along with evidence of replicative and endoplasmic reticulum-related stress in the Skp2 disruption models, and showed that interferon induction was correlated with improved survival in OS patients. Additionally, our scRNA-seq analysis uncovered decreased activities of metastasis-related gene signatures in the Skp2-disrupted OS, which we validated by observation of a strong reduction in lung metastasis in the Skp2 knockout mice. Finally, we report several potential mechanisms of escape from targeting Skp2 in OS, including upregulation of Myc targets, DNA copy number amplification and overexpression of alternative E3 ligase genes, and potential alternative lineage activation. These mechanistic insights into OS tumor biology and Skp2 function suggest novel targets for new, synergistic therapies, while the data and our comprehensive analysis may serve as a public resource for further big data-driven OS research.
]]></description>
<dc:creator>Ferrena, A.</dc:creator>
<dc:creator>Zhang, R.</dc:creator>
<dc:creator>Wang, J.</dc:creator>
<dc:creator>Zheng, X. Y.</dc:creator>
<dc:creator>Goker, B.</dc:creator>
<dc:creator>Borjihan, H.</dc:creator>
<dc:creator>Chae, S.-S.</dc:creator>
<dc:creator>Lo, Y.</dc:creator>
<dc:creator>Zhao, H.</dc:creator>
<dc:creator>Schwartz, E.</dc:creator>
<dc:creator>Loeb, D.</dc:creator>
<dc:creator>Yang, R.</dc:creator>
<dc:creator>Geller, D.</dc:creator>
<dc:creator>Zheng, D.</dc:creator>
<dc:creator>Hoang, B.</dc:creator>
<dc:date>2024-06-06</dc:date>
<dc:identifier>doi:10.1101/2024.06.04.597347</dc:identifier>
<dc:title><![CDATA[Comprehensive single cell transcriptomics analysis of murine osteosarcoma uncovers Skp2 function in metastasis, genomic instability and immune activation and reveals additional target pathways]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-06-06</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.06.14.599064v1?rss=1">
<title>
<![CDATA[
Polyamine Depletion by D, L-alpha-difluoromethylornithine Inhibits Ewing Sarcoma Metastasis by Inducing Ferroptosis 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.06.14.599064v1?rss=1</link>
<description><![CDATA[
AO_SCPLOWBSTRACTC_SCPLOWPolyamine metabolism and signaling play important roles in multiple cancers but have not previously been studied in Ewing sarcoma. Here, we show that blocking polyamine synthesis with D, L-alpha-difluoromethylornithine (DFMO) causes a G1 cell cycle arrest, dose-dependent decreases in sarcosphere formation from Ewing sarcoma cell lines growing in non-adherent conditions and a decrease in clonogenic growth in soft agar. Further, we utilized our orthotopic implantation/amputation model of Ewing sarcoma metastasis to demonstrate that DFMO slowed primary tumor growth in addition to limiting metastasis. RNA sequencing demonstrated gene expression patterns consistent with induction of ferroptosis caused by polyamine depletion. Induction of ferroptosis was validated in vitro by demonstrating that ferrostatin-1, an inhibitor of ferroptosis, allows sphere formation even in the presence of DFMO. Collectively, these results reveal a novel mechanism by which DFMO prevents metastasis - induction of ferroptosis due to polyamine depletion. Our results provide preclinical justification to test the ability of DFMO to prevent metastatic recurrence in Ewing sarcoma patients at high risk for relapse.
]]></description>
<dc:creator>Offenbacher, R.</dc:creator>
<dc:creator>Jackson, K.</dc:creator>
<dc:creator>Hayashi, M.</dc:creator>
<dc:creator>Zhang, J.</dc:creator>
<dc:creator>Peng, D.</dc:creator>
<dc:creator>Tan, Y.</dc:creator>
<dc:creator>Stewart, T. M.</dc:creator>
<dc:creator>Ciero, P.</dc:creator>
<dc:creator>Foley, J. R.</dc:creator>
<dc:creator>Casero, R. A.</dc:creator>
<dc:creator>Cahan, P.</dc:creator>
<dc:creator>Loeb, D. M.</dc:creator>
<dc:date>2024-06-17</dc:date>
<dc:identifier>doi:10.1101/2024.06.14.599064</dc:identifier>
<dc:title><![CDATA[Polyamine Depletion by D, L-alpha-difluoromethylornithine Inhibits Ewing Sarcoma Metastasis by Inducing Ferroptosis]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-06-17</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.06.14.599073v1?rss=1">
<title>
<![CDATA[
Weighted variance component test for the integrative multi-omics analysis of microbiome data 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.06.14.599073v1?rss=1</link>
<description><![CDATA[
Metabolic dysregulation and alterations have been linked to various diseases and conditions. Innovations in high-throughput technology now allow rapid profiling of the metabolome and metagenome -- often the gene content of bacterial populations -- for characterizing metabolism. Due to the small sample sizes and high dimensionality of the data, pathway analysis (wherein the effect of multiple genes or metabolites on an outcome is cumulatively assessed) of metabolomic data is commonly conducted and also represents a standard for metagenomic analysis. However, how to integrate both data types remains unclear. Recognizing that a metabolic pathway can be complementarily characterized by both metagenomics and metabolomics, we propose a weighted variance components framework to test if the joint effect of genes and metabolites in a biological pathway is associated with outcomes. The approach allows analytic p-value calculation, correlation between data types, and optimal weighting. Power simulations show that our approach often outperforms other strategies while maintaining type I error. The approach is illustrated on real data.
]]></description>
<dc:creator>Zhang, A.</dc:creator>
<dc:creator>Ling, W.</dc:creator>
<dc:creator>Little, A.</dc:creator>
<dc:creator>Williams-Nguyen, J. S.</dc:creator>
<dc:creator>Moon, J.-Y.</dc:creator>
<dc:creator>Burk, R. D.</dc:creator>
<dc:creator>Knight, R.</dc:creator>
<dc:creator>Wang, D. D.</dc:creator>
<dc:creator>Qi, Q.</dc:creator>
<dc:creator>Kaplan, R.</dc:creator>
<dc:creator>Zhao, N.</dc:creator>
<dc:creator>Wu, M.</dc:creator>
<dc:date>2024-06-17</dc:date>
<dc:identifier>doi:10.1101/2024.06.14.599073</dc:identifier>
<dc:title><![CDATA[Weighted variance component test for the integrative multi-omics analysis of microbiome data]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-06-17</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.06.20.599756v1?rss=1">
<title>
<![CDATA[
Neocortical long-range inhibition promotes cortical synchrony and sleep 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.06.20.599756v1?rss=1</link>
<description><![CDATA[
Sleep and wakefulness are associated with distinct cortical patterns of rhythmic activity. During low-arousal states such as slow wave sleep, synchronous low-frequency rhythms dominate activity across widespread cortical regions. Although inhibitory neurons are increasingly recognized as key players of cortical state, the in vivo circuit mechanisms coordinating synchronized activity across local and distant neocortical networks remain poorly understood. Here, we show that somatostatin and chondrolectin co-expressing cells (Sst-Chodl), a sparse and genetically distinct class of neocortical GABAergic inhibitory neurons, are selectively active during low-arousal states and largely silent during periods of high arousal. In contrast to most neocortical inhibitory neurons, Sst-Chodl cells, despite being extremely sparse, exert widespread influence across the neocortex via long-range axons that simultaneously target multiple regions. Selective activation of Sst-Chodl cells is sufficient to promote multi-region cortical synchronization characteristic of low-arousal states and to induce sleep. Together, these findings show that long-range Sst-Chodl inhibitory neurons not only track behavioral state but can actively promote sleep-like cortical activity and sleep behavior, highlighting an important contribution of cortical circuits to sleep regulation alongside established subcortical mechanisms.
]]></description>
<dc:creator>Ratliff, J. M.</dc:creator>
<dc:creator>Terral, G.</dc:creator>
<dc:creator>Lutzu, S.</dc:creator>
<dc:creator>Heiss, J.</dc:creator>
<dc:creator>Mota, J.</dc:creator>
<dc:creator>Stith, B.</dc:creator>
<dc:creator>Vazquez Lechuga, A.</dc:creator>
<dc:creator>Ramakrishnan, C. M.</dc:creator>
<dc:creator>Fenno, L. E.</dc:creator>
<dc:creator>Daigle, T.</dc:creator>
<dc:creator>Deisseroth, K.</dc:creator>
<dc:creator>Zeng, H.</dc:creator>
<dc:creator>Ngai, J.</dc:creator>
<dc:creator>Tasic, B.</dc:creator>
<dc:creator>Sjulson, L.</dc:creator>
<dc:creator>Rudolph, S.</dc:creator>
<dc:creator>Kilduff, T.</dc:creator>
<dc:creator>Batista-Brito, R.</dc:creator>
<dc:date>2024-06-23</dc:date>
<dc:identifier>doi:10.1101/2024.06.20.599756</dc:identifier>
<dc:title><![CDATA[Neocortical long-range inhibition promotes cortical synchrony and sleep]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-06-23</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.06.24.600393v1?rss=1">
<title>
<![CDATA[
Epistasis between N-terminal and receptor-binding domains drives cell entry in a bat coronavirus spike 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.06.24.600393v1?rss=1</link>
<description><![CDATA[
Understanding the zoonotic risks posed by bat coronaviruses (CoVs) is critical for pandemic preparedness. Herein, we generated recombinant vesicular stomatitis viruses (rVSVs) bearing spikes from divergent bat CoVs to investigate their cell entry mechanisms. Unexpectedly, the successful recovery of rVSVs bearing the spike from SHC014, a SARS-like bat CoV, was associated with the acquisition of a novel substitution in the S2 fusion peptide-proximal region (FPPR). This substitution enhanced viral entry in both VSV and coronavirus contexts by increasing the availability of the spike receptor-binding domain to recognize its cellular receptor, ACE2. A second substitution in the spike N-terminal domain, uncovered through forward-genetic selection, interacted epistatically with the FPPR substitution to synergistically enhance spike:ACE2 interaction and viral entry. Our findings identify genetic pathways for adaptation by bat CoVs during spillover and host-to-host transmission, fitness trade-offs inherent to these pathways, and potential Achilles heels that could be targeted with countermeasures.
]]></description>
<dc:creator>Tse, A. L.</dc:creator>
<dc:creator>Acreman, C. M.</dc:creator>
<dc:creator>Ricardo-Lax, I.</dc:creator>
<dc:creator>Berrigan, J.</dc:creator>
<dc:creator>Lasso, G.</dc:creator>
<dc:creator>Balogun, T.</dc:creator>
<dc:creator>Kearns, F. L.</dc:creator>
<dc:creator>Casalino, L.</dc:creator>
<dc:creator>McClain, G. L.</dc:creator>
<dc:creator>Chandran, A. M.</dc:creator>
<dc:creator>Lemeunier, C.</dc:creator>
<dc:creator>Amaro, R. E.</dc:creator>
<dc:creator>Rice, C. M.</dc:creator>
<dc:creator>Jangra, R. K.</dc:creator>
<dc:creator>McLellan, J. S.</dc:creator>
<dc:creator>Chandran, K.</dc:creator>
<dc:creator>Miller, E. H.</dc:creator>
<dc:date>2024-06-27</dc:date>
<dc:identifier>doi:10.1101/2024.06.24.600393</dc:identifier>
<dc:title><![CDATA[Epistasis between N-terminal and receptor-binding domains drives cell entry in a bat coronavirus spike]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-06-27</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.06.25.600651v1?rss=1">
<title>
<![CDATA[
ClOneHORT: Approaches for Improved Fidelity in Generative Models of Synthetic Genomes 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.06.25.600651v1?rss=1</link>
<description><![CDATA[
MotivationDeep generative models have the potential to overcome difficulties in sharing individual-level genomic data by producing synthetic genomes that preserve the genomic associations specific to a cohort while not violating the privacy of any individual cohort member. However, there is significant room for improvement in the fidelity and usability of existing synthetic genome approaches.

ResultsWe demonstrate that when combined with plentiful data and with population-specific selection criteria, deep generative models can produce synthetic genomes and cohorts that closely model the original populations. Our methods improve fidelity in the site-frequency spectra and linkage disequilibrium decay and yield synthetic genomes that can be substituted in downstream local ancestry inference analysis, recreating results with .91 to .94 accuracy.

AvailabilityThe model described in this paper is freely available at github.com/rlaboulaye/clonehort.
]]></description>
<dc:creator>Laboulaye, R.</dc:creator>
<dc:creator>Borda, V.</dc:creator>
<dc:creator>Chen, S.</dc:creator>
<dc:creator>North, K. E.</dc:creator>
<dc:creator>Kaplan, R.</dc:creator>
<dc:creator>O'Connor, T. D.</dc:creator>
<dc:date>2024-06-29</dc:date>
<dc:identifier>doi:10.1101/2024.06.25.600651</dc:identifier>
<dc:title><![CDATA[ClOneHORT: Approaches for Improved Fidelity in Generative Models of Synthetic Genomes]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-06-29</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.07.08.602528v1?rss=1">
<title>
<![CDATA[
FLASH proton reirradiation, with or without hypofractionation, mitigates chronic toxicity in the normal murine intestine, skin, and bone. 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.07.08.602528v1?rss=1</link>
<description><![CDATA[
Background and purposeThe normal tissue sparing afforded by FLASH radiotherapy (RT) is being intensely investigated for potential clinical translation. Here, we studied the effects of FLASH proton RT (F-PRT) in the reirradiation setting, with or without hypofractionation. Chronic toxicities in three murine models of normal tissue toxicity including the intestine, skin, and bone were investigated.

Materials and methodsIn studies of the intestine, single-dose irradiation was performed with 12 Gy of Standard proton RT (S-PRT), followed by a second dose of 12 Gy of F-PRT or S-PRT. Additionally, a hypofractionation scheme was applied in the reirradiation setting (3 x 6.4 Gy of F-PRT or S-PRT, given every 48 hrs). In studies of skin/bone of the murine leg, 15 Gy of S-PRT was followed by hypofractionated reirradiation with F-PRT or S-PRT (3 x 11 Gy).

ResultsCompared to reirradiation with S-PRT, F-PRT reduced intestinal fibrosis and collagen deposition in the reirradiation setting and significantly increased survival rate, demonstrating its protective effects on intestinal tissues. In previously irradiated leg tissues, reirradiation with hypofractionated F-PRT created transient dermatitis that fully resolved in contrast to reirradiation with hypofractionated S-PRT. Lymphedema was also alleviated after a second course of radiation with F-PRT, along with significant reductions in the accumulation of fibrous connective tissue in the skin compared to mice reirradiated with S-PRT. The delivery of a second course of fractionated S-PRT induced tibial fractures in 83.3% of the mice, whereas only 20% of mice reirradiated with F-PRT presented with fractures.

ConclusionThese studies provide the first evidence of the sparing effects of F-PRT, in the setting of hypofractionated reirradiation. The results support FLASH as highly relevant to the reirradiation regimen where it exhibits significant potential to minimize chronic complications for patients undergoing RT.
]]></description>
<dc:creator>Verginadis, I. I.</dc:creator>
<dc:creator>Velalopoulou, A.</dc:creator>
<dc:creator>Kim, M. M.</dc:creator>
<dc:creator>Kim, K.</dc:creator>
<dc:creator>Paraskevaidis, I.</dc:creator>
<dc:creator>Bell, B.</dc:creator>
<dc:creator>Oliaei Motlagh, S. A.</dc:creator>
<dc:creator>Karaj, A.</dc:creator>
<dc:creator>Banerjee, E.</dc:creator>
<dc:creator>Finesso, G. E.</dc:creator>
<dc:creator>Assenmacher, C.-A.</dc:creator>
<dc:creator>Radaelli, E.</dc:creator>
<dc:creator>Lu, J.</dc:creator>
<dc:creator>Lin, Y.</dc:creator>
<dc:creator>Putt, M. E.</dc:creator>
<dc:creator>Diffenderfer, E. S.</dc:creator>
<dc:creator>Guha, C.</dc:creator>
<dc:creator>Qin, L.</dc:creator>
<dc:creator>Metz, J. M.</dc:creator>
<dc:creator>Maity, A.</dc:creator>
<dc:creator>Cengel, K. A.</dc:creator>
<dc:creator>Koumenis, C.</dc:creator>
<dc:creator>Busch, T. M.</dc:creator>
<dc:date>2024-07-11</dc:date>
<dc:identifier>doi:10.1101/2024.07.08.602528</dc:identifier>
<dc:title><![CDATA[FLASH proton reirradiation, with or without hypofractionation, mitigates chronic toxicity in the normal murine intestine, skin, and bone.]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-07-11</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.07.08.602568v1?rss=1">
<title>
<![CDATA[
Optically Mapped Black Genomes: Distinct Structures and 22q11.2 Deletion Syndrome Mechanisms 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.07.08.602568v1?rss=1</link>
<description><![CDATA[
The genomic architecture of 22q11.2 Deletion Syndrome (22q11.2DS) has focused on analysis of white genomes. However, Black individuals appear to have a lower prevalence of 22q11.2DS compared to whites. To improve the understanding of different populations in relation to 22q11.2DS, optical mapping data from 106 genomes across various Black and white genomes were used to determine the organization of 22q11.2 genomic structures. This revealed extensive variability between the groups regarding copy number and orientation changes of the elements comprising the 22q11.2 low copy repeats (LCR22s). Several novel CNVs and whole haplotype configurations, private and of different prevalence to each group were detected. The diversity of CNVs within Black genomes compared to white genomes was especially striking. To determine the impact of this variability, Black families with de novo 22q11.2DS probands were compared to white families. The highly variable configurations of Black and white haplotypes led to several unique non-allelic homologous recombination (NAHR) scenarios with recombinations at different loci. In particular, Black families had unique recombinations yet to be observed. Thus, the unique and highly variable haplotype configurations of LCR22s in Black individuals may play a role in their decreased incidence of 22q11.2DS.
]]></description>
<dc:creator>Pastor, S.</dc:creator>
<dc:creator>Tran, O.</dc:creator>
<dc:creator>Lapointe, R.</dc:creator>
<dc:creator>Olali, A. Z.</dc:creator>
<dc:creator>Wallace, D. C.</dc:creator>
<dc:creator>Morrow, B. E.</dc:creator>
<dc:creator>Zackai, E. H.</dc:creator>
<dc:creator>McDonald-McGinn, D. M.</dc:creator>
<dc:creator>Emanuel, B. S.</dc:creator>
<dc:date>2024-07-11</dc:date>
<dc:identifier>doi:10.1101/2024.07.08.602568</dc:identifier>
<dc:title><![CDATA[Optically Mapped Black Genomes: Distinct Structures and 22q11.2 Deletion Syndrome Mechanisms]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-07-11</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.07.19.603617v1?rss=1">
<title>
<![CDATA[
A Novel Whole Tissue Explant Model of Hidradenitis Suppurativa 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.07.19.603617v1?rss=1</link>
<description><![CDATA[
Hidradenitis Suppurativa (HS) is a relatively common and highly morbid inflammatory skin disease. Due to our relatively limited understanding of HSs pathogenesis, there are currently insufficient treatment options available, and many patients medical needs are not being met. This is partly due to a scarcity of ex vivo human assays and animal models that accurately recapitulate the disease. To address this deficit, we have developed a whole-tissue explant model of HS to examine its pathogenic mechanisms and the efficacy of potential treatments within intact human tissue. We measured cytokine protein and RNA within whole tissue maintained in an agar-media solution, finding that IL-6 and IL-8 concentrations trended upwards in both HS explants and healthy controls, while IL-17A, IL-1{beta}, and TNF- exhibited increases in HS tissue alone. We also show that the explants were responsive to treatment with both dexamethasone and IL-2. Not only do our results show that this model effectively delivers treatments throughout the explants, but they also elucidate which cytokines are related to the explant process regardless of tissue state and which are related to HS tissue specifically, laying the groundwork for future implementations of this model.
]]></description>
<dc:creator>Leboit, P. E.</dc:creator>
<dc:creator>Patel, D. U.</dc:creator>
<dc:creator>Cohen, J. N.</dc:creator>
<dc:creator>Moss, M. I.</dc:creator>
<dc:creator>Naik, H. B.</dc:creator>
<dc:creator>Yates, A. E.</dc:creator>
<dc:creator>Harris, H. W.</dc:creator>
<dc:creator>Klufas, D. M.</dc:creator>
<dc:creator>Kim, E. A.</dc:creator>
<dc:creator>Neuhaus, I. M.</dc:creator>
<dc:creator>Hansen, S. L.</dc:creator>
<dc:creator>Kyle, R. L.</dc:creator>
<dc:creator>Kelly, M.</dc:creator>
<dc:creator>Rosenblum, M. D.</dc:creator>
<dc:creator>Lowe, M. M.</dc:creator>
<dc:date>2024-07-23</dc:date>
<dc:identifier>doi:10.1101/2024.07.19.603617</dc:identifier>
<dc:title><![CDATA[A Novel Whole Tissue Explant Model of Hidradenitis Suppurativa]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-07-23</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.07.19.604219v1?rss=1">
<title>
<![CDATA[
Structural diversity of mitochondria in the neuromuscular system across development 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.07.19.604219v1?rss=1</link>
<description><![CDATA[
As an animal matures, its neural circuit undergoes alterations, yet the developmental changes in intracellular organelles to facilitate these changes is less understood. Using 3D electron microscopy and deep learning, we developed semi-automated methods for reconstructing mitochondria in C. elegans and collected mitochondria reconstructions from normal reproductive stages and dauer, enabling comparative study on mitochondria structure within the neuromuscular system. We found that various mitochondria structural properties in neurons correlate with synaptic connections and these properties are preserved across development in different neural circuits. To test the necessity of these universal mitochondria properties, we examined the behavior in drp-1 mutants with impaired mitochondria fission and discovered that it caused behavioral deficits. Moreover, we observed that dauer neurons display distinctive mitochondrial features, and mitochondria in dauer muscles exhibit unique reticulum-like structure. We propose that this specialized mitochondria structure may serve as an adaptive mechanism to support stage-specific behavioral and physiological needs.
]]></description>
<dc:creator>Bae, J. A.</dc:creator>
<dc:creator>Choi, M.-k.</dc:creator>
<dc:creator>Ahn, S.</dc:creator>
<dc:creator>Ko, G.</dc:creator>
<dc:creator>Choe, D. T.</dc:creator>
<dc:creator>Yim, H.</dc:creator>
<dc:creator>Nguyen, K. C. Q.</dc:creator>
<dc:creator>Hall, D. H.</dc:creator>
<dc:creator>Kim, J. S.</dc:creator>
<dc:creator>Lee, J.</dc:creator>
<dc:date>2024-07-23</dc:date>
<dc:identifier>doi:10.1101/2024.07.19.604219</dc:identifier>
<dc:title><![CDATA[Structural diversity of mitochondria in the neuromuscular system across development]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-07-23</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.07.23.604814v1?rss=1">
<title>
<![CDATA[
In vivo-Active Soluble Epoxide Hydrolase-targeting PROTACs with Improved Potency and Stability 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.07.23.604814v1?rss=1</link>
<description><![CDATA[
Soluble epoxide hydrolase (sEH) is a bifunctional enzyme involved in fatty acid metabolism and promising drug target. We previously reported first-generation sEH proteolysis-targeting chimeras (PROTACs) with limited degradation potency and low aqueous and metabolic stability. Herein, we report the development of next-generation sEH PROTAC molecules with improved stability and degradation potency. One of the most potent molecules (compound 8) exhibits a half-maximal degradation concentration in the sub-nM range, is stable in vivo, and effectively degrades sEH in mouse livers and brown adipose tissues. Given the role played by sEH in many metabolic and nonmetabolic diseases, the presented molecules provide useful chemical probes for the study of sEH biology. They also hold potential for therapeutic development against a range of disease conditions, including diabetes, inflammation, and metabolic disorders.
]]></description>
<dc:creator>Nakane, K.</dc:creator>
<dc:creator>Morisseau, C.</dc:creator>
<dc:creator>Dowker-Key, P. D.</dc:creator>
<dc:creator>Benitez, G.</dc:creator>
<dc:creator>Aguilan, J. T.</dc:creator>
<dc:creator>Nagai, E.</dc:creator>
<dc:creator>Sidoli, S.</dc:creator>
<dc:creator>Hammock, B. D.</dc:creator>
<dc:creator>Bettaieb, A.</dc:creator>
<dc:creator>Shinoda, K.</dc:creator>
<dc:creator>Kitamura, S.</dc:creator>
<dc:date>2024-07-24</dc:date>
<dc:identifier>doi:10.1101/2024.07.23.604814</dc:identifier>
<dc:title><![CDATA[In vivo-Active Soluble Epoxide Hydrolase-targeting PROTACs with Improved Potency and Stability]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-07-24</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.07.29.605645v1?rss=1">
<title>
<![CDATA[
Senescent fibroblasts in the tumor stroma rewire lung cancer metabolism and plasticity 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.07.29.605645v1?rss=1</link>
<description><![CDATA[
Senescence has been demonstrated to either inhibit or promote tumorigenesis. Resolving this paradox requires spatial mapping and functional characterization of senescent cells in the native tumor niche. Here, we identified senescent p16Ink4a+ cancer-associated fibroblasts with a secretory phenotype that promotes fatty acid uptake and utilization by aggressive lung adenocarcinoma driven by Kras and p53 mutations. Furthermore, rewiring of lung cancer metabolism by p16Ink4a+ cancer- associated fibroblasts also altered tumor cell identity to a highly plastic/dedifferentiated state associated with progression in murine and human LUAD. Our ex vivo senolytic screening platform identified XL888, a HSP90 inhibitor, that cleared p16Ink4a+ cancer- associated fibroblasts in vivo. XL888 administration after establishment of advanced lung adenocarcinoma significantly reduced tumor burden concurrent with the loss of plastic tumor cells. Our study identified a druggable component of the tumor stroma that fulfills the metabolic requirement of tumor cells to acquire a more aggressive phenotype.
]]></description>
<dc:creator>Lee, J.</dc:creator>
<dc:creator>Nabora, S. R.</dc:creator>
<dc:creator>Woo, S.-H.</dc:creator>
<dc:creator>Goel, S.</dc:creator>
<dc:creator>Stratton, F.</dc:creator>
<dc:creator>Kuang, C.</dc:creator>
<dc:creator>Mansfield, A.</dc:creator>
<dc:creator>LaFave, L.</dc:creator>
<dc:creator>Peng, T.</dc:creator>
<dc:date>2024-07-30</dc:date>
<dc:identifier>doi:10.1101/2024.07.29.605645</dc:identifier>
<dc:title><![CDATA[Senescent fibroblasts in the tumor stroma rewire lung cancer metabolism and plasticity]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-07-30</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.07.31.606086v1?rss=1">
<title>
<![CDATA[
PROSER1 Modulates DNA Demethylation through Dual Mechanisms to Prevent Syndromic Developmental Malformations 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.07.31.606086v1?rss=1</link>
<description><![CDATA[
The link between DNA methylation and neurodevelopmental disorders is well established. However, how DNA methylation is fine-tuned - ensuring precise gene expression and developmental fidelity - remains poorly understood. PROSER1, a known TET2 interactor, was recently linked to a severe neurodevelopmental disorder. Here, we demonstrate that PROSER1 interacts with all TET enzymes and stabilizes chromatin-bound TET-OGT-PROSER1-DBHS (TOPD) complexes, which regulate DNA demethylation and developmental gene expression. Surprisingly, we find that PROSER1 also sequesters TET enzymes, preventing widespread demethylation and transposable element de-repression. Our findings identify PROSER1 as a key factor which both positively and negatively regulates DNA demethylation essential for mammalian neurodevelopment.
]]></description>
<dc:creator>Fleming, A.</dc:creator>
<dc:creator>Knatko, E. V.</dc:creator>
<dc:creator>Li, X.</dc:creator>
<dc:creator>Zoch, A.</dc:creator>
<dc:creator>Heckhausen, Z.</dc:creator>
<dc:creator>Stransky, S.</dc:creator>
<dc:creator>Brenes, A. J.</dc:creator>
<dc:creator>Sidoli, S.</dc:creator>
<dc:creator>Hajkova, P.</dc:creator>
<dc:creator>O'Carroll, D.</dc:creator>
<dc:creator>Rasmussen, K. D.</dc:creator>
<dc:date>2024-08-02</dc:date>
<dc:identifier>doi:10.1101/2024.07.31.606086</dc:identifier>
<dc:title><![CDATA[PROSER1 Modulates DNA Demethylation through Dual Mechanisms to Prevent Syndromic Developmental Malformations]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-08-02</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.08.13.607447v1?rss=1">
<title>
<![CDATA[
Single-cell analysis identifies distinct CD4+ T cells associated with the pathobiology of pediatric obesity-related asthma 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.08.13.607447v1?rss=1</link>
<description><![CDATA[
Pediatric obesity-related asthma is characterized by non-atopic T helper 1 (Th1) inflammation and steroid resistance. CDC42 upregulation in CD4+T cells underliesTh1 inflammation but the CD4+T cell subtype(s) with CDC42 upregulation and their contribution to steroid resistance are not known. Compared to healthy-weight asthma, obesity-alone and healthy-weight controls, single-cell transcriptomics of obese asthma CD4+T cells revealed CDC42 upregulation in 3 clusters comprised of naive and central memory T cells, which differed from the cluster enriched for Th1 responses that was comprised of effector T cells. NR3C1, coding for glucocorticoid receptor, was downregulated, while genes coding for NLRP3 inflammasome were upregulated, in clusters with CDC42 upregulation and Th1 responses. Conserved genes in these clusters correlated with pulmonary function deficits in obese asthma. These findings suggest that several distinct CD4+T cell subtypes are programmed in obese asthma for CDC42 upregulation, Th1 inflammation, and steroid resistance, and together contribute to obese asthma phenotype.

SummaryCD4+T cells from obese children with asthma are distinctly programmed for non-allergic immune responses, steroid resistance and inflammasome activation, that underlie the obese asthma phenotype.
]]></description>
<dc:creator>Thompson, D.</dc:creator>
<dc:creator>Wabara, Y.</dc:creator>
<dc:creator>Duran, S.</dc:creator>
<dc:creator>Reichenbach, A.</dc:creator>
<dc:creator>Chen, L.</dc:creator>
<dc:creator>Collado, K.</dc:creator>
<dc:creator>Yon, C.</dc:creator>
<dc:creator>Greally, J. M.</dc:creator>
<dc:creator>Rastogi, D.</dc:creator>
<dc:date>2024-08-16</dc:date>
<dc:identifier>doi:10.1101/2024.08.13.607447</dc:identifier>
<dc:title><![CDATA[Single-cell analysis identifies distinct CD4+ T cells associated with the pathobiology of pediatric obesity-related asthma]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-08-16</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.08.15.608063v1?rss=1">
<title>
<![CDATA[
MYH11 rare variant augments aortic growth and induces cardiac hypertrophy and heart failure with pressure overload 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.08.15.608063v1?rss=1</link>
<description><![CDATA[
Smooth muscle cell-specific myosin heavy chain, encoded by MYH11, is selectively expressed in smooth muscle cells (SMCs). Pathogenic variants in MYH11 predispose to a number of disorders, including heritable thoracic aortic disease associated with patent ductus arteriosus, visceral myopathy, and megacystis-microcolon-intestinal hypoperistalsis syndrome. Rare variants of uncertain significance occur throughout the gene, including MYH11 p.Glu1892Asp, and we sought to determine if this variant causes thoracic aortic disease in mice. Genomic editing was used to generate Myh11E1892D/E1892D mice. Wild-type (WT) and mutant mice underwent cardiovascular phenotyping and with transverse aortic constriction (TAC). Myh11E1892D/E1892D and WT mice displayed similar growth, blood pressure, root and ascending aortic diameters, and cardiac function up to 13 months of age, along with similar contraction and relaxation on myographic testing. TAC induced hypertension similarly in Myh11E1892D/E1892D and WT mice, but mutant mice showed augmented ascending aortic enlargement and increased elastic fragmentation on histology. Unexpectedly, male Myh11E1892D/E1892D mice two weeks post-TAC had decreased ejection fraction, stroke volume, fractional shortening, and cardiac output compared to similarly treated male WT mice. Importantly, left ventricular mass increased significantly due to primarily posterior wall thickening, and cardiac histology confirmed cardiomyocyte hypertrophy and increased collagen deposition in the myocardium and surrounding arteries. These results further highlight the clinical heterogeneity associated with MYH11 rare variants. Given that MYH11 is selectively expressed in SMCs, these results implicate a role of vascular SMCs in the heart contributing to cardiac hypertrophy and failure with pressure overload.

Author SummaryIn this study, we explore the impact of a specific genetic variant, MYH11 p.Glu1892Asp, on the heart and blood vessels in mice. The MYH11 gene is crucial for smooth muscle cells, which are found in the walls of blood vessels and play an important role in various vascular diseases. We created mice with this genetic variant to see if it would lead to thoracic aortic disease, a condition affecting the main artery from the heart. We found that mice with the variant were similar to normal mice in many aspects, such as growth, blood pressure, and heart function, for up to 13 months. However, when we induced high blood pressure in the mice, the mutant mice showed more significant enlargement of the aorta and damage to the elastic fibers in the aortic walls. Interestingly, male mutant mice also developed heart problems, such as reduced heart pumping ability and increased heart muscle thickness, after the high blood pressure challenge. This was accompanied by signs of heart muscle cell enlargement and increased tissue stiffness. These findings suggest that this rare MYH11 variant can contribute to a range of heart and vascular issues, particularly under conditions of pressure overload, and highlight the importance of smooth muscle cells in the development of these problems.
]]></description>
<dc:creator>Zhou, Z.</dc:creator>
<dc:creator>Hughes, K.</dc:creator>
<dc:creator>Saif, N.</dc:creator>
<dc:creator>Kim, H.</dc:creator>
<dc:creator>Massett, M. P.</dc:creator>
<dc:creator>Zheng, M.</dc:creator>
<dc:creator>Cecchi, A. C.</dc:creator>
<dc:creator>Guo, D.</dc:creator>
<dc:creator>Murdock, D. R.</dc:creator>
<dc:creator>Pan, P.</dc:creator>
<dc:creator>Clinton, J. S.</dc:creator>
<dc:creator>Wang, J.</dc:creator>
<dc:creator>Greally, J. M.</dc:creator>
<dc:creator>Milewicz, D. M.</dc:creator>
<dc:date>2024-08-16</dc:date>
<dc:identifier>doi:10.1101/2024.08.15.608063</dc:identifier>
<dc:title><![CDATA[MYH11 rare variant augments aortic growth and induces cardiac hypertrophy and heart failure with pressure overload]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-08-16</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.08.23.609227v1?rss=1">
<title>
<![CDATA[
Rearrangement of 3D genome organization in breast cancer epithelial - mesenchymal transition and metastasis organotropism 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.08.23.609227v1?rss=1</link>
<description><![CDATA[
Breast cancer cells exhibit organotropism during metastasis, showing preferential homing to certain organs such as bone, lung, liver, and brain. One potential explanation for this organotropic behavior is that cancer cells gain properties that enable thriving in certain microenvironments. Such specific metastatic traits may arise from gene regulation at the primary tumor site. Spatial genome organization plays a crucial role in oncogenic transformation and progression, but the extent to which chromosome architecture contributes to organ-specific metastatic traits is unclear. This work characterizes chromosome architecture changes associated with organotropic metastatic traits. By comparing a collection of genomic data from different subtypes of localized and lung metastatic breast cancer cells with both normal and cancerous lung cells, we find important trends of genomic reorganization. The most striking differences in 3D genome compartments segregate cell types according to their epithelial vs. mesenchymal status. This EMT compartment signature occurs at genomic regions distinct from transcription-defined EMT signatures, suggesting a separate layer of regulation. Specifically querying organotropism, we find 3D genome changes consistent with adaptations needed to survive in a new microenvironment, with lung metastatic breast cells exhibiting compartment switch signatures that shift the genome architecture to a lung cell-like conformation and brain metastatic prostate cancer cells showing compartment shifts toward a brain-like state. TCGA patient data reveals gene expression changes concordant with these organ-permissive compartment changes. These results suggest that genome architecture provides an additional level of cell fate specification informing organotropism and enabling survival at the metastatic site.

SIGNIFICANCEComputational analysis of a cohort of cancer cell lines reveals some 3D genome spatial compartment changes are associated with transitions in cancer cell state that relate to metastasis (EMT) and others reflect the characteristics of the metastatic organ context.
]]></description>
<dc:creator>Das, P.</dc:creator>
<dc:creator>San Martin, R.</dc:creator>
<dc:creator>Hong, T.</dc:creator>
<dc:creator>McCord, R. P.</dc:creator>
<dc:date>2024-08-25</dc:date>
<dc:identifier>doi:10.1101/2024.08.23.609227</dc:identifier>
<dc:title><![CDATA[Rearrangement of 3D genome organization in breast cancer epithelial - mesenchymal transition and metastasis organotropism]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-08-25</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.08.24.609506v1?rss=1">
<title>
<![CDATA[
Single-cell analysis of the somatic mutational landscape in human chondrocytes during aging and in osteoarthritis 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.08.24.609506v1?rss=1</link>
<description><![CDATA[
Somatic mutation is now recognized as a cause of multiple human diseases other than cancer. Osteoarthritis (OA), a highly prevalent age-related disease, has been associated with increased chromosomal abnormalities in articular cartilage of OA patients. Thus far no systematic attempt has been made to characterize the somatic mutational landscape of chondrocytes during normal aging and in affected cartilage of OA patients. Here we used single-cell whole genome sequencing to quantitatively analyze single-nucleotide variants (SNVs) and small insertions and deletions (InDels) in 100 single chondrocytes isolated from the cartilage of hip femoral heads of 17 subjects aged from 26 to 90 years, including 9 OA patients and 8 non-OA donors. Both SNVs and InDels were found to accumulate with age in chondrocytes with a clock-like mutational signature. Surprisingly, the age-related accumulation rate of these mutations was found to be lower in OA chondrocytes compared with chondrocytes from non-OA control subjects.
]]></description>
<dc:creator>Ren, P.</dc:creator>
<dc:creator>Zheng, C.</dc:creator>
<dc:creator>Pang, Y.</dc:creator>
<dc:creator>Sun, S.</dc:creator>
<dc:creator>Wang, Q.</dc:creator>
<dc:creator>Xu, W.</dc:creator>
<dc:creator>Lee, M.</dc:creator>
<dc:creator>Qiang, Y.</dc:creator>
<dc:creator>Lu, Z.</dc:creator>
<dc:creator>Zhou, M.</dc:creator>
<dc:creator>He, J.</dc:creator>
<dc:creator>Liu, N.-N.</dc:creator>
<dc:creator>Maslov, A. Y.</dc:creator>
<dc:creator>Dong, X.</dc:creator>
<dc:creator>Gao, J.</dc:creator>
<dc:creator>Zhang, C.</dc:creator>
<dc:creator>Vijg, J.</dc:creator>
<dc:date>2024-08-25</dc:date>
<dc:identifier>doi:10.1101/2024.08.24.609506</dc:identifier>
<dc:title><![CDATA[Single-cell analysis of the somatic mutational landscape in human chondrocytes during aging and in osteoarthritis]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-08-25</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.08.29.610396v1?rss=1">
<title>
<![CDATA[
Robustness Revisited: On the Neutral Evolution of Centrality and Localization 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.08.29.610396v1?rss=1</link>
<description><![CDATA[
This study investigates the intricate interplay among neutral landscape structure, mutation rate, recombination rate, and population dynamics in shaping evolutionary robustness. We provide a comprehensive framework that elucidates how different evolutionary forces interact to influence genotypic robustness and localization within haploid and diploid populations. We demonstrate that in haploid populations, high mutation rates relative to recombination typically drive the population toward regions of increased eigencentrality, a graphtheoretic measure of centrality which is correlated while not identical to mutational robustness. On the other hand, recombination increases the localization of the population to a smaller region of genotypic space, while high values of recombination relative to mutation can introduce shifts in distribution away from eigencentrality and toward attractors of the recombination dynamics. Diploid dynamics further complicate these interactions, showing reduced alignment with eigencentrality under both high mutation and recombination rates, with the exception of structured diploid landscapes where dynamics are still aligned with increasing eigencentrality. Our findings underscore the nuanced dependencies of evolutionary outcomes on both local and global landscape structures as well as evolutionary parameters.

Significance StatementOur work advances the theory of neutral evolution, paying particular attention to the question of how the holistic fitness landscape structure shapes the process of evolution and gives rise to emergent evolutionary phenomena. Since neutral evolution does not depend on direct selection, its ramifications can be both subtle, as they depend on network-wide properties, and ubiquitous, as they are not tied to context-specific adaptations. Our study provides a theoretical framework that connects the structure of neutral fitness landscapes with the dynamics of mutation and recombination rates, and the distinct behaviors of haploid and diploid populations. We establish general heuristic principles regarding the way evolutionary outcomes, such as robustness and localization, are influenced by the interplay of these factors.
]]></description>
<dc:creator>Sella, Y.</dc:creator>
<dc:creator>Bergman, A.</dc:creator>
<dc:date>2024-08-30</dc:date>
<dc:identifier>doi:10.1101/2024.08.29.610396</dc:identifier>
<dc:title><![CDATA[Robustness Revisited: On the Neutral Evolution of Centrality and Localization]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-08-30</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.09.02.610840v1?rss=1">
<title>
<![CDATA[
Early brain neuroinflammatory and metabolic changes identified by dual tracer microPET imaging in mice with acute liver injury 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.09.02.610840v1?rss=1</link>
<description><![CDATA[
BackgroundAcute liver injury (ALI) that progresses into acute liver failure (ALF) is a life-threatening condition with an increasing incidence and associated costs. Acetaminophen (N-acetyl-p-aminophenol, APAP) overdosing is among the leading causes of ALI and ALF in the Northern Hemisphere. Brain dysfunction defined as hepatic encephalopathy is one of the main diagnostic criteria for ALF. While neuroinflammation and brain metabolic alterations significantly contribute to hepatic encephalopathy, their evaluation at early stages of ALI remained challenging. To provide insights, we utilized post-mortem analysis and non-invasive brain micro positron emission tomography (microPET) imaging of mice with APAP-induced ALI.

MethodsMale C57BL/6 mice were treated with vehicle or APAP (600 mg/kg, i.p.). Serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), liver damage (using H&E staining), hepatic and serum IL-6 levels, and hippocampal IBA1 (using immunolabeling) were evaluated at 24h and 48h. Vehicle and APAP treated animals also underwent microPET imaging utilizing a dual tracer approach, including [11C]-peripheral benzodiazepine receptor ([11C]PBR28) to assess microglia/astrocyte activation and [18F]-fluoro-2-deoxy-2-D-glucose ([18F]FDG) to assess energy metabolism. Brain images were pre-processed and evaluated using conjunction and individual tracer uptake analysis.

ResultsAPAP-induced ALI and hepatic and systemic inflammation were detected at 24h and 48h by significantly elevated serum ALT and AST levels, hepatocellular damage, and increased hepatic and serum IL-6 levels. In parallel, increased microglial numbers, indicative for neuroinflammation were observed in the hippocampus of APAP-treated mice. MicroPET imaging revealed overlapping increases in [11C]PBR28 and [18F]FDG uptake in the hippocampus, thalamus, and habenular nucleus indicating microglial/astroglial activation and increased energy metabolism in APAP-treated mice (vs. vehicle-treated mice) at 24h. Similar significant increases were also found in the hypothalamus, thalamus, and cerebellum at 48h. The individual tracer uptake analyses (APAP vs vehicle) at 24h and 48h confirmed increases in these brain areas and indicated additional tracer- and region-specific effects including hippocampal alterations.

ConclusionPeripheral manifestations of APAP-induced ALI in mice are associated with brain neuroinflammatory and metabolic alterations at relatively early stages of disease progression, which can be non-invasively evaluated using microPET imaging and conjunction analysis. These findings support further PET-based investigations of brain function in ALI/ALF that may inform timely therapeutic interventions.
]]></description>
<dc:creator>Palandira, S.</dc:creator>
<dc:creator>Falvey, A.</dc:creator>
<dc:creator>Carrion, J.</dc:creator>
<dc:creator>Zeng, Q.</dc:creator>
<dc:creator>Chaudhry, S.</dc:creator>
<dc:creator>Grossman, K.</dc:creator>
<dc:creator>Turecki, L.</dc:creator>
<dc:creator>Nguyen, N.</dc:creator>
<dc:creator>Brines, M.</dc:creator>
<dc:creator>Chavan, S. S.</dc:creator>
<dc:creator>Metz, C. N.</dc:creator>
<dc:creator>Al-Abed, Y.</dc:creator>
<dc:creator>Chang, E. H.</dc:creator>
<dc:creator>Ma, Y.</dc:creator>
<dc:creator>Eidelberg, D.</dc:creator>
<dc:creator>Vo, A.</dc:creator>
<dc:creator>Tracey, K. J.</dc:creator>
<dc:creator>Pavlov, V. A.</dc:creator>
<dc:date>2024-09-03</dc:date>
<dc:identifier>doi:10.1101/2024.09.02.610840</dc:identifier>
<dc:title><![CDATA[Early brain neuroinflammatory and metabolic changes identified by dual tracer microPET imaging in mice with acute liver injury]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-09-03</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.09.06.611694v1?rss=1">
<title>
<![CDATA[
Structure-Based Computational Analysis of Interactions between Insulin Receptor and Insulin Inhibitory Receptor 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.09.06.611694v1?rss=1</link>
<description><![CDATA[
The recently discovered insulin inhibitory receptor (inceptor) plays a crucial role in insulin resistance and diabetes by reducing the insulin receptor count on cell membranes, resulting in higher blood glucose levels and decreased insulin sensitivity. Therefore, understanding the mechanism of how the inceptor insulin receptor complex interacts is exceedingly important. This study uses computational drug discovery to inhibit this interaction. Initially, we employed AlphaFold-Multimer to model the inceptor-insulin receptor protein complex and subsequently identified specific inceptor residues likely involved in binding to the insulin receptor. Through virtual screening, thousands of potential small molecules were found to bind to the inceptor, and 10 with the highest probability were chosen for docking. Beta-L-fucose, beta-D-fucose, and alpha-L-fucose showed the most promising binding energies, meaning these three small molecules can effectively interrupt the binding between the complex. We also computationally mutated the binding site of the insulin receptor and calculated the change in binding energy of the inceptor insulin receptor complex, the most dramatic being a 0.4 kcal mol^-1 change when Arginine mutated to Tryptophan at residue 926. Our study suggests that the mutations led to disease primarily due to the change in interactions of the inceptor insulin receptor complex.
]]></description>
<dc:creator>Li, V.</dc:creator>
<dc:creator>Wu, Y.</dc:creator>
<dc:date>2024-09-11</dc:date>
<dc:identifier>doi:10.1101/2024.09.06.611694</dc:identifier>
<dc:title><![CDATA[Structure-Based Computational Analysis of Interactions between Insulin Receptor and Insulin Inhibitory Receptor]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-09-11</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.09.10.612261v1?rss=1">
<title>
<![CDATA[
Platelet PI3Kβ regulates breast cancer metastasis 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.09.10.612261v1?rss=1</link>
<description><![CDATA[
Platelets promote tumor metastasis by several mechanisms. Platelet-tumor cell interactions induce the release of platelet cytokines, chemokines, and other factors that promote tumor cell epithelial-mesenchymal transition and invasion, granulocyte recruitment to circulating tumor cells (CTCs), and adhesion of CTCs to the endothelium, assisting in their extravasation at metastatic sites. Previous studies have shown that platelet activation in the context of thrombus formation requires the Class IA PI 3-kinase PI3K{beta}. We now define a role for platelet PI3K{beta} in breast cancer metastasis. Platelet PI3K{beta} is essential for platelet-stimulated tumor cell invasion through Matrigel. Consistent with this finding, in vitro platelet-tumor cell binding and tumor cell-stimulated platelet activation are reduced in platelets isolated from PI3K{beta} mutant mice. RNAseq and proteomic analysis of human breast epithelial cells co-cultured with platelets revealed that platelet PI3K{beta} regulates the expression of EMT and metastasis-associated genes in these cells. The EMT and metastasis-associated proteins PAI-1 and IL-8 were specifically downregulated in co-cultures with PI3K{beta} mutant platelets. PI3K{beta} mutant platelets are impaired in their ability to stimulate YAP and Smad2 signaling in tumor cells, two pathways regulating PAI-1 expression. Finally, we show that mice expressing mutant PI3K{beta} show reduced spontaneous metastasis, and platelets isolated from these mice are less able to stimulate experimental metastasis in WT mice. Taken together, these data support a role for platelet PI3K{beta} in promoting breast cancer metastasis and highlight platelet PI3K{beta} as a potential therapeutic target.

SignificanceWe demonstrate that platelet PI3K{beta} regulates metastasis, broadening the potential use of PI3K{beta}-selective inhibitors as novel agents to treat metastasis.
]]></description>
<dc:creator>Graff, R. C.</dc:creator>
<dc:creator>Haimowitz, A.</dc:creator>
<dc:creator>Aguilan, J.</dc:creator>
<dc:creator>Levine, A.</dc:creator>
<dc:creator>Zhang, J.</dc:creator>
<dc:creator>Yuan, W.</dc:creator>
<dc:creator>Roose-Girma, M.</dc:creator>
<dc:creator>Seshagiri, S.</dc:creator>
<dc:creator>Porcelli, S. A.</dc:creator>
<dc:creator>Gamble, M. J.</dc:creator>
<dc:creator>Sidoli, S.</dc:creator>
<dc:creator>Bresnick, A. R.</dc:creator>
<dc:creator>Backer, J.</dc:creator>
<dc:date>2024-09-14</dc:date>
<dc:identifier>doi:10.1101/2024.09.10.612261</dc:identifier>
<dc:title><![CDATA[Platelet PI3Kβ regulates breast cancer metastasis]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-09-14</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.09.16.613227v1?rss=1">
<title>
<![CDATA[
Linker histone regulates the myeloid versus lymphoid bifurcation of multipotent hematopoietic stem and progenitors 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.09.16.613227v1?rss=1</link>
<description><![CDATA[
Myeloid-biased differentiation of multipotent hematopoietic stem and progenitor cells (HSPCs) occurs with aging or exhaustion. The molecular mechanism(s) responsible for this fate bias remain unclear. Here we report that linker histone regulates HSPC fate choice at the lymphoid versus myeloid bifurcation. HSPCs expressing H1.0 from a doxycycline (dox) inducible transgene favor the lymphoid fate, display strengthened nucleosome organization and reduced chromatin accessibility at genomic regions hosting key myeloid fate drivers. The transcription factor Hlf is located in one of such regions, where chromatin accessibility and gene expression is reduced in H1.0high HSPCs. Furthermore, H1.0 protein in HSPCs decreases in an aspartyl protease dependent manner, a process enhanced in response to interferon alpha (IFN) signaling. Aspartyl protease inhibitors preserve endogenous H1.0 levels and promote the lymphoid fate of wild type HSPCs. Thus, our work uncovers a point of intervention to mitigate myeloid skewed hematopoiesis.
]]></description>
<dc:creator>Guo, S.</dc:creator>
<dc:creator>Karatepe, K.</dc:creator>
<dc:creator>Mafra de Faria, B.</dc:creator>
<dc:creator>zhang, j.</dc:creator>
<dc:creator>Chen, X.</dc:creator>
<dc:creator>Pinto, H.</dc:creator>
<dc:creator>Fyodorov, D.</dc:creator>
<dc:creator>Sefik, E.</dc:creator>
<dc:creator>Willcockson, M.</dc:creator>
<dc:creator>Flavell, R.</dc:creator>
<dc:creator>Skoultchi, A. I.</dc:creator>
<dc:date>2024-09-16</dc:date>
<dc:identifier>doi:10.1101/2024.09.16.613227</dc:identifier>
<dc:title><![CDATA[Linker histone regulates the myeloid versus lymphoid bifurcation of multipotent hematopoietic stem and progenitors]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-09-16</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.09.23.614600v1?rss=1">
<title>
<![CDATA[
Oxidative Phosphorylation Inhibition in Different Prostate Cancer Models and the Interplay with Androgen Receptor Signaling 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.09.23.614600v1?rss=1</link>
<description><![CDATA[
IntroductionIn prostate cancer (PCa), androgen receptor signaling stimulates both glycolysis and oxidative phosphorylation (OxPhos). Early-stage prostate cancer is particularly reliant on OxPhos for its bioenergetic needs. OxPhos inhibitors have entered clinical trials. Here we investigated their interplay with androgens in different PCa cell lines.

MethodsWe investigated the effects on PCa cell viability of an ATPase inhibitor (oligomycin) and a complex 1 inhibitor (IACS-010759) in the presence or absence of low testosterone concentrations in vitro. Both androgen-sensitive and insensitive PCa cell lines were used. The effects were assessed using MTT assay, flow cytometry and cell morphology.

ResultsTreatment with oligomycin resulted in massive apoptotic death of VCAP cells in castrate conditions within 48 hours, but the simultaneous addition of low testosterone levels restored VCAP cell viability. However, complex 1 inhibition with IACS-010759 increased cell viability, which was further promoted in the presence of testosterone. Both oligomycin and IACS-010759 dramatically decreased viability in LNCaP cells, while testosterone had a small but statistically non-significant effect. The antitumor effect of OxPhos inhibitors was smaller in LNCaP-C4-2B compared to LNCaP cells. OxPhos inhibitors slightly decreased proliferation rates in androgen-independent PC3 cells and HEK293 cells. Oligomycin on LNCaP-C4-2B and PC3 cells resulted in an increased number of cells in G0-G1 phase and decreased in S-phase and G2M phase, rather than massive apoptosis.

ConclusionThere is an interplay between androgen signaling and OxPhos in androgen-dependent PCa cells. Complex 1 inhibitors should be used with caution, given potential pro-tumorigenic effects in subsets of PCa cells.
]]></description>
<dc:creator>Sakellakis, M.</dc:creator>
<dc:creator>Ramachandran, S.</dc:creator>
<dc:creator>Jain, P.</dc:creator>
<dc:creator>Titus, M. A.</dc:creator>
<dc:date>2024-09-25</dc:date>
<dc:identifier>doi:10.1101/2024.09.23.614600</dc:identifier>
<dc:title><![CDATA[Oxidative Phosphorylation Inhibition in Different Prostate Cancer Models and the Interplay with Androgen Receptor Signaling]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-09-25</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.09.24.613949v1?rss=1">
<title>
<![CDATA[
Slit3 Fragments Orchestrate Neurovascular Expansion and Thermogenesis in Brown Adipose Tissue 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.09.24.613949v1?rss=1</link>
<description><![CDATA[
Brown adipose tissue (BAT) is an evolutionary innovation that enables placental mammals to regulate body temperature through adaptive thermogenesis. Brown adipocytes are embedded within an intricate network of blood vessels and sympathetic nerves that support their development and thermogenic function. Cold exposure activates BAT thermogenesis through the coordinated induction of brown adipogenesis, angiogenesis, and sympathetic innervation. However, how these distinct processes are coordinated remains unclear. Here, we show that fragments of Slit guidance ligand 3 (Slit3) drive crosstalk among adipocyte progenitors, endothelial cells, and sympathetic nerves. We demonstrate that adipocyte progenitors secrete Slit3, which regulates both angiogenesis and sympathetic innervation in BAT and is essential for BAT thermogenesis in vivo. Proteolytic cleavage of Slit3 generates secreted Slit3-N and Slit3-C fragments, which bind distinct receptors to stimulate angiogenesis and sympathetic innervation, respectively. We identify Plxna1 as a previously unrecognized receptor for Slit3-C and show that it is essential for sympathetic innervation and cold-induced neurite expansion in BAT. Moreover, we introduce bone morphogenetic protein 1 (Bmp1) as the first Slit protease identified in vertebrates. In summary, this work establishes a mechanistic framework for the coordinated regulation of sympathetic innervation and angiogenesis to enhance thermogenic function. The co-regulation of neurovascular expansion by distinct Slit3 fragments offers a bifurcated yet harmonized mechanism to ensure a synchronized BAT response to environmental challenges. Finally, this study provides the first evidence that adipocyte progenitors regulate tissue innervation, revealing a previously unrecognized dimension of cellular interaction within adipose tissue.
]]></description>
<dc:creator>Duarte Afonso Serdan, T.</dc:creator>
<dc:creator>Cervantes, H.</dc:creator>
<dc:creator>Frank, B.</dc:creator>
<dc:creator>Tian, Q.</dc:creator>
<dc:creator>Choi, C. H. J.</dc:creator>
<dc:creator>Hoffmann, A.</dc:creator>
<dc:creator>Cohen, P.</dc:creator>
<dc:creator>Bluher, M.</dc:creator>
<dc:creator>Schwartz, G. J.</dc:creator>
<dc:creator>Shamsi, F.</dc:creator>
<dc:date>2024-09-26</dc:date>
<dc:identifier>doi:10.1101/2024.09.24.613949</dc:identifier>
<dc:title><![CDATA[Slit3 Fragments Orchestrate Neurovascular Expansion and Thermogenesis in Brown Adipose Tissue]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-09-26</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.09.25.615077v1?rss=1">
<title>
<![CDATA[
Multi-omics identification of extracellular components of the fetal monkey and human neocortex. 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.09.25.615077v1?rss=1</link>
<description><![CDATA[
During development, precursor cells are continuously and intimately interacting with their extracellular environment, which guides their ability to generate functional tissues and organs. Much is known about the development of the neocortex in mammals. This information has largely been derived from histological analyses, heterochronic cell transplants, and genetic manipulations in mice, and to a lesser extent from transcriptomic and histological analyses in humans. However, these approaches have not led to a characterization of the extracellular composition of the developing neocortex in any species. Here, using a combination of single-cell transcriptomic analyses from published datasets, and our proteomics and immunohistofluorescence analyses, we provide a more comprehensive and unbiased picture of the early developing fetal neocortex in humans and non-human primates. Our findings provide a starting point for further hypothesis-driven studies on structural and signaling components in the developing cortex that had previously not been identified.
]]></description>
<dc:creator>Vilicich, F.</dc:creator>
<dc:creator>Vettiatil, D.</dc:creator>
<dc:creator>Kattapong Graber, S.</dc:creator>
<dc:creator>Nawsheen, N.</dc:creator>
<dc:creator>Patel, N.</dc:creator>
<dc:creator>Quezada, A.</dc:creator>
<dc:creator>Gurney, E.</dc:creator>
<dc:creator>Smith, E. M.</dc:creator>
<dc:creator>Nelson, H.</dc:creator>
<dc:creator>Pesci, S.</dc:creator>
<dc:creator>Atrio, J.</dc:creator>
<dc:creator>Moreno, N.</dc:creator>
<dc:creator>Jones, A.</dc:creator>
<dc:creator>Murphy, M.</dc:creator>
<dc:creator>Benfield, N.</dc:creator>
<dc:creator>Hennelbold, J.</dc:creator>
<dc:creator>Solansky, N.</dc:creator>
<dc:creator>Lisgo, S.</dc:creator>
<dc:creator>Glass, I.</dc:creator>
<dc:creator>Birth Defects Research Laboratory,</dc:creator>
<dc:creator>Sidoli, S.</dc:creator>
<dc:date>2024-09-26</dc:date>
<dc:identifier>doi:10.1101/2024.09.25.615077</dc:identifier>
<dc:title><![CDATA[Multi-omics identification of extracellular components of the fetal monkey and human neocortex.]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-09-26</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.09.26.615190v1?rss=1">
<title>
<![CDATA[
Rationalize the Functional Roles of Protein-Protein Interactions in Targeted Protein Degradation by Kinetic Monte-Carlo Simulations 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.09.26.615190v1?rss=1</link>
<description><![CDATA[
Targeted protein degradation is a promising therapeutic strategy to tackle disease-causing proteins that lack binding pockets for traditional small-molecule inhibitors. Its first step is to trigger the proximity between a ubiquitin ligase complex and a target protein through a heterobifunctional molecule, such as proteolysis targeting chimeras (PROTACs), leading to the formation of a ternary complex. The properties of protein-protein interactions play an important regulatory role during this process, which can be reflected by binding cooperativity. Unfortunately, although computer-aided drug design has become a cornerstone of modern drug development, the endeavor to model targeted protein degradation is still in its infancy. The development of computational tools to understand the impacts of protein-protein interactions on targeted protein degradation, therefore, is highly demanded. To reach this goal, we constructed a non-redundant structural benchmark of the most updated ternary complexes and applied a kinetic Monte-Carlo method to simulate the association between ligases and PROTAC-targeted proteins in the benchmark. Our results show that proteins in most complexes with positive cooperativity tend to associate into native-like configurations more often. In contrast, proteins very likely failed to associate into native-like configurations in complexes with negative cooperativity. Moreover, we compared the protein-protein association through different interfaces generated from molecular docking. The native-like binding interface shows a higher association probability than all the other alternative interfaces only in the complex with positive cooperativity. These observations support the idea that the formation of ternary complexes is closely regulated by the binary interactions between proteins. Finally, we applied our method to cyclin-dependent kinases 4 and 6 (CDK4/6). We found that their interactions with the ligase are not as similar as their structures. Altogether, our study paves the way for understanding the role of protein-protein interactions in PROTACE-induced ternary complex formation. It can potentially help in searching for degraders that selectively target specific proteins.
]]></description>
<dc:creator>Su, Z.</dc:creator>
<dc:creator>Yin, S.</dc:creator>
<dc:creator>Wu, Y.</dc:creator>
<dc:date>2024-09-28</dc:date>
<dc:identifier>doi:10.1101/2024.09.26.615190</dc:identifier>
<dc:title><![CDATA[Rationalize the Functional Roles of Protein-Protein Interactions in Targeted Protein Degradation by Kinetic Monte-Carlo Simulations]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-09-28</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.09.30.615685v1?rss=1">
<title>
<![CDATA[
High-throughput diversification of protein-ligand surfaces to discover chemical inducers of proximity 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.09.30.615685v1?rss=1</link>
<description><![CDATA[
Chemical inducers of proximity (CIPs) stabilize biomolecular interactions, often causing an emergent rewiring of cellular biochemistry1,2. While rational design strategies can expedite the discovery of heterobifunctional CIPs, monovalent, molecular glue-like CIPs have relied predominantly on serendipity3. Envisioning a prospective approach to discover molecular glues for a pre-selected target, we hypothesized that pre-existing ligands could be systematically decorated with chemical modifications to empirically discover protein-ligand surfaces that are tuned to cooperatively engage another protein interface. Here, we used sulfur(VI)-fluoride exchange (SuFEx)-based high-throughput chemistry (HTC) to install 3,163 structurally diverse chemical building blocks onto ENL and BRD4 ligands and then screened the crude products for degrader activity. This revealed dHTC1, a potent, selective, and stereochemistry-dependent degrader of ENL. It recruits CRL4CRBN to ENL through an extended interface of protein-protein and protein-ligand contacts, but only after pre-forming the ENL:dHTC1 complex. We also characterized two structurally distinct BRD4 degraders, including dHTC3, a molecular glue that selectively dimerizes the first bromodomain of BRD4 to SCFFBXO3, an E3 ligase not previously accessible for chemical rewiring. Altogether, this study introduces HTC as a facile tool to discover new CIPs and actionable cellular effectors of proximity pharmacology.
]]></description>
<dc:creator>Shaum, J. B.</dc:creator>
<dc:creator>Steen, E. A.</dc:creator>
<dc:creator>Munoz i Ordono, M.</dc:creator>
<dc:creator>Wenge, D. V.</dc:creator>
<dc:creator>Cheong, H.</dc:creator>
<dc:creator>Hunkeler, M.</dc:creator>
<dc:creator>Bilotta, E. M.</dc:creator>
<dc:creator>Rutter, Z.</dc:creator>
<dc:creator>Barta, P. A.</dc:creator>
<dc:creator>Milosevich, N.</dc:creator>
<dc:creator>Hargis, L. M.</dc:creator>
<dc:creator>Janowski, J.</dc:creator>
<dc:creator>Bishop, T. R.</dc:creator>
<dc:creator>Carter, T. R.</dc:creator>
<dc:creator>da Camara, B.</dc:creator>
<dc:creator>Hinterndorfer, M.</dc:creator>
<dc:creator>Dada, L.</dc:creator>
<dc:creator>He, W.-J.</dc:creator>
<dc:creator>Offensperger, F.</dc:creator>
<dc:creator>Furihata, H.</dc:creator>
<dc:creator>Schweber, S. R.</dc:creator>
<dc:creator>Hatton, C.</dc:creator>
<dc:creator>Wen, Y.</dc:creator>
<dc:creator>Cravatt, B. F.</dc:creator>
<dc:creator>Engle, K. M.</dc:creator>
<dc:creator>Melillo, B.</dc:creator>
<dc:creator>Kitamura, S.</dc:creator>
<dc:creator>Ciulli, A.</dc:creator>
<dc:creator>Armstrong, S. A.</dc:creator>
<dc:creator>Fischer, E. S.</dc:creator>
<dc:creator>Winter, G. E.</dc:creator>
<dc:creator>Erb, M. A.</dc:creator>
<dc:date>2024-09-30</dc:date>
<dc:identifier>doi:10.1101/2024.09.30.615685</dc:identifier>
<dc:title><![CDATA[High-throughput diversification of protein-ligand surfaces to discover chemical inducers of proximity]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-09-30</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.10.03.616482v1?rss=1">
<title>
<![CDATA[
APC coordinates GSK3 phosphorylation of SETD8 to suppress colorectal cancer 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.10.03.616482v1?rss=1</link>
<description><![CDATA[
Colorectal cancer (CRC) is the second-leading cause of cancer-related deaths with increasing incidence globally. Mutations in the tumor suppressor APC initiate CRC at least in part by preventing the GSK3 kinase from phosphorylating {beta}-CATENIN, leading to its constitutive stabilization and transactivation of mitogenic target genes. While the importance of {beta}-CATENIN phosphorylation by GSK3 is well-established, APC regulation of GSK3 activity upon other targets with potential oncogenic relevance are not understood. Here, we identify the H4K20 methyltransferase SETD8 as target of APC-coordinated GSK3 phosphorylation in the intestinal epithelium. We found that phosphorylation by GSK3 restrains the oncogenic activity of SETD8, with loss of phosphorylation sensitizing mice to oncogenic insults. Mechanistically, phosphorylation alters the role of SETD8 in transcriptional regulation, most notably by preventing it from activating oncogenic YAP signaling and a fetal-like transcriptional program. These results underscore the importance of SETD8 in CRC and represent a novel {beta}-CATENIN -independent oncogenic consequence of APC loss.

SignificanceGSK3 is thought to restrain colorectal cancer primarily by phosphorylation of {beta}-CATENIN. We show that GSK3 also phosphorylates SETD8, preventing SETD8 activation of oncogenic programs including YAP-driven fetal-like gene expression.
]]></description>
<dc:creator>Cramer, Z.</dc:creator>
<dc:creator>Monaghan, K.</dc:creator>
<dc:creator>Petroni, R.</dc:creator>
<dc:creator>Wang, X.</dc:creator>
<dc:creator>Adams, S.</dc:creator>
<dc:creator>Durning, K.</dc:creator>
<dc:creator>Kim, M.</dc:creator>
<dc:creator>Tian, Y.</dc:creator>
<dc:creator>Johnson, N.</dc:creator>
<dc:creator>Leu, N. A.</dc:creator>
<dc:creator>Sidoli, S.</dc:creator>
<dc:creator>Li, N.</dc:creator>
<dc:creator>Blanco, M. A.</dc:creator>
<dc:creator>Lengner, C.</dc:creator>
<dc:date>2024-10-04</dc:date>
<dc:identifier>doi:10.1101/2024.10.03.616482</dc:identifier>
<dc:title><![CDATA[APC coordinates GSK3 phosphorylation of SETD8 to suppress colorectal cancer]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-10-04</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.10.10.617646v1?rss=1">
<title>
<![CDATA[
H2AK119ub dynamics controls hair follicle stem cell quiescence 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.10.10.617646v1?rss=1</link>
<description><![CDATA[
The transition of stem cells from a quiescent state to an active state is a finely tuned process that requires the dismantling of the quiescence program and the establishment of a cell cycle-promoting transcriptional landscape. Whether epigenetic processes control stem cell states to promote the regeneration of adult tissues remains elusive. In this study, we show that a repressive histone modification, H2AK119ub, is dynamic between quiescent and active hair follicle stem cells (HFSCs) in the adult murine skin. Ablation of H2AK119ub in HFSCs leads to impaired quiescence leading to premature activation and an eventual exhaustion of HFSC pool. Transcriptional and chromatin studies revealed that H2AK119ub directly represses a proliferation promoting transcriptional program in the HFSCs to preserve quiescence. Lastly, we identify that the inhibitory FGF signaling produced by the hair follicle niche keratinocytes maintains H2AK119ub in quiescent HFSCs. Together, these findings reveal that a repressive histone mark, H2AK119ub, is under the dynamic regulation of inhibitory niche signaling to prevent the untimely establishment of an activated state to preserve SC function and longevity.
]]></description>
<dc:creator>Flora, P.</dc:creator>
<dc:creator>Li, M.-Y.</dc:creator>
<dc:creator>Zhou, Y.</dc:creator>
<dc:creator>Mercedes, M.</dc:creator>
<dc:creator>Zheng, X. Y.</dc:creator>
<dc:creator>Galbo, P. M.</dc:creator>
<dc:creator>Zheng, D.</dc:creator>
<dc:creator>Ezhkova, E.</dc:creator>
<dc:date>2024-10-11</dc:date>
<dc:identifier>doi:10.1101/2024.10.10.617646</dc:identifier>
<dc:title><![CDATA[H2AK119ub dynamics controls hair follicle stem cell quiescence]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-10-11</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.10.11.617885v1?rss=1">
<title>
<![CDATA[
Identification of functional rare coding variants in IGF-1 gene in humans with exceptional longevity 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.10.11.617885v1?rss=1</link>
<description><![CDATA[
Diminished signaling via insulin/insulin-like growth factor-1 (IGF-1) axis is associated with longevity in different model organisms. IGF-1 gene is highly conserved across species, with only few evolutionary changes identified in it. Despite its potential role in regulating life span, no coding variants in IGF-1 have been reported in human longevity cohorts to date. This study investigated the whole exome sequencing data from 2,487 individuals in a cohort of Ashkenazi Jewish centenarians, their offspring, and controls without familial longevity to identify functional IGF-1 coding variants. We identified two likely functional coding variants IGF-1:p.Ile91Leu and IGF-1:p.Ala118Thr in our longevity cohort. Notably, a centenarian specific novel variant IGF-1:p.Ile91Leu was located at the binding interface of IGF-1 - IGF-1R, whereas IGF-1:p.Ala118Thr was significantly associated with lower circulating levels of IGF-1. We performed extended all-atom molecular dynamics simulations to evaluate the impact of Ile91Leu on stability, binding dynamics and energetics of IGF-1 bound to IGF-1R. The IGF-1:p.Ile91Leu formed less stable interactions with IGF-1Rs critical binding pocket residues and demonstrated lower binding affinity at the extracellular binding site compared to wild-type IGF-1. Our findings suggest that IGF-1:p.Ile91Leu and IGF-1:p.Ala118Thr variants attenuate IGF-1R activity by impairing IGF-1 binding and diminishing the circulatory levels of IGF-1, respectively. Consequently, diminished IGF-1 signaling resulting from these variants may contribute to exceptional longevity in humans.
]]></description>
<dc:creator>Ali, A.</dc:creator>
<dc:creator>Zhang, Z.</dc:creator>
<dc:creator>Gao, T.</dc:creator>
<dc:creator>Aleksic, S.</dc:creator>
<dc:creator>Gavathiotis, E.</dc:creator>
<dc:creator>Barzilai, N.</dc:creator>
<dc:creator>Milman, S.</dc:creator>
<dc:date>2024-10-13</dc:date>
<dc:identifier>doi:10.1101/2024.10.11.617885</dc:identifier>
<dc:title><![CDATA[Identification of functional rare coding variants in IGF-1 gene in humans with exceptional longevity]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-10-13</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.10.15.618571v1?rss=1">
<title>
<![CDATA[
Intratumoral CXCL12 Gradients Contextualize Tumor Cell Invasion, Migration and Immune Suppression in Breast Cancer 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.10.15.618571v1?rss=1</link>
<description><![CDATA[
Although the CXCL12/CXCR4 pathway has been prior investigated for its prometastatic and immuno- suppressive roles in the tumor microenvironment, evidence on the spatiotemporal regulation of these hallmarks has been lacking. Here, we demonstrate that CXCL12 forms a gradient specifically around cancer cell intravasation doorways, also known as Tumor Microenvironment of Metastasis (TMEM) doorways, thus facilitating the chemotactic translocation of prometastatic tumor cells expressing CXCR4 toward the perivascular TMEM doorways for subsequent entry into peripheral circulation. Fur- thermore, we demonstrate that the CXCL12-rich micro-environment around TMEM doorways may cre- ate immunosuppressive niches, whereby CD8+ T cells, despite being attracted to these regions, often exhibit reduced effector functions, limiting their efficacy. While the CXCL12/CXCR4 pathway can mini- mally influence the overall composition of immune cell populations, it biases the distribution of CD8+ T cells away from TMEM doorways, justifying its prior-established role as immunosuppressive factor for CD8+ T cells. Our research suggests that the complex interactions between CXCL12 and the various tumor and immune cell types contributes not only to the completion of the initial steps of the metastatic cascade, but also offers an immunological "sanctuary" to prometastatic tumor cells homed around TMEM doorways. Overall, our study enhances our current understanding on the mechanisms, via which CXCL12 orchestrates tumor cell behavior and immune dynamics, potentially guiding future thera- peutic strategies to combat breast cancer metastasis and improve anti-tumor immunity.
]]></description>
<dc:creator>Anastasiadou, D. P.</dc:creator>
<dc:creator>Couturier, N.</dc:creator>
<dc:creator>Goel, S.</dc:creator>
<dc:creator>Argyris, D. G.</dc:creator>
<dc:creator>Vodopyanov, S.</dc:creator>
<dc:creator>Rivera-Sanchez, L.</dc:creator>
<dc:creator>Gonzalez, E.</dc:creator>
<dc:creator>Kreger, J.</dc:creator>
<dc:creator>Griffen, A.</dc:creator>
<dc:creator>Kazakov, A.</dc:creator>
<dc:creator>Burt, J.</dc:creator>
<dc:creator>Recoder, N.</dc:creator>
<dc:creator>Duran, C. L.</dc:creator>
<dc:creator>Harney, A. S.</dc:creator>
<dc:creator>Quesnel, A.</dc:creator>
<dc:creator>Filippou, P. S.</dc:creator>
<dc:creator>Lenis, V. P.</dc:creator>
<dc:creator>Shukla, S.</dc:creator>
<dc:creator>Entenberg, D.</dc:creator>
<dc:creator>Zintiridou, A.</dc:creator>
<dc:creator>Chen, X.</dc:creator>
<dc:creator>Eddy, R. J.</dc:creator>
<dc:creator>Oktay, M. H.</dc:creator>
<dc:creator>Condeelis, J. S.</dc:creator>
<dc:creator>Karagiannis, N. S.</dc:creator>
<dc:creator>Briceno, A.</dc:creator>
<dc:creator>Guzik, H.</dc:creator>
<dc:creator>Alon, R.</dc:creator>
<dc:creator>DesMarais, V.</dc:creator>
<dc:creator>Ioannou, G.</dc:creator>
<dc:creator>Gnjatic, S.</dc:creator>
<dc:creator>Raynolds, D. M.</dc:creator>
<dc:creator>Macedo, R.</dc:creator>
<dc:creator>Reshef, R.</dc:creator>
<dc:creator>Gil-Henn, H.</dc:creator>
<dc:creator>MacLean, A. L.</dc:creator>
<dc:creator>Roussos Torres, E.</dc:creator>
<dc:creator>LaFave, L. M.</dc:creator>
<dc:creator>Lauvau, G.</dc:creator>
<dc:creator>Karagiannis, G. S.</dc:creator>
<dc:date>2024-10-18</dc:date>
<dc:identifier>doi:10.1101/2024.10.15.618571</dc:identifier>
<dc:title><![CDATA[Intratumoral CXCL12 Gradients Contextualize Tumor Cell Invasion, Migration and Immune Suppression in Breast Cancer]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-10-18</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.10.18.619102v1?rss=1">
<title>
<![CDATA[
The representational geometry for naturalistic textures in macaque V1 and V2 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.10.18.619102v1?rss=1</link>
<description><![CDATA[
Our understanding of visual cortical processing has relied primarily on studying the selectivity of individual neurons in different areas. A complementary approach is to study how the representational geometry of neuronal populations differs across areas. Though the geometry is derived from individual neuronal selectivity, it can reveal encoding strategies difficult to infer from single neuron responses. In addition, recent theoretical work has begun to relate distinct functional objectives to different representational geometries. To understand how the representational geometry changes across stages of processing, we measured neuronal population responses in primary visual cortex (V1) and area V2 of macaque monkeys to an ensemble of synthetic, naturalistic textures. Responses were lower dimensional in V2 than V1, and there was a better alignment of V2 population responses to different textures. The representational geometry in V2 afforded better discriminability between out-of-sample textures. We performed complementary analyses of standard convolutional network models, which did not replicate the representational geometry of cortex. We conclude that there is a shift in the representational geometry between V1 and V2, with the V2 representation exhibiting features of a low-dimensional, systematic encoding of different textures and of different instantiations of each texture. Our results suggest that comparisons of representational geometry can reveal important transformations that occur across successive stages of visual processing.
]]></description>
<dc:creator>Pavuluri, A.</dc:creator>
<dc:creator>Kohn, A.</dc:creator>
<dc:date>2024-10-22</dc:date>
<dc:identifier>doi:10.1101/2024.10.18.619102</dc:identifier>
<dc:title><![CDATA[The representational geometry for naturalistic textures in macaque V1 and V2]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-10-22</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.10.21.619434v1?rss=1">
<title>
<![CDATA[
Continuous nucleolar ribosomal RNA synthesis in differentiating lens fiber cells until abrupt nuclear degradation required for ocular lens transparency 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.10.21.619434v1?rss=1</link>
<description><![CDATA[
Cellular differentiation requires highly coordinate action of all three transcriptional systems to produce rRNAs, mRNAs, and various "short" and "long" non-coding RNAs by RNA Polymerase I, II, and III systems, respectively. The RNA Polymerase I catalyzes transcription of about 400 copies of rDNA genes generating 18S, 5.8S, and 28S rRNA molecules from the individual primary transcript. Lens fiber cell differentiation is a unique process to study transcriptional mechanisms of individual crystallin genes as their very high transcriptional outputs are directly comparable only to globin genes in erythrocytes. Importantly, both terminally differentiated lens fiber cells and mammalian erythrocytes degrade their nuclei though by different mechanisms. In lens, generation of organelle-free zone (OFZ) includes degradation of mitochondria, endoplasmic reticulum, Golgi apparatus, and nuclei; nevertheless, very little is known about their nucleoli and rRNA transcription. Here, using RNA fluorescence in situ hybridization (FISH) we evaluated nascent rRNA transcription during the entire process of lens fiber cell differentiation. The lens fiber cell nuclei undergo morphological changes prior their denucleation, including chromatin condensation; remarkably, the nascent rRNA transcription persists in all nuclei next to the OFZ. The changes in both nuclei and nucleoli shape and microarchitecture were evaluated by immunofluorescence to detect fibrillarin, nucleolin, UBF, and other nuclear proteins. These studies demonstrate for the first time that highly condensed lens fiber cell nuclei have the capacity to support rRNA transcription. Thus, "late" production of rRNA molecules and consequently the ribosomes contribute to the terminal translational mechanisms to produce maximal quantities of the crystallin proteins.
]]></description>
<dc:creator>Rayee, D.</dc:creator>
<dc:creator>Meier, U. T.</dc:creator>
<dc:creator>Eliscovich, C.</dc:creator>
<dc:creator>Cvekl, A.</dc:creator>
<dc:date>2024-10-22</dc:date>
<dc:identifier>doi:10.1101/2024.10.21.619434</dc:identifier>
<dc:title><![CDATA[Continuous nucleolar ribosomal RNA synthesis in differentiating lens fiber cells until abrupt nuclear degradation required for ocular lens transparency]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-10-22</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.10.23.619918v1?rss=1">
<title>
<![CDATA[
T cell epitope mapping reveals immunodominance of evolutionarily conserved regions within SARS-CoV-2 proteome. 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.10.23.619918v1?rss=1</link>
<description><![CDATA[
As SARS-CoV-2 variants continue to emerge capable of evading neutralizing antibodies, it has become increasingly important to fully understand the breadth and functional profile of T cell responses to determine their impact on the immune surveillance of variant strains. Here, sampling healthy individuals, we profiled the kinetics and polyfunctionality of T cell immunity elicited by mRNA vaccination. Modeling of anti-spike T cell responses against ancestral and variant strains of SARS-CoV-2 suggested that epitope immunodominance and cross-reactivity are major predictive determinants of T cell immunity. To identify immunodominant epitopes across the viral proteome, we generated a comprehensive map of CD4+ and CD8+ T cell epitopes within non-spike proteins that induced polyfunctional T cell responses in convalescent patients. We found that immunodominant epitopes mainly resided within regions that were minimally disrupted by mutations in emerging variants. Conservation analysis across historical human coronaviruses combined with in silico alanine scanning mutagenesis of non-spike proteins underscored the functional importance of mutationally-constrained immunodominant regions. Collectively, these findings identify immunodominant T cell epitopes across the mutationally-constrained SARS-CoV-2 proteome, potentially providing immune surveillance against emerging variants, and inform the design of next-generation vaccines targeting antigens throughout SARS-CoV-2 proteome for broader and more durable protection.

One Sentence SummaryPolyfunctional CD8+ and CD4+ T cells directed against SARS-CoV-2 target mutationally constrained regions of the viral proteome.
]]></description>
<dc:creator>Bozkus, C. C.</dc:creator>
<dc:creator>Brown, M.</dc:creator>
<dc:creator>Velazquez, L.</dc:creator>
<dc:creator>Thomas, M.</dc:creator>
<dc:creator>Wilson, E. A.</dc:creator>
<dc:creator>O'Donnell, T.</dc:creator>
<dc:creator>Ruchnewitz, D.</dc:creator>
<dc:creator>Geertz, D.</dc:creator>
<dc:creator>Bykov, Y.</dc:creator>
<dc:creator>Kodysh, J.</dc:creator>
<dc:creator>Oguntuyo, K. Y.</dc:creator>
<dc:creator>Roudko, V.</dc:creator>
<dc:creator>Hoyos, D.</dc:creator>
<dc:creator>Srivastava, K.</dc:creator>
<dc:creator>Kleiner, G.</dc:creator>
<dc:creator>Alshammary, H.</dc:creator>
<dc:creator>Karekar, N.</dc:creator>
<dc:creator>McClain, C.</dc:creator>
<dc:creator>Gopal, R.</dc:creator>
<dc:creator>Nie, K.</dc:creator>
<dc:creator>Del Valle, D.</dc:creator>
<dc:creator>Delbeau-Zagelbaum, D.</dc:creator>
<dc:creator>Rodriguez, D.</dc:creator>
<dc:creator>Setal, J.</dc:creator>
<dc:creator>The Mount Sinai COVID-19 Biobank Team,</dc:creator>
<dc:creator>Carroll, E.</dc:creator>
<dc:creator>Wiesendanger, M.</dc:creator>
<dc:creator>Gulko, P.</dc:creator>
<dc:creator>Charney, A.</dc:creator>
<dc:creator>Merad, M.</dc:creator>
<dc:creator>Kim-Schulze, S.</dc:creator>
<dc:creator>Lee, B.</dc:creator>
<dc:creator>Wajnberg, A.</dc:creator>
<dc:creator>Simon, V.</dc:creator>
<dc:creator>Greenbaum, B. D.</dc:creator>
<dc:creator>Chowell, D.</dc:creator>
<dc:creator>Vabret, N.</dc:creator>
<dc:creator>Luksza, M.</dc:creator>
<dc:creator>Bhardwaj, N.</dc:creator>
<dc:date>2024-10-24</dc:date>
<dc:identifier>doi:10.1101/2024.10.23.619918</dc:identifier>
<dc:title><![CDATA[T cell epitope mapping reveals immunodominance of evolutionarily conserved regions within SARS-CoV-2 proteome.]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-10-24</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.11.01.621616v1?rss=1">
<title>
<![CDATA[
Dampened α7 nAChR activity contributes to audiogenic seizures and hyperactivity in a mouse model of Fragile X Syndrome 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.11.01.621616v1?rss=1</link>
<description><![CDATA[
Fragile X Syndrome (FXS) is the most common form of inherited intellectual disability and often accompanied with debilitating pathologies including seizures and hyperactivity. FXS arises from a trinucleotide repeat expansion in the 5 UTR of the FMR1 gene that silences expression of the RNA-binding protein FMRP. Despite progress in understanding FMRP functions, the identification of effective therapeutic targets has lagged and at present there are no viable treatment options. Here we identify the 7 nicotinic acetylcholine receptor (nAChR) as candidate target for intervention in FXS. In the early postnatal hippocampus of Fmr1 knockout (Fmr1KO) mice, an established pre-clinical model of FXS, the 7 nAChR accessory protein Ly6H is abnormally distributed, showing enrichment at the neuronal surface and mislocalization in dendrites. Ly6H, a GPI-anchored protein, binds 7 nAChRs with high affinity and can limit 7 nAChR surface expression and signaling. We find that 7 nAChR-evoked Ca2+ responses are dampened in immature glutamatergic and GABAergic Fmr1KO neurons compared to wild type. Knockdown of endogenous Ly6H in Fmr1KO neurons is sufficient to rescue dampened 7 nAChR Ca2+ responses in vitro, providing evidence of a cell-autonomous role for Ly6H aberrant expression in 7 nAChR hypofunction. In line with intrinsic deficits in 7 nAChR activity in Fmr1KO neurons, in vivo administration of the 7 nAChR-selective positive allosteric modulator PNU-120596 improved spatial memory and reduced hyperactivity and seizure severity in adolescent Fmr1KO mice. Taken together, our in vitro mechanistic findings and in vivo rescue studies implicate 7 nAChR hypofunction in FXS pathology.
]]></description>
<dc:creator>Goebel, S.</dc:creator>
<dc:creator>Cordova-Martinez, D.</dc:creator>
<dc:creator>Verselis, V. K.</dc:creator>
<dc:creator>Francesconi, A.</dc:creator>
<dc:date>2024-11-03</dc:date>
<dc:identifier>doi:10.1101/2024.11.01.621616</dc:identifier>
<dc:title><![CDATA[Dampened α7 nAChR activity contributes to audiogenic seizures and hyperactivity in a mouse model of Fragile X Syndrome]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-11-03</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.11.03.621750v1?rss=1">
<title>
<![CDATA[
Neurovirulent and non-neurovirulent strains of HIV-1 and their Tat proteins induce differential cytokine-chemokine profiles 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.11.03.621750v1?rss=1</link>
<description><![CDATA[
HIV-1 enters the central nervous system (CNS) early in infection, and a significant proportion of people with HIV experience CNS complications despite anti-retroviral therapy. Chronic immune dysfunction, inflammatory cytokines and chemokines, and viral proteins like Tat and gp120 released by HIV-1-infected immune cells are implicated in the pathogenesis of HIV-1-associated neurocognitive disorders (HAND). To elucidate the contribution of non-viral factors to CNS complications in people with HIV-1, a comparative analysis of neurovirulent subtype B (HIV-1ADA) and non-neurovirulent subtype C (HIV-1Indie-C1) isolates was performed. Culture supernatants from HIV-1-infected PBMCs, either with or without immunodepletion of Tat and gp120, were used to treat SH-SY5Y neuroblastoma cells. HIV-1ADA-infected PBMC media showed significantly higher cytotoxicity than HIV-1IndieC1-infected PBMC media, notwithstanding the depletion of Tat and gp120, highlighting the role of non-viral factors contributing to neurotoxicity. A comparison of inflammatory profiles revealed that HIV-1ADA media contained elevated levels of cytokines (IL-1, IL-1{beta}, IL-6, TNF) and chemokines (CCL2, CCL3, CCL4, IP10). Given the involvement of Tat in upregulating immune mediators, PBMCs from healthy subjects were treated with recombinant purified Tat from subtype B or C. Subtype B Tat induced a stronger inflammatory response than subtype C Tat. These results confirm that both viral and non-viral immune factors mediate neuronal damage in people with HIV.
]]></description>
<dc:creator>Rao, V. R.</dc:creator>
<dc:creator>Rodriguez, M. R.</dc:creator>
<dc:creator>Byrareddy, S.</dc:creator>
<dc:creator>Ranga, U.</dc:creator>
<dc:creator>Prasad, V. R.</dc:creator>
<dc:date>2024-11-03</dc:date>
<dc:identifier>doi:10.1101/2024.11.03.621750</dc:identifier>
<dc:title><![CDATA[Neurovirulent and non-neurovirulent strains of HIV-1 and their Tat proteins induce differential cytokine-chemokine profiles]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-11-03</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.11.06.622283v1?rss=1">
<title>
<![CDATA[
Measuring Stimulus Information Transfer Between Neural Populations through the Communication Subspace 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.11.06.622283v1?rss=1</link>
<description><![CDATA[
Sensory processing arises from the communication between neural populations across multiple brain areas. While the widespread presence of neural response variability shared throughout a neural population limits the amount of stimulus-related information those populations can accurately represent, how this variability affects the interareal communication of sensory information is unknown. We propose a mathematical framework to understand the impact of neural population response variability on sensory information transmission. We combine linear Fisher information, a metric connecting stimulus representation and variability, with the framework of communication subspaces, which suggests that functional mappings between cortical populations are low-dimensional relative to the space of population activity patterns. From this, we partition Fisher information depending on the alignment between the population covariance and the mean tuning direction projected onto the communication subspace or its orthogonal complement. We provide mathematical and numerical analyses of our proposed decomposition of Fisher information and examine theoretical scenarios that demonstrate how to leverage communication subspaces for flexible routing and gating of stimulus information. This work will provide researchers investigating interareal communication with a theoretical lens through which to understand sensory information transmission and guide experimental design.
]]></description>
<dc:creator>Weiss, O.</dc:creator>
<dc:creator>Coen-Cagli, R.</dc:creator>
<dc:date>2024-11-07</dc:date>
<dc:identifier>doi:10.1101/2024.11.06.622283</dc:identifier>
<dc:title><![CDATA[Measuring Stimulus Information Transfer Between Neural Populations through the Communication Subspace]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-11-07</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.11.07.622257v1?rss=1">
<title>
<![CDATA[
Resting-state connectivity modifies the effects of amyloid on cognitive and physical function: evidence for network-based cognitive reserve 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.11.07.622257v1?rss=1</link>
<description><![CDATA[
Cognitive and physical function are interrelated in aging co-occurring impairments in both domains can be debilitating and lead to increased risk of developing dementia. Amyloid beta (A{beta}) deposition in the brain is linked to cognitive decline and is also associated with poorer physical function in older adults. However, significant inter-individual variability exists with respect to the influence of increased brain A{beta} concentrations on cognitive and physical outcomes. Identifying factors that explain inter-individual variability in associations between A{beta} and clinical outcomes could inform interventions designed to delay declines in both cognitive and physical function. Cognitive reserve (CR) is considered a buffer that allows for cognitive performance that is better than expected for a given level of brain injury or pathology. Although the neural mechanisms underlying CR remain unknown, there is growing evidence that resting-state brain networks may serve as a neural surrogate for CR. The currently study evaluated whether functional brain networks modified associations between brain A{beta} and cognitive and physical function in community-dwelling older adults from the Brain Networks and Mobility (B-NET) study. We found that the integrity of the central executive and basal ganglia networks modified associations of A{beta} with cognitive and physical performance. Associations between brain A{beta} and cognitive and physical function were less pronounced when brain network integrity was high. The current study introduces novel evidence for brain networks underlying CR as a buffer against the influence of A{beta} accumulation on cognitive and physical function.

Significance StatementThere is a growing number of medications targeting beta amyloid for the treatment of Alzheimers disease. The treatments effectively lower brain amyloid but do not have as robust of an effect on clinical outcomes. The current study introduces novel evidence for brain networks as a buffer against the influence of A{beta} accumulation on cognitive and physical function in older adults with normal cognition. Future studies should examine if brain network integrity underlies the variability in treatment response to amyloid-lowering drugs in patients with cognitive decline.
]]></description>
<dc:creator>Laurienti, P. J.</dc:creator>
<dc:creator>Kritchevsky, S. B.</dc:creator>
<dc:creator>Lyday, R. G.</dc:creator>
<dc:creator>Miller, M. E.</dc:creator>
<dc:creator>Lockhart, S. N.</dc:creator>
<dc:creator>Rundle, M. M.</dc:creator>
<dc:creator>Hugenschmidt, C. E.</dc:creator>
<dc:creator>Burdette, J. H.</dc:creator>
<dc:creator>Shappell, H. M.</dc:creator>
<dc:creator>Chen, H.</dc:creator>
<dc:creator>Baker, L. D.</dc:creator>
<dc:creator>Neyland, B. R.</dc:creator>
<dc:creator>Holtzer, R.</dc:creator>
<dc:date>2024-11-07</dc:date>
<dc:identifier>doi:10.1101/2024.11.07.622257</dc:identifier>
<dc:title><![CDATA[Resting-state connectivity modifies the effects of amyloid on cognitive and physical function: evidence for network-based cognitive reserve]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-11-07</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.11.14.623614v1?rss=1">
<title>
<![CDATA[
TUDCA modulates drug bioavailability to regulate resistance to acute ER stress in Saccharomyces cerevisiae 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.11.14.623614v1?rss=1</link>
<description><![CDATA[
Cells counter accumulation of misfolded secretory proteins in the endoplasmic reticulum (ER) through activation of the Unfolded Protein Response (UPR). Small molecules termed chemical chaperones can promote protein folding to alleviate ER stress. The bile acid tauroursodeoxycholic acid (TUDCA), has been described as a chemical chaperone. While promising in models of protein folding diseases, TUDCAs mechanism of action remains unclear. Here, we found TUDCA can rescue growth of yeast treated with the ER stressor tunicamycin (Tm), even in the absence of a functional UPR. In contrast, TUDCA failed to rescue growth on other ER stressors. Nor could TUDCA attenuate chronic UPR associated with specific gene deletions or over-expression of a misfolded mutant secretory protein. Neither pretreatment with or delayed addition of TUDCA conferred protection against Tm. Importantly, attenuation of Tm-induced toxicity required TUDCAs critical micelle forming concentration, suggesting a mechanism where TUDCA directly sequesters drugs. Indeed, in several assays, TUDCA treated cells closely resembled cells treated with lower doses of Tm. In addition, we found TUDCA can inhibit dyes from labeling intracellular compartments. Thus, our study challenges the model of TUDCA as a chemical chaperone and suggests that TUDCA decreases drug bioavailability, allowing cells to adapt to ER stress.
]]></description>
<dc:creator>Chadwick, S. R.</dc:creator>
<dc:creator>Stack-Couture, S.</dc:creator>
<dc:creator>Berg, M. D.</dc:creator>
<dc:creator>Di Gregorio, S. E.</dc:creator>
<dc:creator>Lung, B.</dc:creator>
<dc:creator>Genereaux, J.</dc:creator>
<dc:creator>Moir, R. D.</dc:creator>
<dc:creator>Brandl, C. J.</dc:creator>
<dc:creator>Willis, I. M.</dc:creator>
<dc:creator>Snapp, E.</dc:creator>
<dc:creator>Lajoie, P.</dc:creator>
<dc:date>2024-11-15</dc:date>
<dc:identifier>doi:10.1101/2024.11.14.623614</dc:identifier>
<dc:title><![CDATA[TUDCA modulates drug bioavailability to regulate resistance to acute ER stress in Saccharomyces cerevisiae]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-11-15</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.11.18.624208v1?rss=1">
<title>
<![CDATA[
SuperWater: Predicting Water Molecule Positions on Protein Structures by Generative AI 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.11.18.624208v1?rss=1</link>
<description><![CDATA[
Water molecules play a significant role in maintaining protein structural stability and facilitating molecular interactions. Accurate prediction of water molecule positions around protein structures is essential for understanding their biological roles and has significant implications for protein engineering and drug discovery. Here, we introduce SuperWater, a novel generative AI framework that integrates a score-based diffusion model with equivariant graph neural networks to predict water molecule placements around proteins with high accuracy. SuperWater surpasses existing methods, delivering state-of-the-art performance in both crystal water coverage and prediction precision, achieving water localization within 0.3 {+/-} 0.06 {degrees}A of experimentally validated positions. We demonstrate the capabilities of SuperWater through case studies involving protein hydration, protein-ligand binding, and protein-protein binding sites. This framework can be adapted for various applications, including structural biology, binding site prediction, multi-body docking, and water-mediated drug design.
]]></description>
<dc:creator>Kuang, X.</dc:creator>
<dc:creator>su, z.</dc:creator>
<dc:creator>Liu, Y.</dc:creator>
<dc:creator>Lin, X.</dc:creator>
<dc:creator>Smith, J. S.</dc:creator>
<dc:creator>Derr, T.</dc:creator>
<dc:creator>Wu, Y.</dc:creator>
<dc:creator>Meiler, J.</dc:creator>
<dc:date>2024-11-20</dc:date>
<dc:identifier>doi:10.1101/2024.11.18.624208</dc:identifier>
<dc:title><![CDATA[SuperWater: Predicting Water Molecule Positions on Protein Structures by Generative AI]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-11-20</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.11.21.624638v1?rss=1">
<title>
<![CDATA[
Unravelling the molecular activation of the reparative cardiac fibroblasts after myocardial infarction 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.11.21.624638v1?rss=1</link>
<description><![CDATA[
Activated cardiac fibroblasts (Postn+ CFs) are responsible for the healing of the heart tissue after a myocardial infarction (MI). However, so far little is known about the moment that CFs are activated, and the genes involved in this process. This is especially relevant in the context of CF heterogeneity and their role in the response to the damage. In this context, we have described a subpopulation of activated CFs responsible for the healing scar and for preventing the rupture of the ventricle after the damage: the Reparative Cardiac Fibroblasts (RCFs). Our new data indicate that RCFs directly derived from activated CFs, and this transcriptional shift happens in a close window after damage. Interestingly, our results exhibited two different molecular dynamics that would give rise to this activation and, consequently, the appearance of definitive RCFs. Using bulk RNA-Seq, RNAScope and Spatial Transcriptomics, we anatomically localized some of the genes related to both dynamics in the infarcted heart and highlight the potential role of Aspn as a new marker of this transcriptional transition in mice, pigs and patients.
]]></description>
<dc:creator>Hernandez, S. C.</dc:creator>
<dc:creator>Ainciburu, M.</dc:creator>
<dc:creator>Sudupe, L.</dc:creator>
<dc:creator>Planell, N.</dc:creator>
<dc:creator>Vilas-Zornoza, A.</dc:creator>
<dc:creator>Lopez-Moreno, M.</dc:creator>
<dc:creator>Sarvide, S.</dc:creator>
<dc:creator>Diaz-Martinez, L.</dc:creator>
<dc:creator>Cobos-Figueroa, J.</dc:creator>
<dc:creator>San Martin-Uriz, P.</dc:creator>
<dc:creator>Muinos-Lopez, E.</dc:creator>
<dc:creator>Abizanda, G.</dc:creator>
<dc:creator>Ripalda-Cemborain, P.</dc:creator>
<dc:creator>Lagani, V.</dc:creator>
<dc:creator>Romero, J. P.</dc:creator>
<dc:creator>Tegner, J.</dc:creator>
<dc:creator>Perez-Pomares, J. M.</dc:creator>
<dc:creator>Wu, M.</dc:creator>
<dc:creator>Janssens, S.</dc:creator>
<dc:creator>Prosper, F.</dc:creator>
<dc:creator>Gomez-Cabrero, D.</dc:creator>
<dc:creator>Ruiz-Villalba, A.</dc:creator>
<dc:date>2024-11-21</dc:date>
<dc:identifier>doi:10.1101/2024.11.21.624638</dc:identifier>
<dc:title><![CDATA[Unravelling the molecular activation of the reparative cardiac fibroblasts after myocardial infarction]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-11-21</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.11.26.625211v1?rss=1">
<title>
<![CDATA[
Neural Mechanisms of Intersensory Switching: Evidence for Delayed Sensory Processing and Increased Cognitive Effort 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.11.26.625211v1?rss=1</link>
<description><![CDATA[
Intersensory switching (IS), the ability to shift attention between different sensory systems, is essential for cognitive flexibility, yet leads to slower responses compared to repeating the same sensory modality. The underlying neural mechanisms of IS remain largely unknown. In this study, high-density EEG was used to investigate these mechanisms in healthy adults (n=53) performing a speeded reaction time (RT) task involving visual and auditory stimuli. Trials were categorized as Repeat (same preceding modality) or Switch (different preceding modality). Switch trials showed slower RTs and delayed sensory responses (N1 and P2 components). Furthermore, across both Repeat and Switch trials, RT correlated with the latency of these neural responses. Additionally, lower alpha-band inter-trial phase coherence (ITPC) in primary sensory regions was noted for Switch compared to Repeat trials, suggesting reduced efficiency of sensory processing. Greater induced theta activity over fronto-central scalp regions in Switch trials suggested increased cognitive control demands, potentially involving the anterior cingulate cortex (ACC). These findings reveal that IS is characterized by delayed sensory processing and heightened cognitive load, supporting a model where prior stimulus primes the sensory cortex for faster processing in Repeat trials, while Switch trials demand more cognitive resources for adjustment. The similarity of effects across both auditory and visual sensory modalities suggests that IS effects represent core features of sensory processing, potentially reflecting a fundamental, modality-independent mechanism of attentional switching across sensory domains.
]]></description>
<dc:creator>Vanneau, T.</dc:creator>
<dc:creator>Quiquempoix, M.</dc:creator>
<dc:creator>Foxe, J. J.</dc:creator>
<dc:creator>Molholm, S.</dc:creator>
<dc:date>2024-11-26</dc:date>
<dc:identifier>doi:10.1101/2024.11.26.625211</dc:identifier>
<dc:title><![CDATA[Neural Mechanisms of Intersensory Switching: Evidence for Delayed Sensory Processing and Increased Cognitive Effort]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-11-26</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.11.26.625481v1?rss=1">
<title>
<![CDATA[
Uncovering the electrical synapse proteome in retinal neurons via in vivo proximity labeling 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.11.26.625481v1?rss=1</link>
<description><![CDATA[
AbstractElectrical synapses containing Connexin 36 (Cx36) represent the main means for direct electrical communication among neurons in the mammalian nervous system. However, little is known about the protein complexes that constitute these synapses. In the present study, we applied different BioID strategies to screen the interactomes of Connexin 36 and its zebrafish orthologue Cx35b in retinal neurons. For in vivo proximity labeling in mice, we took advantage of the Cx36-EGFP strain and expressed a GFP-nanobody-TurboID fusion construct selectively in AII amacrine cells. For in vivo BioID in zebrafish, we generated a transgenic line expressing a Cx35b-TurboID fusion under control of the Cx35b promoter. Both strategies allowed us to capture a plethora of molecules that were associated with electrical synapses and showed a high degree of evolutionary conservation in the proteomes of both species. Besides known interactors of Cx36 such as ZO-1 and ZO-2 we have identified more than 50 new proteins, such as scaffold proteins, adhesion molecules and regulators of the cytoskeleton. Moreover, we determined the subcellular localization of these proteins in mouse retina and tested potential binding interactions with Cx36. Amongst these new interactors, we identified signal induced proliferation associated 1 like 3 (Sipa1l3), a protein that has been implicated in cell junction formation and cell polarity, as a new scaffold of electrical synapses. Interestingly, Sipa1l3 was able to interact with ZO-1, ZO-2 and Cx36, suggesting a pivotal role in electrical synapse function. In summary, our study provides the first detailed view of the electrical synapse proteome in retinal neurons, which is likely to apply to electrical synapses elsewhere.
]]></description>
<dc:creator>Tetenborg, S.</dc:creator>
<dc:creator>Shihabeddin, E.</dc:creator>
<dc:creator>Kumar, E. O. A. M.</dc:creator>
<dc:creator>Sigulinsky, C.</dc:creator>
<dc:creator>Dedek, K.</dc:creator>
<dc:creator>Lin, Y.-P.</dc:creator>
<dc:creator>Echeverry, F.</dc:creator>
<dc:creator>Hoff, H.</dc:creator>
<dc:creator>Pereda, A.</dc:creator>
<dc:creator>Jones, B. W.</dc:creator>
<dc:creator>Ribelayga, C.</dc:creator>
<dc:creator>Ebnet, K.</dc:creator>
<dc:creator>Matsuura, K.</dc:creator>
<dc:creator>O'Brien, J.</dc:creator>
<dc:date>2024-11-26</dc:date>
<dc:identifier>doi:10.1101/2024.11.26.625481</dc:identifier>
<dc:title><![CDATA[Uncovering the electrical synapse proteome in retinal neurons via in vivo proximity labeling]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-11-26</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.11.25.625252v1?rss=1">
<title>
<![CDATA[
Platelet Factor 4 (PF4) Regulates Hematopoietic Stem Cell Aging 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.11.25.625252v1?rss=1</link>
<description><![CDATA[
Hematopoietic stem cells (HSCs) responsible for blood cell production and their bone marrow regulatory niches undergo age-related changes, impacting immune responses and predisposing individuals to hematologic malignancies. Here, we show that the age-related alterations of the megakaryocytic niche and associated downregulation of Platelet Factor 4 (PF4) are pivotal mechanisms driving HSC aging. PF4-deficient mice display several phenotypes reminiscent of accelerated HSC aging, including lymphopenia, increased myeloid output, and DNA damage, mimicking physiologically aged HSCs. Remarkably, recombinant PF4 administration restored old HSCs to youthful functional phenotypes characterized by improved cell polarity, reduced DNA damage, enhanced in vivo reconstitution capacity, and balanced lineage output. Mechanistically, we identified LDLR and CXCR3 as the HSC receptors transmitting the PF4 signal, with double knockout mice showing exacerbated HSC aging phenotypes similar to PF4-deficient mice. Furthermore, human HSCs across various age groups also respond to the youthful PF4 signaling, highlighting its potential for rejuvenating aged hematopoietic systems. These findings pave the way for targeted therapies aimed at reversing age-related HSC decline with potential implications in the prevention or improvement of the course of age-related hematopoietic diseases.

Key PointsO_LIAge-related attrition of the megakaryocytic niche and associated PF4 downregulation is a central mechanism in HSC aging.
C_LIO_LIPF4 supplementation, acting on LDLR and CXCR3 receptors, rejuvenates the function of aged HSCs.
C_LI
]]></description>
<dc:creator>Zhang, S.</dc:creator>
<dc:creator>Ayemoba, C. E.</dc:creator>
<dc:creator>Di Staulo, A. M.</dc:creator>
<dc:creator>Joves, K.</dc:creator>
<dc:creator>Patel, C. M.</dc:creator>
<dc:creator>Leung, E. H. W.</dc:creator>
<dc:creator>Ong, S.-G.</dc:creator>
<dc:creator>Nerlov, C.</dc:creator>
<dc:creator>Maryanovich, M.</dc:creator>
<dc:creator>Chronis, C.</dc:creator>
<dc:creator>Pinho, S.</dc:creator>
<dc:date>2024-11-27</dc:date>
<dc:identifier>doi:10.1101/2024.11.25.625252</dc:identifier>
<dc:title><![CDATA[Platelet Factor 4 (PF4) Regulates Hematopoietic Stem Cell Aging]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-11-27</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.11.29.624972v1?rss=1">
<title>
<![CDATA[
Two distinct durable human class-switched memory B cell populations are induced by vaccination and infection 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.11.29.624972v1?rss=1</link>
<description><![CDATA[
Memory lymphocytes are durable cells that persist in the absence of antigen, but few human B cell subsets have been characterized in terms of durability. The relative durability of eight non-overlapping human B cell sub-populations covering 100% of all human class-switched B cells was interrogated. Only two long-lived B cell populations persisted in the relative absence of antigen. In addition to canonical germinal center-derived switched-memory B cells with an IgD-CD27+ CXCR5+ phenotype, a second, non-canonical, but distinct memory population of IgD-CD27- CXCR5+ DN1 B cells was also durable, exhibited a unique TP63-linked transcriptional and anti-apoptotic signature, had low levels of somatic hypermutation, but was more clonally expanded than canonical switched-memory B cells. DN1 B cells likely evolved to preserve immunological breadth and may represent the human counterparts of rodent extrafollicular memory B cells that, unlike canonical memory B cells, can enter germinal centers and facilitate B cell and antibody evolution.

Graphical Abstract

O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=140 SRC="FIGDIR/small/624972v1_ufig1.gif" ALT="Figure 1">
View larger version (31K):
org.highwire.dtl.DTLVardef@169c77forg.highwire.dtl.DTLVardef@1a872f5org.highwire.dtl.DTLVardef@1360cforg.highwire.dtl.DTLVardef@38d7ed_HPS_FORMAT_FIGEXP  M_FIG C_FIG
]]></description>
<dc:creator>Perugino, C.</dc:creator>
<dc:creator>Liu, H.</dc:creator>
<dc:creator>Feldman, J.</dc:creator>
<dc:creator>Marbourg, J.</dc:creator>
<dc:creator>Guy, T.</dc:creator>
<dc:creator>Hui, A.</dc:creator>
<dc:creator>Ingram, N.</dc:creator>
<dc:creator>Liebaert, J.</dc:creator>
<dc:creator>Chaudhary, N.</dc:creator>
<dc:creator>Tao, W.</dc:creator>
<dc:creator>Jacob-Dolan, C.</dc:creator>
<dc:creator>Hauser, B. M.</dc:creator>
<dc:creator>Mian, Z.</dc:creator>
<dc:creator>Nathan, A.</dc:creator>
<dc:creator>Zhao, Z.</dc:creator>
<dc:creator>Kaseke, C.</dc:creator>
<dc:creator>Tano-Menka, R.</dc:creator>
<dc:creator>Getz, M.</dc:creator>
<dc:creator>Senjobe, F.</dc:creator>
<dc:creator>Berrios, C.</dc:creator>
<dc:creator>Ofoman, O.</dc:creator>
<dc:creator>Manickas-Hill, Z.</dc:creator>
<dc:creator>Wesemann, D.</dc:creator>
<dc:creator>Lemieux, J.</dc:creator>
<dc:creator>Goldberg, M. B.</dc:creator>
<dc:creator>Nundel, K.</dc:creator>
<dc:creator>Moormann, A. M.</dc:creator>
<dc:creator>Marshak-Rothstein, A.</dc:creator>
<dc:creator>Larocque, R.</dc:creator>
<dc:creator>Ryan, E.</dc:creator>
<dc:creator>Iafrate, A. J.</dc:creator>
<dc:creator>Lingwood, D.</dc:creator>
<dc:creator>Gaiha, G.</dc:creator>
<dc:creator>Charles, R.</dc:creator>
<dc:creator>Balazs, A. B.</dc:creator>
<dc:creator>Pandit, A.</dc:creator>
<dc:creator>Naranbhai, V.</dc:creator>
<dc:creator>Schmidt, A.</dc:creator>
<dc:creator>Pillai, S.</dc:creator>
<dc:date>2024-12-04</dc:date>
<dc:identifier>doi:10.1101/2024.11.29.624972</dc:identifier>
<dc:title><![CDATA[Two distinct durable human class-switched memory B cell populations are induced by vaccination and infection]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-12-04</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.12.10.627181v1?rss=1">
<title>
<![CDATA[
Inhibition of DKK-1 by WAY262611 Inhibits Osteosarcoma Metastasis 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.12.10.627181v1?rss=1</link>
<description><![CDATA[
Osteosarcoma (OS) is the most common primary malignant bone tumor in childhood. Patients who present with metastatic disease at diagnosis or relapse have a very poor prognosis, and this has not changed over the past four decades. The Wnt signaling pathway plays a role in regulating osteogenesis and is implicated in OS pathogenesis. DKK-1 inhibits the canonical Wnt signaling pathway, causing inhibition of osteoblast differentiation and disordered bone repair. Our lab previously demonstrated that a monoclonal antibody against DKK-1 prevented metastatic disease in a mouse model. This study expands upon those findings by demonstrating similar results with a small molecule inhibitor of DKK-1, WAY262611, both in vitro and in vivo. WAY262611 was evaluated in vitro on osteosarcoma cell lines, including proliferation, caspase activation, cell cycle analysis, and signaling pathway activation. We utilized our orthotopic implantation-amputation model of osteosarcoma metastasis in vivo to determine the impact of WAY262611 on primary tumor progression and metastatic outgrowth of disseminated tumor cells. Differentiation status was determined using single cell RNA sequencing. We show here that WAY262611 activates canonical Wnt signaling, enhances nuclear localization and transcriptional activity of beta-catenin, and slows proliferation of OS cell lines. We also show that WAY262611 induces osteoblastic differentiation of an OS patient-derived xenograft in vivo, as well as inhibiting metastasis. This work credentials DKK-1 as a therapeutic target in OS, allowing for manipulation of the Wnt signaling pathway and providing preclinical justification for the development of new biologics for prevention of osteosarcoma metastasis.
]]></description>
<dc:creator>Tal, A.</dc:creator>
<dc:creator>Gunawardana-Zeigler, S.</dc:creator>
<dc:creator>Peng, D.</dc:creator>
<dc:creator>Tan, Y.</dc:creator>
<dc:creator>Perez, N. M.</dc:creator>
<dc:creator>Offenbacher, R.</dc:creator>
<dc:creator>Kastner, L.</dc:creator>
<dc:creator>Ciero, P.</dc:creator>
<dc:creator>Randolph, M. E.</dc:creator>
<dc:creator>Gong, Y.</dc:creator>
<dc:creator>Deng, H.-W.</dc:creator>
<dc:creator>Cahan, P.</dc:creator>
<dc:creator>Loeb, D. M.</dc:creator>
<dc:date>2024-12-11</dc:date>
<dc:identifier>doi:10.1101/2024.12.10.627181</dc:identifier>
<dc:title><![CDATA[Inhibition of DKK-1 by WAY262611 Inhibits Osteosarcoma Metastasis]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-12-11</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.12.12.627852v1?rss=1">
<title>
<![CDATA[
CoREST Complex Inhibition Alters RNA Splicing to Promote Neoantigen Expression and Enhance Tumor Immunity 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.12.12.627852v1?rss=1</link>
<description><![CDATA[
ABSTRACTEpigenetic complexes tightly regulate gene expression and colocalize with RNA splicing machinery; however, the consequences of these interactions are uncertain. Here, we identify unique interactions of the CoREST repressor complex with RNA splicing factors and their functional consequences in tumorigenesis. Using mass spectrometry, in vivo binding assays, and cryo-EM we find that CoREST complex-splicing factor interactions are direct and perturbed by the CoREST complex inhibitor, corin, leading to extensive changes in RNA splicing in melanoma and other malignancies. Using predictive machine learning models and MHC IP-MS, we identify thousands of corin-induced neopeptides derived from unannotated splice sites which generate immunogenic splice-neoantigens. Furthermore, corin reactivates the response to immune checkpoint blockade and promotes dramatic expansion of cytotoxic T cells in an immune cold melanoma model. CoREST complex inhibition thus represents a unique therapeutic opportunity in cancer which creates tumor-associated neoantigens that enhance the immunogenicity of current therapeutics.

Statement of SignificanceWe identify a novel role of the CoREST transcriptional repressor complex in regulating pre-mRNA splicing and find that the small molecule inhibitor, corin, promotes alternative splicing events in cancer leading to neoantigen expression and T cell-mediated immunity. This represents a potential approach to promote immunoreactive neoantigen expression in immune-cold tumors.
]]></description>
<dc:creator>Fisher, R. J.</dc:creator>
<dc:creator>Park, K.</dc:creator>
<dc:creator>Lee, K.</dc:creator>
<dc:creator>Pinjusic, K.</dc:creator>
<dc:creator>Vanasse, A.</dc:creator>
<dc:creator>Ennis, C. S.</dc:creator>
<dc:creator>Ficcaro, S.</dc:creator>
<dc:creator>Marto, J.</dc:creator>
<dc:creator>Stransky, S.</dc:creator>
<dc:creator>Duke-Cohan, J.</dc:creator>
<dc:creator>Geethadevi, A.</dc:creator>
<dc:creator>Raabe, E. H.</dc:creator>
<dc:creator>Sidoli, S.</dc:creator>
<dc:creator>Hicks, C. W.</dc:creator>
<dc:creator>Keskin, D.</dc:creator>
<dc:creator>Wu, C. J.</dc:creator>
<dc:creator>Cole, P. A.</dc:creator>
<dc:creator>Alani, R. M.</dc:creator>
<dc:date>2024-12-12</dc:date>
<dc:identifier>doi:10.1101/2024.12.12.627852</dc:identifier>
<dc:title><![CDATA[CoREST Complex Inhibition Alters RNA Splicing to Promote Neoantigen Expression and Enhance Tumor Immunity]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-12-12</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.12.16.628685v1?rss=1">
<title>
<![CDATA[
Immuno-moodulin is Differentially Expressed in T Cells and Plasma in Obsessive-Compulsive Disorder Patients 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.12.16.628685v1?rss=1</link>
<description><![CDATA[
Immuno-moodulin (Imood), a recently discovered protein expressed in T cells, is associated with anxiety-like behavior in mice. However, its mechanism of action in modulating neuroimmune interactions remains unclear. To investigate this problem, we characterized Imood in human blood and immune cells using neutralizing monoclonal antibodies, revealing its nature as an intrinsically disordered protein (IDP) with unique expression patterns. Our findings indicate that Imood is predominantly expressed intracellularly in peripheral blood mononuclear cells (PBMCs), particularly T lymphocytes, but is absent in polymorphonuclear cells. Upon T-cell activation, Imood exhibits distinct mobilization patterns with increased surface expression. Bioinformatics analysis identified a strong propensity for oligomerization and liquid-liquid phase separation. We also found that T cells from patients with Obsessive-Compulsive-Disorder (OCD) displayed significantly elevated surface Imood expression compared to healthy controls, as well as an altered level of Imood polymerization in the plasma. Taken together, these results elucidate the expression patterns and structural properties of Imood in human immune cells, which open new avenues for OCD diagnostics, and prompt further study for understanding the aetiology of OCD and related disorders.
]]></description>
<dc:creator>Blacksell, I. A.</dc:creator>
<dc:creator>Vismara, M.</dc:creator>
<dc:creator>Lim, C. M.</dc:creator>
<dc:creator>Dell'Osso, B.</dc:creator>
<dc:creator>Pallanti, S.</dc:creator>
<dc:creator>Hollander, E.</dc:creator>
<dc:creator>Vendruscolo, M.</dc:creator>
<dc:creator>D'Addario, C.</dc:creator>
<dc:creator>Cooper, D.</dc:creator>
<dc:creator>D'Acquisto, F.</dc:creator>
<dc:date>2024-12-20</dc:date>
<dc:identifier>doi:10.1101/2024.12.16.628685</dc:identifier>
<dc:title><![CDATA[Immuno-moodulin is Differentially Expressed in T Cells and Plasma in Obsessive-Compulsive Disorder Patients]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-12-20</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.12.19.627509v1?rss=1">
<title>
<![CDATA[
Image Processing in the Acute to Chronic Pain Signatures (A2CPS) Project 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.12.19.627509v1?rss=1</link>
<description><![CDATA[
The Acute to Chronic Pain Signatures (A2CPS) project is a large-scale, multi-site initiative aimed at identifying biomarkers and biosignatures that predict the transition from acute to chronic pain. The project is collecting multimodal, longitudinal data from over 2,500 individuals at risk for developing chronic pain after surgery. Here we describe the neuroimaging component of A2CPS, including the acquisition protocols, processing pipelines, and contents of the initial data release. The imaging protocol includes structural, diffusion, resting-state and task-based functional magnetic resonance imaging (MRI) data. Data are collected across multiple clinical sites using different scanner manufacturers, with attention to protocol harmonization and quality control. The processing pipeline integrates several established neuroimaging tools to extract potential biomarkers, including measures of brain structure, connectivity, and pain-related neural signatures. The first data release includes pre-surgical imaging data for 595 participants, with high quality ratings across modalities (98.7% of sMRI, 99.8% of dMRI, and 94.6% of fMRI images were rated as acceptable or better). Initial analyses demonstrate expected relationships between brain-derived measures and clinical variables, such as associations between brain age and psychological factors. This dataset represents a valuable resource for both pain research and neuroimaging methods development, with future releases planned to include additional participants and expanded analysis pipelines and processed data derivatives.
]]></description>
<dc:creator>Sadil, P.</dc:creator>
<dc:creator>Arfanakis, K.</dc:creator>
<dc:creator>Bhuiyan, E. H.</dc:creator>
<dc:creator>Caffo, B.</dc:creator>
<dc:creator>Calhoun, V. D.</dc:creator>
<dc:creator>Clauw, D. J.</dc:creator>
<dc:creator>DeLano, M. C.</dc:creator>
<dc:creator>Ford, J. C.</dc:creator>
<dc:creator>Gattu, R.</dc:creator>
<dc:creator>Guo, X.</dc:creator>
<dc:creator>Harris, R. E.</dc:creator>
<dc:creator>Ichesco, E.</dc:creator>
<dc:creator>Johnson, M. A.</dc:creator>
<dc:creator>Jung, H.</dc:creator>
<dc:creator>Kahn, A. B.</dc:creator>
<dc:creator>Kaplan, C. M.</dc:creator>
<dc:creator>Leloudas, N.</dc:creator>
<dc:creator>Lindquist, M. A.</dc:creator>
<dc:creator>Luo, Q.</dc:creator>
<dc:creator>Mulderink, T. A.</dc:creator>
<dc:creator>Peltier, S. J.</dc:creator>
<dc:creator>Prasad, P. V.</dc:creator>
<dc:creator>Sica, C.</dc:creator>
<dc:creator>Urrutia, J.</dc:creator>
<dc:creator>Vance, C. G.</dc:creator>
<dc:creator>Wager, T. D.</dc:creator>
<dc:creator>Xuan, Y.</dc:creator>
<dc:creator>Zhou, X. J.</dc:creator>
<dc:creator>Zhou, Y.</dc:creator>
<dc:creator>Shu, D. C.</dc:creator>
<dc:creator>The Acute to Chronic Pain Signatures Consortium,</dc:creator>
<dc:date>2024-12-20</dc:date>
<dc:identifier>doi:10.1101/2024.12.19.627509</dc:identifier>
<dc:title><![CDATA[Image Processing in the Acute to Chronic Pain Signatures (A2CPS) Project]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-12-20</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.12.20.629603v1?rss=1">
<title>
<![CDATA[
Mobilization of nuclear antiviral factors by Exportin XPO1 via the actin network inhibits RNA virus replication 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.12.20.629603v1?rss=1</link>
<description><![CDATA[
The intricate interplay between +RNA viruses and their hosts involves the exploitation of host resources to build virus-induced membranous replication organelles (VROs) in cytosol of infected cells. Previous genome- and proteome-wide approaches have identified numerous nuclear proteins, including restriction factors that affect replication of tomato bushy stunt virus (TBSV). However, it is currently unknown how cells mobilize nuclear antiviral proteins and how tombusviruses manipulate nuclear-cytoplasmic communication. The authors discovered that XPO1/CRM1 exportin plays a central role in TBSV replication in plants. Based on knockdown, chemical inhibition, transient expression and in vitro experiments, we show that XPO1 acts as a cellular restriction factor against TBSV. XPO1 is recruited by TBSV p33 replication protein into the cytosolic VROs via direct interaction. Blocking nucleocytoplasmic transport function of XPO1 inhibits delivery of several nuclear antiviral proteins into VROs resulting in dampened antiviral effects. The co-opted actin network is critical for XPO1 to deliver nuclear proteins to VROs for antiviral activities. We show that XPO1 and XPO1-delivered restriction factors accumulate in vir-condensates associated with membranous VROs. Altogether, the emerging theme on the role of vir-condensates is complex: we propose that vir-condensate serves as a central battleground between virus and the host for supremacy in controlling virus infection. It seems that the balance between co-opted pro-viral and antiviral factors within vir-condensates associated with membranous VROs could be a major determining factor of virus replication and host susceptibility. We conclude that XPO1 and nuclear antiviral cargos are key players in nuclear-cytoplasmic communication during cytosolic +RNA virus replication.

SignificanceTomato bushy stunt virus (TBSV), similar to other (+)RNA viruses, replicates in the cytosol and exploits organellar membrane surfaces to build viral replication organelles (VROs) that represent the sites of virus replication. The authors discovered that XPO1 exportin nuclear shuttle protein inhibited TBSV replication in plants. The conserved XPO1 is a central protein interaction nod, which propelled nucleocytoplasmic transport of several viral restriction factors into the cytosolic VROs that restricted tombusviruses replication. The delivered virus restriction factors provided inhibitory functions within virus-induced condensates associated with membranous VROs. The authors propose that the VRO-associated condensate serves as a central battleground between virus and the host for supremacy in controlling virus infection. Altogether, XPO1 is a critical protein interaction hub with major implications in viral replication. The authors conclude that XPO1 and its nuclear antiviral cargos are key players in nuclear-cytoplasmic communication during cytosolic (+)RNA virus replication.
]]></description>
<dc:creator>Sun, B.</dc:creator>
<dc:creator>Wu, C.-Y.</dc:creator>
<dc:creator>Gonzalez, P. A.</dc:creator>
<dc:creator>Nagy, P. D.</dc:creator>
<dc:date>2024-12-20</dc:date>
<dc:identifier>doi:10.1101/2024.12.20.629603</dc:identifier>
<dc:title><![CDATA[Mobilization of nuclear antiviral factors by Exportin XPO1 via the actin network inhibits RNA virus replication]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-12-20</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.12.30.630700v1?rss=1">
<title>
<![CDATA[
Rapid clonal selection within early hematopoietic cell compartments presages outcome to ivosidenib combination therapy 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.12.30.630700v1?rss=1</link>
<description><![CDATA[
Acquired resistance to targeted non-intensive therapies is common in myeloid malignancies. Yet, key questions remain as to how rapidly resistant clones are selected by treatment and in which hematopoietic cell compartments clonal selection occurs. To address this gap, we studied clonal responses to ivosidenib + venetoclax {+/-} azacitidine combination therapy in 8 patients with IDH1-mutant myeloid malignancy. Whilst all 8 patients initially responded to treatment, 6 relapsed and 2 remained in sustained remission for > 4 years. To study longitudinal clonal dynamics through hematopoietic differentiation, we performed high-sensitivity single-cell genotyping in index-sorted sequential patient samples. In all patients who relapsed, therapy-resistant clones were selected rapidly, within 1-3 treatment cycles, at times when hematopoiesis was still largely sustained by either normal or pre-leukemic cells. Selection of therapy-resistant clones preceded overt treatment failure by months or even years. Relapse was associated either with clones harboring newly-detected myeloid driver mutations or expansion of minor pre-existing clones that had reduced fitness prior to treatment. In both cases, resistant clones were selected within immature cell populations previously shown to contain leukemic stem cell (LSC) potential, preceding malignant expansion of these compartments by immunophenotyping. In contrast, in both patients remaining in remission, leukemic clones were eradicated and rapidly replaced by clonal and wild-type hematopoiesis. These observations suggest that, in patients treated with non-intensive ivosidenib combination therapy, rapid clonal selection occurs in populations with LSC potential, where failure to eliminate either genetically evolved or persistent leukemic clones ultimately leads to relapse.

Key points- Rapid selection of leukemic clones occurs within small populations with LSC potential, months or years prior to relapse.

- Rapid eradication of leukemic clones leads to sustained remission in the context of ivosidenib combination therapy.
]]></description>
<dc:creator>Turkalj, S.</dc:creator>
<dc:creator>Stoilova, B.</dc:creator>
<dc:creator>Groom, A. J.</dc:creator>
<dc:creator>Radtke, F. A.</dc:creator>
<dc:creator>Mecklenbrauck, R.</dc:creator>
<dc:creator>Jakobsen, N. A.</dc:creator>
<dc:creator>Lachowiez, C. A.</dc:creator>
<dc:creator>Metzner, M.</dc:creator>
<dc:creator>Usukhbayar, B.</dc:creator>
<dc:creator>Salazar, M. A.</dc:creator>
<dc:creator>Zeng, Z.</dc:creator>
<dc:creator>Loghavi, S.</dc:creator>
<dc:creator>Marvin-Peek, J.</dc:creator>
<dc:creator>Koerber, V.</dc:creator>
<dc:creator>Ravandi, F.</dc:creator>
<dc:creator>Issa, G.</dc:creator>
<dc:creator>Kadia, T.</dc:creator>
<dc:creator>Symeonido, V.</dc:creator>
<dc:creator>de Groot, A. P.</dc:creator>
<dc:creator>Kantarjian, H.</dc:creator>
<dc:creator>Takahashi, K.</dc:creator>
<dc:creator>Konopleva, M.</dc:creator>
<dc:creator>DiNardo, C. D.</dc:creator>
<dc:creator>Vyas, P.</dc:creator>
<dc:date>2024-12-31</dc:date>
<dc:identifier>doi:10.1101/2024.12.30.630700</dc:identifier>
<dc:title><![CDATA[Rapid clonal selection within early hematopoietic cell compartments presages outcome to ivosidenib combination therapy]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-12-31</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2024.12.30.630781v1?rss=1">
<title>
<![CDATA[
Analysis of mouse lens morphological and proteomic abnormalities following depletion of βB3-crystallin 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2024.12.30.630781v1?rss=1</link>
<description><![CDATA[
Crystallin proteins serve as both essential structural and as well as protective components of the ocular lens and are required for the transparency and light refraction properties of the organ. The mouse lens crystallin proteome is represented by A-, B-, {beta}A1-, {beta}A2-, {beta}A3-, {beta}A4-, {beta}B1-, {beta}B2-, {beta}B3-, {gamma}A-, {gamma}B-, {gamma}C-, {gamma}D-, {gamma}E, {gamma}F-, {gamma}N-, and {gamma}S-crystallin proteins encoded by 16 genes. Their mutations are responsible for lens opacification and early onset cataract formation. While many cataract-causing missense and nonsense mutations are known for these proteins, including the human CRYBB3 gene, the mammalian loss-of function model of the Crybb3 gene remains to be established. Herein, we generated the first mouse model via deletion of the Crybb3 promoter that abolished expression of the {beta}B3-crystallin. Histological analysis of lens morphology using newborn {beta}B3-crystallin-deficient lenses revealed disrupted lens morphology with early-onset phenotypic variability. In-depth lens proteomics at four time points (newborn, 3-weeks, 6-weeks, and 3-months) showed both down- and up-regulation of various proteins, with the highest divergence from control mice observed in 3-months lenses. Apart from the {beta}B3-crystallin, another protein Smarcc1/Baf155 was down-regulated in all four samples. In addition, downregulation of Hspe1, Pdlim1, Ast/Got, Lsm7, Ddx23, and Acad11 was found in three time points. Finally, we show that the {beta}B3-crystallin promoter region, which contains multiple binding sites for the transcription factors AP-2, c-Jun, c-Maf, Etv5, and Pax6 is activated by FGF2 in primary lens cell culture experiments. Together, these studies establish the mouse Crybb3 loss-of-function model and its disrupted crystallin and non-crystallin proteomes.
]]></description>
<dc:creator>Rayee, D.</dc:creator>
<dc:creator>Wilmarth, P. A.</dc:creator>
<dc:creator>VanSlyke, J. K.</dc:creator>
<dc:creator>Zientek, K.</dc:creator>
<dc:creator>Reddy, A. P.</dc:creator>
<dc:creator>Musil, L. S.</dc:creator>
<dc:creator>David, L. L.</dc:creator>
<dc:creator>Cvekl, A.</dc:creator>
<dc:date>2024-12-31</dc:date>
<dc:identifier>doi:10.1101/2024.12.30.630781</dc:identifier>
<dc:title><![CDATA[Analysis of mouse lens morphological and proteomic abnormalities following depletion of βB3-crystallin]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2024-12-31</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.01.03.631181v1?rss=1">
<title>
<![CDATA[
Extracellular vesicles from diverse fungal pathogens induce species-specific and endocytosis-dependent immunomodulation 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.01.03.631181v1?rss=1</link>
<description><![CDATA[
Microbial pathogens generate extracellular vesicles (EVs) for intercellular communication and quorum sensing. Microbial EVs also induce inflammatory pathways within host innate immune cells. We previously demonstrated that EVs secreted by Candida albicans trigger type I interferon signaling in host cells specifically via the cGAS-STING innate immune signaling pathway. Here, we show that despite sharing similar properties of morphology and internal DNA content, the interactions between EVs and the innate immune system differ according to the parental fungal species. EVs secreted by C. albicans, Saccharomyces cerevisiae, Cryptococcus neoformans, and Aspergillus fumigatus are endocytosed at different rates by murine macrophages triggering varied cytokine responses, innate immune signaling, and subsequent immune cell recruitment. Notably, cell wall constituents that decorate C. neoformans and A. fumigatus EVs inhibit efficient internalization by macrophages and dampen innate immune activation. Our data uncover the transcriptional and functional consequences of the internalization of diverse fungal EVs by immune cells and reveal novel insights into the early innate immune response to distinct clinically significant fungal pathogens.
]]></description>
<dc:creator>Kwaku, G.</dc:creator>
<dc:creator>Simaku, P.</dc:creator>
<dc:creator>Jensen, K. N.</dc:creator>
<dc:creator>Floyd, D.</dc:creator>
<dc:creator>Saelens, J.</dc:creator>
<dc:creator>Reardon, C.</dc:creator>
<dc:creator>Ward, R.</dc:creator>
<dc:creator>Basham, K.</dc:creator>
<dc:creator>Hepworth, O.</dc:creator>
<dc:creator>Vyas, T.</dc:creator>
<dc:creator>Zamith Miranda, D.</dc:creator>
<dc:creator>Nosanchuk, J.</dc:creator>
<dc:creator>Vyas, J.</dc:creator>
<dc:creator>Brown Harding, H.</dc:creator>
<dc:date>2025-01-03</dc:date>
<dc:identifier>doi:10.1101/2025.01.03.631181</dc:identifier>
<dc:title><![CDATA[Extracellular vesicles from diverse fungal pathogens induce species-specific and endocytosis-dependent immunomodulation]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-01-03</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.01.05.631374v1?rss=1">
<title>
<![CDATA[
Cycling Molecular Assemblies for Selective Cancer Cell Golgi Disruption 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.01.05.631374v1?rss=1</link>
<description><![CDATA[
The Golgi apparatus is a critical organelle responsible for intracellular trafficking and signaling, orchestrating essential processes such as protein and lipid sorting1-5. Dysregulation of its function has been implicated in various pathologies, including obesity, diabetes, and cancer, highlighting its importance as a potential therapeutic target. Despite this, the development of tools to selectively target the Golgi in specific cell types remain a significant unmet challenge in imaging and drug discovery. Golgi-specific enzyme activities, such as those mediated by protein acyltransferases and thioesterases6, offer an untapped opportunity to develop subcellularly localized therapeutics. Current approaches predominantly rely on direct protein binding but lack the necessary cell selectivity7, underscoring the unmet need for innovative strategies to selectively disrupt Golgi function in cancer cells. Here, we report the development of cycling molecular assemblies (CyMA), a novel class of small peptide derivatives (e.g., dipeptides), which exploit the unique enzymatic environment of the Golgi to establish futile cycles of reversible S-acylation. These assemblies selectively accumulate in cancer cell Golgi, interfering with protein S-acylation cycles and disrupting organelle homeostasis. CyMA impair key Golgi functions, including protein trafficking, glycosylation, and secretion, while demonstrating selective sparing hepatocytes and immune cells such as M1 macrophages. This selective activity represents a paradigm shift, utilizing an enzyme switch and leveraging intracellular environment rather than direct protein binding. Unlike conventional approaches, CyMA reduce tumor growth, drug resistance, and metastasis by pleiotropically disrupting Golgi related functions. By demonstrating the potential of futile cycles as a therapeutic strategy8, this study introduces a generalizable method for targeting organelle-specific enzyme activities. These findings not only underscore the therapeutic potential of CyMA in cancer but also pave the way for future applications in other Golgi-associated diseases.
]]></description>
<dc:creator>Tan, W.</dc:creator>
<dc:creator>Zhang, Q.</dc:creator>
<dc:creator>Liu, Z.</dc:creator>
<dc:creator>Qiu, K.</dc:creator>
<dc:creator>Divyanshu, M.</dc:creator>
<dc:creator>Gerton, T.</dc:creator>
<dc:creator>Copperman, N.</dc:creator>
<dc:creator>Xia, C.</dc:creator>
<dc:creator>Lin, C.</dc:creator>
<dc:creator>Lau, W.</dc:creator>
<dc:creator>Lee, M.</dc:creator>
<dc:creator>Ashton-Rickardt, I.</dc:creator>
<dc:creator>hong, P.</dc:creator>
<dc:creator>Dinulescu, D.</dc:creator>
<dc:creator>Hsieh, J.-T.</dc:creator>
<dc:creator>Loeb, D.</dc:creator>
<dc:creator>Drapkin, R.</dc:creator>
<dc:creator>Diao, J.</dc:creator>
<dc:creator>Lu, L.</dc:creator>
<dc:creator>Xu, B.</dc:creator>
<dc:date>2025-01-05</dc:date>
<dc:identifier>doi:10.1101/2025.01.05.631374</dc:identifier>
<dc:title><![CDATA[Cycling Molecular Assemblies for Selective Cancer Cell Golgi Disruption]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-01-05</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.01.06.631600v1?rss=1">
<title>
<![CDATA[
Polymerase Eta Recruits FANCD2 to Common Fragile Sites to Maintain Genome Stability 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.01.06.631600v1?rss=1</link>
<description><![CDATA[
The replicative polymerase delta is inefficient copying repetitive DNA sequences. Error-prone translesion polymerases have been shown to switch with high-fidelity replicative polymerases to help navigate repetitive DNA. We and others have demonstrated the importance of one such translesion polymerase, polymerase Eta (pol eta), in facilitating replication at genomic regions called common fragile sites (CFS), which are difficult-to-replicate genomic regions that are hypersensitive to replication stress. However, the mechanistic basis for pol etas role in facilitating DNA replication at CFS and(or) at other genomic regions is currently unclear. Importantly, the functional importance of three non-catalytic domains of pol eta, the Ubiquitin-binding Zinc finger (UBZ), PCNA interacting protein (PIP) domain, and the F1 domain which mediates its switch with replicative DNA polymerases in mediating replication stress, especially at CFS loci is not clear. Here, we report that the PIP and UBZ domains of Pol Eta are both critical for its role in mediating cellular replication stress, especially at CFS. The absence of either domain induced elevated replication stress, replication stalling and DNA damage accumulation genome wide. This effect was even more pronounced at CFS loci leading to the accumulation of under replication DNA in G2/M. Importantly, while the inactivation of the UBZ domain resulted in a robust FANCD2 monoubiquitylation (a prominent marker of FANCD2 activation), FANCD2 recruitment genome wide was significantly impacted, especially at CFSs such as FRA16D. These S-phase phenotypes result in ssDNA gap formation and the persistence of under-replicated genomic regions upon transition to G2/M. While post-replicative gap filing/ repair by Mitotic DNA synthesis is activated in the mutants, it only effectively resolves UFBs in the F1* cells. The PIP*, UBZ* and pol eta-/- cells unfortunately manifest excessive toxic cytosolic DNA that instigates a strong innate immune response. These results collectively show that translesion polymerase Eta functions in a common pathway with FANCD2 to prevent replication perturbation and instability at CFS loci.
]]></description>
<dc:creator>Niljikar, M.</dc:creator>
<dc:creator>Barreto-Galvez, A.</dc:creator>
<dc:creator>Patel, S.</dc:creator>
<dc:creator>Gagliardi, J. E.</dc:creator>
<dc:creator>Kumar, V.</dc:creator>
<dc:creator>Pradeep, A.</dc:creator>
<dc:creator>Juwarwala, A.</dc:creator>
<dc:creator>Gerhardt, J.</dc:creator>
<dc:creator>Chang, Y.</dc:creator>
<dc:creator>Montagna, C.</dc:creator>
<dc:creator>Madireddy, A.</dc:creator>
<dc:date>2025-01-08</dc:date>
<dc:identifier>doi:10.1101/2025.01.06.631600</dc:identifier>
<dc:title><![CDATA[Polymerase Eta Recruits FANCD2 to Common Fragile Sites to Maintain Genome Stability]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-01-08</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.01.10.632466v1?rss=1">
<title>
<![CDATA[
Identification and classification of abundant RNA-binding proteins in the mouse lens and interactions of Carhsp1, Igf2bp1/ZBP1, and Ybx1 with crystallin and β-actin mRNAs 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.01.10.632466v1?rss=1</link>
<description><![CDATA[
RNA-binding proteins (RBPs) are critical regulators of mRNAs controlling all processes such as RNA transcription, transport, localization, translation, mRNA:ncRNA interactions, and decay. Cellular differentiation is driven by tissue-specific and/or tissue-preferred expression of proteins needed for the optimal function of mature cells, tissues and organs. Lens fiber cell differentiation is marked by high levels of expression of crystallin genes encoding critical proteins for lens transparency and light refraction. Herein we performed proteomic and transcriptomic analyses of RBPs in differentiating mouse lenses to identify the most abundant RBPs and establish dynamic changes of their expression in differentiating lens. Expression analyses include highly abundant RBPs, including Carhsp1, Igf2bp1/ZBP1, Ybx1, Pabpc1, Ddx39, and Rbm38. Binding sites of Carhsp1, Ybx1, and Igf2bp1/ZBP1 were predicted in various crystallin and {beta}-actin mRNAs. Immunoprecipitations using antibodies against Carhsp1, Igf2bp1/ZBP1, and Ybx1 confirmed their interactions with A-, B-, and {gamma}A-crystallin mRNAs. A combination of single molecule RNA FISH (smFISH) and immunofluorescence was used to probe in vivo interactions of these RBPs with A-, B-crystallin, and {beta}-actin mRNAs in cytoplasm and nucleoplasm of cultured mouse lens epithelial cells. Together, these results open new avenues to perform comprehensive genetic, cell, and molecular biology studies of individual RBPs in the lens.
]]></description>
<dc:creator>Rayee, D.</dc:creator>
<dc:creator>Hwang, D.-W.</dc:creator>
<dc:creator>Chang, W. K.</dc:creator>
<dc:creator>Karp, I. N.</dc:creator>
<dc:creator>Zhao, Y.</dc:creator>
<dc:creator>Bowman, T. V.</dc:creator>
<dc:creator>Lachke, S.</dc:creator>
<dc:creator>Singer, R.</dc:creator>
<dc:creator>Eliscovich, C.</dc:creator>
<dc:creator>Cvekl, A.</dc:creator>
<dc:date>2025-01-11</dc:date>
<dc:identifier>doi:10.1101/2025.01.10.632466</dc:identifier>
<dc:title><![CDATA[Identification and classification of abundant RNA-binding proteins in the mouse lens and interactions of Carhsp1, Igf2bp1/ZBP1, and Ybx1 with crystallin and β-actin mRNAs]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-01-11</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.01.08.631945v1?rss=1">
<title>
<![CDATA[
SELECTION OF ANTI-NUCLEAR ANTIGEN (ANA) REACTIVE B CELLS IN SYSTEMIC LUPUS ERYTHEMATOSUS. 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.01.08.631945v1?rss=1</link>
<description><![CDATA[
ObjectiveAutoreactive B cells that recognize nuclear antigens are normally present in healthy individuals and patients with systemic lupus erythematosus (SLE), yet their activation and the production of IgG autoantibodies is a hallmark of SLE. The selection process and regulation of these cells in patients with SLE has not been completely understood. To gain insights into tolerance checkpoints and the developmental trajectories of autoreactive clones, we studied the BCR sequences from thousands of anti-nuclear antigen binding (ANA)+ and ANA-B cells from patients with SLE.

MethodsFrom a cohort of 13 patients with SLE, we identified and isolated ANA+ and ANA-B cells by flow cytometry using a method based on their binding to nuclear extracts. We sequenced B cell receptor (BCR) heavy chain variable regions and investigated the features of the IgH repertoire of ANA+ and ANA-B cells from naive, memory and age-associated B cells (ABCs), and from total plasmablasts.

ResultsThe frequency of ANA+ B cells was similar in ABCs and naive B cells and higher in both than in memory B cells. We observed preferential usage of some VH (IGHV1-18, IGHV3-21, IGHV3-23|3-23D, IGHV4-34, IGHV4-39 and IGHV4-59) and VJ genes (IGHJ4 and IGHJ6) in B cells from these patients. ANA+ naive and ANA+ ABCs used different gene segments and have longer CDR3 sequences than ANA+ memory B cells and ANA-subsets. ANA+ ABCs and memory B cells have a lower frequency of somatic hypermutation (SHM) and less activation induced deaminase (AID) targeting to WRC hotspots compared with their ANA-counterparts. Patients with active disease have a lower frequency of SHM in ANA+ ABCs and memory B cells and in ANA-ABCs.

ConclusionCompared to memory B cells, ABCs are enriched in autoreactivity. Our results suggest that there is an immune checkpoint that restricts the differentiation of ANA+ naive B cells into memory B cells and that ANA+ ABCs originate from ANA+ naive B cells. Lower frequencies of SHM in antigen experienced ANA+ B cells, and particularly ANA+ ABCs, suggest that these cells might be generated through an extrafollicular (EF) pathway, and that in patients with active SLE there is more EF activation.
]]></description>
<dc:creator>Atisha-Fregoso, Y.</dc:creator>
<dc:creator>Meng, W.</dc:creator>
<dc:creator>Rosenfeld, A.</dc:creator>
<dc:creator>Liu, F.</dc:creator>
<dc:creator>Feltman, S.</dc:creator>
<dc:creator>Aranow, C.</dc:creator>
<dc:creator>Mackay, M.</dc:creator>
<dc:creator>Terestchenko, C.</dc:creator>
<dc:creator>Dunn, M.</dc:creator>
<dc:creator>Scharff, M.</dc:creator>
<dc:creator>Prak, E. L.</dc:creator>
<dc:creator>Diamond, B.</dc:creator>
<dc:date>2025-01-13</dc:date>
<dc:identifier>doi:10.1101/2025.01.08.631945</dc:identifier>
<dc:title><![CDATA[SELECTION OF ANTI-NUCLEAR ANTIGEN (ANA) REACTIVE B CELLS IN SYSTEMIC LUPUS ERYTHEMATOSUS.]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-01-13</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.01.13.632767v1?rss=1">
<title>
<![CDATA[
Paclitaxel causes de novo induction of invasive breast cancer cells by repolarizing tumor-associated macrophages 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.01.13.632767v1?rss=1</link>
<description><![CDATA[
Metastasis is the leading cause of breast cancer death, and tumor cells must migrate and invade to metastasize. Breast cancer cells that express the pro-metastatic actin regulatory protein MenaINV have an enhanced ability to migrate and intravasate within the primary tumor and extravasate at secondary sites. Though chemotherapy improves patient survival, treatment with paclitaxel leads to upregulation of MenaINV and an increase in metastasis in mice. MenaINV expression can be induced in breast cancer cells through cooperative NF-{kappa}B/ Notch1 signaling with macrophages, which are often increased in tumors in response to chemotherapy. MenaINV-expressing cells are also resistant to paclitaxel, raising the question of whether paclitaxel increases MenaINV by de novo induction or by selectively killing non-MenaINV-expressing cells. We hypothesized that paclitaxel causes de novo MenaINV induction by increasing macrophage-tumor cell NF-{kappa}B/ Notch1 signaling. Understanding this pro-metastatic effect of chemotherapy is crucial to refining treatment strategies.

In this study, we demonstrate that paclitaxel increases MenaINV expression by de novo induction. Mechanistically, paclitaxel induces MenaINV by repolarizing tumor-associated macrophages towards a pro-inflammatory phenotype. These pro-inflammatory macrophages then participate in enhanced NF-{kappa}B/ Notch1 signaling with tumor cells, which leads to MenaINV induction in the tumor cells. These results lay the groundwork for novel microenvironment-based therapies to alleviate the pro-metastatic effects of chemotherapy in breast cancer.
]]></description>
<dc:creator>Friedman-DeLuca, M.</dc:creator>
<dc:creator>Karagiannis, G. S.</dc:creator>
<dc:creator>Duran, C. L.</dc:creator>
<dc:creator>Shukla, S.</dc:creator>
<dc:creator>Li, J.</dc:creator>
<dc:creator>Condeelis, J. S.</dc:creator>
<dc:creator>Oktay, M. H.</dc:creator>
<dc:creator>Entenberg, D.</dc:creator>
<dc:date>2025-01-15</dc:date>
<dc:identifier>doi:10.1101/2025.01.13.632767</dc:identifier>
<dc:title><![CDATA[Paclitaxel causes de novo induction of invasive breast cancer cells by repolarizing tumor-associated macrophages]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-01-15</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.01.15.633097v1?rss=1">
<title>
<![CDATA[
Cytosolic transport of citrate protects nutrient-austere pancreatic cancer from ferroptosis 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.01.15.633097v1?rss=1</link>
<description><![CDATA[
Pancreatic cancer (PDAC) cells experience nutrient starvation in a poorly perfused tumor microenvironment. Metabolic dependencies that protect PDAC cells from detrimental oxidative stress in a nutrient-restricted niche represent as tumor-specific targets. While the role of mitochondria in supporting energy production and biosynthetic requirements of cells has been well investigated, their contribution to maintaining intracellular redox homeostasis when PDAC cells are exposed to nutrient deprivation is unknown. Our results demonstrate that cytosolic transport of citrate via SLC25A1 confers a survival advantage to PDAC cells by protecting them from ferroptosis, a well-established iron-dependent cell death mechanism, under nutrient-limited conditions. Employing selective SLC25A1 inhibitor or targeting mitochondrial OXPHOS dramatically reduced GPX4 expression and PDAC cell viability. Rescuing GPX4 expression with the products of both ACLY and ACO1-dependent pathways uncovered their critical role in conferring survival advantage under metabolic stress. Importantly, exogenous expression of GPX4 reversed redox imbalance and metabolic discordance resulting from the lack of SLC25A1 activity, indicating the requirement of citrate-induced GPX4 expression to support mitochondrial health and function. As observed with cultured cells under nutrient limitation, SLC25A1 function was revealed to be indispensable in pancreatic tumor microenvironment, and the reduced growth, due to the lack of SLC25A1 activity, was rescued with antioxidant NAC in preclinical models of PDAC. Lastly, SLC25A1 suppression was accompanied by elevated glutamine metabolism, and combination therapy with pharmacologic inhibitors of SLC25A1 and glutaminase inhibitor CB-839 dramatically suppressed tumor growth, highlighting this combinatorial approach as a potential therapeutic strategy in PDAC.
]]></description>
<dc:creator>Kneebone, A.</dc:creator>
<dc:creator>Lindaur, K.</dc:creator>
<dc:creator>Abbas, A.</dc:creator>
<dc:creator>Cassel, J.</dc:creator>
<dc:creator>Graff, S.</dc:creator>
<dc:creator>Abood, G.</dc:creator>
<dc:creator>Ding, X.</dc:creator>
<dc:creator>Small, W.</dc:creator>
<dc:creator>Tatsuoka, C.</dc:creator>
<dc:creator>Sidoli, S.</dc:creator>
<dc:creator>Salvino, J. M.</dc:creator>
<dc:creator>Vaziri-Gohar, A.</dc:creator>
<dc:date>2025-01-17</dc:date>
<dc:identifier>doi:10.1101/2025.01.15.633097</dc:identifier>
<dc:title><![CDATA[Cytosolic transport of citrate protects nutrient-austere pancreatic cancer from ferroptosis]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-01-17</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.01.14.632505v1?rss=1">
<title>
<![CDATA[
A Two-Heads-Bound State Drives KIF1A Superprocessivity 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.01.14.632505v1?rss=1</link>
<description><![CDATA[
KIF1A, a neuron-specific Kinesin-3 motor, is indispensable for long-distance axonal transport and nuclear migration, processes vital for neuronal function. Using MINFLUX tracking, we reveal that KIF1A predominantly adopts a two-heads-bound state, even under ATP-limiting conditions, challenging prior models proposing a one-head-bound rate-limiting step. This two-heads-bound conformation, stabilized by interactions between the positively charged K-loop and negatively charged tubulin tails, enhances microtubule affinity and minimizes detachment. The shorter neck linker facilitates inter-head tension, keeping the heads out of phase and enabling highly coordinated stepping. In contrast, Kinesin-1 (KIF5B) transitions to a one-head-bound state under similar conditions, limiting its processivity. Perturbing KIF1As mechanochemical cycle by prolonging its one-head-bound state significantly reduces processivity, underscoring the critical role of the two-heads-bound state in motility. These findings establish a mechanistic framework for understanding KIF1As adaptations for neuronal transport and dysfunction in neurological diseases.
]]></description>
<dc:creator>Rao, L.</dc:creator>
<dc:creator>Wirth, J. O.</dc:creator>
<dc:creator>Matthias, J.</dc:creator>
<dc:creator>Gennerich, A.</dc:creator>
<dc:date>2025-01-18</dc:date>
<dc:identifier>doi:10.1101/2025.01.14.632505</dc:identifier>
<dc:title><![CDATA[A Two-Heads-Bound State Drives KIF1A Superprocessivity]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-01-18</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.01.14.632506v1?rss=1">
<title>
<![CDATA[
The Power of Three: Dynactin associates with three dyneins under load for greater force production 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.01.14.632506v1?rss=1</link>
<description><![CDATA[
Cytoplasmic dynein is an essential microtubule motor protein that powers organelle transport and mitotic spindle assembly. Its activity depends on dynein-dynactin-cargo adaptor complexes, such as dynein-dynactin-BicD2 (DDB), which typically function with two dynein motors. We show that mechanical tension recruits a third dynein motor via an auxiliary BicD adaptor binding the light intermediate chain of the third dynein, stabilizing multi-dynein assemblies and enhancing force generation. Lis1 prevents dynein from transitioning into a force-limiting phi-like conformation, allowing single-dynein DDB to sustain forces up to [~]4.5 pN, whereas force generation often ends at [~]2.5 pN without Lis1. Complexes with two or three dyneins generate [~]7 pN and [~]9 pN, respectively, consistent with a staggered motor arrangement that enhances collective output. Under load, DDB primarily takes [~]8 nm steps, challenging existing dynein coordination models. These findings reveal adaptive mechanisms that enable robust intracellular transport under varying mechanical demands.
]]></description>
<dc:creator>Rao, L.</dc:creator>
<dc:creator>Liu, X.</dc:creator>
<dc:creator>Berger, F.</dc:creator>
<dc:creator>McKenney, R. J.</dc:creator>
<dc:creator>Arnold, M.</dc:creator>
<dc:creator>Stengel, K.</dc:creator>
<dc:creator>Sidoli, S.</dc:creator>
<dc:creator>Gennerich, A.</dc:creator>
<dc:date>2025-01-18</dc:date>
<dc:identifier>doi:10.1101/2025.01.14.632506</dc:identifier>
<dc:title><![CDATA[The Power of Three: Dynactin associates with three dyneins under load for greater force production]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-01-18</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.01.14.632928v1?rss=1">
<title>
<![CDATA[
The Single-Cell Landscape of Peripheral and Tumor-infiltrating Immune Cells in HPV- HNSCC 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.01.14.632928v1?rss=1</link>
<description><![CDATA[
Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer worldwide. HPV-negative HNSCC, which arises in the upper airway mucosa, is particularly aggressive, with nearly half of patients succumbing to the disease within five years and limited response to immune checkpoint inhibitors compared to other cancers. There is a need to further explore the complex immune landscape in HPV-negative HNSCC to identify potential therapeutic targets. Here, we integrated two single-cell RNA sequencing datasets from 29 samples and nearly 300,000 immune cells to investigate immune cell dynamics across tumor progression and lymph node metastasis. Notable shifts toward adaptative immune cell populations were observed in the 14 distinct HNSCC-associated peripheral blood mononuclear (PBMCs) and 21 tumor-infiltrating immune cells (TICs) considering disease stages. All PBMCs and TICs revealed unique molecular signatures correlating with lymph node involvement; however, broadly, TICs increased ligand expression among effector cytokines, growth factors, and interferon-related genes. Pathway analysis comparing PBMCs and TICs further confirmed active cell signaling among Monocyte-Macrophage, Dendritic cell, Natural Killer (NK), and T cell populations. Receptor-ligand analysis revealed significant communication patterns shifts among TICs, between CD8+ T cells and NK cells, showing heightened immunosuppressive signaling that correlated with disease progression. In locally invasive HPV-negative HNSCC samples, highly multiplexed immunofluorescence assays highlighted peri-tumoral clustering of exhausted CD8+ T and NK cells, alongside their exclusion from intra-tumoral niches. These findings emphasize cytotoxic immune cells as valuable biomarkers and therapeutic targets, shedding light on the mechanisms by which the HNSCC sustainably evades immune responses.
]]></description>
<dc:creator>Galvani, R. G. A.</dc:creator>
<dc:creator>Rojas, A.</dc:creator>
<dc:creator>Matuck, B. F.</dc:creator>
<dc:creator>Rupp, B. T.</dc:creator>
<dc:creator>Kumar, N.</dc:creator>
<dc:creator>Huynh, K.</dc:creator>
<dc:creator>de Biagi, C. A. O.</dc:creator>
<dc:creator>Liu, J.</dc:creator>
<dc:creator>Sheth, S.</dc:creator>
<dc:creator>Krol, J. M. M.</dc:creator>
<dc:creator>Maracaja-Coutinho, V.</dc:creator>
<dc:creator>Byrd, K. M.</dc:creator>
<dc:creator>Severino, P.</dc:creator>
<dc:date>2025-01-19</dc:date>
<dc:identifier>doi:10.1101/2025.01.14.632928</dc:identifier>
<dc:title><![CDATA[The Single-Cell Landscape of Peripheral and Tumor-infiltrating Immune Cells in HPV- HNSCC]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-01-19</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.01.22.633435v1?rss=1">
<title>
<![CDATA[
The E2F4 transcriptional repressor is a key mechanistic regulator of colon cancer resistance to irinotecan (CPT-11). 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.01.22.633435v1?rss=1</link>
<description><![CDATA[
Background. Colorectal carcinomas (CRCs) are seldom eradicated by cytotoxic chemotherapy. Cancer cells with stem-like functional properties, often referred to as "cancer stem cells" (CSCs), display preferential resistance to several anti-tumor agents used in cancer chemotherapy, but the molecular mechanisms underpinning their selective survival remain only partially understood. Methods. In this study, we used Transcription Factor Target Genes (TFTG) enrichment analysis to identify transcriptional regulators (activators or repressors) that undergo preferential activation by chemotherapy in CRC cells with a "bottom-of-the-crypt" phenotype (EPCAM+/CD44+/CD166+; CSC-enriched) as compared to CRC cells with a "top-of-the-crypt" phenotype (EPCAM+/CD44neg/CD166neg; CSC-depleted). The two cell populations were purified in parallel by fluorescence-activated cell sorting (FACS) from a patient-derived xenograft (PDX) line representative of a moderately differentiated human CRC, following in vivo chemotherapy with irinotecan (CPT-11). The transcriptional regulators identified as differentially activated were tested for differential expression in normal vs. cancer tissues, and in cell populations enriched in stem/progenitor cell-types as compared to differentiated lineages (goblet cells, enterocytes) in the mouse colon epithelium. Finally, the top candidate was tested for mechanistic contribution to drug-resistance by selective down-regulation using short-hairpin RNAs (shRNAs). Results. Our analysis identified E2F4 and TFDP1, two core components of the DREAM transcriptional repression complex, as transcriptional modulators preferentially activated by irinotecan in EPCAM+/CD44+/CD166+ as compared to EPCAM+/CD44neg/CD166neg cancer cells. The expression levels of both genes (E2F4, TFDP1) were found up-regulated in CRCs as compared to human normal colon tissues, and in a sub-population of mouse colon epithelial cells enriched in stem/progenitor elements (Epcam+/Cd44+/Cd66alow/Kitneg) as compared to other sub-populations enriched in either goblet cells (Epcam+/Cd44+/Cd66alow/Kit+) or enterocytes (Epcam+/Cd44neg/Cd66ahigh). Most importantly, E2F4 down-regulation using shRNAs dramatically enhanced the sensitivity of human CRCs to in vivo treatment with irinotecan, across three independent PDX models. Conclusions. Our data identified E2F4 and the DREAM repressor complex as critical regulators of human CRC resistance to irinotecan, and as candidate targets for the development of chemo-sensitizing agents.
]]></description>
<dc:creator>Matsubara, J.</dc:creator>
<dc:creator>Li, Y. F.</dc:creator>
<dc:creator>Koul, S.</dc:creator>
<dc:creator>Mukohyama, J.</dc:creator>
<dc:creator>Valencia Salazar, L. E.</dc:creator>
<dc:creator>Isobe, T.</dc:creator>
<dc:creator>Qian, D.</dc:creator>
<dc:creator>Clarke, M. F.</dc:creator>
<dc:creator>Sahoo, D.</dc:creator>
<dc:creator>Altman, R. B.</dc:creator>
<dc:creator>Dalerba, P.</dc:creator>
<dc:date>2025-01-24</dc:date>
<dc:identifier>doi:10.1101/2025.01.22.633435</dc:identifier>
<dc:title><![CDATA[The E2F4 transcriptional repressor is a key mechanistic regulator of colon cancer resistance to irinotecan (CPT-11).]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-01-24</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.01.27.635083v1?rss=1">
<title>
<![CDATA[
Diet links gut chemistry with cancer risk in C57Bl/6 mice and human colorectal cancer patients 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.01.27.635083v1?rss=1</link>
<description><![CDATA[
Background & AimsWestern-style diets, characterized by higher fat and protein, and low micronutrient levels, promote the development of colorectal cancer (CRC). Here, we investigate the role of a Western diet on microbiome composition, sulfide production, and intestinal epithelial damage in pre-CRC mice, and validate taxonomic changes in a meta-analysis of human CRC patients.

MethodsNWD1 is a purified Western-style diet that produces sporadic intestinal and colon tumors in wild-type C57BL/6 mice in the absence of genetic or carcinogen exposure. To determine how this diet influences cancer risk by shaping microbial composition and sulfide chemistry, mice were fed NWD1 or a purified control diet for 24 weeks. Microbiome composition, sulfide production, and intestinal stem cell mRNA expression were assessed. Observed microbiome changes were validated in a human CRC meta-analysis.

ResultsFecal sulfide levels were tripled in NWD1-fed mice (P< 0.00001), concurrent with increased abundance of the sulfidogenic Erysipelotrichaceae family. NWD1-fed mice had increased expression of mitochondrial sulfide oxidation genes in Lgr5hi intestinal stem cells, demonstrating an adaptive response to elevated sulfide. In a meta-analysis of human CRC studies, we observed that Erysipelotrichaceae were associated with CRC, validating both canonical CRC microbes such as Solobacterium moorei and highlighting the potential contribution of previously unrecognized, disease-associated microbes.

ConclusionsOur analyses connect the risk factors of Western diet, sulfide, and epithelial damage in a pre-cancer mouse model to microbiome changes observed in human CRC patients and suggest that microbial signatures of CRC and gut ecosystem alteration may manifest long before disease development.
]]></description>
<dc:creator>Cohen, Z.</dc:creator>
<dc:creator>Choi, J.</dc:creator>
<dc:creator>Peregrina, K.</dc:creator>
<dc:creator>Khan, S.</dc:creator>
<dc:creator>Wolfson, S.</dc:creator>
<dc:creator>Sherman, C.</dc:creator>
<dc:creator>Augenlicht, L. H.</dc:creator>
<dc:creator>Kelly, L.</dc:creator>
<dc:date>2025-01-28</dc:date>
<dc:identifier>doi:10.1101/2025.01.27.635083</dc:identifier>
<dc:title><![CDATA[Diet links gut chemistry with cancer risk in C57Bl/6 mice and human colorectal cancer patients]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-01-28</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.01.28.635348v1?rss=1">
<title>
<![CDATA[
WormSNAP: A software for fast, accurate, and unbiased detection of fluorescent puncta in C. elegans 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.01.28.635348v1?rss=1</link>
<description><![CDATA[
The detection and characterization of fluorescent puncta are critical tasks in image analysis pipelines for fluorescence imaging. Existing methods for quantitative characterization of such puncta often suffer from biases and limitations, compromising the reliability and reproducibility of results. Moreover, the widespread adoption of many available analysis scripts is often hampered by over-optimization for specific samples, requiring extensive coding knowledge to repurpose for other datasets. We present WormSNAP (Worm SyNapse Analysis Program), a freely available, stand-alone, no-code approach to automated unbiased detection and characterization of 2D fluorescent puncta, originally developed to characterize images of the synapses residing in C. elegans nerve cords but suitable for broader 2D fluorescence image analysis. WormSNAP incorporates a local means thresholding algorithm and a user-friendly Graphical User Interface (GUI) for efficient and accurate analysis of large datasets, with user control of thresholding and restriction parameters and visualization options for further refinement. WormSNAP also calculates three types of correlation metrics for 2-channel images, enabling users to select the ideal metric for their dataset. WormSNAP provides robust and accurate fluorescent puncta detection in a variety of conditions, accelerating the image analysis workflow from data acquisition to figure generation.
]]></description>
<dc:creator>Tiroumalechetty, A.</dc:creator>
<dc:creator>Frankel, E. B.</dc:creator>
<dc:creator>Kurshan, P. T.</dc:creator>
<dc:date>2025-01-29</dc:date>
<dc:identifier>doi:10.1101/2025.01.28.635348</dc:identifier>
<dc:title><![CDATA[WormSNAP: A software for fast, accurate, and unbiased detection of fluorescent puncta in C. elegans]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-01-29</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.02.03.636318v1?rss=1">
<title>
<![CDATA[
Active DNA demethylation is upstream of rod-photoreceptor fate determination and required for retinal development 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.02.03.636318v1?rss=1</link>
<description><![CDATA[
Retinal cell fate specification from multipotent retinal progenitors is governed by dynamic changes in chromatin structure and gene expression. Methylation at cytosines in DNA (5mC) is actively regulated for proper control of gene expression and chromatin architecture. Numerous genes display active DNA demethylation across retinal development; a process that requires oxidation of 5mC to 5-hydroxymethylcytosine (5hmC) and is controlled by the ten-eleven translocation methylcytosine dioxygenase (TET) enzymes. Using an allelic series of conditional TET enzyme mutants, we determine that DNA demethylation is required upstream of NRL and NR2E3 expression for the establishment of rod-photoreceptor fate. Using histological, behavioral, transcriptomic, and base-pair resolution DNA methylation analyses, we establish that inhibition of active DNA demethylation results in global changes in gene expression and methylation patterns that prevent photoreceptor precursors from adopting a rod-photoreceptor fate, instead producing a retina in which all photoreceptors specify as cones. Our results establish the TET enzymes and DNA demethylation as critical regulators of retinal development and cell fate specification, elucidating a novel mechanism required for the specification of rod-photoreceptors.
]]></description>
<dc:creator>Hernandez-Nunez, I.</dc:creator>
<dc:creator>Urman, A.</dc:creator>
<dc:creator>Zhang, X.</dc:creator>
<dc:creator>Jacobs, W.</dc:creator>
<dc:creator>Hoffman, C.</dc:creator>
<dc:creator>Rebba, S.</dc:creator>
<dc:creator>Harding, E. G.</dc:creator>
<dc:creator>Li, Q.</dc:creator>
<dc:creator>Mao, F.</dc:creator>
<dc:creator>Cani, A. K.</dc:creator>
<dc:creator>Chen, S.</dc:creator>
<dc:creator>Dawlaty, M. M.</dc:creator>
<dc:creator>Rao, R. C.</dc:creator>
<dc:creator>Ruzycki, P. A.</dc:creator>
<dc:creator>Edwards, J. R.</dc:creator>
<dc:creator>Clark, B. S.</dc:creator>
<dc:date>2025-02-03</dc:date>
<dc:identifier>doi:10.1101/2025.02.03.636318</dc:identifier>
<dc:title><![CDATA[Active DNA demethylation is upstream of rod-photoreceptor fate determination and required for retinal development]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-02-03</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.01.31.635980v1?rss=1">
<title>
<![CDATA[
Swirling motion of breast cancer cells radially aligns collagen fibers to enable collective invasion 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.01.31.635980v1?rss=1</link>
<description><![CDATA[
In breast cancer (BC), radial alignment of collagen fibers at the tumor-matrix interface facilitates collective invasion of cancer cells into the surrounding stromal matrix, a critical step toward metastasis. Collagen remodeling is driven by proteases and cellular forces, mediated by matrix mechanical plasticity, or irreversible matrix deformation in response to force. However, the specific mechanisms causing collagen radial alignment remain unclear. Here, we study collective invasion of BC tumor spheroids in collagen-rich matrices. Increasing plasticity to BC-relevant ranges facilitates invasion, with increasing stiffness potentiating a transition from single cell to collective invasion. At enhanced plasticity, cells radially align collagen at the tumor-matrix interface prior to invasion. Surprisingly, cells migrate tangentially to the tumor-matrix interface in a swirling-like motion, perpendicular to the direction of alignment. Mechanistically, swirling generates local shear stresses, leading to distally propagating contractile radial stresses due to negative normal stress, an underappreciated property of collagen-rich matrices. These contractile stresses align collagen fibers radially, facilitating collective invasion. The basement membrane (BM), which separates epithelia from stroma in healthy tissues, acts as a mechanical insulator by preventing swirling cells from aligning collagen. Thus, after breaching the BM, swirling of BC cells at the tumor-stroma interface radially aligns collagen to facilitate invasion.
]]></description>
<dc:creator>Saraswathibhatla, A.</dc:creator>
<dc:creator>Rabbi, M. F.</dc:creator>
<dc:creator>Varma, S.</dc:creator>
<dc:creator>Srivastava, V.</dc:creator>
<dc:creator>Ilina, O.</dc:creator>
<dc:creator>Alyafei, N. H. K.</dc:creator>
<dc:creator>Hodgson, L.</dc:creator>
<dc:creator>Gartner, Z.</dc:creator>
<dc:creator>Friedl, P.</dc:creator>
<dc:creator>West, R.</dc:creator>
<dc:creator>Kim, T. B.</dc:creator>
<dc:creator>Chaudhuri, O.</dc:creator>
<dc:date>2025-02-06</dc:date>
<dc:identifier>doi:10.1101/2025.01.31.635980</dc:identifier>
<dc:title><![CDATA[Swirling motion of breast cancer cells radially aligns collagen fibers to enable collective invasion]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-02-06</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.02.07.637147v1?rss=1">
<title>
<![CDATA[
Acetylation of histone H2B on lysine 120 regulates BRD4 binding to intergenic enhancers 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.02.07.637147v1?rss=1</link>
<description><![CDATA[
BRD4 is a bromodomain-containing transcriptional co-regulator that plays important roles in driving transcription by binding to histone acetyl-lysines at enhancers and promoters while recruiting additional transcriptional cofactors. While the mechanisms by which BRD4 regulates transcription have been explored, the critical acetylations primarily responsible for targeting it to chromatin remain unclear. Through a machine learning approach, we determined that distinct sets of histone acetylations dominate the prediction of chromatin accessibility and BRD4 binding in distinct chromatin contexts (e.g. intergenic enhancers, gene body enhancers and promoters). Using human fibroblasts engineered to predominantly express specific histones with lysine-to-arginine mutations, we demonstrate that one such acetylation, H2BK120ac, is required to recruit BRD4 specifically to intergenic enhancers, while not affecting chromatin accessibility. Loss of H2BK120ac did not affect BRD4 binding to either promoters or gene body enhancers, demonstrating that the rules governing BRD4 recruitment to regulatory regions depends on the specific genomic context. Highlighting the importance of H2BK120ac in directing BRD4 recruitment, we found that expression of the H2BK120R mutant significantly reduces the phenotypes driven by BRD4-NUT, an oncogenic fusion protein that drives NUT midline carcinoma. This work demonstrates the critical nature that genomic context plays in BRD4 recruitment to distinct classes of regulatory elements, and suggests that intergenic and gene body enhancers represent classes of functional distinct elements.
]]></description>
<dc:creator>Hamilton, G. A.</dc:creator>
<dc:creator>Ruiz, P. D.</dc:creator>
<dc:creator>Ye, K.</dc:creator>
<dc:creator>Gamble, M. J.</dc:creator>
<dc:date>2025-02-08</dc:date>
<dc:identifier>doi:10.1101/2025.02.07.637147</dc:identifier>
<dc:title><![CDATA[Acetylation of histone H2B on lysine 120 regulates BRD4 binding to intergenic enhancers]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-02-08</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.03.02.640812v1?rss=1">
<title>
<![CDATA[
A highly resolved integrated single-cell atlas of HPV-negative head and neck cancer 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.03.02.640812v1?rss=1</link>
<description><![CDATA[
Head and Neck Squamous Cell Carcinomas (HNSCC) are the seventh most prevalent form of cancer and are associated with human papilloma virus infection (HPV-positive) or with tobacco and alcohol use (HPV-negative). HPV-negative HNSCCs have a high recurrence rate, and individual patients responses to treatment vary greatly due to the high level of cellular heterogeneity of the tumor and its microenvironment. Here, we describe a HNSCC single cell atlas, which we created by integrating six publicly available datasets encompassing over 230,000 cells across 54 patients. We contextualized the relationships between existing signatures and cell populations, identified new subpopulations, and show the power of this large-scale resource to robustly identify associations between transcriptional signatures and clinical phenotypes that would not be possible to discover using fewer patients. We reveal a previously undefined myeloid population, sex-associated changes in cell type proportions, and novel interactions between CXCL8-positive fibroblasts and vascular endothelial cells. Beyond our findings, the atlas will serve as a public resource for the high-resolution characterization of tumor heterogeneity of HPV-negative HNSCC.
]]></description>
<dc:creator>Kroehling, L.</dc:creator>
<dc:creator>Chen, A.</dc:creator>
<dc:creator>Spinella, A.</dc:creator>
<dc:creator>Reed, E.</dc:creator>
<dc:creator>Kukuruzinska, M.</dc:creator>
<dc:creator>Varelas, X.</dc:creator>
<dc:creator>Monti, S.</dc:creator>
<dc:date>2025-03-04</dc:date>
<dc:identifier>doi:10.1101/2025.03.02.640812</dc:identifier>
<dc:title><![CDATA[A highly resolved integrated single-cell atlas of HPV-negative head and neck cancer]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-03-04</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.03.09.642162v1?rss=1">
<title>
<![CDATA[
Uncovering synaptic and cellular nanoarchitecture of brain tissue via seamless in situ trimming and milling for cryo-electron tomography 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.03.09.642162v1?rss=1</link>
<description><![CDATA[
Cell-cell communication underlies all emergent properties of the brain, including cognition, learning and memory. The physical basis for these communications is the synapse, a multi-component structure requiring coordinated interactions between diverse cell types. However, many aspects of three-dimensional (3D) synaptic organization remain poorly understood. Here, we developed an approach, seamless in situ trimming and milling (SISTM), to reliably fabricate sufficiently thin lamellae for mapping of the 3D nanoarchitecture of synapses in mouse, monkey and human brain tissue under near-native conditions via cryo-electron tomography (cryo-ET). We validated SISTM in a mouse model of Huntingtons disease, demonstrating distinct 3D alterations to synaptic vesicles and mitochondria. By successfully applying SISTM to macaque brain, we described the 3D architecture of a tripartite synapse within the cortex. Subtomogram averaging (STA) enabled spatial mapping of astrocyte-neuron contacts within the tripartite synapse, revealing neurexin-neuroligin complexes as potential constituents that tether the two cell types. Finally, we showed that the defining features of synaptic nanoarchitecture were conserved across species and evident in human brain tissue obtained postmortem. Combining SISTM with cryo-ET and STA is a starting point for a new understanding of brain organization, disease-induced structural alterations and the development of rational, structure-guided therapeutics.
]]></description>
<dc:creator>Ning, J.</dc:creator>
<dc:creator>Glausier, J. R.</dc:creator>
<dc:creator>Warshamanage, R.</dc:creator>
<dc:creator>Gunther-Cummins, L.</dc:creator>
<dc:creator>Burnley, T.</dc:creator>
<dc:creator>Palmer, C. M.</dc:creator>
<dc:creator>Gonzalez-Burgos, G.</dc:creator>
<dc:creator>Miyamae, T.</dc:creator>
<dc:creator>Wang, J.</dc:creator>
<dc:creator>Carlisle, D.</dc:creator>
<dc:creator>Hsieh, C.</dc:creator>
<dc:creator>Schmelzer, T.</dc:creator>
<dc:creator>Buck, S. A.</dc:creator>
<dc:creator>Franks, J.</dc:creator>
<dc:creator>Hampton, C. M.</dc:creator>
<dc:creator>Stauffer, W. R.</dc:creator>
<dc:creator>Lewis, D. A.</dc:creator>
<dc:creator>Friedlander, R. M.</dc:creator>
<dc:creator>Macaluso, F. P.</dc:creator>
<dc:creator>Winn, M.</dc:creator>
<dc:creator>Freyberg, Z.</dc:creator>
<dc:date>2025-03-11</dc:date>
<dc:identifier>doi:10.1101/2025.03.09.642162</dc:identifier>
<dc:title><![CDATA[Uncovering synaptic and cellular nanoarchitecture of brain tissue via seamless in situ trimming and milling for cryo-electron tomography]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-03-11</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.03.10.642430v1?rss=1">
<title>
<![CDATA[
Pathogenic Viruses, Genome Integrations, and Viral::Human Chimeric Transcripts Detected by VirusIntegrationFinder Across >30k Human Tumor and Normal Samples 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.03.10.642430v1?rss=1</link>
<description><![CDATA[
Viruses are a leading cause of human morbidity and mortality. Certain viruses, including human papillomaviruses (HPVs), play a significant role in the etiology of cancer. Detection of viral DNA insertions in the human genome from next generation sequencing data defines viral associations with cancer and other diseases, identifies impacted organs and tissues, provides insights into disease mechanisms and has the potential to enhance clinical evaluations. In this study, we developed VirusIntegrationFinder (CTAT-VIF), a tool for surveying human genome insertions of various human viruses using both DNA and RNA sequencing data. We applied CTAT-VIF to analyze a dataset of over 30,000 tumor and normal samples, as well as more than 1,000 cancer cell lines. This effort resulted in the compilation of a catalog of over 30,0000 virus-human DNA or RNA junctions at more than 20,000 insertion loci and reassessed viral cancer-insertion hotspots across the human genome. Furthermore, we characterized the functional impacts of insertions with respect to human copy number alterations, effects on the expression of flanking human genes, and the identification of potentially oncogenic chimeric human and human/virus fusion transcripts at insertion loci. In addition to confirming known viral associations with specific tumor types, our study revealed both shared and virus-specific insertion hotspots in addition to variable functional impacts based on virus type. Besides some rare events of interest, we also found evidence for sequencing contamination, which underscores the need for vigilance when studying viral content or genome integrations.
]]></description>
<dc:creator>Haas, B. J.</dc:creator>
<dc:creator>Van Arsdale, A.</dc:creator>
<dc:creator>Dobin, A.</dc:creator>
<dc:creator>Brown, M.</dc:creator>
<dc:creator>Gould, J.</dc:creator>
<dc:creator>Georgescu, C.</dc:creator>
<dc:creator>Agosta, E.</dc:creator>
<dc:creator>Baulande, S.</dc:creator>
<dc:creator>Jamail, I.</dc:creator>
<dc:creator>Kamal, M.</dc:creator>
<dc:creator>Bieche, I.</dc:creator>
<dc:creator>Lenz, J.</dc:creator>
<dc:creator>Montagna, C.</dc:creator>
<dc:creator>Al'Khafaji, A.</dc:creator>
<dc:date>2025-03-13</dc:date>
<dc:identifier>doi:10.1101/2025.03.10.642430</dc:identifier>
<dc:title><![CDATA[Pathogenic Viruses, Genome Integrations, and Viral::Human Chimeric Transcripts Detected by VirusIntegrationFinder Across >30k Human Tumor and Normal Samples]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-03-13</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.03.12.642709v1?rss=1">
<title>
<![CDATA[
U2-2 snRNA Mutations Alter the Transcriptome 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.03.12.642709v1?rss=1</link>
<description><![CDATA[
Intron removal from pre-mRNA is catalyzed by the spliceosome, which comprises 5 snRNPs containing small nuclear RNAs (snRNAs). U2 snRNA makes critical RNA-RNA and RNA-protein contacts throughout the splicing cycle. Mutations in U2 snRNA, particularly at position C28, have been linked to cancers. To study gene expression changes mediated by mutated U2 snRNAs, U2-2 C28 mutants, U2-2 knockout (KO), and U2-2 overexpression (OE) cell lines were constructed followed by RNA sequencing. We observed significant changes in splicing and over 4,000 differentially expressed genes enriched in pathways like RNA processing and non-coding RNAs upon knocking out U2-2 snRNA. Splicing patterns were more influenced by U2-2 dosage than mutations alone. Therefore, the mutant exhibits a compound phenotype, resulting from reduced U2-2 levels (and thus mostly phenocopying the KO) and additional mutant-specific splicing changes.

HIGHLIGHTSO_LIU2-2 snRNA BSL mutants alter splicing and the transcriptome
C_LIO_LIU2-2 KO phenocopies most altered splice events in the mutants
C_LIO_LIBoth U2-2 levels and mutations alter splicing
C_LIO_LIMany altered splice events lead to NMD
C_LI
]]></description>
<dc:creator>Chi, Z.</dc:creator>
<dc:creator>Gupta, V.</dc:creator>
<dc:creator>Query, C. C.</dc:creator>
<dc:date>2025-03-14</dc:date>
<dc:identifier>doi:10.1101/2025.03.12.642709</dc:identifier>
<dc:title><![CDATA[U2-2 snRNA Mutations Alter the Transcriptome]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-03-14</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.03.12.642925v1?rss=1">
<title>
<![CDATA[
Tissue Engineering Applications for Novel Integrated and Mobile Perfusion System 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.03.12.642925v1?rss=1</link>
<description><![CDATA[
Perfusion offers unique benefits to tissue-engineered systems, enhancing oxygen and nutrient transport which improves tissue formation and growth. In this study, we present a novel and integrated portable perfusion system, termed the FluidON. Weighing <10 lbs, the system can maintain continuous flow in a standard incubation environment (37{degrees}C, 5% CO2), effectively functioning as a portable perfusion and culture chamber. To test the systems perfusion parameters, we measured the volumetric flow rate across a range of pressures and found that the system could achieve flow as low as 0.40{+/-} 0.19uL/s, which is similar to in vivo interstitial flow. Computational fluid dynamics revealed uniform flow distribution, laminar flow, and gentle circulation, helping ensure even fluid and nutrient distribution. To study the biocompatibility of the system, bioengineered tissue patches were created and perfused. Viability was assessed through flow cytometry. The system does not adversely affect cell health as the viability of perfused samples was found to be 40.99{+/-}6.22% alive after 24 hours (n=4), while that of the static control was 38.56{+/-}4.22% alive (n=4). To determine the effects of perfusion on spheroid spatial arrangement, perfused tissue patches were analyzed with light microscopy. It was discovered that perfusion promoted spheroid aggregation and cohesion, causing the distance from one spheroid to its nearest neighbor to decrease after 24 hours of perfusion. Perfusion was also found to improve the strength of hydrogels as the average hole area, caused by hydrolytic enzymes that degrade the hydrogel matrix, was smaller in perfused conditions compared to the control. Complemented by its ability to provide mobile perfusion and incubation, this novel integrated portable perfusion system holds promise for promoting tissue maturation, elevating tissue bioengineering studies.
]]></description>
<dc:creator>Zhu, A.</dc:creator>
<dc:creator>Jain, T.</dc:creator>
<dc:creator>Reid, E.</dc:creator>
<dc:creator>Siddiqi, U.</dc:creator>
<dc:creator>Mir, A.</dc:creator>
<dc:creator>Dunne, O.</dc:creator>
<dc:creator>Hibino, N.</dc:creator>
<dc:date>2025-03-14</dc:date>
<dc:identifier>doi:10.1101/2025.03.12.642925</dc:identifier>
<dc:title><![CDATA[Tissue Engineering Applications for Novel Integrated and Mobile Perfusion System]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-03-14</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.03.19.644221v1?rss=1">
<title>
<![CDATA[
The Dynamics of Cryptococcus neoformans infection in Galleria mellonella 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.03.19.644221v1?rss=1</link>
<description><![CDATA[
Galleria mellonella has emerged as an important host for the study of fungal virulence, insect immune responses, and the evaluation of antifungal agents. In this study we investigated the dynamics of fungal infections in G. mellonella using Cryptococcus neoformans, a human pathogenic fungus. Since the analysis of infection dynamics requires a fine temporal resolution of larval death, we employed a photographic timelapse technique that allowed us to simultaneously measure death by proxy of larval melanization and absence of movement. Larval mortality occurred in two phases, early and late, which differed in their timing of melanization. Early phase deaths occurred with rapid whole-body onset of melanization, followed by sudden cessation of movement several hours later. Contrastingly, late phase deaths occurred with a gradual cessation of movement, followed by melanization, typically radiating from one location on the larva. The differences in mortality kinetics suggests differences in fungal pathogenesis with one population succumbing early while the rest linger for later death. Subsequent analysis of mortality data using the inversion method revealed predictable deterministic dynamics without evidence for chaotic signatures, indicating that this C. neoformans-G. mellonella infection model behaves differently than bacterial-insect models.

ImportanceThe ability to predict the course of an infection is critical to anticipating disease progression and effectively treating patients. Similarly, the ability to make predictions about pathogenesis in laboratory infection models could further our understanding of pathogenesis and lead to new treatments. As fungal diseases are expected to rise, understanding the dynamics of fungal infections will be important to anticipate and mitigate future threats. Here, we developed a timelapse method to visualize infections of Galleria mellonella larvae with the fungal pathogen Cryptococcus neoformans. This method provided insight into infection progression that are not apparent from standard survival measurement protocols, including the relationship between melanization and death. Further, it enabled us to explore the dynamics of disease progression in this system, which revealed deterministic dynamics without evidence of chaos, implying predictability in the outcome of cryptococcal infection in this moth.
]]></description>
<dc:creator>Smith, D. F. Q.</dc:creator>
<dc:creator>Bergman, A.</dc:creator>
<dc:creator>Casadevall, A.</dc:creator>
<dc:date>2025-03-19</dc:date>
<dc:identifier>doi:10.1101/2025.03.19.644221</dc:identifier>
<dc:title><![CDATA[The Dynamics of Cryptococcus neoformans infection in Galleria mellonella]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-03-19</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.03.17.642023v1?rss=1">
<title>
<![CDATA[
Serial dependence during visuomotor integration is robust to the passage of time and interference from intervening tasks 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.03.17.642023v1?rss=1</link>
<description><![CDATA[
When intercepting a moving target, responses are systematically biased toward the time of impact from the previous trial. This phenomenon, known as serial dependence, relies on a memory mechanism that remains poorly understood. In interceptive tasks, multiple stimulus features -- such as speed, time, or motor responses -- can guide behavior on the current trial and may be stored to influence subsequent trials. Here, we examined how memory decays over short inter-trial intervals (Experiment 1, N = 23) and whether interleaved tasks influence serial dependence (Experiment 2, N = 28). Participants performed either a temporal reproduction task or a speed judgment task, designed to compete for temporal and speed-processing resources, respectively. Our findings reveal that serial dependence persists across all inter-trial durations and remains unaffected by intervening tasks. While serial dependence was neither reduced nor eliminated, variations in responses were partially influenced by prior temporal reproductions from the interfering task. These results suggest that serial dependence in visuomotor tasks is robust to both the passage of time and external interference, though task responses may be subtly modulated by preceding temporal reproductions.
]]></description>
<dc:creator>Sirius, E. V. P.</dc:creator>
<dc:creator>Cravo, A. M.</dc:creator>
<dc:creator>de Azevedo Neto, R. M.</dc:creator>
<dc:date>2025-03-20</dc:date>
<dc:identifier>doi:10.1101/2025.03.17.642023</dc:identifier>
<dc:title><![CDATA[Serial dependence during visuomotor integration is robust to the passage of time and interference from intervening tasks]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-03-20</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.03.27.645863v1?rss=1">
<title>
<![CDATA[
Molecular Dynamics Reveal Base Flipping as a Key Mechanism in Tc3a Transposase DNA Recognition 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.03.27.645863v1?rss=1</link>
<description><![CDATA[
Transposons, or "jumping genes," are mobile genetic elements that reshape genomes. The Tc1/Mariner family, including Tc3a transposase, has been studied for decades, but key aspects of its DNA recognition and cleavage remain unresolved. Existing models propose a homo-dimeric process for DNA excision and integration, yet conflicting hypotheses exist about the initial steps of DNA cleavage and target site recognition. Here, we reveal a previously unrecognized base-flipping mechanism in Tc3a transposase that challenges long-standing models of Mariner transposon activity. Using molecular dynamics simulations, we demonstrate that N-terminal acetylation induces a structural shift in the transposase-DNA complex, forcing a nucleotide in the inverted repeat to flip outward. This base-flipping event alters the local DNA conformation, creating torsional strain that may facilitate transposon inverted terminal repeat association. Unlike prior models, which assumed the entire protein, or protein dimers, were needed to illicit DNA interactions necessary for any types of torsion, our findings indicate that transposase bipartite binding itself actively reshapes DNA structure. We further show that this mechanism is dependent on the bipartite helix-turn-helix domains, which differentially contribute to DNA stabilization and recognition. Our simulations also reveal that the processed N-terminus plays an unexpected role in modulating DNA binding affinity, contradicting previous assumptions that it was structurally inconsequential. Together, the two helix-turn-helix motifs act to propagate the force caused by base flipping along one direction of the cognate DNA double helix axis. The fact that previous structural studies lacked this amino acid modification may explain why this mechanism was overlooked. These results provide a new framework for understanding transposase-DNA interactions, highlighting how a single molecular modification can trigger major DNA rearrangements. This discovery not only redefines the Tc3a transposition process but also calls for a reassessment of long-standing Mariner family transposon models.
]]></description>
<dc:creator>Watkins, S. L.</dc:creator>
<dc:creator>Nakaya, H. I.</dc:creator>
<dc:date>2025-03-28</dc:date>
<dc:identifier>doi:10.1101/2025.03.27.645863</dc:identifier>
<dc:title><![CDATA[Molecular Dynamics Reveal Base Flipping as a Key Mechanism in Tc3a Transposase DNA Recognition]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-03-28</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.03.26.645360v1?rss=1">
<title>
<![CDATA[
RNA sequence analysis of somatic mutations in aging and Parkinson's Disease 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.03.26.645360v1?rss=1</link>
<description><![CDATA[
Parkinsons Disease (PD) is an age-related neurodegenerative disorder that has been associated with increased DNA damage. To test if PD is associated with increased somatic mutations, we analyzed RNA-seq data in whole blood from 5 visits of the Parkinsons Progression Markers Initiative for clonally amplified somatic variants. Comprehensive analysis of RNA-sequencing data revealed a total of 5,927 somatic variants (2.4 variants per sample on average). Mutation frequencies were significantly elevated in PD subjects as compared to age-matched controls at the time of the last visit. This was confirmed by RNA analysis of substantia nigra. By contrast, the fraction of carriers with clonal hematopoiesis, was significantly reduced in old PD patients as compared to old healthy controls. These results indicate that while the overall mutation rate is higher in PD, specific clonally amplified mutations are protective against PD, as has been found for Alzheimers Disease.
]]></description>
<dc:creator>Sun, S.</dc:creator>
<dc:creator>Sproviero, D.</dc:creator>
<dc:creator>Payan-Gomez, C.</dc:creator>
<dc:creator>Hoeijmakers, J.</dc:creator>
<dc:creator>Maslov, A. Y.</dc:creator>
<dc:creator>Mastroberardino, P. G.</dc:creator>
<dc:creator>Vijg, J.</dc:creator>
<dc:date>2025-03-29</dc:date>
<dc:identifier>doi:10.1101/2025.03.26.645360</dc:identifier>
<dc:title><![CDATA[RNA sequence analysis of somatic mutations in aging and Parkinson's Disease]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-03-29</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.04.07.647605v1?rss=1">
<title>
<![CDATA[
TTLL4 glutamyltransferase is a therapeutic target for NPM1-mutated acute myeloid leukemia 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.04.07.647605v1?rss=1</link>
<description><![CDATA[
NPM1-mutated acute myeloid leukemia (AML) is defined by aberrant cytoplasmic localization of the mutant NPM1c protein, and therapeutic strategies targeting this specific disease remain limited. Here, we identify TTLL4, a mono-glutamate glutamyltransferase, as a selective vulnerability in NPM1c AML. TTLL4 catalyzes post-translational hyper-glutamylation of NPM1c at E126, stabilizes its cytoplasmic localization and promotes a differentiation block in leukemic cells. Multiple genetic TTLL4 inactivation approaches in human NPM1c-mutant cell lines reduce NPM1c glutamylation, trigger myeloid differentiation, and impair proliferation. Transcriptomic analyses show that TTLL4 knockdown pheno-copies NPM1c degradation and aligns with KMT2A and XPO1-targeted gene expression programs. Furthermore, Ttll4 knockout significantly prolonged survival in an NPM1c/NRAS-driven mouse AML model and promoted differentiation. We identify a small molecule, EN7, that selectively inhibits TTLL4 and recapitulates these phenotypes in NPM1c+ cells. These findings identify glutamylation as a new axis of leukemic regulation and highlight TTLL4 as a druggable epigenetic regulator in NPM1c AML.
]]></description>
<dc:creator>Schurer, A.</dc:creator>
<dc:creator>Ilyas, H.</dc:creator>
<dc:creator>Maron, M. I.</dc:creator>
<dc:creator>Hegde, S.</dc:creator>
<dc:creator>Leyden, M. R.</dc:creator>
<dc:creator>Roy, I.</dc:creator>
<dc:creator>Hyka, R.</dc:creator>
<dc:creator>Dada, L.</dc:creator>
<dc:creator>Shabanowitz, J.</dc:creator>
<dc:creator>Hunt, D.</dc:creator>
<dc:creator>Angeles, E.</dc:creator>
<dc:creator>Morell, V.</dc:creator>
<dc:creator>Lorton, B. M.</dc:creator>
<dc:creator>Glushakow-Smith, S.</dc:creator>
<dc:creator>Borger, D. K.</dc:creator>
<dc:creator>Wang, Y.</dc:creator>
<dc:creator>Miles, L. A.</dc:creator>
<dc:creator>Belizaire, R.</dc:creator>
<dc:creator>Kitamura, S.</dc:creator>
<dc:creator>Gritsman, K.</dc:creator>
<dc:creator>Shechter, D.</dc:creator>
<dc:date>2025-04-09</dc:date>
<dc:identifier>doi:10.1101/2025.04.07.647605</dc:identifier>
<dc:title><![CDATA[TTLL4 glutamyltransferase is a therapeutic target for NPM1-mutated acute myeloid leukemia]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-04-09</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.04.11.648440v1?rss=1">
<title>
<![CDATA[
Loss of the ESX-5 secretion locus in Mycobacterium tuberculosis reshapes the mycomembrane and enhances ESX-1 substrate secretion 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.04.11.648440v1?rss=1</link>
<description><![CDATA[
The ESX-5 secretion system, uniquely found in slow-growing mycobacteria, is predicted to secrete over 150 proteins across the inner membrane of Mycobacterium tuberculosis (M.tb). Although many of these substrates are believed to promote M.tb virulence, most remain poorly characterized. Here, we use a complete locus deletion strain of ESX-5 in M.tb to examine the molecular changes caused by a broad loss in ESX-5 secretory substrates. We confirmed the selective loss of PE/PPE proteins secreted by ESX-5 into both the culture filtrate (CF) and outer mycomembrane (OMM) fractions of the M.tb {Delta}esx5 mutant. In examining other ESX systems, we found that ESX-1 substrate levels were increased in both the CF and OMM fractions of the {Delta}esx5 mutant. Conversely, the ESX-3 locus was transcriptionally repressed upon ESX-5 deletion. We noted that the {Delta}esx5 mutant had altered morphology in the form of wrinkled distortions of the bacterial surface. Likewise, we identified increased susceptibility of the {Delta}esx5 mutant to a variety of large (molecular weight >550 g/mol) antimicrobial compounds, suggesting that an intact ESX-5 system is required for M.tb to exclude such molecules. Our findings suggest that removing the ESX-5 system from M.tb fundamentally alters the properties of the mycobacterial OMM and impacts the expression and secretion activity of other ESX systems.

Significance StatementMycobacterium tuberculosis (M.tb) uses the ESX-5 secretion system to export numerous proteins that shape host-pathogen interactions. Here, we found that deleting ESX-5 from M.tb not only prevented the secretion of many ESX-5 substrates but also impacted other ESX systems. The M.tb {Delta}esx5 mutant had increased ESX-1 substrate secretion but reduced ESX-3 expression. In addition, the M.tb {Delta}esx5 mutant displayed altered cell surface morphology and increased vulnerability to large antibiotic drugs, suggesting a critical role for ESX-5 for maintaining outer membrane integrity. These findings highlight ESX-5 as a central modulator of secretion and cell envelope composition with implications for drug targeting and vaccine development.
]]></description>
<dc:creator>Koleske, B.</dc:creator>
<dc:creator>Rajagopalan, S.</dc:creator>
<dc:creator>Schill, C.</dc:creator>
<dc:creator>Lun, S.</dc:creator>
<dc:creator>Vilcheze, C.</dc:creator>
<dc:creator>Das, L.</dc:creator>
<dc:creator>Gupta, M.</dc:creator>
<dc:creator>Martinez-Martinez, Y. B.</dc:creator>
<dc:creator>Jacobs, W. R.</dc:creator>
<dc:creator>Bishai, W. R.</dc:creator>
<dc:date>2025-04-11</dc:date>
<dc:identifier>doi:10.1101/2025.04.11.648440</dc:identifier>
<dc:title><![CDATA[Loss of the ESX-5 secretion locus in Mycobacterium tuberculosis reshapes the mycomembrane and enhances ESX-1 substrate secretion]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-04-11</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.04.14.648681v1?rss=1">
<title>
<![CDATA[
Bat sarbecovirus WIV1-CoV bears an adaptive mutation that alters spike dynamics and enhances ACE2 binding 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.04.14.648681v1?rss=1</link>
<description><![CDATA[
SARS-like betacoronaviruses (sarbecoviruses) endemic in bats pose a significant zoonotic threat to humans. Genetic pathways associated with spillover of bat sarbecoviruses into humans are incompletely understood. We previously showed that the WT spike of the rhinolophid bat coronavirus SHC014-CoV has poor entry activity and uncovered two distinct genetic pathways outside the receptor-binding domain (RBD) that increased spike opening, ACE2 binding, and cell entry. Herein, we show that the widely studied bat sarbecovirus WIV1-CoV is likely a cell culture-adapted variant of Rs3367-CoV, which was sequenced from the same population of rhinolophid bats as SHC014-CoV. We demonstrate that the acquisition of a single amino-acid substitution in the  630 loop of the S1 subunit was the key spike adaptation event during the successful isolation of WIV1-CoV, and that it enhances spike opening, virus-receptor recognition, and cell entry in much the same manner as the substitutions we previously identified in SHC014-CoV using a pseudotype system. The conformational constraints on both the SHC014-CoV and Rs3367-CoV spikes could be alleviated by pre-cleaving them with trypsin, suggesting that the spike-opening substitutions arose to circumvent the lack of S1-S2 cleavage. We propose that the  locked-down nature of these spikes and their requirement for S1-S2 cleavage to engage ACE2 represent viral optimizations for a fecal-oral lifestyle and immune evasion in their natural hosts. These adaptations may be a broader property of bat sarbecoviruses than currently recognized. The acquisition of a polybasic furin cleavage site at the S1-S2 boundary is accepted as a key viral adaptation for SARS-CoV-2 emergence that overcame a host protease barrier to viral entry in the mammalian respiratory tract. Our results suggest alternative spillover scenarios in which spike-opening substitutions that promote virus-receptor binding and entry could precede, or even initially replace, substitutions that enhance spike cleavage in the zoonotic host.

Author SummaryRecent epidemic-causing coronaviruses, including SARS-CoV-2, originated in bats. Large numbers of such viruses circulate in bats and pose clear and present risks to humans. However, our incomplete understanding of the variables that influence viral  spillover into new hosts challenges attempts to stratify viruses by threat level. We showed previously that the entry spike of the bat coronavirus SHC014-CoV, closely related to SARS-CoV-1 and SARS-CoV-2, exists largely in a closed conformation that is incompatible with its binding to the viral receptor, ACE2, and that genetic changes in key control sequences  open the spike and unlock its entry activity. Here, we extend these findings to a second bat coronavirus. We demonstrate that WIV1-CoV, a highly studied virus that was previously isolated from the same population of Chinese horseshoe bats, is in fact a variant of the bat coronavirus Rs3367-CoV that acquired a genetic change in the same hotspot region of the spike during its propagation in cell culture. Our findings support the idea that the closed spikes of at least some (and likely, many) bat coronaviruses, while exquisitely adapted to their natural milieu in the bat digestive system, suffer poor functional activity outside this milieu, imposing a barrier to viral spillover that must be overcome through viral adaptation. Further, we identify spike genetic changes that overcome this deficit and may have value as prognostic markers of zoonotic risk.
]]></description>
<dc:creator>Tse, A. L.</dc:creator>
<dc:creator>Lasso, G.</dc:creator>
<dc:creator>McLellan, J. S.</dc:creator>
<dc:creator>Chandran, K.</dc:creator>
<dc:creator>Miller, E. H.</dc:creator>
<dc:date>2025-04-15</dc:date>
<dc:identifier>doi:10.1101/2025.04.14.648681</dc:identifier>
<dc:title><![CDATA[Bat sarbecovirus WIV1-CoV bears an adaptive mutation that alters spike dynamics and enhances ACE2 binding]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-04-15</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.04.11.647869v1?rss=1">
<title>
<![CDATA[
Loss of CARM1 alters the developmental programming of Glioma stem-like cells and creates a druggable NGFR/NTRK dependency 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.04.11.647869v1?rss=1</link>
<description><![CDATA[
A key driver of Glioblastoma (GBM) heterogeneity and therapy resistance is the capacity of glioma stem-like cells (GSCs) to hijack developmental signaling programs. However, it remains unclear how GSCs regulate these adapted developmental signaling pathways and how these pathways might be therapeutically exploited. The arginine methyltransferase, CARM1, has been shown to play critical roles in maintaining stem cell pluripotency, preventing differentiation, and recently was discovered to be upregulated in Glioblastoma. To date, there is little to no understanding of the role that CARM1 plays in regulating developmental processes in Glioblastoma. To address this gap in knowledge, we applied a multi-omics approach to characterize developmental processes that are specifically regulated by CARM1 in GSCs. We found that loss of CARM1 results in dysregulation of several developmental markers: ARX, GFAP, NGFR, PDGFRA and results in both a proteomic and transcriptomic shift towards the radial glia cell lineage. Moreover, CARM1 depleted cells reprogram their signaling to develop an increased survival dependency on NGFR/NTRK signaling and are hypersensitive to the FDA approved brain penetrant NTRK inhibitor--Entrectinib. Mechanistically, we find that NFIA is a CARM1 substrate and can repress NGFR signaling just as CARM1 does, and thus the CARM1/NFIA relationship is likely a key regulator of NGFR/NTRK signaling in GSCs. Altogether, we demonstrate that CARM1 regulates the cell lineage of GSCs at the transcriptomic and proteomic level, and naturally represses NGFR/NTRK signaling--likely through CARM1 dependent methylation of NFIA. Further, CARM1 depletion leads GSCs to develop a survival dependency on NGFR/NTRK signaling and creates a therapeutic vulnerability to NTRK inhibition.
]]></description>
<dc:creator>Young, D.</dc:creator>
<dc:creator>Aguilan, J.</dc:creator>
<dc:creator>Cutler, R.</dc:creator>
<dc:creator>Stransky, S.</dc:creator>
<dc:creator>DeAngelo, J.</dc:creator>
<dc:creator>Roth, J.</dc:creator>
<dc:creator>Malachowska, B.</dc:creator>
<dc:creator>Vercellino, J.</dc:creator>
<dc:creator>Bell, B.</dc:creator>
<dc:creator>Shechter, D.</dc:creator>
<dc:creator>Tofilon, P.</dc:creator>
<dc:creator>Phillips, R.</dc:creator>
<dc:creator>Guha, C.</dc:creator>
<dc:creator>Sidoli, S.</dc:creator>
<dc:date>2025-04-17</dc:date>
<dc:identifier>doi:10.1101/2025.04.11.647869</dc:identifier>
<dc:title><![CDATA[Loss of CARM1 alters the developmental programming of Glioma stem-like cells and creates a druggable NGFR/NTRK dependency]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-04-17</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.04.13.647987v1?rss=1">
<title>
<![CDATA[
Inhibition Of One-Carbon Metabolism In Ewing Sarcoma Results In Profound And Prolonged Growth Suppression Associated With Purine Depletion 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.04.13.647987v1?rss=1</link>
<description><![CDATA[
Ewing sarcoma (EWS) is the second most common primary bone malignancy in adolescents and young adults. Patients who present with localized disease have experienced a steadily improving survival rate over the years, whereas those who present with metastatic disease have the same dismal prognosis as 30 years ago, with long term survival rates less than 20%, despite maximal intensification of chemotherapy. Thus, novel treatment approaches are a significant unmet clinical need. Targeting metabolic differences between EWS and normal cells offers a promising approach to improve outcomes for these patients. One-carbon metabolism utilizes serine and folate to generate glycine and tetrahydrofolate (THF)-bound one-carbon units required for de novo nucleotide biosynthesis. Elevated expression of several one-carbon metabolism genes is significantly associated with reduced survival in EWS patients. We show that both genetic and pharmacological inhibition of a key enzyme of the mitochondrial arm of the one-carbon metabolic pathway, serine hydroxymethyltransferase 2 (SHMT2), leads to substantial inhibition of EWS cell proliferation and colony-forming ability, and that this effect is primarily caused by depletion of glycine and one-carbon units required for synthesis of purine nucleotides. Inhibition of one-carbon metabolism at a different node, using the clinically relevant dihydrofolate reductase inhibitor Pralatrexate, similarly yields a profound growth inhibition, with depletion of thymidylate and purine nucleotides. Genetic depletion of SHMT2 dramatically impairs tumor growth in a xenograft model of EWS. Together, these data establish the upregulation of the one-carbon metabolism as a novel and targetable vulnerability of EWS cells, which can be exploited for therapy.

Statement of SignificanceUsing both genetic and pharmacologic approaches, this study identifies Ewing sarcomas dependence on the mitochondrial arm, but not the cytoplasmic arm, of one-carbon metabolism as a targetable vulnerability that can be effectively harnessed for therapy.
]]></description>
<dc:creator>Zirpoli, S.</dc:creator>
<dc:creator>Copperman, N.</dc:creator>
<dc:creator>Patel, S.</dc:creator>
<dc:creator>Forrest, A.</dc:creator>
<dc:creator>Hou, Z.</dc:creator>
<dc:creator>Matherly, L. H.</dc:creator>
<dc:creator>Loeb, D. M.</dc:creator>
<dc:creator>Di Cristofano, A.</dc:creator>
<dc:date>2025-04-18</dc:date>
<dc:identifier>doi:10.1101/2025.04.13.647987</dc:identifier>
<dc:title><![CDATA[Inhibition Of One-Carbon Metabolism In Ewing Sarcoma Results In Profound And Prolonged Growth Suppression Associated With Purine Depletion]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-04-18</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.04.22.649812v1?rss=1">
<title>
<![CDATA[
Chromosomal Aneuploidy in Normal, Non-Neuronal Brain Nuclei of Glioblastoma Patients is Not a Cancer Driver 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.04.22.649812v1?rss=1</link>
<description><![CDATA[
Aneuploidy is a hallmark of cancers, including high-grade glioma (GBM), one of the most aggressive brain tumors. To assess whether increased aneuploidy already occurs in normal brain tissue of GBM patients, we performed single-nucleus whole-genome sequencing on 225 non-neuronal cortical nuclei from 12 disease-free individuals and 6 GBM patients, in the latter analyzing both tumor and non-tumor distal regions. Somatic aneuploidy was found in approximately 15% of non-neuronal nuclei in the adult human cortex, with recurrent chromosome 16p aneuploidy in up to 4% of nuclei. In contrast, about 51% of GBM tumor nuclei showed frequent aneuploidy of chromosomes 7 and 10, consistent with known GBM profiles. Notably, non-tumor brain regions from GBM patients exhibited aneuploidy frequencies and patterns similar to controls, including recurrent 16p involvement. These findings indicate that somatic aneuploidy in non-neuronal cells is a normal feature of the adult human brain and not linked to increased GBM risk.
]]></description>
<dc:creator>Montagna, C.</dc:creator>
<dc:creator>Albert, O.</dc:creator>
<dc:creator>Sun, S.</dc:creator>
<dc:creator>Lin, J.-R.</dc:creator>
<dc:creator>Lee, M.</dc:creator>
<dc:creator>Chan, C.</dc:creator>
<dc:creator>Maslov, A. Y.</dc:creator>
<dc:creator>Ellerby, L.</dc:creator>
<dc:creator>Huttner, A.</dc:creator>
<dc:creator>Zhang, Z.</dc:creator>
<dc:creator>Vijg, J. V.</dc:creator>
<dc:date>2025-04-24</dc:date>
<dc:identifier>doi:10.1101/2025.04.22.649812</dc:identifier>
<dc:title><![CDATA[Chromosomal Aneuploidy in Normal, Non-Neuronal Brain Nuclei of Glioblastoma Patients is Not a Cancer Driver]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-04-24</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.04.24.648993v1?rss=1">
<title>
<![CDATA[
TIGIT expression dictates the immunosuppressive reprogramming of myeloid cells in glioblastoma 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.04.24.648993v1?rss=1</link>
<description><![CDATA[
Glioblastoma (GBM) is a deadly brain cancer with near-universal recurrence despite maximal treatment for which new innovations are sorely needed. Immunotherapy has yet to make significant gains in GBM treatment despite revolutionizing other cancer therapies, due in part to GBM-mediated immune suppression. This immune derangement proceeds through several mechanisms, but increasing evidence points to critical roles for tumor-derived extracellular vesicles (EVs) and immunosuppressive myeloid cells as key factors in this process. In the present study, we demonstrate broad expression of TIGIT across myeloid cell populations in the GBM microenvironment, a finding recapitulated by conditioning healthy monocytes with GBM-derived EVs. Further, knockdown of TIGIT expression reduced the immunosuppressive polarization of monocytes, resulting in improvement in T cell function. This finding proceeded in an NLRP3-dependent manner, with substantial co-localization of TIGIT and NLRP3 expression prior to knockdown. These findings point to a novel role for TIGIT expression in diverse myeloid cells in the GBM microenvironment as a marker of immunosuppressive activity and further indicate a hierarchy of immunomodulatory protein activity in these myeloid cells, with TIGIT knockdown unmasking the pro-inflammatory activity of NLRP3. This study bolsters understanding of the immunosuppressive complexities of myeloid cells in the GBM microenvironment, while lending further support to prevention or attenuation of immunosuppressive myeloid cell activity as a means of restoring immune function in GBM.

Graphical abstract(Created in BioRender. Asad, M. (2025) https://BioRender.com/euiljoq

O_FIG O_LINKSMALLFIG WIDTH=153 HEIGHT=200 SRC="FIGDIR/small/648993v2_ufig1.gif" ALT="Figure 1">
View larger version (30K):
org.highwire.dtl.DTLVardef@13dc389org.highwire.dtl.DTLVardef@1f06765org.highwire.dtl.DTLVardef@14200forg.highwire.dtl.DTLVardef@144f245_HPS_FORMAT_FIGEXP  M_FIG C_FIG Key PointsO_LITumor-mediated immune suppression is a key barrier to the development of effective immunotherapies for GBM.
C_LIO_LITIGIT is broadly expressed in myeloid cells within the GBM microenvironment and can be induced by GBM-derived extracellular vesicles.
C_LIO_LIKnockdown of TIGIT reduces immunosuppressive polarization of monocytes and enhances T cell activity via NLRP3 signaling, implicating TIGIT expression as a targetable modifier of immunosuppressive activity in GBM-associated myeloid cells.
C_LI

Importance of the StudyGlioblastoma (GBM) remains a formidable clinical challenge, with poor prognosis and limited response to current immunotherapies. This study uncovers a novel immunosuppressive axis involving TIGIT expression in myeloid cells, which are key players in the GBM tumor microenvironment. By demonstrating GBM-derived extracellular vesicles induce TIGIT in healthy monocytes and TIGIT knockdown diminishes immunosuppressive polarization in an NLRP3-dependent manner, this study highlights TIGIT as both a marker and modulator of immune dysfunction in GBM. These findings introduce a functional hierarchy of immunoregulatory proteins in tumor-associated myeloid cells, positioning TIGIT as a potential checkpoint target. Restoring immune activity by disrupting this axis could enhance the efficacy of immunotherapy in GBM. Thus, this research not only advances our understanding of tumor-induced immune suppression but also opens a promising therapeutic avenue to reinvigorate anti-tumor immunity in a cancer type historically resistant to immunotherapeutic approaches.
]]></description>
<dc:creator>Asad, M.</dc:creator>
<dc:creator>Inocencio, J.</dc:creator>
<dc:creator>Mitrasinovic, S.</dc:creator>
<dc:creator>Aoki, M.</dc:creator>
<dc:creator>Crisman, C.</dc:creator>
<dc:creator>Lasala, P.</dc:creator>
<dc:creator>Eskandar, E.</dc:creator>
<dc:creator>Guha, C.</dc:creator>
<dc:creator>Zang, X.</dc:creator>
<dc:creator>Parney, I. F.</dc:creator>
<dc:creator>Himes, B. T.</dc:creator>
<dc:date>2025-04-25</dc:date>
<dc:identifier>doi:10.1101/2025.04.24.648993</dc:identifier>
<dc:title><![CDATA[TIGIT expression dictates the immunosuppressive reprogramming of myeloid cells in glioblastoma]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-04-25</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.05.01.651639v1?rss=1">
<title>
<![CDATA[
Insights into gallbladder cancer pathogenesis from a living organoid gallbladder cholangiocyte biorepository 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.05.01.651639v1?rss=1</link>
<description><![CDATA[
Gallbladder cancer (GBC) while rare worldwide has a high prevalence in India. Pathogenesis is unclear and outcomes poor. Gallbladder cholangiocyte organoids (GCOs) or gallbladder carcinoma organoids (GBCOs) were developed and serially propagated from surgically resected gallbladder tissues with benign or malignant diseases, respectively. Patient derived organoids (PDOs) were derived from 15 normal; 58 inflamed; 12 xanthogranulomatous cholecystitis (XGC); 5 pre-invasive neoplasm and 13 invasive malignant gallbladder pathologies. Protocol optimisation achieved 58% (69/119) success in organoid generation and expansion. Organoids maintained tight junction integrity; P-gp pump and enzymatic activity; preserved tissue-specific gene and protein marker expression; histological features and genetic variations. Cryopreserved organoids from 62 patients with primary tissue and high-quality DNA, RNA and protein derivatives have been banked. In gene expression analyses of tissue, XGC samples clustered with malignant subtypes, separate from benign pathologies. Derived XGC organoids showed a similar clustering. Enriched hallmark pathways in XGC support neoplastic change through chronic inflammation. PDOs generated from different gallbladder pathologies are a promising model to investigate the pathogenesis of GBC.

Graphical Abstract

O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=199 SRC="FIGDIR/small/651639v1_ufig1.gif" ALT="Figure 1">
View larger version (69K):
org.highwire.dtl.DTLVardef@465f3dorg.highwire.dtl.DTLVardef@16c5f0org.highwire.dtl.DTLVardef@11d4807org.highwire.dtl.DTLVardef@163d072_HPS_FORMAT_FIGEXP  M_FIG C_FIG
]]></description>
<dc:creator>Dutta, A.</dc:creator>
<dc:creator>Chowdhury, N.</dc:creator>
<dc:creator>Selvarajan, A. V.</dc:creator>
<dc:creator>Banerjee, P.</dc:creator>
<dc:creator>Kar, A.</dc:creator>
<dc:creator>Chandra, S.</dc:creator>
<dc:creator>Sunderam, U.</dc:creator>
<dc:creator>Ganguli, D.</dc:creator>
<dc:creator>Dutta, T.</dc:creator>
<dc:creator>Basak, D.</dc:creator>
<dc:creator>Satheeshkumar, S. J.</dc:creator>
<dc:creator>Ragate, A. S.</dc:creator>
<dc:creator>Krishnan, S.</dc:creator>
<dc:creator>Sen, S.</dc:creator>
<dc:creator>Roy, M. K.</dc:creator>
<dc:creator>Banerjee, S.</dc:creator>
<dc:creator>Srinivasan, R.</dc:creator>
<dc:creator>Roy, P.</dc:creator>
<dc:creator>Saha, V.</dc:creator>
<dc:creator>Dutta, A.</dc:creator>
<dc:creator>GuhaSarkar, D.</dc:creator>
<dc:date>2025-05-07</dc:date>
<dc:identifier>doi:10.1101/2025.05.01.651639</dc:identifier>
<dc:title><![CDATA[Insights into gallbladder cancer pathogenesis from a living organoid gallbladder cholangiocyte biorepository]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-05-07</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.05.09.651611v1?rss=1">
<title>
<![CDATA[
The Establishment of Prostate-specific, SKP2 Humanized Mice by CRISPR Knock-in Method Reveals Neoplastic Initiation and Microenvironmental Reprogramming 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.05.09.651611v1?rss=1</link>
<description><![CDATA[
A recent study has shown that SKP2 inactivation can prevent cancer initiation by extension of total cell cycle duration without perturbing normal division, which suggests a new strategy for cancer prevention. However, direct in vivo evidence for human SKP2 on cancer initiation and prostatic microenvironment is still lacking and a prostate-specific SKP2 humanized mouse model is critical for developing prostate cancer immunoprevention approaches through targeting human SKP2. We therefore have established a prostate-specific human SKP2 (hSKP2) knock-in mouse model by a CRISPR knock-in approach. Overexpression of hSKP2, which is driven by an endogenous mouse probasin promoter, induces prostatic lesions including hyperplasia, mouse prostate intraepithelial neoplasia (mPIN), and low-grade carcinoma and increases prostate weights. Transcriptional profiling by RNA-sequencing analysis revealed significant gene expression alterations in epithelial to mesenchymal transition (EMT), extracellular matrix, and interferon signaling in the prostate of hSKP2 knock-in mice compared to wild-type mice. Single cell deconvolution showed an increase of fibroblasts population and a decrease of CD8+ T cell and B cell populations in the prostate of hSKP2-knock-in mice. Consistently with these results from the SKP2 humanized mouse, overexpression of hSKP2 in human prostate cancer PC3 cells markedly increased cell migration and invasion and induced the gene expression of EMT and interferon pathways, including FMOD, THY1, PFKP, USP18, IL15, etc. In addition, paired prostate organoids were derived from SKP2 humanized and wild-type mice for drug screening and validated by known SKP2 inhibitors, Flavokawain A and C1. Both of which selectively decrease the viability and alter the morphologies of organoids of hSKP2 knock-in rather than wild-type mice. Our studies provide a well-characterized prostate-specific hSKP2 knock-in mouse model and offer new mechanistic insights for understanding the oncogenic role of SKP2 in shaping the prostatic microenvironment during early carcinogenesis.
]]></description>
<dc:creator>Song, L.</dc:creator>
<dc:creator>Nguyen, V.</dc:creator>
<dc:creator>Xu, S.</dc:creator>
<dc:creator>Ho, K. V. T.</dc:creator>
<dc:creator>Hoang, B. H.</dc:creator>
<dc:creator>Yu, J.</dc:creator>
<dc:creator>Uchio, E.</dc:creator>
<dc:creator>Zi, X.</dc:creator>
<dc:date>2025-05-10</dc:date>
<dc:identifier>doi:10.1101/2025.05.09.651611</dc:identifier>
<dc:title><![CDATA[The Establishment of Prostate-specific, SKP2 Humanized Mice by CRISPR Knock-in Method Reveals Neoplastic Initiation and Microenvironmental Reprogramming]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-05-10</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.05.07.652662v1?rss=1">
<title>
<![CDATA[
Dynamic transcription pre-initiation complex assembly governs initiation efficiency 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.05.07.652662v1?rss=1</link>
<description><![CDATA[
Transcription initiation is a highly regulated process that determines gene expression outcomes1,2, yet the dynamics of initiation and the mechanisms governing efficiency remain poorly understood. Here, we combine endogenous tagging of human RNA polymerase II (Pol II) and TFIID with simultaneous live-cell, multi-color single-molecule imaging to quantitatively map Pol II behavior during transcription initiation and early elongation. Using GRID (Genuine Rate Identification) analysis, we resolved four distinct kinetic populations of chromatin-bound Pol II. The dynamics of Pol II populations reveal that initiation is highly inefficient, with over 94% of Pol II molecules dissociating within tens of seconds. Kinetic partitioning of Pol II dwell times enables quantification of proximal pausing, which is globally sensitive to CDK9 inhibition. Single-cell analysis uncovers substantial heterogeneity in initiation efficiency and pausing across individual cells. Colocalization of Pol II with TFIID is associated with higher initiation efficiency and reduced promoter-proximal pausing compared to global Pol II. Further dissection of Pol II-TFIID assembly pathways reveals that canonical assembly, where TFIID binds first, is linked to inefficient initiation and frequent pausing. In contrast, non-canonical assembly, where Pol II binds first followed by TFIID, supports more efficient initiation with lower pausing. Together, these findings establish that transcription initiation efficiency is shaped by both the kinetic stability of Pol II engagement and the temporal order of pre-initiation complex assembly, providing a new framework for understanding dynamic gene regulation in vivo.
]]></description>
<dc:creator>Haque, N.</dc:creator>
<dc:creator>Coleman, R. A.</dc:creator>
<dc:date>2025-05-12</dc:date>
<dc:identifier>doi:10.1101/2025.05.07.652662</dc:identifier>
<dc:title><![CDATA[Dynamic transcription pre-initiation complex assembly governs initiation efficiency]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-05-12</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.05.14.654083v1?rss=1">
<title>
<![CDATA[
Peroxisomes regulate virulence and cell density sensing in Cryptococcus neoformans 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.05.14.654083v1?rss=1</link>
<description><![CDATA[
Cryptococcus neoformans, a ubiquitous environmental fungus that causes cryptococcosis, survives in diverse environments including human hosts due to metabolic flexibility. Consequently, identifying how C. neoformans connects diverse metabolic pathways and virulence factor expression is important for understanding fungal pathogenesis. Peroxisomes play an essential role in metabolic homeostasis and regulation of carbon and lipid metabolism. In this article, we report a link between nickel exposure, a known hypoxia-mimetic and mitochondrial respiration inhibitor in yeast, and peroxisomal {beta}-oxidation. Loss of the last two genes involved in the peroxisomal {beta}-oxidation pathway, MFE2 (CNAG_05721) and POT1 (CNAG_00490), resulted in cell density-dependent virulence factor defects and growth inhibition attributed to a metabolic state involving large peroxisomes. We found that increasing cell density rescued virulence factor phenotypes and growth. Our results implicate mitochondrial retrograde signaling (RTG), a previously uncharacterized pathway in C. neoformans, in cell density sensing, peroxisomal {beta}-oxidation pathway expression, and virulence, thus highlighting a critical role for metabolism in cryptococcal virulence.
]]></description>
<dc:creator>Jacobs, E.</dc:creator>
<dc:creator>Dragotakes, Q.</dc:creator>
<dc:creator>dos Santos, S. R.</dc:creator>
<dc:creator>Smith, D. F.</dc:creator>
<dc:creator>Smith, B.</dc:creator>
<dc:creator>Wolf, J. M.</dc:creator>
<dc:creator>Coelho, C.</dc:creator>
<dc:creator>Casadevall, A.</dc:creator>
<dc:date>2025-05-14</dc:date>
<dc:identifier>doi:10.1101/2025.05.14.654083</dc:identifier>
<dc:title><![CDATA[Peroxisomes regulate virulence and cell density sensing in Cryptococcus neoformans]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-05-14</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.05.09.653155v1?rss=1">
<title>
<![CDATA[
Affinity-matured CD72-targeting Nanobody CAR T-cells Enhance Elimination of Antigen-Low B-cell Malignancies 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.05.09.653155v1?rss=1</link>
<description><![CDATA[
BackgroundChimeric antigen receptor (CAR) T-cell therapies are highly efficacious for several different hematologic cancers. However, for most CAR T targets it is observed that low surface antigen density on tumors can significantly reduce therapeutic efficacy. Here, we explore this dynamic in the context of CD72, a surface antigen we recently found as a promising target for refractory B-cell cancers, but for which CD72 low antigen density can lead to therapeutic resistance in preclinical models.

MethodsPrimary samples were accessed via institutional review board-approved protocols. Affinity-matured and humanized nanobody clones were previously described in Temple et al.1 CAR T-cells were generated via lentiviral transduction. In vitro cytotoxicity assays were performed using luciferase-labeled cell lines. In vivo studies were performed using cell line- or patient-derived xenografts implanted in NOD scid gamma (NSG) mice.

ResultsWe first confirmed ubiquitous CD72 expression across a range of primary B-cell non-Hodgkin lymphomas. We further found that after resistance to CD19-directed therapies, across both B-cell acute lymphoblastic leukemia (B-ALL) models and primary tumor samples, surface CD72 expression was largely preserved while CD22 expression was significantly diminished. Affinity maturation of a nanobody targeting CD72, when incorporated into chimeric antigen receptor (CAR) T-cells, led to more effective elimination in vitro of isogenic models of CD72 low-expressing tumors. These results suggested that nanobody-based CAR T-cells (nanoCARs) may exhibit a similar relationship between binder affinity, antigen expression, and efficacy as previously demonstrated only for scFv-based CAR T-cells. Surprisingly, however, this significantly improved in vitro efficacy only translated to modest in vivo survival benefit. As a parallel strategy to enhance CAR T function, we found that the small molecule bryostatin could also significantly increase CD72 surface antigen density on B-cell malignancy models. Structural modeling and biochemical analysis identified critical residues improving CD72 antigen recognition of our lead affinity-matured nanobody.

ConclusionsTogether, these findings support affinity-matured CD72 nanoCARs as a potential immunotherapy product for CD19-refractory B-cell cancers. Our results also suggest that for B-ALL in particular, CD72 may be a preferable second-line immunotherapy target over CD22.

What is already known on this topicPrevious work using single chain variable fragment (scFv) based CAR Ts has suggested that improving affinity for target antigen could potentially help mitigate tumor resistance mediated by antigen downregulation, or baseline low antigen density. However, it is unknown whether this same dynamic holds for CAR T-cells that utilize different antigen recognition elements, such as nanobodies.

What this study addsHere we show that affinity maturation of nanobody-based CAR T-cells (nanoCARs) targeting CD72 can improve their in vitro efficacy versus CD72-low tumors; however, in vivo efficacy differences are more modest. Furthermore, we show that for refractory B-cell malignancies, surface CD72 appears preserved after CD19 resistance even in situations where CD22 is strongly downregulated.

How this study might affect research, practice or policyCD72 warrants further investigation as a preferred immunotherapy target in the context of CD19-refractory B-cell cancers, though nanobody affinity maturation is not a universal solution to the challenge of low tumor surface antigen density.
]]></description>
<dc:creator>Izgutdina, A.</dc:creator>
<dc:creator>Rashid, T.</dc:creator>
<dc:creator>Temple, W. C.</dc:creator>
<dc:creator>Patino-Escobar, B.</dc:creator>
<dc:creator>Walunj, S.</dc:creator>
<dc:creator>Geng, H.</dc:creator>
<dc:creator>Takamatsu, H.</dc:creator>
<dc:creator>Gil-Alos, D.</dc:creator>
<dc:creator>Kang, A. S.</dc:creator>
<dc:creator>Ramos, E.</dc:creator>
<dc:creator>Chen, S.-Y.</dc:creator>
<dc:creator>Johnson, H.</dc:creator>
<dc:creator>Nix, M. A.</dc:creator>
<dc:creator>Naik, A.</dc:creator>
<dc:creator>Yuan, C. M.</dc:creator>
<dc:creator>Wang, H.-W.</dc:creator>
<dc:creator>Aminov, S.</dc:creator>
<dc:creator>Sahu, S.</dc:creator>
<dc:creator>Larson, R. C.</dc:creator>
<dc:creator>Carpenter, C.</dc:creator>
<dc:creator>Salangsang, F.</dc:creator>
<dc:creator>Phojanakong, P.</dc:creator>
<dc:creator>Camara Serrano, J. A.</dc:creator>
<dc:creator>Tariq, I.</dc:creator>
<dc:creator>Zakraoui, O.</dc:creator>
<dc:creator>Steri, V.</dc:creator>
<dc:creator>Valeri, A.</dc:creator>
<dc:creator>Martinez-Lopez, J.</dc:creator>
<dc:creator>Maus, M. V.</dc:creator>
<dc:creator>Parekh, S.</dc:creator>
<dc:creator>Verma, A.</dc:creator>
<dc:creator>Shah, N. N.</dc:creator>
<dc:creator>Wiita, A.</dc:creator>
<dc:date>2025-05-15</dc:date>
<dc:identifier>doi:10.1101/2025.05.09.653155</dc:identifier>
<dc:title><![CDATA[Affinity-matured CD72-targeting Nanobody CAR T-cells Enhance Elimination of Antigen-Low B-cell Malignancies]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-05-15</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.05.12.653589v1?rss=1">
<title>
<![CDATA[
Hematopoietic Single Cell Atlas Reveals a Diverse Repertoire of Lymphoid Cells in Larval Zebrafish 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.05.12.653589v1?rss=1</link>
<description><![CDATA[
Embryonic development is a critical time window for the establishment of the hematopoietic and immune systems. During embryogenesis, hematopoietic stem and progenitor cells (HSPCs) that possess divergent differentiation preferences arise and sustain lifelong hematopoiesis. How the pace and differentiation repertoire of native hematopoiesis is set in development and how it evolves as the organism grows is incompletely elucidated. Here, we use temporal lineage tracing of the emerging hematopoietic system during zebrafish development coupled with single cell RNA sequencing to define the origins of larval and adult hematopoietic cells. In both larvae and adult tissues, HSPCs arising earlier during embryogenesis show a predilection for lymphoid lineage production while those arising later are skewed towards erythroid. Moreover, early arising HSPCs are the main contributors to adult tissue resident lymphocytes. Mechanistically, early and late arising HSPCs show divergent transcriptional signatures and differential sensitivities to the levels of the transcription factor Runx1. Additionally, we identified that young larvae possess a more heterogeneous set of lymphoid cells than previously recognized including diverse T-lymphocytes and Innate Lymphoid-like Cells (ILCs). We demonstrated that these newly described larval ILC-like cells reside in lymphoid and mucosal organs and are responsive to viral mimic immune stimulation, indicating their relevance in early vertebrate life. The work provides new fundamental knowledge on how the heterogeneous HSPC pool establishes early immune hierarchies during embryogenesis and its persistence in adulthood.
]]></description>
<dc:creator>Nizhnik, A.</dc:creator>
<dc:creator>Ulloa, B. A.</dc:creator>
<dc:creator>Jackson, K.</dc:creator>
<dc:creator>Zheng, D.</dc:creator>
<dc:creator>Bowman, T. V.</dc:creator>
<dc:date>2025-05-15</dc:date>
<dc:identifier>doi:10.1101/2025.05.12.653589</dc:identifier>
<dc:title><![CDATA[Hematopoietic Single Cell Atlas Reveals a Diverse Repertoire of Lymphoid Cells in Larval Zebrafish]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-05-15</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.05.15.654401v1?rss=1">
<title>
<![CDATA[
Neutralizing Activity of Cervicovaginal Secretions against Herpes Simplex Virus is Mediated by Mucosal IgG and Viral Glycoprotein E and Adversely Impacted by Vaginal Dysbiosis 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.05.15.654401v1?rss=1</link>
<description><![CDATA[
Genital herpes simplex virus (HSV) recurrences are more common in women with bacterial vaginosis (BV). Prior studies demonstrated that genital tract secretions exhibit variable neutralizing activity against HSV, independent of serostatus, but the relationship of this activity to the vaginal microbiome and underlying mechanisms have not been defined. To test the hypothesis that cervicovaginal antiviral activity is lower in women with BV, we took advantage of cervicovaginal lavage (CVL) available from two studies conducted among women with symptomatic BV and healthy controls. CVL obtained from women with BV had significantly less antiviral activity than controls (p< 0.001). Inhibitory activity correlated negatively and most strongly with Shannon diversity index (p<0.0001). The innate activity did not differ comparing HSV-seropositive versus seronegative participants and no HSV-specific antibodies were detected in CVL. Activity was enriched in the immunoglobulin fraction but was lost when IgG (but not IgA) was depleted. Increasing doses of an anti-glycoprotein E (gE) monoclonal antibody overcame the neutralizing activity, suggesting that interactions between the Fc region of IgG and gE, a viral Fc gamma receptor (Fc{gamma}R), contribute. Consistent with this notion, CVL had less HSV inhibitory activity against a gE-null virus. Glycan analysis demonstrated a decrease in mature glycans in IgG from CVL with low antiviral activity and treatment of CVL with peptide N-glycanase F, which cleaves N-glycans in IgG, resulted in a loss of HSV inhibitory activity. We speculate that glycosidases elaborated by anaerobic bacteria cleave Fc glycans, resulting in decreased affinity for gE and a reduction in protective activity.

IMPORTANCE: This study provides a mechanistic link for the increased risk of HSV infection and replication in the setting of symptomatic bacterial vaginosis and asymptomatic vaginal dysbiosis. Independent of Fab antigen specificity, the Fc region of mucosal IgG may neutralize HSV by binding to glycoprotein E, a viral Fc receptor. Vaginal dysbiosis leads to a loss of Fc glycans and a concomitant decrease in this innate antiviral activity. These findings suggest that viral Fc receptors, previously thought to function only in immune evasion, may also play a protective role. The results highlight the importance of developing and implementing strategies to protect against vaginal dysbiosis.
]]></description>
<dc:creator>MAHANT MAHANT, A.</dc:creator>
<dc:creator>Fong, V.</dc:creator>
<dc:creator>Gromisch, M.</dc:creator>
<dc:creator>Hunte, R.</dc:creator>
<dc:creator>Michael, I.</dc:creator>
<dc:creator>Aguilan, J. T.</dc:creator>
<dc:creator>Murphy, K.</dc:creator>
<dc:creator>Keller, M. J.</dc:creator>
<dc:creator>Herold, B.</dc:creator>
<dc:date>2025-05-16</dc:date>
<dc:identifier>doi:10.1101/2025.05.15.654401</dc:identifier>
<dc:title><![CDATA[Neutralizing Activity of Cervicovaginal Secretions against Herpes Simplex Virus is Mediated by Mucosal IgG and Viral Glycoprotein E and Adversely Impacted by Vaginal Dysbiosis]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-05-16</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.05.14.654104v1?rss=1">
<title>
<![CDATA[
Integrative analysis across metagenomic taxonomic classifiers: A case study of the gut microbiome in aging and longevity 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.05.14.654104v1?rss=1</link>
<description><![CDATA[
Despite calls for the development of consensus methods, most analyses of shotgun metagenomics data for microbiome studies use a single taxonomic classifier. In this study, we compare inferences from two broadly used classifiers, MetaPhlAn4 (marker-gene-based) and Kraken2 (k-mer-based), applied to stool metagenomic samples from participants in the Integrative Longevity Omics study to measure associations of taxonomic diversity and relative abundance with age, replicating analyses in an independent cohort. We also introduce consensus and meta-analytic approaches to compare and integrate results from multiple classifiers. While many results are consistent across the two classifiers, we find classifier-specific inferences that would be lost when using one classifier alone. When using a correlated meta-analysis approach across classifiers, differential abundance analysis captures more age-associated taxa, including 17 taxa robustly age-associated across cohorts. This study emphasizes the value of employing multiple classifiers and recommends novel approaches that facilitate the integration of results from multiple methodologies.
]]></description>
<dc:creator>Karagiannis, T. T.</dc:creator>
<dc:creator>Chen, Y.</dc:creator>
<dc:creator>Bald, S.</dc:creator>
<dc:creator>Tai, A.</dc:creator>
<dc:creator>Milman, S.</dc:creator>
<dc:creator>Andersen, S. L.</dc:creator>
<dc:creator>Perls, T. T.</dc:creator>
<dc:creator>Segre, D.</dc:creator>
<dc:creator>Sebastiani, P.</dc:creator>
<dc:creator>Short, M. I.</dc:creator>
<dc:date>2025-05-18</dc:date>
<dc:identifier>doi:10.1101/2025.05.14.654104</dc:identifier>
<dc:title><![CDATA[Integrative analysis across metagenomic taxonomic classifiers: A case study of the gut microbiome in aging and longevity]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-05-18</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.05.20.655238v1?rss=1">
<title>
<![CDATA[
Real-time imaging of transcriptional feedback in nonsense-mediated mRNA decay 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.05.20.655238v1?rss=1</link>
<description><![CDATA[
Nonsense-mediated mRNA decay (NMD) is a translation-coupled mRNA decay pathway triggered by a premature termination codon (PTC). While in-frame stop codons are typically defined by cytoplasmic ribosomes, unexpected changes in transcription have been reported in genes containing PTCs. This observation suggests the possibility of PTC detection at the transcription site, which has not been thoroughly investigated with high temporal and spatial resolution. Here we utilize a real-time imaging approach to simultaneously detect transcription sites expressing wild-type or NMD-targeted {beta}-globin reporter genes in the same cell. Our data indicates a dynamic change in the transcription of PTC-containing {beta}-globin mRNA that depends on translation, NMD, and nuclear protein import, supporting the existence of rapid transcriptional feedback following NMD in the cytoplasm. This study establishes a robust temporal link between cytoplasmic mRNA decay and nuclear transcription.

One-Sentence SummaryHigh temporal and spatial detection of transcriptional feedback in Nonsense-mediated mRNA decay.
]]></description>
<dc:creator>Sato, H.</dc:creator>
<dc:creator>Islam, M. D.</dc:creator>
<dc:creator>Das, T.</dc:creator>
<dc:creator>Singer, R. H.</dc:creator>
<dc:date>2025-05-21</dc:date>
<dc:identifier>doi:10.1101/2025.05.20.655238</dc:identifier>
<dc:title><![CDATA[Real-time imaging of transcriptional feedback in nonsense-mediated mRNA decay]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-05-21</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.05.21.655101v1?rss=1">
<title>
<![CDATA[
In vivo anti-tumor activity of high-dose parenteral ascorbic acid is mediated primarily via cofactor activity, not via oxidative stress. 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.05.21.655101v1?rss=1</link>
<description><![CDATA[
The anti-tumor effect of high-dose ascorbic acid (AA) has been demonstrated in multiple in vitro and in vivo cancer models with the postulation of two primary categories of mechanisms: antioxidant/cofactor activity and H2O2-mediated oxidative damage. Both mechanisms have been conclusively demonstrated in vitro. However, while parenteral high-dose AA-induced cofactor activity (TET-mediated DNA demethylation and prolyl/asparaginyl hydroxylase-mediated HIF activity inhibition via reduction of enzymatic Fe3+ to Fe2+) has been demonstrated intratumorally in vivo in multiple models, the cumulative data on parenteral high-dose AA-induced intratumoral oxidative damage in vivo has been inconclusive. Furthermore, the relative contribution of the seemingly opposing mechanisms towards in vivo anti-cancer activity has not been studied concurrently. We therefore sought to definitively delineate the roles of both antioxidant/cofactor activity and prooxidant functions of high-dose AA in the in vivo anti-tumor response. Using two syngeneic mouse tumor models, the AA-sensitive A20 model and the AA-resistant Renca model, we assessed markers of DNA and lipid oxidative damage as well as the specific roles of TET2 and AA transporter SLC23A2 in the anti-tumor response to parenteral high-dose AA. In the sensitive A20 model, loss of either Tet2 or Slc23a2 fully reversed anti-tumor activity. Similarly, overexpression of Tet2 in the resistant Renca model (which expresses high baseline levels of AA transporters SLC23A1 and SLC23A2, but does not express TET2), resulted in increased CD8+T cell infiltration and dramatic reduction in tumor growth overall. In both A20 and Renca models, high-dose parenteral AA increased total intratumoral antioxidant capacity, and this was attenuated by Slc23a2 knockdown in A20. High-dose AA treatment also resulted in a Tet2- and Slc23a2-dependent increase in intratumoral 5-hydroxymethylcytosine. Intracellular oxidative damage markers, 8-OHdG and 4-HNE, were not induced in tumors by high-dose AA in either model. In contrast, these markers were robustly induced in vitro by high-dose AA in A20 and Renca cells. Using dynamic real-time extracellular H2O2 measurements with high-dose AA, difference in molecular oxygen concentration between standard in vitro and hypoxic in vivo conditions was identified as an important factor underlying the marked discrepancy between the abundant in vitro and absent in vivo intratumoral oxidative stress with high-dose AA. Furthermore, using additional syngeneic models resistant (MB49) and sensitive (MC38) to AA-induced potentiation of anti-PD1 checkpoint inhibition, we demonstrate that very low catalase expression does not confer sensitivity to high-dose AA in vivo (further arguing against the H2O2 mechanism in vivo), that TET2 expression alone is not sufficient to drive an AA-induced anti-tumor response (either as a single agent or in combination with immunotherapy), and that high-dose AA can significantly enhance the efficacy of anti-PD1 immunotherapy even in the absence of single-agent activity. Our data strongly indicate that the in vivo anti-tumor effect of high-dose parenteral AA-including potentiation of immunotherapy-is mediated primarily by its specific antioxidant/cofactor activity (with TET2 expression likely being necessary but certainly not sufficient), and not via oxidative stress. Collectively, the study represents a paradigm shift in our understanding of the cumulative mechanisms of in vivo anti-cancer activity of high-dose AA, with critical implications not just for the clinical translation of AA as an anti-cancer agent (including in enhancing immunotherapy efficacy) but also the field of free radical biology.

O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=114 SRC="FIGDIR/small/655101v1_ufig1.gif" ALT="Figure 1">
View larger version (33K):
org.highwire.dtl.DTLVardef@efc305org.highwire.dtl.DTLVardef@ecb41corg.highwire.dtl.DTLVardef@24ac2dorg.highwire.dtl.DTLVardef@1a3f0b1_HPS_FORMAT_FIGEXP  M_FIG C_FIG
]]></description>
<dc:creator>Akram, T.</dc:creator>
<dc:creator>Luchtel, R. A.</dc:creator>
<dc:creator>Dubey, V.</dc:creator>
<dc:creator>Seal, S.</dc:creator>
<dc:creator>Aggarwal, R.</dc:creator>
<dc:creator>Sai, H.</dc:creator>
<dc:creator>Shenoy, N. K.</dc:creator>
<dc:date>2025-05-24</dc:date>
<dc:identifier>doi:10.1101/2025.05.21.655101</dc:identifier>
<dc:title><![CDATA[In vivo anti-tumor activity of high-dose parenteral ascorbic acid is mediated primarily via cofactor activity, not via oxidative stress.]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-05-24</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.05.22.655602v1?rss=1">
<title>
<![CDATA[
DNA2 and FANCM function in two distinctive pathways in disrupting TERRA R-loops and suppressing replication stress at ALT telomeres 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.05.22.655602v1?rss=1</link>
<description><![CDATA[
Cancers maintain their telomeres through two main telomere maintenance mechanisms (TMMs): 85-90% of cancers rely on telomerase, while 10-15% of cancers adopt the Alternative Lengthening of Telomere (ALT) pathway. Previously, we and others reported that FANCM, one of the Fanconi Anemia proteins, plays a critical role in suppressing replication stress and DNA damage at ALT telomeres by actively disrupting TERRA R-loops [1-4]. Here, we showed that inactivation of DNA2 in ALT-positive (ALT+) cells, but not in telomerase-positive (TEL+) cells, induces a robust increase of replication stress and DNA damage at telomeres, which leads to a pronounced increase of many ALT properties, including telomere dysfunction-induced foci (TIFs), ALT-associated PML bodies (APBs), and C-circles. We further demonstrated that depletion of DNA2 induces a pronounced increase of TERRA R-loops and a decrease in replication efficiency at ALT telomeres. Most importantly, we uncovered a strong additive genetic interaction between DNA2 and FANCM in the ALT pathway. Furthermore, co-depletion of DNA2 and FANCM causes synthetic lethality in ALT+ cells, but not in TEL+ cells, suggesting that targeting DNA2 and FANCM could be a viable strategy to treat ALT+ cancers. Finally, utilizing the single-molecule telomere assay via optical mapping (SMTA-OM) technology, we thoroughly characterized genome-wide changes in DNA2 deficient cells and FANCM deficient cells and found that most chromosome arms manifested increased telomere length. Unexpectedly, we uncovered many chromosome arm-specific telomere changes in those cells, suggesting that telomeres at different chromosome arms may regulate and respond to replication stress differently. Collectively, our study not only shed new light on the molecular mechanisms of the ALT pathway, but also discovered a new strategy for targeting ALT+ cancer.
]]></description>
<dc:creator>Ragupathi, A.</dc:creator>
<dc:creator>Abid, H. Z.</dc:creator>
<dc:creator>Chen, Y.</dc:creator>
<dc:creator>Zhao, R.</dc:creator>
<dc:creator>Kosiyatrakul, S. T.</dc:creator>
<dc:creator>Yetil, D. I.</dc:creator>
<dc:creator>Neiswander, J.</dc:creator>
<dc:creator>Feltman, R.</dc:creator>
<dc:creator>Thomas, S.</dc:creator>
<dc:creator>Yusupov, B.</dc:creator>
<dc:creator>Singh, M.</dc:creator>
<dc:creator>Zheng, L.</dc:creator>
<dc:creator>Shen, B.</dc:creator>
<dc:creator>Zhang, H.</dc:creator>
<dc:creator>Chu, H.-P. C.</dc:creator>
<dc:creator>Schildkraut, C. L.</dc:creator>
<dc:creator>Xiao, M.</dc:creator>
<dc:creator>Zhang, D.</dc:creator>
<dc:date>2025-05-24</dc:date>
<dc:identifier>doi:10.1101/2025.05.22.655602</dc:identifier>
<dc:title><![CDATA[DNA2 and FANCM function in two distinctive pathways in disrupting TERRA R-loops and suppressing replication stress at ALT telomeres]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-05-24</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.05.25.655971v1?rss=1">
<title>
<![CDATA[
The H3K36M oncohistone inhibits NSD2 to activate a SETD2-dependent antiviral-like immune response in KRAS-driven lung cancer 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.05.25.655971v1?rss=1</link>
<description><![CDATA[
Mutations in histone 3 at or near lysine 36 (H3K36) have dominantly acting oncogenic effects in multiple tumor types by limiting H3K36-directed methyltransferases. Paradoxically, we find that expression of the H3K36M oncohistone unexpectedly inhibits tumor formation in KRAS-driven lung adenocarcinoma by inducing a potent immune-mediated tumor clearance. Mechanistically, oncohistone expression derepresses endogenous retroviral element transcription, results in the accumulation of double-stranded RNA (dsRNA), and activates an innate antiviral-like immune response that eradicates tumor growth. Surprisingly, while inactivation of the H3K36 di-methyltransferase NSD2 replicated all effects of oncohistone expression, inactivation of the H3K36 tri-methyltransferase SETD2 abolished element derepression and all associated downstream anti-cancer effects that are induced by oncohistone expression. These observations restructure our understanding of the roles of H3K36 methylation, the consequences of its deregulation in cancer, and shape our expectations for therapeutic interventions targeting H3K36 methyltransferases.
]]></description>
<dc:creator>Gladstein, A. C.</dc:creator>
<dc:creator>Poltorack, C. D.</dc:creator>
<dc:creator>Solomon, A. M. C.</dc:creator>
<dc:creator>Venkatesh, S.</dc:creator>
<dc:creator>Adler, K. M.</dc:creator>
<dc:creator>Robertson, M. R.</dc:creator>
<dc:creator>Stransky, S.</dc:creator>
<dc:creator>Irizarry-Negron, V. M.</dc:creator>
<dc:creator>Ruiz, D. A.</dc:creator>
<dc:creator>Freeburg, N. F.</dc:creator>
<dc:creator>Sidoli, S.</dc:creator>
<dc:creator>Asangani, I. A.</dc:creator>
<dc:creator>Shaffer, S. M.</dc:creator>
<dc:creator>Feldser, D. M.</dc:creator>
<dc:date>2025-05-28</dc:date>
<dc:identifier>doi:10.1101/2025.05.25.655971</dc:identifier>
<dc:title><![CDATA[The H3K36M oncohistone inhibits NSD2 to activate a SETD2-dependent antiviral-like immune response in KRAS-driven lung cancer]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-05-28</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.05.24.655950v1?rss=1">
<title>
<![CDATA[
Robust Serum Proteomic Signatures of APOE2 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.05.24.655950v1?rss=1</link>
<description><![CDATA[
We previously identified a signature of 16 serum proteins that highlighted a role of the e2 allele of APOE in lipid regulation via apolipoprotein B (APOB) and apolipoprotein E (APOE), and in inflammation. The serum proteins were profiled using the aptamer-based Somalogic technology. Here, we validate and expand the serum protein signature of APOE using a combination of mass-spectrometry, ELISA, Luminex, antibody-based Olink proteomics, and blood transcriptomics. We replicate the association between APOB and the e2 allele of APOE, we correct the pattern of association between APOE genotypes and serum level of APOE, and we detect new associations between APOE genotypes and the complex of apolipoproteins APOC1, APOC4, APOC2, APOC3, APOE, APOF and APOL1. In addition, we discover 13 new proteins that correlate with APOE genotypes. This extended signature includes granule proteins CAMP, CTSG, DEFA3, and MPO secreted from neutrophils and points to olfactomedin 4 (OLFM4) as a new target for the prevention of Alzheimers disease.
]]></description>
<dc:creator>Sebastiani, P.</dc:creator>
<dc:creator>Reed, E.</dc:creator>
<dc:creator>Chandler, K. B.</dc:creator>
<dc:creator>Lopez, P.</dc:creator>
<dc:creator>Lords, H.</dc:creator>
<dc:creator>Bae, H.</dc:creator>
<dc:creator>Costello, C. E.</dc:creator>
<dc:creator>Au, M.</dc:creator>
<dc:creator>Denn, L.</dc:creator>
<dc:creator>Li, M.</dc:creator>
<dc:creator>Xiang, Q.</dc:creator>
<dc:creator>Noh, H.</dc:creator>
<dc:creator>Pflieger, L.</dc:creator>
<dc:creator>Funk, C.</dc:creator>
<dc:creator>Rappaport, N.</dc:creator>
<dc:creator>Nygaard, M.</dc:creator>
<dc:creator>Short, M.</dc:creator>
<dc:creator>Brent, M.</dc:creator>
<dc:creator>Monti, S.</dc:creator>
<dc:creator>Andersen-Toomey, S. L.</dc:creator>
<dc:creator>Perls, T.</dc:creator>
<dc:date>2025-05-29</dc:date>
<dc:identifier>doi:10.1101/2025.05.24.655950</dc:identifier>
<dc:title><![CDATA[Robust Serum Proteomic Signatures of APOE2]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-05-29</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.06.01.657217v1?rss=1">
<title>
<![CDATA[
NeuID, a novel neuron-specific lncRNA, resolved a key epigenetic mechanisms linking gene silencing to Alzheimer's disease 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.06.01.657217v1?rss=1</link>
<description><![CDATA[
The increasing evidence that non-coding RNAs can become deregulated during pathogenesis is dramatically expanding the space for drug discovery beyond the protein-coding genome. Long noncoding RNAs (lncRNAs) are emerging as key regulators of cellular function, yet most remain uncharacterized. Here, we identify a previously unstudied lncRNA, which we named Neuronal Identity (NeuID)--a conserved, brain-enriched transcript expressed exclusively in neurons. NeuID is downregulated in the brains of Alzheimers disease (AD) patients. Mechanistically, NeuID maintains neuronal identity by repressing developmental and glial genes via interaction with the PRC2 subunit EZH2 and regulation of H3K27me3. Knockdown of NeuID disrupts this repression, leading to impaired neuronal activity and memory formation. Importantly, CRISPRa-mediated NeuID overexpression restores neuronal function in A{beta}42-treated neurons. These findings identify NeuID as a critical regulator of neuronal plasticity and position it as a promising therapeutic target for AD.

One sentence summaryWe identify NeuID, a novel brain and neuron-specific long non-coding RNA downregulated in Alzheimers disease, as a key regulator of neuronal identity and a promising therapeutic target to restore neuronal function.
]]></description>
<dc:creator>Pradhan, R.</dc:creator>
<dc:creator>Petrovic, Z.</dc:creator>
<dc:creator>Sakib, M. S.</dc:creator>
<dc:creator>Schroeder, S.</dc:creator>
<dc:creator>Krueger, D. M.</dc:creator>
<dc:creator>Pena, T.</dc:creator>
<dc:creator>Diniz, E.</dc:creator>
<dc:creator>Burkhardt, S.</dc:creator>
<dc:creator>Schuetz, A.-L.</dc:creator>
<dc:creator>Grz_dzielewska, I.</dc:creator>
<dc:creator>Toischer, K.</dc:creator>
<dc:creator>Stein, T. D.</dc:creator>
<dc:creator>Blusztajn, J. K.</dc:creator>
<dc:creator>Delalle, I.</dc:creator>
<dc:creator>Radulovic, J.</dc:creator>
<dc:creator>Sananbenesi, F.</dc:creator>
<dc:creator>Fischer, A.</dc:creator>
<dc:date>2025-06-03</dc:date>
<dc:identifier>doi:10.1101/2025.06.01.657217</dc:identifier>
<dc:title><![CDATA[NeuID, a novel neuron-specific lncRNA, resolved a key epigenetic mechanisms linking gene silencing to Alzheimer's disease]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-06-03</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.06.02.657442v1?rss=1">
<title>
<![CDATA[
Increased Genetic Protection Against Alzheimer's Disease in Centenarians 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.06.02.657442v1?rss=1</link>
<description><![CDATA[
We constructed a polygenic protective score specific to Alzheimers disease (AD PPS) based on the current literature among the participants enrolled in five studies of healthy aging and extreme longevity in the US, Europe, and Asia. This AD PPS did not include variants on Apolipoprotein E (APOE) gene. Comparisons of AD PPS in different data sets of healthy agers and centenarians showed that centenarians have stronger genetic protection against AD compared to individuals without familial longevity. The current study also shows evidence that this genetic protection increases with increasingly older ages in centenarians (centenarians who died before reaching age 105 years, semi-supercentenarians who reached age 105 to 109 years, and supercentenarians who reached age 110 years and older). However, the genetic protection was of modest size: the average increase in AD PPS was approximately one additional protective allele per 5 years of gained lifetime. Additionally, we show that the higher AD PPS was associated with better cognitive function and decreased mortality. Taken together, this analysis suggests that individuals who achieve the most extreme ages, on average, have the greatest protection against AD. This finding is robust to different genetic backgrounds with important implications for universal applicability of therapeutics that target this AD PPS.
]]></description>
<dc:creator>Bae, H.</dc:creator>
<dc:creator>Song, Z.</dc:creator>
<dc:creator>Ali, A.</dc:creator>
<dc:creator>Sasaki, T.</dc:creator>
<dc:creator>Tesi, N.</dc:creator>
<dc:creator>Lords, H.</dc:creator>
<dc:creator>Leshchyk, A.</dc:creator>
<dc:creator>Abe, Y.</dc:creator>
<dc:creator>Hirose, N.</dc:creator>
<dc:creator>Arai, Y.</dc:creator>
<dc:creator>Barzilai, N.</dc:creator>
<dc:creator>Weiss, E. F.</dc:creator>
<dc:creator>Hulsman, M.</dc:creator>
<dc:creator>van der Lee, S. J.</dc:creator>
<dc:creator>van Schoor, N. M.</dc:creator>
<dc:creator>Huisman, M.</dc:creator>
<dc:creator>Pijnenburg, Y. A. L.</dc:creator>
<dc:creator>van der Flier, W. M.</dc:creator>
<dc:creator>Reinders, M.</dc:creator>
<dc:creator>Holstege, H.</dc:creator>
<dc:creator>Milman, S.</dc:creator>
<dc:creator>Perls, T.</dc:creator>
<dc:creator>Andersen, S. L.</dc:creator>
<dc:creator>Sebastiani, P.</dc:creator>
<dc:date>2025-06-03</dc:date>
<dc:identifier>doi:10.1101/2025.06.02.657442</dc:identifier>
<dc:title><![CDATA[Increased Genetic Protection Against Alzheimer's Disease in Centenarians]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-06-03</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.06.03.657682v1?rss=1">
<title>
<![CDATA[
Linker Histone H1.5 Contributes to Centromere Integrity in Human Cells 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.06.03.657682v1?rss=1</link>
<description><![CDATA[
Mammalian H1 linker histones comprise a group of 11 non-allelic variants which have key roles in modulating chromatin. H1 variant specific genomic distribution contributes to fine tuning regulation of gene expression and chromatin architecture. Contradictory reports on the presence and role of H1 histones at centromeres led us to further investigate whether H1s impact centromeric chromatin. In this study, we focused on H1.5 and by in vitro assays we showed that H1.5 directly interacts with centromeric-protein A (CENP-A) mononucleosomes. Notably, our in vitro findings revealed that H1 variants H1.0 and H1.2 can also bind CENP-A nucleosomes, although with differing affinities and signatures, asserting centromeric localization may not be unique to H1.5. In human cells, H1.5 localized to the centromere and chromatin immuno-precipitation revealed an interaction between H1.5 with CENP-A nucleosomes. Knocking down of H1.5 resulted in the loss of centromeric -satellite transcription, reduction in loading of new CENP-A, and the accumulation of mitotic defects. These data point to an unreported role for histone H1 in the regulation of mitotic integrity in human cells.

O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=120 SRC="FIGDIR/small/657682v1_ufig1.gif" ALT="Figure 1">
View larger version (29K):
org.highwire.dtl.DTLVardef@26a35borg.highwire.dtl.DTLVardef@aecc44org.highwire.dtl.DTLVardef@1e49939org.highwire.dtl.DTLVardef@107a485_HPS_FORMAT_FIGEXP  M_FIG Graphical AbstractProposed model of H1.5 function at the centromere. When H1.5 is bound to the CENP-A nucleosomes at the centromere, the centromeric chromatin allows RNAPII based transcription to generate -satellite transcripts, which in turn allows for de novo CENP-A loading. The absence of H1.5 blocks this transcription, leading to an accumulation of mitotic defects.

C_FIG
]]></description>
<dc:creator>Saha, A.</dc:creator>
<dc:creator>Bui, M.</dc:creator>
<dc:creator>Melters, D. P.</dc:creator>
<dc:creator>Ganesan, A. K.</dc:creator>
<dc:creator>Baek, S.</dc:creator>
<dc:creator>Bentahar, R. S.</dc:creator>
<dc:creator>Dalal, Y.</dc:creator>
<dc:date>2025-06-03</dc:date>
<dc:identifier>doi:10.1101/2025.06.03.657682</dc:identifier>
<dc:title><![CDATA[Linker Histone H1.5 Contributes to Centromere Integrity in Human Cells]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-06-03</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.06.02.657511v1?rss=1">
<title>
<![CDATA[
Identifying Space-Resolved Proteins of the Murine Thymus, by Combining MALDI Mass Spectrometry Imaging and Proteomics 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.06.02.657511v1?rss=1</link>
<description><![CDATA[
The ability to identify spatially resolved proteomes has advanced markedly in recent years, yet integrating definitive protein identification with precise spatial localization in a single workflow remains a challenge. Matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI-MSI) enables antibody-free mapping of proteins directly in tissue sections, but its capacity for unambiguous protein identification is limited. Here, we present a combined MALDI-MSI and liquid chromatography-tandem mass spectrometry (LC-MS/MS) approach, to map protein localization, and track spatial changes in murine thymus during chemotherapy-induced involution and regeneration. Our workflow incorporates a scoring algorithm (pepBridge) that aligns MALDI-MSI molecular signals with LC-MS/MS identifications, enabling confident assignment of proteins that are critical to thymic function. Using this pipeline, we reveal spatiotemporal changes in proteins involved in cell migration, cytoskeletal remodeling, and endogenous thymic regeneration. Notably, we identify distinct spatial shifts in Nucleoprotein TPR and Tubulin-associated chaperone A (TBCA), corresponding to chemotherapy-driven architectural remodeling. From a translational perspective, these findings highlight pathways and candidate targets to promote immune recovery in pediatric cancer patients undergoing cytoreductive therapy. Analytically, this framework advances spatial proteomics by enabling high-confidence protein identification in lymphoid and other tissues, broadening the potential of translational proteomic research.
]]></description>
<dc:creator>Aguilan, J. T.</dc:creator>
<dc:creator>Madrid-Aliste, C.</dc:creator>
<dc:creator>Lagou, M. K.</dc:creator>
<dc:creator>Sidoli, S.</dc:creator>
<dc:creator>Karagiannis, G. S.</dc:creator>
<dc:date>2025-06-05</dc:date>
<dc:identifier>doi:10.1101/2025.06.02.657511</dc:identifier>
<dc:title><![CDATA[Identifying Space-Resolved Proteins of the Murine Thymus, by Combining MALDI Mass Spectrometry Imaging and Proteomics]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-06-05</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.06.10.658848v1?rss=1">
<title>
<![CDATA[
Metadimensional simulation for biochemistry and pharmacology learning 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.06.10.658848v1?rss=1</link>
<description><![CDATA[
The integration of active learning strategies in health education is essential for improving student engagement and understanding, particularly in basic sciences like pharmacology and biochemistry. However, these disciplines are often perceived as abstract and disconnected from clinical practice. The aim was to develop and evaluate two innovative, live-action simulations for teaching fundamental concepts in pharmacokinetics and enzyme kinetics, using accessible materials and student-centered design. The study involved 305 students from health-related undergraduate and graduate programs. Two simulations were designed: a pharmacokinetics (PK) simulation representing systemic circulation and drug metabolism using plastic blocks and classroom stations; an enzyme kinetics (EK) simulation using both digital slides and physical block sets to model substrate-product reactions and construct Michaelis-Menten curves. Student perceptions were measured using a Likert-scale instrument adapted from validated educational models. Quantitative data (pharmacokinetic and enzymatic curves) were also generated from simulation outcomes. Students successfully built representative pharmacokinetic and enzymatic activity curves, allowing exploration of key concepts such as drug absorption, metabolism, Cmax, Tmax, half-life, and enzyme-substrate reaction rates. Perception surveys revealed high approval levels, particularly regarding the effectiveness, engagement, and collaborative aspects of the simulations. Over 85% of participants preferred the simulation-based approach over traditional lectures. These live-action activities represent a novel, effective, and low-cost strategy for enhancing the teaching of basic sciences in health education. The methods promote experiential learning, integrate cognitive, affective, and psychomotor domains, and foster student autonomy and motivation. These findings support the broader application of active methodologies in foundational science curricula.
]]></description>
<dc:creator>Liguori, M. A. S.</dc:creator>
<dc:creator>Aparicio, A. F.</dc:creator>
<dc:creator>Rocha e Silva, T. A.</dc:creator>
<dc:date>2025-06-11</dc:date>
<dc:identifier>doi:10.1101/2025.06.10.658848</dc:identifier>
<dc:title><![CDATA[Metadimensional simulation for biochemistry and pharmacology learning]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-06-11</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.06.10.658945v1?rss=1">
<title>
<![CDATA[
Neural responses underlying ITD discrimination as a function of sensory reliability in the barn owl 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.06.10.658945v1?rss=1</link>
<description><![CDATA[
Discrimination of sensory stimuli is fundamentally constrained by the information encoded in neuronal responses. In the barn owl, interaural time difference (ITD) serves as a primary cue for azimuthal sound localization and is represented topographically in the midbrain auditory space map in the external nucleus of the inferior colliculus (ICx). While prior studies have demonstrated a correspondence between spatial tuning and behavioral acuity, it remains unclear how changes in sensory reliability influence this relationship. Here, we examined how behavioral and neuronal ITD discrimination thresholds vary with binaural correlation (BC), which manipulates ITD cue reliability. Using the pupil dilation response (PDR) as a behavioral metric in head-fixed owls, we found that ITD just-noticeable-differences increased exponentially as BC decreased. In contrast, the widths of ICx ITD tuning curves increased more modestly, indicating that tuning resolution alone does not account for behavioral discrimination performance. By computing the Fisher information from ICx neuronal responses, we showed that the average neuronal discriminability predicts behavioral thresholds across BC levels. A habituation-based model incorporating BC-dependent changes in tuning width, firing rate, and response variability successfully accounted for both direction and ITD discrimination. These findings support a model in which perceptual acuity is governed by the combined influence of neuronal tuning and variability and provide a unified framework for understanding how midbrain auditory representations underlie adaptive spatial hearing.
]]></description>
<dc:creator>Fischer, B. J.</dc:creator>
<dc:creator>Shadron, K.</dc:creator>
<dc:creator>Keller, C. H.</dc:creator>
<dc:creator>Bala, A. D. S.</dc:creator>
<dc:creator>Cazettes, F.</dc:creator>
<dc:creator>Ferger, R.</dc:creator>
<dc:creator>Pena, J. L.</dc:creator>
<dc:date>2025-06-11</dc:date>
<dc:identifier>doi:10.1101/2025.06.10.658945</dc:identifier>
<dc:title><![CDATA[Neural responses underlying ITD discrimination as a function of sensory reliability in the barn owl]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-06-11</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.06.12.659386v1?rss=1">
<title>
<![CDATA[
Proof-of-Concept in a Murine Model of Treatment of Thrombotic Thrombocytopenic Purpura Using Engineered Red Blood Cells 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.06.12.659386v1?rss=1</link>
<description><![CDATA[
Thrombotic Thrombocytopenic Purpura (TTP) is caused by congenital or acquired deficiency of ADAMTS13, a metalloproteinase that cleaves von Willebrand Factor (vWF) multimers. Current treatments--plasma exchange and immunosuppression--are costly and associated with significant morbidity therefore, alternative strategies are needed.

We developed the kitJak2 platform for producing genetically engineered lab-grown red blood cells (lgRBCs) as drug delivery vectors. We hypothesized that membrane-bound ADAMTS13 displayed on lgRBCs could provide a durable treatment for TTP. To test this, we engineered erythroid cells expressing both wild-type and mutant variants MDTCS fragments of ADAMTS13, conferring resistance to autoantibodies. Flow cytometry and FRET-based assays confirmed robust membrane expression and enzymatic activity. Importantly, mutant MDTCS variants retained catalytic activity in the presence of plasma from TTP patients, whereas wild-type variants were inhibited.

For in vivo evaluation, we generated transgenic mice expressing MDTCS ADAMTS13 on their RBC membranes. These mice exhibited normal RBC half-lives and stable, catalytically active ADAMTS13 expression. Using a murine model of TTP--where ADAMTS13 knockout mice challenged with recombinant human vWF (rhvWF) develop thrombocytopenia and schistocytes--we demonstrated that transfusion of ADAMTS13-expressing RBCs significantly mitigated disease, preventing platelet loss and schistocyte formation. This confirms that membrane-bound MDTCS ADAMTS13 cleaves circulating rhvWF under physiological flow conditions in vivo.

Finally, employing our KitJak2 platform, we generated human enucleated lgRBCs expressing high levels of catalytically active ADAMTS13.

This novel work establishes proof-of-concept that membrane-anchored ADAMTS13-expressing lab- grown RBCs may offer a feasible and effective therapeutic approach for both congenital and acquired TTP.
]]></description>
<dc:creator>Roberts, K. S.</dc:creator>
<dc:creator>Zhang, S.</dc:creator>
<dc:creator>Batbayar, K.</dc:creator>
<dc:creator>Yan, Z.</dc:creator>
<dc:creator>Muia, J.</dc:creator>
<dc:creator>Mulvey, J. J.</dc:creator>
<dc:creator>Olivier, E.</dc:creator>
<dc:creator>Pullman, J. M.</dc:creator>
<dc:creator>Cataland, S. R.</dc:creator>
<dc:creator>Bouhassira, E. E.</dc:creator>
<dc:date>2025-06-15</dc:date>
<dc:identifier>doi:10.1101/2025.06.12.659386</dc:identifier>
<dc:title><![CDATA[Proof-of-Concept in a Murine Model of Treatment of Thrombotic Thrombocytopenic Purpura Using Engineered Red Blood Cells]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-06-15</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.06.12.659393v1?rss=1">
<title>
<![CDATA[
Response dynamics of discrete subiculum->retrosplenial cortex projections underlying trace fear conditioning 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.06.12.659393v1?rss=1</link>
<description><![CDATA[
Associating events separated in time depends on the CA1, subiculum (SUB), and retrosplenial cortex (RSP). The degree to which their connectivity and underlying circuit mechanisms contribute to the association of such temporally discontiguous events is not known. Here we showed, using trace fear conditioning (TFC), wherein mice learn to associate tone and shock separated by a temporal trace, that molecularly distinct excitatory VGluT1+ and VGluT2+ SUB[-&gt;]RSP projections subserve the associative and temporal components of TFC. During trace memory formation, VGluT2+ SUB[-&gt;]RSP projections showed increased and decreased bulk calcium activity at tone and trace onset, respectively, an activity pattern that was reestablished during memory recall. Such pattern was not observed in CA subfields, suggesting that associative and temporal components of TFC are integrated at the SUB or SUB[-&gt;]RSP synapses before being presented to the RSP. Our findings establish a circuit mechanism for representing complex temporal information in episodic memory.
]]></description>
<dc:creator>Bassett, T. E.</dc:creator>
<dc:creator>Wang, Y.-Z.</dc:creator>
<dc:creator>Wood, E. M.</dc:creator>
<dc:creator>Zhang, H.</dc:creator>
<dc:creator>Petrovic, Z.</dc:creator>
<dc:creator>Prifti, V.</dc:creator>
<dc:creator>Jovasevic, V.</dc:creator>
<dc:creator>Yamawaki, N.</dc:creator>
<dc:creator>Ren, L.</dc:creator>
<dc:creator>Khalatyan, N.</dc:creator>
<dc:creator>Grayson, V.</dc:creator>
<dc:creator>Savas, J. N.</dc:creator>
<dc:creator>Radulovic, J.</dc:creator>
<dc:creator>Cicvaric, A.</dc:creator>
<dc:date>2025-06-15</dc:date>
<dc:identifier>doi:10.1101/2025.06.12.659393</dc:identifier>
<dc:title><![CDATA[Response dynamics of discrete subiculum->retrosplenial cortex projections underlying trace fear conditioning]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-06-15</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.06.17.660152v1?rss=1">
<title>
<![CDATA[
High-resolution in situ structures of hantavirus glycoprotein tetramers 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.06.17.660152v1?rss=1</link>
<description><![CDATA[
SUMMARY/ABSTRACTNew World hantaviruses cause severe infections in humans, with case fatality rates approaching 40%. Previous structural studies have advanced our understanding of hantavirus glycoprotein architecture and function, however, the lack of high-resolution in situ structures of the glycoprotein tetramer and its lattice organization has limited mechanistic insights into viral assembly, entry, and antigenicity. Here, we leveraged a virus-like particle (VLP) system to establish a cryo-electron microscopy workflow for lattice-forming viral glycoproteins. This enabled the determination of a 2.35 [A] resolution structure of the membrane-embedded Andes virus (ANDV) glycoprotein tetramer, as well as structures of dimers of tetramers and a complex with antibody ADI-65534. These structures reveal previously uncharacterized features of glycoprotein organization, stability, and pH-sensing. Immunization of mice with self-amplifying replicon RNA (repRNA) encoding ANDV-VLPs elicited high levels of glycoprotein-binding antibodies but equivalent titers of neutralizing antibodies compared to repRNA-encoded native ANDV glycoprotein complex. Collectively, these findings advance our understanding of hantavirus glycoprotein assemblies and their function, laying a foundation for structure-based vaccine design efforts.
]]></description>
<dc:creator>Guo, L.</dc:creator>
<dc:creator>McFadden, E.</dc:creator>
<dc:creator>Slough, M. M.</dc:creator>
<dc:creator>Stone, E. T.</dc:creator>
<dc:creator>Berrigan, J.</dc:creator>
<dc:creator>Mittler, E.</dc:creator>
<dc:creator>Hatzakis, K.</dc:creator>
<dc:creator>Hinkley, T.</dc:creator>
<dc:creator>Kain, H.</dc:creator>
<dc:creator>Ke, Z.</dc:creator>
<dc:creator>Warner, N. L.</dc:creator>
<dc:creator>Erasmus, J. H.</dc:creator>
<dc:creator>Chandran, K.</dc:creator>
<dc:creator>McLellan, J. S.</dc:creator>
<dc:date>2025-06-18</dc:date>
<dc:identifier>doi:10.1101/2025.06.17.660152</dc:identifier>
<dc:title><![CDATA[High-resolution in situ structures of hantavirus glycoprotein tetramers]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-06-18</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.06.19.660520v1?rss=1">
<title>
<![CDATA[
The unique role of nucS-mediated non-canonical mismatch repair in Mycobacterium tuberculosis resistance evolution 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.06.19.660520v1?rss=1</link>
<description><![CDATA[
DNA surveillance mechanisms play a vital role in maintaining genome stability and minimizing mutation rates. One such mechanism, post-replicative mismatch repair (MMR), corrects replication errors that escape DNA polymerase proofreading activity. In most bacteria and eukaryotes, MMR is orchestrated by MutS and MutL proteins. However, certain archaeal and actinobacterial species, including the major human pathogen Mycobacterium tuberculosis, lack these components. Instead, they rely on the nuclease EndoMS/NucS, a structurally distinct enzyme that governs a non-canonical MMR pathway. Given that M. tuberculosis acquires drug resistance exclusively through chromosomal mutations, understanding mutation rate regulation in this pathogen is critical. Nevertheless, despite its anticipated significance, the role of NucS in drug resistance evolution remains largely unexplored in this organism.

This study investigates NucS function in M. tuberculosis and uncovers a unique resistance dynamic distinct from other Actinobacteria. While nucS deletion alters the mutational spectrum, it minimally affects the emergence of rifampicin-, isoniazid-, and ethambutol-resistant mutations, in stark contrast to its role in other Actinobacteria. We demonstrated that this atypical behaviour is not attributable to the presence of a single NucS polymorphism, R144S, in the NucS sequence of the M. tuberculosis reference strain H37Rv, which differs from the NucS consensus sequence. Constructing and analysing an H37Rv variant possessing the NucS consensus sequence revealed a subtly altered mutational spectrum but unchanged mutation rates. Notably, database analysis of the R144S polymorphism in clinical isolates revealed its prevalence and significant association with ethambutol resistance. These findings challenge the established view that nucS serves as a genome stability guardian that minimizes mutation rates in M. tuberculosis, suggesting additional mismatch repair mechanisms beyond NucS or a highly efficient replication system in this pathogen.
]]></description>
<dc:creator>Martin-Blecua, I.</dc:creator>
<dc:creator>Valverde, J. R.</dc:creator>
<dc:creator>Garcia-Bravo, P.</dc:creator>
<dc:creator>Ruiz-Enamorado, A.</dc:creator>
<dc:creator>Prados-Rosales, R.</dc:creator>
<dc:creator>Sastre-Dominguez, J.</dc:creator>
<dc:creator>Das, L.</dc:creator>
<dc:creator>Jacobs, W. R.</dc:creator>
<dc:creator>San Millan, A.</dc:creator>
<dc:creator>Blazquez, J.</dc:creator>
<dc:creator>Gullon, S.</dc:creator>
<dc:date>2025-06-19</dc:date>
<dc:identifier>doi:10.1101/2025.06.19.660520</dc:identifier>
<dc:title><![CDATA[The unique role of nucS-mediated non-canonical mismatch repair in Mycobacterium tuberculosis resistance evolution]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-06-19</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.06.18.660405v1?rss=1">
<title>
<![CDATA[
Intrinsically Disordered Regions Form Nucleoli and Cajal Bodies While Fostering RNA Modification 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.06.18.660405v1?rss=1</link>
<description><![CDATA[
One of the densest compartments in the cell is the dense fibrillar component (DFC) of the nucleolus, consisting mainly of nascent ribosomal RNA (rRNA), small nucleolar ribonucleoproteins (snoRNPs) and their chaperone Nopp140. How this biomolecular condensate is formed and what underlies its structure is poorly understood like that of most liquid-liquid phase separated condensates. Although we established that Nopp140 is important for the cohesiveness of the DFC and for rRNA modification, it is not known how this is achieved. Here we demonstrate that Nopp140 concentrates intrinsically disordered and nuclear localization signal (NLS)-rich protein regions (IDRs), including a newly identified RNA polymerase I C-terminal domain (CTD) of the RNA polymerase I associated factor PAF49. Altogether, this network forms the DFC, a liquid-liquid phase separated biomolecular condensate that fosters rRNA modification. This mechanism ensures near 100 percent modification efficiency at some 200 nucleotides in every one of the 10 million or so rRNAs per cell.
]]></description>
<dc:creator>Meznad, K.</dc:creator>
<dc:creator>Deogharia, M.</dc:creator>
<dc:creator>Wacheul, L.</dc:creator>
<dc:creator>Zorbas, C.</dc:creator>
<dc:creator>Lafontaine, D. L.</dc:creator>
<dc:creator>Meier, U. T.</dc:creator>
<dc:date>2025-06-20</dc:date>
<dc:identifier>doi:10.1101/2025.06.18.660405</dc:identifier>
<dc:title><![CDATA[Intrinsically Disordered Regions Form Nucleoli and Cajal Bodies While Fostering RNA Modification]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-06-20</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.07.03.662851v1?rss=1">
<title>
<![CDATA[
The ASNS inhibitor ASX-173 potentiates L-asparaginase anticancer activity 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.07.03.662851v1?rss=1</link>
<description><![CDATA[
Cancer cells reprogram metabolic pathways to meet increased energy and biosynthetic demands. Among those pathways, elevated asparagine metabolism regulated by asparagine synthetase (ASNS) has been linked to tumor progression in various cancers, driving cell proliferation, chemoresistance, and metastasis. ASNS inhibition represents a promising therapeutic strategy, but inhibitors have shown limited efficacy due to poor specificity and cell permeability. Through phenotypic screening, we identified ASX-173, a cell-permeable small molecule that inhibits ASNS at nanomolar concentrations. Biochemical and cellular assays confirm the specificity of ASX-173 activity and demonstrate its potentiation of the anti-cancer activity of L-asparaginase (ASNase), a key component of childhood acute lymphoblastic leukemia therapy. Mechanistically, the combination treatment disrupted nucleotide synthesis and induced cell cycle arrest and apoptosis. In a mouse model of acute myeloid leukemia, the combination significantly delayed the growth of OCI-AML2 xenografts. Analysis of data from The Cancer Genome Atlas (TCGA) revealed that ASNS mRNA expression is associated with poor survival in some cancer types and that ASNS protein levels are elevated in multiple solid tumors compared with the levels in normal tissues, suggesting possible broad utility of ASNS inhibition across the landscape of cancer. Together, these findings establish ASX-173 as a promising ASNS inhibitor and, for the first time, demonstrate a viable strategy to target ASNS therapeutically--an approach that has long remained elusive.
]]></description>
<dc:creator>Tatarskiy, V.</dc:creator>
<dc:creator>Chan, W.-K.</dc:creator>
<dc:creator>Tan, L.</dc:creator>
<dc:creator>Khamidullina, A.</dc:creator>
<dc:creator>Mahmud, I.</dc:creator>
<dc:creator>Kumar, S. V.</dc:creator>
<dc:creator>Nuzhina, J.</dc:creator>
<dc:creator>Martinez, S. A.</dc:creator>
<dc:creator>Tran, B. Q.</dc:creator>
<dc:creator>Skwarska, A.</dc:creator>
<dc:creator>Pavlenko, N.</dc:creator>
<dc:creator>Dorofeeva, A.</dc:creator>
<dc:creator>Konopleva, M.</dc:creator>
<dc:creator>Genis, D.</dc:creator>
<dc:creator>Weinstein, J. N.</dc:creator>
<dc:creator>Kombarov, R.</dc:creator>
<dc:creator>Lorenzi, P. L.</dc:creator>
<dc:date>2025-07-07</dc:date>
<dc:identifier>doi:10.1101/2025.07.03.662851</dc:identifier>
<dc:title><![CDATA[The ASNS inhibitor ASX-173 potentiates L-asparaginase anticancer activity]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-07-07</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.07.03.663002v1?rss=1">
<title>
<![CDATA[
PRMT5 activity sustains histone production to maintain genome integrity 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.07.03.663002v1?rss=1</link>
<description><![CDATA[
Histone proteins package DNA into nucleosomes, forming chromatin and thereby safeguarding genome integrity. Proper histone expression is essential for cell proliferation and chromatin organization, yet the upstream regulators of histone supply remain incompletely understood. PRMT5--a cell essential type II protein arginine methyltransferase frequently overexpressed in cancer--catalyzes symmetric dimethylation of arginine residues. Using time-resolved nascent transcriptional profiling, quantitative proteomics, and imaging, we show that PRMT5 activity is required to sustain histone transcription and histone protein synthesis during S phase. PRMT5 inhibition or knockdown leads to rapid histone mRNA depletion, loss of histone proteins, and accumulation of replicationassociated nuclear abnormalities. We further show that soluble histone H4 accumulates at histone locus bodies (HLBs) upon PRMT5 inhibition, and that PRMT5-substrate H4 Arginine 3 mutants localize more robustly to HLBs than do wildtype H4. These findings support a model in which PRMT5-mediated methylation of histone H4 regulates histone transcription. Our findings establish PRMT5 as a central coordinator of histone homeostasis and provide a mechanistic rationale for its essential role in proliferating cells.
]]></description>
<dc:creator>Roth, J. S.</dc:creator>
<dc:creator>DeAngelo, J. D.</dc:creator>
<dc:creator>Young, D. L.</dc:creator>
<dc:creator>Maron, M. I.</dc:creator>
<dc:creator>Saha, A.</dc:creator>
<dc:creator>Pinto, H.</dc:creator>
<dc:creator>Gupta, V.</dc:creator>
<dc:creator>Jacobs, N.</dc:creator>
<dc:creator>Hegde, S.</dc:creator>
<dc:creator>Aguilan, J. T.</dc:creator>
<dc:creator>Basken, J.</dc:creator>
<dc:creator>Azofeifa, J.</dc:creator>
<dc:creator>Query, C. C.</dc:creator>
<dc:creator>Sidoli, S.</dc:creator>
<dc:creator>Skoultchi, A.</dc:creator>
<dc:creator>Shechter, D.</dc:creator>
<dc:date>2025-07-07</dc:date>
<dc:identifier>doi:10.1101/2025.07.03.663002</dc:identifier>
<dc:title><![CDATA[PRMT5 activity sustains histone production to maintain genome integrity]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-07-07</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.07.02.662876v1?rss=1">
<title>
<![CDATA[
Not Just Noise: Impaired Oscillatory Entrainment Reflects Reduced Temporal Flexibility in Autism 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.07.02.662876v1?rss=1</link>
<description><![CDATA[
Rhythmic patterns in the environment enhance neural activity, perception, and action. However, natural rhythms are often imprecise, requiring flexible adaptation. In autism Spectrum Disorder (ASD), characterized by cognitive rigidity and atypical use of prior information - favoring immediate sensory input over predictive cues - entrainment to temporally variable input may be reduced at both neural and behavioral levels, though the neural mechanisms remain unclear. Here, we recorded high-density EEG and behavior in adults with ASD (n=20) and neurotypical (NT) controls (n=21) during a visual detection task with four rhythmic structures, parametrically varied from an isochronous fully regular rhythm, to a highly irregular one. Spectral analysis and temporal response function (TRF) models revealed significantly reduced modulation by temporal regularity in ASD, particularly in mildly jittered stimulation streams. Additionally, the coupling between phases of neural oscillations and behavior was diminished in ASD under the jittered conditions, suggesting reduced functional relevance of neural synchronization. Residual spectral power post-stimulation showed lower oscillatory entrainment in ASD, ruling out simple evoked-response explanations. Notably, the degree of neural modulation by temporal regularity was correlated with IQ within the ASD group, suggesting a link between temporal flexibility and individual cognitive profiles. These findings highlight impaired neural entrainment and reduced behavioral modulation by temporal structure in ASD, offering insight into inflexible responses to uncertain, volatile sensory environments.

InnovationEntrainment to rhythmic events is reduced in autism, but it remains unclear whether this reflects a general, non-selective deficit in neuro-oscillatory alignment or a selective vulnerability to volatile temporal structures, such as those with embedded jitter. To address this, we recorded cortical activity and behavioral performance as participants with ASD engaged with visual sequences of varying rhythmic regularity, and examined how temporal predictability modulated oscillatory entrainment. By correlating neural entrainment with target detection and clinical profiles, we sought to uncover a key feature of the autistic phenotype: reduced temporal flexibility in adapting to unpredictable sensory environments.
]]></description>
<dc:creator>Beker, S.</dc:creator>
<dc:creator>Vanneau, T.</dc:creator>
<dc:creator>Akinyemi, E.</dc:creator>
<dc:creator>Foxe, J. J.</dc:creator>
<dc:creator>Molholm, S.</dc:creator>
<dc:date>2025-07-08</dc:date>
<dc:identifier>doi:10.1101/2025.07.02.662876</dc:identifier>
<dc:title><![CDATA[Not Just Noise: Impaired Oscillatory Entrainment Reflects Reduced Temporal Flexibility in Autism]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-07-08</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.07.09.663942v1?rss=1">
<title>
<![CDATA[
Male mice lacking Magel2 in hypothalamic POMC neurons that innervate the medial amygdala exhibit increased stress-induced anxiety-like behavior and display reduced spatial reward learning. 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.07.09.663942v1?rss=1</link>
<description><![CDATA[
Prader-Willi syndrome (PWS) results from a lack of expression in several paternally inherited, imprinted contiguous genes. Among the genes inactivated in PWS, the Magel2 gene is considered a significant contributor to the etiology of the syndrome. The loss of the Magel2 gene causes abnormalities in growth and fertility and increased adiposity with altered metabolism in adulthood, which aligns with some of the pathologies observed in PWS. Given that anxiety is a prominent phenotypic behavior in PWS, we investigate the role of the Magel2 gene, particularly in hypothalamic POMC neurons innervating the medial amygdala (MeA), in the behavioral phenotypes associated with Prader-Willi Syndrome (PWS). Both male and female mice lacking the Magel2 gene in MeA-innervating ARCPomc neurons display no alterations in anxiety-like behavior during the open field test, light/dark test, and elevated plus maze test in the absence of exposure to acute stress. However, male mice with a Magel2 gene deletion in these particular neurons exhibit increased stress-induced anxiety-like behavior and reduce motivation/spatial learning, while female mice do not show these behavioral changes. Our results suggest that the Magel2 gene in ARCPomc neurons, especially in males, influences the impact of stress on anxiety-like behavior and spatial learning deficits associated with a food reward. With the recent approval of a novel treatment for hyperphagia in PWS by the FDA that seems to target the hypothalamic melanocortin system, understanding the cellular mechanisms by which MAGEL2 in ARCPomc neurons innervating the MeA regulates emotional behaviors might help the development of new therapeutic strategies for addressing mental illness in individuals with PWS.
]]></description>
<dc:creator>Lee, S.</dc:creator>
<dc:creator>JO, Y.-H.</dc:creator>
<dc:date>2025-07-14</dc:date>
<dc:identifier>doi:10.1101/2025.07.09.663942</dc:identifier>
<dc:title><![CDATA[Male mice lacking Magel2 in hypothalamic POMC neurons that innervate the medial amygdala exhibit increased stress-induced anxiety-like behavior and display reduced spatial reward learning.]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-07-14</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.07.11.663968v1?rss=1">
<title>
<![CDATA[
Exploiting an Epigenetic Resistance Mechanism to PI3 Kinase Inhibition in Leukemic Stem Cells 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.07.11.663968v1?rss=1</link>
<description><![CDATA[
Acquired non-genetic resistance mechanisms to existing therapies contribute to poor outcomes for acute myeloid leukemia (AML) patients, and inability to target leukemic stem cells (LSCs) can lead to relapse. To overcome these challenges, we tested whether LSCs have dependencies on PI3 kinase (PI3K). We found that LSCs are susceptible to isoform-selective targeting of PI3K and are particularly dependent on the P110 alpha isoform of PI3K. We discovered that PI3K inactivation leads to dynamic changes in EZH2/PRC2 function in leukemic cells, and we uncovered downregulation of EZH2 protein levels as a resistance mechanism in response to PI3K inhibition. We found that PI3K inhibition in AML cells can lead to compensatory upregulation of EZH1, and that EZH1 knockdown can sensitize AML cells to PI3K inhibition. We leveraged this resistance mechanism by combining a PI3K inhibitor with an EZH1/2 dual inhibitor, which successfully overcomes the acquired resistance and leads to sustained targeting of AML cells ex vivo and in murine AML and PDX models in vivo. This study identifies a promising novel therapeutic regimen for targeting LSCs in AML.
]]></description>
<dc:creator>Glushakow-Smith, S. G.</dc:creator>
<dc:creator>Kaur, I.</dc:creator>
<dc:creator>Sidoli, S.</dc:creator>
<dc:creator>Hemmati, S.</dc:creator>
<dc:creator>Angeles, E.</dc:creator>
<dc:creator>Sinclair, T.</dc:creator>
<dc:creator>Chakraborty, S.</dc:creator>
<dc:creator>Battle, A.</dc:creator>
<dc:creator>Ames, K.</dc:creator>
<dc:creator>Narayanagari, S.-R.</dc:creator>
<dc:creator>Hyka, R.</dc:creator>
<dc:creator>Soto, M.</dc:creator>
<dc:creator>Tracy, M.</dc:creator>
<dc:creator>Vankudoth, J.</dc:creator>
<dc:creator>Kitamura, S.</dc:creator>
<dc:creator>Miles, L. A.</dc:creator>
<dc:creator>Steidl, U.</dc:creator>
<dc:creator>Shastri, A.</dc:creator>
<dc:creator>Verma, A.</dc:creator>
<dc:creator>Gritsman, K.</dc:creator>
<dc:date>2025-07-15</dc:date>
<dc:identifier>doi:10.1101/2025.07.11.663968</dc:identifier>
<dc:title><![CDATA[Exploiting an Epigenetic Resistance Mechanism to PI3 Kinase Inhibition in Leukemic Stem Cells]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-07-15</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.07.15.664976v1?rss=1">
<title>
<![CDATA[
Whole blood transcriptional signatures of age and survival identified in Long Life Family and Integrative Longevity Omics Studies 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.07.15.664976v1?rss=1</link>
<description><![CDATA[
Although aging is a universal event, some individuals are able to achieve extreme longevity. The Long-Life Family Study (LLFS) enrolls participants from families enriched with long-lived individuals, serves as a valuable dataset for studying ageing phenotypes and identify potential intervention targets. We analyzed the association between age at blood draw and 16,284 RNAseq-based blood transcriptomic data from 2,167 LLFS participants with ages ranging from 18 to 107, replicated the results in the Integrative Longevity Omics Study (ILO) dataset of 20,884 RNAseq-based blood transcriptomic data from 419 participants, with ages ranging from 60 to 108, and further compared our findings to a published reference aging signature.

We identified 4,227 transcripts increasing and 4,044 transcripts decreasing with age, and enrichment analysis revealed age-related upregulation of inflammatory and senescence-related pathways, and downregulation of MYC and Wnt/{beta}-catenin targets, among others. Further, a subset of transcripts showed age associations unique to the longevity-enriched cohorts (LLFS and ILO). We also identified 314 transcripts significantly associated with mortality risk and found that pro-survival gene sets included NK cell-mediated cytotoxicity and GPCR signaling. Finally, increased transcriptomic age predicted using transcriptomic clock was strongly associated with increased mortality. In summary, this study identified robust transcriptomic signatures of aging and mortality in a longevity-enriched population, highlighting key biological pathways such as immune modulation, inflammation, and senescence.

Authors notesThis manuscript has been peer-reviewed and accepted by GeroScience (Springer). This bioRxiv article reflects the published version, incorporating revisions made in response to reviewers comments. The main content, results, and conclusions remain unchanged from the previous version, while the Discussion section has been expanded to further address the functional annotation and clinical relevance of the identified markers.

Copy of the acceptance letterThe editors are pleased to inform you that your manuscript, JAAA-D-25-01946R1 entitled "Whole blood transcriptional signatures of age and survival identified in Long Life Family and Integrative Longevity Omics Studies" has been accepted for publication in GeroScience as an Original Article. The editors commend you on your outstanding contribution to the journal. Your manuscript can be published online ahead of print within approximately two weeks.
]]></description>
<dc:creator>Li, M.</dc:creator>
<dc:creator>Song, Z.</dc:creator>
<dc:creator>Reed, E.</dc:creator>
<dc:creator>Karagiannis, T. T.</dc:creator>
<dc:creator>Andersen, S.</dc:creator>
<dc:creator>Brent, M.</dc:creator>
<dc:creator>Mateusiak, C.</dc:creator>
<dc:creator>Acharya, S.</dc:creator>
<dc:creator>Jung, W. S.</dc:creator>
<dc:creator>Liao, S.</dc:creator>
<dc:creator>Wojczynski, M. K.</dc:creator>
<dc:creator>Feitosa, M. F.</dc:creator>
<dc:creator>O'Connell, J. R.</dc:creator>
<dc:creator>Montasser, M. E.</dc:creator>
<dc:creator>Thorpe, R. J.</dc:creator>
<dc:creator>Arbeev, K.</dc:creator>
<dc:creator>Milman, S.</dc:creator>
<dc:creator>Tai, A.</dc:creator>
<dc:creator>Perls, T. T.</dc:creator>
<dc:creator>Sebastiani, P.</dc:creator>
<dc:creator>Monti, S.</dc:creator>
<dc:date>2025-07-18</dc:date>
<dc:identifier>doi:10.1101/2025.07.15.664976</dc:identifier>
<dc:title><![CDATA[Whole blood transcriptional signatures of age and survival identified in Long Life Family and Integrative Longevity Omics Studies]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-07-18</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.07.14.664830v1?rss=1">
<title>
<![CDATA[
TIGAR DEFICIENCY ENHANCES CARDIAC RESILIENCE THROUGH EPIGENETIC PROGRAMMING OF PARKIN EXPRESSION 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.07.14.664830v1?rss=1</link>
<description><![CDATA[
BACKGROUNDWhile mitochondrial dysfunction clearly drives cardiac deterioration in major heart diseases, the mechanisms controlling mitochondrial quality remain incompletely understood. This study investigated whether TIGAR (TP53-induced glycolysis and apoptosis regulator) deficiency influences cardiac protection through mitochondrial quality control pathways.

METHODSWe generated both whole-body and cardiomyocyte-specific TIGAR knockout mice that were assessed for cardiac function following myocardial infarction (induced by left anterior descending coronary artery ligation) and diet-induced cardiomyopathy (using a 6-month high-fat diet protocol). Mitochondrial quality control was evaluated through mitophagy assays, subcellular fractionation, and molecular analyses. Epigenetic regulation was assessed using whole-genome bisulfite sequencing, chromatin immunoprecipitation, and CRISPR-mediated gene editing in multiple cell lines.

RESULTSBoth whole-body (TKO) and cardiomyocyte-specific (hTKO) TIGAR knockout mice demonstrated cardioprotection following myocardial infarction. These animals maintained significantly better ejection fraction (43.35{+/-}17.76% vs 26.36{+/-}9.83% in wild-type controls, P<0.05) and displayed complete resistance to diet-induced cardiac hypertrophy, despite comparable weight gain. TIGAR deficiency led to dramatic increases in Parkin expression across multiple tissues, 6-fold increases in heart and muscle, and 5-fold increases in brain, which enhanced mitophagic responses during metabolic stress conditions including fasting and high-fat diet feeding. Generation of Parkin/TIGAR double knockout mice eliminated this protection, confirming Parkins essential role. Notably, adult manipulation of TIGAR through viral overexpression or knockdown failed to alter Parkin levels, suggesting developmental programming. Whole-genome bisulfite sequencing revealed reduced DNA methylation in a specific 3.2 kb region within Parkin gene intron 10, and CRISPR deletion of this regulatory region increased Parkin expression 10-fold in C2C12 myoblasts and 6-fold in 3T3-L1 fibroblasts.

CONCLUSIONSThese findings reveal a novel TIGAR-Parkin regulatory axis operating through epigenetic mechanisms during cardiac development to establish lifelong cardioprotection via enhanced mitochondrial quality control. This discovery points toward new therapeutic approaches targeting developmental metabolic programming for heart disease prevention and identifies specific epigenetic targets for cardiovascular therapy.

CLINICAL PERSPECTIVEO_ST_ABSWhat Is New?C_ST_ABSO_LITIGAR deficiency establishes lifelong cardiac protection through developmental epigenetic programming of Parkin expression.
C_LIO_LIA novel 3.2 kb differentially methylated region in Parkin intron 10 regulates mitochondrial quality control in the heart.
C_LIO_LIEarly metabolic programming during cardiac development can establish permanent cardioprotective phenotypes.
C_LIO_LIThe TIGAR-Parkin axis provides protection against both acute ischemic injury and chronic metabolic cardiomyopathy.
C_LI

What Are the Clinical Implications?O_LITargeting the TIGAR-Parkin pathway could provide novel therapeutic approaches for preventing both ischemic heart disease and diabetic cardiomyopathy.
C_LIO_LIEarly developmental interventions targeting cardiac metabolism might establish lifelong cardiovascular protection.
C_LIO_LIEpigenetic modifications of mitochondrial quality control genes represent potential therapeutic targets.
C_LIO_LIThe findings suggest optimal timing for cardiovascular preventive interventions may be during critical developmental windows.
C_LI
]]></description>
<dc:creator>Tang, Y.</dc:creator>
<dc:creator>Jankauskas, S. S.</dc:creator>
<dc:creator>Liu, L.</dc:creator>
<dc:creator>Wang, X.</dc:creator>
<dc:creator>Xiaoli, A.</dc:creator>
<dc:creator>Yang, F.</dc:creator>
<dc:creator>Santulli, G.</dc:creator>
<dc:creator>Pessin, J. E.</dc:creator>
<dc:date>2025-07-21</dc:date>
<dc:identifier>doi:10.1101/2025.07.14.664830</dc:identifier>
<dc:title><![CDATA[TIGAR DEFICIENCY ENHANCES CARDIAC RESILIENCE THROUGH EPIGENETIC PROGRAMMING OF PARKIN EXPRESSION]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-07-21</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.08.04.668542v1?rss=1">
<title>
<![CDATA[
Optogenetic activation of liver-innervating vagal sensory neurons increases anxiety-like behavior in mice. 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.08.04.668542v1?rss=1</link>
<description><![CDATA[
The liver plays a central role in energy balance, glucose homeostasis, and lipid metabolism through neural and humoral pathways. Intriguingly, impaired hepatic lipid metabolism has been also associated with an increased risk of anxiety and depression in rodents and humans. However, the mechanisms by which it affects mood behaviors via neural pathways remain poorly understood. This study investigated whether activation of the liver-brain axis can modulate anxiety-like behavior in mice. Advillin (Avil)CreERT2; channelrhodopsin-tdTomato mice and wireless optogenetics were used to selectively stimulate Avil-positive vagal sensory neurons that innervate the liver in freely moving mice. Acute optogenetic stimulation of their nerves in the liver activated neurons in the nodose ganglia and the dorsal motor nucleus of the vagus, and to a lesser extent, those in the nucleus of the solitary tract (NTS). Behavioral assessments revealed that acute optogenetic stimulation of these liver-innervating vagal sensory nerves increased anxiety-like behavior in male and female mice during open field, elevated plus maze, and light/dark box tests. Retrograde viral tracing revealed that neurons in the NTS sent projections to the locus coeruleus (LC), and optogenetic stimulation of liver-innervating vagal sensory nerves resulted in significant activation of norepinephrine-expressing neurons in the LC. Chemogenetic inhibition of LC norepinephrine (NE) neurons completely abolished the anxiogenic effect of stimulating Slc6a2{square}positive vagal sensory neurons, demonstrating that LC NE neuron activity is essential for this behavioral response. Therefore, these findings reveal a novel liver - NTS - LC circuit that plays a role in the regulation of anxiety-like behavior through vagal sensory neurons. Unlike the traditional top-down neuronal circuits associated with the liver, this newly identified liver-brain axis is essential for regulating not only systemic energy homeostasis but also emotional behaviors.
]]></description>
<dc:creator>Lee, S.</dc:creator>
<dc:creator>Hwang, j.</dc:creator>
<dc:creator>Jo, Y.-H.</dc:creator>
<dc:date>2025-08-06</dc:date>
<dc:identifier>doi:10.1101/2025.08.04.668542</dc:identifier>
<dc:title><![CDATA[Optogenetic activation of liver-innervating vagal sensory neurons increases anxiety-like behavior in mice.]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-08-06</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.08.07.669162v1?rss=1">
<title>
<![CDATA[
A bone marrow stromal secretome screen identifies semaphorin 3A as a regulator of hematopoiesis 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.08.07.669162v1?rss=1</link>
<description><![CDATA[
Bone marrow mesenchymal stromal cells (MSCs) are a major source of secreted factors that control hematopoietic stem and progenitor cell (HSPC) function. We previously reported the generation of revitalized MSCs (rMSCs), which more effectively support HSPCs in culture. In a secretome screen using rMSCs, we identified semaphorin 3A (SEM3A) as a secreted factor upregulated as part of a pro-inflammatory signature that may contribute to HSPC expansion by rMSCs. We show that recombinant SEM3A acts directly on HSPCs to inhibit their cycling ex vivo. Analysis of a SEM3A loss of function mutation in vivo revealed hematopoietic progenitor expansion and accelerated recovery after myeloablation, consistent with a role for SEM3A in regulating HSPCs at steady state and during hematopoietic stress. This work highlights proteomic screening using rMSCs as a method to identify novel secreted niche factors and uncovers a novel role for SEM3A in controlling HSPC proliferation in stress hematopoiesis.

SummaryBorger et al. characterize the secretome of revitalized bone marrow stromal cells and identify a novel role of the protein semaphorin 3A in regulating hematopoietic stem and progenitor cell proliferation in steady state and stress conditions.
]]></description>
<dc:creator>Borger, D. K.</dc:creator>
<dc:creator>Mitchell, S. P.</dc:creator>
<dc:creator>Nakahara, F.</dc:creator>
<dc:creator>Colombo, D. F.</dc:creator>
<dc:creator>Torres, L. S.</dc:creator>
<dc:creator>Garforth, S. J.</dc:creator>
<dc:creator>Sidoli, S.</dc:creator>
<dc:creator>Krijgsveld, J.</dc:creator>
<dc:creator>Silberstein, L.</dc:creator>
<dc:creator>Frenette, P. S.</dc:creator>
<dc:creator>Gritsman, K.</dc:creator>
<dc:date>2025-08-07</dc:date>
<dc:identifier>doi:10.1101/2025.08.07.669162</dc:identifier>
<dc:title><![CDATA[A bone marrow stromal secretome screen identifies semaphorin 3A as a regulator of hematopoiesis]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-08-07</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.08.11.669754v1?rss=1">
<title>
<![CDATA[
A population-scale atlas of blood and tissue in lupus nephritis 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.08.11.669754v1?rss=1</link>
<description><![CDATA[
One Sentence SummaryA single-cell atlas of paired blood and tissue samples from Lupus Nephritis patients and healthy controls identified stromal and immune populations within renal tissue, including the scar-associated macrophage populations, which correlate with and may drive renal disease activity.

Lupus nephritis (LN), a severe manifestation of Systemic Lupus Erythematosus (SLE), is a heterogeneous disease driven by diverse immune and tissue cell types. We obtained 538K single-cell and 140K single-nuclear profiles from kidney biopsies of 155 LN patients and 30 pre-implantation transplant biopsy controls, along with 325K single-cell blood profiles overlapping many of these patients. We identified key tissue cell types and cell states, and immune cell states; we were able to determine cell states that were tissue specific, and those that were present in the blood. We observed that LN pathological features are significantly associated with cell states using differential gene expression and Covarying Neighborhood Analysis (CNA). These analyses revealed broad changes in cell states associated with irreversible chronic tissue damage. After controlling for the effects of ongoing tissue damage, we observed that expansion of key glomerular and Scar Associated Macrophages (SAMs) populations tracked with increasing inflammatory disease activity. SAMs appear to drive LN fibrosis and, in active disease, infiltrate the glomeruli more than other myeloid cells. These observations strongly support that therapeutic targeting of myeloid populations may offer an as-of-yet unproven strategy to prevent renal inflammation and ongoing kidney damage in LN.
]]></description>
<dc:creator>Gurajala, S.</dc:creator>
<dc:creator>Sugiarto, N. W.</dc:creator>
<dc:creator>Curtis, M.</dc:creator>
<dc:creator>Eisenhaure, T. M.</dc:creator>
<dc:creator>Arazi, A.</dc:creator>
<dc:creator>Fava, A.</dc:creator>
<dc:creator>Xiao, Q.</dc:creator>
<dc:creator>Mears, J.</dc:creator>
<dc:creator>Rovin, B.</dc:creator>
<dc:creator>Berthier, C. C.</dc:creator>
<dc:creator>Izmirly, P. M.</dc:creator>
<dc:creator>Barnas, J. L.</dc:creator>
<dc:creator>Hoover, P. J.</dc:creator>
<dc:creator>Peters, M.</dc:creator>
<dc:creator>Raychowdhury, R.</dc:creator>
<dc:creator>Horisberger, A.</dc:creator>
<dc:creator>Sakaue, S.</dc:creator>
<dc:creator>Zhao, Y.</dc:creator>
<dc:creator>Furie, R. A.</dc:creator>
<dc:creator>Belmont, H. M.</dc:creator>
<dc:creator>Hildeman, D. A.</dc:creator>
<dc:creator>Woodle, E. S.</dc:creator>
<dc:creator>Dall'Era, M.</dc:creator>
<dc:creator>Putterman, C.</dc:creator>
<dc:creator>Kamen, D. L.</dc:creator>
<dc:creator>McMahon, M. A.</dc:creator>
<dc:creator>Grossman, J.</dc:creator>
<dc:creator>Kalunian, K. C.</dc:creator>
<dc:creator>Hodgin, J. B.</dc:creator>
<dc:creator>Payan-Schober, F.</dc:creator>
<dc:creator>Apruzzese, W.</dc:creator>
<dc:creator>Perlman, H.</dc:creator>
<dc:creator>Cuda, C. M.</dc:creator>
<dc:creator>Wofsy, D.</dc:creator>
<dc:creator>Guthridge, J. M.</dc:creator>
<dc:creator>Anolik, J. H.</dc:creator>
<dc:creator>James, J. A.</dc:creator>
<dc:creator>Accelerating Medicines Partnerships Rheumatoid Arthritis/Systemic Lu</dc:creator>
<dc:date>2025-08-14</dc:date>
<dc:identifier>doi:10.1101/2025.08.11.669754</dc:identifier>
<dc:title><![CDATA[A population-scale atlas of blood and tissue in lupus nephritis]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-08-14</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.08.19.671152v1?rss=1">
<title>
<![CDATA[
Long Non-Coding RNAs in Response to Ebola Virus Vaccine-Induced Immunity 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.08.19.671152v1?rss=1</link>
<description><![CDATA[
Long noncoding RNAs (lncRNAs) have emerged as critical regulators of gene expression, yet their role in shaping human responses to vaccination remains largely uncharacterized. Here, we analyzed RNA-sequencing data from three independent human cohorts vaccinated with the rVSV{Delta}G-ZEBOV-GP Ebola vaccine to profile lncRNA expression dynamics. Using differential expression analysis and correlation meta-analysis across cohorts, we identified an expression signature with several lncRNAs, including LEF1-AS1 and DOCK8-AS1, that exhibit conserved transcriptional activation following vaccination. Correlation of lncRNA expression with gene targets and IgG titers revealed putative roles for lncRNAs in regulating and/or participate in both innate immune responses and adaptive antibody production. Functional enrichment of lncRNA co-expressed protein-coding genes highlighted involvement in T-cell differentiation, interferon signaling, and leukocyte activation. Integrating global run-on sequencing data and comparative transcriptomic analysis across other vaccine studies suggests that LEF1-AS1 modulation is distinctively associated with Ebola vaccination. Our findings demonstrate that lncRNAs are potential integral components of the human vaccine response and provide a foundation for future mechanistic studies targeting noncoding RNA regulation of immunity

SignificanceEbola virus remains a significant global health threat due to its high mortality rate and potential for widespread outbreaks, underscoring the urgent need for effective and durable vaccines to control future epidemics. Understanding the transcriptional mechanisms underlying immune responses to vaccination is important to improving vaccine design and efficacy. While protein-coding genes have been extensively studied, the role of long noncoding RNAs (lncRNAs) in vaccine-induced immunity remains poorly understood. Here, we characterize the dynamics of lncRNA expression following administration of the rVSV{Delta}G-ZEBOV-GP Ebola vaccine across multiple human cohorts and identify conserved lncRNA signatures associated with both innate and adaptive immunity.

Graphical abstract

O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=154 SRC="FIGDIR/small/671152v1_ufig1.gif" ALT="Figure 1">
View larger version (27K):
org.highwire.dtl.DTLVardef@25581aorg.highwire.dtl.DTLVardef@1bb31cforg.highwire.dtl.DTLVardef@c3299eorg.highwire.dtl.DTLVardef@e176b9_HPS_FORMAT_FIGEXP  M_FIG C_FIG
]]></description>
<dc:creator>Mamede, I.</dc:creator>
<dc:creator>Luscher-Dias, T.</dc:creator>
<dc:creator>Moscardini, I. F.</dc:creator>
<dc:creator>Gonzalez, P.</dc:creator>
<dc:creator>Marinho, B.</dc:creator>
<dc:creator>Marcon, F.</dc:creator>
<dc:creator>Hirata, T. D. C.</dc:creator>
<dc:creator>VSV-EBOPLUS Consortium,</dc:creator>
<dc:creator>Eichberg, M.</dc:creator>
<dc:creator>Medaglini, D.</dc:creator>
<dc:creator>Harandi, A. M.</dc:creator>
<dc:creator>Siegrist, C. A.</dc:creator>
<dc:creator>Ottenhoff, T. H. M.</dc:creator>
<dc:creator>Santoro, F.</dc:creator>
<dc:creator>Goncalves, A. N. A.</dc:creator>
<dc:creator>Polidoro, R.</dc:creator>
<dc:creator>Franco, G. R.</dc:creator>
<dc:creator>Amaral, P. P.</dc:creator>
<dc:creator>Nakaya, H.</dc:creator>
<dc:date>2025-08-23</dc:date>
<dc:identifier>doi:10.1101/2025.08.19.671152</dc:identifier>
<dc:title><![CDATA[Long Non-Coding RNAs in Response to Ebola Virus Vaccine-Induced Immunity]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-08-23</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.08.24.671942v1?rss=1">
<title>
<![CDATA[
Engineering Antibody-Drug Conjugates targeting an Adhesion GPCR, CD97 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.08.24.671942v1?rss=1</link>
<description><![CDATA[
Adhesion G protein-coupled receptors (aGPCRs) are key cell-adhesion molecules involved in many cellular functions and contribute to human diseases, including cancer. aGPCRs are characterized by large extracellular regions that could serve as readily accessible antigens. However, the potential of aGPCRs as targets for biologic therapeutics has not been extensively explored. CD97, also known as ADGRE5, is an aGPCR that is upregulated in various cancer types, including acute myeloid leukemia (AML) and glioblastoma (GBM), and their respective cancer stem cells. Here, we developed antibody-drug conjugates (ADCs) targeting CD97 and assessed their efficacy against AML and GBM cells. We generated a panel of synthetic human antibodies targeting distinct epitopes of CD97, from which we identified an antibody that was efficiently internalized. This antibody binds to all isoforms of human CD97 but not to its close homolog, EMR2. Structure determination by single-particle cryo-electron microscopy revealed that this antibody targets the CD97 GPCR autoproteolysis-inducing (GAIN) domain, whose presence is conserved in aGPCRs, through an unconventional binding mode where it extensively utilizes the light chain framework for antigen recognition. Screening of conjugation methods and payloads resulted in a stable ADC that effectively killed AML and GBM cell lines, as well as patient-derived GBM stem cells, with minimal cytotoxicity against peripheral blood mononuclear cells from healthy donors. Our study demonstrates the therapeutic potential of targeting CD97, as well as the aGPCR GAIN domain in general, and broadens our mechanistic understanding of antibody-antigen interactions.
]]></description>
<dc:creator>Hattori, T.</dc:creator>
<dc:creator>Wang, M.</dc:creator>
<dc:creator>Corrado, A. D.</dc:creator>
<dc:creator>Gross, S.</dc:creator>
<dc:creator>Fang, M.</dc:creator>
<dc:creator>Bang, I.</dc:creator>
<dc:creator>Roy, N.</dc:creator>
<dc:creator>Berezniuk, I.</dc:creator>
<dc:creator>Donaldson, H.</dc:creator>
<dc:creator>Groff, K.</dc:creator>
<dc:creator>Ravn-Boess, N.</dc:creator>
<dc:creator>Koide, A.</dc:creator>
<dc:creator>Placantonakis, D.</dc:creator>
<dc:creator>Park, C.</dc:creator>
<dc:creator>Koide, S.</dc:creator>
<dc:date>2025-08-28</dc:date>
<dc:identifier>doi:10.1101/2025.08.24.671942</dc:identifier>
<dc:title><![CDATA[Engineering Antibody-Drug Conjugates targeting an Adhesion GPCR, CD97]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-08-28</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.08.27.672621v1?rss=1">
<title>
<![CDATA[
shinyUMAP: an online tool for promoting understanding of single cell omics data visualization 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.08.27.672621v1?rss=1</link>
<description><![CDATA[
Visualization is widely used to help explore and interpret high dimensional single cell (sc) omics data, such as scRNA-seq expression data. In particular, uniform manifold approximation and projection (UMAP) has become nearly ubiquitous in scientific publications that apply single cell omics technologies. Some experts have expressed concerns that the global cell-cell relationship, especially the spatial distances among cell clusters in a dataset, may not be faithfully depicted in a 2-dimensional (2D) UMAP. To help users to better appreciate this issue with their own data, we created an online server for the community to upload their single cell data and interactively make UMAPs with different hyper-parameters to witness how the distribution of cell clusters changes. The server thus can help promote proper usages of UMAP, especially to avoid the common pitfalls in misinterpretation of inter-cluster relationships in single cell studies.

Availability and ImplementationShinyUMAP is freely available as an online Shiny server implemented in Python at https://scviewer.shinyapps.io/shinyUMAP/.
]]></description>
<dc:creator>Misra, R.</dc:creator>
<dc:creator>O'Leary, K.</dc:creator>
<dc:creator>Chen, W.</dc:creator>
<dc:creator>Zheng, D.</dc:creator>
<dc:date>2025-09-01</dc:date>
<dc:identifier>doi:10.1101/2025.08.27.672621</dc:identifier>
<dc:title><![CDATA[shinyUMAP: an online tool for promoting understanding of single cell omics data visualization]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-09-01</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.09.01.673561v1?rss=1">
<title>
<![CDATA[
Single-molecule imaging reveals activity-dependent regulation of Camk2a mRNAs at dendritic spines 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.09.01.673561v1?rss=1</link>
<description><![CDATA[
AbstractPostsynaptic calcium/calmodulin-dependent protein kinase type II (CaMKII) integrates fleeting Ca2+ transients into long-term synaptic potentiation (LTP). A persistent presence of CaMKII at dendritic spines during the maintenance of LTP facilitates the prolongation of synaptic transmission. Yet, it remains unclear how the perpetuation of CaMKII, despite protein turnover, is achieved at dendritic spines. By visualizing endogenous Camk2a mRNAs at single molecule resolution using a newly developed mouse model, we identified a rapid activity-dependent localization of mRNAs to stimulated spines near the postsynaptic density (PSD) of hippocampal neurons. This spine localization was conferred by cis-acting regulatory elements termed cytoplasmic polyadenylation elements (CPEs) in Camk2a mRNA. Spine-localized Camk2a underwent on-site translation, which persisted for extended periods. These findings uncovered a novel local regulation of Camk2a mRNA, which serves to supply dendritic spines with a steady pool of highly concentrated CaMKII for maintaining long-lasting synaptic plasticity.
]]></description>
<dc:creator>Hwang, D.-W.</dc:creator>
<dc:creator>Krishnamurthy, K.</dc:creator>
<dc:creator>Nagare, A.</dc:creator>
<dc:creator>Singer, R. H.</dc:creator>
<dc:creator>Das, S.</dc:creator>
<dc:date>2025-09-03</dc:date>
<dc:identifier>doi:10.1101/2025.09.01.673561</dc:identifier>
<dc:title><![CDATA[Single-molecule imaging reveals activity-dependent regulation of Camk2a mRNAs at dendritic spines]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-09-03</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.09.03.673494v1?rss=1">
<title>
<![CDATA[
Children with Autism Show Impaired Oculomotor Entrainment to Predictable Stimuli 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.09.03.673494v1?rss=1</link>
<description><![CDATA[
Individuals with Autism Spectrum Disorder (ASD) show altered synchronization with external events, which may underlie the rigidity and reduced adaptability that characterize the condition. We previously demonstrated that electroencephalography (EEG) recorded from children with ASD reveals impaired neuronal entrainment to predictable visual sequences. Whether similar effects are reflected in other physiological signals remains unclear. Here, we investigated whether eye movement and pupil dilation responses exhibit comparable entrainment differences in ASD. Microsaccades (MS) and pupil diameter were recorded from 31 children with ASD (6-9 years) and 21 age- and IQ-matched typically developing (TD) controls during a task in which four equally spaced visual cues preceded an auditory target. We analyzed modulation of MS release time (MS RT) and pupil response time (pupil RT), along with trial-by-trial variability, as indices of ocular entrainment. Both groups exhibited periodic oculomotor responses to the cues, including phasic MS inhibition and repeated pupil constrictions. In TD children, MS RT and pupil RT increased across cues while their variability decreased, consistent with progressive temporal alignment. These effects were significantly reduced in the ASD group. Oculomotor entrainment measures correlated with EEG inter-trial phase coherence (ITPC) in TD but not ASD children. They also correlated with behavioral response times in both groups, and moderately correlated with autism severity scores. Children with ASD thus showed diminished oculomotor modulation and greater variability in response to predictable stimuli, paralleling earlier EEG findings. These results suggest convergence across physiological systems in indexing impaired processing of predictability in ASD and highlight the promise of multimodal approaches.
]]></description>
<dc:creator>Beker, S.</dc:creator>
<dc:creator>Kadosh, O.</dc:creator>
<dc:creator>Foxe, J. J.</dc:creator>
<dc:creator>Molholm, S.</dc:creator>
<dc:creator>Bonneh, Y. S.</dc:creator>
<dc:date>2025-09-04</dc:date>
<dc:identifier>doi:10.1101/2025.09.03.673494</dc:identifier>
<dc:title><![CDATA[Children with Autism Show Impaired Oculomotor Entrainment to Predictable Stimuli]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-09-04</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.09.04.673943v1?rss=1">
<title>
<![CDATA[
TDP-43 loss of function drives aberrant splicing in Parkinson's disease 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.09.04.673943v1?rss=1</link>
<description><![CDATA[
Introductory paragraphWhile mRNA splicing dysregulation is a well-established contributor to neurodegeneration in disorders such as amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), its role in Parkinsons disease (PD) remains underexplored. Here, we analyse transcriptomic data from >500 post-mortem human brain samples from individuals with and without PD to show that splicing alterations are frequently detected. Differentially spliced genes were significantly more enriched for those causally-implicated in both PD and ALS than genes that were differentially expressed. Furthermore, we observed a strong association between these splicing alterations and dysfunction of the RNA-binding protein (RBP), TAR DNA-binding protein 43 (TDP-43). Strikingly, genes and exon junctions affected by TDP-43 knockdown overlapped significantly with those dysregulated across brain regions in PD. In brains from individuals with the LRRK2 c.6055G>A (p.G2019S) mutation, the most common genetic cause of PD, we also observed significant enrichment of TDP-43-dependent splicing changes. This finding was corroborated in human pluripotent stem cell-derived midbrain dopaminergic neurons and a LRRK2 p.G2019S knock-in mouse model, where reduced nuclear TDP-43 levels evidenced the well-recognised loss-of-function mechanism contributing to splicing dysregulation. By leveraging our RNA-based analyses we predicted TDP-43-dependent novel peptide sequences and validated their existence within human LRRK2 mutation mDNs, while also demonstrating an overall loss of protein and mRNA expression in mis-spliced genes. Collectively, our findings reveal that PD is marked by extensive splicing dysregulation dependent on TDP-43, making TDP-43 a promising new therapeutic target in PD.
]]></description>
<dc:creator>Brenton, J. W.</dc:creator>
<dc:creator>Follett, J.</dc:creator>
<dc:creator>Nirujogi, R.</dc:creator>
<dc:creator>Toomey, C. E.</dc:creator>
<dc:creator>Lopez-Garcia, P.</dc:creator>
<dc:creator>Evans, J. R.</dc:creator>
<dc:creator>Lee, Y. J.</dc:creator>
<dc:creator>Syed, K. M.</dc:creator>
<dc:creator>Rocamora Perez, G.</dc:creator>
<dc:creator>Fairbrother-Browne, A.</dc:creator>
<dc:creator>D'Sa, K.</dc:creator>
<dc:creator>Grant-Peters, M.</dc:creator>
<dc:creator>Lachica, J.</dc:creator>
<dc:creator>Hicks, A. R.</dc:creator>
<dc:creator>Wagen, A. Z.</dc:creator>
<dc:creator>O'Callaghan, B.</dc:creator>
<dc:creator>Macpherson, H.</dc:creator>
<dc:creator>Montgomery, K.-a.</dc:creator>
<dc:creator>Busquets, O.</dc:creator>
<dc:creator>Reynolds, R. H.</dc:creator>
<dc:creator>Garcia Ruiz, S.</dc:creator>
<dc:creator>Cao, T.</dc:creator>
<dc:creator>Chen, Z.</dc:creator>
<dc:creator>Plun-Favreau, H.</dc:creator>
<dc:creator>Wong, P. C.</dc:creator>
<dc:creator>Farrer, M.</dc:creator>
<dc:creator>Lashley, T.</dc:creator>
<dc:creator>Soldner, F.</dc:creator>
<dc:creator>Hockemeyer, D.</dc:creator>
<dc:creator>Alessi, D.</dc:creator>
<dc:creator>Wood, N. W.</dc:creator>
<dc:creator>Hardy, J.</dc:creator>
<dc:creator>Rio, D. C.</dc:creator>
<dc:creator>Jaunmuktane, Z.</dc:creator>
<dc:creator>Gustavsson, E. K.</dc:creator>
<dc:creator>Gandhi, S.</dc:creator>
<dc:creator>Ryten, M.</dc:creator>
<dc:date>2025-09-09</dc:date>
<dc:identifier>doi:10.1101/2025.09.04.673943</dc:identifier>
<dc:title><![CDATA[TDP-43 loss of function drives aberrant splicing in Parkinson's disease]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-09-09</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.09.13.675998v1?rss=1">
<title>
<![CDATA[
Impact of storage on the stability and the protective effect of extracellular vesicles released by Candida albicans 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.09.13.675998v1?rss=1</link>
<description><![CDATA[
Extracellular vesicles (EVs) released by Candida albicans are multi-antigenic compartments considered as promising prototypes for vaccine development. However, their stability, appropriate storage and handling conditions are largely unexplored, which raises questions related to their biotechnological applicability. Here, we evaluated the physical and functional stability of C. albicans EVs under long-term storage. Furthermore, we conducted a comparative analysis of these properties in C. albicans EVs obtained through three commonly utilized isolation protocols documented in the literature. After identifying the most efficient isolation method for optimal yield, we devised a potential quality control for EVs isolation based on protein and sterol ratio. Subsequently, we investigated the impact of drying EVs using vacuum centrifugation at room temperature or -4 {degrees}C and the effect of freeze-thaw cycles in EVs stability. Transmission electron microscopy (TEM) revealed that EVs maintained morphological stability after long-term (up to 4 years) storage at -80 {degrees}C as well as storage at room temperature, 4 {degrees}C and -20 {degrees}C for 7 days with or without vacuum centrifugation, with a tendency of higher recovery when lower temperature is used. Remarkably, all of the C. albicans EVs suspensions maintained their biological properties as demonstrated by their ability to protect Galleria mellonella against C. albicans infection. However, the number of freeze-thaw cycles significantly impacted on the protective effect of the EVs. Overall, our findings demonstrate that C. albicans EVs maintain notable morphological and biological stability of under several conditions, enabling their efficient and reproducible utilization in research and potentially as therapeutic agents.

ImportanceExtracellular vesicles (EVs) released by Candida albicans are promising vaccine prototypes due to their multi-antigenic nature. However, their storage and handling conditions are not well understood, raising concerns about their biotechnological use. This study evaluated the long-term physical and functional stability of C. albicans EVs. We compared three isolation methods to identify the most effective one and suggested a quality control measure based on protein and sterol ratios. We also examined the effects of vacuum drying and freeze-thaw cycles on EV stability. Our findings show that C. albicans EVs maintain their biological function after long-term storage at -80 {degrees}C and under various conditions. Notably, their protective effect in an insect model was reduced though repeated freeze-thaw cycles. This research provides valuable insights for the efficient use of these vesicles in future studies.
]]></description>
<dc:creator>Honorato, L.</dc:creator>
<dc:creator>Bonilla, J. J. A.</dc:creator>
<dc:creator>Valdez, A. F.</dc:creator>
<dc:creator>Reis, F.</dc:creator>
<dc:creator>Kornetz, J.</dc:creator>
<dc:creator>Sabino, A. L. R. d. N.</dc:creator>
<dc:creator>Rodrigues, M.</dc:creator>
<dc:creator>Nosanchuk, J. D.</dc:creator>
<dc:creator>Nimrichter, L.</dc:creator>
<dc:date>2025-09-15</dc:date>
<dc:identifier>doi:10.1101/2025.09.13.675998</dc:identifier>
<dc:title><![CDATA[Impact of storage on the stability and the protective effect of extracellular vesicles released by Candida albicans]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-09-15</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.09.14.676124v1?rss=1">
<title>
<![CDATA[
SomaMutDB 2.0: A comprehensive database for exploring somatic mutations and their functional impact in normal human tissues 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.09.14.676124v1?rss=1</link>
<description><![CDATA[
Recent advances in ultra-accurate sequencing technologies have revealed that somatic mutations accumulate across the human lifespan and may contribute to both normal aging and disease. These mutations are highly diverse, often non-recurrent, and functionally heterogeneous, which makes their biological impact difficult to evaluate systematically. Although many studies have profiled somatic mutations in individual tissues or limited cohorts, a centralized and scalable platform that integrates discoveries and supports functional interpretation has been lacking. To address this gap, we present SomaMutDB 2.0 (https://somamutdb.org/SomaMutDB/), a substantially expanded database that catalogs 8.9 million mutations (8.57 million SNVs and 0.29 million INDELs) from 10,852 samples of 607 human subjects across 47 studies. Beyond expanded data coverage, SomaMutDB 2.0 introduces a comprehensive functional annotation framework that applies 22 predictive models, encompassing coding, regulatory, expression-based, and ensemble predictors, to systematically assess mutational impact. Users can browse pre-annotated variants through an interactive interface or upload their own variants for real-time analysis, with results contextualized against all mutations from normal, non-diseased tissues in the database. Together, these advances establish SomaMutDB 2.0 as the most comprehensive resource currently available for characterizing somatic mosaicism and functional interpretation in human health and aging.

Graphical AbstractSomaMutDB 2.0 provides an expanded catalog of 8.9 million somatic mutations across 30 tissues, along with pipelines for mutational signature analysis and 22-tool functional annotation that enable user-submitted variant interpretation.



O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=113 SRC="FIGDIR/small/676124v1_ufig1.gif" ALT="Figure 1">
View larger version (39K):
org.highwire.dtl.DTLVardef@1c76484org.highwire.dtl.DTLVardef@1984f71org.highwire.dtl.DTLVardef@8789a9org.highwire.dtl.DTLVardef@5ed54a_HPS_FORMAT_FIGEXP  M_FIG C_FIG
]]></description>
<dc:creator>Shea, A.</dc:creator>
<dc:creator>Sun, S.</dc:creator>
<dc:creator>Kennedy, J.</dc:creator>
<dc:creator>Zhang, L.</dc:creator>
<dc:creator>Vijg, J.</dc:creator>
<dc:creator>Dong, X.</dc:creator>
<dc:date>2025-09-17</dc:date>
<dc:identifier>doi:10.1101/2025.09.14.676124</dc:identifier>
<dc:title><![CDATA[SomaMutDB 2.0: A comprehensive database for exploring somatic mutations and their functional impact in normal human tissues]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-09-17</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.09.16.676573v1?rss=1">
<title>
<![CDATA[
ZNF180 modulates tumor intrinsic immunotherapy resistance in melanoma through driving plasticity 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.09.16.676573v1?rss=1</link>
<description><![CDATA[
BackgroundBased on our previous study, we have identified ZNF180, a zinc finger protein, as a pro-tumorigenic regulator in primary melanoma and a marker for poor prognosis. Herein, we report that ZNF180-regulated pathway, hence ZNF180-regulome, underlies resistance towards immune checkpoint inhibitions (ICIs).

MethodsTo investigate regulatory roles of ZNF180 to confer these immune suppressive phenotypes, we performed ZNF180 knock-down in melanoma cells in vitro with different genetic backgrounds, namely A375 (BRAF-mutant) and SKMEL147 (NRAS-mutant) cells, and performed RNA- and ATAC-sequencing. We performed integrative analysis of RNA- and ATAC-sequencing data with publicly available sequencing data from ICI-treated cohorts to construct comprehensive model of ZNF180-regulome and its impacts on immune microenvironment. Further, we performed ZNF180 silencing in immune competent Yumm1.7 murine model to confirm the changes in immune microenvironments.

ResultsZNF180-regulome was predictive of ICI responses in independent bulk sequencing cohorts, and ZNF180+ tumors persisted after the therapy with immune-suppressive features such as MHC-I loss and CD155 expressions, the primary ligand to TIGIT inhibitory receptor. Further, ZNF180 silencing revealed its regulations on AP-1 transcription factors to drive melanoma reprogramming towards de-differentiated MITFlowAXLhigh cells, an established melanoma subtypes associated with recurrence and ICI resistance. In tandem, we observed that ZNF180+ tumor neighborhood significantly excluded with CD4 T-cells in metastatic tumor, and its silencing in immune competent murine model increased CD4 helper T-cell infiltrations with significant tumor regression in vivo.

ConclusionCollectively, these results indicate ZNF180 is a tumor intrinsic regulator of melanoma plasticity to drive de-differentiated phenotypes with immune-suppressive features including loss of immunogenicity, T-cell inhibitory signals through TIGIT/CD155 checkpoint and exclusion of CD4 helper T-cells. As ZNF180-regulome manifests in non-metastatic melanoma in contrast to the current focus of standard-of-care ICI on the metastatic disease, these results establish ZNF180-regulome as a biomarker and novel therapeutic avenue for early-stage, non-metastatic melanoma to intervene ICI resistance.
]]></description>
<dc:creator>Song, W.-M.</dc:creator>
<dc:creator>Kondapuram, S. K.</dc:creator>
<dc:creator>Zhou, X.</dc:creator>
<dc:creator>Chen, S.-h.</dc:creator>
<dc:creator>Agrawal, P.</dc:creator>
<dc:date>2025-09-18</dc:date>
<dc:identifier>doi:10.1101/2025.09.16.676573</dc:identifier>
<dc:title><![CDATA[ZNF180 modulates tumor intrinsic immunotherapy resistance in melanoma through driving plasticity]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-09-18</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.09.16.676613v1?rss=1">
<title>
<![CDATA[
Dual EZH1/2 inhibition enhances DNMT inhibitor efficacy in colon cancer through targeting H3K27me1 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.09.16.676613v1?rss=1</link>
<description><![CDATA[
Abnormal DNA methylation patterning is a defining epigenetic hallmark of human cancer and is therapeutically targetable with DNA methyltransferase inhibitors (DNMTis). However, DNMTi-induced DNA hypomethylation promotes adaptive chromatin remodeling that limits molecular and therapeutic responses to these drugs. Here, we identify EZH1-dependent H3K27 mono-methylation (H3K27me1) as a previously unrecognized adaptive barrier to DNMTi response in colorectal cancer. While EZH2-selective inhibitors deplete H3K27me2 and H3K27me3, they preserve EZH1-dependent H3K27me1 at Polycomb-enriched genomic regions. In contrast, dual EZH1/2 inhibition eliminates all H3K27 methylation states and robustly synergizes with DNMTi to enhance transcriptional activation and growth suppression. Mechanistically, dual EZH1/2 inhibition induces a redistribution of p300/CBP-dependent H3K27 acetylation (H3K27ac), generating a therapy-associated bivalent chromatin state characterized by coexisting DNA methylation and H3K27ac. DNMT inhibition resolves this induced bivalency, enabling activation of tumor-suppressive transcriptional programs. At the same time, coordinated loss of H3K27me1 and gene-body DNA methylation, together with depletion of promoter-associated H3K27ac, suppresses MYC- and E2F-driven oncogenic transcription networks that define the cancer cell-intrinsic therapeutic response. Collectively, these findings establish EZH1-dependent H3K27me1 as a key mediator of adaptive epigenetic plasticity and provide mechanistic rationale for combining DNMT inhibitors with dual EZH1/2i inhibitors to reprogram chromatin and suppress oncogenic transcription in solid tumors.

HighlightsO_LIEZH1-dependent H3K27me1 sustains an adaptive barrier to DNMT inhibitor response in colorectal cancer.
C_LIO_LIDual EZH1/2 inhibition eliminates all H3K27 methylation states and remodels chromatin architecture.
C_LIO_LIEZH inhibition induces a DNA methylation-H3K27ac bivalent chromatin state.
C_LIO_LIDNMT and EZH1/2 co-inhibition reprograms enhancers and promoters to activate tumor-suppressive pathways.
C_LIO_LICombination therapy suppresses MYC/E2F-driven oncogenic transcription, defining its cancer cell-intrinsic therapeutic efficacy.
C_LI
]]></description>
<dc:creator>Chomiak, A. A.</dc:creator>
<dc:creator>Wiseman, A. K.</dc:creator>
<dc:creator>Hrit, J.</dc:creator>
<dc:creator>Liu, Y.</dc:creator>
<dc:creator>Stransky, S.</dc:creator>
<dc:creator>Sidoli, S.</dc:creator>
<dc:creator>Tiedemann, R. L.</dc:creator>
<dc:creator>Rothbart, S. B.</dc:creator>
<dc:date>2025-09-18</dc:date>
<dc:identifier>doi:10.1101/2025.09.16.676613</dc:identifier>
<dc:title><![CDATA[Dual EZH1/2 inhibition enhances DNMT inhibitor efficacy in colon cancer through targeting H3K27me1]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-09-18</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.09.18.677095v1?rss=1">
<title>
<![CDATA[
Multisensory attenuation of the pupil light response in autistic and non-autistic children 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.09.18.677095v1?rss=1</link>
<description><![CDATA[
Autonomic responses to sensory stimuli are altered in autism, yet little is known about how multisensory input modulates these responses. This study examined whether auditory stimuli affect the pupil light reflex (PLR), a parasympathetically driven response to light, in autistic and non-autistic children. Pupillometry was used to measure responses to visual-only (V), auditory-only (A), and audiovisual (AV) stimuli in 72 children aged 6-14 years (34 non-autistic, 38 autistic). We hypothesized that auditory input would attenuate pupil constriction in non-autistic children and that this cross-modal modulation might differ in autism, reflecting altered sensory-autonomic functioning. Across groups, results revealed a consistent pattern: auditory stimuli elicited pupil dilation, visual stimuli evoked constriction, and simultaneous audiovisual stimuli led to attenuated constriction relative to visual-only trials. This attenuation lends support to prior findings of multisensory attenuation of the PLR. Time-binned analysis revealed a group effect during the 500-1000 ms post-stimulus window: autistic children showed significantly more positive baseline-corrected pupil responses across conditions (i.e., less constriction in V/AV and greater dilation in A), suggesting group differences in the dynamic trajectory of the pupil response. Contrary to expectations, autistic and non-autistic children did not differ significantly on peak constriction or constriction latency within visual conditions. Findings support the presence of cross-modal modulation of the PLR in both autistic and non-autistic children and suggest that auditory signals influence early-stage visual-autonomic processing similarly across groups. Pupillometry may provide a promising, noninvasive tool for probing sensory-autonomic interactions in autism. Future studies with paradigms optimized for pupil measurement may reveal more nuanced group differences and clarify links to real-world sensory challenges.
]]></description>
<dc:creator>Brittenham, C.</dc:creator>
<dc:creator>Vanneau, T.</dc:creator>
<dc:creator>Molholm, S.</dc:creator>
<dc:date>2025-09-19</dc:date>
<dc:identifier>doi:10.1101/2025.09.18.677095</dc:identifier>
<dc:title><![CDATA[Multisensory attenuation of the pupil light response in autistic and non-autistic children]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-09-19</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.09.19.677076v1?rss=1">
<title>
<![CDATA[
An immunocompetent murine model of virus-elicited liver fibrosis and hepatocellular carcinoma 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.09.19.677076v1?rss=1</link>
<description><![CDATA[
Hepatocellular carcinoma (HCC) is the third deadliest cancer worldwide. Over 75% of HCC cases are associated with chronic viral infections. Mechanistic studies and preclinical therapeutic development for virus-associated HCC have been limited by a paucity of small animal models of chronic hepatotropic virus infection that faithfully recapitulate human disease. Here we demonstrate the induction of chronic hepatitis, progressive liver fibrosis, and HCC in immunocompetent laboratory mice upon chronic viral infection with Norway rat hepacivirus (NrHV) - a virus closely related to hepatitis C virus (HCV). NrHV-elicited tumors resemble HCV-associated tumors and liver transcriptome analyses reveal numerous similarities between chronic NrHV and HCV. These findings establish an experimentally tractable, physiologically relevant, and immunocompetent mouse model of virus-elicited progressive liver fibrosis and oncogenesis.
]]></description>
<dc:creator>Batista, M. N.</dc:creator>
<dc:creator>Bordignon, J.</dc:creator>
<dc:creator>Mosimann, A. L. P.</dc:creator>
<dc:creator>Bobrowski, T.</dc:creator>
<dc:creator>Chen, H.-A.</dc:creator>
<dc:creator>Tobin-Xet, G.</dc:creator>
<dc:creator>Barrall, E. A.</dc:creator>
<dc:creator>Prokhnevska, N.</dc:creator>
<dc:creator>Vaidya, A. B.</dc:creator>
<dc:creator>Lewy, T.</dc:creator>
<dc:creator>Dinnon, K. H.</dc:creator>
<dc:creator>Seifert, L. L.</dc:creator>
<dc:creator>Zeck, B.</dc:creator>
<dc:creator>Quirk, C.</dc:creator>
<dc:creator>Ho, Y.-J.</dc:creator>
<dc:creator>Filiol, A.</dc:creator>
<dc:creator>Wolfisberg, R.</dc:creator>
<dc:creator>Jiang, C.</dc:creator>
<dc:creator>Cogliati, B.</dc:creator>
<dc:creator>Chiriboga, L.</dc:creator>
<dc:creator>Theise, N.</dc:creator>
<dc:creator>MacDonald, M. R.</dc:creator>
<dc:creator>Kamphorst, A.</dc:creator>
<dc:creator>Scheel, T. K. H.</dc:creator>
<dc:creator>Sheahan, T. P.</dc:creator>
<dc:creator>Billerbeck, E.</dc:creator>
<dc:creator>Lowe, S.</dc:creator>
<dc:creator>Rosenberg, B. R.</dc:creator>
<dc:creator>Rice, C. M.</dc:creator>
<dc:date>2025-09-21</dc:date>
<dc:identifier>doi:10.1101/2025.09.19.677076</dc:identifier>
<dc:title><![CDATA[An immunocompetent murine model of virus-elicited liver fibrosis and hepatocellular carcinoma]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-09-21</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.09.22.677755v1?rss=1">
<title>
<![CDATA[
Inferring Dynamic Information from Protein Structures by Gaussian Integrals and Deep Learning 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.09.22.677755v1?rss=1</link>
<description><![CDATA[
Protein conformational flexibility underlies a wide range of biological functions, yet experimentally probing dynamics at atomic resolution remains costly and low-throughput. Here, we present a deep learning framework that predicts protein flexibility directly from static structural descriptors, bypassing the need for molecular dynamics (MD) simulations. Using the ATLAS database of standardized all-atom MD trajectories, we encoded 1,374 protein chains as 30-dimensional Gaussian integral (GI) vectors--global shape and topology invariants of the protein backbone. Principal component analysis of GI profiles revealed four structural clusters with distinct secondary structure compositions and flexibility distributions. We trained an attention-based one-dimensional convolutional neural network (1D-CNN) to classify proteins as flexible or non-flexible based on their root-mean-square fluctuation (RMSF) relative to the dataset-wide mean. The classifier achieved an AUC of 0.772 (95% CI: 0.712-0.826) on an independent test set, with balanced sensitivity and specificity, and identified a small subset of GI components as the most predictive. In a regression setting, a recurrent neural network outperformed other architectures, attaining an R2 of 0.537, though high-flexibility values were systematically underestimated. Cluster-specific analyses indicated that coil-rich and {beta}-sheet-dominated proteins were more amenable to flexibility prediction than -helical proteins, likely due to greater structural heterogeneity. Our results demonstrate that compact GI descriptors preserve sufficient information to recover MD-derived flexibility trends, offering a computationally efficient complement to simulation-based approaches. This framework enables large-scale screening of protein dynamics from structural data alone, with potential applications in structural bioinformatics, drug design, and functional annotation.
]]></description>
<dc:creator>Vilicich, F.</dc:creator>
<dc:creator>Yin, S.</dc:creator>
<dc:creator>Su, Z.</dc:creator>
<dc:creator>Wu, Y.</dc:creator>
<dc:date>2025-09-24</dc:date>
<dc:identifier>doi:10.1101/2025.09.22.677755</dc:identifier>
<dc:title><![CDATA[Inferring Dynamic Information from Protein Structures by Gaussian Integrals and Deep Learning]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-09-24</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.09.29.679368v1?rss=1">
<title>
<![CDATA[
A microfluidic rheometer for tumor mechanics and invasion studies 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.09.29.679368v1?rss=1</link>
<description><![CDATA[
Clinically, the feel, touch, and shape of a solid tumor are important diagnostic methods for determining the malignant state of the disease. However, there are limited tools for quantifying the mechanics and the malignancy of the tumor in a physiologically realistic setting. Here, we developed a microfluidic rheometer - termed the microrheometer - that enables simultaneous measurements of tumor spheroid mechanics and their invasiveness into a 3D extracellular matrix (ECM). The microrheometer consists of a pneumatic pressure control unit for applying controlled static or cyclic compression to tumor spheroids, and a sample chamber for containing spheroid embedded ECM. The innovation here lies in the integration of a polyacrylamide membrane force sensor within the sample chamber, enabling a direct force measurement in a physiologically relevant setting. We found that both tumor stiffness and the viscoelastic properties of the tumor are closely correlated with tumor invasiveness. The microrheometer allowed us to measure tumor mechanics in a short time (less than a minute) and has the potential to be used clinically in the future. We note that the microrheometer here can be easily extended to studies of mechanics of single cell, nucleus, as well as other cell/tissue types.
]]></description>
<dc:creator>Suh, Y. J.</dc:creator>
<dc:creator>Liu, M.</dc:creator>
<dc:creator>Zhu, B.</dc:creator>
<dc:creator>Pandey, M.</dc:creator>
<dc:creator>Cheung, B. C. H.</dc:creator>
<dc:creator>Kim, J.</dc:creator>
<dc:creator>Bouklas, N.</dc:creator>
<dc:creator>Roh, C.</dc:creator>
<dc:creator>Segall, J. E.</dc:creator>
<dc:creator>Hui, C. Y.</dc:creator>
<dc:creator>Wu, M.</dc:creator>
<dc:date>2025-10-01</dc:date>
<dc:identifier>doi:10.1101/2025.09.29.679368</dc:identifier>
<dc:title><![CDATA[A microfluidic rheometer for tumor mechanics and invasion studies]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-10-01</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.09.30.679317v1?rss=1">
<title>
<![CDATA[
SiteCELL enables on-site PBMCs purification and cryopreservation for immune single cell profiling of diverse ancestries 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.09.30.679317v1?rss=1</link>
<description><![CDATA[
Single cell genomics has improved our knowledge of immune function and heterogeneity. In recent years, the steady increase in the number of cells and individuals profiled as part of large multinational projects has enabled the characterization of cellular differences across human populations and ancestries. However, methods for collecting and processing peripheral blood mononuclear cells (PBMCs) for downstream single cell sequencing are difficult to implement in remote and rural settings. This has resulted in a lack of representation of underserved communities across the Global South in current initiatives. Hence, we developed SiteCELL, a method that enables purification and cryopreservation of PBMCs from whole blood at the site of collection using minimal laboratory equipment and without electricity. By comparing matched samples of purified PBMCs, we showed that SiteCELL performs as well as ficoll density gradient (FDG), both in laboratory and rural settings. This method ensures accurate recovery of cell type proportions and excels in reducing stress and minimizing variability across sampling batches. These advantages make it particularly well suited for implementation in challenging settings across countries, thereby enabling the inclusion of underrepresented ancestries in cellular atlases.
]]></description>
<dc:creator>Espinosa-Jaime, A.</dc:creator>
<dc:creator>Zambada-Moreno, O.</dc:creator>
<dc:creator>Corona-Gomez, J. A.</dc:creator>
<dc:creator>Ortega, M. d. J.</dc:creator>
<dc:creator>Hernandez-Coronado, M.</dc:creator>
<dc:creator>Dos Santos Dias, B.</dc:creator>
<dc:creator>Alvez Diniz, L.</dc:creator>
<dc:creator>Leaden, L.</dc:creator>
<dc:creator>Martelossi Cebinelli, G.</dc:creator>
<dc:creator>Marchese, D.</dc:creator>
<dc:creator>Rojas-Hidalgo, A.</dc:creator>
<dc:creator>Vicencio, E.</dc:creator>
<dc:creator>Perez-Stuardo, D.</dc:creator>
<dc:creator>Urquiza-Zurich, S.</dc:creator>
<dc:creator>Espitia Fajardo, M.</dc:creator>
<dc:creator>Colombo, A.</dc:creator>
<dc:creator>Donoso, G.</dc:creator>
<dc:creator>Mendez, T.</dc:creator>
<dc:creator>Gallo, C.</dc:creator>
<dc:creator>Guerrero-Cazares, H.</dc:creator>
<dc:creator>Robles-Espinoza, C. D.</dc:creator>
<dc:creator>Possik, P. A.</dc:creator>
<dc:creator>Barreto, G.</dc:creator>
<dc:creator>Spangenberg, L.</dc:creator>
<dc:creator>Verdugo, R. A.</dc:creator>
<dc:creator>Maracaja-Coutinho, V.</dc:creator>
<dc:creator>Severino, P.</dc:creator>
<dc:creator>Moreno-Estrada, A.</dc:creator>
<dc:creator>Ortiz-Ramirez, C. H.</dc:creator>
<dc:date>2025-10-02</dc:date>
<dc:identifier>doi:10.1101/2025.09.30.679317</dc:identifier>
<dc:title><![CDATA[SiteCELL enables on-site PBMCs purification and cryopreservation for immune single cell profiling of diverse ancestries]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-10-02</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.10.06.680684v1?rss=1">
<title>
<![CDATA[
Complex HPV-human DNA structures revealed by large-scale DNA analyses in an HPV-cancer derived cell line 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.10.06.680684v1?rss=1</link>
<description><![CDATA[
Most human papillomavirus (HPV)-associated cancers harbor viral DNA integrated into the human genome as extrachromosomal circles, intrachromosomal segments, or both. Distinguishing intrachromosomal from identical-sequence extrachromosomal DNA (ecDNA) by sequencing alone is challenging, and the architecture of large-scale HPV-human DNA structures remains incompletely understood. To address this, we applied complementary genomic tools, spanning single-nucleotide to megabase resolution, to the HPV16-positive oropharyngeal cancer-cell line UM-SCC-47. These revealed that an initial integration event formed a 23 kb extrachromosomal heterocatemer circle comprising 7.5 kb of HPV16 DNA and 16 kb of the human TP63 gene. Subsequent genomic rearrangements generated heterocatemer tandem arrays extending to 0.6 megabases, plus additional large-scale rearrangements involving the HPV-TP63 structures, as revealed by long-read DNA sequencing and optical genome mapping. Fluorescent in situ Hybridization (FISH) showed that the heterocatemers were intrachromosomally localized at chromosome 3 at the TP63 locus in 100% of the cells. Long-read RNA sequencing further showed that these intrachromosomal templates produced spliced, polyadenylated transcripts. A subset of cells also harbored HPV16 ecDNA derived from the intrachromosomal HPV-TP63 DNAs. These findings define previously unrecognized higher-order architecture of integrated HPV DNA and highlight the power of FISH for distinguishing intrachromosomal from extrachromosomal DNA structures.

GRAPHICAL ABSTRACT

O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=76 SRC="FIGDIR/small/680684v1_ufig1.gif" ALT="Figure 1">
View larger version (20K):
org.highwire.dtl.DTLVardef@f3d584org.highwire.dtl.DTLVardef@470811org.highwire.dtl.DTLVardef@162c88corg.highwire.dtl.DTLVardef@5c80dd_HPS_FORMAT_FIGEXP  M_FIG C_FIG
]]></description>
<dc:creator>Montagna, C.</dc:creator>
<dc:creator>Agosta, E. J.</dc:creator>
<dc:creator>Chang, Y. C.</dc:creator>
<dc:creator>Rao, V.</dc:creator>
<dc:creator>Hollingsworth, J.</dc:creator>
<dc:creator>Brown, M.</dc:creator>
<dc:creator>Kabiraj, D.</dc:creator>
<dc:creator>Einstein, M.</dc:creator>
<dc:creator>Van Arsdale, A.</dc:creator>
<dc:creator>Van Doorslaer, K.</dc:creator>
<dc:creator>Chan, C.</dc:creator>
<dc:creator>De, S.</dc:creator>
<dc:creator>Madireddy, A.</dc:creator>
<dc:creator>Haas, B.</dc:creator>
<dc:creator>Miller, D.</dc:creator>
<dc:creator>Lenz, J.</dc:creator>
<dc:date>2025-10-06</dc:date>
<dc:identifier>doi:10.1101/2025.10.06.680684</dc:identifier>
<dc:title><![CDATA[Complex HPV-human DNA structures revealed by large-scale DNA analyses in an HPV-cancer derived cell line]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-10-06</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.10.06.680702v1?rss=1">
<title>
<![CDATA[
Controlled Delivery of a Neurotrophic Factor in the Adult Mouse Brain Using Engineered Microglia 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.10.06.680702v1?rss=1</link>
<description><![CDATA[
Microglia, the resident immune cells of the central nervous system, have been proposed as vehicles for delivering therapeutic biologics. These cells can be genetically engineered in vitro and transplanted into host animals following ablation of endogenous microglia, enabling repopulation of the brain parenchyma. However, current replacement strategies often rely on radiation or transgenic models, limiting their clinical relevance. CSF1R inhibitors offer a more translational approach to microglia ablation, though surviving host cells can compete with transplanted microglia during repopulation.

In this study, we successfully ablated endogenous microglia using a CSF1R inhibitor in adult mice and developed a method to transplant engineered microglia expressing Brain-Derived Neurotrophic Factor (BDNF) in a doxycycline-inducible manner. To enhance engraftment, transplanted cells also expressed a constitutively active CSF1R mutant (caCSF1R).

BDNF-expressing transplanted microglia spread through large areas of host mice brains, displayed similar morphology and transcriptional profile to repopulating host microglia, and responded to pro-inflammatory stimuli. Treatment with doxycycline resulted in increased BDNF expression and TrkB phosphorylation in the host brain. Expression of caCSF1R provided transplanted cells with a competitive advantage over endogenous repopulating cells, resulting in the accelerated spread of the transplants.

Our results demonstrate the functional integration and therapeutic potential of microglia as vehicles for delivering neurotrophic factors to the brain in a controllable manner. Furthermore, we show that caCSF1R expression is able to enhance the spread of transplanted microglia.

SIGNIFICANCEThis study demonstrates the potential of engineered microglia to deliver the protein Brain-Derived Neurotrophic Factor to the brain parenchyma, under the control of orally-administered doxycycline. The technique can be generalized to a wide array of proteins, offering a novel paradigm for neurological therapy.
]]></description>
<dc:creator>Hofland, R. J.</dc:creator>
<dc:creator>Gronska-Peski, M.</dc:creator>
<dc:creator>Nobuta, H.</dc:creator>
<dc:creator>Buitrago, N.</dc:creator>
<dc:creator>Malhotra, K.</dc:creator>
<dc:creator>Hebert, J. M.</dc:creator>
<dc:creator>Goncalves, J. T.</dc:creator>
<dc:date>2025-10-07</dc:date>
<dc:identifier>doi:10.1101/2025.10.06.680702</dc:identifier>
<dc:title><![CDATA[Controlled Delivery of a Neurotrophic Factor in the Adult Mouse Brain Using Engineered Microglia]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-10-07</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.10.08.681128v1?rss=1">
<title>
<![CDATA[
WNK kinase regulates plasma membrane levels of the WNT inhibitor RNF43 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.10.08.681128v1?rss=1</link>
<description><![CDATA[
The E3 ubiquitin ligases RNF43 and ZNRF3 are key negative regulators of canonical WNT signaling, promoting turnover of the WNT receptors FRIZZLED and LRP5/6 at the plasma membrane. While their mechanism of action is well established, how RNF43/ZNRF3 themselves are regulated remains unclear. Here, we identify WNK kinases as novel upstream regulators of RNF43 through proximity labeling proteomics. Using gain- and loss-of-function approaches, we show that WNKs control RNF43 surface localization and thereby its ability to ubiquitinate and downregulate WNT receptors. Pharmacological inhibition of WNKs increases RNF43 membrane abundance and enhances WNT suppression - an effect abolished in RNF43/ZNRF3 double knockout cells and organoids. Mechanistically, WNK inhibition alters RNF43 trafficking and ubiquitination, revealing a role for WNKs in regulating its plasma membrane distribution. These findings define a new regulatory axis linking the pro-WNT activity of WNKs to RNF43/ZNRF3-mediated feedback inhibition. Targeting WNK now offers a novel therapeutic strategy to restore WNT pathway control in cancers with RSPO fusions or RNF43 mutations.
]]></description>
<dc:creator>Colozza, G.</dc:creator>
<dc:creator>Jordens, I.</dc:creator>
<dc:creator>Sosa, E. A.</dc:creator>
<dc:creator>Ha, j.</dc:creator>
<dc:creator>Wu, S.</dc:creator>
<dc:creator>Tavernini, K.</dc:creator>
<dc:creator>Catala, A.</dc:creator>
<dc:creator>Farnhammer, F.</dc:creator>
<dc:creator>Urban Avellaneda, N.</dc:creator>
<dc:creator>Maurice, M.</dc:creator>
<dc:creator>Koo, B.-K.</dc:creator>
<dc:date>2025-10-08</dc:date>
<dc:identifier>doi:10.1101/2025.10.08.681128</dc:identifier>
<dc:title><![CDATA[WNK kinase regulates plasma membrane levels of the WNT inhibitor RNF43]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-10-08</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.10.10.681517v1?rss=1">
<title>
<![CDATA[
Age Associated Increase in Microglia Inflammation and Phagocytosis in the Adult Neural Stem Cell Niche. 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.10.10.681517v1?rss=1</link>
<description><![CDATA[
Adult SVZ neurogenesis declines with age, but the niche mechanisms remain incompletely defined. Here, we show that SVZ microglia acquire activation-associated morphology with aging. Reanalysis of published SVZ single-cell RNA-Seq data revealed that aged microglia upregulate inflammatory and lysosome/phagosome-related gene programs, including multiple phagocytosis-associated receptors and effectors. Functionally, young SVZ-derived microglia exhibit reduced basal phagocytic activity compared with non-SVZ microglia in vitro, whereas aged SVZ microglia show increased phagocytosis. In vivo SVZ wholemounts reveal increased progenitor-derived material within lysosomal compartments of microglia with age, without an accompanying increase in SVZ apoptosis. Inhibiting complement C3 activation or reducing inflammation with minocycline treatment partially restores SVZ proliferation in aged mice, but does not reduce progenitor-derived material within lysosomal compartments of aged microglia. These data support a model in which microglial inflammatory signaling contributes to age-related suppression of SVZ proliferation, while microglial engagement with neural progenitors is sustained by additional mechanisms.
]]></description>
<dc:creator>Cutler, R.</dc:creator>
<dc:creator>Harrison, S. J.</dc:creator>
<dc:creator>Sandoval-Kuhn, N.</dc:creator>
<dc:creator>Tomlinson, S.</dc:creator>
<dc:creator>Kokovay, E.</dc:creator>
<dc:date>2025-10-13</dc:date>
<dc:identifier>doi:10.1101/2025.10.10.681517</dc:identifier>
<dc:title><![CDATA[Age Associated Increase in Microglia Inflammation and Phagocytosis in the Adult Neural Stem Cell Niche.]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-10-13</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.10.20.683390v1?rss=1">
<title>
<![CDATA[
Cross-Species Insights from ART-D to Uncover Evolutionarily Conserved Oncogenic Mechanisms 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.10.20.683390v1?rss=1</link>
<description><![CDATA[
Cancer arises from oncogenic clones, yet the dynamic mechanisms governing their stepwise evolution toward malignancy remain incompletely understood. Here, we establish the Atlas of Ras-driven Tumors in Drosophila (ART-D), a systematic, cross-species platform that dissects the molecular and phenotypic trajectories of tumorigenesis through ten genetically defined RasV12-driven models. By integrating longitudinal phenotypic profiling, we define three conserved stages of tumor development--initiation, promotion, and progression--distinguished by dynamic changes in tumor burden and tumor-induced cachexia. Transcriptomic dynamics reveal stage-specific signaling rewiring: early tumorigenesis is marked by co-activation of JAK/STAT, NF-{kappa}B/Toll, and MAPK pathways, whereas malignant progression is driven by Notch hyperactivation and Hippo pathway inactivation. Through integrative multi-omics and machine learning, we uncover an evolutionarily conserved pathogenic network involving coordinated JNK, NF-{kappa}B/Toll, Notch, and Hippo signaling that is functionally validated across species. ART-D provides a transformative resource that bridges Drosophila genetics and human cancer biology, offering a framework for decoding conserved oncogenic principles and enabling precision targeting of stage-specific vulnerabilities in RAS-driven cancers.
]]></description>
<dc:creator>Guo, Y.</dc:creator>
<dc:creator>Zheng, J.</dc:creator>
<dc:creator>Wu, Y.</dc:creator>
<dc:creator>Zhao, K.</dc:creator>
<dc:creator>Lv, D.</dc:creator>
<dc:creator>Liu, W.</dc:creator>
<dc:creator>Wang, M.</dc:creator>
<dc:creator>Lu, J.</dc:creator>
<dc:creator>Xu, W.</dc:creator>
<dc:creator>Wang, X.</dc:creator>
<dc:creator>Ma, X.</dc:creator>
<dc:date>2025-10-20</dc:date>
<dc:identifier>doi:10.1101/2025.10.20.683390</dc:identifier>
<dc:title><![CDATA[Cross-Species Insights from ART-D to Uncover Evolutionarily Conserved Oncogenic Mechanisms]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-10-20</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.10.26.684512v1?rss=1">
<title>
<![CDATA[
A bioluminescence-based chemical screen identifies a bactericidal naphthalene scaffold targeting MmpL3 in Mycobacterium abscessus 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.10.26.684512v1?rss=1</link>
<description><![CDATA[
Mycobacterium abscessus pulmonary disease (Mabs-PD) presents a significant and growing global health threat, particularly in individuals with underlying lung conditions like cystic fibrosis and chronic obstructive pulmonary disease. A key challenge in treating Mabs-PD is the lack of bactericidal antibiotics effective at therapeutically relevant concentrations, underscoring an urgent need for drug discovery. Targeting cell-wall synthesis is a promising approach, as evidenced by the success of broad-spectrum {beta}-lactam antibiotics and the frontline antituberculosis drug isoniazid. However, these agents exhibit limited efficacy against Mabs, often requiring concentrations unachievable in lung tissues. Here, we used a bioluminescence-based whole-cell assay optimized to identify drugs targeting both cell-wall synthesis and the oxidative phosphorylation pathway. Screening a small drug library against Mabs revealed multiple hits, including {beta}-lactam antibiotics, validating the effectiveness of this approach to identify cell wall-targeting agents. Among these, we identified a chemically tractable naphthalene scaffold with potent bactericidal activity. The optimized derivative GM47-1 targets MmpL3, disrupting cell wall integrity, inducing ATP leakage into the extracellular milieu, and uncoupling respiration, predominantly through the cytochrome bcc:aa3 branch. Further chemical optimization resulted in a new derivative exhibiting a nanomolar minimum inhibitory concentration, with potent activity against intracellular Mabs and in a zebrafish model of infection. This study offers a promising scaffold for future therapeutic development and highlights the utility of this approach as a rapid assay platform for identifying bactericidal compounds against Mabs.
]]></description>
<dc:creator>Singh, S.</dc:creator>
<dc:creator>Sorayah, R.</dc:creator>
<dc:creator>Chen, Y.</dc:creator>
<dc:creator>Mulholland, C. V.</dc:creator>
<dc:creator>Daher, W.</dc:creator>
<dc:creator>Pee, C. J. E.</dc:creator>
<dc:creator>Casandra, T. A. Z.</dc:creator>
<dc:creator>Wee, D.</dc:creator>
<dc:creator>Oehlers, S. H.</dc:creator>
<dc:creator>Kline, K. A.</dc:creator>
<dc:creator>Chng, S. S.</dc:creator>
<dc:creator>Berney, M.</dc:creator>
<dc:creator>Kremer, L.</dc:creator>
<dc:creator>Moraski, G.</dc:creator>
<dc:creator>Pethe, K.</dc:creator>
<dc:date>2025-10-26</dc:date>
<dc:identifier>doi:10.1101/2025.10.26.684512</dc:identifier>
<dc:title><![CDATA[A bioluminescence-based chemical screen identifies a bactericidal naphthalene scaffold targeting MmpL3 in Mycobacterium abscessus]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-10-26</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.10.27.684934v1?rss=1">
<title>
<![CDATA[
Synthetic multicolor antigen-stabilizable nanobody platform for intersectional labelling and functional imaging. 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.10.27.684934v1?rss=1</link>
<description><![CDATA[
We present a synthetic toolkit of antigen-stabilizable fluorescent nanobodies (VIS-Fbs) spanning the entire visible spectrum from 450 nm to 660 nm. By engineering over twenty fluorescent proteins (FPs) and biosensors into eight nanobodies, we established a generalizable design of VIS-Fbs, which fluoresce brightly only upon binding to cognate antigens. Our synthetic approach includes constitutive, photoactivatable and photoswitchable FPs, and intensiometric FP-based biosensors. VIS-Fbs carrying biosensors enable simultaneous monitoring of two metabolites at confined locations, while FP-based VIS-Fbs targeting biosensors allow ratiometric functional imaging in the mouse brain. We further used VIS-Fbs to track endogenous {beta}-catenin dynamics in zebrafish embryos during normal development and under Wnt/{beta}-catenin signaling modulation. VIS-Fbs provide background-free visualization of intracellular proteins, multicolor detection of multiple antigens, and selective targeting of defined cell populations and compartments. This synthetic biology-driven platform enables precise studies of protein dynamics, cellular processes, and complex biological systems with high specificity and minimal background.
]]></description>
<dc:creator>Barykina, N. V.</dc:creator>
<dc:creator>Carey, E. M.</dc:creator>
<dc:creator>Oliinyk, O. S.</dc:creator>
<dc:creator>Mendonca-Gomes, J. M.</dc:creator>
<dc:creator>de Oliveira, S.</dc:creator>
<dc:creator>Nimmerjahn, A.</dc:creator>
<dc:creator>Verkhusha, V. V.</dc:creator>
<dc:date>2025-10-27</dc:date>
<dc:identifier>doi:10.1101/2025.10.27.684934</dc:identifier>
<dc:title><![CDATA[Synthetic multicolor antigen-stabilizable nanobody platform for intersectional labelling and functional imaging.]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-10-27</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.10.28.685002v1?rss=1">
<title>
<![CDATA[
Glypican-1 upregulation elicited in response to a cell-impermeable kinase inhibitor and its overexpression enhance HIV-1 infection 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.10.28.685002v1?rss=1</link>
<description><![CDATA[
Studies of herpes simplex virus (HSV) entry uncovered a previously unappreciated "outside-in" signaling pathway whereby activation of the calcium (Ca2+) responsive enzyme phospholipid scramblase 1 (PLSCR1), which is known to trigger the bidirectional movement of phosphatidylserines (PS) between the inner and outer leaflet of the plasma membrane, also induces the translocation and subsequent extracellular activation of intracellular proteins, including Akt. We hypothesized that HIV-1, which has been shown to elicit scramblase TMEM16F-mediated PS externalization, may trigger a similar "outside-in" signaling cascade involving exofacial kinase activity to promote its entry into CD4+ T cells. To study this process, we utilized a cell impermeable staurosporine analogue, alkyl-CIMSS, which is a broadly active kinase inhibitor that blocks HSV-induced exofacial Akt phosphorylation and HSV infection. Using multiple cell types including TZM-bl, Jurkat T cells, and human peripheral blood mononuclear cells (PBMCs), we show that, in contrast to the effects on HSV, treatment of cells with alkyl-CIMSS enhances HIV-1 infection post-entry that is not dependent on TMEM16F. To identify potential biological processes that are responsive to alkyl-CIMSS, we performed bulk RNA-sequencing and whole cell proteomics and found that alkyl-CIMSS treatment of cells robustly upregulates the cell surface density of the proteoglycan glypican-1 (GPC1). Lentiviral delivery of GPC1 overexpression and shRNA knockdown constructs reveal that the presence and absence of GPC1 independently of alkyl-CIMSS treatment significantly impact HIV-1 infection, with the effect on infection corresponding to GPC1 expression. Further, we demonstrate that the influence of GPC1 on HIV-1 infection is in part mediated by TGF-{beta} signaling. Collectively, these findings implicate a cell surface protein susceptible to alkyl-CIMSS in restricting HIV-1 infection and identify GPC1 as a novel modulator of HIV-1 infection.

Author SummaryWe utilized a cell-impermeable pan-kinase tool compound, alkyl-CIMSS, to identify cell surface molecules that might be involved in viral infection. Treatment of CD4+ T cells with alkyl-CIMSS increased the expression of the cell-surface protein glypican-1, which led to an increase in early HIV reverse transcriptase products and promoted viral infection. Conversely, alkyl-CIMSS inhibited herpes simplex virus entry and infection. These findings illustrate that viruses interact with exofacial cell membrane molecules differently to promote or impede infection.
]]></description>
<dc:creator>Vinzant, K.</dc:creator>
<dc:creator>Cheshenko, N.</dc:creator>
<dc:creator>Pan, H.</dc:creator>
<dc:creator>Cutler, R.</dc:creator>
<dc:creator>Buckler, J. N.</dc:creator>
<dc:creator>Luxenburger, A.</dc:creator>
<dc:creator>Harris, L. D.</dc:creator>
<dc:creator>Johnson, J. R.</dc:creator>
<dc:creator>Almo, S. C.</dc:creator>
<dc:creator>Herold, B. C.</dc:creator>
<dc:date>2025-10-28</dc:date>
<dc:identifier>doi:10.1101/2025.10.28.685002</dc:identifier>
<dc:title><![CDATA[Glypican-1 upregulation elicited in response to a cell-impermeable kinase inhibitor and its overexpression enhance HIV-1 infection]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-10-28</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.10.27.684888v1?rss=1">
<title>
<![CDATA[
Pitavastatin counteracts venetoclax resistance mechanisms in acute myeloid leukemia 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.10.27.684888v1?rss=1</link>
<description><![CDATA[
The BCL2 inhibitor venetoclax has therapeutic activity in several hematological malignancies. In acute myeloid leukemia (AML), venetoclax combined with hypomethylating agents is the standard of care for patients unfit for intensive chemotherapy, but intrinsic and acquired resistance are common. Loss of p53 function is strongly associated with venetoclax resistance, and adding venetoclax to 5-azacitidine provides no overall survival benefit in TP53-mutant AML. Other frequent mechanisms of venetoclax resistance in AML include FLT3 mutations, MCL-1 upregulation, and altered mitochondrial metabolism. Unfortunately, it has been challenging to develop agents that target these mechanisms directly and combinatorially. Here we report that pitavastatin, an inhibitor of HMG-CoA-reductase, promotes apoptosis and overcomes several venetoclax resistance mechanisms in human AML cells. At clinically achievable concentrations, pitavastatin treatment has potent cytotoxic activity in cells with mutations in TP53 or FLT3. The apoptotic mechanism involves p53-independent PUMA upregulation and reduced MCL-1 expression. Pitavastatin also suppresses mitochondrial gene expression and oxidative metabolism. The pro-apoptotic actions of pitavastatin depend on depletion of geranylgeranyl pyrophosphate (GGPP) and can be recapitulated by inhibiting GGPP synthase or geranylgeranyltransferase-1 enzymes. These results provide a mechanistic rationale for adding pitavastatin to AML regimens to prevent or overcome venetoclax resistance.
]]></description>
<dc:creator>Fruman, D.</dc:creator>
<dc:creator>Buono, R.</dc:creator>
<dc:creator>Juarez, D.</dc:creator>
<dc:creator>Paul, M.</dc:creator>
<dc:creator>Skuli, S. J.</dc:creator>
<dc:creator>Wong, I. B.</dc:creator>
<dc:creator>Tarnekar, I.</dc:creator>
<dc:creator>Ying, Z.</dc:creator>
<dc:creator>Le, I.</dc:creator>
<dc:creator>Wertheim, G.</dc:creator>
<dc:creator>Bakayoko, A.</dc:creator>
<dc:creator>Kruidenier, M.</dc:creator>
<dc:creator>Sebti, S.</dc:creator>
<dc:creator>Konopleva, M.</dc:creator>
<dc:creator>Fleischman, A. G.</dc:creator>
<dc:creator>Jang, C.</dc:creator>
<dc:creator>Carroll, M.</dc:creator>
<dc:date>2025-10-29</dc:date>
<dc:identifier>doi:10.1101/2025.10.27.684888</dc:identifier>
<dc:title><![CDATA[Pitavastatin counteracts venetoclax resistance mechanisms in acute myeloid leukemia]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-10-29</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.10.29.685313v1?rss=1">
<title>
<![CDATA[
Structure-based Predictions of Conformational B Cell Epitopes by Protein Language Model and Deep Learning 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.10.29.685313v1?rss=1</link>
<description><![CDATA[
Mapping conformational B-cell epitopes remains a central challenge for antibody discovery: experiments are costly and most computational tools trained on generic protein-protein interfaces transfer poorly to antibody-antigen recognition. We introduce a patch-centric framework that predicts epitopes directly on antigen structures. Each surface "patch" is defined as a triad of neighboring residues, capturing the smallest local unit that encodes both shape and chemistry. We evaluate two classifiers: (i) a protein language model (PLM) approach that averages ESM-2 embeddings over each triad and scores them with a small multilayer perceptron [1], and (ii) a convolutional baseline that consumes a hand-crafted 15x20 feature matrix summarizing amino-acid identity, secondary structure, solvent accessibility, and shape index. Trained with five-fold cross-validation on 1,151 AbDb antibody-antigen complexes, the PLM model markedly outperforms the CNN at the patch level (e.g., F1{approx} 0.986, ROC-AUC{approx} 0.998). Aggregating patch scores to residues with an ensemble over all folds yields robust residue-wise performance, surpassing the CNN (ROC-AUC 0.689{+/-}0.072 vs. 0.548{+/-}0.018). Against widely used sequence- and structure-based tools on AbDb, our PLM achieves the best summary metrics (ROC-AUC 0.67, PR- AUC 0.56) with full coverage of all antigens. On five external complexes unseen during development, the model generalizes well (ROC-AUC 0.663) and accurately localizes binding regions qualitatively. The method converts PLM representations into interpretable epitope likelihood maps, offering a practical aid for antigen prioritization, antibody engineering, and vaccine design.
]]></description>
<dc:creator>Zhang, Y.</dc:creator>
<dc:creator>Vilicich, F.</dc:creator>
<dc:creator>Kuang, X.</dc:creator>
<dc:creator>Liu, Y.</dc:creator>
<dc:creator>Zhang, G.</dc:creator>
<dc:creator>Su, Z.</dc:creator>
<dc:creator>Wu, Y.</dc:creator>
<dc:date>2025-10-30</dc:date>
<dc:identifier>doi:10.1101/2025.10.29.685313</dc:identifier>
<dc:title><![CDATA[Structure-based Predictions of Conformational B Cell Epitopes by Protein Language Model and Deep Learning]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-10-30</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.11.03.684159v1?rss=1">
<title>
<![CDATA[
Neural oscillatory dynamics reveal altered top-down and integrative mechanisms during face processing in autistic children and unaffected siblings of autistic children 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.11.03.684159v1?rss=1</link>
<description><![CDATA[
Face processing is fundamental to social communication and has been a major focus of autism research. While event-related potential (ERPs) studies of face processing have produced mixed results, little work has examined neuro-oscillatory dynamics, which may better capture the integrity of underlying networks. To address this gap, EEG was recorded from children aged 8-13 across three groups: autistic (n = 50), non-autistic (n = 38) and siblings of autistic children (n = 26), during a visual oddball task. In a blocked design, participants viewed faces and objects, presented upright and inverted (non-targets), to assess the face inversion effect (the FIE; a larger or earlier N170 to inverted than upright faces), and responded to infrequent shadow versions (targets). Analyses using permutation statistics and linear mixed models focused on non-target stimuli, quantifying face-related ERPs (P1, N170) and oscillatory activity associated with sensory and attentional processing (theta, alpha, gamma). Across groups, faces elicited earlier P1 and larger N170 amplitudes than objects, and showed a FIE. Furthermore, the rightward lateralization of the FIE was reduced for autistic participants. Analyses in the frequency domain revealed greater induced theta for inverted versus upright stimuli and for faces versus objects, revealing face specific effects, and stronger theta for inverted faces for the autistic and sibling groups, suggesting greater cognitive effort in processing these social stimuli. Gamma-band inter-trial phase coherence exhibited face selectivity only in the non-autistic group, pointing to differences in early network synchronization in autistic children relative to their non-autistic peers, whereas alpha event-related desynchronization did not vary by group or category. Altogether, these findings support altered neural synchronization/efficiency for autistic participants and siblings of autistic children, that is specific to face stimuli and seen despite largely typical sensory driven encoding. These data suggest that neural oscillatory assays are more sensitive to face processing differences in autism than broadband ERPs and that these oscillatory assays may be endophenotypic.
]]></description>
<dc:creator>Vanneau, T.</dc:creator>
<dc:creator>Brittenham, C.</dc:creator>
<dc:creator>Darrell, M.</dc:creator>
<dc:creator>Foxe, J. J.</dc:creator>
<dc:creator>Molholm, S.</dc:creator>
<dc:date>2025-11-04</dc:date>
<dc:identifier>doi:10.1101/2025.11.03.684159</dc:identifier>
<dc:title><![CDATA[Neural oscillatory dynamics reveal altered top-down and integrative mechanisms during face processing in autistic children and unaffected siblings of autistic children]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-11-04</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.11.04.686414v1?rss=1">
<title>
<![CDATA[
Identification of distinct cDC2 subpopulations that direct microbiota-specific T cell differentiation 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.11.04.686414v1?rss=1</link>
<description><![CDATA[
How the complex network of intestinal antigen presenting cells (APCs) instructs CD4+ T cell responses against the microbiota remains unclear. Here, we use Labeling Immune Partnerships by SorTagging Intercellular Contacts (LIPSTIC) to characterize the APCs that prime CD4+ T cells recognizing the commensal bacterium Akkermansia muciniphila. A. muciniphila-specific T cells engaged multiple transcriptionally distinct migratory cDC2 subpopulations, both at homeostasis, when A. muciniphila promotes TFH differentiation, and during inflammation, when it also drives TH1 and TH17 differentiation. The identity of these subpopulations was unchanged by inflammation; however, the distribution of presentation across the subpopulations shifted, with increased presentation by inflammatory cDC2s favoring TH1 and TH17 polarization. These results reveal how distinct T cell differentiation trajectories can be determined through varied interactions with multiple, functionally distinct subpopulations of APCs.
]]></description>
<dc:creator>Carroll, S. L.</dc:creator>
<dc:creator>Ly, A.</dc:creator>
<dc:creator>Liu, A. K.</dc:creator>
<dc:creator>Canesso, M. C. C.</dc:creator>
<dc:creator>Victora, G. D.</dc:creator>
<dc:creator>Mucida, D.</dc:creator>
<dc:creator>Barton, G. M.</dc:creator>
<dc:date>2025-11-05</dc:date>
<dc:identifier>doi:10.1101/2025.11.04.686414</dc:identifier>
<dc:title><![CDATA[Identification of distinct cDC2 subpopulations that direct microbiota-specific T cell differentiation]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-11-05</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.11.07.687224v1?rss=1">
<title>
<![CDATA[
Histone H1 Promotes Silencing of Unintegrated HIV-1 DNA 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.11.07.687224v1?rss=1</link>
<description><![CDATA[
In eukaryotic cells, genomic DNA is packaged into chromatin with nucleosomes formed by core histones H2A, H2B, H3, and H4, and further stabilized by the linker histone H1. During the early stages of retroviral infection, such as with murine leukemia virus (MLV) and human immunodeficiency virus type 1 (HIV-1), host core and H1 histones are rapidly deposited onto unintegrated viral DNAs upon nuclear entry. These unintegrated viral DNAs are transcriptionally silenced through histone post-translational modifications (PTMs), including high levels of H3K9 trimethylation and low levels of H3 acetylation. Linker histone H1 is closely associated with chromatin compaction and histone PTMs, suggesting a potential role in regulating retroviral DNA fate. In this study, we demonstrate that simultaneous knockdown of four somatic H1 variants (H1.2, H1.3, H1.4, and H1.5) in K562 cells reverses the silencing of unintegrated HIV-1 DNA, resulting in increased viral expression. Notably, this effect was specific to HIV-1, as the same H1 depletion did not alter the silencing of MLV unintegrated DNA. These results reveal distinct roles of H1 in regulating HIV-1 and MLV unintegrated DNA expression.
]]></description>
<dc:creator>Zhu, J.</dc:creator>
<dc:creator>Wang, G. Z.</dc:creator>
<dc:creator>Pinto, H. D.</dc:creator>
<dc:creator>Hilton, S. E.</dc:creator>
<dc:creator>Skoultchi, A. I.</dc:creator>
<dc:creator>Goff, S. P.</dc:creator>
<dc:date>2025-11-07</dc:date>
<dc:identifier>doi:10.1101/2025.11.07.687224</dc:identifier>
<dc:title><![CDATA[Histone H1 Promotes Silencing of Unintegrated HIV-1 DNA]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-11-07</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.11.07.687288v1?rss=1">
<title>
<![CDATA[
A dimerization-activated proximity labeling system for direct characterization of cadherin cis interactions 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.11.07.687288v1?rss=1</link>
<description><![CDATA[
E-cadherins (Ecads) are essential transmembrane cell-cell adhesion proteins that mediate epithelial tissue formation and maintenance. Robust adhesion requires cis dimerization between neighboring Ecads on the cell surface and previous structural and biophysical studies have proposed conflicting models on the role of specific and nonspecific interactions in mediating cis dimerization. However, since these studies were carried out with isolated Ecad extracellular regions in cell-free systems, it is unknown if specific and nonspecific cis binding modes also occur with transmembrane Ecads in live cells, and if specific and nonspecific cis dimers recruit different sets of cytoplasmic proteins to Ecad junctions. To directly address these knowledge gaps, we developed a Dimerization Activated TuboID (DAT) proximity labeling system that reports on different modes of Ecad cis binding and their corresponding proteomes. Using DAT, fluorescence measurements, diffusion-reaction simulations, and adhesion assays, we demonstrate that Ecads in live cells form cis dimers via both specific and non-specific interactions and that cis dimerization does not require either prior trans contacts or an intact actin cytoskeleton. However, we show that the loss of specific cis interactions results in increased junctional instability and Ecad mobility, which leads to dysregulated peripheral protein interactions without affecting recruitment of core junctional proteins. Our study provides key mechanistic insights on cadherin cis interactions and also presents a toolkit that can be used to study a broad range of protein cis dimers in live cells.
]]></description>
<dc:creator>Davis, C. M. O.</dc:creator>
<dc:creator>Pagay, S. S.</dc:creator>
<dc:creator>Khatiwada, P.</dc:creator>
<dc:creator>Wu, Y.</dc:creator>
<dc:creator>Sivasankar, S.</dc:creator>
<dc:date>2025-11-10</dc:date>
<dc:identifier>doi:10.1101/2025.11.07.687288</dc:identifier>
<dc:title><![CDATA[A dimerization-activated proximity labeling system for direct characterization of cadherin cis interactions]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-11-10</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.11.08.687376v1?rss=1">
<title>
<![CDATA[
Longitudinal multimodal characterization of radiation dermatitis in the C57BL/6J mouse model 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.11.08.687376v1?rss=1</link>
<description><![CDATA[
Radiation dermatitis (RD) is a frequent and therapy-limiting toxicity of cancer radiotherapy, yet its mechanistic basis remains poorly understood. To address the need for quantitative, mechanistic insight, we developed a longitudinal C57BL/6J mouse model integrating clinical grading, non-invasive biophysical ("mesoscopic") measurements, histopathology, and bulk transcriptomics. This controlled design enabled pseudo-longitudinal analysis of inflammation, barrier dysfunction, and fibrosis across four weeks after a single 25 Gy exposure. Transcriptomic profiling revealed early activation of phagosome formation, MHC I antigen presentation, and neutrophil degranulation preceding visible skin injury, followed by enrichment of IL-1, IL-10, and IL-13 signaling at peak disease. Mesoscopic erythema, fibrosis, and transepidermal water loss each displayed distinct temporal and molecular signatures, with limited overlap among gene sets. Histologic scoring confirmed early epidermal and inflammatory responses, linked to extracellular matrix remodeling and vascular development. The observed pathways align with prior studies implicating IL-17 and a senescence-associated IL-6/CCR6 axis, extending these findings into a quantitative, time-resolved framework. This multimodal resource bridges molecular, morphological, and functional scales, providing a platform for mechanistic and therapeutic studies of RD.
]]></description>
<dc:creator>Wong, J. H.</dc:creator>
<dc:creator>Rivas, S.</dc:creator>
<dc:creator>Liu, L.</dc:creator>
<dc:creator>Koba, W.</dc:creator>
<dc:creator>Brodin, N. P.</dc:creator>
<dc:creator>Guha, C.</dc:creator>
<dc:creator>Deutsch, A.</dc:creator>
<dc:creator>Mir, A.</dc:creator>
<dc:creator>McLellan, B. N.</dc:creator>
<dc:creator>Shinoda, K.</dc:creator>
<dc:date>2025-11-10</dc:date>
<dc:identifier>doi:10.1101/2025.11.08.687376</dc:identifier>
<dc:title><![CDATA[Longitudinal multimodal characterization of radiation dermatitis in the C57BL/6J mouse model]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-11-10</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.11.15.688639v1?rss=1">
<title>
<![CDATA[
Deep cerebellar tFUS engages cortical circuits via convergent local and sensory-driven mechanisms 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.11.15.688639v1?rss=1</link>
<description><![CDATA[
Transcranial focused ultrasound (tFUS) enables non-invasive access to deep brain structures with high spatial precision, but its mechanisms of action remain elusive and under active investigation. The leading hypothesis posits that tFUS exerts its neuromodulatory effects through direct activation of neurons, while others attribute effects to indirect activation of auditory pathways. Here, we investigated the neuromodulatory effects of tFUS on the dentato- thalamo-cortical (DTC) pathway by targeting either the lateral cerebellar nucleus (LCN) or auditory cortex (AUD) in anesthetized rats. Electroencephalography (EEG) recordings from bilateral motor cortices and the contralateral auditory cortex revealed that tFUS reliably evoked cortical potentials, whereas sham stimulation produced no responses. Both LCN and AUD stimulation activated the auditory cortex, suggesting auditory pathway involvements. However, only LCN stimulation elicited early and significant event-related potentials and gamma-band activity in the contralateral motor cortex, consistent with DTC pathway engagement. We propose that LCN-targeted stimulation engages the DTC pathway through modulation of neuronal excitability, while concurrent auditory inputs account for global cortical activation. These results are consistent with a hybrid mechanism in which tFUS modulates neuronal dynamics, converging both direct and indirect components depending on the stimulation site. Proposed framework reconciles competing views of tFUS as either a direct or indirect modulator and clarifies how ultrasound can differentially influence cortical circuits depending on the stimulation target.
]]></description>
<dc:creator>Sariev, A.</dc:creator>
<dc:creator>Baek, H.</dc:creator>
<dc:creator>Jung, D.</dc:creator>
<dc:creator>Kim, H.</dc:creator>
<dc:creator>Pak, A.</dc:creator>
<dc:date>2025-11-16</dc:date>
<dc:identifier>doi:10.1101/2025.11.15.688639</dc:identifier>
<dc:title><![CDATA[Deep cerebellar tFUS engages cortical circuits via convergent local and sensory-driven mechanisms]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-11-16</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.11.18.689044v1?rss=1">
<title>
<![CDATA[
Astrocytic RNA degradation suppresses calcium signaling to support synapse function and restrain anxiety 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.11.18.689044v1?rss=1</link>
<description><![CDATA[
How astrocytes achieve their diverse roles in the brain at the molecular level is poorly understood. In this study, we leverage mouse models, electrophysiology, calcium imaging, behavioral assays, and bioinformatic approaches to demonstrate that astrocyte activity and astrocyte-mediated mouse behavior depends on the highly conserved and selective RNA turnover pathway-nonsense-mediated RNA decay (NMD). Conditional deletion of the core NMD gene, Upf2, in mature astrocytes leads to enhanced basal Ca2+ signaling coupled with synapse dysfunction and elevated anxiety. Restoring basal Ca2+ signaling in NMD-deficient astrocytes rescued synaptic transmission and minimized anxiety-associated behavior. Molecular bioinformatic analysis identified specific NMD target transcripts in astrocytes as candidates influencing calcium signaling pathways and neuro-glia interactions that support brain function. Our study is the first to demonstrate functional roles for NMD in astrocytes.

SIGNIFICANCE STATEMENTNon-sense mediated mRNA Decay (NMD) is the only RNA regulatory pathway linked to numerous neurodevelopmental and neuropsychiatric conditions, such as autism spectrum disorders and schizophrenia. To date, several studies indicate the NMD pathway regulates specific mRNAs to support fundamental neuronal processes in the mammalian brain. Yet, the biological role of NMD in brain astrocytes remains unknown. This study identifies the mRNA transcripts targeted by NMD and characterizes their contribution to critical neuro-glia interactions supporting proper brain function. In doing so, our work advances our knowledge of glial RNA biology in health and disease.
]]></description>
<dc:creator>Lituma, P. J.</dc:creator>
<dc:creator>Deveci, A.</dc:creator>
<dc:creator>Barrio-Alonso, E.</dc:creator>
<dc:creator>Tan, K.</dc:creator>
<dc:creator>Wilkinson, M. F.</dc:creator>
<dc:creator>Castillo, P. E.</dc:creator>
<dc:creator>Colak, D.</dc:creator>
<dc:date>2025-11-18</dc:date>
<dc:identifier>doi:10.1101/2025.11.18.689044</dc:identifier>
<dc:title><![CDATA[Astrocytic RNA degradation suppresses calcium signaling to support synapse function and restrain anxiety]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-11-18</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.11.20.687493v1?rss=1">
<title>
<![CDATA[
Diverse infection models demonstrate robust resistance of Mycobacterium tuberculosis to innate immunity 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.11.20.687493v1?rss=1</link>
<description><![CDATA[
Mycobacterium tuberculosis (Mtb) is a robust activator of innate immunity. However, there is little evidence that innate immune mechanisms control Mtb before the onset of adaptive immunity. Prior work has generally used specific pathogen-free (SPF) mouse models and relatively large infectious doses, which may obscure the capacity of innate immunity to control Mtb. Here, we performed ultra-low dose Mtb infections and found that the initial innate immune response was unable to curb even minimal Mtb infectious doses. Additionally, we primed the immune systems of C57BL/6 mice by co-housing with "pet shop" mice prior to Mtb exposure. Co-housed mice were as susceptible to Mtb infection as SPF mice. To more specifically pre-activate innate immunity at the site of Mtb infection, we also infected the lungs of mice with Legionella pneumophila (Lp) prior to Mtb. Innate immunity alone can clear large doses (>100,000 CFU) of Lp from the lung within a few days. However, pre-infection with Lp only modestly reduced Mtb CFU compared to mice infected with only Mtb, indicating that Mtb can robustly replicate even in the presence of a strong innate inflammatory response. We performed single-cell RNA-sequencing on myeloid cells from mice either infected with Mtb alone or mice primed with Lp. We found that Lp priming before Mtb infection induced measurable changes in myeloid cells responding to Mtb, but these changes had little effect on innate control of Mtb. Together, these data demonstrate the robust resistance of Mtb to innate immune clearance under diverse experimental conditions.
]]></description>
<dc:creator>Fairgrieve, M. R.</dc:creator>
<dc:creator>Brydon, E. C.</dc:creator>
<dc:creator>Chavez, R. A.</dc:creator>
<dc:creator>Kotov, D. I.</dc:creator>
<dc:creator>Vance, R.</dc:creator>
<dc:date>2025-11-20</dc:date>
<dc:identifier>doi:10.1101/2025.11.20.687493</dc:identifier>
<dc:title><![CDATA[Diverse infection models demonstrate robust resistance of Mycobacterium tuberculosis to innate immunity]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-11-20</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.11.21.689840v1?rss=1">
<title>
<![CDATA[
Crossover formation and coordinated assembly of synaptonemal complex relies on a direct interaction between Zip1 and Zip3 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.11.21.689840v1?rss=1</link>
<description><![CDATA[
Several proteins collaborate to promote the crossover recombination events critical for accurate chromosome segregation during meiosis. How these "ZMM" factors (Zip2, Zip3, Zip4, Spo16, Mer3 and MutS{gamma}) collaboratively function remains incompletely understood. We previously reported that Zip3s abundance and activity rely on the synaptonemal complex (SC) component Zip1, and specifically on Zip1s N-terminal residues associated with crossovers and coupling SC assembly to the crossover pathway. Here, we demonstrate that Zip3 co-immunoprecipitates Zip1 from meiotic cells independent of recombination initiation and other ZMMs, and that Zip3s interaction with Zip1 relies on Zip1s N terminal residues. Co-expression and pull-down experiments in bacterial cells demonstrate that Zip1 and Zip3 interact directly. Experiments to identify Zip3 regions required for the Zip1 interaction unexpectedly revealed an incorrectly annotated translational start; we also determined that Zip3s N-terminal structured region is necessary and sufficient for the interaction, and a predicted coil downstream of Zip3s RING domain is essential for specific activities attributed to Zip1s N-terminal tip such as proximity labeling of Zip3 by Zip2 and the coupling of crossover recombination to SC assembly. Finally, we discovered that interaction with Zip1 protects Zip3 not only from proteasome-mediated degradation but also from post-translational modification when another ZMM is absent. We propose that direct interaction with Zip1s N terminus orients Zip3 within a nascent ZMM ensemble in a manner that facilitates crossover formation and the coupling of crossover intermediates to SC assembly, and furthermore ensures Zip3 remains both abundant and unmodified until all requisite ZMMs have joined the group.
]]></description>
<dc:creator>MacQueen, A. J.</dc:creator>
<dc:creator>Sharmin, S.</dc:creator>
<dc:creator>Voelkel-Meiman, K.</dc:creator>
<dc:creator>Poppel, A. J.</dc:creator>
<dc:date>2025-11-22</dc:date>
<dc:identifier>doi:10.1101/2025.11.21.689840</dc:identifier>
<dc:title><![CDATA[Crossover formation and coordinated assembly of synaptonemal complex relies on a direct interaction between Zip1 and Zip3]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-11-22</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/2025.11.26.690831v1?rss=1">
<title>
<![CDATA[
A Functional Resting-State Network Atlas Based on 420 Older Adults with Hypertension 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/2025.11.26.690831v1?rss=1</link>
<description><![CDATA[
The Risk Reduction for Alzheimers Disease (rrAD) trial included 513 cognitively normal, sedentary, hypertensive older adults (aged 60 to 85 years) with dementia risk factors. We utilized 420 high-quality baseline resting-state functional MRI (rs-fMRI) scans from this cohort to develop a functional atlas tailored for aging populations. Typical rs-fMRI atlases derived from healthy young adults do not account for age-related changes, such as cortical atrophy, enlarged ventricles, and altered connectivity. To address this gap, we created a cohort-specific MNI-adjacent anatomical template, rrAD420, using SPM12s DARTEL registration. In this space, we derived a comprehensive functional atlas using both group independent component analysis (GICA) and probabilistic functional mode decomposition (PROFUMO). The rrAD420 atlas offers detailed representations of Resting-State Network (RSN) connectivity, encompassing unique configurations and overlapping interactions. It features two Default-Mode Network (DMN)-specific seed-based maps (DMN24 with cerebellum, DMN18 without) and data-driven components resembling the major RSNs. Furthermore, PROFUMO allowed for the identification of multimodal and combinatory networks, capturing connections within and between RSNs. While optimized for hypertensive older adults, the rrAD420 atlas serves as a versatile tool for broader aging populations, aiding in the study of neurodegenerative processes and biomarker discovery.
]]></description>
<dc:creator>Scheel, N.</dc:creator>
<dc:creator>Fernandez, Z.</dc:creator>
<dc:creator>Baker, J.</dc:creator>
<dc:creator>Yanev, P.</dc:creator>
<dc:creator>Keller, J. N.</dc:creator>
<dc:creator>Binder, E. F.</dc:creator>
<dc:creator>Vidoni, E.</dc:creator>
<dc:creator>Burns, J. M.</dc:creator>
<dc:creator>Stowe, A. M.</dc:creator>
<dc:creator>Kerwin, D. R.</dc:creator>
<dc:creator>Cullum, C. M.</dc:creator>
<dc:creator>Hynan, L. S.</dc:creator>
<dc:creator>Vongpatanasin, W.</dc:creator>
<dc:creator>Zhang, R.</dc:creator>
<dc:creator>Zhu, D. C.</dc:creator>
<dc:date>2025-12-01</dc:date>
<dc:identifier>doi:10.1101/2025.11.26.690831</dc:identifier>
<dc:title><![CDATA[A Functional Resting-State Network Atlas Based on 420 Older Adults with Hypertension]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-12-01</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.64898/2025.12.05.692608v1?rss=1">
<title>
<![CDATA[
TMEM Doorway Mediated Metastasis in Pancreatic Ductal Adenocarcinoma by Tie2 Signaling 
]]>
</title>
<link>https://biorxiv.org/content/10.64898/2025.12.05.692608v1?rss=1</link>
<description><![CDATA[
Pancreatic ductal adenocarcinoma (PDAC) is almost invariably fatal due to early hematogenous dissemination that occurs before the primary tumor is clinically detectable, yet the cellular mechanism of tumor cell intravasation has remained unknown. Using multiphoton intravital imaging in autochthonous and orthotopic PDAC models, we demonstrate that intravasation occurs at Tumor Microenvironment of Metastasis (TMEM) doorways--tri-cellular structures comprising a MENA-expressing tumor cell, a Tie2 macrophage, and an endothelial cell in direct contact. These structures are abundant in human PDAC, enriched for Tie2 macrophages, and markedly reduced after neoadjuvant chemotherapy. Selective pharmacologic inhibition of Tie2 with rebastinib decreases TMEM-associated transient vascular openings, suppresses circulating and hepatic disseminated tumor cells, and--when combined with perioperative FOLFIRINOX after curative-intent resection--improves median survival in murine PDAC. These findings establish TMEM doorways as a common, druggable mechanism of intravasation across epithelial cancers and identify Tie2 macrophages as a therapeutic target to prevent metastatic seeding in PDAC, a disease with no anti-metastatic therapies. TMEM doorway-mediated intravasation in PDAC supports its role as a common gateway for hematogenous metastasis in carcinoma.
]]></description>
<dc:creator>Pereira Zambalde, E.</dc:creator>
<dc:creator>Ariyan, L. A.</dc:creator>
<dc:creator>Puerta-Martinez, F.</dc:creator>
<dc:creator>Zhu, Y.</dc:creator>
<dc:creator>Patil, P.</dc:creator>
<dc:creator>Panarelli, N. .</dc:creator>
<dc:creator>Li, J.</dc:creator>
<dc:creator>Jung, Y.</dc:creator>
<dc:creator>Adkisson, C.</dc:creator>
<dc:creator>Petersen, J.</dc:creator>
<dc:creator>Cox, D.</dc:creator>
<dc:creator>Gil-Henn, H.</dc:creator>
<dc:creator>Eddy, R.</dc:creator>
<dc:creator>Stanger, B. A.</dc:creator>
<dc:creator>Entenberg, D.</dc:creator>
<dc:creator>Oktay, M.</dc:creator>
<dc:creator>Condeelis, J.</dc:creator>
<dc:creator>McAuliffe, J.</dc:creator>
<dc:date>2025-12-09</dc:date>
<dc:identifier>doi:10.64898/2025.12.05.692608</dc:identifier>
<dc:title><![CDATA[TMEM Doorway Mediated Metastasis in Pancreatic Ductal Adenocarcinoma by Tie2 Signaling]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-12-09</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.64898/2025.12.06.692757v1?rss=1">
<title>
<![CDATA[
Innate antiviral readiness drives the expansion of protective T stem cell memory against influenza 
]]>
</title>
<link>https://biorxiv.org/content/10.64898/2025.12.06.692757v1?rss=1</link>
<description><![CDATA[
The development of T-cell-based influenza vaccines relies on eliciting broad CD8+ T-cell immunity, wherein T stem cell-like memory (TSCM) cells serve as the ultimate long-lived reservoir for immune memory, thereby unlocking the potential for durable protection against viral drift and shift. However, the specific immunological cues that drive the robust expansion and functional preservation of this self-renewing, multipotent subset remain unknown. Here, utilizing multi-omic systems immunology in a pediatric cohort immunized with live attenuated influenza vaccine, we identified the determinants governing the expansion of influenza virus-reactive TSCM cells. We show that a pre-existing state of innate antiviral readiness, defined by a plasmacytoid dendritic cell-associated type I interferon signature, is the requisite condition for a robust TSCM expansion. Mechanistically, this baseline innate state enhances antigen priming and enforces a qualitative divergence in T-cell fate, driving responders toward a functionally poised, Th1-dominant phenotype while non-responders default to a dysfunctional, hyper-proliferative state. To determine the clinical relevance of this cellular subset, we analyzed an independent controlled human influenza challenge study. This validation revealed a critical functional division of labor in host defense: whereas pre-existing antibodies primarily mitigated symptom severity, the baseline frequency of influenza virus-reactive TSCM cells was the strongest predictor of rapid viral load clearance. These findings establish that the expansion of durable cellular memory is not stochastic but is predetermined by the innate cytokine environment, providing a predictive biomarker for patient stratification and a validated target for adjuvants designed to expand the TSCM reservoir deliberately.
]]></description>
<dc:creator>Tomic, I.</dc:creator>
<dc:creator>Ahern, D.</dc:creator>
<dc:creator>Tomalka, J.</dc:creator>
<dc:creator>Escalera, A.</dc:creator>
<dc:creator>Aydillo, T.</dc:creator>
<dc:creator>Pauly, M. D.</dc:creator>
<dc:creator>Rouphael, N.</dc:creator>
<dc:creator>Lakdawala, S. S.</dc:creator>
<dc:creator>Sadek, N.</dc:creator>
<dc:creator>Clutterbuck, E.</dc:creator>
<dc:creator>Singh, N.</dc:creator>
<dc:creator>Aley, P.</dc:creator>
<dc:creator>Robinson, H.</dc:creator>
<dc:creator>Marinou, S.</dc:creator>
<dc:creator>Hao, S. P.</dc:creator>
<dc:creator>Fish, M.</dc:creator>
<dc:creator>Nakaya, H.</dc:creator>
<dc:creator>CHIM Study Group,</dc:creator>
<dc:creator>Monaco, C.</dc:creator>
<dc:creator>Garcia-Sastre, A.</dc:creator>
<dc:creator>Pollard, A. J.</dc:creator>
<dc:creator>Tomic, A.</dc:creator>
<dc:date>2025-12-10</dc:date>
<dc:identifier>doi:10.64898/2025.12.06.692757</dc:identifier>
<dc:title><![CDATA[Innate antiviral readiness drives the expansion of protective T stem cell memory against influenza]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-12-10</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.64898/2025.12.10.693486v1?rss=1">
<title>
<![CDATA[
Conserved Landscape of Chemokine Receptor Co-expression Defines the Functional States of CD8+ T Cells in Melanoma 
]]>
</title>
<link>https://biorxiv.org/content/10.64898/2025.12.10.693486v1?rss=1</link>
<description><![CDATA[
Cancer immunotherapies, from checkpoint blockade to adoptive cell therapies like tumor-infiltrating lymphocytes (TILs), have revolutionized cancer treatment but are limited by variable efficacy and significant toxicities. A central challenge is identifying ideal T-cell populations that effectively eliminate tumors without causing off-target damage, a distinction not captured by existing biomarkers. We show that co-expression patterns of chemokine receptors (CRs) CXCR3, CCR5, and CXCR6 on CD8+ T cells provide a functional "code" defining subsets with divergent roles in on-target immunity versus off-target inflammation. In mouse and human melanoma, a triple-positive (CXCR3+CCR5+CXCR6+) T-cell subset is essential for tumor control, and its genetic signature correlates with positive clinical response, while a distinct CCR5+CXCR6+ subset drives liver immune-related adverse events (IRAEs). Crucially, this CR code reveals that immunotherapy actively reshapes T-cell trafficking patterns, uncovering profound heterogeneity within conventional populations and distinguishing potent anti-tumor progenitors from cells predisposed to exhaustion or off-target migration. This work establishes CR co-expression as a practical tool, providing a surface marker-based strategy to identify and enrich optimized T cells for adoptive therapies, thereby offering a framework to uncouple efficacy from toxicity.

One Sentence SummaryCo-expression of CCR5, CXCR6, and CXCR3 provides a functional code that separates T-cell-mediated anti-tumor efficacy from off-target toxicity, enabling the selection of superior cells for safer and more effective cancer immunotherapies.

Graphical Abstract

O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=120 SRC="FIGDIR/small/693486v2_ufig1.gif" ALT="Figure 1">
View larger version (29K):
org.highwire.dtl.DTLVardef@19b0f44org.highwire.dtl.DTLVardef@1076129org.highwire.dtl.DTLVardef@17c0be6org.highwire.dtl.DTLVardef@f14893_HPS_FORMAT_FIGEXP  M_FIG C_FIG HighlightsO_LI{middle dot} CXCR6, CXCR3 and CCR5 co-expression signature stratifies patient survival in human melanoma
C_LIO_LI{middle dot} CD8+ T cells co-expressing CXCR6, CXCR3 and CCR5 are critical effectors with high proliferative, cytotoxic, and activation profile in human and mice melanoma
C_LIO_LI{middle dot} CD8+ T cells co-expressing CXCR6, CXCR3 and CCR5 drive anti-tumoral responses during checkpoint blockade in both human and mice
C_LI
]]></description>
<dc:creator>Macedo, R.</dc:creator>
<dc:creator>Harle, D. W.</dc:creator>
<dc:creator>Hoffer-Hawlik, K.</dc:creator>
<dc:creator>Wang, X. K.</dc:creator>
<dc:creator>McMahon-Skates, T.</dc:creator>
<dc:creator>Matschiner, A.</dc:creator>
<dc:creator>Belay, K.</dc:creator>
<dc:creator>Saenger, Y. M.</dc:creator>
<dc:creator>Izar, B.</dc:creator>
<dc:creator>Azizi, E.</dc:creator>
<dc:creator>Reshef, R.</dc:creator>
<dc:date>2025-12-13</dc:date>
<dc:identifier>doi:10.64898/2025.12.10.693486</dc:identifier>
<dc:title><![CDATA[Conserved Landscape of Chemokine Receptor Co-expression Defines the Functional States of CD8+ T Cells in Melanoma]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-12-13</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.64898/2025.12.12.693972v1?rss=1">
<title>
<![CDATA[
Structural Dynamics and Allosteric Communication of a SARS-Like Bat Coronavirus Spike Glycoprotein 
]]>
</title>
<link>https://biorxiv.org/content/10.64898/2025.12.12.693972v1?rss=1</link>
<description><![CDATA[
SARS-like bat coronaviruses (CoVs) pose ongoing public health risks due to their zoonotic potential, making it important to understand the molecular pathways driving their evolution. We recently showed that SHC014-CoV can infect human cell lines in an ACE2-dependent manner after acquiring two spike ectodomain mutations (F294L and A835D). However, how the wild-type (WT) SHC014 spike differs dynamically from these mutants remains unclear. Here, we built fully glycosylated ectodomain models of WT and three mutants (F294L, A835D, and the double mutant, DM) and performed triplicate 1-s all-atom molecular dynamics (MD) simulations for each variant. The two mutations exhibit epistasis, altering structural rearrangements relative to WT. Notably, the DM receptor binding domain (RBD) begins sampling the open conformation in our conventional MD. At the atomic level, the DM spike mitigates the dense negative packing introduced by A835D through a salt-bridge network, while F294L disrupts {pi}-mediated interactions, together enhancing RBD opening propensity--critical for viral entry. Increased flexibility of the subdomain-2 "620-loop" further modulates DM RBD openness. Dynamical network analysis identified three allosteric communication pathways. In WT and F294L, "Pathway 1" forms the baseline route linking the 620-loop to the RBD, whereas in A835D and DM it extends to the FPPR, reshaping long-range communication. "Pathway 2" is conserved across variants but is most prominent in WT and F294L. "Pathway 3" appears only in A835D and DM, compensating for reduced communication along Pathway 2. Overall, this work provides an atomistic perspective on SHC014 molecular adaptation during host-to-host transmission and highlights mechanistic features that may inform future therapeutic and pandemic-preparedness efforts.

Statement of SignificanceBat coronaviruses are an important source of future pandemic threats, but we still know little about how small genetic changes help them infect humans. In this study, we used detailed computer simulations to watch how tiny mutations in a bat coronavirus spike protein change its motion and shape. We found that two specific mutations work together to make the spike more likely to open--a step required for the virus to enter human cells. By revealing how these molecular changes increase infection potential, our work helps improve understanding of coronavirus evolution and may guide strategies to prepare for future outbreaks.
]]></description>
<dc:creator>Balogun, T.</dc:creator>
<dc:creator>Kearns, F.</dc:creator>
<dc:creator>Calvo-Tusell, C.</dc:creator>
<dc:creator>Tse, A. L.</dc:creator>
<dc:creator>Acreman, C. M.</dc:creator>
<dc:creator>Casalino, L.</dc:creator>
<dc:creator>Lasso, G.</dc:creator>
<dc:creator>Miller, E. H.</dc:creator>
<dc:creator>Chandran, K.</dc:creator>
<dc:creator>McLellan, J. S.</dc:creator>
<dc:creator>Amaro, R. E.</dc:creator>
<dc:date>2025-12-15</dc:date>
<dc:identifier>doi:10.64898/2025.12.12.693972</dc:identifier>
<dc:title><![CDATA[Structural Dynamics and Allosteric Communication of a SARS-Like Bat Coronavirus Spike Glycoprotein]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-12-15</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.64898/2025.12.15.694406v1?rss=1">
<title>
<![CDATA[
Medial prefrontal cortex encodes implicit temporal expectations in mice 
]]>
</title>
<link>https://biorxiv.org/content/10.64898/2025.12.15.694406v1?rss=1</link>
<description><![CDATA[
Temporal prediction allows animals to align their actions with upcoming events, yet most work has focused on explicit duration judgments rather than the implicit timing that shapes ongoing behavior. Here, we ask how medial prefrontal cortex implements such latent temporal expectations and how cerebellar input contributes. Head-fixed mice learned a cued water-delivery task in which reward occurred after either a short or long delay, or after a single fixed delay. During variable delays, running and licking became anticipatory, and medial prefrontal local field potentials and single neurons showed ramping and reward-locked activity patterns aligned to expected reward time. Switching to a fixed delay rapidly sharpened behavioral anticipation and temporal coding. Optogenetic activation of cerebellar Purkinje cells selectively perturbed these dynamics and biased behavior around the earliest possible reward time. These results identify a cerebello-prefrontal circuit that encodes implicit temporal predictions on the sub-second scale.
]]></description>
<dc:creator>Lareno Faccini, F.</dc:creator>
<dc:creator>Le Cabec, P.</dc:creator>
<dc:creator>Spaeth, L.</dc:creator>
<dc:creator>Pasquet, M.</dc:creator>
<dc:creator>Ciocca, D.</dc:creator>
<dc:creator>Giersch, A.</dc:creator>
<dc:creator>Isope, P.</dc:creator>
<dc:date>2025-12-16</dc:date>
<dc:identifier>doi:10.64898/2025.12.15.694406</dc:identifier>
<dc:title><![CDATA[Medial prefrontal cortex encodes implicit temporal expectations in mice]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-12-16</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.64898/2025.12.16.693978v1?rss=1">
<title>
<![CDATA[
Romaciclib, a CDK8/CDK19 inhibitor, can overcome venetoclax resistance through a combinatorial strategy 
]]>
</title>
<link>https://biorxiv.org/content/10.64898/2025.12.16.693978v1?rss=1</link>
<description><![CDATA[
The combination of venetoclax (VEN) and hypomethylating agents (HMA) is the standard of care in acute myeloid leukemia (AML) for elderly patients unfit for intensive chemotherapy. Despite its clinical success, most patients eventually relapse, creating an urgent need for effective therapeutic alternatives. In this study, we aimed to evaluate the potential of romaciclib, a first-in-class CDK8/CDK19 inhibitor, in combination with VEN to overcome stroma-mediated and primary/acquired VEN-resistance. We assessed the efficacy of RVU120+VEN combination in both sensitive and resistant AML cell lines and primary patient-derived models. Our finding demonstrated that romaciclib synergizes with VEN in AML cell lines and in 8 out of 11 patient-derived cell samples. The proteomic and functional studies demonstrated that combination induced apoptosis through caspase-dependent cleavage of MCL-1. In vivo studies confirmed the efficacy of RVU120+VEN, showing eradication of leukemic cells and bone marrow recovery. Importantly, the combination effectively overcame both stroma-mediated and transcriptionally dependent VEN-resistance. Mechanistic studies, focusing on transcriptomic analyses, identified key resistance-associated pathways, including IL6/JAK/STAT3, TGF-{beta}, PI3K/AKT/MTOR, and inflammatory signaling, being suppressed by combination treatment. Furthermore, an in vivo study using a VEN-resistant patient-derived xenograft (PDX) model confirmed the efficacy of the combination, demonstrating a significant reduction in leukemia burden and a decreased proportion of leukemia initiating cells (LIC) following treatment. These findings prove the highly synergistic mechanism of action of RVU120+VEN combination and the potential to overcome primary/acquired VEN resistance in relapse/refractory AML disease. Altogether, the presented results support ongoing clinical studies evaluating romaciclib and VEN in VEN/HMA-refractory patients (NCT06191263) and provide a basis for future exploration as a frontline therapy in VEN-naive patients.
]]></description>
<dc:creator>Pakulska, U.</dc:creator>
<dc:creator>Obacz, M.</dc:creator>
<dc:creator>Woznicki, J.</dc:creator>
<dc:creator>Wiklik, K.</dc:creator>
<dc:creator>Chakraborty, S.</dc:creator>
<dc:creator>Micek, M.</dc:creator>
<dc:creator>Mohanty, V.</dc:creator>
<dc:creator>Coelho, D.</dc:creator>
<dc:creator>Adamczyk, E.</dc:creator>
<dc:creator>Golas, A.</dc:creator>
<dc:creator>Moszynska, A.</dc:creator>
<dc:creator>Zhang, H.</dc:creator>
<dc:creator>Cybulska-Lubak, M.</dc:creator>
<dc:creator>Kaniuga, E.</dc:creator>
<dc:creator>Sadowska-Markiewicz, Z.</dc:creator>
<dc:creator>Konopleva, M.</dc:creator>
<dc:creator>Mikula, M.</dc:creator>
<dc:creator>Juszczynski, P.</dc:creator>
<dc:creator>Shastri, A.</dc:creator>
<dc:creator>Baran, N.</dc:creator>
<dc:creator>Rzymski, T.</dc:creator>
<dc:creator>Mazan, M.</dc:creator>
<dc:date>2025-12-18</dc:date>
<dc:identifier>doi:10.64898/2025.12.16.693978</dc:identifier>
<dc:title><![CDATA[Romaciclib, a CDK8/CDK19 inhibitor, can overcome venetoclax resistance through a combinatorial strategy]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-12-18</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.64898/2025.12.19.695525v1?rss=1">
<title>
<![CDATA[
Direct measurement of sub-kilobase chromatin structure reveals that linker histone H1 broadly compacts chromatin, with differential impact amongst epigenetic states 
]]>
</title>
<link>https://biorxiv.org/content/10.64898/2025.12.19.695525v1?rss=1</link>
<description><![CDATA[
Chromatin compaction by linker histone H1 family proteins is a long-standing model for transcriptional repression. However, the biophysical and conformational details of such compaction in situ, at the kilobase- and sub-kilobase length scale relevant to the activity of transcriptional regulatory elements, remain under debate. Rather than inferring such compaction from indirect measurements of features like DNA accessibility, we sought to directly probe sub-kilobase contacts between nearby nucleosomes. We developed an improved version of radiation-induced correlated cleavage with sequencing (RICC-seq), which we term RICC-seq 2.0, and used it in parallel with Micro-C to cross-validate our measurements of chromatin structure in both diverse cell types with different levels of linker histone and different levels of chromatin compaction, as well as a CRISPRi system for pan-H1 depletion. Using this system, we find that chromatin fiber de-compaction upon H1 depletion is global across the genome, reducing the contrast in inter-nucleosome contacts between acetylated chromatin and the rest of the genome. Surprisingly, this does not dramatically change higher-order chromatin organization such as nuclear compartments. Nevertheless, we observe a broad increase in accessibility at tens of thousands of sites and an increase in expression of over a thousand genes, which are enriched in polycomb repressive complex targets. Investigating the local chromatin compaction at upregulated genes as opposed to genes that do not change transcription, we observe that upregulated genes are not specifically de-compacted. Rather, our data support a model in which linker histone globally induces local compaction of nucleosome contacts and an increase in linker lengths, and repression by PRC1/2 is particularly dependent on these local features of chromatin architecture.
]]></description>
<dc:creator>Canaj, H.</dc:creator>
<dc:creator>Duba, I.</dc:creator>
<dc:creator>Mansisidor, A.</dc:creator>
<dc:creator>Scortea, A.</dc:creator>
<dc:creator>Johnson, R.</dc:creator>
<dc:creator>Pinto, H.</dc:creator>
<dc:creator>Ou, A.</dc:creator>
<dc:creator>Pagane, N.</dc:creator>
<dc:creator>Pae, J.</dc:creator>
<dc:creator>Fyodorov, D.</dc:creator>
<dc:creator>Skoultchi, A. I.</dc:creator>
<dc:creator>Risca, V. I.</dc:creator>
<dc:date>2025-12-23</dc:date>
<dc:identifier>doi:10.64898/2025.12.19.695525</dc:identifier>
<dc:title><![CDATA[Direct measurement of sub-kilobase chromatin structure reveals that linker histone H1 broadly compacts chromatin, with differential impact amongst epigenetic states]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-12-23</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.64898/2025.12.30.696960v1?rss=1">
<title>
<![CDATA[
Structural, biophysical, and virological mechanistic characterization of HIV-1 capsid-targeting antivirals 
]]>
</title>
<link>https://biorxiv.org/content/10.64898/2025.12.30.696960v1?rss=1</link>
<description><![CDATA[
Due to its significant role in virus replication, the HIV capsid is an attractive antiviral target. This is validated by the recent clinical approval of lenacapavir for both treatment and pre-exposure prophylaxis (PrEP). PF74 is a well-characterized capsid-targeting antiviral that was discontinued in further study due to potency and metabolic issues. We hypothesized that making chemical modifications at certain sites of PF74 could result in capsid-targeting antivirals with improved potency and bioavailability. Our cumulative studies show that making changes at the R1 and R3 positions of PF74 results in compounds with increased antiviral potency, increased stability of wild-type HIV capsid hexamers and virions, tighter binding to wild-type HIV capsid hexamer compared to PF74, and different interactions at the "FG" binding site of capsid compared to PF74. These data provide insights into the design of future capsid-targeting antivirals relevant for clinical use.
]]></description>
<dc:creator>Kirby, K. A.</dc:creator>
<dc:creator>McFadden, W. M.</dc:creator>
<dc:creator>Wang, L.</dc:creator>
<dc:creator>Du, H.</dc:creator>
<dc:creator>Zhang, H.</dc:creator>
<dc:creator>Emanuelli Castaner, A.</dc:creator>
<dc:creator>Lorson, Z. C.</dc:creator>
<dc:creator>Nafisi, A.</dc:creator>
<dc:creator>Luchsinger, C.</dc:creator>
<dc:creator>Hachiya, A.</dc:creator>
<dc:creator>Cilento, M. E.</dc:creator>
<dc:creator>Snyder, A. A.</dc:creator>
<dc:creator>Ravichandran, S. M.</dc:creator>
<dc:creator>Cai, X.</dc:creator>
<dc:creator>Tedbury, P. R.</dc:creator>
<dc:creator>Francis, A. C.</dc:creator>
<dc:creator>Melikyan, G. B.</dc:creator>
<dc:creator>Diaz-Griffero, PhD, F. R.</dc:creator>
<dc:creator>Wang, Z.</dc:creator>
<dc:creator>Sarafianos, S. G.</dc:creator>
<dc:date>2025-12-31</dc:date>
<dc:identifier>doi:10.64898/2025.12.30.696960</dc:identifier>
<dc:title><![CDATA[Structural, biophysical, and virological mechanistic characterization of HIV-1 capsid-targeting antivirals]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-12-31</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.64898/2025.12.30.697078v1?rss=1">
<title>
<![CDATA[
Expression of the human immunomodulatory protein, human B7-1 (CD80), accelerates neuroinflammation, synaptic loss, microvascular instability and lethality in a murine model of Alzheimers Disease 
]]>
</title>
<link>https://biorxiv.org/content/10.64898/2025.12.30.697078v1?rss=1</link>
<description><![CDATA[
Immune-mediated inflammatory processes play a pivotal role in the pathogenesis of Alzheimers disease (AD). However, immune loci exhibit significant sequence diversity, with human proteins sharing only [~]45-70% identity with their murine orthologs. This divergence contributes to the inability of many established mouse models to accurately capture key neuroinflammatory mechanisms relevant to human AD. We recently identified that the human, but not murine, immunomodulatory protein B7-1 (CD80) activates the p75 neurotrophin receptor (p75), a function arising from evolutionary divergence in human B7-1. This discovery provides an opportunity to directly interrogate the role of this interaction in disease progression using a well-characterized murine model of mutant A{beta} overexpression (CRND8). We generated a mouse line in which murine B7-1 was replaced with a chimeric human:murine B7-1 that retains normal interactions with CTLA-4 and CD28, while gaining the ability to bind p75, and evaluated its effects in CRND8 mice. Expression of human:murine B7-1 in vivo resulted in increased lethality, accelerated neuroinflammation of resident glia, more rapid synaptic and dendritic loss, and enhanced microvascular compromise in the subiculum compared to CRND8 mice expressing murine B7-1. Together, these findings identify the human B7-1:p75 interaction as a previously unrecognized contributor to AD pathogenesis and a potential therapeutic target in a brain region critical for learning and memory that is affected in early stages of disease.
]]></description>
<dc:creator>Danelon, V.</dc:creator>
<dc:creator>Garrett-Thomson, S.</dc:creator>
<dc:creator>Morano, N.</dc:creator>
<dc:creator>Constanza, R.</dc:creator>
<dc:creator>Kermani, P.</dc:creator>
<dc:creator>Smith, R.</dc:creator>
<dc:creator>Almo, S. C.</dc:creator>
<dc:creator>Lee, F. S.</dc:creator>
<dc:creator>Hempstead, B. L.</dc:creator>
<dc:date>2025-12-31</dc:date>
<dc:identifier>doi:10.64898/2025.12.30.697078</dc:identifier>
<dc:title><![CDATA[Expression of the human immunomodulatory protein, human B7-1 (CD80), accelerates neuroinflammation, synaptic loss, microvascular instability and lethality in a murine model of Alzheimers Disease]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2025-12-31</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.64898/2026.01.01.697017v1?rss=1">
<title>
<![CDATA[
Transcriptional Heterogeneity Reveals a Synaptic Gene Program in Developing and Adult Human Oligodendrocyte Precursor Cells 
]]>
</title>
<link>https://biorxiv.org/content/10.64898/2026.01.01.697017v1?rss=1</link>
<description><![CDATA[
Human oligodendrocyte precursor cells (OPCs) arise early in gestation and expand broadly during cortical development, yet the extent of their heterogeneity remains poorly defined. Here, we isolated >2,300 highly pure OPCs from post-conceptional week (PCW) 17 human cortex using an optimized PDGFR-based immunopanning and performed single-cell RNA sequencing. Unsupervised clustering revealed four transcriptionally distinct embryonic OPC subsets, including a previously unrecognized population that expressed genes linked to synaptic development, synaptic signaling, and neuromodulation. This subset - designated embryonic synaptic OPCs (eSyn-OPCs) - comprised approximately 28.5% of all embryonic OPCs in the cortex and was characterized by robust expression of synapse-associated secreted factors (THBS2, WNT5A, WNT7A, PLAT, ACHE) and multiple neurotransmitter receptor subunits. Histological analyses across PCW 12-22 demonstrated that eSyn-OPCs first appear around PCW 15 and are enriched in proliferative germinal zones. Spatial transcriptomics confirmed their localization near neural stem and progenitor cells, suggesting proximal neuron-OPC communication during early cortical assembly. Purified eSyn-OPCs differentiated into mature oligodendrocytes in vitro, confirming their oligodendrocyte lineage identity. Reanalysis of adult human single-nucleus RNA-seq datasets uncovered a transcriptionally analogous OPC subset (adult synaptic OPCs, aSyn-OPCs), though with reduced representation of structural synaptic genes and neurotransmitter receptor diversity compared to eSyn-OPCs. Together, these results identify a synaptically specialized OPC population in both developing and adult human cortex and reveal that eSyn-OPCs possess unexpectedly rich synaptic signaling machinery. These findings suggest that human OPCs may participate directly in neuron-glia communication during early cortical development and raise the possibility of developmental stage-specific roles for eSyn-OPCs in shaping neural circuit formation.
]]></description>
<dc:creator>Grinberg, A. R.</dc:creator>
<dc:creator>Liu, L.</dc:creator>
<dc:creator>Patel, I.</dc:creator>
<dc:creator>Guntur, B.</dc:creator>
<dc:creator>Glass, I. A.</dc:creator>
<dc:creator>Birth Defects Research Laboratory,</dc:creator>
<dc:creator>Shinoda, K.</dc:creator>
<dc:creator>Nobuta, H.</dc:creator>
<dc:date>2026-01-02</dc:date>
<dc:identifier>doi:10.64898/2026.01.01.697017</dc:identifier>
<dc:title><![CDATA[Transcriptional Heterogeneity Reveals a Synaptic Gene Program in Developing and Adult Human Oligodendrocyte Precursor Cells]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2026-01-02</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.64898/2026.01.07.698161v1?rss=1">
<title>
<![CDATA[
Mena (ENAH) Promotes KRAS-Driven Tumor Growth and Metastatic Progression in Pancreatic Ductal Adenocarcinoma 
]]>
</title>
<link>https://biorxiv.org/content/10.64898/2026.01.07.698161v1?rss=1</link>
<description><![CDATA[
Metastatic pancreatic ductal adenocarcinoma (PDAC) remains incurable and is projected to become the second leading cause of cancer-related death by 2030. Despite therapeutic advances, median survival remains under one year. Activating KRAS mutations drive the majority of PDAC and underlie their highly aggressive behavior. Although emerging KRAS inhibitors show promise, resistance limits their clinical efficacy, underscoring the need to identify additional regulators of mutant KRAS signaling. We investigated the role of the actin-regulatory protein Mena (ENAH) in KRASG12D-driven PDAC using novel in vitro and orthotopic in vivo models with Mena overexpression and knockdown. Mena overexpression markedly increased primary tumor growth and spontaneous liver metastasis, whereas Mena knockdown delayed tumor onset and reduced metastatic burden. Mechanistically, Mena depletion significantly decreased AKT and ERK activity downstream of KRAS in a SHIP2-mediated manner, indicating that Mena enhances oncogenic signaling required for PDAC progression. These findings reveal Mena as a critical modulator of KRASG12D-driven pancreatic tumor growth and metastasis. By promoting key survival and proliferation pathways, Mena contributes to the aggressive phenotype characteristic of KRAS-mutant PDAC and represents a promising therapeutic target for patients with both locoregional and metastatic disease.
]]></description>
<dc:creator>Ariyan, L. A.</dc:creator>
<dc:creator>Zambalde, E.</dc:creator>
<dc:creator>Li, J.</dc:creator>
<dc:creator>McAuliffe, T. T.</dc:creator>
<dc:creator>Ma, E.</dc:creator>
<dc:creator>Martinez, F. P.</dc:creator>
<dc:creator>Panarelli, N. C.</dc:creator>
<dc:creator>Eddy, R. J.</dc:creator>
<dc:creator>Patil, P.</dc:creator>
<dc:creator>Condeelis, J.</dc:creator>
<dc:creator>Gil-Henn, H.</dc:creator>
<dc:creator>McAuliffe, J. C.</dc:creator>
<dc:date>2026-01-08</dc:date>
<dc:identifier>doi:10.64898/2026.01.07.698161</dc:identifier>
<dc:title><![CDATA[Mena (ENAH) Promotes KRAS-Driven Tumor Growth and Metastatic Progression in Pancreatic Ductal Adenocarcinoma]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2026-01-08</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.64898/2026.01.07.698224v1?rss=1">
<title>
<![CDATA[
Modular presynaptic assemblages scale to postsynaptic partner number 
]]>
</title>
<link>https://biorxiv.org/content/10.64898/2026.01.07.698224v1?rss=1</link>
<description><![CDATA[
Behavioral diversification can arise through, and is constrained by, evolutionary and inter-individual differences in neural circuit development. Moreover, alteration of focal neural parameters changes the environment in which cells connect into circuits. In the mushroom body, an associative learning center of arthropods, the number of principal Kenyon cells varies widely across species and among individuals. How such variation is developmentally accommodated by projection neurons, which provide sensory input to Kenyon cells, is not understood. In Drosophila melanogaster, we previously demonstrated that projection neurons scale their presynaptic bouton number to Kenyon cell population size. Here, we identify the developmental mechanisms underlying this input flexibility. Boutons arise from projection neuron axonal collaterals; we find that a PNs collateral number is subtype-specific and serves as the substrate through which bouton number scales to Kenyon cell population size. Independent of projection neuron identity or Kenyon cell number, individual collaterals most often produce just one bouton, suggesting collaterals are modular cell biological bouton units. Developing projection neurons initially overproduce nascent collaterals in the early pupa. The set of nascent collaterals that mature and eventually bear boutons is conditional on Kenyon cell number, thereby executing scaling. Finally, early boutons bear filopodia that frequently contact neighboring PN processes, suggesting that bouton-bouton interactions contribute to shaping these structures.
]]></description>
<dc:creator>Punal, V. M.</dc:creator>
<dc:creator>Thornton-Kolbe, E. M.</dc:creator>
<dc:creator>Dhillon, J.</dc:creator>
<dc:creator>Rogow, J. A.</dc:creator>
<dc:creator>Clowney, E. J.</dc:creator>
<dc:date>2026-01-08</dc:date>
<dc:identifier>doi:10.64898/2026.01.07.698224</dc:identifier>
<dc:title><![CDATA[Modular presynaptic assemblages scale to postsynaptic partner number]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2026-01-08</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.64898/2026.01.13.699355v1?rss=1">
<title>
<![CDATA[
A new single chain, genetically encoded biosensor for RhoB GTPase based on FRET, useful for live-cell imaging 
]]>
</title>
<link>https://biorxiv.org/content/10.64898/2026.01.13.699355v1?rss=1</link>
<description><![CDATA[
RhoB is an atypical Rho GTPase whose function is tightly linked to its subcellular localization and membrane trafficking, reflecting its unique post-translational modifications and association with endosomal membranes in addition to the plasma membrane. Despite its implication in membrane trafficking and cytoskeletal regulation, tools to directly monitor RhoB activity in space and time have been lacking. Here, we describe the development and validation of a single-chain, genetically encoded Forster resonance energy transfer (FRET) biosensor that enables direct visualization of RhoB activity in living cells while preserving its native membrane-targeting determinants. The biosensor exhibits a large dynamic range and resolves spatially heterogeneous RhoB activity during leading-edge protrusion - retraction cycles in migrating mouse embryonic fibroblasts. To demonstrate the utility of this tool, we performed multiplex live-cell imaging with a previously developed near-infrared FRET biosensor for the exocytic Rho GTPase TC10. Quantitative morphodynamic and cross-correlation analyses reveal coordinated yet antagonistic spatiotemporal patterns of RhoB and TC10 activities at the leading edge and show that perturbation of TC10 regulation reorganizes their spatial coupling. Together, this work introduces a robust biosensor for RhoB and establishes a multiplex imaging framework to study the coordination of trafficking and signaling during cell migration.
]]></description>
<dc:creator>Pagano, S.</dc:creator>
<dc:creator>Hodgson, L.</dc:creator>
<dc:date>2026-01-14</dc:date>
<dc:identifier>doi:10.64898/2026.01.13.699355</dc:identifier>
<dc:title><![CDATA[A new single chain, genetically encoded biosensor for RhoB GTPase based on FRET, useful for live-cell imaging]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2026-01-14</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.64898/2026.01.16.699998v1?rss=1">
<title>
<![CDATA[
B Lymphocyte Protein Factories produced by Hematopoietic Stem Cell Gene Editing 
]]>
</title>
<link>https://biorxiv.org/content/10.64898/2026.01.16.699998v1?rss=1</link>
<description><![CDATA[
Long-term in vivo production of therapeutic proteins and development of vaccines that elicit protective levels of broadly neutralizing antibodies (bNAbs) against major pathogens face challenges. Here we report on an alternative gene-editing approach using small numbers of hematopoietic stem and progenitor cells (HSPCs) to direct long-term, high-level expression of antibodies or cargo proteins. Edited B lymphocyte offspring can be activated by cognate antigen to undergo clonal expansion and develop into specific antibody or cargo protein-synthesizing plasma cells. These cells produce long-lasting, therapeutic levels of serum antibody against HIV-1 or malaria and an anti-influenza virus bNAb that mediated universal protection from heterologous lethal challenge. Our data provide a paradigm for cell therapy approaches to prevent or treat disease using self-amplifying B cell protein factories.
]]></description>
<dc:creator>Hartweger, H.</dc:creator>
<dc:creator>Ruprecht, C.</dc:creator>
<dc:creator>Yao, K.-H.</dc:creator>
<dc:creator>Laffont, P.</dc:creator>
<dc:creator>Lima dos Reis, G.</dc:creator>
<dc:creator>Zhou, P.</dc:creator>
<dc:creator>Hägglöf, T.</dc:creator>
<dc:creator>Binet, L.</dc:creator>
<dc:creator>Loewe, M.</dc:creator>
<dc:creator>Hong, J. P.</dc:creator>
<dc:creator>Xiao, T.</dc:creator>
<dc:creator>Sefik, E.</dc:creator>
<dc:creator>Hernandez, B.</dc:creator>
<dc:creator>Gazumyan, A.</dc:creator>
<dc:creator>Jankovic, M.</dc:creator>
<dc:creator>Seaman, M. S.</dc:creator>
<dc:creator>Costa, G.</dc:creator>
<dc:creator>Nelson, S. A.</dc:creator>
<dc:creator>Clark, J.</dc:creator>
<dc:creator>Kanatani, S.</dc:creator>
<dc:creator>Wilson, P. C.</dc:creator>
<dc:creator>Krammer, F.</dc:creator>
<dc:creator>Levashina, E. A.</dc:creator>
<dc:creator>Julien, J.-P.</dc:creator>
<dc:creator>Wardemann, H.</dc:creator>
<dc:creator>Sinnis, P.</dc:creator>
<dc:creator>Stamatatos, L.</dc:creator>
<dc:creator>Flavell, R. A.</dc:creator>
<dc:creator>Nussenzweig, M. C.</dc:creator>
<dc:date>2026-01-18</dc:date>
<dc:identifier>doi:10.64898/2026.01.16.699998</dc:identifier>
<dc:title><![CDATA[B Lymphocyte Protein Factories produced by Hematopoietic Stem Cell Gene Editing]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2026-01-18</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.64898/2026.01.17.700083v1?rss=1">
<title>
<![CDATA[
Neonatal social communication and single genes predict the variability of post-pubertal social behavior in a mouse model of paternal 15q11-13 duplication 
]]>
</title>
<link>https://biorxiv.org/content/10.64898/2026.01.17.700083v1?rss=1</link>
<description><![CDATA[
Mental illnesses associated with high-risk copy number variations (CNVs) are characterized by incomplete penetrance and variable severity, with their underlying mechanisms remaining inadequately understood. We hypothesized that such phenotypic variability is evident from the neonatal stage and is, at least in part, attributable to individual differences in the expression levels of CNV-encoded genes in the brain. We conducted an analysis of the quantitative and functional structure of neonatal social communication, assessed post-pubertal social interaction, and evaluated the brain expression levels of genes within the same cohort of a mouse model of paternal human 15q11-13 duplication, a high-risk factor variably associated with neurodevelopmental disorders.

Subsequently, computational methods were utilized to identify predictive variables for the variability of post-pubertal social interaction. Mice harboring the 15q11-13 duplication exhibited distinctive call sequences characterized by diverse connections, which lacked the incentive value necessary for effective social communication with mother mice. The neonatal call sequences and the expression levels of Magel2, along with, to a lesser extent, Herc2 and Ndn, in the prefrontal cortex of the 15q11-13 duplication model were predictive of post-pubertal social interaction. Our findings demonstrate that variability in post-pubertal social interaction--a dimensional characteristic of neurodevelopmental disorders--can be predicted by the variability of neonatal social communication and is influenced by the expression levels of specific CNV-encoded genes in the prefrontal cortex. This computational approach has the potential to predict the developmental trajectories of various dimensions of mental illness among CNV carriers in humans and to identify CNV-encoded driver genes in preclinical models, thereby providing potential mechanistic bases for the development of gene-based therapeutic strategies.
]]></description>
<dc:creator>Yamauchi, T.</dc:creator>
<dc:creator>Tamada, K.</dc:creator>
<dc:creator>Takano, T.</dc:creator>
<dc:creator>Nakamura, M.</dc:creator>
<dc:creator>Silva, M. B. E.</dc:creator>
<dc:creator>Ye, K.</dc:creator>
<dc:creator>Inada, H.</dc:creator>
<dc:creator>Tanifuji, T.</dc:creator>
<dc:creator>Hiramoto, T.</dc:creator>
<dc:creator>Stevens, L.</dc:creator>
<dc:creator>Kang, G.</dc:creator>
<dc:creator>Esparza, M.</dc:creator>
<dc:creator>Kikusui, T.</dc:creator>
<dc:creator>Osumi, N.</dc:creator>
<dc:creator>O Broin, P.</dc:creator>
<dc:creator>Takumi, T.</dc:creator>
<dc:creator>Hiroi, N.</dc:creator>
<dc:date>2026-01-18</dc:date>
<dc:identifier>doi:10.64898/2026.01.17.700083</dc:identifier>
<dc:title><![CDATA[Neonatal social communication and single genes predict the variability of post-pubertal social behavior in a mouse model of paternal 15q11-13 duplication]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2026-01-18</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.64898/2026.01.16.700032v1?rss=1">
<title>
<![CDATA[
Dysregulated TGFb-ERK Signaling Drives Aberrant Extracellular Matrix Production in Noonan Syndrome-Associated Pulmonary Valve Stenosis 
]]>
</title>
<link>https://biorxiv.org/content/10.64898/2026.01.16.700032v1?rss=1</link>
<description><![CDATA[
Pulmonary valve stenosis (PVS) is the most common congenital heart defect in Noonan syndrome (NS) and related RASopathies, yet the molecular mechanisms linking pathogenic variants to the valve pathology remain poorly defined. Here, we utilized a human iPSC-based valve differentiation platform to generate the cardiac valve cell lineages--including fibrosa and spongiosa valve interstitial cell (VIC) subtypes. CRISPR-edited iPSCs harboring NS gain-of-function RAS/MAPK and Noonan syndrome with multiple lentigines (NSML) dominant-negative RAS/MAPK variants exhibited early defects in mesodermal and endocardial specification in all genotypes. Additionally, NS-iPSC endocardial cells exhibited defects in endothelial-to-mesenchymal transition (EndMT) specifically towards fibrosa VICs, which was most pronounced in PTPN11N308D (N308D) cells. Single-cell transcriptomics revealed widespread dysregulation of extracellular matrix (ECM) programs in N308D fibrosa VICs, including increased expression of collagens and proteoglycans, as well as dysregulation of multiple genes involved in ECM remodeling. We also detected activation of RAS-MAPK, TGF{beta}, and fibrosis-associated pathways in our transcriptional dataset. Mass spectrometry-based phosphoproteomics confirmed coordinated increases in ERK, PKC, and stress-related kinases, as well as enhanced activity of the TGF{beta} receptor. Functionally, N308D fibrosa VICs exhibited exaggerated upregulation of ECM genes in the presence of TGF{beta}2 ligand, suggesting that these cells are hypersensitive to TGF{beta} stimulation. Furthermore, we demonstrated that this pathological ECM-program occurs independently of BAMBI, a negative regulator of TGF{beta} signaling that was found to be decreased in N308D fibrosa VICs. Lastly, we performed histopathological analyses of stenotic pulmonary valves from two NS infants, which demonstrated marked overproduction and disorganization of ECM, mirroring the findings from our iPSC-based disease model. Together, our data reveal a central mechanism where NS-associated alleles sensitize fibrosa VICs to TGF{beta}, which leads to aberrant downstream signaling and drives the pathological ECM program in NS-associated PVS.
]]></description>
<dc:creator>Liu, C. Z.</dc:creator>
<dc:creator>Patel, S.</dc:creator>
<dc:creator>Sidoli, S.</dc:creator>
<dc:creator>Prasad, A.</dc:creator>
<dc:creator>Charytonowicz, D.</dc:creator>
<dc:creator>Mazine, A.</dc:creator>
<dc:creator>Mikryukov, A. A.</dc:creator>
<dc:creator>Abdul-Ghafar, J.</dc:creator>
<dc:creator>Kahn, E. S.</dc:creator>
<dc:creator>Young, D.</dc:creator>
<dc:creator>Porter, G. A.</dc:creator>
<dc:creator>Katzman, P. J.</dc:creator>
<dc:creator>Sanders, S. P.</dc:creator>
<dc:creator>Carreon, C. K.</dc:creator>
<dc:creator>Hubmacher, D.</dc:creator>
<dc:creator>Lincoln, J.</dc:creator>
<dc:creator>Keller, G.</dc:creator>
<dc:creator>Chung, W. K.</dc:creator>
<dc:creator>Sebra, R.</dc:creator>
<dc:creator>Gelb, B. D.</dc:creator>
<dc:date>2026-01-20</dc:date>
<dc:identifier>doi:10.64898/2026.01.16.700032</dc:identifier>
<dc:title><![CDATA[Dysregulated TGFb-ERK Signaling Drives Aberrant Extracellular Matrix Production in Noonan Syndrome-Associated Pulmonary Valve Stenosis]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2026-01-20</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.64898/2026.01.21.700685v1?rss=1">
<title>
<![CDATA[
Metastatic dissemination of breast cancer stem cells requires MenaINV for lung extravasation but not survival 
]]>
</title>
<link>https://biorxiv.org/content/10.64898/2026.01.21.700685v1?rss=1</link>
<description><![CDATA[
Cancer stemness is a pivotal driver of tumor initiation, treatment resistance, and tumor cell survival. Cancer stem cells (CSCs), though constituting only a small fraction of primary tumor cells, are progressively enriched during metastatic progression: from circulating tumor cells traveling in the bloodstream, to disseminated tumor cells lodged in the lung vasculature, to extravasated tumor cells that have entered tissue parenchyma. However, whether CSCs have an intrinsic advantage for extravasation over cancer non-stem cells (CnSCs), or simply their increased representation in circulation renders them more likely to extravasate, remains unresolved. MenaINV, an invasive isoform of the actin regulatory protein Mena, promotes tumor cell transendothelial migration in primary and secondary sites, yet the direct mechanistic link between stemness and MenaINV in lung metastasis remains unresolved. Here, using a validated fluorescent stemness reporter (SORE6) to identify CSCs, we found that CSCs display elevated MenaINV expression relative to CnSCs. High-resolution intravital imaging showed that CSCs extravasate efficiently into lung parenchyma and survive at higher levels, robustly forming metastatic lesions, while CnSCs show limited extravasation, low survival, and poor colonization. Mechanistically, MenaINV disruption in CSCs specifically impaired extravasation without affecting survival, demonstrating that MenaINV is the key extravasation effector downstream of stemness, whereas stemness-associated factors independently confer survival advantages. Moreover, reintroduction of MenaINV in CnSCs restores their extravasation ability upon which extravasated CnSCs reactivate stem program and form metastases. Overall, we discovered a hierarchical framework where stemness regulates both survival and extravasation capacity, with MenaINV as the key CSC extravasation effector.

Significance: This study reveals how breast cancer stem cells achieve metastatic dominance through separable pathways: MenaINV-dependent extravasation and MenaINV-independent survival, providing rationale for targeting stem program to improve patient outcome.
]]></description>
<dc:creator>Nauman, M.</dc:creator>
<dc:creator>Jung, Y.</dc:creator>
<dc:creator>Karadal, B. F.</dc:creator>
<dc:creator>Suryansh, S.</dc:creator>
<dc:creator>Duran, C. L.</dc:creator>
<dc:creator>Li, J.</dc:creator>
<dc:creator>Patel, P.</dc:creator>
<dc:creator>Friedman-DeLuca, M.</dc:creator>
<dc:creator>Barth, N. D.</dc:creator>
<dc:creator>Eddy, R.</dc:creator>
<dc:creator>Guo, W.</dc:creator>
<dc:creator>Condeelis, J. S.</dc:creator>
<dc:creator>Entenberg, D.</dc:creator>
<dc:creator>Oktay, M. H.</dc:creator>
<dc:date>2026-01-23</dc:date>
<dc:identifier>doi:10.64898/2026.01.21.700685</dc:identifier>
<dc:title><![CDATA[Metastatic dissemination of breast cancer stem cells requires MenaINV for lung extravasation but not survival]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2026-01-23</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.64898/2026.01.21.700837v1?rss=1">
<title>
<![CDATA[
FAK Inhibition Remodels the Metastatic ECM and Restores CD8+ T Cell Trafficking and Immunosurveillance 
]]>
</title>
<link>https://biorxiv.org/content/10.64898/2026.01.21.700837v1?rss=1</link>
<description><![CDATA[
Metastatic breast cancer remains largely incurable, driven in part by immunosuppressive microenvironments that limit CD8+ T cell-mediated clearance. Using a murine pulmonary metastatic breast cancer model, we show that the focal adhesion kinase (FAK) inhibitor VS-4718 promotes a CD8+ T cell-dependent regression of metastatic lesions by reprograming the metastatic microenvironment. VS-4718 reduced immunosuppressive myeloid and regulatory T cells while increasing CD8+ T cell infiltration. Cellular and secreted proteome profiling revealed that VS-4718 downregulates ECM components such as laminin 5 and collagen VIII1, which we show impair CD8+ T cell migration and activity. In human breast cancer cohorts, elevated LAMA5/COL8A1 expression and a FAK-dependent ECM signature associate with poor outcome and prognostic for residual disease. Intravital imaging demonstrated that VS-4718 enhances CD8 T cell extravasation and induces T cell-tumor cell contacts necessary for cytotoxicity. Ex vivo lung slice cultures recapitulated these findings, showing enhanced T cell swarming, metastatic cluster shrinkage, and apoptosis. These findings reveal how FAK inhibition remodels the metastatic ECM to potentiate coordinated CD8+ T cell responses. VS-4718 might aid in clearing metastases in breast cancer patients through modulating both stromal and immune components.

STATEMENT OF SIGNIFICANCEFocal adhesion kinase (FAK) inhibition remodels collagen- and laminin-rich extracellular matrix barriers and alleviates physical constraints that limit CD8 T cell access and activity in metastases. This enhances infiltration, migration, and tumor cell engagement, and synergizes with PD-1 blockade, supporting combined therapeutic strategies in metastatic breast cancer.
]]></description>
<dc:creator>Barth, N. D.</dc:creator>
<dc:creator>Peng, B.</dc:creator>
<dc:creator>Papanicolaou, M.</dc:creator>
<dc:creator>Moughari, F. A.</dc:creator>
<dc:creator>Duran, C. L.</dc:creator>
<dc:creator>McGinnis, C. S.</dc:creator>
<dc:creator>Dawson, J. C.</dc:creator>
<dc:creator>Webb, E. R.</dc:creator>
<dc:creator>Muir, M.</dc:creator>
<dc:creator>Laing, F.</dc:creator>
<dc:creator>Jung, Y.</dc:creator>
<dc:creator>He, X.-Y.</dc:creator>
<dc:creator>Satpathy, A.</dc:creator>
<dc:creator>Egeblad, M.</dc:creator>
<dc:creator>Haider, S.</dc:creator>
<dc:creator>Natrajan, R.</dc:creator>
<dc:creator>Oktay, M. H.</dc:creator>
<dc:creator>Entenberg, D.</dc:creator>
<dc:creator>Brunton, V. G.</dc:creator>
<dc:date>2026-01-23</dc:date>
<dc:identifier>doi:10.64898/2026.01.21.700837</dc:identifier>
<dc:title><![CDATA[FAK Inhibition Remodels the Metastatic ECM and Restores CD8+ T Cell Trafficking and Immunosurveillance]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2026-01-23</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.64898/2026.01.21.700897v1?rss=1">
<title>
<![CDATA[
Systematic functional dissection of germline noncoding risk variants impacting clonal hematopoiesis 
]]>
</title>
<link>https://biorxiv.org/content/10.64898/2026.01.21.700897v1?rss=1</link>
<description><![CDATA[
Clonal hematopoiesis of indeterminate potential (CHIP) is a precursor condition characterized by the expansion of blood cell clones harboring somatic mutations originating in hematopoietic stem cells (HSCs). Since individuals with CHIP face a high risk of developing myeloid malignancies, targeting CHIP clones could provide a viable strategy for leukemia prevention. Despite its clinical significance, the mechanisms underlying CHIP predisposition and progression remain poorly understood. Recent genome wide association studies (GWAS) have identified several non-coding genetic loci that are strongly associated with CHIP; however, their underlying mechanisms still remain unknown. We hypothesize that risk variants in these non-coding loci modulate enhancer elements active in HSCs. To test this, we selected 1,374 non-coding variants from 51 loci associated for CHIP risk in the UK Biobank and screened them for regulatory activity using a Massively Parallel Reporter Assay (MPRA). We performed our lentiviral MPRA screen in MUTZ-3 cells, a human hematopoietic cell line relevant to HSCs, which express CD34 surface marker and are dependent on HSC-specific transcription factors. Using a MPRA library of [~]73,000 constructs in CD34+ fraction of MUTZ-3 cells, we identified 87 variants representing 32 GWAS loci. We used targeted genome editing to demonstrate endogenous enhancer activity across 3 MPRA variants that affect the transcription of NKD2, FLT3, and MSI2. Our functional studies on MSI2 indicate that presence of higher levels of MSI2 mediated by CHIP risk allele enhances the clonal expansion of TET2 knockout hematopoietic stem and progenitor cells, providing a mechanistic link whereby non-coding genetic variants can influence the expansion of mutant CHIP clones.
]]></description>
<dc:creator>Nguyen, T.</dc:creator>
<dc:creator>Jeejan, J.</dc:creator>
<dc:creator>Iwasaki, T.</dc:creator>
<dc:creator>Kales, S.</dc:creator>
<dc:creator>Chakraborty, J.</dc:creator>
<dc:creator>Yanase, C.</dc:creator>
<dc:creator>Shekhar, A.</dc:creator>
<dc:creator>Kwasniak, D.</dc:creator>
<dc:creator>Hegde, A.</dc:creator>
<dc:creator>Voit, R.</dc:creator>
<dc:creator>Stengel, K.</dc:creator>
<dc:creator>Ito, K.</dc:creator>
<dc:creator>Tewhey, R.</dc:creator>
<dc:creator>Nandakumar, S.</dc:creator>
<dc:date>2026-01-23</dc:date>
<dc:identifier>doi:10.64898/2026.01.21.700897</dc:identifier>
<dc:title><![CDATA[Systematic functional dissection of germline noncoding risk variants impacting clonal hematopoiesis]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2026-01-23</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.64898/2026.01.28.702389v1?rss=1">
<title>
<![CDATA[
AADAT-Driven Metabolic Control of Malate and CoQ10 Shapes Immune Evasion in Triple-Negative Breast Cancer 
]]>
</title>
<link>https://biorxiv.org/content/10.64898/2026.01.28.702389v1?rss=1</link>
<description><![CDATA[
Compared to other subtypes of breast cancer, triple-negative breast cancers (TNBC) have fewer treatment options and exhibit a worse prognosis. Through integrated transcriptomic, metabolomic, immunohistochemical, spatial, and clinical analyses, we identify the mitochondrial enzyme, -aminoadipate aminotransferase (AADAT) as a previously unrecognized metabolic immune checkpoint in TNBC. AADAT mRNA and protein were significantly upregulated in human TNBC, and high AADAT expression was associated with reduced intra-tumoral CD8 T-cell density and inferior survival. Genetic silencing of AADAT in orthotopic murine TNBC models curtailed primary tumor growth and distant metastasis in a CD8 T-cell-dependent manner, enhanced effector T-cell activation, and sensitized tumors to dual PD-1/CTLA-4 blockade. Mechanistically, unbiased metabolomics showed increased malate levels after AADAT knockdown. Additionally, 4-hydroxyphenylpyruvate, an essential precursor for coenzyme Q10(CoQ10) biosynthesis, decreased following AADAT knockdown, suggesting an impaired mitochondrial electron transport chain. CoQ10 supplementation restored metabolic balance and reversed malate accumulation caused by AADAT knockdown, indicating that AADAT helps maintain CoQ10-supported redox homeostasis, thereby preventing malate buildup and export. Notably, malate addition directly boosted CD8 T-cell oxidative metabolism, increased the NAD/NADH ratio and reactive oxygen species, and augmented TNF- and IFN-{gamma} production. In vivo, malate supplementation in drinking water phenocopied AADAT knockdown, restored the response to paclitaxel plus anti-PD-1 therapy in multiple independent syngeneic TNBC models with de novo or acquired resistance to immunotherapy, reduced tumor burden, and prolonged survival. In patient cohorts, higher spatially clustered intra-tumoral malate is associated with co-localization of functional CD8 T cells, decreased exhausted T-cell neighborhoods, and superior post-chemotherapy outcomes. These data position AADAT as a central metabolic orchestrator of immune escape in TNBC and nominate oral malate as a readily translatable adjuvant to reverse chemo-immunotherapy resistance in TNBC.

Statement of SignificanceAADAT defines a metabolic-immune axis driving immune evasion and therapy resistance in triple-negative breast cancer. Blocking AADAT or administering oral malate reactivates CD8 T-cell immunity and sensitizes chemo-immunotherapy-resistant tumors to these agents. These findings uncover a readily translatable metabolic vulnerability with potential to improve outcomes for patients with aggressive breast cancer subtypes.
]]></description>
<dc:creator>Chatterjee, M.</dc:creator>
<dc:creator>Gu, F.</dc:creator>
<dc:creator>Samanta, S.</dc:creator>
<dc:creator>Rasaily, U.</dc:creator>
<dc:creator>Thota, S. M.</dc:creator>
<dc:creator>Varghese, D.</dc:creator>
<dc:creator>Qiu, Y.</dc:creator>
<dc:creator>Fordwuo, L. E. E.</dc:creator>
<dc:creator>Villanueva, H.</dc:creator>
<dc:creator>McKenna, M. K.</dc:creator>
<dc:creator>Park, J. H.</dc:creator>
<dc:creator>Zhang, W.</dc:creator>
<dc:creator>Tian, L.</dc:creator>
<dc:creator>Yu, L.</dc:creator>
<dc:creator>Piyarathna, B.</dc:creator>
<dc:creator>Gao, Y.</dc:creator>
<dc:creator>Simons, B. W.</dc:creator>
<dc:creator>Jung, S. Y.</dc:creator>
<dc:creator>Karanam, B.</dc:creator>
<dc:creator>Putluri, V.</dc:creator>
<dc:creator>chandandeep, N.</dc:creator>
<dc:creator>Mohamed, N.</dc:creator>
<dc:creator>Asirvatham, J. R.</dc:creator>
<dc:creator>Jebakumar, D.</dc:creator>
<dc:creator>Rao, A.</dc:creator>
<dc:creator>Gutierrez, C.</dc:creator>
<dc:creator>Omilian, A. R.</dc:creator>
<dc:creator>Morrison, C.</dc:creator>
<dc:creator>Das, G. M.</dc:creator>
<dc:creator>Ambrosone, C.</dc:creator>
<dc:creator>Seeley, E. H.</dc:creator>
<dc:creator>Kaipparettu, B. A.</dc:creator>
<dc:creator>Kurland, I. J.</dc:creator>
<dc:creator>Putluri, N.</dc:creator>
<dc:creator>Elkhanany, A.</dc:creator>
<dc:creator>Davis, A.</dc:creator>
<dc:creator>Zhu, Q.</dc:creator>
<dc:creator>Zhang, X. H.</dc:creator>
<dc:creator>Sreekumar, A.</dc:creator>
<dc:date>2026-01-30</dc:date>
<dc:identifier>doi:10.64898/2026.01.28.702389</dc:identifier>
<dc:title><![CDATA[AADAT-Driven Metabolic Control of Malate and CoQ10 Shapes Immune Evasion in Triple-Negative Breast Cancer]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2026-01-30</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.64898/2026.01.30.702866v1?rss=1">
<title>
<![CDATA[
PRMT5 inhibitors actively promote metastatic progression of lung adenocarcinoma 
]]>
</title>
<link>https://biorxiv.org/content/10.64898/2026.01.30.702866v1?rss=1</link>
<description><![CDATA[
Epigenetic changes are a major driver of cancer progression, placing considerable focus on epigenetic regulators as therapeutic targets. Protein arginine methyltransferase 5 (PRMT5) is one such regulator, and numerous PRMT5 inhibitors (PRMT5i) in clinical trials. Despite this, the mechanisms and consequences of PRMT5i-resistance are unknown. Here, we demonstrate that aggressive cancer progression is an inbuilt feature of PRMT5i-resistance acquisition in lung adenocarcinoma (LUAD). Independently-generated resistant cell lines gain dedifferentiation signatures that typify late-stage disease and show increased metastatic potential in vivo. We establish that these state shifts are a direct consequence of PRMT5i action; treatment induces rapid and widespread chromatin rewiring, enabling derepression of late-stage disease states that are stably established in resistant cells. Notably, treatment of lung tumor-bearing mice drives rapid disease advancement without decreasing tumor burden, showing that drug-induced disease progression supersedes any benefits from PRMT5 inhibition in vivo. Furthermore, analyses of human cell lines and patient cohorts supports the notion of PRMT5 inhibition-mediated dedifferentiation. Collectively our data show that PRMT5i can actively promote self-resistance and disease progression in different tumor types. This raises serious concerns for the use of PRMT5i in patients, arguing that clinical studies should consider the possibility of drug-induced plasticity, resistance, and disease advancement.
]]></description>
<dc:creator>Fowler, C. E.</dc:creator>
<dc:creator>O'Hearn, N.</dc:creator>
<dc:creator>Henning, N.</dc:creator>
<dc:creator>Griffen, A.</dc:creator>
<dc:creator>Mathey-Andrews, N.</dc:creator>
<dc:creator>Salus, G.</dc:creator>
<dc:creator>Hazan, R.</dc:creator>
<dc:creator>Jacks, T.</dc:creator>
<dc:creator>Burds, A.</dc:creator>
<dc:creator>Mueller, H.</dc:creator>
<dc:creator>Soto-Feliciano, Y.</dc:creator>
<dc:creator>LaFave, L.</dc:creator>
<dc:creator>Lees, J.</dc:creator>
<dc:date>2026-02-02</dc:date>
<dc:identifier>doi:10.64898/2026.01.30.702866</dc:identifier>
<dc:title><![CDATA[PRMT5 inhibitors actively promote metastatic progression of lung adenocarcinoma]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2026-02-02</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.64898/2026.02.07.704600v1?rss=1">
<title>
<![CDATA[
Recurrent Escape from Osimertinib-Induced Senescence Promotes Genomic Instability Associated with Therapeutic Resistance 
]]>
</title>
<link>https://biorxiv.org/content/10.64898/2026.02.07.704600v1?rss=1</link>
<description><![CDATA[
Acquired resistance to osimertinib remains a major challenge in treating EGFR-mutant (EGFR+) Non-Small-Cell Lung Cancer (NSCLC). Although most patients initially respond to treatment, relapses are universal, even after prolonged remission during which tumor dormancy occurs. Here, we show that osimertinib induces and maintains senescence in EGFR+ NSCLC. Importantly, osimertinib does not kill senescent cells; however, following drug withdrawal, cells escape and resume proliferation. To examine the consequences of recurrent senescence and escape on resistance, we generated four isogenic cell lines clonally expanded through sequential cycles of Osimertinib-Induced Senescence (OsIS). Phylogenetic reconstruction based on de novo somatic variants revealed that these lines form four distinct evolutionary clades with varying degrees of osimertinib resistance. All had elevated tumor mutational burden with distinct single-nucleotide and copy-number variants, and without acquisition of tertiary EGFR mutations or MET amplification. Resistance was predominately associated with chromosomal instability characterized by extensive loss of heterozygosity, high copy-number alteration burden, and mutational signatures consistent with replication-associated DNA damage and repair. A second resistance genotype exhibited extreme focal amplifications with breakage-fusion-bridge-like genome remodeling. Despite profound genomic instability, targeting DNA repair or replication stress pathways was ineffective, whereas sensitivity to platinum-based chemotherapy was retained across clades. Collectively, these findings indicate that recurrent senescence escape drives osimertinib resistance through widespread genomic instability and is most effectively treated by cytotoxic strategies rather than pathway-targeted approaches.

SignificanceAlthough most patients with EGFR+ lung cancer relapse after osimertinib therapy, only a small fraction of cases are explained by on-target resistance mutations. This study shows that recurrent cycles of osimertinib-induced senescence and escape promote resistance through chromosomal instability, identifying dormant cells as critical reservoirs for relapse.



O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=77 SRC="FIGDIR/small/704600v1_ufig1.gif" ALT="Figure 1">
View larger version (20K):
org.highwire.dtl.DTLVardef@6e2b66org.highwire.dtl.DTLVardef@e337cforg.highwire.dtl.DTLVardef@16526adorg.highwire.dtl.DTLVardef@1ce4d80_HPS_FORMAT_FIGEXP  M_FIG C_FIG
]]></description>
<dc:creator>Mcdaid, H.</dc:creator>
<dc:creator>Jamil, N.</dc:creator>
<dc:creator>Hooker, Q.</dc:creator>
<dc:creator>Cornejal, N.</dc:creator>
<dc:creator>Hosgood, D.</dc:creator>
<dc:date>2026-02-08</dc:date>
<dc:identifier>doi:10.64898/2026.02.07.704600</dc:identifier>
<dc:title><![CDATA[Recurrent Escape from Osimertinib-Induced Senescence Promotes Genomic Instability Associated with Therapeutic Resistance]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2026-02-08</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.64898/2026.02.09.704594v1?rss=1">
<title>
<![CDATA[
Elevated endocytic trafficking mediated by GPRASP2 maintains HSC fidelity. 
]]>
</title>
<link>https://biorxiv.org/content/10.64898/2026.02.09.704594v1?rss=1</link>
<description><![CDATA[
Endolysosomal trafficking supports cellular homeostasis through coordinated regulation of extrinsic signaling inputs. Hematopoietic stem cell (HSC) function requires a tightly regulated balance between quiescence for long-term preservation and rapid activation for blood production. Although lysosomal regulation of metabolism and quiescence has been linked to stem cell maintenance, the contribution of endocytic routing to lysosomal function remains incompletely understood. Here, we show that quiescent HSCs rely on elevated endocytosis to maintain self-renewal. This activity is mediated in part by GPRASP2, a post-endosomal sorting protein. HSCs enriched in GPRASP2 are functionally dormant yet molecularly primed for activation however, in response to proliferative cues, dormant HSCs exhibit reduced signaling and proliferation. Disruption of GPRASP2-mediated endocytosis induces rapid proliferation and increased expression of signaling constituents, consistent with a model in which elevated endocytosis attenuates signaling through receptor internalization. Thus, we identify endocytosis as a mechanism by which HSCs limit functional exhaustion arising from chronic activation.
]]></description>
<dc:creator>Vanhuizen, A. V.</dc:creator>
<dc:creator>Zhai, M.</dc:creator>
<dc:creator>Totani, H.</dc:creator>
<dc:creator>Rathnayake, D.</dc:creator>
<dc:creator>Kooienga, E. E.</dc:creator>
<dc:creator>Sharma, I.</dc:creator>
<dc:creator>Kelley, Z.</dc:creator>
<dc:creator>Rodgers, M.</dc:creator>
<dc:creator>Zanotti, F.</dc:creator>
<dc:creator>Palmer, L.</dc:creator>
<dc:creator>Tisdale, K.</dc:creator>
<dc:creator>Dabas, P.</dc:creator>
<dc:creator>Loeffler, D.</dc:creator>
<dc:creator>Nunes, J.</dc:creator>
<dc:creator>Klein, J. V.</dc:creator>
<dc:creator>Pruett-Miller, S. M.</dc:creator>
<dc:creator>Ito, K.</dc:creator>
<dc:creator>Morales-Hernandez, A.</dc:creator>
<dc:creator>McKinney-Freeman, S.</dc:creator>
<dc:date>2026-02-11</dc:date>
<dc:identifier>doi:10.64898/2026.02.09.704594</dc:identifier>
<dc:title><![CDATA[Elevated endocytic trafficking mediated by GPRASP2 maintains HSC fidelity.]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2026-02-11</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.64898/2026.02.10.705133v1?rss=1">
<title>
<![CDATA[
Absence of EOGT Precludes Defective Development in Fringe-null Mouse Intestine 
]]>
</title>
<link>https://biorxiv.org/content/10.64898/2026.02.10.705133v1?rss=1</link>
<description><![CDATA[
Identifying biological roles for glycosyltransferases is a continuing challenge and important for defining morbidities associated with congenital disorders of glycosylation. Here we investigate the consequences to intestinal development of conditionally deleting Lfng alone or Lfng, Mfng and Rfng together in a mixed or Eogt-null genetic background. Each Fringe transfers N-acetylglucosamine (GlcNAc) to fucose (Fuc) attached to Ser or Thr by POFUT1 in a consensus sequence found in certain epithelial growth factor-like (EGF) repeats. EOGT transfers GlcNAc directly to Ser/Thr in a separate consensus sequence of the EGF repeat. Notch receptors and Notch ligands contain the largest number of EGF repeats with consensus sites for these O-glycans. Conditional deletion of Pofut1 in mouse intestine causes similar developmental defects to deletion of Notch1 and Notch2 or Dll1 and Dll4. LFNG also contributes to optimal Notch signaling in mouse intestine. In this work, we generated Lfng[F/F]:Villin-Cre and Lfng[F/F]Mfng[-/-]Rfng[-/-]:Villin-Cre mice in which extension of O-Fuc on EGF repeats was inhibited or prevented in intestinal epithelium. Conditional deletion of either Lfng alone or all three Fringe activities together led to defective intestinal development with a marked increase in goblet and Paneth cells, increased crypt width and reduced villus length. Unexpectedly, in mice globally lacking EOGT, conditional inactivation of the three Fringe genes did not lead to defective intestinal development. Thus, the absence of EOGT prevented disruption of development in Fringe-null intestine, identifying a novel role for EOGT in regulating intestinal development.
]]></description>
<dc:creator>Nauman, M.</dc:creator>
<dc:creator>Stanley, P.</dc:creator>
<dc:date>2026-02-11</dc:date>
<dc:identifier>doi:10.64898/2026.02.10.705133</dc:identifier>
<dc:title><![CDATA[Absence of EOGT Precludes Defective Development in Fringe-null Mouse Intestine]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2026-02-11</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.64898/2026.02.19.706872v1?rss=1">
<title>
<![CDATA[
Cellular Senescence Drives Zinc Accumulation and Transporter Dysregulation in Intestinal Epithelial Cells 
]]>
</title>
<link>https://biorxiv.org/content/10.64898/2026.02.19.706872v1?rss=1</link>
<description><![CDATA[
Zinc is essential for life, and its regulation is tightly controlled by numerous transporters. As we age, our micronutrient levels, intake, and absorption change. Additionally, senescent cells increase with age and can contribute to the progression of age-related diseases. The study of Zn homeostasis in senescent intestinal cells is a relatively unexplored area that we aimed to investigate. Using two models to induce senescence in intestinal epithelial cells--etoposide treatment and {gamma}-irradiation--we observed that Zn levels increased in the cells, likely due to the upregulation of Zn transporters ZIP4 and ZnT7. This upregulated Zn seems to accumulate in the Golgi apparatus, and when Zn accumulation is blocked through chelation, a rescue effect occurs, marked by a decrease in senescence markers. This research emphasizes the role of Zn in senescent cells and its possible involvement in the development of senescence and the disrupted Zn homeostasis seen with aging.
]]></description>
<dc:creator>Terrell, K. C.</dc:creator>
<dc:creator>Choi, S.</dc:creator>
<dc:creator>Choi, J.</dc:creator>
<dc:creator>Choi, S.</dc:creator>
<dc:date>2026-02-20</dc:date>
<dc:identifier>doi:10.64898/2026.02.19.706872</dc:identifier>
<dc:title><![CDATA[Cellular Senescence Drives Zinc Accumulation and Transporter Dysregulation in Intestinal Epithelial Cells]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2026-02-20</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.64898/2026.02.20.707089v1?rss=1">
<title>
<![CDATA[
Explaining the unexplained admixture mapping signals via rare variants: the HCHS/SOL 
]]>
</title>
<link>https://biorxiv.org/content/10.64898/2026.02.20.707089v1?rss=1</link>
<description><![CDATA[
In admixed populations, formed by a mixing of two or more previously isolated populations, genomic segments can be traced to their ancestral populations ("ancestries"). Admixture mapping (AM) associates local ancestry with outcomes in admixed populations, detecting signals when causal variants differ in frequency or effect across ancestral populations. Prior work showed that adjusting for nearby GWAS-identified common variants does not fully explain some AM signals. Here, we assessed two approaches to explain the previously unexplained AM signal: (1) including sets of rare variants; (2) increasing the genomic region considered when searching for common variants. We studied these hypotheses comprehensively using a whole-genome sequencing dataset coupled with metabolomics from the Hispanic Community Health Study/Study of Latinos. We detected multiple sets of rare variants with replicated association with metabolite levels. Yet these rare variants appear to explain only a small fraction of the AM signal, while inclusion of common variants from a larger genomic region appears to explain the majority of the AM signals.
]]></description>
<dc:creator>Chen, X.</dc:creator>
<dc:creator>Argos, M.</dc:creator>
<dc:creator>Yu, B.</dc:creator>
<dc:creator>Boerwinkle, E.</dc:creator>
<dc:creator>Qi, Q.</dc:creator>
<dc:creator>Kaplan, R.</dc:creator>
<dc:creator>Franceschini, N.</dc:creator>
<dc:creator>Sofer, T.</dc:creator>
<dc:date>2026-02-23</dc:date>
<dc:identifier>doi:10.64898/2026.02.20.707089</dc:identifier>
<dc:title><![CDATA[Explaining the unexplained admixture mapping signals via rare variants: the HCHS/SOL]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2026-02-23</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.64898/2026.02.23.707584v1?rss=1">
<title>
<![CDATA[
A Developmental Lectin-Glycan Program Enables Early Breast Cancer Dissemination and Metastatic Onset 
]]>
</title>
<link>https://biorxiv.org/content/10.64898/2026.02.23.707584v1?rss=1</link>
<description><![CDATA[
Early dissemination of breast cancer cells can occur before clinically detectable tumor progression; yet the molecular programs enabling this process remain poorly defined. Here, we identify a conserved glycocheckpoint, mediated by the galectin-1 (GAL1)-glycan axis, that links normal mammary gland morphogenesis to early breast cancer dissemination and metastasis. During mammary gland development, regulated GAL1 expression and glycan accessibility directed epithelial lineage specification and progesterone-induced branching morphogenesis. This morphogenetic program was aberrantly reactivated in early breast cancer lesions and co-opted to promote tumor cell dissemination. Genetic ablation and pharmacological inhibition of GAL1 in mouse models (mammary tumor virus-polyoma middle T antigen (MMTV-PyMT and MMTV-HER2), together with patient-derived data, revealed that this lectin drives epithelial-to-mesenchymal transition, acquisition of stem-like traits, and metastatic competence in breast cancer. Therapeutic targeting of GAL1 reduced early lesions and their progression, decreased circulating tumor cell frequency, and limited lung metastasis in the MMTV-HER2 tumor model. Consistently, high transcriptomic levels of GAL1 together with low levels of the enzyme {beta}-galactoside 2,6-sialyltransferase 1 (ST6GAL1), that catalyzes 2,6-linked sialylation and limits GAL1 binding, was associated with poor clinical outcome in breast cancer patients. These findings reveal that early breast cancer dissemination hijacks a GAL1-glycan morphogenetic program, uncovering a direct link between mammary development and metastatic progression, highlighting GAL1 as a therapeutic vulnerability in early-stage disease.
]]></description>
<dc:creator>Perrotta, R. M.</dc:creator>
<dc:creator>Berton, M.</dc:creator>
<dc:creator>Valencia Salazar, L.</dc:creator>
<dc:creator>Mahmoud, Y.</dc:creator>
<dc:creator>Perez Saez, J. M.</dc:creator>
<dc:creator>Dalotto-Moreno, T.</dc:creator>
<dc:creator>Morales, R. M.</dc:creator>
<dc:creator>Gatto, S. G.</dc:creator>
<dc:creator>Aguirre-Ghiso, J. A.</dc:creator>
<dc:creator>Rabinovich, G. A.</dc:creator>
<dc:creator>Salatino, M.</dc:creator>
<dc:date>2026-02-25</dc:date>
<dc:identifier>doi:10.64898/2026.02.23.707584</dc:identifier>
<dc:title><![CDATA[A Developmental Lectin-Glycan Program Enables Early Breast Cancer Dissemination and Metastatic Onset]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2026-02-25</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.64898/2026.02.27.707579v1?rss=1">
<title>
<![CDATA[
Structural Basis for C8 methylation of 23S ribosomal RNA by Cfr 
]]>
</title>
<link>https://biorxiv.org/content/10.64898/2026.02.27.707579v1?rss=1</link>
<description><![CDATA[
Cfr methylates C8 of adenosine 2503 (A2503) in 23S ribosomal RNA (rRNA) and will also methylate C2 of A2503 after methylating C8. C8 methylation confers resistance to more than five classes of clinically used antibiotics, highlighting it as a worrisome mechanism of antibiotic resistance. Here, we report the structure of Cfr, determined by cryogenic electron microscopy (Cryo-EM). Despite its small size ([~]36 kDa), we exploit a transient protein-RNA crosslink that forms during catalysis, which requires Cys105 to resolve. Using a Cfr Cys105Ala variant and an 87-nucleotide strand of rRNA, we isolate the crosslinked species and determine its structure to 3.0 [A] resolution. Notably, the 87-mer rRNA adopts an L-shaped conformation characteristic of tRNAs, rather than the conformation it assumes in the ribosome.

One Sentence SummaryCryo-EM structure of Cfr, a radical S-adenosylmethionine methylase that confers antibiotic resistance
]]></description>
<dc:creator>Esakova, O. A.</dc:creator>
<dc:creator>Jung, J.</dc:creator>
<dc:creator>Lee, H.</dc:creator>
<dc:creator>Cho, S. H.</dc:creator>
<dc:creator>Alumasa, J. N.</dc:creator>
<dc:creator>Schwalm, E.</dc:creator>
<dc:creator>Grove, T. L.</dc:creator>
<dc:creator>Bauerle, M.</dc:creator>
<dc:creator>Hafenstein, S.</dc:creator>
<dc:creator>Yu, Z.</dc:creator>
<dc:creator>Booker, S.</dc:creator>
<dc:date>2026-03-02</dc:date>
<dc:identifier>doi:10.64898/2026.02.27.707579</dc:identifier>
<dc:title><![CDATA[Structural Basis for C8 methylation of 23S ribosomal RNA by Cfr]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2026-03-02</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.64898/2026.02.28.707294v1?rss=1">
<title>
<![CDATA[
Aberrant oxidative metabolism selects for TET2-deficient hematopoietic stem and progenitor cells 
]]>
</title>
<link>https://biorxiv.org/content/10.64898/2026.02.28.707294v1?rss=1</link>
<description><![CDATA[
The mechanism(s) driving selective expansion of mutant hematopoietic stem and progenitor cells (HSPC) in clonal hematopoiesis (CH) are incompletely understood. Here, we address the role of metabolism in selection for HSPC with loss of function mutations in TET2. Loss of Tet2 in murine HSPC triggers overexpression of glycolysis and oxidative phosphorylation genes and increased oxidative metabolism via an enlarged mitochondrial network. However, Tet2-deficient HSPC maintain a normal redox state. Strikingly, compound loss of the rate-limiting pentose phosphate pathway (PPP) enzyme glucose-6-phosphate dehydrogenase (G6PD) triggers increased reactive oxygen species and impairs the fitness of Tet2-deficient HSPC. We find that aberrant oxidative metabolism is also a feature of HSPC in human CH and clonal cytopenia of unknown significance (CCUS). Overall, our data point to aberrant metabolism as a critical and conserved driver of selection in TET2-deficient CH and identify the PPP as a crucial compensatory pathway needed to maintain their selective advantage.

Statement of SignificanceThis study identifies oxidative metabolism as a critical driver of selection for TET2-deficient HSPC in clonal hematopoiesis (CH). It also demonstrates that cellular redox state is a vulnerability that impairs their fitness. These insights establish targetable metabolic pathway(s) that could be exploited in the setting of TET2 mutant CH.
]]></description>
<dc:creator>Nino, K. E.</dc:creator>
<dc:creator>Adema, V.</dc:creator>
<dc:creator>Gray, A.</dc:creator>
<dc:creator>Cowan, C. M.</dc:creator>
<dc:creator>Schleicher, W. E.</dc:creator>
<dc:creator>Hosseini, M.</dc:creator>
<dc:creator>Bennett, S. N.</dc:creator>
<dc:creator>Patel, S. B.</dc:creator>
<dc:creator>Moreira, S.</dc:creator>
<dc:creator>Danis, E.</dc:creator>
<dc:creator>Ma, F.</dc:creator>
<dc:creator>Lin, H.-Y.</dc:creator>
<dc:creator>Young, T. N.</dc:creator>
<dc:creator>Anderson, C. A.</dc:creator>
<dc:creator>Sharma, D.</dc:creator>
<dc:creator>Varesi, A.</dc:creator>
<dc:creator>Filippi, M.-D.</dc:creator>
<dc:creator>Ito, K.</dc:creator>
<dc:creator>Dawlaty, M. M.</dc:creator>
<dc:creator>Huang, G.</dc:creator>
<dc:creator>Reisz, J. A.</dc:creator>
<dc:creator>Xie, S. Z.</dc:creator>
<dc:creator>Chan, S. M.</dc:creator>
<dc:creator>Tan, L.</dc:creator>
<dc:creator>Garcia-Manero, G.</dc:creator>
<dc:creator>Chien, K.</dc:creator>
<dc:creator>Ganan-Gomez, I.</dc:creator>
<dc:creator>D'Alessandro, A.</dc:creator>
<dc:creator>Colla, S.</dc:creator>
<dc:creator>Pietras, E.</dc:creator>
<dc:date>2026-03-02</dc:date>
<dc:identifier>doi:10.64898/2026.02.28.707294</dc:identifier>
<dc:title><![CDATA[Aberrant oxidative metabolism selects for TET2-deficient hematopoietic stem and progenitor cells]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2026-03-02</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.64898/2026.03.01.708859v1?rss=1">
<title>
<![CDATA[
Membrane localisation and checkpoint blockade enhance xenoantigen delivery to redirect pre-existing immunity against tumours 
]]>
</title>
<link>https://biorxiv.org/content/10.64898/2026.03.01.708859v1?rss=1</link>
<description><![CDATA[
Cancer immunotherapies often rely on the recognition of tumour antigens, which strongly limits their efficacy upon heterogeneous antigen expression or downregulation. A strategy to overcome this limitation is to redirect pre-existing antiviral immunity against tumours through the delivery of xenoantigens. While many studies have addressed this by repurposing licensed vaccines, we here investigated the underlying mechanisms of immune redirection via the delivery of non-adjuvanted xenoantigen proteins, thereby avoiding confounding adjuvant- or pathogen-specific effects. Using B16F10 melanoma cells engineered to express the model antigen OVA, we found that tumour rejection in pre-immunised mice depends on the subcellular localisation of the xenoantigen, with membrane-bound antigens eliciting stronger rejection than dose-matched soluble cytoplasmic antigens. Enhanced rejection of membrane-bound OVA expressing tumours was associated with stronger CD4+ T cell responses. In addition, pre-immunisation also increased recruitment of inflammatory monocytes and macrophages at the tumour site. To translate this concept therapeutically, we developed a membrane-targeting OVA fusion protein which, upon intratumoural delivery, redirected pre-existing immunity and made tumours responsive to anti-PD-1 therapy. Importantly, these findings were further validated using the clinically relevant varicella zoster virus (VZV) glycoprotein E (gE) antigen and the licensed varicella vaccine Varivax. Our approach provides a mechanistic and translational perspective for treating poorly immunogenic tumours, leveraging widespread pathogen-specific immune memory in combination with anti-PD1 therapy in cancer patients.
]]></description>
<dc:creator>Briquez, P. S.</dc:creator>
<dc:creator>Hauert, S.</dc:creator>
<dc:creator>Zhou, F.</dc:creator>
<dc:creator>Sidiskis, J.</dc:creator>
<dc:creator>Saxena, A.</dc:creator>
<dc:creator>Goldberger, Z.</dc:creator>
<dc:creator>Chang, K.</dc:creator>
<dc:creator>Kling, C.</dc:creator>
<dc:creator>Koehler, N.</dc:creator>
<dc:creator>Fichtner-Feigl, S.</dc:creator>
<dc:creator>Hubbell, J. A.</dc:creator>
<dc:creator>Jumaa, H.</dc:creator>
<dc:date>2026-03-03</dc:date>
<dc:identifier>doi:10.64898/2026.03.01.708859</dc:identifier>
<dc:title><![CDATA[Membrane localisation and checkpoint blockade enhance xenoantigen delivery to redirect pre-existing immunity against tumours]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2026-03-03</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.64898/2026.03.05.709895v1?rss=1">
<title>
<![CDATA[
Transitory enhancement of GATA2 chromatin engagement during early erythroid differentiation 
]]>
</title>
<link>https://biorxiv.org/content/10.64898/2026.03.05.709895v1?rss=1</link>
<description><![CDATA[
Erythroid differentiation requires precise regulation of transcription factor binding to chromatin targets as hematopoietic progenitors relinquish multipotency and activate lineage programs. GATA2 maintains progenitor identity and is thought to be progressively silenced as GATA1 levels rise. However, the precise changes in GATA2 chromatin binding kinetics during this transition remain undefined. Here, we combined live-cell single-molecule imaging in cell lines and primary mouse progenitors with CUT&Tag chromatin profiling to define GATA2 activity during erythropoiesis. Single-molecule tracking resolved two interaction modes: short-lived (<1 s) searching interactions and long-lived (>5 s) binding. Surprisingly, early erythroid differentiation was characterized by a transitory strengthening of long-lived GATA2 chromatin engagement. This manifested as increased residence time of GATA2 bound to chromatin in G1E-ER4 cells and an expansion of the long-lived bound population in HPC7 cells and primary mouse progenitors. This transitory phase of enhanced engagement declined upon further differentiation. Genome-wide mapping identified regulatory elements selectively occupied by GATA2 during this early transition state, revealing promoter-proximal sites enriched for GATA/RUNX motifs and distal elements containing composite GATA/E-box signatures. Together, our imaging and chromatin profiling indicate that GATA2 chromatin engagement is kinetically remodeled at the onset of differentiation, with early recruitment targets partitioning into distinct promoter- and enhancer-associated subclasses. These results support a model in which transcription factor kinetics constitute a dynamic chromatin engagement layer that characterizes the GATA2-to-GATA1 transition.
]]></description>
<dc:creator>Hobbs, J. W.</dc:creator>
<dc:creator>Taylor, S. J.</dc:creator>
<dc:creator>Kumari, R.</dc:creator>
<dc:creator>Haque, N.</dc:creator>
<dc:creator>Victor, L.</dc:creator>
<dc:creator>Steidl, U.</dc:creator>
<dc:creator>Coleman, R. A.</dc:creator>
<dc:date>2026-03-06</dc:date>
<dc:identifier>doi:10.64898/2026.03.05.709895</dc:identifier>
<dc:title><![CDATA[Transitory enhancement of GATA2 chromatin engagement during early erythroid differentiation]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2026-03-06</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.64898/2026.03.05.709908v1?rss=1">
<title>
<![CDATA[
Apical spectrin organizes cortical actin filament bundles to pattern C. elegans cuticle ridges 
]]>
</title>
<link>https://biorxiv.org/content/10.64898/2026.03.05.709908v1?rss=1</link>
<description><![CDATA[
The apical extracellular matrix can form elaborate three-dimensional structures on animal surfaces. To better understand the mechanisms that pattern and shape these structures, we focus on development of collagen-rich cuticle ridges (alae) in adult C. elegans. Previous studies suggested that longitudinal actin filament bundles (AFBs) in the lateral seam epidermis specify alae position through a mechanism that involves post-secretory matrix delamination. Here we identify additional components of this highly organized cortical actin network and show that loss of the apical {beta}H-spectrin SMA-1 specifically disrupts organization of the two AFBs that would normally flank the site where the middle alae ridge forms. Correspondingly, sma-1 loss, or mutation of its actin binding domains, also disrupts formation of the middle alae ridge. Ultrastructurally, sma-1 mutants have expanded regions of matrix delamination that can explain middle ridge loss. Together, these data highlight the importance of apical spectrin for organizing a patterned actin network within epithelia and show that, via its effects on actin organization, spectrin can also change the extracellular matrix and its patterns on animal surfaces.
]]></description>
<dc:creator>Sarwar, P. F.</dc:creator>
<dc:creator>Barker, T. J.</dc:creator>
<dc:creator>Nguyen, K. C. Q.</dc:creator>
<dc:creator>Chan, F.-Y.</dc:creator>
<dc:creator>Hall, D. H.</dc:creator>
<dc:creator>Carvalho, A. X.</dc:creator>
<dc:creator>Sundaram, M. V.</dc:creator>
<dc:date>2026-03-09</dc:date>
<dc:identifier>doi:10.64898/2026.03.05.709908</dc:identifier>
<dc:title><![CDATA[Apical spectrin organizes cortical actin filament bundles to pattern C. elegans cuticle ridges]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2026-03-09</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.64898/2026.03.09.710500v1?rss=1">
<title>
<![CDATA[
MEF2A is a negative regulator of β-Cell maturation and function 
]]>
</title>
<link>https://biorxiv.org/content/10.64898/2026.03.09.710500v1?rss=1</link>
<description><![CDATA[
Pancreatic beta cells produce and secrete insulin to maintain glucose homeostasis. Due to their high secretory activity, beta cells rely heavily on endoplasmic reticulum (ER) function and are particularly susceptible to ER stress, which contributes to beta cell dysfunction in diabetes. However, the transcriptional mechanisms linking ER stress to beta cell failure remain poorly understood. In this study, we investigated the role of the transcription factor Mef2a in ER stress-mediated beta cell dysfunction using primary mouse islet cells. ER stress induced by thapsigargin increased Mef2a expression and activated canonical unfolded protein response (UPR) pathways. Overexpression of Mef2a reduced beta cell proliferation, suppressed expression of key beta cell transcription factors including Pdx1, MafA, NeuroD1, and Nkx6.1, and impaired glucose-stimulated insulin secretion. Mef2a overexpression also altered mitochondrial respiration, characterized by reduced glucose-coupled respiration and increased maximal respiratory capacity. In contrast, Mef2a knockdown attenuated ER stress induced activation of ATF6 and IRE1/XBP1 dependent UPR genes. Importantly, reducing Mef2a expression preserved beta cell identity gene expression and improved insulin secretion during ER stress induced by thapsigargin or tunicamycin. Together, these findings identify Mef2a as a stress-responsive regulator that contributes to ER stress-mediated beta cell dysfunction and suggest that modulating Mef2a activity may help preserve beta cell function during metabolic stress.
]]></description>
<dc:creator>Wang, Y.</dc:creator>
<dc:creator>Darko, C.</dc:creator>
<dc:creator>Lama, T. D.</dc:creator>
<dc:creator>Rappa, A.</dc:creator>
<dc:creator>Tessem, J.</dc:creator>
<dc:creator>Sharma, R.</dc:creator>
<dc:date>2026-03-11</dc:date>
<dc:identifier>doi:10.64898/2026.03.09.710500</dc:identifier>
<dc:title><![CDATA[MEF2A is a negative regulator of β-Cell maturation and function]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2026-03-11</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.64898/2026.03.09.710526v1?rss=1">
<title>
<![CDATA[
A novel subset of hepatocytes is simultaneously gluconeogenic and de novo lipogenic in the fed state and is naturally insulin resistant 
]]>
</title>
<link>https://biorxiv.org/content/10.64898/2026.03.09.710526v1?rss=1</link>
<description><![CDATA[
It is generally accepted that hepatic gluconeogenesis, the synthesis of glucose from non-carbohydrate substrates is active in the fasted state and inactive in the fed state. In contrast, de novo lipogenesis is active in the fed state and is inactive in the fasted state. Here, we used targeted single cell RNA-seq, HCR RNA-FISH, and PrimeFlow in normal physiological mouse liver, and identified a subpopulation of periportal hepatocytes that simultaneously co-express both gluconeogenic and lipogenic genes in the fed state. Euglycemic-hyperinsulinemic clamps further demonstrated that this novel hepatocyte subpopulation is naturally insulin resistant. Spatial metabolic imaging coupled with stable isotope tracing analyses revealed individual hepatocytes that simultaneously undergo both gluconeogenesis and de novo lipogenesis. These dual-positive hepatocytes were also present in human hepatocytes from humanized mouse livers. Moreover, the number of dual-positive hepatocytes increased in high-fat diet-fed mice, suggesting a paradigm shift in our understanding of how the liver becomes insulin resistant.
]]></description>
<dc:creator>Okada, J.</dc:creator>
<dc:creator>Landgraf, A.</dc:creator>
<dc:creator>Horton, M.</dc:creator>
<dc:creator>Qiu, Y.</dc:creator>
<dc:creator>Xiaoli, A. M.</dc:creator>
<dc:creator>Ribas, R.</dc:creator>
<dc:creator>Liu, L.</dc:creator>
<dc:creator>Krylova, S. V.</dc:creator>
<dc:creator>Schuster, V. L.</dc:creator>
<dc:creator>Yang, F.</dc:creator>
<dc:creator>Saito, T.</dc:creator>
<dc:creator>Sun, R. C.</dc:creator>
<dc:creator>Hawkins, M.</dc:creator>
<dc:creator>Schwartz, G. J.</dc:creator>
<dc:creator>Eliscovich, C.</dc:creator>
<dc:creator>Shinoda, K.</dc:creator>
<dc:creator>Kurland, I. J.</dc:creator>
<dc:creator>Pessin, J. E.</dc:creator>
<dc:date>2026-03-11</dc:date>
<dc:identifier>doi:10.64898/2026.03.09.710526</dc:identifier>
<dc:title><![CDATA[A novel subset of hepatocytes is simultaneously gluconeogenic and de novo lipogenic in the fed state and is naturally insulin resistant]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2026-03-11</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.64898/2026.03.09.710561v1?rss=1">
<title>
<![CDATA[
In vitro reconstitution of vertebrate Sonic Hedgehog protein cholesterolysis 
]]>
</title>
<link>https://biorxiv.org/content/10.64898/2026.03.09.710561v1?rss=1</link>
<description><![CDATA[
Extracellular secretion of the oncogenic sonic hedgehog signaling ligand is contingent on its release from a precursor protein through peptide bond cholesterolysis, mediated by the hedgehog C-terminal domain, SHhC. In this work, we describe the in vitro reconstitution of cholesterolysis activity for SHhC domains from vertebrate model organisms, Xenopus laevis (Xla) and Danio rerio (Dre). Cholesterolysis is assayed continuously in multi-well plates by monitoring changes in fluorescence resonance energy transfer (FRET) from an engineered precursor construct, expressed in E. coli and purified in soluble form. Using this FRET assay, we found that Xla and Dre SHhC exhibit high substrate stereospecificity, accepting cholesterol, (KM, 1-2 {micro}M, cholesterolysis t1/2 of [~]11 min) while rejecting the 3-alpha epimer, epi-cholesterol (KM > 100 {micro}M, t1/2 > 10 hr). By screening a 96-member detergent/surfactant library for compatibility with SHhC activity, we identify cationic detergents that inhibit cholesterolysis and find a shared preference for the zwitterionic n-dodecyl-phosphocholine (DPC, Fos-choline-12), which supported the fastest reaction kinetics. Lastly, we report that alanine point mutation at a conserved aspartate residue (D46A) in Xla SHhC and Dre SHhC blocks cholesterolysis; however, activity could be chemically rescued with rationally designed hyper-nucleophilic sterols. Of those sterols, 2-beta carboxy cholestanol was active as a substrate with D46A variants only; the remaining sterols were accepted by both D46A and wild-type SHhC. In summary, we have established the first in vitro kinetic assay to continuously monitor enzymatic activity of wild-type and mutant vertebrate SHhC domains in multi-well plates, a key step toward pharmacological manipulation of Sonic hedgehog protein biosynthesis in vivo.
]]></description>
<dc:creator>Seidel, D. C.</dc:creator>
<dc:creator>Wagner, A. G.</dc:creator>
<dc:creator>Pezzullo, J. L.</dc:creator>
<dc:creator>Thayer, K. A.</dc:creator>
<dc:creator>Beadle, S.</dc:creator>
<dc:creator>Olejarczyk, M. L.</dc:creator>
<dc:creator>Giner, J.-L.</dc:creator>
<dc:creator>Callahan, B. P.</dc:creator>
<dc:date>2026-03-11</dc:date>
<dc:identifier>doi:10.64898/2026.03.09.710561</dc:identifier>
<dc:title><![CDATA[In vitro reconstitution of vertebrate Sonic Hedgehog protein cholesterolysis]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2026-03-11</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.64898/2026.03.12.711373v1?rss=1">
<title>
<![CDATA[
HTLV-1-Induced Neuroimmunome Correlates with Disease Progression and Severity 
]]>
</title>
<link>https://biorxiv.org/content/10.64898/2026.03.12.711373v1?rss=1</link>
<description><![CDATA[
Human T-cell lymphotropic virus type 1 (HTLV-1) is a retrovirus that infects approximately 5-10 million people worldwide. While most individuals remain asymptomatic, a significant subset develops debilitating neuroinflammatory or malignant disorders, including adult T-cell leukemia/lymphoma (ATL) and HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). To unravel the systemic molecular mechanisms underlying HTLV-1 pathogenesis, we employed a multi-dimensional systems biology approach, integrating bulk transcriptomic data from total PBMCs (n = 200) with single-cell RNA sequencing (scRNA-seq) from 233,093 peripheral blood mononuclear cells (PBMCs). Our analysis revealed a consistent and clinically relevant neuroimmune signature within leukocytes, termed the neuroimmunome, comprising a set of differentially expressed genes shared across the nervous and immune systems. Through dimensionality reduction and machine learning techniques, such as PCA, gradient boosting, and MANOVA with bootstrapping, we identified potential biomarkers predictive of HTLV-1-driven leukemogenesis, which were subsequently validated across ATL, HAM/TSP, and asymptomatic cohorts via flow cytometry. Notably, expression levels of proteins such as ATF4 and SKIL were strongly correlated with proviral load, suggesting that sustained neuroimmune dysregulation may contribute to disease progression. These findings highlight a previously underappreciated neuroimmunological layer, redefining HTLV-1-associated disease as a condition deeply rooted in neuroimmune network disruption within leukocytes and offering potential novel targets.
]]></description>
<dc:creator>Vale, F. Y. d. N.</dc:creator>
<dc:creator>Miranda Sole, C.</dc:creator>
<dc:creator>Leal Nobile, A.</dc:creator>
<dc:creator>Usuda, J. N.</dc:creator>
<dc:creator>Fonseca, D. L. M.</dc:creator>
<dc:creator>Schimke, L. F.</dc:creator>
<dc:creator>Morais, M. C. C.</dc:creator>
<dc:creator>Freitas, D. G. d. A.</dc:creator>
<dc:creator>Adri, A. S.</dc:creator>
<dc:creator>Nava, R. G.</dc:creator>
<dc:creator>Correa, Y. L. G.</dc:creator>
<dc:creator>Nery do Vale, H. F. N. d. V. F.</dc:creator>
<dc:creator>Nakaya, H. I.</dc:creator>
<dc:creator>Dalmolin, R. J. S. D. J. S.</dc:creator>
<dc:creator>Dias, H. D.</dc:creator>
<dc:creator>Saito, Y.</dc:creator>
<dc:creator>Kogure, Y.</dc:creator>
<dc:creator>Koya, J.</dc:creator>
<dc:creator>Kataoka, K.</dc:creator>
<dc:creator>Filgueiras, I. S.</dc:creator>
<dc:creator>Dominguez Villar, M.</dc:creator>
<dc:creator>Cabral Marques, O.</dc:creator>
<dc:date>2026-03-12</dc:date>
<dc:identifier>doi:10.64898/2026.03.12.711373</dc:identifier>
<dc:title><![CDATA[HTLV-1-Induced Neuroimmunome Correlates with Disease Progression and Severity]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2026-03-12</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.64898/2026.03.10.710898v1?rss=1">
<title>
<![CDATA[
STEVE: Single-cell Transcriptomics Expression Visualization and Evaluation 
]]>
</title>
<link>https://biorxiv.org/content/10.64898/2026.03.10.710898v1?rss=1</link>
<description><![CDATA[
Single-cell RNA sequencing (scRNA-seq) has become a key technology for characterizing cell-type heterogeneity in complex tissues. However, its utility depends on accurate and reproducible cell-type annotation, which remains a major analytical challenge. Although hundreds of computational tools have been developed for automated annotation, there is currently no systematic framework to evaluate annotation robustness in a dataset-specific manner or within the context of complete analytical pipelines. Here, we present STEVE (Single-cell Transcriptomics Expression Visualization and Evaluation), a quantitative framework designed to assess the accuracy, robustness, and reproducibility of cell-type annotation in scRNA-seq studies. STEVE implements three complementary in silico evaluation modules: (i) Subsampling Evaluation to quantify annotation stability under varying reference sizes and data partitions; (ii) Novel Cell Evaluation to assess the ability to detect previously unseen cell types; and (iii) Annotation Benchmarking to compare alternative annotation tools against ground-truth labels. In addition, STEVE includes a Reference Transfer Annotation module that enables cross-dataset cell-type mapping using external reference datasets. All modules are built upon a unified probabilistic framework that provides consistent confidence estimation across evaluation scenarios. We evaluated STEVE across four independent scRNA-seq datasets with experimentally defined or expert-curated cell-type labels. Our results show that annotation robustness is strongly influenced by the annotation method, biological separability, dataset complexity, and batch effects. STEVE provides a practical framework for quantifying annotation uncertainty and improving reproducibility in single-cell transcriptomic analyses. STEVE is freely available at GitHub (https://github.com/XiaoDongLab/STEVE).
]]></description>
<dc:creator>Torbenson, E. J.</dc:creator>
<dc:creator>Ma, X.</dc:creator>
<dc:creator>Lin, J.-R.</dc:creator>
<dc:creator>Garry, D.</dc:creator>
<dc:creator>Jameson, S. C.</dc:creator>
<dc:creator>Zhang, Z.</dc:creator>
<dc:creator>Niedernhofer, L. J.</dc:creator>
<dc:creator>Zhang, L.</dc:creator>
<dc:creator>Li, M.</dc:creator>
<dc:creator>Dong, X.</dc:creator>
<dc:date>2026-03-13</dc:date>
<dc:identifier>doi:10.64898/2026.03.10.710898</dc:identifier>
<dc:title><![CDATA[STEVE: Single-cell Transcriptomics Expression Visualization and Evaluation]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2026-03-13</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.64898/2026.03.11.711061v1?rss=1">
<title>
<![CDATA[
Multiscale conformational sampling of multidomain fusion proteins by a physics informed diffusion model 
]]>
</title>
<link>https://biorxiv.org/content/10.64898/2026.03.11.711061v1?rss=1</link>
<description><![CDATA[
Multidomain fusion proteins, such as bispecific antibodies, rely on highly flexible linker regions for their therapeutic efficacy. Characterizing these vast conformational ensembles is crucial for rational drug design; however, while all-atom molecular dynamics (MD) is the traditional gold standard, its immense computational cost makes simulating large-scale domain motions prohibitive. Recently, deep generative diffusion models have emerged as a rapid alternative for sampling protein dynamics. Yet, being trained primarily on massive databases of structured, static domains, these generic models often lack the biophysical constraints required to thoroughly sample the large-scale dynamics of highly flexible multidomain architectures. To overcome this, we leverage microsecond MD trajectories of a multidomain protein construct with various linkers to train a multiscale diffusion framework utilizing an Equivariant Graph Neural Network (EGNN). To efficiently model the dynamics of the large molecular complexes, we employ a coarse-grained spatial graph that condenses rigid domains into center-of-mass anchors while preserving explicit backbone resolution for the flexible linker. By further integrating foundational rules in biophysics directly into both the training objective and the inference process, our model generates high-fidelity conformational ensembles that reproduce the thermodynamic distributions of long-timescale MD. This physics-informed approach provides a mathematically stable, highly scalable platform for the rapid multiscale characterization of flexible biologics, significantly accelerating the rational design of fusion protein therapeutics.
]]></description>
<dc:creator>Su, Z.</dc:creator>
<dc:creator>Wang, B.</dc:creator>
<dc:creator>Wu, Y.</dc:creator>
<dc:date>2026-03-13</dc:date>
<dc:identifier>doi:10.64898/2026.03.11.711061</dc:identifier>
<dc:title><![CDATA[Multiscale conformational sampling of multidomain fusion proteins by a physics informed diffusion model]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2026-03-13</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.64898/2026.03.13.711665v1?rss=1">
<title>
<![CDATA[
The extracellular matrix gene mec-9 regulates C. elegans sensory cilia 
]]>
</title>
<link>https://biorxiv.org/content/10.64898/2026.03.13.711665v1?rss=1</link>
<description><![CDATA[
Cilia are critical sensory organelles that project from the cell surface into the tissue environment, where they are surrounded by extracellular matrix (ECM). Abnormal ECM and fibrosis are two hallmarks of ciliopathies, yet the relationship between cilia and ECM is not well understood. Using the sense organs of C. elegans as a model, we found that a neomorphic mutation in the ECM gene mec-9 impacts sensory cilia function, ciliary protein localization, microtubule ultrastructure, and shedding of ciliary extracellular vesicles (EVs). We show that mec-9 is not expressed in EV releasing neurons, but rather by companion neurons in the sense organs, and may act cell non-autonomously. Our studies reveal pleiotropic roles for mec-9 in the C. elegans ciliated nervous system and provide an in vivo model to study the relationship between cilia and ECM.
]]></description>
<dc:creator>Jacobs, K. C.</dc:creator>
<dc:creator>De Vore, D. M.</dc:creator>
<dc:creator>Knobel, K. M.</dc:creator>
<dc:creator>Walsh, J. D.</dc:creator>
<dc:creator>Das, A.</dc:creator>
<dc:creator>Dobossy, L. M.</dc:creator>
<dc:creator>Nikonorova, I. A.</dc:creator>
<dc:creator>Nguyen, K. C. Q.</dc:creator>
<dc:creator>Goodman, M. B.</dc:creator>
<dc:creator>Hall, D. H.</dc:creator>
<dc:creator>Barr, M. M.</dc:creator>
<dc:date>2026-03-16</dc:date>
<dc:identifier>doi:10.64898/2026.03.13.711665</dc:identifier>
<dc:title><![CDATA[The extracellular matrix gene mec-9 regulates C. elegans sensory cilia]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2026-03-16</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.64898/2026.03.13.711672v1?rss=1">
<title>
<![CDATA[
ATM functions as a rheostat of metabolic stress in small-cell lung cancer 
]]>
</title>
<link>https://biorxiv.org/content/10.64898/2026.03.13.711672v1?rss=1</link>
<description><![CDATA[
ATM is best known as a guardian of genomic stability, yet its contributions to oncogenic signaling in aggressive malignancies like small-cell lung cancer (SCLC) remain poorly understood. Despite ATM being an established clinical vulnerability in SCLC, its influence on dysregulated tumorigenic circuits remains unclear. We demonstrate that inhibition of ATM disrupts the AKT-mTORC1-4EBP1 signaling axis, leading to attenuation of the master regulator of stress, ATF4. ATF4 and MYC appear to co-regulate one another in a feedback loop critical for redox homeostasis. ATM inhibition perturbs both the expression and function of MYC and ATF4, leading to increased intracellular reactive oxygen species, impaired glutathione recycling, and ferroptotic cell death, thereby exposing a crucial dependency of SCLC on stress-adaptive signaling. We uncover previously unrecognized metabolic vulnerability in SCLC, nominating ATM as a regulator of adaptive stress, expanding its role beyond canonical DNA damage repair (DDR) and highlighting therapeutically exploitable opportunities in aggressive tumors.

Statement of SignificanceThe metabolic landscape of SCLC remains poorly characterized, particularly its interaction with dysregulated signaling networks, limiting the development of effective strategies to overcome therapeutic resistance. Our work reveals an expanded role for ATM beyond DNA repair, positioning it as a key regulator of metabolic rewiring and highlighting new therapeutic opportunities for SCLC.
]]></description>
<dc:creator>Halder, D.</dc:creator>
<dc:creator>Sen, U. D.</dc:creator>
<dc:creator>Jethalia, V.</dc:creator>
<dc:creator>Chakraborty, S.</dc:creator>
<dc:creator>Elliott, A.</dc:creator>
<dc:creator>Ventura, K.</dc:creator>
<dc:creator>Vanderwalde, A.</dc:creator>
<dc:creator>Halmos, B.</dc:creator>
<dc:creator>Borghaei, H.</dc:creator>
<dc:creator>Thin, T. H.</dc:creator>
<dc:creator>Soto, A.</dc:creator>
<dc:creator>Berisa, M.</dc:creator>
<dc:creator>Brody, R.</dc:creator>
<dc:creator>Demircioglu, D.</dc:creator>
<dc:creator>Hasson, D.</dc:creator>
<dc:creator>Sen, T.</dc:creator>
<dc:date>2026-03-17</dc:date>
<dc:identifier>doi:10.64898/2026.03.13.711672</dc:identifier>
<dc:title><![CDATA[ATM functions as a rheostat of metabolic stress in small-cell lung cancer]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2026-03-17</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.64898/2026.03.16.712104v1?rss=1">
<title>
<![CDATA[
A Multiscale Computational Architecture to Study Signaling Dynamics at Cell-Cell Interfaces 
]]>
</title>
<link>https://biorxiv.org/content/10.64898/2026.03.16.712104v1?rss=1</link>
<description><![CDATA[
Intercellular communication is governed by the spatiotemporal dynamics of protein complexes at the cell-cell interface. However, conventional static interaction models fail to incorporate key physical constraints, such as steric hindrance, spatial compartmentalization, and dimensionality reduction that regulate complex assembly in vivo. To bridge the gap between static network topology and dynamic systems biology, we developed a multi-scale computational framework. We first identified a highly conserved, Fibroblast Growth Factor Receptor 1 (FGFR1)-centered cell adhesion and signaling motif by analyzing a diverse set of human cell-cell interfaces. We then constructed a multi-layer spatial stochastic simulator to recapitulate and interrogate the dynamic behavior of this network motif at cell-cell interfaces. Atomic-resolution structural models of the protein complexes within the motif were further generated using AlphaFold to define interaction rules for the stochastic simulations by categorizing binding interfaces. Our results show that the structural arrangement of cell-cell adhesion complexes controls how FGFR1 receptors cluster at the cell-cell interface, effectively dividing the membrane into distinct functional microdomains. Competition from decoy receptors further regulates this process by capturing receptors before they can participate in signaling. Even small changes in binding affinity can therefore alter receptor organization and disrupt normal signal transduction, which may contribute to human disease. By integrating macro-scale interactomics, atomic-level structural bioinformatics, and mesoscale stochastic modeling, this study reveals how structural interaction rules, combined with spatial constraints, shape the formation and function of intercellular signaling networks.
]]></description>
<dc:creator>Wu, Y.</dc:creator>
<dc:date>2026-03-18</dc:date>
<dc:identifier>doi:10.64898/2026.03.16.712104</dc:identifier>
<dc:title><![CDATA[A Multiscale Computational Architecture to Study Signaling Dynamics at Cell-Cell Interfaces]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2026-03-18</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.64898/2026.03.18.712743v1?rss=1">
<title>
<![CDATA[
Targeting MTHFD2 disrupts mitochondrial redox homeostasis and restores venetoclax sensitivity in acute myeloid leukemia 
]]>
</title>
<link>https://biorxiv.org/content/10.64898/2026.03.18.712743v1?rss=1</link>
<description><![CDATA[
One-carbon metabolism is frequently dysregulated in human cancer including acute myeloid leukemia. However, the mitochondrial mechanisms by which one-carbon enzymes support leukemia survival and therapeutic response remain incompletely defined. Here, we report that the one-carbon metabolism enzyme MTHFD2 is a critical regulator of acute myeloid leukemia nucleotide metabolism, redox homeostasis, and disease progression. We show that genetic ablation of MTHFD2 suppresses acute myeloid leukemia cell proliferation in vitro and significantly delays leukemia onset in a genetically engineered mouse model, while sparing healthy hematopoietic stem and progenitor cell function. Stable isotope tracing demonstrates that MTHFD2 supports de novo purine synthesis and sustains mitochondrial NADH and NADPH production. Consistent with this role, MTHFD2 inhibition increases mitochondrial superoxide levels, and combined purine supplementation and mitochondrial reactive oxygen species neutralization rescues acute myeloid leukemia cell viability. We also demonstrate that the small-molecule inhibitor DS18561882 directly inhibits mitochondrial MTHFD2 activity and phenocopies genetic deletion. DS18561882 exhibits activity across a cohort of 60 primary AML patient samples, synergizes with venetoclax in treatment-naive acute myeloid leukemia, and restores venetoclax sensitivity in resistant AML models. These findings establish mitochondrial MTHFD2 as a genetically validated, therapeutically targetable metabolic vulnerability in acute myeloid leukemia and support targeting mitochondrial one-carbon metabolism to enhance and restore venetoclax response.
]]></description>
<dc:creator>Sokei, J. O.</dc:creator>
<dc:creator>di Martino, O.</dc:creator>
<dc:creator>Basse, M.</dc:creator>
<dc:creator>Gabriel, N.</dc:creator>
<dc:creator>Valin, L.</dc:creator>
<dc:creator>York, C. R.</dc:creator>
<dc:creator>Arthur, N. B. J.</dc:creator>
<dc:creator>Zhang, W.</dc:creator>
<dc:creator>Goldman, A. R.</dc:creator>
<dc:creator>Ferraro, F.</dc:creator>
<dc:creator>Sykes, S. M.</dc:creator>
<dc:date>2026-03-20</dc:date>
<dc:identifier>doi:10.64898/2026.03.18.712743</dc:identifier>
<dc:title><![CDATA[Targeting MTHFD2 disrupts mitochondrial redox homeostasis and restores venetoclax sensitivity in acute myeloid leukemia]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2026-03-20</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.64898/2026.03.23.713644v1?rss=1">
<title>
<![CDATA[
Understanding the neurocognitive impact of outdoor PM10 and PM2.5 exposure: an in silico dosimetric modeling study using MPPD 
]]>
</title>
<link>https://biorxiv.org/content/10.64898/2026.03.23.713644v1?rss=1</link>
<description><![CDATA[
Air pollution has been increasingly linked to adverse neurodevelopmental and neurodegenerative outcomes. While experimental and preclinical studies suggest that exposure to particulate matter (PM), particularly during gestation, may disrupt cognitive development, the impact of short-term PM exposure on cognitive and behavioral functioning in healthy young populations remains insufficiently explored in Spain. Moreover, few studies have incorporated individualized dosimetry models to estimate exposure more accurately. This study included 186 healthy young adults (mean age = 20.4 years) recruited from three Spanish cities (Teruel, Almeria, and Talavera) characterized by different pollution levels. Ambient fine and coarse PM concentrations were recorded 8, 15, and 30 days prior to psychological assessment. Instead of relying solely on raw in situ environmental measurements, individualized PM deposition was estimated using the Multiple-Path Particle Dosimetry Model (MPPD), allowing a more biologically meaningful exposure approximation. Psychological outcomes were assessed using validated questionnaires: DASS-21 (depression, anxiety, stress), BIS-11 (impulsivity), UCLA Loneliness Scale, and SWLS (life satisfaction). Behavioral performance was evaluated using computerized versions of the Attentional Network Task (ANT) and the Stroop Task. Blood NRF2 concentrations were analyzed as a biomarker potentially related to oxidative stress mechanisms. In situ data indicated that Talavera presented the highest pollution levels, followed by Almeria and Teruel. Linear regression analyses showed that coarse PM exposure across 8-, 15-, and 30-day windows significantly predicted poorer Executive Control Index performance in the ANT. Additionally, 15-day coarse PM and 30-day fine PM exposure were associated with greater cognitive interference. Oxidative stress markers were significantly associated with PM exposure levels. These findings support emerging evidence that short-term PM exposure may negatively affect executive and attentional processes even in healthy young adults. Further longitudinal research incorporating individualized exposure modeling is warranted to clarify causal pathways and underlying biological mechanisms.

Graphical Abstract

O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=97 SRC="FIGDIR/small/713644v1_ufig1.gif" ALT="Figure 1">
View larger version (79K):
org.highwire.dtl.DTLVardef@1a0ac13org.highwire.dtl.DTLVardef@1812accorg.highwire.dtl.DTLVardef@120bf07org.highwire.dtl.DTLVardef@dd9a7c_HPS_FORMAT_FIGEXP  M_FIG C_FIG
]]></description>
<dc:creator>Ruiz Sobremazas, D.</dc:creator>
<dc:creator>Cativiela-Campos, B.</dc:creator>
<dc:creator>Cadalso, M.</dc:creator>
<dc:creator>Barrasa, A.</dc:creator>
<dc:creator>Catalan-Edo, P.</dc:creator>
<dc:creator>Perez-Fernandez, C.</dc:creator>
<dc:creator>Ferrer Villahoz, B.</dc:creator>
<dc:creator>Sanchez-Santed, F.</dc:creator>
<dc:creator>Colomina, T.</dc:creator>
<dc:creator>Lopez-Granero, C.</dc:creator>
<dc:date>2026-03-25</dc:date>
<dc:identifier>doi:10.64898/2026.03.23.713644</dc:identifier>
<dc:title><![CDATA[Understanding the neurocognitive impact of outdoor PM10 and PM2.5 exposure: an in silico dosimetric modeling study using MPPD]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2026-03-25</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.64898/2026.03.24.713941v1?rss=1">
<title>
<![CDATA[
OPTIMIS: Optimizing Personalized Therapies through Integrated Multiscale Intelligent Simulation 
]]>
</title>
<link>https://biorxiv.org/content/10.64898/2026.03.24.713941v1?rss=1</link>
<description><![CDATA[
Controlling complex biological systems across multiple scales remains a major challenge in computational medicine, because whole-body disease behavior is closely shaped by noisy cellular events at much smaller scales. Standard deterministic models often miss this molecular variability, while fully stochastic simulations are too slow for the repeated, high-throughput interactions needed to train artificial intelligence. To address this problem, we developed a new AI-based framework that combines a discrete stochastic Gillespie algorithm for microscale receptor dynamics with continuous, nonlinear ordinary differential equations for systemic macroscale behavior. To reach the speed needed for deep reinforcement learning (RL), we compress this hybrid system into a differentiable Neural ODE surrogate that acts as a fast digital twin. As a proof of concept, we applied this framework to engineered cellular therapy and used RL agents to learn dynamic, closed-loop treatment policies inside the surrogate environment. By tracking microscopic, unpredictable cellular activity as an early-warning signal, the AI learned to continuously adjust the drug dose--anticipating and stopping dangerous immune reactions before they could spiral out of control. This computational advance improved successful control rates to more than 70% in highly unstable simulated phenotypes and provides a practical, general framework for adaptive intervention in multiscale biological systems.
]]></description>
<dc:creator>Su, Z.</dc:creator>
<dc:creator>Wu, Y.</dc:creator>
<dc:date>2026-03-26</dc:date>
<dc:identifier>doi:10.64898/2026.03.24.713941</dc:identifier>
<dc:title><![CDATA[OPTIMIS: Optimizing Personalized Therapies through Integrated Multiscale Intelligent Simulation]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2026-03-26</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.64898/2026.03.25.714015v1?rss=1">
<title>
<![CDATA[
Frontal theta phase modulates asymmetric posterior neural mechanisms of spatial attention 
]]>
</title>
<link>https://biorxiv.org/content/10.64898/2026.03.25.714015v1?rss=1</link>
<description><![CDATA[
Selective attention enables prioritization of behaviorally relevant information through coordinated control of neural excitability. Although theta-band (3-7 Hz) rhythms are implicated in top-down attentional sampling in non-human primates, how intrinsic theta phase organizes sensory gain and behavior in humans, and whether this control operates symmetrically across hemispheres, remains unknown. We recorded electroencephalography (EEG) and pupillometry in typically developing human participants (n = 21; 14.7 {+/-} 3.8 YO) performing a covert spatial attention task. Behaviorally, participants responded faster during leftward relative to rightward attention. This behavioral asymmetry was paralleled in the neural data: anticipatory modulation of parieto-occipital alpha and beta power emerged selectively during leftward attention, whereas rightward attention did not recruit comparable posterior oscillatory processes.

Mechanistically, ipsilateral fronto-central theta phase emerged as a potential driver of this asymmetry. Intrinsic theta phase predicted trial-by-trial reaction time (RT) in a cue-direction-specific manner. During leftward attention, 3-Hz theta-phase over left fronto-central cortex modulated behavior and was significantly coupled to coordinated posterior alpha-band activity. In contrast, 6-7-Hz theta-phase over right fronto-central cortex modulated behavior during rightward attention but showed no relationship with alpha or beta modulation; instead, it modulated early sensory gain, indexed by P1 amplitude. Consistent with these distinct architectures, RT was jointly predicted by lower pre-stimulus alpha power and higher P1 amplitude over the attended hemisphere during leftward attention, whereas only P1 amplitude predicted performance during rightward attention. Resting-state alpha power did not differ across hemispheres, indicating that these effects were task-evoked rather than baseline spectral differences. Critically, older participants, who demonstrated enhanced behavioral performance, also exhibited a larger hemispheric asymmetry. Together, these findings reveal developmentally emerging, direction-specific neural control dynamics underlying human spatial attention.

Significance StatementSpatial attention is often assumed to rely on symmetric neural mechanisms across left and right space. Using EEG in typically developing children and adolescents, we show that intrinsic theta rhythms organize attention through direction-specific control architectures. Leftward attention engages slower frontal theta (3-Hz) that coordinates posterior alpha and beta activity, consistent with oscillatory sensory gating. Rightward attention instead relies on faster theta (6-7-Hz) that modulates early sensory responses without coordinated alpha dynamics. These asymmetric mechanisms occur despite lack of hemispheric differences in resting alpha activity, indicating that they emerge during active control rather than reflecting baseline biases. These findings reveal that human attentional sampling is rhythmically organized but fundamentally asymmetric across space.
]]></description>
<dc:creator>Darrell, M.</dc:creator>
<dc:creator>Vanneau, T.</dc:creator>
<dc:creator>Brittenham, C.</dc:creator>
<dc:creator>Foxe, J. J.</dc:creator>
<dc:creator>Molholm, S. J.</dc:creator>
<dc:date>2026-03-27</dc:date>
<dc:identifier>doi:10.64898/2026.03.25.714015</dc:identifier>
<dc:title><![CDATA[Frontal theta phase modulates asymmetric posterior neural mechanisms of spatial attention]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2026-03-27</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.64898/2026.03.26.711344v1?rss=1">
<title>
<![CDATA[
Acute degron-mediated RUNX1 loss reprograms enhancer activity to epigenetically drive epithelial destabilization and initiate cancer hallmarks 
]]>
</title>
<link>https://biorxiv.org/content/10.64898/2026.03.26.711344v1?rss=1</link>
<description><![CDATA[
The RUNX1 transcription factor mediates cell-type specific gene expression. RUNX1 suppression and perturbations are recurrently associated with breast tumor initiation and progression. However, the mechanisms governing the dual roles of RUNX1 in sustaining the mammary epithelial phenotype while epigenetically suppressing initiation of cancer-compromised gene expression are poorly understood. To address this, we used the power of degron-mediated acute, selective, and complete RUNX1 ablation in human mammary epithelial cells. RUNX1 mediates promoter and distal enhancer-driven expression of a gene cohort. Dynamic epigenomic responsiveness upon RUNX1 ablation reveals a rapid and selective decrease in chromatin accessibility and H3K27ac at RUNX1-bound enhancers, but not promoters. While differentially initiated and expressed genes contacted by RUNX1-bound enhancers are enriched in pathways involved in epithelial maintenance and stemness, genes with RUNX1-promoter occupancy support DNA damage responsiveness. Modified cell morphology, metabolic control, increased breast cancer stemness, plasticity, anchorage-independent survival, chemoresistance, and perturbed DNA damage reactivity are observed upon RUNX1 ablation. Together, these findings define RUNX1 as an epigenetic tumor suppressor that maintains epithelial cell state by preserving enhancer activity and preventing gene expression associated with hallmarks of cancer.
]]></description>
<dc:creator>Fritz, A.</dc:creator>
<dc:creator>Greenyer, H.</dc:creator>
<dc:creator>Dillac, L.</dc:creator>
<dc:creator>Chavarkar, P.</dc:creator>
<dc:creator>Ullah, R.</dc:creator>
<dc:creator>Malik, M.</dc:creator>
<dc:creator>Hong, D.</dc:creator>
<dc:creator>Toor, R.</dc:creator>
<dc:creator>Pacht, E.</dc:creator>
<dc:creator>Person, A.</dc:creator>
<dc:creator>Zotkin, G.</dc:creator>
<dc:creator>Korzec, S.</dc:creator>
<dc:creator>Gao, C.</dc:creator>
<dc:creator>Abuarqoub, A.</dc:creator>
<dc:creator>Warren, J.</dc:creator>
<dc:creator>Del Porto, J.</dc:creator>
<dc:creator>Perelman, J.</dc:creator>
<dc:creator>Montecino, M.</dc:creator>
<dc:creator>Lian, J.</dc:creator>
<dc:creator>Van Wijnen, A.</dc:creator>
<dc:creator>Heath, J.</dc:creator>
<dc:creator>Ghule, P.</dc:creator>
<dc:creator>Frietze, S.</dc:creator>
<dc:creator>Stengal, K.</dc:creator>
<dc:creator>Reed, K. S. M.</dc:creator>
<dc:creator>Misteli, T.</dc:creator>
<dc:creator>Gordon, J.</dc:creator>
<dc:creator>Stein, J.</dc:creator>
<dc:creator>Stein, G.</dc:creator>
<dc:date>2026-03-28</dc:date>
<dc:identifier>doi:10.64898/2026.03.26.711344</dc:identifier>
<dc:title><![CDATA[Acute degron-mediated RUNX1 loss reprograms enhancer activity to epigenetically drive epithelial destabilization and initiate cancer hallmarks]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2026-03-28</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.64898/2026.03.27.714773v1?rss=1">
<title>
<![CDATA[
IDBSpred: An intrinsically disordered binding site predictor using machine learning and protein language model 
]]>
</title>
<link>https://biorxiv.org/content/10.64898/2026.03.27.714773v1?rss=1</link>
<description><![CDATA[
Intrinsically disordered proteins (IDPs) mediate many cellular functions through interactions with structured protein partners, but predicting the corresponding binding sites on the structured partner remains challenging. Here, we present IDBSpred, a sequence-based method for residue-level prediction of IDP-binding sites on structured proteins. Training and test data were collected from the DIBS database, which contains more than 700 non-redundant IDP-protein complexes. Residue-level embeddings of structured partner sequences were generated using the ESM-2 protein language model and used as input to a multilayer perceptron classifier for binary prediction of binding versus non-binding residues. Analysis of amino acid composition showed that IDP-binding sites are enriched in aromatic residues, especially Trp, Tyr, and Phe, as well as several charged and polar residues, whereas Ala and several small or conformationally restrictive residues are depleted. The classifier achieved an ROC AUC of 0.87 and an average precision of 0.61. Structural case studies further showed that the predicted sites largely recapitulate the major experimentally defined binding interfaces. These results demonstrate that protein language model embeddings plus machine learning algorithms can effectively capture sequence features associated with IDP recognition on structured proteins. IDBSpred provides a practical framework for studying IDP-mediated interfaces and identifying potential therapeutic hotspots.
]]></description>
<dc:creator>Jones, D.</dc:creator>
<dc:creator>Wu, Y.</dc:creator>
<dc:date>2026-03-30</dc:date>
<dc:identifier>doi:10.64898/2026.03.27.714773</dc:identifier>
<dc:title><![CDATA[IDBSpred: An intrinsically disordered binding site predictor using machine learning and protein language model]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2026-03-30</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.64898/2026.03.30.715297v1?rss=1">
<title>
<![CDATA[
Neural Responses to Unexpected Stimulus Repetitions and Omissions in Auditory Cortex Provide Mixed Evidence for Predictive Coding 
]]>
</title>
<link>https://biorxiv.org/content/10.64898/2026.03.30.715297v1?rss=1</link>
<description><![CDATA[
Humans and other animals process sensory uncertainty by integrating stimulus information with prior knowledge and expectations. Predictive coding conceptualizes perception as a form of Bayesian inference wherein hierarchical brain circuits update internal models to reconcile bottom-up sensory input with top-down predictions. Whereas predictive coding is a leading theory, the extent to which it is implemented in primary sensory cortices remains a matter of debate. To further investigate this issue, we examined single-neuron spiking activity in macaque primary auditory cortex (A1) to expected versus unexpected stimulus repetitions and to expected versus unexpected omissions. On average, we found that A1 neurons did not show enhanced responses to unexpected stimulus repetitions, contrary to predictive-coding theory. However, they did show enhanced responses to unexpected stimulus omissions. Taken together, these mixed results place empirical restraints on how PC is implemented in A1.

Significance StatementPerception depends on the brains ability to infer the causes of sensory inputs by integrating new information with prior knowledge under uncertainty. Our results reveal nuanced evidence for predictive coding within the primary auditory cortex (A1). Specifically, spiking activity during unexpected stimuli and unexpected stimulus omissions provide conflicting and supporting, respectively, data for this Bayesian framework. These findings refine our understanding of neural mechanisms underlying perception and provide empirical constraints on the neurobiological implementation of predictive processing.
]]></description>
<dc:creator>Shukla, B.</dc:creator>
<dc:creator>Shirley, H.</dc:creator>
<dc:creator>Goodovitch, L.</dc:creator>
<dc:creator>Fishman, Y.</dc:creator>
<dc:creator>Cohen, Y.</dc:creator>
<dc:date>2026-04-01</dc:date>
<dc:identifier>doi:10.64898/2026.03.30.715297</dc:identifier>
<dc:title><![CDATA[Neural Responses to Unexpected Stimulus Repetitions and Omissions in Auditory Cortex Provide Mixed Evidence for Predictive Coding]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2026-04-01</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.64898/2026.03.31.715637v1?rss=1">
<title>
<![CDATA[
Short-term synaptic plasticity at neuron-OPC synapses in the corpus callosum during postnatal development of mice: experimental and computational study 
]]>
</title>
<link>https://biorxiv.org/content/10.64898/2026.03.31.715637v1?rss=1</link>
<description><![CDATA[
Neuronal circuits rely on precisely timed synaptic transmission and plasticity, which are established through activity-dependent maturation during development. While these processes are well characterized at neuronal synapses, far less is known about how synaptic communication between neurons and glial cells develops. Pyramidal cortical neurons project axons through white matter where they release glutamate ectopically along their shafts and form glutamatergic synapses with oligodendrocyte precursor cells (OPCs). The functional maturation of these neuron-glia connections remains unknown. Here, using single-cell electrophysiology combined with computational modelling, we show that neuron-OPC synapses in the mouse corpus callosum undergo a pronounced developmental transformation in short-term synaptic plasticity. During the first two postnatal months, these synapses switch from strong synaptic depression to facilitation. This transition is accompanied by a shortening of synaptic delay and a reduction in asynchronous glutamate release, indicating an increase in temporal precision of neurotransmitter signalling in white matter. Computational modelling suggests that both pre- and postsynaptic changes may underlie this functional maturation. Taken together, our findings demonstrate that neuron-OPC synapses in white matter are not static but undergo developmental transition towards facilitation and temporally precise transmission that parallels the maturation trajectory of classical neuronal synapses in cortical grey matter. These results identify neuron-glia synapses in white matter as dynamic elements of developing neural circuits, and suggest that synaptic release machineries at axonal shafts in white matter and synaptic boutons in grey matter mature in a similar fashion.
]]></description>
<dc:creator>Kula, B.</dc:creator>
<dc:creator>Chen, T.-J.</dc:creator>
<dc:creator>Nagy, B.</dc:creator>
<dc:creator>Hovhannisyan, A.</dc:creator>
<dc:creator>Terman, D.</dc:creator>
<dc:creator>Sun, W.</dc:creator>
<dc:creator>Kukley, M.</dc:creator>
<dc:date>2026-04-03</dc:date>
<dc:identifier>doi:10.64898/2026.03.31.715637</dc:identifier>
<dc:title><![CDATA[Short-term synaptic plasticity at neuron-OPC synapses in the corpus callosum during postnatal development of mice: experimental and computational study]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2026-04-03</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.64898/2026.04.03.716324v1?rss=1">
<title>
<![CDATA[
Instability of Alpha Oscillatory States in Autism and Familial Liability: Evidence from Burst-Resolved High-Density Electroencephalography (EEG) 
]]>
</title>
<link>https://biorxiv.org/content/10.64898/2026.04.03.716324v1?rss=1</link>
<description><![CDATA[
Atypical sensory experiences are highly prevalent in autistic children and include both hyper- and hypo-responsivity, often accompanied by sensory overload. Alpha oscillations (7-13 Hz), which dynamically regulate cortical excitability, represent a plausible neural mechanism underlying these phenomena: reduced alpha activity is associated with enhanced sensory responsiveness, whereas increased alpha supports suppression of external input. Although decreased alpha power has been repeatedly reported in autism, it remains unclear whether this reduction reflects lower oscillatory amplitude or reduced temporal stability of alpha rhythms, two mechanisms with distinct neurophysiological implications. To better characterize alpha activity in autism, we examined resting-state alpha dynamics in non-autistic children (NA; n = 39), autistic children (AU; n = 52), and siblings of autistic children (SIB; n = 26), aged 8-14 years. We combined traditional broadband measures of relative alpha power, parametric separation of periodic and aperiodic activity, and single-event analyses that quantify the temporal structure of alpha oscillations. Both broadband relative alpha power and periodic alpha power were reduced in autism over parietal regions, replicating prior findings. Importantly, ordinal analyses revealed an intermediate profile in siblings, supporting a liability-related gradient of alpha alterations. However, single-event analyses demonstrated that the average amplitude of individual alpha bursts did not differ between groups. Instead, autistic children showed significantly shorter alpha burst duration and reduced alpha abundance (i.e., proportion of time occupied by rhythmic alpha episodes), with siblings again exhibiting intermediate values. Linear regression analyses confirmed that reductions in relative and periodic alpha power were primarily driven by decreased alpha abundance rather than diminished burst amplitude. These findings indicate that altered alpha activity in autism reflects reduced temporal stability and density of alpha events rather than weaker oscillatory amplitude per se. Reduced persistence of alpha rhythms may therefore represent a neural marker of altered cortical excitability and sensory regulation in autism.

Lay summaryAutistic children often experience the world differently at the sensory level, including being more easily overwhelmed by sounds, lights, or other stimuli. In this study, we looked at a type of brain activity called alpha rhythms, which help regulate how strongly the brain responds to incoming information. We found that, in autistic children, these alpha rhythms were not weaker when they occurred, but they lasted for a shorter time and happened less often. Siblings of autistic children showed an intermediate pattern. These results suggest that sensory differences in autism may be linked to less stable brain rhythms that normally help control sensory input.

Graphical Abstract

O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=158 SRC="FIGDIR/small/716324v1_ufig1.gif" ALT="Figure 1">
View larger version (32K):
org.highwire.dtl.DTLVardef@1be733dorg.highwire.dtl.DTLVardef@7fea49org.highwire.dtl.DTLVardef@1ee9124org.highwire.dtl.DTLVardef@17af139_HPS_FORMAT_FIGEXP  M_FIG C_FIG
]]></description>
<dc:creator>Vanneau, T.</dc:creator>
<dc:creator>Brittenham, C.</dc:creator>
<dc:creator>Darrell, M.</dc:creator>
<dc:creator>Quiquempoix, M.</dc:creator>
<dc:creator>Foxe, J. J.</dc:creator>
<dc:creator>Molholm, S.</dc:creator>
<dc:date>2026-04-07</dc:date>
<dc:identifier>doi:10.64898/2026.04.03.716324</dc:identifier>
<dc:title><![CDATA[Instability of Alpha Oscillatory States in Autism and Familial Liability: Evidence from Burst-Resolved High-Density Electroencephalography (EEG)]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2026-04-07</prism:publicationDate>
<prism:section></prism:section>
</item>
</rdf:RDF>
